Citrus Sinensis ID: 023609

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280
Protein Sequence
MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYRQQ
Secondary Structure (PSIPRED)
cccccccccccccccccccccccEEEEcccHHcHHHHHHHccccccHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccHHHHHcccccccccHHHHHHHHHHHHHHccccccccccHHHHHHHHHHccccccHHHHHHHcHHHHHHHHHcccccccccccccccccHHHHHHHHHHccccccccccHHHHHcccccccccccccccccccccccccccccccHHHHHHHHHHHHHHccHHHHcc
Secondary Structure Prediction (SSPRO)
cccccEEEEHHccccccHHHcccEEEEHHHHHHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEcccccEEEccHHHcEHEccHcccccccHHHHcccHHHHcccccccccHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHccccHHHHHHHcHHHHHHHccccccccccHHHccccccHHHHHHHHHHccccHHHcccHHHHHccHHHcccccHHHccccccccccccccccccHHHHHHHHHHHHcccccccccc
Coil and Loop (DISEMBL)
MDHENVVAIrdiipppqresfnDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAnvlhrdlkpsnlllnancdlkicdfglarvtsetdFMTEYVVTrwyrapelllnssdytaAIDVWSVGCIFMelmdrkplfpgrdhVHQLRLLIELigtpseaelgFLNENAKKYICqlpryqrqsftekfpnvhpsAIDLVEKMltfdprqritvedalahpylgslhdisdepvcmspfsfdfeQHALTEGQMKELIYQEALafnpeyrqq
Flexible Loop (DISEMBL)
mdhenvvairdiipppqresFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYRQQ
Low Complexity Region (SEG)
MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYRQQ
Disordered region (IsUnstruct)
******VAIRDIIP***RESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAF*******
Disordered Region (DISOPRED)
MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLP*****SFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP*****
Disordered Region (DISEMBL)
MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYRQQ
Disordered Region (DISPRO)
*DHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPE****
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYRQQ
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	280	2.2.26 [Sep-21-2011]
Q06060	394	Mitogen-activated protein	N/A	no	0.996	0.708	0.935	1e-155
Q07176	387	Mitogen-activated protein	N/A	no	0.996	0.720	0.935	1e-155
Q40532	393	Mitogen-activated protein	N/A	no	0.996	0.709	0.917	1e-153
Q84UI5	398	Mitogen-activated protein	yes	no	0.992	0.698	0.906	1e-151
Q39026	395	Mitogen-activated protein	yes	no	0.996	0.706	0.896	1e-142
Q39023	370	Mitogen-activated protein	no	no	0.989	0.748	0.762	1e-128
Q10N20	369	Mitogen-activated protein	no	no	0.992	0.753	0.745	1e-127
A2XFC8	369	Mitogen-activated protein	N/A	no	0.992	0.753	0.745	1e-127
Q39024	376	Mitogen-activated protein	no	no	0.985	0.734	0.722	1e-123
Q9M1Z5	393	Mitogen-activated protein	no	no	0.982	0.699	0.745	1e-122

>sp|Q06060|MAPK_PEA Mitogen-activated protein kinase homolog D5 OS=Pisum sativum PE=2 SV=1

 Score =  548 bits (1412), Expect = e-155,   Method: Compositional matrix adjust.
 Identities = 261/279 (93%), Positives = 271/279 (97%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRG 60
           MDHENVVAIRDI+PPPQRE FNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRG
Sbjct: 116 MDHENVVAIRDIVPPPQREVFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRG 175

Query: 61  LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL 120
           LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL
Sbjct: 176 LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL 235

Query: 121 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAK 180
           NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL+ELIGTPSEA+LGFLNENAK
Sbjct: 236 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLMELIGTPSEADLGFLNENAK 295

Query: 181 KYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISD 240
           +YI QLP Y+RQSF EKFP+VHP AIDLVEKMLTFDPRQRITVE+ALAHPYL SLHDISD
Sbjct: 296 RYIRQLPLYRRQSFQEKFPHVHPEAIDLVEKMLTFDPRQRITVENALAHPYLTSLHDISD 355

Query: 241 EPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYRQ 279
           EPVC +PFSFDFEQHALTE QMKELIY+EALAFNPEY+Q
Sbjct: 356 EPVCTTPFSFDFEQHALTEEQMKELIYREALAFNPEYQQ 394

Pisum sativum (taxid: 3888)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 4

>sp|Q07176|MMK1_MEDSA Mitogen-activated protein kinase homolog MMK1 OS=Medicago sativa GN=MMK1 PE=1 SV=1

 Score =  547 bits (1409), Expect = e-155,   Method: Compositional matrix adjust.
 Identities = 261/279 (93%), Positives = 271/279 (97%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRG 60
           MDHENVVAIRDI+PPPQRE FNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRG
Sbjct: 109 MDHENVVAIRDIVPPPQREVFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRG 168

Query: 61  LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL 120
           LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL
Sbjct: 169 LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL 228

Query: 121 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAK 180
           NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL+ELIGTPSE +LGFLNENAK
Sbjct: 229 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLMELIGTPSEDDLGFLNENAK 288

Query: 181 KYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISD 240
           +YI QLP Y+RQSF EKFP+VHP AIDLVEKMLTFDPR+RITVEDALAHPYL SLHDISD
Sbjct: 289 RYIRQLPPYRRQSFQEKFPHVHPEAIDLVEKMLTFDPRKRITVEDALAHPYLTSLHDISD 348

Query: 241 EPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYRQ 279
           EPVCM+PFSFDFEQHALTE QMKELIY+EALAFNPEY+Q
Sbjct: 349 EPVCMTPFSFDFEQHALTEEQMKELIYREALAFNPEYQQ 387

May play a role in the mitogenic induction of symbiotic root nodules on Alfalfa by Rhizobium signal molecules.

Medicago sativa (taxid: 3879)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q40532|NTF4_TOBAC Mitogen-activated protein kinase homolog NTF4 OS=Nicotiana tabacum GN=NTF4 PE=2 SV=1

 Score =  541 bits (1393), Expect = e-153,   Method: Compositional matrix adjust.
 Identities = 256/279 (91%), Positives = 270/279 (96%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRG 60
           MDHEN+VAIRDIIPPPQRE+FNDVYIAYELMDTDLHQIIRSNQ LSEEHCQYFLYQILRG
Sbjct: 114 MDHENIVAIRDIIPPPQREAFNDVYIAYELMDTDLHQIIRSNQGLSEEHCQYFLYQILRG 173

Query: 61  LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL 120
           LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL
Sbjct: 174 LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL 233

Query: 121 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAK 180
           NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL+ELIGTPSEAE+ FLNENAK
Sbjct: 234 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLMELIGTPSEAEMEFLNENAK 293

Query: 181 KYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISD 240
           +YI QLP Y+RQSF EKFP+V+P+AIDLVEKMLTFDPR+RITVEDALAHPYL SLHDISD
Sbjct: 294 RYIRQLPLYRRQSFVEKFPHVNPAAIDLVEKMLTFDPRRRITVEDALAHPYLTSLHDISD 353

Query: 241 EPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYRQ 279
           EPVCM+PF+FDFEQHALTE QMKELIY+E LAFNPEY+ 
Sbjct: 354 EPVCMTPFNFDFEQHALTEEQMKELIYREGLAFNPEYQH 392

Nicotiana tabacum (taxid: 4097)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q84UI5|MPK1_ORYSJ Mitogen-activated protein kinase 1 OS=Oryza sativa subsp. japonica GN=MPK1 PE=1 SV=1

 Score =  532 bits (1371), Expect = e-151,   Method: Compositional matrix adjust.
 Identities = 252/278 (90%), Positives = 266/278 (95%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRG 60
           MDHEN+VAIRDIIPPPQR SFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRG
Sbjct: 121 MDHENIVAIRDIIPPPQRNSFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRG 180

Query: 61  LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL 120
           LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR TSETDFMTEYVVTRWYRAPELLL
Sbjct: 181 LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSETDFMTEYVVTRWYRAPELLL 240

Query: 121 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAK 180
           NSS+YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL+ELIGTP+EA+L F+NENA+
Sbjct: 241 NSSEYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLMELIGTPNEADLDFVNENAR 300

Query: 181 KYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISD 240
           +YI QLPR+ RQSF EKFP+VHP AIDLVEKMLTFDPRQRITVE ALAHPYL SLHDISD
Sbjct: 301 RYIRQLPRHARQSFPEKFPHVHPLAIDLVEKMLTFDPRQRITVEGALAHPYLASLHDISD 360

Query: 241 EPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYR 278
           EPVC SPFSFDFEQHAL+E QMK+LIYQE LAFNP+Y+
Sbjct: 361 EPVCSSPFSFDFEQHALSEEQMKDLIYQEGLAFNPDYQ 398

Involved in sphingolipid elicitor (SE)-dependent defense signaling pathway. Acts downstream of heterotrimeric G protein alpha subunit and small GTPase RAC1. May regulate the expression of various genes involved in biotic and abiotic stress response.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q39026|MPK6_ARATH Mitogen-activated protein kinase 6 OS=Arabidopsis thaliana GN=MPK6 PE=1 SV=1

 Score =  504 bits (1299), Expect = e-142,   Method: Compositional matrix adjust.
 Identities = 250/279 (89%), Positives = 262/279 (93%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRG 60
           MDHEN+VAIRDIIPPP R +FNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRG
Sbjct: 117 MDHENIVAIRDIIPPPLRNAFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRG 176

Query: 61  LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL 120
           LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSE+DFMTEYVVTRWYRAPELLL
Sbjct: 177 LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSESDFMTEYVVTRWYRAPELLL 236

Query: 121 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAK 180
           NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL+ELIGTPSE EL FLNENAK
Sbjct: 237 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLMELIGTPSEEELEFLNENAK 296

Query: 181 KYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISD 240
           +YI QLP Y RQS T+KFP VHP AIDL+EKMLTFDPR+RITV DALAHPYL SLHDISD
Sbjct: 297 RYIRQLPPYPRQSITDKFPTVHPLAIDLIEKMLTFDPRRRITVLDALAHPYLNSLHDISD 356

Query: 241 EPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYRQ 279
           EP C  PF+FDFE HAL+E QMKELIY+EALAFNPEY+Q
Sbjct: 357 EPECTIPFNFDFENHALSEEQMKELIYREALAFNPEYQQ 395

Involved in oxidative stress-mediated signaling cascade (such as ozone). Involved in the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6) downstream of bacterial flagellin receptor FLS2. May be involved in hypersensitive response (HR)-mediated signaling cascade. May phosphorylate regulators of WRKY transcription factors. Phosphorylates 1-aminocyclopropane-1-carboxylic acid synthases (ACS2 and ACS6) and may be involved in the regulation of bacterial elicitor flagellin-induced ethylene production. Regulates locally gene-mediated and basal resitance response to certain pathogens. May be involved in the cold and salinity stress-mediated MAP kinase signaling cascade (MEKK1, MEK1/MKK2 and MPK4/MPK6).

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q39023|MPK3_ARATH Mitogen-activated protein kinase 3 OS=Arabidopsis thaliana GN=MPK3 PE=1 SV=2

 Score =  456 bits (1174), Expect = e-128,   Method: Compositional matrix adjust.
 Identities = 212/278 (76%), Positives = 245/278 (88%), Gaps = 1/278 (0%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRG 60
           +DHEN++AIRD++PPP R  F+DVYI+ ELMDTDLHQIIRSNQ+LSEEHCQYFLYQ+LRG
Sbjct: 92  LDHENIIAIRDVVPPPLRRQFSDVYISTELMDTDLHQIIRSNQSLSEEHCQYFLYQLLRG 151

Query: 61  LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL 120
           LKYIHSAN++HRDLKPSNLLLNANCDLKICDFGLAR TSE DFMTEYVVTRWYRAPELLL
Sbjct: 152 LKYIHSANIIHRDLKPSNLLLNANCDLKICDFGLARPTSENDFMTEYVVTRWYRAPELLL 211

Query: 121 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL-NENA 179
           NSSDYTAAIDVWSVGCIFMELM+RKPLFPG+DHVHQ+RLL EL+GTP+E++LGF  NE+A
Sbjct: 212 NSSDYTAAIDVWSVGCIFMELMNRKPLFPGKDHVHQMRLLTELLGTPTESDLGFTHNEDA 271

Query: 180 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDIS 239
           K+YI QLP + RQ   + F +V+P AIDLV++MLTFDP +RITVE AL H YL  LHD +
Sbjct: 272 KRYIRQLPNFPRQPLAKLFSHVNPMAIDLVDRMLTFDPNRRITVEQALNHQYLAKLHDPN 331

Query: 240 DEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEY 277
           DEP+C  PFSF+FEQ  L E Q+KE+IYQEA+A NP Y
Sbjct: 332 DEPICQKPFSFEFEQQPLDEEQIKEMIYQEAIALNPTY 369

Involved in oxidative stress-mediated signaling cascade to oxidative (such as ozone). Involved in the innate immune MAP kinase signaling cascade (MEKK1, MKK4/MKK5 and MPK3/MPK6) downstream of bacterial flagellin receptor FLS2. May be involved in hypersensitive response (HR)-mediated signaling cascade. May phosphorylate regulators of WRKY transcription factors. Mediates the phosphorylation of VIP1 and subsequent stress genes transcription in response to Agrobacterium.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q10N20|MPK5_ORYSJ Mitogen-activated protein kinase 5 OS=Oryza sativa subsp. japonica GN=MPK5 PE=1 SV=1

 Score =  454 bits (1169), Expect = e-127,   Method: Compositional matrix adjust.
 Identities = 208/279 (74%), Positives = 247/279 (88%), Gaps = 1/279 (0%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRG 60
           +DHEN++ IRD+IPPP  ++FNDVYIA ELMDTDLH IIRSNQ LSEEHCQYFLYQILRG
Sbjct: 90  LDHENIIGIRDVIPPPIPQAFNDVYIATELMDTDLHHIIRSNQELSEEHCQYFLYQILRG 149

Query: 61  LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL 120
           LKYIHSANV+HRDLKPSNLLLNANCDLKICDFGLAR +SE+D MTEYVVTRWYRAPELLL
Sbjct: 150 LKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPSSESDMMTEYVVTRWYRAPELLL 209

Query: 121 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL-NENA 179
           NS+DY+AAIDVWSVGCIFMEL++R+PLFPGRDH+HQ+RL+ E+IGTP++ ELGF+ NE+A
Sbjct: 210 NSTDYSAAIDVWSVGCIFMELINRQPLFPGRDHMHQMRLITEVIGTPTDDELGFIRNEDA 269

Query: 180 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDIS 239
           +KY+  LP+Y R++F   FP V P+A+DL+E+MLTF+P QRITVE+AL HPYL  LHDI+
Sbjct: 270 RKYMRHLPQYPRRTFASMFPRVQPAALDLIERMLTFNPLQRITVEEALDHPYLERLHDIA 329

Query: 240 DEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYR 278
           DEP+C+ PFSFDFEQ AL E QMK+LI+ EA+  NP  R
Sbjct: 330 DEPICLEPFSFDFEQKALNEDQMKQLIFNEAIEMNPNIR 368

Involved in disease resistance and abiotic stress tolerance signaling pathways. Acts as a positive regulator of drought, salt and cold tolerance. Negatively modulates pathogenesis-related (PR) gene expression and broad-spectrum disease resistance.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|A2XFC8|MPK5_ORYSI Mitogen-activated protein kinase 5 OS=Oryza sativa subsp. indica GN=MPK5 PE=1 SV=2

 Score =  454 bits (1169), Expect = e-127,   Method: Compositional matrix adjust.
 Identities = 208/279 (74%), Positives = 247/279 (88%), Gaps = 1/279 (0%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRG 60
           +DHEN++ IRD+IPPP  ++FNDVYIA ELMDTDLH IIRSNQ LSEEHCQYFLYQILRG
Sbjct: 90  LDHENIIGIRDVIPPPIPQAFNDVYIATELMDTDLHHIIRSNQELSEEHCQYFLYQILRG 149

Query: 61  LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL 120
           LKYIHSANV+HRDLKPSNLLLNANCDLKICDFGLAR +SE+D MTEYVVTRWYRAPELLL
Sbjct: 150 LKYIHSANVIHRDLKPSNLLLNANCDLKICDFGLARPSSESDMMTEYVVTRWYRAPELLL 209

Query: 121 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL-NENA 179
           NS+DY+AAIDVWSVGCIFMEL++R+PLFPGRDH+HQ+RL+ E+IGTP++ ELGF+ NE+A
Sbjct: 210 NSTDYSAAIDVWSVGCIFMELINRQPLFPGRDHMHQMRLITEVIGTPTDDELGFIRNEDA 269

Query: 180 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDIS 239
           +KY+  LP+Y R++F   FP V P+A+DL+E+MLTF+P QRITVE+AL HPYL  LHDI+
Sbjct: 270 RKYMRHLPQYPRRTFASMFPRVQPAALDLIERMLTFNPLQRITVEEALDHPYLERLHDIA 329

Query: 240 DEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYR 278
           DEP+C+ PFSFDFEQ AL E QMK+LI+ EA+  NP  R
Sbjct: 330 DEPICLEPFSFDFEQKALNEDQMKQLIFNEAIEMNPNIR 368

Involved in disease resistance and abiotic stress tolerance signaling pathways.

Oryza sativa subsp. indica (taxid: 39946)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q39024|MPK4_ARATH Mitogen-activated protein kinase 4 OS=Arabidopsis thaliana GN=MPK4 PE=1 SV=2

 Score =  441 bits (1135), Expect = e-123,   Method: Compositional matrix adjust.
 Identities = 200/277 (72%), Positives = 243/277 (87%), Gaps = 1/277 (0%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRG 60
           MDHENV+A++DII PPQRE+FNDVYI YELMDTDLHQIIRSNQ L+++HC++FLYQ+LRG
Sbjct: 97  MDHENVIAVKDIIKPPQRENFNDVYIVYELMDTDLHQIIRSNQPLTDDHCRFFLYQLLRG 156

Query: 61  LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL 120
           LKY+HSANVLHRDLKPSNLLLNANCDLK+ DFGLAR  SETDFMTEYVVTRWYRAPELLL
Sbjct: 157 LKYVHSANVLHRDLKPSNLLLNANCDLKLGDFGLARTKSETDFMTEYVVTRWYRAPELLL 216

Query: 121 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL-NENA 179
           N S+YTAAID+WSVGCI  E M R+PLFPG+D+VHQLRL+ ELIG+P ++ LGFL ++NA
Sbjct: 217 NCSEYTAAIDIWSVGCILGETMTREPLFPGKDYVHQLRLITELIGSPDDSSLGFLRSDNA 276

Query: 180 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDIS 239
           ++Y+ QLP+Y RQ+F  +FPN+   A+DL+EKML FDP +RITV++AL HPYL  LHDI+
Sbjct: 277 RRYVRQLPQYPRQNFAARFPNMSAGAVDLLEKMLVFDPSRRITVDEALCHPYLAPLHDIN 336

Query: 240 DEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPE 276
           +EPVC+ PF+FDFEQ  LTE  +KELIY+E + FNP+
Sbjct: 337 EEPVCVRPFNFDFEQPTLTEENIKELIYRETVKFNPQ 373

Involved in cortical microtubules organization and stabilization by regulating the phosphorylation state of microtubule-associated proteins such as MAP65-1. Involved in root hair development process. Negative regulator of systemic acquired resistance (SAR) and salicylic acid- (SA) mediated defense response. Required for jasmonic acid- (JA) mediated defense gene expression. May regulate activity of transcription factor controlling pathogenesis-related (PR) gene expression. Seems to act independently of the SAR regulatory protein NPR1 (Nonexpresser of PR1). Phosphorylates MKS1 and transcription factors WRKY25 and WRKY33. May be involved in the cold and salinity stress-mediated MAP kinase signaling cascade (MEKK1, MEK1/MKK2 and MPK4/MPK6). May act as negative regulator of salt tolerance.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

>sp|Q9M1Z5|MPK10_ARATH Mitogen-activated protein kinase 10 OS=Arabidopsis thaliana GN=MPK10 PE=1 SV=1

 Score =  436 bits (1122), Expect = e-122,   Method: Compositional matrix adjust.
 Identities = 205/275 (74%), Positives = 239/275 (86%)

Query: 2   DHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGL 61
           DHEN+VAIRD+I PPQR+SF DVYI  ELM+ DL++ ++S+Q L+++H  YF+YQILRGL
Sbjct: 115 DHENIVAIRDVILPPQRDSFEDVYIVNELMEFDLYRTLKSDQELTKDHGMYFMYQILRGL 174

Query: 62  KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLN 121
           KYIHSANVLHRDLKPSNLLL+  CDLKICDFGLAR T E++ MTEYVVTRWYRAPELLL 
Sbjct: 175 KYIHSANVLHRDLKPSNLLLSTQCDLKICDFGLARATPESNLMTEYVVTRWYRAPELLLG 234

Query: 122 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 181
           SSDYTAAIDVWSVGCIFME+M+R+PLFPG+D V+QLRLL+ELIGTPSE ELG L+E AK+
Sbjct: 235 SSDYTAAIDVWSVGCIFMEIMNREPLFPGKDQVNQLRLLLELIGTPSEEELGSLSEYAKR 294

Query: 182 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 241
           YI QLP   RQSFTEKFPNV P AIDLVEKMLTFDP+QRI+V++ALAHPYL S HDI+DE
Sbjct: 295 YIRQLPTLPRQSFTEKFPNVPPLAIDLVEKMLTFDPKQRISVKEALAHPYLSSFHDITDE 354

Query: 242 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPE 276
           P C  PF+FD ++H  +E Q +ELIY EALAFNPE
Sbjct: 355 PECSEPFNFDLDEHPFSEEQFRELIYCEALAFNPE 389

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 4

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	280
255567750	402	big map kinase/bmk, putative [Ricinus co	1.0	0.696	0.942	1e-155
7649153	389	mitogen-activated protein kinase [Euphor	1.0	0.719	0.935	1e-155
224095467	363	predicted protein [Populus trichocarpa]	0.996	0.768	0.931	1e-154
449452881	405	PREDICTED: mitogen-activated protein kin	1.0	0.691	0.939	1e-154
585454	394	RecName: Full=Mitogen-activated protein	0.996	0.708	0.935	1e-153
351721680	391	mitogen-activated protein kinase 2 [Glyc	0.996	0.713	0.931	1e-153
357475629	387	Mitogen-activated protein kinase [Medica	0.996	0.720	0.935	1e-153
585519	387	RecName: Full=Mitogen-activated protein	0.996	0.720	0.935	1e-153
71068415	397	mitogen-activated protein kinase 1 [Arac	0.992	0.700	0.931	1e-153
356521451	433	PREDICTED: mitogen-activated protein kin	0.996	0.644	0.931	1e-153

>gi|255567750|ref|XP_002524853.1| big map kinase/bmk, putative [Ricinus communis] gi|223535816|gb|EEF37477.1| big map kinase/bmk, putative [Ricinus communis]

 Score =  553 bits (1426), Expect = e-155,   Method: Compositional matrix adjust.
 Identities = 264/280 (94%), Positives = 273/280 (97%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRG 60
           MDHENVVAIRDIIPPP+RE FNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRG
Sbjct: 123 MDHENVVAIRDIIPPPKRELFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRG 182

Query: 61  LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL 120
           LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL
Sbjct: 183 LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL 242

Query: 121 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAK 180
           NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL+ELIGTPSEAELGFLNENAK
Sbjct: 243 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLMELIGTPSEAELGFLNENAK 302

Query: 181 KYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISD 240
           +YI QLP Y+RQSFT+KFPNVHP+AIDLVEKMLTFDPR RITVEDALAHPYL SLHDISD
Sbjct: 303 RYIRQLPLYRRQSFTDKFPNVHPAAIDLVEKMLTFDPRLRITVEDALAHPYLTSLHDISD 362

Query: 241 EPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYRQQ 280
           EPVC +PFSFDFEQHALTE QMKELIY+EALAFNPEY+QQ
Sbjct: 363 EPVCTTPFSFDFEQHALTEDQMKELIYREALAFNPEYQQQ 402

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|7649153|gb|AAF65766.1|AF242308_1 mitogen-activated protein kinase [Euphorbia esula]

 Score =  552 bits (1422), Expect = e-155,   Method: Compositional matrix adjust.
 Identities = 262/280 (93%), Positives = 272/280 (97%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRG 60
           MDHENVVAIRDI+PPPQRE FNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRG
Sbjct: 110 MDHENVVAIRDIMPPPQREVFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRG 169

Query: 61  LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL 120
           LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL
Sbjct: 170 LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL 229

Query: 121 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAK 180
           NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL+ELIGTPSE ELGFLNENAK
Sbjct: 230 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLMELIGTPSEEELGFLNENAK 289

Query: 181 KYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISD 240
           +YI Q+  ++RQSFTEKFP VHP+AIDLVEKMLTFDPRQRITVEDALAHPYL SLHDISD
Sbjct: 290 RYIRQMSVFRRQSFTEKFPTVHPAAIDLVEKMLTFDPRQRITVEDALAHPYLTSLHDISD 349

Query: 241 EPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYRQQ 280
           EPVCM+PFSFDFEQHALTE QMKELIY+EALAFNPEY+QQ
Sbjct: 350 EPVCMTPFSFDFEQHALTEEQMKELIYREALAFNPEYQQQ 389

Source: Euphorbia esula

Species: Euphorbia esula

Genus: Euphorbia

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224095467|ref|XP_002310398.1| predicted protein [Populus trichocarpa] gi|222853301|gb|EEE90848.1| predicted protein [Populus trichocarpa]

 Score =  550 bits (1418), Expect = e-154,   Method: Compositional matrix adjust.
 Identities = 260/279 (93%), Positives = 272/279 (97%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRG 60
           MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ LSEEHCQYFLYQILRG
Sbjct: 85  MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQVLSEEHCQYFLYQILRG 144

Query: 61  LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL 120
           LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL
Sbjct: 145 LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL 204

Query: 121 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAK 180
           NSSDYTAAIDVWSVGC+FMELMDRKPLFPGRDHVHQLRLL+ELIGTPSEAELGFLNENAK
Sbjct: 205 NSSDYTAAIDVWSVGCVFMELMDRKPLFPGRDHVHQLRLLMELIGTPSEAELGFLNENAK 264

Query: 181 KYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISD 240
           +YI QLP ++RQSFTEKFP VHP+AIDL+EKMLTFDPRQRITVE+ALAHPYL SLHDISD
Sbjct: 265 RYIRQLPLHRRQSFTEKFPTVHPAAIDLIEKMLTFDPRQRITVEEALAHPYLTSLHDISD 324

Query: 241 EPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYRQ 279
           EP+CM+PFSFDFEQHALTE QMKELIY+EALAFNPEY+ 
Sbjct: 325 EPICMTPFSFDFEQHALTEEQMKELIYREALAFNPEYQN 363

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449452881|ref|XP_004144187.1| PREDICTED: mitogen-activated protein kinase homolog MMK1-like [Cucumis sativus] gi|449511404|ref|XP_004163946.1| PREDICTED: mitogen-activated protein kinase homolog MMK1-like [Cucumis sativus]

 Score =  549 bits (1415), Expect = e-154,   Method: Compositional matrix adjust.
 Identities = 263/280 (93%), Positives = 270/280 (96%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRG 60
           MDHENVVAIRDIIPPP RE+FNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRG
Sbjct: 126 MDHENVVAIRDIIPPPLRETFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRG 185

Query: 61  LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL 120
           LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL
Sbjct: 186 LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL 245

Query: 121 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAK 180
           NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL+ELIGTPSEA+LGFLNENAK
Sbjct: 246 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLLELIGTPSEADLGFLNENAK 305

Query: 181 KYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISD 240
           +YI QLP Y RQSFTEKFP+VHP+AIDLVEKMLTFDP QRITVEDALAHPYL SLHDISD
Sbjct: 306 RYIRQLPHYHRQSFTEKFPHVHPAAIDLVEKMLTFDPGQRITVEDALAHPYLTSLHDISD 365

Query: 241 EPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYRQQ 280
           EPVCM+PFSFDFEQHALTE QMKELIY EALAFNPEY  Q
Sbjct: 366 EPVCMTPFSFDFEQHALTEEQMKELIYLEALAFNPEYHHQ 405

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|585454|sp|Q06060.1|MAPK_PEA RecName: Full=Mitogen-activated protein kinase homolog D5 gi|20808|emb|CAA50036.1| MAP kinase homologue [Pisum sativum]

 Score =  548 bits (1412), Expect = e-153,   Method: Compositional matrix adjust.
 Identities = 261/279 (93%), Positives = 271/279 (97%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRG 60
           MDHENVVAIRDI+PPPQRE FNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRG
Sbjct: 116 MDHENVVAIRDIVPPPQREVFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRG 175

Query: 61  LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL 120
           LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL
Sbjct: 176 LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL 235

Query: 121 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAK 180
           NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL+ELIGTPSEA+LGFLNENAK
Sbjct: 236 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLMELIGTPSEADLGFLNENAK 295

Query: 181 KYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISD 240
           +YI QLP Y+RQSF EKFP+VHP AIDLVEKMLTFDPRQRITVE+ALAHPYL SLHDISD
Sbjct: 296 RYIRQLPLYRRQSFQEKFPHVHPEAIDLVEKMLTFDPRQRITVENALAHPYLTSLHDISD 355

Query: 241 EPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYRQ 279
           EPVC +PFSFDFEQHALTE QMKELIY+EALAFNPEY+Q
Sbjct: 356 EPVCTTPFSFDFEQHALTEEQMKELIYREALAFNPEYQQ 394

Source: Pisum sativum

Species: Pisum sativum

Genus: Pisum

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|351721680|ref|NP_001235426.1| mitogen-activated protein kinase 2 [Glycine max] gi|33340593|gb|AAQ14867.1|AF329506_1 mitogen-activated protein kinase 2 [Glycine max]

 Score =  547 bits (1410), Expect = e-153,   Method: Compositional matrix adjust.
 Identities = 260/279 (93%), Positives = 271/279 (97%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRG 60
           MDHENVVAIRDI+PPPQRE FNDVYIAYELMDTDLHQIIRSNQ LSEEHCQYFLYQILRG
Sbjct: 113 MDHENVVAIRDIVPPPQREIFNDVYIAYELMDTDLHQIIRSNQGLSEEHCQYFLYQILRG 172

Query: 61  LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL 120
           LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL
Sbjct: 173 LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL 232

Query: 121 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAK 180
           NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL+ELIGTPSEA+LGFLNENAK
Sbjct: 233 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLMELIGTPSEADLGFLNENAK 292

Query: 181 KYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISD 240
           +YI QLP Y+RQSF EKFP+VHP AIDLVEKMLTFDPR+RITVEDALAHPYL SLHDISD
Sbjct: 293 RYIRQLPLYRRQSFQEKFPHVHPEAIDLVEKMLTFDPRKRITVEDALAHPYLTSLHDISD 352

Query: 241 EPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYRQ 279
           EPVCM+PF+FDFEQHALTE QMKELIY+EALAFNPEY+Q
Sbjct: 353 EPVCMTPFNFDFEQHALTEEQMKELIYREALAFNPEYQQ 391

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|357475629|ref|XP_003608100.1| Mitogen-activated protein kinase [Medicago truncatula] gi|355509155|gb|AES90297.1| Mitogen-activated protein kinase [Medicago truncatula]

 Score =  547 bits (1410), Expect = e-153,   Method: Compositional matrix adjust.
 Identities = 261/279 (93%), Positives = 270/279 (96%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRG 60
           MDHENVVAIRDI+PPPQRE FNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRG
Sbjct: 109 MDHENVVAIRDIVPPPQREVFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRG 168

Query: 61  LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL 120
           LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL
Sbjct: 169 LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL 228

Query: 121 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAK 180
           NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL+ELIGTPSE +LGFLNENAK
Sbjct: 229 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLMELIGTPSEDDLGFLNENAK 288

Query: 181 KYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISD 240
           +YI QLP Y+RQSF EKFP VHP AIDLVEKMLTFDPR+RITVEDALAHPYL SLHDISD
Sbjct: 289 RYIRQLPPYRRQSFQEKFPQVHPEAIDLVEKMLTFDPRKRITVEDALAHPYLTSLHDISD 348

Query: 241 EPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYRQ 279
           EPVCM+PFSFDFEQHALTE QMKELIY+EALAFNPEY+Q
Sbjct: 349 EPVCMTPFSFDFEQHALTEEQMKELIYREALAFNPEYQQ 387

Source: Medicago truncatula

Species: Medicago truncatula

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|585519|sp|Q07176.1|MMK1_MEDSA RecName: Full=Mitogen-activated protein kinase homolog MMK1; AltName: Full=MAP kinase ERK1; AltName: Full=MAP kinase MSK7 gi|289125|gb|AAB41548.1| MAP kinase [Medicago sativa] gi|298019|emb|CAA47099.1| MAP Kinase [Medicago sativa]

 Score =  547 bits (1409), Expect = e-153,   Method: Compositional matrix adjust.
 Identities = 261/279 (93%), Positives = 271/279 (97%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRG 60
           MDHENVVAIRDI+PPPQRE FNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRG
Sbjct: 109 MDHENVVAIRDIVPPPQREVFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRG 168

Query: 61  LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL 120
           LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL
Sbjct: 169 LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL 228

Query: 121 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAK 180
           NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL+ELIGTPSE +LGFLNENAK
Sbjct: 229 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLMELIGTPSEDDLGFLNENAK 288

Query: 181 KYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISD 240
           +YI QLP Y+RQSF EKFP+VHP AIDLVEKMLTFDPR+RITVEDALAHPYL SLHDISD
Sbjct: 289 RYIRQLPPYRRQSFQEKFPHVHPEAIDLVEKMLTFDPRKRITVEDALAHPYLTSLHDISD 348

Query: 241 EPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYRQ 279
           EPVCM+PFSFDFEQHALTE QMKELIY+EALAFNPEY+Q
Sbjct: 349 EPVCMTPFSFDFEQHALTEEQMKELIYREALAFNPEYQQ 387

Source: Medicago sativa

Species: Medicago sativa

Genus: Medicago

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|71068415|gb|AAZ23128.1| mitogen-activated protein kinase 1 [Arachis hypogaea]

 Score =  547 bits (1409), Expect = e-153,   Method: Compositional matrix adjust.
 Identities = 259/278 (93%), Positives = 271/278 (97%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRG 60
           MDHENVVAIRDI+PPPQRE+FNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRG
Sbjct: 120 MDHENVVAIRDIVPPPQREAFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRG 179

Query: 61  LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL 120
           LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET+FMTEYVVTRWYRAPELLL
Sbjct: 180 LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETNFMTEYVVTRWYRAPELLL 239

Query: 121 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAK 180
           NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL+ELIGTPSEA+LGFLNENAK
Sbjct: 240 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLMELIGTPSEADLGFLNENAK 299

Query: 181 KYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISD 240
           +YI QLP Y+RQSF EKFP VHP+AIDLVEKMLTFDPRQRITVEDALAHPYL SLHDISD
Sbjct: 300 RYIRQLPLYRRQSFQEKFPQVHPAAIDLVEKMLTFDPRQRITVEDALAHPYLTSLHDISD 359

Query: 241 EPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYR 278
           EPVCM+PF+FDFE HALTE QMKELIY+EALAFNPEY+
Sbjct: 360 EPVCMTPFNFDFEHHALTEEQMKELIYREALAFNPEYQ 397

Source: Arachis hypogaea

Species: Arachis hypogaea

Genus: Arachis

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356521451|ref|XP_003529369.1| PREDICTED: mitogen-activated protein kinase homolog MMK1-like isoform 1 [Glycine max]

 Score =  546 bits (1408), Expect = e-153,   Method: Compositional matrix adjust.
 Identities = 260/279 (93%), Positives = 271/279 (97%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRG 60
           MDHENVVAIRDI+PPPQRE FNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRG
Sbjct: 155 MDHENVVAIRDIVPPPQREIFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRG 214

Query: 61  LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL 120
           LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL
Sbjct: 215 LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL 274

Query: 121 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAK 180
           NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL+ELIGTPSEA+LGFLNENAK
Sbjct: 275 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLMELIGTPSEADLGFLNENAK 334

Query: 181 KYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISD 240
           +YI QLP Y+RQSF EKFP+VHP AIDLVEKMLTFDPR+RITVEDALAHPYL SLHDISD
Sbjct: 335 RYIRQLPLYRRQSFQEKFPHVHPEAIDLVEKMLTFDPRKRITVEDALAHPYLTSLHDISD 394

Query: 241 EPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYRQ 279
           EPVC++PFSFDFEQHALTE QMKELIY+EALAFN EY+Q
Sbjct: 395 EPVCLTPFSFDFEQHALTEEQMKELIYREALAFNLEYQQ 433

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	280
TAIR|locus:2043904	395	MPK6 "MAP kinase 6" [Arabidops	0.996	0.706	0.896	1.8e-135
TAIR|locus:2085632	370	MPK3 "mitogen-activated protei	0.989	0.748	0.762	2.6e-118
TAIR|locus:2124943	376	MPK4 "MAP kinase 4" [Arabidops	0.985	0.734	0.722	1.9e-113
TAIR|locus:2080457	393	MPK10 "MAP kinase 10" [Arabido	0.982	0.699	0.745	1.2e-111
TAIR|locus:2025341	369	MPK11 "MAP kinase 11" [Arabido	0.982	0.745	0.699	4.9e-108
TAIR|locus:2128263	376	MPK5 "MAP kinase 5" [Arabidops	0.982	0.731	0.699	1e-107
TAIR|locus:2026484	363	ATMPK13 [Arabidopsis thaliana	0.975	0.752	0.693	3.5e-107
TAIR|locus:2062897	372	MPK12 "mitogen-activated prote	0.989	0.744	0.640	8.8e-102
DICTYBASE|DDB_G0286353	529	erkA "mitogen-activated protei	0.978	0.517	0.606	4.5e-91
TAIR|locus:2053119	368	MPK7 "MAP kinase 7" [Arabidops	0.975	0.741	0.543	1.5e-83

TAIR|locus:2043904 MPK6 "MAP kinase 6" [Arabidopsis thaliana (taxid:3702)]

 Score = 1327 (472.2 bits), Expect = 1.8e-135, P = 1.8e-135
 Identities = 250/279 (89%), Positives = 262/279 (93%)

Query:     1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRG 60
             MDHEN+VAIRDIIPPP R +FNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRG
Sbjct:   117 MDHENIVAIRDIIPPPLRNAFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRG 176

Query:    61 LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL 120
             LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSE+DFMTEYVVTRWYRAPELLL
Sbjct:   177 LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSESDFMTEYVVTRWYRAPELLL 236

Query:   121 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAK 180
             NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL+ELIGTPSE EL FLNENAK
Sbjct:   237 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLMELIGTPSEEELEFLNENAK 296

Query:   181 KYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISD 240
             +YI QLP Y RQS T+KFP VHP AIDL+EKMLTFDPR+RITV DALAHPYL SLHDISD
Sbjct:   297 RYIRQLPPYPRQSITDKFPTVHPLAIDLIEKMLTFDPRRRITVLDALAHPYLNSLHDISD 356

Query:   241 EPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYRQ 279
             EP C  PF+FDFE HAL+E QMKELIY+EALAFNPEY+Q
Sbjct:   357 EPECTIPFNFDFENHALSEEQMKELIYREALAFNPEYQQ 395

GO:0005634 "nucleus" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0004707 "MAP kinase activity" evidence=ISS;IDA

GO:0006979 "response to oxidative stress" evidence=IEP

GO:0000302 "response to reactive oxygen species" evidence=IEP

GO:0042742 "defense response to bacterium" evidence=IEP

GO:0007165 "signal transduction" evidence=IC

GO:0006970 "response to osmotic stress" evidence=RCA;IDA

GO:0009723 "response to ethylene stimulus" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

GO:0009409 "response to cold" evidence=RCA;IDA

GO:0009651 "response to salt stress" evidence=IGI;RCA

GO:2000037 "regulation of stomatal complex patterning" evidence=IGI

GO:2000038 "regulation of stomatal complex development" evidence=IGI

GO:0009864 "induced systemic resistance, jasmonic acid mediated signaling pathway" evidence=IMP

GO:0042542 "response to hydrogen peroxide" evidence=IDA

GO:0009737 "response to abscisic acid stimulus" evidence=IEP;RCA

GO:0048481 "ovule development" evidence=IGI;RCA

GO:0010120 "camalexin biosynthetic process" evidence=IMP

GO:0080136 "priming of cellular response to stress" evidence=IMP

GO:0005802 "trans-Golgi network" evidence=IDA

GO:0009524 "phragmoplast" evidence=IDA

GO:0009574 "preprophase band" evidence=IDA

GO:0048364 "root development" evidence=IMP

GO:0051301 "cell division" evidence=IMP

GO:0010224 "response to UV-B" evidence=IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0000303 "response to superoxide" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0007154 "cell communication" evidence=RCA

GO:0009733 "response to auxin stimulus" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009743 "response to carbohydrate stimulus" evidence=RCA

GO:0009751 "response to salicylic acid stimulus" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0009873 "ethylene mediated signaling pathway" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0010374 "stomatal complex development" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

GO:0004672 "protein kinase activity" evidence=IDA

GO:0010229 "inflorescence development" evidence=IMP

TAIR|locus:2085632 MPK3 "mitogen-activated protein kinase 3" [Arabidopsis thaliana (taxid:3702)]

 Score = 1165 (415.2 bits), Expect = 2.6e-118, P = 2.6e-118
 Identities = 212/278 (76%), Positives = 245/278 (88%)

Query:     1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRG 60
             +DHEN++AIRD++PPP R  F+DVYI+ ELMDTDLHQIIRSNQ+LSEEHCQYFLYQ+LRG
Sbjct:    92 LDHENIIAIRDVVPPPLRRQFSDVYISTELMDTDLHQIIRSNQSLSEEHCQYFLYQLLRG 151

Query:    61 LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL 120
             LKYIHSAN++HRDLKPSNLLLNANCDLKICDFGLAR TSE DFMTEYVVTRWYRAPELLL
Sbjct:   152 LKYIHSANIIHRDLKPSNLLLNANCDLKICDFGLARPTSENDFMTEYVVTRWYRAPELLL 211

Query:   121 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL-NENA 179
             NSSDYTAAIDVWSVGCIFMELM+RKPLFPG+DHVHQ+RLL EL+GTP+E++LGF  NE+A
Sbjct:   212 NSSDYTAAIDVWSVGCIFMELMNRKPLFPGKDHVHQMRLLTELLGTPTESDLGFTHNEDA 271

Query:   180 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDIS 239
             K+YI QLP + RQ   + F +V+P AIDLV++MLTFDP +RITVE AL H YL  LHD +
Sbjct:   272 KRYIRQLPNFPRQPLAKLFSHVNPMAIDLVDRMLTFDPNRRITVEQALNHQYLAKLHDPN 331

Query:   240 DEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEY 277
             DEP+C  PFSF+FEQ  L E Q+KE+IYQEA+A NP Y
Sbjct:   332 DEPICQKPFSFEFEQQPLDEEQIKEMIYQEAIALNPTY 369

GO:0005634 "nucleus" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0006979 "response to oxidative stress" evidence=IEP;TAS

GO:0004707 "MAP kinase activity" evidence=ISS

GO:0007165 "signal transduction" evidence=IC

GO:0000169 "activation of MAPK activity involved in osmosensory signaling pathway" evidence=IDA

GO:0006970 "response to osmotic stress" evidence=RCA;IDA

GO:0004672 "protein kinase activity" evidence=IDA;TAS

GO:0009738 "abscisic acid mediated signaling pathway" evidence=TAS

GO:0005515 "protein binding" evidence=IPI

GO:0010200 "response to chitin" evidence=IEP;RCA

GO:2000037 "regulation of stomatal complex patterning" evidence=IGI

GO:2000038 "regulation of stomatal complex development" evidence=IGI

GO:0009611 "response to wounding" evidence=IEP

GO:0048481 "ovule development" evidence=IGI;RCA

GO:0010120 "camalexin biosynthetic process" evidence=IMP

GO:0009617 "response to bacterium" evidence=IEP;RCA

GO:0080136 "priming of cellular response to stress" evidence=IMP

GO:0010224 "response to UV-B" evidence=IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0001666 "response to hypoxia" evidence=RCA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009409 "response to cold" evidence=IEP;RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009814 "defense response, incompatible interaction" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0010374 "stomatal complex development" evidence=RCA

GO:0019684 "photosynthesis, light reaction" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035304 "regulation of protein dephosphorylation" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0043900 "regulation of multi-organism process" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

GO:0051707 "response to other organism" evidence=RCA

GO:0010229 "inflorescence development" evidence=IGI

TAIR|locus:2124943 MPK4 "MAP kinase 4" [Arabidopsis thaliana (taxid:3702)]

 Score = 1119 (399.0 bits), Expect = 1.9e-113, P = 1.9e-113
 Identities = 200/277 (72%), Positives = 243/277 (87%)

Query:     1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRG 60
             MDHENV+A++DII PPQRE+FNDVYI YELMDTDLHQIIRSNQ L+++HC++FLYQ+LRG
Sbjct:    97 MDHENVIAVKDIIKPPQRENFNDVYIVYELMDTDLHQIIRSNQPLTDDHCRFFLYQLLRG 156

Query:    61 LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL 120
             LKY+HSANVLHRDLKPSNLLLNANCDLK+ DFGLAR  SETDFMTEYVVTRWYRAPELLL
Sbjct:   157 LKYVHSANVLHRDLKPSNLLLNANCDLKLGDFGLARTKSETDFMTEYVVTRWYRAPELLL 216

Query:   121 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL-NENA 179
             N S+YTAAID+WSVGCI  E M R+PLFPG+D+VHQLRL+ ELIG+P ++ LGFL ++NA
Sbjct:   217 NCSEYTAAIDIWSVGCILGETMTREPLFPGKDYVHQLRLITELIGSPDDSSLGFLRSDNA 276

Query:   180 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDIS 239
             ++Y+ QLP+Y RQ+F  +FPN+   A+DL+EKML FDP +RITV++AL HPYL  LHDI+
Sbjct:   277 RRYVRQLPQYPRQNFAARFPNMSAGAVDLLEKMLVFDPSRRITVDEALCHPYLAPLHDIN 336

Query:   240 DEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPE 276
             +EPVC+ PF+FDFEQ  LTE  +KELIY+E + FNP+
Sbjct:   337 EEPVCVRPFNFDFEQPTLTEENIKELIYRETVKFNPQ 373

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0009868 "jasmonic acid and ethylene-dependent systemic resistance, jasmonic acid mediated signaling pathway" evidence=TAS

GO:0004707 "MAP kinase activity" evidence=ISS;IDA

GO:0007165 "signal transduction" evidence=IC;RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA;IMP;TAS

GO:0005515 "protein binding" evidence=IPI

GO:0009409 "response to cold" evidence=RCA;IDA

GO:0009651 "response to salt stress" evidence=RCA;IDA

GO:0006972 "hyperosmotic response" evidence=RCA;IMP

GO:0042539 "hypotonic salinity response" evidence=IDA

GO:0005737 "cytoplasm" evidence=IDA

GO:0016310 "phosphorylation" evidence=IDA

GO:0009620 "response to fungus" evidence=IMP

GO:0009861 "jasmonic acid and ethylene-dependent systemic resistance" evidence=IMP

GO:0009737 "response to abscisic acid stimulus" evidence=IEP

GO:0006468 "protein phosphorylation" evidence=IDA

GO:0043622 "cortical microtubule organization" evidence=IMP

GO:0005829 "cytosol" evidence=IDA

GO:0007112 "male meiosis cytokinesis" evidence=IMP

GO:0009555 "pollen development" evidence=IMP

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006096 "glycolysis" evidence=RCA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006833 "water transport" evidence=RCA

GO:0006970 "response to osmotic stress" evidence=RCA

GO:0007030 "Golgi organization" evidence=RCA

GO:0007154 "cell communication" evidence=RCA

GO:0009266 "response to temperature stimulus" evidence=RCA

GO:0009414 "response to water deprivation" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009611 "response to wounding" evidence=RCA

GO:0009617 "response to bacterium" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009723 "response to ethylene stimulus" evidence=RCA

GO:0009733 "response to auxin stimulus" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009753 "response to jasmonic acid stimulus" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0010374 "stomatal complex development" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035304 "regulation of protein dephosphorylation" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0042538 "hyperosmotic salinity response" evidence=RCA

GO:0042742 "defense response to bacterium" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0043900 "regulation of multi-organism process" evidence=RCA

GO:0045088 "regulation of innate immune response" evidence=RCA

GO:0046686 "response to cadmium ion" evidence=RCA

GO:0048481 "ovule development" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

GO:0051707 "response to other organism" evidence=RCA

GO:0004672 "protein kinase activity" evidence=IDA

TAIR|locus:2080457 MPK10 "MAP kinase 10" [Arabidopsis thaliana (taxid:3702)]

 Score = 1102 (393.0 bits), Expect = 1.2e-111, P = 1.2e-111
 Identities = 205/275 (74%), Positives = 239/275 (86%)

Query:     2 DHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGL 61
             DHEN+VAIRD+I PPQR+SF DVYI  ELM+ DL++ ++S+Q L+++H  YF+YQILRGL
Sbjct:   115 DHENIVAIRDVILPPQRDSFEDVYIVNELMEFDLYRTLKSDQELTKDHGMYFMYQILRGL 174

Query:    62 KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLN 121
             KYIHSANVLHRDLKPSNLLL+  CDLKICDFGLAR T E++ MTEYVVTRWYRAPELLL 
Sbjct:   175 KYIHSANVLHRDLKPSNLLLSTQCDLKICDFGLARATPESNLMTEYVVTRWYRAPELLLG 234

Query:   122 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 181
             SSDYTAAIDVWSVGCIFME+M+R+PLFPG+D V+QLRLL+ELIGTPSE ELG L+E AK+
Sbjct:   235 SSDYTAAIDVWSVGCIFMEIMNREPLFPGKDQVNQLRLLLELIGTPSEEELGSLSEYAKR 294

Query:   182 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 241
             YI QLP   RQSFTEKFPNV P AIDLVEKMLTFDP+QRI+V++ALAHPYL S HDI+DE
Sbjct:   295 YIRQLPTLPRQSFTEKFPNVPPLAIDLVEKMLTFDPKQRISVKEALAHPYLSSFHDITDE 354

Query:   242 PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPE 276
             P C  PF+FD ++H  +E Q +ELIY EALAFNPE
Sbjct:   355 PECSEPFNFDLDEHPFSEEQFRELIYCEALAFNPE 389

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007165 "signal transduction" evidence=IC

GO:0005515 "protein binding" evidence=IPI

TAIR|locus:2025341 MPK11 "MAP kinase 11" [Arabidopsis thaliana (taxid:3702)]

 Score = 1068 (381.0 bits), Expect = 4.9e-108, P = 4.9e-108
 Identities = 193/276 (69%), Positives = 239/276 (86%)

Query:     1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRG 60
             MDH+NV+AI DII PPQ ++FNDV+I YELMDTDLH IIRSNQ L+++H ++FLYQ+LRG
Sbjct:    94 MDHDNVIAIIDIIRPPQPDNFNDVHIVYELMDTDLHHIIRSNQPLTDDHSRFFLYQLLRG 153

Query:    61 LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL 120
             LKY+HSANVLHRDLKPSNLLLNANCDLKI DFGLAR  SETDFMTEYVVTRWYRAPELLL
Sbjct:   154 LKYVHSANVLHRDLKPSNLLLNANCDLKIGDFGLARTKSETDFMTEYVVTRWYRAPELLL 213

Query:   121 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL-NENA 179
             N S+YTAAID+WSVGCI  E+M R+PLFPGRD+V QLRL+ ELIG+P ++ LGFL ++NA
Sbjct:   214 NCSEYTAAIDIWSVGCILGEIMTREPLFPGRDYVQQLRLITELIGSPDDSSLGFLRSDNA 273

Query:   180 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDIS 239
             ++Y+ QLP+Y RQ+F  +FPN+  +A+DL++KML FDP +RITV++AL HPYL  LH+ +
Sbjct:   274 RRYVRQLPQYPRQNFAARFPNMSVNAVDLLQKMLVFDPNRRITVDEALCHPYLAPLHEYN 333

Query:   240 DEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 275
             +EPVC+ PF FDFEQ +LTE  +KELIY+E++ FNP
Sbjct:   334 EEPVCVRPFHFDFEQPSLTEENIKELIYRESVKFNP 369

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007165 "signal transduction" evidence=IC;RCA

GO:0009737 "response to abscisic acid stimulus" evidence=IEP

GO:0005515 "protein binding" evidence=IPI

GO:0005829 "cytosol" evidence=IDA

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0007154 "cell communication" evidence=RCA

GO:0009409 "response to cold" evidence=RCA

GO:0009414 "response to water deprivation" evidence=RCA

GO:0009581 "detection of external stimulus" evidence=RCA

GO:0009595 "detection of biotic stimulus" evidence=RCA

GO:0009611 "response to wounding" evidence=RCA

GO:0009617 "response to bacterium" evidence=RCA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0009723 "response to ethylene stimulus" evidence=RCA

GO:0009733 "response to auxin stimulus" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009753 "response to jasmonic acid stimulus" evidence=RCA

GO:0009814 "defense response, incompatible interaction" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035304 "regulation of protein dephosphorylation" evidence=RCA

GO:0042538 "hyperosmotic salinity response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0045087 "innate immune response" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2128263 MPK5 "MAP kinase 5" [Arabidopsis thaliana (taxid:3702)]

 Score = 1065 (380.0 bits), Expect = 1.0e-107, P = 1.0e-107
 Identities = 193/276 (69%), Positives = 242/276 (87%)

Query:     1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRG 60
             ++HENVV I+DII PP++E F DVYI +ELMDTDLHQIIRSNQ+L+++HCQYFLYQILRG
Sbjct:    97 LEHENVVVIKDIIRPPKKEDFVDVYIVFELMDTDLHQIIRSNQSLNDDHCQYFLYQILRG 156

Query:    61 LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL 120
             LKYIHSANVLHRDLKPSNLLLN+NCDLKI DFGLAR TSET++MTEYVVTRWYRAPELLL
Sbjct:   157 LKYIHSANVLHRDLKPSNLLLNSNCDLKITDFGLARTTSETEYMTEYVVTRWYRAPELLL 216

Query:   121 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNE-NA 179
             NSS+YT+AIDVWSVGCIF E+M R+PLFPG+D+VHQL+L+ ELIG+P  A L FL   NA
Sbjct:   217 NSSEYTSAIDVWSVGCIFAEIMTREPLFPGKDYVHQLKLITELIGSPDGASLEFLRSANA 276

Query:   180 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDIS 239
             +KY+ +LP++ RQ+F+ +FP+++ +AIDL+EKML FDP +RITVE+AL +PYL +LHD++
Sbjct:   277 RKYVKELPKFPRQNFSARFPSMNSTAIDLLEKMLVFDPVKRITVEEALCYPYLSALHDLN 336

Query:   240 DEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 275
             DEPVC + FSF FE  + TE ++KEL++ E++ FNP
Sbjct:   337 DEPVCSNHFSFHFEDPSSTEEEIKELVWLESVKFNP 372

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA;ISS

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007165 "signal transduction" evidence=IC

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0009617 "response to bacterium" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010310 "regulation of hydrogen peroxide metabolic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035304 "regulation of protein dephosphorylation" evidence=RCA

TAIR|locus:2026484 ATMPK13 [Arabidopsis thaliana (taxid:3702)]

 Score = 1060 (378.2 bits), Expect = 3.5e-107, P = 3.5e-107
 Identities = 190/274 (69%), Positives = 236/274 (86%)

Query:     1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRG 60
             MDH+NV+ I+DII  P++E F DVYI YELMDTDLHQIIRS Q L+++HCQYFLYQILRG
Sbjct:    87 MDHDNVIKIKDIIELPEKERFEDVYIVYELMDTDLHQIIRSTQTLTDDHCQYFLYQILRG 146

Query:    61 LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL 120
             LKYIHSANVLHRDLKPSNL+LN NCDLKICDFGLAR ++ET+ MTEYVVTRWYRAPELLL
Sbjct:   147 LKYIHSANVLHRDLKPSNLVLNTNCDLKICDFGLARTSNETEIMTEYVVTRWYRAPELLL 206

Query:   121 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL-NENA 179
             NSS+YT AID+WSVGCIFME++ R+ LFPG+D+V QL+L+ EL+G+P +++L FL ++NA
Sbjct:   207 NSSEYTGAIDIWSVGCIFMEILRRETLFPGKDYVQQLKLITELLGSPDDSDLDFLRSDNA 266

Query:   180 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDIS 239
             +KY+ QLP  Q+QSF EKFPN+ P A+DL EKML FDP +RITV++AL  PYL SLH+I+
Sbjct:   267 RKYVKQLPHVQKQSFREKFPNISPMALDLAEKMLVFDPSKRITVDEALKQPYLASLHEIN 326

Query:   240 DEPVCMSPFSFDFEQHALTEGQMKELIYQEALAF 273
             +EP C +PFSFDFE+ AL E  +KEL+++E+L F
Sbjct:   327 EEPTCPTPFSFDFEETALDEQDIKELVWRESLHF 360

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007165 "signal transduction" evidence=IC

GO:0005515 "protein binding" evidence=IPI

TAIR|locus:2062897 MPK12 "mitogen-activated protein kinase 12" [Arabidopsis thaliana (taxid:3702)]

 Score = 1009 (360.2 bits), Expect = 8.8e-102, P = 8.8e-102
 Identities = 178/278 (64%), Positives = 232/278 (83%)

Query:     1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRG 60
             MDHENV+ I+DI+ PPQR+ FNDVYI YELMDTDL +I+RSNQ L+ + C++ +YQ+LRG
Sbjct:    95 MDHENVITIKDIVRPPQRDIFNDVYIVYELMDTDLQRILRSNQTLTSDQCRFLVYQLLRG 154

Query:    61 LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL 120
             LKY+HSAN+LHRDL+PSN+LLN+  +LKI DFGLAR TS+TDFMTEYVVTRWYRAPELLL
Sbjct:   155 LKYVHSANILHRDLRPSNVLLNSKNELKIGDFGLARTTSDTDFMTEYVVTRWYRAPELLL 214

Query:   121 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL-NENA 179
             N S+YTAAID+WSVGCI  E+M  +PLFPG+D+VHQLRL+ EL+G+P  + LGFL ++NA
Sbjct:   215 NCSEYTAAIDIWSVGCILGEIMTGQPLFPGKDYVHQLRLITELVGSPDNSSLGFLRSDNA 274

Query:   180 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDIS 239
             ++Y+ QLPRY +Q F  +FP +  +AIDL+E+ML FDP +RI+V++AL H YL   HD++
Sbjct:   275 RRYVRQLPRYPKQQFAARFPKMPTTAIDLLERMLVFDPNRRISVDEALGHAYLSPHHDVA 334

Query:   240 DEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEY 277
              EPVC +PFSFDFE  + TE  +KELIY+E++ FNP++
Sbjct:   335 KEPVCSTPFSFDFEHPSCTEEHIKELIYKESVKFNPDH 372

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS;IDA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007165 "signal transduction" evidence=IC

GO:0005515 "protein binding" evidence=IPI

GO:0007243 "intracellular protein kinase cascade" evidence=IC

GO:0009733 "response to auxin stimulus" evidence=IMP

GO:0080026 "response to indolebutyric acid stimulus" evidence=IMP

DICTYBASE|DDB_G0286353 erkA "mitogen-activated protein kinase" [Dictyostelium discoideum (taxid:44689)]

 Score = 908 (324.7 bits), Expect = 4.5e-91, P = 4.5e-91
 Identities = 168/277 (60%), Positives = 213/277 (76%)

Query:     3 HENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLK 62
             HEN+++I+DI+ P  +E F DVYI  ELMDTDLHQII S Q LS++HCQYF+YQ+LRGLK
Sbjct:   205 HENLISIKDILKPNSKEQFEDVYIVSELMDTDLHQIITSPQPLSDDHCQYFVYQMLRGLK 264

Query:    63 YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLL 120
             +IHSANVLHRDLKPSNLL+N +C LKICD GLARV   T   FMTEYV TRWYRAPE++L
Sbjct:   265 HIHSANVLHRDLKPSNLLINEDCLLKICDLGLARVEDATHQGFMTEYVATRWYRAPEVIL 324

Query:   121 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL-GFLNENA 179
             + + YT AID+WSVGCIF EL+ RKPLF G+D++HQ+ L+IE IG+PSE ++    NE A
Sbjct:   325 SWNKYTKAIDIWSVGCIFAELLGRKPLFQGKDYIHQITLIIETIGSPSEEDICNIANEQA 384

Query:   180 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDIS 239
             +++I  +    + +F   FP  +P AIDL+E+ML FDP +R+TVE+ALAHPY  SLHD S
Sbjct:   385 RQFIRNMGNQPKVNFANMFPKANPDAIDLLERMLYFDPSKRLTVEEALAHPYFQSLHDPS 444

Query:   240 DEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPE 276
             DEP+C+  FS +FE   L    +KELIY E LA++PE
Sbjct:   445 DEPICLHKFSLNFEAWDLNRDLLKELIYNEMLAYHPE 481

GO:0030587 "sorocarp development" evidence=IMP

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0000165 "MAPK cascade" evidence=IEA

GO:0051301 "cell division" evidence=IEA

GO:0016740 "transferase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0007067 "mitosis" evidence=IEA

GO:0007049 "cell cycle" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

TAIR|locus:2053119 MPK7 "MAP kinase 7" [Arabidopsis thaliana (taxid:3702)]

 Score = 837 (299.7 bits), Expect = 1.5e-83, P = 1.5e-83
 Identities = 150/276 (54%), Positives = 210/276 (76%)

Query:     3 HENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLK 62
             HENV+A++D++ P  R SF DVY+ YELMDTDLHQII+S+Q+LS++HC+YFL+Q+LRGLK
Sbjct:    88 HENVIALKDVMLPANRSSFKDVYLVYELMDTDLHQIIKSSQSLSDDHCKYFLFQLLRGLK 147

Query:    63 YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLN 121
             Y+HSAN+LHRDLKP NLL+NANCDLKICDFGLAR +   + FMTEYVVTRWYRAPELLL 
Sbjct:   148 YLHSANILHRDLKPGNLLVNANCDLKICDFGLARTSQGNEQFMTEYVVTRWYRAPELLLC 207

Query:   122 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL-NENAK 180
               +Y  +IDVWSVGCIF E++ RKP+FPG + ++QL+L+I ++G+  E+++ F+ N  A+
Sbjct:   208 CDNYGTSIDVWSVGCIFAEILGRKPIFPGTECLNQLKLIINVVGSQQESDIRFIDNPKAR 267

Query:   181 KYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISD 240
             ++I  LP  +    +  +P  +P AIDL+++ML FDP +RI+V DAL HPY+  L D   
Sbjct:   268 RFIKSLPYSRGTHLSNLYPQANPLAIDLLQRMLVFDPTKRISVTDALLHPYMAGLFDPGS 327

Query:   241 EPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPE 276
              P    P S D +++ + E  ++E+++ E L ++PE
Sbjct:   328 NPPAHVPISLDIDEN-MEEPVIREMMWNEMLYYHPE 362

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004707 "MAP kinase activity" evidence=IEA;ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007165 "signal transduction" evidence=IC

GO:0007623 "circadian rhythm" evidence=TAS

GO:0042542 "response to hydrogen peroxide" evidence=IDA

GO:0005515 "protein binding" evidence=IPI

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q06060	MAPK_PEA	2, ., 7, ., 1, 1, ., 2, 4	0.9354	0.9964	0.7081	N/A	no
P28482	MK01_HUMAN	2, ., 7, ., 1, 1, ., 2, 4	0.5409	0.9821	0.7638	yes	no
Q84UI5	MPK1_ORYSJ	2, ., 7, ., 1, 1, ., 2, 4	0.9064	0.9928	0.6984	yes	no
P40417	ERKA_DROME	2, ., 7, ., 1, 1, ., 2, 4	0.5217	0.9642	0.6338	yes	no
P21708	MK03_RAT	2, ., 7, ., 1, 1, ., 2, 4	0.5395	0.9714	0.7157	yes	no
Q40531	NTF6_TOBAC	2, ., 7, ., 1, 1, ., 2, 4	0.7210	0.9821	0.7412	N/A	no
Q63844	MK03_MOUSE	2, ., 7, ., 1, 1, ., 2, 4	0.5395	0.9714	0.7157	yes	no
Q40532	NTF4_TOBAC	2, ., 7, ., 1, 1, ., 2, 4	0.9175	0.9964	0.7099	N/A	no
Q39026	MPK6_ARATH	2, ., 7, ., 1, 1, ., 2, 4	0.8960	0.9964	0.7063	yes	no
A2XFC8	MPK5_ORYSI	2, ., 7, ., 1, 1, ., 2, 4	0.7455	0.9928	0.7533	N/A	no
P27638	SPK1_SCHPO	2, ., 7, ., 1, 1, ., 2, 4	0.5289	0.95	0.7150	yes	no
Q07176	MMK1_MEDSA	2, ., 7, ., 1, 1, ., 2, 4	0.9354	0.9964	0.7209	N/A	no
Q40353	MMK2_MEDSA	2, ., 7, ., 1, 1, ., 2, 4	0.7111	0.9857	0.7439	N/A	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.24	0.991
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.976

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	280
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	0.0
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-166
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-148
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-132
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-124
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-122
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	1e-118
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	1e-105
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-104
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-98
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-97
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-92
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-91
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	9e-91
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	4e-90
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	3e-86
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-82
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	2e-82
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	3e-81
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	5e-79
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	8e-77
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	4e-75
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	5e-75
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-73
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	7e-72
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-69
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	3e-69
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	4e-68
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	2e-67
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-65
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	6e-65
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	9e-65
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-64
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-63
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	4e-63
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	5e-62
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	1e-61
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	3e-60
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	1e-59
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-59
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	4e-57
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	5e-57
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	4e-56
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	7e-56
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	7e-56
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	2e-55
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	5e-53
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	8e-51
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	1e-50
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	9e-50
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	7e-49
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	1e-48
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	6e-44
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	2e-42
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	2e-42
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-42
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	2e-39
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	8e-38
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	4e-36
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	1e-35
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	5e-34
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	6e-34
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-32
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	6e-32
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	5e-31
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	7e-31
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	4e-30
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	3e-28
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	6e-28
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-27
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	4e-27
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	5e-27
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-26
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	6e-25
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	1e-24
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	1e-24
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	3e-24
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	3e-24
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	3e-24
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	7e-24
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	9e-23
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-22
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	7e-22
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	5e-21
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-20
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	1e-19
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	2e-19
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	2e-19
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-19
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	4e-19
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	4e-19
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	5e-19
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	6e-19
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	8e-19
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	8e-19
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	9e-19
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-18
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-18
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	1e-18
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-18
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-18
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	3e-18
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	3e-18
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	4e-18
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	6e-18
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	7e-18
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	8e-18
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-17
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	2e-17
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	3e-17
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	3e-17
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	3e-17
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	3e-17
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	4e-17
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	4e-17
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	6e-17
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	8e-17
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-16
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-16
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-16
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-16
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	2e-16
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	3e-16
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	3e-16
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	4e-16
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	5e-16
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	1e-15
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	1e-15
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	1e-15
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	1e-15
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	1e-15
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-15
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	6e-15
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	6e-15
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	6e-15
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	7e-15
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	7e-15
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	1e-14
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	1e-14
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	1e-14
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-14
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	1e-14
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-14
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-14
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	2e-14
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-14
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-14
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	3e-14
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	4e-14
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	4e-14
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	4e-14
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	5e-14
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	5e-14
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	6e-14
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	6e-14
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	6e-14
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	7e-14
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	7e-14
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	9e-14
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	1e-13
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	1e-13
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	1e-13
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-13
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-13
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	2e-13
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	2e-13
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	3e-13
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	3e-13
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	4e-13
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	4e-13
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	4e-13
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	5e-13
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	6e-13
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	7e-13
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	8e-13
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	9e-13
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	9e-13
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	9e-13
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	1e-12
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-12
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-12
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	1e-12
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-12
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-12
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	4e-12
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	4e-12
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	4e-12
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	4e-12
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	4e-12
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	5e-12
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	7e-12
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	9e-12
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	1e-11
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	1e-11
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	1e-11
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-11
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	1e-11
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-11
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	2e-11
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-11
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-11
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-11
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-11
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	3e-11
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	4e-11
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	4e-11
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	5e-11
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	5e-11
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	5e-11
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	5e-11
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	6e-11
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	6e-11
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	7e-11
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	7e-11
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	9e-11
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-10
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	1e-10
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	1e-10
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	1e-10
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-10
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-10
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-10
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-10
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-10
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-10
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	2e-10
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-10
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	2e-10
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	3e-10
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	3e-10
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	3e-10
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	3e-10
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	3e-10
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	3e-10
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	3e-10
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	3e-10
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	6e-10
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	6e-10
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	6e-10
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	6e-10
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	6e-10
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	6e-10
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	1e-09
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-09
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	1e-09
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-09
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	2e-09
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-09
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	3e-09
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	3e-09
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	4e-09
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	4e-09
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	4e-09
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	5e-09
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	5e-09
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	5e-09
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	5e-09
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	1e-08
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	2e-08
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-08
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-08
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-08
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	2e-08
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	3e-08
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	3e-08
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	4e-08
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	4e-08
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	4e-08
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	4e-08
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	5e-08
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	5e-08
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	5e-08
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	7e-08
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	7e-08
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	7e-08
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	8e-08
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	9e-08
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	1e-07
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	1e-07
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	1e-07
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	2e-07
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-07
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-07
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	2e-07
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	3e-07
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	3e-07
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	6e-07
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	7e-07
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	1e-06
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	1e-06
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	2e-06
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	2e-06
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	2e-06
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	3e-06
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	6e-06
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-05
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	1e-05
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	2e-05
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	2e-05
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	3e-05
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	4e-05
PRK09605	535	PRK09605, PRK09605, bifunctional UGMP family prote	3e-04
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	5e-04
PRK14879	211	PRK14879, PRK14879, serine/threonine protein kinas	5e-04
TIGR03724	199	TIGR03724, arch_bud32, Kae1-associated kinase Bud3	6e-04
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	0.001
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	0.002

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score =  560 bits (1444), Expect = 0.0
 Identities = 212/277 (76%), Positives = 243/277 (87%), Gaps = 2/277 (0%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRG 60
           +DHENV+AI+DI+PPP RE+FNDVYI YELMDTDLHQIIRS+Q LS++HCQYFLYQ+LRG
Sbjct: 61  LDHENVIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRG 120

Query: 61  LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELL 119
           LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR TSE  DFMTEYVVTRWYRAPELL
Sbjct: 121 LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELL 180

Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL-NEN 178
           LN S+YT AIDVWSVGCIF EL+ RKPLFPG+D+VHQL+L+ EL+G+PSE +LGF+ NE 
Sbjct: 181 LNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEK 240

Query: 179 AKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDI 238
           A++YI  LP   RQSF   FP+ +P AIDL+EKML FDP +RITVE+ALAHPYL SLHD 
Sbjct: 241 ARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDP 300

Query: 239 SDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 275
           SDEPVC +PFSFDFE+ ALTE  +KELIY E LA++P
Sbjct: 301 SDEPVCQTPFSFDFEEDALTEEDIKELIYNEMLAYHP 337

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  463 bits (1194), Expect = e-166
 Identities = 171/275 (62%), Positives = 215/275 (78%), Gaps = 6/275 (2%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRG 60
           + HEN++ + DI+ PP  E FNDVYI  ELM+TDLH++I+S Q L+++H QYFLYQILRG
Sbjct: 56  LRHENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRG 115

Query: 61  LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVT----SETDFMTEYVVTRWYRAP 116
           LKY+HSANV+HRDLKPSN+L+N+NCDLKICDFGLAR       E  F+TEYVVTRWYRAP
Sbjct: 116 LKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAP 175

Query: 117 ELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGF-L 175
           ELLL+SS YT AID+WSVGCIF EL+ RKPLFPGRD++ QL L++E++GTPSE +L F  
Sbjct: 176 ELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFIT 235

Query: 176 NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL 235
           +E A+ Y+  LP+  ++  ++ FP   P AIDL+EKML FDP++RIT ++ALAHPYL  L
Sbjct: 236 SEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL 295

Query: 236 HDISDEPVCMSPFSFDFEQHA-LTEGQMKELIYQE 269
           HD  DEPV   PF FDF     LTE ++KELIY+E
Sbjct: 296 HDPEDEPVAKPPFDFDFFDDDELTEEELKELIYEE 330

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score =  417 bits (1073), Expect = e-148
 Identities = 166/277 (59%), Positives = 210/277 (75%), Gaps = 7/277 (2%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRG 60
             HEN++ I DII PP  ESFNDVYI  ELM+TDL+++I++ Q LS +H QYFLYQILRG
Sbjct: 60  FKHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKT-QHLSNDHIQYFLYQILRG 118

Query: 61  LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSE----TDFMTEYVVTRWYRAP 116
           LKYIHSANVLHRDLKPSNLLLN NCDLKICDFGLAR+       T F+TEYV TRWYRAP
Sbjct: 119 LKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAP 178

Query: 117 ELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL-GFL 175
           E++LNS  YT AID+WSVGCI  E++  +PLFPG+D++HQL L++ ++GTPS+ +L   +
Sbjct: 179 EIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCII 238

Query: 176 NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL 235
           +  A+ YI  LP   +  + + FPN  P A+DL++KMLTF+P +RITVE+ALAHPYL   
Sbjct: 239 SLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY 298

Query: 236 HDISDEPVCMSPFSFDFEQH-ALTEGQMKELIYQEAL 271
           HD SDEPV   PF FDFE    L + ++KELI++E +
Sbjct: 299 HDPSDEPVAEEPFPFDFELFDDLPKEKLKELIFEEIM 335

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  377 bits (970), Expect = e-132
 Identities = 156/276 (56%), Positives = 205/276 (74%), Gaps = 13/276 (4%)

Query: 3   HENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLK 62
           H+N++AIRDI+ PP  + F DVY+  +LM++DLH II S+Q L+EEH +YFLYQ+LRGLK
Sbjct: 63  HDNIIAIRDILRPPGAD-FKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLK 121

Query: 63  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR--VTSETD---FMTEYVVTRWYRAPE 117
           YIHSANV+HRDLKPSNLL+N +C+L+I DFG+AR   +S T+   FMTEYV TRWYRAPE
Sbjct: 122 YIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPE 181

Query: 118 LLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLN- 176
           LLL+  +YT AID+WSVGCIF E++ R+ LFPG+++VHQL+L++ ++G+PSE     LN 
Sbjct: 182 LLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSE---EVLNR 238

Query: 177 ---ENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLG 233
              +  +KYI  LPR Q   +++ FP   P A+DL+ +ML FDP +RITVE AL HP+L 
Sbjct: 239 IGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLA 298

Query: 234 SLHDISDEPVCMSPFSFDFEQHALTEGQMKELIYQE 269
             HD  DEP C  PF FDFE   L+  Q+KE I +E
Sbjct: 299 QYHDPDDEPTCPPPFDFDFEAIELSREQLKEAIVKE 334

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  356 bits (917), Expect = e-124
 Identities = 143/277 (51%), Positives = 187/277 (67%), Gaps = 6/277 (2%)

Query: 1   MDHENVVAIRDIIPPPQ-RESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           MDHENV+ + D+  P    E F DVY+   LM  DL+ I++  Q LS++H Q+ +YQILR
Sbjct: 71  MDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKC-QKLSDDHIQFLVYQILR 129

Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           GLKYIHSA ++HRDLKPSN+ +N +C+LKI DFGLAR T +   MT YV TRWYRAPE++
Sbjct: 130 GLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIM 187

Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLN-EN 178
           LN   Y   +D+WSVGCI  EL+  K LFPG DH+ QL+ ++ L+GTP E  L  ++ E+
Sbjct: 188 LNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSES 247

Query: 179 AKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDI 238
           A+ YI  LP+  ++ F E F   +P AIDL+EKML  DP +RIT  +ALAHPYL   HD 
Sbjct: 248 ARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDP 307

Query: 239 SDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 275
            DEPV   P+   FE   LT  + KEL+Y+E + F P
Sbjct: 308 EDEPVA-PPYDQSFESRDLTVDEWKELVYKEIMNFKP 343

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score =  351 bits (903), Expect = e-122
 Identities = 149/274 (54%), Positives = 194/274 (70%), Gaps = 10/274 (3%)

Query: 3   HENVVAIRDI-IPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGL 61
           H+N+  + D+ I  P   +FN++Y+  ELM+ DLHQIIRS Q L++ H Q F+YQIL GL
Sbjct: 61  HKNITCLYDMDIVFP--GNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGL 118

Query: 62  KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSE-----TDFMTEYVVTRWYRAP 116
           KYIHSANVLHRDLKP NLL+NA+C+LKICDFGLAR  SE       FMTEYV TRWYRAP
Sbjct: 119 KYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAP 178

Query: 117 ELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELG-FL 175
           E++L+   YT AIDVWSVGCI  EL+ RKP+F G+D+V QL  +++++GTP E  L    
Sbjct: 179 EIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIG 238

Query: 176 NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL 235
           +  A+ YI  LP   ++ F   FPN +P A+DL+EK+L FDP +RI+VE+AL HPYL   
Sbjct: 239 SPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIW 298

Query: 236 HDISDEPVCMSPFSFDFEQHALTEGQMKELIYQE 269
           HD  DEPVC  PF F FE    +  +++++I +E
Sbjct: 299 HDPDDEPVCQKPFDFSFE-SEDSMEELRDMIIEE 331

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score =  341 bits (877), Expect = e-118
 Identities = 144/281 (51%), Positives = 197/281 (70%), Gaps = 8/281 (2%)

Query: 3   HENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLK 62
           H ++V I+ I+ PP R  F D+Y+ +ELM++DLHQ+I++N  L+ EH Q+FLYQ+LR LK
Sbjct: 58  HPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALK 117

Query: 63  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV----TSETDFMTEYVVTRWYRAPEL 118
           YIH+ANV HRDLKP N+L NA+C LKICDFGLARV    T    F T+YV TRWYRAPEL
Sbjct: 118 YIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPEL 177

Query: 119 LLN-SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPS-EAELGFLN 176
             +  S YT AID+WS+GCIF E++  KPLFPG++ VHQL L+ +L+GTPS E      N
Sbjct: 178 CGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRN 237

Query: 177 ENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH 236
           E A++Y+  + + Q   F++KFPN  P A+ L+E++L FDP+ R T E+ALA PY   L 
Sbjct: 238 EKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKGLA 297

Query: 237 DISDEPVC--MSPFSFDFEQHALTEGQMKELIYQEALAFNP 275
            +  EP    ++   F+FE+  LT+  ++ELIY+E L ++P
Sbjct: 298 KVEREPSAQPITKLEFEFERRRLTKEDVRELIYREILEYHP 338

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score =  307 bits (788), Expect = e-105
 Identities = 134/268 (50%), Positives = 184/268 (68%), Gaps = 8/268 (2%)

Query: 3   HENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLK 62
           HEN++++ DI   P      D+Y   EL+ TDLH+++ S + L ++  QYFLYQILRGLK
Sbjct: 68  HENIISLSDIFISP----LEDIYFVTELLGTDLHRLLTS-RPLEKQFIQYFLYQILRGLK 122

Query: 63  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNS 122
           Y+HSA V+HRDLKPSN+L+N NCDLKICDFGLAR+      MT YV TR+YRAPE++L  
Sbjct: 123 YVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ--MTGYVSTRYYRAPEIMLTW 180

Query: 123 SDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL-NENAKK 181
             Y   +D+WS GCIF E+++ KPLFPG+DHV+Q  ++ +L+GTP +  +  + +EN  +
Sbjct: 181 QKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLR 240

Query: 182 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDE 241
           ++  LP+ +   F+EKF N  PSAIDL+EKML FDP++RI+  +ALAHPYL   HD +DE
Sbjct: 241 FVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPTDE 300

Query: 242 PVCMSPFSFDFEQHALTEGQMKELIYQE 269
           PV    F + F    L     K ++Y E
Sbjct: 301 PVAEEKFDWSFNDADLPVDTWKVMMYSE 328

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  307 bits (788), Expect = e-104
 Identities = 121/276 (43%), Positives = 178/276 (64%), Gaps = 12/276 (4%)

Query: 2   DHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGL 61
           DH N+V + ++I     E+  D+Y+ +E M+TDLH +IR+N  L + H +Y +YQ+L+ L
Sbjct: 65  DHPNIVKLLNVIKA---ENDKDIYLVFEYMETDLHAVIRAN-ILEDVHKRYIMYQLLKAL 120

Query: 62  KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD------FMTEYVVTRWYRA 115
           KYIHS NV+HRDLKPSN+LLN++C +K+ DFGLAR  SE +       +T+YV TRWYRA
Sbjct: 121 KYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRA 180

Query: 116 PELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL 175
           PE+LL S+ YT  +D+WSVGCI  E++  KPLFPG   ++QL  +IE+IG PS  ++  +
Sbjct: 181 PEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESI 240

Query: 176 NEN-AKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS 234
               A   +  LP   R+   E  P     A+DL++K+L F+P +R+T E+AL HPY+  
Sbjct: 241 KSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQ 300

Query: 235 LHDISDEPVCMSPFSFDF-EQHALTEGQMKELIYQE 269
            H+ SDEPV   P +    +   L+  + +  +Y+E
Sbjct: 301 FHNPSDEPVLPYPITIPLDDNVKLSVAEYRNKLYEE 336

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  290 bits (744), Expect = 1e-98
 Identities = 104/234 (44%), Positives = 142/234 (60%), Gaps = 7/234 (2%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQA-LSEEHCQYFLYQILR 59
           ++H N++ + D+          D+Y+ +E MDTDL+++I+  Q  L E   + +LYQ+L+
Sbjct: 55  LNHPNIIKLLDVFRHKG-----DLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQ 109

Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV-TSETDFMTEYVVTRWYRAPEL 118
           GL + HS  +LHRDLKP NLL+N    LK+ DFGLAR   S     T YVVTRWYRAPEL
Sbjct: 110 GLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPEL 169

Query: 119 LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNEN 178
           LL    Y+  +D+WSVGCIF EL+ R+PLFPG+  + QL  +   +GTP           
Sbjct: 170 LLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSL 229

Query: 179 AKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
           A+ Y    P+       + FPN  P A+DL+ +ML +DP +RIT E ALAHPY 
Sbjct: 230 ARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score =  290 bits (744), Expect = 2e-97
 Identities = 129/291 (44%), Positives = 182/291 (62%), Gaps = 26/291 (8%)

Query: 3   HENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLK 62
           H+NV++  DI+ PP  + F ++Y+  ELM +DLH+II S Q LS +H + FLYQILRGLK
Sbjct: 58  HDNVLSALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLK 117

Query: 63  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS--ETDFMTEYVVTRWYRAPELLL 120
           Y+HSA +LHRD+KP NLL+N+NC LKICDFGLARV    E+  MT+ VVT++YRAPE+L+
Sbjct: 118 YLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILM 177

Query: 121 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAK 180
            S  YT+A+D+WSVGCIF EL+ R+ LF  +  + QL L+ +L+GTPS   +    E A+
Sbjct: 178 GSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGAR 237

Query: 181 KYICQLPRYQ--RQS-FTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL----- 232
            +I + P         +T      H  A+ L+ +ML FDP +RI+  DALAHPYL     
Sbjct: 238 AHILRGPHKPPSLPVLYTLSSQATH-EAVHLLCRMLVFDPDKRISAADALAHPYLDEGRL 296

Query: 233 ---------------GSLHDISDEPVCMSPFSFDFEQHALTEGQMKELIYQ 268
                          G ++    EP    PF  ++E++  +  Q+KE ++Q
Sbjct: 297 RYHTCMCKCCYTTSGGRVYTSDFEPSANPPFDDEYEKNLTSVRQVKEELHQ 347

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score =  276 bits (708), Expect = 2e-92
 Identities = 134/277 (48%), Positives = 180/277 (64%), Gaps = 6/277 (2%)

Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           M HENV+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILR
Sbjct: 73  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 131

Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           GLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T +   MT YV TRWYRAPE++
Sbjct: 132 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIM 189

Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL-NEN 178
           LN   Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP    L  + +E+
Sbjct: 190 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 249

Query: 179 AKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDI 238
           A+ YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD 
Sbjct: 250 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 309

Query: 239 SDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 275
            DEPV   P+   FE   L   + K L Y E ++F P
Sbjct: 310 DDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 345

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  272 bits (698), Expect = 1e-91
 Identities = 93/234 (39%), Positives = 137/234 (58%), Gaps = 8/234 (3%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ-ALSEEHCQYFLYQILR 59
           + H N+V + D+I      +   +Y+ +E  D DL + +      LS    +  +YQ+LR
Sbjct: 55  LKHPNIVKLLDVIH-----TERKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLR 109

Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSETDFMTEYVVTRWYRAPEL 118
           GL Y HS  +LHRDLKP N+L+N +  LK+ DFGLAR         T  VVT WYRAPE+
Sbjct: 110 GLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEI 169

Query: 119 LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNEN 178
           LL S  Y+ A+D+WSVGCIF E++  KPLFPG   + QL  + +++GTP+E     + + 
Sbjct: 170 LLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKL 229

Query: 179 AKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
              Y    P++  +   +  P + P  IDL+ KML ++P +RI+ ++AL HPY 
Sbjct: 230 -PDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score =  272 bits (697), Expect = 9e-91
 Identities = 125/277 (45%), Positives = 182/277 (65%), Gaps = 6/277 (2%)

Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           M HENV+ + D+  P    + F+D Y+    M TDL ++++ ++ LSE+  Q+ +YQ+L+
Sbjct: 71  MKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMK-HEKLSEDRIQFLVYQMLK 129

Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           GLKYIH+A ++HRDLKP NL +N +C+LKI DFGLAR T     MT YVVTRWYRAPE++
Sbjct: 130 GLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE--MTGYVVTRWYRAPEVI 187

Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL-NEN 178
           LN   YT  +D+WSVGCI  E++  KPLF G DH+ QL  ++++ GTPS+  +  L +E+
Sbjct: 188 LNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSED 247

Query: 179 AKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDI 238
           AK Y+ +LPR++++ F    PN +P A++++EKML  D   RIT  +ALAHPY    HD 
Sbjct: 248 AKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDP 307

Query: 239 SDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 275
            DE     P+   F++   +  + K L + E L+F P
Sbjct: 308 EDETE-APPYDDSFDEVDQSLEEWKRLTFTEILSFQP 343

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score =  270 bits (692), Expect = 4e-90
 Identities = 134/277 (48%), Positives = 181/277 (65%), Gaps = 6/277 (2%)

Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           M HENV+ + D+  P    E+FN+VY+   LM  DL+ I++  Q LS+EH Q+ +YQ+LR
Sbjct: 71  MKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKC-QKLSDEHVQFLIYQLLR 129

Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           GLKYIHSA ++HRDLKPSN+ +N +C+L+I DFGLAR     D MT YV TRWYRAPE++
Sbjct: 130 GLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQAD--DEMTGYVATRWYRAPEIM 187

Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL-NEN 178
           LN   Y   +D+WSVGCI  EL+  K LFPG D++ QL+ ++E++GTPS   L  + +E+
Sbjct: 188 LNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEH 247

Query: 179 AKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDI 238
           A+KYI  LP   +Q   + F   +P AIDL+EKML  D  +RI+  +ALAHPY    HD 
Sbjct: 248 ARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDP 307

Query: 239 SDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 275
            DEP    P+    E    T  + KEL Y+E  +F P
Sbjct: 308 EDEPEA-EPYDESPENKERTIEEWKELTYEEVSSFKP 343

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score =  260 bits (667), Expect = 3e-86
 Identities = 122/277 (44%), Positives = 168/277 (60%), Gaps = 7/277 (2%)

Query: 1   MDHENVVAIRDI-IPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           M HENV+ + D+       + F D Y+    M TDL +I+     LSE+  QY +YQ+L 
Sbjct: 71  MQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIM--GHPLSEDKVQYLVYQMLC 128

Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           GLKYIHSA ++HRDLKP NL +N +C+LKI DFGLAR       MT YVVTRWYRAPE++
Sbjct: 129 GLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE--MTGYVVTRWYRAPEVI 186

Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNE-N 178
           LN   Y   +D+WSVGCI  E++  K LF G+D++ QL  ++++ G P    +  L +  
Sbjct: 187 LNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKA 246

Query: 179 AKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDI 238
           AK YI  LP+Y R+ F+  FP   P A+DL+EKML  D  +R+T  +AL HPY  S  D 
Sbjct: 247 AKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA 306

Query: 239 SDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 275
            +E     P+    E   L+  + K+ IY+E  +F+P
Sbjct: 307 DEETE-QQPYDDSLENEKLSVDEWKKHIYKEVKSFSP 342

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  249 bits (638), Expect = 1e-82
 Identities = 87/243 (35%), Positives = 141/243 (58%), Gaps = 23/243 (9%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQA-LSEEHCQYFLYQILR 59
           + H N+V +++I+    +     +Y+ +E MD DL  ++ S +   +E   + ++ Q+L 
Sbjct: 55  LRHPNIVRLKEIVTSKGK---GSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLE 111

Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS--ETDFMTEYVVTRWYRAPE 117
           GL+Y+HS  +LHRD+K SN+L+N +  LK+ DFGLAR  +   +   T  V+T WYR PE
Sbjct: 112 GLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPE 171

Query: 118 LLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNE 177
           LLL ++ Y   +D+WSVGCI  EL   KP+F G   + QL  + EL G+P         +
Sbjct: 172 LLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSP--------TD 223

Query: 178 NAKKYICQLPRYQ--------RQSFTEKFPNVH-PSAIDLVEKMLTFDPRQRITVEDALA 228
                + +LP ++        ++   E F ++  PSA+DL++K+LT DP++RI+ + AL 
Sbjct: 224 ENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283

Query: 229 HPY 231
           H Y
Sbjct: 284 HEY 286

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score =  251 bits (643), Expect = 2e-82
 Identities = 120/287 (41%), Positives = 170/287 (59%), Gaps = 24/287 (8%)

Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           ++H+N++ + ++  P +  E F DVY+  ELMD +L Q+I     L  E   Y LYQ+L 
Sbjct: 72  VNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVI--QMDLDHERMSYLLYQMLC 129

Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           G+K++HSA ++HRDLKPSN+++ ++C LKI DFGLAR    +  MT YVVTR+YRAPE++
Sbjct: 130 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 189

Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENA 179
           L    Y   +D+WSVGCI  E++    LFPG DH+ Q   +IE +GTPS+  +  L    
Sbjct: 190 LGMG-YKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTV 248

Query: 180 KKYICQLPRYQRQSFTEKFPNV-------HPS------AIDLVEKMLTFDPRQRITVEDA 226
           + Y+   P+Y   SF E FP+V         +      A DL+ KML  DP +RI+V+DA
Sbjct: 249 RNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDA 308

Query: 227 LAHPYLGSLHDISDEPVCMSPF----SFDFEQHALTEGQMKELIYQE 269
           L HPY+   +D   E     P     S D  +H + E   KELIY+E
Sbjct: 309 LQHPYINVWYD-PSEVEAPPPAPYDHSIDEREHTVEE--WKELIYKE 352

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score =  248 bits (634), Expect = 3e-81
 Identities = 110/267 (41%), Positives = 164/267 (61%), Gaps = 15/267 (5%)

Query: 1   MDHENVVAIRDIIPPPQRE---------SFNDVYIAYELMDTDLHQIIRSNQALSEEHCQ 51
           +DH+N+V + +++ P   +           N VYI  E M+TDL  ++     LSEEH +
Sbjct: 59  LDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGP-LSEEHAR 117

Query: 52  YFLYQILRGLKYIHSANVLHRDLKPSNLLLNA-NCDLKICDFGLARVT----SETDFMTE 106
            F+YQ+LRGLKYIHSANVLHRDLKP+N+ +N  +  LKI DFGLAR+     S   +++E
Sbjct: 118 LFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSE 177

Query: 107 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGT 166
            +VT+WYR+P LLL+ ++YT AID+W+ GCIF E++  KPLF G   + Q++L++E +  
Sbjct: 178 GLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPV 237

Query: 167 PSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDA 226
             E +   L      ++       R+   +  P V+P A+D +E++LTF+P  R+T E+A
Sbjct: 238 VREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEA 297

Query: 227 LAHPYLGSLHDISDEPVCMSPFSFDFE 253
           L HPY+       DEPV + PF  + E
Sbjct: 298 LMHPYMSCYSCPFDEPVSLHPFHIEDE 324

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  239 bits (612), Expect = 5e-79
 Identities = 82/233 (35%), Positives = 123/233 (52%), Gaps = 33/233 (14%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILR 59
           + H N+V + D+      E  + +Y+  E  +  DL  +++    LSE+  +++L QIL 
Sbjct: 54  LKHPNIVRLYDVF-----EDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILS 108

Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
            L+Y+HS  ++HRDLKP N+LL+ +  +K+ DFGLAR     + +T +V T  Y APE+L
Sbjct: 109 ALEYLHSKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVL 168

Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENA 179
           L    Y  A+D+WS+G I  EL+  KP FPG D   QL  L + IG P            
Sbjct: 169 LGKG-YGKAVDIWSLGVILYELLTGKPPFPGDD---QLLELFKKIGKPKP---------- 214

Query: 180 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
                         F     ++ P A DL+ K+L  DP +R+T E+AL HP+ 
Sbjct: 215 -------------PFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  235 bits (601), Expect = 8e-77
 Identities = 91/239 (38%), Positives = 131/239 (54%), Gaps = 21/239 (8%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQA-LSEEHCQYFLYQILR 59
           + H N++ + D+           + + +E M+TDL ++I+     L+    + ++   LR
Sbjct: 59  LKHPNIIGLLDVFGHKSN-----INLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLR 113

Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVT-SETDFMTEYVVTRWYRAPEL 118
           GL+Y+HS  +LHRDLKP+NLL+ ++  LK+ DFGLAR   S    MT  VVTRWYRAPEL
Sbjct: 114 GLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPEL 173

Query: 119 LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNEN 178
           L  +  Y   +D+WSVGCIF EL+ R P  PG   + QL  + E +GTP+E         
Sbjct: 174 LFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEEN----WPG 229

Query: 179 AKKYICQLPRY------QRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPY 231
                  LP Y            + FP     A+DL++++LT +P +RIT   AL HPY
Sbjct: 230 VTS----LPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPY 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  230 bits (589), Expect = 4e-75
 Identities = 92/242 (38%), Positives = 142/242 (58%), Gaps = 27/242 (11%)

Query: 3   HENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ--ALSEEHCQYFLYQILRG 60
           H N+V ++++     RE+ +++Y  +E M+ +L+Q+++  +    SE   +  +YQIL+G
Sbjct: 57  HPNIVKLKEVF----REN-DELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQG 111

Query: 61  LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL 120
           L +IH     HRDLKP NLL++    +KI DFGLAR        T+YV TRWYRAPE+LL
Sbjct: 112 LAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILL 171

Query: 121 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAE--------- 171
            S+ Y++ +D+W++GCI  EL   +PLFPG   + QL  +  ++GTP++ +         
Sbjct: 172 RSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLAS 231

Query: 172 -LGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHP 230
            LGF          + P++   S  +  PN  P AIDL++ ML +DP++R T   AL HP
Sbjct: 232 KLGF----------RFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHP 281

Query: 231 YL 232
           Y 
Sbjct: 282 YF 283

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  230 bits (588), Expect = 5e-75
 Identities = 90/243 (37%), Positives = 139/243 (57%), Gaps = 24/243 (9%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIR-SNQALSEEHCQYFLYQILR 59
             H  VV + D+ P           +  E M +DL +++R   + L E   + ++  +L+
Sbjct: 56  CQHPYVVKLLDVFPHGSG-----FVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLK 110

Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPE 117
           G+ Y+H+  ++HRDLKP+NLL++A+  LKI DFGLAR+ SE +    +  V TRWYRAPE
Sbjct: 111 GVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPE 170

Query: 118 LLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNE 177
           LL  +  Y   +D+W+VGCIF EL++  PLFPG + + QL ++   +GTP+E     L  
Sbjct: 171 LLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLT- 229

Query: 178 NAKKYICQLPRYQRQSFTEK--------FPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 229
                   LP Y + +F E         FP+  P A+DL++ +L +DP +R++  +AL H
Sbjct: 230 -------SLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282

Query: 230 PYL 232
           PY 
Sbjct: 283 PYF 285

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  225 bits (577), Expect = 2e-73
 Identities = 93/233 (39%), Positives = 135/233 (57%), Gaps = 6/233 (2%)

Query: 2   DHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIR--SNQALSEEHCQYFLYQILR 59
           +H N+V + D+   P+ +    + + +E +D DL   +       L  E  +  + Q+LR
Sbjct: 59  EHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLR 118

Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           G+ ++HS  ++HRDLKP N+L+ ++  +KI DFGLAR+ S    +T  VVT WYRAPE+L
Sbjct: 119 GVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVL 178

Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENA 179
           L SS Y   +D+WSVGCIF EL  R+PLF G     QL  + ++IG PSE E      N 
Sbjct: 179 LQSS-YATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEE---WPRNV 234

Query: 180 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
                  P Y  +SF    P +    +DL++KMLTF+P +RI+  +AL HPY 
Sbjct: 235 SLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  222 bits (568), Expect = 7e-72
 Identities = 99/236 (41%), Positives = 143/236 (60%), Gaps = 11/236 (4%)

Query: 2   DHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQII-RSNQALSEEHCQYFLYQILRG 60
            H N+V +++++      + + +Y+  E ++ DL  ++    Q   +   +  + Q+L G
Sbjct: 62  QHPNIVTVKEVV---VGSNLDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSG 118

Query: 61  LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSETDFMTEYVVTRWYRAPELL 119
           + ++H   +LHRDLK SNLLLN    LKICDFGLAR   S     T+ VVT WYRAPELL
Sbjct: 119 VAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELL 178

Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL-GFLN-E 177
           L + +Y+ AID+WSVGCIF EL+ +KPLFPG+  + QL  + +L+GTP+E    GF    
Sbjct: 179 LGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP 238

Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPS--AIDLVEKMLTFDPRQRITVEDALAHPY 231
            AKK      +Y      +KFP +  S    DL+ ++LT+DP +RI+ EDAL HPY
Sbjct: 239 GAKK--KTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPY 292

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score =  218 bits (556), Expect = 2e-69
 Identities = 116/287 (40%), Positives = 173/287 (60%), Gaps = 21/287 (7%)

Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           ++H+N++++ ++  P +  E F DVY+  ELMD +L Q+I  +  L  E   Y LYQ+L 
Sbjct: 77  VNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVI--HMELDHERMSYLLYQMLC 134

Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           G+K++HSA ++HRDLKPSN+++ ++C LKI DFGLAR       MT YVVTR+YRAPE++
Sbjct: 135 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVI 194

Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENA 179
           L    Y   +D+WSVGCI  EL+    +F G DH+ Q   +IE +GTPS   +  L    
Sbjct: 195 LGMG-YKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTV 253

Query: 180 KKYICQLPRYQRQSFTEKFPN-VHPS-----------AIDLVEKMLTFDPRQRITVEDAL 227
           + Y+   P+Y   SF E FP+ + PS           A DL+ KML  DP +RI+V++AL
Sbjct: 254 RNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEAL 313

Query: 228 AHPYLGSLHDISDE---PVCMSPFSFDFEQHALTEGQMKELIYQEAL 271
            HPY+   +D ++    P  +     +  +HA+   + KELIY+E +
Sbjct: 314 RHPYITVWYDPAEAEAPPPQIYDAQLEEREHAIE--EWKELIYKEVM 358

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  214 bits (547), Expect = 3e-69
 Identities = 81/234 (34%), Positives = 122/234 (52%), Gaps = 30/234 (12%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILR 59
           + H N+V + D       E  + +Y+  E  +  DL   +     LSE+  +    QILR
Sbjct: 55  LSHPNIVRLIDAF-----EDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILR 109

Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPEL 118
           GL+Y+HS  ++HRDLKP N+LL+ N  +KI DFGLA+   ++   +T +V T WY APE+
Sbjct: 110 GLEYLHSNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEV 169

Query: 119 LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNEN 178
           LL  + Y   +DVWS+G I  EL+  KP F G + + QL+L+  ++G P E +       
Sbjct: 170 LLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDE------ 223

Query: 179 AKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
                             K+ +    A DL++K L  DP +R T E+ L HP+ 
Sbjct: 224 -----------------PKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score =  214 bits (547), Expect = 4e-68
 Identities = 116/287 (40%), Positives = 169/287 (58%), Gaps = 21/287 (7%)

Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           ++H+N++ + ++  P +  E F DVYI  ELMD +L Q+I+    L  E   Y LYQ+L 
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLC 137

Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           G+K++HSA ++HRDLKPSN+++ ++C LKI DFGLAR    +  MT YVVTR+YRAPE++
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197

Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENA 179
           L    Y   +D+WSVGCI  E++    LFPG DH+ Q   +IE +GTP    +  L    
Sbjct: 198 LGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 256

Query: 180 KKYICQLPRYQRQSFTEKFPNV------------HPSAIDLVEKMLTFDPRQRITVEDAL 227
           + Y+   P+Y   SF + FP+V               A DL+ KML  D  +RI+V++AL
Sbjct: 257 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 316

Query: 228 AHPYLGSLHDISDE---PVCMSPFSFDFEQHALTEGQMKELIYQEAL 271
            HPY+   +D S+    P  +     D  +H + E   KELIY+E +
Sbjct: 317 QHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEE--WKELIYKEVM 361

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score =  213 bits (543), Expect = 2e-67
 Identities = 115/287 (40%), Positives = 174/287 (60%), Gaps = 21/287 (7%)

Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           ++H+N++++ ++  P +  E F DVY+  ELMD +L Q+I+    L  E   Y LYQ+L 
Sbjct: 73  VNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLC 130

Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           G+K++HSA ++HRDLKPSN+++ ++C LKI DFGLAR    +  MT YVVTR+YRAPE++
Sbjct: 131 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 190

Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENA 179
           L    Y   +D+WSVGCI  E++  K LFPGRD++ Q   +IE +GTP    +  L    
Sbjct: 191 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249

Query: 180 KKYICQLPRYQRQSFTEKFPN-VHPS-----------AIDLVEKMLTFDPRQRITVEDAL 227
           + Y+   P+Y   +F + FP+ + P+           A DL+ KML  DP +RI+V++AL
Sbjct: 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEAL 309

Query: 228 AHPYLGSLHD---ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEAL 271
            HPY+   +D   +   P  +     D  +H + E   KELIY+E +
Sbjct: 310 QHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEE--WKELIYKEVM 354

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  205 bits (523), Expect = 2e-65
 Identities = 94/234 (40%), Positives = 139/234 (59%), Gaps = 12/234 (5%)

Query: 3   HENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN---QALSEEHCQYFLYQILR 59
           HEN+V + D+I      + N + + +E MD DL + + ++    AL     + F YQ+L+
Sbjct: 57  HENIVRLHDVI-----HTENKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLK 111

Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV--TSETDFMTEYVVTRWYRAPE 117
           G+ + H   VLHRDLKP NLL+N   +LK+ DFGLAR        F  E VVT WYRAP+
Sbjct: 112 GIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNE-VVTLWYRAPD 170

Query: 118 LLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNE 177
           +LL S  Y+ +ID+WSVGCI  E++  +PLFPG ++  QL  +  ++GTP+E+    ++ 
Sbjct: 171 VLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGIS- 229

Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPY 231
              +Y    PRY  Q   + FP+  P  IDL+ ++L  +P  RI+  DAL HP+
Sbjct: 230 QLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPW 283

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  204 bits (521), Expect = 6e-65
 Identities = 97/240 (40%), Positives = 142/240 (59%), Gaps = 19/240 (7%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS--NQALSEEHCQYFLYQIL 58
           ++H N+V + D++      S N +Y+ +E +D DL + + S     L     + +LYQ+L
Sbjct: 55  LNHPNIVRLLDVV-----HSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLL 109

Query: 59  RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR---VTSETDFMTEYVVTRWYRA 115
           +G+ Y HS  VLHRDLKP NLL++    LK+ DFGLAR   V   T   T  VVT WYRA
Sbjct: 110 QGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT--YTHEVVTLWYRA 167

Query: 116 PELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEA---EL 172
           PE+LL S  Y+  +D+WS+GCIF E+++R+PLFPG   + QL  +   +GTP E     +
Sbjct: 168 PEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGV 227

Query: 173 GFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
             L +    Y    P++ RQ  ++  PN+    +DL+ KML +DP +RI+ + AL HPY 
Sbjct: 228 TSLPD----YKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score =  204 bits (520), Expect = 9e-65
 Identities = 90/235 (38%), Positives = 135/235 (57%), Gaps = 10/235 (4%)

Query: 3   HENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGL 61
           H N+V + DII    +++   V+   E +DTDL Q +      LS  + + FL+Q+LRGL
Sbjct: 62  HANIVTLHDIIH--TKKTLTLVF---EYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGL 116

Query: 62  KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLL 120
            Y H   VLHRDLKP NLL++   +LK+ DFGLAR  S  +   +  VVT WYR P++LL
Sbjct: 117 AYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLL 176

Query: 121 NSSDYTAAIDVWSVGCIFMELMDRKPLFPG-RDHVHQLRLLIELIGTPSEAELGFLNENA 179
            S++Y+ ++D+W VGCIF E+   +PLFPG  D   QL  +  ++GTP+E     ++ N 
Sbjct: 177 GSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNP 236

Query: 180 KKYICQLPRYQRQSFTEKFPNV--HPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
           +      P Y  +      P +   P   +L  K L ++P++RI+  +A+ HPY 
Sbjct: 237 EFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF 291

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score =  204 bits (520), Expect = 2e-64
 Identities = 88/254 (34%), Positives = 132/254 (51%), Gaps = 34/254 (13%)

Query: 3   HENVVAIRDII---PPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQY--FLYQI 57
           H NVV + D+    P   +     VY+    MD DL  ++  N ++     Q   ++ Q+
Sbjct: 66  HPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLL-ENPSVKLTESQIKCYMLQL 124

Query: 58  LRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV-------------TSETDFM 104
           L G+ Y+H  ++LHRD+K +N+L++    LKI DFGLAR                   + 
Sbjct: 125 LEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKY- 183

Query: 105 TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELI 164
           T  VVTRWYR PELLL    YT A+D+W +GC+F E+  R+P+  G+  + QL L+ +L 
Sbjct: 184 TNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLC 243

Query: 165 GTPSEAEL-------GFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDP 217
           GTP+E          G    ++         Y R +  E+F  + P  +DL+ K+L+ DP
Sbjct: 244 GTPTEETWPGWRSLPGCEGVHSF------TNYPR-TLEERFGKLGPEGLDLLSKLLSLDP 296

Query: 218 RQRITVEDALAHPY 231
            +R+T  DAL HPY
Sbjct: 297 YKRLTASDALEHPY 310

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  201 bits (513), Expect = 2e-63
 Identities = 90/233 (38%), Positives = 137/233 (58%), Gaps = 9/233 (3%)

Query: 3   HENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQA-LSEEHCQYFLYQILRGL 61
           H N+V +++++     +  + +++  E  + DL  ++ +     SE   +  + Q+LRGL
Sbjct: 65  HPNIVELKEVV---VGKHLDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGL 121

Query: 62  KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF-MTEYVVTRWYRAPELLL 120
           +Y+H   ++HRDLK SNLLL     LKI DFGLAR        MT  VVT WYRAPELLL
Sbjct: 122 QYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLL 181

Query: 121 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNE--N 178
             + YT AID+W+VGCI  EL+  KPL PG+  + QL L+I+L+GTP+E+     ++   
Sbjct: 182 GCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPL 241

Query: 179 AKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPY 231
             K+   LP+    +   KFP +  + + L+  +L +DP++R T E+AL   Y
Sbjct: 242 VGKFT--LPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSY 292

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  200 bits (509), Expect = 4e-63
 Identities = 90/236 (38%), Positives = 138/236 (58%), Gaps = 13/236 (5%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQA--LSEEHCQYFLYQIL 58
           ++H N+V + D+I      + N +Y+ +E +  DL + + ++    +     + +L+Q+L
Sbjct: 56  LNHPNIVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLL 110

Query: 59  RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR---VTSETDFMTEYVVTRWYRA 115
           +GL + HS  VLHRDLKP NLL+N    +K+ DFGLAR   V   T   T  VVT WYRA
Sbjct: 111 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT--YTHEVVTLWYRA 168

Query: 116 PELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL 175
           PE+LL    Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +
Sbjct: 169 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGV 228

Query: 176 NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPY 231
                 Y    P++ RQ F++  P +     DL+ +ML +DP +RI+ + ALAHP+
Sbjct: 229 TS-LPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPF 283

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  197 bits (502), Expect = 5e-62
 Identities = 78/235 (33%), Positives = 136/235 (57%), Gaps = 10/235 (4%)

Query: 3   HENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQA-LSEEHCQYFLYQILRGL 61
           HEN+V +++            +Y+ +E ++  L +++ ++   L  +  + +++Q+L+ +
Sbjct: 59  HENIVNLKEAF-----RRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAI 113

Query: 62  KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSE--TDFMTEYVVTRWYRAPELL 119
            Y HS N++HRD+KP N+L++ +  LK+CDFG AR         +T+YV TRWYRAPELL
Sbjct: 114 AYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELL 173

Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENA 179
           +  ++Y   +DVW++GCI  EL+D +PLFPG   + QL L+ + +G    +     + N 
Sbjct: 174 VGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNP 233

Query: 180 KKYICQLPR-YQRQSFTEKFPNVHPS-AIDLVEKMLTFDPRQRITVEDALAHPYL 232
           +      P   Q +S   ++P    S A+D ++  L  DP++R+T ++ L HPY 
Sbjct: 234 RFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  195 bits (498), Expect = 1e-61
 Identities = 77/233 (33%), Positives = 130/233 (55%), Gaps = 10/233 (4%)

Query: 2   DHENVVAIRDII--PPPQRESFNDVYIAYELMDTDLHQIIRSN-QALSEEHCQYFLYQIL 58
            H N++ + +++      R +       +ELMD +L+++I+   + L E+  + ++YQ+L
Sbjct: 56  PHPNILRLIEVLFDRKTGRLAL-----VFELMDMNLYELIKGRKRPLPEKRVKSYMYQLL 110

Query: 59  RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPEL 118
           + L ++H   + HRD+KP N+L+  +  LK+ DFG  R        TEY+ TRWYRAPE 
Sbjct: 111 KSLDHMHRNGIFHRDIKPENILIKDDI-LKLADFGSCRGIYSKPPYTEYISTRWYRAPEC 169

Query: 119 LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNEN 178
           LL    Y   +D+W+VGC+F E++   PLFPG + + Q+  + +++GTP    L    ++
Sbjct: 170 LLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKS 229

Query: 179 AKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPY 231
                   P  +     +  PN     +DL++K+L +DP +RIT + AL HPY
Sbjct: 230 RHMNY-NFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPY 281

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  192 bits (490), Expect = 3e-60
 Identities = 88/234 (37%), Positives = 134/234 (57%), Gaps = 10/234 (4%)

Query: 3   HENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQI---IRSNQALSEEHCQYFLYQILR 59
           H N+V ++D++    R     +Y+ +E +  DL +    +   Q +  E  + +LYQIL+
Sbjct: 58  HPNIVCLQDVLMQESR-----LYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQ 112

Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPEL 118
           G+ + HS  VLHRDLKP NLL++    +K+ DFGLAR         T  VVT WYRAPE+
Sbjct: 113 GILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEV 172

Query: 119 LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNEN 178
           LL S  Y+  +D+WS+G IF E+  +KPLF G   + QL  +  ++GTP+E     +  +
Sbjct: 173 LLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGV-TS 231

Query: 179 AKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
              Y    P++++ S      N+    +DL+EKML +DP +RI+ + AL HPY 
Sbjct: 232 LPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score =  192 bits (490), Expect = 1e-59
 Identities = 88/247 (35%), Positives = 131/247 (53%), Gaps = 28/247 (11%)

Query: 3   HENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLK 62
           HEN++ + D+        F  + +  ++M +DL +++     L+E   +  L QIL GL 
Sbjct: 79  HENIMGLVDVY---VEGDF--INLVMDIMASDLKKVVDRKIRLTESQVKCILLQILNGLN 133

Query: 63  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR---------------VTSETDFMTEY 107
            +H    +HRDL P+N+ +N+    KI DFGLAR                    + MT  
Sbjct: 134 VLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSK 193

Query: 108 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTP 167
           VVT WYRAPELL+ +  Y  A+D+WSVGCIF EL+  KPLFPG + + QL  + EL+GTP
Sbjct: 194 VVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTP 253

Query: 168 SEAELGFLNENAKKYI---CQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVE 224
           +E      N    K +    +    + +     FPN    AIDL++ +L  +P +RI+ +
Sbjct: 254 NED-----NWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAK 308

Query: 225 DALAHPY 231
           +AL H Y
Sbjct: 309 EALKHEY 315

Length = 335

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  191 bits (486), Expect = 1e-59
 Identities = 95/242 (39%), Positives = 141/242 (58%), Gaps = 10/242 (4%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEH--CQYFLYQIL 58
           M H N+V ++D++   +R     +Y+ +E +D DL + + S+   ++     + +LYQIL
Sbjct: 58  MQHGNIVRLQDVVHSEKR-----LYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQIL 112

Query: 59  RGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARVTS-ETDFMTEYVVTRWYRAP 116
           RG+ Y HS  VLHRDLKP NLL++   + LK+ DFGLAR         T  VVT WYRAP
Sbjct: 113 RGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAP 172

Query: 117 ELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLN 176
           E+LL S  Y+  +D+WSVGCIF E++++KPLFPG   + +L  +  ++GTP+E     + 
Sbjct: 173 EILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVT 232

Query: 177 ENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH 236
            +   Y    P++  +      P + P+ +DL+ KML  DP +RIT   AL H Y   L 
Sbjct: 233 -SLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLG 291

Query: 237 DI 238
           D 
Sbjct: 292 DA 293

Length = 294

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score =  184 bits (470), Expect = 4e-57
 Identities = 95/246 (38%), Positives = 137/246 (55%), Gaps = 20/246 (8%)

Query: 1   MDHENVVAIRDIIPPPQ-----RESFNDVYIAYELMDTDLHQIIRSNQA-LSEEHCQYFL 54
           ++H N+V +++I+   Q     ++     Y+ +E MD DL  ++ S     SE+H + F+
Sbjct: 63  LNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFM 122

Query: 55  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV--TSETDFMTEYVVTRW 112
            Q+L GL Y H  N LHRD+K SN+LLN    +K+ DFGLAR+  + E+   T  V+T W
Sbjct: 123 KQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLW 182

Query: 113 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEA-- 170
           YR PELLL    Y  AIDVWS GCI  EL  +KP+F     + QL L+  L G+P  A  
Sbjct: 183 YRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVW 242

Query: 171 ----ELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDA 226
               +L + N    K      +  R+   E+F  +   A+DL++ MLT DP +R T E+A
Sbjct: 243 PDVIKLPYFNTMKPK------KQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEA 296

Query: 227 LAHPYL 232
           L  P+L
Sbjct: 297 LNSPWL 302

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score =  184 bits (469), Expect = 5e-57
 Identities = 84/216 (38%), Positives = 132/216 (61%), Gaps = 11/216 (5%)

Query: 24  VYIAYELMDTDLHQIIRSN-----QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN 78
           +Y+ +E +D+DL + + SN     + L  +  + F+YQ+L+G+ + H   V+HRDLKP N
Sbjct: 81  LYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQN 140

Query: 79  LLLNANCD-LKICDFGLARV-TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 136
           LL++     LKI D GL R  +      T  +VT WYRAPE+LL S+ Y+  +D+WSVGC
Sbjct: 141 LLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGC 200

Query: 137 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL-GFLNENAKKYICQLPRYQRQSFT 195
           IF E+  ++PLFPG   + QL  + +L+GTP+E    G       +   + P+++ Q  +
Sbjct: 201 IFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSK---LRDWHEFPQWKPQDLS 257

Query: 196 EKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPY 231
              P++ P  +DL++KML +DP +RI+ + AL HPY
Sbjct: 258 RAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPY 293

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score =  182 bits (465), Expect = 4e-56
 Identities = 94/268 (35%), Positives = 140/268 (52%), Gaps = 48/268 (17%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQII---RSNQA--LSEEHCQYFLY 55
           + HENVV++ ++      +S   VY+ ++  + DL QII   R  +   +     +  L+
Sbjct: 59  LKHENVVSLVEVFLEHADKS---VYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLW 115

Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCD----LKICDFGLARVTSE--TDFMTE--Y 107
           QIL G+ Y+HS  VLHRDLKP+N+L+         +KI D GLAR+ +            
Sbjct: 116 QILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPV 175

Query: 108 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD---------HVHQLR 158
           VVT WYRAPELLL +  YT AID+W++GCIF EL+  +P+F GR+            QL 
Sbjct: 176 VVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLE 235

Query: 159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQR---QSFTEKFPN------VH------P 203
            + E++GTP+E +           I ++P Y        T+ +P+      +        
Sbjct: 236 RIFEVLGTPTEKDW--------PDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDS 287

Query: 204 SAIDLVEKMLTFDPRQRITVEDALAHPY 231
              DL+ K+L +DP +RIT E+AL HPY
Sbjct: 288 QGFDLLRKLLEYDPTKRITAEEALEHPY 315

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score =  181 bits (461), Expect = 7e-56
 Identities = 97/239 (40%), Positives = 135/239 (56%), Gaps = 11/239 (4%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEH-CQYFLYQILR 59
           + H N+V + DII      +   + + +E +D DL Q +         H  + FL+Q+LR
Sbjct: 61  LKHANIVTLHDII-----HTEKSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLR 115

Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPEL 118
           GL Y H   VLHRDLKP NLL+N   +LK+ DFGLAR  S  T   +  VVT WYR P++
Sbjct: 116 GLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDI 175

Query: 119 LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL-GFL-N 176
           LL S+DY+  ID+W VGCIF E+   +PLFPG     QL  +  ++GTP+E    G L N
Sbjct: 176 LLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN 235

Query: 177 ENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL 235
           E  K Y    P+Y+        P +     +L+ K+L F+ R+RI+ E+A+ HPY   L
Sbjct: 236 EEFKSY--NYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCL 292

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score =  182 bits (462), Expect = 7e-56
 Identities = 94/237 (39%), Positives = 137/237 (57%), Gaps = 7/237 (2%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILR 59
           + H N+V + DI+      +   + + +E +D DL Q +      +S  + + FLYQILR
Sbjct: 61  LKHANIVTLHDIV-----HTDKSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILR 115

Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPEL 118
           GL Y H   VLHRDLKP NLL+N   +LK+ DFGLAR  S  T   +  VVT WYR P++
Sbjct: 116 GLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDV 175

Query: 119 LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNEN 178
           LL SS+Y+  ID+W VGCIF E+   +PLFPG     +L L+  L+GTP+E     ++ N
Sbjct: 176 LLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSN 235

Query: 179 AKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL 235
            +      P+Y+ Q      P +    I+L+ K L ++ ++RI+ E+A+ H Y  SL
Sbjct: 236 DEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL 292

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  179 bits (457), Expect = 2e-55
 Identities = 91/243 (37%), Positives = 135/243 (55%), Gaps = 31/243 (12%)

Query: 3   HENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEH-CQYFLYQILRGL 61
           H+N+V + D++      S   + + +E  D DL +   S     +    + F++Q+L+GL
Sbjct: 58  HKNIVRLYDVL-----HSDKKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGL 112

Query: 62  KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-----VTSETDFMTEYVVTRWYRAP 116
            + HS NVLHRDLKP NLL+N N +LK+ DFGLAR     V     +  E VVT WYR P
Sbjct: 113 AFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRC---YSAE-VVTLWYRPP 168

Query: 117 ELLLNSSDYTAAIDVWSVGCIFMELMDR-KPLFPGRDHVHQLRLLIELIGTPSEAELGFL 175
           ++L  +  Y+ +ID+WS GCIF EL +  +PLFPG D   QL+ +  L+GTP        
Sbjct: 169 DVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTP-------- 220

Query: 176 NENAKKYICQLPRYQ-------RQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA 228
            E +   + +LP Y+         S     P ++ +  DL++ +L  +P QRI+ E+AL 
Sbjct: 221 TEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280

Query: 229 HPY 231
           HPY
Sbjct: 281 HPY 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score =  174 bits (441), Expect = 5e-53
 Identities = 87/234 (37%), Positives = 133/234 (56%), Gaps = 7/234 (2%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILR 59
           + H N+V + DII      +   + + +E +D+DL Q + +    +S  + + F++Q+LR
Sbjct: 60  LKHANIVTLHDII-----HTERCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLR 114

Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPEL 118
           GL Y H   +LHRDLKP NLL+N   +LK+ DFGLAR  S  T   +  VVT WYR P++
Sbjct: 115 GLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDV 174

Query: 119 LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNEN 178
           LL S++Y+  ID+W VGCI  E+   +P+FPG     +L L+  L+GTP+E     +  N
Sbjct: 175 LLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSN 234

Query: 179 AKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
            +      P+Y+ Q      P +    IDL+  +L ++ + RI+ E AL H Y 
Sbjct: 235 EEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF 288

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  168 bits (427), Expect = 8e-51
 Identities = 76/233 (32%), Positives = 133/233 (57%), Gaps = 10/233 (4%)

Query: 3   HENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGL 61
           H N+V + ++    ++     +++ +E  D T L+++ ++ + + E   +  ++Q L+ +
Sbjct: 59  HPNLVNLIEVFRRKRK-----LHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAV 113

Query: 62  KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM-TEYVVTRWYRAPELLL 120
            + H  N +HRD+KP N+L+     +K+CDFG AR+ +      T+YV TRWYRAPELL+
Sbjct: 114 NFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLV 173

Query: 121 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIG--TPSEAELGFLNEN 178
             + Y   +DVW++GC+F EL+  +PL+PG+  V QL L+ + +G   P   ++   N+ 
Sbjct: 174 GDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQF 233

Query: 179 AKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPY 231
            K      P   R+    KFPN+   A+  ++  L  DP +R++ E+ L HPY
Sbjct: 234 FKGLSIPEPE-TREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPY 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  167 bits (425), Expect = 1e-50
 Identities = 78/232 (33%), Positives = 133/232 (57%), Gaps = 8/232 (3%)

Query: 3   HENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGL 61
           HEN+V + ++    +R     +Y+ +E +D T L  + +    L E   + +L+QILRG+
Sbjct: 59  HENLVNLIEVFRRKKR-----LYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGI 113

Query: 62  KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSETDFMTEYVVTRWYRAPELLL 120
           ++ HS N++HRD+KP N+L++ +  +K+CDFG AR + +  +  T+YV TRWYRAPELL+
Sbjct: 114 EFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLV 173

Query: 121 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAK 180
             + Y  A+D+W+VGC+  E++  +PLFPG   + QL  +I+ +G           +N  
Sbjct: 174 GDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPL 233

Query: 181 KYICQLPRYQ-RQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPY 231
               +LP  +  +   ++FP +    +DL ++ L  DP  R +    L H +
Sbjct: 234 FAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEF 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score =  165 bits (419), Expect = 9e-50
 Identities = 92/245 (37%), Positives = 139/245 (56%), Gaps = 26/245 (10%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQ-IIRSNQALSEEHCQYFLYQILR 59
           + H N+V + DII   +  +F      +E M TDL Q +I+    L   + + F++Q+LR
Sbjct: 60  LKHANIVLLHDIIHTKETLTF-----VFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLR 114

Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPEL 118
           GL YIH  ++LHRDLKP NLL++   +LK+ DFGLAR  S  +   +  VVT WYR P++
Sbjct: 115 GLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDV 174

Query: 119 LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHV-HQLRLLIELIGTPSEAELGFLNE 177
           LL ++DY++A+D+W  GCIF+E++  +P FPG   V  QL  +  ++G P+        E
Sbjct: 175 LLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPT--------E 226

Query: 178 NAKKYICQLPRYQRQSFT-EKFPNVH---------PSAIDLVEKMLTFDPRQRITVEDAL 227
           +    + +LP Y+ + F   K   +          P A DL  +ML   P+ RI+ +DAL
Sbjct: 227 DTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDAL 286

Query: 228 AHPYL 232
            HPY 
Sbjct: 287 LHPYF 291

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score =  163 bits (413), Expect = 7e-49
 Identities = 87/233 (37%), Positives = 127/233 (54%), Gaps = 6/233 (2%)

Query: 2   DHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQA--LSEEHCQYFLYQILR 59
           DH N+V + D+    + +    V + +E +D DL   +       L  E  +  + Q LR
Sbjct: 60  DHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLR 119

Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           GL ++H+  ++HRDLKP N+L+ +   +K+ DFGLAR+ S    +T  VVT WYRAPE+L
Sbjct: 120 GLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVL 179

Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENA 179
           L S+ Y   +D+WSVGCIF E+  RKPLF G     QL  + +LIG P E +  +  +  
Sbjct: 180 LQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD--WPRDVT 236

Query: 180 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
                  PR  R       P +  S   L+ +MLTF+P +RI+   AL HP+ 
Sbjct: 237 LPRGAFSPRGPR-PVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score =  163 bits (414), Expect = 1e-48
 Identities = 85/249 (34%), Positives = 126/249 (50%), Gaps = 29/249 (11%)

Query: 3   HENVVAIRDII---PPPQRESFNDVYIAYELMDTDLHQIIRSNQAL--SEEHCQYFLYQI 57
           HENVV + +I      P        Y+ +E  + DL  ++ SN+ +  +    +  +  +
Sbjct: 70  HENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLL-SNKNVKFTLSEIKKVMKML 128

Query: 58  LRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET-----DFMTEYVVTRW 112
           L GL YIH   +LHRD+K +N+L+  +  LK+ DFGLAR  S +     +  T  VVT W
Sbjct: 129 LNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLW 188

Query: 113 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIG--TPSEA 170
           YR PELLL   DY   ID+W  GCI  E+  R P+  G    HQL L+ +L G  TP   
Sbjct: 189 YRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPE-- 246

Query: 171 ELGFLNENAKKY----ICQLPRYQRQSFTEK----FPNVHPSAIDLVEKMLTFDPRQRIT 222
               +     K       +LP+ Q++   E+      + H  A+DL++K+L  DP +RI 
Sbjct: 247 ----VWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPH--ALDLIDKLLVLDPAKRID 300

Query: 223 VEDALAHPY 231
            + AL H +
Sbjct: 301 ADTALNHDF 309

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score =  150 bits (380), Expect = 6e-44
 Identities = 87/232 (37%), Positives = 133/232 (57%), Gaps = 6/232 (2%)

Query: 2   DHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS--NQALSEEHCQYFLYQILR 59
           +H NVV + D+    + +    + + +E +D DL   +       +  E  +  ++Q+LR
Sbjct: 62  EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLR 121

Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           GL ++HS  V+HRDLKP N+L+ ++  +K+ DFGLAR+ S    +T  VVT WYRAPE+L
Sbjct: 122 GLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVL 181

Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENA 179
           L SS Y   +D+WSVGCIF E+  RKPLF G   V QL  ++++IG P E +  +  + A
Sbjct: 182 LQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED--WPRDVA 238

Query: 180 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPY 231
                   +   Q   +   ++     DL+ K LTF+P +RI+   AL+HPY
Sbjct: 239 LPRQAFHSK-SAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 289

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score =  150 bits (379), Expect = 2e-42
 Identities = 77/200 (38%), Positives = 119/200 (59%), Gaps = 4/200 (2%)

Query: 40  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANC-DLKICDFGLARVT 98
           R+N AL     + + YQ+ R L YIHS  + HRDLKP NLL++ N   LK+CDFG A+  
Sbjct: 162 RNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNL 221

Query: 99  SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR 158
                   Y+ +R+YRAPEL+L +++YT  ID+WS+GCI  E++   P+F G+  V QL 
Sbjct: 222 LAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLV 281

Query: 159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHP-SAIDLVEKMLTFDP 217
            +I+++GTP+E +L  +N N      + P  + +   + FP   P  AI+ + + L ++P
Sbjct: 282 RIIQVLGTPTEDQLKEMNPNYAD--IKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEP 339

Query: 218 RQRITVEDALAHPYLGSLHD 237
            +R+   +ALA P+   L D
Sbjct: 340 LKRLNPIEALADPFFDDLRD 359

Length = 440

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score =  146 bits (370), Expect = 2e-42
 Identities = 90/249 (36%), Positives = 137/249 (55%), Gaps = 28/249 (11%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQA-LSEEHCQYFLYQILR 59
           + H N+V + DII      +   + + +E + TDL Q +  +   L  E+ + FL+Q+LR
Sbjct: 60  LKHANIVLLHDII-----HTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLR 114

Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPEL 118
           GL YIH   +LHRDLKP NLL++   +LK+ DFGLAR  S  +   +  VVT WYR P++
Sbjct: 115 GLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDV 174

Query: 119 LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPG-RDHVHQLRLLIELIGTPSEAELGFLNE 177
           LL S++Y+  +D+W VGCIF+E++     FPG +D   QL  +  ++GTP        NE
Sbjct: 175 LLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTP--------NE 226

Query: 178 NAKKYICQLPRYQRQSFT-----------EKFPNVHPSAIDLVEKMLTFDPRQRITVEDA 226
           +    +  LP ++ + FT            K   V+  A DL  K+L   P+ R++ + A
Sbjct: 227 DTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVN-HAEDLASKLLQCFPKNRLSAQAA 285

Query: 227 LAHPYLGSL 235
           L+H Y   L
Sbjct: 286 LSHEYFSDL 294

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  143 bits (364), Expect = 2e-42
 Identities = 53/147 (36%), Positives = 86/147 (58%), Gaps = 9/147 (6%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQA-LSEEHCQYFLYQIL 58
           ++H N+V +  +      E  N +Y+  E  +   L  +++ N+  LSE+     L QIL
Sbjct: 48  LNHPNIVKLYGVF-----EDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQIL 102

Query: 59  RGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLAR-VTSETDFMTEYVVTRWYRAP 116
            GL+Y+HS  ++HRDLKP N+LL+++   +K+ DFGL++ +TS+   +   V T  Y AP
Sbjct: 103 EGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAP 162

Query: 117 ELLLNSSDYTAAIDVWSVGCIFMELMD 143
           E+LL    Y+   D+WS+G I  EL +
Sbjct: 163 EVLLGKGYYSEKSDIWSLGVILYELPE 189

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score =  138 bits (349), Expect = 2e-39
 Identities = 73/213 (34%), Positives = 122/213 (57%), Gaps = 8/213 (3%)

Query: 24  VYIAYELMDTDLHQIIRS--NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 81
           +Y+ +E ++ ++ +++    N    E+  + ++YQ+++ + + H  +++HRD+KP NLL+
Sbjct: 75  LYLVFEYVEKNMLELLEEMPNGVPPEK-VRSYIYQLIKAIHWCHKNDIVHRDIKPENLLI 133

Query: 82  NANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFM 139
           + N  LK+CDFG AR  SE      TEYV TRWYR+PELLL +  Y  A+D+WSVGCI  
Sbjct: 134 SHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAP-YGKAVDMWSVGCILG 192

Query: 140 ELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQR-QSFTEKF 198
           EL D +PLFPG   + QL  + +++G     ++     N + +  + P     QS   ++
Sbjct: 193 ELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRY 252

Query: 199 PNVHPSA-IDLVEKMLTFDPRQRITVEDALAHP 230
             +     +DL++ +L  +P  R   E  L HP
Sbjct: 253 LGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHP 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  133 bits (338), Expect = 8e-38
 Identities = 56/201 (27%), Positives = 95/201 (47%), Gaps = 31/201 (15%)

Query: 35  LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL 94
           L  +++    L E   + +  QIL GL Y+HS  ++HRD+K +N+L++++  +K+ DFG 
Sbjct: 88  LSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGC 147

Query: 95  ARV--TSETDFMTEYVV-TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGR 151
           A+     ET   T  V  T ++ APE ++   +Y  A D+WS+GC  +E+   KP +   
Sbjct: 148 AKRLGDIETGEGTGSVRGTPYWMAPE-VIRGEEYGRAADIWSLGCTVIEMATGKPPWSEL 206

Query: 152 DHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEK 211
            +       I   G P                 ++P            ++   A D + K
Sbjct: 207 GNPMAALYKIGSSGEPP----------------EIP-----------EHLSEEAKDFLRK 239

Query: 212 MLTFDPRQRITVEDALAHPYL 232
            L  DP++R T ++ L HP+L
Sbjct: 240 CLRRDPKKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  129 bits (326), Expect = 4e-36
 Identities = 68/242 (28%), Positives = 111/242 (45%), Gaps = 49/242 (20%)

Query: 1   MDHENVVAIRDIIPPPQRESFND---VYIAYELMD-TDLHQIIRS----NQALSEEHCQY 52
           ++H N++           ESF +   + I  E  D  DL Q I+      +   EE    
Sbjct: 56  LNHPNIIKYY--------ESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILD 107

Query: 53  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVV-TR 111
           +  Q+   LKY+HS  +LHRD+KP N+ L +N  +K+ DFG+++V S T  + + VV T 
Sbjct: 108 WFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTP 167

Query: 112 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAE 171
           +Y +PEL  N   Y    D+WS+GC+  EL   K  F G +++ +L L I          
Sbjct: 168 YYLSPELCQNKP-YNYKSDIWSLGCVLYELCTLKHPFEG-ENLLELALKI---------- 215

Query: 172 LGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAI-DLVEKMLTFDPRQRITVEDALAHP 230
                              +  +    P+ + S + +LV  +L  DP +R ++   L  P
Sbjct: 216 ------------------LKGQY-PPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSP 256

Query: 231 YL 232
           ++
Sbjct: 257 FI 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  131 bits (328), Expect = 1e-35
 Identities = 64/264 (24%), Positives = 110/264 (41%), Gaps = 36/264 (13%)

Query: 2   DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ---ALSEEHCQYFLYQI 57
              N+V + D       +    +Y+  E +D   L  +++       LSE    + L QI
Sbjct: 56  HPPNIVKLYDFF-----QDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQI 110

Query: 58  LRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDFGLARVTSETD-------FMTEYVV 109
           L  L+Y+HS  ++HRD+KP N+LL+ +   +K+ DFGLA++  +           +  V 
Sbjct: 111 LSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVG 170

Query: 110 TRWYRAPELLLNSSD--YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTP 167
           T  Y APE+LL  S    +++ D+WS+G    EL+   P F G  +       +++I   
Sbjct: 171 TPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKII--- 227

Query: 168 SEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDAL 227
                              P             +  +A DL++K+L  DP+ R++    L
Sbjct: 228 --------------LELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDL 273

Query: 228 AHPYLGSLHDISDEPVCMSPFSFD 251
           +H  L  L     +   +      
Sbjct: 274 SHDLLAHLKLKESDLSDLLKPDDS 297

Length = 384

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score =  125 bits (314), Expect = 5e-34
 Identities = 89/270 (32%), Positives = 137/270 (50%), Gaps = 45/270 (16%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQA---------LSEEHCQ 51
           + H NV+A++ +       S   V++ ++  + DL  II+ ++A         L     +
Sbjct: 55  LKHPNVIALQKVF---LSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVK 111

Query: 52  YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD----LKICDFGLARVTSET----DF 103
             LYQIL G+ Y+H+  VLHRDLKP+N+L+         +KI D G AR+ +        
Sbjct: 112 SLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLAD 171

Query: 104 MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD---------HV 154
           +   VVT WYRAPELLL +  YT AID+W++GCIF EL+  +P+F  R          H 
Sbjct: 172 LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHH 231

Query: 155 HQLRLLIELIGTPSEAELGFLNENAKK---YICQLPRYQRQSFTE----KFPNVHPSAID 207
            QL  +  ++G P++ +     E+ +K   Y      ++R ++      K+   H    D
Sbjct: 232 DQLDRIFSVMGFPADKDW----EDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPD 287

Query: 208 -----LVEKMLTFDPRQRITVEDALAHPYL 232
                L++K+LT DP +RIT E AL  PY 
Sbjct: 288 SKVFLLLQKLLTMDPTKRITSEQALQDPYF 317

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score =  125 bits (314), Expect = 6e-34
 Identities = 87/270 (32%), Positives = 139/270 (51%), Gaps = 45/270 (16%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQA---------LSEEHCQ 51
           + H NV++++ +       +   V++ ++  + DL  II+ ++A         L     +
Sbjct: 55  LKHPNVISLQKVF---LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVK 111

Query: 52  YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD----LKICDFGLARVTSET----DF 103
             LYQIL G+ Y+H+  VLHRDLKP+N+L+         +KI D G AR+ +        
Sbjct: 112 SLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLAD 171

Query: 104 MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD---------HV 154
           +   VVT WYRAPELLL +  YT AID+W++GCIF EL+  +P+F  R          H 
Sbjct: 172 LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHH 231

Query: 155 HQLRLLIELIGTPSEAELGFLNENAKK---YICQLPRYQRQSFTE----KFPNVH----- 202
            QL  +  ++G P++ +     E+ KK   +   +  ++R ++T     K+   H     
Sbjct: 232 DQLDRIFNVMGFPADKDW----EDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPD 287

Query: 203 PSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
             A  L++K+LT DP +RIT E A+  PY 
Sbjct: 288 SKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  120 bits (303), Expect = 2e-32
 Identities = 68/245 (27%), Positives = 114/245 (46%), Gaps = 60/245 (24%)

Query: 3   HENVVAIRDIIPPPQRESF---NDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLY 55
           H N+V   D       +S+   +++++  E MD    TD+  I ++   ++E    Y   
Sbjct: 74  HPNIV---DYY-----DSYLVGDELWVVMEYMDGGSLTDI--ITQNFVRMNEPQIAYVCR 123

Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL-ARVTSETDFMTEYVVTRWYR 114
           ++L+GL+Y+HS NV+HRD+K  N+LL+ +  +K+ DFG  A++T E       V T ++ 
Sbjct: 124 EVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWM 183

Query: 115 APELLLNSSDYTAAIDVWSVGCIFMEL-------MDRKPLFPGRDHVHQLRLLIELIGTP 167
           APE++    DY   +D+WS+G + +E+       +   PL        +   LI   G P
Sbjct: 184 APEVIK-RKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPL--------RALFLITTKGIP 234

Query: 168 SEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDAL 227
               L    +N +K                     P   D + K L  DP +R + E+ L
Sbjct: 235 ---PL----KNPEK-------------------WSPEFKDFLNKCLVKDPEKRPSAEELL 268

Query: 228 AHPYL 232
            HP+L
Sbjct: 269 QHPFL 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  118 bits (297), Expect = 6e-32
 Identities = 60/203 (29%), Positives = 96/203 (47%), Gaps = 37/203 (18%)

Query: 34  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 93
           +L   +      SEE  +++  +I+  L+Y+HS  +++RDLKP N+LL+A+  +K+ DFG
Sbjct: 79  ELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFG 138

Query: 94  LAR-VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD 152
           LA+ ++SE      +  T  Y APE+LL    Y  A+D WS+G +  E++  KP F   D
Sbjct: 139 LAKELSSEGSRTNTFCGTPEYLAPEVLLG-KGYGKAVDWWSLGVLLYEMLTGKPPFYAED 197

Query: 153 HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP-NVHPSAIDLVEK 211
                  + E I                                +FP  + P A DL+  
Sbjct: 198 RK----EIYEKI---------------------------LKDPLRFPEFLSPEARDLISG 226

Query: 212 MLTFDPRQRIT---VEDALAHPY 231
           +L  DP +R+     E+  AHP+
Sbjct: 227 LLQKDPTKRLGSGGAEEIKAHPF 249

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  116 bits (292), Expect = 5e-31
 Identities = 64/216 (29%), Positives = 104/216 (48%), Gaps = 35/216 (16%)

Query: 23  DVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHS-ANVLHRDLKPSNLL 80
           ++ I  E MD   L  +++    + E    Y   QIL+GL Y+H+  +++HRD+KPSNLL
Sbjct: 73  EISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLL 132

Query: 81  LNANCDLKICDFGLARVTSETDFMT-EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFM 139
           +N+  ++KI DFG+++V   T      +V T  Y +PE +   S Y+ A D+WS+G   +
Sbjct: 133 INSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGES-YSYAADIWSLGLTLL 191

Query: 140 EL-MDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQ--LPRYQRQSFTE 196
           E  + + P  P               G PS  EL        + IC    P    + F+ 
Sbjct: 192 ECALGKFPFLPP--------------GQPSFFEL-------MQAICDGPPPSLPAEEFSP 230

Query: 197 KFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
           +F        D +   L  DP++R +  + L HP++
Sbjct: 231 EF-------RDFISACLQKDPKKRPSAAELLQHPFI 259

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  115 bits (290), Expect = 7e-31
 Identities = 64/233 (27%), Positives = 105/233 (45%), Gaps = 35/233 (15%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQIL 58
             H N+V              ++++I  E      L  +++S NQ L+E    Y   ++L
Sbjct: 54  CKHPNIVKYYGSYLKK-----DELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELL 108

Query: 59  RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPEL 118
           +GL+Y+HS  ++HRD+K +N+LL ++ ++K+ DFGL+   S+T      V T ++ APE 
Sbjct: 109 KGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPE- 167

Query: 119 LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNEN 178
           ++N   Y    D+WS+G   +EL + KP +       +    I   G P     G  N  
Sbjct: 168 VINGKPYDYKADIWSLGITAIELAEGKPPY-SELPPMKALFKIATNGPP-----GLRN-- 219

Query: 179 AKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPY 231
                   P      F            D ++K L  +P +R T E  L HP+
Sbjct: 220 --------PEKWSDEFK-----------DFLKKCLQKNPEKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  113 bits (285), Expect = 4e-30
 Identities = 62/228 (27%), Positives = 108/228 (47%), Gaps = 42/228 (18%)

Query: 22  NDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL 80
            ++Y+  E +   DL  ++ +  +L E+  + ++ +I+  L+Y+HS  ++HRDLKP N+L
Sbjct: 66  KNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNIL 125

Query: 81  LNANCDLKICDFGLARV--TSETDFM-------TEYVVTRWYRAPELLLNSSDYTAAIDV 131
           +++N  LK+ DFGL++V        +          V T  Y APE++L    ++  +D 
Sbjct: 126 IDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQG-HSKTVDW 184

Query: 132 WSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQR 191
           WS+GCI  E +   P F G               TP E     + +N      + P    
Sbjct: 185 WSLGCILYEFLVGIPPFHGE--------------TPEE-----IFQNILNGKIEWP---- 221

Query: 192 QSFTEKFPNVHPSAIDLVEKMLTFDPRQRI---TVEDALAHPYLGSLH 236
                +   V   AIDL+ K+L  DP +R+   ++E+   HP+   + 
Sbjct: 222 -----EDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKGID 264

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  108 bits (273), Expect = 3e-28
 Identities = 72/243 (29%), Positives = 108/243 (44%), Gaps = 48/243 (19%)

Query: 3   HENVVAI--RDIIPPPQRESFNDVYIAYELMDT-DLHQII----RSNQALSEEHCQYFLY 55
           H N+V    R I    Q      +YI  E  +  DL Q+I    +  + + EE     L 
Sbjct: 58  HPNIVRYYDRIIDRSNQT-----LYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILT 112

Query: 56  QILRGLKYIH-----SANVLHRDLKPSNLLLNANCDLKICDFGLARV-TSETDFMTEYVV 109
           Q+L  L   H        VLHRDLKP+N+ L+AN ++K+ DFGLA++   ++ F   YV 
Sbjct: 113 QLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVG 172

Query: 110 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSE 169
           T +Y +PE L + S Y    D+WS+GC+  EL    P F  R+ + QL   I+       
Sbjct: 173 TPYYMSPEQLNHMS-YDEKSDIWSLGCLIYELCALSPPFTARNQL-QLASKIK------- 223

Query: 170 AELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 229
                      K+     RY  +               +++ ML  DP +R + E+ L  
Sbjct: 224 ---------EGKFRRIPYRYSSELNE------------VIKSMLNVDPDKRPSTEELLQL 262

Query: 230 PYL 232
           P +
Sbjct: 263 PLI 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  108 bits (271), Expect = 6e-28
 Identities = 69/241 (28%), Positives = 105/241 (43%), Gaps = 60/241 (24%)

Query: 20  SFND---VYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 75
           +F D   +Y   E   + +L Q IR   +L E+  +++  +IL  L+Y+HS  ++HRDLK
Sbjct: 70  TFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLK 129

Query: 76  PSNLLLNANCDLKICDFGLARVTSETDFMTE---------------------YVVTRWYR 114
           P N+LL+ +  +KI DFG A+V                              +V T  Y 
Sbjct: 130 PENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYV 189

Query: 115 APELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGF 174
           +PELL        + D+W++GCI  +++  KP F G                 +E    F
Sbjct: 190 SPELLNE-KPAGKSSDLWALGCIIYQMLTGKPPFRG----------------SNEYLT-F 231

Query: 175 LNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDAL----AHP 230
                 +Y          SF   FP   P A DL+EK+L  DP+ R+ V +      AHP
Sbjct: 232 QKILKLEY----------SFPPNFP---PDAKDLIEKLLVLDPQDRLGVNEGYDELKAHP 278

Query: 231 Y 231
           +
Sbjct: 279 F 279

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  106 bits (266), Expect = 2e-27
 Identities = 64/233 (27%), Positives = 107/233 (45%), Gaps = 38/233 (16%)

Query: 3   HENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGL 61
           H N+V         +RE  N +YI  EL+    L ++++   +  E   + +  QIL GL
Sbjct: 61  HPNIVQYLGT----EREEDN-LYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGL 115

Query: 62  KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLN 121
           +Y+H  N +HRD+K +N+L++ N  +K+ DFG+A+   E  F   +  + ++ APE++  
Sbjct: 116 EYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQ 175

Query: 122 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIEL--IGTPSEAELGFLNENA 179
              Y  A D+WS+GC  +E+   KP +       QL  +  +  IG   E          
Sbjct: 176 QGGYGLAADIWSLGCTVLEMATGKPPW------SQLEGVAAVFKIGRSKELPP------- 222

Query: 180 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
                 +P            ++   A D + K L  DP  R T  + L HP++
Sbjct: 223 ------IPD-----------HLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  105 bits (264), Expect = 4e-27
 Identities = 59/222 (26%), Positives = 99/222 (44%), Gaps = 36/222 (16%)

Query: 18  RESFNDVYIAYELMDT----DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRD 73
             SF D    Y ++D     DL   +      SEE  ++++ +I+  L+Y+HS  ++HRD
Sbjct: 66  WYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRD 125

Query: 74  LKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWS 133
           +KP N+LL+    + I DF +A   +     T    T  Y APE +L    Y+ A+D WS
Sbjct: 126 IKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPE-VLCRQGYSVAVDWWS 184

Query: 134 VGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQS 193
           +G    E +  K  + G       R + + I                       R ++++
Sbjct: 185 LGVTAYECLRGKRPYRGHS-----RTIRDQI-----------------------RAKQET 216

Query: 194 FTEKFPNVHPS-AIDLVEKMLTFDPRQRI--TVEDALAHPYL 232
               +P    + AID + K+L  DP++R+   ++D   HPY 
Sbjct: 217 ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  105 bits (264), Expect = 5e-27
 Identities = 64/240 (26%), Positives = 108/240 (45%), Gaps = 39/240 (16%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILR 59
           + H N+V    +     RE    VYI  E      L +++   + L E   + +  Q+L 
Sbjct: 56  LKHPNLVKYYGV--EVHRE---KVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLE 110

Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVV----TRWYR 114
           GL Y+HS  ++HRD+KP+N+ L+ N  +K+ DFG A ++ + T  M E V     T  Y 
Sbjct: 111 GLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYM 170

Query: 115 APELLLN--SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL 172
           APE++       +  A D+WS+GC+ +E+   K  +   D+  Q+   +     P     
Sbjct: 171 APEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKP----- 225

Query: 173 GFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
                        +P   + S         P   D +++ L  DP++R T  + L HP++
Sbjct: 226 ------------PIPDSLQLS---------PEGKDFLDRCLESDPKKRPTASELLQHPFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  103 bits (260), Expect = 1e-26
 Identities = 60/236 (25%), Positives = 102/236 (43%), Gaps = 41/236 (17%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILR 59
           + H N+V     I     E+ + +YI  E  +   L QII+      E     ++YQ+L+
Sbjct: 56  LKHPNIVKYIGSI-----ETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQ 110

Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPEL 118
           GL Y+H   V+HRD+K +N+L   +  +K+ DFG+A ++   +      V T ++ APE 
Sbjct: 111 GLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPE- 169

Query: 119 LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNEN 178
           ++  S  + A D+WS+GC  +EL+   P +   + +  L                     
Sbjct: 170 VIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAAL--------------------- 208

Query: 179 AKKY-ICQLPRYQRQSFTEKFP-NVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
              + I Q             P  + P   D + +    DP  R T +  L HP++
Sbjct: 209 ---FRIVQDDHP-------PLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score = 99.5 bits (249), Expect = 6e-25
 Identities = 52/150 (34%), Positives = 72/150 (48%), Gaps = 18/150 (12%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQ-ALSEEHCQYFLYQIL 58
           +DH NVV +  +    +      +YI  E M+  DL   +R N+  LS      F  QI 
Sbjct: 58  LDHPNVVKLLGVCTEEEP-----LYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIA 112

Query: 59  RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT------RW 112
           RG++Y+ S N +HRDL   N L+  N  +KI DFGL+R   + D    Y         RW
Sbjct: 113 RGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD---YYRKRGGKLPIRW 169

Query: 113 YRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
             APE L     +T+  DVWS G +  E+ 
Sbjct: 170 M-APESLKEGK-FTSKSDVWSFGVLLWEIF 197

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score = 98.8 bits (247), Expect = 1e-24
 Identities = 51/151 (33%), Positives = 71/151 (47%), Gaps = 19/151 (12%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQ--ALSEEHCQYFLYQI 57
           +DH N+V +  +    +      + I  E M   DL   +R N+   LS      F  QI
Sbjct: 58  LDHPNIVKLLGVCTEEEP-----LMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQI 112

Query: 58  LRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT------R 111
            RG++Y+ S N +HRDL   N L+  N  +KI DFGL+R   + D    Y V       R
Sbjct: 113 ARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD---YYKVKGGKLPIR 169

Query: 112 WYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
           W  APE L     +T+  DVWS G +  E+ 
Sbjct: 170 WM-APESLKEGK-FTSKSDVWSFGVLLWEIF 198

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 99.3 bits (248), Expect = 1e-24
 Identities = 61/207 (29%), Positives = 100/207 (48%), Gaps = 35/207 (16%)

Query: 33  TDLHQ-IIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD 91
           TDL + + +  + L EE   Y L + LRGL Y+H   V+HRD+K  N+LL  N ++K+ D
Sbjct: 97  TDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVD 156

Query: 92  FGLAR-VTSETDFMTEYVVTRWYRAPELLLNSS----DYTAAIDVWSVGCIFMELMDRKP 146
           FG++  + S       ++ T ++ APE++         Y A  DVWS+G   +EL D KP
Sbjct: 157 FGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKP 216

Query: 147 LFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPR-YQRQSFTEKFPNVHPSA 205
             P  D +H +R L ++   P                   P     +++++KF       
Sbjct: 217 --PLCD-MHPMRALFKIPRNPP------------------PTLKSPENWSKKF------- 248

Query: 206 IDLVEKMLTFDPRQRITVEDALAHPYL 232
            D + + L  +  QR  +E+ L HP++
Sbjct: 249 NDFISECLIKNYEQRPFMEELLEHPFI 275

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 98.2 bits (245), Expect = 3e-24
 Identities = 62/216 (28%), Positives = 97/216 (44%), Gaps = 32/216 (14%)

Query: 22  NDVYIAYELMD-TDLHQII-RSNQALSEEHCQYFLYQILRGLKYIHSA-NVLHRDLKPSN 78
            D+ I  E MD   L +I+      + E         +L+GL Y+H    ++HRD+KPSN
Sbjct: 72  GDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSN 131

Query: 79  LLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIF 138
           +L+N+   +K+CDFG++     +   T +V T  Y APE  +  +DY+   D+WS+G   
Sbjct: 132 ILVNSRGQIKLCDFGVSGQLVNSLAKT-FVGTSSYMAPE-RIQGNDYSVKSDIWSLGLSL 189

Query: 139 MEL-MDRKPL-FPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 196
           +EL   R P             LL  ++  P                 +LP       + 
Sbjct: 190 IELATGRFPYPPENDPPDGIFELLQYIVNEPPP---------------RLP-------SG 227

Query: 197 KFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
           KF    P   D V   L  DPR+R + ++ L HP++
Sbjct: 228 KFS---PDFQDFVNLCLIKDPRERPSYKELLEHPFI 260

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 97.9 bits (244), Expect = 3e-24
 Identities = 53/205 (25%), Positives = 91/205 (44%), Gaps = 33/205 (16%)

Query: 34  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 93
           D   +I++   L E+  + ++ +++ G++ +H   ++HRD+KP NLL++    LK+ DFG
Sbjct: 83  DCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFG 142

Query: 94  LARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDH 153
           L+R   E     ++V T  Y APE +L   D     D WS+GC+  E             
Sbjct: 143 LSRNGLEN---KKFVGTPDYLAPETILGVGD-DKMSDWWSLGCVIFEF------------ 186

Query: 154 VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKML 213
                    L G P      F  E        +   +     E      P A+DL+ ++L
Sbjct: 187 ---------LFGYPP-----FHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLL 232

Query: 214 TFDPRQRI---TVEDALAHPYLGSL 235
             DP +R+     ++  +HP+  S+
Sbjct: 233 CMDPAKRLGANGYQEIKSHPFFKSI 257

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 97.7 bits (244), Expect = 3e-24
 Identities = 57/201 (28%), Positives = 94/201 (46%), Gaps = 33/201 (16%)

Query: 34  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 93
           D+ +I   N+ L+EE     LYQ L+GL+Y+HS   +HRD+K  N+LLN     K+ DFG
Sbjct: 87  DIMKIT--NKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFG 144

Query: 94  LARVTSETDFMTEYVV-TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD 152
           ++   ++T      V+ T ++ APE++     Y    D+WS+G   +E+ + KP  P   
Sbjct: 145 VSGQLTDTMAKRNTVIGTPFWMAPEVIQE-IGYNNKADIWSLGITAIEMAEGKP--P-YS 200

Query: 153 HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP-NVHPSAIDLVEK 211
            +H +R +                         +P     + ++  P    P   D V+K
Sbjct: 201 DIHPMRAIFM-----------------------IPNKPPPTLSD--PEKWSPEFNDFVKK 235

Query: 212 MLTFDPRQRITVEDALAHPYL 232
            L  DP +R +    L HP++
Sbjct: 236 CLVKDPEERPSAIQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 97.3 bits (243), Expect = 7e-24
 Identities = 51/189 (26%), Positives = 91/189 (48%), Gaps = 30/189 (15%)

Query: 45  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA-RVTSETDF 103
           L E +  + L ++L GL+Y+H    +HRD+K +N+LL+   D+K+ DFG++ ++TS    
Sbjct: 95  LDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSK 154

Query: 104 MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIEL 163
              +V T ++ APE++  S  Y    D+WS+G   +EL   +P  P    +H +R+L  +
Sbjct: 155 RNTFVGTPFWMAPEVIKQSG-YDEKADIWSLGITAIELAKGEP--P-LSDLHPMRVLFLI 210

Query: 164 IGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV 223
                                  P  +   F++ F        D V   L  DP++R + 
Sbjct: 211 PKNNP------------------PSLEGNKFSKPFK-------DFVSLCLNKDPKERPSA 245

Query: 224 EDALAHPYL 232
           ++ L H ++
Sbjct: 246 KELLKHKFI 254

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 93.7 bits (233), Expect = 9e-23
 Identities = 58/222 (26%), Positives = 91/222 (40%), Gaps = 39/222 (17%)

Query: 19  ESFNDVYIAYELM----DTDLHQIIRSNQA----LSEEHCQYFLYQILRGLKYIHSANVL 70
           E+F D      +M      DL + I   +     + E+       Q+LRGL+ +H   +L
Sbjct: 66  EAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKIL 125

Query: 71  HRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAID 130
           HRDLK +N+LL AN  +KI D G+++V  +    T+ + T  Y APE +     Y+   D
Sbjct: 126 HRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQ-IGTPHYMAPE-VWKGRPYSYKSD 183

Query: 131 VWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQ 190
           +WS+GC+  E+    P F  R  +  LR                             + Q
Sbjct: 184 IWSLGCLLYEMATFAPPFEARS-MQDLRY----------------------------KVQ 214

Query: 191 RQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
           R  +    P       + +  ML   P+ R   +  LA P +
Sbjct: 215 RGKYPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 93.8 bits (234), Expect = 1e-22
 Identities = 50/179 (27%), Positives = 88/179 (49%), Gaps = 15/179 (8%)

Query: 17  QRESFNDVYIAYELMDT----DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHR 72
              +F D    Y LM+     +L  I+R      E   ++++  ++   +Y+H+  +++R
Sbjct: 58  LYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYR 117

Query: 73  DLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVW 132
           DLKP NLLL++N  +K+ DFG A+          +  T  Y APE++LN   Y  ++D W
Sbjct: 118 DLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKG-YDFSVDYW 176

Query: 133 SVGCIFMELMDRKPLFPGRDH----VHQLRL-LIELIGTPSEAELGFLNENAKKYICQL 186
           S+G +  EL+  +P F   D     ++   L     +  P+     ++++ AK  I QL
Sbjct: 177 SLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPN-----YIDKAAKDLIKQL 230

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 91.8 bits (228), Expect = 7e-22
 Identities = 62/248 (25%), Positives = 108/248 (43%), Gaps = 58/248 (23%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLH------------QIIRSNQALSEE 48
           +DH N+V                 Y+ +E  +  L               +R+     E+
Sbjct: 65  LDHLNIVQ----------------YLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQ 108

Query: 49  HCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSE---TDFMT 105
             ++F  Q+L GL Y+HS  +LHRDLK  NLL++A+   KI DFG+++ + +    D   
Sbjct: 109 LVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNM 168

Query: 106 EYVVTRWYRAPELLLNSSD-YTAAIDVWSVGCIFMELM-DRKPLFPGRDHVHQLRLLIEL 163
               + ++ APE++ + S  Y+A +D+WS+GC+ +E+   R+P     +           
Sbjct: 169 SMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPW--SDEEAIAAMF---- 222

Query: 164 IGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV 223
                  +LG      K+    +P        +   N+ P A+D +    T +P  R T 
Sbjct: 223 -------KLG-----NKRSAPPIP-------PDVSMNLSPVALDFLNACFTINPDNRPTA 263

Query: 224 EDALAHPY 231
            + L HP+
Sbjct: 264 RELLQHPF 271

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 89.0 bits (221), Expect = 5e-21
 Identities = 64/239 (26%), Positives = 105/239 (43%), Gaps = 45/239 (18%)

Query: 1   MDHENVVAIRDIIPPPQRESFND---VYIAYELMDT-DLHQII--RSNQALSEEHCQYFL 54
           + H N++A  +         F D   + I  E  +   L+  I  +  Q   EE   ++L
Sbjct: 56  LQHPNIIAYYN--------HFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYL 107

Query: 55  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVV-TRWY 113
           +QI+  + YIH A +LHRD+K  N+ L     +K+ DFG++++      M E VV T +Y
Sbjct: 108 FQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYY 167

Query: 114 RAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELG 173
            +PE L     Y    D+W++GC+  EL+  K  F   D  + L L+++++         
Sbjct: 168 MSPE-LCQGVKYNFKSDIWALGCVLYELLTLKRTF---DATNPLNLVVKIV--------- 214

Query: 174 FLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
                   Y   +  Y  +             I LV  +L  DP +R T ++ L  P L
Sbjct: 215 -----QGNYTPVVSVYSSE------------LISLVHSLLQQDPEKRPTADEVLDQPLL 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 88.3 bits (219), Expect = 1e-20
 Identities = 53/178 (29%), Positives = 80/178 (44%), Gaps = 24/178 (13%)

Query: 57  ILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSE--TDFMTEYVVTRWYR 114
           +L+GL Y+HS  ++HRD+KPSN+LL     +K+CDFG   V+ E        +  T +Y 
Sbjct: 114 VLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFG---VSGELVNSLAGTFTGTSFYM 170

Query: 115 APELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGF 174
           APE +     Y+   DVWS+G   +E             V Q R      G P    +  
Sbjct: 171 APERIQGKP-YSITSDVWSLGLTLLE-------------VAQNRFPFPPEGEPPLGPIEL 216

Query: 175 LNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
           L+     YI  +P  + +              D +++ L  DP +R T  D L HP++
Sbjct: 217 LS-----YIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWI 269

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 85.4 bits (211), Expect = 1e-19
 Identities = 54/152 (35%), Positives = 77/152 (50%), Gaps = 10/152 (6%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQA--LSEEHCQYFLYQI 57
           M H N+VA ++       E+   +YI  E  D  DL Q I+  +     E+    +  Q+
Sbjct: 55  MKHPNIVAFKESF-----EADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQM 109

Query: 58  LRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV-TSETDFMTEYVVTRWYRAP 116
             G+++IH   VLHRD+K  N+ L  N  +K+ DFG AR+ TS   +   YV T +Y  P
Sbjct: 110 CLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPP 169

Query: 117 ELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 148
           E+  N   Y    D+WS+GCI  EL   K  F
Sbjct: 170 EIWENMP-YNNKSDIWSLGCILYELCTLKHPF 200

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 85.2 bits (211), Expect = 2e-19
 Identities = 40/128 (31%), Positives = 71/128 (55%), Gaps = 6/128 (4%)

Query: 24  VYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 82
           + I  E M    +   +++  AL+E   + +  QIL G++Y+HS  ++HRD+K +N+L +
Sbjct: 79  LSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRD 138

Query: 83  ANCDLKICDFG----LARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIF 138
           +  ++K+ DFG    L  + S    M     T ++ +PE +++   Y    DVWSVGC  
Sbjct: 139 SAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPE-VISGEGYGRKADVWSVGCTV 197

Query: 139 MELMDRKP 146
           +E++  KP
Sbjct: 198 VEMLTEKP 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 84.9 bits (211), Expect = 2e-19
 Identities = 46/151 (30%), Positives = 71/151 (47%), Gaps = 19/151 (12%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSN-QALSEEHCQYFLYQIL 58
           + H N+V +  +    +      +YI  E M   DL   +R + + L+ +       QI 
Sbjct: 58  LSHPNIVRLLGVCTQGEP-----LYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIA 112

Query: 59  RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-------R 111
           +G++Y+ S N +HRDL   N L+  N  +KI DFGL+R   E D    Y          +
Sbjct: 113 KGMEYLESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDD---YYRKRGGGKLPIK 169

Query: 112 WYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
           W  APE L +   +T+  DVWS G +  E+ 
Sbjct: 170 WM-APESLKDGK-FTSKSDVWSFGVLLWEIF 198

Length = 258

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 84.9 bits (210), Expect = 2e-19
 Identities = 64/221 (28%), Positives = 96/221 (43%), Gaps = 37/221 (16%)

Query: 19  ESFNDVYIAYELMD----TDLHQIIRS--NQALSEEHCQYFLYQILRGLKYIHSANVLHR 72
           ESF D      +M+     DLH++++    + L E+    F  QIL GL ++HS  +LHR
Sbjct: 66  ESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHR 125

Query: 73  DLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLNSSDYTAAIDV 131
           D+K  NL L+A  ++KI D G+A++ S  T+F    V T +Y +PE L     Y    DV
Sbjct: 126 DIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPE-LCEDKPYNEKSDV 184

Query: 132 WSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQR 191
           W++G +  E    K  F   +    +  +I  +  P              Y  QL     
Sbjct: 185 WALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQ----------MYSQQL----- 229

Query: 192 QSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
                           L+++ LT D RQR      L +P L
Sbjct: 230 --------------AQLIDQCLTKDYRQRPDTFQLLRNPSL 256

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 84.4 bits (209), Expect = 4e-19
 Identities = 63/218 (28%), Positives = 101/218 (46%), Gaps = 37/218 (16%)

Query: 23  DVYIAYELMDTDLH----QIIRSNQALSEEHCQYFLYQILRGLKYIHSA-NVLHRDLKPS 77
           DV+I  E+MDT L     ++      + E+        I++ L+Y+HS  +V+HRD+KPS
Sbjct: 74  DVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPS 133

Query: 78  NLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL---LNSSDYTAAIDVWSV 134
           N+L+N N  +K+CDFG++    ++   T     + Y APE +   LN   Y    DVWS+
Sbjct: 134 NVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSL 193

Query: 135 GCIFMEL-MDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQS 193
           G   +EL   R P    +    QL+ ++E    PS                  P+   + 
Sbjct: 194 GITMIELATGRFPYDSWKTPFQQLKQVVE---EPS------------------PQLPAEK 232

Query: 194 FTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPY 231
           F+ +F        D V K L  + ++R    + L HP+
Sbjct: 233 FSPEF-------QDFVNKCLKKNYKERPNYPELLQHPF 263

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 83.9 bits (208), Expect = 4e-19
 Identities = 58/203 (28%), Positives = 98/203 (48%), Gaps = 32/203 (15%)

Query: 33  TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDF 92
            D++Q+ R    LSE    Y   + L+GL Y+H    +HRD+K +N+LL  + D+K+ DF
Sbjct: 88  QDIYQVTRG--PLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADF 145

Query: 93  GL-ARVTSETDFMTEYVVTRWYRAPELLLNSS--DYTAAIDVWSVGCIFMELMDRKPLFP 149
           G+ A++T+       ++ T ++ APE+        Y    D+W++G   +EL + +P  P
Sbjct: 146 GVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQP--P 203

Query: 150 GRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQS-FTEKFPNVHPSAIDL 208
             D +H +R L  LI                K     P+ + +  ++  F        D 
Sbjct: 204 MFD-LHPMRALF-LIS---------------KSNFPPPKLKDKEKWSPVF-------HDF 239

Query: 209 VEKMLTFDPRQRITVEDALAHPY 231
           ++K LT DP++R T    L HP+
Sbjct: 240 IKKCLTKDPKKRPTATKLLQHPF 262

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 84.0 bits (208), Expect = 5e-19
 Identities = 42/186 (22%), Positives = 84/186 (45%), Gaps = 29/186 (15%)

Query: 43  QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL-ARVTSET 101
             ++E++    + ++L  LKYIH   V+HRD+K +N+L+    ++K+CDFG+ A +   +
Sbjct: 96  GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS 155

Query: 102 DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI 161
              + +V T ++ APE++     Y    D+WS+G    E+    P +   D    + L+ 
Sbjct: 156 SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIP 215

Query: 162 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI 221
           +                      + PR +   ++           + V   L  +P++R+
Sbjct: 216 K---------------------SKPPRLEDNGYS-------KLLREFVAACLDEEPKERL 247

Query: 222 TVEDAL 227
           + E+ L
Sbjct: 248 SAEELL 253

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 84.0 bits (208), Expect = 6e-19
 Identities = 53/199 (26%), Positives = 93/199 (46%), Gaps = 34/199 (17%)

Query: 45  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL-ARVTSETDF 103
           L+E   +Y   Q+L  L ++HS  V+HRDLK  N+LL  + D+K+ DFG+ A+  S    
Sbjct: 100 LTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK 159

Query: 104 MTEYVVTRWYRAPELLL--NSSD--YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL 159
              ++ T ++ APE++      D  Y    D+WS+G   +EL   +P  P  + ++ +R+
Sbjct: 160 RDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEP--PHHE-LNPMRV 216

Query: 160 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQS-FTEKFPNVHPSAIDLVEKMLTFDPR 218
           L++++ +                    P   + S ++  F        D ++  L  DP 
Sbjct: 217 LLKILKSEP------------------PTLDQPSKWSSSFN-------DFLKSCLVKDPD 251

Query: 219 QRITVEDALAHPYLGSLHD 237
            R T  + L HP++    D
Sbjct: 252 DRPTAAELLKHPFVSDQSD 270

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 83.4 bits (206), Expect = 8e-19
 Identities = 44/128 (34%), Positives = 70/128 (54%), Gaps = 10/128 (7%)

Query: 53  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANC-DLKICDFGLA-----RVTSETDFMTE 106
           +  Q+LRGL Y+H   ++HRD+K +NLL+++    L+I DFG A     + T   +F  +
Sbjct: 108 YTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQ 167

Query: 107 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIEL--- 163
            + T  + APE+L     Y  + DVWSVGC+ +E+   KP +    H + L L+ ++   
Sbjct: 168 LLGTIAFMAPEVLRGEQ-YGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASA 226

Query: 164 IGTPSEAE 171
              PS  E
Sbjct: 227 TTAPSIPE 234

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 83.4 bits (207), Expect = 8e-19
 Identities = 46/159 (28%), Positives = 71/159 (44%), Gaps = 27/159 (16%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN---------QALSEEHC 50
           + H NVV +  +    +      +Y+  E M+  DL   +R +           LS +  
Sbjct: 53  LGHPNVVRLLGVCTEEEP-----LYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDL 107

Query: 51  QYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT 110
             F  QI +G++Y+ S   +HRDL   N L+  +  +KI DFGL+R   + D+   Y   
Sbjct: 108 LSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDY---YRKK 164

Query: 111 -------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
                  RW  APE  L    +T+  DVWS G +  E+ 
Sbjct: 165 TGGKLPIRWM-APE-SLKDGIFTSKSDVWSFGVLLWEIF 201

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 83.5 bits (206), Expect = 9e-19
 Identities = 58/214 (27%), Positives = 100/214 (46%), Gaps = 39/214 (18%)

Query: 39  IRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL-ARV 97
           I S   L+EE        +L+ L Y+HS  V+HRD+K  ++LL  +  +K+ DFG  A++
Sbjct: 108 IVSQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQI 167

Query: 98  TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL 157
           + +       V T ++ APE +++ + Y   +D+WS+G + +E++D +P +     V  +
Sbjct: 168 SKDVPKRKSLVGTPYWMAPE-VISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAM 226

Query: 158 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVH---PSAIDLVEKMLT 214
           + L                              R S   K  N H   P   D +E+MLT
Sbjct: 227 KRL------------------------------RDSPPPKLKNAHKISPVLRDFLERMLT 256

Query: 215 FDPRQRITVEDALAHPYLGSLHDISDEPVCMSPF 248
            +P++R T ++ L HP+L      +  P C+ P 
Sbjct: 257 REPQERATAQELLDHPFLLQ----TGLPECLVPL 286

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 83.4 bits (207), Expect = 1e-18
 Identities = 40/120 (33%), Positives = 67/120 (55%), Gaps = 7/120 (5%)

Query: 20  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 75
           SF D    Y +M+     +L   +R +    E   +++  Q++  L+Y+HS ++++RDLK
Sbjct: 69  SFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLK 128

Query: 76  PSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVG 135
           P NLLL+++  +KI DFG A+      +      T  Y APE++L S  Y  A+D W++G
Sbjct: 129 PENLLLDSDGYIKITDFGFAKRVKGRTYTL--CGTPEYLAPEIIL-SKGYGKAVDWWALG 185

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 82.9 bits (205), Expect = 1e-18
 Identities = 48/151 (31%), Positives = 80/151 (52%), Gaps = 20/151 (13%)

Query: 1   MDHENVVAIRDIIPPPQRESF---NDVYIAYELMDT-DLHQII---RSNQALSEEHC--Q 51
           +DH NV+            SF   N++ I  EL D  DL ++I   +  + L  E    +
Sbjct: 59  LDHPNVIKYLA--------SFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWK 110

Query: 52  YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV-TSETDFMTEYVVT 110
           YF  Q+   L+++HS  ++HRD+KP+N+ + A   +K+ D GL R  +S+T      V T
Sbjct: 111 YF-VQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGT 169

Query: 111 RWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 141
            +Y +PE  ++ + Y    D+WS+GC+  E+
Sbjct: 170 PYYMSPE-RIHENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 83.6 bits (207), Expect = 1e-18
 Identities = 60/221 (27%), Positives = 104/221 (47%), Gaps = 29/221 (13%)

Query: 20  SFND---VYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 75
           +F D   +Y+A E +   D   ++ +   LSE+H ++++ ++   +  +H    +HRDLK
Sbjct: 69  AFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLK 128

Query: 76  PSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVG 135
           P N L++A+  +K+ DFGL++      +    V +  Y APE +L    Y   +D WS+G
Sbjct: 129 PENFLIDASGHIKLTDFGLSKGIVT--YANSVVGSPDYMAPE-VLRGKGYDFTVDYWSLG 185

Query: 136 CIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFT 195
           C+  E +   P F G               TP+E       EN K +   L   QR  + 
Sbjct: 186 CMLYEFLCGFPPFSG--------------STPNETW-----ENLKYWKETL---QRPVYD 223

Query: 196 EKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH 236
           +   N+   A DL+ K++    R+  ++ED   HP+   + 
Sbjct: 224 DPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEVD 264

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 82.7 bits (204), Expect = 2e-18
 Identities = 60/221 (27%), Positives = 98/221 (44%), Gaps = 32/221 (14%)

Query: 32  DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD 91
           D   H     N    EE   ++  +IL GL+ +H  N ++RDLKP N+LL+    ++I D
Sbjct: 86  DLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISD 145

Query: 92  FGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGR 151
            GLA    E + +   V T  Y APE +LN+  YT + D W +GC+  E+++ +  F GR
Sbjct: 146 LGLAVKIPEGESIRGRVGTVGYMAPE-VLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGR 204

Query: 152 DHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEK 211
               +   +   +    E      +E AK  IC++                         
Sbjct: 205 KEKVKREEVDRRVLETEEVYSAKFSEEAKS-ICKM------------------------- 238

Query: 212 MLTFDPRQRITVEDALA-----HPYLGSLHDISDEPVCMSP 247
           +LT DP+QR+  ++  A     HP+  +++    E   + P
Sbjct: 239 LLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKRLEAGMLDP 279

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 82.9 bits (205), Expect = 2e-18
 Identities = 63/228 (27%), Positives = 105/228 (46%), Gaps = 22/228 (9%)

Query: 20  SFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYI---HSANVLHRDLK 75
           S  ++ I  E MD   L Q+++    + E         +LRGL Y+   H   ++HRD+K
Sbjct: 70  SDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHK--IMHRDVK 127

Query: 76  PSNLLLNANCDLKICDFGLARVTSE-TDFM-TEYVVTRWYRAPELLLNSSDYTAAIDVWS 133
           PSN+L+N+  ++K+CDFG   V+ +  D M   +V TR Y +PE  L  + YT   D+WS
Sbjct: 128 PSNILVNSRGEIKLCDFG---VSGQLIDSMANSFVGTRSYMSPE-RLQGTHYTVQSDIWS 183

Query: 134 VGCIFMEL-MDRKPLFPGRDHVHQLRLL------IELIGTPSEAELGFLNENAKKYICQL 186
           +G   +E+ + R P+ P  D      +        E   +         +      I +L
Sbjct: 184 LGLSLVEMAIGRYPI-PPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFEL 242

Query: 187 PRYQRQSFTEKFPNVH--PSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
             Y       K P+        D V+K L  +P++R  +++   HP++
Sbjct: 243 LDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFI 290

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 82.4 bits (203), Expect = 3e-18
 Identities = 60/253 (23%), Positives = 115/253 (45%), Gaps = 50/253 (19%)

Query: 3   HENVVAIRDIIPPPQRESF---NDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           HENVV + +        S+   +++++  E ++      I ++  ++EE        +L+
Sbjct: 76  HENVVEMYN--------SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLK 127

Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL-ARVTSETDFMTEYVVTRWYRAPEL 118
            L  +H+  V+HRD+K  ++LL  +  +K+ DFG  A+V+ E       V T ++ APEL
Sbjct: 128 ALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEL 187

Query: 119 LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNEN 178
           + +   Y   +D+WS+G + +E++D +P +     +  ++++                  
Sbjct: 188 I-SRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI------------------ 228

Query: 179 AKKYICQLPRYQRQSFTEKFPNVH---PSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL 235
                       R +   K  N+H   PS    ++++L  DP QR T  + L HP+L   
Sbjct: 229 ------------RDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK- 275

Query: 236 HDISDEPVCMSPF 248
              +  P C+ P 
Sbjct: 276 ---AGPPSCIVPL 285

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 81.8 bits (202), Expect = 3e-18
 Identities = 55/191 (28%), Positives = 91/191 (47%), Gaps = 27/191 (14%)

Query: 57  ILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR--VTSETDFMTEYVVTRWYR 114
           +++GL Y+ S  +LHRD+KPSN+L+N    +K+CDFG++   V S       YV T  Y 
Sbjct: 104 VVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---IAKTYVGTNAYM 160

Query: 115 APELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGF 174
           APE +     Y    DVWS+G  FMEL   +  +P         + ++L+          
Sbjct: 161 APERIS-GEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQC-------I 212

Query: 175 LNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS 234
           ++E+        P      F+EKF       +  + + +   P++R   E+ + HP++  
Sbjct: 213 VDEDP-------PVLPVGQFSEKF-------VHFITQCMRKQPKERPAPENLMDHPFIVQ 258

Query: 235 LHDISDEPVCM 245
            +D + E V M
Sbjct: 259 YNDGNAEVVSM 269

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 81.6 bits (201), Expect = 4e-18
 Identities = 55/185 (29%), Positives = 96/185 (51%), Gaps = 21/185 (11%)

Query: 54  LYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE-YVVTRW 112
           L +IL+GL Y+HS   +HRD+K +N+LL+   D+K+ DFG+A   ++T      +V T +
Sbjct: 107 LKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPF 166

Query: 113 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL 172
           + APE++  S+ Y +  D+WS+G   +EL   +P  P  D +H +R+L  +         
Sbjct: 167 WMAPEVIQQSA-YDSKADIWSLGITAIELAKGEP--PNSD-MHPMRVLFLIPKNNPPTLT 222

Query: 173 GFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
           G  ++  K++I         +   K P+  P+A +L+        + +  V++A    YL
Sbjct: 223 GEFSKPFKEFI--------DACLNKDPSFRPTAKELL--------KHKFIVKNAKKTSYL 266

Query: 233 GSLHD 237
             L D
Sbjct: 267 TELID 271

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 80.8 bits (199), Expect = 6e-18
 Identities = 68/237 (28%), Positives = 103/237 (43%), Gaps = 40/237 (16%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQAL--SEEHCQYFLYQI 57
           M H N+V         Q      ++I  E  D  DL + I   + +  SE+    +  QI
Sbjct: 56  MKHPNIVTFFASF---QEN--GRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQI 110

Query: 58  LRGLKYIHSANVLHRDLKPSNLLLNANCDL-KICDFGLARVTSET-DFMTEYVVTRWYRA 115
             GLK+IH   +LHRD+K  N+ L+ N  + K+ DFG+AR  +++ +     V T +Y +
Sbjct: 111 SLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLS 170

Query: 116 PELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL 175
           PE+  N   Y    D+WS+GC+  EL   K  F G +++HQL L                
Sbjct: 171 PEICQNRP-YNNKTDIWSLGCVLYELCTLKHPFEG-NNLHQLVL---------------- 212

Query: 176 NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
                  ICQ        F    PN       L+ ++    PR R ++   L  P+L
Sbjct: 213 ------KICQ------GYFAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 80.3 bits (198), Expect = 7e-18
 Identities = 55/192 (28%), Positives = 83/192 (43%), Gaps = 31/192 (16%)

Query: 40  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARVT 98
           R N  L E+   +F  QIL  L ++H+  +LHRDLK  N+LL+ +   +KI DFG++++ 
Sbjct: 93  RCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKIL 152

Query: 99  SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR 158
           S        V T  Y +PE L     Y    D+W++GC+  EL   K  F   +    L 
Sbjct: 153 SSKSKAYTVVGTPCYISPE-LCEGKPYNQKSDIWALGCVLYELASLKRAFEAAN----LP 207

Query: 159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPR 218
            L+  I + + A +               RY             P    L+  ML  DP 
Sbjct: 208 ALVLKIMSGTFAPIS-------------DRYS------------PDLRQLILSMLNLDPS 242

Query: 219 QRITVEDALAHP 230
           +R  +   +A P
Sbjct: 243 KRPQLSQIMAQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 80.4 bits (198), Expect = 8e-18
 Identities = 54/204 (26%), Positives = 92/204 (45%), Gaps = 34/204 (16%)

Query: 31  MDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKIC 90
           +D  L ++  + + LSE     +  Q+L G+ Y+H   +LHRDLK  N+ L  N  LKI 
Sbjct: 89  LDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNNL-LKIG 147

Query: 91  DFGLAR-VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFP 149
           DFG++R +    D  T +  T +Y +PE  L    Y +  D+WS+GCI  E+      F 
Sbjct: 148 DFGVSRLLMGSCDLATTFTGTPYYMSPE-ALKHQGYDSKSDIWSLGCILYEMCCLAHAFE 206

Query: 150 GRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLV 209
           G++    L +++ ++  P                           T   P  +   ++ +
Sbjct: 207 GQNF---LSVVLRIVEGP---------------------------TPSLPETYSRQLNSI 236

Query: 210 -EKMLTFDPRQRITVEDALAHPYL 232
            + ML  DP  R +  + L +P++
Sbjct: 237 MQSMLNKDPSLRPSAAEILRNPFI 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 81.0 bits (200), Expect = 1e-17
 Identities = 61/204 (29%), Positives = 96/204 (47%), Gaps = 39/204 (19%)

Query: 39  IRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV- 97
           +   +  SE+  +++  +I+  L Y+HS +V++RDLK  NL+L+ +  +KI DFGL +  
Sbjct: 86  LSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEG 145

Query: 98  TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL 157
            S+   M  +  T  Y APE +L  +DY  A+D W +G +  E+M  +  F  +DH    
Sbjct: 146 ISDGATMKTFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH---- 200

Query: 158 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP-NVHPSAIDLVEKMLTFD 216
             L ELI          L E                   +FP  + P A  L+  +L  D
Sbjct: 201 EKLFELI----------LMEEI-----------------RFPRTLSPEAKSLLAGLLKKD 233

Query: 217 PRQRI--TVEDAL---AHPYLGSL 235
           P+QR+    EDA     H +  S+
Sbjct: 234 PKQRLGGGPEDAKEIMEHRFFASI 257

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 79.5 bits (196), Expect = 2e-17
 Identities = 52/196 (26%), Positives = 89/196 (45%), Gaps = 37/196 (18%)

Query: 44  ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF 103
           A  E   + F+ QIL+GL Y+H+  ++HRD+K +N+L++    +KI DFG+++       
Sbjct: 102 AFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSL 161

Query: 104 MTEYVVTR-------WYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ 156
            T+    R       ++ APE++  +S YT   D+WS+GC+ +E++  K  FP       
Sbjct: 162 STKTNGARPSLQGSVFWMAPEVVKQTS-YTRKADIWSLGCLVVEMLTGKHPFP------- 213

Query: 157 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFD 216
                              +    + I ++             N+   AID +EK    D
Sbjct: 214 -------------------DCTQLQAIFKIGENASPEIPS---NISSEAIDFLEKTFEID 251

Query: 217 PRQRITVEDALAHPYL 232
             +R T  + L HP+L
Sbjct: 252 HNKRPTAAELLKHPFL 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 80.0 bits (197), Expect = 3e-17
 Identities = 54/196 (27%), Positives = 88/196 (44%), Gaps = 41/196 (20%)

Query: 47  EEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVT-SETDFMT 105
               +++  ++L  L+ +H  NV++RDLKP N+LL+    + +CDFGL ++   + D   
Sbjct: 92  LSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTN 151

Query: 106 EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIG 165
            +  T  Y APELLL    YT A+D W++G +  E+                     L G
Sbjct: 152 TFCGTPEYLAPELLLGHG-YTKAVDWWTLGVLLYEM---------------------LTG 189

Query: 166 TPSEAELGFLNENAKKYICQLPRYQRQSFTE--KFP-NVHPSAIDLVEKMLTFDPRQRIT 222
            P      F +EN       +    R+   E  +FP      A DL+  +L+ DP +R+ 
Sbjct: 190 LPP-----FYDEN-------VNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSRDPTRRLG 237

Query: 223 V---EDALAHPYLGSL 235
               ++   HP+   L
Sbjct: 238 YNGAQEIKNHPFFSQL 253

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 79.0 bits (195), Expect = 3e-17
 Identities = 47/189 (24%), Positives = 89/189 (47%), Gaps = 29/189 (15%)

Query: 45  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL-ARVTSETDF 103
           ++EE        +L+ L ++H+  V+HRD+K  ++LL ++  +K+ DFG  A+V+ E   
Sbjct: 112 MNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPR 171

Query: 104 MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIEL 163
               V T ++ APE +++   Y   +D+WS+G + +E++D +P +     +  ++ + + 
Sbjct: 172 RKSLVGTPYWMAPE-VISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN 230

Query: 164 IGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV 223
                                 LP   +         V P     +++ML  DP QR T 
Sbjct: 231 ----------------------LPPKLKNLH-----KVSPRLRSFLDRMLVRDPAQRATA 263

Query: 224 EDALAHPYL 232
            + L HP+L
Sbjct: 264 AELLNHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 78.7 bits (194), Expect = 3e-17
 Identities = 45/154 (29%), Positives = 72/154 (46%), Gaps = 12/154 (7%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS----NQALSEEHCQYFLY 55
           + H N+V          R     +YI  +L++   L +   S     Q  +EE       
Sbjct: 66  LRHPNIVRYYKTFLENDR-----LYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFV 120

Query: 56  QILRGLKYIHSAN-VLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYR 114
           Q++  L+Y+H    ++HRDL P+N++L  +  + I DFGLA+       +T  V T  Y 
Sbjct: 121 QMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYS 180

Query: 115 APELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 148
            PE++ N   Y    DVW+ GCI  ++   +P F
Sbjct: 181 CPEIVKNEP-YGEKADVWAFGCILYQMCTLQPPF 213

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 79.1 bits (195), Expect = 3e-17
 Identities = 54/210 (25%), Positives = 93/210 (44%), Gaps = 34/210 (16%)

Query: 32  DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD 91
           D   H     N    EE   ++  +I  GL+ +H   +++RDLKP N+LL+    ++I D
Sbjct: 86  DLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISD 145

Query: 92  FGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGR 151
            GLA    E + +   V T  Y APE ++ +  YT + D W +GC+  E+++ K  F  R
Sbjct: 146 LGLAVEIPEGETIRGRVGTVGYMAPE-VVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQR 204

Query: 152 DHVHQLRLLIELIGTPSEAELGFLNENAKK-YICQLPRYQRQSFTEKFPNVHPSAIDLVE 210
                                    E  K+  + +  +  ++ ++EKF     +A  +  
Sbjct: 205 ------------------------KEKVKREEVERRVKEDQEEYSEKFS---EAARSICR 237

Query: 211 KMLTFDPRQRI-----TVEDALAHPYLGSL 235
           ++LT DP  R+       E+  AHP+  + 
Sbjct: 238 QLLTKDPGFRLGCRGEGAEEVKAHPFFRTA 267

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 78.9 bits (194), Expect = 4e-17
 Identities = 57/228 (25%), Positives = 109/228 (47%), Gaps = 33/228 (14%)

Query: 22  NDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 81
           +++++  E ++      I ++  ++EE        +LR L Y+H+  V+HRD+K  ++LL
Sbjct: 92  DELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILL 151

Query: 82  NANCDLKICDFGL-ARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 140
            ++  +K+ DFG  A+V+ E       V T ++ APE++ +   Y   +D+WS+G + +E
Sbjct: 152 TSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVI-SRLPYGTEVDIWSLGIMVIE 210

Query: 141 LMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPN 200
           ++D +P +     +  +R + +                       LP   + S   K  +
Sbjct: 211 MIDGEPPYFNEPPLQAMRRIRD----------------------NLPPRVKDS--HKVSS 246

Query: 201 VHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMSPF 248
           V    +DL   ML  +P QR T ++ L HP+L     ++  P C+ P 
Sbjct: 247 VLRGFLDL---MLVREPSQRATAQELLQHPFL----KLAGPPSCIVPL 287

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 79.6 bits (196), Expect = 4e-17
 Identities = 32/98 (32%), Positives = 62/98 (63%), Gaps = 1/98 (1%)

Query: 45  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVT-SETDF 103
            SE+  ++++ +++  L+++H  ++++RDLKP N+LL+A   + +CDFGL++   ++   
Sbjct: 93  FSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKT 152

Query: 104 MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 141
              +  T  Y APE+LL+   YT  +D WS+G +  E+
Sbjct: 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEM 190

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 77.9 bits (192), Expect = 6e-17
 Identities = 47/155 (30%), Positives = 77/155 (49%), Gaps = 16/155 (10%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMD----TDLHQIIRSNQ--ALSEEHCQYFL 54
           M H N+V  +        ESF +    Y +MD     DL++ I + +     E+    + 
Sbjct: 56  MKHPNIVQYQ--------ESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWF 107

Query: 55  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWY 113
            QI   LK++H   +LHRD+K  N+ L  +  +K+ DFG+ARV + T +     + T +Y
Sbjct: 108 VQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYY 167

Query: 114 RAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 148
            +PE+  N   Y    D+W++GC+  E+   K  F
Sbjct: 168 LSPEICENRP-YNNKSDIWALGCVLYEMCTLKHAF 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 77.9 bits (192), Expect = 8e-17
 Identities = 61/223 (27%), Positives = 99/223 (44%), Gaps = 43/223 (19%)

Query: 22  NDVYIAYELMDTD-LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN-VLHRDLKPSNL 79
           N++ +  E MD   L +I +    +  E        ++ GL Y+++ + ++HRD+KPSN+
Sbjct: 76  NNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNI 135

Query: 80  LLNANCDLKICDFGLA--RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 137
           L+N+   +K+CDFG++   + S  D    +V T  Y +PE  +    YT   DVWS+G  
Sbjct: 136 LVNSRGQIKLCDFGVSGELINSIAD---TFVGTSTYMSPE-RIQGGKYTVKSDVWSLGIS 191

Query: 138 FMELMDRKPLFP---------GRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPR 188
            +EL   K  FP         G+D    +  L++ I          + E   +    LP 
Sbjct: 192 IIELALGK--FPFAFSNIDDDGQDDPMGILDLLQQI----------VQEPPPR----LP- 234

Query: 189 YQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPY 231
                 +  FP       D V+  L  DP +R T +   A P 
Sbjct: 235 ------SSDFP---EDLRDFVDACLLKDPTERPTPQQLCAMPP 268

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 77.4 bits (190), Expect = 1e-16
 Identities = 57/189 (30%), Positives = 96/189 (50%), Gaps = 31/189 (16%)

Query: 45  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM 104
           L E +    L +IL+GL Y+HS   +HRD+K +N+LL+   D+K+ DFG+A   ++T   
Sbjct: 98  LEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK 157

Query: 105 -TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIEL 163
              +V T ++ APE++  S+ Y    D+WS+G   +EL   +P  P  D +H +R+L   
Sbjct: 158 RNTFVGTPFWMAPEVIKQSA-YDFKADIWSLGITAIELAKGEP--PNSD-LHPMRVLF-- 211

Query: 164 IGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV 223
                      + +N+       P  + Q +++ F        + VE  L  DPR R T 
Sbjct: 212 ----------LIPKNSP------PTLEGQ-YSKPFK-------EFVEACLNKDPRFRPTA 247

Query: 224 EDALAHPYL 232
           ++ L H ++
Sbjct: 248 KELLKHKFI 256

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 76.9 bits (189), Expect = 2e-16
 Identities = 55/203 (27%), Positives = 88/203 (43%), Gaps = 35/203 (17%)

Query: 37  QIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 96
            I+     L E     +  QIL G+ Y+H+  V+HRD+K +N++L  N  +K+ DFG AR
Sbjct: 91  SILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCAR 150

Query: 97  V-------TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFP 149
                    + ++ +     T ++ APE ++N S Y    D+WS+GC   E+   KP   
Sbjct: 151 RLAWVGLHGTHSNMLKSMHGTPYWMAPE-VINESGYGRKSDIWSIGCTVFEMATGKPPLA 209

Query: 150 GRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLV 209
             D +  +                F     +  + +LP     SF+        +AID V
Sbjct: 210 SMDRLAAM----------------FYIGAHRGLMPRLP----DSFSA-------AAIDFV 242

Query: 210 EKMLTFDPRQRITVEDALAHPYL 232
              LT D  +R +    L H +L
Sbjct: 243 TSCLTRDQHERPSALQLLRHDFL 265

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 76.9 bits (189), Expect = 2e-16
 Identities = 54/191 (28%), Positives = 84/191 (43%), Gaps = 31/191 (16%)

Query: 43  QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV-TSET 101
           + L E     +  QI   L+Y+H  ++LHRDLK  N+ L     +K+ D G+ARV  ++ 
Sbjct: 97  KLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156

Query: 102 DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI 161
           D  +  + T +Y +PEL  N   Y    DVW++GC   E+   K  F  +D    +  +I
Sbjct: 157 DMASTLIGTPYYMSPELFSNKP-YNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRII 215

Query: 162 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI 221
           E          G L    K Y  +L                    +L+  ML+  P +R 
Sbjct: 216 E----------GKLPPMPKDYSPEL-------------------GELIATMLSKRPEKRP 246

Query: 222 TVEDALAHPYL 232
           +V+  L  PY+
Sbjct: 247 SVKSILRQPYI 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 77.2 bits (190), Expect = 2e-16
 Identities = 55/225 (24%), Positives = 96/225 (42%), Gaps = 35/225 (15%)

Query: 19  ESFNDVYIAYELMDT-DLH-QIIRSNQA-LSEEHCQYFLYQILRGLKYIHSANVLHRDLK 75
           E+ +D+ +   LM+  DL   I    +    E    ++  QI+ GL+++H   +++RDLK
Sbjct: 63  ETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLK 122

Query: 76  PSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVG 135
           P N+LL+ + +++I D GLA        +     T  Y APE+L     Y  ++D +++G
Sbjct: 123 PENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQG-EVYDFSVDWFALG 181

Query: 136 CIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFT 195
           C   E++  +   P R                 E       E  K+   ++       F+
Sbjct: 182 CTLYEMIAGRS--PFRQR-----------KEKVE------KEELKRRTLEMAVEYPDKFS 222

Query: 196 EKFPNVHPSAIDLVEKMLTFDPRQRI-----TVEDALAHPYLGSL 235
                  P A DL E +L  DP +R+     + ++   HP    L
Sbjct: 223 -------PEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKDL 260

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 77.0 bits (189), Expect = 2e-16
 Identities = 60/200 (30%), Positives = 97/200 (48%), Gaps = 28/200 (14%)

Query: 35  LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL 94
           L  I      LSE    Y   + L+GL Y+HS   +HRD+K +N+LL  N D+K+ DFG+
Sbjct: 93  LQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGV 152

Query: 95  -ARVTSETDFMTEYVVTRWYRAPEL--LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGR 151
            A++T+       ++ T ++ APE+  +  +  Y    D+W+VG   +EL + +P  P  
Sbjct: 153 AAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQP--PMF 210

Query: 152 DHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEK 211
           D +H +R L             FL     K   Q P+ + +  T+     H    + V+ 
Sbjct: 211 D-LHPMRAL-------------FL---MSKSNFQPPKLKDK--TKWSSTFH----NFVKI 247

Query: 212 MLTFDPRQRITVEDALAHPY 231
            LT +P++R T E  L H +
Sbjct: 248 SLTKNPKKRPTAERLLTHLF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 76.3 bits (187), Expect = 3e-16
 Identities = 57/205 (27%), Positives = 98/205 (47%), Gaps = 34/205 (16%)

Query: 33  TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDF 92
           TDL +  + N  L EE   Y   +ILRGL ++H   V+HRD+K  N+LL  N ++K+ DF
Sbjct: 97  TDLIKNTKGN-TLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDF 155

Query: 93  GL-ARVTSETDFMTEYVVTRWYRAPELLLNSSD----YTAAIDVWSVGCIFMELMDRKPL 147
           G+ A++         ++ T ++ APE++    +    Y    D+WS+G   +E+ +  P 
Sbjct: 156 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP- 214

Query: 148 FPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAID 207
            P  D +H +R L  +   P+                  PR + + +++KF +       
Sbjct: 215 -PLCD-MHPMRALFLIPRNPA------------------PRLKSKKWSKKFQS------- 247

Query: 208 LVEKMLTFDPRQRITVEDALAHPYL 232
            +E  L  +  QR T E  + HP++
Sbjct: 248 FIESCLVKNHSQRPTTEQLMKHPFI 272

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 76.6 bits (189), Expect = 3e-16
 Identities = 60/215 (27%), Positives = 97/215 (45%), Gaps = 31/215 (14%)

Query: 23  DVYIAYELMDTDLHQI-IRSNQALSEEHCQYFLYQILRGLKYIHSA-NVLHRDLKPSNLL 80
           DV+I  ELM T L ++  R    + E+        I++ L Y+     V+HRD+KPSN+L
Sbjct: 88  DVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNIL 147

Query: 81  LNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL---LNSSDYTAAIDVWSVGCI 137
           L+A+ ++K+CDFG++    ++   T       Y APE +     +  Y    DVWS+G  
Sbjct: 148 LDASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGIS 207

Query: 138 FMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEK 197
            +EL      FP ++   +  +L ++           L E        LP    + F+  
Sbjct: 208 LVELA--TGQFPYKNCKTEFEVLTKI-----------LQEEPPS----LP--PNEGFSPD 248

Query: 198 FPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
           F          V+  LT D R+R    + L HP++
Sbjct: 249 F-------CSFVDLCLTKDHRKRPKYRELLQHPFI 276

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 76.6 bits (188), Expect = 4e-16
 Identities = 56/192 (29%), Positives = 100/192 (52%), Gaps = 13/192 (6%)

Query: 43  QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR--VTSE 100
           +  +EE  +++  +I+  L+Y+HS +V++RD+K  NL+L+ +  +KI DFGL +  ++  
Sbjct: 90  RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 149

Query: 101 TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL- 159
              M  +  T  Y APE +L  +DY  A+D W +G +  E+M  +  F  +DH     L 
Sbjct: 150 AT-MKTFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 207

Query: 160 LIELIGTP----SEAE---LGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKM 212
           L+E I  P     EA+    G L ++ K+ +   P   ++    +F     +  D+V+K 
Sbjct: 208 LMEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL-SINWQDVVQKK 266

Query: 213 LTFDPRQRITVE 224
           L    + ++T E
Sbjct: 267 LLPPFKPQVTSE 278

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 75.5 bits (186), Expect = 5e-16
 Identities = 43/154 (27%), Positives = 70/154 (45%), Gaps = 8/154 (5%)

Query: 24  VYIAYELMDT-DLHQIIRS--NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL 80
           VYI  ELM+   L   +RS   Q L          Q+  G+ Y+   N +HRDL   N+L
Sbjct: 77  VYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNIL 136

Query: 81  LNANCDLKICDFGLARVTSETDFMTE--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIF 138
           +  +   K+ DFGLAR+  E  +++    +  +W  APE   +   ++   DVWS G + 
Sbjct: 137 VGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKW-TAPE-AASHGTFSTKSDVWSFGILL 194

Query: 139 MELMDRKPL-FPGRDHVHQLRLLIELIGTPSEAE 171
            E+     + +PG ++      +      P  A+
Sbjct: 195 YEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAK 228

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 75.6 bits (186), Expect = 1e-15
 Identities = 42/102 (41%), Positives = 63/102 (61%), Gaps = 6/102 (5%)

Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYR 114
           QIL G+ Y+H  +++HRD+KPSNLL+N+  ++KI DFG++R+ ++T D     V T  Y 
Sbjct: 176 QILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYM 235

Query: 115 APELL---LNSSDYTA-AIDVWSVGCIFMEL-MDRKPLFPGR 151
           +PE +   LN   Y   A D+WS+G   +E  + R P   GR
Sbjct: 236 SPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGR 277

Length = 353

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 74.9 bits (184), Expect = 1e-15
 Identities = 54/217 (24%), Positives = 94/217 (43%), Gaps = 34/217 (15%)

Query: 42  NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET 101
           N    E    ++  QI+ GL+++H   +++RDLKP N+LL+ + +++I D GLA    + 
Sbjct: 91  NPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDG 150

Query: 102 DFMTE-YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL 160
              T+ Y  T  + APELL    +Y  ++D +++G    E++  +  F  R         
Sbjct: 151 QSKTKGYAGTPGFMAPELLQG-EEYDFSVDYFALGVTLYEMIAARGPFRAR--------- 200

Query: 161 IELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQR 220
               G   E      N+  K+ I         ++ +KF    P++    E +L  DP +R
Sbjct: 201 ----GEKVE------NKELKQRILNDS----VTYPDKFS---PASKSFCEALLAKDPEKR 243

Query: 221 ITVEDA-----LAHPYLGSLH-DISDEPVCMSPFSFD 251
           +   D        HP    L+    +  +   PF  D
Sbjct: 244 LGFRDGNCDGLRTHPLFRDLNWRQLEAGMLPPPFVPD 280

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 74.7 bits (183), Expect = 1e-15
 Identities = 57/205 (27%), Positives = 99/205 (48%), Gaps = 34/205 (16%)

Query: 33  TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDF 92
           TDL +  + N AL E+   Y   +ILRGL ++H+  V+HRD+K  N+LL  N ++K+ DF
Sbjct: 107 TDLVKNTKGN-ALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDF 165

Query: 93  GL-ARVTSETDFMTEYVVTRWYRAPELLL----NSSDYTAAIDVWSVGCIFMELMDRKPL 147
           G+ A++         ++ T ++ APE++       + Y    D+WS+G   +E+ +  P 
Sbjct: 166 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAP- 224

Query: 148 FPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAID 207
            P  D +H +R L  +   P                   P+ + + +++KF       ID
Sbjct: 225 -PLCD-MHPMRALFLIPRNPP------------------PKLKSKKWSKKF-------ID 257

Query: 208 LVEKMLTFDPRQRITVEDALAHPYL 232
            +E  L  +   R + E  L HP++
Sbjct: 258 FIEGCLVKNYLSRPSTEQLLKHPFI 282

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 74.7 bits (183), Expect = 1e-15
 Identities = 68/242 (28%), Positives = 111/242 (45%), Gaps = 39/242 (16%)

Query: 2   DHENVVAIRDIIPPPQRESFNDVYIAYELMD----TDLHQ-IIRSNQALSEEHCQYFLYQ 56
           DH NVV    +      ++ + +++  EL +    TDL +  ++  + + E    Y L++
Sbjct: 73  DHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHE 132

Query: 57  ILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL-ARVTSETDFMTEYVVTRWYRA 115
            L GL+++H    +HRD+K +N+LL     +K+ DFG+ A++TS        V T ++ A
Sbjct: 133 ALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMA 192

Query: 116 PELL-----LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEA 170
           PE++     L+S+ Y A  DVWS+G   +EL D  P  P  D +H +R L ++   P   
Sbjct: 193 PEVIACEQQLDST-YDARCDVWSLGITAIELGDGDP--PLAD-LHPMRALFKIPRNPPPT 248

Query: 171 ELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHP 230
                           P      F            D + K LT D  +R TV D L H 
Sbjct: 249 -------------LHQPELWSNEFN-----------DFIRKCLTKDYEKRPTVSDLLQHV 284

Query: 231 YL 232
           ++
Sbjct: 285 FI 286

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 75.1 bits (184), Expect = 1e-15
 Identities = 44/130 (33%), Positives = 76/130 (58%), Gaps = 5/130 (3%)

Query: 23  DVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN-VLHRDLKPSNLL 80
           ++ I  E MD   L Q+++  + + EE        +LRGL Y+   + ++HRD+KPSN+L
Sbjct: 77  EISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNIL 136

Query: 81  LNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 140
           +N+  ++K+CDFG++    ++     +V TR Y +PE  L  + Y+   D+WS+G   +E
Sbjct: 137 VNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLSLVE 194

Query: 141 L-MDRKPLFP 149
           L + R P+ P
Sbjct: 195 LAIGRYPIPP 204

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 73.7 bits (181), Expect = 2e-15
 Identities = 57/181 (31%), Positives = 85/181 (46%), Gaps = 40/181 (22%)

Query: 47  EEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARVTSETDFMT 105
           E+   ++  QIL GLKY+H   ++HRD+K  N+L+N     +KI DFG ++  +  +  T
Sbjct: 107 EQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCT 166

Query: 106 E-YVVTRWYRAPELL-LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIEL 163
           E +  T  Y APE++      Y A  D+WS+GC  +E+   KP F            IEL
Sbjct: 167 ETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPF------------IEL 214

Query: 164 IGTPSEA--ELGF----------LNENAKKYI--CQLPRYQRQSFTEKFPNVHPSAIDLV 209
            G P  A  ++G           L+  AK +I  C  P           P+   SA DL+
Sbjct: 215 -GEPQAAMFKVGMFKIHPEIPESLSAEAKNFILRCFEPD----------PDKRASAHDLL 263

Query: 210 E 210
           +
Sbjct: 264 Q 264

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 72.7 bits (178), Expect = 6e-15
 Identities = 53/178 (29%), Positives = 89/178 (50%), Gaps = 15/178 (8%)

Query: 2   DHENVVAIRDIIPPPQRESFNDVYIAYELMD----TDLHQ-IIRSNQALSEEHCQYFLYQ 56
           +H NVV    +     +     +++  EL +    T+L + ++   Q L E    Y LY 
Sbjct: 77  NHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYG 136

Query: 57  ILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL-ARVTSETDFMTEYVVTRWYRA 115
            L GL+++H+  ++HRD+K +N+LL     +K+ DFG+ A++TS        V T ++ A
Sbjct: 137 ALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMA 196

Query: 116 PELLL----NSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQLRLLIELIGTPS 168
           PE++         Y A  DVWS+G   +EL D   PLF     +H ++ L ++   P 
Sbjct: 197 PEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLF----DMHPVKTLFKIPRNPP 250

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 72.9 bits (179), Expect = 6e-15
 Identities = 38/96 (39%), Positives = 57/96 (59%), Gaps = 6/96 (6%)

Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRA 115
             L+GL Y+HS   +HRD+K  N+LL     +K+ DFG A + S  +    +V T ++ A
Sbjct: 123 GALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPAN---SFVGTPYWMA 179

Query: 116 PELLL--NSSDYTAAIDVWSVGCIFMELMDRK-PLF 148
           PE++L  +   Y   +DVWS+G   +EL +RK PLF
Sbjct: 180 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 215

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 73.1 bits (179), Expect = 6e-15
 Identities = 37/91 (40%), Positives = 57/91 (62%), Gaps = 5/91 (5%)

Query: 58  LRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPE 117
           L+GL Y+HS N++HRD+K  N+LL     +K+ DFG A  +S  +    +V T ++ APE
Sbjct: 131 LQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSPAN---SFVGTPYWMAPE 187

Query: 118 LLL--NSSDYTAAIDVWSVGCIFMELMDRKP 146
           ++L  +   Y   +DVWS+G   +EL +RKP
Sbjct: 188 VILAMDEGQYDGKVDVWSLGITCIELAERKP 218

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 72.4 bits (177), Expect = 7e-15
 Identities = 58/200 (29%), Positives = 95/200 (47%), Gaps = 28/200 (14%)

Query: 35  LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL 94
           L  I      LSE    Y   + L+GL Y+HS   +HRD+K +N+LL  N  +K+ DFG+
Sbjct: 93  LQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGV 152

Query: 95  -ARVTSETDFMTEYVVTRWYRAPEL--LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGR 151
            A++T+       ++ T ++ APE+  +     Y    D+W+VG   +EL + +P  P  
Sbjct: 153 SAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQP--PMF 210

Query: 152 DHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEK 211
           D +H +R L   + T S  +   L +  K             ++  F +        V+ 
Sbjct: 211 D-LHPMRAL--FLMTKSNFQPPKLKDKMK-------------WSNSFHH-------FVKM 247

Query: 212 MLTFDPRQRITVEDALAHPY 231
            LT +P++R T E  L HP+
Sbjct: 248 ALTKNPKKRPTAEKLLQHPF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 72.4 bits (178), Expect = 7e-15
 Identities = 61/242 (25%), Positives = 100/242 (41%), Gaps = 44/242 (18%)

Query: 2   DHENVVAIRDIIPPPQRESF---NDVYIAYELMDT-DLHQIIRS---NQALSEEHCQYFL 54
           +H NVV            SF   +++++    +    L  I++S      L E      L
Sbjct: 57  NHPNVVK--------YYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVL 108

Query: 55  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE-----YVV 109
            ++L+GL+Y+HS   +HRD+K  N+LL  +  +KI DFG++   ++    T      +V 
Sbjct: 109 KEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVG 168

Query: 110 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSE 169
           T  + APE++     Y    D+WS G   +EL       P   +     L++ L   P  
Sbjct: 169 TPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAA--PYSKYPPMKVLMLTLQNDPPS 226

Query: 170 AELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 229
            E      + KKY         +SF             ++   L  DP +R T E+ L H
Sbjct: 227 LE---TGADYKKY--------SKSFR-----------KMISLCLQKDPSKRPTAEELLKH 264

Query: 230 PY 231
            +
Sbjct: 265 KF 266

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 73.5 bits (180), Expect = 1e-14
 Identities = 59/229 (25%), Positives = 99/229 (43%), Gaps = 44/229 (19%)

Query: 39  IRSNQALSEEHCQYFLYQILRGLKYIHSA-NVLHRDLKPSNLLLNAN------------- 84
           I  +   S  H    ++Q    L Y H+  +++H DLKP N+L+  +             
Sbjct: 222 IMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALP 281

Query: 85  ---CDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 141
              C ++ICD G      E    T  V TR YR+PE++L    +  + D+WS+GCI  EL
Sbjct: 282 PDPCRVRICDLG--GCCDERHSRTAIVSTRHYRSPEVVL-GLGWMYSTDMWSMGCIIYEL 338

Query: 142 MDRKPLFPGRDHVHQLRLLIELIGT-PSEAELGFLNENAK---------------KYICQ 185
              K L+   D++  L L+ + +G  PSE       E A+               K++ +
Sbjct: 339 YTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLAR 398

Query: 186 LPRYQ--RQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
           + R +  R+   +          DL+  +L +D ++R+       HPY+
Sbjct: 399 IARARPVREVIRDDL------LCDLIYGLLHYDRQKRLNARQMTTHPYV 441

Length = 467

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 73.0 bits (179), Expect = 1e-14
 Identities = 55/195 (28%), Positives = 87/195 (44%), Gaps = 27/195 (13%)

Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV-TSETDFMTEYVVTRWYR 114
           QIL GL+Y+H+  ++HRD+K  N+ +N    + I D G A+       F+     T    
Sbjct: 165 QILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG-LAGTVETN 223

Query: 115 APELLLNSSDYTAAIDVWSVGCIFMELM----------DRKPLFPGRD-HVHQLRLLIEL 163
           APE+L     Y +  D+WS G +  E++             P    +  H H L+++  L
Sbjct: 224 APEVLARDK-YNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTL 282

Query: 164 IGTPSEAELGFLNENAKKYICQLPRY---QRQSFTEKFP-----NVHPSAIDLVEKMLTF 215
              P E    F  +   + +     Y   +RQ +T ++P     N+      LV KMLTF
Sbjct: 283 KVHPEE----FPRDPGSRLVRGFIEYASLERQPYT-RYPCFQRVNLPIDGEFLVHKMLTF 337

Query: 216 DPRQRITVEDALAHP 230
           D   R + E+ L +P
Sbjct: 338 DAAMRPSAEEILNYP 352

Length = 357

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 72.4 bits (177), Expect = 1e-14
 Identities = 37/91 (40%), Positives = 57/91 (62%), Gaps = 5/91 (5%)

Query: 58  LRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPE 117
           L+GL Y+HS N++HRD+K  N+LL     +K+ DFG A + S  +    +V T ++ APE
Sbjct: 135 LQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPAN---SFVGTPYWMAPE 191

Query: 118 LLL--NSSDYTAAIDVWSVGCIFMELMDRKP 146
           ++L  +   Y   +DVWS+G   +EL +RKP
Sbjct: 192 VILAMDEGQYDGKVDVWSLGITCIELAERKP 222

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 72.4 bits (177), Expect = 1e-14
 Identities = 39/120 (32%), Positives = 68/120 (56%), Gaps = 2/120 (1%)

Query: 43  QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV-TSET 101
           +  SE+  +++  +I+  L Y+HS  +++RDLK  NL+L+ +  +KI DFGL +   ++ 
Sbjct: 90  RVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA 149

Query: 102 DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI 161
             M  +  T  Y APE +L  +DY  A+D W +G +  E+M  +  F  +DH     L++
Sbjct: 150 ATMKTFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELIL 208

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 72.5 bits (178), Expect = 1e-14
 Identities = 56/198 (28%), Positives = 90/198 (45%), Gaps = 51/198 (25%)

Query: 47  EEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE 106
           E+   ++L +I   L+++H   +++RDLKP N+LL+A   +K+ DFGL + +     +T 
Sbjct: 99  EDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTH 158

Query: 107 -YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIG 165
            +  T  Y APE+L+ S  +  A+D WS+G +  ++                     L G
Sbjct: 159 TFCGTIEYMAPEILMRSG-HGKAVDWWSLGALMYDM---------------------LTG 196

Query: 166 TPSEAELGFLNENAKKYI-------CQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPR 218
            P      F  EN KK I         LP Y           + P A DL++K+L  +P 
Sbjct: 197 APP-----FTAENRKKTIDKILKGKLNLPPY-----------LTPEARDLLKKLLKRNPS 240

Query: 219 QRI--TVEDAL---AHPY 231
            R+     DA    +HP+
Sbjct: 241 SRLGAGPGDAAEVQSHPF 258

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 71.9 bits (176), Expect = 1e-14
 Identities = 47/178 (26%), Positives = 88/178 (49%), Gaps = 29/178 (16%)

Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL-ARVTSETDFMTEYVVTRWYR 114
           + L+ L+++HS  V+HRD+K  N+LL  +  +K+ DFG  A++T E    +  V T ++ 
Sbjct: 123 ECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWM 182

Query: 115 APELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGF 174
           APE++   + Y   +D+WS+G + +E+++ +P +   + +  L  LI   GTP       
Sbjct: 183 APEVVTRKA-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL-YLIATNGTP------- 233

Query: 175 LNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
                     +L   ++ S             D + + L  D  +R + ++ L HP+L
Sbjct: 234 ----------ELQNPEKLS---------AIFRDFLNRCLEMDVEKRGSAKELLQHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 71.2 bits (174), Expect = 2e-14
 Identities = 64/251 (25%), Positives = 111/251 (44%), Gaps = 55/251 (21%)

Query: 1   MDHENVVAIRDIIPPPQRESF---NDVYIAYELMDT-DLHQII----RSNQALSEEHCQY 52
           ++H NV+   D        SF   N++ I  EL D  DL Q+I    +  + + E     
Sbjct: 59  LNHPNVIKYLD--------SFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWK 110

Query: 53  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSETDFMTEYVVTR 111
           +  Q+   ++++HS  V+HRD+KP+N+ + A   +K+ D GL R  +S+T      V T 
Sbjct: 111 YFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTP 170

Query: 112 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEA 170
           +Y +PE  ++ + Y    D+WS+GC+  E+   + P +  + ++  L   IE        
Sbjct: 171 YYMSPE-RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQ------- 222

Query: 171 ELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHP 230
                        C  P    + ++EK         +LV   +  DP QR         P
Sbjct: 223 -------------CDYPPLPTEHYSEKLR-------ELVSMCIYPDPDQR---------P 253

Query: 231 YLGSLHDISDE 241
            +G +H I+ +
Sbjct: 254 DIGYVHQIAKQ 264

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 71.2 bits (175), Expect = 2e-14
 Identities = 46/147 (31%), Positives = 74/147 (50%), Gaps = 13/147 (8%)

Query: 23  DVYIAYELMDTDL-------HQIIRSNQALSEEHCQYFLYQILRGLKYIHSA-NVLHRDL 74
           D +I  ELMD  L       +++++S   + EE         ++ L Y+     ++HRD+
Sbjct: 77  DCWICMELMDISLDKFYKYVYEVLKSV--IPEEILGKIAVATVKALNYLKEELKIIHRDV 134

Query: 75  KPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD--YTAAIDVW 132
           KPSN+LL+ N ++K+CDFG++    ++   T     R Y APE +  S+   Y    DVW
Sbjct: 135 KPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVW 194

Query: 133 SVGCIFMELMDRKPLFPGRDHV-HQLR 158
           S+G    E+   K  +P  + V  QL 
Sbjct: 195 SLGITLYEVATGKFPYPKWNSVFDQLT 221

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 71.1 bits (174), Expect = 2e-14
 Identities = 43/130 (33%), Positives = 74/130 (56%), Gaps = 12/130 (9%)

Query: 29  ELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDL 87
           +LM+  DLH  +  +   SE   +++  +I+ GL+++H+  V++RDLKP+N+LL+ +  +
Sbjct: 77  DLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHV 136

Query: 88  KICDFGLARVTSETDFMTE----YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD 143
           +I D GLA      DF  +     V T  Y APE+L     Y ++ D +S+GC+  +L+ 
Sbjct: 137 RISDLGLA-----CDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL- 190

Query: 144 RKPLFPGRDH 153
            +   P R H
Sbjct: 191 -RGHSPFRQH 199

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 71.3 bits (174), Expect = 2e-14
 Identities = 37/113 (32%), Positives = 68/113 (60%), Gaps = 3/113 (2%)

Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL-ARVTSETDFMTEYVVTRWYR 114
           + L+ L+++HS  V+HRD+K  N+LL  +  +K+ DFG  A++T E    +  V T ++ 
Sbjct: 124 ECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWM 183

Query: 115 APELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTP 167
           APE++   + Y   +D+WS+G + +E+++ +P +   + +  L  LI   GTP
Sbjct: 184 APEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRAL-YLIATNGTP 234

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 71.9 bits (176), Expect = 3e-14
 Identities = 56/207 (27%), Positives = 91/207 (43%), Gaps = 27/207 (13%)

Query: 57  ILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWY--- 113
           +LR ++Y+H   ++HRD+K  N+ +N   D+ + DFG A       F  +    ++Y   
Sbjct: 191 VLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAAC------FPVDINANKYYGWA 244

Query: 114 -----RAPELLLNSSDYTAAIDVWSVGCIFME-------LMDRKPLFPGRDHVHQLRLLI 161
                 APELL     Y  A+D+WS G +  E       L ++  L    D   Q++L+I
Sbjct: 245 GTIATNAPELLARDP-YGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLII 303

Query: 162 ELIGT-PSEAELGFLNENAKKYICQLPRYQRQSFTEK-FPNVHPSAID---LVEKMLTFD 216
              GT P+E  +       + YI    +  R+  +   + N++   ID   L+ KML FD
Sbjct: 304 RRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFD 363

Query: 217 PRQRITVEDALAHPYLGSLHDISDEPV 243
              R + E  L       + D    P+
Sbjct: 364 AHHRPSAEALLDFAAFQDIPDPYPNPM 390

Length = 391

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 70.6 bits (173), Expect = 4e-14
 Identities = 61/230 (26%), Positives = 100/230 (43%), Gaps = 53/230 (23%)

Query: 24  VYIAYELMDT----DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA-NVLHRDLKPSN 78
           VY+  E MD      L+    + + + E+  +   Y +++GLK++    N++HRD+KP+N
Sbjct: 74  VYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTN 133

Query: 79  LLLNANCDLKICDFG----LARVTSETDFMTEYVVTRWYRAPELL--LNSSD---YTAAI 129
           +L+N N  +K+CDFG    L    ++T+     +  + Y APE +     +    YT   
Sbjct: 134 VLVNGNGQVKLCDFGVSGNLVASLAKTN-----IGCQSYMAPERIKSGGPNQNPTYTVQS 188

Query: 130 DVWSVGCIFMEL-MDRKPLFPGRDHVH---QLRLLIELIGTPSEAELGFLNENAKKYICQ 185
           DVWS+G   +E+ + R P +P   + +   QL  +++  G P                  
Sbjct: 189 DVWSLGLSILEMALGRYP-YPPETYANIFAQLSAIVD--GDPP----------------T 229

Query: 186 LPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL 235
           LP                 A D V K L   P +R T    L HP+L   
Sbjct: 230 LP-----------SGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKY 268

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 70.8 bits (173), Expect = 4e-14
 Identities = 36/91 (39%), Positives = 58/91 (63%), Gaps = 5/91 (5%)

Query: 58  LRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPE 117
           L+GL Y+HS N++HRD+K  N+LL+    +K+ DFG A + +  +    +V T ++ APE
Sbjct: 125 LQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN---XFVGTPYWMAPE 181

Query: 118 LLL--NSSDYTAAIDVWSVGCIFMELMDRKP 146
           ++L  +   Y   +DVWS+G   +EL +RKP
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERKP 212

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 70.8 bits (173), Expect = 4e-14
 Identities = 56/182 (30%), Positives = 87/182 (47%), Gaps = 33/182 (18%)

Query: 42  NQALSEEHCQYFLYQILRGLKYIHSA-NVLHRDLKPSNLLLNANCDLKICDFGLARV-TS 99
            +  SE+  +++  +I+  L Y+HS  NV++RDLK  NL+L+ +  +KI DFGL +    
Sbjct: 89  ERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIK 148

Query: 100 ETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL 159
           +   M  +  T  Y APE +L  +DY  A+D W +G +  E+M  +  F  +DH      
Sbjct: 149 DGATMKTFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----EK 203

Query: 160 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQ 219
           L ELI          L E  +      PR            + P A  L+  +L  DP+Q
Sbjct: 204 LFELI----------LMEEIR-----FPR-----------TLSPEAKSLLSGLLKKDPKQ 237

Query: 220 RI 221
           R+
Sbjct: 238 RL 239

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 70.8 bits (173), Expect = 5e-14
 Identities = 59/231 (25%), Positives = 108/231 (46%), Gaps = 20/231 (8%)

Query: 20  SFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN-VLHRDLKPS 77
           S  ++ I  E MD   L Q+++    + E+        +++GL Y+   + ++HRD+KPS
Sbjct: 74  SDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPS 133

Query: 78  NLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 137
           N+L+N+  ++K+CDFG++    ++     +V TR Y +PE  L  + Y+   D+WS+G  
Sbjct: 134 NILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLS 191

Query: 138 FMEL-MDRKPLFPGRDHVHQLRLLIELIGTPSEAELG-------------FLNENAKKYI 183
            +E+ + R P+ P      +L     + G P+E+E                 +      I
Sbjct: 192 LVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAI 251

Query: 184 CQLPRYQRQSFTEKFPNVHPSA--IDLVEKMLTFDPRQRITVEDALAHPYL 232
            +L  Y       K P+    A   D V K L  +P +R  ++  + H ++
Sbjct: 252 FELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFI 302

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 70.1 bits (171), Expect = 5e-14
 Identities = 52/194 (26%), Positives = 96/194 (49%), Gaps = 21/194 (10%)

Query: 45  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM 104
           L E      L +IL+GL Y+HS   +HRD+K +N+LL+ + ++K+ DFG+A   ++T   
Sbjct: 98  LDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 157

Query: 105 -TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIEL 163
              +V T ++ APE++  S+ Y +  D+WS+G   +EL   +   P    +H +++L  +
Sbjct: 158 RNTFVGTPFWMAPEVIKQSA-YDSKADIWSLGITAIELAKGE---PPHSELHPMKVLFLI 213

Query: 164 IGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV 223
                    G  ++  K+++        ++   K P+  P+A +L+        + +  V
Sbjct: 214 PKNNPPTLEGNYSKPLKEFV--------EACLNKEPSFRPTAKELL--------KHKFIV 257

Query: 224 EDALAHPYLGSLHD 237
             A    YL  L D
Sbjct: 258 RFAKKTSYLTELID 271

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 70.0 bits (171), Expect = 6e-14
 Identities = 38/113 (33%), Positives = 68/113 (60%), Gaps = 9/113 (7%)

Query: 34  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 93
           DLH  +  +   SE+  +++  +I+ GL+++H+  V++RDLKP+N+LL+ +  ++I D G
Sbjct: 83  DLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLG 142

Query: 94  LARVTSETDFMTE----YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
           LA      DF  +     V T  Y APE+L   + Y ++ D +S+GC+  +L+
Sbjct: 143 LA-----CDFSKKKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLL 190

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 69.7 bits (170), Expect = 6e-14
 Identities = 42/135 (31%), Positives = 74/135 (54%), Gaps = 7/135 (5%)

Query: 22  NDVYIAYELMDT-DLHQIIR----SNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKP 76
           N++ I  EL D  DL ++I+      + + E+    +  Q+   L+++HS  V+HRD+KP
Sbjct: 75  NELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKP 134

Query: 77  SNLLLNANCDLKICDFGLAR-VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVG 135
           +N+ + A   +K+ D GL R  +S+T      V T +Y +PE  ++ + Y    D+WS+G
Sbjct: 135 ANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE-RIHENGYNFKSDIWSLG 193

Query: 136 CIFMELMDRKPLFPG 150
           C+  E+   +  F G
Sbjct: 194 CLLYEMAALQSPFYG 208

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 69.7 bits (170), Expect = 6e-14
 Identities = 42/149 (28%), Positives = 77/149 (51%), Gaps = 9/149 (6%)

Query: 3   HENVVAIRDIIPPPQRESFNDVYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGL 61
           HE +V     +  P   + +   I  E M    +   ++S  AL+E   + +  QIL G+
Sbjct: 63  HERIVQYYGCLRDPMERTLS---IFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGV 119

Query: 62  KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR----VTSETDFMTEYVVTRWYRAPE 117
            Y+HS  ++HRD+K +N+L ++  ++K+ DFG ++    +      M     T ++ +PE
Sbjct: 120 SYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPE 179

Query: 118 LLLNSSDYTAAIDVWSVGCIFMELMDRKP 146
            +++   Y    D+WSVGC  +E++  KP
Sbjct: 180 -VISGEGYGRKADIWSVGCTVVEMLTEKP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 69.6 bits (170), Expect = 7e-14
 Identities = 51/227 (22%), Positives = 97/227 (42%), Gaps = 38/227 (16%)

Query: 32  DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD 91
           D   H     N    E+   ++  ++  GL+ +    +++RDLKP N+LL+    ++I D
Sbjct: 86  DLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISD 145

Query: 92  FGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGR 151
            GLA    E + +   V T  Y APE++ N   YT + D W +GC+  E++  +   P R
Sbjct: 146 LGLAVQIPEGETVRGRVGTVGYMAPEVINNEK-YTFSPDWWGLGCLIYEMIQGQS--PFR 202

Query: 152 DHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEK 211
               +++                  E   + + +     ++ ++EKF      A  +   
Sbjct: 203 KRKERVK-----------------REEVDRRVKE----DQEEYSEKFSE---DAKSICRM 238

Query: 212 MLTFDPRQRITVEDALA-----HPYLGSLH------DISDEPVCMSP 247
           +LT +P++R+      A     HP   +++      ++ + P C  P
Sbjct: 239 LLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRLEANMLEPPFCPDP 285

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 69.8 bits (170), Expect = 7e-14
 Identities = 49/178 (27%), Positives = 91/178 (51%), Gaps = 29/178 (16%)

Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL-ARVTSETDFMTEYVVTRWYR 114
           + L+ L+++H+  V+HRD+K  N+LL  +  +K+ DFG  A++T E    +  V T ++ 
Sbjct: 123 ECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWM 182

Query: 115 APELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGF 174
           APE++   + Y   +D+WS+G + +E+++ +P +   + +  L  LI   GTP   EL  
Sbjct: 183 APEVVTRKA-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL-YLIATNGTP---EL-- 235

Query: 175 LNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
             +N +K                   + P   D + + L  D  +R + ++ L HP+L
Sbjct: 236 --QNPEK-------------------LSPIFRDFLNRCLEMDVEKRGSAKELLQHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 69.7 bits (171), Expect = 9e-14
 Identities = 36/125 (28%), Positives = 65/125 (52%), Gaps = 12/125 (9%)

Query: 34  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 93
           DL   I+ +    E   +++  +I+ GL+++H   +++RDLK  N+LL++   +KI DFG
Sbjct: 82  DLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFG 141

Query: 94  LARVTSETDFMTEYVVTRW------YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL 147
           + +     + +   V T        Y APE+L     Y  A+D W++G +  E++  +  
Sbjct: 142 MCK-----EGILGGVTTSTFCGTPDYIAPEILS-YQPYGPAVDWWALGVLLYEMLAGQSP 195

Query: 148 FPGRD 152
           F G D
Sbjct: 196 FEGDD 200

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 69.2 bits (169), Expect = 1e-13
 Identities = 49/151 (32%), Positives = 74/151 (49%), Gaps = 22/151 (14%)

Query: 3   HENVVAIRDIIPPPQRESFNDVYIAYELMDTD-LHQIIRSNQALSEEHCQYFLYQILRG- 60
           H N++ +  ++       F    I  E M+   L + +R +     E   Y L  +LRG 
Sbjct: 65  HHNIIRLEGVV-----TKFKPAMIITEYMENGALDKYLRDHDG---EFSSYQLVGMLRGI 116

Query: 61  ---LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT------R 111
              +KY+   N +HRDL   N+L+N+N + K+ DFGL+RV  E D    Y  +      R
Sbjct: 117 AAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVL-EDDPEGTYTTSGGKIPIR 175

Query: 112 WYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
           W  APE  +    +T+A DVWS G +  E+M
Sbjct: 176 W-TAPE-AIAYRKFTSASDVWSFGIVMWEVM 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 69.4 bits (169), Expect = 1e-13
 Identities = 48/178 (26%), Positives = 88/178 (49%), Gaps = 29/178 (16%)

Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL-ARVTSETDFMTEYVVTRWYR 114
           + L+ L ++HS  V+HRD+K  N+LL  +  +K+ DFG  A++T E    +  V T ++ 
Sbjct: 123 ECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWM 182

Query: 115 APELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGF 174
           APE++   + Y   +D+WS+G + +E+++ +P +   + +  L  LI   GTP       
Sbjct: 183 APEVVTRKA-YGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL-YLIATNGTP------- 233

Query: 175 LNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
                     +L   +R S   +         D + + L  D  +R + ++ L HP+L
Sbjct: 234 ----------ELQNPERLSAVFR---------DFLNRCLEMDVDRRGSAKELLQHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 69.4 bits (170), Expect = 1e-13
 Identities = 53/202 (26%), Positives = 90/202 (44%), Gaps = 37/202 (18%)

Query: 34  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 93
           DL   I+S+    E   +++  +I+ GL+++H   +++RDLK  N+LL+ +  +KI DFG
Sbjct: 82  DLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFG 141

Query: 94  LARVTSETDFMTE-YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD 152
           + +     +     +  T  Y APE+L     Y  ++D WS G +  E++  +  F G D
Sbjct: 142 MCKENMNGEGKASTFCGTPDYIAPEILKGQK-YNESVDWWSFGVLLYEMLIGQSPFHGED 200

Query: 153 HVHQLRLLIELIGTPSEAEL--GFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVE 210
                           E EL    LN+         PR+           +   A D + 
Sbjct: 201 ----------------EDELFDSILNDRP-----HFPRW-----------ISKEAKDCLS 228

Query: 211 KMLTFDPRQRITVE-DALAHPY 231
           K+   DP +R+ V+ D   HP+
Sbjct: 229 KLFERDPTKRLGVDGDIRQHPF 250

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 68.9 bits (169), Expect = 2e-13
 Identities = 56/206 (27%), Positives = 92/206 (44%), Gaps = 42/206 (20%)

Query: 34  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 93
           DL   I ++   SE    ++   ++ GL+Y+H   +++RDLK  NLLL+    +KI DFG
Sbjct: 88  DLMMHIHTDV-FSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFG 146

Query: 94  LARV-TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD 152
           L +      D  + +  T  + APE+L  +S YT A+D W +G +  E++  +  FPG D
Sbjct: 147 LCKEGMGFGDRTSTFCGTPEFLAPEVLTETS-YTRAVDWWGLGVLIYEMLVGESPFPGDD 205

Query: 153 HVHQLRLLIELIGTPSEAEL--GFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVE 210
                           E E+    +N+          RY R    E        AI ++ 
Sbjct: 206 ----------------EEEVFDSIVNDE--------VRYPRFLSRE--------AISIMR 233

Query: 211 KMLTFDPRQRI-----TVEDALAHPY 231
           ++L  +P +R+       ED    P+
Sbjct: 234 RLLRRNPERRLGSGEKDAEDVKKQPF 259

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 68.9 bits (168), Expect = 2e-13
 Identities = 47/181 (25%), Positives = 88/181 (48%), Gaps = 28/181 (15%)

Query: 42  NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL-ARVTSE 100
           ++ L+E   Q    Q+L  L+Y+HS  ++HRDLK  N+LL  + D+K+ DFG+ A+    
Sbjct: 104 DRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT 163

Query: 101 TDFMTEYVVTRWYRAPELL----LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ 156
                 ++ T ++ APE++    +  + Y    D+WS+G   +E+     + P    ++ 
Sbjct: 164 LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQ---IEPPHHELNP 220

Query: 157 LRLLIEL-------IGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLV 209
           +R+L+++       +  PS+  + F  +  K  +            +K P   PSA  L+
Sbjct: 221 MRVLLKIAKSEPPTLSQPSKWSMEF-RDFLKTAL------------DKHPETRPSAAQLL 267

Query: 210 E 210
           E
Sbjct: 268 E 268

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 69.7 bits (170), Expect = 2e-13
 Identities = 45/146 (30%), Positives = 74/146 (50%), Gaps = 9/146 (6%)

Query: 1   MDHENVVAIRDIIPPPQRESF-NDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
            D +  V   DI        +   +  A E    D   +I  + ALS      F YQ+  
Sbjct: 193 QDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDT--LINESPALSYMDLVGFSYQVAN 250

Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSETDFMTE---YVVTRWYRA 115
           G++++ S N +HRDL   N+L+     +KICDFGLAR +  +++++++   ++  +W  A
Sbjct: 251 GMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWM-A 309

Query: 116 PELLLNSSDYTAAIDVWSVGCIFMEL 141
           PE + N+  YT   DVWS G +  E+
Sbjct: 310 PESIFNNL-YTTLSDVWSFGILLWEI 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 68.9 bits (169), Expect = 2e-13
 Identities = 54/261 (20%), Positives = 98/261 (37%), Gaps = 80/261 (30%)

Query: 20  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 75
           SF D    Y +M+     D+  ++      +EE  ++++ + +  +  IH    +HRD+K
Sbjct: 69  SFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIK 128

Query: 76  PSNLLLNANCDLKICDFGL-----------------------ARVTSETDFMTEYVVTRW 112
           P NLLL+A   +K+ DFGL                                 ++     W
Sbjct: 129 PDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETW 188

Query: 113 ----------------YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ 156
                           Y APE+ L +  Y    D WS+G I  E+               
Sbjct: 189 KRNRRALAYSTVGTPDYIAPEVFLQTG-YNKECDWWSLGVIMYEM--------------- 232

Query: 157 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP---NVHPSAIDLVEKML 213
                 L+G P      F ++N ++   +     ++  T +FP    + P A DL++++ 
Sbjct: 233 ------LVGYPP-----FCSDNPQE-TYRKIINWKE--TLQFPDEVPLSPEAKDLIKRLC 278

Query: 214 TFDPRQRI---TVEDALAHPY 231
             +  +R+    V +  +HP+
Sbjct: 279 C-EAERRLGNNGVNEIKSHPF 298

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 68.2 bits (167), Expect = 3e-13
 Identities = 39/133 (29%), Positives = 69/133 (51%), Gaps = 7/133 (5%)

Query: 20  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 75
           + +D    Y LM+     +L   +R++   S     ++  +I+  L+Y+HS  +++RDLK
Sbjct: 69  TEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLK 128

Query: 76  PSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVG 135
           P N+LL+    +K+ DFG A+     D       T  Y APE ++ S  +  A+D W++G
Sbjct: 129 PENILLDKEGHIKLTDFGFAKKLR--DRTWTLCGTPEYLAPE-VIQSKGHNKAVDWWALG 185

Query: 136 CIFMELMDRKPLF 148
            +  E++   P F
Sbjct: 186 ILIYEMLVGYPPF 198

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 67.7 bits (165), Expect = 3e-13
 Identities = 35/113 (30%), Positives = 68/113 (60%), Gaps = 7/113 (6%)

Query: 39  IRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVT 98
           +++  AL+E   + +  QIL+G+ Y+HS  ++HRD+K +N+L ++  ++K+ DFG ++  
Sbjct: 97  LKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRI 156

Query: 99  SETDFMTEYVV-----TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP 146
            +T  M+   +     T ++ +PE +++   Y    DVWSV C  +E++  KP
Sbjct: 157 -QTICMSGTGIKSVTGTPYWMSPE-VISGEGYGRKADVWSVACTVVEMLTEKP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 67.8 bits (166), Expect = 4e-13
 Identities = 36/104 (34%), Positives = 55/104 (52%), Gaps = 6/104 (5%)

Query: 43  QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD 102
           + L+++    F YQ+ RG++++ S   +HRDL   N+L+  +  +KI DFGLAR     D
Sbjct: 127 ETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHID 186

Query: 103 FMTEYVVTR----WYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
           +  +    R    W  APE L +   YT   DVWS G +  E+ 
Sbjct: 187 YYRKTTNGRLPVKWM-APEALFDRV-YTHQSDVWSFGVLLWEIF 228

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 67.9 bits (166), Expect = 4e-13
 Identities = 45/119 (37%), Positives = 61/119 (51%), Gaps = 18/119 (15%)

Query: 34  DLHQIIRSNQA--LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD 91
           DL   +R  +   L+ E    F YQ+ +G+ ++ S N +HRDL   N+LL     +KICD
Sbjct: 125 DLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICD 184

Query: 92  FGLARVTSETDFMTE--YVV-------TRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 141
           FGLAR     D M +  YVV        +W  APE + N   YT   DVWS G +  E+
Sbjct: 185 FGLAR-----DIMNDSNYVVKGNARLPVKWM-APESIFNCV-YTFESDVWSYGILLWEI 236

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 67.4 bits (164), Expect = 4e-13
 Identities = 34/112 (30%), Positives = 64/112 (57%), Gaps = 5/112 (4%)

Query: 39  IRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG----L 94
           +++  AL+E   + +  QIL G+ Y+HS  ++HRD+K +N+L ++  ++K+ DFG    L
Sbjct: 97  LKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRL 156

Query: 95  ARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP 146
             +      +     T ++ +PE +++   Y    DVWS+GC  +E++  KP
Sbjct: 157 QTICMSGTGIRSVTGTPYWMSPE-VISGEGYGRKADVWSLGCTVVEMLTEKP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 67.0 bits (164), Expect = 5e-13
 Identities = 49/156 (31%), Positives = 73/156 (46%), Gaps = 22/156 (14%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDV--YIAYELMDTDLHQIIRSNQALSEEHCQYFLY--Q 56
           +DHEN+V  + +   P   S   +  Y+    +   L Q  R    L     +  L+  Q
Sbjct: 63  LDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYL-QRHRDQINLK----RLLLFSSQ 117

Query: 57  ILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR----- 111
           I +G+ Y+ S   +HRDL   N+L+ +   +KI DFGLA+V  E     +Y   +     
Sbjct: 118 ICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDK---DYYYVKEPGES 174

Query: 112 ---WYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR 144
              WY APE  L +S +++A DVWS G    EL   
Sbjct: 175 PIFWY-APE-CLRTSKFSSASDVWSFGVTLYELFTY 208

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 67.3 bits (164), Expect = 6e-13
 Identities = 36/120 (30%), Positives = 67/120 (55%), Gaps = 3/120 (2%)

Query: 39  IRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV- 97
           ++  ++  E   +++  +I   L Y+HS N+++RDLKP N+LL++   + + DFGL +  
Sbjct: 87  LQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEG 146

Query: 98  TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL 157
            +++D  T +  T  Y APE ++    Y   +D W +G +  E++   P F  RD V ++
Sbjct: 147 IAQSDTTTTFCGTPEYLAPE-VIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD-VAEM 204

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 67.7 bits (165), Expect = 7e-13
 Identities = 42/131 (32%), Positives = 72/131 (54%), Gaps = 13/131 (9%)

Query: 15  PPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDL 74
           P   +  ND  +   L+  D  + + +   LS      F YQ+ RG++++ S N +HRDL
Sbjct: 211 PASYKGSNDSEVK-NLLSDDGSEGLTTLDLLS------FTYQVARGMEFLASKNCVHRDL 263

Query: 75  KPSNLLLNANCDLKICDFGLAR-VTSETDFMTE---YVVTRWYRAPELLLNSSDYTAAID 130
              N+LL     +KICDFGLAR +  +++++++   ++  +W  APE + ++  YT   D
Sbjct: 264 AARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWM-APESIFDNL-YTTLSD 321

Query: 131 VWSVGCIFMEL 141
           VWS G +  E+
Sbjct: 322 VWSYGILLWEI 332

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 67.0 bits (163), Expect = 8e-13
 Identities = 50/210 (23%), Positives = 91/210 (43%), Gaps = 32/210 (15%)

Query: 32  DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD 91
           D   H          E    ++  +I  GL+ +H   +++RDLKP N+LL+ +  ++I D
Sbjct: 86  DLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISD 145

Query: 92  FGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGR 151
            GLA    E   +   V T  Y APE++ N   YT + D W++GC+  E++  +  F  R
Sbjct: 146 LGLAVHVPEGQTIKGRVGTVGYMAPEVVKNER-YTFSPDWWALGCLLYEMIAGQSPFQQR 204

Query: 152 DHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEK 211
                                    +  ++ + +L +  ++ ++EKF    P A  L + 
Sbjct: 205 K-----------------------KKIKREEVERLVKEVQEEYSEKFS---PDARSLCKM 238

Query: 212 MLTFDPRQRI-----TVEDALAHPYLGSLH 236
           +L  DP++R+        +   HP    ++
Sbjct: 239 LLCKDPKERLGCQGGGAREVKEHPLFKQIN 268

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 66.2 bits (162), Expect = 9e-13
 Identities = 45/149 (30%), Positives = 70/149 (46%), Gaps = 17/149 (11%)

Query: 2   DHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSN-QALSEEHCQYFLYQILR 59
           DH N++ +  ++          V I  E M+   L + +R N    +       L  I  
Sbjct: 63  DHPNIIRLEGVV-----TKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIAS 117

Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT------RWY 113
           G+KY+   N +HRDL   N+L+N+N   K+ DFGL+R   +++    Y         RW 
Sbjct: 118 GMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSE--ATYTTKGGKIPIRW- 174

Query: 114 RAPELLLNSSDYTAAIDVWSVGCIFMELM 142
            APE  +    +T+A DVWS G +  E+M
Sbjct: 175 TAPE-AIAYRKFTSASDVWSFGIVMWEVM 202

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 66.2 bits (162), Expect = 9e-13
 Identities = 48/145 (33%), Positives = 69/145 (47%), Gaps = 14/145 (9%)

Query: 24  VYIAYELMDT-DLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL 80
           +YI  E M    L   ++S   + L          QI  G+ Y+ S N +HRDL   N+L
Sbjct: 76  IYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNIL 135

Query: 81  LNANCDLKICDFGLARVTSETDFMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCI 137
           +  N   KI DFGLAR+  E D  T     ++   + APE   N   +T   DVWS G +
Sbjct: 136 VGENLVCKIADFGLARLI-EDDEYTAREGAKFPIKWTAPE-AANYGRFTIKSDVWSFGIL 193

Query: 138 FMELMD--RKPLFPG---RDHVHQL 157
             E++   R P +PG   R+ + Q+
Sbjct: 194 LTEIVTYGRVP-YPGMTNREVLEQV 217

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 66.8 bits (163), Expect = 9e-13
 Identities = 55/218 (25%), Positives = 95/218 (43%), Gaps = 43/218 (19%)

Query: 22  NDVYIAYE-LMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL 80
           N VY   E ++  +L   +R       +  +++  +++   +Y+HS ++++RDLKP NLL
Sbjct: 91  NRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLL 150

Query: 81  LNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 140
           L+    +K+ DFG A+   +  F      T  Y APE ++ S  +  A+D W++G +  E
Sbjct: 151 LDNKGHVKVTDFGFAKKVPDRTFT--LCGTPEYLAPE-VIQSKGHGKAVDWWTMGVLLYE 207

Query: 141 LMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQR-QSFTEKFP 199
                                 + G P      F ++   +       Y++  +   KFP
Sbjct: 208 F---------------------IAGYPP-----FFDDTPFRI------YEKILAGRLKFP 235

Query: 200 N-VHPSAIDLVEKMLTFDPRQRI-----TVEDALAHPY 231
           N     A DLV+ +L  D  +R+      V D   HPY
Sbjct: 236 NWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPY 273

Length = 329

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 67.2 bits (164), Expect = 1e-12
 Identities = 45/130 (34%), Positives = 66/130 (50%), Gaps = 21/130 (16%)

Query: 20  SFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL 79
           S+ D  +  E+++ D         AL  E    F YQ+ +G+ ++ S N +HRDL   N+
Sbjct: 193 SYIDQDVTSEILEED-------ELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNI 245

Query: 80  LLNANCDLKICDFGLAR-VTSETDFMTEYVV-------TRWYRAPELLLNSSDYTAAIDV 131
           LL      KICDFGLAR + ++++    YVV        +W  APE + N   YT   DV
Sbjct: 246 LLTHGRITKICDFGLARDIRNDSN----YVVKGNARLPVKWM-APESIFNCV-YTFESDV 299

Query: 132 WSVGCIFMEL 141
           WS G +  E+
Sbjct: 300 WSYGILLWEI 309

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 66.8 bits (163), Expect = 1e-12
 Identities = 41/145 (28%), Positives = 79/145 (54%), Gaps = 12/145 (8%)

Query: 46  SEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMT 105
           +EE  +++L ++   L ++HS  +++RDLKP N+LL+    +K+ DFGL++ + + +   
Sbjct: 96  TEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA 155

Query: 106 -EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELI 164
             +  T  Y APE ++N   +T + D WS G +  E++     F G+D    + +++   
Sbjct: 156 YSFCGTVEYMAPE-VVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMIL--- 211

Query: 165 GTPSEAELG---FLNENAKKYICQL 186
               +A+LG   FL+  A+  +  L
Sbjct: 212 ----KAKLGMPQFLSPEAQSLLRAL 232

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 66.7 bits (163), Expect = 1e-12
 Identities = 35/109 (32%), Positives = 58/109 (53%), Gaps = 2/109 (1%)

Query: 46  SEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSE-TDFM 104
            E   +++  +I   L Y+HS N+++RDLKP N+LL++   + + DFGL +   E +   
Sbjct: 94  PEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTT 153

Query: 105 TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDH 153
           + +  T  Y APE+L     Y   +D W +G +  E++   P F  RD 
Sbjct: 154 STFCGTPEYLAPEVLRK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDT 201

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 66.1 bits (161), Expect = 1e-12
 Identities = 41/138 (29%), Positives = 75/138 (54%), Gaps = 7/138 (5%)

Query: 52  YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR 111
           ++  QI  G+ ++HS ++++RD+KP N+LL+   + ++ D GLA    +   +T+   T 
Sbjct: 99  HYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTN 158

Query: 112 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAE 171
            Y APE+L     Y+  +D +++GC   E++  +   P +DH  ++    EL     E E
Sbjct: 159 GYMAPEILKEEP-YSYPVDWFAMGCSIYEMVAGRT--PFKDHKEKVAKE-ELKRRTLEDE 214

Query: 172 LGFLNEN---AKKYICQL 186
           + F ++N     K IC+L
Sbjct: 215 VKFEHQNFTEESKDICRL 232

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 65.4 bits (159), Expect = 2e-12
 Identities = 35/109 (32%), Positives = 58/109 (53%), Gaps = 5/109 (4%)

Query: 43  QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL-ARVTSET 101
           + L+E   +    Q L  L Y+H   ++HRDLK  N+L   + D+K+ DFG+ A+ T   
Sbjct: 98  RPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 157

Query: 102 DFMTEYVVTRWYRAPELLL--NSSD--YTAAIDVWSVGCIFMELMDRKP 146
                ++ T ++ APE+++   S D  Y    DVWS+G   +E+   +P
Sbjct: 158 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEP 206

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 65.9 bits (160), Expect = 2e-12
 Identities = 51/223 (22%), Positives = 108/223 (48%), Gaps = 30/223 (13%)

Query: 34  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 93
           DL   ++  + L EEH +++  +I   L Y+H   +++RDLK  N+LL++   +K+ D+G
Sbjct: 82  DLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYG 141

Query: 94  LARV-TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD 152
           + +      D  + +  T  Y APE +L   DY  ++D W++G +  E+M  +  F    
Sbjct: 142 MCKEGLRPGDTTSTFCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSPF---- 196

Query: 153 HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKM 212
                    +++G+    +     +N + Y+ Q+   ++Q    +  +V  +++  ++  
Sbjct: 197 ---------DIVGSSDNPD-----QNTEDYLFQVI-LEKQIRIPRSLSVKAASV--LKSF 239

Query: 213 LTFDPRQRITV------EDALAHPYLGSLH-DISDEPVCMSPF 248
           L  DP++R+         D   HP+  ++  D+ ++   + PF
Sbjct: 240 LNKDPKERLGCHPQTGFADIQGHPFFRNVDWDLMEQKQVVPPF 282

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 65.2 bits (159), Expect = 4e-12
 Identities = 34/107 (31%), Positives = 58/107 (54%), Gaps = 2/107 (1%)

Query: 47  EEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE 106
           E H  ++  +I  GL ++HS  +++RDLK  N++L+A   +KI DFG+ +        T 
Sbjct: 100 EPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTR 159

Query: 107 -YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD 152
            +  T  Y APE++     Y  ++D W+ G +  E++  +P F G D
Sbjct: 160 TFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVLLYEMLAGQPPFDGED 205

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 65.7 bits (160), Expect = 4e-12
 Identities = 39/126 (30%), Positives = 68/126 (53%), Gaps = 8/126 (6%)

Query: 34  DLHQIIRS----NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKI 89
           DL Q I+S    N+   E        Q+L  + ++HS +++HRD+K +N+LL +N  +K+
Sbjct: 125 DLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKL 184

Query: 90  CDFGLARVTSET---DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP 146
            DFG +++ + T   D    +  T +Y APE +     Y+   D++S+G +  EL+  K 
Sbjct: 185 GDFGFSKMYAATVSDDVGRTFCGTPYYVAPE-IWRRKPYSKKADMFSLGVLLYELLTLKR 243

Query: 147 LFPGRD 152
            F G +
Sbjct: 244 PFDGEN 249

Length = 496

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 65.9 bits (160), Expect = 4e-12
 Identities = 61/255 (23%), Positives = 105/255 (41%), Gaps = 36/255 (14%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEE-----HCQYFLY 55
           ++HEN++ I +I+         + Y+  +  D DL+  +       ++       +  + 
Sbjct: 220 LNHENILKIEEILRSE-----ANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMK 274

Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEY--VVTRWY 113
           Q+L  ++YIH   ++HRD+K  N+ LN +  + + DFG A    +     +Y  V T   
Sbjct: 275 QLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVAT 334

Query: 114 RAPELLLNSSDYTAAIDVWSVGCIFMELMDRK--PLFPGRDHVH-QLRLLIELIGTPSEA 170
            +PE+L     Y    D+WS G I ++++     P+  G      QL  +I+        
Sbjct: 335 NSPEILAGDG-YCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIID-------- 385

Query: 171 ELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAI-----------DLVEKMLTFDPRQ 219
            L   +E      C+L  Y   +  +   +  P  I            LV KMLTFD   
Sbjct: 386 SLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLV-KMLTFDWHL 444

Query: 220 RITVEDALAHPYLGS 234
           R    + LA P   +
Sbjct: 445 RPGAAELLALPLFSA 459

Length = 501

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 65.0 bits (159), Expect = 4e-12
 Identities = 58/230 (25%), Positives = 91/230 (39%), Gaps = 72/230 (31%)

Query: 39  IRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA--- 95
           IR +    EE  ++++ +++  L  +H    +HRD+KP N+L++A+  +K+ DFGL    
Sbjct: 93  IRKDV-FPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKM 151

Query: 96  ---------RVTSETDFMTEYVVTRW------------------YRAPELLLNSSDYTAA 128
                       S      + V+ R                   Y APE+L   + Y   
Sbjct: 152 NKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLR-GTPYGLE 210

Query: 129 IDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTP---SEAELGFLNENAKKYICQ 185
            D WS+G I  E+                     L G P   S+     L E   K I  
Sbjct: 211 CDWWSLGVILYEM---------------------LYGFPPFYSDT----LQETYNKII-- 243

Query: 186 LPRYQRQSFTEKFP---NVHPSAIDLVEKMLTFDPRQRIT-VEDALAHPY 231
                ++S    FP    V P AIDL+ ++L  DP  R+   E+  +HP+
Sbjct: 244 ---NWKESLR--FPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPF 287

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 64.3 bits (156), Expect = 4e-12
 Identities = 47/145 (32%), Positives = 75/145 (51%), Gaps = 11/145 (7%)

Query: 24  VYIAYELMDT-DLHQIIRSNQALSEEHCQY--FLYQILRGLKYIHSANVLHRDLKPSNLL 80
           +YI  E M    L   ++S++   +   +   F  QI  G+ +I   N +HRDL+ +N+L
Sbjct: 75  IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANIL 134

Query: 81  LNANCDLKICDFGLARVTSETDFMTE---YVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 137
           ++A+   KI DFGLARV  + ++          +W  APE  +N   +T   DVWS G +
Sbjct: 135 VSASLVCKIADFGLARVIEDNEYTAREGAKFPIKW-TAPE-AINFGSFTIKSDVWSFGIL 192

Query: 138 FMELMD--RKPLFPGRDHVHQLRLL 160
            ME++   R P +PG  +   +R L
Sbjct: 193 LMEIVTYGRIP-YPGMSNPEVIRAL 216

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 65.0 bits (158), Expect = 5e-12
 Identities = 35/101 (34%), Positives = 59/101 (58%), Gaps = 6/101 (5%)

Query: 45  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSETDF 103
           L+ E    + +Q+ +G++++ S   +HRDL   N+LL+ N  +KICDFGLAR +  + D+
Sbjct: 176 LTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY 235

Query: 104 MTE---YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 141
           + +    +  +W  APE + +   YT   DVWS G +  E+
Sbjct: 236 VRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEI 274

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 64.2 bits (156), Expect = 7e-12
 Identities = 34/115 (29%), Positives = 61/115 (53%), Gaps = 2/115 (1%)

Query: 39  IRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVT 98
           ++  +   E   +++  ++   + Y+HS N+++RDLKP N+LL++   + + DFGL +  
Sbjct: 87  LQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEG 146

Query: 99  SETDFMTE-YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD 152
            E +  T  +  T  Y APE +L    Y   +D W +G +  E++   P F  RD
Sbjct: 147 VEPEETTSTFCGTPEYLAPE-VLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD 200

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 64.2 bits (156), Expect = 9e-12
 Identities = 55/196 (28%), Positives = 98/196 (50%), Gaps = 16/196 (8%)

Query: 20  SFND---VYIAYE-LMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 75
           SF D   +Y+  E ++  +    +R N+    +   ++  QI+   +Y+ S N+++RDLK
Sbjct: 99  SFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLK 158

Query: 76  PSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVG 135
           P NLLL+ +  +K+ DFG A+V     +      T  Y APE+LLN     AA D W++G
Sbjct: 159 PENLLLDKDGFIKMTDFGFAKVVDTRTYT--LCGTPEYIAPEILLNVGHGKAA-DWWTLG 215

Query: 136 CIFMELMDRKPLFPGRDHVHQLRLLIE-LIGTPSEAELGFLNENAKKYICQLPRYQRQSF 194
               E++   P F   + +   + ++E +I  P      FL+ N K  + +L  +     
Sbjct: 216 IFIYEILVGCPPFYANEPLLIYQKILEGIIYFPK-----FLDNNCKHLMKKLLSH---DL 267

Query: 195 TEKFPNVHPSAIDLVE 210
           T+++ N+   A ++ E
Sbjct: 268 TKRYGNLKKGAQNVKE 283

Length = 340

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 63.5 bits (154), Expect = 1e-11
 Identities = 35/107 (32%), Positives = 59/107 (55%), Gaps = 2/107 (1%)

Query: 47  EEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE 106
           E   +++  +I   L Y+HS N+++RDLKP N+LL++   + + DFGL +   E +  T 
Sbjct: 95  EPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTS 154

Query: 107 -YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD 152
            +  T  Y APE +L+   Y   +D W +G +  E++   P F  R+
Sbjct: 155 TFCGTPEYLAPE-VLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN 200

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 63.3 bits (154), Expect = 1e-11
 Identities = 44/203 (21%), Positives = 91/203 (44%), Gaps = 36/203 (17%)

Query: 41  SNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR--VT 98
             +  +E   + ++ +I+  L ++H   +++RD+K  N+LL++   + + DFGL++  + 
Sbjct: 98  QREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLA 157

Query: 99  SETDFMTEYVVTRWYRAPELLLNSSD-YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL 157
            E +    +  T  Y APE++   S  +  A+D WS+G +  EL+     F         
Sbjct: 158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDG----- 212

Query: 158 RLLIELIGTPSEAELGFLNENAKKYI-CQLPRYQRQSFTEKFPN-VHPSAIDLVEKMLTF 215
                     S++E+      +++ +  + P          FP  +   A D ++K+L  
Sbjct: 213 -------EQNSQSEI------SRRILKSKPP----------FPKTMSAEARDFIQKLLEK 249

Query: 216 DPRQRITVEDA---LAHPYLGSL 235
           DP++R+    A     HP+   +
Sbjct: 250 DPKKRLGANGADEIKNHPFFQGI 272

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 63.1 bits (153), Expect = 1e-11
 Identities = 35/90 (38%), Positives = 50/90 (55%), Gaps = 4/90 (4%)

Query: 55  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRW-- 112
           YQ+ RG++Y+ S   +HRDL   N+L+  N  +KI DFGLAR  +  D+  +    R   
Sbjct: 144 YQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPV 203

Query: 113 -YRAPELLLNSSDYTAAIDVWSVGCIFMEL 141
            + APE L +   YT   DVWS G +  E+
Sbjct: 204 KWMAPEALFDRV-YTHQSDVWSFGVLMWEI 232

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 63.4 bits (154), Expect = 1e-11
 Identities = 39/120 (32%), Positives = 64/120 (53%), Gaps = 2/120 (1%)

Query: 34  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 93
           DL   I+S          ++  +I+ GL+++HS  +++RDLK  N+LL+ +  +KI DFG
Sbjct: 82  DLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFG 141

Query: 94  LARVTSETDFMT-EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD 152
           + +     D  T  +  T  Y APE+LL    Y  ++D WS G +  E++  +  F G D
Sbjct: 142 MCKENMLGDAKTCTFCGTPDYIAPEILLGQK-YNTSVDWWSFGVLLYEMLIGQSPFHGHD 200

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 63.5 bits (154), Expect = 1e-11
 Identities = 34/93 (36%), Positives = 56/93 (60%), Gaps = 6/93 (6%)

Query: 53  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSETDFM---TEYV 108
           + +Q+ RG++++ S   +HRDL   N+LL+ N  +KICDFGLAR +  + D++   +  +
Sbjct: 179 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL 238

Query: 109 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 141
             +W  APE + +   YT   DVWS G +  E+
Sbjct: 239 PLKWM-APESIFDKV-YTTQSDVWSFGVLLWEI 269

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 63.4 bits (154), Expect = 2e-11
 Identities = 50/218 (22%), Positives = 98/218 (44%), Gaps = 37/218 (16%)

Query: 25  YIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN 84
           Y++   M T L+Q        SE+  +++  +I+  L+++H   +++RD+K  N+LL++ 
Sbjct: 86  YVSGGEMFTHLYQ----RDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSE 141

Query: 85  CDLKICDFGLAR--VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
             + + DFGL++  ++ E +    +  T  Y APE++     +  A+D WS+G +  EL+
Sbjct: 142 GHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELL 201

Query: 143 DRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVH 202
                F                    E E    +E +++ +   P +           + 
Sbjct: 202 TGASPF------------------TLEGERNTQSEVSRRILKCDPPFP--------SFIG 235

Query: 203 PSAIDLVEKMLTFDPRQRI-----TVEDALAHPYLGSL 235
           P A DL+ K+L  DP++R+        +   HP+   L
Sbjct: 236 PEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL 273

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 63.3 bits (154), Expect = 2e-11
 Identities = 57/217 (26%), Positives = 87/217 (40%), Gaps = 31/217 (14%)

Query: 34  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 93
           DL   +  +  L  E       ++L  L Y+H   ++HRD+K  N+ L+   +  + DFG
Sbjct: 171 DLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFG 230

Query: 94  LARVTSETDFMTE---YVVTRWYRAPELL-LNSSDYTAAIDVWSVGCIFME-LMDRKPLF 148
            A          +   +  T    +PELL L+   Y A  D+WS G +  E  +    LF
Sbjct: 231 AACKLDAHPDTPQCYGWSGTLETNSPELLALDP--YCAKTDIWSAGLVLFEMSVKNVTLF 288

Query: 149 PGRDHV--HQLRLLIELIGTPSEAELGF-LNENA------KKYICQL------PRYQRQS 193
             +      QLR +I  +       L F  N +       K+Y   L      P   R+ 
Sbjct: 289 GKQVKSSSSQLRSIIRCMQV---HPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKY 345

Query: 194 FTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHP 230
                  +H     L+ KMLTFD   R + +D L+ P
Sbjct: 346 ------GMHMDVEYLIAKMLTFDQEFRPSAQDILSLP 376

Length = 392

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 63.1 bits (153), Expect = 2e-11
 Identities = 34/116 (29%), Positives = 65/116 (56%), Gaps = 2/116 (1%)

Query: 34  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 93
           DL   ++  + L EEH +++  +I   L ++H   +++RDLK  N+LL+A+  +K+ D+G
Sbjct: 82  DLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYG 141

Query: 94  LARV-TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 148
           + +      D  + +  T  Y APE +L   +Y  ++D W++G +  E+M  +  F
Sbjct: 142 MCKEGLGPGDTTSTFCGTPNYIAPE-ILRGEEYGFSVDWWALGVLMFEMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 62.2 bits (151), Expect = 2e-11
 Identities = 48/155 (30%), Positives = 73/155 (47%), Gaps = 28/155 (18%)

Query: 2   DHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQ---I 57
           DH N++ +  ++   +      V I  E M+   L   +R +        Q+ + Q   +
Sbjct: 63  DHPNIIHLEGVVTKSK-----PVMIVTEYMENGSLDAFLRKHDG------QFTVIQLVGM 111

Query: 58  LRG----LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT--- 110
           LRG    +KY+     +HRDL   N+L+N+N   K+ DFGL+RV  E D    Y      
Sbjct: 112 LRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVL-EDDPEAAYTTRGGK 170

Query: 111 ---RWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
              RW  APE  +    +T+A DVWS G +  E+M
Sbjct: 171 IPIRW-TAPE-AIAYRKFTSASDVWSYGIVMWEVM 203

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 62.9 bits (153), Expect = 2e-11
 Identities = 40/109 (36%), Positives = 57/109 (52%), Gaps = 19/109 (17%)

Query: 53  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE--YVV- 109
           F  Q+ +G+ ++ S N +HRD+   N+LL      KICDFGLAR     D M +  YVV 
Sbjct: 217 FSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLAR-----DIMNDSNYVVK 271

Query: 110 ------TRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL--MDRKPLFPG 150
                  +W  APE + +   YT   DVWS G +  E+  + + P +PG
Sbjct: 272 GNARLPVKWM-APESIFDCV-YTVQSDVWSYGILLWEIFSLGKSP-YPG 317

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 62.1 bits (151), Expect = 2e-11
 Identities = 47/157 (29%), Positives = 69/157 (43%), Gaps = 26/157 (16%)

Query: 2   DHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQY------FLY 55
            H NV+++  I  P   E    V + Y +   DL   IRS     E H         F  
Sbjct: 54  SHPNVLSLLGICLPS--EGSPLVVLPY-MKHGDLRNFIRS-----ETHNPTVKDLIGFGL 105

Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRA 115
           Q+ +G++Y+ S   +HRDL   N +L+ +  +K+ DFGLAR   +     EY     +  
Sbjct: 106 QVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYD----KEYYSVHNHTG 161

Query: 116 PEL--------LLNSSDYTAAIDVWSVGCIFMELMDR 144
            +L         L +  +T   DVWS G +  ELM R
Sbjct: 162 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTR 198

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 62.0 bits (150), Expect = 3e-11
 Identities = 37/103 (35%), Positives = 55/103 (53%), Gaps = 6/103 (5%)

Query: 53  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE---YVV 109
           F  QI  G+ YI   N +HRDL+ +N+L++ +   KI DFGLARV  + ++         
Sbjct: 108 FSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFP 167

Query: 110 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR-KPLFPGR 151
            +W  APE  +N   +T   DVWS G +  E++   K  +PG 
Sbjct: 168 IKW-TAPE-AINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGM 208

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 61.7 bits (150), Expect = 4e-11
 Identities = 35/108 (32%), Positives = 55/108 (50%), Gaps = 6/108 (5%)

Query: 39  IRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVT 98
             + QALS +   +   QI  G+ Y+H   V+H+D+   N +++    +KI D  L+R  
Sbjct: 108 ANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDL 167

Query: 99  SETDFM----TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
              D+      E    +W  A E L+N  +Y++A DVWS G +  ELM
Sbjct: 168 FPMDYHCLGDNENRPVKWM-ALESLVN-KEYSSASDVWSFGVLLWELM 213

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 61.8 bits (150), Expect = 4e-11
 Identities = 34/110 (30%), Positives = 62/110 (56%), Gaps = 2/110 (1%)

Query: 34  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 93
           DL   ++  + L EEH +++  +I   L ++H   +++RDLK  N+LL+A   +K+ D+G
Sbjct: 82  DLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYG 141

Query: 94  LARV-TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
           + +      D  + +  T  Y APE +L   DY  ++D W++G +  E+M
Sbjct: 142 MCKEGIRPGDTTSTFCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMM 190

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 62.0 bits (150), Expect = 5e-11
 Identities = 36/100 (36%), Positives = 52/100 (52%), Gaps = 5/100 (5%)

Query: 55  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRW-- 112
           YQ+ RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR     D+  +    R   
Sbjct: 141 YQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPV 200

Query: 113 -YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL-FPG 150
            + APE L +   YT   DVWS G +  E+       +PG
Sbjct: 201 KWMAPEALFDRV-YTHQSDVWSFGVLLWEIFTLGGSPYPG 239

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 61.9 bits (150), Expect = 5e-11
 Identities = 34/90 (37%), Positives = 50/90 (55%), Gaps = 4/90 (4%)

Query: 55  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRW-- 112
           YQ+ RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR   + D+  +    R   
Sbjct: 141 YQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPV 200

Query: 113 -YRAPELLLNSSDYTAAIDVWSVGCIFMEL 141
            + APE L +   YT   DVWS G +  E+
Sbjct: 201 KWMAPEALFDRV-YTHQSDVWSFGILMWEI 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 61.8 bits (150), Expect = 5e-11
 Identities = 36/101 (35%), Positives = 59/101 (58%), Gaps = 6/101 (5%)

Query: 45  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSETDF 103
           L+ E    + +Q+ RG++++ S   +HRDL   N+LL+ N  +KICDFGLAR +  + D+
Sbjct: 170 LTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDY 229

Query: 104 MTE---YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 141
           + +    +  +W  APE + +   YT   DVWS G +  E+
Sbjct: 230 VRKGDARLPLKWM-APESIFDKV-YTTQSDVWSFGVLLWEI 268

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 61.0 bits (149), Expect = 5e-11
 Identities = 49/206 (23%), Positives = 88/206 (42%), Gaps = 38/206 (18%)

Query: 32  DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD-LKIC 90
           D DL  +++    LSE   +  + Q++  L  +H  N++H D+K  N+L +   D + +C
Sbjct: 93  DGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLC 152

Query: 91  DFGLARV---TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL 147
           D+GL ++    S  D   +Y       +PE  +   +Y  + D W+VG +  EL+  K  
Sbjct: 153 DYGLCKIIGTPSCYDGTLDYF------SPE-KIKGHNYDVSFDWWAVGVLTYELLTGK-- 203

Query: 148 FPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAID 207
            P ++   +     EL                      L + Q++       NV  +A D
Sbjct: 204 HPFKEDEDE-----EL--DLES----------------LLKRQQKKLP-FIKNVSKNAND 239

Query: 208 LVEKMLTFDPRQR-ITVEDALAHPYL 232
            V+ ML ++   R     + + HP+L
Sbjct: 240 FVQSMLKYNINYRLTNYNEIIKHPFL 265

Length = 267

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 61.1 bits (148), Expect = 6e-11
 Identities = 46/151 (30%), Positives = 76/151 (50%), Gaps = 14/151 (9%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSN--QALSEEHCQYFLYQI 57
           + H+N+V +  +I        N +YI  ELM   +L   +R+     +S      F   +
Sbjct: 56  LHHKNLVRLLGVI------LHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDV 109

Query: 58  LRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPE 117
             G++Y+ S  ++HRDL   N+L++ +   K+ DFGLARV S     ++  V +W  APE
Sbjct: 110 AEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPV-KW-TAPE 167

Query: 118 LLLNSSDYTAAIDVWSVGCIFMELMD--RKP 146
            L +   +++  DVWS G +  E+    R P
Sbjct: 168 ALKHKK-FSSKSDVWSYGVLLWEVFSYGRAP 197

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 62.0 bits (150), Expect = 6e-11
 Identities = 37/123 (30%), Positives = 62/123 (50%), Gaps = 4/123 (3%)

Query: 31  MDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKIC 90
           ++  + Q ++ +    E       YQI+  L  +HS  ++HRDLK +N+ L     +K+ 
Sbjct: 152 LNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLG 211

Query: 91  DFGLARVTSET---DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL 147
           DFG ++  S++   D  + +  T +Y APE L     Y+   D+WS+G I  EL+     
Sbjct: 212 DFGFSKQYSDSVSLDVASSFCGTPYYLAPE-LWERKRYSKKADMWSLGVILYELLTLHRP 270

Query: 148 FPG 150
           F G
Sbjct: 271 FKG 273

Length = 478

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 60.7 bits (147), Expect = 7e-11
 Identities = 32/110 (29%), Positives = 62/110 (56%), Gaps = 5/110 (4%)

Query: 35  LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL 94
           L++ ++ N+ ++E++    ++Q+  G+KY+   N +HRDL   N+LL      KI DFGL
Sbjct: 82  LNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGL 141

Query: 95  AR-VTSETDFMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFME 140
           ++ + ++ ++       +W   + APE  +N   +++  DVWS G +  E
Sbjct: 142 SKALGADENYYKAKTHGKWPVKWYAPE-CMNYYKFSSKSDVWSFGVLMWE 190

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 62.2 bits (151), Expect = 7e-11
 Identities = 43/165 (26%), Positives = 74/165 (44%), Gaps = 27/165 (16%)

Query: 3   HENVVAIRDI-IPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRG 60
           H N+VA+ D    PP       ++  +E +    L +++ ++ AL        + Q+L  
Sbjct: 37  HPNIVALLDSGEAPPGL-----LFAVFEYVPGRTLREVLAADGALPAGETGRLMLQVLDA 91

Query: 61  LKYIHSANVLHRDLKPSNLLLNANCD---LKICDFGL------------ARVTSETDFMT 105
           L   H+  ++HRDLKP N++++        K+ DFG+            A +T      T
Sbjct: 92  LACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRT----T 147

Query: 106 EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPG 150
           E + T  Y APE L      T   D+++ G IF+E +  + +  G
Sbjct: 148 EVLGTPTYCAPEQLRGEP-VTPNSDLYAWGLIFLECLTGQRVVQG 191

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 60.8 bits (147), Expect = 9e-11
 Identities = 34/90 (37%), Positives = 49/90 (54%), Gaps = 4/90 (4%)

Query: 55  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRW-- 112
           YQ+ RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR     D+  +    R   
Sbjct: 147 YQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPV 206

Query: 113 -YRAPELLLNSSDYTAAIDVWSVGCIFMEL 141
            + APE L +   YT   DVWS G +  E+
Sbjct: 207 KWMAPEALFDRI-YTHQSDVWSFGVLLWEI 235

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 60.3 bits (146), Expect = 1e-10
 Identities = 35/101 (34%), Positives = 54/101 (53%), Gaps = 8/101 (7%)

Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE---YVVTRW 112
           QI  G+ +I   N +HRDL+ +N+L++     KI DFGLAR+  + ++          +W
Sbjct: 110 QIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKW 169

Query: 113 YRAPELLLNSSDYTAAIDVWSVGCIFMELMD--RKPLFPGR 151
             APE  +N   +T   DVWS G +  E++   R P +PG 
Sbjct: 170 -TAPE-AINYGTFTIKSDVWSFGILLTEIVTYGRIP-YPGM 207

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 60.8 bits (147), Expect = 1e-10
 Identities = 40/151 (26%), Positives = 77/151 (50%), Gaps = 13/151 (8%)

Query: 19  ESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 77
           ++ + +Y   E ++  DL   I+      E H  ++  +I  GL ++HS  +++RDLK  
Sbjct: 71  QTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLD 130

Query: 78  NLLLNANCDLKICDFGLAR------VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDV 131
           N++L++   +KI DFG+ +      VT++T     +  T  Y APE ++    Y  ++D 
Sbjct: 131 NVMLDSEGHIKIADFGMCKENMWDGVTTKT-----FCGTPDYIAPE-IIAYQPYGKSVDW 184

Query: 132 WSVGCIFMELMDRKPLFPGRDHVHQLRLLIE 162
           W+ G +  E++  +  F G D     + ++E
Sbjct: 185 WAFGVLLYEMLAGQAPFEGEDEDELFQSIME 215

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 60.1 bits (146), Expect = 1e-10
 Identities = 32/99 (32%), Positives = 50/99 (50%), Gaps = 12/99 (12%)

Query: 50  CQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVV 109
           C Y + QI  G++Y+ S   +HRDL   N+LL ++  +KI DFGL R   + +   ++ V
Sbjct: 100 CDYAV-QIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNE---DHYV 155

Query: 110 TRWYR-------APELLLNSSDYTAAIDVWSVGCIFMEL 141
              +        APE  L +  ++ A DVW  G    E+
Sbjct: 156 MEEHLKVPFAWCAPE-SLRTRTFSHASDVWMFGVTLWEM 193

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 59.9 bits (145), Expect = 1e-10
 Identities = 47/156 (30%), Positives = 74/156 (47%), Gaps = 28/156 (17%)

Query: 2   DHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQ---I 57
           DH N++ +  ++   +      V I  E M+   L   +R N        Q+ + Q   +
Sbjct: 63  DHPNIIHLEGVVTKSR-----PVMIITEFMENGALDSFLRQNDG------QFTVIQLVGM 111

Query: 58  LRG----LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSE-------TDFMTE 106
           LRG    +KY+   N +HRDL   N+L+N+N   K+ DFGL+R   +       T  +  
Sbjct: 112 LRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGG 171

Query: 107 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
            +  RW  APE  +    +T+A DVWS G +  E+M
Sbjct: 172 KIPIRW-TAPE-AIAYRKFTSASDVWSYGIVMWEVM 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 60.2 bits (146), Expect = 1e-10
 Identities = 39/104 (37%), Positives = 55/104 (52%), Gaps = 15/104 (14%)

Query: 48  EHCQYFLY--QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMT 105
           +H +  LY  QI +G++Y+ S   +HRDL   N+L+ +   +KI DFGL +V  +     
Sbjct: 106 DHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQD---K 162

Query: 106 EYVVTR--------WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 141
           EY   R        WY APE  L  S ++ A DVWS G +  EL
Sbjct: 163 EYYKVREPGESPIFWY-APE-SLTESKFSVASDVWSFGVVLYEL 204

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 60.2 bits (146), Expect = 2e-10
 Identities = 53/224 (23%), Positives = 96/224 (42%), Gaps = 38/224 (16%)

Query: 22  NDVYIAYELM-DTDLHQII-RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL 79
           +++Y+  E     DL  ++ R      E+  Q++L +++  +  +H    +HRD+KP N+
Sbjct: 74  DNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENV 133

Query: 80  LLNANCDLKICDFG-LARVTSE-TDFMTEYVVTRWYRAPELL--LNSSD---YTAAIDVW 132
           L++    +K+ DFG  AR+T+         V T  Y APE+L  +N      Y    D W
Sbjct: 134 LIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWW 193

Query: 133 SVGCIFMELM-DRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQR 191
           S+G I  E++  R P   G        ++                 N ++++        
Sbjct: 194 SLGVIAYEMIYGRSPFHEGTSAKTYNNIM-----------------NFQRFL-------- 228

Query: 192 QSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL 235
             F E  P V    +DL++ +L    ++R+  E    HP+   +
Sbjct: 229 -KFPED-PKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSKI 269

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 60.2 bits (146), Expect = 2e-10
 Identities = 34/116 (29%), Positives = 61/116 (52%), Gaps = 2/116 (1%)

Query: 34  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 93
           DL   I+ ++   E   +++  ++   L ++H   V++RDLK  N+LL+A    K+ DFG
Sbjct: 82  DLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFG 141

Query: 94  LARVTSETDFMTE-YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 148
           + +        T  +  T  Y APE +L   +Y  ++D W++G +  E+M  +P F
Sbjct: 142 MCKEGILNGVTTTTFCGTPDYIAPE-ILQELEYGPSVDWWALGVLMYEMMAGQPPF 196

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 59.7 bits (145), Expect = 2e-10
 Identities = 31/108 (28%), Positives = 51/108 (47%), Gaps = 11/108 (10%)

Query: 35  LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL 94
           L + ++  + +     +   +Q+  G+ Y+ S + +HRDL   N+LL      KI DFG+
Sbjct: 82  LLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGM 141

Query: 95  ARVTSETDFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVG 135
           +R          Y  T       +WY APE  +N   +++  DVWS G
Sbjct: 142 SRALGAGS--DYYRATTAGRWPLKWY-APE-CINYGKFSSKSDVWSYG 185

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 59.7 bits (144), Expect = 2e-10
 Identities = 44/157 (28%), Positives = 71/157 (45%), Gaps = 15/157 (9%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIR--SNQALSEEHCQYFLYQI 57
           + HE +V +  ++      S   +YI  E M    L   ++    + L          QI
Sbjct: 58  LRHEKLVQLYAVV------SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQI 111

Query: 58  LRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEY---VVTRWYR 114
             G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR+  + ++          +W  
Sbjct: 112 ASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW-T 170

Query: 115 APELLLNSSDYTAAIDVWSVGCIFMELMDRKPL-FPG 150
           APE  L    +T   DVWS G +  EL  +  + +PG
Sbjct: 171 APEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 206

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 60.0 bits (145), Expect = 2e-10
 Identities = 43/192 (22%), Positives = 87/192 (45%), Gaps = 33/192 (17%)

Query: 33  TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDF 92
           T L Q  R      E+  Q +  +I+  L+++H   +++RD+K  N+LL++N  + + DF
Sbjct: 94  THLSQRER----FKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDF 149

Query: 93  GLAR--VTSETDFMTEYVVTRWYRAPELLL-NSSDYTAAIDVWSVGCIFMELMDRKPLFP 149
           GL++     E +    +  T  Y AP+++      +  A+D WS+G +  EL+     F 
Sbjct: 150 GLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPF- 208

Query: 150 GRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLV 209
                              + E     E +++ +   P Y ++        +   A D++
Sbjct: 209 -----------------TVDGEKNSQAEISRRILKSEPPYPQE--------MSALAKDII 243

Query: 210 EKMLTFDPRQRI 221
           +++L  DP++R+
Sbjct: 244 QRLLMKDPKKRL 255

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 59.4 bits (144), Expect = 2e-10
 Identities = 33/128 (25%), Positives = 59/128 (46%), Gaps = 17/128 (13%)

Query: 24  VYIAYELMDTD-LHQIIRSNQALSE-----EHCQYFLYQILRGLKYIHSANVLHRDLKPS 77
           ++I  E M    L   +R  +         + C      +   ++Y+ S   +HRDL   
Sbjct: 74  IFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCS----DVCEAMEYLESNGFIHRDLAAR 129

Query: 78  NLLLNANCDLKICDFGLARVTSETDFM----TEYVVTRWYRAPELLLNSSDYTAAIDVWS 133
           N L+  +  +K+ DFGLAR   +  +     T++ V +W  AP  + + S +++  DVWS
Sbjct: 130 NCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPV-KW--APPEVFDYSRFSSKSDVWS 186

Query: 134 VGCIFMEL 141
            G +  E+
Sbjct: 187 FGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 59.4 bits (144), Expect = 2e-10
 Identities = 33/100 (33%), Positives = 52/100 (52%), Gaps = 8/100 (8%)

Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRW--- 112
           Q+  G+ Y+ + N +HRDL   N+L+  N   K+ DFGLARV  E  +       ++   
Sbjct: 111 QVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY-EAREGAKFPIK 169

Query: 113 YRAPELLLNSSDYTAAIDVWSVGCIFMELMD--RKPLFPG 150
           + APE     + ++   DVWS G +  E++   R P +PG
Sbjct: 170 WTAPE-AALYNRFSIKSDVWSFGILLTEIVTYGRMP-YPG 207

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 59.5 bits (144), Expect = 2e-10
 Identities = 38/100 (38%), Positives = 50/100 (50%), Gaps = 13/100 (13%)

Query: 53  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR- 111
           F  QI  G+ Y+HS + +HRDL   N+LL+ +  +KI DFGLA+   E     EY   R 
Sbjct: 112 FAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH---EYYRVRE 168

Query: 112 -------WYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR 144
                  WY A E L  +    A+ DVWS G    EL+  
Sbjct: 169 DGDSPVFWY-AVECLKENKFSYAS-DVWSFGVTLYELLTH 206

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 59.6 bits (144), Expect = 3e-10
 Identities = 48/166 (28%), Positives = 81/166 (48%), Gaps = 22/166 (13%)

Query: 1   MDHENVVAIRDIIPPP---QRES-FNDVYIAYELMD----TDLHQIIRSNQALSEEHCQY 52
           M  + V+A++D   PP   Q  S F  V   Y +M+     DL   I+      E    +
Sbjct: 48  MVEKRVLALQD--KPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVF 105

Query: 53  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRW 112
           +  +I  GL ++H   +++RDLK  N++L++   +KI DFG+ +     + M + V TR 
Sbjct: 106 YAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCK-----EHMVDGVTTRT 160

Query: 113 ------YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD 152
                 Y APE++     Y  ++D W+ G +  E++  +P F G D
Sbjct: 161 FCGTPDYIAPEIIAYQP-YGKSVDWWAYGVLLYEMLAGQPPFDGED 205

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 59.2 bits (143), Expect = 3e-10
 Identities = 38/95 (40%), Positives = 51/95 (53%), Gaps = 13/95 (13%)

Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR---- 111
           QI +G+ Y+ S   +HRDL   N+L+ +   +KI DFGL +   ETD   EY   +    
Sbjct: 117 QICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI-ETD--KEYYTVKDDLD 173

Query: 112 ----WYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
               WY APE L+ S  Y A+ DVWS G    EL+
Sbjct: 174 SPVFWY-APECLIQSKFYIAS-DVWSFGVTLYELL 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 59.6 bits (144), Expect = 3e-10
 Identities = 34/103 (33%), Positives = 60/103 (58%), Gaps = 4/103 (3%)

Query: 52  YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR--VTSETDFMTEYVV 109
           ++  +I+ GL+++HS  +++RDLK  N++L+ +  +KI DFG+ +  V  +    T +  
Sbjct: 100 FYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST-FCG 158

Query: 110 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD 152
           T  Y APE+L     YT ++D WS G +  E++  +  F G D
Sbjct: 159 TPDYIAPEILQGLK-YTFSVDWWSFGVLLYEMLIGQSPFHGDD 200

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 59.0 bits (143), Expect = 3e-10
 Identities = 61/247 (24%), Positives = 102/247 (41%), Gaps = 50/247 (20%)

Query: 2   DHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQ-ALSEEHCQYFLYQILR 59
           DH ++V +  +I      + N V+I  EL    +L   ++ N+ +L       + YQ+  
Sbjct: 65  DHPHIVKLIGVI------TENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLST 118

Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVV---TRWYRAP 116
            L Y+ S   +HRD+   N+L+++   +K+ DFGL+R   +  +          +W  AP
Sbjct: 119 ALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWM-AP 177

Query: 117 ELLLNSSDYTAAIDVWSVGCIFMELMDR--KPLFPGRDHVHQLRLLIELIGTPSEAELGF 174
           E  +N   +T+A DVW  G    E++    KP                  G  +   +G 
Sbjct: 178 E-SINFRRFTSASDVWMFGVCMWEILMLGVKPFQ----------------GVKNNDVIGR 220

Query: 175 LNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS 234
           + EN ++    LP           PN  P+   L+ K   +DP +R    +  A      
Sbjct: 221 I-ENGER----LP---------MPPNCPPTLYSLMTKCWAYDPSKRPRFTELKA-----Q 261

Query: 235 LHDISDE 241
           L DI  E
Sbjct: 262 LSDILQE 268

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 59.8 bits (145), Expect = 3e-10
 Identities = 55/206 (26%), Positives = 86/206 (41%), Gaps = 47/206 (22%)

Query: 10  RDIIPPPQRE-------SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQIL 58
           RDI+     E       +F D    Y +M+     DL  ++ SN  + E+  +++  +++
Sbjct: 94  RDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLM-SNYDIPEKWARFYTAEVV 152

Query: 59  RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL-------ARVTSETDFMTEYVVTR 111
             L  IHS   +HRD+KP N+LL+ +  LK+ DFG          V  +T      V T 
Sbjct: 153 LALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTA-----VGTP 207

Query: 112 WYRAPELLLN---SSDYTAAIDVWSVGCIFMELMDRKPLFPGR----------DHVHQLR 158
            Y +PE+L +      Y    D WSVG    E++     F             DH + L 
Sbjct: 208 DYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLT 267

Query: 159 LLIELIGTPSEAELGFLNENAKKYIC 184
                   P + E   +++ AK  IC
Sbjct: 268 F-------PDDIE---ISKQAKDLIC 283

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 58.9 bits (142), Expect = 3e-10
 Identities = 34/102 (33%), Positives = 54/102 (52%), Gaps = 6/102 (5%)

Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEY---VVTRW 112
           Q+  G+ YI   N +HRDL+ +N+L+      KI DFGLAR+  + ++          +W
Sbjct: 110 QVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKW 169

Query: 113 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL-FPGRDH 153
             APE  L    +T   DVWS G +  EL+ +  + +PG ++
Sbjct: 170 -TAPEAALYGR-FTIKSDVWSFGILLTELVTKGRVPYPGMNN 209

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 58.9 bits (142), Expect = 3e-10
 Identities = 36/99 (36%), Positives = 53/99 (53%), Gaps = 6/99 (6%)

Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEY---VVTRW 112
           QI  G+ YI   N +HRDL+ +N+L+  N   KI DFGLAR+  + ++          +W
Sbjct: 110 QIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKW 169

Query: 113 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL-FPG 150
             APE  L    +T   DVWS G +  EL+ +  + +PG
Sbjct: 170 -TAPEAALYGR-FTIKSDVWSFGILLTELVTKGRVPYPG 206

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 59.2 bits (143), Expect = 3e-10
 Identities = 33/94 (35%), Positives = 50/94 (53%), Gaps = 6/94 (6%)

Query: 53  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE----YV 108
           F +QI RG++Y+    ++HRDL   N+L+     +KI DFGL+R   E D   +     +
Sbjct: 132 FAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRI 191

Query: 109 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
             +W  A E L +   YT   DVWS G +  E++
Sbjct: 192 PVKWM-AIESLFDHI-YTTQSDVWSFGVLLWEIV 223

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 58.6 bits (142), Expect = 6e-10
 Identities = 38/114 (33%), Positives = 61/114 (53%), Gaps = 19/114 (16%)

Query: 52  YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV-------------- 97
           YF   +L  L+Y+H+  ++HRDLKP NLL+ +   +K+ DFGL+++              
Sbjct: 106 YFAETVL-ALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHI 164

Query: 98  TSET-DFMTEYVV-TRWYRAPELLLNSSDYTAAIDVWSVGCIFME-LMDRKPLF 148
             +T +F+ + V  T  Y APE++L    Y   +D W++G I  E L+   P F
Sbjct: 165 EKDTREFLDKQVCGTPEYIAPEVILRQG-YGKPVDWWAMGIILYEFLVGCVPFF 217

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 58.1 bits (140), Expect = 6e-10
 Identities = 44/144 (30%), Positives = 68/144 (47%), Gaps = 12/144 (8%)

Query: 2   DHENVVAIRDIIPPPQRESFNDVYIAYELMDTD--LHQIIRSNQALSEEHCQYFLYQILR 59
           DH N+V +  +    QR+    +YI  EL+     L  + +    L  +    F      
Sbjct: 50  DHPNIVKLIGVCT--QRQP---IYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAA 104

Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMT---EYVVTRWYRAP 116
           G+ Y+ S N +HRDL   N L+  N  LKI DFG++R   +  + +   + +  +W  AP
Sbjct: 105 GMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKW-TAP 163

Query: 117 ELLLNSSDYTAAIDVWSVGCIFME 140
           E  LN   Y++  DVWS G +  E
Sbjct: 164 E-ALNYGRYSSESDVWSYGILLWE 186

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 58.4 bits (141), Expect = 6e-10
 Identities = 32/91 (35%), Positives = 46/91 (50%), Gaps = 6/91 (6%)

Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM----TEYVVTR 111
           QI  G+KY+ S N +HRDL   N L+  N  +KI DFG++R     D+        +  R
Sbjct: 138 QIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIR 197

Query: 112 WYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
           W     +LL    +T A DVW+ G    E++
Sbjct: 198 WMSWESILLGK--FTTASDVWAFGVTLWEIL 226

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 57.9 bits (140), Expect = 6e-10
 Identities = 45/147 (30%), Positives = 69/147 (46%), Gaps = 17/147 (11%)

Query: 2   DHENVVAIRDIIPPPQRESFNDVYIAYELM-DTDLHQIIRSNQA-LSEEHCQYFLYQILR 59
           DH N+V +  +    Q++    +YI  EL+    L   +R  +  L+ +           
Sbjct: 50  DHPNIVKLIGVCV--QKQP---IYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAA 104

Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM------TEYVVTRWY 113
           G++Y+ S N +HRDL   N L+  N  LKI DFG++R   E   +       + +  +W 
Sbjct: 105 GMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSR--EEEGGIYTVSDGLKQIPIKW- 161

Query: 114 RAPELLLNSSDYTAAIDVWSVGCIFME 140
            APE  LN   YT+  DVWS G +  E
Sbjct: 162 TAPE-ALNYGRYTSESDVWSYGILLWE 187

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 58.0 bits (140), Expect = 6e-10
 Identities = 36/124 (29%), Positives = 65/124 (52%), Gaps = 9/124 (7%)

Query: 24  VYIAYELMDTD-LHQIIRSNQA-LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 81
           + + +E M+   L   +R+ +   S+E        +  G+ Y+ S+NV+HRDL   N L+
Sbjct: 74  ICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLV 133

Query: 82  NANCDLKICDFGLARVTSETDFM----TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 137
             N  +K+ DFG+ R   +  +     T++ V +W  +PE + + S Y++  DVWS G +
Sbjct: 134 GENQVVKVSDFGMTRFVLDDQYTSSTGTKFPV-KW-SSPE-VFSFSKYSSKSDVWSFGVL 190

Query: 138 FMEL 141
             E+
Sbjct: 191 MWEV 194

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 59.4 bits (143), Expect = 6e-10
 Identities = 56/187 (29%), Positives = 79/187 (42%), Gaps = 33/187 (17%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQAL---SEEHCQY-FLY 55
           + H+N+V   D       ++   +YI  E  D  DL + I+    +    EEH       
Sbjct: 69  LKHKNIVRYIDRF---LNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITR 125

Query: 56  QILRGLKYIHS-------ANVLHRDLKPSNLLL-----------------NANCDLKICD 91
           Q+L  L Y H+         VLHRDLKP N+ L                 N     KI D
Sbjct: 126 QLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGD 185

Query: 92  FGLARVTSETDFMTEYVVTRWYRAPELLLNSS-DYTAAIDVWSVGCIFMELMDRKPLFPG 150
           FGL++           V T +Y +PELLL+ +  Y    D+W++GCI  EL   K  F  
Sbjct: 186 FGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245

Query: 151 RDHVHQL 157
            ++  QL
Sbjct: 246 ANNFSQL 252

Length = 1021

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 58.1 bits (140), Expect = 1e-09
 Identities = 40/125 (32%), Positives = 65/125 (52%), Gaps = 7/125 (5%)

Query: 24  VYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 82
           +Y+  E M   DL  ++ SN  + E+  +++  +++  L  IHS  ++HRD+KP N+LL+
Sbjct: 118 LYMVMEYMPGGDLVNLM-SNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLD 176

Query: 83  ANCDLKICDFGLARVTSETDFM--TEYVVTRWYRAPELLLNSSD---YTAAIDVWSVGCI 137
            +  LK+ DFG      ET  +     V T  Y +PE+L +      Y    D WSVG  
Sbjct: 177 KHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVF 236

Query: 138 FMELM 142
             E++
Sbjct: 237 LFEML 241

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 57.4 bits (139), Expect = 1e-09
 Identities = 31/93 (33%), Positives = 45/93 (48%), Gaps = 12/93 (12%)

Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT----- 110
           +I  G+ Y+ +   +HRDL   N ++  +  +KI DFG+ R   ETD+   Y        
Sbjct: 127 EIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDY---YRKGGKGLL 183

Query: 111 --RWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 141
             RW  APE  L    +T   DVWS G +  E+
Sbjct: 184 PVRWM-APE-SLKDGVFTTKSDVWSFGVVLWEM 214

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 57.2 bits (138), Expect = 1e-09
 Identities = 31/96 (32%), Positives = 47/96 (48%), Gaps = 6/96 (6%)

Query: 53  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-- 110
           F+  I  G++Y+ S N +HRDL   N +LN N  + + DFGL++     D+  +   +  
Sbjct: 118 FMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177

Query: 111 --RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR 144
             +W     L  N   YT   DVW+ G    E+M R
Sbjct: 178 PVKWLALESLADNV--YTTHSDVWAFGVTMWEIMTR 211

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 57.1 bits (138), Expect = 2e-09
 Identities = 51/199 (25%), Positives = 82/199 (41%), Gaps = 41/199 (20%)

Query: 1   MDHENVVAIRDII----PPPQRESFNDVYIAYELMDT-DLHQIIRSN------------- 42
             HEN+V    +     PP          + +E M+  DL++ +RS+             
Sbjct: 65  FQHENIVKFYGVCTEGDPP---------IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSP 115

Query: 43  -QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET 101
              L+         QI  G+ Y+ S + +HRDL   N L+  +  +KI DFG++R    T
Sbjct: 116 MGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTT 175

Query: 102 DFM----TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD--RKPLFPGRD--- 152
           D+        +  RW   PE ++    +T   DVWS G +  E+    ++P +   +   
Sbjct: 176 DYYRVGGHTMLPIRWM-PPESIMYRK-FTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEV 233

Query: 153 --HVHQLRLLIELIGTPSE 169
              + Q RLL      PSE
Sbjct: 234 IECITQGRLLQRPRTCPSE 252

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 56.6 bits (136), Expect = 2e-09
 Identities = 44/161 (27%), Positives = 76/161 (47%), Gaps = 13/161 (8%)

Query: 2   DHENVVAIRDI-IPPPQRESF-NDVYIAYELMDTDLHQIIRSN------QALSEEHCQYF 53
           DH NV+ +  + +   + E + + V I   +   DLH  +  +      Q L  +    F
Sbjct: 58  DHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKF 117

Query: 54  LYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRW- 112
           +  I  G++Y+ S + +HRDL   N +LN N ++ + DFGL++     D+  +  + +  
Sbjct: 118 MTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMP 177

Query: 113 --YRAPELLLNSSDYTAAIDVWSVGCIFMELMDR-KPLFPG 150
             + A E L +   YT   DVWS G    E+  R +  +PG
Sbjct: 178 VKWIAIESLADRV-YTTKSDVWSFGVTMWEIATRGQTPYPG 217

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 56.6 bits (137), Expect = 2e-09
 Identities = 42/144 (29%), Positives = 69/144 (47%), Gaps = 11/144 (7%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRS-NQALSEEHCQY-FLYQI 57
           + H N+V +  ++        N +YI  E M    L   +RS  +A+     Q  F   +
Sbjct: 57  LRHPNLVQLLGVVLQG-----NPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDV 111

Query: 58  LRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPE 117
             G++Y+   N +HRDL   N+L++ +   K+ DFGLA+  S+     +  V +W  APE
Sbjct: 112 CEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPV-KW-TAPE 169

Query: 118 LLLNSSDYTAAIDVWSVGCIFMEL 141
            L     ++   DVWS G +  E+
Sbjct: 170 ALREKK-FSTKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 56.3 bits (136), Expect = 3e-09
 Identities = 37/112 (33%), Positives = 53/112 (47%), Gaps = 15/112 (13%)

Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT----- 110
           QI +G+ Y+    ++HRDL   N+L+     +KI DFGLA++    +   EY        
Sbjct: 117 QIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE--KEYHAEGGKVP 174

Query: 111 -RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD--RKPL--FPGRDHVHQL 157
            +W  A E +L+   YT   DVWS G    ELM    KP    P  + +  L
Sbjct: 175 IKWM-ALESILH-RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE-IPDL 223

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 56.2 bits (136), Expect = 3e-09
 Identities = 60/266 (22%), Positives = 102/266 (38%), Gaps = 57/266 (21%)

Query: 1   MDHENVVAIRDIIPPPQRESF---NDVYIAYELMD----TDLHQIIRSN--QALSEEHCQ 51
           + H N++        P   SF   +++Y+   LM      DL   ++++  + L E    
Sbjct: 56  LQHPNIL--------PYVTSFIVDSELYVVSPLMAYGSCEDL---LKTHFPEGLPELAIA 104

Query: 52  YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA--------RVTSETDF 103
           + L  +L  L YIHS   +HR +K S++LL+ +  + +     +        R     DF
Sbjct: 105 FILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDF 164

Query: 104 MTEYVVTRWYRAPELL-LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIE 162
               V    + +PE+L  N   Y    D++SVG    EL +     P +D      LL +
Sbjct: 165 PKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELAN--GHVPFKDMPATQMLLEK 222

Query: 163 LIGTP----------------SEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAI 206
           + GT                 S++     + N +     +     ++F+E F   H    
Sbjct: 223 VRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRD---SVDHPYTRTFSEHF---H---- 272

Query: 207 DLVEKMLTFDPRQRITVEDALAHPYL 232
             VE  L  DP  R +    L H + 
Sbjct: 273 QFVELCLQRDPESRPSASQLLNHSFF 298

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 56.1 bits (136), Expect = 4e-09
 Identities = 50/207 (24%), Positives = 89/207 (42%), Gaps = 59/207 (28%)

Query: 45  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA--------- 95
           LSEE  +++  ++L  L+Y+H   +++RDLKP N+LL+ +  + + DF L+         
Sbjct: 100 LSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPP 159

Query: 96  --------------------RVTSETDFMT-EYVVTRWYRAPELLLNSSDYTAAIDVWSV 134
                                 + E  F +  +V T  Y APE +++   + +A+D W++
Sbjct: 160 VSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPE-VISGDGHGSAVDWWTL 218

Query: 135 GCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSF 194
           G +  E+     L+ G               TP      F   N  +    + + +  +F
Sbjct: 219 GILLYEM-----LY-GT--------------TP------FKGSNRDETFSNILK-KEVTF 251

Query: 195 TEKFPNVHPSAIDLVEKMLTFDPRQRI 221
               P V  SA DL+ K+L  DP +R+
Sbjct: 252 PGS-PPVSSSARDLIRKLLVKDPSKRL 277

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 56.6 bits (136), Expect = 4e-09
 Identities = 74/313 (23%), Positives = 118/313 (37%), Gaps = 101/313 (32%)

Query: 5   NVVAIRDIIPPPQRE-------SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYF 53
           +V A RDI+     E       SF D    Y +MD     D+  ++       E+  +++
Sbjct: 47  HVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFY 106

Query: 54  LYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA---RVTSET--------- 101
           + ++   ++ +H    +HRD+KP N+L++ +  +K+ DFGL    R T ++         
Sbjct: 107 IAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHV 166

Query: 102 -----DFMTEY-------------------------------VVTRWYRAPELLLNSSDY 125
                DF  E+                               V T  Y APE+LL +  Y
Sbjct: 167 RQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTG-Y 225

Query: 126 TAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQ 185
           T   D WSVG I  E++  +P F              L  TP E ++  +N     +I  
Sbjct: 226 TQLCDWWSVGVILYEMLVGQPPF--------------LAQTPLETQMKVINWQTSLHI-- 269

Query: 186 LPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI---TVEDALAHPYLGSLHDISDEP 242
            P   + S         P A DL+ K L   P  R+     ++  AHP+  ++       
Sbjct: 270 -PPQAKLS---------PEASDLIIK-LCRGPEDRLGKNGADEIKAHPFFKTID------ 312

Query: 243 VCMSPFSFDFEQH 255
                FS D  Q 
Sbjct: 313 -----FSSDLRQQ 320

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 55.6 bits (134), Expect = 4e-09
 Identities = 34/123 (27%), Positives = 61/123 (49%), Gaps = 7/123 (5%)

Query: 24  VYIAYELMDTD-LHQIIRSNQA-LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 81
           +YI  E M+   L   +R  Q  LS++        +  G++Y+   + +HRDL   N L+
Sbjct: 74  LYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLV 133

Query: 82  NANCDLKICDFGLARVTSETDFMTEY---VVTRWYRAPELLLNSSDYTAAIDVWSVGCIF 138
           ++   +K+ DFG+ R   + ++ +        +W   PE + N S Y++  DVWS G + 
Sbjct: 134 SSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKW-SPPE-VFNFSKYSSKSDVWSFGVLM 191

Query: 139 MEL 141
            E+
Sbjct: 192 WEV 194

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 55.8 bits (134), Expect = 5e-09
 Identities = 33/102 (32%), Positives = 50/102 (49%), Gaps = 6/102 (5%)

Query: 44  ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF 103
           ++S  +  Y   QI  G+KY+ S N +HRDL   N L+  +  +KI DFG++R     D+
Sbjct: 125 SVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDY 184

Query: 104 M----TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 141
                   +  RW     +LL    +T A DVW+ G    E+
Sbjct: 185 YRIQGRAVLPIRWMAWESILLGK--FTTASDVWAFGVTLWEM 224

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 55.8 bits (134), Expect = 5e-09
 Identities = 38/105 (36%), Positives = 56/105 (53%), Gaps = 10/105 (9%)

Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV--TSETDFMTE--YVVTR 111
           QI +G+ Y+    ++HRDL   N+L+ +   +KI DFGLAR+    ET++  +   V  +
Sbjct: 117 QIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIK 176

Query: 112 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMD--RKPL--FPGRD 152
           W  A E +L+   +T   DVWS G    ELM    KP    P R+
Sbjct: 177 WM-ALESILHRR-FTHQSDVWSYGVTVWELMTFGAKPYDGIPARE 219

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 55.8 bits (134), Expect = 5e-09
 Identities = 45/169 (26%), Positives = 69/169 (40%), Gaps = 41/169 (24%)

Query: 20  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 75
           SF D    Y +M+     D+  ++     LSEE  Q+++ + +  +  IH    +HRD+K
Sbjct: 69  SFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIK 128

Query: 76  PSNLLLNANCDLKICDFGLA---RVTSETDFMTEY------------------------- 107
           P NLLL+A   +K+ DFGL    +    T+F                             
Sbjct: 129 PDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKN 188

Query: 108 --------VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 148
                   V T  Y APE+ + +  Y    D WS+G I  E++   P F
Sbjct: 189 RRQLAYSTVGTPDYIAPEVFMQTG-YNKLCDWWSLGVIMYEMLIGYPPF 236

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 55.8 bits (134), Expect = 5e-09
 Identities = 72/308 (23%), Positives = 115/308 (37%), Gaps = 93/308 (30%)

Query: 5   NVVAIRDIIPPPQRE-------SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYF 53
           +V A RDI+     E       SF D    Y +MD     D+  ++   +   E   +++
Sbjct: 47  HVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFY 106

Query: 54  LYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL------------------- 94
           + ++   ++ +H    +HRD+KP N+L++ +  +K+ DFGL                   
Sbjct: 107 IAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHI 166

Query: 95  -----------------------------ARVTSETDFMTEYVVTRWYRAPELLLNSSDY 125
                                        A    +       V T  Y APE+LL    Y
Sbjct: 167 RQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKG-Y 225

Query: 126 TAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLN-ENAKKYIC 184
           T   D WSVG I  E++  +P F              L  TP+E +L  +N EN      
Sbjct: 226 TQLCDWWSVGVILFEMLVGQPPF--------------LAPTPTETQLKVINWENT----L 267

Query: 185 QLPRYQRQSFTEKFPNVHPSAIDLVEKM-LTFDPR-QRITVEDALAHPYLGSL---HDIS 239
            +P   + S         P A+DL+ K+  + + R  R   +D  AHP+   +    DI 
Sbjct: 268 HIPPQVKLS---------PEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVDFSSDIR 318

Query: 240 DEPVCMSP 247
            +P    P
Sbjct: 319 TQPAPYVP 326

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 54.2 bits (130), Expect = 1e-08
 Identities = 39/125 (31%), Positives = 56/125 (44%), Gaps = 16/125 (12%)

Query: 34  DLHQIIRSNQALSEEHC-----QYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLK 88
           DL   +RS +            Q    +I  GL ++H  N +H DL   N LL A+  +K
Sbjct: 81  DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVK 140

Query: 89  ICDFGLARVTSETDFMTE----YVVTRWYRAPELL------LNSSDYTAAIDVWSVGCIF 138
           I D+GL+    + D+       +V  RW  APEL+      L   D T   +VWS+G   
Sbjct: 141 IGDYGLSHNKYKEDYYVTPDQLWVPLRWI-APELVDEVHGNLLVVDQTKESNVWSLGVTI 199

Query: 139 MELMD 143
            EL +
Sbjct: 200 WELFE 204

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 54.7 bits (131), Expect = 2e-08
 Identities = 42/169 (24%), Positives = 72/169 (42%), Gaps = 41/169 (24%)

Query: 20  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 75
           SF D    Y +M+     D+  ++     L+EE  Q+++ + +  +  IH    +HRD+K
Sbjct: 69  SFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIK 128

Query: 76  PSNLLLNANCDLKICDFGLARVTSE---------------TDFMTEYVVTR-----WYR- 114
           P NLLL++   +K+ DFGL     +               +DF  + + ++     W R 
Sbjct: 129 PDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRN 188

Query: 115 ---------------APELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 148
                          APE+ + +  Y    D WS+G I  E++   P F
Sbjct: 189 RRQLAFSTVGTPDYIAPEVFMQTG-YNKLCDWWSLGVIMYEMLIGYPPF 236

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 53.7 bits (129), Expect = 2e-08
 Identities = 39/125 (31%), Positives = 57/125 (45%), Gaps = 16/125 (12%)

Query: 34  DLHQIIRSNQALSEEHCQYFLYQ-----ILRGLKYIHSANVLHRDLKPSNLLLNANCDLK 88
           DL   +RSN+ +  +  Q  + Q     +  GL ++H A+ +H DL   N  L A+  +K
Sbjct: 81  DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVK 140

Query: 89  ICDFGLARVTSETDFMT----EYVVTRWYRAPELL------LNSSDYTAAIDVWSVGCIF 138
           I D+GLA      D+        V  RW  APEL+      L   D T   ++WS+G   
Sbjct: 141 IGDYGLALEQYPEDYYITKDCHAVPLRWL-APELVEIRGQDLLPKDQTKKSNIWSLGVTM 199

Query: 139 MELMD 143
            EL  
Sbjct: 200 WELFT 204

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 53.8 bits (129), Expect = 2e-08
 Identities = 33/106 (31%), Positives = 51/106 (48%), Gaps = 7/106 (6%)

Query: 40  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS 99
            +   LS +   +F   + RG+ Y+     +HRDL   N+L+  N   KI DFGL+R   
Sbjct: 116 STASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR--G 173

Query: 100 ETDFMTEY---VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
           +  ++ +    +  RW       LN S YT   DVWS G +  E++
Sbjct: 174 QEVYVKKTMGRLPVRWMAIES--LNYSVYTTNSDVWSYGVLLWEIV 217

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 53.9 bits (129), Expect = 2e-08
 Identities = 37/118 (31%), Positives = 56/118 (47%), Gaps = 8/118 (6%)

Query: 37  QIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 96
           Q  ++   L      +   QI  G+ Y+ S + +HRDL   N L+ AN  +KI DFG++R
Sbjct: 112 QPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 171

Query: 97  VTSETDFMT----EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD--RKPLF 148
               TD+        +  RW   PE ++    +T   DVWS G I  E+    ++P F
Sbjct: 172 DVYSTDYYRVGGHTMLPIRWM-PPESIMYRK-FTTESDVWSFGVILWEIFTYGKQPWF 227

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 54.1 bits (130), Expect = 2e-08
 Identities = 32/88 (36%), Positives = 47/88 (53%), Gaps = 4/88 (4%)

Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG---LARVTSETDFMTEYVVTRW 112
           Q+L  + YIH   ++HRD+K  N+L+N   D+ + DFG    AR +  T F      T  
Sbjct: 268 QLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVD 327

Query: 113 YRAPELLLNSSDYTAAIDVWSVGCIFME 140
             APE+L     YT ++D+WS G +  E
Sbjct: 328 TNAPEVLAGDP-YTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 53.6 bits (129), Expect = 3e-08
 Identities = 32/94 (34%), Positives = 46/94 (48%), Gaps = 12/94 (12%)

Query: 55  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVV----- 109
            QI  G++Y+ S + +HRDL   N L+     +KI DFGL+R     D+   Y V     
Sbjct: 131 IQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADY---YRVQSKSL 187

Query: 110 --TRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 141
              RW   PE +L    +T   D+WS G +  E+
Sbjct: 188 LPVRWM-PPEAIL-YGKFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 53.3 bits (128), Expect = 3e-08
 Identities = 28/90 (31%), Positives = 42/90 (46%), Gaps = 6/90 (6%)

Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM----TEYVVTR 111
           Q+  G+ Y+     +HRDL   N L+  N  +KI DFGL+R     D+      + +  R
Sbjct: 138 QVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIR 197

Query: 112 WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 141
           W     +  N   YT   DVW+ G +  E+
Sbjct: 198 WMPPESIFYNR--YTTESDVWAYGVVLWEI 225

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 53.7 bits (129), Expect = 4e-08
 Identities = 27/81 (33%), Positives = 48/81 (59%), Gaps = 1/81 (1%)

Query: 19  ESFNDVYIAYE-LMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 77
           +S N+VY+  E L+  D+  ++       EE    ++ ++   L Y+H   ++HRDLKP 
Sbjct: 74  QSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPD 133

Query: 78  NLLLNANCDLKICDFGLARVT 98
           N+L++    +K+ DFGL++VT
Sbjct: 134 NMLISNEGHIKLTDFGLSKVT 154

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 53.1 bits (127), Expect = 4e-08
 Identities = 35/109 (32%), Positives = 57/109 (52%), Gaps = 7/109 (6%)

Query: 39  IRSNQ-ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV 97
           +R ++  +  ++   +  QI +G+ Y+    ++HRDL   N+L+     +KI DFGLA++
Sbjct: 99  VREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKL 158

Query: 98  --TSETDFMTE--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
               E ++  E   V  +W  A E +L+   YT   DVWS G    ELM
Sbjct: 159 LGADEKEYHAEGGKVPIKWM-ALESILHRI-YTHQSDVWSYGVTVWELM 205

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 53.1 bits (127), Expect = 4e-08
 Identities = 54/230 (23%), Positives = 96/230 (41%), Gaps = 40/230 (17%)

Query: 20  SFNDVYIAYELMD----TDLHQII-RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDL 74
           +F D    Y +MD     DL  ++ +    L E+  ++++ +++  +  IH  + +HRD+
Sbjct: 69  AFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDI 128

Query: 75  KPSNLLLNANCDLKICDFG--LARVTSETDFMTEYVVTRWYRAPELLLNSSD----YTAA 128
           KP N+LL+ N  +++ DFG  L      T   +  V T  Y +PE+L    D    Y   
Sbjct: 129 KPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPE 188

Query: 129 IDVWSVG-CIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLP 187
            D WS+G C++  L    P +           L+E  G     E                
Sbjct: 189 CDWWSLGVCMYEMLYGETPFYA--------ESLVETYGKIMNHE---------------- 224

Query: 188 RYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQ--RITVEDALAHPYLGSL 235
             +R  F     +V   A DL+++++    R+  +  +ED   H +   +
Sbjct: 225 --ERFQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEGI 272

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 52.7 bits (126), Expect = 4e-08
 Identities = 32/86 (37%), Positives = 47/86 (54%), Gaps = 8/86 (9%)

Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-----VTSETDFMTEYVVTRWYR 114
           G++Y+ S + +HRDL   N L+     LKI DFG++R     V + T  M + +  +W  
Sbjct: 106 GMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQ-IPVKW-T 163

Query: 115 APELLLNSSDYTAAIDVWSVGCIFME 140
           APE  LN   Y++  DVWS G +  E
Sbjct: 164 APE-ALNYGRYSSESDVWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 52.6 bits (126), Expect = 5e-08
 Identities = 28/91 (30%), Positives = 50/91 (54%), Gaps = 7/91 (7%)

Query: 55  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM----TEYVVT 110
             +  G+ Y+ S   +HRDL   N L++    +K+ DFGL+R   + ++     +++ V 
Sbjct: 107 KDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPV- 165

Query: 111 RWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 141
           RW   PE+LL S  +++  DVW+ G +  E+
Sbjct: 166 RW-SPPEVLLYSK-FSSKSDVWAFGVLMWEV 194

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 53.1 bits (127), Expect = 5e-08
 Identities = 38/125 (30%), Positives = 64/125 (51%), Gaps = 7/125 (5%)

Query: 24  VYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 82
           +Y+  E M   DL  ++ SN  + E+  +++  +++  L  IHS   +HRD+KP N+LL+
Sbjct: 118 LYMVMEYMPGGDLVNLM-SNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD 176

Query: 83  ANCDLKICDFGLARVTSETDFM--TEYVVTRWYRAPELLLNSSD---YTAAIDVWSVGCI 137
            +  LK+ DFG     ++   +     V T  Y +PE+L +      Y    D WSVG  
Sbjct: 177 KSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVF 236

Query: 138 FMELM 142
             E++
Sbjct: 237 LYEML 241

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 52.6 bits (126), Expect = 5e-08
 Identities = 30/110 (27%), Positives = 56/110 (50%), Gaps = 2/110 (1%)

Query: 34  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 93
           DL   I+ ++   E   +++  +I   L ++H   +++RDLK  N+LL+     K+ DFG
Sbjct: 82  DLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFG 141

Query: 94  LARVTSETDFMTE-YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
           + +        T  +  T  Y APE +L    Y  ++D W++G +  E++
Sbjct: 142 MCKEGIFNGKTTSTFCGTPDYIAPE-ILQEMLYGPSVDWWAMGVLLYEML 190

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 52.4 bits (125), Expect = 7e-08
 Identities = 50/213 (23%), Positives = 93/213 (43%), Gaps = 36/213 (16%)

Query: 45  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG--LARVTSETD 102
           L E+  +++L +++  +  +H  + +HRD+KP N+L++ N  +++ DFG  L  +   T 
Sbjct: 99  LPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV 158

Query: 103 FMTEYVVTRWYRAPELLLNSSD----YTAAIDVWSVG-CIFMELMDRKPLFPGRDHVHQL 157
             +  V T  Y +PE+L    D    Y    D WS+G C++  L    P +         
Sbjct: 159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYA-------- 210

Query: 158 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDP 217
             L+E  G               K +    R+Q   F  +  +V   A DL+ +++    
Sbjct: 211 ESLVETYG---------------KIMNHKERFQ---FPAQVTDVSEDAKDLIRRLICSRE 252

Query: 218 RQ--RITVEDALAHPYLGSLHDISDEPVCMSPF 248
            +  +  +ED   HP+   + D  +   C +P+
Sbjct: 253 HRLGQNGIEDFKQHPFFTGI-DWDNIRNCEAPY 284

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 51.8 bits (124), Expect = 7e-08
 Identities = 36/123 (29%), Positives = 60/123 (48%), Gaps = 8/123 (6%)

Query: 25  YIAYELMDT-DLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 81
           YI  E M   +L   +R    Q ++     Y   QI   ++Y+   N +HRDL   N L+
Sbjct: 78  YIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLV 137

Query: 82  NANCDLKICDFGLARVTSETDFMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIF 138
             N  +K+ DFGL+R+ +  D  T +   ++   + APE L  +  ++   DVW+ G + 
Sbjct: 138 GENHLVKVADFGLSRLMTG-DTYTAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLL 195

Query: 139 MEL 141
            E+
Sbjct: 196 WEI 198

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 51.9 bits (124), Expect = 7e-08
 Identities = 41/144 (28%), Positives = 66/144 (45%), Gaps = 10/144 (6%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELM-DTDLHQIIRSN--QALSEEHCQYFLYQI 57
           + H N+V +  +I     E    +YI  E M    L   +RS     L  +    F   +
Sbjct: 56  LRHSNLVQLLGVIV----EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 111

Query: 58  LRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPE 117
              ++Y+ + N +HRDL   N+L++ +   K+ DFGL +  S T    +  V +W  APE
Sbjct: 112 CEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV-KW-TAPE 169

Query: 118 LLLNSSDYTAAIDVWSVGCIFMEL 141
             L    ++   DVWS G +  E+
Sbjct: 170 -ALREKKFSTKSDVWSFGILLWEI 192

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 52.2 bits (125), Expect = 8e-08
 Identities = 31/91 (34%), Positives = 46/91 (50%), Gaps = 6/91 (6%)

Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM----TEYVVTR 111
           QI  G+KY+ S N +HRDL   N L+  N  +KI DFG++R     D+        +  R
Sbjct: 146 QIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIR 205

Query: 112 WYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
           W     +L+    +T A DVW+ G    E++
Sbjct: 206 WMAWECILMGK--FTTASDVWAFGVTLWEIL 234

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 52.0 bits (124), Expect = 9e-08
 Identities = 32/102 (31%), Positives = 51/102 (50%), Gaps = 6/102 (5%)

Query: 45  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM 104
           L++    +   QI  G+ Y+ S + +HRDL   N L+  N  +KI DFG++R    TD+ 
Sbjct: 117 LTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYY 176

Query: 105 T----EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
                  +  RW   PE ++    +T   DVWS+G +  E+ 
Sbjct: 177 RVGGHTMLPIRWM-PPESIMYRK-FTTESDVWSLGVVLWEIF 216

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 51.5 bits (123), Expect = 1e-07
 Identities = 33/96 (34%), Positives = 46/96 (47%), Gaps = 13/96 (13%)

Query: 53  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR- 111
            ++Q+  G+KY+   N +HRDL   N+LL      KI DFGL++     D    Y   R 
Sbjct: 100 LMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADD---SYYKARS 156

Query: 112 -------WYRAPELLLNSSDYTAAIDVWSVGCIFME 140
                  WY APE  +N   +++  DVWS G    E
Sbjct: 157 AGKWPLKWY-APE-CINFRKFSSRSDVWSYGITMWE 190

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 51.6 bits (123), Expect = 1e-07
 Identities = 34/113 (30%), Positives = 59/113 (52%), Gaps = 9/113 (7%)

Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE----YVVTR 111
           +I  G+ Y+++   +HRDL   N ++  +  +KI DFG+ R   ETD+  +     +  R
Sbjct: 127 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186

Query: 112 WYRAPELLLNSSDYTAAIDVWSVGCIFMEL--MDRKPLFPGRDHVHQLRLLIE 162
           W  +PE L +   +T   DVWS G +  E+  +  +P + G  +   LR ++E
Sbjct: 187 WM-SPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQP-YQGMSNEQVLRFVME 236

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 51.6 bits (124), Expect = 1e-07
 Identities = 38/127 (29%), Positives = 58/127 (45%), Gaps = 23/127 (18%)

Query: 34  DLHQIIRSNQALSEEHCQY--------FLY---QILRGLKYIHSANVLHRDLKPSNLLLN 82
           DL+Q ++ + A +               LY   QI  G++Y+ S N +HRDL   N L+ 
Sbjct: 105 DLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVG 164

Query: 83  ANCDLKICDFGLARVTSETDFMTEYVV-------TRWYRAPELLLNSSDYTAAIDVWSVG 135
            N  +KI DFG++R    +D+   Y V        RW     +LL    +T   DVW+ G
Sbjct: 165 KNYTIKIADFGMSRNLYSSDY---YRVQGRAPLPIRWMAWESVLLGK--FTTKSDVWAFG 219

Query: 136 CIFMELM 142
               E++
Sbjct: 220 VTLWEIL 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 51.3 bits (123), Expect = 2e-07
 Identities = 64/289 (22%), Positives = 107/289 (37%), Gaps = 88/289 (30%)

Query: 6   VVAIRDIIPPPQRE-------SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFL 54
           V A RDI+     E       SF D    Y +MD     D+  ++       E+  ++++
Sbjct: 48  VKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYI 107

Query: 55  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL------------------AR 96
            ++   ++ +H    +HRD+KP N+L++ +  +K+ DFGL                   R
Sbjct: 108 AELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHR 167

Query: 97  VTSETDFMTEY---------------------------VVTRWYRAPELLLNSSDYTAAI 129
             S  +   E+                           V T  Y APE+LL +  YT   
Sbjct: 168 QDS-MEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTG-YTQLC 225

Query: 130 DVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRY 189
           D WSVG I  E++  +P F              L  TP+E +L  +N     +I      
Sbjct: 226 DWWSVGVILYEMLVGQPPF--------------LADTPAETQLKVINWETTLHI----PS 267

Query: 190 QRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI---TVEDALAHPYLGSL 235
           Q          +   A DL+ ++       R+     ++  AHP+   +
Sbjct: 268 Q--------AKLSREASDLILRLCC-GAEDRLGKNGADEIKAHPFFKGI 307

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 50.8 bits (121), Expect = 2e-07
 Identities = 32/101 (31%), Positives = 49/101 (48%), Gaps = 7/101 (6%)

Query: 45  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM 104
           L+ +    F   +  G++Y+     +HRDL   N+L+  N   KI DFGL+R   E  ++
Sbjct: 116 LTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSR--GEEVYV 173

Query: 105 TEY---VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
            +    +  RW       LN S YT   DVWS G +  E++
Sbjct: 174 KKTMGRLPVRWMAIES--LNYSVYTTKSDVWSFGVLLWEIV 212

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 50.7 bits (121), Expect = 2e-07
 Identities = 29/90 (32%), Positives = 49/90 (54%), Gaps = 6/90 (6%)

Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE----YVVTR 111
           +I  G+ Y+++   +HRDL   N ++  +  +KI DFG+ R   ETD+  +     +  R
Sbjct: 127 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 186

Query: 112 WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 141
           W  APE L +   +T + D+WS G +  E+
Sbjct: 187 WM-APESLKDGV-FTTSSDMWSFGVVLWEI 214

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 50.5 bits (121), Expect = 2e-07
 Identities = 39/156 (25%), Positives = 69/156 (44%), Gaps = 28/156 (17%)

Query: 3   HENVVAI----RDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQA---------LSEE 48
           H+NVV +    R+  P          Y+  E  D  DL Q +R+ ++         LS +
Sbjct: 67  HKNVVRLLGLCREAEPH---------YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTK 117

Query: 49  HCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMT 105
                  QI  G+ ++ +A  +HRDL   N L+++  ++K+    L++    ++      
Sbjct: 118 QKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRN 177

Query: 106 EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 141
             +  RW  APE +    D++   DVWS G +  E+
Sbjct: 178 ALIPLRWL-APEAVQE-DDFSTKSDVWSFGVLMWEV 211

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 50.2 bits (120), Expect = 3e-07
 Identities = 29/97 (29%), Positives = 49/97 (50%), Gaps = 8/97 (8%)

Query: 53  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRW 112
           F+  I  G++Y+ + N +HRDL   N +L  +  + + DFGL++     D+   Y   R 
Sbjct: 118 FMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDY---YRQGRI 174

Query: 113 YRAPE--LLLNS-SD--YTAAIDVWSVGCIFMELMDR 144
            + P   + + S +D  YT+  DVW+ G    E+  R
Sbjct: 175 AKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATR 211

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 50.1 bits (119), Expect = 3e-07
 Identities = 33/101 (32%), Positives = 50/101 (49%), Gaps = 7/101 (6%)

Query: 45  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM 104
           LS +   +F   + RG+ Y+     +HRDL   N+L+  N   KI DFGL+R   +  ++
Sbjct: 109 LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYV 166

Query: 105 TEY---VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
            +    +  RW       LN S YT   DVWS G +  E++
Sbjct: 167 KKTMGRLPVRWMAIES--LNYSVYTTNSDVWSYGVLLWEIV 205

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 49.4 bits (118), Expect = 6e-07
 Identities = 40/156 (25%), Positives = 72/156 (46%), Gaps = 21/156 (13%)

Query: 45  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG-LARVTSETDF 103
           L E+  +++L +++  +  +H    +HRD+KP N+LL+ N  +++ DFG   R+ ++   
Sbjct: 99  LPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV 158

Query: 104 MTEYVV-TRWYRAPELLLNSSD----YTAAIDVWSVG-CIFMELMDRKPLFP-------G 150
            +   V T  Y +PE+L    D    Y    D WS+G C++  L    P +        G
Sbjct: 159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG 218

Query: 151 RDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQL 186
           +   H+          P +     ++E AK  I +L
Sbjct: 219 KIMNHKEHFQF-----PPDVTD--VSEEAKDLIRRL 247

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 49.2 bits (117), Expect = 7e-07
 Identities = 39/146 (26%), Positives = 69/146 (47%), Gaps = 10/146 (6%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ-ALSEEHCQYFLYQILR 59
           +DH  +V +  I P    +    +     L+D      +R ++ +L  +    +  QI +
Sbjct: 66  LDHAYIVRLLGICPGASLQLVTQLSPLGSLLDH-----VRQHRDSLDPQRLLNWCVQIAK 120

Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAP 116
           G+ Y+    ++HR+L   N+LL ++  ++I DFG+A +    D   F +E+     + A 
Sbjct: 121 GMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMAL 180

Query: 117 ELLLNSSDYTAAIDVWSVGCIFMELM 142
           E +L    YT   DVWS G    E+M
Sbjct: 181 ESILFGR-YTHQSDVWSYGVTVWEMM 205

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 48.9 bits (116), Expect = 1e-06
 Identities = 19/42 (45%), Positives = 29/42 (69%)

Query: 54  LYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA 95
           + Q+L GL+ +H   ++HRD+KP NLL+  +  +KI DFG A
Sbjct: 315 MRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356

Length = 507

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 48.4 bits (115), Expect = 1e-06
 Identities = 52/217 (23%), Positives = 79/217 (36%), Gaps = 33/217 (15%)

Query: 45  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET--- 101
           +SE    Y L  +L+ L YIH    +HR +K S++L++   D K+   GL    S     
Sbjct: 98  MSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISV--DGKVYLSGLRSNLSMINHG 155

Query: 102 -------DFMTEYVVTRWYRAPELL-LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDH 153
                  DF    V    + +PE+L  N   Y A  D++SVG    EL +     P +D 
Sbjct: 156 QRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH--VPFKDM 213

Query: 154 VHQLRLLIELIGT-----------PSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVH 202
                LL +L GT             E  +      A   + +         +    + H
Sbjct: 214 PATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSH 273

Query: 203 P-------SAIDLVEKMLTFDPRQRITVEDALAHPYL 232
           P            VE+ L  +P  R +    L H + 
Sbjct: 274 PYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFF 310

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 48.3 bits (115), Expect = 2e-06
 Identities = 22/80 (27%), Positives = 44/80 (55%), Gaps = 4/80 (5%)

Query: 20  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 75
           SF D    Y +M+     DL  ++      SE+  ++++ + +  ++ +H    +HRD+K
Sbjct: 69  SFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIK 128

Query: 76  PSNLLLNANCDLKICDFGLA 95
           P N+L++    +K+ DFGL+
Sbjct: 129 PDNILIDRGGHIKLSDFGLS 148

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 47.7 bits (113), Expect = 2e-06
 Identities = 30/90 (33%), Positives = 45/90 (50%), Gaps = 6/90 (6%)

Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM----TEYVVTR 111
           QI  G+ Y+ S + +HRDL   N L+     +KI DFG++R    TD+        +  R
Sbjct: 130 QIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 189

Query: 112 WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 141
           W   PE +L    +T   D+WS G +  E+
Sbjct: 190 WM-PPESILYRK-FTTESDIWSFGVVLWEI 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 47.6 bits (113), Expect = 2e-06
 Identities = 28/98 (28%), Positives = 50/98 (51%), Gaps = 11/98 (11%)

Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMT----EYVVTR 111
           +I  G+ ++H  N LH DL   N  L ++  +K+ D+G+     + D++     + V  R
Sbjct: 107 EIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLR 166

Query: 112 WYRAPELL------LNSSDYTAAIDVWSVGCIFMELMD 143
           W  APEL+      L +++ T   +VW++G    EL +
Sbjct: 167 WL-APELVGEFHGGLITAEQTKPSNVWALGVTLWELFE 203

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 47.2 bits (112), Expect = 3e-06
 Identities = 31/101 (30%), Positives = 50/101 (49%), Gaps = 3/101 (2%)

Query: 47  EEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE 106
           EE  + +  +++  L  +H   ++ RDL P+N+LL+    +++  F   R +   D    
Sbjct: 84  EECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFS--RWSEVEDSCDG 141

Query: 107 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL 147
             V   Y APE +   S+ T A D WS+G I  EL+  K L
Sbjct: 142 EAVENMYCAPE-VGGISEETEACDWWSLGAILFELLTGKTL 181

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 46.6 bits (110), Expect = 6e-06
 Identities = 29/91 (31%), Positives = 47/91 (51%), Gaps = 6/91 (6%)

Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS--ETDFMTE--YVVTR 111
           QI +G+ Y+    ++HRDL   N+L+ +   +KI DFGLAR+    E ++  +   +  +
Sbjct: 117 QIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIK 176

Query: 112 WYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
           W       ++   +T   DVWS G    ELM
Sbjct: 177 WMALE--CIHYRKFTHQSDVWSYGVTIWELM 205

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 45.6 bits (108), Expect = 1e-05
 Identities = 46/159 (28%), Positives = 74/159 (46%), Gaps = 26/159 (16%)

Query: 2   DHENVVAIRDIIPPPQRESFND-VYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQIL- 58
           +H N+V +  +         N+  YI  ELM+  DL   +R  +          L ++L 
Sbjct: 57  NHPNIVKLLGVC------LLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLD 110

Query: 59  ------RGLKYIHSANVLHRDLKPSNLLLNA---NCD--LKICDFGLARVTSETDFMTE- 106
                 +G  Y+   + +HRDL   N L++    + D  +KI DFGLAR   ++D+  + 
Sbjct: 111 ICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKE 170

Query: 107 ---YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
               +  RW  APE LL+   +T   DVWS G +  E++
Sbjct: 171 GEGLLPVRWM-APESLLDGK-FTTQSDVWSFGVLMWEIL 207

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 45.3 bits (107), Expect = 1e-05
 Identities = 39/146 (26%), Positives = 63/146 (43%), Gaps = 12/146 (8%)

Query: 2   DHENVVAIRDIIPPPQRESFNDVYIAYELMDTD-LHQIIRSNQA-LSEEHCQYFLYQILR 59
           DH N+V +  +I        N + I  E M    L   +R ++  L        L  +  
Sbjct: 64  DHSNIVRLEGVI-----TRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLAS 118

Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG-LARVTSETDF--MTEYVVTRWYRAP 116
           G+KY+     +H+ L    +L+N++   KI  F  L    SE  +  M+      W  AP
Sbjct: 119 GMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLW-AAP 177

Query: 117 ELLLNSSDYTAAIDVWSVGCIFMELM 142
           E  +    +++A DVWS G +  E+M
Sbjct: 178 E-AIQYHHFSSASDVWSFGIVMWEVM 202

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 45.9 bits (109), Expect = 2e-05
 Identities = 44/191 (23%), Positives = 71/191 (37%), Gaps = 47/191 (24%)

Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR------------------- 96
           +I   ++Y+HS  VLHRDLKP N+LL    ++ I D+G A                    
Sbjct: 121 KICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNI 180

Query: 97  VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ 156
             S      + V T  Y APE LL     + + D++++G I  +++     FP R    +
Sbjct: 181 CYSSMTIPGKIVGTPDYMAPERLL-GVPASESTDIYALGVILYQMLTLS--FPYRRKKGR 237

Query: 157 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFD 216
                ++I +P E                            +  + P    +  K L  D
Sbjct: 238 KISYRDVILSPIE-------------------------VAPYREIPPFLSQIAMKALAVD 272

Query: 217 PRQRITVEDAL 227
           P +R +    L
Sbjct: 273 PAERYSSVQEL 283

Length = 932

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 45.0 bits (106), Expect = 2e-05
 Identities = 26/90 (28%), Positives = 45/90 (50%), Gaps = 6/90 (6%)

Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM----TEYVVTR 111
           QI  G++Y+ S   +H+DL   N+L+     +KI D GL+R     D+        +  R
Sbjct: 132 QIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIR 191

Query: 112 WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 141
           W   PE ++    +++  D+WS G +  E+
Sbjct: 192 WM-PPEAIMYGK-FSSDSDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 43.5 bits (103), Expect = 3e-05
 Identities = 29/130 (22%), Positives = 48/130 (36%), Gaps = 19/130 (14%)

Query: 35  LHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 93
           L  I+    + L+EE       Q L  L+ +H        L   + LL           G
Sbjct: 3   LADILEVRGRPLNEEEIWAVCLQCLGALRELHRQAKSGNILLTWDGLLKL--------DG 54

Query: 94  -LARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD 152
            +A  T E      Y +     APE++     YT   D++S+G    E +D +      +
Sbjct: 55  SVAFKTPEQSRPDPYFM-----APEVIQG-QSYTEKADIYSLGITLYEALDYE---LPYN 105

Query: 153 HVHQLRLLIE 162
              +L  ++E
Sbjct: 106 EERELSAILE 115

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 43.9 bits (103), Expect = 4e-05
 Identities = 38/161 (23%), Positives = 72/161 (44%), Gaps = 26/161 (16%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQ--IIRS--------------NQA 44
           + H N+V +  ++   Q  S    Y ++    +DLH+  ++RS                 
Sbjct: 65  LQHPNIVCLLGVVTKEQPLSMIFSYCSH----SDLHEFLVMRSPHSDVGSTDDDKTVKST 120

Query: 45  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM 104
           L      + + QI  G++++ S +V+H+DL   N+L+    ++KI D GL R     D+ 
Sbjct: 121 LEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYY 180

Query: 105 ----TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 141
                  +  RW  +PE ++    ++   D+WS G +  E+
Sbjct: 181 KLMGNSLLPIRWM-SPEAIMYGK-FSIDSDIWSYGVVLWEV 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|236586 PRK09605, PRK09605, bifunctional UGMP family protein/serine/threonine protein kinase; Validated

 Score = 41.8 bits (99), Expect = 3e-04
 Identities = 19/92 (20%), Positives = 36/92 (39%), Gaps = 15/92 (16%)

Query: 9   IRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN 68
           I D+ P           +   +   DL  ++  N  L  +        +   +  +H A 
Sbjct: 403 IYDVDP------EEKTIVMEYIGGKDLKDVLEGNPELVRK--------VGEIVAKLHKAG 448

Query: 69  VLHRDLKPSNLLLNANCDLKICDFGLARVTSE 100
           ++H DL  SN ++  +  L + DFGL + +  
Sbjct: 449 IVHGDLTTSNFIVRDD-RLYLIDFGLGKYSDL 479

Length = 535

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 40.5 bits (95), Expect = 5e-04
 Identities = 42/157 (26%), Positives = 66/157 (42%), Gaps = 26/157 (16%)

Query: 3   HENVVAIRDIIPPPQRESFNDV--YIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILR 59
           H+N+V +  +       SF  +  +I  ELM   DL   +R N+   E      +  +L 
Sbjct: 68  HQNIVRLIGV-------SFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLF 120

Query: 60  -------GLKYIHSANVLHRDLKPSNLLLNANCD---LKICDFGLARVTSETDFMTE--- 106
                  G KY+   + +HRD+   N LL         KI DFG+AR      +  +   
Sbjct: 121 CARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGR 180

Query: 107 -YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
             +  +W   PE  L+   +T+  DVWS G +  E+ 
Sbjct: 181 AMLPIKWM-PPEAFLDGI-FTSKTDVWSFGVLLWEIF 215

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional

 Score = 39.9 bits (94), Expect = 5e-04
 Identities = 19/66 (28%), Positives = 33/66 (50%), Gaps = 5/66 (7%)

Query: 35  LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL 94
           L  +I SN     E  +     + +    +HSA ++H DL  SN++L+    + + DFGL
Sbjct: 86  LKDLINSNGMEELELSREIGRLVGK----LHSAGIIHGDLTTSNMILSGG-KIYLIDFGL 140

Query: 95  ARVTSE 100
           A  + +
Sbjct: 141 AEFSKD 146

Length = 211

>gnl|CDD|234331 TIGR03724, arch_bud32, Kae1-associated kinase Bud32

 Score = 39.5 bits (93), Expect = 6e-04
 Identities = 13/37 (35%), Positives = 23/37 (62%), Gaps = 1/37 (2%)

Query: 64  IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSE 100
           +H A ++H DL  SN+++  +  L + DFGL + + E
Sbjct: 106 LHKAGIVHGDLTTSNIIVRDD-KLYLIDFGLGKYSDE 141

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine [Unknown function, General]. Length = 199

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 39.8 bits (93), Expect = 0.001
 Identities = 53/218 (24%), Positives = 83/218 (38%), Gaps = 60/218 (27%)

Query: 51  QYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANC-DLKICDFGLARVTSETDFMT---- 105
           Q  + QIL  L  +HS  ++HRD+KP N++ +      KI D G A      D       
Sbjct: 258 QTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAA-----ADLRVGINY 312

Query: 106 ---EYVVTRWYRAPELLLNSSDYTAA---------------------IDVWSVGCIFMEL 141
              E+++   Y APE  + S+   +A                      D++S G IF+++
Sbjct: 313 IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQM 372

Query: 142 MDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNV 201
                 FP       LR    LI      +L   + +   +   +           F   
Sbjct: 373 A-----FPN------LRSDSNLIQF--NRQLKRNDYDLVAWRKLVEPRASPDLRRGF--- 416

Query: 202 HPSAID--------LVEKMLTFDPRQRITVEDALAHPY 231
               +D        L++ M+ F  RQRI+ + ALAHPY
Sbjct: 417 --EVLDLDGGAGWELLKSMMRFKGRQRISAKAALAHPY 452

Length = 566

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score = 38.4 bits (90), Expect = 0.002
 Identities = 11/28 (39%), Positives = 16/28 (57%)

Query: 203 PSAIDLVEKMLTFDPRQRITVEDALAHP 230
           P   DL+ KML  DP +R + ++ L H 
Sbjct: 188 PELKDLIRKMLQKDPEKRPSAKEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	280
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.98
PLN00181	793	protein SPA1-RELATED; Provisional	99.98
KOG1187	361	consensus Serine/threonine protein kinase [Signal	99.98
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	99.98
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.98
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	99.97
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.97
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.97
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.97
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.97
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.97
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.97
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.97
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	99.97
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.97
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	99.96
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.96
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	99.96
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.96
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.96
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.96
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.95
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.95
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.95
KOG1152	772	consensus Signal transduction serine/threonine kin	99.95
KOG3653	534	consensus Transforming growth factor beta/activin	99.95
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.95
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.95
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.94
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.93
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.93
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.92
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.92
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.9
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.88
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.87
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.86
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.86
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.84
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.81
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.81
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.8
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.79
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.75
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.73
PRK12274	218	serine/threonine protein kinase; Provisional	99.71
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.69
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.68
PRK09188	365	serine/threonine protein kinase; Provisional	99.66
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.65
PRK10345	210	hypothetical protein; Provisional	99.64
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.63
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.61
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.6
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.51
KOG1243	690	consensus Protein kinase [General function predict	99.51
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.45
PRK14879	211	serine/threonine protein kinase; Provisional	99.41
smart00090	237	RIO RIO-like kinase.	99.41
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.37
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.36
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.35
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.21
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.18
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.14
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.13
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.11
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.08
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.02
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.01
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.0
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	99.0
COG4248	637	Uncharacterized protein with protein kinase and he	98.97
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	98.91
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	98.75
KOG3087	229	consensus Serine/threonine protein kinase [General	98.74
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	98.7
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.65
PRK09902	216	hypothetical protein; Provisional	98.6
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.53
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.44
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.28
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	98.22
KOG1093	725	consensus Predicted protein kinase (contains TBC a	97.99
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	97.85
COG0661	517	AarF Predicted unusual protein kinase [General fun	97.7
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.63
KOG1235	538	consensus Predicted unusual protein kinase [Genera	97.59
KOG0576	829	consensus Mitogen-activated protein kinase kinase	97.39
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.29
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.25
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	97.05
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	97.01
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.84
KOG2268	465	consensus Serine/threonine protein kinase [Signal	96.47
PLN02876	822	acyl-CoA dehydrogenase	96.31
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	95.39
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	95.24
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	95.0
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	94.98
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	94.88
PRK05231	319	homoserine kinase; Provisional	94.67
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	94.58
PRK10271	188	thiK thiamine kinase; Provisional	94.55
PF01636	239	APH: Phosphotransferase enzyme family This family	94.51
COG0510	269	ycfN Thiamine kinase and related kinases [Coenzyme	94.43
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	93.77
smart00587	196	CHK ZnF_C4 abd HLH domain containing kinases domai	93.47
COG2334	331	Putative homoserine kinase type II (protein kinase	93.4
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	93.28
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	93.16
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	92.8
PLN02236	344	choline kinase	92.73
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	92.37
KOG2270	520	consensus Serine/threonine protein kinase involved	92.21
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	91.39
PRK14559	645	putative protein serine/threonine phosphatase; Pro	90.77
PRK11768	325	serine/threonine protein kinase; Provisional	90.55
PRK06148	1013	hypothetical protein; Provisional	89.85
PHA03111	444	Ser/Thr kinase; Provisional	89.8
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	89.78
PF02958	294	EcKinase: Ecdysteroid kinase; InterPro: IPR004119	89.51
PRK06149	972	hypothetical protein; Provisional	88.89
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	88.8
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	86.8
PF05445	434	Pox_ser-thr_kin: Poxvirus serine/threonine protein	85.49
PRK12396	409	5-methylribose kinase; Reviewed	85.19

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-59  Score=385.83  Aligned_cols=277  Identities=64%  Similarity=1.137  Sum_probs=257.4

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   80 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nil   80 (280)
                      |+|+||+.+++++..+..+.++++|+|+|+|+.+|.+.+++++.+++..+..+++||+.||.|+|+.|++|||+||.|++
T Consensus        78 ~~HeNIi~l~di~~p~~~~~f~DvYiV~elMetDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll  157 (359)
T KOG0660|consen   78 LRHENIIGLLDIFRPPSRDKFNDVYLVFELMETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLL  157 (359)
T ss_pred             hcCCCcceEEeecccccccccceeEEehhHHhhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhhee
Confidence            58999999999998876677899999999999999999999888999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccceeeccC---CCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 023609           81 LNANCDLKICDFGLARVTSE---TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL  157 (280)
Q Consensus        81 i~~~~~~~l~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  157 (280)
                      ++.+..+|++|||+|+....   ....+..+.|.+|.|||.+.....|+.+.||||+|||+.||++|++.|+|.+...++
T Consensus       158 ~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql  237 (359)
T KOG0660|consen  158 LNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQL  237 (359)
T ss_pred             eccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHH
Confidence            99999999999999998753   444567788999999999988889999999999999999999999999999999999


Q ss_pred             HHHHHHhCCCCHHHHhHh-hHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCc
Q 023609          158 RLLIELIGTPSEAELGFL-NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  236 (280)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~  236 (280)
                      ..|...+|.|+...+..+ ++.+..++...+..+..++...+|+.++.+.+|+++||..||.+|+|++|+|+||||..+.
T Consensus       238 ~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~h  317 (359)
T KOG0660|consen  238 QLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYH  317 (359)
T ss_pred             HHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhc
Confidence            999999999999888777 5778889999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCccCCCCCcchhhccccHHHHHHHHHHHHHhhChhhhc
Q 023609          237 DISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYRQ  279 (280)
Q Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  279 (280)
                      +++++|.+...+.. ++.. ++.++++++++.|+..|+|..++
T Consensus       318 dp~dEP~~~~~~~~-~~~~-~~~~~~r~~i~~e~~~~~~~~~~  358 (359)
T KOG0660|consen  318 DPEDEPVCQPIFDS-FEHE-LTEEELRELIYKEILDFHPDVSK  358 (359)
T ss_pred             CCccCCCCCCCCcc-cccc-ccHHHHHHHHHHHHHhhCccccC
Confidence            99999988766554 3333 99999999999999999998653

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-52  Score=349.29  Aligned_cols=232  Identities=37%  Similarity=0.710  Sum_probs=216.8

Q ss_pred             CC-CCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MD-HENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~-HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      |+ |||||++++++.++.    ..+|+|||||+.+|++.++.+ +.|++..++.|++||+.||+|+|++|+.|||+||+|
T Consensus        65 ln~hpniikL~Evi~d~~----~~L~fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPEN  140 (538)
T KOG0661|consen   65 LNPHPNIIKLKEVIRDND----RILYFVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPEN  140 (538)
T ss_pred             cCCCCcchhhHHHhhccC----ceEeeeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhh
Confidence            45 999999999998763    389999999999999999855 569999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023609           79 LLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  158 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  158 (280)
                      |++..+..+||+|||+|+........+..+.|++|.|||++...+.|+.+.|+||+|||++|+.+-++.|+|.++.+++-
T Consensus       141 iLi~~~~~iKiaDFGLARev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~  220 (538)
T KOG0661|consen  141 ILISGNDVIKIADFGLAREVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIY  220 (538)
T ss_pred             eEecccceeEecccccccccccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHH
Confidence            99999899999999999988877778888999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCc
Q 023609          159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  236 (280)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~  236 (280)
                      +|.+.+|.|....+..-...+...-...|......+....|..++++.++|.+||.+||.+||||.++|+||||+...
T Consensus       221 KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~~  298 (538)
T KOG0661|consen  221 KICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVGR  298 (538)
T ss_pred             HHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCccccccc
Confidence            999999999999888777777777788888888889999999999999999999999999999999999999998653

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=5.9e-52  Score=344.54  Aligned_cols=208  Identities=32%  Similarity=0.589  Sum_probs=177.1

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      |+|||||+++++|..+     ...||||||++ |+|.+.+-.++.+.++..+.+++||+.|+.|||++||+||||||+||
T Consensus       233 L~HP~IV~~~d~f~~~-----ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNI  307 (475)
T KOG0615|consen  233 LSHPNIVRIKDFFEVP-----DSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENI  307 (475)
T ss_pred             cCCCCEEEEeeeeecC-----CceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceE
Confidence            6899999999999776     66799999997 69999999999999999999999999999999999999999999999


Q ss_pred             EEccC---CCEEEeeccceeeccCCCccccceeccccccchhccCCC--CCCcchhHHHHHHHHHHHHhCCCCCCCCChH
Q 023609           80 LLNAN---CDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS--DYTAAIDVWSVGCIFMELMDRKPLFPGRDHV  154 (280)
Q Consensus        80 li~~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  154 (280)
                      |++.+   ..+|++|||+|+..+....+.+.|||+.|.|||++.+.+  .+..++|+||+||++|.+++|.+||.+....
T Consensus       308 Ll~~~~e~~llKItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~  387 (475)
T KOG0615|consen  308 LLSNDAEDCLLKITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTD  387 (475)
T ss_pred             EeccCCcceEEEecccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCC
Confidence            99776   779999999999999888889999999999999986543  2445899999999999999999999876544


Q ss_pred             H-HHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCC
Q 023609          155 H-QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLG  233 (280)
Q Consensus       155 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~  233 (280)
                      . ....|.+.-.                          ...+..+..+|.++++||..||..||++|||++|+|+||||+
T Consensus       388 ~sl~eQI~~G~y--------------------------~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~  441 (475)
T KOG0615|consen  388 PSLKEQILKGRY--------------------------AFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFK  441 (475)
T ss_pred             ccHHHHHhcCcc--------------------------cccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhh
Confidence            4 2222222111                          111123347889999999999999999999999999999999


Q ss_pred             CCcCCC
Q 023609          234 SLHDIS  239 (280)
Q Consensus       234 ~~~~~~  239 (280)
                      ...-.+
T Consensus       442 ~~~~~s  447 (475)
T KOG0615|consen  442 DAPCLS  447 (475)
T ss_pred             cccccc
Confidence            765443

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.7e-50  Score=347.04  Aligned_cols=206  Identities=33%  Similarity=0.555  Sum_probs=183.6

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      |+|||||+++++|+++     .++|||.|+|. ++|..+++.+++++|.+++.+++||+.||.|||++||+|||||..|+
T Consensus        75 L~HpnIV~f~~~FEDs-----~nVYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNl  149 (592)
T KOG0575|consen   75 LKHPNIVQFYHFFEDS-----NNVYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNL  149 (592)
T ss_pred             cCCCcEEeeeeEeecC-----CceEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhhe
Confidence            6899999999999776     88999999998 89999999999999999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCC-CccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  158 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.+..+||+|||+|...... +...+.||||.|.|||++...+ .+..+||||+|||+|.||.|+|||...+-.+.+.
T Consensus       150 fL~~~~~VKIgDFGLAt~le~~~Erk~TlCGTPNYIAPEVl~k~g-HsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~  228 (592)
T KOG0575|consen  150 FLNENMNVKIGDFGLATQLEYDGERKKTLCGTPNYIAPEVLNKSG-HSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYN  228 (592)
T ss_pred             eecCcCcEEecccceeeeecCcccccceecCCCcccChhHhccCC-CCCchhhhhhhhHHHhhhhCCCCcccchHHHHHH
Confidence            9999999999999999987643 5567889999999999996554 7999999999999999999999999998888888


Q ss_pred             HHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCcCC
Q 023609          159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDI  238 (280)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~~~  238 (280)
                      .|...-...|                              ..+|.++++||.+||++||.+|||++++|.|+||++-..+
T Consensus       229 ~Ik~~~Y~~P------------------------------~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~~p  278 (592)
T KOG0575|consen  229 KIKLNEYSMP------------------------------SHLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSGFTP  278 (592)
T ss_pred             HHHhcCcccc------------------------------cccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCCCcC
Confidence            8765432222                              1678999999999999999999999999999999655444


Q ss_pred             CCCC
Q 023609          239 SDEP  242 (280)
Q Consensus       239 ~~~~  242 (280)
                      ...|
T Consensus       279 ~~lp  282 (592)
T KOG0575|consen  279 ARLP  282 (592)
T ss_pred             CCCC
Confidence            4444

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.4e-48  Score=316.89  Aligned_cols=236  Identities=39%  Similarity=0.677  Sum_probs=209.1

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ-ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~-~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      .+|||||.+.++.....   .+.+|||||||+.+|..++..-+ +|+..+++.++.|++.||+|||+++|+|||||++|+
T Consensus       132 ~~H~NIV~vkEVVvG~~---~d~iy~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNL  208 (419)
T KOG0663|consen  132 ARHPNIVEVKEVVVGSN---MDKIYIVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNL  208 (419)
T ss_pred             cCCCCeeeeEEEEeccc---cceeeeeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhhe
Confidence            37999999999986543   36799999999999999998654 899999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCC-CccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  158 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++..|.+|++|||+|+..+.+ ...+..+.|.+|.|||.+.+...|+.++|+||+|||+.+|+++.+.|+|.+..+++.
T Consensus       209 Lm~~~G~lKiaDFGLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~  288 (419)
T KOG0663|consen  209 LLSHKGILKIADFGLAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLD  288 (419)
T ss_pred             eeccCCcEEecccchhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHH
Confidence            9999999999999999987766 445667889999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCC--hHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCc
Q 023609          159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVH--PSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  236 (280)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~  236 (280)
                      +|+..+|.|.+..|..+.+....-....+..+...+...|+..+  ....+|+.++|.+||.+|.||++.|.|+||....
T Consensus       289 ~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P  368 (419)
T KOG0663|consen  289 KIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETP  368 (419)
T ss_pred             HHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCC
Confidence            99999999999988877665443334555666667777777654  8999999999999999999999999999999854


Q ss_pred             CCC
Q 023609          237 DIS  239 (280)
Q Consensus       237 ~~~  239 (280)
                      .+.
T Consensus       369 ~p~  371 (419)
T KOG0663|consen  369 LPI  371 (419)
T ss_pred             CCC
Confidence            433

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=2.5e-49  Score=317.43  Aligned_cols=231  Identities=33%  Similarity=0.703  Sum_probs=200.3

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ-ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~-~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      |+|||||.++++|.-.     ..+++|+|||+-++.+-++... .++...++++++|++.|+.|+|+++++||||||+||
T Consensus        58 LkH~NLVnLiEVFrrk-----rklhLVFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENI  132 (396)
T KOG0593|consen   58 LKHENLVNLIEVFRRK-----RKLHLVFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENI  132 (396)
T ss_pred             cccchHHHHHHHHHhc-----ceeEEEeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhhe
Confidence            6899999999999665     6799999999988888887654 499999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeecc-CCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  158 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.+|.+||||||+|+... ++...+..+.|.+|.|||.+.+...|+..+||||+||++.||++|.+.|+|+++.+++-
T Consensus       133 Lit~~gvvKLCDFGFAR~L~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy  212 (396)
T KOG0593|consen  133 LITQNGVVKLCDFGFARTLSAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLY  212 (396)
T ss_pred             EEecCCcEEeccchhhHhhcCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHH
Confidence            99999999999999999876 55566778899999999999998889999999999999999999999999999999999


Q ss_pred             HHHHHhCCCCHHHHhHhhHhHHHHhhhcC-ccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCc
Q 023609          159 LLIELIGTPSEAELGFLNENAKKYICQLP-RYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  236 (280)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~  236 (280)
                      .|.+.+|...+........+-.-.-...| .....+.++.+|+++.-+.+|+++||..||.+|++.++++.|+||.++-
T Consensus       213 ~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~  291 (396)
T KOG0593|consen  213 LIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFI  291 (396)
T ss_pred             HHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHHH
Confidence            99999998887755443332111111111 1234567888999999999999999999999999999999999998763

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=6.7e-49  Score=322.74  Aligned_cols=236  Identities=36%  Similarity=0.723  Sum_probs=209.2

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS----NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKP   76 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~----~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~   76 (280)
                      ++|||||++.-+|......+.....+||||++.+|.++++.    +..++.-.++-+++||++||+|||+.||+||||||
T Consensus        74 l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKP  153 (364)
T KOG0658|consen   74 LDHPNIVRLLYFFSSSTESDEVYLNLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKP  153 (364)
T ss_pred             cCCcCeeeEEEEEEecCCCchhHHHHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCCh
Confidence            58999999999997765433346788999999999999984    57799999999999999999999999999999999


Q ss_pred             CcEEEccC-CCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 023609           77 SNLLLNAN-CDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVH  155 (280)
Q Consensus        77 ~nili~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~  155 (280)
                      .|+++|.+ |.+||||||.|+....++......+|..|.|||.+.+...|+.+.||||.||++.||+-|++.|+|.+..+
T Consensus       154 qNlLvD~~tg~LKicDFGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~d  233 (364)
T KOG0658|consen  154 QNLLVDPDTGVLKICDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVD  233 (364)
T ss_pred             heEEEcCCCCeEEeccCCcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHH
Confidence            99999986 99999999999998888878888999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccc-cCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCC
Q 023609          156 QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE-KFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS  234 (280)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~  234 (280)
                      ++..|.+.+|.|+...+..++.+..  ....|......+.+ .....++++.+|+.++|+.+|++|.++.|++.||||..
T Consensus       234 QL~eIik~lG~Pt~e~I~~mn~~y~--~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFde  311 (364)
T KOG0658|consen  234 QLVEIIKVLGTPTREDIKSMNPNYT--EFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDE  311 (364)
T ss_pred             HHHHHHHHhCCCCHHHHhhcCcccc--cccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHH
Confidence            9999999999999988876655433  22344444455545 55678999999999999999999999999999999999


Q ss_pred             CcCC
Q 023609          235 LHDI  238 (280)
Q Consensus       235 ~~~~  238 (280)
                      ++++
T Consensus       312 lr~~  315 (364)
T KOG0658|consen  312 LRDP  315 (364)
T ss_pred             hhCc
Confidence            8765

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=2.6e-48  Score=306.36  Aligned_cols=233  Identities=39%  Similarity=0.747  Sum_probs=202.7

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      |+||||+.++|+|...     ..+.||+||++.+|...++.+ ..++...++.++.+++.||+|||+++|+||||||+|+
T Consensus        58 l~h~nIi~LiD~F~~~-----~~l~lVfEfm~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNL  132 (318)
T KOG0659|consen   58 LKHPNIIELIDVFPHK-----SNLSLVFEFMPTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNL  132 (318)
T ss_pred             ccCcchhhhhhhccCC-----CceEEEEEeccccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccce
Confidence            6899999999999765     679999999999999999855 4699999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCCcc-ccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSETDFM-TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  158 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +|+.+|.+|++|||+++..+..... ...+.|.+|.|||.+.+.+.|+..+|+||+|||+.||+.|.+.|+|.++.+++.
T Consensus       133 Lis~~g~lKiADFGLAr~f~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~  212 (318)
T KOG0659|consen  133 LISSDGQLKIADFGLARFFGSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLS  212 (318)
T ss_pred             EEcCCCcEEeecccchhccCCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHH
Confidence            9999999999999999987665433 334789999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCcCC
Q 023609          159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDI  238 (280)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~~~  238 (280)
                      .|+..+|.|.+..|..+.+...-..  ...++.......++..+.++.||+.+||..||.+|+|+.|+++|+||++...+
T Consensus       213 ~If~~LGTP~~~~WP~~~~lpdY~~--~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~p  290 (318)
T KOG0659|consen  213 KIFRALGTPTPDQWPEMTSLPDYVK--IQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLP  290 (318)
T ss_pred             HHHHHcCCCCcccCccccccccHHH--HhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCC
Confidence            9999999999998876644321111  11223334445888999999999999999999999999999999999986554


Q ss_pred             CC
Q 023609          239 SD  240 (280)
Q Consensus       239 ~~  240 (280)
                      ..
T Consensus       291 t~  292 (318)
T KOG0659|consen  291 TP  292 (318)
T ss_pred             CC
Confidence            43

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.4e-48  Score=328.74  Aligned_cols=230  Identities=39%  Similarity=0.697  Sum_probs=198.0

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      |+||||+++.++..+...   ..+|+|+|||+.||..++... -.|++.+++.+|.||+.||+|+|++||+|||||.+||
T Consensus       173 l~HpNIikL~eivt~~~~---~siYlVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNi  249 (560)
T KOG0600|consen  173 LDHPNIIKLEEIVTSKLS---GSIYLVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNI  249 (560)
T ss_pred             cCCCcccceeeEEEecCC---ceEEEEEecccchhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccce
Confidence            689999999999976522   679999999999999999874 3699999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCC--CccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSET--DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL  157 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  157 (280)
                      ||+.+|.+||+|||+|+.....  ...+..+.|.+|.|||.+.+...|+.++|+||+|||+.||+.|++.|.|+++.+++
T Consensus       250 Lidn~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl  329 (560)
T KOG0600|consen  250 LIDNNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQL  329 (560)
T ss_pred             EEcCCCCEEeccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHH
Confidence            9999999999999999965443  34677889999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCC
Q 023609          158 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS  234 (280)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~  234 (280)
                      .+|++..|.|.+..|. ....-..........-.+.+.+.+..+++.+.+|+.+||..||.+|.||.++|.|+||..
T Consensus       330 ~kIfklcGSP~e~~W~-~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t  405 (560)
T KOG0600|consen  330 HKIFKLCGSPTEDYWP-VSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYFTT  405 (560)
T ss_pred             HHHHHHhCCCChhccc-cccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccccc
Confidence            9999999999998776 111110001111111133455667889999999999999999999999999999999944

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-48  Score=318.97  Aligned_cols=202  Identities=28%  Similarity=0.509  Sum_probs=172.8

Q ss_pred             CCCCeeeeeceecCCCCCCCC-cEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCc
Q 023609            2 DHENVVAIRDIIPPPQRESFN-DVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHS-ANVLHRDLKPSN   78 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~-~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~-~gi~H~di~~~n   78 (280)
                      +|||||++|++|..+     + .++|+||||+ |+|.+++..-++++|.....++.+++.||.|||. ++|+||||||+|
T Consensus       135 ~spyIV~~ygaF~~~-----~~~isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsN  209 (364)
T KOG0581|consen  135 QSPYIVGFYGAFYSN-----GEEISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSN  209 (364)
T ss_pred             CCCCeeeEeEEEEeC-----CceEEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHH
Confidence            699999999999876     4 5999999998 7999999988999999999999999999999995 899999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC-----Ch
Q 023609           79 LLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGR-----DH  153 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-----~~  153 (280)
                      +|++..|.+||+|||.++..... ...+..||..|||||.+.+. .|+.++||||||++++|+++|+.||...     ..
T Consensus       210 lLvNskGeVKicDFGVS~~lvnS-~a~tfvGT~~YMsPERi~g~-~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~  287 (364)
T KOG0581|consen  210 LLVNSKGEVKICDFGVSGILVNS-IANTFVGTSAYMSPERISGE-SYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDI  287 (364)
T ss_pred             eeeccCCCEEeccccccHHhhhh-hcccccccccccChhhhcCC-cCCcccceecccHHHHHHhhCCCCCCCcCCCCCCH
Confidence            99999999999999999876655 55788999999999999655 5899999999999999999999999764     33


Q ss_pred             HHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCC-CCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 023609          154 VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP-NVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  232 (280)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~  232 (280)
                      .+.+..|...   |++                          +.-. .+|+++++||..||++||.+|||+.++++|||+
T Consensus       288 ~~Ll~~Iv~~---ppP--------------------------~lP~~~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi  338 (364)
T KOG0581|consen  288 FELLCAIVDE---PPP--------------------------RLPEGEFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFI  338 (364)
T ss_pred             HHHHHHHhcC---CCC--------------------------CCCcccCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHH
Confidence            3333333221   111                          0001 378999999999999999999999999999999


Q ss_pred             CCCcCCC
Q 023609          233 GSLHDIS  239 (280)
Q Consensus       233 ~~~~~~~  239 (280)
                      ++.....
T Consensus       339 ~~~~~~~  345 (364)
T KOG0581|consen  339 KKFEDPN  345 (364)
T ss_pred             hhccccc
Confidence            9875533

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.5e-47  Score=334.47  Aligned_cols=206  Identities=31%  Similarity=0.550  Sum_probs=187.6

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++|||++++|++|.+.     .++|+|.||++ |.|++++..++++++.++.++++||+.|+.|+|..+|+|||+||+|+
T Consensus        69 i~HpnVl~LydVwe~~-----~~lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENl  143 (786)
T KOG0588|consen   69 IEHPNVLRLYDVWENK-----QHLYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENL  143 (786)
T ss_pred             hcCCCeeeeeeeeccC-----ceEEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhh
Confidence            5799999999999766     78999999997 79999999999999999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  159 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      +++..+.|||+|||.|....++....+.||+++|+|||++.+....+.++||||+|+|+|.||+|..||++.+....+.+
T Consensus       144 LLd~~~nIKIADFGMAsLe~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlK  223 (786)
T KOG0588|consen  144 LLDVKNNIKIADFGMASLEVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLK  223 (786)
T ss_pred             hhhcccCEeeeccceeecccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHH
Confidence            99999999999999999998899999999999999999999888889999999999999999999999998887776666


Q ss_pred             HHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCcCCC
Q 023609          160 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDIS  239 (280)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~~~~  239 (280)
                      +.+..                   .++|           ..+|+++++||++||..||++|+|.+|++.|||++++....
T Consensus       224 V~~G~-------------------f~MP-----------s~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~~~  273 (786)
T KOG0588|consen  224 VQRGV-------------------FEMP-----------SNISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTSLP  273 (786)
T ss_pred             HHcCc-------------------ccCC-----------CcCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCCCC
Confidence            54322                   1222           27899999999999999999999999999999999987665


Q ss_pred             CC
Q 023609          240 DE  241 (280)
Q Consensus       240 ~~  241 (280)
                      ..
T Consensus       274 ~~  275 (786)
T KOG0588|consen  274 SS  275 (786)
T ss_pred             hh
Confidence            54

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=4.2e-46  Score=321.93  Aligned_cols=275  Identities=51%  Similarity=0.992  Sum_probs=222.3

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   80 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nil   80 (280)
                      |+||||+++++++......+....|+||||++++|.+++..++.+++..++.++.||+.||+|||++|++||||||+||+
T Consensus        56 l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl  135 (338)
T cd07859          56 LRHPDIVEIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNIL  135 (338)
T ss_pred             CCCCCEeeecceEeccCCCCCceEEEEEecCCCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeE
Confidence            58999999999987654444467899999999999999988888999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccceeeccCCC----ccccceeccccccchhccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 023609           81 LNANCDLKICDFGLARVTSETD----FMTEYVVTRWYRAPELLLNS-SDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVH  155 (280)
Q Consensus        81 i~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~  155 (280)
                      ++.++.++|+|||++.......    ......+++.|+|||++.+. ..++.++||||+||++|+|++|++||.+.+...
T Consensus       136 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~  215 (338)
T cd07859         136 ANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVH  215 (338)
T ss_pred             ECCCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHH
Confidence            9999999999999987542221    12345689999999987542 457889999999999999999999999998888


Q ss_pred             HHHHHHHHhCCCCHHHHhHhh-HhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCC
Q 023609          156 QLRLLIELIGTPSEAELGFLN-ENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS  234 (280)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~  234 (280)
                      ....+....+.++........ .....+...........+...++.+++++.++|.+||+.||++|||++++++||||++
T Consensus       216 ~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~  295 (338)
T cd07859         216 QLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKG  295 (338)
T ss_pred             HHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhh
Confidence            888888888888776554432 2222333333333344455667788999999999999999999999999999999998


Q ss_pred             CcCCCCCCccC--CCCCcchhhccccHHHHHHHHHHHHHhhCh
Q 023609          235 LHDISDEPVCM--SPFSFDFEQHALTEGQMKELIYQEALAFNP  275 (280)
Q Consensus       235 ~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (280)
                      +......+...  ....+.++...++.++.+..+.++....+|
T Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  338 (338)
T cd07859         296 LAKVEREPSAQPITKLEFEFERRRLTKEDVRELIYREILEYHP  338 (338)
T ss_pred             cCccccccccCccccccccHHHHhcCHHHHHHHHHHHHHhcCC
Confidence            87655444332  234556678889999999999988776664

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=5.3e-46  Score=321.35  Aligned_cols=275  Identities=77%  Similarity=1.302  Sum_probs=234.7

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   80 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nil   80 (280)
                      ++||||+++++++...........|+|+||++++|.+++..++++++..+..++.|++.||.|||+.|++|+||+|+||+
T Consensus        61 l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil  140 (337)
T cd07858          61 LDHENVIAIKDIMPPPHREAFNDVYIVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLL  140 (337)
T ss_pred             cCCCCccchHHheecccccccCcEEEEEeCCCCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEE
Confidence            47999999999987654444456899999999999999988889999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccceeeccCC-CccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023609           81 LNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  159 (280)
Q Consensus        81 i~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      ++.++.++|+|||++...... .......++..|+|||.+.....++.++|+||+||++++|++|.+||.+.+.......
T Consensus       141 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~  220 (337)
T cd07858         141 LNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKL  220 (337)
T ss_pred             EcCCCCEEECcCccccccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Confidence            999999999999998765433 2233446788899999886545578999999999999999999999999888888888


Q ss_pred             HHHHhCCCCHHHHhHh-hHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCcCC
Q 023609          160 LIELIGTPSEAELGFL-NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDI  238 (280)
Q Consensus       160 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~~~  238 (280)
                      +....+.+....+... ......+....+......+....+.++++++++|++||+.||++|||+.++++||||..++.+
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~~~~  300 (337)
T cd07858         221 ITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASLHDP  300 (337)
T ss_pred             HHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhhcCc
Confidence            8888888776655332 233344444444444445555667899999999999999999999999999999999999999


Q ss_pred             CCCCccCCCCCcchhhccccHHHHHHHHHHHHHhhCh
Q 023609          239 SDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP  275 (280)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (280)
                      +.++....++.+++++...+.+++++.++.++++++|
T Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (337)
T cd07858         301 SDEPVCQTPFSFDFEEDALTEEDIKELIYNEMLAYHP  337 (337)
T ss_pred             ccCccCCCccchhhhhhhcCHHHHHHHHHHHHhhcCC
Confidence            9999989999999999999999999999999999875

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-46  Score=322.03  Aligned_cols=198  Identities=30%  Similarity=0.550  Sum_probs=179.1

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nil   80 (280)
                      .||.|++++-.|++.     ..+|+|+||++ |+|.++|.+-+.|++..++.++.||+.||+|||++||+||||||+|||
T Consensus       132 ~hPgivkLy~TFQD~-----~sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENIL  206 (604)
T KOG0592|consen  132 GHPGIVKLYFTFQDE-----ESLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENIL  206 (604)
T ss_pred             CCCCeEEEEEEeecc-----cceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhhee
Confidence            699999999999887     67999999997 899999999999999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccceeeccCCC------------c--cccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCC
Q 023609           81 LNANCDLKICDFGLARVTSETD------------F--MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP  146 (280)
Q Consensus        81 i~~~~~~~l~dfg~~~~~~~~~------------~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~  146 (280)
                      ++.+|+++|.|||.++...+..            .  ...++||..|.+||++ ..+..+..+|+|+||||+|+|+.|.+
T Consensus       207 Ld~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL-~~~~~~~~sDiWAlGCilyQmlaG~P  285 (604)
T KOG0592|consen  207 LDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELL-NDSPAGPSSDLWALGCILYQMLAGQP  285 (604)
T ss_pred             EcCCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHh-cCCCCCcccchHHHHHHHHHHhcCCC
Confidence            9999999999999998654321            1  1447899999999988 45568999999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHH
Q 023609          147 LFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDA  226 (280)
Q Consensus       147 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~el  226 (280)
                      ||.+.++....++|++.-...+                              +++++.+++||+++|..||++|+|+.+|
T Consensus       286 PFra~NeyliFqkI~~l~y~fp------------------------------~~fp~~a~dLv~KLLv~dp~~Rlt~~qI  335 (604)
T KOG0592|consen  286 PFRAANEYLIFQKIQALDYEFP------------------------------EGFPEDARDLIKKLLVRDPSDRLTSQQI  335 (604)
T ss_pred             CCccccHHHHHHHHHHhcccCC------------------------------CCCCHHHHHHHHHHHccCccccccHHHH
Confidence            9999999999999987643333                              3788999999999999999999999999


Q ss_pred             hcCCCCCCC
Q 023609          227 LAHPYLGSL  235 (280)
Q Consensus       227 l~h~~~~~~  235 (280)
                      .+||||.++
T Consensus       336 k~HpFF~~V  344 (604)
T KOG0592|consen  336 KAHPFFEGV  344 (604)
T ss_pred             hhCcccccC
Confidence            999999975

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-46  Score=309.13  Aligned_cols=199  Identities=29%  Similarity=0.551  Sum_probs=178.1

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||.||+++-.|++.     .++|+|+||+. |+|+-++++.+.|+|+.++.++.+|+.||.|||+.||+|||+||+||
T Consensus        82 v~hPFiv~l~ysFQt~-----~kLylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENI  156 (357)
T KOG0598|consen   82 IKHPFIVKLIYSFQTE-----EKLYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENI  156 (357)
T ss_pred             CCCCcEeeeEEecccC-----CeEEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHe
Confidence            5899999999999887     78999999997 69999999999999999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeec-cCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023609           80 LLNANCDLKICDFGLARVT-SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  158 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.+|+++|+|||+++.. .......+.+||+.|||||++.+.+ ++.++|.||||+++|+|++|.+||.+.+.....+
T Consensus       157 LLd~~GHi~LtDFgL~k~~~~~~~~t~tfcGT~eYmAPEil~~~g-y~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~  235 (357)
T KOG0598|consen  157 LLDEQGHIKLTDFGLCKEDLKDGDATRTFCGTPEYMAPEILLGKG-YDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYD  235 (357)
T ss_pred             eecCCCcEEEeccccchhcccCCCccccccCCccccChHHHhcCC-CCcccchHhHHHHHHHHhhCCCCCcCccHHHHHH
Confidence            9999999999999999853 3444556789999999999997664 8999999999999999999999999999888888


Q ss_pred             HHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCC-CCChHHHHHHHHhhcCCCCCCC----CHHHHhcCCCCC
Q 023609          159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP-NVHPSAIDLVEKMLTFDPRQRI----TVEDALAHPYLG  233 (280)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~L~~dp~~R~----t~~ell~h~~~~  233 (280)
                      +|...-...                              .| .++.+++++++++|..||++|.    .+.++-+||||.
T Consensus       236 ~I~~~k~~~------------------------------~p~~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~  285 (357)
T KOG0598|consen  236 KILKGKLPL------------------------------PPGYLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFK  285 (357)
T ss_pred             HHhcCcCCC------------------------------CCccCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCcccc
Confidence            776543111                              12 3789999999999999999996    788999999999


Q ss_pred             CC
Q 023609          234 SL  235 (280)
Q Consensus       234 ~~  235 (280)
                      ++
T Consensus       286 ~i  287 (357)
T KOG0598|consen  286 GI  287 (357)
T ss_pred             cC
Confidence            75

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-46  Score=323.19  Aligned_cols=197  Identities=31%  Similarity=0.556  Sum_probs=175.9

Q ss_pred             CCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE
Q 023609            3 HENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   81 (280)
Q Consensus         3 HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nili   81 (280)
                      ||||+++++++..+     ..+|+|||||. |+|++++.+.++++|.+++.++.||+.||+|||++||+||||||+|+++
T Consensus        79 HpnI~~l~ev~~t~-----~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENill  153 (370)
T KOG0583|consen   79 HPNIIRLLEVFATP-----TKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILL  153 (370)
T ss_pred             CCCEeEEEEEEecC-----CeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEe
Confidence            99999999999776     66999999998 5999999998999999999999999999999999999999999999999


Q ss_pred             ccC-CCEEEeeccceeec-cCCCccccceeccccccchhccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023609           82 NAN-CDLKICDFGLARVT-SETDFMTEYVVTRWYRAPELLLNSS-DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  158 (280)
Q Consensus        82 ~~~-~~~~l~dfg~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +.+ +.+||+|||++... .......+.+|++.|+|||++.+.. ..+.++||||+|+++|.|++|+.||.+.+......
T Consensus       154 d~~~~~~Kl~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~  233 (370)
T KOG0583|consen  154 DGNEGNLKLSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYR  233 (370)
T ss_pred             cCCCCCEEEeccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHH
Confidence            999 99999999999988 5667788999999999999997766 55799999999999999999999999877766666


Q ss_pred             HHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCC-ChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCC
Q 023609          159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNV-HPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS  234 (280)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~  234 (280)
                      ++.+..-..+                              ..+ |+++++|+++||.+||.+|+|+.+++.||||+.
T Consensus       234 ki~~~~~~~p------------------------------~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  234 KIRKGEFKIP------------------------------SYLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             HHhcCCccCC------------------------------CCcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence            6433211110                              134 899999999999999999999999999999997

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=2.8e-47  Score=301.99  Aligned_cols=203  Identities=31%  Similarity=0.583  Sum_probs=182.0

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nil   80 (280)
                      -||||+++.++|..+     ..+|+|+|+|. |.|+|++.+.-.+|+++.++||+|+++|++|||.++|||||+||+||+
T Consensus        81 GHP~II~l~D~yes~-----sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENIL  155 (411)
T KOG0599|consen   81 GHPYIIDLQDVYESD-----AFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENIL  155 (411)
T ss_pred             CCCcEEEeeeeccCc-----chhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhhee
Confidence            499999999999776     67999999998 899999999889999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccceeeccCCCccccceeccccccchhccC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 023609           81 LNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLN-----SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVH  155 (280)
Q Consensus        81 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~  155 (280)
                      ++.+.+++|+|||+++...+++....-||||.|+|||.+.+     ...|+..+|+||+|+|+|.|+.|++||--+...-
T Consensus       156 lddn~~i~isDFGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQml  235 (411)
T KOG0599|consen  156 LDDNMNIKISDFGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQML  235 (411)
T ss_pred             eccccceEEeccceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHH
Confidence            99999999999999999988888888999999999999843     2347889999999999999999999998877777


Q ss_pred             HHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCC
Q 023609          156 QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  235 (280)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~  235 (280)
                      +++.|++.-.....+                          .|.++|...++||.+||+.||++|.|++|+|+||||.++
T Consensus       236 MLR~ImeGkyqF~sp--------------------------eWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~  289 (411)
T KOG0599|consen  236 MLRMIMEGKYQFRSP--------------------------EWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQI  289 (411)
T ss_pred             HHHHHHhcccccCCc--------------------------chhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHH
Confidence            777776644333332                          334788999999999999999999999999999999765

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=5.7e-46  Score=305.41  Aligned_cols=237  Identities=39%  Similarity=0.784  Sum_probs=205.0

Q ss_pred             CCCCC-eeeeeceecCCCC-CCCCcEEEEeecCCccHHHHHHcCC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccC
Q 023609            1 MDHEN-VVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQ----ALSEEHCQYFLYQILRGLKYIHSANVLHRDL   74 (280)
Q Consensus         1 l~Hpn-Iv~~~~~~~~~~~-~~~~~~~iv~e~~~g~L~~~l~~~~----~l~~~~~~~i~~qll~al~~LH~~gi~H~di   74 (280)
                      |+|+| |+.+++++...+. ++...+++|+||++-+|.+++....    .++...++.+++||+.||+|||++||+||||
T Consensus        67 L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDL  146 (323)
T KOG0594|consen   67 LSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDL  146 (323)
T ss_pred             hCCCcceEEEEeeeeecccccccceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccC
Confidence            57999 9999999977541 2234799999999999999998654    4888899999999999999999999999999


Q ss_pred             CCCcEEEccCCCEEEeeccceeeccCC-CccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh
Q 023609           75 KPSNLLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDH  153 (280)
Q Consensus        75 ~~~nili~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~  153 (280)
                      ||.||+|+.+|.+||+|||+++..+.+ ......+.|.+|.|||++.+...|+..+||||+|||+++|+++++.|+|.++
T Consensus       147 KPQNlLi~~~G~lKlaDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se  226 (323)
T KOG0594|consen  147 KPQNLLISSSGVLKLADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE  226 (323)
T ss_pred             CcceEEECCCCcEeeeccchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcH
Confidence            999999999999999999999977643 4467788999999999999998899999999999999999999999999999


Q ss_pred             HHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccc-cccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 023609          154 VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQ-RQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  232 (280)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~  232 (280)
                      .+++..|++.+|.|....|....... ++...++... ...+....+..++++.+++.+||+.+|.+|.|+..+|.||||
T Consensus       227 ~~ql~~If~~lGtP~e~~Wp~v~~~~-~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf  305 (323)
T KOG0594|consen  227 IDQLFRIFRLLGTPNEKDWPGVSSLP-DYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYF  305 (323)
T ss_pred             HHHHHHHHHHcCCCCccCCCCccccc-cccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhh
Confidence            99999999999999998776543221 1222333333 556777778888999999999999999999999999999999


Q ss_pred             CCCcCC
Q 023609          233 GSLHDI  238 (280)
Q Consensus       233 ~~~~~~  238 (280)
                      ......
T Consensus       306 ~~~~~~  311 (323)
T KOG0594|consen  306 SELPEK  311 (323)
T ss_pred             cccccc
Confidence            987543

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=8e-46  Score=299.16  Aligned_cols=270  Identities=43%  Similarity=0.785  Sum_probs=232.2

Q ss_pred             CCCCCeeeeeceecCCC-CCCCCcEEEEeecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQ-RESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~-~~~~~~~~iv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++|+||++++.+|.... .+.....|+|||++..+|.+.+..  .+....+..+++|++.|+.+||+.||+||||||+||
T Consensus        72 v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~~nl~~vi~~--elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsni  149 (369)
T KOG0665|consen   72 VNHKNIISLLNVFTPQKTLEEFQEVYLVMELMDANLCQVILM--ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNI  149 (369)
T ss_pred             hcccceeeeeeccCccccHHHHHhHHHHHHhhhhHHHHHHHH--hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccc
Confidence            58999999999996643 333467999999999999999873  478889999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  159 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      ++..++.+|+.|||+++..+..-..+..+.+..|.|||++.+.+ +...+||||+||++.+|++|...|+|.+..+++.+
T Consensus       150 vv~~~~~lKi~dfg~ar~e~~~~~mtpyVvtRyyrapevil~~~-~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~k  228 (369)
T KOG0665|consen  150 VVNSDCTLKILDFGLARTEDTDFMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNK  228 (369)
T ss_pred             eecchhheeeccchhhcccCcccccCchhheeeccCchheeccC-CcccchhhhhhhHHHHHhhceEEecCchHHHHHHH
Confidence            99999999999999998776664566778899999999998877 89999999999999999999999999999999999


Q ss_pred             HHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCC------------ChHHHHHHHHhhcCCCCCCCCHHHHh
Q 023609          160 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNV------------HPSAIDLVEKMLTFDPRQRITVEDAL  227 (280)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~li~~~L~~dp~~R~t~~ell  227 (280)
                      +.+.+|.|.+.....+..-...+....+.++...+.+.+|+.            +..+++++.+||..||++|.+++++|
T Consensus       229 i~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL  308 (369)
T KOG0665|consen  229 IIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDAL  308 (369)
T ss_pred             HHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHh
Confidence            999999999999999999899998888888887777777742            24589999999999999999999999


Q ss_pred             cCCCCCCCcC---CCCCCccCCCCCcchhhccccHHHHHHHHHHHHHhhCh
Q 023609          228 AHPYLGSLHD---ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP  275 (280)
Q Consensus       228 ~h~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (280)
                      +|||++-|..   +.-++ .. +..-..+....+.++|+++|+.|+..|++
T Consensus       309 ~HPY~~vw~~~~ev~ap~-pe-~~d~~~d~~~~t~~e~ke~If~ev~~f~~  357 (369)
T KOG0665|consen  309 RHPYIKVWYDPDEVEAPP-PE-IYDKQLDEREHTIEEWKELIFKEVQRFEE  357 (369)
T ss_pred             cCCeeeeecccccccCCC-Cc-hhhhhcccccCCHHHHHHHHHHHHHhhcc
Confidence            9999994422   22211 11 22223345566799999999999999987

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-45  Score=294.10  Aligned_cols=215  Identities=30%  Similarity=0.501  Sum_probs=179.8

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQA--LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~--l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      -|||||.++++|.+.. .+...+.||||.++ |+|+..+..++.  |+|.++..|+.||..|+.|||+.+|.||||||+|
T Consensus       113 ~h~~iV~IidVyeNs~-~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpEN  191 (400)
T KOG0604|consen  113 GHPHIVSIIDVYENSY-QGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPEN  191 (400)
T ss_pred             CCCceEEeehhhhhhc-cCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhh
Confidence            4999999999997754 33467899999998 699999987764  9999999999999999999999999999999999


Q ss_pred             EEEcc---CCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh--
Q 023609           79 LLLNA---NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDH--  153 (280)
Q Consensus        79 ili~~---~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--  153 (280)
                      ++...   +..+||+|||+++....+....+.+.||.|.|||++ +...|+.++|+||+||++|-|+||.+||.+...  
T Consensus       192 LLyt~t~~na~lKLtDfGFAK~t~~~~~L~TPc~TPyYvaPevl-g~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a  270 (400)
T KOG0604|consen  192 LLYTTTSPNAPLKLTDFGFAKETQEPGDLMTPCFTPYYVAPEVL-GPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA  270 (400)
T ss_pred             eeeecCCCCcceEecccccccccCCCccccCCcccccccCHHHh-CchhcCCCCCccchhHHHHHhhcCCCcccccCCcc
Confidence            99964   566999999999988777778889999999999988 666699999999999999999999999976542  


Q ss_pred             --HHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCC
Q 023609          154 --VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPY  231 (280)
Q Consensus       154 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~  231 (280)
                        ..+..+|...-...+.                          ..|..+|++++++|+++|..+|++|+|+.++++|||
T Consensus       271 ispgMk~rI~~gqy~FP~--------------------------pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpw  324 (400)
T KOG0604|consen  271 ISPGMKRRIRTGQYEFPE--------------------------PEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPW  324 (400)
T ss_pred             CChhHHhHhhccCccCCC--------------------------hhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCch
Confidence              2223333322222222                          334467889999999999999999999999999999


Q ss_pred             CCCCcCCCCCCcc
Q 023609          232 LGSLHDISDEPVC  244 (280)
Q Consensus       232 ~~~~~~~~~~~~~  244 (280)
                      +.+.....+-+.+
T Consensus       325 i~~~~~vp~tpl~  337 (400)
T KOG0604|consen  325 INQYEAVPQTPLS  337 (400)
T ss_pred             hcccccCCCCCch
Confidence            9998776665554

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=2.6e-44  Score=304.26  Aligned_cols=227  Identities=38%  Similarity=0.752  Sum_probs=188.0

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ-ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~-~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++...     ...|+||||++|+|.+++...+ .+++..+..++.||+.||+|||++||+||||||+||
T Consensus        60 l~h~niv~~~~~~~~~-----~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Ni  134 (288)
T cd07871          60 LKHANIVTLHDIIHTE-----RCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNL  134 (288)
T ss_pred             CCCCCEeeEEEEEcCC-----CeEEEEEeCCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHE
Confidence            5899999999998665     6789999999999999987544 589999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCC-CccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  158 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.++.++|+|||++...... .......+++.|+|||.+.+...++.++|+||+||++|+|++|.+||.+.+..+.+.
T Consensus       135 l~~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~  214 (288)
T cd07871         135 LINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELH  214 (288)
T ss_pred             EECCCCCEEECcCcceeeccCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            9999999999999998764332 223345778999999988665668899999999999999999999999999889999


Q ss_pred             HHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 023609          159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  232 (280)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~  232 (280)
                      .+....+.|+...+..............+...........+.++.++++||++||++||.+|||++|+++||||
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         215 LIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             HHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence            99999998888766544322111111122222233334556789999999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.8e-43  Score=309.44  Aligned_cols=273  Identities=46%  Similarity=0.776  Sum_probs=215.7

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   80 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nil   80 (280)
                      ++||||+++++++...........|+||||++++|.+.+...+.+++..++.++.||+.||+|||+.|++||||||+||+
T Consensus        56 l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil  135 (372)
T cd07853          56 FKHDNVLSALDILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLL  135 (372)
T ss_pred             CCCCCcCCHhheecCCCccccceEEEEeeccccCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEE
Confidence            58999999999997764334457899999999999999988888999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccceeeccCC--CccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023609           81 LNANCDLKICDFGLARVTSET--DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  158 (280)
Q Consensus        81 i~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  158 (280)
                      ++.++.++|+|||++......  .......+++.|+|||.+.+...++.++||||+||++++|++|+.||.+.+..+...
T Consensus       136 i~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~  215 (372)
T cd07853         136 VNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLD  215 (372)
T ss_pred             ECCCCCEEeccccceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            999999999999999764332  222344678899999998766667899999999999999999999999999999999


Q ss_pred             HHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccc--cccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCc
Q 023609          159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQ--SFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  236 (280)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~  236 (280)
                      .+.+..+.++...+..............+.....  ......+..++++.+||.+||+.||.+|||+.++++||||.+..
T Consensus       216 ~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~~  295 (372)
T cd07853         216 LITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEGR  295 (372)
T ss_pred             HHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCCc
Confidence            9999999888765544333333333222222111  11123345688999999999999999999999999999998742


Q ss_pred             C--------------------CCCCCccCCCCCcchhhccccHHHHHHHHHHHHHhh
Q 023609          237 D--------------------ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAF  273 (280)
Q Consensus       237 ~--------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (280)
                      .                    ...++....++..+.+....+..++++.++..+..+
T Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (372)
T cd07853         296 LRYHTCMCKCCYTTSGGRVYTSDFEPSANPPFDDEYEKNLTSVRQVKEELHQFILEQ  352 (372)
T ss_pred             chhccccccccccccccccCCcccCCCCCCCCCcccccccCCHHHHHHHHHHHHHHh
Confidence            1                    112232334555666666778888999888876543

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-45  Score=284.67  Aligned_cols=203  Identities=31%  Similarity=0.536  Sum_probs=175.1

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      |+||||+++++.+...     +..|||+|+++| +|..-+-++-.++|..+..++.||++||+|+|.+||+|||+||.|+
T Consensus        67 LqHP~IvrL~~ti~~~-----~~~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nl  141 (355)
T KOG0033|consen   67 LQHPNIVRLHDSIQEE-----SFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENL  141 (355)
T ss_pred             cCCCcEeehhhhhccc-----ceeEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhhe
Confidence            6899999999999554     678999999985 7776666666799999999999999999999999999999999999


Q ss_pred             EEcc---CCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023609           80 LLNA---NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ  156 (280)
Q Consensus        80 li~~---~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  156 (280)
                      ++-.   ...+||+|||++...+.+..-....|||.|+|||++. ..+++..+|||+.|+|+|-|+.|++||.+.+....
T Consensus       142 lLASK~~~A~vKL~~FGvAi~l~~g~~~~G~~GtP~fmaPEvvr-kdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rl  220 (355)
T KOG0033|consen  142 LLASKAKGAAVKLADFGLAIEVNDGEAWHGFAGTPGYLSPEVLK-KDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL  220 (355)
T ss_pred             eeeeccCCCceeecccceEEEeCCccccccccCCCcccCHHHhh-cCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHH
Confidence            9943   3458999999999887665556778999999999884 45689999999999999999999999999887777


Q ss_pred             HHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCC
Q 023609          157 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  235 (280)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~  235 (280)
                      +..|+..--.-+.                          ..++++++++++|+++||..||++|+|+.|+|+|||+.+-
T Consensus       221 ye~I~~g~yd~~~--------------------------~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r  273 (355)
T KOG0033|consen  221 YEQIKAGAYDYPS--------------------------PEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNR  273 (355)
T ss_pred             HHHHhccccCCCC--------------------------cccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcch
Confidence            7777654322221                          3457999999999999999999999999999999999873

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1e-44  Score=289.98  Aligned_cols=197  Identities=29%  Similarity=0.516  Sum_probs=178.0

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      +.||+|+++++.+.+.     ..+|+||||.+ |.|+.++++.++|++..++.++.||+.||+|||+++|++||+||+||
T Consensus       101 v~~PFlv~l~~t~~d~-----~~lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENi  175 (355)
T KOG0616|consen  101 VSHPFLVKLYGTFKDN-----SNLYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENL  175 (355)
T ss_pred             ccCceeEEEEEeeccC-----CeEEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHe
Confidence            4699999999999776     78999999997 69999999999999999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  159 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      ++|.+|.+|++|||+++.....  ..+-||||.|+|||++... .++.++|.||||+++|||+.|.+||.+.+..+.+.+
T Consensus       176 LlD~~G~iKitDFGFAK~v~~r--T~TlCGTPeYLAPEii~sk-~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~K  252 (355)
T KOG0616|consen  176 LLDQNGHIKITDFGFAKRVSGR--TWTLCGTPEYLAPEIIQSK-GYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEK  252 (355)
T ss_pred             eeccCCcEEEEeccceEEecCc--EEEecCCccccChHHhhcC-CCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHH
Confidence            9999999999999999988766  4577999999999998654 589999999999999999999999999999888888


Q ss_pred             HHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCC-----CHHHHhcCCCCCC
Q 023609          160 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI-----TVEDALAHPYLGS  234 (280)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~ell~h~~~~~  234 (280)
                      |.+.--.-+                              +.+++++++||+++|+.|-++|.     ..+++.+||||++
T Consensus       253 I~~~~v~fP------------------------------~~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~  302 (355)
T KOG0616|consen  253 ILEGKVKFP------------------------------SYFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKG  302 (355)
T ss_pred             HHhCcccCC------------------------------cccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCccccc
Confidence            876432222                              26789999999999999999994     6789999999997


Q ss_pred             C
Q 023609          235 L  235 (280)
Q Consensus       235 ~  235 (280)
                      +
T Consensus       303 v  303 (355)
T KOG0616|consen  303 V  303 (355)
T ss_pred             c
Confidence            5

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.9e-43  Score=306.08  Aligned_cols=271  Identities=49%  Similarity=0.899  Sum_probs=218.9

Q ss_pred             CCCCCeeeeeceecCCCC-CCCCcEEEEeecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~-~~~~~~~iv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++..... ......|+++++++++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+||
T Consensus        71 l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Ni  149 (343)
T cd07878          71 MKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNV  149 (343)
T ss_pred             cCCCchhhhhhhhcccccccccCcEEEEeecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhE
Confidence            589999999999865431 22356899999999999988754 5699999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  159 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      +++.++.++|+|||++......  .....+++.|+|||++.+...++.++||||+||++|+|++|..||.+.+..+.+..
T Consensus       150 l~~~~~~~kl~Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~  227 (343)
T cd07878         150 AVNEDCELRILDFGLARQADDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKR  227 (343)
T ss_pred             EECCCCCEEEcCCccceecCCC--cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence            9999999999999999865443  23456889999999987655688999999999999999999999999888888888


Q ss_pred             HHHHhCCCCHHHHhHhh-HhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCcCC
Q 023609          160 LIELIGTPSEAELGFLN-ENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDI  238 (280)
Q Consensus       160 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~~~  238 (280)
                      +.+..+.+......... .....+....+......+...+...++.+.+||.+||+.||.+|||+.++++||||..+..+
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~~  307 (343)
T cd07878         228 IMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDP  307 (343)
T ss_pred             HHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCCC
Confidence            88888877765444332 22333344444444444555666788899999999999999999999999999999988766


Q ss_pred             CCCCccCCCCCcchhhccccHHHHHHHHHHHHHhhCh
Q 023609          239 SDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP  275 (280)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (280)
                      ...+.. .+..........+.+++++..+.+..++.|
T Consensus       308 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (343)
T cd07878         308 EDEPEA-EPYDESPENKERTIEEWKELTYEEVSSFKP  343 (343)
T ss_pred             cccccc-CccccchhhhhccHHHHHHHHHHHHHhcCC
Confidence            544432 344444456677889999999999988876

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=2.8e-43  Score=307.43  Aligned_cols=268  Identities=42%  Similarity=0.762  Sum_probs=209.3

Q ss_pred             CCCCCeeeeeceecCCCC-CCCCcEEEEeecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~-~~~~~~~iv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++..... ......|+||||++++|.+.+..  .+++..++.++.|++.||+|||++||+||||||+||
T Consensus        80 l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NI  157 (364)
T cd07875          80 VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI  157 (364)
T ss_pred             cCCCCccccceeecccccccccCeEEEEEeCCCCCHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHE
Confidence            579999999998865421 22356899999999999988853  589999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  159 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      +++.++.++|+|||+++............+++.|+|||++.+. .++.++||||+||++|+|++|..||.+.+..+....
T Consensus       158 ll~~~~~~kL~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~  236 (364)
T cd07875         158 VVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNK  236 (364)
T ss_pred             EECCCCcEEEEeCCCccccCCCCcccCCcccCCcCCHHHHhCC-CCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            9999999999999999876554444456789999999998554 478999999999999999999999999999999999


Q ss_pred             HHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCC------------CCChHHHHHHHHhhcCCCCCCCCHHHHh
Q 023609          160 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP------------NVHPSAIDLVEKMLTFDPRQRITVEDAL  227 (280)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~li~~~L~~dp~~R~t~~ell  227 (280)
                      +....+.|..............+....+......+...++            ..+..+++||.+||+.||.+|||+.++|
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L  316 (364)
T cd07875         237 VIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL  316 (364)
T ss_pred             HHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHh
Confidence            9888888877655555444444444433332222222221            2356789999999999999999999999


Q ss_pred             cCCCCCCCcCCCCCCccCCCC-CcchhhccccHHHHHHHHHHHHH
Q 023609          228 AHPYLGSLHDISDEPVCMSPF-SFDFEQHALTEGQMKELIYQEAL  271 (280)
Q Consensus       228 ~h~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  271 (280)
                      +||||..+.++.......+.. ....+.......+++++++.+.+
T Consensus       317 ~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  361 (364)
T cd07875         317 QHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKEVM  361 (364)
T ss_pred             cCcccccccCcccCCCCCCCCCCccchhhhccHHHHHHHHHHHHH
Confidence            999999876655444322222 22334455677788888887764

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.3e-43  Score=303.97  Aligned_cols=269  Identities=63%  Similarity=1.135  Sum_probs=230.1

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   80 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nil   80 (280)
                      ++||||+++++++......+....|+||+|++++|.+++.++..+++..++.++.||+.||++||+.|++|+||||+||+
T Consensus        56 l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nil  135 (330)
T cd07834          56 LRHENIIGLLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNIL  135 (330)
T ss_pred             cCCcchhhhhhhhcccCcccccceEEEecchhhhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence            57999999999987764344567999999999999999988889999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccceeeccCCC----ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023609           81 LNANCDLKICDFGLARVTSETD----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ  156 (280)
Q Consensus        81 i~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  156 (280)
                      ++.++.++|+|||.+.......    ......++..|+|||.+.+....+.++|+||+|+++++|++|.+||.+.+..+.
T Consensus       136 i~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~  215 (330)
T cd07834         136 VNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQ  215 (330)
T ss_pred             EcCCCCEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHH
Confidence            9999999999999998765442    233456788899999986654688999999999999999999999999999999


Q ss_pred             HHHHHHHhCCCCHHHHhHh-hHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCC
Q 023609          157 LRLLIELIGTPSEAELGFL-NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  235 (280)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~  235 (280)
                      ...+....+.+....+... ......+...........+....+.+++++.++|++||+.+|.+|||+.+++.||||+++
T Consensus       216 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~  295 (330)
T cd07834         216 LNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQL  295 (330)
T ss_pred             HHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhh
Confidence            9999998888887655422 333444444455555556666778899999999999999999999999999999999999


Q ss_pred             cCCCCCCccCCCCCc-chhhccccHHHHHHHHHHH
Q 023609          236 HDISDEPVCMSPFSF-DFEQHALTEGQMKELIYQE  269 (280)
Q Consensus       236 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~  269 (280)
                      ..+++++....++++ .++...+++++.+++|+++
T Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  330 (330)
T cd07834         296 HDPEDEPVAKPPFDFDFFDDDELTEEELKELIYEE  330 (330)
T ss_pred             cccccCCCCCCcccccccchhhcCHHHHhHHhhcC
Confidence            999999988888877 6788889999999998764

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-44  Score=310.19  Aligned_cols=202  Identities=27%  Similarity=0.550  Sum_probs=174.0

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++|+|||++++.|...     ..+++||||++ |+|.|.+... .++|.++..|+++++.||+|||.+||+|||||.+||
T Consensus       327 ~~H~NiVnfl~Sylv~-----deLWVVMEym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnI  400 (550)
T KOG0578|consen  327 LHHPNIVNFLDSYLVG-----DELWVVMEYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNI  400 (550)
T ss_pred             ccchHHHHHHHHhccc-----ceeEEEEeecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcceeeecccccee
Confidence            4799999999999876     67999999998 6999998764 499999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCC-ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  158 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.+|.+||+|||++....... ...+-+|||.|||||++ ....|++++||||||++++||+.|.+||-..+....+.
T Consensus       401 LL~~~g~vKltDFGFcaqi~~~~~KR~TmVGTPYWMAPEVv-trk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAly  479 (550)
T KOG0578|consen  401 LLTMDGSVKLTDFGFCAQISEEQSKRSTMVGTPYWMAPEVV-TRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY  479 (550)
T ss_pred             EeccCCcEEEeeeeeeeccccccCccccccCCCCccchhhh-hhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHH
Confidence            99999999999999998766554 34567899999999988 45569999999999999999999999998777666655


Q ss_pred             HHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCc
Q 023609          159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  236 (280)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~  236 (280)
                      .|.. .|.|..                          +..+.+|+.+++||.+||+.|+.+|+++.|||+||||+...
T Consensus       480 LIa~-ng~P~l--------------------------k~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a~  530 (550)
T KOG0578|consen  480 LIAT-NGTPKL--------------------------KNPEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKMAK  530 (550)
T ss_pred             HHhh-cCCCCc--------------------------CCccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhhcC
Confidence            5543 222221                          22247899999999999999999999999999999996543

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.7e-42  Score=302.05  Aligned_cols=237  Identities=44%  Similarity=0.822  Sum_probs=190.9

Q ss_pred             CCCCCeeeeeceecCCCC-CCCCcEEEEeecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~-~~~~~~~iv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++..... ......|+||||++++|.+.+..  .+++..+..++.||+.||+|||++||+||||||+||
T Consensus        77 l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NI  154 (359)
T cd07876          77 VNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI  154 (359)
T ss_pred             CCCCCEeeeeeeeccCCCccccceeEEEEeCCCcCHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHE
Confidence            589999999999865431 22346899999999998888753  489999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  159 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      +++.+|.++|+|||++.............+++.|+|||++.+. .++.++||||+||++|+|++|..||.+.+.......
T Consensus       155 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~  233 (359)
T cd07876         155 VVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNK  233 (359)
T ss_pred             EECCCCCEEEecCCCccccccCccCCCCcccCCCCCchhccCC-CCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            9999999999999999765444334456789999999998554 478899999999999999999999999988888888


Q ss_pred             HHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCC------------CCChHHHHHHHHhhcCCCCCCCCHHHHh
Q 023609          160 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP------------NVHPSAIDLVEKMLTFDPRQRITVEDAL  227 (280)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~li~~~L~~dp~~R~t~~ell  227 (280)
                      +.+..+.|..............+....+......+.+.++            ..++++++||.+||+.||++|||+.|++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l  313 (359)
T cd07876         234 VIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEAL  313 (359)
T ss_pred             HHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHh
Confidence            8888888887655544444444444333333333322222            2467899999999999999999999999


Q ss_pred             cCCCCCCCcCCCC
Q 023609          228 AHPYLGSLHDISD  240 (280)
Q Consensus       228 ~h~~~~~~~~~~~  240 (280)
                      +||||..+.++..
T Consensus       314 ~hp~~~~~~~~~~  326 (359)
T cd07876         314 RHPYITVWYDPAE  326 (359)
T ss_pred             cCchhhhhcCccc
Confidence            9999987665543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=6.9e-43  Score=295.63  Aligned_cols=228  Identities=37%  Similarity=0.673  Sum_probs=185.5

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      ++||||+++++++.....+.....++||||++++|.+++...  ..+++..++.++.||+.||+|||+.|++||||||+|
T Consensus        61 ~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~N  140 (290)
T cd07862          61 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQN  140 (290)
T ss_pred             cCCCCcceEEEEEecccCCCCCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHH
Confidence            369999999999865433333679999999999999999753  458999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023609           79 LLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  158 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  158 (280)
                      |+++.++.++|+|||.+.............+++.|+|||.+.+. .++.++||||+||++|+|++|.+||.+....+.+.
T Consensus       141 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~  219 (290)
T cd07862         141 ILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLG  219 (290)
T ss_pred             EEEcCCCCEEEccccceEeccCCcccccccccccccChHHHhCC-CCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHH
Confidence            99999999999999999876554444456789999999988544 47889999999999999999999999999989999


Q ss_pred             HHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 023609          159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  232 (280)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~  232 (280)
                      .+....+.+....+........   ...............+.+++.+++++.+||+.||++|||+.++++||||
T Consensus       220 ~i~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         220 KILDVIGLPGEEDWPRDVALPR---QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             HHHHHhCCCChhhchhhhcccc---hhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence            9988887766544322111000   0111122233445557889999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=1.3e-42  Score=296.68  Aligned_cols=232  Identities=40%  Similarity=0.773  Sum_probs=194.2

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++...     ...|+||||++++|.+++... ..+++..++.++.||+.||+|||+.|++||||||+||
T Consensus        61 l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Ni  135 (309)
T cd07872          61 LKHANIVTLHDIVHTD-----KSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNL  135 (309)
T ss_pred             CCCCCcceEEEEEeeC-----CeEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHE
Confidence            5799999999999765     679999999999999988754 3589999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCC-CccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  158 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.++.++|+|||++...... .......+++.|+|||.+.+...++.++|+||+||++++|++|.+||.+.+..+...
T Consensus       136 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~  215 (309)
T cd07872         136 LINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELH  215 (309)
T ss_pred             EECCCCCEEECccccceecCCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence            9999999999999998764332 222345678899999988666667899999999999999999999999999889999


Q ss_pred             HHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCcC
Q 023609          159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD  237 (280)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~~  237 (280)
                      .+....+.+....+..............+...........+.+++++++||.+||+.||.+|||+.|+++||||+.+..
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~  294 (309)
T cd07872         216 LIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLGT  294 (309)
T ss_pred             HHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhccc
Confidence            9999999888876655433322222333444444445566788999999999999999999999999999999998753

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.3e-44  Score=297.20  Aligned_cols=206  Identities=31%  Similarity=0.481  Sum_probs=165.2

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ-ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~-~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      |+|||||++++......  + ..++|.|||+. |+|.+++...+ .+++..++.+..||++||+|||++|++|+||||+|
T Consensus        71 l~~p~IV~~~G~~~~~~--~-~~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~N  147 (313)
T KOG0198|consen   71 LNHPNIVQYYGSSSSRE--N-DEYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPAN  147 (313)
T ss_pred             CCCCCEEeeCCcccccc--C-eeeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccce
Confidence            57999999999754442  1 36999999997 79999999876 79999999999999999999999999999999999


Q ss_pred             EEEcc-CCCEEEeeccceeeccC----CCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC-C
Q 023609           79 LLLNA-NCDLKICDFGLARVTSE----TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGR-D  152 (280)
Q Consensus        79 ili~~-~~~~~l~dfg~~~~~~~----~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~  152 (280)
                      |+++. ++.+||+|||++.....    ........||+.|||||++........++||||+||++.+|+||.+||... .
T Consensus       148 iLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~  227 (313)
T KOG0198|consen  148 ILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFE  227 (313)
T ss_pred             EEEeCCCCeEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcc
Confidence            99999 79999999999876553    122345689999999999965333345999999999999999999999763 2


Q ss_pred             hHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 023609          153 HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  232 (280)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~  232 (280)
                      ....+-.+...-                            ..+..-+.+|.++++||.+||..||++||||+++|+|||.
T Consensus       228 ~~~~~~~ig~~~----------------------------~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~  279 (313)
T KOG0198|consen  228 EAEALLLIGRED----------------------------SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFL  279 (313)
T ss_pred             hHHHHHHHhccC----------------------------CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhh
Confidence            222111111100                            0012223688999999999999999999999999999999


Q ss_pred             CCCcC
Q 023609          233 GSLHD  237 (280)
Q Consensus       233 ~~~~~  237 (280)
                      .+-..
T Consensus       280 ~~~~~  284 (313)
T KOG0198|consen  280 KQNSI  284 (313)
T ss_pred             hcccc
Confidence            87543

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1.6e-42  Score=299.31  Aligned_cols=266  Identities=58%  Similarity=1.061  Sum_probs=222.2

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   80 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nil   80 (280)
                      ++||||+++++++.... ......|+||||++++|.+++..++.+++..++.++.||+.||+|||+.|++||||||+||+
T Consensus        61 l~h~~iv~~~~~~~~~~-~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil  139 (334)
T cd07855          61 FKHDNIIAIRDILRPPG-ADFKDVYVVMDLMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLL  139 (334)
T ss_pred             cCCCCccCHHHhccccC-CCCceEEEEEehhhhhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEE
Confidence            57999999999886543 22357899999999999999988888999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccceeeccCCC-----ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 023609           81 LNANCDLKICDFGLARVTSETD-----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVH  155 (280)
Q Consensus        81 i~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~  155 (280)
                      ++.++.++|+|||.+.......     ......++..|+|||.+.+...++.++|+||+||++|+|++|+.||.+.+...
T Consensus       140 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~  219 (334)
T cd07855         140 VNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVH  219 (334)
T ss_pred             EcCCCcEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHH
Confidence            9999999999999987543221     11234678889999987655557899999999999999999999999998888


Q ss_pred             HHHHHHHHhCCCCHHHHhHhh-HhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCC
Q 023609          156 QLRLLIELIGTPSEAELGFLN-ENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS  234 (280)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~  234 (280)
                      .+..+....+.|+........ .....+....+......+....+.++.+++++|++||+.+|.+|||+.+++.||||++
T Consensus       220 ~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~  299 (334)
T cd07855         220 QLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQ  299 (334)
T ss_pred             HHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhh
Confidence            888888888888766543332 2222333344444444455666788999999999999999999999999999999999


Q ss_pred             CcCCCCCCccCCCCCcchhhccccHHHHHHHHH
Q 023609          235 LHDISDEPVCMSPFSFDFEQHALTEGQMKELIY  267 (280)
Q Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (280)
                      ...+..++.+..++..+++....+.+.+.+.|-
T Consensus       300 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (334)
T cd07855         300 YHDPDDEPTCPPPFDFDFEAIELSREQLKEAIV  332 (334)
T ss_pred             ccCCcccccCCCCCCCChhhhhcChhhHHHHhh
Confidence            999999999999999999999888888887653

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-43  Score=293.12  Aligned_cols=201  Identities=30%  Similarity=0.540  Sum_probs=176.5

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      |+|||||.++++++.+     +.+|+|||||+ |+|.++++..+.++++.++.++.||+.||++||+++|+||||||.||
T Consensus        66 l~H~nIV~l~d~~~~~-----~~i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNi  140 (429)
T KOG0595|consen   66 LKHPNIVRLLDCIEDD-----DFIYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNI  140 (429)
T ss_pred             cCCcceeeEEEEEecC-----CeEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceE
Confidence            6899999999999887     78999999998 79999999999999999999999999999999999999999999999


Q ss_pred             EEccC------CCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh
Q 023609           80 LLNAN------CDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDH  153 (280)
Q Consensus        80 li~~~------~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~  153 (280)
                      +++..      ..+||.|||+++...+.....+.+|++.|||||++. ...|..++|+||+|+|+|+|++|.+||...+.
T Consensus       141 LLs~~~~~~~~~~LKIADFGfAR~L~~~~~a~tlcGSplYMAPEV~~-~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~  219 (429)
T KOG0595|consen  141 LLSTTARNDTSPVLKIADFGFARFLQPGSMAETLCGSPLYMAPEVIM-SQQYDAKADLWSIGTILYQCLTGKPPFDAETP  219 (429)
T ss_pred             EeccCCCCCCCceEEecccchhhhCCchhHHHHhhCCccccCHHHHH-hccccchhhHHHHHHHHHHHHhCCCCccccCH
Confidence            99765      568999999999999888888899999999999995 44599999999999999999999999999888


Q ss_pred             HHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCC
Q 023609          154 VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLG  233 (280)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~  233 (280)
                      .+....+.+.....+...                           ...+....+++...|+.+|..|.+..+-+.|+++.
T Consensus       220 ~eL~~~~~k~~~~~~~~~---------------------------~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~  272 (429)
T KOG0595|consen  220 KELLLYIKKGNEIVPVLP---------------------------AELSNPLRELLISLLQRNPKDRISFEDFFDHPFLA  272 (429)
T ss_pred             HHHHHHHhccccccCchh---------------------------hhccCchhhhhhHHHhcCccccCchHHhhhhhhcc
Confidence            887775544332222111                           13456677999999999999999999999999987


Q ss_pred             C
Q 023609          234 S  234 (280)
Q Consensus       234 ~  234 (280)
                      .
T Consensus       273 ~  273 (429)
T KOG0595|consen  273 A  273 (429)
T ss_pred             c
Confidence            5

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-42  Score=296.70  Aligned_cols=269  Identities=61%  Similarity=1.085  Sum_probs=215.8

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   80 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nil   80 (280)
                      ++||||+++++++......+....|+|+||++++|.+.+.. +.+++..++.++.|++.||++||+.|++||||||+||+
T Consensus        60 l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nil  138 (336)
T cd07849          60 FKHENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLL  138 (336)
T ss_pred             CCCCCcCchhheeecccccccceEEEEehhcccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEE
Confidence            57999999999886654344467899999999999988854 57999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccceeeccCCC----ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023609           81 LNANCDLKICDFGLARVTSETD----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ  156 (280)
Q Consensus        81 i~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  156 (280)
                      ++.++.++|+|||++.......    ......++..|+|||.+.+...++.++|+||+||++++|++|++||.+.+....
T Consensus       139 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~  218 (336)
T cd07849         139 LNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQ  218 (336)
T ss_pred             ECCCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            9999999999999987654322    112346788899999876555578899999999999999999999999888888


Q ss_pred             HHHHHHHhCCCCHHHHhHhhH-hHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCC
Q 023609          157 LRLLIELIGTPSEAELGFLNE-NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  235 (280)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~  235 (280)
                      ...+....+.+.......... ....+....+......+....+.+++++.++|.+||+.||++|||+.++++||||..+
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~  298 (336)
T cd07849         219 LNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY  298 (336)
T ss_pred             HHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence            888888888777655443322 2223333333333344445567789999999999999999999999999999999999


Q ss_pred             cCCCCCCccCCCCCcchhh-ccccHHHHHHHHHHHH
Q 023609          236 HDISDEPVCMSPFSFDFEQ-HALTEGQMKELIYQEA  270 (280)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  270 (280)
                      ...++++....++.++++. ..++..++++.++.++
T Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (336)
T cd07849         299 HDPSDEPVAEEPFPFDFELFDDLPKEKLKELIFEEI  334 (336)
T ss_pred             CCCCCcccCCCCCChhhccccccCHHHHHHHHHHHh
Confidence            9888888775555555433 4567888999988775

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.5e-42  Score=298.21  Aligned_cols=271  Identities=53%  Similarity=0.971  Sum_probs=225.4

Q ss_pred             CCCCCeeeeeceecCCCC-CCCCcEEEEeecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~-~~~~~~~iv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++..... ......|+|+||++++|.+++.. .++++..++.++.|++.||+|||+.|++|+||+|+||
T Consensus        71 l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Ni  149 (343)
T cd07851          71 MDHENVIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNI  149 (343)
T ss_pred             ccCCCHHHHHHHhhccccccccccEEEEEecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHe
Confidence            479999999998865532 33356899999999999999875 5799999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  159 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      +++.++.++|+|||.+......  .....++..|+|||.+.+....+.++|+||+||++++|++|+.||.+.........
T Consensus       150 ll~~~~~~kL~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~  227 (343)
T cd07851         150 AVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKR  227 (343)
T ss_pred             EECCCCCEEEcccccccccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence            9999999999999998765433  23446678899999886544578899999999999999999999998888888888


Q ss_pred             HHHHhCCCCHHHHhHh-hHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCcCC
Q 023609          160 LIELIGTPSEAELGFL-NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDI  238 (280)
Q Consensus       160 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~~~  238 (280)
                      +.+..+.+++..+... ......+....+......+...++.+++++.++|++||+.||.+|||+.++++||||+++...
T Consensus       228 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~~~  307 (343)
T cd07851         228 IMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYHDP  307 (343)
T ss_pred             HHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccCCC
Confidence            8888777766544332 333344444555555555556667789999999999999999999999999999999999888


Q ss_pred             CCCCccCCCCCcchhhccccHHHHHHHHHHHHHhhCh
Q 023609          239 SDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP  275 (280)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (280)
                      ++++. ...++.+++...+..++|+++++.++-.|.|
T Consensus       308 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (343)
T cd07851         308 EDEPV-APPYDQSFESRDLTVDEWKELVYKEIMNFKP  343 (343)
T ss_pred             ccccc-ccccCcchhhhhcCHHHHHHHhHHHHHhccC
Confidence            77664 6777788899999999999999999887765

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=4.8e-42  Score=298.73  Aligned_cols=266  Identities=41%  Similarity=0.755  Sum_probs=201.0

Q ss_pred             CCCCCeeeeeceecCCCC-CCCCcEEEEeecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~-~~~~~~~iv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++..... +.....|+||||++++|.+.+..  .+++..++.++.|++.||+|||+.|++||||||+||
T Consensus        73 l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Ni  150 (355)
T cd07874          73 VNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI  150 (355)
T ss_pred             hCCCchhceeeeeeccccccccceeEEEhhhhcccHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHE
Confidence            579999999999865432 22356899999999999888754  589999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  159 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      +++.++.++|+|||+++............+++.|+|||++.+. .++.++|+||+||++|+|++|..||.+.+..+....
T Consensus       151 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~  229 (355)
T cd07874         151 VVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK  229 (355)
T ss_pred             EECCCCCEEEeeCcccccCCCccccCCccccCCccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            9999999999999999876555444556789999999998544 478999999999999999999999999998888888


Q ss_pred             HHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccc------------cCCCCChHHHHHHHHhhcCCCCCCCCHHHHh
Q 023609          160 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE------------KFPNVHPSAIDLVEKMLTFDPRQRITVEDAL  227 (280)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~~~~li~~~L~~dp~~R~t~~ell  227 (280)
                      +.+..+.+..............+....+......+..            .....+.++++||.+||+.||.+|||+.|++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell  309 (355)
T cd07874         230 VIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEAL  309 (355)
T ss_pred             HHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHh
Confidence            8888888776655544444444433333222111111            1123456789999999999999999999999


Q ss_pred             cCCCCCCCcCCCCCCccCCC-CCcchhhccccHHHHHHHHHHH
Q 023609          228 AHPYLGSLHDISDEPVCMSP-FSFDFEQHALTEGQMKELIYQE  269 (280)
Q Consensus       228 ~h~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~  269 (280)
                      +||||+.+.++.......+. +.....+...+..++++.++..
T Consensus       310 ~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (355)
T cd07874         310 QHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKE  352 (355)
T ss_pred             cCcchhcccChhhccCCCccccccchhhhhccHHHHHHHHHHH
Confidence            99999987654332221111 1122233334555666666554

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=3.6e-42  Score=306.84  Aligned_cols=236  Identities=34%  Similarity=0.663  Sum_probs=187.2

Q ss_pred             CCCCCeeeeeceecCCC---CCCCCcEEEEeecCCccHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHHCCceecc
Q 023609            1 MDHENVVAIRDIIPPPQ---RESFNDVYIAYELMDTDLHQIIR----SNQALSEEHCQYFLYQILRGLKYIHSANVLHRD   73 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~---~~~~~~~~iv~e~~~g~L~~~l~----~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~d   73 (280)
                      ++||||+++++++....   ......+++||||++++|.+++.    .+..+++..++.++.||+.||+|||+.||+|||
T Consensus       116 l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrD  195 (440)
T PTZ00036        116 LNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRD  195 (440)
T ss_pred             cCCCCCcceeeeEeecccccCCCceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCC
Confidence            58999999999875432   11123477999999998888775    346799999999999999999999999999999


Q ss_pred             CCCCcEEEccCC-CEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 023609           74 LKPSNLLLNANC-DLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD  152 (280)
Q Consensus        74 i~~~nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  152 (280)
                      |||+||+++.++ .++|+|||+++............+++.|+|||++.+...++.++||||+||++|+|++|.+||.+.+
T Consensus       196 LKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~  275 (440)
T PTZ00036        196 LKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQS  275 (440)
T ss_pred             cCHHHEEEcCCCCceeeeccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            999999998765 6999999999865544434456789999999998766668999999999999999999999999999


Q ss_pred             hHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCC-CCChHHHHHHHHhhcCCCCCCCCHHHHhcCCC
Q 023609          153 HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP-NVHPSAIDLVEKMLTFDPRQRITVEDALAHPY  231 (280)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~  231 (280)
                      ..+.+..+.+..+.|..............  ...+......+...+| ..+.++++||.+||+.||.+|||+.++++|||
T Consensus       276 ~~~~~~~i~~~~~~p~~~~~~~~~~~~~~--~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~  353 (440)
T PTZ00036        276 SVDQLVRIIQVLGTPTEDQLKEMNPNYAD--IKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPF  353 (440)
T ss_pred             hHHHHHHHHHHhCCCCHHHHHHhchhhhc--ccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChh
Confidence            99999999999998877654433221111  0112222222333333 46789999999999999999999999999999


Q ss_pred             CCCCcCC
Q 023609          232 LGSLHDI  238 (280)
Q Consensus       232 ~~~~~~~  238 (280)
                      |..+.+.
T Consensus       354 f~~~~~~  360 (440)
T PTZ00036        354 FDDLRDP  360 (440)
T ss_pred             HHhhhcc
Confidence            9987653

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.5e-42  Score=295.50  Aligned_cols=231  Identities=36%  Similarity=0.667  Sum_probs=176.8

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++.+.     ...|+||||++++|.+++... +.+++..++.++.||+.||+|||+.|++||||||+||
T Consensus        60 l~h~niv~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Ni  134 (303)
T cd07869          60 LKHANIVLLHDIIHTK-----ETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNL  134 (303)
T ss_pred             CCCCCcCeEEEEEecC-----CeEEEEEECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHE
Confidence            5899999999999765     679999999999999988754 5699999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCC-CccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-hHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD-HVHQL  157 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~  157 (280)
                      +++.++.++|+|||.+...... .......+++.|+|||++.+...++.++|+||+||++|+|++|..||.+.. ....+
T Consensus       135 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~  214 (303)
T cd07869         135 LISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQL  214 (303)
T ss_pred             EECCCCCEEECCCCcceeccCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHH
Confidence            9999999999999998754322 223345678999999998665567889999999999999999999998764 34556


Q ss_pred             HHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCC--CCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCC
Q 023609          158 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP--NVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  235 (280)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~  235 (280)
                      ..+....+.+....+.....................+...+.  .++.++++||++||+.||++|||+.++++||||+++
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~  294 (303)
T cd07869         215 ERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL  294 (303)
T ss_pred             HHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence            666666666654433221110000000000011111111111  346789999999999999999999999999999886


Q ss_pred             c
Q 023609          236 H  236 (280)
Q Consensus       236 ~  236 (280)
                      .
T Consensus       295 ~  295 (303)
T cd07869         295 P  295 (303)
T ss_pred             C
Confidence            3

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=8.2e-44  Score=283.14  Aligned_cols=190  Identities=29%  Similarity=0.463  Sum_probs=161.0

Q ss_pred             CCCCCeeeeec-eecCCCCCCCCcEEEEeecCC-ccHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHH--CC--ce
Q 023609            1 MDHENVVAIRD-IIPPPQRESFNDVYIAYELMD-TDLHQIIR----SNQALSEEHCQYFLYQILRGLKYIHS--AN--VL   70 (280)
Q Consensus         1 l~HpnIv~~~~-~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~----~~~~l~~~~~~~i~~qll~al~~LH~--~g--i~   70 (280)
                      |+|||||++++ .|..+    ...++||||||+ |+|.+.++    +++.++|..+|+++.|++.||..+|+  ..  |+
T Consensus        75 L~HpNIVqYy~~~f~~~----~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~Vm  150 (375)
T KOG0591|consen   75 LNHPNIVQYYAHSFIED----NEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVM  150 (375)
T ss_pred             cCCchHHHHHHHhhhcc----chhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhcccccccee
Confidence            68999999999 44333    144899999998 89999986    34579999999999999999999998  44  99


Q ss_pred             eccCCCCcEEEccCCCEEEeeccceeeccCCCc-cccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 023609           71 HRDLKPSNLLLNANCDLKICDFGLARVTSETDF-MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFP  149 (280)
Q Consensus        71 H~di~~~nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  149 (280)
                      ||||||.||+++.+|.+||+|||+++....... ....+|||.||+||.+... .|+.++||||+||++|||+.-.+||.
T Consensus       151 HRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~-~Y~~kSDiWslGCllyEMcaL~~PF~  229 (375)
T KOG0591|consen  151 HRDIKPANIFLTANGVVKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHES-GYNFKSDIWSLGCLLYEMCALQSPFY  229 (375)
T ss_pred             eccCcchheEEcCCCceeeccchhHhHhcchhHHHHhhcCCCcccCHHHHhcC-CCCcchhHHHHHHHHHHHHhcCCCcc
Confidence            999999999999999999999999998766543 4567899999999999655 49999999999999999999999999


Q ss_pred             CCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCH
Q 023609          150 GRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV  223 (280)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~  223 (280)
                      |++-.+..++|...--+|.+.                            ..+|.++..+|..|+..||..||+.
T Consensus       230 g~n~~~L~~KI~qgd~~~~p~----------------------------~~YS~~l~~li~~ci~vd~~~RP~t  275 (375)
T KOG0591|consen  230 GDNLLSLCKKIEQGDYPPLPD----------------------------EHYSTDLRELINMCIAVDPEQRPDT  275 (375)
T ss_pred             cccHHHHHHHHHcCCCCCCcH----------------------------HHhhhHHHHHHHHHccCCcccCCCc
Confidence            998777777776543222211                            1578899999999999999999986

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=9.8e-43  Score=298.28  Aligned_cols=201  Identities=28%  Similarity=0.528  Sum_probs=172.1

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nil   80 (280)
                      ++|+||+++-.|++.     ..+|+||||++ |++-.+|...+.|+++.++.++.+++.|++.+|+.|++||||||+|+|
T Consensus       199 ds~~vVKLyYsFQD~-----~~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlL  273 (550)
T KOG0605|consen  199 DSPWVVKLYYSFQDK-----EYLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLL  273 (550)
T ss_pred             CCCcEEEEEEEecCC-----CeeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhhee
Confidence            579999999999887     78999999997 699999999999999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccceeeccC----------------------CCcc--------------------------ccceeccc
Q 023609           81 LNANCDLKICDFGLARVTSE----------------------TDFM--------------------------TEYVVTRW  112 (280)
Q Consensus        81 i~~~~~~~l~dfg~~~~~~~----------------------~~~~--------------------------~~~~~~~~  112 (280)
                      ||.+|++||+|||++.....                      ....                          ...+|||.
T Consensus       274 iD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPD  353 (550)
T KOG0605|consen  274 IDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPD  353 (550)
T ss_pred             ecCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCcc
Confidence            99999999999999842110                      0000                          12368999


Q ss_pred             cccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccc
Q 023609          113 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQ  192 (280)
Q Consensus       113 y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (280)
                      |+|||++.+.+ |+..+|.||||||+||||.|.+||.+.+..+.+++|..--...                 ..|.    
T Consensus       354 YiAPEVll~kg-Y~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l-----------------~fP~----  411 (550)
T KOG0605|consen  354 YIAPEVLLGKG-YGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETL-----------------KFPE----  411 (550)
T ss_pred             ccchHHHhcCC-CCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhc-----------------cCCC----
Confidence            99999998776 8999999999999999999999999999999999886432110                 0000    


Q ss_pred             cccccCCCCChHHHHHHHHhhcCCCCCCCC---HHHHhcCCCCCCC
Q 023609          193 SFTEKFPNVHPSAIDLVEKMLTFDPRQRIT---VEDALAHPYLGSL  235 (280)
Q Consensus       193 ~~~~~~~~~~~~~~~li~~~L~~dp~~R~t---~~ell~h~~~~~~  235 (280)
                           -...+.+++|||.+||. ||.+|..   ++||.+||||+++
T Consensus       412 -----~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v  451 (550)
T KOG0605|consen  412 -----EVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGV  451 (550)
T ss_pred             -----cCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccC
Confidence                 02567899999999999 9999995   8899999999986

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=2.4e-43  Score=303.37  Aligned_cols=201  Identities=32%  Similarity=0.583  Sum_probs=180.2

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   80 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nil   80 (280)
                      |+|||||.+++.|..+     .++++|+|||.|+|+.++...+.++|+.++.+++|++.||.|||+.+|.|||+||.||+
T Consensus        58 lkHpniv~m~esfEt~-----~~~~vVte~a~g~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniL  132 (808)
T KOG0597|consen   58 LKHPNIVEMLESFETS-----AHLWVVTEYAVGDLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNIL  132 (808)
T ss_pred             cCCcchhhHHHhhccc-----ceEEEEehhhhhhHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceee
Confidence            6899999999999766     88999999999999999999999999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccceeeccCCCc-cccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023609           81 LNANCDLKICDFGLARVTSETDF-MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  159 (280)
Q Consensus        81 i~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      ++..|.+|++|||+++.++.+.. .....|||.|||||.+. ...|+..+|.||+|||+||+..|++||.+.+..+..+.
T Consensus       133 l~~~~~~KlcdFg~Ar~m~~~t~vltsikGtPlYmAPElv~-e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~  211 (808)
T KOG0597|consen  133 LEKGGTLKLCDFGLARAMSTNTSVLTSIKGTPLYMAPELVE-EQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKS  211 (808)
T ss_pred             ecCCCceeechhhhhhhcccCceeeeeccCcccccCHHHHc-CCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHH
Confidence            99999999999999999887754 44567999999999885 66799999999999999999999999988877777666


Q ss_pred             HHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCcC
Q 023609          160 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD  237 (280)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~~  237 (280)
                      |...--.++.                              ..|..+++|++++|.+||.+|+|..+++.|||+++--.
T Consensus       212 I~~d~v~~p~------------------------------~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~~  259 (808)
T KOG0597|consen  212 ILKDPVKPPS------------------------------TASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKIN  259 (808)
T ss_pred             HhcCCCCCcc------------------------------cccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhhh
Confidence            6543322221                              67889999999999999999999999999999987543

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=7.2e-42  Score=289.05  Aligned_cols=228  Identities=37%  Similarity=0.661  Sum_probs=184.5

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      ++||||+++++++...........++|||+++++|.+++...  ..+++..++.++.|++.||+|||+.|++||||||+|
T Consensus        59 ~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~N  138 (288)
T cd07863          59 FDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPEN  138 (288)
T ss_pred             cCCCCeeeeeeeeccccCCCCceEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence            369999999999876443334568999999999999998754  348999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023609           79 LLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  158 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  158 (280)
                      |+++.++.++|+|||.+.............++..|+|||++.+. .++.++||||+||++|+|++|.+||.+....+...
T Consensus       139 ili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~  217 (288)
T cd07863         139 ILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLG  217 (288)
T ss_pred             EEECCCCCEEECccCccccccCcccCCCccccccccCchHhhCC-CCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHH
Confidence            99999999999999999866544333455678899999988544 48899999999999999999999999988888888


Q ss_pred             HHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 023609          159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  232 (280)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~  232 (280)
                      .+....+.+....+.......   ................+.++..++++|.+||+.||.+|||+.+++.||||
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         218 KIFDLIGLPPEDDWPRDVTLP---RGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             HHHHHhCCCChhhCccccccc---ccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            888887776654432111000   00111122333445667888999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=2.5e-42  Score=302.69  Aligned_cols=223  Identities=36%  Similarity=0.673  Sum_probs=184.3

Q ss_pred             CCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE
Q 023609            4 ENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ--ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   81 (280)
Q Consensus         4 pnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~--~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nili   81 (280)
                      -|+|+++++|...     +++|||+|+++.+|+++++.++  .|+...++.++.||+.||.+||+.||+|+||||+|||+
T Consensus       248 ~n~Vrm~d~F~fr-----~HlciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL  322 (586)
T KOG0667|consen  248 YNIVRMLDYFYFR-----NHLCIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILL  322 (586)
T ss_pred             eeEEEeeeccccc-----cceeeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheee
Confidence            4899999999776     8999999999999999999764  59999999999999999999999999999999999999


Q ss_pred             ccC--CCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023609           82 NAN--CDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  159 (280)
Q Consensus        82 ~~~--~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      ...  ..+|++|||++...+....  ..+.++.|.|||++.+.. |+.+.||||||||++||.+|.+.|+|.+..++++.
T Consensus       323 ~~~~r~~vKVIDFGSSc~~~q~vy--tYiQSRfYRAPEVILGlp-Y~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~  399 (586)
T KOG0667|consen  323 KDPKRSRIKVIDFGSSCFESQRVY--TYIQSRFYRAPEVILGLP-YDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLAR  399 (586)
T ss_pred             ccCCcCceeEEecccccccCCcce--eeeeccccccchhhccCC-CCCccceeehhhhHHhHhcCccccCCCCHHHHHHH
Confidence            653  4699999999998876644  778899999999998765 89999999999999999999999999999999999


Q ss_pred             HHHHhCCCCHHHHhHhhHhHHHHhhh---cCcc------------------------------ccccccccCC-CCChHH
Q 023609          160 LIELIGTPSEAELGFLNENAKKYICQ---LPRY------------------------------QRQSFTEKFP-NVHPSA  205 (280)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~------------------------------~~~~~~~~~~-~~~~~~  205 (280)
                      |.+.+|.|+...+...... ..|...   .+..                              ..+.+....+ .-...+
T Consensus       400 I~e~lG~Pp~~mL~~~~~~-~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F  478 (586)
T KOG0667|consen  400 IIEVLGLPPPKMLDTAKKA-HKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLF  478 (586)
T ss_pred             HHHHhCCCCHHHHHhcccc-ceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHH
Confidence            9999999988755433222 111111   1100                              0011111112 223568


Q ss_pred             HHHHHHhhcCCCCCCCCHHHHhcCCCCCCC
Q 023609          206 IDLVEKMLTFDPRQRITVEDALAHPYLGSL  235 (280)
Q Consensus       206 ~~li~~~L~~dp~~R~t~~ell~h~~~~~~  235 (280)
                      .+||.+||.+||.+|+|+.++|+||||.+.
T Consensus       479 ~dflk~~L~~dP~~R~tp~qal~Hpfl~~~  508 (586)
T KOG0667|consen  479 IDFLKRCLEWDPAERITPAQALNHPFLTGT  508 (586)
T ss_pred             HHHHHHHhccCchhcCCHHHHhcCcccccc
Confidence            999999999999999999999999999954

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1.2e-41  Score=289.74  Aligned_cols=231  Identities=39%  Similarity=0.768  Sum_probs=187.8

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      |+||||+++++++...     ...|+||||++++|.+++... ..+++..++.++.||+.||+|||+.|++|+||||+||
T Consensus        61 l~h~nI~~~~~~~~~~-----~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Ni  135 (301)
T cd07873          61 LKHANIVTLHDIIHTE-----KSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNL  135 (301)
T ss_pred             cCCCCcceEEEEEecC-----CeEEEEEeccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHE
Confidence            5899999999999765     679999999999999988753 5699999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCC-CccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  158 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.++.++|+|||.+...... .......+++.|+|||.+.+...++.++|+||+||++|+|++|.+||.+.+..+...
T Consensus       136 l~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~  215 (301)
T cd07873         136 LINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLH  215 (301)
T ss_pred             EECCCCcEEECcCcchhccCCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            9999999999999998754332 222344668899999998665567889999999999999999999999988888888


Q ss_pred             HHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCc
Q 023609          159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  236 (280)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~  236 (280)
                      .+....+.+....+..............+...........+.+++++++||.+||+.||.+|||+.++++||||+.+.
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~  293 (301)
T cd07873         216 FIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLG  293 (301)
T ss_pred             HHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence            888888887766554332211111112222222223344467899999999999999999999999999999998875

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-42  Score=287.30  Aligned_cols=212  Identities=25%  Similarity=0.416  Sum_probs=172.2

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS   77 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~   77 (280)
                      ++||||++++..|...     ..+|+||+||. |++.+.++..  ..++|..+..|+++++.||.|||.+|.+|||||+.
T Consensus        81 ~~HPNIv~~~~sFvv~-----~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAg  155 (516)
T KOG0582|consen   81 IDHPNIVTYHCSFVVD-----SELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAG  155 (516)
T ss_pred             cCCCCcceEEEEEEec-----ceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccc
Confidence            5899999999999887     78999999997 7999999753  34999999999999999999999999999999999


Q ss_pred             cEEEccCCCEEEeeccceeeccCCC----cc-ccceeccccccchhc-cCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 023609           78 NLLLNANCDLKICDFGLARVTSETD----FM-TEYVVTRWYRAPELL-LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGR  151 (280)
Q Consensus        78 nili~~~~~~~l~dfg~~~~~~~~~----~~-~~~~~~~~y~aPE~~-~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~  151 (280)
                      ||+|+.+|.++|+|||.+...-..+    .. ....+++.|||||++ .....|..++||||+|++..||++|..||...
T Consensus       156 nILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~  235 (516)
T KOG0582|consen  156 NILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKY  235 (516)
T ss_pred             cEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccC
Confidence            9999999999999999886543322    11 456899999999994 44456899999999999999999999999887


Q ss_pred             ChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCC
Q 023609          152 DHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPY  231 (280)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~  231 (280)
                      .+.+++...  .-+.|+.......+.                  +....++..++.+|..||+.||.+|||++++|+|+|
T Consensus       236 pPmkvLl~t--Lqn~pp~~~t~~~~~------------------d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~F  295 (516)
T KOG0582|consen  236 PPMKVLLLT--LQNDPPTLLTSGLDK------------------DEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAF  295 (516)
T ss_pred             ChHHHHHHH--hcCCCCCcccccCCh------------------HHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHH
Confidence            776654432  234443221110000                  111256678999999999999999999999999999


Q ss_pred             CCCCcC
Q 023609          232 LGSLHD  237 (280)
Q Consensus       232 ~~~~~~  237 (280)
                      |++...
T Consensus       296 Fk~~k~  301 (516)
T KOG0582|consen  296 FKKAKS  301 (516)
T ss_pred             Hhhccc
Confidence            998654

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=6.4e-41  Score=291.42  Aligned_cols=265  Identities=43%  Similarity=0.798  Sum_probs=203.5

Q ss_pred             CCCCCeeeeeceecCCCC-CCCCcEEEEeecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~-~~~~~~~iv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++..... .+....|+||||++++|.+.+...  +++..+..++.|++.||+|||+.|++||||||+||
T Consensus        72 l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Ni  149 (353)
T cd07850          72 VNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI  149 (353)
T ss_pred             cCCCCCcceeeeeccCCCccccCcEEEEEeccCCCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHE
Confidence            579999999999865431 223568999999999999988654  99999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  159 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      +++.++.++|+|||.+.............++..|+|||.+.+. .++.++|+||+||++++|++|..||.+.+.......
T Consensus       150 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~  228 (353)
T cd07850         150 VVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNK  228 (353)
T ss_pred             EECCCCCEEEccCccceeCCCCCCCCCCcccccccCHHHHhCC-CCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHH
Confidence            9999999999999999876554434445678899999998554 478999999999999999999999999988888888


Q ss_pred             HHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccC-------------CCCChHHHHHHHHhhcCCCCCCCCHHHH
Q 023609          160 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF-------------PNVHPSAIDLVEKMLTFDPRQRITVEDA  226 (280)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------~~~~~~~~~li~~~L~~dp~~R~t~~el  226 (280)
                      +.+..+.|+......+......+....+......+...+             ...+..++++|.+||+.||.+|||+.++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ei  308 (353)
T cd07850         229 IIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDA  308 (353)
T ss_pred             HHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHH
Confidence            888888888765555444444443333322222222221             1345678999999999999999999999


Q ss_pred             hcCCCCCCCcCCCCCCcc-CCCCCcchhhccccHHHHHHHHHH
Q 023609          227 LAHPYLGSLHDISDEPVC-MSPFSFDFEQHALTEGQMKELIYQ  268 (280)
Q Consensus       227 l~h~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~  268 (280)
                      |.||||..+...++.... ....+...+......++|+..++-
T Consensus       309 L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  351 (353)
T cd07850         309 LQHPYINVWYDPSEVEAPPPAPYDHSIDEREHTVEEWKELIYK  351 (353)
T ss_pred             hcChhHhhccCCccCCCCCCCccccccccccccHHHHHHHHHh
Confidence            999999987665443321 122223334444556677765554

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=9.7e-41  Score=289.15  Aligned_cols=271  Identities=46%  Similarity=0.879  Sum_probs=219.9

Q ss_pred             CCCCCeeeeeceecCCCC-CCCCcEEEEeecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~-~~~~~~~iv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++..... .....+++||+|++++|.+++.. ..+++..++.++.||+.||+|||+.|++||||+|+||
T Consensus        71 l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Ni  149 (343)
T cd07880          71 MKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNL  149 (343)
T ss_pred             cCCCCccceeeeecCCccccccceEEEEEecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence            579999999999865431 22345799999998899988864 5799999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  159 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      +++.++.++|+|||.+......  .....+++.|++||.+.+...++.++|+||+|++++++++|..||.+.+.......
T Consensus       150 ll~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~  227 (343)
T cd07880         150 AVNEDCELKILDFGLARQTDSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLME  227 (343)
T ss_pred             EEcCCCCEEEeecccccccccC--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            9999999999999998765433  22345688899999886544578899999999999999999999998888777777


Q ss_pred             HHHHhCCCCHHHHhHh-hHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCcCC
Q 023609          160 LIELIGTPSEAELGFL-NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDI  238 (280)
Q Consensus       160 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~~~  238 (280)
                      +.+..+.++......+ ......+....+......+....+.+++++.++|.+||+.||++|||+.+++.||||+.....
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~~~~  307 (343)
T cd07880         228 IMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEFHDP  307 (343)
T ss_pred             HHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhhcCc
Confidence            7776666554433222 222333444445444445555667889999999999999999999999999999999998776


Q ss_pred             CCCCccCCCCCcchhhccccHHHHHHHHHHHHHhhCh
Q 023609          239 SDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP  275 (280)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (280)
                      +.++ ...++...++....+.++|+.+.+-++++|.|
T Consensus       308 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (343)
T cd07880         308 EDET-EAPPYDDSFDEVDQSLEEWKRLTFTEILSFQP  343 (343)
T ss_pred             cccc-CCCCccccHHhhccchHHHHHHHHHHHHhcCC
Confidence            6655 34567777888889999999999999999976

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=9.5e-42  Score=293.15  Aligned_cols=199  Identities=27%  Similarity=0.482  Sum_probs=167.8

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++...     ...|+||||++ |+|.+++..++.+++..++.++.||+.||+|||+.||+||||||+||
T Consensus        52 l~hp~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NI  126 (323)
T cd05571          52 TRHPFLTALKYSFQTH-----DRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENL  126 (323)
T ss_pred             CCCCCCCCEEEEEEcC-----CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHE
Confidence            5799999999998665     67999999997 69999998888999999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeecc-CCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  158 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.++.++|+|||+++... .........+++.|+|||++.+ ..++.++||||+||++|+|++|..||.+.+......
T Consensus       127 ll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~  205 (323)
T cd05571         127 MLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE  205 (323)
T ss_pred             EECCCCCEEEeeCCCCcccccCCCcccceecCccccChhhhcC-CCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHH
Confidence            99999999999999987532 2222345678999999998854 447899999999999999999999998776554443


Q ss_pred             HHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCC-----CHHHHhcCCCCC
Q 023609          159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI-----TVEDALAHPYLG  233 (280)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~ell~h~~~~  233 (280)
                      .+.....                              ..-..+++++++||++||+.||++||     ++.++++||||.
T Consensus       206 ~~~~~~~------------------------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~  255 (323)
T cd05571         206 LILMEEI------------------------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFA  255 (323)
T ss_pred             HHHcCCC------------------------------CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcC
Confidence            3321100                              01125788999999999999999999     899999999998


Q ss_pred             CC
Q 023609          234 SL  235 (280)
Q Consensus       234 ~~  235 (280)
                      +.
T Consensus       256 ~~  257 (323)
T cd05571         256 SI  257 (323)
T ss_pred             CC
Confidence            75

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=1.4e-40  Score=286.95  Aligned_cols=265  Identities=55%  Similarity=0.980  Sum_probs=212.9

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   81 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nili   81 (280)
                      +||||+++++...... ......|+++++++++|.+++.....+++..++.++.||+.||+|||+.|++||||||+||++
T Consensus        60 ~h~~iv~~~~~~~~~~-~~~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili  138 (332)
T cd07857          60 GHKNITCLYDMDIVFP-GNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLV  138 (332)
T ss_pred             CCCChheeeeeeeecc-ccCCcEEEEEecccCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEE
Confidence            5999999999754321 223568999999999999999888889999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccceeeccCCC-----ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023609           82 NANCDLKICDFGLARVTSETD-----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ  156 (280)
Q Consensus        82 ~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  156 (280)
                      +.++.++|+|||.+.......     ......++..|+|||.+.+...++.++|+||+||++++|++|.+||.+.+....
T Consensus       139 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~  218 (332)
T cd07857         139 NADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQ  218 (332)
T ss_pred             cCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHH
Confidence            999999999999987543321     122346788999999876555578899999999999999999999999998889


Q ss_pred             HHHHHHHhCCCCHHHHhHhhH-hHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCC
Q 023609          157 LRLLIELIGTPSEAELGFLNE-NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  235 (280)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~  235 (280)
                      ...+....+.++...+..... ....+...........+....+..+..+++++.+||+.||.+|||+.+++.||||.++
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~  298 (332)
T cd07857         219 LNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIW  298 (332)
T ss_pred             HHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhh
Confidence            999999988887765443322 2222333333334444555667788999999999999999999999999999999999


Q ss_pred             cCCCCCCccCCCCCcchhhccccHHHHHHHHHH
Q 023609          236 HDISDEPVCMSPFSFDFEQHALTEGQMKELIYQ  268 (280)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (280)
                      +++...+.|..++.++++.. -+..+++..|..
T Consensus       299 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  330 (332)
T cd07857         299 HDPDDEPVCQKPFDFSFESE-DSMEELRDMIIE  330 (332)
T ss_pred             cCccccccccccccCCcccc-ccHHHHHHHHhh
Confidence            99888888988877766544 234455555543

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=4.1e-41  Score=284.39  Aligned_cols=226  Identities=32%  Similarity=0.674  Sum_probs=174.6

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIR-SNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~-~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++...     ...|+||||+++++.+.+. ....+++..++.++.|++.||+|||+.|++||||||+||
T Consensus        57 l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Ni  131 (287)
T cd07848          57 LKQENIVELKEAFRRR-----GKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENL  131 (287)
T ss_pred             CCCccccchhhhEecC-----CEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHE
Confidence            5899999999999655     6799999999976555554 445799999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCC--ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL  157 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  157 (280)
                      +++.++.++|+|||.+.......  ......+++.|+|||++.+. .++.++|+||+||++|+|++|.+||.+.+..+..
T Consensus       132 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~  210 (287)
T cd07848         132 LISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGA-PYGKAVDMWSVGCILGELSDGQPLFPGESEIDQL  210 (287)
T ss_pred             EEcCCCcEEEeeccCcccccccccccccccccccccCCcHHHcCC-CCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            99999999999999987654321  22345688999999998654 4789999999999999999999999998887777


Q ss_pred             HHHHHHhCCCCHHHHhHhhHhHHHHhhhcCc--cccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 023609          158 RLLIELIGTPSEAELGFLNENAKKYICQLPR--YQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  232 (280)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~  232 (280)
                      ..+....+..+..................+.  ..........+.+|.++++||++||++||++|||++++++||||
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         211 FTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             HHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            7777776666554333221110000000000  00001112223578899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-42  Score=290.96  Aligned_cols=203  Identities=28%  Similarity=0.490  Sum_probs=170.8

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCC-CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQA-LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~-l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      |+|||||+++++..++..   ..+|||+|||. |.+. +.-..++ +++.+++++++.++.||+|||.+||+||||||+|
T Consensus       165 l~H~nVV~LiEvLDDP~s---~~~YlVley~s~G~v~-w~p~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsN  240 (576)
T KOG0585|consen  165 LHHPNVVKLIEVLDDPES---DKLYLVLEYCSKGEVK-WCPPDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSN  240 (576)
T ss_pred             cCCcCeeEEEEeecCccc---CceEEEEEeccCCccc-cCCCCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhh
Confidence            589999999999977654   78999999998 5544 4444556 9999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeec------cCCCccccceeccccccchhccCC---CCCCcchhHHHHHHHHHHHHhCCCCCC
Q 023609           79 LLLNANCDLKICDFGLARVT------SETDFMTEYVVTRWYRAPELLLNS---SDYTAAIDVWSVGCIFMELMDRKPLFP  149 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~------~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~~DiwslG~il~~ll~g~~pf~  149 (280)
                      +|++.+|++||+|||.+...      +.........|||.|+|||.+...   ...+.+.||||+||++|.|+.|..||-
T Consensus       241 LLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~  320 (576)
T KOG0585|consen  241 LLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFF  320 (576)
T ss_pred             eEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcc
Confidence            99999999999999998754      222334557899999999988652   234689999999999999999999999


Q ss_pred             CCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 023609          150 GRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  229 (280)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h  229 (280)
                      +....+...+|....-..                            ...|.+.+++++||.+||++||++|+++.++..|
T Consensus       321 ~~~~~~l~~KIvn~pL~f----------------------------P~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~H  372 (576)
T KOG0585|consen  321 DDFELELFDKIVNDPLEF----------------------------PENPEINEDLKDLIKRLLEKDPEQRITLPDIKLH  372 (576)
T ss_pred             cchHHHHHHHHhcCcccC----------------------------CCcccccHHHHHHHHHHhhcChhheeehhhheec
Confidence            988888888776532211                            1223567899999999999999999999999999


Q ss_pred             CCCCCC
Q 023609          230 PYLGSL  235 (280)
Q Consensus       230 ~~~~~~  235 (280)
                      ||....
T Consensus       373 pwvt~~  378 (576)
T KOG0585|consen  373 PWVTRD  378 (576)
T ss_pred             ceeccC
Confidence            999865

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.7e-41  Score=295.36  Aligned_cols=233  Identities=22%  Similarity=0.314  Sum_probs=175.9

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   80 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nil   80 (280)
                      |+||||+++++++...     ...++|+|++.++|.+++...+.+++..++.++.||+.||+|||++||+||||||+||+
T Consensus       140 l~HpnIv~~~~~~~~~-----~~~~lv~e~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIl  214 (391)
T PHA03212        140 INHPSIIQLKGTFTYN-----KFTCLILPRYKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIF  214 (391)
T ss_pred             CCCCCCCCEeEEEEEC-----CeeEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEE
Confidence            6899999999999665     67899999999999999988888999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccceeeccCC--CccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC-------
Q 023609           81 LNANCDLKICDFGLARVTSET--DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGR-------  151 (280)
Q Consensus        81 i~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-------  151 (280)
                      ++.++.++|+|||++......  .......+|+.|+|||++.+ ..++.++||||+||++|+|++|..||.+.       
T Consensus       215 l~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~  293 (391)
T PHA03212        215 INHPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLAR-DPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDC  293 (391)
T ss_pred             EcCCCCEEEEeCCcccccccccccccccccCccCCCChhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccC
Confidence            999999999999998653221  12234578999999998854 45899999999999999999999776432       


Q ss_pred             ChHHHHHHHHHHhCCCCHHHHhH----hhHhHHHHhhhcCc-cccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHH
Q 023609          152 DHVHQLRLLIELIGTPSEAELGF----LNENAKKYICQLPR-YQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDA  226 (280)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~el  226 (280)
                      .....+..+....+.++......    .............. ............++.++.+||.+||+.||.+|||+.|+
T Consensus       294 ~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~el  373 (391)
T PHA03212        294 DSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEAL  373 (391)
T ss_pred             chhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHH
Confidence            23445666666666554322111    11100011010000 00011111122457789999999999999999999999


Q ss_pred             hcCCCCCCCcCCC
Q 023609          227 LAHPYLGSLHDIS  239 (280)
Q Consensus       227 l~h~~~~~~~~~~  239 (280)
                      |+||||+.+..+.
T Consensus       374 L~hp~f~~~~~~~  386 (391)
T PHA03212        374 LDFAAFQDIPDPY  386 (391)
T ss_pred             hcChhhccCCCCC
Confidence            9999999876543

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=8.6e-42  Score=283.92  Aligned_cols=197  Identities=28%  Similarity=0.529  Sum_probs=178.8

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      |+||||+.+|++|...     ..+.|||||.. |+|+||+..++.+++.+++.+++||..|+.|+|+++++|||||.+||
T Consensus       110 LNHPhII~IyEVFENk-----dKIvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENI  184 (668)
T KOG0611|consen  110 LNHPHIIQIYEVFENK-----DKIVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENI  184 (668)
T ss_pred             cCCCceeehhhhhcCC-----ceEEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhhe
Confidence            6999999999999766     77999999997 79999999999999999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  159 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      ++|+++.+|+.|||++.........+++||++.|++||++.+...-++.+|.||||+++|.|+.|..||+|.+..-..+.
T Consensus       185 LLD~N~NiKIADFGLSNly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQ  264 (668)
T KOG0611|consen  185 LLDQNNNIKIADFGLSNLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQ  264 (668)
T ss_pred             eecCCCCeeeeccchhhhhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHH
Confidence            99999999999999999988888899999999999999987776678999999999999999999999999987777666


Q ss_pred             HHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCC
Q 023609          160 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLG  233 (280)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~  233 (280)
                      |.......                               |.-+.++.-||+-||-.||++|.|++++-+|=|++
T Consensus       265 Is~GaYrE-------------------------------P~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvN  307 (668)
T KOG0611|consen  265 ISRGAYRE-------------------------------PETPSDASGLIRWMLMVNPERRATIEDIASHWWVN  307 (668)
T ss_pred             hhcccccC-------------------------------CCCCchHHHHHHHHHhcCcccchhHHHHhhhheee
Confidence            65432221                               24466789999999999999999999999998886

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-41  Score=286.28  Aligned_cols=197  Identities=24%  Similarity=0.397  Sum_probs=167.4

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++.+.     ...|+||||+. |+|.+++..++.+++..+..++.||+.||+|||++|++||||||+||
T Consensus        58 l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NI  132 (291)
T cd05612          58 VSHPFIIRLFWTEHDQ-----RFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENI  132 (291)
T ss_pred             CCCCcHhhhHhhhccC-----CeEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHe
Confidence            5799999999998655     67999999997 69999999888999999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  159 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      +++.+|.++|+|||++......  .....+++.|+|||++.+. .++.++||||+||++|+|++|..||.+.+.......
T Consensus       133 li~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~  209 (291)
T cd05612         133 LLDKEGHIKLTDFGFAKKLRDR--TWTLCGTPEYLAPEVIQSK-GHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEK  209 (291)
T ss_pred             EECCCCCEEEEecCcchhccCC--cccccCChhhcCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            9999999999999998765433  2345689999999988544 478999999999999999999999988776555444


Q ss_pred             HHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCC-----HHHHhcCCCCCC
Q 023609          160 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT-----VEDALAHPYLGS  234 (280)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~ell~h~~~~~  234 (280)
                      +.....                              ..-..+++.+++||++||+.||.+|++     ++++++||||..
T Consensus       210 i~~~~~------------------------------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~  259 (291)
T cd05612         210 ILAGKL------------------------------EFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKS  259 (291)
T ss_pred             HHhCCc------------------------------CCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccC
Confidence            432110                              001245788999999999999999995     999999999987


Q ss_pred             C
Q 023609          235 L  235 (280)
Q Consensus       235 ~  235 (280)
                      .
T Consensus       260 ~  260 (291)
T cd05612         260 V  260 (291)
T ss_pred             C
Confidence            5

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5e-40  Score=284.95  Aligned_cols=271  Identities=49%  Similarity=0.917  Sum_probs=217.5

Q ss_pred             CCCCCeeeeeceecCCCC-CCCCcEEEEeecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~-~~~~~~~iv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++..... ......|+++++++++|.+++.. +.+++..++.++.|++.||+|||+.|++||||+|+||
T Consensus        73 l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NI  151 (345)
T cd07877          73 MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL  151 (345)
T ss_pred             cCCCcccceeeeeeecccccccccEEEEehhcccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHE
Confidence            589999999998865421 12245899999999999888765 4699999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  159 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      +++.++.++|+|||++......  .....++..|+|||.+.+...++.++|+||+||++++|++|.+||.+.+.......
T Consensus       152 ll~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~  229 (345)
T cd07877         152 AVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL  229 (345)
T ss_pred             EEcCCCCEEEeccccccccccc--ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            9999999999999998765432  23446788899999886645578899999999999999999999998888777788


Q ss_pred             HHHHhCCCCHHHHhHhhH-hHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCcCC
Q 023609          160 LIELIGTPSEAELGFLNE-NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDI  238 (280)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~~~  238 (280)
                      +....+.+.......... ....+....+......+.......++++.++|.+||+.||.+|||+.++++||||+++..+
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~~~~  309 (345)
T cd07877         230 ILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP  309 (345)
T ss_pred             HHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhcCCC
Confidence            877777766655443322 2233333334433444444445678899999999999999999999999999999998887


Q ss_pred             CCCCccCCCCCcchhhccccHHHHHHHHHHHHHhhCh
Q 023609          239 SDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP  275 (280)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (280)
                      ..++. ...+...+..+.+-.+++...+|.++..|.|
T Consensus       310 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  345 (345)
T cd07877         310 DDEPV-ADPYDQSFESRDLLIDEWKSLTYDEVISFVP  345 (345)
T ss_pred             Ccccc-CCCccCcchhcccCHHHHHHHHHHHHHhcCC
Confidence            77664 3456666677777789999999999998865

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1.2e-40  Score=285.51  Aligned_cols=229  Identities=35%  Similarity=0.673  Sum_probs=174.1

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHcC---------CCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN---------QALSEEHCQYFLYQILRGLKYIHSANVLH   71 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~---------~~l~~~~~~~i~~qll~al~~LH~~gi~H   71 (280)
                      ++||||+++++++.....   ..+|+||||++++|.+++...         ..+++..++.++.||+.||+|||+.|++|
T Consensus        55 l~h~niv~~~~~~~~~~~---~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH  131 (317)
T cd07868          55 LKHPNVISLQKVFLSHAD---RKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLH  131 (317)
T ss_pred             cCCCCCcceeeeEecCCC---cEEEEEEeccCCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEc
Confidence            589999999999865422   568999999999999887532         25899999999999999999999999999


Q ss_pred             ccCCCCcEEE----ccCCCEEEeeccceeeccCCC----ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh
Q 023609           72 RDLKPSNLLL----NANCDLKICDFGLARVTSETD----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD  143 (280)
Q Consensus        72 ~di~~~nili----~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~  143 (280)
                      |||||+||++    +.++.++|+|||++.......    ......+|+.|+|||++.+...++.++|+||+||++++|++
T Consensus       132 rDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~  211 (317)
T cd07868         132 RDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT  211 (317)
T ss_pred             CCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHh
Confidence            9999999999    456789999999997654321    22345678999999998766668899999999999999999


Q ss_pred             CCCCCCCCCh---------HHHHHHHHHHhCCCCHHHHhHhhHhHH--HHhhhcCc--ccc----ccccccCCCCChHHH
Q 023609          144 RKPLFPGRDH---------VHQLRLLIELIGTPSEAELGFLNENAK--KYICQLPR--YQR----QSFTEKFPNVHPSAI  206 (280)
Q Consensus       144 g~~pf~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~--~~~----~~~~~~~~~~~~~~~  206 (280)
                      |.+||.+...         ...+..+....+.|....+........  ........  ...    ..........+.++.
T Consensus       212 g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (317)
T cd07868         212 SEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAF  291 (317)
T ss_pred             CCCCccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHH
Confidence            9999975432         456777888888877765544321110  00000000  000    011111223467799


Q ss_pred             HHHHHhhcCCCCCCCCHHHHhcCCCC
Q 023609          207 DLVEKMLTFDPRQRITVEDALAHPYL  232 (280)
Q Consensus       207 ~li~~~L~~dp~~R~t~~ell~h~~~  232 (280)
                      +||.+||+.||.+|||++|+|+||||
T Consensus       292 dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         292 HLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             HHHHHHhccCcccCCCHHHHhcCCCC
Confidence            99999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=2.4e-41  Score=292.38  Aligned_cols=197  Identities=26%  Similarity=0.431  Sum_probs=169.0

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++...     ...|+||||+. |+|.+++..++.+++..++.++.||+.||+|||+.|++||||||+||
T Consensus        88 l~hp~Iv~~~~~~~~~-----~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NI  162 (340)
T PTZ00426         88 INHPFCVNLYGSFKDE-----SYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENL  162 (340)
T ss_pred             CCCCCCcceEEEEEeC-----CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHE
Confidence            5799999999999665     67999999996 69999999888999999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  159 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      +++.+|.++|+|||++......  .....+|+.|+|||++.+. .++.++|+||+||++|+|++|..||.+.+.......
T Consensus       163 Ll~~~~~ikL~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~  239 (340)
T PTZ00426        163 LLDKDGFIKMTDFGFAKVVDTR--TYTLCGTPEYIAPEILLNV-GHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQK  239 (340)
T ss_pred             EECCCCCEEEecCCCCeecCCC--cceecCChhhcCHHHHhCC-CCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHH
Confidence            9999999999999999865433  2355789999999998654 478899999999999999999999988776655554


Q ss_pred             HHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCC-----CHHHHhcCCCCCC
Q 023609          160 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI-----TVEDALAHPYLGS  234 (280)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~ell~h~~~~~  234 (280)
                      +......                              .-+.+++.++++|++||+.||.+|+     |+.++++||||.+
T Consensus       240 i~~~~~~------------------------------~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~  289 (340)
T PTZ00426        240 ILEGIIY------------------------------FPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGN  289 (340)
T ss_pred             HhcCCCC------------------------------CCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCC
Confidence            4321110                              1125678899999999999999995     8999999999987


Q ss_pred             C
Q 023609          235 L  235 (280)
Q Consensus       235 ~  235 (280)
                      +
T Consensus       290 ~  290 (340)
T PTZ00426        290 I  290 (340)
T ss_pred             C
Confidence            5

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=3.5e-40  Score=283.96  Aligned_cols=261  Identities=51%  Similarity=0.980  Sum_probs=216.0

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   80 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nil   80 (280)
                      ++||||+++++++....    ...|+|+||++++|.+++.. .++++..+..++.|++.||+|||+.|++|+||+|.||+
T Consensus        66 l~hpniv~~~~~~~~~~----~~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nil  140 (328)
T cd07856          66 LRHENIISLSDIFISPL----EDIYFVTELLGTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNIL  140 (328)
T ss_pred             cCCCCeeeEeeeEecCC----CcEEEEeehhccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEe
Confidence            57999999999986532    46899999999999888764 46899999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 023609           81 LNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL  160 (280)
Q Consensus        81 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~  160 (280)
                      ++.++.++|+|||.+......  .....++..|+|||.+.+...++.++|+||+||++++|++|.+||.+.........+
T Consensus       141 i~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~  218 (328)
T cd07856         141 INENCDLKICDFGLARIQDPQ--MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSII  218 (328)
T ss_pred             ECCCCCEEeCccccccccCCC--cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            999999999999998754332  233456788999998765455789999999999999999999999988887777778


Q ss_pred             HHHhCCCCHHHHhHh-hHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCcCCC
Q 023609          161 IELIGTPSEAELGFL-NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDIS  239 (280)
Q Consensus       161 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~~~~  239 (280)
                      .+..+.++....... ......+....+...........+.++..++++|++||+.+|++|||+++++.||||..+..+.
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~~~~  298 (328)
T cd07856         219 TDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHDPT  298 (328)
T ss_pred             HHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCccccccCCc
Confidence            888888776544322 2222333333333333444556678889999999999999999999999999999999999998


Q ss_pred             CCCccCCCCCcchhhccccHHHHHHHHHH
Q 023609          240 DEPVCMSPFSFDFEQHALTEGQMKELIYQ  268 (280)
Q Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (280)
                      .++.....|.+.+++..++.+.|+-++|.
T Consensus       299 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  327 (328)
T cd07856         299 DEPVAEEKFDWSFNDADLPVDTWKVMMYS  327 (328)
T ss_pred             cccCchhhcCCchhcccCCHHHHHHHhcC
Confidence            88888889999999999999999988764

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-41  Score=286.42  Aligned_cols=201  Identities=29%  Similarity=0.513  Sum_probs=180.8

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      +.|||||++|++....     ..+|+|.|+-+ |+|+|||.+. ..++|+-+++++.||+.|+.|+|+..+|||||||+|
T Consensus        74 VQHpNiVRLYEViDTQ-----TKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPEN  148 (864)
T KOG4717|consen   74 VQHPNIVRLYEVIDTQ-----TKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPEN  148 (864)
T ss_pred             hcCcCeeeeeehhccc-----ceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcce
Confidence            4799999999998544     77999999987 6999999754 469999999999999999999999999999999999


Q ss_pred             EEE-ccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 023609           79 LLL-NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL  157 (280)
Q Consensus        79 ili-~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  157 (280)
                      +.+ ..-|-+||.|||++....++....+.+|+..|.|||++.+.....+++||||||+|+|.|+||++||...++.+.+
T Consensus       149 VVFFEKlGlVKLTDFGFSNkf~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETL  228 (864)
T KOG4717|consen  149 VVFFEKLGLVKLTDFGFSNKFQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETL  228 (864)
T ss_pred             eEEeeecCceEeeeccccccCCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhh
Confidence            876 4569999999999998888887889999999999999999887789999999999999999999999999888888


Q ss_pred             HHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCc
Q 023609          158 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  236 (280)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~  236 (280)
                      ..|++.....+.                              .+|.++++||..||..||.+|.+.+++.+++|++..-
T Consensus       229 TmImDCKYtvPs------------------------------hvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D  277 (864)
T KOG4717|consen  229 TMIMDCKYTVPS------------------------------HVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGD  277 (864)
T ss_pred             hhhhcccccCch------------------------------hhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCC
Confidence            888776544332                              6789999999999999999999999999999999864

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.2e-40  Score=285.10  Aligned_cols=270  Identities=45%  Similarity=0.849  Sum_probs=213.8

Q ss_pred             CCCCCeeeeeceecCCCC-CCCCcEEEEeecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~-~~~~~~~iv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++..... .....+|+|+||+..+|.++..  ..+++..+..++.|++.||+|||+.|++||||+|+||
T Consensus        71 l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NI  148 (342)
T cd07879          71 MQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMG--HPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNL  148 (342)
T ss_pred             cCCCCccchhheecccccCCCCceEEEEecccccCHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHE
Confidence            579999999999865431 2234679999999988887753  4699999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  159 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      +++.++.++|+|||++......  .....++..|+|||.+.+...++.++|+||+||++++|++|+.||.+.+.......
T Consensus       149 ll~~~~~~kL~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~  226 (342)
T cd07879         149 AVNEDCELKILDFGLARHADAE--MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQ  226 (342)
T ss_pred             EECCCCCEEEeeCCCCcCCCCC--CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            9999999999999998764332  23446788899999886555578899999999999999999999999888778888


Q ss_pred             HHHHhCCCCHHHHhHhhH-hHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCcCC
Q 023609          160 LIELIGTPSEAELGFLNE-NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDI  238 (280)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~~~  238 (280)
                      +....+.+.......... ....+....+......+...++..++++.+||++||+.||.+|||+.+++.||||+.+...
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~~~  306 (342)
T cd07879         227 ILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFRDA  306 (342)
T ss_pred             HHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcccc
Confidence            877777666544333321 1222333334444444555667889999999999999999999999999999999999765


Q ss_pred             CCCCccCCCCCcchhhccccHHHHHHHHHHHHHhhCh
Q 023609          239 SDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP  275 (280)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (280)
                      ...+ +..+++...+...+..+++..-++++..+|.|
T Consensus       307 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (342)
T cd07879         307 DEET-EQQPYDDSLENEKLSVDEWKKHIYKEVKSFSP  342 (342)
T ss_pred             cccC-CCCcccchhhhhhCCHHHHHHHhhhhhhccCC
Confidence            4433 45556666666677889999999999887765

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-41  Score=289.11  Aligned_cols=204  Identities=35%  Similarity=0.591  Sum_probs=177.9

Q ss_pred             CCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE
Q 023609            3 HENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   81 (280)
Q Consensus         3 HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nili   81 (280)
                      |||||.++++|.++     ..+|+|||+|. |+|++.+... .+++..+..++.|++.|++|||+.|++|||+||+|+++
T Consensus        95 hpniv~l~~~~e~~-----~~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~  168 (382)
T KOG0032|consen   95 HPNIVQLKDAFEDP-----DSVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLL  168 (382)
T ss_pred             CCCEEEEEEEEEcC-----CeEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeee
Confidence            99999999999776     68999999998 6999999876 59999999999999999999999999999999999999


Q ss_pred             cc----CCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 023609           82 NA----NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL  157 (280)
Q Consensus        82 ~~----~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  157 (280)
                      ..    ++.++++|||++............+||+.|+|||++. ...++..+||||+|+++|.|++|.+||.+.+.....
T Consensus       169 ~~~~~~~~~ik~~DFGla~~~~~~~~~~~~~Gtp~y~APEvl~-~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~  247 (382)
T KOG0032|consen  169 ASKDEGSGRIKLIDFGLAKFIKPGERLHTIVGTPEYVAPEVLG-GRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIF  247 (382)
T ss_pred             ccccCCCCcEEEeeCCCceEccCCceEeeecCCccccCchhhc-CCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHH
Confidence            54    3579999999999888766778899999999999884 345899999999999999999999999998877766


Q ss_pred             HHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCcC
Q 023609          158 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD  237 (280)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~~  237 (280)
                      ..+...-..                          .....|+.+|..+++||++||..||.+|+|+.++|+|||+++...
T Consensus       248 ~~i~~~~~~--------------------------f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~~  301 (382)
T KOG0032|consen  248 LAILRGDFD--------------------------FTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIGE  301 (382)
T ss_pred             HHHHcCCCC--------------------------CCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCcc
Confidence            654432211                          112456788999999999999999999999999999999988644


Q ss_pred             CC
Q 023609          238 IS  239 (280)
Q Consensus       238 ~~  239 (280)
                      ..
T Consensus       302 ~~  303 (382)
T KOG0032|consen  302 AT  303 (382)
T ss_pred             cc
Confidence            33

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=3.7e-40  Score=278.10  Aligned_cols=226  Identities=39%  Similarity=0.747  Sum_probs=181.5

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN---QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS   77 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~---~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~   77 (280)
                      ++||||+++++++...     ...|+||||++++|.+++...   +.+++..++.++.||+.||+|||+.|++|+||+|+
T Consensus        56 l~h~~i~~~~~~~~~~-----~~~~~v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~  130 (285)
T cd07861          56 LQHPNIVCLQDVLMQE-----SRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQ  130 (285)
T ss_pred             cCCCCEeeeEEEEeeC-----CeEEEEEecCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHH
Confidence            5799999999999765     679999999999999988643   46999999999999999999999999999999999


Q ss_pred             cEEEccCCCEEEeeccceeeccCCC-ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023609           78 NLLLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ  156 (280)
Q Consensus        78 nili~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  156 (280)
                      ||+++.+|.++|+|||++...+... ......+++.|+|||.+.+...++.++|+||+||++++|++|++||.+......
T Consensus       131 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~  210 (285)
T cd07861         131 NLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQ  210 (285)
T ss_pred             HEEEcCCCcEEECcccceeecCCCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH
Confidence            9999999999999999987654332 122345678899999886655578899999999999999999999998887777


Q ss_pred             HHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 023609          157 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  232 (280)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~  232 (280)
                      ...+....+.+....+..... ...+....+...........+.++++++++|++||+.||.+|||+.++++||||
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         211 LFRIFRILGTPTEDVWPGVTS-LPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             HHHHHHHhCCCChhhhhcchh-hHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence            777777777665554432221 111222222222333334455789999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=7.3e-41  Score=278.75  Aligned_cols=202  Identities=24%  Similarity=0.449  Sum_probs=170.6

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS   77 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~   77 (280)
                      ++||.|+++|..|..+     ...|++||||. |+|+..++++  +.|++..++.++.+++.||+|||.+|||+|||||+
T Consensus       134 lDHPFlPTLYa~fet~-----~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPE  208 (459)
T KOG0610|consen  134 LDHPFLPTLYASFETD-----KYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPE  208 (459)
T ss_pred             cCCCccchhhheeecc-----ceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcc
Confidence            5899999999999776     78999999997 6999888754  46999999999999999999999999999999999


Q ss_pred             cEEEccCCCEEEeeccceeecc-------C--------------------------C-C---------------------
Q 023609           78 NLLLNANCDLKICDFGLARVTS-------E--------------------------T-D---------------------  102 (280)
Q Consensus        78 nili~~~~~~~l~dfg~~~~~~-------~--------------------------~-~---------------------  102 (280)
                      ||+|-++|++.|+||.++....       .                          . +                     
T Consensus       209 NILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~  288 (459)
T KOG0610|consen  209 NILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPT  288 (459)
T ss_pred             eeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCC
Confidence            9999999999999998863210       0                          0 0                     


Q ss_pred             --ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHH
Q 023609          103 --FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAK  180 (280)
Q Consensus       103 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (280)
                        .....+||-.|.|||++.+.+ -+.++|.|++|+++|||+.|..||+|.+..+.+..++..--..+            
T Consensus       289 ~~RSnSFVGThEYlAPEvI~G~G-HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp------------  355 (459)
T KOG0610|consen  289 GARSNSFVGTHEYLAPEVIRGEG-HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFP------------  355 (459)
T ss_pred             CccccccccccccccceeeecCC-CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCC------------
Confidence              001246788999999997776 68899999999999999999999999999888887754321111            


Q ss_pred             HHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCC----HHHHhcCCCCCCCc
Q 023609          181 KYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT----VEDALAHPYLGSLH  236 (280)
Q Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t----~~ell~h~~~~~~~  236 (280)
                                      ..+.++..++|||+++|.+||++|+.    |.||-+||||++++
T Consensus       356 ----------------~~~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gVn  399 (459)
T KOG0610|consen  356 ----------------EEPEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGVN  399 (459)
T ss_pred             ----------------CCCcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCCC
Confidence                            11366789999999999999999998    99999999999874

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=5.7e-41  Score=289.03  Aligned_cols=197  Identities=25%  Similarity=0.426  Sum_probs=167.2

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++.+...     ...|+||||+. |+|.+++.+.+.+++..++.++.||+.||+|||++|++||||||+||
T Consensus        75 l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NI  149 (329)
T PTZ00263         75 LSHPFIVNMMCSFQDE-----NRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENL  149 (329)
T ss_pred             CCCCCCCcEEEEEEcC-----CEEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHE
Confidence            5799999999999765     67999999997 69999999888999999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  159 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      +++.++.++|+|||++.......  ....+++.|+|||++.+. .++.++|+||+||++|+|++|..||.+.+.......
T Consensus       150 ll~~~~~~kl~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~  226 (329)
T PTZ00263        150 LLDNKGHVKVTDFGFAKKVPDRT--FTLCGTPEYLAPEVIQSK-GHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEK  226 (329)
T ss_pred             EECCCCCEEEeeccCceEcCCCc--ceecCChhhcCHHHHcCC-CCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHH
Confidence            99999999999999998764432  245789999999998554 478899999999999999999999987766554443


Q ss_pred             HHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCC-----HHHHhcCCCCCC
Q 023609          160 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT-----VEDALAHPYLGS  234 (280)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~ell~h~~~~~  234 (280)
                      +....  +                            ..-..++..+++||++||+.||.+|++     +.++++||||.+
T Consensus       227 i~~~~--~----------------------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~  276 (329)
T PTZ00263        227 ILAGR--L----------------------------KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHG  276 (329)
T ss_pred             HhcCC--c----------------------------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence            32210  0                            000136788999999999999999997     799999999987


Q ss_pred             C
Q 023609          235 L  235 (280)
Q Consensus       235 ~  235 (280)
                      .
T Consensus       277 ~  277 (329)
T PTZ00263        277 A  277 (329)
T ss_pred             C
Confidence            4

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.3e-41  Score=286.34  Aligned_cols=199  Identities=26%  Similarity=0.510  Sum_probs=167.3

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++...     ...|+||||+. |+|.+++..++.+++..++.++.||+.||+|||++|++||||||+||
T Consensus        50 l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Ni  124 (312)
T cd05585          50 VNCPFIVPLKFSFQSP-----EKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENI  124 (312)
T ss_pred             CCCCcEeceeeEEecC-----CeEEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHe
Confidence            5799999999998655     67999999997 69999998888899999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCC-CccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  158 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.++.++|+|||++...... .......+++.|+|||++.+. .++.++||||+||++|+|++|..||.+.+..+...
T Consensus       125 li~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~  203 (312)
T cd05585         125 LLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGH-GYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYR  203 (312)
T ss_pred             EECCCCcEEEEECcccccCccCCCccccccCCcccCCHHHHcCC-CCCCccceechhHHHHHHHhCCCCcCCCCHHHHHH
Confidence            9999999999999998753322 223345689999999998554 57899999999999999999999998776655444


Q ss_pred             HHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCC---CHHHHhcCCCCCCC
Q 023609          159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI---TVEDALAHPYLGSL  235 (280)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~---t~~ell~h~~~~~~  235 (280)
                      .+....   .                           ...+.++++++++|.+||+.||.+||   ++.++++||||...
T Consensus       204 ~~~~~~---~---------------------------~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~  253 (312)
T cd05585         204 KILQEP---L---------------------------RFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQL  253 (312)
T ss_pred             HHHcCC---C---------------------------CCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCC
Confidence            332110   0                           11125788999999999999999997   57999999999975

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=2.3e-40  Score=279.33  Aligned_cols=225  Identities=39%  Similarity=0.718  Sum_probs=180.0

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++.+.     ...|+|+||++++|.+++.+ ++.+++..++.++.||+.||.|||++|++|+||+|+||
T Consensus        56 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~ni  130 (284)
T cd07839          56 LKHKNIVRLYDVLHSD-----KKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNL  130 (284)
T ss_pred             cCCCCeeeHHHHhccC-----CceEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHE
Confidence            5799999999999765     67999999999999998864 56799999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCC-ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCC-CCCCChHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL-FPGRDHVHQL  157 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p-f~~~~~~~~~  157 (280)
                      +++.++.++|+|||.+...+... ......++..|+|||.+.+...++.++|+||+||++++|++|..| |.+.+....+
T Consensus       131 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~  210 (284)
T cd07839         131 LINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL  210 (284)
T ss_pred             EEcCCCcEEECccchhhccCCCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHH
Confidence            99999999999999987654332 223345678899999986655578899999999999999998766 5666777778


Q ss_pred             HHHHHHhCCCCHHHHhHhhHhHHHHhhhcCcc-ccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 023609          158 RLLIELIGTPSEAELGFLNENAKKYICQLPRY-QRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  232 (280)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~  232 (280)
                      ..+.+..+.+....+.........  ...+.. ....+....+.++++++++|.+||+.||.+|||+.++++||||
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         211 KRIFRLLGTPTEESWPGVSKLPDY--KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             HHHHHHhCCCChHHhHHhhhcccc--cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence            888888777766544332221111  001111 1112334556789999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=9.6e-41  Score=286.54  Aligned_cols=198  Identities=22%  Similarity=0.422  Sum_probs=168.0

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nil   80 (280)
                      +||||+++++++...     ..+|+||||++ |+|.+++...+.+++..++.++.|++.||+|||++|++||||||+||+
T Consensus        54 ~h~~iv~~~~~~~~~-----~~~~iv~Ey~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIl  128 (320)
T cd05590          54 NHPFLTQLYCCFQTP-----DRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVL  128 (320)
T ss_pred             CCCchhceeeEEEcC-----CEEEEEEcCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeE
Confidence            699999999999665     67999999997 699999988888999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccceeeccC-CCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023609           81 LNANCDLKICDFGLARVTSE-TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  159 (280)
Q Consensus        81 i~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      ++.++.++|+|||++..... ........+++.|+|||++.+ ..++.++|+||+||++|+|++|..||.+.+..+....
T Consensus       129 i~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~  207 (320)
T cd05590         129 LDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQE-MLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEA  207 (320)
T ss_pred             ECCCCcEEEeeCCCCeecCcCCCcccccccCccccCHHHHcC-CCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHH
Confidence            99999999999999875322 222344578999999998854 4578899999999999999999999988776665554


Q ss_pred             HHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCH------HHHhcCCCCC
Q 023609          160 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV------EDALAHPYLG  233 (280)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~------~ell~h~~~~  233 (280)
                      +......                              ..+.++.+++++|++||+.||.+|+++      +++++||||.
T Consensus       208 i~~~~~~------------------------------~~~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~  257 (320)
T cd05590         208 ILNDEVV------------------------------YPTWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFK  257 (320)
T ss_pred             HhcCCCC------------------------------CCCCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcC
Confidence            4321100                              012467899999999999999999998      8999999998


Q ss_pred             CC
Q 023609          234 SL  235 (280)
Q Consensus       234 ~~  235 (280)
                      .+
T Consensus       258 ~~  259 (320)
T cd05590         258 EL  259 (320)
T ss_pred             CC
Confidence            75

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=8.1e-40  Score=282.76  Aligned_cols=264  Identities=45%  Similarity=0.864  Sum_probs=209.2

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   81 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nili   81 (280)
                      +||||+++++++.....   ...|+||||++++|.+++..+ .+++..++.++.||+.||+|||+.|++|+||+|+||++
T Consensus        65 ~h~ni~~~~~~~~~~~~---~~~~lv~e~~~~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill  140 (337)
T cd07852          65 DHPNIVKLLNVIKAEND---KDIYLVFEYMETDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILL  140 (337)
T ss_pred             CCCCccceeeeeccCCC---ceEEEEecccccCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE
Confidence            89999999999865421   568999999999999999775 78999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccceeeccCCC------ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 023609           82 NANCDLKICDFGLARVTSETD------FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVH  155 (280)
Q Consensus        82 ~~~~~~~l~dfg~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~  155 (280)
                      +.++.++|+|||.+.......      ......++..|+|||.+.+....+.++|+||+|+++|+|++|++||.+.....
T Consensus       141 ~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~  220 (337)
T cd07852         141 NSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLN  220 (337)
T ss_pred             cCCCcEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHH
Confidence            999999999999987543221      12234578889999988665567889999999999999999999999998888


Q ss_pred             HHHHHHHHhCCCCHHHHhHhhHhH-HHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCC
Q 023609          156 QLRLLIELIGTPSEAELGFLNENA-KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS  234 (280)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~  234 (280)
                      ....+....+.+....+..+.... ...................+.++.++.++|.+||+.||.+|||+.++++|||+++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~  300 (337)
T cd07852         221 QLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQ  300 (337)
T ss_pred             HHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhh
Confidence            888888888887766554443222 2222233333444455666778999999999999999999999999999999999


Q ss_pred             CcCCCCCCccCCCCCcc-hhhccccHHHHHHHHHHH
Q 023609          235 LHDISDEPVCMSPFSFD-FEQHALTEGQMKELIYQE  269 (280)
Q Consensus       235 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~  269 (280)
                      +...+.++....++... .....++..+.+..+|.+
T Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  336 (337)
T cd07852         301 FHNPSDEPVLPYPITIPLDDNVKLSVAEYRNKLYEE  336 (337)
T ss_pred             hccCCCCCCCCCCccCCccccceeeHHHHHhhhhhc
Confidence            87766665544443322 244567777777776654

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.5e-40  Score=285.75  Aligned_cols=199  Identities=27%  Similarity=0.473  Sum_probs=167.1

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++.+...     ...|+||||++ |+|.+++..++.+++..++.++.||+.||+|||++|++||||||+||
T Consensus        52 l~hp~i~~~~~~~~~~-----~~~~lv~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NI  126 (323)
T cd05595          52 TRHPFLTALKYAFQTH-----DRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENL  126 (323)
T ss_pred             CCCCCCcceeeEEecC-----CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHE
Confidence            5799999999999665     67999999997 69999998888899999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccC-CCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSE-TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  158 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.++.++|+|||++..... ........+++.|+|||.+.+. .++.++|+||+||++|+|++|..||.+.+......
T Consensus       127 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~  205 (323)
T cd05595         127 MLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE  205 (323)
T ss_pred             EEcCCCCEEecccHHhccccCCCCccccccCCcCcCCcccccCC-CCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            999999999999999875322 2223345689999999988544 57899999999999999999999998776554444


Q ss_pred             HHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCC-----CHHHHhcCCCCC
Q 023609          159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI-----TVEDALAHPYLG  233 (280)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~ell~h~~~~  233 (280)
                      .+.....                              ..-..++++++++|.+||+.||.+|+     ++.++++|+||.
T Consensus       206 ~~~~~~~------------------------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~  255 (323)
T cd05595         206 LILMEEI------------------------------RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL  255 (323)
T ss_pred             HHhcCCC------------------------------CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcC
Confidence            3321100                              00125788999999999999999998     899999999998


Q ss_pred             CC
Q 023609          234 SL  235 (280)
Q Consensus       234 ~~  235 (280)
                      +.
T Consensus       256 ~~  257 (323)
T cd05595         256 SI  257 (323)
T ss_pred             CC
Confidence            75

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=5.8e-40  Score=280.32  Aligned_cols=235  Identities=38%  Similarity=0.691  Sum_probs=186.4

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++....   ....|+||||++++|.+++.. ...+++.+++.++.||+.||+|||+.|++||||+|+||
T Consensus        63 l~h~~i~~~~~~~~~~~---~~~~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~ni  139 (309)
T cd07845          63 LRHPNIVELKEVVVGKH---LDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNL  139 (309)
T ss_pred             CCCCCCcceEEEEecCC---CCeEEEEEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence            58999999999986542   246899999999999998875 36799999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCC-CccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  158 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.++.++|+|||.+...... .......++..|+|||.+.+...++.++|+||+||++|+|++|.+||.+.+..+...
T Consensus       140 l~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~  219 (309)
T cd07845         140 LLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLD  219 (309)
T ss_pred             EECCCCCEEECccceeeecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            9999999999999999865543 222333457789999988665667899999999999999999999999999999999


Q ss_pred             HHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCcCC
Q 023609          159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDI  238 (280)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~~~  238 (280)
                      .+....+.+....+..............+......+...++..++.+.++|.+||+.||++|||+.++++||||.+...+
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~  299 (309)
T cd07845         220 LIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLP  299 (309)
T ss_pred             HHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCC
Confidence            88888887766544322211110001111111122333445578999999999999999999999999999999876554

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.4e-40  Score=286.50  Aligned_cols=199  Identities=25%  Similarity=0.455  Sum_probs=166.5

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++.+...     ...|+||||++ |+|.+++...+.+++.+++.++.||+.||+|||++||+||||||+||
T Consensus        52 l~hp~iv~~~~~~~~~-----~~~~lv~Ey~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NI  126 (328)
T cd05593          52 TRHPFLTSLKYSFQTK-----DRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENL  126 (328)
T ss_pred             CCCCCCcceEEEEEcC-----CEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHe
Confidence            5799999999998665     67999999997 69999998888899999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccC-CCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSE-TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  158 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.++.++|+|||++..... ........+++.|+|||.+.+. .++.++||||+||++|+|++|..||.+.+......
T Consensus       127 ll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~  205 (328)
T cd05593         127 MLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFE  205 (328)
T ss_pred             EECCCCcEEEecCcCCccCCCcccccccccCCcCccChhhhcCC-CCCccCCccccchHHHHHhhCCCCCCCCCHHHHHH
Confidence            999999999999999875322 2223345689999999998544 47899999999999999999999998766554433


Q ss_pred             HHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCC-----CHHHHhcCCCCC
Q 023609          159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI-----TVEDALAHPYLG  233 (280)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~ell~h~~~~  233 (280)
                      .+.....                              ..-+.+++++.+||++||+.||.+|+     ++.++++||||.
T Consensus       206 ~~~~~~~------------------------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~  255 (328)
T cd05593         206 LILMEDI------------------------------KFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFT  255 (328)
T ss_pred             HhccCCc------------------------------cCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcC
Confidence            3221000                              01125788999999999999999997     899999999998


Q ss_pred             CC
Q 023609          234 SL  235 (280)
Q Consensus       234 ~~  235 (280)
                      +.
T Consensus       256 ~~  257 (328)
T cd05593         256 GV  257 (328)
T ss_pred             CC
Confidence            74

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=1.4e-40  Score=268.07  Aligned_cols=233  Identities=40%  Similarity=0.726  Sum_probs=188.5

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-----NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK   75 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~-----~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~   75 (280)
                      |+||||+.+..+|....    ..+++++||.+.+|...++-     .+.++...++.|++||+.|+.|||++.|+|||+|
T Consensus        84 l~h~nvi~Lv~Vfl~~d----~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLK  159 (438)
T KOG0666|consen   84 LKHPNVISLVKVFLSHD----KKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLK  159 (438)
T ss_pred             hcCCcchhHHHHHhccC----ceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCC
Confidence            58999999999997742    67999999999999999962     2469999999999999999999999999999999


Q ss_pred             CCcEEEccC----CCEEEeeccceeeccCC----CccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCC
Q 023609           76 PSNLLLNAN----CDLKICDFGLARVTSET----DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL  147 (280)
Q Consensus        76 ~~nili~~~----~~~~l~dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p  147 (280)
                      |.||++..+    |.+||+|+|+++....+    ......+.|.+|.|||.+.+...|+.+.|+||+|||+.||++-.+.
T Consensus       160 PaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~Pl  239 (438)
T KOG0666|consen  160 PANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPL  239 (438)
T ss_pred             cceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCcc
Confidence            999999888    99999999999865433    1234567799999999999999999999999999999999999999


Q ss_pred             CCCCC---------hHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccc--------cccccccCCCCChHHHHHHH
Q 023609          148 FPGRD---------HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQ--------RQSFTEKFPNVHPSAIDLVE  210 (280)
Q Consensus       148 f~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~li~  210 (280)
                      |.+..         ..+++.+|++.+|.|....|..+...- ++.....++.        -..+......-++.+.+|+.
T Consensus       240 F~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~P-e~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~  318 (438)
T KOG0666|consen  240 FKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMP-EYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQ  318 (438)
T ss_pred             ccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCc-chHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHH
Confidence            97642         467899999999999998876553221 1111111111        11122222334666999999


Q ss_pred             HhhcCCCCCCCCHHHHhcCCCCCCCcCC
Q 023609          211 KMLTFDPRQRITVEDALAHPYLGSLHDI  238 (280)
Q Consensus       211 ~~L~~dp~~R~t~~ell~h~~~~~~~~~  238 (280)
                      +||+.||.+|.|++++|+|+||..-..+
T Consensus       319 klL~yDP~kRIta~qAleh~yF~~d~lp  346 (438)
T KOG0666|consen  319 KLLTYDPIKRITAEQALEHPYFTEDPLP  346 (438)
T ss_pred             HHhccCchhhccHHHHhcccccccCCCC
Confidence            9999999999999999999999875433

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.6e-41  Score=287.03  Aligned_cols=201  Identities=29%  Similarity=0.487  Sum_probs=181.5

Q ss_pred             CCCCCeeeeeceecCCCCCCCCc-EEEEeecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFND-VYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKP   76 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~-~~iv~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~   76 (280)
                      ++|||||.+++.|..+     +. ++|||+||+ |++.+.+.+.  ..++++.+..|+.|++.||.|||+++|+|||||+
T Consensus        60 ~~hP~iv~y~ds~~~~-----~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~  134 (426)
T KOG0589|consen   60 LLHPNIVEYKDSFEED-----GQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKC  134 (426)
T ss_pred             ccCCCeeeeccchhcC-----CceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchh
Confidence            5899999999999776     45 999999998 6999999754  4699999999999999999999999999999999


Q ss_pred             CcEEEccCCCEEEeeccceeeccCCC-ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 023609           77 SNLLLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVH  155 (280)
Q Consensus        77 ~nili~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~  155 (280)
                      .||+++.++.++|+|||+++..+... ...+..||+.|++||.+. ..+|+.++|||||||++|+|++-+++|.+.+...
T Consensus       135 ~Nifltk~~~VkLgDfGlaK~l~~~~~~a~tvvGTp~YmcPEil~-d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~  213 (426)
T KOG0589|consen  135 ANIFLTKDKKVKLGDFGLAKILNPEDSLASTVVGTPYYMCPEILS-DIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSE  213 (426)
T ss_pred             hhhhccccCceeecchhhhhhcCCchhhhheecCCCcccCHHHhC-CCCCCccCcchhhcchHHHHHhcccccCccchHH
Confidence            99999999999999999999888775 667789999999999885 4569999999999999999999999999999999


Q ss_pred             HHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCC
Q 023609          156 QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  235 (280)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~  235 (280)
                      ...+|......|.+.                             .++.+++.+|+.||..+|..||++.++|.+|.+..+
T Consensus       214 Li~ki~~~~~~Plp~-----------------------------~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~~  264 (426)
T KOG0589|consen  214 LILKINRGLYSPLPS-----------------------------MYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLRY  264 (426)
T ss_pred             HHHHHhhccCCCCCc-----------------------------cccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhhH
Confidence            988888776555432                             678999999999999999999999999999998854


Q ss_pred             c
Q 023609          236 H  236 (280)
Q Consensus       236 ~  236 (280)
                      .
T Consensus       265 ~  265 (426)
T KOG0589|consen  265 L  265 (426)
T ss_pred             H
Confidence            3

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-41  Score=251.00  Aligned_cols=228  Identities=41%  Similarity=0.769  Sum_probs=198.7

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      |+|.|||+++++....     +.+.+|+|+|..+|..+..+ ++.+....++.++.|++.||.|+|++++.|||+||.|.
T Consensus        58 lkhknivrl~dvlhsd-----kkltlvfe~cdqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnl  132 (292)
T KOG0662|consen   58 LKHKNIVRLHDVLHSD-----KKLTLVFEFCDQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNL  132 (292)
T ss_pred             hhhcceeehhhhhccC-----ceeEEeHHHhhHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceE
Confidence            6899999999998665     77999999999999999874 67899999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCC-ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQL  157 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~  157 (280)
                      +|+.+|.+||.|||+++..+.+. +......|.+|.+|.++.+.+.|+.+.|+||.|||+.++.. |++.|+|.+..+++
T Consensus       133 lin~ngelkladfglarafgipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddql  212 (292)
T KOG0662|consen  133 LINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL  212 (292)
T ss_pred             EeccCCcEEecccchhhhcCCceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHH
Confidence            99999999999999999877664 55667889999999999988889999999999999999985 89999999999999


Q ss_pred             HHHHHHhCCCCHHHHhHhhHhHHHHhhhcCcc-ccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCC
Q 023609          158 RLLIELIGTPSEAELGFLNENAKKYICQLPRY-QRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  235 (280)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~  235 (280)
                      .+|+..+|.|.+..|....+.. .+. ..|-+ ....+....|.++...+++++++|.-+|.+|++++++++||||...
T Consensus       213 krif~~lg~p~ed~wps~t~lp-dyk-~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~  289 (292)
T KOG0662|consen  213 KRIFRLLGTPTEDQWPSMTKLP-DYK-PYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF  289 (292)
T ss_pred             HHHHHHhCCCccccCCccccCC-CCc-ccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence            9999999999998776443210 111 11111 2345677788899999999999999999999999999999999875

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=8.5e-40  Score=294.19  Aligned_cols=229  Identities=24%  Similarity=0.413  Sum_probs=176.8

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEE
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHS-ANVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~-~gi~H~di~~~nil   80 (280)
                      +|++|+++++++....    .++|+||++++++|.+++.+.+.+++..++.++.||+.||+|||+ .||+||||||+||+
T Consensus       189 ~~~~i~~i~~~~~~~~----~~~~iv~~~~g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NIL  264 (467)
T PTZ00284        189 DRFPLMKIQRYFQNET----GHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENIL  264 (467)
T ss_pred             cCcceeeeEEEEEcCC----ceEEEEEeccCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEE
Confidence            4677999999986532    579999999999999999888899999999999999999999998 59999999999999


Q ss_pred             EccCC----------------CEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhC
Q 023609           81 LNANC----------------DLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR  144 (280)
Q Consensus        81 i~~~~----------------~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g  144 (280)
                      ++.++                .+||+|||.+......  .....+|+.|+|||++.+. .++.++||||+||++|+|++|
T Consensus       265 l~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~~--~~~~~gt~~Y~APE~~~~~-~~~~~~DiwSlGvil~elltG  341 (467)
T PTZ00284        265 METSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHS--RTAIVSTRHYRSPEVVLGL-GWMYSTDMWSMGCIIYELYTG  341 (467)
T ss_pred             EecCCcccccccccccCCCCceEEECCCCccccCccc--cccccCCccccCcHHhhcC-CCCcHHHHHHHHHHHHHHHhC
Confidence            98765                4999999987543322  2355789999999998654 488999999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCCHHHHhHh-hHhHHHHhhhcCc----ccccccccc-----C--CCCChHHHHHHHHh
Q 023609          145 KPLFPGRDHVHQLRLLIELIGTPSEAELGFL-NENAKKYICQLPR----YQRQSFTEK-----F--PNVHPSAIDLVEKM  212 (280)
Q Consensus       145 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~----~~~~~~~~~-----~--~~~~~~~~~li~~~  212 (280)
                      ++||.+.+..+.+..+.+.++.++....... ......+......    .....+...     .  ...++.+.+||.+|
T Consensus       342 ~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~m  421 (467)
T PTZ00284        342 KLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGL  421 (467)
T ss_pred             CCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHh
Confidence            9999999988888888888887765433211 1111111111100    000000000     0  01246788999999


Q ss_pred             hcCCCCCCCCHHHHhcCCCCCCCcC
Q 023609          213 LTFDPRQRITVEDALAHPYLGSLHD  237 (280)
Q Consensus       213 L~~dp~~R~t~~ell~h~~~~~~~~  237 (280)
                      |++||.+|||+.|+|+||||.++..
T Consensus       422 L~~dP~~R~ta~e~L~Hp~~~~~~~  446 (467)
T PTZ00284        422 LHYDRQKRLNARQMTTHPYVLKYYP  446 (467)
T ss_pred             CCcChhhCCCHHHHhcCccccccCC
Confidence            9999999999999999999998654

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=3.5e-40  Score=278.60  Aligned_cols=204  Identities=24%  Similarity=0.413  Sum_probs=166.2

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS--NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS   77 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~--~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~   77 (280)
                      ++||||+++++++...     ...++||||++ |+|.+++..  ...+++..+..++.|++.||+|||+.|++||||||+
T Consensus        57 l~~~~iv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~  131 (285)
T cd05631          57 VNSRFVVSLAYAYETK-----DALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPE  131 (285)
T ss_pred             cCCCcEEEEEEEEccC-----CeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHH
Confidence            5799999999999665     67999999997 689888754  346999999999999999999999999999999999


Q ss_pred             cEEEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 023609           78 NLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL  157 (280)
Q Consensus        78 nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  157 (280)
                      ||+++.++.++|+|||++.............++..|+|||++.+. .++.++||||+||++|+|++|..||.+.+.....
T Consensus       132 Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~  210 (285)
T cd05631         132 NILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNE-KYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR  210 (285)
T ss_pred             HEEECCCCCEEEeeCCCcEEcCCCCeecCCCCCCCccCHhhhcCC-CCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH
Confidence            999999999999999999876544444456789999999998644 5889999999999999999999999876543222


Q ss_pred             HHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCC-----HHHHhcCCCC
Q 023609          158 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT-----VEDALAHPYL  232 (280)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~ell~h~~~  232 (280)
                      ..+......+.                          ......+++++.+||++||+.||.+||+     ++++++||||
T Consensus       211 ~~~~~~~~~~~--------------------------~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~  264 (285)
T cd05631         211 EEVDRRVKEDQ--------------------------EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIF  264 (285)
T ss_pred             HHHHHHhhccc--------------------------ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhh
Confidence            22211111000                          0112357889999999999999999997     8999999999


Q ss_pred             CCCc
Q 023609          233 GSLH  236 (280)
Q Consensus       233 ~~~~  236 (280)
                      .+..
T Consensus       265 ~~~~  268 (285)
T cd05631         265 KNIN  268 (285)
T ss_pred             cCCC
Confidence            8863

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1.5e-39  Score=275.65  Aligned_cols=229  Identities=40%  Similarity=0.782  Sum_probs=184.5

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ-ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~-~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++....   ....|+||||++++|.+++.... .+++.+++.++.|++.||+|||+.|++|+||+|+||
T Consensus        61 l~h~ni~~~~~~~~~~~---~~~~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~ni  137 (293)
T cd07843          61 LQHPNIVTVKEVVVGSN---LDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNL  137 (293)
T ss_pred             cCCCCEEEEEEEEEecC---CCcEEEEehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHE
Confidence            57999999999986542   26799999999999999987644 599999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCC-CccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  158 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.++.++|+|||.+...... .......+++.|+|||.+.+....+.++|+||+|+++++|++|.+||.+........
T Consensus       138 li~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~  217 (293)
T cd07843         138 LLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLN  217 (293)
T ss_pred             EECCCCcEEEeecCceeeccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence            9999999999999998866544 223345568889999988665556889999999999999999999999998888888


Q ss_pred             HHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCC--CChHHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 023609          159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPN--VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  232 (280)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~  232 (280)
                      ++....+.|....+.....................+...++.  +++.+.++|++||+.||++|||+.|++.||||
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         218 KIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             HHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence            888888888776655433221111111111122223344555  48899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=4.9e-40  Score=281.66  Aligned_cols=198  Identities=24%  Similarity=0.448  Sum_probs=165.6

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nil   80 (280)
                      +||||+++++++...     ...|+||||+. |+|.+++..++.+++..+..++.||+.||+|||++|++||||||+||+
T Consensus        54 ~~~~i~~~~~~~~~~-----~~~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil  128 (316)
T cd05620          54 ENPFLTHLYCTFQTK-----EHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVM  128 (316)
T ss_pred             CCCCccCeeEEEEeC-----CEEEEEECCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeE
Confidence            799999999999665     67999999997 699999988888999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccceeeccC-CCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023609           81 LNANCDLKICDFGLARVTSE-TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  159 (280)
Q Consensus        81 i~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      ++.++.++|+|||++..... ........+++.|+|||++.+. .++.++|+||+||++|+|++|..||.+.+..+....
T Consensus       129 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~  207 (316)
T cd05620         129 LDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGL-KYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFES  207 (316)
T ss_pred             ECCCCCEEeCccCCCeecccCCCceeccCCCcCccCHHHHcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            99999999999999864322 1223345689999999998544 478999999999999999999999987766554443


Q ss_pred             HHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCH-HHHhcCCCCCCC
Q 023609          160 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV-EDALAHPYLGSL  235 (280)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~-~ell~h~~~~~~  235 (280)
                      +...  .+                            ..-..++.+++++|++||+.||++|+++ +++++||||...
T Consensus       208 ~~~~--~~----------------------------~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~  254 (316)
T cd05620         208 IRVD--TP----------------------------HYPRWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTI  254 (316)
T ss_pred             HHhC--CC----------------------------CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCC
Confidence            3211  00                            0011467899999999999999999998 588899999875

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=3.9e-40  Score=282.90  Aligned_cols=198  Identities=22%  Similarity=0.410  Sum_probs=168.1

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nil   80 (280)
                      +||||+++++++...     ...|+||||++ |+|.+++.+.+.+++..++.++.||+.||.|||+.|++||||||+||+
T Consensus        54 ~hp~i~~~~~~~~~~-----~~~~lv~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nil  128 (321)
T cd05591          54 KHPFLTALHCCFQTK-----DRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNIL  128 (321)
T ss_pred             CCCCccceeeEEEcC-----CeEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeE
Confidence            699999999999765     67999999997 699999988888999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccceeeccC-CCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023609           81 LNANCDLKICDFGLARVTSE-TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  159 (280)
Q Consensus        81 i~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      ++.++.++|+|||++..... ........+++.|+|||++.+ ..++.++|+||+||++|+|++|..||.+.+..+....
T Consensus       129 l~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~  207 (321)
T cd05591         129 LDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQE-LEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFES  207 (321)
T ss_pred             ECCCCCEEEeecccceecccCCccccccccCccccCHHHHcC-CCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHH
Confidence            99999999999999875322 222344568999999998854 4578999999999999999999999988877666554


Q ss_pred             HHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCC-------CHHHHhcCCCC
Q 023609          160 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI-------TVEDALAHPYL  232 (280)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-------t~~ell~h~~~  232 (280)
                      +......                              .-..++.++.++|.+||+.||.+|+       ++.++++||||
T Consensus       208 i~~~~~~------------------------------~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~  257 (321)
T cd05591         208 ILHDDVL------------------------------YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFF  257 (321)
T ss_pred             HHcCCCC------------------------------CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCcc
Confidence            4321100                              0014678999999999999999999       99999999999


Q ss_pred             CCC
Q 023609          233 GSL  235 (280)
Q Consensus       233 ~~~  235 (280)
                      ..+
T Consensus       258 ~~~  260 (321)
T cd05591         258 KEI  260 (321)
T ss_pred             CCC
Confidence            874

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=3.9e-40  Score=283.11  Aligned_cols=199  Identities=25%  Similarity=0.485  Sum_probs=167.4

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++.+...     +..|+||||+. ++|.+++...+.+++..++.++.||+.||+|||++|++||||||+||
T Consensus        57 l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Ni  131 (323)
T cd05584          57 VKHPFIVDLIYAFQTG-----GKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENI  131 (323)
T ss_pred             CCCCchhceeeEEecC-----CeEEEEEeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHe
Confidence            5899999999999665     67999999997 59999998888899999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCC-CccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  158 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.+|.++|+|||++...... .......+++.|+|||++.+. .++.++||||+||++|+|++|..||.+.+......
T Consensus       132 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~  210 (323)
T cd05584         132 LLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRS-GHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTID  210 (323)
T ss_pred             EECCCCCEEEeeCcCCeecccCCCcccccCCCccccChhhccCC-CCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHH
Confidence            9999999999999998753222 223345689999999988554 47889999999999999999999998776655444


Q ss_pred             HHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCC-----CHHHHhcCCCCC
Q 023609          159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI-----TVEDALAHPYLG  233 (280)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~ell~h~~~~  233 (280)
                      .+.....                              ...+.+++++.++|++||+.||++||     ++.++++||||.
T Consensus       211 ~~~~~~~------------------------------~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~  260 (323)
T cd05584         211 KILKGKL------------------------------NLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFR  260 (323)
T ss_pred             HHHcCCC------------------------------CCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcC
Confidence            3332100                              11135678999999999999999999     899999999998


Q ss_pred             CC
Q 023609          234 SL  235 (280)
Q Consensus       234 ~~  235 (280)
                      ..
T Consensus       261 ~~  262 (323)
T cd05584         261 HV  262 (323)
T ss_pred             CC
Confidence            64

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.3e-39  Score=274.80  Aligned_cols=228  Identities=38%  Similarity=0.773  Sum_probs=186.0

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++...     ...|+|+||++++|.+++.. .+.+++.+++.++.||+.||+|||+.|++|+||+|+||
T Consensus        56 ~~~~~i~~~~~~~~~~-----~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni  130 (286)
T cd07832          56 CQHPYVVKLLDVFPHG-----SGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANL  130 (286)
T ss_pred             CCCCCCcceeeEEecC-----CeeEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHE
Confidence            4799999999999765     67899999998899999864 45799999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCC--ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL  157 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  157 (280)
                      +++.++.++|+|||.+.......  ......++..|+|||.+.+...++.++||||+||++++|++|.++|.+.......
T Consensus       131 ~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~  210 (286)
T cd07832         131 LISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQL  210 (286)
T ss_pred             EEcCCCcEEEeeeeecccccCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHH
Confidence            99999999999999987654432  1334567889999998866555788999999999999999999999998888888


Q ss_pred             HHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCC
Q 023609          158 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLG  233 (280)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~  233 (280)
                      ..+.+..+.+....+....+.........+......+...++..+.++.++|++||..||.+|||++++++||||.
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         211 AIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             HHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCcC
Confidence            8888888887765544332211111111222222234455677889999999999999999999999999999984

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-40  Score=280.02  Aligned_cols=196  Identities=28%  Similarity=0.418  Sum_probs=166.5

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCC-ceeccCCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS--NQALSEEHCQYFLYQILRGLKYIHSAN-VLHRDLKP   76 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~--~~~l~~~~~~~i~~qll~al~~LH~~g-i~H~di~~   76 (280)
                      |+|||||++++++..+.    ..++|||||++ |+|.+++..  ++.++...+..|+.||+.|++|||+++ |+||||||
T Consensus        96 l~HpNIV~f~G~~~~~~----~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~  171 (362)
T KOG0192|consen   96 LRHPNIVQFYGACTSPP----GSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKS  171 (362)
T ss_pred             CCCCCeeeEEEEEcCCC----CceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccCh
Confidence            68999999999997762    26899999998 799999987  578999999999999999999999999 99999999


Q ss_pred             CcEEEccCC-CEEEeeccceeeccCC-CccccceeccccccchhccC-CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh
Q 023609           77 SNLLLNANC-DLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLN-SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDH  153 (280)
Q Consensus        77 ~nili~~~~-~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~  153 (280)
                      +|+|++.++ ++||+|||+++..... .......||+.|||||++.+ ...++.++||||+|+++|+|++|..||.+...
T Consensus       172 ~NiLv~~~~~~~KI~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~  251 (362)
T KOG0192|consen  172 DNILVDLKGKTLKIADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP  251 (362)
T ss_pred             hhEEEcCCCCEEEECCCccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH
Confidence            999999997 9999999999876654 33445789999999999964 35699999999999999999999999998887


Q ss_pred             HHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          154 VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                      .+....+.....+|...                            ...++.+..+|..||..||.+||+..+++.
T Consensus       252 ~~~~~~v~~~~~Rp~~p----------------------------~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  252 VQVASAVVVGGLRPPIP----------------------------KECPPHLSSLMERCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             HHHHHHHHhcCCCCCCC----------------------------ccCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence            55444443333232211                            136788999999999999999999998876

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=2.3e-39  Score=277.45  Aligned_cols=229  Identities=35%  Similarity=0.659  Sum_probs=171.4

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHcC---------CCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN---------QALSEEHCQYFLYQILRGLKYIHSANVLH   71 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~---------~~l~~~~~~~i~~qll~al~~LH~~gi~H   71 (280)
                      ++||||+++++++.....   ...|+||||++++|.+++...         ..+++..++.++.||+.||.|||+.|++|
T Consensus        55 l~h~niv~~~~~~~~~~~---~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH  131 (317)
T cd07867          55 LKHPNVIALQKVFLSHSD---RKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLH  131 (317)
T ss_pred             CCCCCeeeEEEEEeccCC---CeEEEEEeeeCCcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEc
Confidence            579999999999855322   568999999999999887521         24889999999999999999999999999


Q ss_pred             ccCCCCcEEE----ccCCCEEEeeccceeeccCCC----ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh
Q 023609           72 RDLKPSNLLL----NANCDLKICDFGLARVTSETD----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD  143 (280)
Q Consensus        72 ~di~~~nili----~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~  143 (280)
                      |||||+||++    +.++.++|+|||+++......    ......+++.|+|||.+.+...++.++||||+||++|+|++
T Consensus       132 ~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~t  211 (317)
T cd07867         132 RDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT  211 (317)
T ss_pred             CCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHh
Confidence            9999999999    456789999999998654331    12345678999999998765667899999999999999999


Q ss_pred             CCCCCCCCC---------hHHHHHHHHHHhCCCCHHHHhHhhHhHH--HHhhh--cCccccc----cccccCCCCChHHH
Q 023609          144 RKPLFPGRD---------HVHQLRLLIELIGTPSEAELGFLNENAK--KYICQ--LPRYQRQ----SFTEKFPNVHPSAI  206 (280)
Q Consensus       144 g~~pf~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~--~~~~~~~----~~~~~~~~~~~~~~  206 (280)
                      |.+||....         .......+.+..+.+....+........  .....  .......    .........+..+.
T Consensus       212 g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (317)
T cd07867         212 SEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVF  291 (317)
T ss_pred             CCCCcccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHH
Confidence            999997543         2345666777777766655443321100  00000  0000000    01111223466799


Q ss_pred             HHHHHhhcCCCCCCCCHHHHhcCCCC
Q 023609          207 DLVEKMLTFDPRQRITVEDALAHPYL  232 (280)
Q Consensus       207 ~li~~~L~~dp~~R~t~~ell~h~~~  232 (280)
                      +||.+||+.||.+|||+.|+++||||
T Consensus       292 ~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         292 LLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             HHHHHHhccCcccccCHHHHhcCCCC
Confidence            99999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=3.3e-40  Score=283.59  Aligned_cols=199  Identities=25%  Similarity=0.476  Sum_probs=167.9

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++.+...     ...|+||||+. |+|.+++..++.+++..++.++.||+.||+|||++|++||||||+||
T Consensus        53 l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NI  127 (323)
T cd05575          53 VKHPFLVGLHYSFQTA-----DKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENI  127 (323)
T ss_pred             CCCCCCCCeeEEEEeC-----CEEEEEEcCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHe
Confidence            5799999999999665     67999999997 69999998888899999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccC-CCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSE-TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  158 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.++.++|+|||++..... ........+++.|+|||++.+ ..++.++||||+||++|+|++|..||.+.+..+...
T Consensus       128 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~  206 (323)
T cd05575         128 LLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYD  206 (323)
T ss_pred             EECCCCcEEEeccCCCcccccCCCccccccCChhhcChhhhcC-CCCCccccccccchhhhhhhcCCCCCCCCCHHHHHH
Confidence            999999999999999865322 222344578999999998854 457889999999999999999999998876655444


Q ss_pred             HHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCH----HHHhcCCCCCC
Q 023609          159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV----EDALAHPYLGS  234 (280)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~----~ell~h~~~~~  234 (280)
                      .+....                              ....+.+++.+.++|++||+.||.+||++    .++++||||.+
T Consensus       207 ~i~~~~------------------------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~  256 (323)
T cd05575         207 NILNKP------------------------------LRLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSS  256 (323)
T ss_pred             HHHcCC------------------------------CCCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCC
Confidence            332110                              01224678899999999999999999998    69999999987


Q ss_pred             C
Q 023609          235 L  235 (280)
Q Consensus       235 ~  235 (280)
                      .
T Consensus       257 ~  257 (323)
T cd05575         257 I  257 (323)
T ss_pred             C
Confidence            5

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=2e-40  Score=285.25  Aligned_cols=199  Identities=27%  Similarity=0.482  Sum_probs=166.3

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHS-ANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~-~gi~H~di~~~n   78 (280)
                      ++||||+++++.+...     ...|+||||++ |+|.+++...+.+++..++.++.||+.||+|||+ .|++||||||+|
T Consensus        52 ~~hp~i~~~~~~~~~~-----~~~~lv~E~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~N  126 (325)
T cd05594          52 SRHPFLTALKYSFQTH-----DRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLEN  126 (325)
T ss_pred             CCCCCCCceEEEEEcC-----CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCe
Confidence            4799999999998665     67999999997 6999999888889999999999999999999997 799999999999


Q ss_pred             EEEccCCCEEEeeccceeecc-CCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 023609           79 LLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL  157 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  157 (280)
                      |+++.++.++|+|||++.... .........+++.|+|||++.+ ..++.++||||+||++|+|++|..||.+.+.....
T Consensus       127 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~  205 (325)
T cd05594         127 LMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF  205 (325)
T ss_pred             EEECCCCCEEEecCCCCeecCCCCcccccccCCcccCCHHHHcc-CCCCCccccccccceeeeeccCCCCCCCCCHHHHH
Confidence            999999999999999987532 2222334568999999999854 45789999999999999999999999877655444


Q ss_pred             HHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCC-----CHHHHhcCCCC
Q 023609          158 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI-----TVEDALAHPYL  232 (280)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~ell~h~~~  232 (280)
                      ..+.....                              ..-..+++++.++|++||+.||.+|+     ++.++++||||
T Consensus       206 ~~i~~~~~------------------------------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~  255 (325)
T cd05594         206 ELILMEEI------------------------------RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFF  255 (325)
T ss_pred             HHHhcCCC------------------------------CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCc
Confidence            33321100                              00125688999999999999999997     99999999999


Q ss_pred             CCC
Q 023609          233 GSL  235 (280)
Q Consensus       233 ~~~  235 (280)
                      .+.
T Consensus       256 ~~~  258 (325)
T cd05594         256 AGI  258 (325)
T ss_pred             CCC
Confidence            875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.2e-40  Score=257.95  Aligned_cols=198  Identities=23%  Similarity=0.440  Sum_probs=176.8

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIR--SNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS   77 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~--~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~   77 (280)
                      |+||||+++|++|.+.     ..+|+++||.. |+++..+.  ..+++++...+.+++|++.||.|+|..+++||||||+
T Consensus        79 L~hpnilrlY~~fhd~-----~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpe  153 (281)
T KOG0580|consen   79 LRHPNILRLYGYFHDS-----KRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPE  153 (281)
T ss_pred             cCCccHHhhhhheecc-----ceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHH
Confidence            6899999999999887     67999999997 89999998  5567999999999999999999999999999999999


Q ss_pred             cEEEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 023609           78 NLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL  157 (280)
Q Consensus        78 nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  157 (280)
                      |++++.+|.+++.|||.+.....+ ...+-+||..|.+||...+. ..+..+|+|++|++.|+++.|.+||.+....+.+
T Consensus       154 nlLlg~~~~lkiAdfGwsV~~p~~-kR~tlcgt~dyl~pEmv~~~-~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etY  231 (281)
T KOG0580|consen  154 NLLLGSAGELKIADFGWSVHAPSN-KRKTLCGTLDYLPPEMVEGR-GHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETY  231 (281)
T ss_pred             HhccCCCCCeeccCCCceeecCCC-CceeeecccccCCHhhcCCC-CccchhhHHHHHHHHHHHHhcCCchhhhhhHHHH
Confidence            999999999999999999876643 34577999999999998655 4789999999999999999999999999888888


Q ss_pred             HHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCC
Q 023609          158 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  235 (280)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~  235 (280)
                      ++|.+.--..+                              +.++.+++|+|.+||..+|.+|++..|++.|||....
T Consensus       232 krI~k~~~~~p------------------------------~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~  279 (281)
T KOG0580|consen  232 KRIRKVDLKFP------------------------------STISGGAADLISRLLVKNPIERLALTEVMDHPWIVAN  279 (281)
T ss_pred             HHHHHccccCC------------------------------cccChhHHHHHHHHhccCccccccHHHHhhhHHHHhc
Confidence            88876532222                              2788999999999999999999999999999998653

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=3.3e-39  Score=272.26  Aligned_cols=226  Identities=39%  Similarity=0.762  Sum_probs=182.4

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS--NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~--~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      ++||||+++++++...     ...++||||+.++|.+++..  +..+++..+..++.|++.||+|||+.|++|+||+|+|
T Consensus        56 l~h~~i~~~~~~~~~~-----~~~~~v~e~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~n  130 (284)
T cd07860          56 LNHPNIVKLLDVIHTE-----NKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQN  130 (284)
T ss_pred             cCCCCCcchhhhcccC-----CcEEEEeeccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHH
Confidence            5899999999998654     67899999999899998865  3568999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCCC-ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 023609           79 LLLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL  157 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  157 (280)
                      |+++.++.++|+|||.+....... ......++..|+|||.+.+....+.++|+||+|+++|+|++|..||.+.+.....
T Consensus       131 ill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~  210 (284)
T cd07860         131 LLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL  210 (284)
T ss_pred             EEECCCCCEEEeeccchhhcccCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence            999999999999999987544321 2223456788999998866555678899999999999999999999998888888


Q ss_pred             HHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 023609          158 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  232 (280)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~  232 (280)
                      ..+....+.+....+..... ...+....+......+....+.++++++++|.+||+.||.+|||+.+++.||||
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         211 FRIFRTLGTPDEVVWPGVTS-LPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             HHHHHHhCCCChhhhhhhhH-HHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence            88888888776554332211 112222223333333444456788999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=9.4e-40  Score=285.08  Aligned_cols=202  Identities=24%  Similarity=0.408  Sum_probs=164.6

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++.+.+.     ..+|+||||++ |+|.+++.+++.+++..++.++.|++.||+|||++||+||||||+||
T Consensus        58 ~~~~~iv~~~~~~~~~-----~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NI  132 (363)
T cd05628          58 ADSLWVVKMFYSFQDK-----LNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNL  132 (363)
T ss_pred             CCCCCcceEEEEEecC-----CeEEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHe
Confidence            4799999999999765     67999999997 69999999888999999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCC------------------------------------ccccceeccccccchhccCCC
Q 023609           80 LLNANCDLKICDFGLARVTSETD------------------------------------FMTEYVVTRWYRAPELLLNSS  123 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~------------------------------------~~~~~~~~~~y~aPE~~~~~~  123 (280)
                      +++.++.++|+|||+++......                                    .....+||+.|+|||++.+. 
T Consensus       133 Li~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~-  211 (363)
T cd05628         133 LLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQT-  211 (363)
T ss_pred             EECCCCCEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCC-
Confidence            99999999999999986432110                                    01234789999999998654 


Q ss_pred             CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCCh
Q 023609          124 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHP  203 (280)
Q Consensus       124 ~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  203 (280)
                      .++.++|+||+||++|+|++|..||.+.+..+....+........                         +.. ...+++
T Consensus       212 ~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~-------------------------~p~-~~~~s~  265 (363)
T cd05628         212 GYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLI-------------------------FPP-EVPISE  265 (363)
T ss_pred             CCCCchhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCccc-------------------------CCC-cCCCCH
Confidence            478999999999999999999999988876666555543111100                         000 114688


Q ss_pred             HHHHHHHHhhcCCCC---CCCCHHHHhcCCCCCCC
Q 023609          204 SAIDLVEKMLTFDPR---QRITVEDALAHPYLGSL  235 (280)
Q Consensus       204 ~~~~li~~~L~~dp~---~R~t~~ell~h~~~~~~  235 (280)
                      +++++|.+|+. +|.   .||+++++++||||++.
T Consensus       266 ~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~  299 (363)
T cd05628         266 KAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGV  299 (363)
T ss_pred             HHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCC
Confidence            99999999876 454   46899999999999875

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=2.8e-39  Score=274.55  Aligned_cols=232  Identities=38%  Similarity=0.750  Sum_probs=186.1

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ-ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~-~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++.+.     ...|+||||++++|.+++.... .+++..+..++.||+.||+|||++|++|+||+|+||
T Consensus        59 ~~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~ni  133 (298)
T cd07841          59 LKHPNIIGLLDVFGHK-----SNINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNL  133 (298)
T ss_pred             cCCCCChhhhheeecC-----CEEEEEEcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhE
Confidence            5799999999999764     6799999999889999998766 799999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCC-ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  158 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.++.++|+|||.+....... ......++..|+|||.+.+...++.++|+||+||++++|++|.++|.+......+.
T Consensus       134 ll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~  213 (298)
T cd07841         134 LIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLG  213 (298)
T ss_pred             EEcCCCCEEEccceeeeeccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHH
Confidence            99999999999999997654432 22334567789999988655567889999999999999999999999888877777


Q ss_pred             HHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCcCC
Q 023609          159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDI  238 (280)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~~~  238 (280)
                      .+....+.+....+....... .+ ..............+...+..+.++|.+||+.||++|||+.+++.|+||.+...+
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~  291 (298)
T cd07841         214 KIFEALGTPTEENWPGVTSLP-DY-VEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAP  291 (298)
T ss_pred             HHHHHcCCCchhhhhhccccc-cc-ccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCC
Confidence            777777766654432211110 00 1111112223344456678899999999999999999999999999999987654


Q ss_pred             C
Q 023609          239 S  239 (280)
Q Consensus       239 ~  239 (280)
                      .
T Consensus       292 ~  292 (298)
T cd07841         292 T  292 (298)
T ss_pred             C
Confidence            3

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=3.4e-39  Score=271.70  Aligned_cols=226  Identities=34%  Similarity=0.713  Sum_probs=180.5

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nil   80 (280)
                      +||||+++++++.+...   +..++||||++++|.+.+... +.+++..++.++.|++.||+|||+.|++|+||+|+||+
T Consensus        56 ~h~~i~~~~~~~~~~~~---~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~  132 (282)
T cd07831          56 PHPNILRLIEVLFDRKT---GRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENIL  132 (282)
T ss_pred             CCCCccceEEEEecCCC---CcEEEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEE
Confidence            59999999999876421   468999999999999988764 57999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 023609           81 LNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL  160 (280)
Q Consensus        81 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~  160 (280)
                      ++. +.++|+|||.+.............++..|+|||.+......+.++|+||+||++++|++|.+||.+.+..+....+
T Consensus       133 l~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~  211 (282)
T cd07831         133 IKD-DILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKI  211 (282)
T ss_pred             EcC-CCeEEEecccccccccCCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHH
Confidence            999 9999999999986654433344567889999998755555788999999999999999999999999888888888


Q ss_pred             HHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 023609          161 IELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  232 (280)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~  232 (280)
                      .+..+.+............ ......+......+....+.++.+++++|.+||++||++|||+.++++||||
T Consensus       212 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         212 HDVLGTPDAEVLKKFRKSR-HMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             HHHcCCCCHHHHHhhcccc-cccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence            8888777764322111100 0001111112222333445778999999999999999999999999999997

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-39  Score=273.41  Aligned_cols=227  Identities=39%  Similarity=0.762  Sum_probs=178.2

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++...     ...|+||||++++|.+++... ..+++..++.++.|++.||.|||++|++|+||+|+||
T Consensus        60 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~ni  134 (291)
T cd07844          60 LKHANIVTLHDIIHTK-----KTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNL  134 (291)
T ss_pred             CCCcceeeEEEEEecC-----CeEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHE
Confidence            5899999999999665     679999999999999988754 4689999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCC-ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-hHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD-HVHQL  157 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~  157 (280)
                      +++.++.++|+|||.+....... ......++..|+|||.+.+...++.++|+||+|+++++|++|..||.+.. ..+..
T Consensus       135 l~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~  214 (291)
T cd07844         135 LISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQL  214 (291)
T ss_pred             EEcCCCCEEECccccccccCCCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHH
Confidence            99999999999999986543221 12223467889999988665567889999999999999999999997765 56677


Q ss_pred             HHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCC--hHHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 023609          158 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVH--PSAIDLVEKMLTFDPRQRITVEDALAHPYL  232 (280)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~li~~~L~~dp~~R~t~~ell~h~~~  232 (280)
                      ..+.+..+.+....+..........................+.++  .++.+++.+||+.+|.+|||+.++++||||
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         215 HKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             HHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            777777777766544333221111111111122222334444555  889999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.2e-39  Score=279.33  Aligned_cols=198  Identities=25%  Similarity=0.477  Sum_probs=166.1

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nil   80 (280)
                      +||||+++++++...     ...|+||||++ |+|.+++...+.+++..++.++.||+.||+|||+.||+||||||+||+
T Consensus        54 ~hp~i~~~~~~~~~~-----~~~~lv~e~~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nil  128 (316)
T cd05592          54 EHPFLTHLFCTFQTK-----EHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVL  128 (316)
T ss_pred             CCCCccceeeEEEcC-----CEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeE
Confidence            799999999998655     67999999997 699999988888999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccceeeccCC-CccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023609           81 LNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  159 (280)
Q Consensus        81 i~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      ++.++.++|+|||++...... .......+++.|+|||.+.+. .++.++|+||+||++|+|++|..||.+.+..+....
T Consensus       129 l~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~  207 (316)
T cd05592         129 LDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQ-KYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDS  207 (316)
T ss_pred             ECCCCCEEEccCcCCeECCCCCCccccccCCccccCHHHHcCC-CCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            999999999999998754322 223345789999999998544 478999999999999999999999988776555443


Q ss_pred             HHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHH-HHhcCCCCCCC
Q 023609          160 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVE-DALAHPYLGSL  235 (280)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~-ell~h~~~~~~  235 (280)
                      +....  +                            ..-..++.++.++|.+||+.||.+||++. +++.||||...
T Consensus       208 i~~~~--~----------------------------~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~  254 (316)
T cd05592         208 ILNDR--P----------------------------HFPRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGI  254 (316)
T ss_pred             HHcCC--C----------------------------CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCC
Confidence            32110  0                            00124678899999999999999999875 88899999875

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.9e-39  Score=282.52  Aligned_cols=228  Identities=24%  Similarity=0.369  Sum_probs=166.5

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++...     ...++|||++.++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+||
T Consensus       114 l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Ni  188 (357)
T PHA03209        114 VNHPSVIRMKDTLVSG-----AITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENI  188 (357)
T ss_pred             CCCCCCcChhheEEeC-----CeeEEEEEccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHE
Confidence            5899999999999765     66899999999999999865 45799999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCC-CCCCCCCh-----
Q 023609           80 LLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFPGRDH-----  153 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~-~pf~~~~~-----  153 (280)
                      +++.++.++|+|||.+.............++..|+|||++.+. .++.++|+||+||++|+|+++. ++|.+...     
T Consensus       189 ll~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~  267 (357)
T PHA03209        189 FINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLARD-KYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEY  267 (357)
T ss_pred             EECCCCCEEEecCccccccccCcccccccccccccCCeecCCC-CCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHH
Confidence            9999999999999998754433333445689999999988554 4889999999999999999754 44443211     


Q ss_pred             ----HHHHHHHHHHhCCCCHHHHhHh-hHhHHHHhhhcCccccccc----cccCCCCChHHHHHHHHhhcCCCCCCCCHH
Q 023609          154 ----VHQLRLLIELIGTPSEAELGFL-NENAKKYICQLPRYQRQSF----TEKFPNVHPSAIDLVEKMLTFDPRQRITVE  224 (280)
Q Consensus       154 ----~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~L~~dp~~R~t~~  224 (280)
                          ...+..+....+..+....... ......+.... ......+    ......++.++.+||.+||+.||.+|||+.
T Consensus       268 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~  346 (357)
T PHA03209        268 VKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYA-SLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAE  346 (357)
T ss_pred             HHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhc-ccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHH
Confidence                2233333444333222111000 01111111100 0000000    011125677899999999999999999999


Q ss_pred             HHhcCCCCCCC
Q 023609          225 DALAHPYLGSL  235 (280)
Q Consensus       225 ell~h~~~~~~  235 (280)
                      |+|+||||+++
T Consensus       347 e~l~hp~f~~~  357 (357)
T PHA03209        347 EILNYPMFAQL  357 (357)
T ss_pred             HHhcCchhccC
Confidence            99999999863

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-40  Score=285.60  Aligned_cols=200  Identities=23%  Similarity=0.454  Sum_probs=167.5

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nil   80 (280)
                      +||||+++++.+...     ...|+||||+. |+|.+++..++.+++..++.++.||+.||+|||++||+||||||+||+
T Consensus        54 ~~p~i~~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nil  128 (330)
T cd05586          54 ESPFIVGLKFSFQTD-----SDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENIL  128 (330)
T ss_pred             CCCcCcceEEEEecC-----CeEEEEEcCCCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeE
Confidence            699999999999765     67999999997 699999988889999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccceeeccC-CCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023609           81 LNANCDLKICDFGLARVTSE-TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  159 (280)
Q Consensus        81 i~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      ++.++.++|+|||++..... ........+++.|+|||++.+...++.++||||+||++|+|++|..||.+.+..+....
T Consensus       129 i~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~  208 (330)
T cd05586         129 LDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRN  208 (330)
T ss_pred             ECCCCCEEEecCCcCcCCCCCCCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHH
Confidence            99999999999999875322 22234567899999999986655578999999999999999999999987765554443


Q ss_pred             HHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCC----CHHHHhcCCCCCCC
Q 023609          160 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI----TVEDALAHPYLGSL  235 (280)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~----t~~ell~h~~~~~~  235 (280)
                      +.......+                             ...++.+++++|++||+.||.+||    ++.++++||||...
T Consensus       209 i~~~~~~~~-----------------------------~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~  259 (330)
T cd05586         209 IAFGKVRFP-----------------------------KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADI  259 (330)
T ss_pred             HHcCCCCCC-----------------------------CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCC
Confidence            321100000                             014678899999999999999998    79999999999864

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.6e-40  Score=283.64  Aligned_cols=199  Identities=24%  Similarity=0.480  Sum_probs=167.7

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++...     ...|+||||++ |+|.+++.++..+++..++.++.||+.||+|||+.|++||||||+||
T Consensus        55 l~h~niv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Ni  129 (318)
T cd05582          55 VNHPFIVKLHYAFQTE-----GKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENI  129 (318)
T ss_pred             CCCCCcccEEEEEEcC-----CEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHe
Confidence            5799999999999765     67999999997 69999998888899999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCC-CccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  158 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.++.++|+|||++...... .......+++.|+|||.+.+. .++.++|+||+||++|+|++|..||.+.+..+...
T Consensus       130 l~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~  208 (318)
T cd05582         130 LLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRR-GHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMT  208 (318)
T ss_pred             EECCCCcEEEeeccCCcccCCCCCceecccCChhhcCHHHHcCC-CCCCccceeccceEeeeeccCCCCCCCCCHHHHHH
Confidence            9999999999999998765433 223345688999999988544 47889999999999999999999998876655544


Q ss_pred             HHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCC-----HHHHhcCCCCC
Q 023609          159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT-----VEDALAHPYLG  233 (280)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~ell~h~~~~  233 (280)
                      .+.....                              ..-+.+++++.++|++||+.||.+|||     +.+++.||||.
T Consensus       209 ~i~~~~~------------------------------~~p~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~  258 (318)
T cd05582         209 MILKAKL------------------------------GMPQFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFS  258 (318)
T ss_pred             HHHcCCC------------------------------CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcC
Confidence            4322110                              001246789999999999999999999     77899999998


Q ss_pred             CC
Q 023609          234 SL  235 (280)
Q Consensus       234 ~~  235 (280)
                      ..
T Consensus       259 ~~  260 (318)
T cd05582         259 TI  260 (318)
T ss_pred             CC
Confidence            75

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.5e-39  Score=278.92  Aligned_cols=198  Identities=23%  Similarity=0.451  Sum_probs=166.3

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nil   80 (280)
                      +||||+++++++...     ..+|+||||++ |+|.+++.+.+.+++..+..++.||+.||+|||+.|++||||||+||+
T Consensus        54 ~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil  128 (318)
T cd05570          54 KHPFLTQLHSCFQTK-----DRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVL  128 (318)
T ss_pred             CCCCccceeeEEEcC-----CEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeE
Confidence            699999999998665     67999999997 699999988888999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccceeeccC-CCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023609           81 LNANCDLKICDFGLARVTSE-TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  159 (280)
Q Consensus        81 i~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      ++.++.++|+|||++..... ........+++.|+|||++.+ ..++.++|+||+||++|+|++|..||.+.+.......
T Consensus       129 l~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~  207 (318)
T cd05570         129 LDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSY-QPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQS  207 (318)
T ss_pred             ECCCCcEEecccCCCeecCcCCCcccceecCccccCHHHhcC-CCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHH
Confidence            99999999999999865322 222334568999999999854 4578999999999999999999999987765554433


Q ss_pred             HHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCH-----HHHhcCCCCCC
Q 023609          160 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV-----EDALAHPYLGS  234 (280)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~-----~ell~h~~~~~  234 (280)
                      +....                      .        ..-..++..+.++|++||+.||.+|||+     .++++||||..
T Consensus       208 i~~~~----------------------~--------~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~  257 (318)
T cd05570         208 ILEDE----------------------V--------RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFRE  257 (318)
T ss_pred             HHcCC----------------------C--------CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCC
Confidence            32110                      0        0012467899999999999999999999     99999999987


Q ss_pred             C
Q 023609          235 L  235 (280)
Q Consensus       235 ~  235 (280)
                      .
T Consensus       258 ~  258 (318)
T cd05570         258 I  258 (318)
T ss_pred             C
Confidence            5

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.3e-40  Score=282.61  Aligned_cols=205  Identities=26%  Similarity=0.465  Sum_probs=170.5

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++...     ...|+||||++ |+|.+++...+.+++..++.++.||+.||.|||+.|++||||||+||
T Consensus        58 ~~h~~iv~~~~~~~~~-----~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Ni  132 (333)
T cd05600          58 TKSEWLVKLLYAFQDD-----EYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENF  132 (333)
T ss_pred             CCCCCCccEEEEEEcC-----CEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHE
Confidence            4799999999999665     67999999997 69999998888899999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  159 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      +++.++.++|+|||++.....  ......+++.|+|||.+.+. .++.++||||+||++|+|++|..||.+.+..+....
T Consensus       133 l~~~~~~~kL~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~  209 (333)
T cd05600         133 LIDASGHIKLTDFGLSKGIVT--YANSVVGSPDYMAPEVLRGK-GYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWEN  209 (333)
T ss_pred             EECCCCCEEEEeCcCCccccc--ccCCcccCccccChhHhcCC-CCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHH
Confidence            999999999999999876543  23456789999999998655 588999999999999999999999988776665544


Q ss_pred             HHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCC
Q 023609          160 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  235 (280)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~  235 (280)
                      +........                 .     .........++.++.++|.+||..+|.+||++.++++||||.+.
T Consensus       210 i~~~~~~~~-----------------~-----~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~  263 (333)
T cd05600         210 LKYWKETLQ-----------------R-----PVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEV  263 (333)
T ss_pred             HHhcccccc-----------------C-----CCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence            432111000                 0     00001113568899999999999999999999999999999975

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=2e-39  Score=277.90  Aligned_cols=200  Identities=25%  Similarity=0.451  Sum_probs=166.5

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++.+.     ..+|+||||++ |+|.+++.....+++.++..++.|++.||+|||++|++||||||+||
T Consensus        53 ~~hp~iv~~~~~~~~~-----~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Ni  127 (316)
T cd05619          53 WEHPFLTHLYCTFQTK-----ENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNI  127 (316)
T ss_pred             cCCCcCcceEEEEEeC-----CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHE
Confidence            3799999999999765     67999999997 69999998878899999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCC-CccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  158 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.++.++|+|||++...... .......+++.|+|||++.+. .++.++|+||+||++|+|++|..||.+.+..+...
T Consensus       128 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~  206 (316)
T cd05619         128 LLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQ-KYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQ  206 (316)
T ss_pred             EECCCCCEEEccCCcceECCCCCCceeeecCCccccCHHHHcCC-CCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            9999999999999998753222 123345689999999998544 47899999999999999999999998776555444


Q ss_pred             HHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHH-HHhcCCCCCCCc
Q 023609          159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVE-DALAHPYLGSLH  236 (280)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~-ell~h~~~~~~~  236 (280)
                      .+....  +                            ..-+.++.+++++|.+||+.||.+||++. ++++||||....
T Consensus       207 ~i~~~~--~----------------------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~~  255 (316)
T cd05619         207 SIRMDN--P----------------------------CYPRWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREID  255 (316)
T ss_pred             HHHhCC--C----------------------------CCCccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCCC
Confidence            332100  0                            00114678899999999999999999996 899999998853

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.7e-40  Score=286.15  Aligned_cols=202  Identities=27%  Similarity=0.490  Sum_probs=166.0

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++.+.+.     ...|+||||++ |+|.+++..++.+++..++.++.||+.||+|||+.|++||||||+||
T Consensus        58 l~h~~iv~~~~~~~~~-----~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NI  132 (364)
T cd05599          58 ADNPWVVKLYYSFQDE-----NYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNL  132 (364)
T ss_pred             CCCCCCcceEEEEEcC-----CeEEEEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHe
Confidence            5799999999999765     77999999997 69999998888899999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCC---------------------------------------ccccceeccccccchhcc
Q 023609           80 LLNANCDLKICDFGLARVTSETD---------------------------------------FMTEYVVTRWYRAPELLL  120 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~---------------------------------------~~~~~~~~~~y~aPE~~~  120 (280)
                      +++.+|.++|+|||++.......                                       .....+||+.|+|||++.
T Consensus       133 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  212 (364)
T cd05599         133 LLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFL  212 (364)
T ss_pred             EECCCCCEEEeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHc
Confidence            99999999999999986532110                                       011235899999999885


Q ss_pred             CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCC
Q 023609          121 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPN  200 (280)
Q Consensus       121 ~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  200 (280)
                      +. .++.++||||+||++|+|++|..||.+.+..+....+........                         + .....
T Consensus       213 ~~-~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~-------------------------~-~~~~~  265 (364)
T cd05599         213 QT-GYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQ-------------------------F-PDEVP  265 (364)
T ss_pred             CC-CCCCeeeeecchhHHHHhhcCCCCCCCCCHHHHHHHHHcCCCccC-------------------------C-CCCCC
Confidence            44 478999999999999999999999988776655444432110000                         0 00114


Q ss_pred             CChHHHHHHHHhhcCCCCCCCC---HHHHhcCCCCCCC
Q 023609          201 VHPSAIDLVEKMLTFDPRQRIT---VEDALAHPYLGSL  235 (280)
Q Consensus       201 ~~~~~~~li~~~L~~dp~~R~t---~~ell~h~~~~~~  235 (280)
                      +++++++||++||. +|.+|++   +.++++||||+..
T Consensus       266 ~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~  302 (364)
T cd05599         266 LSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGV  302 (364)
T ss_pred             CCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence            68899999999997 9999998   9999999999875

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.4e-39  Score=285.22  Aligned_cols=229  Identities=23%  Similarity=0.304  Sum_probs=173.8

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   80 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nil   80 (280)
                      |+||||+++++++...     ...|+|||++.++|.+++...+.+++..++.++.||+.||+|||+.||+||||||+||+
T Consensus       143 l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nil  217 (392)
T PHA03207        143 ISHRAIINLIHAYRWK-----STVCMVMPKYKCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIF  217 (392)
T ss_pred             cCCCCccceeeeEeeC-----CEEEEEehhcCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEE
Confidence            5899999999998654     67999999999999999987788999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccceeeccCCCc---cccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC---hH
Q 023609           81 LNANCDLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD---HV  154 (280)
Q Consensus        81 i~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~---~~  154 (280)
                      ++.++.++|+|||++........   .....+|+.|+|||++.+ ..++.++||||+||++|+|++|..||.+..   ..
T Consensus       218 l~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~  296 (392)
T PHA03207        218 LDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLAL-DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSS  296 (392)
T ss_pred             EcCCCCEEEccCccccccCcccccccccccccccCccCHhHhcC-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcH
Confidence            99999999999999875543321   223468999999998854 447899999999999999999999997653   34


Q ss_pred             HHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccc--cccccC--CCCChHHHHHHHHhhcCCCCCCCCHHHHhcCC
Q 023609          155 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQ--SFTEKF--PNVHPSAIDLVEKMLTFDPRQRITVEDALAHP  230 (280)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~--~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~  230 (280)
                      ..+..+.+.++..+........................  .....+  ..++.++.++|++||..||.+|||+.++++||
T Consensus       297 ~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p  376 (392)
T PHA03207        297 SQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLP  376 (392)
T ss_pred             HHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCc
Confidence            55666666555433321111111111111111100000  011111  24577899999999999999999999999999


Q ss_pred             CCCCC
Q 023609          231 YLGSL  235 (280)
Q Consensus       231 ~~~~~  235 (280)
                      ||.+.
T Consensus       377 ~f~~~  381 (392)
T PHA03207        377 LFTKE  381 (392)
T ss_pred             hhhcc
Confidence            99763

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-40  Score=288.80  Aligned_cols=196  Identities=27%  Similarity=0.524  Sum_probs=171.4

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nil   80 (280)
                      +||.|++++..|+++     .++|.||||+. |++. .+.+.+.|++..++.++..|+.||.|||++||+|||||.+||+
T Consensus       427 ~HPFL~~L~~~fQT~-----~~l~fvmey~~Ggdm~-~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiL  500 (694)
T KOG0694|consen  427 RHPFLVNLFSCFQTK-----EHLFFVMEYVAGGDLM-HHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLL  500 (694)
T ss_pred             cCCeEeecccccccC-----CeEEEEEEecCCCcEE-EEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheE
Confidence            599999999999887     88999999997 4633 3445578999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccceeecc-CCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023609           81 LNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  159 (280)
Q Consensus        81 i~~~~~~~l~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      +|.+|.+||+|||+++... ......+.+|||.|+|||++.+. .|+.++|.|||||++|+|+.|.+||+|.+..+....
T Consensus       501 LD~eGh~kiADFGlcKe~m~~g~~TsTfCGTpey~aPEil~e~-~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~Fds  579 (694)
T KOG0694|consen  501 LDTEGHVKIADFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQ-SYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDS  579 (694)
T ss_pred             EcccCcEEecccccccccCCCCCccccccCChhhcChhhhccC-cccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Confidence            9999999999999998643 44566789999999999999655 599999999999999999999999999999888777


Q ss_pred             HHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCC-CCChHHHHHHHHhhcCCCCCCCCH-----HHHhcCCCCC
Q 023609          160 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP-NVHPSAIDLVEKMLTFDPRQRITV-----EDALAHPYLG  233 (280)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~L~~dp~~R~t~-----~ell~h~~~~  233 (280)
                      |..--                               -.+| .+|.++.++|+++|.+||++|+.+     +++..||||.
T Consensus       580 I~~d~-------------------------------~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr  628 (694)
T KOG0694|consen  580 IVNDE-------------------------------VRYPRFLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFR  628 (694)
T ss_pred             HhcCC-------------------------------CCCCCcccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCccc
Confidence            65321                               1122 578999999999999999999965     7999999999


Q ss_pred             CC
Q 023609          234 SL  235 (280)
Q Consensus       234 ~~  235 (280)
                      ++
T Consensus       629 ~i  630 (694)
T KOG0694|consen  629 SI  630 (694)
T ss_pred             cC
Confidence            75

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=1.2e-38  Score=276.03  Aligned_cols=249  Identities=43%  Similarity=0.822  Sum_probs=187.5

Q ss_pred             CCCCCeeeeeceecCCCCCC---------CCcEEEEeecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q 023609            1 MDHENVVAIRDIIPPPQRES---------FNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLH   71 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~---------~~~~~iv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H   71 (280)
                      ++||||+++++.+.......         ....|+||||++++|.+++.. ..+++..++.++.||+.||+|||+.|++|
T Consensus        59 l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~givH  137 (342)
T cd07854          59 LDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLH  137 (342)
T ss_pred             cCCCcchhhHhhhcccccccccccccccccceEEEEeecccccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence            57999999999876543211         135899999999999988864 46999999999999999999999999999


Q ss_pred             ccCCCCcEEEcc-CCCEEEeeccceeeccCCC----ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCC
Q 023609           72 RDLKPSNLLLNA-NCDLKICDFGLARVTSETD----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP  146 (280)
Q Consensus        72 ~di~~~nili~~-~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~  146 (280)
                      |||||+||+++. ++.++++|||.+.......    ......++..|+|||.+.....++.++|+||+||++++|++|..
T Consensus       138 ~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~  217 (342)
T cd07854         138 RDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKP  217 (342)
T ss_pred             CCCCHHHEEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCC
Confidence            999999999975 5678999999987543221    11234567889999987555557889999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHH
Q 023609          147 LFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDA  226 (280)
Q Consensus       147 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~el  226 (280)
                      ||.+.........+.+....+...............................+.++.++++||++||+.||.+|||+.++
T Consensus       218 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~el  297 (342)
T cd07854         218 LFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEA  297 (342)
T ss_pred             CCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHH
Confidence            99988887777776666544443322221111111111111222233444566789999999999999999999999999


Q ss_pred             hcCCCCCCCcCCCCCCccCCCCCc
Q 023609          227 LAHPYLGSLHDISDEPVCMSPFSF  250 (280)
Q Consensus       227 l~h~~~~~~~~~~~~~~~~~~~~~  250 (280)
                      ++||||+.+..+.+++....++..
T Consensus       298 l~h~~~~~~~~~~~~~~~~~~~~~  321 (342)
T cd07854         298 LMHPYMSCYSCPFDEPVSLHPFHI  321 (342)
T ss_pred             hCCCccccccCCccccCCCCCccc
Confidence            999999988777666665555543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.7e-39  Score=279.81  Aligned_cols=207  Identities=23%  Similarity=0.462  Sum_probs=161.8

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nil   80 (280)
                      +||||+++++++...     ..+|+||||++ |+|.+++.+.+.+++..++.++.||+.||+|||++|++||||||+||+
T Consensus        54 ~hp~Iv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil  128 (329)
T cd05588          54 NHPFLVGLHSCFQTE-----SRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVL  128 (329)
T ss_pred             CCCCCCceEEEEEcC-----CEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeE
Confidence            699999999999765     67999999997 699999988889999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccceeec-cCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023609           81 LNANCDLKICDFGLARVT-SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  159 (280)
Q Consensus        81 i~~~~~~~l~dfg~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      ++.++.++|+|||++... ..........+++.|+|||++.+. .++.++|+||+||++|+|++|+.||.......    
T Consensus       129 i~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~----  203 (329)
T cd05588         129 LDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGMSD----  203 (329)
T ss_pred             ECCCCCEEECcCccccccccCCCccccccCCccccCHHHHcCC-CCCCccceechHHHHHHHHHCCCCcccccccc----
Confidence            999999999999998642 222233456789999999998554 47889999999999999999999996321100    


Q ss_pred             HHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCC------HHHHhcCCCCC
Q 023609          160 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT------VEDALAHPYLG  233 (280)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t------~~ell~h~~~~  233 (280)
                            .+.........+   .......        ..-+.++..+.++|++||+.||.+|+|      +.++++||||.
T Consensus       204 ------~~~~~~~~~~~~---~~~~~~~--------~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~  266 (329)
T cd05588         204 ------NPDQNTEDYLFQ---VILEKQI--------RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFR  266 (329)
T ss_pred             ------cccccchHHHHH---HHHcCCC--------CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCC
Confidence                  000000000000   0000000        111256888999999999999999997      78999999998


Q ss_pred             CC
Q 023609          234 SL  235 (280)
Q Consensus       234 ~~  235 (280)
                      .+
T Consensus       267 ~~  268 (329)
T cd05588         267 NI  268 (329)
T ss_pred             CC
Confidence            64

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=1e-39  Score=281.61  Aligned_cols=203  Identities=21%  Similarity=0.377  Sum_probs=163.2

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nil   80 (280)
                      +||||+++++++...     ..+|+||||++ |+|.+++.+++.+++.+++.++.||+.||+|||+.|++||||||+||+
T Consensus        63 ~~~~i~~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil  137 (332)
T cd05614          63 QSPFLVTLHYAFQTE-----AKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENIL  137 (332)
T ss_pred             CCCCcccEEEEEecC-----CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeE
Confidence            599999999998665     67999999997 699999988888999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccceeeccCC--CccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023609           81 LNANCDLKICDFGLARVTSET--DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  158 (280)
Q Consensus        81 i~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  158 (280)
                      ++.++.++|+|||++......  .......+++.|+|||.+.+...++.++||||+||++|+|++|..||..........
T Consensus       138 i~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~  217 (332)
T cd05614         138 LDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQS  217 (332)
T ss_pred             ECCCCCEEEeeCcCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHH
Confidence            999999999999998754322  122345689999999998655557889999999999999999999996432211111


Q ss_pred             HHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCC-----CHHHHhcCCCCC
Q 023609          159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI-----TVEDALAHPYLG  233 (280)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~ell~h~~~~  233 (280)
                      .+....                  ....+        ...+.+++.++++|.+||+.||++||     ++.++++||||+
T Consensus       218 ~~~~~~------------------~~~~~--------~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~  271 (332)
T cd05614         218 EVSRRI------------------LKCDP--------PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFK  271 (332)
T ss_pred             HHHHHH------------------hcCCC--------CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcC
Confidence            111100                  00000        11125788999999999999999999     888999999998


Q ss_pred             CC
Q 023609          234 SL  235 (280)
Q Consensus       234 ~~  235 (280)
                      +.
T Consensus       272 ~~  273 (332)
T cd05614         272 GL  273 (332)
T ss_pred             CC
Confidence            75

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=9.5e-40  Score=280.99  Aligned_cols=199  Identities=25%  Similarity=0.476  Sum_probs=167.5

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++.+...     ...|+||||+. |+|.+++...+.+++..+..++.||+.||+|||+.|++||||||+||
T Consensus        53 ~~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NI  127 (325)
T cd05604          53 VKHPFLVGLHYSFQTT-----EKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENI  127 (325)
T ss_pred             CCCCCCccEEEEEecC-----CEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHe
Confidence            4799999999999665     67999999997 69999998888999999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccC-CCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSE-TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  158 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.+|.++|+|||++..... ........+++.|+|||++.+ ..++.++||||+||++|+|++|..||.+.+..+...
T Consensus       128 ll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~  206 (325)
T cd05604         128 LLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRK-QPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYD  206 (325)
T ss_pred             EECCCCCEEEeecCCcccCCCCCCCcccccCChhhCCHHHHcC-CCCCCcCccccccceehhhhcCCCCCCCCCHHHHHH
Confidence            999999999999999875322 222345578999999998854 447889999999999999999999998876655544


Q ss_pred             HHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCH----HHHhcCCCCCC
Q 023609          159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV----EDALAHPYLGS  234 (280)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~----~ell~h~~~~~  234 (280)
                      .+....                              ....+..+..+.++|++||+.||.+||++    .++++||||.+
T Consensus       207 ~~~~~~------------------------------~~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~  256 (325)
T cd05604         207 NILHKP------------------------------LVLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFES  256 (325)
T ss_pred             HHHcCC------------------------------ccCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCC
Confidence            432210                              01224678899999999999999999977    59999999987


Q ss_pred             C
Q 023609          235 L  235 (280)
Q Consensus       235 ~  235 (280)
                      .
T Consensus       257 ~  257 (325)
T cd05604         257 L  257 (325)
T ss_pred             C
Confidence            5

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=3.3e-39  Score=277.51  Aligned_cols=198  Identities=26%  Similarity=0.457  Sum_probs=164.8

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++...     ...|+||||++ |+|...+.. +.+++..+..++.||+.||+|||+.|++||||||+||
T Consensus        59 l~hp~i~~~~~~~~~~-----~~~~lv~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Ni  132 (324)
T cd05589          59 ERHPFLVNLFACFQTE-----DHVCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNL  132 (324)
T ss_pred             cCCCChhceeeEEEcC-----CEEEEEEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHe
Confidence            4699999999999665     67999999998 588887754 5799999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccC-CCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSE-TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  158 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.++.++|+|||++..... ........+++.|+|||.+.+. .++.++|+||+||++|+|++|..||.+.+..+...
T Consensus       133 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~  211 (324)
T cd05589         133 LLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTET-SYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFD  211 (324)
T ss_pred             EECCCCcEEeCcccCCccCCCCCCcccccccCccccCHhHhcCC-CCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            999999999999998864322 2223445789999999988544 47889999999999999999999998877655544


Q ss_pred             HHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCC-----CHHHHhcCCCCC
Q 023609          159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI-----TVEDALAHPYLG  233 (280)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~ell~h~~~~  233 (280)
                      .+......                              .-+.+++++.++|.+||+.||.+||     ++.++++||||+
T Consensus       212 ~i~~~~~~------------------------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~  261 (324)
T cd05589         212 SIVNDEVR------------------------------YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFR  261 (324)
T ss_pred             HHHhCCCC------------------------------CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcC
Confidence            43221100                              0125688999999999999999999     799999999998


Q ss_pred             CC
Q 023609          234 SL  235 (280)
Q Consensus       234 ~~  235 (280)
                      +.
T Consensus       262 ~~  263 (324)
T cd05589         262 DI  263 (324)
T ss_pred             CC
Confidence            75

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=6.8e-39  Score=270.26  Aligned_cols=226  Identities=41%  Similarity=0.803  Sum_probs=183.3

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN---QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS   77 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~---~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~   77 (280)
                      ++||||+++++++...     ...++||||++++|.+++...   ..+++..+..++.|++.||+|||+.|++|+||+|+
T Consensus        55 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~  129 (284)
T cd07836          55 LKHENIVRLHDVIHTE-----NKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQ  129 (284)
T ss_pred             hcCCCEeeeeeeEeeC-----CcEEEEEecCCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHH
Confidence            5799999999999765     678999999999999988754   35899999999999999999999999999999999


Q ss_pred             cEEEccCCCEEEeeccceeeccCCC-ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023609           78 NLLLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ  156 (280)
Q Consensus        78 nili~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  156 (280)
                      ||+++.++.++|+|||.+....... ......++..|++||.+.+...++.++|+||+||++++|++|..||.+.+..+.
T Consensus       130 ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~  209 (284)
T cd07836         130 NLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQ  209 (284)
T ss_pred             HEEECCCCcEEEeecchhhhhcCCccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHH
Confidence            9999999999999999987543321 223345678899999886655578899999999999999999999999988888


Q ss_pred             HHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 023609          157 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  232 (280)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~  232 (280)
                      ...+......|....+.... ....+....+...........+.+++.++++|.+||+.||.+|||+.++++||||
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         210 LLKIFRIMGTPTESTWPGIS-QLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             HHHHHHHhCCCChhhHHHHh-cCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            88888888777765544332 1111112222222223333445678899999999999999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=2.9e-39  Score=278.65  Aligned_cols=224  Identities=25%  Similarity=0.408  Sum_probs=168.1

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA-NVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~-gi~H~di~~~n   78 (280)
                      ++||||+++++++...     ...++||||++ |+|.+++...+.+++..+..++.|++.||.|||+. +++||||||+|
T Consensus        60 l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~N  134 (331)
T cd06649          60 CNSPYIVGFYGAFYSD-----GEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSN  134 (331)
T ss_pred             CCCCCCCeEEEEEEEC-----CEEEEEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhh
Confidence            5799999999999665     67999999998 59999998888899999999999999999999986 69999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023609           79 LLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  158 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  158 (280)
                      |+++.++.++|+|||++....... .....+++.|+|||++.+. .++.++|+||+||++|+|++|+.||.+.+..+...
T Consensus       135 il~~~~~~~kl~Dfg~~~~~~~~~-~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~  212 (331)
T cd06649         135 ILVNSRGEIKLCDFGVSGQLIDSM-ANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEA  212 (331)
T ss_pred             EEEcCCCcEEEccCcccccccccc-cccCCCCcCcCCHhHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            999999999999999987654332 2345688999999998544 48899999999999999999999998766544332


Q ss_pred             HHHHHhCCCCHHHHhHh-----------------------hHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcC
Q 023609          159 LLIELIGTPSEAELGFL-----------------------NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTF  215 (280)
Q Consensus       159 ~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  215 (280)
                      .+...............                       ............   .  .......+++++++||.+||+.
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~--~~~~~~~~~~~l~~li~~~L~~  287 (331)
T cd06649         213 IFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEP---P--PKLPNGVFTPDFQEFVNKCLIK  287 (331)
T ss_pred             HhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCC---C--cCCCCccccHHHHHHHHHHccC
Confidence            22111100000000000                       000000000000   0  0001124688999999999999


Q ss_pred             CCCCCCCHHHHhcCCCCCCCc
Q 023609          216 DPRQRITVEDALAHPYLGSLH  236 (280)
Q Consensus       216 dp~~R~t~~ell~h~~~~~~~  236 (280)
                      ||++|||+.++++||||+...
T Consensus       288 ~P~~Rpt~~ell~h~~~~~~~  308 (331)
T cd06649         288 NPAERADLKMLMNHTFIKRSE  308 (331)
T ss_pred             CcccCCCHHHHhcChHHhhcc
Confidence            999999999999999998753

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=1.8e-39  Score=279.18  Aligned_cols=199  Identities=24%  Similarity=0.474  Sum_probs=168.1

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++.+...     ...|+||||++ |+|.+++...+.+++..++.++.||+.||+|||++|++||||||+||
T Consensus        53 ~~h~~Iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Ni  127 (325)
T cd05602          53 VKHPFLVGLHFSFQTA-----DKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENI  127 (325)
T ss_pred             CCCCCCCceeEEEEcC-----CeEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHe
Confidence            4799999999999665     67999999998 59999998888899999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccC-CCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSE-TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  158 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.++.++|+|||++..... ........+++.|+|||++.+ ..++.++||||+||++|+|++|..||.+.+..+...
T Consensus       128 li~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~  206 (325)
T cd05602         128 LLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYD  206 (325)
T ss_pred             EECCCCCEEEccCCCCcccccCCCCcccccCCccccCHHHHcC-CCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHH
Confidence            999999999999999875322 222345578999999998854 457889999999999999999999998877665544


Q ss_pred             HHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHH----HHhcCCCCCC
Q 023609          159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVE----DALAHPYLGS  234 (280)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~----ell~h~~~~~  234 (280)
                      .+....                              ....+.++..+.++|++||+.||.+|+++.    ++++|+||..
T Consensus       207 ~i~~~~------------------------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~  256 (325)
T cd05602         207 NILNKP------------------------------LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSP  256 (325)
T ss_pred             HHHhCC------------------------------cCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCC
Confidence            443210                              012246788999999999999999999876    8999999976


Q ss_pred             C
Q 023609          235 L  235 (280)
Q Consensus       235 ~  235 (280)
                      .
T Consensus       257 ~  257 (325)
T cd05602         257 I  257 (325)
T ss_pred             C
Confidence            4

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-38  Score=268.45  Aligned_cols=226  Identities=41%  Similarity=0.807  Sum_probs=184.4

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ--ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~--~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      ++||||+++++++.+.     ...|++|||++++|.+++....  .+++..+..++.|++.||+|||+.|++|+||+|+|
T Consensus        55 l~~~~iv~~~~~~~~~-----~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~n  129 (283)
T cd07835          55 LNHPNIVRLLDVVHSE-----NKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQN  129 (283)
T ss_pred             cCCCCccCHhheeccC-----CeEEEEEeccCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHH
Confidence            5799999999999765     6799999999999999997665  69999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCCC-ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 023609           79 LLLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL  157 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  157 (280)
                      |+++.++.++|+|||.+....... ......++..|+|||.+.+...++.++|+||+|+++|+|++|.+||.+.+.....
T Consensus       130 il~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~  209 (283)
T cd07835         130 LLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQL  209 (283)
T ss_pred             EEEcCCCcEEEeecccccccCCCccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            999999999999999987543321 1223355788999998765555788999999999999999999999988888888


Q ss_pred             HHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 023609          158 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  232 (280)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~  232 (280)
                      ..+.+..+.+....+..... ...+....+...........+.++.++.++|.+||+.||.+|||+.+++.||||
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         210 FRIFRTLGTPDEDVWPGVTS-LPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             HHHHHHhCCCChHHhhhhhh-chhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence            88888777777654432211 112222333333334445566888999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-39  Score=283.49  Aligned_cols=202  Identities=27%  Similarity=0.500  Sum_probs=168.5

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++.+.     ...|+||||+. ++|.+++.+.+.+++..++.++.||+.||+|||+.|++||||||+||
T Consensus        58 ~~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NI  132 (350)
T cd05573          58 ADSPWIVKLYYSFQDE-----EHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNI  132 (350)
T ss_pred             cCCCCccchhhheecC-----CeEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHe
Confidence            4799999999998665     67999999997 69999998888899999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCC------------------------------ccccceeccccccchhccCCCCCCcch
Q 023609           80 LLNANCDLKICDFGLARVTSETD------------------------------FMTEYVVTRWYRAPELLLNSSDYTAAI  129 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~  129 (280)
                      +++.++.++|+|||++.......                              ......+++.|+|||++.+. .++.++
T Consensus       133 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~  211 (350)
T cd05573         133 LIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGT-PYGLEC  211 (350)
T ss_pred             EECCCCCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCC-CCCCce
Confidence            99999999999999987654332                              22345689999999998654 588999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHH
Q 023609          130 DVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLV  209 (280)
Q Consensus       130 DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  209 (280)
                      ||||+||++|+|++|+.||.+.+.......+........                          ....+.+++++++||
T Consensus       212 DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~--------------------------~p~~~~~~~~~~~li  265 (350)
T cd05573         212 DWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESLR--------------------------FPPDPPVSPEAIDLI  265 (350)
T ss_pred             eeEecchhhhhhccCCCCCCCCCHHHHHHHHhccCCccc--------------------------CCCCCCCCHHHHHHH
Confidence            999999999999999999988776555554433111000                          001123688999999


Q ss_pred             HHhhcCCCCCCCC-HHHHhcCCCCCCC
Q 023609          210 EKMLTFDPRQRIT-VEDALAHPYLGSL  235 (280)
Q Consensus       210 ~~~L~~dp~~R~t-~~ell~h~~~~~~  235 (280)
                      .+||. ||.+|++ +.++++||||++.
T Consensus       266 ~~ll~-dp~~R~~s~~~ll~hp~~~~~  291 (350)
T cd05573         266 CRLLC-DPEDRLGSFEEIKSHPFFKGI  291 (350)
T ss_pred             HHHcc-ChhhcCCCHHHHhcCCCcCCC
Confidence            99998 9999999 9999999999875

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=8.9e-39  Score=269.21  Aligned_cols=227  Identities=45%  Similarity=0.860  Sum_probs=188.8

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++...     ...++|+||++++|.+++... ..+++..+..++.|++.||.+||+.|++|+||+|+||
T Consensus        55 l~~~~i~~~~~~~~~~-----~~~~~v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~ni  129 (283)
T cd05118          55 LNHPNIIKLLDVFRHK-----GDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENL  129 (283)
T ss_pred             hcCCCcchHHHhhccC-----CCEEEEEeccCCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHE
Confidence            4799999999998765     679999999999999988763 5799999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCC-ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  158 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.++.++|+|||.+....... ......++..|+|||.+.+....+.++|+||+|+++++|++|..||.+.+..+...
T Consensus       130 li~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~  209 (283)
T cd05118         130 LINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLF  209 (283)
T ss_pred             EECCCCcEEEeeeeeeEecCCCcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            99999999999999987665443 22334567889999998665467899999999999999999999999998888888


Q ss_pred             HHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 023609          159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  232 (280)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~  232 (280)
                      .+....+.+....+..............+...........+.++.+++++|.+||++||.+||++.+++.||||
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         210 KIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             HHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence            88888888776655544443333333333333334445556789999999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-39  Score=285.06  Aligned_cols=202  Identities=24%  Similarity=0.429  Sum_probs=163.5

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++.++     ...|+||||++ |+|.+++...+.+++..++.++.|++.||+|||+.||+||||||+||
T Consensus        58 l~hp~iv~~~~~~~~~-----~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NI  132 (377)
T cd05629          58 SDSPWVVSLYYSFQDA-----QYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNI  132 (377)
T ss_pred             CCCCCcceEEEEEEcC-----CeeEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHE
Confidence            5799999999999765     67999999996 69999998888899999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCC------------------------------------------------ccccceecc
Q 023609           80 LLNANCDLKICDFGLARVTSETD------------------------------------------------FMTEYVVTR  111 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~------------------------------------------------~~~~~~~~~  111 (280)
                      +++.++.++|+|||+++......                                                ......||+
T Consensus       133 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  212 (377)
T cd05629         133 LIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTP  212 (377)
T ss_pred             EECCCCCEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCc
Confidence            99999999999999885211000                                                001246899


Q ss_pred             ccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCcccc
Q 023609          112 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQR  191 (280)
Q Consensus       112 ~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (280)
                      .|+|||++.+. .++.++||||+||++|+|++|.+||.+.+..+....+........                       
T Consensus       213 ~y~aPE~~~~~-~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~-----------------------  268 (377)
T cd05629         213 DYIAPEIFLQQ-GYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLY-----------------------  268 (377)
T ss_pred             cccCHHHHccC-CCCCceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccC-----------------------
Confidence            99999998544 478999999999999999999999988776655554432110000                       


Q ss_pred             ccccccCCCCChHHHHHHHHhhcCCCCCC---CCHHHHhcCCCCCCC
Q 023609          192 QSFTEKFPNVHPSAIDLVEKMLTFDPRQR---ITVEDALAHPYLGSL  235 (280)
Q Consensus       192 ~~~~~~~~~~~~~~~~li~~~L~~dp~~R---~t~~ell~h~~~~~~  235 (280)
                        + .....++.++++||.+||. +|.+|   +|+.++++||||.+.
T Consensus       269 --~-p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~  311 (377)
T cd05629         269 --F-PDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGV  311 (377)
T ss_pred             --C-CCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence              0 0012468899999999998 77765   599999999999865

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=6.3e-39  Score=270.27  Aligned_cols=204  Identities=25%  Similarity=0.438  Sum_probs=163.0

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIR----SNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK   75 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~----~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~   75 (280)
                      ++||||+++.+++...     ...|+||||++ |+|.+.+.    .+..+++..++.++.||+.||+|||+.|++|||||
T Consensus        50 l~~~~i~~~~~~~~~~-----~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlk  124 (280)
T cd05608          50 VHSRFIVSLAYAFQTK-----TDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLK  124 (280)
T ss_pred             CCCCcEeeeeEEEcCC-----CeEEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence            5899999999998655     67999999997 68987774    33569999999999999999999999999999999


Q ss_pred             CCcEEEccCCCEEEeeccceeeccCCC-ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH
Q 023609           76 PSNLLLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHV  154 (280)
Q Consensus        76 ~~nili~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  154 (280)
                      |+||+++.++.++|+|||.+....... ......+++.|+|||.+.+. .++.++|+||+||++|+|++|..||.+....
T Consensus       125 p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~~g~~pf~~~~~~  203 (280)
T cd05608         125 PENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGE-EYDFSVDYFALGVTLYEMIAARGPFRARGEK  203 (280)
T ss_pred             HHHEEECCCCCEEEeeCccceecCCCCccccccCCCcCccCHHHhcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCcc
Confidence            999999999999999999987654332 22345688999999998654 5788999999999999999999999765432


Q ss_pred             HHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCC-----CHHHHhcC
Q 023609          155 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI-----TVEDALAH  229 (280)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~ell~h  229 (280)
                      .....+.......+                          ....+.+++++.+++.+||+.||++||     |++++++|
T Consensus       204 ~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h  257 (280)
T cd05608         204 VENKELKQRILNDS--------------------------VTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTH  257 (280)
T ss_pred             hhHHHHHHhhcccC--------------------------CCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcC
Confidence            22111111110000                          011135788999999999999999999     88999999


Q ss_pred             CCCCCCc
Q 023609          230 PYLGSLH  236 (280)
Q Consensus       230 ~~~~~~~  236 (280)
                      |||++..
T Consensus       258 ~~~~~~~  264 (280)
T cd05608         258 PLFRDLN  264 (280)
T ss_pred             hhhhcCC
Confidence            9998853

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=3.1e-39  Score=277.30  Aligned_cols=199  Identities=23%  Similarity=0.459  Sum_probs=165.7

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++.+...     ...|+||||++ |+|.+.+...+.+++..++.++.||+.||+|||+.||+||||||+||
T Consensus        53 ~~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NI  127 (321)
T cd05603          53 LKHPFLVGLHYSFQTA-----EKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENI  127 (321)
T ss_pred             CCCCCccceeeEEEcC-----CEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHe
Confidence            5799999999998665     67999999997 59999998888899999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccC-CCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSE-TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  158 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.+|.++|+|||++..... ........+++.|+|||.+.+ ..++.++|+||+||++|+|++|..||.+.+......
T Consensus       128 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~  206 (321)
T cd05603         128 LLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRK-EPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYD  206 (321)
T ss_pred             EECCCCCEEEccCCCCccCCCCCCccccccCCcccCCHHHhcC-CCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHH
Confidence            999999999999999875322 222344578999999998854 457889999999999999999999998876555443


Q ss_pred             HHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCH----HHHhcCCCCCC
Q 023609          159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV----EDALAHPYLGS  234 (280)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~----~ell~h~~~~~  234 (280)
                      .+...   +                           ...-+..+.++.++|.+||+.||.+|+++    .++++|+||..
T Consensus       207 ~i~~~---~---------------------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~  256 (321)
T cd05603         207 NILHK---P---------------------------LQLPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSP  256 (321)
T ss_pred             HHhcC---C---------------------------CCCCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCC
Confidence            33211   0                           01113567889999999999999999976    49999999986


Q ss_pred             C
Q 023609          235 L  235 (280)
Q Consensus       235 ~  235 (280)
                      +
T Consensus       257 ~  257 (321)
T cd05603         257 I  257 (321)
T ss_pred             C
Confidence            5

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=4e-39  Score=281.65  Aligned_cols=203  Identities=25%  Similarity=0.391  Sum_probs=166.7

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++.+.     ...|+||||++ |+|.+++.. ..+++..+..++.||+.||+|||+.||+||||||+||
T Consensus       100 ~~h~~iv~~~~~~~~~-----~~~~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NI  173 (370)
T cd05596         100 ANSEWIVQLHYAFQDD-----KYLYMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNM  173 (370)
T ss_pred             CCCCCcceEEEEEecC-----CEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHE
Confidence            4799999999998665     67999999997 699998865 4699999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCC--ccccceeccccccchhccCC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCChH
Q 023609           80 LLNANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNS---SDYTAAIDVWSVGCIFMELMDRKPLFPGRDHV  154 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  154 (280)
                      +++.++.++|+|||.+.......  ......+++.|+|||++.+.   ..++.++|+||+||++|+|++|..||.+.+..
T Consensus       174 Ll~~~~~~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~  253 (370)
T cd05596         174 LLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV  253 (370)
T ss_pred             EEcCCCCEEEEeccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHH
Confidence            99999999999999987654332  12345789999999988543   23678999999999999999999999887766


Q ss_pred             HHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCC--CCCHHHHhcCCCC
Q 023609          155 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQ--RITVEDALAHPYL  232 (280)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~--R~t~~ell~h~~~  232 (280)
                      .....+........                         + .....+|.++++||++||+.+|.+  |+|++++++||||
T Consensus       254 ~~~~~i~~~~~~~~-------------------------~-~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~  307 (370)
T cd05596         254 GTYSKIMDHKNSLT-------------------------F-PDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFF  307 (370)
T ss_pred             HHHHHHHcCCCcCC-------------------------C-CCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCccc
Confidence            55554432111000                         0 111257899999999999999988  9999999999999


Q ss_pred             CCC
Q 023609          233 GSL  235 (280)
Q Consensus       233 ~~~  235 (280)
                      ++.
T Consensus       308 ~~~  310 (370)
T cd05596         308 KND  310 (370)
T ss_pred             CCC
Confidence            863

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=2.4e-39  Score=284.38  Aligned_cols=202  Identities=25%  Similarity=0.464  Sum_probs=163.9

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++.+.+.     ...|+||||++ |+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||
T Consensus        58 ~~h~~iv~~~~~~~~~-----~~~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NI  132 (382)
T cd05625          58 ADNEWVVRLYYSFQDK-----DNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNI  132 (382)
T ss_pred             CCCCcCCeEEEEEEeC-----CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence            4799999999999765     67999999997 69999998888899999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCC------------------------------------------------Cccccceecc
Q 023609           80 LLNANCDLKICDFGLARVTSET------------------------------------------------DFMTEYVVTR  111 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~------------------------------------------------~~~~~~~~~~  111 (280)
                      +++.+|.++|+|||++......                                                .......||+
T Consensus       133 Ll~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  212 (382)
T cd05625         133 LIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTP  212 (382)
T ss_pred             EECCCCCEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCc
Confidence            9999999999999986421100                                                0011236889


Q ss_pred             ccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCcccc
Q 023609          112 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQR  191 (280)
Q Consensus       112 ~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (280)
                      .|+|||++.+. .++.++||||+||++|+|++|.+||.+.+..+....+........                       
T Consensus       213 ~Y~aPE~~~~~-~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~-----------------------  268 (382)
T cd05625         213 NYIAPEVLLRT-GYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLH-----------------------  268 (382)
T ss_pred             ccCCHHHhcCC-CCCCeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcC-----------------------
Confidence            99999998554 478999999999999999999999988776555444332111100                       


Q ss_pred             ccccccCCCCChHHHHHHHHhhcCCCCCCCC---HHHHhcCCCCCCC
Q 023609          192 QSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT---VEDALAHPYLGSL  235 (280)
Q Consensus       192 ~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t---~~ell~h~~~~~~  235 (280)
                         ......+++++.++|.+|+ .+|.+|++   ++++++||||+..
T Consensus       269 ---~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~  311 (382)
T cd05625         269 ---IPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTI  311 (382)
T ss_pred             ---CCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCc
Confidence               0111357889999999986 59999997   9999999999875

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=6.4e-39  Score=275.59  Aligned_cols=198  Identities=22%  Similarity=0.408  Sum_probs=167.5

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nil   80 (280)
                      +||+|+++++++...     ...|+||||++ |+|.+++...+.+++..+..++.||+.||+|||++|++||||||+||+
T Consensus        59 ~~~~i~~~~~~~~~~-----~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nil  133 (323)
T cd05616          59 KPPFLTQLHSCFQTM-----DRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVM  133 (323)
T ss_pred             CCCeEeeEEEEEecC-----CEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeE
Confidence            589999999998665     67999999997 699999988888999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccceeeccC-CCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023609           81 LNANCDLKICDFGLARVTSE-TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  159 (280)
Q Consensus        81 i~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      ++.++.++|+|||++..... ........|++.|+|||++.+ ..++.++|+||+||++|+|++|..||.+.+.......
T Consensus       134 l~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~  212 (323)
T cd05616         134 LDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS  212 (323)
T ss_pred             ECCCCcEEEccCCCceecCCCCCccccCCCChhhcCHHHhcC-CCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            99999999999999875432 222335578999999999854 4588999999999999999999999988776665555


Q ss_pred             HHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCH-----HHHhcCCCCCC
Q 023609          160 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV-----EDALAHPYLGS  234 (280)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~-----~ell~h~~~~~  234 (280)
                      +.......                              -..++.++.+++.+||+.||.+|+++     .++++||||..
T Consensus       213 i~~~~~~~------------------------------p~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~  262 (323)
T cd05616         213 IMEHNVAY------------------------------PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY  262 (323)
T ss_pred             HHhCCCCC------------------------------CCcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCC
Confidence            44321110                              12568899999999999999999984     89999999986


Q ss_pred             C
Q 023609          235 L  235 (280)
Q Consensus       235 ~  235 (280)
                      +
T Consensus       263 ~  263 (323)
T cd05616         263 I  263 (323)
T ss_pred             C
Confidence            4

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=4.2e-39  Score=277.36  Aligned_cols=202  Identities=24%  Similarity=0.475  Sum_probs=161.1

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nil   80 (280)
                      +||||+++++++...     ...|+||||++ |+|.+++...+.+++..++.++.||+.||+|||++|++||||||+||+
T Consensus        54 ~hp~iv~~~~~~~~~-----~~~~lv~E~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nil  128 (329)
T cd05618          54 NHPFLVGLHSCFQTE-----SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVL  128 (329)
T ss_pred             CCCcCCceeeEEEeC-----CEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEE
Confidence            799999999999665     67999999998 699999988888999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccceeecc-CCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH-----
Q 023609           81 LNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHV-----  154 (280)
Q Consensus        81 i~~~~~~~l~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-----  154 (280)
                      ++.++.++|+|||++.... .........+++.|+|||++.+. .++.++|+||+||++|+|++|..||......     
T Consensus       129 i~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~  207 (329)
T cd05618         129 LDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ  207 (329)
T ss_pred             ECCCCCEEEeeCCccccccCCCCccccccCCccccCHHHHcCC-CCCCccceecccHHHHHHhhCCCCCccCCCcCCccc
Confidence            9999999999999987532 22223345789999999998544 4788999999999999999999999532100     


Q ss_pred             HHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCC------HHHHhc
Q 023609          155 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT------VEDALA  228 (280)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t------~~ell~  228 (280)
                      .....+.+.+                  ....        ....+.++..+.++|++||+.||.+|||      +.++++
T Consensus       208 ~~~~~~~~~i------------------~~~~--------~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~  261 (329)
T cd05618         208 NTEDYLFQVI------------------LEKQ--------IRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQG  261 (329)
T ss_pred             ccHHHHHHHH------------------hcCC--------CCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhc
Confidence            0000000000                  0000        0111256788999999999999999998      479999


Q ss_pred             CCCCCCC
Q 023609          229 HPYLGSL  235 (280)
Q Consensus       229 h~~~~~~  235 (280)
                      ||||.+.
T Consensus       262 hp~f~~~  268 (329)
T cd05618         262 HPFFRNV  268 (329)
T ss_pred             CCCCCCC
Confidence            9999875

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=8e-39  Score=275.13  Aligned_cols=197  Identities=23%  Similarity=0.441  Sum_probs=164.7

Q ss_pred             CCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE
Q 023609            3 HENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   81 (280)
Q Consensus         3 HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nili   81 (280)
                      |++|+++++++...     ...|+||||++ |+|.+++...+.+++..+..++.||+.||+|||+.||+||||||+||++
T Consensus        60 ~~~i~~~~~~~~~~-----~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill  134 (324)
T cd05587          60 PPFLTQLHSCFQTM-----DRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML  134 (324)
T ss_pred             CCceeeeEEEEEcC-----CEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEE
Confidence            45688999988655     67999999997 6999999888889999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccceeecc-CCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 023609           82 NANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL  160 (280)
Q Consensus        82 ~~~~~~~l~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~  160 (280)
                      +.+|.++|+|||++.... .........+++.|+|||++.+. .++.++|+||+||++|+|++|..||.+.+..+....+
T Consensus       135 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i  213 (324)
T cd05587         135 DAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQ-PYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSI  213 (324)
T ss_pred             cCCCCEEEeecCcceecCCCCCceeeecCCccccChhhhcCC-CCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            999999999999986432 22223345689999999998544 4789999999999999999999999887766555544


Q ss_pred             HHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCH-----HHHhcCCCCCCC
Q 023609          161 IELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV-----EDALAHPYLGSL  235 (280)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~-----~ell~h~~~~~~  235 (280)
                      .....                              .....+++++.+++++||+.||.+|+++     .++++||||.+.
T Consensus       214 ~~~~~------------------------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~~  263 (324)
T cd05587         214 MEHNV------------------------------SYPKSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRRI  263 (324)
T ss_pred             HcCCC------------------------------CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence            32110                              0112578899999999999999999987     899999999875

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=2.8e-38  Score=268.05  Aligned_cols=230  Identities=37%  Similarity=0.739  Sum_probs=181.0

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCC
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN-----QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKP   76 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~-----~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~   76 (280)
                      +||||+++++++.....++....|+||||++++|.+++...     ..+++..++.++.||+.||.|||+.|++||||+|
T Consensus        59 ~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~  138 (295)
T cd07837          59 ESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKP  138 (295)
T ss_pred             CCCCccceeeeEeecCCCCCceEEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCh
Confidence            47999999999876543333458999999999999988642     3589999999999999999999999999999999


Q ss_pred             CcEEEcc-CCCEEEeeccceeeccCC-CccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH
Q 023609           77 SNLLLNA-NCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHV  154 (280)
Q Consensus        77 ~nili~~-~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  154 (280)
                      +||+++. ++.++|+|||.+...... .......+++.|+|||.+.+...++.++|+||+|+++|+|++|..||.+.+..
T Consensus       139 ~nil~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~  218 (295)
T cd07837         139 QNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSEL  218 (295)
T ss_pred             HHEEEecCCCeEEEeecccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHH
Confidence            9999998 899999999998754322 11223456788999998866555788999999999999999999999998888


Q ss_pred             HHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCC
Q 023609          155 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLG  233 (280)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~  233 (280)
                      .....+....+.+....+.........  ...+...........+.+++++.+||.+||..||.+|||+.+++.||||+
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         219 QQLLHIFKLLGTPTEQVWPGVSKLRDW--HEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             HHHHHHHHHhCCCChhhCcchhhccch--hhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence            888888887777665543222111100  01122222233445567899999999999999999999999999999995

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=2.6e-38  Score=266.84  Aligned_cols=227  Identities=32%  Similarity=0.694  Sum_probs=174.6

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++...     ...++||||+++ .|..++.....+++..++.++.||+.||+|||+.|++|+||+|+||
T Consensus        57 ~~h~~i~~~~~~~~~~-----~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~ni  131 (286)
T cd07847          57 LKHPNLVNLIEVFRRK-----RKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENI  131 (286)
T ss_pred             CCCCCEeeeeeEEeeC-----CEEEEEEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhE
Confidence            5799999999999765     678999999986 5555555666799999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCC-ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  158 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.++.++|+|||.+....... ......++..|+|||.+.+...++.++|+||+|+++++|++|.+||.+....+...
T Consensus       132 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~  211 (286)
T cd07847         132 LITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLY  211 (286)
T ss_pred             EEcCCCcEEECccccceecCCCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence            99999999999999998654432 22234567889999998665567889999999999999999999999888777666


Q ss_pred             HHHHHhCCCCHHHHhHhhHhHH-HHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 023609          159 LLIELIGTPSEAELGFLNENAK-KYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  232 (280)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~  232 (280)
                      .+.+..+............... .................++.++..+.+||.+||+.||++|||+.+++.||||
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         212 LIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             HHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence            6666555443321111110000 0000000011122334456788999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=7.8e-39  Score=288.34  Aligned_cols=200  Identities=26%  Similarity=0.412  Sum_probs=166.4

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS----NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK   75 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~----~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~   75 (280)
                      ++||||+++++++...     ...||||||+. |+|.+++..    ..++++.++..++.||+.||+|||+.||+|||||
T Consensus       122 l~Hpniv~~~~~~~~~-----~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlk  196 (478)
T PTZ00267        122 CDHFGIVKHFDDFKSD-----DKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLK  196 (478)
T ss_pred             CCCCCEeEEEEEEEEC-----CEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcC
Confidence            5899999999999665     67999999997 699887753    4569999999999999999999999999999999


Q ss_pred             CCcEEEccCCCEEEeeccceeeccCCC---ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 023609           76 PSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD  152 (280)
Q Consensus        76 ~~nili~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  152 (280)
                      |+||+++.++.++|+|||++.......   .....+||+.|+|||++.+ ..++.++||||+||++|+|++|..||.+.+
T Consensus       197 p~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~  275 (478)
T PTZ00267        197 SANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWER-KRYSKKADMWSLGVILYELLTLHRPFKGPS  275 (478)
T ss_pred             HHhEEECCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCC-CCCCcHHhHHHHHHHHHHHHhCCCCCCCCC
Confidence            999999999999999999998654332   2334568999999998854 458899999999999999999999998776


Q ss_pred             hHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 023609          153 HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  232 (280)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~  232 (280)
                      ..+.+..+......+                             ....++.+++++|.+||+.||++|||+.+++.|+|+
T Consensus       276 ~~~~~~~~~~~~~~~-----------------------------~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~  326 (478)
T PTZ00267        276 QREIMQQVLYGKYDP-----------------------------FPCPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFL  326 (478)
T ss_pred             HHHHHHHHHhCCCCC-----------------------------CCccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHH
Confidence            655544443211110                             012567889999999999999999999999999999


Q ss_pred             CCC
Q 023609          233 GSL  235 (280)
Q Consensus       233 ~~~  235 (280)
                      +..
T Consensus       327 ~~~  329 (478)
T PTZ00267        327 KYV  329 (478)
T ss_pred             HHH
Confidence            754

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=7.1e-39  Score=281.28  Aligned_cols=203  Identities=26%  Similarity=0.441  Sum_probs=162.3

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++.+.     ..+|+||||++ |+|.+++.+.+.+++..++.++.||+.||+|||+.||+||||||+||
T Consensus        58 l~h~~iv~l~~~~~~~-----~~~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Ni  132 (381)
T cd05626          58 ADNEWVVKLYYSFQDK-----DNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNI  132 (381)
T ss_pred             cCCCCeeeeEEEEecC-----CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHE
Confidence            5799999999999765     67999999997 69999998888899999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCC------------------------------------------------Cccccceecc
Q 023609           80 LLNANCDLKICDFGLARVTSET------------------------------------------------DFMTEYVVTR  111 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~------------------------------------------------~~~~~~~~~~  111 (280)
                      +++.++.++|+|||++......                                                .......||+
T Consensus       133 li~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~  212 (381)
T cd05626         133 LIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTP  212 (381)
T ss_pred             EECCCCCEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCc
Confidence            9999999999999986422100                                                0012346899


Q ss_pred             ccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCcccc
Q 023609          112 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQR  191 (280)
Q Consensus       112 ~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (280)
                      .|+|||.+.+. .++.++||||+||++|+|++|..||.+.+.......+........                       
T Consensus       213 ~Y~aPE~~~~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~-----------------------  268 (381)
T cd05626         213 NYIAPEVLLRK-GYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLH-----------------------  268 (381)
T ss_pred             cccCHHHHcCC-CCCCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccC-----------------------
Confidence            99999998554 478999999999999999999999987765544433321110000                       


Q ss_pred             ccccccCCCCChHHHHHHHHhhcC--CCCCCCCHHHHhcCCCCCCC
Q 023609          192 QSFTEKFPNVHPSAIDLVEKMLTF--DPRQRITVEDALAHPYLGSL  235 (280)
Q Consensus       192 ~~~~~~~~~~~~~~~~li~~~L~~--dp~~R~t~~ell~h~~~~~~  235 (280)
                         ......+++++++||.+||..  ++.+|+++.++++||||.++
T Consensus       269 ---~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~  311 (381)
T cd05626         269 ---IPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEV  311 (381)
T ss_pred             ---CCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCC
Confidence               001125788999999996654  45559999999999999875

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-38  Score=266.84  Aligned_cols=225  Identities=40%  Similarity=0.766  Sum_probs=184.9

Q ss_pred             CCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 023609            3 HENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ--ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   80 (280)
Q Consensus         3 HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~--~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nil   80 (280)
                      ||||+++++++...     ...|+||||++|+|.+.+..+.  .+++..+..++.|++.+|.|||++|++|+||+|+||+
T Consensus        57 h~~i~~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~  131 (283)
T cd07830          57 HPNIVKLKEVFREN-----DELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLL  131 (283)
T ss_pred             CCCchhHHHHhhcC-----CcEEEEEecCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEE
Confidence            99999999999764     6799999999999999998764  7899999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 023609           81 LNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL  160 (280)
Q Consensus        81 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~  160 (280)
                      ++.++.++|+|||.+.............++..|+|||.+......+.++|+||+|+++++|++|.+||.+.+..+....+
T Consensus       132 i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~  211 (283)
T cd07830         132 VSGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKI  211 (283)
T ss_pred             EcCCCCEEEeecccceeccCCCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHH
Confidence            99999999999999987654433344567888999998866656788999999999999999999999999988888888


Q ss_pred             HHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 023609          161 IELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  232 (280)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~  232 (280)
                      .+..+.+....+..............+..........++..+.+++++|++||+.||.+|||+.|++.||||
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         212 CSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             HHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence            888888776544332222211111222222222334455667899999999999999999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=2e-39  Score=279.48  Aligned_cols=203  Identities=22%  Similarity=0.434  Sum_probs=167.3

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      ++||||+++++++.+.     ...|+||||++ |+|.+++... +.+++..++.++.||+.||+|||+.||+||||||+|
T Consensus        58 ~~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~N  132 (330)
T cd05601          58 SNSPWIPQLQYAFQDK-----DNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPEN  132 (330)
T ss_pred             CCCCCCcceeeEEecC-----CeEEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHh
Confidence            4799999999998665     67999999996 6999999875 679999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCCCc--cccceeccccccchhccC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 023609           79 LLLNANCDLKICDFGLARVTSETDF--MTEYVVTRWYRAPELLLN-----SSDYTAAIDVWSVGCIFMELMDRKPLFPGR  151 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~-----~~~~~~~~DiwslG~il~~ll~g~~pf~~~  151 (280)
                      |+++.+|.++|+|||++........  .....+++.|+|||++..     ...++.++||||+||++|+|++|..||.+.
T Consensus       133 Ill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~  212 (330)
T cd05601         133 VLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEG  212 (330)
T ss_pred             eEECCCCCEEeccCCCCeECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCC
Confidence            9999999999999999976544322  223468899999998753     334678999999999999999999999877


Q ss_pred             ChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCC
Q 023609          152 DHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPY  231 (280)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~  231 (280)
                      ........+.......                         .+ ...+.+++++++||++||+ +|.+|||+.++++|||
T Consensus       213 ~~~~~~~~i~~~~~~~-------------------------~~-~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~  265 (330)
T cd05601         213 TSAKTYNNIMNFQRFL-------------------------KF-PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPF  265 (330)
T ss_pred             CHHHHHHHHHcCCCcc-------------------------CC-CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCC
Confidence            6655554443221000                         00 1123578899999999998 9999999999999999


Q ss_pred             CCCC
Q 023609          232 LGSL  235 (280)
Q Consensus       232 ~~~~  235 (280)
                      |...
T Consensus       266 ~~~~  269 (330)
T cd05601         266 FSKI  269 (330)
T ss_pred             cCCC
Confidence            9875

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-38  Score=266.84  Aligned_cols=226  Identities=41%  Similarity=0.794  Sum_probs=187.9

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++...     ...++|+|+++++|.+++.+. ..+++..+..++.|++.||++||+.|++|+||+|+||
T Consensus        55 ~~~~~i~~~~~~~~~~-----~~~~~v~e~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni  129 (282)
T cd07829          55 LKHPNIVKLLDVIHTE-----RKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNI  129 (282)
T ss_pred             cCCCCHHHHHhhhhcC-----CceEEEecCcCcCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheE
Confidence            4799999999999765     679999999999999999876 5799999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCC-ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  158 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.++.++|+|||.+....... .......+..|+|||.+.+...++.++|+||+||+++++++|.+||.+....+...
T Consensus       130 ~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~  209 (282)
T cd07829         130 LINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLF  209 (282)
T ss_pred             EEcCCCCEEEecCCcccccCCCccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHH
Confidence            99999999999999987654432 22233456779999988665467899999999999999999999999999888889


Q ss_pred             HHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 023609          159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  232 (280)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~  232 (280)
                      .+.+..+.+....+....... .+....+..........++.++..+.++|++||+.||++||++.++++||||
T Consensus       210 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         210 KIFQILGTPTEESWPGVTKLP-DYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             HHHHHhCCCcHHHHHhhcccc-cccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence            898888888776554433222 1222333333334445566778999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=2.6e-38  Score=273.12  Aligned_cols=230  Identities=37%  Similarity=0.675  Sum_probs=185.6

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   80 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nil   80 (280)
                      ++||||+++++++...     ...++||||++|+|.+++.....+++..+..++.|++.||++||+.|++|+||+|+||+
T Consensus        77 l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nil  151 (335)
T PTZ00024         77 IKHENIMGLVDVYVEG-----DFINLVMDIMASDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIF  151 (335)
T ss_pred             CCCcceeeeeEEEecC-----CcEEEEEeccccCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeE
Confidence            5799999999998655     67899999999999999988888999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccceeeccCC---------------CccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCC
Q 023609           81 LNANCDLKICDFGLARVTSET---------------DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK  145 (280)
Q Consensus        81 i~~~~~~~l~dfg~~~~~~~~---------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~  145 (280)
                      ++.++.++|+|||.+...+..               .......++..|+|||.+.+...++.++|+||+||++++|++|.
T Consensus       152 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~  231 (335)
T PTZ00024        152 INSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK  231 (335)
T ss_pred             ECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCC
Confidence            999999999999998765411               11122345778999998866555788999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHH
Q 023609          146 PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVED  225 (280)
Q Consensus       146 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e  225 (280)
                      +||.+.+....+..+....+.+....+.......  .................+..+.++.++|.+||+.+|.+|||+++
T Consensus       232 ~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~  309 (335)
T PTZ00024        232 PLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLP--LYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKE  309 (335)
T ss_pred             CCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcc--cccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHH
Confidence            9999999888888888888877665332211000  00011111222333445677889999999999999999999999


Q ss_pred             HhcCCCCCCCcC
Q 023609          226 ALAHPYLGSLHD  237 (280)
Q Consensus       226 ll~h~~~~~~~~  237 (280)
                      ++.||||++...
T Consensus       310 ~l~~~~~~~~~~  321 (335)
T PTZ00024        310 ALKHEYFKSDPL  321 (335)
T ss_pred             HhcCcccCCCCC
Confidence            999999997643

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=2.2e-38  Score=266.57  Aligned_cols=204  Identities=22%  Similarity=0.360  Sum_probs=162.8

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ--ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS   77 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~--~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~   77 (280)
                      ++||||+++++.+...     ...|+||||++ ++|.+++...+  .+++..+..++.|++.||+|||+.|++||||||+
T Consensus        50 l~hp~i~~~~~~~~~~-----~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~  124 (277)
T cd05607          50 VNSPFIVNLAYAFESK-----THLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPE  124 (277)
T ss_pred             cCCCcEEEEEEEEecC-----CeEEEEEecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChH
Confidence            5899999999999655     67999999997 69988886433  5899999999999999999999999999999999


Q ss_pred             cEEEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 023609           78 NLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL  157 (280)
Q Consensus        78 nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  157 (280)
                      ||+++.++.++|+|||++.............++..|+|||++.+.. ++.++|+||+||++|+|++|..||.+.......
T Consensus       125 Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~  203 (277)
T cd05607         125 NVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEP-YSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK  203 (277)
T ss_pred             hEEEcCCCCEEEeeceeeeecCCCceeeccCCCCCccCHHHHccCC-CCCchhHHHHHHHHHHHHhCCCCCCCCcchhhH
Confidence            9999999999999999987765443334456888999999986554 889999999999999999999999764322111


Q ss_pred             HHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCH----HHHhcCCCCC
Q 023609          158 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV----EDALAHPYLG  233 (280)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~----~ell~h~~~~  233 (280)
                      ..+......                         .........++.+++++|++||+.||.+||++    .+++.||||+
T Consensus       204 ~~~~~~~~~-------------------------~~~~~~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~  258 (277)
T cd05607         204 EELKRRTLE-------------------------DEVKFEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFK  258 (277)
T ss_pred             HHHHHHhhc-------------------------cccccccccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhc
Confidence            111110000                         00001113578899999999999999999999    6788999998


Q ss_pred             CC
Q 023609          234 SL  235 (280)
Q Consensus       234 ~~  235 (280)
                      .+
T Consensus       259 ~~  260 (277)
T cd05607         259 TI  260 (277)
T ss_pred             CC
Confidence            85

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=3.6e-38  Score=267.34  Aligned_cols=231  Identities=41%  Similarity=0.783  Sum_probs=181.6

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHcCCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQA--LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~--l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      ++||||+++++++...     ...|+||||++++|.+++.....  +++..++.++.||+.||+|||++|++|+||+|+|
T Consensus        58 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~n  132 (294)
T PLN00009         58 MQHGNIVRLQDVVHSE-----KRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQN  132 (294)
T ss_pred             ccCCCEeeEEEEEecC-----CeEEEEEecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcce
Confidence            5799999999999765     67999999999999999875543  5888999999999999999999999999999999


Q ss_pred             EEEcc-CCCEEEeeccceeeccCC-CccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023609           79 LLLNA-NCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ  156 (280)
Q Consensus        79 ili~~-~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  156 (280)
                      |+++. ++.++|+|||.+...... .......+++.|+|||.+.+...++.++|+||+||++|+|++|.+||.+.+..+.
T Consensus       133 ill~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~  212 (294)
T PLN00009        133 LLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDE  212 (294)
T ss_pred             EEEECCCCEEEEcccccccccCCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            99985 567999999998754332 1223345678899999886655678899999999999999999999998888888


Q ss_pred             HHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCc
Q 023609          157 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  236 (280)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~  236 (280)
                      ..++....+.+....+...... ..+....+...........+.+++++.+++.+||+.+|++||++.++++||||.++.
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~~  291 (294)
T PLN00009        213 LFKIFRILGTPNEETWPGVTSL-PDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDLG  291 (294)
T ss_pred             HHHHHHHhCCCChhhccccccc-hhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHHh
Confidence            8888777777765543211110 011111111122222233467889999999999999999999999999999999875


Q ss_pred             C
Q 023609          237 D  237 (280)
Q Consensus       237 ~  237 (280)
                      .
T Consensus       292 ~  292 (294)
T PLN00009        292 D  292 (294)
T ss_pred             c
Confidence            4

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=7.2e-39  Score=279.83  Aligned_cols=203  Identities=25%  Similarity=0.370  Sum_probs=165.1

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++.+...     ...|+||||++ |+|.+++.. ..+++..+..++.||+.||+|||++||+||||||+||
T Consensus       100 ~~hp~iv~~~~~~~~~-----~~~~lv~Ey~~gg~L~~~l~~-~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NI  173 (370)
T cd05621         100 ANSPWVVQLFCAFQDD-----KYLYMVMEYMPGGDLVNLMSN-YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNM  173 (370)
T ss_pred             CCCCCEeeEEEEEEcC-----CEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHE
Confidence            4799999999999765     67999999997 699999865 4689999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCC--ccccceeccccccchhccCCC---CCCcchhHHHHHHHHHHHHhCCCCCCCCChH
Q 023609           80 LLNANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNSS---DYTAAIDVWSVGCIFMELMDRKPLFPGRDHV  154 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  154 (280)
                      +++.++.++|+|||++.......  ......+|+.|+|||++.+..   .++.++|+||+||++|+|++|..||.+.+..
T Consensus       174 Ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~  253 (370)
T cd05621         174 LLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLV  253 (370)
T ss_pred             EECCCCCEEEEecccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHH
Confidence            99999999999999998654332  123557899999999985432   3678999999999999999999999887766


Q ss_pred             HHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCC--CCCHHHHhcCCCC
Q 023609          155 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQ--RITVEDALAHPYL  232 (280)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~--R~t~~ell~h~~~  232 (280)
                      .....+.........                          .....++..+++++.+||+.++.+  |+|+.++++||||
T Consensus       254 ~~~~~i~~~~~~~~~--------------------------p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~  307 (370)
T cd05621         254 GTYSKIMDHKNSLNF--------------------------PEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFF  307 (370)
T ss_pred             HHHHHHHhCCcccCC--------------------------CCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcCccc
Confidence            655554432111100                          001246888999999999866544  8999999999999


Q ss_pred             CCC
Q 023609          233 GSL  235 (280)
Q Consensus       233 ~~~  235 (280)
                      +..
T Consensus       308 ~~~  310 (370)
T cd05621         308 KND  310 (370)
T ss_pred             CCC
Confidence            863

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=5.4e-39  Score=280.03  Aligned_cols=202  Identities=28%  Similarity=0.470  Sum_probs=164.5

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++.+.+.     ..+|+||||++ |+|.+++.+++.+++..++.++.|++.||+|||+.||+||||||+||
T Consensus        58 l~~~~iv~~~~~~~~~-----~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NI  132 (360)
T cd05627          58 ADGAWVVKMFYSFQDK-----RNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNL  132 (360)
T ss_pred             CCCCCEeeEEEEEEcC-----CEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHE
Confidence            4799999999999665     67999999997 69999998888899999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCC------------------------------------ccccceeccccccchhccCCC
Q 023609           80 LLNANCDLKICDFGLARVTSETD------------------------------------FMTEYVVTRWYRAPELLLNSS  123 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~------------------------------------~~~~~~~~~~y~aPE~~~~~~  123 (280)
                      +++.+|.++|+|||++.......                                    .....+||+.|+|||++.+. 
T Consensus       133 li~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~-  211 (360)
T cd05627         133 LLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQT-  211 (360)
T ss_pred             EECCCCCEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCC-
Confidence            99999999999999876432110                                    01134689999999998554 


Q ss_pred             CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCCh
Q 023609          124 DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHP  203 (280)
Q Consensus       124 ~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  203 (280)
                      .++.++|+||+||++|+|++|..||.+.+.......+.......                         .+.. ...+++
T Consensus       212 ~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~~~i~~~~~~~-------------------------~~p~-~~~~s~  265 (360)
T cd05627         212 GYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETL-------------------------VFPP-EVPISE  265 (360)
T ss_pred             CCCCcceeccccceeeecccCCCCCCCCCHHHHHHHHHcCCCce-------------------------ecCC-CCCCCH
Confidence            47899999999999999999999998877665555443211000                         0000 113688


Q ss_pred             HHHHHHHHhhcCCCCCCC---CHHHHhcCCCCCCC
Q 023609          204 SAIDLVEKMLTFDPRQRI---TVEDALAHPYLGSL  235 (280)
Q Consensus       204 ~~~~li~~~L~~dp~~R~---t~~ell~h~~~~~~  235 (280)
                      +++++|.+|+. ||.+|+   ++.++++||||++.
T Consensus       266 ~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~~  299 (360)
T cd05627         266 KAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEGV  299 (360)
T ss_pred             HHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCCC
Confidence            99999999874 999998   47999999999975

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=4.5e-39  Score=282.13  Aligned_cols=202  Identities=24%  Similarity=0.434  Sum_probs=163.2

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++.+...     +.+|+||||++ |+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||
T Consensus        58 l~h~~iv~~~~~~~~~-----~~~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Ni  132 (376)
T cd05598          58 ADNEWVVKLYYSFQDK-----DNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNI  132 (376)
T ss_pred             CCCCCcceEEEEEEcC-----CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHE
Confidence            5799999999999765     67999999997 69999999888899999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCC--------------------------------------------Cccccceecccccc
Q 023609           80 LLNANCDLKICDFGLARVTSET--------------------------------------------DFMTEYVVTRWYRA  115 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~--------------------------------------------~~~~~~~~~~~y~a  115 (280)
                      +++.++.++|+|||++......                                            .......||+.|+|
T Consensus       133 ll~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a  212 (376)
T cd05598         133 LIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIA  212 (376)
T ss_pred             EECCCCCEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccC
Confidence            9999999999999987421100                                            00112368999999


Q ss_pred             chhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCcccccccc
Q 023609          116 PELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFT  195 (280)
Q Consensus       116 PE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (280)
                      ||++.+. .++.++||||+||++|+|++|..||.+.+..+....+.......                          ..
T Consensus       213 PE~~~~~-~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~--------------------------~~  265 (376)
T cd05598         213 PEVLLRT-GYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTL--------------------------HI  265 (376)
T ss_pred             HHHHcCC-CCCcceeeeeccceeeehhhCCCCCCCCCHHHHHHHHhccCccc--------------------------cC
Confidence            9998544 47899999999999999999999998876554433322110000                          00


Q ss_pred             ccCCCCChHHHHHHHHhhcCCCCCCC---CHHHHhcCCCCCCC
Q 023609          196 EKFPNVHPSAIDLVEKMLTFDPRQRI---TVEDALAHPYLGSL  235 (280)
Q Consensus       196 ~~~~~~~~~~~~li~~~L~~dp~~R~---t~~ell~h~~~~~~  235 (280)
                      .....+++++.++|.+|+ .+|.+|+   |+.++++||||+.+
T Consensus       266 ~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~  307 (376)
T cd05598         266 PSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGI  307 (376)
T ss_pred             CCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCC
Confidence            111357889999999977 5999999   99999999999875

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=2.3e-38  Score=272.61  Aligned_cols=202  Identities=23%  Similarity=0.452  Sum_probs=161.8

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nil   80 (280)
                      +||||+++++.+...     ..+|+||||++ |+|.+++...+.+++..++.++.||+.||+|||++|++||||||+||+
T Consensus        54 ~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nil  128 (327)
T cd05617          54 SNPFLVGLHSCFQTT-----SRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVL  128 (327)
T ss_pred             CCCCEeeEEEEEEeC-----CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEE
Confidence            699999999998665     67999999997 699999988888999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccceeecc-CCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH---H
Q 023609           81 LNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVH---Q  156 (280)
Q Consensus        81 i~~~~~~~l~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~  156 (280)
                      ++.++.++|+|||++.... .........+++.|+|||.+.+ ..++.++|+||+||++|+|++|..||.......   .
T Consensus       129 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~  207 (327)
T cd05617         129 LDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRG-EEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNT  207 (327)
T ss_pred             EeCCCCEEEeccccceeccCCCCceecccCCcccCCHHHHCC-CCCCchheeehhHHHHHHHHhCCCCCCccCCCccccc
Confidence            9999999999999987532 2223345678999999999854 457899999999999999999999996432110   0


Q ss_pred             HHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCC------HHHHhcCC
Q 023609          157 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT------VEDALAHP  230 (280)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t------~~ell~h~  230 (280)
                      ...+.+..                   ...+       ...-..++..+.++|++||+.||.+|++      ++++++||
T Consensus       208 ~~~~~~~~-------------------~~~~-------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~  261 (327)
T cd05617         208 EDYLFQVI-------------------LEKP-------IRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHT  261 (327)
T ss_pred             HHHHHHHH-------------------HhCC-------CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCC
Confidence            00000000                   0000       0111246788999999999999999998      57999999


Q ss_pred             CCCCC
Q 023609          231 YLGSL  235 (280)
Q Consensus       231 ~~~~~  235 (280)
                      ||.+.
T Consensus       262 ~f~~~  266 (327)
T cd05617         262 FFRSI  266 (327)
T ss_pred             CCCCC
Confidence            99875

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-38  Score=266.27  Aligned_cols=203  Identities=27%  Similarity=0.439  Sum_probs=165.7

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS   77 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~   77 (280)
                      ++||||+++++.+...     ...++||||++ |+|.+++...  ..+++..+..++.|++.||+|||+.|++||||+|+
T Consensus        57 l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~  131 (285)
T cd05605          57 VNSRFVVSLAYAYETK-----DALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPE  131 (285)
T ss_pred             cCCCCEeeeeeeecCC-----CeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHH
Confidence            5799999999998665     67999999997 6898887643  46999999999999999999999999999999999


Q ss_pred             cEEEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 023609           78 NLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL  157 (280)
Q Consensus        78 nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  157 (280)
                      ||+++.++.++|+|||++.............+++.|+|||.+.+ ..++.++|+||+||++|+|++|..||.+.......
T Consensus       132 Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~  210 (285)
T cd05605         132 NILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKN-ERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKR  210 (285)
T ss_pred             HEEECCCCCEEEeeCCCceecCCCCccccccCCCCccCcHHhcC-CCCCccccchhHHHHHHHHHHCCCCCCCCchhhHH
Confidence            99999999999999999887654433345578899999999854 44788999999999999999999999876543333


Q ss_pred             HHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCC-----CHHHHhcCCCC
Q 023609          158 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI-----TVEDALAHPYL  232 (280)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~ell~h~~~  232 (280)
                      ..+...+....                          ....+.++..+.+||.+||..||.+||     +++++++||||
T Consensus       211 ~~~~~~~~~~~--------------------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~  264 (285)
T cd05605         211 EEVERRVKEDQ--------------------------EEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFF  264 (285)
T ss_pred             HHHHHHhhhcc--------------------------cccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCc
Confidence            22222111100                          011125788899999999999999999     89999999999


Q ss_pred             CCC
Q 023609          233 GSL  235 (280)
Q Consensus       233 ~~~  235 (280)
                      ...
T Consensus       265 ~~~  267 (285)
T cd05605         265 RTA  267 (285)
T ss_pred             cCC
Confidence            874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6e-38  Score=279.47  Aligned_cols=227  Identities=24%  Similarity=0.352  Sum_probs=164.6

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      |+||||+++++++...     ...++||+++.++|.+++... +.+++..++.++.||+.||+|||++||+||||||+||
T Consensus       217 L~HpnIv~l~~~~~~~-----~~~~lv~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NI  291 (461)
T PHA03211        217 LSHPAVLALLDVRVVG-----GLTCLVLPKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENV  291 (461)
T ss_pred             CCCCCCCcEEEEEEEC-----CEEEEEEEccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHE
Confidence            6899999999998665     678999999999999998764 4699999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCC---ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCC-CCCCC---
Q 023609           80 LLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL-FPGRD---  152 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p-f~~~~---  152 (280)
                      +++.++.++|+|||+++......   ......+|..|+|||++.+. .++.++|||||||++|+|++|..+ |....   
T Consensus       292 Ll~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~  370 (461)
T PHA03211        292 LVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGD-PYTPSVDIWSAGLVIFEAAVHTASLFSASRGDE  370 (461)
T ss_pred             EECCCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcCC-CCCchHHHHHHHHHHHHHHHcCCCcccCCcccc
Confidence            99999999999999987643321   12234689999999998554 478999999999999999987654 33221   


Q ss_pred             ---hHHHHHHHHHHhCCCCHHHHhHh-hHhHHHHh-----hhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCH
Q 023609          153 ---HVHQLRLLIELIGTPSEAELGFL-NENAKKYI-----CQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV  223 (280)
Q Consensus       153 ---~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~  223 (280)
                         ....+..+............... ......+.     ...+......+.. +..++.++++||.+||+.||.+|||+
T Consensus       371 ~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~dli~~mL~~DP~~RPsa  449 (461)
T PHA03211        371 RRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTR-YYKLDLDVEYLVCRALTFDGARRPSA  449 (461)
T ss_pred             cCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhh-hccccchHHHHHHHHcccChhhCcCH
Confidence               12333333333222111100000 00000110     0111111111211 22567789999999999999999999


Q ss_pred             HHHhcCCCCCC
Q 023609          224 EDALAHPYLGS  234 (280)
Q Consensus       224 ~ell~h~~~~~  234 (280)
                      .|+|+||||++
T Consensus       450 ~elL~hp~f~~  460 (461)
T PHA03211        450 AELLRLPLFQS  460 (461)
T ss_pred             HHHhhCcccCC
Confidence            99999999975

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-38  Score=278.00  Aligned_cols=191  Identities=30%  Similarity=0.537  Sum_probs=163.8

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nil   80 (280)
                      +||||+++++.+.+.     .+.|+|||++.| .+.+.+...+.+. .++..|+.||+.|+.|||++|++|||+||+||+
T Consensus       374 ~h~niv~~~~v~~~~-----~~~~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL  447 (612)
T KOG0603|consen  374 DHPNIVKSHDVYEDG-----KEIYLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNIL  447 (612)
T ss_pred             CCCcceeecceecCC-----ceeeeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhhee
Confidence            699999999999665     789999999984 7777777766666 888899999999999999999999999999999


Q ss_pred             E-ccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023609           81 L-NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  159 (280)
Q Consensus        81 i-~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      + +..|+++|+|||.+......  ....+.|..|.|||++. ...++.++|+||||+++|+|++|+.||......   ..
T Consensus       448 ~~~~~g~lrltyFG~a~~~~~~--~~tp~~t~~y~APEvl~-~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~---~e  521 (612)
T KOG0603|consen  448 LDGSAGHLRLTYFGFWSELERS--CDTPALTLQYVAPEVLA-IQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG---IE  521 (612)
T ss_pred             ecCCCCcEEEEEechhhhCchh--hcccchhhcccChhhhc-cCCCCcchhhHHHHHHHHHHHhCCCccccCCch---HH
Confidence            9 68999999999999866544  44668899999999986 555899999999999999999999999876555   23


Q ss_pred             HHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 023609          160 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  232 (280)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~  232 (280)
                      +...++.+...                            ..+|.++++||++||+.||.+|+++.++..||||
T Consensus       522 i~~~i~~~~~s----------------------------~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  522 IHTRIQMPKFS----------------------------ECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             HHHhhcCCccc----------------------------cccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence            33444443321                            2689999999999999999999999999999999

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1e-38  Score=250.67  Aligned_cols=234  Identities=32%  Similarity=0.604  Sum_probs=190.0

Q ss_pred             CCCCCeeeeeceecCCC---CCCCCcEEEEeecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCC
Q 023609            1 MDHENVVAIRDIIPPPQ---RESFNDVYIAYELMDTDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKP   76 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~---~~~~~~~~iv~e~~~g~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~   76 (280)
                      |+|+|++.+++++....   ..+...+|+|+++|+.+|...+... .+++..++++++.++++||.|+|+..|+|||+|+
T Consensus        73 lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKa  152 (376)
T KOG0669|consen   73 LKHENVVNLIEICRTKATPTNRDRATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKA  152 (376)
T ss_pred             hcchhHHHHHHHHhhccCCcccccceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccH
Confidence            68999999999885532   1122459999999999999999765 5799999999999999999999999999999999


Q ss_pred             CcEEEccCCCEEEeeccceeeccCCC-----ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 023609           77 SNLLLNANCDLKICDFGLARVTSETD-----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGR  151 (280)
Q Consensus        77 ~nili~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~  151 (280)
                      .|++|+.+|.++|.|||+++..+..+     .....+.|.+|.+||.+.+.+.++++.|+|..|||+.+|+++.+.+.+.
T Consensus       153 aNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgn  232 (376)
T KOG0669|consen  153 ANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGN  232 (376)
T ss_pred             hhEEEcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCC
Confidence            99999999999999999997644332     2334566999999999999999999999999999999999999999999


Q ss_pred             ChHHHHHHHHHHhCCCCHHHHhHhhHhHHHH-h--hhcCccccccccccCCC--CChHHHHHHHHhhcCCCCCCCCHHHH
Q 023609          152 DHVHQLRLLIELIGTPSEAELGFLNENAKKY-I--CQLPRYQRQSFTEKFPN--VHPSAIDLVEKMLTFDPRQRITVEDA  226 (280)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~~~~~~--~~~~~~~li~~~L~~dp~~R~t~~el  226 (280)
                      +..+++..|....|.....-|........-- +  ...+....+........  -++++.+|+.+||..||.+|++++++
T Consensus       233 teqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~a  312 (376)
T KOG0669|consen  233 TEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQA  312 (376)
T ss_pred             hHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhh
Confidence            9999999999999987776665443221111 1  11222222222222221  25689999999999999999999999


Q ss_pred             hcCCCCCC
Q 023609          227 LAHPYLGS  234 (280)
Q Consensus       227 l~h~~~~~  234 (280)
                      ++|.||..
T Consensus       313 lnh~~F~k  320 (376)
T KOG0669|consen  313 LNHDFFWK  320 (376)
T ss_pred             hchhhhhc
Confidence            99999966

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=8.7e-38  Score=266.75  Aligned_cols=232  Identities=36%  Similarity=0.693  Sum_probs=179.5

Q ss_pred             CCCCCeeeeeceecCCCC---CCCCcEEEEeecCCccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCC
Q 023609            1 MDHENVVAIRDIIPPPQR---ESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKP   76 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~---~~~~~~~iv~e~~~g~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~   76 (280)
                      ++||||+++++++.....   .....+|+||+|++++|.+.+.. ...+++..++.++.||+.||+|||+.|++|+||+|
T Consensus        64 l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p  143 (311)
T cd07866          64 LKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKA  143 (311)
T ss_pred             cCCCCccchhhheecccccccccCceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCH
Confidence            589999999998765431   12245899999999988888765 34799999999999999999999999999999999


Q ss_pred             CcEEEccCCCEEEeeccceeeccCCCc------------cccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhC
Q 023609           77 SNLLLNANCDLKICDFGLARVTSETDF------------MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR  144 (280)
Q Consensus        77 ~nili~~~~~~~l~dfg~~~~~~~~~~------------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g  144 (280)
                      +||+++.++.++|+|||++........            .....+++.|+|||.+.+...++.++|+||+||++++|++|
T Consensus       144 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g  223 (311)
T cd07866         144 ANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTR  223 (311)
T ss_pred             HHEEECCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhC
Confidence            999999999999999999875432211            11234578899999876655578899999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHH
Q 023609          145 KPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVE  224 (280)
Q Consensus       145 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~  224 (280)
                      .+||.+.+.......+....+.+....+.........................++.+++.+.++|.+||+.||.+|||+.
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~  303 (311)
T cd07866         224 RPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTAS  303 (311)
T ss_pred             CCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHH
Confidence            99999998888888888887776655433221111000000001111223334556778899999999999999999999


Q ss_pred             HHhcCCCC
Q 023609          225 DALAHPYL  232 (280)
Q Consensus       225 ell~h~~~  232 (280)
                      ++++||||
T Consensus       304 ell~~~~f  311 (311)
T cd07866         304 DALEHPYF  311 (311)
T ss_pred             HHhcCCCC
Confidence            99999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=5.8e-38  Score=269.66  Aligned_cols=198  Identities=21%  Similarity=0.415  Sum_probs=165.7

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nil   80 (280)
                      +||+|+++++++...     ...|+||||++ |+|.+++...+.+++.++..++.||+.||+|||++|++||||||+||+
T Consensus        59 ~~~~i~~~~~~~~~~-----~~~~lv~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nil  133 (323)
T cd05615          59 KPPFLTQLHSCFQTV-----DRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVM  133 (323)
T ss_pred             CCCchhheeeEEecC-----CEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeE
Confidence            468888999988665     67999999997 699999988888999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccceeeccCC-CccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023609           81 LNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  159 (280)
Q Consensus        81 i~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      ++.++.++|+|||++...... .......+++.|+|||++.+ ..++.++|+||+||++|+|++|..||.+.........
T Consensus       134 l~~~~~ikL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~  212 (323)
T cd05615         134 LDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAY-QPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQS  212 (323)
T ss_pred             ECCCCCEEEeccccccccCCCCccccCccCCccccCHHHHcC-CCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            999999999999998753322 22334568999999998854 4578999999999999999999999988776655554


Q ss_pred             HHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCC-----HHHHhcCCCCCC
Q 023609          160 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT-----VEDALAHPYLGS  234 (280)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~ell~h~~~~~  234 (280)
                      +......                              ....++.++++++.+||+.||.+|++     ..++++||||..
T Consensus       213 i~~~~~~------------------------------~p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~  262 (323)
T cd05615         213 IMEHNVS------------------------------YPKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRR  262 (323)
T ss_pred             HHhCCCC------------------------------CCccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCC
Confidence            4321110                              01256788999999999999999997     479999999997


Q ss_pred             C
Q 023609          235 L  235 (280)
Q Consensus       235 ~  235 (280)
                      .
T Consensus       263 ~  263 (323)
T cd05615         263 I  263 (323)
T ss_pred             C
Confidence            5

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=1.4e-37  Score=265.28  Aligned_cols=232  Identities=34%  Similarity=0.633  Sum_probs=173.7

Q ss_pred             CCCCCeeeeeceecCCCC---CCCCcEEEEeecCCccHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCC
Q 023609            1 MDHENVVAIRDIIPPPQR---ESFNDVYIAYELMDTDLHQIIRSNQ-ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKP   76 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~---~~~~~~~iv~e~~~g~L~~~l~~~~-~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~   76 (280)
                      ++||||+++++++.....   ......|+||||++++|.+.+.... .+++.+++.++.||+.||+|||++|++|+||+|
T Consensus        68 l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p  147 (310)
T cd07865          68 LKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKA  147 (310)
T ss_pred             CCCCCccceEEEEecccccccCCCceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCH
Confidence            579999999998865421   1224579999999999998887543 699999999999999999999999999999999


Q ss_pred             CcEEEccCCCEEEeeccceeeccCCC-----ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 023609           77 SNLLLNANCDLKICDFGLARVTSETD-----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGR  151 (280)
Q Consensus        77 ~nili~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~  151 (280)
                      +||+++.++.++|+|||.+.......     ......++..|+|||.+.+...++.++|+||+|+++++|++|++||.+.
T Consensus       148 ~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~  227 (310)
T cd07865         148 ANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGN  227 (310)
T ss_pred             HHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence            99999999999999999987543221     1123456788999998866555688999999999999999999999988


Q ss_pred             ChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccC-C-CCChHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 023609          152 DHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF-P-NVHPSAIDLVEKMLTFDPRQRITVEDALAH  229 (280)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~-~~~~~~~~li~~~L~~dp~~R~t~~ell~h  229 (280)
                      +.......+....+..+...+..............+........... + ..+..++++|.+||..||.+|||++++++|
T Consensus       228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h  307 (310)
T cd07865         228 TEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH  307 (310)
T ss_pred             CHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence            87777777777666554432221111000000011111111111111 1 235778999999999999999999999999


Q ss_pred             CCC
Q 023609          230 PYL  232 (280)
Q Consensus       230 ~~~  232 (280)
                      |||
T Consensus       308 ~~f  310 (310)
T cd07865         308 DFF  310 (310)
T ss_pred             CCC
Confidence            998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=3.5e-38  Score=275.71  Aligned_cols=203  Identities=24%  Similarity=0.359  Sum_probs=164.7

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++.+...     ...|+||||++ |+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+||
T Consensus       100 ~~hp~iv~~~~~~~~~-----~~~~lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NI  173 (371)
T cd05622         100 ANSPWVVQLFYAFQDD-----RYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNM  173 (371)
T ss_pred             CCCCCCCeEEEEEEcC-----CEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHE
Confidence            4799999999999665     67999999997 699998865 4689999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCC--ccccceeccccccchhccCCC---CCCcchhHHHHHHHHHHHHhCCCCCCCCChH
Q 023609           80 LLNANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNSS---DYTAAIDVWSVGCIFMELMDRKPLFPGRDHV  154 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  154 (280)
                      +++.+|.++|+|||++.......  ......+|+.|+|||++.+..   .++.++||||+||++|+|++|..||.+.+..
T Consensus       174 ll~~~~~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~  253 (371)
T cd05622         174 LLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV  253 (371)
T ss_pred             EECCCCCEEEEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHH
Confidence            99999999999999998654332  123457899999999985432   3678999999999999999999999887766


Q ss_pred             HHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCC--CCCHHHHhcCCCC
Q 023609          155 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQ--RITVEDALAHPYL  232 (280)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~--R~t~~ell~h~~~  232 (280)
                      .....+........                         + ...+.++..++++|.+||..++.+  |+++.++++|+||
T Consensus       254 ~~~~~i~~~~~~~~-------------------------~-~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~  307 (371)
T cd05622         254 GTYSKIMNHKNSLT-------------------------F-PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFF  307 (371)
T ss_pred             HHHHHHHcCCCccc-------------------------C-CCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCccc
Confidence            55555443211100                         0 112367899999999999844443  7899999999999


Q ss_pred             CCC
Q 023609          233 GSL  235 (280)
Q Consensus       233 ~~~  235 (280)
                      ++.
T Consensus       308 ~~~  310 (371)
T cd05622         308 KND  310 (371)
T ss_pred             CCC
Confidence            873

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-37  Score=262.50  Aligned_cols=228  Identities=40%  Similarity=0.740  Sum_probs=181.4

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ--ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~--~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      ++||||+++++++......+....+++||+++++|.+++....  .+++..++.++.|++.||.+||+.|++|+||+|+|
T Consensus        58 ~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~n  137 (287)
T cd07838          58 FEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQN  137 (287)
T ss_pred             cCCCCcceEEEEEeeccCCCCceeEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhh
Confidence            3699999999999776433334599999999999999887643  59999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023609           79 LLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  158 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  158 (280)
                      |+++.++.++|+|||.+.............++..|+|||.+.+. .++.++|+||+||++++|++|.+||.+.+..+...
T Consensus       138 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~  216 (287)
T cd07838         138 ILVTSDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVLLQS-SYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLD  216 (287)
T ss_pred             EEEccCCCEEEeccCcceeccCCcccccccccccccChHHhccC-CCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHH
Confidence            99999999999999998776544433444578889999988654 47889999999999999999999999998888888


Q ss_pred             HHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 023609          159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  232 (280)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~  232 (280)
                      ++.+....+....+........   ...+......+....+.+++.+.++|.+||+.||.+||++.+++.||||
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         217 KIFDVIGLPSEEEWPRNVSLPR---SSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             HHHHHcCCCChHhcCCCcccch---hhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence            8877766554432211110000   0112222223344455678899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-37  Score=259.77  Aligned_cols=198  Identities=24%  Similarity=0.441  Sum_probs=162.5

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++...     ...|+|+||++ ++|.+.+...+.+++..++.++.|++.||.+||+.|++|+||+|+||
T Consensus        61 l~~~~i~~~~~~~~~~-----~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~ni  135 (263)
T cd06625          61 LQHERIVQYYGCLRDD-----ETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANI  135 (263)
T ss_pred             CCCCCeeeeEEEEccC-----CeEEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence            5799999999999765     57999999997 59999998888899999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCCcc----ccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 023609           80 LLNANCDLKICDFGLARVTSETDFM----TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVH  155 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~  155 (280)
                      +++.++.++|+|||.+.........    ....++..|+|||.+.+. .++.++|+||+|+++|+|++|..||.+.....
T Consensus       136 lv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~p~~~~~~~~  214 (263)
T cd06625         136 LRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGE-GYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA  214 (263)
T ss_pred             EEcCCCCEEEeecccceeccccccccccccCCCcCccccCcceeccC-CCCchhhhHHHHHHHHHHHhCCCCccccchHH
Confidence            9999999999999998754332111    234567889999988654 47899999999999999999999997654433


Q ss_pred             HHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 023609          156 QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  232 (280)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~  232 (280)
                      ....+......                            ......++..+.++|++||..+|.+|||+.++++|+||
T Consensus       215 ~~~~~~~~~~~----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         215 AIFKIATQPTN----------------------------PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             HHHHHhccCCC----------------------------CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence            32222111000                            01112567889999999999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.3e-38  Score=269.25  Aligned_cols=205  Identities=21%  Similarity=0.398  Sum_probs=165.1

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      ++||||+++++++.+.     .++|+||||+. |+|.+++.+ ...+++..++.++.||+.||+|||++|++||||||+|
T Consensus        58 ~~~~~i~~~~~~~~~~-----~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~N  132 (331)
T cd05597          58 GDRRWITNLHYAFQDE-----NNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDN  132 (331)
T ss_pred             CCCCCCCceEEEEecC-----CeEEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHH
Confidence            4799999999999765     67999999996 699999976 4579999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCCCc--cccceeccccccchhccC----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 023609           79 LLLNANCDLKICDFGLARVTSETDF--MTEYVVTRWYRAPELLLN----SSDYTAAIDVWSVGCIFMELMDRKPLFPGRD  152 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  152 (280)
                      |+++.++.++|+|||++........  .....+++.|+|||++.+    ...++.++|+||+||++|+|++|..||.+.+
T Consensus       133 ill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~  212 (331)
T cd05597         133 VLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAES  212 (331)
T ss_pred             EEECCCCCEEEEECCceeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCC
Confidence            9999999999999999876543322  122468999999999853    2346789999999999999999999998876


Q ss_pred             hHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCC--CCCHHHHhcCC
Q 023609          153 HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQ--RITVEDALAHP  230 (280)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~--R~t~~ell~h~  230 (280)
                      ..+....+......                         ..+....+.++.+++++|++||..++++  |+++.++++||
T Consensus       213 ~~~~~~~i~~~~~~-------------------------~~~~~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp  267 (331)
T cd05597         213 LVETYGKIMNHKEH-------------------------FQFPPDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHP  267 (331)
T ss_pred             HHHHHHHHHcCCCc-------------------------ccCCCccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCC
Confidence            65554444321100                         0111222357889999999999765554  88999999999


Q ss_pred             CCCCC
Q 023609          231 YLGSL  235 (280)
Q Consensus       231 ~~~~~  235 (280)
                      ||.++
T Consensus       268 ~~~~~  272 (331)
T cd05597         268 FFEGI  272 (331)
T ss_pred             CCCCC
Confidence            99875

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-37  Score=262.49  Aligned_cols=229  Identities=37%  Similarity=0.705  Sum_probs=180.6

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++....   ....++|+||++++|.+++.+. ..+++..++.++.||+.||++||+.|++|+||+|+||
T Consensus        55 l~~~~i~~~~~~~~~~~---~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~ni  131 (287)
T cd07840          55 LRHPNIVRLKEIVTSKG---KGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNI  131 (287)
T ss_pred             ccCCCeeeheeeEecCC---CCcEEEEeccccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHe
Confidence            47999999999986542   2579999999999999998765 5799999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCC--ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL  157 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  157 (280)
                      +++.++.++|+|||.+.......  ......++..|+|||.+.+...++.++|+||+|+++++|++|..||.+.+.....
T Consensus       132 l~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~  211 (287)
T cd07840         132 LINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQL  211 (287)
T ss_pred             EEcCCCCEEEccccceeeccCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence            99999999999999998655442  1233456788999998766556789999999999999999999999998888888


Q ss_pred             HHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCC-ChHHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 023609          158 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNV-HPSAIDLVEKMLTFDPRQRITVEDALAHPYL  232 (280)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~li~~~L~~dp~~R~t~~ell~h~~~  232 (280)
                      ..+.+..+.+....+.........................+... ++++.+++++||+.+|.+|||+.+++.||||
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         212 EKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             HHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence            88888777776554432222100000000001111122333343 8899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=3.3e-37  Score=261.08  Aligned_cols=227  Identities=37%  Similarity=0.683  Sum_probs=170.2

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++|+||+++++++...     ...|+||||++++|.+.+.. .+.+++..++.++.|++.||+|||+.|++|+||||+||
T Consensus        60 l~h~ni~~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Ni  134 (291)
T cd07870          60 LKHANIVLLHDIIHTK-----ETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNL  134 (291)
T ss_pred             cCCCCEeEEEEEEecC-----CeEEEEEecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHE
Confidence            5899999999998654     67899999999888887754 35688999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCC-CccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-hHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD-HVHQL  157 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~  157 (280)
                      +++.++.++|+|||.+...... .......+++.|+|||.+.+...++.++|+||+||++++|++|..||.+.+ ..+.+
T Consensus       135 l~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~  214 (291)
T cd07870         135 LISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQL  214 (291)
T ss_pred             EEcCCCcEEEeccccccccCCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHH
Confidence            9999999999999988754322 122334568889999988655557889999999999999999999997654 34455


Q ss_pred             HHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCC--CCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 023609          158 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP--NVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  232 (280)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~  232 (280)
                      ..+....+.|...................+............  ..+.++.+++.+||+.||++|||+.+++.||||
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         215 EKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             HHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence            666666666655433222211000000000001111111111  136789999999999999999999999999997

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-40  Score=275.10  Aligned_cols=200  Identities=27%  Similarity=0.454  Sum_probs=169.7

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      +++|||.++|+.|...     ..++|+||||+ |++.+.++.+..+.+.++..++++++.||.|||.++.+|||||+.||
T Consensus        68 ~~~~~it~yygsyl~g-----~~LwiiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaani  142 (467)
T KOG0201|consen   68 CDSPNITEYYGSYLKG-----TKLWIIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANI  142 (467)
T ss_pred             cCcchHHhhhhheeec-----ccHHHHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccce
Confidence            4789999999999766     67999999998 69999999888889999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCC-ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  158 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  158 (280)
                      ++..+|.++|+|||.+....... ...+.+||+.|||||++... .|+.++||||||++.++|++|.+|+....+.-.+-
T Consensus       143 l~s~~g~vkl~DfgVa~ql~~~~~rr~tfvGTPfwMAPEVI~~~-~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlf  221 (467)
T KOG0201|consen  143 LLSESGDVKLADFGVAGQLTNTVKRRKTFVGTPFWMAPEVIKQS-GYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLF  221 (467)
T ss_pred             eEeccCcEEEEecceeeeeechhhccccccccccccchhhhccc-cccchhhhhhhhHHHHHHhcCCCCCcccCcceEEE
Confidence            99999999999999998765543 33678999999999999744 58999999999999999999999997655411111


Q ss_pred             HHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCC
Q 023609          159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  235 (280)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~  235 (280)
                      .                          .|.   ...+..-..+|+.+++||..||++||+.||+|.++|.|+|++..
T Consensus       222 l--------------------------Ipk---~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a  269 (467)
T KOG0201|consen  222 L--------------------------IPK---SAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKRA  269 (467)
T ss_pred             e--------------------------ccC---CCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHhc
Confidence            1                          111   11122223788999999999999999999999999999999874

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=7.7e-38  Score=269.88  Aligned_cols=205  Identities=21%  Similarity=0.418  Sum_probs=166.3

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      ++||||+++++.+...     ...|+||||+. |+|.+++.+ .+.+++..++.++.||+.||+|||+.|++||||||+|
T Consensus        58 ~~~~~i~~~~~~~~~~-----~~~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~N  132 (332)
T cd05623          58 GDNQWITTLHYAFQDE-----NNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDN  132 (332)
T ss_pred             CCCCCEeeEEEEEecC-----CEEEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHH
Confidence            4799999999999665     67999999996 799999976 4679999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCCCc--cccceeccccccchhccC----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 023609           79 LLLNANCDLKICDFGLARVTSETDF--MTEYVVTRWYRAPELLLN----SSDYTAAIDVWSVGCIFMELMDRKPLFPGRD  152 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  152 (280)
                      |+++.++.++|+|||++........  .....|++.|+|||++..    ...++.++|+||+||++|+|++|..||.+.+
T Consensus       133 ili~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~  212 (332)
T cd05623         133 ILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES  212 (332)
T ss_pred             EEECCCCCEEEeecchheecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC
Confidence            9999999999999999875433221  223568999999998852    3457889999999999999999999998877


Q ss_pred             hHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCC--CCCHHHHhcCC
Q 023609          153 HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQ--RITVEDALAHP  230 (280)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~--R~t~~ell~h~  230 (280)
                      ..+....+......                         ..+......+++++++||++||..++.+  |++++++++||
T Consensus       213 ~~~~~~~i~~~~~~-------------------------~~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~  267 (332)
T cd05623         213 LVETYGKIMNHKER-------------------------FQFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHP  267 (332)
T ss_pred             HHHHHHHHhCCCcc-------------------------ccCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCC
Confidence            66665554321110                         0111222367899999999999765555  78999999999


Q ss_pred             CCCCC
Q 023609          231 YLGSL  235 (280)
Q Consensus       231 ~~~~~  235 (280)
                      ||.++
T Consensus       268 ~f~~~  272 (332)
T cd05623         268 FFTGI  272 (332)
T ss_pred             CcCCC
Confidence            99875

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=1.4e-37  Score=268.40  Aligned_cols=224  Identities=24%  Similarity=0.417  Sum_probs=165.6

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA-NVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~-gi~H~di~~~n   78 (280)
                      ++||||+++++++...     +..|+||||+. |+|.+++...+.+++..+..++.|++.||.|||+. +++|+||||+|
T Consensus        60 l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~N  134 (333)
T cd06650          60 CNSPYIVGFYGAFYSD-----GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSN  134 (333)
T ss_pred             CCCCcccceeEEEEEC-----CEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhh
Confidence            5799999999999765     67999999997 69999998888899999999999999999999975 79999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023609           79 LLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  158 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  158 (280)
                      |+++.++.++|+|||++...... ......++..|+|||.+.+. .++.++|+||+||++|+|++|..||......+...
T Consensus       135 ili~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~  212 (333)
T cd06650         135 ILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELEL  212 (333)
T ss_pred             EEEcCCCCEEEeeCCcchhhhhh-ccccCCCCccccCHHHhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHH
Confidence            99999999999999998754322 12344678899999998544 47889999999999999999999997665433322


Q ss_pred             HHHHHh-CCCCHHHH-----------hHh---------hHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCC
Q 023609          159 LLIELI-GTPSEAEL-----------GFL---------NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDP  217 (280)
Q Consensus       159 ~~~~~~-~~~~~~~~-----------~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp  217 (280)
                      .+.... +.+.....           ...         ..........   .....  .....++.++++||.+||+.||
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~--~~~~~~~~~~~~li~~~L~~~P  287 (333)
T cd06650         213 MFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVN---EPPPK--LPSGVFGAEFQDFVNKCLIKNP  287 (333)
T ss_pred             HhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhc---CCCcc--CCCCCcCHHHHHHHHHhccCCc
Confidence            111000 00000000           000         0000000000   00000  0012357889999999999999


Q ss_pred             CCCCCHHHHhcCCCCCCCc
Q 023609          218 RQRITVEDALAHPYLGSLH  236 (280)
Q Consensus       218 ~~R~t~~ell~h~~~~~~~  236 (280)
                      ++|||+.+++.||||+...
T Consensus       288 ~~Rpt~~ell~h~~~~~~~  306 (333)
T cd06650         288 AERADLKQLMVHAFIKRSE  306 (333)
T ss_pred             ccCcCHHHHhhCHHHhcCc
Confidence            9999999999999998753

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=2.9e-38  Score=262.78  Aligned_cols=204  Identities=34%  Similarity=0.579  Sum_probs=166.0

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++...     ...++|||++++ +|.+++...+.+++.++..++.||+.||++||+.|++|+||||+||
T Consensus        55 l~~~~i~~~~~~~~~~-----~~~~~v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NI  129 (260)
T PF00069_consen   55 LRHPNIVQILDVFQDD-----NYLYIVMEYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENI  129 (260)
T ss_dssp             HTBTTBCHEEEEEEES-----SEEEEEEEEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGE
T ss_pred             cccccccccccccccc-----ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            4799999999999765     778999999996 9999999778899999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeec-cCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023609           80 LLNANCDLKICDFGLARVT-SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  158 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.++.++|+|||.+... ..........++..|+|||++......+.++|+||+|+++++|++|..||.+........
T Consensus       130 l~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~  209 (260)
T PF00069_consen  130 LLDENGEVKLIDFGSSVKLSENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLE  209 (260)
T ss_dssp             EESTTSEEEESSGTTTEESTSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhh
Confidence            9999999999999998763 333344556788999999998635568899999999999999999999998774444433


Q ss_pred             HHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 023609          159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  232 (280)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~  232 (280)
                      .+.+...........                       .....++.+.++|.+||+.||++|||+.++++||||
T Consensus       210 ~~~~~~~~~~~~~~~-----------------------~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  210 IIEKILKRPLPSSSQ-----------------------QSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             HHHHHHHTHHHHHTT-----------------------SHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred             hhhhccccccccccc-----------------------ccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence            333322111111000                       000112689999999999999999999999999997

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=3.3e-37  Score=260.25  Aligned_cols=227  Identities=33%  Similarity=0.712  Sum_probs=175.3

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++...     ...|+||||+++ .|..+......+++.+++.++.||+.||+|||+.|++|+||+|+||
T Consensus        57 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni  131 (286)
T cd07846          57 LRHENLVNLIEVFRRK-----KRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENI  131 (286)
T ss_pred             cCCcchhhHHHhcccC-----CeEEEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHE
Confidence            5799999999999654     679999999985 6666666666799999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCC-ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  158 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.++.++|+|||++....... ......++..|+|||.+.+...++.++|+||+|+++++|++|.+||.+.+..+...
T Consensus       132 ~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~  211 (286)
T cd07846         132 LVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLY  211 (286)
T ss_pred             EECCCCcEEEEeeeeeeeccCCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHH
Confidence            99999999999999987653332 22334578889999988655557789999999999999999999998888777777


Q ss_pred             HHHHHhCCCCHHHHhHhhHhHHHHhhhcCc-cccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 023609          159 LLIELIGTPSEAELGFLNENAKKYICQLPR-YQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  232 (280)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~  232 (280)
                      .+....+.....................+. ..........+.++..+.+++.+||+.+|.+|||+.++++||||
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         212 HIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             HHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence            777666554332211111110000000111 01112233456789999999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.2e-37  Score=268.05  Aligned_cols=229  Identities=22%  Similarity=0.326  Sum_probs=162.4

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS   77 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~   77 (280)
                      ++||||+++++++..+     ...|+||||++ |+|.+++...  +.+++..++.++.|++.||+|||+.|++||||||+
T Consensus        56 l~hpniv~~~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~  130 (327)
T cd08227          56 FNHPNIVPYRATFIAD-----NELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKAS  130 (327)
T ss_pred             cCCCCeeeEEEEEEEC-----CEEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChh
Confidence            5899999999999765     67899999997 6999998653  45999999999999999999999999999999999


Q ss_pred             cEEEccCCCEEEeeccceeeccCCC--------ccccceeccccccchhccCC-CCCCcchhHHHHHHHHHHHHhCCCCC
Q 023609           78 NLLLNANCDLKICDFGLARVTSETD--------FMTEYVVTRWYRAPELLLNS-SDYTAAIDVWSVGCIFMELMDRKPLF  148 (280)
Q Consensus        78 nili~~~~~~~l~dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf  148 (280)
                      ||+++.++.++++||+.........        ......++..|+|||.+.+. ..++.++||||+||++++|++|..||
T Consensus       131 Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf  210 (327)
T cd08227         131 HILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF  210 (327)
T ss_pred             hEEEecCCcEEEcccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCC
Confidence            9999999999999997643221110        11123456779999998643 34789999999999999999999999


Q ss_pred             CCCChHHHHHHHHHHhCCCCHH-HHhHh-hHhH-HHH--------hh-------hcCccccccccccCCCCChHHHHHHH
Q 023609          149 PGRDHVHQLRLLIELIGTPSEA-ELGFL-NENA-KKY--------IC-------QLPRYQRQSFTEKFPNVHPSAIDLVE  210 (280)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~-~~~--------~~-------~~~~~~~~~~~~~~~~~~~~~~~li~  210 (280)
                      .+............  +..+.. ..... .+.. ...        ..       ..+.............+++++.+||+
T Consensus       211 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  288 (327)
T cd08227         211 KDMPATQMLLEKLN--GTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVE  288 (327)
T ss_pred             CCcchhHHHHHHhc--CCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHH
Confidence            86654443222211  111000 00000 0000 000        00       00000000011122246788999999


Q ss_pred             HhhcCCCCCCCCHHHHhcCCCCCCCc
Q 023609          211 KMLTFDPRQRITVEDALAHPYLGSLH  236 (280)
Q Consensus       211 ~~L~~dp~~R~t~~ell~h~~~~~~~  236 (280)
                      +||+.||++|||+.++++||||+.+.
T Consensus       289 ~~l~~dP~~Rpt~~ell~~p~f~~~~  314 (327)
T cd08227         289 QCLQRNPDARPSASTLLNHSFFKQIK  314 (327)
T ss_pred             HHHhhCchhcCCHHHHhcChhhhhcc
Confidence            99999999999999999999998764

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=2.3e-37  Score=259.01  Aligned_cols=197  Identities=24%  Similarity=0.442  Sum_probs=161.7

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nil   80 (280)
                      +||||+++++.+...     ...|+||||++ ++|.+++..++.+++.+++.++.|++.||.+||+.|++||||+|+||+
T Consensus        67 ~h~~iv~~~~~~~~~-----~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil  141 (267)
T PHA03390         67 DNPNFIKLYYSVTTL-----KGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVL  141 (267)
T ss_pred             cCCCEEEEEEEEecC-----CeeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEE
Confidence            699999999999765     67999999997 699999988778999999999999999999999999999999999999


Q ss_pred             EccCC-CEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH-HH
Q 023609           81 LNANC-DLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ-LR  158 (280)
Q Consensus        81 i~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~  158 (280)
                      ++.++ .++|+|||.+.......   ...++..|+|||++.+. .++.++|+||+|+++++|++|..||.+...... ..
T Consensus       142 ~~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~  217 (267)
T PHA03390        142 YDRAKDRIYLCDYGLCKIIGTPS---CYDGTLDYFSPEKIKGH-NYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLE  217 (267)
T ss_pred             EeCCCCeEEEecCccceecCCCc---cCCCCCcccChhhhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHH
Confidence            99988 99999999987665332   33578889999998544 478899999999999999999999975433221 11


Q ss_pred             HHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCC-HHHHhcCCCCCC
Q 023609          159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT-VEDALAHPYLGS  234 (280)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-~~ell~h~~~~~  234 (280)
                      .......                           ......+.+++.+.++|.+||+.||.+|++ ++++++||||++
T Consensus       218 ~~~~~~~---------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~  267 (267)
T PHA03390        218 SLLKRQQ---------------------------KKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI  267 (267)
T ss_pred             HHHHhhc---------------------------ccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence            1110000                           001122367899999999999999999996 599999999974

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-37  Score=264.34  Aligned_cols=229  Identities=40%  Similarity=0.732  Sum_probs=172.2

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN-----QALSEEHCQYFLYQILRGLKYIHSANVLHRDLK   75 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~-----~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~   75 (280)
                      ++||||+++++++.....   ..+|+||||++++|.+.+...     ..+++..++.++.||+.||+|||+.|++||||+
T Consensus        59 l~h~~i~~~~~~~~~~~~---~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlk  135 (316)
T cd07842          59 LKHENVVSLVEVFLEHAD---KSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLK  135 (316)
T ss_pred             cCCCCccceEEEEeCCCC---ceEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCC
Confidence            589999999999976522   569999999999888877522     368999999999999999999999999999999


Q ss_pred             CCcEEEcc----CCCEEEeeccceeeccCCC----ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCC
Q 023609           76 PSNLLLNA----NCDLKICDFGLARVTSETD----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL  147 (280)
Q Consensus        76 ~~nili~~----~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p  147 (280)
                      |+||+++.    ++.++|+|||++.......    ......++..|+|||.+.+...++.++|+||+||++++|++|.+|
T Consensus       136 p~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~  215 (316)
T cd07842         136 PANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPI  215 (316)
T ss_pred             HHHEEEcCCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCC
Confidence            99999999    8999999999987643322    122345688899999886655678899999999999999999999


Q ss_pred             CCCCChH---------HHHHHHHHHhCCCCHHHHhHhhHhH--HHHh--hhcCcccccc---ccccCCCCChHHHHHHHH
Q 023609          148 FPGRDHV---------HQLRLLIELIGTPSEAELGFLNENA--KKYI--CQLPRYQRQS---FTEKFPNVHPSAIDLVEK  211 (280)
Q Consensus       148 f~~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~--~~~~~~~~~~---~~~~~~~~~~~~~~li~~  211 (280)
                      |.+....         ..+..+...++.+....+.......  ....  ..........   +.......+.++.++|.+
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  295 (316)
T cd07842         216 FKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRK  295 (316)
T ss_pred             CcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHH
Confidence            9765432         3556666666666554443221110  0000  0000000001   111112567889999999


Q ss_pred             hhcCCCCCCCCHHHHhcCCCC
Q 023609          212 MLTFDPRQRITVEDALAHPYL  232 (280)
Q Consensus       212 ~L~~dp~~R~t~~ell~h~~~  232 (280)
                      ||+.||++|||+.++++||||
T Consensus       296 ~l~~~P~~Rps~~eil~~~~f  316 (316)
T cd07842         296 LLEYDPTKRITAEEALEHPYF  316 (316)
T ss_pred             HhcCCcccCcCHHHHhcCCCC
Confidence            999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=2.2e-37  Score=260.82  Aligned_cols=202  Identities=26%  Similarity=0.434  Sum_probs=163.2

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nil   80 (280)
                      +||||+++++.+...     +..|+||||+. |+|.+++..++.+++..+..++.|++.||+|||+.|++|+||||+||+
T Consensus        55 ~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil  129 (279)
T cd05633          55 DCPFIVCMTYAFHTP-----DKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANIL  129 (279)
T ss_pred             CCCcEeEEEEEEecC-----CeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEE
Confidence            699999999998665     57899999997 699999988888999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 023609           81 LNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL  160 (280)
Q Consensus        81 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~  160 (280)
                      ++.++.++|+|||++....... .....++..|+|||.+.....++.++|+||+||++++|++|..||.+....... .+
T Consensus       130 ~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~  207 (279)
T cd05633         130 LDEHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EI  207 (279)
T ss_pred             ECCCCCEEEccCCcceeccccC-ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-HH
Confidence            9999999999999987554332 223468899999998754445788999999999999999999999654321110 00


Q ss_pred             HHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCC-----CHHHHhcCCCCCCC
Q 023609          161 IELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI-----TVEDALAHPYLGSL  235 (280)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~ell~h~~~~~~  235 (280)
                      ......                   .       .....+.++.+++++|++||..||.+|+     |+.++++||||+.+
T Consensus       208 ~~~~~~-------------------~-------~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~~  261 (279)
T cd05633         208 DRMTLT-------------------V-------NVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKGI  261 (279)
T ss_pred             HHHhhc-------------------C-------CcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccCC
Confidence            000000                   0       0011235788999999999999999999     69999999999986


Q ss_pred             c
Q 023609          236 H  236 (280)
Q Consensus       236 ~  236 (280)
                      .
T Consensus       262 ~  262 (279)
T cd05633         262 D  262 (279)
T ss_pred             C
Confidence            4

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.2e-37  Score=280.09  Aligned_cols=228  Identities=24%  Similarity=0.337  Sum_probs=166.0

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN-----QALSEEHCQYFLYQILRGLKYIHSANVLHRDLK   75 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~-----~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~   75 (280)
                      |+||||+++++++...     ...|+|+++++++|.+++...     .......++.++.||+.||+|||++||+|||||
T Consensus       220 l~HpnIv~l~~~~~~~-----~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLK  294 (501)
T PHA03210        220 LNHENILKIEEILRSE-----ANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIK  294 (501)
T ss_pred             CCCCCcCcEeEEEEEC-----CeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence            5899999999999765     668999999999999887542     234567788999999999999999999999999


Q ss_pred             CCcEEEccCCCEEEeeccceeeccCCC--ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCC-CCCC--
Q 023609           76 PSNLLLNANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP-LFPG--  150 (280)
Q Consensus        76 ~~nili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~-pf~~--  150 (280)
                      |+||+++.++.++|+|||++.......  ......|+..|+|||++.+. .++.++||||+||++|+|++|.. |+.+  
T Consensus       295 P~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvil~ell~~~~~p~~~~~  373 (501)
T PHA03210        295 LENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGD-GYCEITDIWSCGLILLDMLSHDFCPIGDGG  373 (501)
T ss_pred             HHHEEECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCC-CCCcHHHHHHHHHHHHHHHHCCCCCccCCC
Confidence            999999999999999999998654432  12235689999999998654 48899999999999999999875 4432  


Q ss_pred             CChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhc-CccccccccccC--CCCChHHHHHHHHhhcCCCCCCCCHHHHh
Q 023609          151 RDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQL-PRYQRQSFTEKF--PNVHPSAIDLVEKMLTFDPRQRITVEDAL  227 (280)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~--~~~~~~~~~li~~~L~~dp~~R~t~~ell  227 (280)
                      ......+.++....+.+...... .......+.... .......+...+  ..++.++.++|.+||+.||.+|||+.|+|
T Consensus       374 ~~~~~~~~~~~~~~~~~~~~~p~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL  452 (501)
T PHA03210        374 GKPGKQLLKIIDSLSVCDEEFPD-PPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELL  452 (501)
T ss_pred             CCHHHHHHHHHHhcccChhhcCC-cHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHh
Confidence            23445555555554433221110 001111111100 000011111111  14677899999999999999999999999


Q ss_pred             cCCCCCCC
Q 023609          228 AHPYLGSL  235 (280)
Q Consensus       228 ~h~~~~~~  235 (280)
                      +||||.+.
T Consensus       453 ~hp~f~~~  460 (501)
T PHA03210        453 ALPLFSAE  460 (501)
T ss_pred             hChhhhcC
Confidence            99999874

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1.3e-37  Score=262.84  Aligned_cols=203  Identities=26%  Similarity=0.448  Sum_probs=163.0

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS   77 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~   77 (280)
                      ++|+||+++++.+.+.     ...|+||||+. ++|.+++...  ..+++..+..++.|++.||.|||+.|++||||||+
T Consensus        57 l~~~~i~~~~~~~~~~-----~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~  131 (285)
T cd05630          57 VNSRFVVSLAYAYETK-----DALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPE  131 (285)
T ss_pred             CCCCCeeeeeEEEecC-----CEEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHH
Confidence            5799999999998665     67999999997 6999988643  35999999999999999999999999999999999


Q ss_pred             cEEEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 023609           78 NLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL  157 (280)
Q Consensus        78 nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  157 (280)
                      ||+++.++.++|+|||++.............++..|+|||.+.+. .++.++|+||+||++|+|++|..||.+.......
T Consensus       132 Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~  210 (285)
T cd05630         132 NILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNE-RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR  210 (285)
T ss_pred             HEEECCCCCEEEeeccceeecCCCccccCCCCCccccChHHHcCC-CCCCccccHHHHHHHHHHHhCCCCCCCCCccchH
Confidence            999999999999999998765544333445788999999998544 4889999999999999999999999765322111


Q ss_pred             HHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCC-----HHHHhcCCCC
Q 023609          158 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT-----VEDALAHPYL  232 (280)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~ell~h~~~  232 (280)
                      .........                   ..       ......+++++++|+++||+.||.+|||     +.++++||||
T Consensus       211 ~~~~~~~~~-------------------~~-------~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~  264 (285)
T cd05630         211 EEVERLVKE-------------------VQ-------EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLF  264 (285)
T ss_pred             HHHHhhhhh-------------------hh-------hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhh
Confidence            111100000                   00       0111357888999999999999999999     8999999999


Q ss_pred             CCC
Q 023609          233 GSL  235 (280)
Q Consensus       233 ~~~  235 (280)
                      .++
T Consensus       265 ~~~  267 (285)
T cd05630         265 KQI  267 (285)
T ss_pred             hcc
Confidence            875

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=4.2e-37  Score=261.64  Aligned_cols=232  Identities=39%  Similarity=0.696  Sum_probs=178.5

Q ss_pred             CCCCCeeeeeceecCCC-----CCCCCcEEEEeecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccC
Q 023609            1 MDHENVVAIRDIIPPPQ-----RESFNDVYIAYELMDTDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDL   74 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~-----~~~~~~~~iv~e~~~g~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~gi~H~di   74 (280)
                      ++||||+++++++.+..     ..+...+|+|+||+++++.+.+... ..+++..+..++.|++.||+|||+.|++|+||
T Consensus        63 l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl  142 (302)
T cd07864          63 LNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDI  142 (302)
T ss_pred             CCCCCeeeeeheecCcchhhhccccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence            57999999999986643     0112479999999999988888754 46999999999999999999999999999999


Q ss_pred             CCCcEEEccCCCEEEeeccceeeccCCC--ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 023609           75 KPSNLLLNANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD  152 (280)
Q Consensus        75 ~~~nili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  152 (280)
                      +|+||+++.++.++|+|||.+.......  ......++..|+|||.+.+....+.++|+||+||++++|++|++||....
T Consensus       143 ~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~  222 (302)
T cd07864         143 KCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQ  222 (302)
T ss_pred             CHHHEEECCCCcEEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence            9999999999999999999987653322  12233557789999988655557889999999999999999999999888


Q ss_pred             hHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 023609          153 HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  232 (280)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~  232 (280)
                      ..+.+..+.+..+.+....+....+....................+..++..+.++|.+||+.||.+|||+.+++.||||
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         223 ELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             hHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence            88888888887777665443222111000000000000111223344578899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=2.1e-37  Score=258.24  Aligned_cols=201  Identities=25%  Similarity=0.481  Sum_probs=165.3

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++.+...     ...|+|+||++ ++|.+++.+...+++..+..++.||+.||+|||+.|++|+||+|+||
T Consensus        50 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~ni  124 (262)
T cd05572          50 CNHPFIVKLYRTFKDK-----KYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENL  124 (262)
T ss_pred             CCCCCEeeeeeeEEcC-----CccEEEEecCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHE
Confidence            5799999999998655     67899999997 69999998888899999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC--hHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD--HVHQL  157 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~--~~~~~  157 (280)
                      +++.++.++|+|||.+.............++..|++||.+... .++.++|+||+|+++|+|++|..||....  .....
T Consensus       125 lv~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~  203 (262)
T cd05572         125 LLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNK-GYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIY  203 (262)
T ss_pred             EEcCCCCEEEeeCCcccccCcccccccccCCcCccChhHhcCC-CCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHH
Confidence            9999999999999999876544323344678889999987543 47889999999999999999999997665  33333


Q ss_pred             HHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCC-----HHHHhcCCCC
Q 023609          158 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT-----VEDALAHPYL  232 (280)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~ell~h~~~  232 (280)
                      ..+......+.                            .-+..+.+++++|.+||+.||.+|||     +.|+++||||
T Consensus       204 ~~~~~~~~~~~----------------------------~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~  255 (262)
T cd05572         204 NDILKGNGKLE----------------------------FPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWF  255 (262)
T ss_pred             HHHhccCCCCC----------------------------CCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhh
Confidence            32221000000                            00134678999999999999999999     9999999999


Q ss_pred             CCC
Q 023609          233 GSL  235 (280)
Q Consensus       233 ~~~  235 (280)
                      +++
T Consensus       256 ~~~  258 (262)
T cd05572         256 NGF  258 (262)
T ss_pred             hCC
Confidence            976

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-38  Score=260.34  Aligned_cols=221  Identities=29%  Similarity=0.580  Sum_probs=172.0

Q ss_pred             eeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcc
Q 023609            6 VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ--ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA   83 (280)
Q Consensus         6 Iv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~--~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nili~~   83 (280)
                      +|.+.++|.-.     ++.+||+|.++-+++|++..++  +++.+.++.|.+||++++++||+.+++|.||||+||++..
T Consensus       153 cv~m~~wFdyr-----ghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvs  227 (415)
T KOG0671|consen  153 CVQMRDWFDYR-----GHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVS  227 (415)
T ss_pred             EEeeehhhhcc-----CceEEEEeccChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEec
Confidence            56676777444     8899999999999999998765  6999999999999999999999999999999999999831


Q ss_pred             --------------------CCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh
Q 023609           84 --------------------NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD  143 (280)
Q Consensus        84 --------------------~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~  143 (280)
                                          +..++++|||.++...+..  ...+.|.+|.|||++.+.+ ++..+||||+|||+.|+.+
T Consensus       228 s~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h--s~iVsTRHYRAPEViLgLG-wS~pCDvWSiGCIL~Elyt  304 (415)
T KOG0671|consen  228 SEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH--STIVSTRHYRAPEVILGLG-WSQPCDVWSIGCILVELYT  304 (415)
T ss_pred             cceEEEeccCCccceeccCCCcceEEEecCCcceeccCc--ceeeeccccCCchheeccC-cCCccCceeeeeEEEEeec
Confidence                                2348999999998866553  4668899999999998876 8999999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhc-Cccc--------------cccccccCC---CCChHH
Q 023609          144 RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQL-PRYQ--------------RQSFTEKFP---NVHPSA  205 (280)
Q Consensus       144 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~--------------~~~~~~~~~---~~~~~~  205 (280)
                      |...|.+.++.+.++-+...+|+.+.....-..  ..++.... .+..              ..+......   ..-.++
T Consensus       305 G~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~--~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~L  382 (415)
T KOG0671|consen  305 GETLFQTHENLEHLAMMERILGPIPSRMIKKTR--KEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQL  382 (415)
T ss_pred             cceecccCCcHHHHHHHHHhhCCCcHHHhhhhh--hHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHH
Confidence            999999999989887777777755544332221  22221111 0000              011111111   122458


Q ss_pred             HHHHHHhhcCCCCCCCCHHHHhcCCCCCCCc
Q 023609          206 IDLVEKMLTFDPRQRITVEDALAHPYLGSLH  236 (280)
Q Consensus       206 ~~li~~~L~~dp~~R~t~~ell~h~~~~~~~  236 (280)
                      .|||++||.+||++|+|+.|+|.||||..+.
T Consensus       383 fDLl~~mL~fDP~~RiTl~EAL~HpFF~~~~  413 (415)
T KOG0671|consen  383 FDLLRRMLEFDPARRITLREALSHPFFARLT  413 (415)
T ss_pred             HHHHHHHHccCccccccHHHHhcCHHhhcCC
Confidence            8999999999999999999999999998764

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=2.8e-37  Score=268.55  Aligned_cols=202  Identities=26%  Similarity=0.386  Sum_probs=156.6

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++...     +.+|+||||+. |+|.+.    ...++..+..++.||+.||+|||++|++||||||+||
T Consensus       129 l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NI  199 (353)
T PLN00034        129 VNHPNVVKCHDMFDHN-----GEIQVLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNL  199 (353)
T ss_pred             CCCCCcceeeeEeccC-----CeEEEEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHE
Confidence            5799999999999665     67999999998 477543    3467888999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCC-ccccceeccccccchhccCC----CCCCcchhHHHHHHHHHHHHhCCCCCCCCChH
Q 023609           80 LLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNS----SDYTAAIDVWSVGCIFMELMDRKPLFPGRDHV  154 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  154 (280)
                      +++.++.++|+|||++....... ......++..|+|||.+...    ...+.++|||||||++|+|++|+.||......
T Consensus       200 ll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~  279 (353)
T PLN00034        200 LINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG  279 (353)
T ss_pred             EEcCCCCEEEcccccceecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCc
Confidence            99999999999999987654332 22345789999999987321    22356899999999999999999999743221


Q ss_pred             HHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCC
Q 023609          155 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS  234 (280)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~  234 (280)
                      +....+......                          ......+.++.++++||.+||+.||++|||+.|+++||||.+
T Consensus       280 ~~~~~~~~~~~~--------------------------~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~  333 (353)
T PLN00034        280 DWASLMCAICMS--------------------------QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILR  333 (353)
T ss_pred             cHHHHHHHHhcc--------------------------CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCccccc
Confidence            111111000000                          001112357889999999999999999999999999999988


Q ss_pred             CcC
Q 023609          235 LHD  237 (280)
Q Consensus       235 ~~~  237 (280)
                      ...
T Consensus       334 ~~~  336 (353)
T PLN00034        334 AQP  336 (353)
T ss_pred             CCc
Confidence            643

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=3e-37  Score=260.46  Aligned_cols=197  Identities=20%  Similarity=0.240  Sum_probs=161.4

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHS-ANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~-~gi~H~di~~~n   78 (280)
                      ++||||+++++++.+.. ++....++||||++ |+|.+++.+.+.+++.....++.|++.|+.+||+ .|++||||||+|
T Consensus        75 l~h~nIv~~~g~~~~~~-~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~n  153 (283)
T PHA02988         75 IDSNNILKIYGFIIDIV-DDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVS  153 (283)
T ss_pred             cCCCCEEEEeeeEEecc-cCCCceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhh
Confidence            58999999999986521 12256899999998 6999999988889999999999999999999998 499999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCCCccccceeccccccchhccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 023609           79 LLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNS-SDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL  157 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  157 (280)
                      |+++.++.++|+|||++.......  ....++..|+|||.+.+. ..++.++||||+||++|+|++|..||.+.+..+..
T Consensus       154 ill~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~  231 (283)
T PHA02988        154 FLVTENYKLKIICHGLEKILSSPP--FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIY  231 (283)
T ss_pred             EEECCCCcEEEcccchHhhhcccc--ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence            999999999999999987654332  345678899999988542 45889999999999999999999999887665554


Q ss_pred             HHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          158 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                      ..+......+.                            .-...++.+.++|.+||+.||.+|||+.++++
T Consensus       232 ~~i~~~~~~~~----------------------------~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~  274 (283)
T PHA02988        232 DLIINKNNSLK----------------------------LPLDCPLEIKCIVEACTSHDSIKRPNIKEILY  274 (283)
T ss_pred             HHHHhcCCCCC----------------------------CCCcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence            44432211111                            00156788999999999999999999999985

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=4.4e-37  Score=260.29  Aligned_cols=198  Identities=27%  Similarity=0.499  Sum_probs=166.8

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++...     ...|+||||++ ++|.+++...+.+++..+..++.||+.||+|||+.|++|+||+|.||
T Consensus        58 l~h~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~ni  132 (290)
T cd05580          58 IRHPFLVNLYGSFQDD-----SNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENL  132 (290)
T ss_pred             CCCCCccceeeEEEcC-----CeEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHE
Confidence            5799999999999665     67999999995 79999999888999999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  159 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      +++.++.++|+|||.+......  .....+++.|+|||.+.+. ..+.++|+||+|+++++|++|..||.+.........
T Consensus       133 li~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~  209 (290)
T cd05580         133 LLDSDGYIKITDFGFAKRVKGR--TYTLCGTPEYLAPEIILSK-GYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEK  209 (290)
T ss_pred             EECCCCCEEEeeCCCccccCCC--CCCCCCCccccChhhhcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            9999999999999998775544  2344678899999988544 478899999999999999999999987664443333


Q ss_pred             HHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCC-----CHHHHhcCCCCCC
Q 023609          160 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI-----TVEDALAHPYLGS  234 (280)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~ell~h~~~~~  234 (280)
                      +...  .+                            ..-+.++..++++|.+||+.||.+|+     +++++++||||+.
T Consensus       210 ~~~~--~~----------------------------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~  259 (290)
T cd05580         210 ILEG--KV----------------------------RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAG  259 (290)
T ss_pred             HhcC--Cc----------------------------cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCccccc
Confidence            3210  00                            01124578899999999999999999     9999999999987


Q ss_pred             Cc
Q 023609          235 LH  236 (280)
Q Consensus       235 ~~  236 (280)
                      +.
T Consensus       260 ~~  261 (290)
T cd05580         260 ID  261 (290)
T ss_pred             CC
Confidence            63

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=4.8e-37  Score=256.83  Aligned_cols=201  Identities=28%  Similarity=0.443  Sum_probs=160.8

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++.+...     ...|+||||++ ++|.+++...+.+++.+++.++.|++.||+|||+.|++|+||+|+||
T Consensus        63 l~h~~ii~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~ni  137 (267)
T cd06645          63 CKHSNIVAYFGSYLRR-----DKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANI  137 (267)
T ss_pred             CCCCCeeeEEEEEEeC-----CEEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHE
Confidence            5799999999998665     67899999998 59999998888999999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCC-ccccceeccccccchhcc--CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023609           80 LLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLL--NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ  156 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~--~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  156 (280)
                      +++.++.++|+|||.+....... ......++..|+|||.+.  ....++.++|+||+||++|+|++|..||........
T Consensus       138 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~  217 (267)
T cd06645         138 LLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA  217 (267)
T ss_pred             EECCCCCEEECcceeeeEccCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh
Confidence            99999999999999987654321 223456788999999874  233477899999999999999999999865443222


Q ss_pred             HHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCC
Q 023609          157 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPY  231 (280)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~  231 (280)
                      ..........++                        . ......++..+.++|.+||+.||.+|||+.++++|||
T Consensus       218 ~~~~~~~~~~~~------------------------~-~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         218 LFLMTKSNFQPP------------------------K-LKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             HHhhhccCCCCC------------------------c-ccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence            211111000000                        0 0111246778999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=5.3e-37  Score=256.45  Aligned_cols=197  Identities=29%  Similarity=0.549  Sum_probs=161.5

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++...     ...++||||++ ++|.+++...+.+++..+..++.|++.||++||+.|++|+||+|+||
T Consensus        63 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~ni  137 (267)
T cd06628          63 LQHENIVQYLGSSLDA-----DHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANI  137 (267)
T ss_pred             cCCCCeeeEEEEEEeC-----CccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHE
Confidence            5799999999998655     67899999997 59999998888899999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCC-------ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 023609           80 LLNANCDLKICDFGLARVTSETD-------FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD  152 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  152 (280)
                      +++.++.++|+|||.+.......       ......++..|+|||.+.+. .++.++|+||+||++++|++|..||.+..
T Consensus       138 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~  216 (267)
T cd06628         138 LVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQT-SYTRKADIWSLGCLVVEMLTGKHPFPDCT  216 (267)
T ss_pred             EEcCCCCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccC-CCCchhhhHHHHHHHHHHhhCCCCCCCcc
Confidence            99999999999999987554211       11123467889999988544 47889999999999999999999998765


Q ss_pred             hHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 023609          153 HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  232 (280)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~  232 (280)
                      .......+..... +                            .....++..+.++|++||+.||.+||++.++++||||
T Consensus       217 ~~~~~~~~~~~~~-~----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         217 QLQAIFKIGENAS-P----------------------------EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             HHHHHHHHhccCC-C----------------------------cCCcccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence            4433332221100 0                            1112567889999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.9e-37  Score=265.30  Aligned_cols=200  Identities=29%  Similarity=0.513  Sum_probs=157.2

Q ss_pred             CCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHcCCC-CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE
Q 023609            3 HENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQA-LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   81 (280)
Q Consensus         3 HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~-l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nili   81 (280)
                      |.+||+++||-..+     +.+||||||-+-+|..++++++. ++.-.++.+..||+.|+.+.|.+||||.||||.|+++
T Consensus       419 ~~~IIqL~DYEv~d-----~~lYmvmE~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl  493 (677)
T KOG0596|consen  419 HDKIIQLYDYEVTD-----GYLYMVMECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL  493 (677)
T ss_pred             CceEEEEeeeeccC-----ceEEEEeecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE
Confidence            78999999997664     77999999888899999988765 4435899999999999999999999999999999988


Q ss_pred             ccCCCEEEeeccceeeccCCC---ccccceeccccccchhccCCC----------CCCcchhHHHHHHHHHHHHhCCCCC
Q 023609           82 NANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSS----------DYTAAIDVWSVGCIFMELMDRKPLF  148 (280)
Q Consensus        82 ~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~----------~~~~~~DiwslG~il~~ll~g~~pf  148 (280)
                       -+|.+||+|||+|.......   .....+||+.||+||.+....          +.++++||||||||+|+|+.|++||
T Consensus       494 -VkG~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf  572 (677)
T KOG0596|consen  494 -VKGRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPF  572 (677)
T ss_pred             -EeeeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCch
Confidence             56789999999998766553   234568999999999984322          2567899999999999999999999


Q ss_pred             CCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCCh--HHHHHHHHhhcCCCCCCCCHHHH
Q 023609          149 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHP--SAIDLVEKMLTFDPRQRITVEDA  226 (280)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~li~~~L~~dp~~R~t~~el  226 (280)
                      ..-..  .+++ +..+-.|.                         .+-.||..++  ++.++++.||.+||.+|||+.++
T Consensus       573 ~~~~n--~~aK-l~aI~~P~-------------------------~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eL  624 (677)
T KOG0596|consen  573 GQIIN--QIAK-LHAITDPN-------------------------HEIEFPDIPENDELIDVMKCCLARDPKKRWSIPEL  624 (677)
T ss_pred             HHHHH--HHHH-HHhhcCCC-------------------------ccccccCCCCchHHHHHHHHHHhcCcccCCCcHHH
Confidence            43211  1111 11121221                         1122333332  38999999999999999999999


Q ss_pred             hcCCCCCCCc
Q 023609          227 LAHPYLGSLH  236 (280)
Q Consensus       227 l~h~~~~~~~  236 (280)
                      |+|||++...
T Consensus       625 LqhpFl~~~~  634 (677)
T KOG0596|consen  625 LQHPFLQIQP  634 (677)
T ss_pred             hcCccccccc
Confidence            9999998853

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.5e-37  Score=270.84  Aligned_cols=200  Identities=23%  Similarity=0.416  Sum_probs=168.5

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN--VLHRDLKPS   77 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~g--i~H~di~~~   77 (280)
                      |+||||+++|++|.+...   ..+.+|+|++. |+|..|+++.+.++.+.++.|++||+.||.|||++.  |+|||||-+
T Consensus        98 L~H~NIirfy~SW~d~~n---~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCD  174 (632)
T KOG0584|consen   98 LKHPNIIRFYDSWVDTDN---KTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCD  174 (632)
T ss_pred             CCCCceeeeeeheecCCC---ceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccc
Confidence            789999999999987643   66899999997 899999999999999999999999999999999997  999999999


Q ss_pred             cEEEccC-CCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC-ChHH
Q 023609           78 NLLLNAN-CDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGR-DHVH  155 (280)
Q Consensus        78 nili~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~  155 (280)
                      ||||+++ |.+||+|+|+|....... ....+|||.|||||.+.  ..|...+||||+|++++||+|+..||.-- +..+
T Consensus       175 NIFinG~~G~VKIGDLGLAtl~r~s~-aksvIGTPEFMAPEmYE--E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQ  251 (632)
T KOG0584|consen  175 NIFVNGNLGEVKIGDLGLATLLRKSH-AKSVIGTPEFMAPEMYE--ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQ  251 (632)
T ss_pred             eEEEcCCcCceeecchhHHHHhhccc-cceeccCccccChHHHh--hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHH
Confidence            9999875 999999999998654432 23478999999999885  45899999999999999999999999754 4555


Q ss_pred             HHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCC
Q 023609          156 QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  235 (280)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~  235 (280)
                      +++++.+.+  .|...                          ..--++++++||.+||.. .++|+|+.|+|.||||..-
T Consensus       252 IYKKV~SGi--KP~sl--------------------------~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  252 IYKKVTSGI--KPAAL--------------------------SKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDED  302 (632)
T ss_pred             HHHHHHcCC--CHHHh--------------------------hccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhccc
Confidence            555554322  22110                          011257899999999998 9999999999999999874

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=2.2e-36  Score=251.30  Aligned_cols=198  Identities=29%  Similarity=0.496  Sum_probs=160.8

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS   77 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~   77 (280)
                      ++||||+++++.+....    ...|++|||++ ++|.+++...  ..+++.+++.++.|++.||++||+.|++|+||+|+
T Consensus        56 l~~~~i~~~~~~~~~~~----~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~  131 (257)
T cd08223          56 LKHPNIVAYRESWEGED----GLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQ  131 (257)
T ss_pred             CCCCCeeeeeeeecCCC----CEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCch
Confidence            57999999999875331    45899999997 6999998753  45999999999999999999999999999999999


Q ss_pred             cEEEccCCCEEEeeccceeeccCCC-ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023609           78 NLLLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ  156 (280)
Q Consensus        78 nili~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  156 (280)
                      ||+++.++.++|+|||.+....... ......+++.|+|||...+ ..++.++|+||+|+++++|++|..||.+.+....
T Consensus       132 nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~  210 (257)
T cd08223         132 NVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSN-KPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL  210 (257)
T ss_pred             hEEEecCCcEEEecccceEEecccCCccccccCCcCccChhHhcC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH
Confidence            9999999999999999987654322 2234467888999998854 4478899999999999999999999987665443


Q ss_pred             HHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 023609          157 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  232 (280)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~  232 (280)
                      ...+......                             ..-+.+++.+.+++.+||+.||.+|||+.++++||||
T Consensus       211 ~~~~~~~~~~-----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         211 VYRIIEGKLP-----------------------------PMPKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             HHHHHhcCCC-----------------------------CCccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            3332221100                             0112567889999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.6e-37  Score=254.61  Aligned_cols=200  Identities=26%  Similarity=0.488  Sum_probs=164.7

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nil   80 (280)
                      +||||+++++++...     ...|+|+||++ ++|.+++...+.+++..+..++.|++.||.|||+.|++|+||+|+||+
T Consensus        55 ~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil  129 (260)
T cd05611          55 ESPYVAKLYYSFQSK-----DYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLL  129 (260)
T ss_pred             CCCCeeeeeeeEEcC-----CeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeE
Confidence            799999999999654     67999999997 699999988888999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 023609           81 LNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL  160 (280)
Q Consensus        81 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~  160 (280)
                      ++.++.++|+|||.+......   ....++..|++||.+.+.. ++.++|+||+|+++|+|++|..||.+.+.......+
T Consensus       130 ~~~~~~~~l~dfg~~~~~~~~---~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~  205 (260)
T cd05611         130 IDQTGHLKLTDFGLSRNGLEN---KKFVGTPDYLAPETILGVG-DDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNI  205 (260)
T ss_pred             ECCCCcEEEeecccceecccc---ccCCCCcCccChhhhcCCC-CcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence            999999999999988764432   2345678899999986554 788999999999999999999999876655443332


Q ss_pred             HHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCC---HHHHhcCCCCCCCc
Q 023609          161 IELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT---VEDALAHPYLGSLH  236 (280)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t---~~ell~h~~~~~~~  236 (280)
                      ......                          ......+.+++++.++|.+||+.||.+|||   ++|++.||||.+.+
T Consensus       206 ~~~~~~--------------------------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~  258 (260)
T cd05611         206 LSRRIN--------------------------WPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSIN  258 (260)
T ss_pred             HhcccC--------------------------CCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCC
Confidence            211000                          000112257889999999999999999995   47999999998753

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1.3e-36  Score=252.40  Aligned_cols=197  Identities=28%  Similarity=0.433  Sum_probs=163.2

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS   77 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~   77 (280)
                      ++||||+++++++...     ...|+||||+. ++|.+++...  ..+++..++.++.|++.||.|||+.|++|+||+|+
T Consensus        56 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~  130 (256)
T cd08529          56 LDSSYIIRYYESFLDK-----GKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSL  130 (256)
T ss_pred             cCCCCeehheeeeccC-----CEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcc
Confidence            5899999999998765     67999999997 6999999764  56999999999999999999999999999999999


Q ss_pred             cEEEccCCCEEEeeccceeeccCCCc-cccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023609           78 NLLLNANCDLKICDFGLARVTSETDF-MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ  156 (280)
Q Consensus        78 nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  156 (280)
                      ||+++.++.++|+|||.+........ .....+++.|+|||...+. .++.++|+||+||++++|++|..||...+....
T Consensus       131 nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~  209 (256)
T cd08529         131 NLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDK-PYNEKSDVWALGVVLYECCTGKHPFDANNQGAL  209 (256)
T ss_pred             eEEEeCCCCEEEcccccceeccCccchhhccccCccccCHHHhcCC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            99999999999999999876544322 2334678889999988544 478899999999999999999999987765544


Q ss_pred             HHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 023609          157 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  232 (280)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~  232 (280)
                      ...+......                             .....++.++.+++++||+.+|++||++.++++|||+
T Consensus       210 ~~~~~~~~~~-----------------------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         210 ILKIIRGVFP-----------------------------PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             HHHHHcCCCC-----------------------------CCccccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence            4433221111                             0111567889999999999999999999999999995

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=3.9e-37  Score=265.38  Aligned_cols=205  Identities=21%  Similarity=0.407  Sum_probs=166.0

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      ++||||+++++++...     +..|+||||+. |+|.+++.. ++.+++..++.++.|++.||+|||++||+||||||+|
T Consensus        58 ~~~~~i~~l~~~~~~~-----~~~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~N  132 (331)
T cd05624          58 GDCQWITTLHYAFQDE-----NYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDN  132 (331)
T ss_pred             CCCCCEeeEEEEEEcC-----CEEEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHH
Confidence            4799999999999665     67999999996 699999986 4679999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCCCcc--ccceeccccccchhccCC----CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 023609           79 LLLNANCDLKICDFGLARVTSETDFM--TEYVVTRWYRAPELLLNS----SDYTAAIDVWSVGCIFMELMDRKPLFPGRD  152 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~  152 (280)
                      |+++.++.++|+|||++.........  ....+++.|+|||++.+.    ..++.++|+||+||++|+|++|+.||.+.+
T Consensus       133 ill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~  212 (331)
T cd05624         133 VLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES  212 (331)
T ss_pred             EEEcCCCCEEEEeccceeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCC
Confidence            99999999999999998765443221  234689999999988542    346789999999999999999999998776


Q ss_pred             hHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCC--CCCHHHHhcCC
Q 023609          153 HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQ--RITVEDALAHP  230 (280)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~--R~t~~ell~h~  230 (280)
                      ..+....+......                         ..+......++.+++++|.+||..++.+  |++++++++||
T Consensus       213 ~~~~~~~i~~~~~~-------------------------~~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~  267 (331)
T cd05624         213 LVETYGKIMNHEER-------------------------FQFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHA  267 (331)
T ss_pred             HHHHHHHHHcCCCc-------------------------ccCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCC
Confidence            65554444321110                         0112223467899999999999976655  56999999999


Q ss_pred             CCCCC
Q 023609          231 YLGSL  235 (280)
Q Consensus       231 ~~~~~  235 (280)
                      ||+..
T Consensus       268 ~f~~~  272 (331)
T cd05624         268 FFEGI  272 (331)
T ss_pred             CcCCC
Confidence            99874

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-36  Score=256.99  Aligned_cols=227  Identities=35%  Similarity=0.757  Sum_probs=173.2

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHH-HHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQ-IIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~-~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++...     ...++||||+++++.+ +..+...+++..++.++.||+.||+|||+.|++|+||+|+||
T Consensus        57 l~~~~i~~~~~~~~~~-----~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni  131 (288)
T cd07833          57 LRHENIVNLKEAFRRK-----GRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENI  131 (288)
T ss_pred             cCCCCeeehhheEEEC-----CEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHe
Confidence            4799999999999664     6799999999975544 445556799999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCC--ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL  157 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  157 (280)
                      +++.++.++|+|||.+.......  ......++..|+|||.+.+...++.++|+||+|+++++|++|.+||.+....+..
T Consensus       132 ~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~  211 (288)
T cd07833         132 LVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQL  211 (288)
T ss_pred             EECCCCCEEEEeeecccccCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            99999999999999987654432  2334567788999999866546789999999999999999999999988777777


Q ss_pred             HHHHHHhCCCCHHHHhHhhHhHHHHhhhcC-ccccccccccCCC-CChHHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 023609          158 RLLIELIGTPSEAELGFLNENAKKYICQLP-RYQRQSFTEKFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  232 (280)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~-~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~  232 (280)
                      ..+....+.....................+ ..........++. ++.++++||++||..+|++|||+.+++.||||
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         212 YLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             HHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence            776666665444322111100000000000 0001112223334 48899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=1.5e-36  Score=259.30  Aligned_cols=225  Identities=23%  Similarity=0.383  Sum_probs=166.9

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHS-ANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~-~gi~H~di~~~n   78 (280)
                      ++||||+++++.+...     +.+|+||||++ ++|.+++.+.+.+++..+..++.|++.||.|||+ .|++|+||+|+|
T Consensus        56 l~h~~iv~~~~~~~~~-----~~~~lv~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~n  130 (308)
T cd06615          56 CNSPYIVGFYGAFYSD-----GEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSN  130 (308)
T ss_pred             CCCCCCCeEEEEEeeC-----CEEEEEeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHH
Confidence            5799999999999765     67999999997 5999999888889999999999999999999997 699999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023609           79 LLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  158 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  158 (280)
                      |+++.++.++|+|||.+....... .....++..|+|||.+.+ ..++.++|+||+||++++|++|..||.+.+......
T Consensus       131 il~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~aPE~~~~-~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~  208 (308)
T cd06615         131 ILVNSRGEIKLCDFGVSGQLIDSM-ANSFVGTRSYMSPERLQG-THYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEA  208 (308)
T ss_pred             EEEecCCcEEEccCCCcccccccc-cccCCCCcCccChhHhcC-CCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHH
Confidence            999999999999999886543321 234567889999998754 347889999999999999999999997665333222


Q ss_pred             HHHHHhCCCCHH--------------HHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHH
Q 023609          159 LLIELIGTPSEA--------------ELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVE  224 (280)
Q Consensus       159 ~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~  224 (280)
                      .+..........              ......+.........    ..  ..-...++.++++++.+||..||++|||+.
T Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~--~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~  282 (308)
T cd06615         209 MFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEP----PP--KLPSGAFSDEFQDFVDKCLKKNPKERADLK  282 (308)
T ss_pred             hhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCC----Cc--cCcCcccCHHHHHHHHHHccCChhhCcCHH
Confidence            111110000000              0000000000000000    00  000113678899999999999999999999


Q ss_pred             HHhcCCCCCCCcCC
Q 023609          225 DALAHPYLGSLHDI  238 (280)
Q Consensus       225 ell~h~~~~~~~~~  238 (280)
                      ++++||||.+...+
T Consensus       283 ~ll~~~~~~~~~~~  296 (308)
T cd06615         283 ELTKHPFIKRAELE  296 (308)
T ss_pred             HHhcChhhhhcccc
Confidence            99999999886443

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.3e-36  Score=256.34  Aligned_cols=203  Identities=24%  Similarity=0.422  Sum_probs=162.9

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      ++||||+++++++...     ...|+|+||++ ++|..++.+ .+++++..+..++.|++.||.|||+.|++||||+|+|
T Consensus        59 l~h~~ii~~~~~~~~~-----~~~~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~n  133 (282)
T cd06643          59 CDHPNIVKLLDAFYYE-----NNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGN  133 (282)
T ss_pred             CCCCCeeeEEEEEeeC-----CEEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCccc
Confidence            5799999999998665     67899999998 588877754 4679999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCC-CccccceeccccccchhccC----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh
Q 023609           79 LLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLN----SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDH  153 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~  153 (280)
                      |+++.++.++++|||++...... .......++..|+|||.+..    ...++.++|+||+||++|+|++|.+||.+.+.
T Consensus       134 ili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~  213 (282)
T cd06643         134 ILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP  213 (282)
T ss_pred             EEEccCCCEEEccccccccccccccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH
Confidence            99999999999999998654322 12234567889999998742    23466789999999999999999999987665


Q ss_pred             HHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCC
Q 023609          154 VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLG  233 (280)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~  233 (280)
                      ......+.......                           ......++.+++++|.+||+.||.+|||+.++++||||.
T Consensus       214 ~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~  266 (282)
T cd06643         214 MRVLLKIAKSEPPT---------------------------LAQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVT  266 (282)
T ss_pred             HHHHHHHhhcCCCC---------------------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEe
Confidence            44433332211000                           001124678899999999999999999999999999998


Q ss_pred             CC
Q 023609          234 SL  235 (280)
Q Consensus       234 ~~  235 (280)
                      ..
T Consensus       267 ~~  268 (282)
T cd06643         267 VN  268 (282)
T ss_pred             cc
Confidence            74

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-37  Score=265.04  Aligned_cols=193  Identities=28%  Similarity=0.454  Sum_probs=166.3

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS--NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS   77 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~--~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~   77 (280)
                      |+|+|||++++++...     ..+||||||+. |+|.++++.  ++.++..+...++.||++|.+||+++++|||||-..
T Consensus       258 L~H~~lV~l~gV~~~~-----~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAAR  332 (468)
T KOG0197|consen  258 LRHEKLVKLYGVCTKQ-----EPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAAR  332 (468)
T ss_pred             CcccCeEEEEEEEecC-----CceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhh
Confidence            6899999999999654     46999999998 999999986  456999999999999999999999999999999999


Q ss_pred             cEEEccCCCEEEeeccceeeccCCCcc--ccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 023609           78 NLLLNANCDLKICDFGLARVTSETDFM--TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHV  154 (280)
Q Consensus        78 nili~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~  154 (280)
                      ||||+.+..+||+|||+++..++....  ........|+|||++.. +.++.+|||||+|++++|+.| |+.||++.+..
T Consensus       333 NiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~-~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~  411 (468)
T KOG0197|consen  333 NILVDEDLVVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNY-GKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNE  411 (468)
T ss_pred             heeeccCceEEEcccccccccCCCceeecCCCCCCceecCHHHHhh-CCcccccceeehhhhHHHHhccCCCCCCCCCHH
Confidence            999999999999999999966554321  22233456999999954 459999999999999999997 89999999999


Q ss_pred             HHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          155 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                      +.+..+.+...-|.+                             +.+|.++-++|..||..+|++|||++.+..
T Consensus       412 ev~~~le~GyRlp~P-----------------------------~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~  456 (468)
T KOG0197|consen  412 EVLELLERGYRLPRP-----------------------------EGCPDEVYELMKSCWHEDPEDRPTFETLRE  456 (468)
T ss_pred             HHHHHHhccCcCCCC-----------------------------CCCCHHHHHHHHHHhhCCcccCCCHHHHHH
Confidence            988888766555443                             267889999999999999999999986543

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1.1e-36  Score=257.17  Aligned_cols=203  Identities=28%  Similarity=0.457  Sum_probs=166.3

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS   77 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~   77 (280)
                      ++|+||+++++.+...     ...++||||+. ++|.+++...  ..+++..+..++.|++.||.|||+.||+||||+|+
T Consensus        57 l~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~  131 (285)
T cd05632          57 VNSQFVVNLAYAYETK-----DALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPE  131 (285)
T ss_pred             cCCcCceeEEEEEecC-----CEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHH
Confidence            5799999999998665     67999999998 5898887643  36999999999999999999999999999999999


Q ss_pred             cEEEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 023609           78 NLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL  157 (280)
Q Consensus        78 nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  157 (280)
                      ||+++.++.++|+|||++.............++..|+|||.+.+. .++.++|+||+||++++|++|..||.+.......
T Consensus       132 Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~  210 (285)
T cd05632         132 NILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQ-RYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKR  210 (285)
T ss_pred             HEEECCCCCEEEecCCcceecCCCCcccCCCCCcCccChHHhcCC-CCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            999999999999999998765443333455789999999998544 4789999999999999999999999876654443


Q ss_pred             HHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCC-----HHHHhcCCCC
Q 023609          158 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT-----VEDALAHPYL  232 (280)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~ell~h~~~  232 (280)
                      ..+.........                          ...+.++.++.+|+.+||+.||.+|||     +.+++.|+||
T Consensus       211 ~~~~~~~~~~~~--------------------------~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~  264 (285)
T cd05632         211 EEVDRRVLETEE--------------------------VYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFF  264 (285)
T ss_pred             HHHHHhhhcccc--------------------------ccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhh
Confidence            333221111100                          112357788999999999999999999     8899999999


Q ss_pred             CCC
Q 023609          233 GSL  235 (280)
Q Consensus       233 ~~~  235 (280)
                      .+.
T Consensus       265 ~~~  267 (285)
T cd05632         265 RNM  267 (285)
T ss_pred             hcC
Confidence            886

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-36  Score=255.35  Aligned_cols=201  Identities=24%  Similarity=0.424  Sum_probs=165.3

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++...     ...|+|+||++ ++|.+++... ++++..++.++.|++.|+.|||+.|++|+||+|+||
T Consensus        56 l~h~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni  129 (274)
T cd06609          56 CRSPYITKYYGSFLKG-----SKLWIIMEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANI  129 (274)
T ss_pred             cCCCCeeeeeEEEEEC-----CeEEEEEEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHE
Confidence            5799999999998655     67999999997 5999998765 899999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCC-CccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  158 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.++.++|+|||.+...... .......++..|+|||.+.+.. ++.++|+||+|+++|+|++|..||.+.+......
T Consensus       130 ~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~  208 (274)
T cd06609         130 LLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSG-YDEKADIWSLGITAIELAKGEPPLSDLHPMRVLF  208 (274)
T ss_pred             EECCCCCEEEcccccceeecccccccccccCCccccChhhhccCC-CCchhhHHHHHHHHHHHHhCCCCcccCchHHHHH
Confidence            9999999999999999876544 2233456778899999886544 8899999999999999999999997665443332


Q ss_pred             HHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCc
Q 023609          159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  236 (280)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~  236 (280)
                      .+......                          ....  ..++.++.+++.+||..||.+|||++++++||||.+..
T Consensus       209 ~~~~~~~~--------------------------~~~~--~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~  258 (274)
T cd06609         209 LIPKNNPP--------------------------SLEG--NKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAK  258 (274)
T ss_pred             HhhhcCCC--------------------------CCcc--cccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCCC
Confidence            22211000                          0000  12678899999999999999999999999999998854

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-36  Score=256.16  Aligned_cols=203  Identities=28%  Similarity=0.486  Sum_probs=163.6

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      |+||||+++++.+...     ...|+||||++ ++|.+++.+. +.+++..++.++.|++.||.|||+.|++|+||+|+|
T Consensus        59 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~n  133 (280)
T cd06611          59 CKHPNIVGLYEAYFYE-----NKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGN  133 (280)
T ss_pred             CCCCceeEEEEEEecC-----CeEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhh
Confidence            5799999999999765     67899999998 5999998763 579999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCC-CccccceeccccccchhccC----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh
Q 023609           79 LLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLN----SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDH  153 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~  153 (280)
                      |+++.++.++|+|||.+...... .......+++.|+|||.+..    ...++.++|+||+|+++|+|++|..||.+.+.
T Consensus       134 ili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~  213 (280)
T cd06611         134 ILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP  213 (280)
T ss_pred             EEECCCCCEEEccCccchhhcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH
Confidence            99999999999999987654332 12234467888999998742    23366789999999999999999999987655


Q ss_pred             HHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCC
Q 023609          154 VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLG  233 (280)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~  233 (280)
                      ......+.... .+.                          ...-+.++.++.++|.+||+.+|.+||++.++++||||.
T Consensus       214 ~~~~~~~~~~~-~~~--------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~  266 (280)
T cd06611         214 MRVLLKILKSE-PPT--------------------------LDQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVS  266 (280)
T ss_pred             HHHHHHHhcCC-CCC--------------------------cCCcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhc
Confidence            44333221110 000                          011125678899999999999999999999999999998


Q ss_pred             CC
Q 023609          234 SL  235 (280)
Q Consensus       234 ~~  235 (280)
                      +.
T Consensus       267 ~~  268 (280)
T cd06611         267 DQ  268 (280)
T ss_pred             cc
Confidence            76

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-37  Score=247.54  Aligned_cols=205  Identities=26%  Similarity=0.427  Sum_probs=170.1

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcE
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIR-SNQALSEEHCQYFLYQILRGLKYIHS-ANVLHRDLKPSNL   79 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~-~~~~l~~~~~~~i~~qll~al~~LH~-~gi~H~di~~~ni   79 (280)
                      +.|+||+.+++|..+     ..++|-||.|...+..+++ ..++++|..+-++...++.||.||.. +||+|||+||+||
T Consensus       149 dcpyIV~c~GyFi~n-----~dV~IcMelMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNI  223 (391)
T KOG0983|consen  149 DCPYIVQCFGYFITN-----TDVFICMELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNI  223 (391)
T ss_pred             CCCeeeeeeeEEeeC-----chHHHHHHHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccce
Confidence            369999999999876     6789999999876666665 34679999999999999999999995 5899999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCCccccceeccccccchhccC--CCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-hHHH
Q 023609           80 LLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLN--SSDYTAAIDVWSVGCIFMELMDRKPLFPGRD-HVHQ  156 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~  156 (280)
                      ++|..|.+||||||++.+..+..-.....|-+.|||||.+..  ...|..++||||||+.+++|.||..||.+.+ +.+.
T Consensus       224 LlDe~GniKlCDFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~  303 (391)
T KOG0983|consen  224 LLDERGNIKLCDFGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEV  303 (391)
T ss_pred             EEccCCCEEeecccccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHH
Confidence            999999999999999998877766667788899999998853  2457889999999999999999999999864 4445


Q ss_pred             HHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCc
Q 023609          157 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  236 (280)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~  236 (280)
                      +.++.... .|.-+                          .-.++|+++++|+..||++|+.+||...++|+|||+..+.
T Consensus       304 ltkvln~e-PP~L~--------------------------~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye  356 (391)
T KOG0983|consen  304 LTKVLNEE-PPLLP--------------------------GHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYE  356 (391)
T ss_pred             HHHHHhcC-CCCCC--------------------------cccCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecc
Confidence            55554411 11110                          0114899999999999999999999999999999998875


Q ss_pred             CC
Q 023609          237 DI  238 (280)
Q Consensus       237 ~~  238 (280)
                      ..
T Consensus       357 ~a  358 (391)
T KOG0983|consen  357 TA  358 (391)
T ss_pred             hh
Confidence            43

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=2.3e-36  Score=252.41  Aligned_cols=199  Identities=28%  Similarity=0.440  Sum_probs=161.9

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++...     ...++|+||+. ++|.+++.+.+++++..+..++.|++.||+|||+.|++|+||+|+||
T Consensus        59 l~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~ni  133 (265)
T cd06631          59 LKHVNIVQYLGTCLDD-----NTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNV  133 (265)
T ss_pred             cCCCCEeeEeeEeecC-----CeEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhE
Confidence            5799999999999665     67999999997 59999998878899999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCC-------CccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 023609           80 LLNANCDLKICDFGLARVTSET-------DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD  152 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  152 (280)
                      +++.++.++|+|||.+......       .......++..|+|||.+.+. .++.++|+||+||++++|++|..||...+
T Consensus       134 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~p~~~~~  212 (265)
T cd06631         134 MLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINES-GYGRKSDIWSIGCTVFEMATGKPPLASMD  212 (265)
T ss_pred             EECCCCeEEeccchhhHhhhhccccccccccccccCCCccccChhhhcCC-CCcchhhHHHHHHHHHHHHhCCCccccCC
Confidence            9999999999999988654211       112234578889999988544 47889999999999999999999997655


Q ss_pred             hHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 023609          153 HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  232 (280)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~  232 (280)
                      .......+....+.                           ....-+.++.++.++|++||+.+|.+|||+.++++||||
T Consensus       213 ~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         213 RLAAMFYIGAHRGL---------------------------MPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             hHHHHHHhhhccCC---------------------------CCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            43332222111000                           011123578899999999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-37  Score=283.54  Aligned_cols=197  Identities=26%  Similarity=0.458  Sum_probs=172.0

Q ss_pred             CCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEc
Q 023609            4 ENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   82 (280)
Q Consensus         4 pnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nili~   82 (280)
                      +=|+.++-+|++.     .++|+||||+. |+|..++.+..+++++.++.++..|+.||.-||+.|+|||||||+||++|
T Consensus       135 ~Wiv~LhyAFQD~-----~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld  209 (1317)
T KOG0612|consen  135 EWIVQLHYAFQDE-----RYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLD  209 (1317)
T ss_pred             HHHHHHHHHhcCc-----cceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEec
Confidence            4477888889877     88999999996 69999999888999999999999999999999999999999999999999


Q ss_pred             cCCCEEEeeccceeeccCCCc--cccceeccccccchhccC----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023609           83 ANCDLKICDFGLARVTSETDF--MTEYVVTRWYRAPELLLN----SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ  156 (280)
Q Consensus        83 ~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  156 (280)
                      ..|+++|.|||.+-.....+.  ....+|||.|.|||++..    .+.|++.+|.||+||++|+|+.|..||.+.+-.+.
T Consensus       210 ~~GHikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveT  289 (1317)
T KOG0612|consen  210 KSGHIKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVET  289 (1317)
T ss_pred             ccCcEeeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHH
Confidence            999999999999876654432  345789999999999852    25689999999999999999999999999999999


Q ss_pred             HHHHHHH---hCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCC---HHHHhcCC
Q 023609          157 LRLLIEL---IGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT---VEDALAHP  230 (280)
Q Consensus       157 ~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t---~~ell~h~  230 (280)
                      +.+|+..   +..|.                             -..+|+++++||++++. +|..|+.   ++++-+||
T Consensus       290 Y~KIm~hk~~l~FP~-----------------------------~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~Hp  339 (1317)
T KOG0612|consen  290 YGKIMNHKESLSFPD-----------------------------ETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHP  339 (1317)
T ss_pred             HHHHhchhhhcCCCc-----------------------------ccccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCc
Confidence            8888764   11121                             12589999999999997 8999998   99999999


Q ss_pred             CCCCC
Q 023609          231 YLGSL  235 (280)
Q Consensus       231 ~~~~~  235 (280)
                      ||.+.
T Consensus       340 FF~g~  344 (1317)
T KOG0612|consen  340 FFEGI  344 (1317)
T ss_pred             cccCC
Confidence            99975

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.2e-36  Score=255.84  Aligned_cols=204  Identities=26%  Similarity=0.424  Sum_probs=164.0

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ--ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS   77 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~--~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~   77 (280)
                      ++||||+++++.+...     ...|+||||++ ++|.+++.+.+  .+++..+..++.|++.||.|||+.|++|+||+|+
T Consensus        50 l~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~  124 (277)
T cd05577          50 VSSRFIVSLAYAFETK-----DDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPE  124 (277)
T ss_pred             CCCCCEeeeeeEEecC-----CeEEEEEecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHH
Confidence            5799999999998654     67899999998 69999997655  6999999999999999999999999999999999


Q ss_pred             cEEEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 023609           78 NLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL  157 (280)
Q Consensus        78 nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  157 (280)
                      ||+++.++.++|+|||.+.............++..|+|||.+.+.. ++.++|+||+|+++++|++|..||.+.......
T Consensus       125 Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~  203 (277)
T cd05577         125 NVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEV-YDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEK  203 (277)
T ss_pred             HEEECCCCCEEEccCcchhhhccCCccccccCCCCcCCHHHhcCCC-CCchhhhHHHHHHHHHHhhCCCCCCCCcccccH
Confidence            9999999999999999887654433333456678899999986544 788999999999999999999999765432111


Q ss_pred             HHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCC-----CHHHHhcCCCC
Q 023609          158 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI-----TVEDALAHPYL  232 (280)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~ell~h~~~  232 (280)
                      ..+......                          ......+.++++++++|++||+.||.+||     ++.++++||||
T Consensus       204 ~~~~~~~~~--------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~  257 (277)
T cd05577         204 EELKRRTLE--------------------------MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLF  257 (277)
T ss_pred             HHHHhcccc--------------------------ccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhh
Confidence            111111000                          00011235688999999999999999999     89999999999


Q ss_pred             CCCc
Q 023609          233 GSLH  236 (280)
Q Consensus       233 ~~~~  236 (280)
                      .++.
T Consensus       258 ~~~~  261 (277)
T cd05577         258 KDLN  261 (277)
T ss_pred             hcCC
Confidence            8653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.1e-36  Score=274.75  Aligned_cols=205  Identities=25%  Similarity=0.420  Sum_probs=165.5

Q ss_pred             CCCCCeeeeeceecCCCC---CCCCcEEEEeecCC-ccHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q 023609            1 MDHENVVAIRDIIPPPQR---ESFNDVYIAYELMD-TDLHQIIRS----NQALSEEHCQYFLYQILRGLKYIHSANVLHR   72 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~---~~~~~~~iv~e~~~-g~L~~~l~~----~~~l~~~~~~~i~~qll~al~~LH~~gi~H~   72 (280)
                      ++|+||+++++.+.....   .....+++||||+. |+|.+++..    ...+++..+..++.|++.||+|||+.||+||
T Consensus        88 ~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHr  167 (496)
T PTZ00283         88 CDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHR  167 (496)
T ss_pred             CCCCcEEEeecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecC
Confidence            479999999987754321   11124789999997 699999864    2469999999999999999999999999999


Q ss_pred             cCCCCcEEEccCCCEEEeeccceeeccCC---CccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 023609           73 DLKPSNLLLNANCDLKICDFGLARVTSET---DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFP  149 (280)
Q Consensus        73 di~~~nili~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  149 (280)
                      ||||+||+++.++.++|+|||+++.....   .......+|+.|+|||.+.+ ..++.++||||+||++|+|++|..||.
T Consensus       168 DLKP~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~s~k~DVwSlGvilyeLltG~~Pf~  246 (496)
T PTZ00283        168 DIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRR-KPYSKKADMFSLGVLLYELLTLKRPFD  246 (496)
T ss_pred             CCCHHHEEEeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCC-CCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence            99999999999999999999998764332   12334578999999999854 458899999999999999999999998


Q ss_pred             CCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 023609          150 GRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  229 (280)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h  229 (280)
                      +.+....+..+......                             ...+.+++++.+++.+||+.||.+||++.++++|
T Consensus       247 ~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        247 GENMEEVMHKTLAGRYD-----------------------------PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             CCCHHHHHHHHhcCCCC-----------------------------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            77665544433221100                             1123678899999999999999999999999999


Q ss_pred             CCCCCC
Q 023609          230 PYLGSL  235 (280)
Q Consensus       230 ~~~~~~  235 (280)
                      ||++.+
T Consensus       298 p~~~~~  303 (496)
T PTZ00283        298 PICKLF  303 (496)
T ss_pred             HHHHHh
Confidence            998764

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-38  Score=295.97  Aligned_cols=204  Identities=27%  Similarity=0.453  Sum_probs=177.0

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      |+|||||++|++=...     ...+|.||||+ |+|.+.++..+..++...+.+..|++.|++|||+.|||||||||+||
T Consensus      1291 lnHpNlV~YyGVEvHR-----ekv~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI 1365 (1509)
T KOG4645|consen 1291 LNHPNLVRYYGVEVHR-----EKVYIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANI 1365 (1509)
T ss_pred             ccCccccccCceeecH-----HHHHHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccce
Confidence            6899999999987665     56899999997 79999999888899999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCC-----ccccceeccccccchhccCCC--CCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 023609           80 LLNANCDLKICDFGLARVTSETD-----FMTEYVVTRWYRAPELLLNSS--DYTAAIDVWSVGCIFMELMDRKPLFPGRD  152 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~  152 (280)
                      +++.+|.+|++|||.|.....+.     ..+...||+.|||||++.+..  .-..++|||||||++.||+||+.||...+
T Consensus      1366 ~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~d 1445 (1509)
T KOG4645|consen 1366 LLDFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELD 1445 (1509)
T ss_pred             eeecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhcc
Confidence            99999999999999998765442     234568999999999996543  24568999999999999999999998877


Q ss_pred             hHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 023609          153 HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  232 (280)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~  232 (280)
                      ..-.+...+.....|+.+.                            .+|++.++||..||+-||++|.++.|+++|-|-
T Consensus      1446 ne~aIMy~V~~gh~Pq~P~----------------------------~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~ 1497 (1509)
T KOG4645|consen 1446 NEWAIMYHVAAGHKPQIPE----------------------------RLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFG 1497 (1509)
T ss_pred             chhHHHhHHhccCCCCCch----------------------------hhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcc
Confidence            7777777766666665432                            478999999999999999999999999999998


Q ss_pred             CCCcC
Q 023609          233 GSLHD  237 (280)
Q Consensus       233 ~~~~~  237 (280)
                      +.-.+
T Consensus      1498 ~~~~d 1502 (1509)
T KOG4645|consen 1498 KSCTD 1502 (1509)
T ss_pred             ccccc
Confidence            77544

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=2e-36  Score=254.76  Aligned_cols=202  Identities=27%  Similarity=0.449  Sum_probs=163.4

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nil   80 (280)
                      .||||+++++++...     ...|+||||+. |+|.+++...+.+++..++.++.|++.||+|||+.|++||||+|+||+
T Consensus        55 ~~~~i~~~~~~~~~~-----~~~~~v~e~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nil  129 (278)
T cd05606          55 DCPFIVCMSYAFHTP-----DKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANIL  129 (278)
T ss_pred             CCCcEeeeeeeeecC-----CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEE
Confidence            699999999999665     67999999997 699999988888999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 023609           81 LNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL  160 (280)
Q Consensus        81 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~  160 (280)
                      ++.++.++|+|||.+....... .....++..|+|||.+.+...++.++|+||+|+++++|++|..||.+......... 
T Consensus       130 i~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~-  207 (278)
T cd05606         130 LDEHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI-  207 (278)
T ss_pred             ECCCCCEEEccCcCccccCccC-CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHH-
Confidence            9999999999999987543322 23456889999999986554578899999999999999999999976532111100 


Q ss_pred             HHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCC-----CHHHHhcCCCCCCC
Q 023609          161 IELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI-----TVEDALAHPYLGSL  235 (280)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~ell~h~~~~~~  235 (280)
                      .......                       .   ....+.++.++.+++.+||..+|.+||     ++.++++||||...
T Consensus       208 ~~~~~~~-----------------------~---~~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~  261 (278)
T cd05606         208 DRMTLTM-----------------------A---VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSL  261 (278)
T ss_pred             HHHhhcc-----------------------C---CCCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCC
Confidence            0000000                       0   011124678999999999999999999     99999999999876


Q ss_pred             c
Q 023609          236 H  236 (280)
Q Consensus       236 ~  236 (280)
                      .
T Consensus       262 ~  262 (278)
T cd05606         262 D  262 (278)
T ss_pred             C
Confidence            3

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=2.3e-36  Score=253.30  Aligned_cols=203  Identities=25%  Similarity=0.432  Sum_probs=159.7

Q ss_pred             CCCCeeeeeceecCCCCCC-CCcEEEEeecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 023609            2 DHENVVAIRDIIPPPQRES-FNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS   77 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~-~~~~~iv~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~   77 (280)
                      +||||+++++++......+ ....|+||||++ ++|.+++...  ..+++..++.++.|++.||+|||+.|++|+||+|+
T Consensus        61 ~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~  140 (272)
T cd06637          61 HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQ  140 (272)
T ss_pred             CCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHH
Confidence            6999999999986543221 246899999998 5999998863  36899999999999999999999999999999999


Q ss_pred             cEEEccCCCEEEeeccceeeccCC-CccccceeccccccchhccC----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 023609           78 NLLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLN----SSDYTAAIDVWSVGCIFMELMDRKPLFPGRD  152 (280)
Q Consensus        78 nili~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  152 (280)
                      ||+++.++.++|+|||++...... .......++..|+|||.+.+    ...++.++|+||+||++|+|++|..||....
T Consensus       141 nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~  220 (272)
T cd06637         141 NVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH  220 (272)
T ss_pred             HEEECCCCCEEEccCCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccC
Confidence            999999999999999998765332 12234567889999998753    2246779999999999999999999996544


Q ss_pred             hHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 023609          153 HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  232 (280)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~  232 (280)
                      ...........                          ...  ......++.++++||.+||..||.+|||+.+++.||||
T Consensus       221 ~~~~~~~~~~~--------------------------~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         221 PMRALFLIPRN--------------------------PAP--RLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             HHHHHHHHhcC--------------------------CCC--CCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence            33222111100                          000  01112467889999999999999999999999999997

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=2e-36  Score=261.64  Aligned_cols=194  Identities=26%  Similarity=0.427  Sum_probs=151.6

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC--------------------------------------
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--------------------------------------   42 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~--------------------------------------   42 (280)
                      +||||+++++++....    ..+++||||++ |+|.+++...                                      
T Consensus        69 ~h~niv~~~~~~~~~~----~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  144 (338)
T cd05102          69 NHLNVVNLLGACTKPN----GPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASV  144 (338)
T ss_pred             cCcceeeEEeEecCCC----CceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCc
Confidence            7999999999886542    46899999997 6999998642                                      


Q ss_pred             ------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCCEEEeeccceeec
Q 023609           43 ------------------------QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVT   98 (280)
Q Consensus        43 ------------------------~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nili~~~~~~~l~dfg~~~~~   98 (280)
                                              .++++..+..++.||+.||+|||+.||+||||||+||+++.++.++|+|||+++..
T Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~  224 (338)
T cd05102         145 LFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDI  224 (338)
T ss_pred             cccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeeccccccc
Confidence                                    24788899999999999999999999999999999999999999999999999754


Q ss_pred             cCCC---ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhH
Q 023609           99 SETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGF  174 (280)
Q Consensus        99 ~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  174 (280)
                      ....   ......++..|+|||++.+. .++.++||||+||++|+|++ |..||.+................+       
T Consensus       225 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~-------  296 (338)
T cd05102         225 YKDPDYVRKGSARLPLKWMAPESIFDK-VYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRM-------  296 (338)
T ss_pred             ccCcchhcccCCCCCccccCcHHhhcC-CCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCC-------
Confidence            3221   11123445789999988544 47899999999999999996 999998754333222111100000       


Q ss_pred             hhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          175 LNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                                           ...+..++++.+++.+||+.||.+|||+.++++
T Consensus       297 ---------------------~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~  329 (338)
T cd05102         297 ---------------------RAPENATPEIYRIMLACWQGDPKERPTFSALVE  329 (338)
T ss_pred             ---------------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence                                 011256788999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.1e-36  Score=285.38  Aligned_cols=205  Identities=28%  Similarity=0.439  Sum_probs=163.3

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHHC-------C
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS----NQALSEEHCQYFLYQILRGLKYIHSA-------N   68 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~----~~~l~~~~~~~i~~qll~al~~LH~~-------g   68 (280)
                      |+|||||+++++|.....   ..+||||||++ |+|.+++..    .+.+++..++.|+.||+.||+|||+.       +
T Consensus        69 L~HPNIVrl~d~f~de~~---~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~  145 (1021)
T PTZ00266         69 LKHKNIVRYIDRFLNKAN---QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGER  145 (1021)
T ss_pred             cCCCCcCeEEEEEEecCC---CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCC
Confidence            589999999999865422   56899999998 699999864    35799999999999999999999985       4


Q ss_pred             ceeccCCCCcEEEcc-----------------CCCEEEeeccceeeccCCCccccceeccccccchhccCC-CCCCcchh
Q 023609           69 VLHRDLKPSNLLLNA-----------------NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNS-SDYTAAID  130 (280)
Q Consensus        69 i~H~di~~~nili~~-----------------~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~D  130 (280)
                      |+||||||+||+++.                 .+.++|+|||++.............+++.|+|||++.+. ..++.++|
T Consensus       146 IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSD  225 (1021)
T PTZ00266        146 VLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSD  225 (1021)
T ss_pred             ceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhH
Confidence            999999999999954                 345899999999876544444455789999999988543 34788999


Q ss_pred             HHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHH
Q 023609          131 VWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVE  210 (280)
Q Consensus       131 iwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  210 (280)
                      |||||||+|+|++|..||........+.......  +.                           ...+..+.++.+||.
T Consensus       226 VWSLG~ILYELLTGk~PF~~~~~~~qli~~lk~~--p~---------------------------lpi~~~S~eL~dLI~  276 (1021)
T PTZ00266        226 MWALGCIIYELCSGKTPFHKANNFSQLISELKRG--PD---------------------------LPIKGKSKELNILIK  276 (1021)
T ss_pred             HHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHhcC--CC---------------------------CCcCCCCHHHHHHHH
Confidence            9999999999999999997655433322221110  00                           011356789999999


Q ss_pred             HhhcCCCCCCCCHHHHhcCCCCCCCcC
Q 023609          211 KMLTFDPRQRITVEDALAHPYLGSLHD  237 (280)
Q Consensus       211 ~~L~~dp~~R~t~~ell~h~~~~~~~~  237 (280)
                      .||+.+|.+|||+.++|.|+|+..+..
T Consensus       277 ~~L~~dPeeRPSa~QlL~h~~ik~i~~  303 (1021)
T PTZ00266        277 NLLNLSAKERPSALQCLGYQIIKNVGP  303 (1021)
T ss_pred             HHhcCChhHCcCHHHHhccHHHhhcCC
Confidence            999999999999999999999986643

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.7e-36  Score=250.68  Aligned_cols=199  Identities=28%  Similarity=0.508  Sum_probs=163.9

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++...     ...|+|+||++ ++|.+++.+.+.+++..+..++.||+.||++||+.|++|+||+|+||
T Consensus        59 ~~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni  133 (258)
T cd06632          59 LQHPNIVQYLGTEREE-----DNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANI  133 (258)
T ss_pred             cCCCCchheeeeEecC-----CeEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHE
Confidence            4799999999998655     67899999997 59999998888899999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  159 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      +++.++.++|+|||.+.............++..|++||.+.....++.++|+||+|+++++|++|..||......+....
T Consensus       134 ~~~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~  213 (258)
T cd06632         134 LVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFK  213 (258)
T ss_pred             EECCCCCEEEccCccceeccccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHH
Confidence            99999999999999987654443334556788899999885443478899999999999999999999976553332222


Q ss_pred             HHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 023609          160 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  232 (280)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~  232 (280)
                      +......                            ....+.+++++.+++++||+.+|.+|||+.+++.|||+
T Consensus       214 ~~~~~~~----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         214 IGRSKEL----------------------------PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             HHhcccC----------------------------CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence            2110000                            01123568899999999999999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.4e-37  Score=248.78  Aligned_cols=210  Identities=24%  Similarity=0.421  Sum_probs=165.8

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nil   80 (280)
                      .|+||+.++++|.+.     ..+|+|||-+. |+|...|.+++.|+|.++..++..|+.||.|||++||.|||+||+||+
T Consensus       134 gh~nilqLiefFEdd-----~~FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiL  208 (463)
T KOG0607|consen  134 GHKNILQLIEFFEDD-----TRFYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENIL  208 (463)
T ss_pred             CCccHHHHHHHhccc-----ceEEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCcccee
Confidence            499999999999776     67999999996 699999999999999999999999999999999999999999999999


Q ss_pred             EccC---CCEEEeeccceeeccCC--------Cccccceeccccccchhcc----CCCCCCcchhHHHHHHHHHHHHhCC
Q 023609           81 LNAN---CDLKICDFGLARVTSET--------DFMTEYVVTRWYRAPELLL----NSSDYTAAIDVWSVGCIFMELMDRK  145 (280)
Q Consensus        81 i~~~---~~~~l~dfg~~~~~~~~--------~~~~~~~~~~~y~aPE~~~----~~~~~~~~~DiwslG~il~~ll~g~  145 (280)
                      -...   ..+||+||.++......        ....+++|+..|||||++.    ....|..+.|.||||+|+|-|++|.
T Consensus       209 C~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGY  288 (463)
T KOG0607|consen  209 CESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGY  288 (463)
T ss_pred             ecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCC
Confidence            8543   44899999876532211        1234678899999999863    2234788999999999999999999


Q ss_pred             CCCCCCCh-----------HHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhc
Q 023609          146 PLFPGRDH-----------VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLT  214 (280)
Q Consensus       146 ~pf~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~  214 (280)
                      +||.|.=.           ..--..+++.+.                      .....-..+.|.++|.+++++++++|.
T Consensus       289 pPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQ----------------------EGkYeFPdkdWahIS~eakdlisnLlv  346 (463)
T KOG0607|consen  289 PPFVGHCGADCGWDRGEVCRVCQNKLFESIQ----------------------EGKYEFPDKDWAHISSEAKDLISNLLV  346 (463)
T ss_pred             CCccCccCCcCCccCCCccHHHHHHHHHHHh----------------------ccCCcCChhhhHHhhHHHHHHHHHHHh
Confidence            99975411           001111111110                      001111234556889999999999999


Q ss_pred             CCCCCCCCHHHHhcCCCCCCCcCC
Q 023609          215 FDPRQRITVEDALAHPYLGSLHDI  238 (280)
Q Consensus       215 ~dp~~R~t~~ell~h~~~~~~~~~  238 (280)
                      .|+.+|.++.++++|||++.....
T Consensus       347 rda~~rlsa~~vlnhPw~~~~~~e  370 (463)
T KOG0607|consen  347 RDAKQRLSAAQVLNHPWVQRCAPE  370 (463)
T ss_pred             ccHHhhhhhhhccCCccccccchh
Confidence            999999999999999999987543

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=4.6e-36  Score=254.26  Aligned_cols=205  Identities=24%  Similarity=0.434  Sum_probs=162.3

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      ++||||+++++.+...     +..|+||||++ ++|..++.+ ...+++..+..++.|++.||+|||+.|++||||+|+|
T Consensus        66 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~N  140 (292)
T cd06644          66 CNHPYIVKLLGAFYWD-----GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGN  140 (292)
T ss_pred             CCCCcEeeeEEEEEeC-----CeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcce
Confidence            5899999999998655     67999999998 578777654 4569999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCC-CccccceeccccccchhccC----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh
Q 023609           79 LLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLN----SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDH  153 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~  153 (280)
                      |+++.++.++|+|||.+...... .......+++.|+|||.+.+    ...++.++|+||+||++|+|++|..||...+.
T Consensus       141 ili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~  220 (292)
T cd06644         141 VLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP  220 (292)
T ss_pred             EEEcCCCCEEEccCccceeccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccH
Confidence            99999999999999988654322 12234457788999998742    23357789999999999999999999976554


Q ss_pred             HHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCC
Q 023609          154 VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLG  233 (280)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~  233 (280)
                      ......+.... .+                          .......++.++.++|.+||..||++||++.++++||||.
T Consensus       221 ~~~~~~~~~~~-~~--------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~  273 (292)
T cd06644         221 MRVLLKIAKSE-PP--------------------------TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVS  273 (292)
T ss_pred             HHHHHHHhcCC-Cc--------------------------cCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCcccc
Confidence            33322221100 00                          0011125678899999999999999999999999999998


Q ss_pred             CCcC
Q 023609          234 SLHD  237 (280)
Q Consensus       234 ~~~~  237 (280)
                      .+..
T Consensus       274 ~~~~  277 (292)
T cd06644         274 SVTS  277 (292)
T ss_pred             cccc
Confidence            8653

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=2.5e-36  Score=252.47  Aligned_cols=200  Identities=24%  Similarity=0.458  Sum_probs=158.7

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++.....   ...++++||++ ++|.+++...+.+++..++.++.|++.||+|||+.|++|+||+|+||
T Consensus        61 l~h~~i~~~~~~~~~~~~---~~~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~ni  137 (266)
T cd06651          61 LQHERIVQYYGCLRDRAE---KTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANI  137 (266)
T ss_pred             cCCCCeeeEEEEEEcCCC---CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHE
Confidence            589999999998865322   56899999997 59999998888899999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCC----CccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 023609           80 LLNANCDLKICDFGLARVTSET----DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVH  155 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~  155 (280)
                      +++.++.++|+|||++......    .......++..|+|||.+.+ ..++.++|+||+||++++|++|..||.+.....
T Consensus       138 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~  216 (266)
T cd06651         138 LRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISG-EGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMA  216 (266)
T ss_pred             EECCCCCEEEccCCCccccccccccCCccccCCccccccCHHHhCC-CCCCchhhhHHHHHHHHHHHHCCCCccccchHH
Confidence            9999999999999998754321    11123456788999998854 447889999999999999999999997654443


Q ss_pred             HHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCC
Q 023609          156 QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLG  233 (280)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~  233 (280)
                      ....+......+                            ..-..+++.+++++ .||..+|++|||++++++||||+
T Consensus       217 ~~~~~~~~~~~~----------------------------~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         217 AIFKIATQPTNP----------------------------QLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             HHHHHhcCCCCC----------------------------CCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence            332221110000                            00114567789999 57778999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.2e-36  Score=260.44  Aligned_cols=230  Identities=20%  Similarity=0.283  Sum_probs=164.0

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS   77 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~   77 (280)
                      ++||||+++++++...     ...|++|||++ |+|.+++...  ..+++..++.++.|++.||+|||++||+||||+|+
T Consensus        56 l~h~~i~~~~~~~~~~-----~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~  130 (314)
T cd08216          56 LQHPNILPYVTSFIVD-----SELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKAS  130 (314)
T ss_pred             cCCcchhhhhheeecC-----CeEEEEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcc
Confidence            5799999999999765     67899999998 6899998753  45899999999999999999999999999999999


Q ss_pred             cEEEccCCCEEEeeccceeeccCCC--------ccccceeccccccchhccCC-CCCCcchhHHHHHHHHHHHHhCCCCC
Q 023609           78 NLLLNANCDLKICDFGLARVTSETD--------FMTEYVVTRWYRAPELLLNS-SDYTAAIDVWSVGCIFMELMDRKPLF  148 (280)
Q Consensus        78 nili~~~~~~~l~dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf  148 (280)
                      ||+++.++.++++|||.+.......        ......++..|+|||.+.+. ..++.++|+||+||++++|++|..||
T Consensus       131 Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf  210 (314)
T cd08216         131 HILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPF  210 (314)
T ss_pred             eEEEecCCceEEecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCC
Confidence            9999999999999999876432211        12233456789999988543 34778999999999999999999999


Q ss_pred             CCCChHHHHHHHHHHhCCCCHHHH-hHhhHhHHHHh-----hhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCC
Q 023609          149 PGRDHVHQLRLLIELIGTPSEAEL-GFLNENAKKYI-----CQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT  222 (280)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t  222 (280)
                      .+............  +....... ...........     ...+.............++.++.+|+.+||+.||++|||
T Consensus       211 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt  288 (314)
T cd08216         211 KDMPATQMLLEKVR--GTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPS  288 (314)
T ss_pred             CCCCHHHHHHHHHh--ccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcC
Confidence            87654443222111  11100000 00000000000     000000000000111234678999999999999999999


Q ss_pred             HHHHhcCCCCCCCcC
Q 023609          223 VEDALAHPYLGSLHD  237 (280)
Q Consensus       223 ~~ell~h~~~~~~~~  237 (280)
                      +.++++||||+..+.
T Consensus       289 ~~~ll~~p~~~~~~~  303 (314)
T cd08216         289 ASQLLNHSFFKQCKR  303 (314)
T ss_pred             HHHHhcCchHhhhcc
Confidence            999999999998764

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-36  Score=259.27  Aligned_cols=202  Identities=25%  Similarity=0.476  Sum_probs=163.8

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS   77 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~   77 (280)
                      ++||||+++++.+...     ...|+||||+. ++|.+++...  ..+++..++.++.|++.||+|||+.|++|+||||+
T Consensus        58 l~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~  132 (316)
T cd05574          58 LDHPFLPTLYASFQTE-----TYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPE  132 (316)
T ss_pred             CCCCCchhheeeeecC-----CEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChH
Confidence            5799999999998654     67999999997 5999998754  46999999999999999999999999999999999


Q ss_pred             cEEEccCCCEEEeeccceeeccCCC------------------------------ccccceeccccccchhccCCCCCCc
Q 023609           78 NLLLNANCDLKICDFGLARVTSETD------------------------------FMTEYVVTRWYRAPELLLNSSDYTA  127 (280)
Q Consensus        78 nili~~~~~~~l~dfg~~~~~~~~~------------------------------~~~~~~~~~~y~aPE~~~~~~~~~~  127 (280)
                      ||+++.++.++|+|||.+.......                              ......++..|+|||.+.+. .++.
T Consensus       133 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~  211 (316)
T cd05574         133 NILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGD-GHGS  211 (316)
T ss_pred             HeEEcCCCCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCC-CCCc
Confidence            9999999999999999876432211                              01123567889999998544 4788


Q ss_pred             chhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHH
Q 023609          128 AIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAID  207 (280)
Q Consensus       128 ~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  207 (280)
                      ++||||+|+++|+|++|..||.+.+.......+......                           + .....++..+++
T Consensus       212 ~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~---------------------------~-~~~~~~~~~~~~  263 (316)
T cd05574         212 AVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKKEVT---------------------------F-PGSPPVSSSARD  263 (316)
T ss_pred             hHHHHHHHHHHHHHhhCCCCCCCCchHHHHHHHhcCCcc---------------------------C-CCccccCHHHHH
Confidence            999999999999999999999877765544433211000                           0 001136789999


Q ss_pred             HHHHhhcCCCCCCCC----HHHHhcCCCCCCCc
Q 023609          208 LVEKMLTFDPRQRIT----VEDALAHPYLGSLH  236 (280)
Q Consensus       208 li~~~L~~dp~~R~t----~~ell~h~~~~~~~  236 (280)
                      +|.+||+.||++|||    +.++++||||++..
T Consensus       264 li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~  296 (316)
T cd05574         264 LIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVN  296 (316)
T ss_pred             HHHHHccCCHhHCCCchhhHHHHHcCchhhcCC
Confidence            999999999999999    99999999999863

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.1e-37  Score=271.33  Aligned_cols=203  Identities=24%  Similarity=0.446  Sum_probs=177.6

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      |+|||||+++.+....     ..+|+||||+. |.+++++.+.+++.+..++.++.|++.|++|||+++|+|||||.+|+
T Consensus       112 l~HPnIvkl~~v~~t~-----~~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNi  186 (596)
T KOG0586|consen  112 LNHPNIVKLFSVIETE-----ATLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENI  186 (596)
T ss_pred             cCCcceeeeeeeeeec-----ceeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhc
Confidence            6899999999999766     78999999986 79999999999999999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  159 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      +++.+..+||+|||++..........+.+|++.|+|||++.+....++.+|+||+|+++|.|++|..||+|.+......+
T Consensus       187 lL~~~mnikIaDfgfS~~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~r  266 (596)
T KOG0586|consen  187 LLDENMNIKIADFGFSTFFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPR  266 (596)
T ss_pred             ccccccceeeeccccceeecccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccch
Confidence            99999999999999999988887888999999999999998888889999999999999999999999987654332221


Q ss_pred             HHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCcCC
Q 023609          160 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDI  238 (280)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~~~  238 (280)
                      .....                   ...+           --++.++.++|++||.++|.+|++.++++.|.|.......
T Consensus       267 vl~gk-------------------~rIp-----------~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~~~~  315 (596)
T KOG0586|consen  267 VLRGK-------------------YRIP-----------FYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDLLEA  315 (596)
T ss_pred             heeee-------------------eccc-----------ceeechhHHHHHHhhccCccccCCHHHhhhhcccchhhhh
Confidence            11100                   0000           0357889999999999999999999999999999987655

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=3.5e-36  Score=254.21  Aligned_cols=205  Identities=25%  Similarity=0.519  Sum_probs=166.5

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++...     ...|+|+||+. ++|.+++.. +++++..+..++.|++.||++||++|++||||+|+||
T Consensus        73 ~~h~~vv~~~~~~~~~-----~~~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Ni  146 (285)
T cd06648          73 YQHPNIVEMYSSYLVG-----DELWVVMEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSI  146 (285)
T ss_pred             cCCCChheEEEEEEcC-----CeEEEEEeccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhE
Confidence            4799999999998665     67899999997 599999877 6799999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCC-ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  158 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.++.++|+|||.+....... ......+++.|+|||.+.+ ..++.++|+||+|+++++|++|..||.+.+......
T Consensus       147 l~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~  225 (285)
T cd06648         147 LLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMK  225 (285)
T ss_pred             EEcCCCcEEEcccccchhhccCCcccccccCCccccCHHHhcC-CCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHH
Confidence            99999999999999876543321 1223457889999998854 447889999999999999999999997766544444


Q ss_pred             HHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCcCC
Q 023609          159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDI  238 (280)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~~~  238 (280)
                      .+.... .+.                          ....+.++..+.++|++||+.+|++|||+.++++||||.+.+.+
T Consensus       226 ~~~~~~-~~~--------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~~  278 (285)
T cd06648         226 RIRDNL-PPK--------------------------LKNLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAGPP  278 (285)
T ss_pred             HHHhcC-CCC--------------------------CcccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCCCc
Confidence            332210 000                          01112367889999999999999999999999999999997754


Q ss_pred             C
Q 023609          239 S  239 (280)
Q Consensus       239 ~  239 (280)
                      .
T Consensus       279 ~  279 (285)
T cd06648         279 S  279 (285)
T ss_pred             c
Confidence            3

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1.7e-36  Score=255.52  Aligned_cols=203  Identities=29%  Similarity=0.470  Sum_probs=161.3

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS----NQALSEEHCQYFLYQILRGLKYIHSA-NVLHRDLK   75 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~----~~~l~~~~~~~i~~qll~al~~LH~~-gi~H~di~   75 (280)
                      ++||||+++++++...     ...|++|||++|+|.+++..    +..+++..++.++.||+.||+|||++ |++|||||
T Consensus        57 ~~~~~iv~~~~~~~~~-----~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlk  131 (283)
T cd06617          57 VDCPYTVTFYGALFRE-----GDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVK  131 (283)
T ss_pred             cCCCCeeeeeEEEecC-----CcEEEEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCC
Confidence            3799999999999665     66999999999998888753    34699999999999999999999997 99999999


Q ss_pred             CCcEEEccCCCEEEeeccceeeccCCCccccceeccccccchhccCC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 023609           76 PSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNS---SDYTAAIDVWSVGCIFMELMDRKPLFPGRD  152 (280)
Q Consensus        76 ~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~  152 (280)
                      |+||+++.++.++|+|||.+.............++..|+|||.+.+.   ..++.++|+||+||++|+|++|..||....
T Consensus       132 p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~  211 (283)
T cd06617         132 PSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWK  211 (283)
T ss_pred             HHHEEECCCCCEEEeecccccccccccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccc
Confidence            99999999999999999998765443333335678889999987542   335789999999999999999999996422


Q ss_pred             -hHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCC
Q 023609          153 -HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPY  231 (280)
Q Consensus       153 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~  231 (280)
                       ..+......... .+                    ..       ....+|.++.++|.+||..+|.+|||+.+++.|||
T Consensus       212 ~~~~~~~~~~~~~-~~--------------------~~-------~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~  263 (283)
T cd06617         212 TPFQQLKQVVEEP-SP--------------------QL-------PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPF  263 (283)
T ss_pred             cCHHHHHHHHhcC-CC--------------------CC-------CccccCHHHHHHHHHHccCChhhCcCHHHHhcCch
Confidence             222222111100 00                    00       00146789999999999999999999999999999


Q ss_pred             CCCCc
Q 023609          232 LGSLH  236 (280)
Q Consensus       232 ~~~~~  236 (280)
                      |....
T Consensus       264 ~~~~~  268 (283)
T cd06617         264 FELHL  268 (283)
T ss_pred             hhhcc
Confidence            98854

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=3e-36  Score=250.20  Aligned_cols=199  Identities=28%  Similarity=0.498  Sum_probs=160.8

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      ++||||+++++.+...     ...|+++||++ ++|.+++.. +..+++..++.++.|++.|+.|||+.|++|+||+|+|
T Consensus        55 l~~~~i~~~~~~~~~~-----~~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~n  129 (256)
T cd06612          55 CDSPYIVKYYGSYFKN-----TDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGN  129 (256)
T ss_pred             CCCCcEeeeeeeeecC-----CcEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcce
Confidence            4799999999999765     67999999998 599999875 4568999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCCC-ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 023609           79 LLLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL  157 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  157 (280)
                      |+++.++.++|+|||.+....... ......++..|+|||.+.+. .++.++|+||+|+++++|++|..||.........
T Consensus       130 i~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~  208 (256)
T cd06612         130 ILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEI-GYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI  208 (256)
T ss_pred             EEECCCCcEEEcccccchhcccCccccccccCCccccCHHHHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh
Confidence            999999999999999987654432 22334567889999988544 5788999999999999999999999765443321


Q ss_pred             HHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 023609          158 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  232 (280)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~  232 (280)
                      ..+..   ...                        ......+.++.++.++|.+||+.||.+|||+.+++.||||
T Consensus       209 ~~~~~---~~~------------------------~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~  256 (256)
T cd06612         209 FMIPN---KPP------------------------PTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI  256 (256)
T ss_pred             hhhcc---CCC------------------------CCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence            11100   000                        0001112467889999999999999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=3.3e-36  Score=255.68  Aligned_cols=208  Identities=23%  Similarity=0.485  Sum_probs=167.3

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++.+...     ...|+|+||+. ++|.+++.. ..+++.++..++.|++.||++||+.|++|+||+|+||
T Consensus        73 l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Ni  146 (296)
T cd06655          73 LKNPNIVNFLDSFLVG-----DELFVVMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNV  146 (296)
T ss_pred             cCCCceeeeeeeEecC-----ceEEEEEEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHE
Confidence            5799999999999665     67999999997 588888865 4699999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCCc-cccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSETDF-MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  158 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.++.++|+|||++........ .....++..|+|||.+.+ ..++.++|+||+||++|+|++|..||.+.+......
T Consensus       147 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~  225 (296)
T cd06655         147 LLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY  225 (296)
T ss_pred             EECCCCCEEEccCccchhcccccccCCCcCCCccccCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            999999999999998875443322 223457788999998754 447889999999999999999999998776544333


Q ss_pred             HHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCcCC
Q 023609          159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDI  238 (280)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~~~  238 (280)
                      .+... ..+.                          ......+++.+.++|++||..||.+|||+.+++.||||+.....
T Consensus       226 ~~~~~-~~~~--------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~~~  278 (296)
T cd06655         226 LIATN-GTPE--------------------------LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKPL  278 (296)
T ss_pred             HHHhc-CCcc--------------------------cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhcccc
Confidence            22111 1100                          01112567889999999999999999999999999999987654


Q ss_pred             CCCC
Q 023609          239 SDEP  242 (280)
Q Consensus       239 ~~~~  242 (280)
                      +..+
T Consensus       279 ~~~~  282 (296)
T cd06655         279 SSLT  282 (296)
T ss_pred             ccCC
Confidence            4433

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-37  Score=252.36  Aligned_cols=198  Identities=27%  Similarity=0.481  Sum_probs=174.3

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nil   80 (280)
                      +||.+..+.-.|+..     ..+|.||||.. |.|+-++...+.++++..+.+...|+.||.|||+++||+||+|.+|.+
T Consensus       226 ~HPFLt~LKYsFQt~-----drlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLl  300 (516)
T KOG0690|consen  226 RHPFLTSLKYSFQTQ-----DRLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLL  300 (516)
T ss_pred             cCcHHHHhhhhhccC-----ceEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhhe
Confidence            699999888888766     77999999997 699999988888999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccceee-ccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023609           81 LNANCDLKICDFGLARV-TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  159 (280)
Q Consensus        81 i~~~~~~~l~dfg~~~~-~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      ++.+|++|+.|||+++. ........+.||||.|+|||++. ...|+.++|.|.+|+++|+|+||+.||.+.+.......
T Consensus       301 LDkDGHIKitDFGLCKE~I~~g~t~kTFCGTPEYLAPEVle-DnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeL  379 (516)
T KOG0690|consen  301 LDKDGHIKITDFGLCKEEIKYGDTTKTFCGTPEYLAPEVLE-DNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFEL  379 (516)
T ss_pred             eccCCceEeeecccchhcccccceeccccCChhhcCchhhc-cccccceeehhhhhHHHHHHHhccCcccccchhHHHHH
Confidence            99999999999999974 44555678899999999999984 55699999999999999999999999998887777666


Q ss_pred             HHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCC-----CHHHHhcCCCCCC
Q 023609          160 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI-----TVEDALAHPYLGS  234 (280)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~ell~h~~~~~  234 (280)
                      |.-.--..+                              ..++++++.|+.++|.+||.+|+     .+.|+.+|+||.+
T Consensus       380 Il~ed~kFP------------------------------r~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~  429 (516)
T KOG0690|consen  380 ILMEDLKFP------------------------------RTLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFAS  429 (516)
T ss_pred             HHhhhccCC------------------------------ccCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhcc
Confidence            643221111                              16899999999999999999998     5789999999997


Q ss_pred             C
Q 023609          235 L  235 (280)
Q Consensus       235 ~  235 (280)
                      +
T Consensus       430 v  430 (516)
T KOG0690|consen  430 V  430 (516)
T ss_pred             C
Confidence            6

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=4.6e-36  Score=254.05  Aligned_cols=205  Identities=27%  Similarity=0.421  Sum_probs=160.8

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCC
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIR----SNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKP   76 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~----~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~   76 (280)
                      +||||+++++++...........|+||||++ ++|.+++.    ....+++..++.++.|++.||++||+.|++|+||+|
T Consensus        77 ~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp  156 (291)
T cd06639          77 NHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKG  156 (291)
T ss_pred             CCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCH
Confidence            7999999999987653323356899999997 59998875    345799999999999999999999999999999999


Q ss_pred             CcEEEccCCCEEEeeccceeeccCCC-ccccceeccccccchhccCCC----CCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 023609           77 SNLLLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSS----DYTAAIDVWSVGCIFMELMDRKPLFPGR  151 (280)
Q Consensus        77 ~nili~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~----~~~~~~DiwslG~il~~ll~g~~pf~~~  151 (280)
                      +||+++.++.++|+|||.+....... ......++..|+|||.+....    .++.++|+||+||++|+|++|++||...
T Consensus       157 ~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~  236 (291)
T cd06639         157 NNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDM  236 (291)
T ss_pred             HHEEEcCCCCEEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCC
Confidence            99999999999999999987644322 122345788899999874332    2578999999999999999999999766


Q ss_pred             ChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCC
Q 023609          152 DHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPY  231 (280)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~  231 (280)
                      ........+...   +..                  .      ....+.++..+.++|.+||+.+|.+||++.++++|||
T Consensus       237 ~~~~~~~~~~~~---~~~------------------~------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~  289 (291)
T cd06639         237 HPVKTLFKIPRN---PPP------------------T------LLHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPF  289 (291)
T ss_pred             cHHHHHHHHhcC---CCC------------------C------CCcccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcc
Confidence            544333322111   000                  0      0001245678999999999999999999999999999


Q ss_pred             CC
Q 023609          232 LG  233 (280)
Q Consensus       232 ~~  233 (280)
                      |+
T Consensus       290 ~~  291 (291)
T cd06639         290 IK  291 (291)
T ss_pred             cC
Confidence            95

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.8e-36  Score=253.27  Aligned_cols=201  Identities=28%  Similarity=0.426  Sum_probs=159.4

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++.+...     ...|+||||++ ++|.+++..++.+++..+..++.|++.||.|||+.|++|+|++|+||
T Consensus        63 ~~h~~ii~~~~~~~~~-----~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~ni  137 (267)
T cd06646          63 CKHCNIVAYFGSYLSR-----EKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANI  137 (267)
T ss_pred             cCCCCeeeeeEEEEeC-----CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHE
Confidence            4799999999998655     67899999998 69999998888899999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCC-ccccceeccccccchhccC--CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023609           80 LLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLN--SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ  156 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  156 (280)
                      +++.++.++|+|||.+....... ......++..|+|||.+..  ...++.++|+||+||++++|++|..||........
T Consensus       138 ll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~  217 (267)
T cd06646         138 LLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA  217 (267)
T ss_pred             EECCCCCEEECcCccceeecccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh
Confidence            99999999999999987654322 2234467888999998742  33467899999999999999999999865433222


Q ss_pred             HHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCC
Q 023609          157 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPY  231 (280)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~  231 (280)
                      ...+......+                        .. ......++..+.++|++||+.||++|||++++++|+|
T Consensus       218 ~~~~~~~~~~~------------------------~~-~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         218 LFLMSKSNFQP------------------------PK-LKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             heeeecCCCCC------------------------CC-CccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence            11110000000                        00 0111256789999999999999999999999999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.6e-36  Score=257.12  Aligned_cols=205  Identities=26%  Similarity=0.490  Sum_probs=165.0

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++.+...     ...|+||||++ ++|.+++.. +.+++.++..++.||+.||+|||++|++||||+|+||
T Consensus        76 l~h~~ii~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Ni  149 (292)
T cd06658          76 YHHENVVDMYNSYLVG-----DELWVVMEFLEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSI  149 (292)
T ss_pred             CCCCcHHHHHHheecC-----CeEEEEEeCCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHE
Confidence            4799999999998665     67899999997 588887754 5699999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCC-ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  158 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.++.++|+|||++....... ......++..|+|||.+.+ ..++.++|+||+|+++++|++|..||.+.+......
T Consensus       150 ll~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~  228 (292)
T cd06658         150 LLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISR-LPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMR  228 (292)
T ss_pred             EEcCCCCEEEccCcchhhcccccccCceeecCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            99999999999999886543221 1233467889999998854 447889999999999999999999998766544433


Q ss_pred             HHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCcCC
Q 023609          159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDI  238 (280)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~~~  238 (280)
                      .+........                           .....++..+.+++.+||..||.+|||+.++++||||.....+
T Consensus       229 ~~~~~~~~~~---------------------------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~~~  281 (292)
T cd06658         229 RIRDNLPPRV---------------------------KDSHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAGPP  281 (292)
T ss_pred             HHHhcCCCcc---------------------------ccccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccCCc
Confidence            3221111000                           1112467889999999999999999999999999999987654


Q ss_pred             C
Q 023609          239 S  239 (280)
Q Consensus       239 ~  239 (280)
                      +
T Consensus       282 ~  282 (292)
T cd06658         282 S  282 (292)
T ss_pred             c
Confidence            4

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-37  Score=268.35  Aligned_cols=196  Identities=21%  Similarity=0.391  Sum_probs=165.7

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      |+||||+++.++|...     ..+|||||||. |.|..+++...+++..-...|..+|+.|..|||.+.|+|||||.-||
T Consensus       169 LkH~NII~FkGVCtqs-----PcyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNi  243 (904)
T KOG4721|consen  169 LKHPNIITFKGVCTQS-----PCYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNI  243 (904)
T ss_pred             ccCcceeeEeeeecCC-----ceeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCce
Confidence            6899999999999766     77999999998 89999999999999999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  159 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      ||+.+..+||+|||.++...+..+.-.+.||..|||||++. ..+.+.++||||+||++|+|+||..||.+.+...+   
T Consensus       244 LIs~~d~VKIsDFGTS~e~~~~STkMSFaGTVaWMAPEvIr-nePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAI---  319 (904)
T KOG4721|consen  244 LISYDDVVKISDFGTSKELSDKSTKMSFAGTVAWMAPEVIR-NEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAI---  319 (904)
T ss_pred             EeeccceEEeccccchHhhhhhhhhhhhhhhHhhhCHHHhh-cCCcccccceehhHHHHHHHHhcCCCccccchhee---
Confidence            99999999999999998877766667889999999999995 45689999999999999999999999976543221   


Q ss_pred             HHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCC
Q 023609          160 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHP  230 (280)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~  230 (280)
                      |+   |.....             ...|         .-..++..++=||+.||+-.|..||++.+++.|=
T Consensus       320 Iw---GVGsNs-------------L~Lp---------vPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hl  365 (904)
T KOG4721|consen  320 IW---GVGSNS-------------LHLP---------VPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHL  365 (904)
T ss_pred             EE---eccCCc-------------cccc---------CcccCchHHHHHHHHHHhcCCCCCccHHHHHHHH
Confidence            11   110000             0000         0014567789999999999999999999999984

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=4.1e-36  Score=253.18  Aligned_cols=203  Identities=25%  Similarity=0.445  Sum_probs=159.0

Q ss_pred             CCCCeeeeeceecCCCC-CCCCcEEEEeecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 023609            2 DHENVVAIRDIIPPPQR-ESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS   77 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~-~~~~~~~iv~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~   77 (280)
                      +||||+++++++..... ......|++|||++ |+|.+++...  ..+++..++.++.||+.||+|||+.|++|+||+|+
T Consensus        71 ~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~  150 (282)
T cd06636          71 HHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQ  150 (282)
T ss_pred             CCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHH
Confidence            69999999999865321 12357899999998 5999998753  35889999999999999999999999999999999


Q ss_pred             cEEEccCCCEEEeeccceeeccCC-CccccceeccccccchhccC----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 023609           78 NLLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLN----SSDYTAAIDVWSVGCIFMELMDRKPLFPGRD  152 (280)
Q Consensus        78 nili~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  152 (280)
                      ||+++.++.++|+|||.+...... .......+++.|+|||.+..    ...++.++|+||+||++|+|++|..||....
T Consensus       151 nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~  230 (282)
T cd06636         151 NVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMH  230 (282)
T ss_pred             HEEECCCCCEEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccC
Confidence            999999999999999998754322 12234567889999998742    2346778999999999999999999996554


Q ss_pred             hHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 023609          153 HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  232 (280)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~  232 (280)
                      .......+...   ..                         .......++.++.++|++||+.||.+|||+.+++.||||
T Consensus       231 ~~~~~~~~~~~---~~-------------------------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         231 PMRALFLIPRN---PP-------------------------PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             HHhhhhhHhhC---CC-------------------------CCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence            33222111100   00                         000112578899999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=3.6e-36  Score=255.50  Aligned_cols=203  Identities=23%  Similarity=0.456  Sum_probs=163.2

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++.+...     ...|+||||+. ++|.+++.. ..+++.++..++.|++.||+|||+.|++|+||+|+||
T Consensus        74 ~~h~~v~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Ni  147 (296)
T cd06654          74 NKNPNIVNYLDSYLVG-----DELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNI  147 (296)
T ss_pred             CCCCCEeeEEEEEEeC-----CEEEEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHE
Confidence            4799999999998665     67999999997 699998864 4689999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCC-ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  158 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.++.++|+|||.+....... ......+++.|+|||.+.+ ..++.++|+||+||++|+|++|..||.+........
T Consensus       148 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~  226 (296)
T cd06654         148 LLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY  226 (296)
T ss_pred             EEcCCCCEEECccccchhccccccccCcccCCccccCHHHHcC-CCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHH
Confidence            99999999999999887543322 1223467889999998854 447889999999999999999999997665433222


Q ss_pred             HHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCcC
Q 023609          159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD  237 (280)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~~  237 (280)
                      .+.. .+.+.                          ....+.++..+.++|.+||..||.+|||+.++++||||...+.
T Consensus       227 ~~~~-~~~~~--------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~  278 (296)
T cd06654         227 LIAT-NGTPE--------------------------LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAKP  278 (296)
T ss_pred             HHhc-CCCCC--------------------------CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhccCC
Confidence            1111 01100                          0111256788999999999999999999999999999987643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.6e-36  Score=253.37  Aligned_cols=206  Identities=26%  Similarity=0.436  Sum_probs=163.6

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN---QALSEEHCQYFLYQILRGLKYIHS-ANVLHRDLK   75 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~---~~l~~~~~~~i~~qll~al~~LH~-~gi~H~di~   75 (280)
                      ++||||+++++.+...     +..|+||||++ ++|..++...   ..+++..+..++.||+.||.|||+ .|++|+||+
T Consensus        56 ~~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~  130 (286)
T cd06622          56 AVSPYIVDFYGAFFIE-----GAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVK  130 (286)
T ss_pred             cCCCcHHhhhhheecC-----CeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCC
Confidence            5799999999998765     67999999998 5898888763   379999999999999999999997 599999999


Q ss_pred             CCcEEEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCC-----CCCcchhHHHHHHHHHHHHhCCCCCCC
Q 023609           76 PSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS-----DYTAAIDVWSVGCIFMELMDRKPLFPG  150 (280)
Q Consensus        76 ~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-----~~~~~~DiwslG~il~~ll~g~~pf~~  150 (280)
                      |+||+++.++.++|+|||.+....... .....+++.|+|||.+.+..     .++.++|+||+||++++|++|..||..
T Consensus       131 p~nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~  209 (286)
T cd06622         131 PTNVLVNGNGQVKLCDFGVSGNLVASL-AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPP  209 (286)
T ss_pred             HHHEEECCCCCEEEeecCCcccccCCc-cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCC
Confidence            999999999999999999987653332 23445778899999874332     247789999999999999999999976


Q ss_pred             CChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCC
Q 023609          151 RDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHP  230 (280)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~  230 (280)
                      .........+......+                          .....+.+++++.++|.+||+.+|.+||++.++++||
T Consensus       210 ~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~  263 (286)
T cd06622         210 ETYANIFAQLSAIVDGD--------------------------PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHP  263 (286)
T ss_pred             cchhhHHHHHHHHhhcC--------------------------CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcCh
Confidence            54333222221111100                          0112235788999999999999999999999999999


Q ss_pred             CCCCCcCC
Q 023609          231 YLGSLHDI  238 (280)
Q Consensus       231 ~~~~~~~~  238 (280)
                      ||......
T Consensus       264 ~~~~~~~~  271 (286)
T cd06622         264 WLVKYKNA  271 (286)
T ss_pred             hhhhccCC
Confidence            99887643

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.1e-36  Score=250.23  Aligned_cols=201  Identities=28%  Similarity=0.460  Sum_probs=161.2

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      ++||||+++++++...     ..+|++|||++ ++|.+++... ..+++..+..++.|++.||+|||+.|++|+||+|+|
T Consensus        57 ~~h~~i~~~~~~~~~~-----~~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~n  131 (262)
T cd06613          57 CRHPNIVAYFGSYLRR-----DKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGAN  131 (262)
T ss_pred             CCCCChhceEEEEEeC-----CEEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhh
Confidence            5899999999998655     67999999998 5999988765 689999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCCC-ccccceeccccccchhccCC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 023609           79 LLLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNS--SDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVH  155 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~  155 (280)
                      |+++.++.++|+|||.+....... ......++..|+|||.+.+.  ..++.++|+||+|+++++|++|.+||.+.+...
T Consensus       132 i~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~  211 (262)
T cd06613         132 ILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMR  211 (262)
T ss_pred             EEECCCCCEEECccccchhhhhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            999999999999999987544322 22334677889999987543  246789999999999999999999998766544


Q ss_pred             HHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCC
Q 023609          156 QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPY  231 (280)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~  231 (280)
                      ....+......+..                         ....+.++.++.++|++||..+|.+|||+.+++.|+|
T Consensus       212 ~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         212 ALFLISKSNFPPPK-------------------------LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             HHHHHHhccCCCcc-------------------------ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence            33322211001000                         0011245678999999999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-37  Score=246.45  Aligned_cols=233  Identities=49%  Similarity=0.867  Sum_probs=194.8

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   80 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nil   80 (280)
                      ++|.|++..+++.+.+..+-+..+|+++|++..+|...+-+-.+++.+.++-+++||+.||.|||+.||.||||||.|.+
T Consensus       109 FkHdNVLSaLDILQPph~dfFqEiYV~TELmQSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLL  188 (449)
T KOG0664|consen  109 FRHDNVLSLLDILQPANPSFFQELYVLTELMQSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLL  188 (449)
T ss_pred             hccccHHHHHHhcCCCCchHHHHHHHHHHHHHhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEE
Confidence            47999999999998876555567899999999999999998889999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccceeeccCCC--ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023609           81 LNANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  158 (280)
Q Consensus        81 i~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  158 (280)
                      ++.+..+|+||||+++......  .+...+.|..|.|||++.+...|+.++||||+|||+.||+.++..|...++.+++.
T Consensus       189 VNSNCvLKICDFGLARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~  268 (449)
T KOG0664|consen  189 VNSNCILKICDFGLARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQ  268 (449)
T ss_pred             eccCceEEecccccccccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHH
Confidence            9999999999999998765443  34556778899999999999999999999999999999999999999999999999


Q ss_pred             HHHHHhCCCCHHHHhHhhHhHHH-HhhhcCccccccccccC-----CCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 023609          159 LLIELIGTPSEAELGFLNENAKK-YICQLPRYQRQSFTEKF-----PNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  232 (280)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~-----~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~  232 (280)
                      .|.+.+|.|.-+.+..--+-++. ..+..++.+.  +...+     .+-..+...++.+||.+||.+|.+..+++.|++.
T Consensus       269 lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps--~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~  346 (449)
T KOG0664|consen  269 MIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPD--TQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYL  346 (449)
T ss_pred             HHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCC--ccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccccc
Confidence            99999999998765433222222 2222221111  11111     1233567899999999999999999999999999


Q ss_pred             CCC
Q 023609          233 GSL  235 (280)
Q Consensus       233 ~~~  235 (280)
                      ...
T Consensus       347 ~e~  349 (449)
T KOG0664|consen  347 EEG  349 (449)
T ss_pred             ccc
Confidence            864

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.9e-36  Score=252.70  Aligned_cols=203  Identities=28%  Similarity=0.513  Sum_probs=162.2

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHS-ANVLHRDLKPS   77 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~-~gi~H~di~~~   77 (280)
                      ++||||+++++.+...     ...++++||++ ++|.+++... ..+++..+..++.|++.|+++||+ .|++|+||+|+
T Consensus        56 ~~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~  130 (265)
T cd06605          56 CNSPYIVGFYGAFYNN-----GDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPS  130 (265)
T ss_pred             CCCCchhhhheeeecC-----CEEEEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHH
Confidence            4799999999998665     77999999998 6999999865 789999999999999999999999 99999999999


Q ss_pred             cEEEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh--HH
Q 023609           78 NLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDH--VH  155 (280)
Q Consensus        78 nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--~~  155 (280)
                      ||+++.++.++|+|||.+......... ...++..|+|||.+.+. .++.++|+||+|+++++|++|..||.....  ..
T Consensus       131 ni~~~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~  208 (265)
T cd06605         131 NILVNSRGQIKLCDFGVSGQLVNSLAK-TFVGTSSYMAPERIQGN-DYSVKSDIWSLGLSLIELATGRFPYPPENDPPDG  208 (265)
T ss_pred             HEEECCCCCEEEeecccchhhHHHHhh-cccCChhccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCcccccccc
Confidence            999999999999999988755433221 25678889999988554 578999999999999999999999965421  11


Q ss_pred             HHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCC-CCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCC
Q 023609          156 QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP-NVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS  234 (280)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~  234 (280)
                      ....+........                          ..... .++.+++++|.+||..||.+|||+.+++.||||+.
T Consensus       209 ~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~  262 (265)
T cd06605         209 IFELLQYIVNEPP--------------------------PRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKK  262 (265)
T ss_pred             HHHHHHHHhcCCC--------------------------CCCChhhcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhc
Confidence            1111100000000                          00001 26788999999999999999999999999999987


Q ss_pred             Cc
Q 023609          235 LH  236 (280)
Q Consensus       235 ~~  236 (280)
                      +.
T Consensus       263 ~~  264 (265)
T cd06605         263 YE  264 (265)
T ss_pred             cc
Confidence            64

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.9e-36  Score=251.27  Aligned_cols=204  Identities=27%  Similarity=0.482  Sum_probs=160.4

Q ss_pred             CCCCeeeeeceecCCCC-CCCCcEEEEeecCC-ccHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCC
Q 023609            2 DHENVVAIRDIIPPPQR-ESFNDVYIAYELMD-TDLHQIIRS----NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK   75 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~-~~~~~~~iv~e~~~-g~L~~~l~~----~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~   75 (280)
                      +||||+++++++..... ......|+||||++ ++|.+++..    +..+++..++.++.|++.||.|||+.|++|+||+
T Consensus        61 ~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~  140 (275)
T cd06608          61 NHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIK  140 (275)
T ss_pred             CCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCC
Confidence            69999999999976542 22356899999998 588888764    3579999999999999999999999999999999


Q ss_pred             CCcEEEccCCCEEEeeccceeeccCCC-ccccceeccccccchhccCC----CCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 023609           76 PSNLLLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNS----SDYTAAIDVWSVGCIFMELMDRKPLFPG  150 (280)
Q Consensus        76 ~~nili~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~  150 (280)
                      |+||+++.++.++|+|||.+....... ......++..|+|||.+...    ..++.++|+||+||++++|++|..||.+
T Consensus       141 p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~  220 (275)
T cd06608         141 GQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCD  220 (275)
T ss_pred             HHHEEEccCCeEEECCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccc
Confidence            999999999999999999987643321 22345678889999987432    2357789999999999999999999976


Q ss_pred             CChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCC
Q 023609          151 RDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHP  230 (280)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~  230 (280)
                      .........+...   +..                       .. .....++.+++++|.+||..||++|||+.++++||
T Consensus       221 ~~~~~~~~~~~~~---~~~-----------------------~~-~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~  273 (275)
T cd06608         221 MHPMRALFKIPRN---PPP-----------------------TL-KSPENWSKKFNDFISECLIKNYEQRPFMEELLEHP  273 (275)
T ss_pred             cchHHHHHHhhcc---CCC-----------------------CC-CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCC
Confidence            5443333222111   000                       00 00113678899999999999999999999999999


Q ss_pred             CC
Q 023609          231 YL  232 (280)
Q Consensus       231 ~~  232 (280)
                      |+
T Consensus       274 ~~  275 (275)
T cd06608         274 FI  275 (275)
T ss_pred             CC
Confidence            96

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=8.2e-36  Score=254.30  Aligned_cols=202  Identities=23%  Similarity=0.379  Sum_probs=163.1

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++.+...     ...|+||||++ ++|.+++...+.+++..+..++.|++.||+|||+.|++|+||+|+||
T Consensus        58 ~~~~~i~~~~~~~~~~-----~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NI  132 (305)
T cd05609          58 AENPFVVSMFCSFETK-----RHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNL  132 (305)
T ss_pred             CCCCCeeeeEEEEecC-----CEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHE
Confidence            4799999999998654     67899999997 59999998888899999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCC----------------ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh
Q 023609           80 LLNANCDLKICDFGLARVTSETD----------------FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD  143 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~----------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~  143 (280)
                      +++.++.++|+|||.++......                ......++..|+|||.+.+. .++.++|+||+||++|+|++
T Consensus       133 ll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~vl~el~~  211 (305)
T cd05609         133 LITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQ-GYGKPVDWWAMGIILYEFLV  211 (305)
T ss_pred             EECCCCCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCC-CCCchhhHHHHHHHHHHHHh
Confidence            99999999999999876321000                01123467789999987554 47899999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCC-
Q 023609          144 RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT-  222 (280)
Q Consensus       144 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-  222 (280)
                      |..||.+....+....+.......                           ....+.++.+++++|.+||+.||.+||+ 
T Consensus       212 g~~pf~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~li~~~l~~~P~~R~~~  264 (305)
T cd05609         212 GCVPFFGDTPEELFGQVISDDIEW---------------------------PEGDEALPADAQDLISRLLRQNPLERLGT  264 (305)
T ss_pred             CCCCCCCCCHHHHHHHHHhcccCC---------------------------CCccccCCHHHHHHHHHHhccChhhccCc
Confidence            999998776554443332211000                           0111256788999999999999999998 


Q ss_pred             --HHHHhcCCCCCCC
Q 023609          223 --VEDALAHPYLGSL  235 (280)
Q Consensus       223 --~~ell~h~~~~~~  235 (280)
                        +.++++||||.+.
T Consensus       265 ~~~~~ll~~~~~~~~  279 (305)
T cd05609         265 GGAFEVKQHRFFLGL  279 (305)
T ss_pred             cCHHHHHhCccccCC
Confidence              7899999999764

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.1e-35  Score=246.90  Aligned_cols=197  Identities=28%  Similarity=0.504  Sum_probs=164.3

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS   77 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~   77 (280)
                      ++||||+++++++...     ...+++|||++ ++|.+++.+.  ..+++..+..++.|++.||.|||+.|++|+||+|+
T Consensus        56 ~~h~~i~~~~~~~~~~-----~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~  130 (256)
T cd08221          56 LQHPNIIAYYNHFMDD-----NTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTL  130 (256)
T ss_pred             CCCCCeeEEEeEEecC-----CeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChH
Confidence            5799999999999765     67999999997 6999999765  46999999999999999999999999999999999


Q ss_pred             cEEEccCCCEEEeeccceeeccCCC-ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023609           78 NLLLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ  156 (280)
Q Consensus        78 nili~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  156 (280)
                      ||+++.++.++|+|||.+....... ......+++.|+|||.+.+. ..+.++|+||+|+++++|++|..||.+....+.
T Consensus       131 ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~y~ape~~~~~-~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~  209 (256)
T cd08221         131 NIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGV-KYNFKSDIWALGCVLYELLTLKRTFDATNPLNL  209 (256)
T ss_pred             hEEEeCCCCEEECcCcceEEcccccccccccCCCccccCHhhcCCC-CCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHH
Confidence            9999999999999999987654433 23345678899999988544 377899999999999999999999987665554


Q ss_pred             HHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 023609          157 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  232 (280)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~  232 (280)
                      ...+......                             ...+.++.++.++|.+||..+|.+||++.++++|+|+
T Consensus       210 ~~~~~~~~~~-----------------------------~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         210 VVKIVQGNYT-----------------------------PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             HHHHHcCCCC-----------------------------CCccccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence            4443321100                             1113578899999999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=8.9e-36  Score=249.79  Aligned_cols=203  Identities=27%  Similarity=0.501  Sum_probs=162.3

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++...     ...++||||+. ++|.+++...+.+++..++.++.|++.||.+||+.|++|+||+|+||
T Consensus        65 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~ni  139 (272)
T cd06629          65 LDHLNIVQYLGFETTE-----EYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNL  139 (272)
T ss_pred             cCCCCcceEEEEeccC-----CceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhE
Confidence            5799999999998654     67899999997 69999998888899999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCC---ccccceeccccccchhccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 023609           80 LLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSS-DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVH  155 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~  155 (280)
                      +++.++.++++|||.+.......   ......++..|+|||.+.... .++.++|+||+|++++++++|..||.......
T Consensus       140 l~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~  219 (272)
T cd06629         140 LVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA  219 (272)
T ss_pred             EEcCCCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH
Confidence            99999999999999987543221   122345678899999875443 36789999999999999999999996554333


Q ss_pred             HHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 023609          156 QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  232 (280)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~  232 (280)
                      ....+......                        ........+.++..++++|.+||..+|.+|||+.++++||||
T Consensus       220 ~~~~~~~~~~~------------------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         220 AMFKLGNKRSA------------------------PPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             HHHHhhccccC------------------------CcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence            22211100000                        000112234678899999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=2.8e-36  Score=250.97  Aligned_cols=199  Identities=28%  Similarity=0.484  Sum_probs=163.2

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++.+...     ...|+|+||+. ++|.+++.+..++++..+..++.||++||.|||+.|++|+||+|+||
T Consensus        57 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~ni  131 (258)
T cd05578          57 LNHPFLVNLWYSFQDE-----ENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNI  131 (258)
T ss_pred             CCCCChHHHHHhhcCC-----CeEEEEEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHe
Confidence            5899999999999655     67999999997 59999998877899999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  159 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      +++.++.++|+|||.+.............++..|+|||.+... .++.++|+||+|+++|+|++|..||...+.... ..
T Consensus       132 l~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~-~~  209 (258)
T cd05578         132 LLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQ-GYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIR-DQ  209 (258)
T ss_pred             EEcCCCCEEEeecccccccCCCccccccCCChhhcCHHHHccc-CCCCcccchhhHHHHHHHHhCCCCCCCCCccHH-HH
Confidence            9999999999999998766554333455678889999988544 478999999999999999999999987653211 11


Q ss_pred             HHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCH--HHHhcCCCC
Q 023609          160 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV--EDALAHPYL  232 (280)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~--~ell~h~~~  232 (280)
                      .........                          ....+.++.++.++|++||..||.+||++  .++++||||
T Consensus       210 ~~~~~~~~~--------------------------~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         210 IRAKQETAD--------------------------VLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             HHHHhcccc--------------------------ccCcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence            111110000                          01112467899999999999999999999  999999998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=5.5e-36  Score=250.35  Aligned_cols=202  Identities=26%  Similarity=0.501  Sum_probs=160.5

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      |+||||+++++++...     .+.++|+||+. ++|.+++...+++++..+..++.||+.||++||++|++|+||+|+||
T Consensus        60 l~h~~iv~~~~~~~~~-----~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~ni  134 (268)
T cd06630          60 LNHPHIIRMLGATCED-----SHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANL  134 (268)
T ss_pred             cCCCceehhhceeccC-----CeEEEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence            5899999999999665     67999999998 59999998888899999999999999999999999999999999999


Q ss_pred             EEccCC-CEEEeeccceeeccCCC-----ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh
Q 023609           80 LLNANC-DLKICDFGLARVTSETD-----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDH  153 (280)
Q Consensus        80 li~~~~-~~~l~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~  153 (280)
                      +++.++ .++|+|||.+.......     ......++..|+|||.+.+ ..++.++|+||+|+++++|++|..||.....
T Consensus       135 l~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~  213 (268)
T cd06630         135 LIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRG-EQYGRSCDVWSVGCVIIEMATAKPPWNAEKH  213 (268)
T ss_pred             EEcCCCCEEEEcccccccccccccccCCccccccccccceeCHhHhcc-CCCCcccchHHHHHHHHHHHhCCCCCCCCCC
Confidence            998776 59999999987654321     1123456788999998854 4478899999999999999999999965443


Q ss_pred             HHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCC
Q 023609          154 VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLG  233 (280)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~  233 (280)
                      ......+.......                         ......+.+++++.+++.+||..+|.+|||+.++++||||+
T Consensus       214 ~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         214 SNHLALIFKIASAT-------------------------TAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             cchHHHHHHHhccC-------------------------CCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence            22222211110000                         00011125678899999999999999999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-36  Score=265.41  Aligned_cols=203  Identities=26%  Similarity=0.468  Sum_probs=166.9

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCc-cHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIR-SNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~~~l~-~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      .+||+||++++.|...     +.++|+.|||+| -....+. -...++++++..+++|++.||.|||+++|+|||||..|
T Consensus        86 CdHP~ivkLl~ayy~e-----nkLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGN  160 (1187)
T KOG0579|consen   86 CDHPVIVKLLSAYYFE-----NKLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGN  160 (1187)
T ss_pred             CCChHHHHHHHHHhcc-----CceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccc
Confidence            3799999999988665     779999999985 5555554 34579999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCC-CccccceeccccccchhccC----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh
Q 023609           79 LLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLN----SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDH  153 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~  153 (280)
                      |+++.+|.++|.|||.+...... .....++|||+|||||+..+    ..+|..++||||||+++.+|..+.+|-...+.
T Consensus       161 iL~TldGdirLADFGVSAKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnp  240 (1187)
T KOG0579|consen  161 ILLTLDGDIRLADFGVSAKNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNP  240 (1187)
T ss_pred             eEEEecCcEeeecccccccchhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccch
Confidence            99999999999999998653322 22346799999999999854    34688899999999999999999999987776


Q ss_pred             HHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCC
Q 023609          154 VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLG  233 (280)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~  233 (280)
                      .-.+-++.+.. +|+-.                          .-.+.+..+.||+.+||.+||..||++.+++.||||+
T Consensus       241 MRVllKiaKSe-PPTLl--------------------------qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~  293 (1187)
T KOG0579|consen  241 MRVLLKIAKSE-PPTLL--------------------------QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQ  293 (1187)
T ss_pred             HHHHHHHhhcC-CCccc--------------------------CcchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccc
Confidence            66655554322 11100                          0014577899999999999999999999999999999


Q ss_pred             CC
Q 023609          234 SL  235 (280)
Q Consensus       234 ~~  235 (280)
                      +.
T Consensus       294 ~~  295 (1187)
T KOG0579|consen  294 NA  295 (1187)
T ss_pred             cC
Confidence            75

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=5.5e-36  Score=250.02  Aligned_cols=203  Identities=25%  Similarity=0.424  Sum_probs=163.2

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN---QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKP   76 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~---~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~   76 (280)
                      ++||||+++++.+...     ...|+|||++. ++|.+++...   +.+++..++.++.|++.||++||+.|++|+||+|
T Consensus        56 l~~~~i~~~~~~~~~~-----~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p  130 (267)
T cd06610          56 CNHPNVVKYYTSFVVG-----DELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKA  130 (267)
T ss_pred             cCCCCEEEEEEEEeeC-----CEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCH
Confidence            5799999999998665     67899999997 5999999764   4599999999999999999999999999999999


Q ss_pred             CcEEEccCCCEEEeeccceeeccCCCc-----cccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 023609           77 SNLLLNANCDLKICDFGLARVTSETDF-----MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGR  151 (280)
Q Consensus        77 ~nili~~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~  151 (280)
                      +||+++.++.++|+|||.+........     .....++..|++||.+.....++.++|+||+||++++|++|..||.+.
T Consensus       131 ~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~  210 (267)
T cd06610         131 GNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKY  210 (267)
T ss_pred             HhEEEcCCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCcccc
Confidence            999999999999999999875443321     123457888999999865545788999999999999999999999766


Q ss_pred             ChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCC
Q 023609          152 DHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPY  231 (280)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~  231 (280)
                      +...........   .+.                     ..........+++.+++++.+||+.||.+|||+.+++.|||
T Consensus       211 ~~~~~~~~~~~~---~~~---------------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~  266 (267)
T cd06610         211 PPMKVLMLTLQN---DPP---------------------SLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKF  266 (267)
T ss_pred             ChhhhHHHHhcC---CCC---------------------CcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCC
Confidence            554433322211   000                     00000112367889999999999999999999999999999


Q ss_pred             C
Q 023609          232 L  232 (280)
Q Consensus       232 ~  232 (280)
                      |
T Consensus       267 ~  267 (267)
T cd06610         267 F  267 (267)
T ss_pred             C
Confidence            8

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=7.4e-36  Score=248.85  Aligned_cols=201  Identities=28%  Similarity=0.494  Sum_probs=165.8

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHS-ANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~-~gi~H~di~~~n   78 (280)
                      ++||||+++++++...     ...++||||++ ++|.+++.....+++..+..++.|++.|+++||+ .|++|+||+|+|
T Consensus        56 l~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~n  130 (264)
T cd06623          56 CESPYVVKCYGAFYKE-----GEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSN  130 (264)
T ss_pred             cCCCCeeeEEEEEccC-----CeEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHH
Confidence            5799999999999765     67999999998 6999999887889999999999999999999999 999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCCCcc-ccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh---H
Q 023609           79 LLLNANCDLKICDFGLARVTSETDFM-TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDH---V  154 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~---~  154 (280)
                      |+++.++.++|+|||.+......... ....++..|+|||.+... .++.++|+||+|+++|+|++|..||.+...   .
T Consensus       131 i~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~  209 (264)
T cd06623         131 LLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGE-SYSYAADIWSLGLTLLECALGKFPFLPPGQPSFF  209 (264)
T ss_pred             EEECCCCCEEEccCccceecccCCCcccceeecccccCHhhhCCC-CCCchhhHHHHHHHHHHHHhCCCCCccccccCHH
Confidence            99999999999999998865543322 245678889999987544 578899999999999999999999976642   2


Q ss_pred             HHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCC-CChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCC
Q 023609          155 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYLG  233 (280)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~  233 (280)
                      +....+..   ...                          ...... ++..+.++|.+||..+|++|||+.++++|||++
T Consensus       210 ~~~~~~~~---~~~--------------------------~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~  260 (264)
T cd06623         210 ELMQAICD---GPP--------------------------PSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIK  260 (264)
T ss_pred             HHHHHHhc---CCC--------------------------CCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHH
Confidence            22221110   000                          011123 678999999999999999999999999999998


Q ss_pred             CCc
Q 023609          234 SLH  236 (280)
Q Consensus       234 ~~~  236 (280)
                      .+.
T Consensus       261 ~~~  263 (264)
T cd06623         261 KAD  263 (264)
T ss_pred             hcc
Confidence            764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=3.9e-36  Score=255.35  Aligned_cols=206  Identities=23%  Similarity=0.465  Sum_probs=165.0

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++...     ...|+||||++ ++|.+++.+ ..+++.++..++.|++.||.|||+.|++|+||+|+||
T Consensus        73 ~~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Ni  146 (297)
T cd06656          73 NKNPNIVNYLDSYLVG-----DELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNI  146 (297)
T ss_pred             CCCCCEeeEEEEEecC-----CEEEEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHE
Confidence            4799999999999665     67999999997 599998865 4689999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCCc-cccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSETDF-MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  158 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.++.++|+|||.+........ .....+++.|+|||.+.+ ..++.++|+||+||++|++++|..||.+.+......
T Consensus       147 li~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~  225 (297)
T cd06656         147 LLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY  225 (297)
T ss_pred             EECCCCCEEECcCccceEccCCccCcCcccCCccccCHHHHcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchhee
Confidence            999999999999999876543322 223467888999998854 447899999999999999999999997654322211


Q ss_pred             HHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCcCC
Q 023609          159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDI  238 (280)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~~~  238 (280)
                      .+.. .+.+..                          .....++..+++++.+||..||.+||++.+++.||||+..+..
T Consensus       226 ~~~~-~~~~~~--------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~  278 (297)
T cd06656         226 LIAT-NGTPEL--------------------------QNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPL  278 (297)
T ss_pred             eecc-CCCCCC--------------------------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhcccccc
Confidence            1110 011100                          0112467889999999999999999999999999999987654


Q ss_pred             CC
Q 023609          239 SD  240 (280)
Q Consensus       239 ~~  240 (280)
                      ..
T Consensus       279 ~~  280 (297)
T cd06656         279 SS  280 (297)
T ss_pred             cc
Confidence            44

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-36  Score=255.57  Aligned_cols=203  Identities=26%  Similarity=0.420  Sum_probs=170.6

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ--ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~--~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      +.+.||.+--+|.+.     ..+++|+..|+ |+|.=+|-+-+  .|++..+..++.+|+.||++||+.+||+||+||+|
T Consensus       243 ~s~FiVslaYAfeTk-----d~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeN  317 (591)
T KOG0986|consen  243 SSPFIVSLAYAFETK-----DALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPEN  317 (591)
T ss_pred             ccCcEEEEeeeecCC-----CceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhh
Confidence            467888888888666     78999999997 69988886544  69999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023609           79 LLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  158 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  158 (280)
                      |++|..|+++|+|+|+|.............||..|||||++.+.. |+.++|.|||||++|+|+.|..||.......-..
T Consensus       318 ILLDd~GhvRISDLGLAvei~~g~~~~~rvGT~GYMAPEvl~ne~-Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~e  396 (591)
T KOG0986|consen  318 ILLDDHGHVRISDLGLAVEIPEGKPIRGRVGTVGYMAPEVLQNEV-YDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKRE  396 (591)
T ss_pred             eeeccCCCeEeeccceEEecCCCCccccccCcccccCHHHHcCCc-ccCCccHHHHHhHHHHHHcccCchhhhhhhhhHH
Confidence            999999999999999999988888777889999999999996655 9999999999999999999999997654433322


Q ss_pred             HHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCC-----CHHHHhcCCCCC
Q 023609          159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI-----TVEDALAHPYLG  233 (280)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~ell~h~~~~  233 (280)
                      ++......-+                          .+.-..+|++++++.+.+|++||++|+     ++.++-+||||+
T Consensus       397 Evdrr~~~~~--------------------------~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk  450 (591)
T KOG0986|consen  397 EVDRRTLEDP--------------------------EEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFK  450 (591)
T ss_pred             HHHHHHhcch--------------------------hhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccc
Confidence            2222211111                          112237899999999999999999998     566999999999


Q ss_pred             CCc
Q 023609          234 SLH  236 (280)
Q Consensus       234 ~~~  236 (280)
                      +++
T Consensus       451 ~ln  453 (591)
T KOG0986|consen  451 DLN  453 (591)
T ss_pred             cCC
Confidence            863

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=9.9e-36  Score=247.09  Aligned_cols=197  Identities=27%  Similarity=0.425  Sum_probs=161.5

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS   77 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~   77 (280)
                      ++||||+++++.+...     ...++||||++ ++|.+++...  ..+++..++.++.|++.|+++||++|++|+||+|+
T Consensus        56 ~~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~  130 (256)
T cd08220          56 LSHPNIIEYYENFLED-----KALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQ  130 (256)
T ss_pred             CCCCchhheeeeEecC-----CEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH
Confidence            4799999999998654     67999999997 5999999764  35899999999999999999999999999999999


Q ss_pred             cEEEccCC-CEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023609           78 NLLLNANC-DLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ  156 (280)
Q Consensus        78 nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  156 (280)
                      ||+++.++ .++|+|||.+.............++..|+|||.+.+. ..+.++|+||+|+++++|++|..||.+.+....
T Consensus       131 nil~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~  209 (256)
T cd08220         131 NILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGK-PYNQKSDIWALGCVLYELASLKRAFEAANLPAL  209 (256)
T ss_pred             HEEEcCCCCEEEEccCCCceecCCCccccccccCCcccCchhccCC-CCCcccchHHHHHHHHHHHhCCCCcccCchHHH
Confidence            99998654 5799999999876655443445678899999988544 478899999999999999999999977655444


Q ss_pred             HHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 023609          157 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  232 (280)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~  232 (280)
                      ...+......                             .....+++++.+++.+||+.||.+|||+.++++||||
T Consensus       210 ~~~~~~~~~~-----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         210 VLKIMSGTFA-----------------------------PISDRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             HHHHHhcCCC-----------------------------CCCCCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence            3333221110                             1112568899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=5.4e-36  Score=249.55  Aligned_cols=201  Identities=30%  Similarity=0.538  Sum_probs=164.0

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++.+...     ...|+|+||+. ++|.+++.+.+.+++..+..++.||+.||+|||+.|++|+||+|+||
T Consensus        50 ~~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~ni  124 (265)
T cd05579          50 AQSPYVVKLYYSFQGK-----KNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNI  124 (265)
T ss_pred             CCCcchhHHHHheecC-----cEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHe
Confidence            4799999999988654     67999999997 59999998877899999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCC---------ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 023609           80 LLNANCDLKICDFGLARVTSETD---------FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPG  150 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~  150 (280)
                      +++.++.++|+|||++.......         ......++..|++||...... .+.++|+||+|++++++++|..||..
T Consensus       125 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Dv~slG~~~~~l~~g~~p~~~  203 (265)
T cd05579         125 LIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQG-HSKTVDWWSLGCILYEFLVGIPPFHG  203 (265)
T ss_pred             EEcCCCCEEEEecccchhcccCcccccccccccccCcccCccccCHHHhcCCC-CCcchhhHHHHHHHHHHHhCCCCCCC
Confidence            99999999999999887543321         122345677899999885444 78899999999999999999999987


Q ss_pred             CChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCH---HHHh
Q 023609          151 RDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV---EDAL  227 (280)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~---~ell  227 (280)
                      ....+....+...  ...                         +.. ...++..+.+++++||+.+|.+|||+   .+++
T Consensus       204 ~~~~~~~~~~~~~--~~~-------------------------~~~-~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l  255 (265)
T cd05579         204 ETPEEIFQNILNG--KIE-------------------------WPE-DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK  255 (265)
T ss_pred             CCHHHHHHHHhcC--CcC-------------------------CCc-cccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence            7655444333220  000                         000 01247889999999999999999999   9999


Q ss_pred             cCCCCCCC
Q 023609          228 AHPYLGSL  235 (280)
Q Consensus       228 ~h~~~~~~  235 (280)
                      +||||+++
T Consensus       256 ~~~~~~~~  263 (265)
T cd05579         256 NHPFFKGI  263 (265)
T ss_pred             cCccccCC
Confidence            99999865

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1.2e-35  Score=247.40  Aligned_cols=199  Identities=33%  Similarity=0.538  Sum_probs=162.0

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHH-----HCCce
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS----NQALSEEHCQYFLYQILRGLKYIH-----SANVL   70 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~----~~~l~~~~~~~i~~qll~al~~LH-----~~gi~   70 (280)
                      ++||||+++++++.....   ...|++|||++ ++|.+++..    ..++++..++.++.||+.||++||     +.|++
T Consensus        56 l~~~~i~~~~~~~~~~~~---~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~  132 (265)
T cd08217          56 LKHPNIVRYYDRIIDRSN---QTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVL  132 (265)
T ss_pred             cCCCccceeeeeeecCCC---CEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcce
Confidence            579999999998865322   56899999997 699999865    457999999999999999999999     89999


Q ss_pred             eccCCCCcEEEccCCCEEEeeccceeeccCCCc-cccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 023609           71 HRDLKPSNLLLNANCDLKICDFGLARVTSETDF-MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFP  149 (280)
Q Consensus        71 H~di~~~nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  149 (280)
                      |+||+|+||+++.++.++|+|||.+........ .....+++.|+|||.+.+. ..+.++|+||+|+++++|++|..||.
T Consensus       133 h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~  211 (265)
T cd08217         133 HRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHM-SYDEKSDIWSLGCLIYELCALSPPFT  211 (265)
T ss_pred             ecCCCHHHEEEecCCCEEEecccccccccCCcccccccccCCCccChhhhcCC-CCCchhHHHHHHHHHHHHHHCCCccc
Confidence            999999999999999999999999887654432 3345678899999988544 47889999999999999999999998


Q ss_pred             CCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 023609          150 GRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  229 (280)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h  229 (280)
                      +.+.......+....                             ....-+.++.++.+++.+||+.+|.+|||+.++++|
T Consensus       212 ~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         212 ARNQLQLASKIKEGK-----------------------------FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             CcCHHHHHHHHhcCC-----------------------------CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence            766433322221110                             001112567889999999999999999999999999


Q ss_pred             CCC
Q 023609          230 PYL  232 (280)
Q Consensus       230 ~~~  232 (280)
                      ||+
T Consensus       263 ~~~  265 (265)
T cd08217         263 PLI  265 (265)
T ss_pred             CCC
Confidence            996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.1e-35  Score=253.70  Aligned_cols=199  Identities=25%  Similarity=0.417  Sum_probs=162.0

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++...     ...|+||||+.|++.+.+.. .+.+++..+..++.|++.||.|||+.|++|+||+|+||
T Consensus        72 l~h~niv~~~~~~~~~-----~~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nI  146 (307)
T cd06607          72 LRHPNTIEYKGCYLRE-----HTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNI  146 (307)
T ss_pred             CCCCCEEEEEEEEEeC-----CeEEEEHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccE
Confidence            5799999999999765     66899999999998888764 45799999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCCccccceeccccccchhccC--CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLN--SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL  157 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  157 (280)
                      +++.++.++|+|||.+......   ....++..|+|||.+.+  ...++.++||||+|+++|+|++|.+||.+.+.....
T Consensus       147 l~~~~~~~kL~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~  223 (307)
T cd06607         147 LLTEPGTVKLADFGSASLVSPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL  223 (307)
T ss_pred             EECCCCCEEEeecCcceecCCC---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHH
Confidence            9999999999999998765433   23456788999998742  345788999999999999999999999766544332


Q ss_pred             HHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCC
Q 023609          158 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  235 (280)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~  235 (280)
                      ..+...  .++.                          .....++..++++|.+||+.||.+||++.+++.||||..-
T Consensus       224 ~~~~~~--~~~~--------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  273 (307)
T cd06607         224 YHIAQN--DSPT--------------------------LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRE  273 (307)
T ss_pred             HHHhcC--CCCC--------------------------CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhccc
Confidence            222110  0000                          0001356789999999999999999999999999999874

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=6.9e-36  Score=252.55  Aligned_cols=206  Identities=26%  Similarity=0.448  Sum_probs=159.4

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHH-----cCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCC
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIR-----SNQALSEEHCQYFLYQILRGLKYIHSA-NVLHRDLK   75 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~-----~~~~l~~~~~~~i~~qll~al~~LH~~-gi~H~di~   75 (280)
                      +||||+++++++..+     ...+++|||+++++.++..     ..+.+++..+..++.|++.||+|||+. |++|||||
T Consensus        61 ~~~~iv~~~~~~~~~-----~~~~~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlk  135 (288)
T cd06616          61 DCPYIVKFYGALFRE-----GDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVK  135 (288)
T ss_pred             CCCCEeeeeeEEecC-----CcEEEEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCC
Confidence            499999999998665     6689999999876655432     246799999999999999999999974 99999999


Q ss_pred             CCcEEEccCCCEEEeeccceeeccCCCccccceeccccccchhccCC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCh
Q 023609           76 PSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNS--SDYTAAIDVWSVGCIFMELMDRKPLFPGRDH  153 (280)
Q Consensus        76 ~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~  153 (280)
                      |+||+++.++.++|+|||++.............++..|+|||.+.+.  ..++.++|+||+||++++|++|..||.....
T Consensus       136 p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~  215 (288)
T cd06616         136 PSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS  215 (288)
T ss_pred             HHHEEEccCCcEEEeecchhHHhccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch
Confidence            99999999999999999998755443333344678889999998654  3578899999999999999999999965431


Q ss_pred             HHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCC
Q 023609          154 VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLG  233 (280)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~  233 (280)
                        ....+........                  +.    ........++.++.+||.+||+.||++|||+.++++||||.
T Consensus       216 --~~~~~~~~~~~~~------------------~~----~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~  271 (288)
T cd06616         216 --VFDQLTQVVKGDP------------------PI----LSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIK  271 (288)
T ss_pred             --HHHHHhhhcCCCC------------------Cc----CCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhh
Confidence              1111111111000                  00    00011135788999999999999999999999999999998


Q ss_pred             CCc
Q 023609          234 SLH  236 (280)
Q Consensus       234 ~~~  236 (280)
                      ...
T Consensus       272 ~~~  274 (288)
T cd06616         272 DYE  274 (288)
T ss_pred             chh
Confidence            753

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.4e-35  Score=250.02  Aligned_cols=194  Identities=22%  Similarity=0.369  Sum_probs=158.0

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC----------------CCCCHHHHHHHHHHHHHHHHH
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN----------------QALSEEHCQYFLYQILRGLKY   63 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~----------------~~l~~~~~~~i~~qll~al~~   63 (280)
                      ++||||+++++++...     ...|++|||++ ++|.+++...                ..+++.++..++.|++.||+|
T Consensus        65 l~h~~i~~~~~~~~~~-----~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~  139 (283)
T cd05048          65 LQHPNIVCLLGVCTKE-----QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEY  139 (283)
T ss_pred             cCCcccceEEEEEcCC-----CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHH
Confidence            5799999999998655     56899999997 6999999754                458889999999999999999


Q ss_pred             HHHCCceeccCCCCcEEEccCCCEEEeeccceeeccCCC---ccccceeccccccchhccCCCCCCcchhHHHHHHHHHH
Q 023609           64 IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME  140 (280)
Q Consensus        64 LH~~gi~H~di~~~nili~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~  140 (280)
                      ||+.|++|+||||+||+++.++.++|+|||++.......   ......+++.|+|||.+.+. .++.++|+||+||++|+
T Consensus       140 lH~~~i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDv~slG~il~e  218 (283)
T cd05048         140 LSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYG-KFTTESDIWSFGVVLWE  218 (283)
T ss_pred             HHhCCeeccccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccC-cCchhhhHHHHHHHHHH
Confidence            999999999999999999999999999999987643321   12234557889999987544 47899999999999999


Q ss_pred             HHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCC
Q 023609          141 LMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQ  219 (280)
Q Consensus       141 ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~  219 (280)
                      |++ |..||.+....+....+.+....                             ..-+.++.++.+|+.+||+.||.+
T Consensus       219 l~~~g~~p~~~~~~~~~~~~i~~~~~~-----------------------------~~~~~~~~~~~~l~~~c~~~~p~~  269 (283)
T cd05048         219 IFSYGLQPYYGFSNQEVIEMIRSRQLL-----------------------------PCPEDCPARVYALMIECWNEIPAR  269 (283)
T ss_pred             HHcCCCCCCCCCCHHHHHHHHHcCCcC-----------------------------CCcccCCHHHHHHHHHHccCChhh
Confidence            997 99999877665544433221110                             011367889999999999999999


Q ss_pred             CCCHHHHhcC
Q 023609          220 RITVEDALAH  229 (280)
Q Consensus       220 R~t~~ell~h  229 (280)
                      |||+.+++++
T Consensus       270 Rp~~~~i~~~  279 (283)
T cd05048         270 RPRFKDIHTR  279 (283)
T ss_pred             CcCHHHHHHH
Confidence            9999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1.7e-35  Score=247.30  Aligned_cols=200  Identities=25%  Similarity=0.476  Sum_probs=159.5

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++.+...   ..++++|||++ ++|.+++.+.+.+++..+..++.|++.||++||+.|++|+||+|+||
T Consensus        61 l~h~~i~~~~~~~~~~~~---~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~ni  137 (265)
T cd06652          61 LLHERIVQYYGCLRDPME---RTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANI  137 (265)
T ss_pred             cCCCCeeeEEeEeccCCC---ceEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHE
Confidence            579999999998865421   46889999997 69999998878899999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCC----CccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 023609           80 LLNANCDLKICDFGLARVTSET----DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVH  155 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~  155 (280)
                      +++.++.++|+|||.+......    .......++..|+|||.+.+. .++.++|+||+||++|+|++|..||.+.....
T Consensus       138 l~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~  216 (265)
T cd06652         138 LRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGE-GYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA  216 (265)
T ss_pred             EecCCCCEEECcCccccccccccccccccccCCCCccccChhhhcCC-CCCcchhHHHHHHHHHHHhhCCCCCCccchHH
Confidence            9999999999999988754321    112234578889999988654 47889999999999999999999997654433


Q ss_pred             HHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCC
Q 023609          156 QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLG  233 (280)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~  233 (280)
                      ....+..   .+..                         ....+.++..+.++|++||. +|++||+++++++|||+.
T Consensus       217 ~~~~~~~---~~~~-------------------------~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~  265 (265)
T cd06652         217 AIFKIAT---QPTN-------------------------PVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH  265 (265)
T ss_pred             HHHHHhc---CCCC-------------------------CCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence            3322211   1100                         00112456788999999995 999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=2.1e-35  Score=245.32  Aligned_cols=197  Identities=26%  Similarity=0.464  Sum_probs=161.1

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ--ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS   77 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~--~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~   77 (280)
                      ++||||+++++++...     +..|+|+||+. ++|.+++....  .+++..+..++.|++.|+.+||++|++|+||+|+
T Consensus        56 l~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~  130 (256)
T cd08218          56 MKHPNIVQYQESFEEN-----GNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQ  130 (256)
T ss_pred             CCCCCeeeeEeeecCC-----CeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHH
Confidence            5799999999998655     67999999997 59999987543  5899999999999999999999999999999999


Q ss_pred             cEEEccCCCEEEeeccceeeccCCCc-cccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023609           78 NLLLNANCDLKICDFGLARVTSETDF-MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ  156 (280)
Q Consensus        78 nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  156 (280)
                      ||+++.++.++++|||.+........ .....+++.|+|||.+.+. ..+.++|+||+||++++|++|..||...+..+.
T Consensus       131 nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~  209 (256)
T cd08218         131 NIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENR-PYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNL  209 (256)
T ss_pred             HEEEcCCCCEEEeeccceeecCcchhhhhhccCCccccCHHHhCCC-CCCCccchhHHHHHHHHHHcCCCCccCCCHHHH
Confidence            99999999999999999876544321 2234567889999988544 478899999999999999999999976655444


Q ss_pred             HHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 023609          157 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  232 (280)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~  232 (280)
                      ...+......                             .....++.++.++|.+||+.+|.+||++.++++||||
T Consensus       210 ~~~~~~~~~~-----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         210 VLKIIRGSYP-----------------------------PVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             HHHHhcCCCC-----------------------------CCcccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence            3333211100                             1112567889999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.2e-35  Score=252.44  Aligned_cols=203  Identities=28%  Similarity=0.510  Sum_probs=164.7

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++.+...     ...|+|+||++ ++|.+++.. ..+++..++.++.|++.||+|||+.|++|+||+|+||
T Consensus        75 l~hp~i~~~~~~~~~~-----~~~~iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Ni  148 (297)
T cd06659          75 YQHQNVVEMYKSYLVG-----EELWVLMEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSI  148 (297)
T ss_pred             CCCCchhhhhhheeeC-----CeEEEEEecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHe
Confidence            5799999999998665     67999999998 588887754 5699999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCC-ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  158 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.++.++|+|||++....... ......++..|+|||.+.+. .++.++|+||+||++++|++|..||......+...
T Consensus       149 ll~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~  227 (297)
T cd06659         149 LLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRT-PYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK  227 (297)
T ss_pred             EEccCCcEEEeechhHhhcccccccccceecCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            99999999999999886543321 12345678899999988544 47889999999999999999999997766544433


Q ss_pred             HHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCcC
Q 023609          159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD  237 (280)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~~  237 (280)
                      .+...   +.                        ........++..+.++|++||+.+|.+||++.++++||||.+...
T Consensus       228 ~~~~~---~~------------------------~~~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~~  279 (297)
T cd06659         228 RLRDS---PP------------------------PKLKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTGL  279 (297)
T ss_pred             HHhcc---CC------------------------CCccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCCC
Confidence            22110   00                        001112356788999999999999999999999999999988754

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.6e-35  Score=249.41  Aligned_cols=202  Identities=26%  Similarity=0.434  Sum_probs=157.5

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++.+...     ...++||||+++ +|..+    ..+++..+..++.|++.||.|||+.|++|+||||+||
T Consensus        56 l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Ni  126 (279)
T cd06619          56 CDSPYIIGFYGAFFVE-----NRISICTEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNM  126 (279)
T ss_pred             CCCCCeeeEEEEEEEC-----CEEEEEEecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHE
Confidence            5799999999999765     678999999985 66543    3588999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH---
Q 023609           80 LLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ---  156 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~---  156 (280)
                      +++.++.++|+|||++....... .....++..|+|||.+.+. .++.++|+||+||++|+|++|..||........   
T Consensus       127 ll~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~  204 (279)
T cd06619         127 LVNTRGQVKLCDFGVSTQLVNSI-AKTYVGTNAYMAPERISGE-QYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLM  204 (279)
T ss_pred             EECCCCCEEEeeCCcceeccccc-ccCCCCChhhcCceeecCC-CCCCcchHHHHHHHHHHHHhCCCCchhhcccccccc
Confidence            99999999999999987654332 2345788899999988544 478999999999999999999999964221110   


Q ss_pred             HHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCc
Q 023609          157 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  236 (280)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~  236 (280)
                      ..........+                  .      .........+++++++|.+||+.||.+||++.++++||||....
T Consensus       205 ~~~~~~~~~~~------------------~------~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~  260 (279)
T cd06619         205 PLQLLQCIVDE------------------D------PPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYN  260 (279)
T ss_pred             hHHHHHHHhcc------------------C------CCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCccccccc
Confidence            00000000000                  0      00001124678899999999999999999999999999998874


Q ss_pred             C
Q 023609          237 D  237 (280)
Q Consensus       237 ~  237 (280)
                      .
T Consensus       261 ~  261 (279)
T cd06619         261 D  261 (279)
T ss_pred             C
Confidence            3

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=2e-35  Score=249.46  Aligned_cols=204  Identities=27%  Similarity=0.423  Sum_probs=158.3

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCC
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIR----SNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKP   76 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~----~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~   76 (280)
                      +||||+++++++...........|+||||++ ++|.+++.    .+..+++..++.++.|++.||.|||+.|++||||+|
T Consensus        73 ~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp  152 (286)
T cd06638          73 DHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKG  152 (286)
T ss_pred             cCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCH
Confidence            6999999999885433223357999999997 58988875    235689999999999999999999999999999999


Q ss_pred             CcEEEccCCCEEEeeccceeeccCCC-ccccceeccccccchhccC----CCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 023609           77 SNLLLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLN----SSDYTAAIDVWSVGCIFMELMDRKPLFPGR  151 (280)
Q Consensus        77 ~nili~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~  151 (280)
                      +||+++.++.++|+|||.+....... ......+++.|+|||.+..    ...++.++|+||+||++++|++|..||.+.
T Consensus       153 ~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~  232 (286)
T cd06638         153 NNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADL  232 (286)
T ss_pred             HhEEECCCCCEEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCC
Confidence            99999999999999999987654332 2234467889999998742    233678999999999999999999999765


Q ss_pred             ChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCC
Q 023609          152 DHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPY  231 (280)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~  231 (280)
                      ........+...  .++                        . ...-..++..+.++|.+||+.||.+|||+.++++|+|
T Consensus       233 ~~~~~~~~~~~~--~~~------------------------~-~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~  285 (286)
T cd06638         233 HPMRALFKIPRN--PPP------------------------T-LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVF  285 (286)
T ss_pred             chhHHHhhcccc--CCC------------------------c-ccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhccc
Confidence            433322111100  000                        0 0000135678999999999999999999999999999


Q ss_pred             C
Q 023609          232 L  232 (280)
Q Consensus       232 ~  232 (280)
                      |
T Consensus       286 ~  286 (286)
T cd06638         286 I  286 (286)
T ss_pred             C
Confidence            7

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-37  Score=260.80  Aligned_cols=200  Identities=27%  Similarity=0.515  Sum_probs=181.6

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecC-CccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~-~g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nil   80 (280)
                      +.|.||++|..|.++     ..+|++||.| +|.|...++.++.|.+..++.++..+++|++|||++||++|||||+|.+
T Consensus       478 ~s~fIvrLYrTfrd~-----kyvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENll  552 (732)
T KOG0614|consen  478 RSDFIVRLYRTFRDS-----KYVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLL  552 (732)
T ss_pred             CchHHHHHHHHhccc-----hhhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhhee
Confidence            578999999999776     7799999998 5899999999999999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 023609           81 LNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL  160 (280)
Q Consensus        81 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~  160 (280)
                      ++.+|-+||.|||+++..+.+....+.+|||.|.|||++.+.+ ...++|.||||+++|||++|.+||.+.++...+..|
T Consensus       553 Ld~~Gy~KLVDFGFAKki~~g~KTwTFcGTpEYVAPEIILnKG-HD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~I  631 (732)
T KOG0614|consen  553 LDNRGYLKLVDFGFAKKIGSGRKTWTFCGTPEYVAPEIILNKG-HDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLI  631 (732)
T ss_pred             eccCCceEEeehhhHHHhccCCceeeecCCcccccchhhhccC-cchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHH
Confidence            9999999999999999999888888999999999999998776 588999999999999999999999999999999888


Q ss_pred             HHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCC-----HHHHhcCCCCCCC
Q 023609          161 IELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT-----VEDALAHPYLGSL  235 (280)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~ell~h~~~~~~  235 (280)
                      .+.+....                 +|           ..++..+.+||+++-.-+|++|+.     +.++-.|.||.++
T Consensus       632 LkGid~i~-----------------~P-----------r~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gf  683 (732)
T KOG0614|consen  632 LKGIDKIE-----------------FP-----------RRITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGF  683 (732)
T ss_pred             Hhhhhhhh-----------------cc-----------cccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcC
Confidence            77553211                 01           156778999999999999999996     8899999999875

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.9e-35  Score=247.25  Aligned_cols=193  Identities=20%  Similarity=0.289  Sum_probs=155.0

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      ++||||+++++++...     ...++||||++ |+|.+++... +.+++..+..++.||+.||+|||+.|++||||||+|
T Consensus        63 l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~n  137 (266)
T cd05064          63 FDHSNIVRLEGVITRG-----NTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHK  137 (266)
T ss_pred             CCCCCcCeEEEEEecC-----CCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhh
Confidence            5799999999998654     67899999998 5899998764 579999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCCCcc--ccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 023609           79 LLLNANCDLKICDFGLARVTSETDFM--TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVH  155 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~  155 (280)
                      |+++.++.++++|||.+.........  ....++..|+|||.+.+ ..++.++||||+||++|++++ |..||.+.+..+
T Consensus       138 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~  216 (266)
T cd05064         138 VLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQY-HHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD  216 (266)
T ss_pred             EEEcCCCcEEECCCcccccccccchhcccCCCCceeecCHHHHhh-CCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH
Confidence            99999999999999987653322111  12234567999998854 458899999999999999774 999998776655


Q ss_pred             HHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          156 QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                      ....+.+....+                             ..+.++..+.+++.+||+.+|.+|||+.++++
T Consensus       217 ~~~~~~~~~~~~-----------------------------~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         217 VIKAVEDGFRLP-----------------------------APRNCPNLLHQLMLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             HHHHHHCCCCCC-----------------------------CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence            444432211111                             11356788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=8.3e-38  Score=251.41  Aligned_cols=202  Identities=25%  Similarity=0.427  Sum_probs=165.9

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIR-SNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~-~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      +.|++|++|+.|.-.     .+++||||||+ |++.|.++ .+++++++++..++...+.||+|||...-+|||||..||
T Consensus        86 ~S~yVVKYYGSYFK~-----sDLWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNI  160 (502)
T KOG0574|consen   86 KSKYVVKYYGSYFKH-----SDLWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNI  160 (502)
T ss_pred             CCchhhhhhhhhccC-----CceEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccE
Confidence            579999999988665     67999999998 89999998 457899999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCC-ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  158 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.+|..||.|||.+....+.. ..++..||+.|||||++..-+ |...+||||||++..+|..|++||.+-.+.   +
T Consensus       161 LLNT~G~AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI~EIG-Y~~~ADIWSLGITaIEMAEG~PPYsDIHPM---R  236 (502)
T KOG0574|consen  161 LLNTDGIAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIEEIG-YDTKADIWSLGITAIEMAEGRPPYSDIHPM---R  236 (502)
T ss_pred             EEcccchhhhhhccccchhhhhHHhhCccccCcccccHHHHHHhc-cchhhhHhhhcchhhhhhcCCCCccccccc---c
Confidence            99999999999999998765542 345678999999999997665 788999999999999999999999653221   1


Q ss_pred             HHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCc
Q 023609          159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  236 (280)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~  236 (280)
                      .|+-   .|.                    .++..+.+ -...|.++-||+++||.+.|++|.|+.++++|||+++..
T Consensus       237 AIFM---IPT--------------------~PPPTF~K-PE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~  290 (502)
T KOG0574|consen  237 AIFM---IPT--------------------KPPPTFKK-PEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAP  290 (502)
T ss_pred             eeEe---ccC--------------------CCCCCCCC-hHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCC
Confidence            1111   111                    11111100 013467899999999999999999999999999999864

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=3.9e-35  Score=251.04  Aligned_cols=199  Identities=26%  Similarity=0.431  Sum_probs=163.0

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++...     ...|+||||+.|++.+.+.. ..++++.++..++.||+.||.|||+.|++|+||+|+||
T Consensus        78 l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~ni  152 (313)
T cd06633          78 LKHPNTIEYKGCYLKE-----HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNI  152 (313)
T ss_pred             CCCCCCccEEEEEEeC-----CEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhE
Confidence            5799999999999765     67899999999999888865 45799999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCCccccceeccccccchhccC--CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLN--SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL  157 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  157 (280)
                      +++.++.++|+|||.+.....   .....++..|+|||.+..  ...++.++|+||+||++++|++|..||.+.+.....
T Consensus       153 li~~~~~~kL~dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~  229 (313)
T cd06633         153 LLTEPGQVKLADFGSASKSSP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL  229 (313)
T ss_pred             EECCCCCEEEeecCCCcccCC---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence            999999999999998864332   234567888999998742  344778999999999999999999999776554443


Q ss_pred             HHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCC
Q 023609          158 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  235 (280)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~  235 (280)
                      ..+.... .+.                           ...+.++..+++|+.+||+.+|.+||++.++++||||...
T Consensus       230 ~~~~~~~-~~~---------------------------~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~  279 (313)
T cd06633         230 YHIAQND-SPT---------------------------LQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRD  279 (313)
T ss_pred             HHHHhcC-CCC---------------------------CCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence            3322110 000                           1112466789999999999999999999999999999874

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=9.9e-36  Score=254.18  Aligned_cols=200  Identities=26%  Similarity=0.418  Sum_probs=161.6

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++|||++++++++...     ...++||||+.|++.+.+.. +.++++..+..++.|++.||.|||+.|++||||+|+||
T Consensus        72 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~ni  146 (308)
T cd06634          72 LRHPNTIQYRGCYLRE-----HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNI  146 (308)
T ss_pred             CCCCCcccEEEEEEcC-----CeeEEEEEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhE
Confidence            5799999999998665     67899999999998888753 45699999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCCccccceeccccccchhccC--CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLN--SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL  157 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  157 (280)
                      +++.++.++|+|||.+......   ....++..|+|||.+.+  ....+.++||||+||++++|++|..||.+.......
T Consensus       147 l~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~  223 (308)
T cd06634         147 LLSEPGLVKLGDFGSASIMAPA---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL  223 (308)
T ss_pred             EECCCCcEEECCcccceeecCc---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHH
Confidence            9999999999999998765433   23456788999998742  234678999999999999999999998665433322


Q ss_pred             HHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCc
Q 023609          158 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  236 (280)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~  236 (280)
                      ..+.... .+.                           .....++..++++|++||+.+|.+||++.++++|||+....
T Consensus       224 ~~~~~~~-~~~---------------------------~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~  274 (308)
T cd06634         224 YHIAQNE-SPA---------------------------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER  274 (308)
T ss_pred             HHHhhcC-CCC---------------------------cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccccC
Confidence            2221100 000                           01125678899999999999999999999999999998854

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=4.8e-35  Score=244.92  Aligned_cols=200  Identities=28%  Similarity=0.472  Sum_probs=156.2

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC-CCC--CHHHHHHHHHHHHHHHHHHHHCCceeccCCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QAL--SEEHCQYFLYQILRGLKYIHSANVLHRDLKP   76 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-~~l--~~~~~~~i~~qll~al~~LH~~gi~H~di~~   76 (280)
                      ++||||+++++++...     ...++|+||+. ++|.+++... ..+  ++..+..++.||+.||+|||+.|++||||+|
T Consensus        62 l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p  136 (268)
T cd06624          62 LKHRNIVQYLGSDSEN-----GFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKG  136 (268)
T ss_pred             cCCCCeeeeeeeeccC-----CEEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCH
Confidence            5899999999998665     67999999997 6999999754 456  8889999999999999999999999999999


Q ss_pred             CcEEEcc-CCCEEEeeccceeeccCCC-ccccceeccccccchhccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCh
Q 023609           77 SNLLLNA-NCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNS-SDYTAAIDVWSVGCIFMELMDRKPLFPGRDH  153 (280)
Q Consensus        77 ~nili~~-~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~  153 (280)
                      +||+++. ++.++|+|||.+....... ......++..|+|||.+.+. ..++.++|+||+|+++++|++|..||.....
T Consensus       137 ~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~  216 (268)
T cd06624         137 DNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGE  216 (268)
T ss_pred             HHEEEcCCCCeEEEecchhheecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccC
Confidence            9999976 6789999999987653322 22234568889999987543 2367899999999999999999999965332


Q ss_pred             HHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 023609          154 VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  232 (280)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~  232 (280)
                      ............                   .        ....-..+++++++++++||+.+|.+|||+.+++.||||
T Consensus       217 ~~~~~~~~~~~~-------------------~--------~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         217 PQAAMFKVGMFK-------------------I--------HPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             hhhhHhhhhhhc-------------------c--------CCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence            111110000000                   0        001112567889999999999999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=3.3e-35  Score=244.25  Aligned_cols=194  Identities=28%  Similarity=0.429  Sum_probs=160.7

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC---------CCCCHHHHHHHHHHHHHHHHHHHHCCce
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN---------QALSEEHCQYFLYQILRGLKYIHSANVL   70 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~---------~~l~~~~~~~i~~qll~al~~LH~~gi~   70 (280)
                      ++||||+++++++...     ..+++||||+. ++|.+++...         ..+++..++.++.|++.||++||+.|++
T Consensus        53 ~~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~  127 (262)
T cd00192          53 LGHPNVVRLLGVCTEE-----EPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFV  127 (262)
T ss_pred             cCCCChheeeeeecCC-----CceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcc
Confidence            4799999999999764     67999999995 7999999875         7799999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCEEEeeccceeeccCCC---ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCC
Q 023609           71 HRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKP  146 (280)
Q Consensus        71 H~di~~~nili~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~  146 (280)
                      |+||+|+||+++.++.++|+|||.+.......   ......++..|+|||.+... .++.++|+||+|+++++|++ |..
T Consensus       128 H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~  206 (262)
T cd00192         128 HRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDG-IFTSKSDVWSFGVLLWEIFTLGAT  206 (262)
T ss_pred             cCccCcceEEECCCCcEEEcccccccccccccccccccCCCcCccccCHHHhccC-CcchhhccHHHHHHHHHHHhcCCC
Confidence            99999999999999999999999998665432   22344567889999988554 57899999999999999998 699


Q ss_pred             CCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHH
Q 023609          147 LFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDA  226 (280)
Q Consensus       147 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~el  226 (280)
                      ||.+....+....+.....                             ....+.++.++.+++.+||+.||.+|||+.++
T Consensus       207 p~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l  257 (262)
T cd00192         207 PYPGLSNEEVLEYLRKGYR-----------------------------LPKPEYCPDELYELMLSCWQLDPEDRPTFSEL  257 (262)
T ss_pred             CCCCCCHHHHHHHHHcCCC-----------------------------CCCCccCChHHHHHHHHHccCCcccCcCHHHH
Confidence            9988765554444332100                             01112568899999999999999999999999


Q ss_pred             hcC
Q 023609          227 LAH  229 (280)
Q Consensus       227 l~h  229 (280)
                      +++
T Consensus       258 ~~~  260 (262)
T cd00192         258 VER  260 (262)
T ss_pred             HHh
Confidence            875

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=3.9e-35  Score=244.58  Aligned_cols=201  Identities=28%  Similarity=0.508  Sum_probs=160.8

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++.+...     ...++|+||++ ++|.+++.+.+.+++..++.++.|++.||.|||+.|++|+||+|+||
T Consensus        56 l~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~ni  130 (264)
T cd06626          56 LKHPNLVKYYGVEVHR-----EKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANI  130 (264)
T ss_pred             CCCCChhheeeeEecC-----CEEEEEEecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHE
Confidence            5799999999998654     67999999997 69999998877899999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCCcc-----ccceeccccccchhccCCC--CCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 023609           80 LLNANCDLKICDFGLARVTSETDFM-----TEYVVTRWYRAPELLLNSS--DYTAAIDVWSVGCIFMELMDRKPLFPGRD  152 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~  152 (280)
                      +++.++.++|+|||.+.........     ....++..|+|||.+.+..  ..+.++|+||+|++++++++|..||.+..
T Consensus       131 l~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~  210 (264)
T cd06626         131 FLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELD  210 (264)
T ss_pred             EECCCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCc
Confidence            9999999999999998765433221     1245678899999885432  26789999999999999999999997653


Q ss_pred             hHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 023609          153 HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  232 (280)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~  232 (280)
                      ..............+.                         + .....+++.+.++|.+||+.+|.+|||+.+++.|||+
T Consensus       211 ~~~~~~~~~~~~~~~~-------------------------~-~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         211 NEFQIMFHVGAGHKPP-------------------------I-PDSLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             chHHHHHHHhcCCCCC-------------------------C-CcccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            3222221111100000                         0 0112457889999999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=1.2e-35  Score=244.36  Aligned_cols=189  Identities=25%  Similarity=0.386  Sum_probs=154.3

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nil   80 (280)
                      .||||+++++++...     ...|+||||++ |+|.+++.+...+++..+..++.|++.||+|||+.|++||||||+||+
T Consensus        43 ~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil  117 (237)
T cd05576          43 CVPNMVCLHKYIVSE-----DSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNIL  117 (237)
T ss_pred             CCCceeehhhheecC-----CeEEEEEecCCCCCHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEE
Confidence            589999999998665     67999999998 699999988778999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 023609           81 LNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL  160 (280)
Q Consensus        81 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~  160 (280)
                      ++.++.++++|||.+......  .....++..|+|||... ...++.++|+||+|+++|+|++|..|+.......     
T Consensus       118 ~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~y~aPE~~~-~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~-----  189 (237)
T cd05576         118 LDDRGHIQLTYFSRWSEVEDS--CDGEAVENMYCAPEVGG-ISEETEACDWWSLGAILFELLTGKTLVECHPSGI-----  189 (237)
T ss_pred             EcCCCCEEEecccchhccccc--cccCCcCccccCCcccC-CCCCCchhhHHHHHHHHHHHHHCcchhhcCchhc-----
Confidence            999999999999987655433  22344567799999874 3447889999999999999999998774321100     


Q ss_pred             HHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCH-----HHHhcCCCC
Q 023609          161 IELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV-----EDALAHPYL  232 (280)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~-----~ell~h~~~  232 (280)
                          ..                   .   ..   ...-+.+++.++++|.+||+.||.+|+|+     +++++||||
T Consensus       190 ----~~-------------------~---~~---~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~  237 (237)
T cd05576         190 ----NT-------------------H---TT---LNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF  237 (237)
T ss_pred             ----cc-------------------c---cc---cCCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence                00                   0   00   00112467889999999999999999996     999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-35  Score=247.43  Aligned_cols=201  Identities=22%  Similarity=0.456  Sum_probs=162.0

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nil   80 (280)
                      .|||++++++++...     ...|+||||+. ++|.+++.. +.+++..+..++.|++.||.|||+.|++|+||+|+||+
T Consensus        60 ~~~~vi~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~  133 (277)
T cd06917          60 QPPNITKYYGSYLKG-----PRLWIIMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANIL  133 (277)
T ss_pred             CCCCeeeEeeeeeeC-----CEEEEEEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEE
Confidence            499999999998654     67899999997 599998865 47999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccceeeccCCC-ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023609           81 LNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  159 (280)
Q Consensus        81 i~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      ++.++.++|+|||.+....... ......++..|+|||.+.+...++.++|+||+||++|+|++|..||.+.........
T Consensus       134 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~  213 (277)
T cd06917         134 VTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMML  213 (277)
T ss_pred             EcCCCCEEEccCCceeecCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhc
Confidence            9999999999999987655432 123346788899999886555578899999999999999999999976543322211


Q ss_pred             HHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCc
Q 023609          160 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  236 (280)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~  236 (280)
                      +...  .+                        ..+.  ...++.++.+++.+||+.||.+|||+.+++.|+||+...
T Consensus       214 ~~~~--~~------------------------~~~~--~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~  262 (277)
T cd06917         214 IPKS--KP------------------------PRLE--DNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHS  262 (277)
T ss_pred             cccC--CC------------------------CCCC--cccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhccc
Confidence            1000  00                        0000  012678899999999999999999999999999997743

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=7e-36  Score=257.26  Aligned_cols=232  Identities=18%  Similarity=0.264  Sum_probs=162.9

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS   77 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~   77 (280)
                      ++||||+++++++...     ...++|+||+. ++|.+++.+.  ..+++..++.++.||+.||+|||+.|++||||||+
T Consensus        56 l~h~niv~~~~~~~~~-----~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~  130 (328)
T cd08226          56 FRHPNIMTSWTVFTTG-----SWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKAS  130 (328)
T ss_pred             CCCCCcceEeeeEecC-----CceEEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH
Confidence            5799999999999765     67899999998 5999988764  35899999999999999999999999999999999


Q ss_pred             cEEEccCCCEEEeeccceeeccCCC--------ccccceeccccccchhccCC-CCCCcchhHHHHHHHHHHHHhCCCCC
Q 023609           78 NLLLNANCDLKICDFGLARVTSETD--------FMTEYVVTRWYRAPELLLNS-SDYTAAIDVWSVGCIFMELMDRKPLF  148 (280)
Q Consensus        78 nili~~~~~~~l~dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf  148 (280)
                      ||+++.++.++++||+.+.......        ......++..|+|||.+.+. ..++.++|+||+||++++|++|..||
T Consensus       131 Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~  210 (328)
T cd08226         131 HILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPF  210 (328)
T ss_pred             HEEEeCCCcEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCC
Confidence            9999999999999997543221110        00112235569999998653 34678999999999999999999999


Q ss_pred             CCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCc----------------c-c-cccccccCCCCChHHHHHHH
Q 023609          149 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPR----------------Y-Q-RQSFTEKFPNVHPSAIDLVE  210 (280)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------------~-~-~~~~~~~~~~~~~~~~~li~  210 (280)
                      .+.................+..... ..............                . . ..........++..+++||+
T Consensus       211 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  289 (328)
T cd08226         211 QDMLRTQMLLQKLKGPPYSPLDITT-FPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVE  289 (328)
T ss_pred             CCcChHHHHHHHhcCCCCCCccccc-cchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHH
Confidence            8776554433332211111100000 00000000000000                0 0 00000111245778999999


Q ss_pred             HhhcCCCCCCCCHHHHhcCCCCCCCcCC
Q 023609          211 KMLTFDPRQRITVEDALAHPYLGSLHDI  238 (280)
Q Consensus       211 ~~L~~dp~~R~t~~ell~h~~~~~~~~~  238 (280)
                      +||+.||++|||+.++++||||.+....
T Consensus       290 ~~l~~dP~~Rpta~e~l~~~~~~~~~~~  317 (328)
T cd08226         290 LCLQQDPEKRPSASSLLSHAFFKQVKEQ  317 (328)
T ss_pred             HHccCCcccCCCHHHHhhCHHHHHHHHh
Confidence            9999999999999999999999887653

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=4e-35  Score=248.07  Aligned_cols=193  Identities=22%  Similarity=0.385  Sum_probs=155.2

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCC-------------CCCHHHHHHHHHHHHHHHHHHHH
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ-------------ALSEEHCQYFLYQILRGLKYIHS   66 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~-------------~l~~~~~~~i~~qll~al~~LH~   66 (280)
                      ++||||+++++++...     ...++||||++ ++|.+++...+             .+++..+..++.|++.||+|||+
T Consensus        64 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~  138 (288)
T cd05093          64 LQHEHIVKFYGVCVEG-----DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLAS  138 (288)
T ss_pred             CCCCCcceEEEEEecC-----CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            5799999999998654     67899999997 69999987543             48999999999999999999999


Q ss_pred             CCceeccCCCCcEEEccCCCEEEeeccceeeccCCC---ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh
Q 023609           67 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD  143 (280)
Q Consensus        67 ~gi~H~di~~~nili~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~  143 (280)
                      .|++||||||+||+++.++.++|+|||.+.......   ......++..|+|||.+.+ ..++.++|+||+||++++|++
T Consensus       139 ~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDiwslG~il~~l~t  217 (288)
T cd05093         139 QHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFT  217 (288)
T ss_pred             CCeeecccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhcc-CCCCchhhHHHHHHHHHHHHh
Confidence            999999999999999999999999999987543221   1122334678999998854 457889999999999999998


Q ss_pred             -CCCCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCC
Q 023609          144 -RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT  222 (280)
Q Consensus       144 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t  222 (280)
                       |.+||.+.........+......                             ......+.++.+++.+||+.||.+|||
T Consensus       218 ~g~~p~~~~~~~~~~~~i~~~~~~-----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt  268 (288)
T cd05093         218 YGKQPWYQLSNNEVIECITQGRVL-----------------------------QRPRTCPKEVYDLMLGCWQREPHMRLN  268 (288)
T ss_pred             CCCCCCCCCCHHHHHHHHHcCCcC-----------------------------CCCCCCCHHHHHHHHHHccCChhhCCC
Confidence             89999776655544433221100                             011246788999999999999999999


Q ss_pred             HHHHhc
Q 023609          223 VEDALA  228 (280)
Q Consensus       223 ~~ell~  228 (280)
                      +.+++.
T Consensus       269 ~~~v~~  274 (288)
T cd05093         269 IKEIHS  274 (288)
T ss_pred             HHHHHH
Confidence            999854

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-37  Score=266.68  Aligned_cols=234  Identities=25%  Similarity=0.382  Sum_probs=180.0

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIR-SNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~-~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      |+|||++.+.+.|.-.     ...++|||||=|+-.|.+. .++++.+.++..|+.+.+.||+|||+.+.+|||||..||
T Consensus        83 l~HPntieYkgCyLre-----~TaWLVMEYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNI  157 (948)
T KOG0577|consen   83 LRHPNTIEYKGCYLRE-----HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNI  157 (948)
T ss_pred             ccCCCcccccceeecc-----chHHHHHHHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccce
Confidence            6899999999999655     6789999999988888876 457899999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCCccccceeccccccchhcc--CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL--NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL  157 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  157 (280)
                      +++..|.+||+|||.+....+.   +.++|||.|||||++.  ..+.|+-++||||||++..+|..+++|+-+.+....+
T Consensus       158 LLse~g~VKLaDFGSAsi~~PA---nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSAL  234 (948)
T KOG0577|consen  158 LLSEPGLVKLADFGSASIMAPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL  234 (948)
T ss_pred             EecCCCeeeeccccchhhcCch---hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHH
Confidence            9999999999999999876544   5789999999999985  3456889999999999999999999998665544433


Q ss_pred             HHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCcC
Q 023609          158 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD  237 (280)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~~  237 (280)
                      -.|...                     .-|.-+       -+..|..|+.|+..||++-|.+|||++++|.|+|+..-+.
T Consensus       235 YHIAQN---------------------esPtLq-------s~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~Rp  286 (948)
T KOG0577|consen  235 YHIAQN---------------------ESPTLQ-------SNEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRERP  286 (948)
T ss_pred             HHHHhc---------------------CCCCCC-------CchhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccCCC
Confidence            333221                     111111       1245778999999999999999999999999999976432


Q ss_pred             CCCCCcc-CCCCCcchhhccccHHHHHHHHHHHH
Q 023609          238 ISDEPVC-MSPFSFDFEQHALTEGQMKELIYQEA  270 (280)
Q Consensus       238 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (280)
                      +...-.. .+--+.-.+-..+...+++.++++++
T Consensus       287 ~tvi~dLIqRTKdaVrELDNlqYrKMkKilf~e~  320 (948)
T KOG0577|consen  287 PTVIMDLIQRTKDAVRELDNLQYRKMKKILFQEA  320 (948)
T ss_pred             chHHHHHHHHHHHHHHHhhhhhHHHHHHHHhhcc
Confidence            1100000 00001111223355667777777764

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=5e-35  Score=248.00  Aligned_cols=203  Identities=26%  Similarity=0.511  Sum_probs=164.5

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++.+...     ...|+||||++ ++|.+++.. +.+++..+..++.|++.||+|||+.|++|+||+|+||
T Consensus        74 l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Ni  147 (292)
T cd06657          74 YQHENVVEMYNSYLVG-----DELWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSI  147 (292)
T ss_pred             cCCcchhheeeEEEeC-----CEEEEEEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHE
Confidence            5799999999999765     67999999997 588887654 5689999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCC-ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  158 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.++.++|+|||.+....... ......+++.|++||.+. ...++.++|+||+|+++++|++|..||.+........
T Consensus       148 lv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~pE~~~-~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~  226 (292)
T cd06657         148 LLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELIS-RLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK  226 (292)
T ss_pred             EECCCCCEEEcccccceecccccccccccccCccccCHHHhc-CCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            99999999999999886543321 122345778899999874 4457889999999999999999999998765554433


Q ss_pred             HHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCcC
Q 023609          159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD  237 (280)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~~  237 (280)
                      .+.....                           ........+++.+.+++.+||+.||.+||++.++++||||.....
T Consensus       227 ~~~~~~~---------------------------~~~~~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~~  278 (292)
T cd06657         227 MIRDNLP---------------------------PKLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGP  278 (292)
T ss_pred             HHHhhCC---------------------------cccCCcccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccCC
Confidence            3221110                           000112356888999999999999999999999999999998864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=3.5e-35  Score=247.00  Aligned_cols=200  Identities=26%  Similarity=0.416  Sum_probs=162.1

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++.+..+     ...|+||||++ ++|.+++.. +++++..+..++.|++.||++||+.|++|+||+|+||
T Consensus        59 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Ni  132 (277)
T cd06640          59 CDSPYVTKYYGSYLKG-----TKLWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANV  132 (277)
T ss_pred             CCCCCEeeEEEEEEEC-----CEEEEEEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhE
Confidence            5799999999999765     67999999997 599998875 5799999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCC-ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  158 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.++.++++|||.+....... ......++..|+|||.+.+. ..+.++|+||+||++|+|++|..||.+........
T Consensus       133 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~  211 (277)
T cd06640         133 LLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQS-AYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF  211 (277)
T ss_pred             EEcCCCCEEEcccccceeccCCccccccccCcccccCHhHhccC-CCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhh
Confidence            99999999999999987654332 12234567789999988544 47889999999999999999999997655433222


Q ss_pred             HHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCc
Q 023609          159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  236 (280)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~  236 (280)
                      .+.. ...                            ......++..+.+++.+||+.+|.+||++.+++.|+||....
T Consensus       212 ~~~~-~~~----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  260 (277)
T cd06640         212 LIPK-NNP----------------------------PTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNA  260 (277)
T ss_pred             hhhc-CCC----------------------------CCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhcc
Confidence            1100 000                            011124567899999999999999999999999999997653

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.6e-35  Score=251.49  Aligned_cols=207  Identities=27%  Similarity=0.432  Sum_probs=162.6

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcE
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHS-ANVLHRDLKPSNL   79 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~-~gi~H~di~~~ni   79 (280)
                      .||||+++++++.+.     ...|++|||++++|.+.+.. .+.+++..+..++.|++.|++|||+ .|++||||+|+||
T Consensus        72 ~~~~i~~~~~~~~~~-----~~~~~v~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~ni  146 (296)
T cd06618          72 DCPYIVKCYGYFITD-----SDVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNI  146 (296)
T ss_pred             CCCchHhhheeeecC-----CeEEEEeeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHE
Confidence            599999999999765     67999999999888887765 4579999999999999999999997 5999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCCccccceeccccccchhccCC---CCCCcchhHHHHHHHHHHHHhCCCCCCCCChH-H
Q 023609           80 LLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNS---SDYTAAIDVWSVGCIFMELMDRKPLFPGRDHV-H  155 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~  155 (280)
                      +++.++.++|+|||.+.............++..|+|||.+.+.   ..++.++|+||+|+++|+|++|..||...... +
T Consensus       147 ll~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~  226 (296)
T cd06618         147 LLDASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFE  226 (296)
T ss_pred             EEcCCCCEEECccccchhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHH
Confidence            9999999999999998765443333344567889999988543   23678999999999999999999999653221 2


Q ss_pred             HHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCC
Q 023609          156 QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  235 (280)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~  235 (280)
                      ....+....                     .+..      .....++.++.+|+.+||..||.+|||+.++++|+||..+
T Consensus       227 ~~~~~~~~~---------------------~~~~------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  279 (296)
T cd06618         227 VLTKILQEE---------------------PPSL------PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRY  279 (296)
T ss_pred             HHHHHhcCC---------------------CCCC------CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhcc
Confidence            222111100                     0000      0011467889999999999999999999999999999987


Q ss_pred             cCCCC
Q 023609          236 HDISD  240 (280)
Q Consensus       236 ~~~~~  240 (280)
                      ....+
T Consensus       280 ~~~~~  284 (296)
T cd06618         280 ETAEV  284 (296)
T ss_pred             chhHH
Confidence            65433

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1e-35  Score=250.21  Aligned_cols=200  Identities=27%  Similarity=0.420  Sum_probs=161.0

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++.+...     ...|+||||++ ++|.+++.. +.+++..++.++.|++.|+.|||+.|++|+||+|+||
T Consensus        59 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni  132 (277)
T cd06642          59 CDSPYITRYYGSYLKG-----TKLWIIMEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSERKIHRDIKAANV  132 (277)
T ss_pred             CCCCccHhhhcccccC-----CceEEEEEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheE
Confidence            5799999999999665     67999999998 589988864 5799999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCCc-cccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSETDF-MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  158 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.++.++++|||.+........ .....++..|+|||.+.+. .++.++|+||+||++++|++|..||.+........
T Consensus       133 ~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~  211 (277)
T cd06642         133 LLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQS-AYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLF  211 (277)
T ss_pred             EEeCCCCEEEccccccccccCcchhhhcccCcccccCHHHhCcC-CCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHh
Confidence            999999999999999876543321 2233567889999988544 47889999999999999999999986544322211


Q ss_pred             HHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCc
Q 023609          159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  236 (280)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~  236 (280)
                      .+...                          .   .......++.++.++|.+||+.+|.+|||+.++++||||..+.
T Consensus       212 ~~~~~--------------------------~---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~  260 (277)
T cd06642         212 LIPKN--------------------------S---PPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYT  260 (277)
T ss_pred             hhhcC--------------------------C---CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHHh
Confidence            11000                          0   0011124677899999999999999999999999999998754

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=6.1e-35  Score=242.85  Aligned_cols=192  Identities=22%  Similarity=0.332  Sum_probs=155.4

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++..      ...++||||++ |+|.+++...+.+++..+..++.|++.||++||++|++||||||.||
T Consensus        53 l~h~~i~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~ni  126 (257)
T cd05116          53 LDNPYIVRMIGICEA------ESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNV  126 (257)
T ss_pred             CCCCCcceEEEEEcC------CCcEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhE
Confidence            579999999998743      34699999998 68999998878899999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCCc----cccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 023609           80 LLNANCDLKICDFGLARVTSETDF----MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHV  154 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~  154 (280)
                      +++.++.++|+|||.+........    .....++..|+|||.+. ...++.++|+||+||++|+|++ |..||.+....
T Consensus       127 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~-~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~  205 (257)
T cd05116         127 LLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMN-YYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN  205 (257)
T ss_pred             EEcCCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhc-cCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            999999999999999876543321    11223356899999874 3457889999999999999997 99999877655


Q ss_pred             HHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          155 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                      .....+.+.. .+                            ..-+.+++++.++|.+||+.||.+||++.++..
T Consensus       206 ~~~~~i~~~~-~~----------------------------~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~  250 (257)
T cd05116         206 EVTQMIESGE-RM----------------------------ECPQRCPPEMYDLMKLCWTYGVDERPGFAVVEL  250 (257)
T ss_pred             HHHHHHHCCC-CC----------------------------CCCCCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence            5444332211 00                            011257889999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6.2e-35  Score=246.34  Aligned_cols=214  Identities=23%  Similarity=0.343  Sum_probs=163.4

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHS-ANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~-~gi~H~di~~~n   78 (280)
                      ++||||+++++++...     ...|+||||++ ++|.+++...+++++..+..++.|++.||.|||+ .|++|+||+|+|
T Consensus        60 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~n  134 (284)
T cd06620          60 CRSPYIVSFYGAFLNE-----NNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSN  134 (284)
T ss_pred             cCCCCcceEeeeEecC-----CEEEEEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHH
Confidence            5799999999999765     67999999998 5999999888889999999999999999999997 699999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023609           79 LLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  158 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  158 (280)
                      |+++.++.++|+|||++....... .....++..|+|||.+.+. .++.++|+||+||+++++++|..||......+...
T Consensus       135 il~~~~~~~~l~d~gl~~~~~~~~-~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~  212 (284)
T cd06620         135 ILVNSRGQIKLCDFGVSGELINSI-ADTFVGTSTYMSPERIQGG-KYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQ  212 (284)
T ss_pred             EEECCCCcEEEccCCcccchhhhc-cCccccCcccCCHHHHccC-CCCccchHHHHHHHHHHHHhCCCCCcccchhhhhh
Confidence            999999999999999886543222 2245678899999988544 57889999999999999999999997654321100


Q ss_pred             HHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCcCC
Q 023609          159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDI  238 (280)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~~~  238 (280)
                      ..        ...   ............    ...+.  ...++.++.+|+.+||+.||.+|||+.|+++|+||.+....
T Consensus       213 ~~--------~~~---~~~~~~~~~~~~----~~~~~--~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~~~  275 (284)
T cd06620         213 DD--------PMG---ILDLLQQIVQEP----PPRLP--SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALRA  275 (284)
T ss_pred             hh--------hhH---HHHHHHHHhhcc----CCCCC--chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccccc
Confidence            00        000   000000000000    00000  01366789999999999999999999999999999775443

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=5e-35  Score=242.02  Aligned_cols=196  Identities=30%  Similarity=0.550  Sum_probs=163.3

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecC-CccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~-~g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++.+...     ...|+|||++ +++|.+++...+.+++..+..++.|++.||.+||+.|++|+||+|+||
T Consensus        50 l~h~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni  124 (250)
T cd05123          50 INHPFIVKLHYAFQTE-----EKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENI  124 (250)
T ss_pred             cCCCcHHHHHHHeecC-----CeeEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceE
Confidence            5799999999998655     6799999999 479999998888899999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCC-CccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  158 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.++.++|+|||.+...... .......++..|++||...+. ..+.++|+||+|++++++++|..||...+......
T Consensus       125 ~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~  203 (250)
T cd05123         125 LLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGK-GYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYE  203 (250)
T ss_pred             EEcCCCcEEEeecCcceecccCCCcccCCcCCccccChHHhCCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence            9999999999999998765443 223345678889999988544 36889999999999999999999997766544333


Q ss_pred             HHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCH---HHHhcCCCC
Q 023609          159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV---EDALAHPYL  232 (280)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~---~ell~h~~~  232 (280)
                      .+..  ...                            ..-...+..+.++|++||..||.+|||+   +++++||||
T Consensus       204 ~~~~--~~~----------------------------~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f  250 (250)
T cd05123         204 KILK--DPL----------------------------RFPEFLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF  250 (250)
T ss_pred             HHhc--CCC----------------------------CCCCCCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence            3322  000                            0111347889999999999999999999   999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=7.9e-35  Score=242.16  Aligned_cols=194  Identities=20%  Similarity=0.350  Sum_probs=155.3

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      ++||||+++++++...     ...|+||||+. |+|.+++... ..+++..++.++.||+.||+|||+.|++|+||+|+|
T Consensus        56 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~n  130 (256)
T cd05113          56 LSHEKLVQLYGVCTKQ-----RPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARN  130 (256)
T ss_pred             CCCCCeeeEEEEEccC-----CCcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcce
Confidence            5899999999998654     55899999997 6999999764 469999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCCCcc--ccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 023609           79 LLLNANCDLKICDFGLARVTSETDFM--TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVH  155 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~  155 (280)
                      |+++.++.++|+|||.+.........  ....++..|++||.+.+. .++.++|+||+||++|+|++ |..||.......
T Consensus       131 ili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~  209 (256)
T cd05113         131 CLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYS-KFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE  209 (256)
T ss_pred             EEEcCCCCEEECCCccceecCCCceeecCCCccChhhCCHHHHhcC-cccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH
Confidence            99999999999999998765433211  122345679999988544 47889999999999999998 999997666544


Q ss_pred             HHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 023609          156 QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  229 (280)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h  229 (280)
                      ....+......+                             .....+..+++++.+||+.||.+|||+.+++.+
T Consensus       210 ~~~~~~~~~~~~-----------------------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         210 TVEKVSQGLRLY-----------------------------RPHLASEKVYAIMYSCWHEKAEERPTFQQLLSS  254 (256)
T ss_pred             HHHHHhcCCCCC-----------------------------CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence            433332211100                             011357889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=3.5e-35  Score=257.02  Aligned_cols=193  Identities=24%  Similarity=0.369  Sum_probs=151.2

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC--------------------------------------
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--------------------------------------   42 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~--------------------------------------   42 (280)
                      +||||+++++++...     ...|+||||+. |+|.+++...                                      
T Consensus       100 ~h~nIv~~~~~~~~~-----~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  174 (374)
T cd05106         100 QHKNIVNLLGACTHG-----GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFS  174 (374)
T ss_pred             cCCceeeEeeEecCC-----CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhccccccccccc
Confidence            799999999998665     67999999997 6999998542                                      


Q ss_pred             --------------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCCEEEe
Q 023609           43 --------------------------------QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKIC   90 (280)
Q Consensus        43 --------------------------------~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nili~~~~~~~l~   90 (280)
                                                      .++++..+..++.||+.||+|||++|++||||||+||+++.++.++|+
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~  254 (374)
T cd05106         175 SQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKIC  254 (374)
T ss_pred             ccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEe
Confidence                                            247888999999999999999999999999999999999999999999


Q ss_pred             eccceeeccCCCc---cccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCC
Q 023609           91 DFGLARVTSETDF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQLRLLIELIGT  166 (280)
Q Consensus        91 dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~  166 (280)
                      |||++........   .....++..|+|||++.+ ..++.++||||+||++|+|++ |..||.+................
T Consensus       255 DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~  333 (374)
T cd05106         255 DFGLARDIMNDSNYVVKGNARLPVKWMAPESIFD-CVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQ  333 (374)
T ss_pred             eceeeeeccCCcceeeccCCCCccceeCHHHhcC-CCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccC
Confidence            9999875433211   111234567999998854 458899999999999999997 99999765433322222111000


Q ss_pred             CCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          167 PSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                      +                            ..-..+++++.+++.+||+.||.+|||+.++++
T Consensus       334 ~----------------------------~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~  367 (374)
T cd05106         334 M----------------------------SRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQ  367 (374)
T ss_pred             c----------------------------cCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            0                            001135789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=3.9e-35  Score=246.57  Aligned_cols=194  Identities=33%  Similarity=0.626  Sum_probs=161.6

Q ss_pred             CCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE
Q 023609            3 HENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   81 (280)
Q Consensus         3 HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nili   81 (280)
                      ||||+++++++...     ...++|||++. ++|.+++.+.+.+++..++.++.|++.||.+||+.|++|+||+|+||++
T Consensus        61 ~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i  135 (280)
T cd05581          61 HPGIIKLYYTFQDE-----ENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILL  135 (280)
T ss_pred             CCCchhHHHHhcCC-----ceEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEE
Confidence            99999999998665     67999999995 7999999988889999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccceeeccCCCc---------------------cccceeccccccchhccCCCCCCcchhHHHHHHHHHH
Q 023609           82 NANCDLKICDFGLARVTSETDF---------------------MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME  140 (280)
Q Consensus        82 ~~~~~~~l~dfg~~~~~~~~~~---------------------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~  140 (280)
                      +.++.++|+|||.+........                     .....++..|+|||.... ...+.++|+||+|+++++
T Consensus       136 ~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Di~slG~~l~~  214 (280)
T cd05581         136 DKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE-KPAGKSSDLWALGCIIYQ  214 (280)
T ss_pred             CCCCCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCC-CCCChhhhHHHHHHHHHH
Confidence            9999999999999875443221                     122345788999998754 347889999999999999


Q ss_pred             HHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCC
Q 023609          141 LMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQR  220 (280)
Q Consensus       141 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R  220 (280)
                      +++|..||...+.....+.+.....                              ...+.+++.+.++|++||+.||.+|
T Consensus       215 l~~g~~p~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~li~~~l~~~p~~R  264 (280)
T cd05581         215 MLTGKPPFRGSNEYLTFQKILKLEY------------------------------SFPPNFPPDAKDLIEKLLVLDPQDR  264 (280)
T ss_pred             HHhCCCCCCCccHHHHHHHHHhcCC------------------------------CCCCccCHHHHHHHHHHhcCCHhhC
Confidence            9999999987765444333321110                              0112557889999999999999999


Q ss_pred             CCH----HHHhcCCCC
Q 023609          221 ITV----EDALAHPYL  232 (280)
Q Consensus       221 ~t~----~ell~h~~~  232 (280)
                      ||+    +++++||||
T Consensus       265 ~~~~~~~~~ll~~~~~  280 (280)
T cd05581         265 LGVNEGYDELKAHPFF  280 (280)
T ss_pred             CCcccCHHHHhcCCCC
Confidence            999    999999997

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=6.6e-35  Score=247.07  Aligned_cols=193  Identities=24%  Similarity=0.392  Sum_probs=154.9

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC----------------CCCCHHHHHHHHHHHHHHHHH
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN----------------QALSEEHCQYFLYQILRGLKY   63 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~----------------~~l~~~~~~~i~~qll~al~~   63 (280)
                      ++||||+++++++...     ...++||||++ ++|.+++...                +.+++..+..++.||+.||+|
T Consensus        64 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~  138 (291)
T cd05094          64 LQHEHIVKFYGVCGDG-----DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVY  138 (291)
T ss_pred             CCCCCcceEEEEEccC-----CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence            5799999999999654     66899999997 6999999753                238999999999999999999


Q ss_pred             HHHCCceeccCCCCcEEEccCCCEEEeeccceeeccCCC---ccccceeccccccchhccCCCCCCcchhHHHHHHHHHH
Q 023609           64 IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME  140 (280)
Q Consensus        64 LH~~gi~H~di~~~nili~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~  140 (280)
                      ||++|++||||||+||+++.++.++|+|||.+.......   ......++..|+|||.+.+. .++.++|+||+||++|+
T Consensus       139 lH~~~i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~e  217 (291)
T cd05094         139 LASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSFGVILWE  217 (291)
T ss_pred             HHhCCeeecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccC-CCCchhhHHHHHHHHHH
Confidence            999999999999999999999999999999987543321   12233457789999988544 47889999999999999


Q ss_pred             HHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCC
Q 023609          141 LMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQ  219 (280)
Q Consensus       141 ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~  219 (280)
                      |++ |..||...+.......+....                             ........+..+.+++.+||+.||++
T Consensus       218 l~t~g~~p~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~~li~~~l~~~P~~  268 (291)
T cd05094         218 IFTYGKQPWFQLSNTEVIECITQGR-----------------------------VLERPRVCPKEVYDIMLGCWQREPQQ  268 (291)
T ss_pred             HHhCCCCCCCCCCHHHHHHHHhCCC-----------------------------CCCCCccCCHHHHHHHHHHcccChhh
Confidence            998 999997766544333221100                             00111245778999999999999999


Q ss_pred             CCCHHHHhc
Q 023609          220 RITVEDALA  228 (280)
Q Consensus       220 R~t~~ell~  228 (280)
                      |||+.++++
T Consensus       269 Rpt~~~v~~  277 (291)
T cd05094         269 RLNIKEIYK  277 (291)
T ss_pred             CcCHHHHHH
Confidence            999999875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=6.3e-35  Score=243.62  Aligned_cols=190  Identities=18%  Similarity=0.283  Sum_probs=149.2

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      ++||||+++++++...     ...++||||++ |+|..++.. ...+++..+..++.||+.||+|||+.|++||||||+|
T Consensus        61 l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N  135 (262)
T cd05077          61 VSHKHIVLLYGVCVRD-----VENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKN  135 (262)
T ss_pred             CCCCCEeeEEEEEecC-----CCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCccc
Confidence            5899999999998655     56799999998 588888764 3569999999999999999999999999999999999


Q ss_pred             EEEccCCC-------EEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHH-hCCCCCCC
Q 023609           79 LLLNANCD-------LKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM-DRKPLFPG  150 (280)
Q Consensus        79 ili~~~~~-------~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll-~g~~pf~~  150 (280)
                      |+++.++.       ++++|||.+......   ....++..|+|||.+.....++.++||||+||++|+|+ +|..||.+
T Consensus       136 ill~~~~~~~~~~~~~~l~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~  212 (262)
T cd05077         136 ILLAREGIDGECGPFIKLSDPGIPITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKD  212 (262)
T ss_pred             EEEecCCccCCCCceeEeCCCCCCccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence            99987654       899999988654322   23356778999998865566888999999999999998 58888865


Q ss_pred             CChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 023609          151 RDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  229 (280)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h  229 (280)
                      ....+... ...   .                   .        .......+.++.++|.+||+.||.+||++.+++++
T Consensus       213 ~~~~~~~~-~~~---~-------------------~--------~~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         213 KTLAEKER-FYE---G-------------------Q--------CMLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             cchhHHHH-HHh---c-------------------C--------ccCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence            54322211 000   0                   0        00111235678999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.1e-34  Score=248.67  Aligned_cols=199  Identities=26%  Similarity=0.424  Sum_probs=162.5

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++|||++++++++...     ...|+||||+.|+|.+.+.. ..++++..+..++.|++.|+.|||+.|++|+||+|+||
T Consensus        82 l~h~~iv~~~~~~~~~-----~~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Ni  156 (317)
T cd06635          82 IKHPNSIEYKGCYLRE-----HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNI  156 (317)
T ss_pred             CCCCCEEEEEEEEeeC-----CeEEEEEeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccE
Confidence            5799999999998665     66899999999998888754 45799999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCCccccceeccccccchhccC--CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLN--SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL  157 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  157 (280)
                      +++.++.++|+|||.+......   ....++..|+|||.+..  .+.++.++|+||+||++++|++|..||.+.......
T Consensus       157 l~~~~~~~kl~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~  233 (317)
T cd06635         157 LLTEPGQVKLADFGSASIASPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL  233 (317)
T ss_pred             EECCCCCEEEecCCCccccCCc---ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHH
Confidence            9999999999999988654432   24467888999998742  344788999999999999999999999766544443


Q ss_pred             HHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCC
Q 023609          158 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  235 (280)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~  235 (280)
                      ..+......+                            .....+++.++++|.+||+.+|.+|||+.++++|+|+...
T Consensus       234 ~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~  283 (317)
T cd06635         234 YHIAQNESPT----------------------------LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRE  283 (317)
T ss_pred             HHHHhccCCC----------------------------CCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhcc
Confidence            3332211110                            0012467789999999999999999999999999999664

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=8.3e-35  Score=244.84  Aligned_cols=193  Identities=25%  Similarity=0.403  Sum_probs=155.8

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC--------------CCCCHHHHHHHHHHHHHHHHHHH
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--------------QALSEEHCQYFLYQILRGLKYIH   65 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~--------------~~l~~~~~~~i~~qll~al~~LH   65 (280)
                      ++||||+++++++...     ...++||||++ ++|.+++...              ..+++..+..++.|++.||.+||
T Consensus        65 l~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH  139 (280)
T cd05049          65 FQHENIVKFYGVCTEG-----DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA  139 (280)
T ss_pred             cCCCCchheeeEEecC-----CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh
Confidence            5799999999999665     67999999997 6999999754              24789999999999999999999


Q ss_pred             HCCceeccCCCCcEEEccCCCEEEeeccceeeccCCC---ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHH
Q 023609           66 SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM  142 (280)
Q Consensus        66 ~~gi~H~di~~~nili~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll  142 (280)
                      +.|++||||+|+||+++.++.++|+|||.+.......   ......+++.|+|||.+.+. .++.++||||+||++|+|+
T Consensus       140 ~~~i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~e~~  218 (280)
T cd05049         140 SQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSFGVVLWEIF  218 (280)
T ss_pred             hCCeeccccccceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccC-CcchhhhHHHHHHHHHHHH
Confidence            9999999999999999999999999999987543221   11233456789999988544 4888999999999999999


Q ss_pred             h-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCC
Q 023609          143 D-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI  221 (280)
Q Consensus       143 ~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~  221 (280)
                      + |..||.+.+.......+......                             .....++..+++++++||+.||.+||
T Consensus       219 ~~g~~p~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp  269 (280)
T cd05049         219 TYGKQPWYGLSNEEVIECITQGRLL-----------------------------QRPRTCPSEVYDIMLGCWKRDPQQRI  269 (280)
T ss_pred             hcCCCCCCCCCHHHHHHHHHcCCcC-----------------------------CCCCCCCHHHHHHHHHHcCCCcccCC
Confidence            8 99999776655443333211000                             11125678899999999999999999


Q ss_pred             CHHHHhc
Q 023609          222 TVEDALA  228 (280)
Q Consensus       222 t~~ell~  228 (280)
                      |+.|+++
T Consensus       270 ~~~eil~  276 (280)
T cd05049         270 NIKDIHE  276 (280)
T ss_pred             CHHHHHH
Confidence            9999975

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=8.2e-35  Score=241.37  Aligned_cols=197  Identities=30%  Similarity=0.517  Sum_probs=163.1

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN----QALSEEHCQYFLYQILRGLKYIHSANVLHRDLK   75 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~----~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~   75 (280)
                      ++|||++++++.+...     ...++|+|+++ ++|.+++...    ..+++..+..++.|++.||++||+.|++|+||+
T Consensus        56 l~~~~~~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~  130 (258)
T cd08215          56 LNHPNIIKYYESFEEK-----GKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIK  130 (258)
T ss_pred             cCCCChhheEEEEecC-----CEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCC
Confidence            5799999999998665     67999999998 5999999763    679999999999999999999999999999999


Q ss_pred             CCcEEEccCCCEEEeeccceeeccCCC-ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH
Q 023609           76 PSNLLLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHV  154 (280)
Q Consensus        76 ~~nili~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  154 (280)
                      |+||+++.++.++|+|||.+....... ......+++.|+|||...+. .++.++|+||+|+++++|++|..||...+..
T Consensus       131 ~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~  209 (258)
T cd08215         131 PQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNK-PYNYKSDIWSLGCVLYELCTLKHPFEGENLL  209 (258)
T ss_pred             hHHeEEcCCCcEEECCccceeecccCcceecceeeeecccChhHhccC-CCCccccHHHHHHHHHHHHcCCCCCCCCcHH
Confidence            999999999999999999987655443 23345678889999987544 4788999999999999999999999776644


Q ss_pred             HHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 023609          155 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  232 (280)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~  232 (280)
                      +...........                             ..-..++.++.+++++||..+|.+|||+.++++||||
T Consensus       210 ~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         210 ELALKILKGQYP-----------------------------PIPSQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             HHHHHHhcCCCC-----------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence            433332211100                             1112567889999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=6.7e-35  Score=247.77  Aligned_cols=193  Identities=24%  Similarity=0.330  Sum_probs=153.0

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCC----------------CCCHHHHHHHHHHHHHHHHHH
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ----------------ALSEEHCQYFLYQILRGLKYI   64 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~----------------~l~~~~~~~i~~qll~al~~L   64 (280)
                      +||||+++++++...     ...|+||||++ ++|.+++.+.+                .+++..+..++.|++.||+||
T Consensus        61 ~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~l  135 (297)
T cd05089          61 HHPNIINLLGACENR-----GYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYL  135 (297)
T ss_pred             CCCchhheEEEEccC-----CcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHH
Confidence            699999999998654     56899999997 69999996532                488999999999999999999


Q ss_pred             HHCCceeccCCCCcEEEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-
Q 023609           65 HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-  143 (280)
Q Consensus        65 H~~gi~H~di~~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-  143 (280)
                      |+.|++||||||+||+++.++.++|+|||++..............+..|+|||...+ ..++.++||||+||++|+|++ 
T Consensus       136 H~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~el~t~  214 (297)
T cd05089         136 SEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNY-SVYTTKSDVWSFGVLLWEIVSL  214 (297)
T ss_pred             HHCCcccCcCCcceEEECCCCeEEECCcCCCccccceeccCCCCcCccccCchhhcc-CCCCchhhHHHHHHHHHHHHcC
Confidence            999999999999999999999999999999864322111111223456999998754 447889999999999999997 


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCH
Q 023609          144 RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV  223 (280)
Q Consensus       144 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~  223 (280)
                      |..||.+....+....+......                             .....++.++++++.+||+.+|.+|||+
T Consensus       215 g~~pf~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~  265 (297)
T cd05089         215 GGTPYCGMTCAELYEKLPQGYRM-----------------------------EKPRNCDDEVYELMRQCWRDRPYERPPF  265 (297)
T ss_pred             CCCCCCCCCHHHHHHHHhcCCCC-----------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCH
Confidence            99999877655544332211100                             0112577899999999999999999999


Q ss_pred             HHHhcC
Q 023609          224 EDALAH  229 (280)
Q Consensus       224 ~ell~h  229 (280)
                      +++++.
T Consensus       266 ~~i~~~  271 (297)
T cd05089         266 AQISVQ  271 (297)
T ss_pred             HHHHHH
Confidence            999764

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-34  Score=239.52  Aligned_cols=197  Identities=28%  Similarity=0.521  Sum_probs=163.0

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++|||++++++++...     ...++|||+++ ++|.+++...+.+++..+..++.|++.||.+||+.|++|+||+|+||
T Consensus        56 l~~~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni  130 (254)
T cd06627          56 LKHPNIVKYIGSIETS-----DSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANI  130 (254)
T ss_pred             CCCCCccEEEEEEEeC-----CEEEEEEecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHE
Confidence            5799999999998654     67899999997 59999998888899999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCCc-cccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSETDF-MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  158 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.++.++|+|||.+........ .....++..|+|||...+.. .+.++|+||+|+++++|++|..||.+.+......
T Consensus       131 ~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~  209 (254)
T cd06627         131 LTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSG-ASTASDIWSLGCTVIELLTGNPPYYDLNPMAALF  209 (254)
T ss_pred             EECCCCCEEEeccccceecCCCcccccccccchhhcCHhhhcCCC-CCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHH
Confidence            999999999999999987654432 23346788899999875444 7889999999999999999999997655333222


Q ss_pred             HHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 023609          159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  232 (280)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~  232 (280)
                      .....                             ......+.++..+++++.+||..+|++|||+.+++.||||
T Consensus       210 ~~~~~-----------------------------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         210 RIVQD-----------------------------DHPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             HHhcc-----------------------------CCCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence            21100                             0001123567899999999999999999999999999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.2e-34  Score=241.88  Aligned_cols=193  Identities=24%  Similarity=0.423  Sum_probs=155.0

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS   77 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~   77 (280)
                      ++||||+++++++...     ...+++|||++ ++|.+++...  ..+++..+..++.|++.||+|||+.|++||||||+
T Consensus        59 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~  133 (263)
T cd05052          59 IKHPNLVQLLGVCTRE-----PPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAAR  133 (263)
T ss_pred             CCCCChhheEEEEcCC-----CCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcc
Confidence            5799999999998655     56899999997 6999998753  35899999999999999999999999999999999


Q ss_pred             cEEEccCCCEEEeeccceeeccCCCcc--ccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 023609           78 NLLLNANCDLKICDFGLARVTSETDFM--TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHV  154 (280)
Q Consensus        78 nili~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~  154 (280)
                      ||+++.++.++|+|||.+.........  .....+..|+|||.+.+ ..++.++|+||+||++|+|++ |..||.+.+..
T Consensus       134 nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~  212 (263)
T cd05052         134 NCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY-NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS  212 (263)
T ss_pred             eEEEcCCCcEEeCCCccccccccceeeccCCCCCccccCCHHHhcc-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence            999999999999999998765433211  11223567999998754 447889999999999999998 89999876655


Q ss_pred             HHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          155 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                      +....+......                             ...+.++.++.+++.+||+.||++|||+.++++
T Consensus       213 ~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~  257 (263)
T cd05052         213 QVYELLEKGYRM-----------------------------ERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQ  257 (263)
T ss_pred             HHHHHHHCCCCC-----------------------------CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            443333211100                             111356789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=1.7e-34  Score=244.18  Aligned_cols=200  Identities=24%  Similarity=0.409  Sum_probs=157.9

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC----------CCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN----------QALSEEHCQYFLYQILRGLKYIHSANV   69 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~----------~~l~~~~~~~i~~qll~al~~LH~~gi   69 (280)
                      ++||||+++++++...     ...|+||||+. |+|.+++...          ..++...+..++.|++.||.|||++|+
T Consensus        66 l~~~~i~~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i  140 (288)
T cd05061          66 FTCHHVVRLLGVVSKG-----QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKF  140 (288)
T ss_pred             CCCCCeeeEEEEEcCC-----CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Confidence            5799999999998655     56899999997 7999999742          235677889999999999999999999


Q ss_pred             eeccCCCCcEEEccCCCEEEeeccceeeccCCCc---cccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CC
Q 023609           70 LHRDLKPSNLLLNANCDLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RK  145 (280)
Q Consensus        70 ~H~di~~~nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~  145 (280)
                      +||||||+||+++.++.++|+|||+++.......   .....++..|+|||.+.+. .++.++|+||+||++++|++ |.
T Consensus       141 ~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~DvwslG~~l~el~~~~~  219 (288)
T cd05061         141 VHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG-VFTTSSDMWSFGVVLWEITSLAE  219 (288)
T ss_pred             cCCCCChheEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccC-CCChHhHHHHHHHHHHHHHhCCC
Confidence            9999999999999999999999999875432211   1122345679999988543 47889999999999999998 78


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHH
Q 023609          146 PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVED  225 (280)
Q Consensus       146 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e  225 (280)
                      .||.+....+....+.... .+                            ......++.+++++.+||+.||.+|||+.+
T Consensus       220 ~p~~~~~~~~~~~~~~~~~-~~----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~  270 (288)
T cd05061         220 QPYQGLSNEQVLKFVMDGG-YL----------------------------DQPDNCPERVTDLMRMCWQFNPKMRPTFLE  270 (288)
T ss_pred             CCCCCCCHHHHHHHHHcCC-CC----------------------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHH
Confidence            8997766554433322110 00                            001145678999999999999999999999


Q ss_pred             Hhc------CCCCCCC
Q 023609          226 ALA------HPYLGSL  235 (280)
Q Consensus       226 ll~------h~~~~~~  235 (280)
                      +++      ||||.++
T Consensus       271 ll~~l~~~~~~~~~~~  286 (288)
T cd05061         271 IVNLLKDDLHPSFPEV  286 (288)
T ss_pred             HHHHHHhhcCCCCCCC
Confidence            987      9998764

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=8.8e-35  Score=241.51  Aligned_cols=195  Identities=29%  Similarity=0.479  Sum_probs=158.9

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS   77 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~   77 (280)
                      ++||||+++++.+...     ...|+||||++ ++|.+++...  ..+++..+..++.|++.||.+||++|++|+||+|+
T Consensus        55 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~  129 (255)
T cd08219          55 MKHPNIVAFKESFEAD-----GHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSK  129 (255)
T ss_pred             CCCCCcceEEEEEEEC-----CEEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcc
Confidence            5799999999999655     67999999997 6999988643  45899999999999999999999999999999999


Q ss_pred             cEEEccCCCEEEeeccceeeccCCC-ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023609           78 NLLLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ  156 (280)
Q Consensus        78 nili~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  156 (280)
                      ||+++.++.++++|||.+....... ......+++.|+|||++.+. ..+.++|+||+|+++++|++|..||.+.+....
T Consensus       130 nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~  208 (255)
T cd08219         130 NIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENM-PYNNKSDIWSLGCILYELCTLKHPFQANSWKNL  208 (255)
T ss_pred             eEEECCCCcEEEcccCcceeecccccccccccCCccccCHHHHccC-CcCchhhhhhhchhheehhhccCCCCCCCHHHH
Confidence            9999999999999999987654332 22334678889999988544 478899999999999999999999987665444


Q ss_pred             HHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCC
Q 023609          157 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHP  230 (280)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~  230 (280)
                      ...+......                             .....++..++++|.+||+.||.+|||+.++++-.
T Consensus       209 ~~~~~~~~~~-----------------------------~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~  253 (255)
T cd08219         209 ILKVCQGSYK-----------------------------PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSRG  253 (255)
T ss_pred             HHHHhcCCCC-----------------------------CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhcc
Confidence            3333211100                             01124677899999999999999999999998754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.8e-34  Score=245.90  Aligned_cols=200  Identities=26%  Similarity=0.380  Sum_probs=153.3

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC-------------------CCCCHHHHHHHHHHHHHH
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-------------------QALSEEHCQYFLYQILRG   60 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-------------------~~l~~~~~~~i~~qll~a   60 (280)
                      ++||||+++++++.+.     ...++||||+. |+|.+++...                   ..+++..+..++.||+.|
T Consensus        76 l~h~niv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~a  150 (304)
T cd05096          76 LKDPNIIRLLGVCVDE-----DPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASG  150 (304)
T ss_pred             cCCCCeeEEEEEEecC-----CceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHH
Confidence            5799999999999665     56899999997 6999998643                   236788899999999999


Q ss_pred             HHHHHHCCceeccCCCCcEEEccCCCEEEeeccceeeccCCCc---cccceeccccccchhccCCCCCCcchhHHHHHHH
Q 023609           61 LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI  137 (280)
Q Consensus        61 l~~LH~~gi~H~di~~~nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i  137 (280)
                      |+|||+.|++||||||+||+++.++.++|+|||+++.......   .....++..|+|||.+.+ ..++.++||||+||+
T Consensus       151 l~~lH~~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~~  229 (304)
T cd05096         151 MKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILM-GKFTTASDVWAFGVT  229 (304)
T ss_pred             HHHHHHCCccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhc-CCCCchhhhHHHHHH
Confidence            9999999999999999999999999999999999876533221   122344678999998854 458899999999999


Q ss_pred             HHHHHh--CCCCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcC
Q 023609          138 FMELMD--RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTF  215 (280)
Q Consensus       138 l~~ll~--g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  215 (280)
                      +|+|++  +..||.+.+..+.............                      ........+.++..+.++|.+||+.
T Consensus       230 l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~~~li~~cl~~  287 (304)
T cd05096         230 LWEILMLCKEQPYGELTDEQVIENAGEFFRDQG----------------------RQVYLFRPPPCPQGLYELMLQCWSR  287 (304)
T ss_pred             HHHHHHccCCCCCCcCCHHHHHHHHHHHhhhcc----------------------ccccccCCCCCCHHHHHHHHHHccC
Confidence            999986  5577876655444433322111000                      0000111235678899999999999


Q ss_pred             CCCCCCCHHHHhc
Q 023609          216 DPRQRITVEDALA  228 (280)
Q Consensus       216 dp~~R~t~~ell~  228 (280)
                      ||.+|||+.++.+
T Consensus       288 ~p~~RPs~~~i~~  300 (304)
T cd05096         288 DCRERPSFSDIHA  300 (304)
T ss_pred             CchhCcCHHHHHH
Confidence            9999999999853

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-36  Score=263.48  Aligned_cols=203  Identities=27%  Similarity=0.444  Sum_probs=165.2

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHc-CCCC--CHHHHHHHHHHHHHHHHHHHHCCceeccCCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQAL--SEEHCQYFLYQILRGLKYIHSANVLHRDLKP   76 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~-~~~l--~~~~~~~i~~qll~al~~LH~~gi~H~di~~   76 (280)
                      |+|.|||++++.+..+     +.+-|.||-++ |+|.+.+++ .+++  +|..+..+.+||++||.|||.+.|||||||-
T Consensus       629 LrHkNIVrYLGs~sen-----Gf~kIFMEqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKG  703 (1226)
T KOG4279|consen  629 LRHKNIVRYLGSVSEN-----GFFKIFMEQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKG  703 (1226)
T ss_pred             HhhHhHHHHhhccCCC-----CeEEEEeecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccC
Confidence            5899999999998544     67889999997 699999984 5888  8999999999999999999999999999999


Q ss_pred             CcEEEcc-CCCEEEeeccceeec-cCCCccccceeccccccchhccC-CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh
Q 023609           77 SNLLLNA-NCDLKICDFGLARVT-SETDFMTEYVVTRWYRAPELLLN-SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDH  153 (280)
Q Consensus        77 ~nili~~-~~~~~l~dfg~~~~~-~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~  153 (280)
                      +|++|+. .|.+|++|||.++.. +.+.+..+..||..|||||++.. ...|+.++||||+||++.||.||++||.....
T Consensus       704 DNVLvNTySGvlKISDFGTsKRLAginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elgs  783 (1226)
T KOG4279|consen  704 DNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGS  783 (1226)
T ss_pred             CcEEEeeccceEEecccccchhhccCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCC
Confidence            9999965 799999999999865 44555667889999999999853 44689999999999999999999999965433


Q ss_pred             HHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCC
Q 023609          154 VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLG  233 (280)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~  233 (280)
                      .+.-.-.+....                           ..+..-..+|.+++.||.+|+.+||.+||++.++|..||++
T Consensus       784 pqAAMFkVGmyK---------------------------vHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq  836 (1226)
T KOG4279|consen  784 PQAAMFKVGMYK---------------------------VHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQ  836 (1226)
T ss_pred             hhHhhhhhccee---------------------------cCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhccCcccc
Confidence            322111111110                           00111114678899999999999999999999999999998


Q ss_pred             CC
Q 023609          234 SL  235 (280)
Q Consensus       234 ~~  235 (280)
                      .-
T Consensus       837 ~~  838 (1226)
T KOG4279|consen  837 HN  838 (1226)
T ss_pred             cC
Confidence            64

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.4e-34  Score=239.91  Aligned_cols=193  Identities=22%  Similarity=0.366  Sum_probs=151.4

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ-ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~-~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      ++||||+++++++...     ...|+||||++ ++|.+++...+ .+++..++.++.|++.||.|||+.|++|+||+|+|
T Consensus        50 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~n  124 (252)
T cd05084          50 YSHPNIVRLIGVCTQK-----QPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARN  124 (252)
T ss_pred             CCCCCcceEEEEEcCC-----CCeEEEEeeccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchhe
Confidence            5899999999998665     66899999997 69999987544 58999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCCCcc---ccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 023609           79 LLLNANCDLKICDFGLARVTSETDFM---TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHV  154 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~  154 (280)
                      |+++.++.++|+|||.+.........   .....+..|+|||.+.+ +.++.++|+||+||++|+|++ |..||......
T Consensus       125 il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~  203 (252)
T cd05084         125 CLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNY-GRYSSESDVWSFGILLWEAFSLGAVPYANLSNQ  203 (252)
T ss_pred             EEEcCCCcEEECccccCcccccccccccCCCCCCceeecCchhhcC-CCCChHHHHHHHHHHHHHHHhCCCCCccccCHH
Confidence            99999999999999998754332111   11122356999998854 447889999999999999997 88888655443


Q ss_pred             HHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          155 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                      .....+......                             ......+..+.+++.+||+.||++|||+.++++
T Consensus       204 ~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  248 (252)
T cd05084         204 QTREAIEQGVRL-----------------------------PCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQ  248 (252)
T ss_pred             HHHHHHHcCCCC-----------------------------CCcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            322222111000                             011245788999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.4e-34  Score=243.22  Aligned_cols=194  Identities=24%  Similarity=0.397  Sum_probs=153.2

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCC----------CCCHHHHHHHHHHHHHHHHHHHHCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ----------ALSEEHCQYFLYQILRGLKYIHSANV   69 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~----------~l~~~~~~~i~~qll~al~~LH~~gi   69 (280)
                      ++||||+++++++...     ...++||||++ |+|.+++.+.+          .+++..+..++.|++.||+|||+.|+
T Consensus        66 l~~~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~  140 (277)
T cd05062          66 FNCHHVVRLLGVVSQG-----QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKF  140 (277)
T ss_pred             CCCCCeeeEEEEEcCC-----CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence            5799999999998654     67899999997 69999987532          35778899999999999999999999


Q ss_pred             eeccCCCCcEEEccCCCEEEeeccceeeccCCCc---cccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CC
Q 023609           70 LHRDLKPSNLLLNANCDLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RK  145 (280)
Q Consensus        70 ~H~di~~~nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~  145 (280)
                      +|+||||+||+++.++.++|+|||++........   .....++..|+|||.+.+ ..++.++|+||+||++|+|++ |.
T Consensus       141 vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~  219 (277)
T cd05062         141 VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKD-GVFTTYSDVWSFGVVLWEIATLAE  219 (277)
T ss_pred             ccCCcchheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhc-CCcCchhHHHHHHHHHHHHHcCCC
Confidence            9999999999999999999999999875432211   112344678999998854 447899999999999999998 78


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHH
Q 023609          146 PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVED  225 (280)
Q Consensus       146 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e  225 (280)
                      .||.+.........+......                             ......+..+++++.+||+.||.+|||+.+
T Consensus       220 ~p~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e  270 (277)
T cd05062         220 QPYQGMSNEQVLRFVMEGGLL-----------------------------DKPDNCPDMLFELMRMCWQYNPKMRPSFLE  270 (277)
T ss_pred             CCCCCCCHHHHHHHHHcCCcC-----------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence            899776654443332211100                             011245778999999999999999999999


Q ss_pred             HhcC
Q 023609          226 ALAH  229 (280)
Q Consensus       226 ll~h  229 (280)
                      ++++
T Consensus       271 ~l~~  274 (277)
T cd05062         271 IISS  274 (277)
T ss_pred             HHHH
Confidence            9864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1.4e-34  Score=240.14  Aligned_cols=196  Identities=28%  Similarity=0.470  Sum_probs=161.3

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS----NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK   75 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~----~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~   75 (280)
                      ++||||+++++++...     ...|+|+||++ ++|.+++..    +..+++..++.++.|++.||++||+.|++|+||+
T Consensus        56 l~~~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~  130 (256)
T cd08530          56 VNHPNIISYKEAFLDG-----NKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLK  130 (256)
T ss_pred             CCCCCchhhhhhhccC-----CEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCC
Confidence            5799999999999765     67999999997 599998865    3569999999999999999999999999999999


Q ss_pred             CCcEEEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 023609           76 PSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVH  155 (280)
Q Consensus        76 ~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~  155 (280)
                      |+||+++.++.++|+|||.+...... ......++..|++||.+.+ ..++.++|+||+|+++++|++|..||...+...
T Consensus       131 ~~ni~~~~~~~~kl~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~-~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~  208 (256)
T cd08530         131 SANILLVANDLVKIGDLGISKVLKKN-MAKTQIGTPHYMAPEVWKG-RPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD  208 (256)
T ss_pred             cceEEEecCCcEEEeeccchhhhccC-CcccccCCccccCHHHHCC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            99999999999999999998766544 2334567888999999854 447889999999999999999999998766443


Q ss_pred             HHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 023609          156 QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  232 (280)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~  232 (280)
                      ....+....                             +...-..++.++++++.+||+.+|.+|||+.++++||++
T Consensus       209 ~~~~~~~~~-----------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         209 LRYKVQRGK-----------------------------YPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             HHHHHhcCC-----------------------------CCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence            322221110                             001112567889999999999999999999999999975

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.2e-34  Score=244.90  Aligned_cols=208  Identities=26%  Similarity=0.458  Sum_probs=157.9

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS----NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK   75 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~----~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~   75 (280)
                      ++||||+++++++.....   ..+|+||||++ ++|.+++..    ...+++..+..++.||+.||+|||+.|++|+||+
T Consensus        56 l~h~~iv~~~~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~  132 (287)
T cd06621          56 CKSPYIVKYYGAFLDESS---SSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIK  132 (287)
T ss_pred             CCCCCeeeeeeEEEccCC---CeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence            589999999999865422   56899999997 588887642    3458999999999999999999999999999999


Q ss_pred             CCcEEEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh--
Q 023609           76 PSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDH--  153 (280)
Q Consensus        76 ~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~--  153 (280)
                      |+||+++.++.++|+|||++........ ....++..|++||.+.+ ..++.++|+||+||++|+|++|..||.....  
T Consensus       133 ~~nil~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~  210 (287)
T cd06621         133 PSNILLTRKGQVKLCDFGVSGELVNSLA-GTFTGTSFYMAPERIQG-KPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPP  210 (287)
T ss_pred             HHHEEEecCCeEEEeecccccccccccc-ccccCCccccCHHHhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCcccCCC
Confidence            9999999999999999999865443321 23456778999998854 4578899999999999999999999976522  


Q ss_pred             ---HHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCC
Q 023609          154 ---VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHP  230 (280)
Q Consensus       154 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~  230 (280)
                         .+....+..   ...                  +  ............++.++++|.+||..||.+|||+.|++.||
T Consensus       211 ~~~~~~~~~~~~---~~~------------------~--~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~  267 (287)
T cd06621         211 LGPIELLSYIVN---MPN------------------P--ELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHP  267 (287)
T ss_pred             CChHHHHHHHhc---CCc------------------h--hhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCc
Confidence               111111100   000                  0  00000000012457899999999999999999999999999


Q ss_pred             CCCCCc
Q 023609          231 YLGSLH  236 (280)
Q Consensus       231 ~~~~~~  236 (280)
                      ||.+..
T Consensus       268 ~~~~~~  273 (287)
T cd06621         268 WIKAQM  273 (287)
T ss_pred             cccccc
Confidence            996643

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=1.9e-35  Score=229.27  Aligned_cols=229  Identities=30%  Similarity=0.656  Sum_probs=183.5

Q ss_pred             CCCeeeeeceecCCCCCCCCcEEEEeecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE
Q 023609            3 HENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   81 (280)
Q Consensus         3 HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nili   81 (280)
                      ||||++++++..++.+   ...-+|+|+++. +.....   ..++.-.++.+++|++.||.|+|++||+|||+||.|++|
T Consensus        92 g~NIi~L~DiV~Dp~S---ktpaLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmI  165 (338)
T KOG0668|consen   92 GPNIIKLLDIVKDPES---KTPSLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMI  165 (338)
T ss_pred             CCCeeehhhhhcCccc---cCchhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeee
Confidence            8999999999988754   567899999985 555443   358889999999999999999999999999999999999


Q ss_pred             ccC-CCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCC-CCCCCCChHHHHHH
Q 023609           82 NAN-CDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRL  159 (280)
Q Consensus        82 ~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~-~pf~~~~~~~~~~~  159 (280)
                      +.. ..++|+|+|++.+.-+....+-.+.+..|--||.+..-..+..+-|+||+||++..|+..+ +.|.|.+..+++-+
T Consensus       166 dh~~rkLrlIDWGLAEFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVk  245 (338)
T KOG0668|consen  166 DHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVK  245 (338)
T ss_pred             chhhceeeeeecchHhhcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHH
Confidence            874 6699999999998777766666677888999999988878899999999999999999876 55689999999999


Q ss_pred             HHHHhCCCCHHHHhHhhHhHHH----HhhhcCccccccccccCC-----CCChHHHHHHHHhhcCCCCCCCCHHHHhcCC
Q 023609          160 LIELIGTPSEAELGFLNENAKK----YICQLPRYQRQSFTEKFP-----NVHPSAIDLVEKMLTFDPRQRITVEDALAHP  230 (280)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~-----~~~~~~~~li~~~L~~dp~~R~t~~ell~h~  230 (280)
                      |.+.+|...-  ..++.+....    +..-+.+..+..|....+     -+++++.||+.++|..|..+|+|+.|++.||
T Consensus       246 IakVLGt~el--~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~Hp  323 (338)
T KOG0668|consen  246 IAKVLGTDEL--YAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHP  323 (338)
T ss_pred             HHHHhChHHH--HHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCc
Confidence            9999886432  2233322222    111122333444444332     3579999999999999999999999999999


Q ss_pred             CCCCCcCCC
Q 023609          231 YLGSLHDIS  239 (280)
Q Consensus       231 ~~~~~~~~~  239 (280)
                      ||....+..
T Consensus       324 yF~~~~~~~  332 (338)
T KOG0668|consen  324 YFAPVREAE  332 (338)
T ss_pred             hHHHHHHHh
Confidence            999876543

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=5.8e-35  Score=247.73  Aligned_cols=208  Identities=24%  Similarity=0.468  Sum_probs=165.8

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++...     ...|+|+||++ ++|.+++.+ ..+++.++..++.|++.||+|||++|++|+||+|+||
T Consensus        73 l~hp~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Ni  146 (293)
T cd06647          73 NKHPNIVNYLDSYLVG-----DELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNI  146 (293)
T ss_pred             cCCCCeeehhheeeeC-----CcEEEEEecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHE
Confidence            4799999999998665     67899999997 699999865 4589999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCC-ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  158 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.++.++|+|||.+....... ......+++.|++||.+.+ ..++.++|+||+|++++++++|..||.+.+......
T Consensus       147 li~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~  225 (293)
T cd06647         147 LLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALY  225 (293)
T ss_pred             EEcCCCCEEEccCcceecccccccccccccCChhhcCchhhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhhee
Confidence            99999999999999886544332 2223457788999998854 447889999999999999999999997665433222


Q ss_pred             HHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCcCC
Q 023609          159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDI  238 (280)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~~~  238 (280)
                      .+.. .+.+.                          ......++..++++|++||..+|.+||++.+++.|+||+..+..
T Consensus       226 ~~~~-~~~~~--------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~~~  278 (293)
T cd06647         226 LIAT-NGTPE--------------------------LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKPL  278 (293)
T ss_pred             ehhc-CCCCC--------------------------CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCccc
Confidence            1110 00000                          00112457789999999999999999999999999999988765


Q ss_pred             CCCC
Q 023609          239 SDEP  242 (280)
Q Consensus       239 ~~~~  242 (280)
                      ++-+
T Consensus       279 ~~~~  282 (293)
T cd06647         279 SSLT  282 (293)
T ss_pred             cccc
Confidence            5443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=1.2e-34  Score=244.81  Aligned_cols=203  Identities=30%  Similarity=0.540  Sum_probs=165.2

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ-ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~-~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      ++||||+++++.+...     ...|+|+||++ ++|.+++...+ .+++..+..++.|++.||++||+.|++|+||+|+|
T Consensus        72 l~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~n  146 (286)
T cd06614          72 CKHPNIVDYYDSYLVG-----DELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDN  146 (286)
T ss_pred             CCCCCeeEEEEEEEEC-----CEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhh
Confidence            5799999999998765     67999999998 69999998876 89999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCCC-ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 023609           79 LLLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL  157 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  157 (280)
                      |+++.++.++|+|||.+....... ......++..|++||.+.+ ..++.++|+||+|+++|+|++|..||.+.+.....
T Consensus       147 i~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~  225 (286)
T cd06614         147 ILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKR-KDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRAL  225 (286)
T ss_pred             EEEcCCCCEEECccchhhhhccchhhhccccCCcccCCHhHhcC-CCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            999999999999999876543321 1123346778999998754 44789999999999999999999999766554433


Q ss_pred             HHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCc
Q 023609          158 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  236 (280)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~  236 (280)
                      ..+.... .+.                          ....+.++..++++|++||+.+|.+|||+.++++|+||.+..
T Consensus       226 ~~~~~~~-~~~--------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~  277 (286)
T cd06614         226 FLITTKG-IPP--------------------------LKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKKAC  277 (286)
T ss_pred             HHHHhcC-CCC--------------------------CcchhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhccC
Confidence            3222110 000                          001123678899999999999999999999999999999843

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=5.3e-35  Score=249.09  Aligned_cols=193  Identities=26%  Similarity=0.346  Sum_probs=152.2

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCC----------------CCCHHHHHHHHHHHHHHHHHH
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ----------------ALSEEHCQYFLYQILRGLKYI   64 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~----------------~l~~~~~~~i~~qll~al~~L   64 (280)
                      +||||+++++++...     ...|+||||++ ++|.+++...+                .+++..++.++.||+.||+||
T Consensus        66 ~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~L  140 (303)
T cd05088          66 HHPNIINLLGACEHR-----GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL  140 (303)
T ss_pred             CCCCcceEEEEECCC-----CCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHH
Confidence            799999999999665     56899999997 69999997432                478999999999999999999


Q ss_pred             HHCCceeccCCCCcEEEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-
Q 023609           65 HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-  143 (280)
Q Consensus        65 H~~gi~H~di~~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-  143 (280)
                      |++|++||||||+||+++.++.++|+|||++..............+..|+|||.+.+ ..++.++||||+||++++|++ 
T Consensus       141 H~~gi~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~  219 (303)
T cd05088         141 SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSL  219 (303)
T ss_pred             HhCCccccccchheEEecCCCcEEeCccccCcccchhhhcccCCCcccccCHHHHhc-cCCcccccchhhhhHHHHHHhc
Confidence            999999999999999999999999999999864321111111223567999998744 447889999999999999998 


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCH
Q 023609          144 RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV  223 (280)
Q Consensus       144 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~  223 (280)
                      |..||.+.+..+....+......                             .....+++++.+++.+||+.+|.+||++
T Consensus       220 g~~p~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~  270 (303)
T cd05088         220 GGTPYCGMTCAELYEKLPQGYRL-----------------------------EKPLNCDDEVYDLMRQCWREKPYERPSF  270 (303)
T ss_pred             CCCCcccCChHHHHHHHhcCCcC-----------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCH
Confidence            99999766554433322110000                             0011467889999999999999999999


Q ss_pred             HHHhcC
Q 023609          224 EDALAH  229 (280)
Q Consensus       224 ~ell~h  229 (280)
                      .+++.+
T Consensus       271 ~~il~~  276 (303)
T cd05088         271 AQILVS  276 (303)
T ss_pred             HHHHHH
Confidence            999875

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.2e-34  Score=253.82  Aligned_cols=194  Identities=27%  Similarity=0.381  Sum_probs=151.0

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCC-------------------------------------
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ-------------------------------------   43 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~-------------------------------------   43 (280)
                      +||||+++++++...     ...|+||||++ |+|.+++....                                     
T Consensus        97 ~HpnIv~l~~~~~~~-----~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~  171 (375)
T cd05104          97 NHINIVNLLGACTVG-----GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDM  171 (375)
T ss_pred             CCcceeeeeeeeccC-----CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhc
Confidence            699999999999665     66899999997 69999986421                                     


Q ss_pred             --------------------------------------CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCC
Q 023609           44 --------------------------------------ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANC   85 (280)
Q Consensus        44 --------------------------------------~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nili~~~~   85 (280)
                                                            .+++..+..++.||+.||+|||+.|++||||||+||+++.++
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~  251 (375)
T cd05104         172 KPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGR  251 (375)
T ss_pred             CCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCC
Confidence                                                  478888999999999999999999999999999999999999


Q ss_pred             CEEEeeccceeeccCCCc---cccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHH
Q 023609           86 DLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQLRLLI  161 (280)
Q Consensus        86 ~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~  161 (280)
                      .++|+|||++........   .....++..|+|||.+.+ ..++.++||||+||++|+|++ |..||.+...........
T Consensus       252 ~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~  330 (375)
T cd05104         252 ITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMI  330 (375)
T ss_pred             cEEEecCccceeccCcccccccCCCCCCcceeChhHhcC-CCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHH
Confidence            999999999876543321   111234567999998854 458899999999999999997 888997654332222111


Q ss_pred             HHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 023609          162 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  229 (280)
Q Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h  229 (280)
                      .....+                            ......+.+++++|.+||+.||++|||+.++++.
T Consensus       331 ~~~~~~----------------------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         331 KEGYRM----------------------------LSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             HhCccC----------------------------CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence            110000                            0011356789999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1.4e-34  Score=240.81  Aligned_cols=190  Identities=15%  Similarity=0.254  Sum_probs=150.0

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ-ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~-~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      ++||||+++++++..+     ...++||||++ |+|.+++..++ .+++..+..++.||+.||+|||+.|++||||||+|
T Consensus        56 ~~h~~iv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~n  130 (258)
T cd05078          56 LSHKHLVLNYGVCVCG-----DESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKN  130 (258)
T ss_pred             CCCCChhheeeEEEeC-----CCcEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccce
Confidence            5799999999999765     56899999997 69999997654 58999999999999999999999999999999999


Q ss_pred             EEEccCCC--------EEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCC-CCCC
Q 023609           79 LLLNANCD--------LKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFP  149 (280)
Q Consensus        79 ili~~~~~--------~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~-~pf~  149 (280)
                      |+++.++.        ++++|||.+......   ....++..|+|||.+.+...++.++|+||+||++|+|++|. +||.
T Consensus       131 ili~~~~~~~~~~~~~~~l~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~  207 (258)
T cd05078         131 VLLIREEDRKTGNPPFIKLSDPGISITVLPK---EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLS  207 (258)
T ss_pred             EEEecccccccCCCceEEecccccccccCCc---hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChh
Confidence            99987765        689999987654332   23456778999999866555788999999999999999984 6665


Q ss_pred             CCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 023609          150 GRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  229 (280)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h  229 (280)
                      ..+...........                       .        ..-+..+.++.++|.+||+.||.+|||++++++.
T Consensus       208 ~~~~~~~~~~~~~~-----------------------~--------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         208 ALDSQKKLQFYEDR-----------------------H--------QLPAPKWTELANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             hccHHHHHHHHHcc-----------------------c--------cCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence            44433221111000                       0        0111345779999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.1e-34  Score=241.96  Aligned_cols=190  Identities=19%  Similarity=0.262  Sum_probs=149.7

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      ++||||+++++++...     ...++||||++ |+|.+++.. ++.+++..+..++.||+.||+|||+.|++||||||+|
T Consensus        73 l~h~niv~~~~~~~~~-----~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~N  147 (274)
T cd05076          73 VSHIHLAFVHGVCVRG-----SENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKN  147 (274)
T ss_pred             CCCCCeeeEEEEEEeC-----CceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCccc
Confidence            5799999999998665     56899999998 689888865 4679999999999999999999999999999999999


Q ss_pred             EEEccCC-------CEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHH-hCCCCCCC
Q 023609           79 LLLNANC-------DLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM-DRKPLFPG  150 (280)
Q Consensus        79 ili~~~~-------~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll-~g~~pf~~  150 (280)
                      |+++..+       .++++|||.+......   ....++..|+|||.+.+...++.++|+||+||++|+++ +|..||.+
T Consensus       148 ill~~~~~~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~  224 (274)
T cd05076         148 ILLARLGLAEGTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKE  224 (274)
T ss_pred             EEEeccCcccCccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccc
Confidence            9997543       4899999987543222   22356778999998865556789999999999999985 68899976


Q ss_pred             CChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 023609          151 RDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  229 (280)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h  229 (280)
                      ....+..........                               .....++.+.++|.+||+.+|++|||+.+++++
T Consensus       225 ~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         225 RTPSEKERFYEKKHR-------------------------------LPEPSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             cChHHHHHHHHhccC-------------------------------CCCCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence            654332221110000                               001235679999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=2.4e-34  Score=237.64  Aligned_cols=198  Identities=29%  Similarity=0.527  Sum_probs=161.8

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      ++||||+++++.+...     ...++++||++ ++|.+++... +.+++..+..++.|++.||.+||+.|++|+||+|+|
T Consensus        54 l~~~~i~~~~~~~~~~-----~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~n  128 (253)
T cd05122          54 CKHPNIVKYYGSYLKK-----DELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAAN  128 (253)
T ss_pred             CCCCCEeEEEEEEecC-----CeEEEEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHH
Confidence            5799999999998665     67899999998 6999998775 579999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023609           79 LLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  158 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  158 (280)
                      |+++.++.++|+|||.+.............++..|++||.+.+. ..+.++|+||+|+++++|++|..||...+......
T Consensus       129 i~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~  207 (253)
T cd05122         129 ILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGK-PYDYKADIWSLGITAIELAEGKPPYSELPPMKALF  207 (253)
T ss_pred             EEEccCCeEEEeeccccccccccccccceecCCcccCHHHHcCC-CCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHH
Confidence            99999999999999998776554323455678889999988544 37889999999999999999999997665433332


Q ss_pred             HHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCC
Q 023609          159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPY  231 (280)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~  231 (280)
                      .... ...+..                          ..-..++..+.++|.+||+.||++|||+.+++.|||
T Consensus       208 ~~~~-~~~~~~--------------------------~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~  253 (253)
T cd05122         208 KIAT-NGPPGL--------------------------RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF  253 (253)
T ss_pred             HHHh-cCCCCc--------------------------CcccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence            2221 000000                          000123788999999999999999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=2.1e-34  Score=239.49  Aligned_cols=193  Identities=20%  Similarity=0.365  Sum_probs=155.5

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      ++||||+++++++...     ...++||||++ |+|.+++... +.+++..+..++.|++.||+|||+.|++|+||+|+|
T Consensus        56 l~h~~i~~~~~~~~~~-----~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~n  130 (256)
T cd05114          56 LSHPKLVQLYGVCTQQ-----KPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARN  130 (256)
T ss_pred             CCCCCceeEEEEEccC-----CCEEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcce
Confidence            5899999999998665     66899999997 6999998753 468999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCCCcc--ccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 023609           79 LLLNANCDLKICDFGLARVTSETDFM--TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVH  155 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~  155 (280)
                      |+++.++.++++|||.+.........  ....++..|+|||.+.+ ..++.++|+||+|+++|+|++ |..||.+.+..+
T Consensus       131 i~i~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~  209 (256)
T cd05114         131 CLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNF-SKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYE  209 (256)
T ss_pred             EEEcCCCeEEECCCCCccccCCCceeccCCCCCchhhCChhhccc-CccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence            99999999999999988754332211  12234457999998854 357889999999999999999 899998776655


Q ss_pred             HHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          156 QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                      ....+.......                             .-...+..+.+++.+||+.||.+|||+.++++
T Consensus       210 ~~~~i~~~~~~~-----------------------------~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~  253 (256)
T cd05114         210 VVEMISRGFRLY-----------------------------RPKLASMTVYEVMYSCWHEKPEGRPTFAELLR  253 (256)
T ss_pred             HHHHHHCCCCCC-----------------------------CCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            555443211100                             00134678999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-34  Score=239.55  Aligned_cols=194  Identities=20%  Similarity=0.315  Sum_probs=155.2

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      ++||||+++++++...     ...|+||||++ ++|.+++..+ +.+++..+..++.||+.||+|||+.|++|+||+|+|
T Consensus        56 l~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~n  130 (256)
T cd05059          56 LSHPNLVQLYGVCTKQ-----RPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARN  130 (256)
T ss_pred             CCCCCEEEEEEEEcCC-----CceEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhh
Confidence            5799999999998654     56899999997 6999999753 468999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCCCcc--ccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 023609           79 LLLNANCDLKICDFGLARVTSETDFM--TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVH  155 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~  155 (280)
                      |+++.++.++|+|||.++........  ....++..|+|||.+.+. .++.++|+||+|+++|+|++ |..||.+.+..+
T Consensus       131 i~i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~  209 (256)
T cd05059         131 CLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYS-RFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE  209 (256)
T ss_pred             EEECCCCcEEECCcccceecccccccccCCCCCCccccCHHHhccC-CCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH
Confidence            99999999999999998765433211  112234579999988544 47889999999999999998 899997766554


Q ss_pred             HHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 023609          156 QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  229 (280)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h  229 (280)
                      ....+......                             ...+..+.++.+++.+||..+|.+|||+.++++.
T Consensus       210 ~~~~~~~~~~~-----------------------------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         210 VVESVSAGYRL-----------------------------YRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             HHHHHHcCCcC-----------------------------CCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence            43332211100                             1112468899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.4e-34  Score=239.23  Aligned_cols=192  Identities=19%  Similarity=0.295  Sum_probs=154.8

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++..      ...++||||+. |+|.+++...+.+++..+..++.|++.||++||+.|++|+||||+||
T Consensus        53 l~h~~iv~~~~~~~~------~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~ni  126 (257)
T cd05060          53 LDHPCIVRLIGVCKG------EPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNV  126 (257)
T ss_pred             cCCCCeeeEEEEEcC------CceEEEEEeCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceE
Confidence            579999999998742      45799999997 69999998888899999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCCcc----ccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 023609           80 LLNANCDLKICDFGLARVTSETDFM----TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHV  154 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~  154 (280)
                      +++.++.++|+|||.+.........    ....++..|+|||.+.+ ..++.++|+||+|+++|++++ |..||...+..
T Consensus       127 li~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~  205 (257)
T cd05060         127 LLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINY-GKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGA  205 (257)
T ss_pred             EEcCCCcEEeccccccceeecCCcccccccCccccccccCHHHhcC-CCCCccchHHHHHHHHHHHHcCCCCCcccCCHH
Confidence            9999999999999998765433211    11223457999998854 458889999999999999997 99999776654


Q ss_pred             HHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          155 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                      +....+.....                             ....+.++..++++|.+||..+|++|||+.++++
T Consensus       206 ~~~~~~~~~~~-----------------------------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~  250 (257)
T cd05060         206 EVIAMLESGER-----------------------------LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELES  250 (257)
T ss_pred             HHHHHHHcCCc-----------------------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            44333321100                             0111356788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1.5e-34  Score=240.18  Aligned_cols=197  Identities=30%  Similarity=0.515  Sum_probs=159.8

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ--ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS   77 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~--~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~   77 (280)
                      ++||||+++++.+...     ...|+|+||+. ++|.+++....  .+++..+..++.|++.||.|||+.|++|+||+|+
T Consensus        56 ~~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~  130 (257)
T cd08225          56 MKHPNIVTFFASFQEN-----GRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQ  130 (257)
T ss_pred             CCCCChhhhhheeccC-----CeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHH
Confidence            5799999999998665     67999999997 59999987543  4899999999999999999999999999999999


Q ss_pred             cEEEccCCC-EEEeeccceeeccCCCc-cccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 023609           78 NLLLNANCD-LKICDFGLARVTSETDF-MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVH  155 (280)
Q Consensus        78 nili~~~~~-~~l~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~  155 (280)
                      ||+++.++. ++++|||.+........ .....+++.|+|||.+.+. .++.++|+||+|+++++|++|..||.+.+..+
T Consensus       131 nil~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~  209 (257)
T cd08225         131 NIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNR-PYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ  209 (257)
T ss_pred             HEEEcCCCCeEEecccccchhccCCcccccccCCCccccCHHHHcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCccHHH
Confidence            999998865 69999998876544321 2234578889999987544 47889999999999999999999997665444


Q ss_pred             HHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 023609          156 QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  232 (280)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~  232 (280)
                      ....+....                             .....+.++.+++++|.+||..+|++|||+.++++||||
T Consensus       210 ~~~~~~~~~-----------------------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         210 LVLKICQGY-----------------------------FAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             HHHHHhccc-----------------------------CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence            333222110                             011224577899999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=2e-34  Score=242.38  Aligned_cols=194  Identities=23%  Similarity=0.397  Sum_probs=153.3

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCC-------CCCHHHHHHHHHHHHHHHHHHHHCCceec
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ-------ALSEEHCQYFLYQILRGLKYIHSANVLHR   72 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~-------~l~~~~~~~i~~qll~al~~LH~~gi~H~   72 (280)
                      ++||||+++++++...     ...++||||+. ++|.+++...+       .+++..+..++.||+.||+|||+.|++|+
T Consensus        66 l~~~~i~~~~~~~~~~-----~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~  140 (277)
T cd05036          66 FNHQNIVRLIGVSFER-----LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHR  140 (277)
T ss_pred             CCCCCEeeEEEEEccC-----CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeec
Confidence            5799999999988655     56799999996 69999997643       48999999999999999999999999999


Q ss_pred             cCCCCcEEEccCC---CEEEeeccceeeccCCCc---cccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CC
Q 023609           73 DLKPSNLLLNANC---DLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RK  145 (280)
Q Consensus        73 di~~~nili~~~~---~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~  145 (280)
                      ||+|+||+++.++   .++|+|||.+........   ......+..|+|||++.+. .++.++||||+||++|+|++ |.
T Consensus       141 dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~~g~  219 (277)
T cd05036         141 DIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDG-IFTSKTDVWSFGVLLWEIFSLGY  219 (277)
T ss_pred             ccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcC-CcCchhHHHHHHHHHHHHHcCCC
Confidence            9999999998754   589999999876532211   1122234679999998544 48899999999999999996 99


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHH
Q 023609          146 PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVED  225 (280)
Q Consensus       146 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e  225 (280)
                      .||.+.+.......+.... .+                            ...+.++..+.+++.+||+.+|.+|||+.+
T Consensus       220 ~pf~~~~~~~~~~~~~~~~-~~----------------------------~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~  270 (277)
T cd05036         220 MPYPGRTNQEVMEFVTGGG-RL----------------------------DPPKGCPGPVYRIMTDCWQHTPEDRPNFAT  270 (277)
T ss_pred             CCCCCCCHHHHHHHHHcCC-cC----------------------------CCCCCCCHHHHHHHHHHcCCCcccCcCHHH
Confidence            9998776554433221110 00                            011356788999999999999999999999


Q ss_pred             HhcC
Q 023609          226 ALAH  229 (280)
Q Consensus       226 ll~h  229 (280)
                      +++|
T Consensus       271 vl~~  274 (277)
T cd05036         271 ILER  274 (277)
T ss_pred             HHHH
Confidence            9876

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=4.1e-34  Score=237.16  Aligned_cols=201  Identities=28%  Similarity=0.479  Sum_probs=162.9

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++.+....   ....++|+|+++ ++|.+++.+...+++..++.++.|++.||+|||+.|++|+||+|+||
T Consensus        56 l~~~~i~~~~~~~~~~~---~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni  132 (260)
T cd06606          56 LQHPNIVRYYGSERDEE---KNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANI  132 (260)
T ss_pred             cCCCCEeeEEEEEecCC---CCeEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHE
Confidence            57999999999986542   256899999995 69999998877999999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCCc---cccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023609           80 LLNANCDLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ  156 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  156 (280)
                      +++.++.++|+|||.+........   .....++..|++||.+... ..+.++|+||+|+++++|++|..||........
T Consensus       133 ~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~  211 (260)
T cd06606         133 LVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGE-EYGRAADIWSLGCTVIEMATGKPPWSELGNPMA  211 (260)
T ss_pred             EEcCCCCEEEcccccEEecccccccccccCCCCCccccCHhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCchHH
Confidence            999999999999999987665532   3445678889999988544 478899999999999999999999976652111


Q ss_pred             HHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 023609          157 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  232 (280)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~  232 (280)
                      .  ......                         ...........+..++++|.+||+.||.+||++.+++.||||
T Consensus       212 ~--~~~~~~-------------------------~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         212 A--LYKIGS-------------------------SGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             H--HHhccc-------------------------cCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence            1  111000                         000011112457889999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.6e-34  Score=242.15  Aligned_cols=192  Identities=26%  Similarity=0.348  Sum_probs=151.2

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCC----------------CCCHHHHHHHHHHHHHHHHHH
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ----------------ALSEEHCQYFLYQILRGLKYI   64 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~----------------~l~~~~~~~i~~qll~al~~L   64 (280)
                      +||||+++++++...     ...|+||||+. |+|.+++..++                .+++..+..++.|++.||+||
T Consensus        54 ~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~l  128 (270)
T cd05047          54 HHPNIINLLGACEHR-----GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL  128 (270)
T ss_pred             cCCCeeeEEEEEecC-----CCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            699999999999654     56899999997 69999997542                478999999999999999999


Q ss_pred             HHCCceeccCCCCcEEEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-
Q 023609           65 HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-  143 (280)
Q Consensus        65 H~~gi~H~di~~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-  143 (280)
                      |+.|++|+||||+||+++.++.++++|||++..............+..|+|||.+.. ..++.++|+||+||++++|++ 
T Consensus       129 H~~~i~H~dikp~nili~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slG~il~el~~~  207 (270)
T cd05047         129 SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSL  207 (270)
T ss_pred             HHCCEeecccccceEEEcCCCeEEECCCCCccccchhhhccCCCCccccCChHHHcc-CCCCchhhHHHHHHHHHHHHcC
Confidence            999999999999999999999999999999853222111112233556999998744 447889999999999999996 


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCH
Q 023609          144 RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV  223 (280)
Q Consensus       144 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~  223 (280)
                      |..||.+.+..+....+.....                             .......+.++.+++.+||..||.+|||+
T Consensus       208 g~~pf~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~  258 (270)
T cd05047         208 GGTPYCGMTCAELYEKLPQGYR-----------------------------LEKPLNCDDEVYDLMRQCWREKPYERPSF  258 (270)
T ss_pred             CCCCccccCHHHHHHHHhCCCC-----------------------------CCCCCcCCHHHHHHHHHHcccChhhCCCH
Confidence            9999976654443332211000                             01112467789999999999999999999


Q ss_pred             HHHhc
Q 023609          224 EDALA  228 (280)
Q Consensus       224 ~ell~  228 (280)
                      .+++.
T Consensus       259 ~~il~  263 (270)
T cd05047         259 AQILV  263 (270)
T ss_pred             HHHHH
Confidence            99975

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.8e-34  Score=238.54  Aligned_cols=193  Identities=26%  Similarity=0.401  Sum_probs=155.6

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ--ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS   77 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~--~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~   77 (280)
                      ++||||+++++++...     ...|+||||++ ++|.+++....  .+++..+..++.|++.||.+||+.|++|+||+|+
T Consensus        58 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~  132 (261)
T cd05068          58 LRHPKLIQLYAVCTLE-----EPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAAR  132 (261)
T ss_pred             CCCCCccceeEEEecC-----CCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcc
Confidence            5799999999998655     66899999995 79999997654  6999999999999999999999999999999999


Q ss_pred             cEEEccCCCEEEeeccceeeccCCCccc--cceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 023609           78 NLLLNANCDLKICDFGLARVTSETDFMT--EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHV  154 (280)
Q Consensus        78 nili~~~~~~~l~dfg~~~~~~~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~  154 (280)
                      ||+++.++.++|+|||.+..........  ....+..|+|||...+ ..++.++|+||+|+++++|++ |..||.+....
T Consensus       133 Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~  211 (261)
T cd05068         133 NVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALY-NRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNA  211 (261)
T ss_pred             eEEEcCCCCEEECCcceEEEccCCcccccCCCcCceeccCcccccc-CCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence            9999999999999999998765332111  1122357999998754 457889999999999999998 99999877655


Q ss_pred             HHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          155 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                      .....+......+                             ..+..+..+.+++.+||+.+|.+||++.+++.
T Consensus       212 ~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         212 EVLQQVDQGYRMP-----------------------------CPPGCPKELYDIMLDCWKEDPDDRPTFETLQW  256 (261)
T ss_pred             HHHHHHHcCCCCC-----------------------------CCCcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence            5444332211100                             11256788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=2e-34  Score=243.95  Aligned_cols=204  Identities=20%  Similarity=0.383  Sum_probs=162.2

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nil   80 (280)
                      +||||+++++.+...     ...|+||||++ ++|.+++..++.+++..+..++.|++.||.|||+.|++||||+|+||+
T Consensus        63 ~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil  137 (290)
T cd05613          63 QSPFLVTLHYAFQTD-----TKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENIL  137 (290)
T ss_pred             cCCChhceeeEeecC-----CeEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeE
Confidence            589999999998665     67899999998 599999988888999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccceeeccCCC--ccccceeccccccchhccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 023609           81 LNANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNS-SDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL  157 (280)
Q Consensus        81 i~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  157 (280)
                      ++.++.++|+|||++.......  ......++..|+|||.+.+. ...+.++|+||+|+++|+|++|..||.........
T Consensus       138 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~  217 (290)
T cd05613         138 LDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQ  217 (290)
T ss_pred             ECCCCCEEEeeCccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccH
Confidence            9999999999999987654322  12234578889999987542 23578899999999999999999999643322222


Q ss_pred             HHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCC-----CHHHHhcCCCC
Q 023609          158 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI-----TVEDALAHPYL  232 (280)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~ell~h~~~  232 (280)
                      ..+.+....                  ..+        ..-+.+++.+.+++++||+.||.+||     ++.+++.||||
T Consensus       218 ~~~~~~~~~------------------~~~--------~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~  271 (290)
T cd05613         218 AEISRRILK------------------SEP--------PYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFF  271 (290)
T ss_pred             HHHHHHhhc------------------cCC--------CCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCccc
Confidence            222111100                  000        00124678899999999999999997     88999999999


Q ss_pred             CCCc
Q 023609          233 GSLH  236 (280)
Q Consensus       233 ~~~~  236 (280)
                      +...
T Consensus       272 ~~~~  275 (290)
T cd05613         272 QKIN  275 (290)
T ss_pred             ccCC
Confidence            8864

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=2.8e-34  Score=242.15  Aligned_cols=194  Identities=19%  Similarity=0.361  Sum_probs=155.2

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC----------------CCCCHHHHHHHHHHHHHHHHH
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN----------------QALSEEHCQYFLYQILRGLKY   63 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~----------------~~l~~~~~~~i~~qll~al~~   63 (280)
                      ++||||+++++++...     ...++++||+. ++|.+++...                ..+++..+..++.|++.||+|
T Consensus        65 l~h~~iv~~~~~~~~~-----~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~  139 (283)
T cd05091          65 LQHPNIVCLLGVVTKE-----QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEF  139 (283)
T ss_pred             CCCCCcCeEEEEEcCC-----CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHH
Confidence            5799999999999765     56899999997 6999998532                348888999999999999999


Q ss_pred             HHHCCceeccCCCCcEEEccCCCEEEeeccceeeccCCCc---cccceeccccccchhccCCCCCCcchhHHHHHHHHHH
Q 023609           64 IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME  140 (280)
Q Consensus        64 LH~~gi~H~di~~~nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~  140 (280)
                      ||++|++||||||+||+++.++.++|+|||+++.......   .....+++.|+|||.+.+. .++.++|+||+||++|+
T Consensus       140 lH~~gi~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~e  218 (283)
T cd05091         140 LSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYG-KFSIDSDIWSYGVVLWE  218 (283)
T ss_pred             HHHcCccccccchhheEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcC-CCCcchhHHHHHHHHHH
Confidence            9999999999999999999999999999999875433221   1223456789999988544 47889999999999999


Q ss_pred             HHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCC
Q 023609          141 LMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQ  219 (280)
Q Consensus       141 ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~  219 (280)
                      |++ |..||.+....+....+......                             ..-.+++..+.+++.+||+.+|.+
T Consensus       219 l~~~g~~p~~~~~~~~~~~~i~~~~~~-----------------------------~~~~~~~~~~~~li~~cl~~~p~~  269 (283)
T cd05091         219 VFSYGLQPYCGYSNQDVIEMIRNRQVL-----------------------------PCPDDCPAWVYTLMLECWNEFPSR  269 (283)
T ss_pred             HHcCCCCCCCCCCHHHHHHHHHcCCcC-----------------------------CCCCCCCHHHHHHHHHHhCCCccc
Confidence            997 88898776655444433221111                             111257788999999999999999


Q ss_pred             CCCHHHHhcC
Q 023609          220 RITVEDALAH  229 (280)
Q Consensus       220 R~t~~ell~h  229 (280)
                      ||++.+++..
T Consensus       270 RP~~~~i~~~  279 (283)
T cd05091         270 RPRFKDIHSR  279 (283)
T ss_pred             CCCHHHHHHH
Confidence            9999999863

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=3.1e-34  Score=240.34  Aligned_cols=199  Identities=24%  Similarity=0.386  Sum_probs=154.5

Q ss_pred             CCCCCeeeeeceecCCC-CCCCCcEEEEeecCC-ccHHHHHHc------CCCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q 023609            1 MDHENVVAIRDIIPPPQ-RESFNDVYIAYELMD-TDLHQIIRS------NQALSEEHCQYFLYQILRGLKYIHSANVLHR   72 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~-~~~~~~~~iv~e~~~-g~L~~~l~~------~~~l~~~~~~~i~~qll~al~~LH~~gi~H~   72 (280)
                      ++||||+++++++.... ..+....+++|||+. |+|.+++..      ...+++..+..++.||+.||+|||+.|++||
T Consensus        57 l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~  136 (272)
T cd05075          57 FDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHR  136 (272)
T ss_pred             CCCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeecc
Confidence            58999999999875432 123346899999997 699988742      2348999999999999999999999999999


Q ss_pred             cCCCCcEEEccCCCEEEeeccceeeccCCCc---cccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCC
Q 023609           73 DLKPSNLLLNANCDLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLF  148 (280)
Q Consensus        73 di~~~nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf  148 (280)
                      ||||+||+++.++.++|+|||++........   ......++.|++||...+ ..++.++|+||+||++|+|++ |..||
T Consensus       137 dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Di~slG~il~el~~~g~~p~  215 (272)
T cd05075         137 DLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLAD-RVYTTKSDVWSFGVTMWEIATRGQTPY  215 (272)
T ss_pred             ccchhheEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccC-CCcChHHHHHHHHHHHHHHHcCCCCCC
Confidence            9999999999999999999999886543321   112234667999998854 457899999999999999998 78999


Q ss_pred             CCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          149 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                      .+.........+.....                             ....+.++..+.++|.+||+.||.+|||+.++++
T Consensus       216 ~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~  266 (272)
T cd05075         216 PGVENSEIYDYLRQGNR-----------------------------LKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRC  266 (272)
T ss_pred             CCCCHHHHHHHHHcCCC-----------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            87655443332221100                             0112356788999999999999999999999986


Q ss_pred             C
Q 023609          229 H  229 (280)
Q Consensus       229 h  229 (280)
                      +
T Consensus       267 ~  267 (272)
T cd05075         267 E  267 (272)
T ss_pred             H
Confidence            3

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-35  Score=230.28  Aligned_cols=203  Identities=27%  Similarity=0.392  Sum_probs=155.9

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS----NQALSEEHCQYFLYQILRGLKYIHSAN--VLHRD   73 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~----~~~l~~~~~~~i~~qll~al~~LH~~g--i~H~d   73 (280)
                      ++|||++++++.......++....||+++|+. |+|.+.++.    +..++|.++..|+.+|+.||++||+..  ++|||
T Consensus        75 f~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~D  154 (302)
T KOG2345|consen   75 FNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRD  154 (302)
T ss_pred             hCCcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccC
Confidence            57999999999987766566678999999997 899999874    236999999999999999999999999  99999


Q ss_pred             CCCCcEEEccCCCEEEeeccceeeccCCCc----------cccceeccccccchhccCCC--CCCcchhHHHHHHHHHHH
Q 023609           74 LKPSNLLLNANCDLKICDFGLARVTSETDF----------MTEYVVTRWYRAPELLLNSS--DYTAAIDVWSVGCIFMEL  141 (280)
Q Consensus        74 i~~~nili~~~~~~~l~dfg~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~--~~~~~~DiwslG~il~~l  141 (280)
                      |||.||+++.++.++++|||.++...-...          -....+|..|.|||.+....  ..+.++|||||||++|.|
T Consensus       155 iKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~  234 (302)
T KOG2345|consen  155 IKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAM  234 (302)
T ss_pred             CCcceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHH
Confidence            999999999999999999999865322211          11245788999999874322  246899999999999999


Q ss_pred             HhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCC
Q 023609          142 MDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI  221 (280)
Q Consensus       142 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~  221 (280)
                      +.|..||.-         +.+..+...   ++          .+.   ...++++. +.+|+.+.++|+.||++||.+||
T Consensus       235 mf~~sPfe~---------~~~~GgSla---LA----------v~n---~q~s~P~~-~~yse~l~~lik~mlqvdP~qRP  288 (302)
T KOG2345|consen  235 MFGESPFER---------IYQQGGSLA---LA----------VQN---AQISIPNS-SRYSEALHQLIKSMLQVDPNQRP  288 (302)
T ss_pred             HHcCCcchH---------HhhcCCeEE---Ee----------eec---cccccCCC-CCccHHHHHHHHHHhcCCcccCC
Confidence            999999941         111111000   00          000   00111111 24889999999999999999999


Q ss_pred             CHHHHhcC
Q 023609          222 TVEDALAH  229 (280)
Q Consensus       222 t~~ell~h  229 (280)
                      ++.+++.+
T Consensus       289 ~i~~ll~~  296 (302)
T KOG2345|consen  289 TIPELLSK  296 (302)
T ss_pred             CHHHHHHH
Confidence            99999874

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=3.7e-34  Score=238.57  Aligned_cols=193  Identities=25%  Similarity=0.409  Sum_probs=155.4

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS--NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS   77 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~--~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~   77 (280)
                      ++||||+++++.+...     ...+++|||+. ++|.+++..  ...+++..+..++.|++.||+|||+.|++|+||+|+
T Consensus        58 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~  132 (261)
T cd05072          58 LQHDKLVRLYAVVTKE-----EPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAA  132 (261)
T ss_pred             CCCCCeeeEEEEEcCC-----CCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchh
Confidence            5799999999998654     56899999996 699999865  346899999999999999999999999999999999


Q ss_pred             cEEEccCCCEEEeeccceeeccCCCc--cccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 023609           78 NLLLNANCDLKICDFGLARVTSETDF--MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHV  154 (280)
Q Consensus        78 nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~  154 (280)
                      ||+++.++.++|+|||.+........  .....++..|+|||.+.+ ..++.++|+||+||++|+|++ |..||.+....
T Consensus       133 nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~  211 (261)
T cd05072         133 NVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNS  211 (261)
T ss_pred             hEEecCCCcEEECCCccceecCCCceeccCCCccceecCCHHHhcc-CCCChhhhhhhhHHHHHHHHccCCCCCCCCCHH
Confidence            99999999999999999986543321  112234567999998754 447889999999999999998 99999876655


Q ss_pred             HHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          155 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                      .....+......                             .....++.++.+++.+||..+|++|||++++++
T Consensus       212 ~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         212 DVMSALQRGYRM-----------------------------PRMENCPDELYDIMKTCWKEKAEERPTFDYLQS  256 (261)
T ss_pred             HHHHHHHcCCCC-----------------------------CCCCCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            444333211110                             112356788999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=3.6e-34  Score=241.28  Aligned_cols=193  Identities=23%  Similarity=0.409  Sum_probs=153.8

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCC---------------CCCHHHHHHHHHHHHHHHHHH
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ---------------ALSEEHCQYFLYQILRGLKYI   64 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~---------------~l~~~~~~~i~~qll~al~~L   64 (280)
                      ++||||+++++++...     ...+++|||+. ++|.+++...+               .+++..+..++.||+.||+||
T Consensus        64 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~L  138 (280)
T cd05092          64 LQHQHIVRFYGVCTEG-----RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYL  138 (280)
T ss_pred             CCCCCCceEEEEEecC-----CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHH
Confidence            5799999999998665     56899999997 69999987542               488999999999999999999


Q ss_pred             HHCCceeccCCCCcEEEccCCCEEEeeccceeeccCCCc---cccceeccccccchhccCCCCCCcchhHHHHHHHHHHH
Q 023609           65 HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL  141 (280)
Q Consensus        65 H~~gi~H~di~~~nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l  141 (280)
                      |+.|++|+||||+||+++.++.++|+|||++........   .....+++.|+|||.+.+. .++.++|+||+||++|+|
T Consensus       139 H~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el  217 (280)
T cd05092         139 ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYR-KFTTESDIWSFGVVLWEI  217 (280)
T ss_pred             HHCCeecccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccC-CcCchhhHHHHHHHHHHH
Confidence            999999999999999999999999999999875432211   1222346779999988544 478899999999999999


Q ss_pred             Hh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCC
Q 023609          142 MD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQR  220 (280)
Q Consensus       142 l~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R  220 (280)
                      ++ |.+||.+.........+......                             .....+++.+.++|.+||+.||.+|
T Consensus       218 ~~~g~~p~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~li~~cl~~~P~~R  268 (280)
T cd05092         218 FTYGKQPWYQLSNTEAIECITQGREL-----------------------------ERPRTCPPEVYAIMQGCWQREPQQR  268 (280)
T ss_pred             HcCCCCCCccCCHHHHHHHHHcCccC-----------------------------CCCCCCCHHHHHHHHHHccCChhhC
Confidence            98 89999766554433322211000                             1112567889999999999999999


Q ss_pred             CCHHHHhc
Q 023609          221 ITVEDALA  228 (280)
Q Consensus       221 ~t~~ell~  228 (280)
                      |++.++++
T Consensus       269 p~~~~l~~  276 (280)
T cd05092         269 MVIKDIHS  276 (280)
T ss_pred             CCHHHHHH
Confidence            99999874

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-34  Score=238.93  Aligned_cols=199  Identities=24%  Similarity=0.479  Sum_probs=159.6

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++.+...   ..+++|+||++ ++|.+++...+.+++..++.++.|++.||.|||+.|++|+||+|+||
T Consensus        61 l~h~~i~~~~~~~~~~~~---~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni  137 (264)
T cd06653          61 LRHDRIVQYYGCLRDPEE---KKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANI  137 (264)
T ss_pred             cCCCCcceEEEEEEcCCC---CEEEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHE
Confidence            589999999999865422   56899999997 59999998878899999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCC----CccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 023609           80 LLNANCDLKICDFGLARVTSET----DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVH  155 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~  155 (280)
                      +++.++.++|+|||.+......    .......++..|+|||.+.+. ..+.++|+||+||++++|++|..||.+.....
T Consensus       138 ~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~  216 (264)
T cd06653         138 LRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGE-GYGRKADVWSVACTVVEMLTEKPPWAEYEAMA  216 (264)
T ss_pred             EEcCCCCEEECccccccccccccccCccccccCCcccccCHhhhcCC-CCCccccHHHHHHHHHHHHhCCCCCCccCHHH
Confidence            9999999999999998754321    111234578889999988554 47889999999999999999999997654443


Q ss_pred             HHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 023609          156 QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  232 (280)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~  232 (280)
                      ....+.   ..+..                         ...-+.++..+.++|.+||. +|.+|||+.++++|||.
T Consensus       217 ~~~~~~---~~~~~-------------------------~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         217 AIFKIA---TQPTK-------------------------PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             HHHHHH---cCCCC-------------------------CCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCCC
Confidence            322221   11110                         01113577889999999999 67999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.8e-34  Score=244.50  Aligned_cols=193  Identities=28%  Similarity=0.478  Sum_probs=154.4

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHc----------------CCCCCHHHHHHHHHHHHHHHHHH
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS----------------NQALSEEHCQYFLYQILRGLKYI   64 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~----------------~~~l~~~~~~~i~~qll~al~~L   64 (280)
                      +||||+++++++...     ...+++|||+. |+|.+++..                .+.+++..+..++.|++.||+||
T Consensus        74 ~h~~i~~~~~~~~~~-----~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~L  148 (293)
T cd05053          74 KHKNIINLLGVCTQE-----GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFL  148 (293)
T ss_pred             CCCCeeeEEEEEcCC-----CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHH
Confidence            699999999998665     56899999997 699999854                24589999999999999999999


Q ss_pred             HHCCceeccCCCCcEEEccCCCEEEeeccceeeccCCCc---cccceeccccccchhccCCCCCCcchhHHHHHHHHHHH
Q 023609           65 HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL  141 (280)
Q Consensus        65 H~~gi~H~di~~~nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l  141 (280)
                      |+.|++||||||+||+++.++.++|+|||.+........   .....++..|+|||.+.+ ..++.++||||+||++|++
T Consensus       149 H~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el  227 (293)
T cd05053         149 ASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFD-RVYTHQSDVWSFGVLLWEI  227 (293)
T ss_pred             HHCCccccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhcc-CCcCcccceeehhhHHHHH
Confidence            999999999999999999999999999999876543221   112234567999998754 4478899999999999999


Q ss_pred             Hh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCC
Q 023609          142 MD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQR  220 (280)
Q Consensus       142 l~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R  220 (280)
                      ++ |..||.+....+....+......                             ......+.++.+|+.+||..||++|
T Consensus       228 ~~~g~~p~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~li~~~l~~~p~~R  278 (293)
T cd05053         228 FTLGGSPYPGIPVEELFKLLKEGYRM-----------------------------EKPQNCTQELYHLMRDCWHEVPSQR  278 (293)
T ss_pred             hcCCCCCCCCCCHHHHHHHHHcCCcC-----------------------------CCCCCCCHHHHHHHHHHcccCcccC
Confidence            97 89999876655544333211100                             0112457889999999999999999


Q ss_pred             CCHHHHhcC
Q 023609          221 ITVEDALAH  229 (280)
Q Consensus       221 ~t~~ell~h  229 (280)
                      ||+.+++++
T Consensus       279 ps~~eil~~  287 (293)
T cd05053         279 PTFKQLVED  287 (293)
T ss_pred             cCHHHHHHH
Confidence            999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=2.6e-34  Score=239.38  Aligned_cols=196  Identities=29%  Similarity=0.526  Sum_probs=157.5

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS----NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK   75 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~----~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~   75 (280)
                      ++||||+++++++...     ...++|+||++ ++|.+++..    +..+++..++.++.|++.||.|||+.|++|+||+
T Consensus        59 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~  133 (260)
T cd08222          59 LDHPAIVKFHASFLER-----DAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLK  133 (260)
T ss_pred             CCCCcHHHHHHHHhcC-----CceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCC
Confidence            5799999999998655     56899999997 588888753    3569999999999999999999999999999999


Q ss_pred             CCcEEEccCCCEEEeeccceeeccCC-CccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH
Q 023609           76 PSNLLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHV  154 (280)
Q Consensus        76 ~~nili~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  154 (280)
                      |+||+++. +.++|+|||.+...... .......+++.|+|||...+ ..++.++|+||+|+++++|++|..||.+....
T Consensus       134 ~~nili~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~  211 (260)
T cd08222         134 AKNIFLKN-NLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKH-QGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL  211 (260)
T ss_pred             hhheEeec-CCEeecccCceeecCCCcccccCCCCCcCccCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCccHH
Confidence            99999975 56999999998765332 22233456788999998754 34678899999999999999999999766544


Q ss_pred             HHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 023609          155 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  232 (280)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~  232 (280)
                      .....+..  +..+                           .....++.++.++|.+||..||.+||++.++++||||
T Consensus       212 ~~~~~~~~--~~~~---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         212 SVVLRIVE--GPTP---------------------------SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             HHHHHHHc--CCCC---------------------------CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence            43333221  0000                           1112567889999999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=4e-34  Score=238.30  Aligned_cols=193  Identities=23%  Similarity=0.405  Sum_probs=157.0

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS   77 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~   77 (280)
                      ++||||+++++++...     ...++||||++ ++|.+++.+.  ..+++..+..++.||+.||+|||+.|++|+||+|+
T Consensus        59 l~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~  133 (261)
T cd05148          59 LRHKHLISLFAVCSVG-----EPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAAR  133 (261)
T ss_pred             CCCcchhheeeeEecC-----CCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcc
Confidence            5899999999998655     66899999997 5999999753  46899999999999999999999999999999999


Q ss_pred             cEEEccCCCEEEeeccceeeccCCCc-cccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 023609           78 NLLLNANCDLKICDFGLARVTSETDF-MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVH  155 (280)
Q Consensus        78 nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~  155 (280)
                      ||+++.++.++|+|||.+........ .....++..|++||.+.. ..++.++|+||+|+++++|++ |..||.+.+..+
T Consensus       134 nilv~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~  212 (261)
T cd05148         134 NILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASH-GTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHE  212 (261)
T ss_pred             eEEEcCCceEEEccccchhhcCCccccccCCCCceEecCHHHHcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHH
Confidence            99999999999999999876543321 122334567999998754 457889999999999999998 899998776555


Q ss_pred             HHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          156 QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                      ....+......+                             ..+..++.+.+++.+||+.||.+|||+.++++
T Consensus       213 ~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         213 VYDQITAGYRMP-----------------------------CPAKCPQEIYKIMLECWAAEPEDRPSFKALRE  256 (261)
T ss_pred             HHHHHHhCCcCC-----------------------------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            555443211111                             11256788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=5.2e-34  Score=237.06  Aligned_cols=192  Identities=22%  Similarity=0.374  Sum_probs=153.5

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ--ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS   77 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~--~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~   77 (280)
                      ++||||+++++++....    ...|+||||++ ++|.+++.+++  .+++..+..++.|++.||+|||++|++||||||+
T Consensus        56 l~~~~i~~~~~~~~~~~----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~  131 (256)
T cd05082          56 LRHSNLVQLLGVIVEEK----GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAAR  131 (256)
T ss_pred             CCCCCeeeEEEEEEcCC----CceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchh
Confidence            57999999999764331    56899999997 69999997644  4899999999999999999999999999999999


Q ss_pred             cEEEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 023609           78 NLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQ  156 (280)
Q Consensus        78 nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~  156 (280)
                      ||+++.++.++|+|||.+.......  .....+..|+|||.+.+ ..++.++|+||+||++|+|++ |..||......+.
T Consensus       132 nil~~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~  208 (256)
T cd05082         132 NVLVSEDNVAKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV  208 (256)
T ss_pred             eEEEcCCCcEEecCCccceeccccC--CCCccceeecCHHHHcc-CCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            9999999999999999987644332  22334567999998854 447889999999999999997 9999976654443


Q ss_pred             HHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          157 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                      ...+.+...                             ....+.+++.+.+++.+||+.+|++|||+.++++
T Consensus       209 ~~~~~~~~~-----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  251 (256)
T cd05082         209 VPRVEKGYK-----------------------------MDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLRE  251 (256)
T ss_pred             HHHHhcCCC-----------------------------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            332211000                             0112357889999999999999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.9e-34  Score=240.37  Aligned_cols=193  Identities=24%  Similarity=0.422  Sum_probs=154.5

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC----------CCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN----------QALSEEHCQYFLYQILRGLKYIHSANV   69 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~----------~~l~~~~~~~i~~qll~al~~LH~~gi   69 (280)
                      ++||||+++++++...     ...|+||||++ |+|.+++...          ..+++..+..++.|++.||.|||+.|+
T Consensus        66 ~~~~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i  140 (277)
T cd05032          66 FNCHHVVRLLGVVSTG-----QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKF  140 (277)
T ss_pred             CCCCceeEEEEEEcCC-----CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence            4799999999998665     67899999997 7999998643          236788999999999999999999999


Q ss_pred             eeccCCCCcEEEccCCCEEEeeccceeeccCCCc---cccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CC
Q 023609           70 LHRDLKPSNLLLNANCDLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RK  145 (280)
Q Consensus        70 ~H~di~~~nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~  145 (280)
                      +|+||+|+||+++.++.++|+|||.++.......   .....++..|+|||.+.+. .++.++|+||+||++|++++ |.
T Consensus       141 ~H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t~g~  219 (277)
T cd05032         141 VHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDG-VFTTKSDVWSFGVVLWEMATLAE  219 (277)
T ss_pred             cccccChheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcC-CCCcccchHHHHHHHHHhhccCC
Confidence            9999999999999999999999999875433321   1223456789999988544 47889999999999999998 89


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHH
Q 023609          146 PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVED  225 (280)
Q Consensus       146 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e  225 (280)
                      .||.+.+.......+.. ...+                            ......+.++.+++.+||+.+|++|||+.+
T Consensus       220 ~p~~~~~~~~~~~~~~~-~~~~----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~  270 (277)
T cd05032         220 QPYQGLSNEEVLKFVID-GGHL----------------------------DLPENCPDKLLELMRMCWQYNPKMRPTFLE  270 (277)
T ss_pred             CCCccCCHHHHHHHHhc-CCCC----------------------------CCCCCCCHHHHHHHHHHcCCChhhCCCHHH
Confidence            99987665554433321 0000                            011245788999999999999999999999


Q ss_pred             Hhc
Q 023609          226 ALA  228 (280)
Q Consensus       226 ll~  228 (280)
                      +++
T Consensus       271 l~~  273 (277)
T cd05032         271 IVS  273 (277)
T ss_pred             HHH
Confidence            976

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=4.8e-34  Score=240.77  Aligned_cols=194  Identities=20%  Similarity=0.393  Sum_probs=153.9

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC-----------------CCCCHHHHHHHHHHHHHHHH
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-----------------QALSEEHCQYFLYQILRGLK   62 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-----------------~~l~~~~~~~i~~qll~al~   62 (280)
                      ++||||+++++++...     ...|+||||++ ++|.+++..+                 ..+++..+..++.|++.||.
T Consensus        64 l~h~niv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~  138 (283)
T cd05090          64 LHHPNIVCLLGVVTQE-----QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGME  138 (283)
T ss_pred             CCCCCeeeEEEEEecC-----CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHH
Confidence            5799999999998665     56899999997 6999998532                 24788999999999999999


Q ss_pred             HHHHCCceeccCCCCcEEEccCCCEEEeeccceeeccCCC---ccccceeccccccchhccCCCCCCcchhHHHHHHHHH
Q 023609           63 YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFM  139 (280)
Q Consensus        63 ~LH~~gi~H~di~~~nili~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~  139 (280)
                      |||++|++|+||||+||+++.++.++|+|||++.......   ......++..|+|||.+.+. .++.++|+||+||+++
T Consensus       139 ~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~il~  217 (283)
T cd05090         139 YLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYG-KFSSDSDIWSFGVVLW  217 (283)
T ss_pred             HHHhcCeehhccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccC-CCCchhhhHHHHHHHH
Confidence            9999999999999999999999999999999987643321   11223345679999988544 4789999999999999


Q ss_pred             HHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCC
Q 023609          140 ELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPR  218 (280)
Q Consensus       140 ~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~  218 (280)
                      +|++ |..||.+.+.......+......                             .....+++.+.+++.+||+.||.
T Consensus       218 el~~~g~~p~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~li~~cl~~~p~  268 (283)
T cd05090         218 EIFSFGLQPYYGFSNQEVIEMVRKRQLL-----------------------------PCSEDCPPRMYSLMTECWQEGPS  268 (283)
T ss_pred             HHHcCCCCCCCCCCHHHHHHHHHcCCcC-----------------------------CCCCCCCHHHHHHHHHHcccCcc
Confidence            9998 88999776544333322211000                             11125678899999999999999


Q ss_pred             CCCCHHHHhcC
Q 023609          219 QRITVEDALAH  229 (280)
Q Consensus       219 ~R~t~~ell~h  229 (280)
                      +||++.+++++
T Consensus       269 ~Rp~~~~i~~~  279 (283)
T cd05090         269 RRPRFKDIHTR  279 (283)
T ss_pred             cCcCHHHHHHH
Confidence            99999998764

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=9.4e-35  Score=242.15  Aligned_cols=193  Identities=28%  Similarity=0.443  Sum_probs=151.4

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS   77 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~   77 (280)
                      ++||||+++++++...     ...++||||+. |+|.+++...  ..++...+..|+.||+.||+|||+.+++|++|+++
T Consensus        58 l~h~ni~~~~g~~~~~-----~~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~  132 (259)
T PF07714_consen   58 LRHPNIVKLYGFCIEN-----EPLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPS  132 (259)
T ss_dssp             HSBTTBE-EEEEEESS-----SSEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGG
T ss_pred             cccccccccccccccc-----ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            4799999999999744     55999999997 7999999876  67999999999999999999999999999999999


Q ss_pred             cEEEccCCCEEEeeccceeeccCCC---ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCh
Q 023609           78 NLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDH  153 (280)
Q Consensus        78 nili~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~  153 (280)
                      ||+++.++.+||+|||.+.......   ..........|+|||.+.... ++.++||||+|++++++++ |..||.+.+.
T Consensus       133 nill~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-~~~ksDVysfG~~l~ei~~~~~~p~~~~~~  211 (259)
T PF07714_consen  133 NILLDSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGE-YTKKSDVYSFGMLLYEILTLGKFPFSDYDN  211 (259)
T ss_dssp             GEEEETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSE-ESHHHHHHHHHHHHHHHHTTSSGTTTTSCH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccc-cccccccccccccccccccccccccccccc
Confidence            9999999999999999998763221   122345677899999885443 7899999999999999999 6799987766


Q ss_pred             HHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          154 VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                      .+....+.+....                             ...+.++..+.++|..||..||.+|||+.++++
T Consensus       212 ~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  212 EEIIEKLKQGQRL-----------------------------PIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             HHHHHHHHTTEET-----------------------------TSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred             ccccccccccccc-----------------------------eeccchhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence            5554444221111                             111257888999999999999999999999874

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=7.3e-34  Score=236.50  Aligned_cols=192  Identities=18%  Similarity=0.294  Sum_probs=152.6

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      |+||||+++++++..      ...++||||++ ++|.+++.. ...+++..++.++.|++.||+|||++|++|+||||+|
T Consensus        52 l~h~~ii~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~n  125 (257)
T cd05115          52 LDNPYIVRMIGVCEA------EALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARN  125 (257)
T ss_pred             cCCCCeEEEEEEEcC------CCeEEEEEeCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchhe
Confidence            579999999998742      45799999997 699999874 4579999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCCCc----cccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCh
Q 023609           79 LLLNANCDLKICDFGLARVTSETDF----MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDH  153 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~  153 (280)
                      |+++.++.++|+|||.+........    .....++..|+|||.+... .++.++|+||+||++|++++ |..||.+...
T Consensus       126 il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~  204 (257)
T cd05115         126 VLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGITMWEAFSYGQKPYKKMKG  204 (257)
T ss_pred             EEEcCCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHccC-CCCchhhHHHHHHHHHHHhcCCCCCcCcCCH
Confidence            9999999999999999875433221    1112234679999987543 47889999999999999996 9999987665


Q ss_pred             HHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          154 VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                      .+....+.+.. .+                            ..-+..++++.++|.+||..||++||++.++.+
T Consensus       205 ~~~~~~~~~~~-~~----------------------------~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~  250 (257)
T cd05115         205 PEVMSFIEQGK-RL----------------------------DCPAECPPEMYALMKDCWIYKWEDRPNFAKVEE  250 (257)
T ss_pred             HHHHHHHHCCC-CC----------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            54433322111 00                            111256789999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=5.2e-34  Score=238.36  Aligned_cols=194  Identities=24%  Similarity=0.392  Sum_probs=155.6

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      ++||||+++++++...     ...++||||+. ++|.+++... +.+++..+..++.|++.||+|||++|++|+||+|+|
T Consensus        62 l~h~~i~~~~~~~~~~-----~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~n  136 (266)
T cd05033          62 FDHPNIIRLEGVVTKS-----RPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARN  136 (266)
T ss_pred             CCCCCcceEeEEEecC-----CceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcce
Confidence            5799999999998654     66899999997 5999998754 479999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCC-Cc--cccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 023609           79 LLLNANCDLKICDFGLARVTSET-DF--MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHV  154 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~-~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~  154 (280)
                      |+++.++.++|+|||.+...... ..  .....++..|+|||.+.+ ..++.++|+||+|+++|+|++ |..||......
T Consensus       137 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~  215 (266)
T cd05033         137 ILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAY-RKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ  215 (266)
T ss_pred             EEEcCCCCEEECccchhhcccccccceeccCCCCCccccChhhhcc-CCCccccchHHHHHHHHHHHccCCCCCCCCCHH
Confidence            99999999999999999865421 11  112233567999998754 447889999999999999997 99999766554


Q ss_pred             HHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 023609          155 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  229 (280)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h  229 (280)
                      .....+.+....+.                             ...++..+.+++.+||+.+|++||++.+++++
T Consensus       216 ~~~~~~~~~~~~~~-----------------------------~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         216 DVIKAVEDGYRLPP-----------------------------PMDCPSALYQLMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             HHHHHHHcCCCCCC-----------------------------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            44433322111111                             12567889999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.6e-34  Score=238.33  Aligned_cols=199  Identities=22%  Similarity=0.343  Sum_probs=155.6

Q ss_pred             CCCCCeeeeeceecCCCC-CCCCcEEEEeecCC-ccHHHHHHcC------CCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q 023609            1 MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMD-TDLHQIIRSN------QALSEEHCQYFLYQILRGLKYIHSANVLHR   72 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~-~~~~~~~iv~e~~~-g~L~~~l~~~------~~l~~~~~~~i~~qll~al~~LH~~gi~H~   72 (280)
                      ++||||+++++++..... .+....++++||+. |+|.+++...      ..+++..+..++.|++.||+|||+.|++||
T Consensus        58 l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~  137 (273)
T cd05035          58 FDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHR  137 (273)
T ss_pred             CCCCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeecc
Confidence            579999999998865432 22345899999997 6999888432      358999999999999999999999999999


Q ss_pred             cCCCCcEEEccCCCEEEeeccceeeccCCCcc---ccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCC
Q 023609           73 DLKPSNLLLNANCDLKICDFGLARVTSETDFM---TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLF  148 (280)
Q Consensus        73 di~~~nili~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf  148 (280)
                      ||||+||+++.++.++|+|||.++........   .....+..|+|||.+. ...++.++|+||+||++|+|++ |..||
T Consensus       138 dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~-~~~~~~~~Dv~SlG~il~el~~~g~~p~  216 (273)
T cd05035         138 DLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLA-DRVYTSKSDVWAFGVTMWEIATRGQTPY  216 (273)
T ss_pred             ccchheEEECCCCeEEECCccceeeccccccccccccccCCccccCHhhcc-cCCCCcccchHHHHHHHHHHHhCCCCCC
Confidence            99999999999999999999998765433211   1123456799999874 4457899999999999999998 88999


Q ss_pred             CCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          149 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                      .+....+....+.....                             ......++..+.+++.+||+.||.+|||+.+++.
T Consensus       217 ~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~  267 (273)
T cd05035         217 PGVENHEIYDYLRHGNR-----------------------------LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLRE  267 (273)
T ss_pred             CCCCHHHHHHHHHcCCC-----------------------------CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            87665544333321110                             0111356788999999999999999999999986


Q ss_pred             C
Q 023609          229 H  229 (280)
Q Consensus       229 h  229 (280)
                      +
T Consensus       268 ~  268 (273)
T cd05035         268 V  268 (273)
T ss_pred             H
Confidence            3

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.3e-34  Score=235.79  Aligned_cols=191  Identities=24%  Similarity=0.388  Sum_probs=155.0

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ--ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS   77 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~--~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~   77 (280)
                      ++||||+++++++...     ...++||||++ ++|.+++....  .+++..++.++.|++.||.|||+.|++|+||+|+
T Consensus        57 l~~~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~  131 (256)
T cd05039          57 LRHPNLVQLLGVVLQG-----NPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAAR  131 (256)
T ss_pred             cCCcceeeeEEEEcCC-----CCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccc
Confidence            5799999999998664     67899999998 69999998665  6999999999999999999999999999999999


Q ss_pred             cEEEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 023609           78 NLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQ  156 (280)
Q Consensus        78 nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~  156 (280)
                      ||+++.++.++|+|||.+........  ....+..|+|||.+.. ..++.++|+||+|++++++++ |..||......+.
T Consensus       132 Nili~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~ape~~~~-~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~  208 (256)
T cd05039         132 NVLVSEDLVAKVSDFGLAKEASQGQD--SGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV  208 (256)
T ss_pred             eEEEeCCCCEEEcccccccccccccc--cCCCcccccCchhhcC-CcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence            99999999999999999876643322  2334567999998854 457889999999999999997 9999976654443


Q ss_pred             HHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          157 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                      ...+.... .                            ......+++.+.++|.+||..+|.+|||+.+++.
T Consensus       209 ~~~~~~~~-~----------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  251 (256)
T cd05039         209 VPHVEKGY-R----------------------------MEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLRE  251 (256)
T ss_pred             HHHHhcCC-C----------------------------CCCccCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence            22221100 0                            0111246788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=5.4e-34  Score=246.32  Aligned_cols=195  Identities=25%  Similarity=0.407  Sum_probs=152.1

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC--------------------------------------
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--------------------------------------   42 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~--------------------------------------   42 (280)
                      +||||+++++++....    ..++++|||+. ++|.+++...                                      
T Consensus        69 ~h~niv~~~~~~~~~~----~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  144 (337)
T cd05054          69 HHLNVVNLLGACTKPG----GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSAS  144 (337)
T ss_pred             cCcchhheeeeEecCC----CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccc
Confidence            6999999999885442    56899999997 6999988542                                      


Q ss_pred             -----------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCCEEEeeccceeecc
Q 023609           43 -----------------------QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS   99 (280)
Q Consensus        43 -----------------------~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nili~~~~~~~l~dfg~~~~~~   99 (280)
                                             .++++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||++....
T Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~  224 (337)
T cd05054         145 SGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIY  224 (337)
T ss_pred             cccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcc
Confidence                                   258899999999999999999999999999999999999999999999999997643


Q ss_pred             CCC---ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhHh
Q 023609          100 ETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFL  175 (280)
Q Consensus       100 ~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  175 (280)
                      ...   ......++..|+|||.+.+. .++.++||||+||++++|++ |..||.+....+...........+        
T Consensus       225 ~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~--------  295 (337)
T cd05054         225 KDPDYVRKGDARLPLKWMAPESIFDK-VYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRM--------  295 (337)
T ss_pred             cCcchhhccCCCCCccccCcHHhcCC-CCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCC--------
Confidence            221   11123445679999988554 48899999999999999997 999997654333222211110000        


Q ss_pred             hHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 023609          176 NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  229 (280)
Q Consensus       176 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h  229 (280)
                                          ..-...++++.+++.+||+.+|.+||++.++++|
T Consensus       296 --------------------~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~  329 (337)
T cd05054         296 --------------------RAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI  329 (337)
T ss_pred             --------------------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                                0012457889999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=5e-35  Score=264.18  Aligned_cols=195  Identities=25%  Similarity=0.423  Sum_probs=152.5

Q ss_pred             CCCeeeeece-ecCCCCCC-CCcEEEEeecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCC
Q 023609            3 HENVVAIRDI-IPPPQRES-FNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSAN--VLHRDLK   75 (280)
Q Consensus         3 HpnIv~~~~~-~~~~~~~~-~~~~~iv~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~g--i~H~di~   75 (280)
                      |||||.++|. .......+ ...++|.||||. |+|-|++.++  ..|++.++.+|++|+++||++||...  |+|||||
T Consensus        94 h~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLK  173 (738)
T KOG1989|consen   94 HKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLK  173 (738)
T ss_pred             CCceeeEeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhh
Confidence            9999999994 33322222 356899999998 6999999843  45999999999999999999999998  9999999


Q ss_pred             CCcEEEccCCCEEEeeccceeeccCCCc----------cccceeccccccchhcc--CCCCCCcchhHHHHHHHHHHHHh
Q 023609           76 PSNLLLNANCDLKICDFGLARVTSETDF----------MTEYVVTRWYRAPELLL--NSSDYTAAIDVWSVGCIFMELMD  143 (280)
Q Consensus        76 ~~nili~~~~~~~l~dfg~~~~~~~~~~----------~~~~~~~~~y~aPE~~~--~~~~~~~~~DiwslG~il~~ll~  143 (280)
                      -+|||++.+|..||||||.+........          .-....|+.|+|||.+.  .+...+.++|||||||++|.|+.
T Consensus       174 iENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy  253 (738)
T KOG1989|consen  174 IENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCY  253 (738)
T ss_pred             hhheEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHH
Confidence            9999999999999999999864322210          01234589999999974  33456899999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCH
Q 023609          144 RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV  223 (280)
Q Consensus       144 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~  223 (280)
                      ...||.......++.-                       ....         ..+|.++..+.+||+.||+.||.+||++
T Consensus       254 ~t~PFe~sg~laIlng-----------------------~Y~~---------P~~p~ys~~l~~LI~~mL~~nP~~RPnI  301 (738)
T KOG1989|consen  254 FTTPFEESGKLAILNG-----------------------NYSF---------PPFPNYSDRLKDLIRTMLQPNPDERPNI  301 (738)
T ss_pred             hCCCcCcCcceeEEec-----------------------cccC---------CCCccHHHHHHHHHHHHhccCcccCCCH
Confidence            9999975432211110                       0011         1125788899999999999999999999


Q ss_pred             HHHhcC
Q 023609          224 EDALAH  229 (280)
Q Consensus       224 ~ell~h  229 (280)
                      -+++.+
T Consensus       302 ~Qv~~~  307 (738)
T KOG1989|consen  302 YQVLEE  307 (738)
T ss_pred             HHHHHH
Confidence            888863

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=5.7e-34  Score=239.63  Aligned_cols=199  Identities=26%  Similarity=0.436  Sum_probs=161.7

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++.+...     ...|+||||++ ++|.+++.. ..+++..+..++.|++.|+.+||+.|++|+||+|+||
T Consensus        59 l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni  132 (277)
T cd06641          59 CDSPYVTKYYGSYLKD-----TKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANV  132 (277)
T ss_pred             cCCCCEeEEEEEEEeC-----CeEEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhE
Confidence            5799999999999665     67999999998 589888864 5699999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCCc-cccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSETDF-MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  158 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.++.++++|||.+........ .....++..|+|||.+.+ ...+.++|+||+||++++|++|..||.+........
T Consensus       133 ~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~  211 (277)
T cd06641         133 LLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLF  211 (277)
T ss_pred             EECCCCCEEEeecccceecccchhhhccccCCccccChhhhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHH
Confidence            999999999999999876543321 223456788999998854 347889999999999999999999997654433322


Q ss_pred             HHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCC
Q 023609          159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  235 (280)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~  235 (280)
                      .+... ..                            ......++.++.+++.+||+.+|.+||++.++++||||...
T Consensus       212 ~~~~~-~~----------------------------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~  259 (277)
T cd06641         212 LIPKN-NP----------------------------PTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRF  259 (277)
T ss_pred             HHhcC-CC----------------------------CCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhh
Confidence            22110 00                            01113567889999999999999999999999999999875

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=7.1e-34  Score=240.59  Aligned_cols=193  Identities=26%  Similarity=0.402  Sum_probs=152.8

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC------------------------CCCCHHHHHHHHH
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN------------------------QALSEEHCQYFLY   55 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~------------------------~~l~~~~~~~i~~   55 (280)
                      ++||||+++++.+...     ...++|+||+. ++|.+++...                        ..+++..+..++.
T Consensus        60 l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~  134 (290)
T cd05045          60 VNHPHVIKLYGACSQD-----GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAW  134 (290)
T ss_pred             CCCCCEeeEEEEEecC-----CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHH
Confidence            5799999999998654     56899999998 6999988642                        2478899999999


Q ss_pred             HHHHHHHHHHHCCceeccCCCCcEEEccCCCEEEeeccceeeccCCCc---cccceeccccccchhccCCCCCCcchhHH
Q 023609           56 QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNSSDYTAAIDVW  132 (280)
Q Consensus        56 qll~al~~LH~~gi~H~di~~~nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Diw  132 (280)
                      |++.||+|||+.|++||||+|+||+++.++.++|+|||.+........   .....++..|+|||.+.+ ..++.++|||
T Consensus       135 ~i~~~l~~LH~~~ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~  213 (290)
T cd05045         135 QISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD-HIYTTQSDVW  213 (290)
T ss_pred             HHHHHHHHHHHCCeehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHcc-CCcchHhHHH
Confidence            999999999999999999999999999999999999999875432211   122334567999998754 4478999999


Q ss_pred             HHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHH
Q 023609          133 SVGCIFMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEK  211 (280)
Q Consensus       133 slG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  211 (280)
                      |+|+++++|++ |..||.+...........+....                             ..-..++.++++++.+
T Consensus       214 slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~i~~  264 (290)
T cd05045         214 SFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGYRM-----------------------------ERPENCSEEMYNLMLT  264 (290)
T ss_pred             HHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCC-----------------------------CCCCCCCHHHHHHHHH
Confidence            99999999998 99999776544433322111100                             0012567899999999


Q ss_pred             hhcCCCCCCCCHHHHhc
Q 023609          212 MLTFDPRQRITVEDALA  228 (280)
Q Consensus       212 ~L~~dp~~R~t~~ell~  228 (280)
                      ||+.+|.+||++.++++
T Consensus       265 cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         265 CWKQEPDKRPTFADISK  281 (290)
T ss_pred             HccCCcccCCCHHHHHH
Confidence            99999999999999875

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=9.7e-34  Score=242.50  Aligned_cols=192  Identities=28%  Similarity=0.453  Sum_probs=153.4

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC----------------CCCCHHHHHHHHHHHHHHHHHH
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN----------------QALSEEHCQYFLYQILRGLKYI   64 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~----------------~~l~~~~~~~i~~qll~al~~L   64 (280)
                      +||||+++++++...     ...|+||||+. |+|.+++...                ..+++..+..++.||+.||.||
T Consensus        76 ~h~~iv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~l  150 (314)
T cd05099          76 KHKNIINLLGVCTQE-----GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYL  150 (314)
T ss_pred             CCCCeeeEEEEEccC-----CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHH
Confidence            599999999998654     56899999997 6999999653                3488899999999999999999


Q ss_pred             HHCCceeccCCCCcEEEccCCCEEEeeccceeeccCCCc---cccceeccccccchhccCCCCCCcchhHHHHHHHHHHH
Q 023609           65 HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL  141 (280)
Q Consensus        65 H~~gi~H~di~~~nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l  141 (280)
                      |++|++|+||||+||+++.++.++|+|||.++.......   .....++..|+|||.+.+ ..++.++|+||+|+++|+|
T Consensus       151 H~~gi~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DiwslG~~l~el  229 (314)
T cd05099         151 ESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFD-RVYTHQSDVWSFGILMWEI  229 (314)
T ss_pred             HHCCeeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHcc-CCcCccchhhHHHHHHHHH
Confidence            999999999999999999999999999999975543211   112233457999998854 4578899999999999999


Q ss_pred             Hh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCC
Q 023609          142 MD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQR  220 (280)
Q Consensus       142 l~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R  220 (280)
                      ++ |..||.+....+....+.....                             ......++.++++++.+||..||++|
T Consensus       230 ~~~g~~p~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~l~~li~~cl~~~p~~R  280 (314)
T cd05099         230 FTLGGSPYPGIPVEELFKLLREGHR-----------------------------MDKPSNCTHELYMLMRECWHAVPTQR  280 (314)
T ss_pred             HhCCCCCCCCCCHHHHHHHHHcCCC-----------------------------CCCCCCCCHHHHHHHHHHcCCCcccC
Confidence            98 8899977665544433321100                             01113567789999999999999999


Q ss_pred             CCHHHHhc
Q 023609          221 ITVEDALA  228 (280)
Q Consensus       221 ~t~~ell~  228 (280)
                      ||+.++++
T Consensus       281 ps~~~ll~  288 (314)
T cd05099         281 PTFKQLVE  288 (314)
T ss_pred             cCHHHHHH
Confidence            99999886

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=5e-34  Score=244.49  Aligned_cols=193  Identities=23%  Similarity=0.319  Sum_probs=153.2

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      ++||||+++++++...      ..++|++|+. |+|.+++.++ ..+++..+..++.||+.||+|||+.|++||||||+|
T Consensus        66 l~h~niv~~~g~~~~~------~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~N  139 (316)
T cd05108          66 VDNPHVCRLLGICLTS------TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARN  139 (316)
T ss_pred             CCCCCCCeEEEEEcCC------CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhh
Confidence            5899999999998643      3679999987 7999999864 468999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCCCcc---ccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 023609           79 LLLNANCDLKICDFGLARVTSETDFM---TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHV  154 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~  154 (280)
                      |+++.++.++|+|||+++........   .....+..|++||.+.+ ..++.++||||+||++|+|++ |..||.+....
T Consensus       140 ill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~-~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~  218 (316)
T cd05108         140 VLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS  218 (316)
T ss_pred             eEecCCCcEEEccccccccccCCCcceeccCCccceeecChHHhcc-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH
Confidence            99999999999999999865433211   12233567999998854 457899999999999999987 99999776544


Q ss_pred             HHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 023609          155 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  229 (280)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h  229 (280)
                      +... +......+                            ...+..+.++.+++.+||..||.+|||+.+++.+
T Consensus       219 ~~~~-~~~~~~~~----------------------------~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         219 EISS-ILEKGERL----------------------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             HHHH-HHhCCCCC----------------------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            3322 11111010                            0112456789999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=9e-34  Score=241.43  Aligned_cols=193  Identities=27%  Similarity=0.402  Sum_probs=153.3

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ--ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~--~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      +||||+++++++...     +..|+||||+. |+|.+++....  .+++.++..++.|++.||+|||+.|++|+||||+|
T Consensus        97 ~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~N  171 (302)
T cd05055          97 NHENIVNLLGACTIG-----GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARN  171 (302)
T ss_pred             CCCCcceEEEEEecC-----CceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccce
Confidence            699999999998665     56899999997 69999997543  38999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCCCc---cccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 023609           79 LLLNANCDLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHV  154 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~  154 (280)
                      |+++.++.++++|||.+........   .....++..|+|||.+.+. .++.++||||+||++|+|++ |..||.+....
T Consensus       172 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DiwslGvil~el~t~g~~p~~~~~~~  250 (302)
T cd05055         172 VLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGILLWEIFSLGSNPYPGMPVD  250 (302)
T ss_pred             EEEcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccC-CCCcHhHHHHHHHHHHHHHhCCCCCcCCCCch
Confidence            9999999999999999875443221   1122346779999988544 47889999999999999998 99999766544


Q ss_pred             HHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          155 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                      ............+                            ......++++.+++.+||..+|.+|||+.+++.
T Consensus       251 ~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         251 SKFYKLIKEGYRM----------------------------AQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             HHHHHHHHcCCcC----------------------------CCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            3322221110000                            011245788999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=9.8e-34  Score=240.26  Aligned_cols=200  Identities=24%  Similarity=0.366  Sum_probs=156.9

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCC-----------CCCHHHHHHHHHHHHHHHHHHHHCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ-----------ALSEEHCQYFLYQILRGLKYIHSAN   68 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~-----------~l~~~~~~~i~~qll~al~~LH~~g   68 (280)
                      ++||||+++++++...     ...+++||++. ++|.+++....           .+++..++.++.|++.||+|||+.|
T Consensus        76 l~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~  150 (296)
T cd05051          76 LSDPNIARLLGVCTVD-----PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN  150 (296)
T ss_pred             cCCCCEeEEEEEEecC-----CCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC
Confidence            5899999999999665     67899999997 69999997655           6899999999999999999999999


Q ss_pred             ceeccCCCCcEEEccCCCEEEeeccceeeccCCC---ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh--
Q 023609           69 VLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD--  143 (280)
Q Consensus        69 i~H~di~~~nili~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~--  143 (280)
                      ++|+||||+||+++.++.++|+|||.+.......   ......++..|+|||.+.+. .++.++||||+||++|+|++  
T Consensus       151 i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~el~~~~  229 (296)
T cd05051         151 FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLG-KFTTKSDVWAFGVTLWEILTLC  229 (296)
T ss_pred             ccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcC-CCCccchhhhhHHHHHHHHhcC
Confidence            9999999999999999999999999987543322   11233456789999988543 47899999999999999987  


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCH
Q 023609          144 RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV  223 (280)
Q Consensus       144 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~  223 (280)
                      +..||...+..+.+...........                      ........+.++.++.+++.+||+.||.+|||+
T Consensus       230 ~~~p~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~  287 (296)
T cd05051         230 REQPYEHLTDQQVIENAGHFFRDDG----------------------RQIYLPRPPNCPKDIYELMLECWRRDEEDRPTF  287 (296)
T ss_pred             CCCCCCCcChHHHHHHHHhcccccc----------------------ccccCCCccCCCHHHHHHHHHHhccChhcCCCH
Confidence            6778876665554444332211100                      000011123567899999999999999999999


Q ss_pred             HHHhc
Q 023609          224 EDALA  228 (280)
Q Consensus       224 ~ell~  228 (280)
                      .+++.
T Consensus       288 ~el~~  292 (296)
T cd05051         288 REIHL  292 (296)
T ss_pred             HHHHH
Confidence            99964

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=1.4e-33  Score=237.57  Aligned_cols=192  Identities=24%  Similarity=0.348  Sum_probs=151.9

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      ++||||+++++++..      ...++++||+. |+|.+++.. .+.+++..+..++.||+.||+|||+.|++|+||||+|
T Consensus        66 l~h~~iv~~~~~~~~------~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~n  139 (279)
T cd05111          66 LDHAYIVRLLGICPG------ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARN  139 (279)
T ss_pred             CCCCCcceEEEEECC------CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcce
Confidence            479999999998743      34688999987 799999975 4579999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCCC---ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 023609           79 LLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHV  154 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~  154 (280)
                      |+++.++.++|+|||.++......   ......++..|++||.+.+ ..++.++|+||+||++|++++ |..||.+....
T Consensus       140 ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~  218 (279)
T cd05111         140 ILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILF-GRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH  218 (279)
T ss_pred             EEEcCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhcc-CCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence            999999999999999997653321   1123345668999998854 447899999999999999998 99999876544


Q ss_pred             HHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          155 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                      .....+ .....+.                            .....+.++.+++.+||..||++|||+.|+++
T Consensus       219 ~~~~~~-~~~~~~~----------------------------~~~~~~~~~~~li~~c~~~~p~~Rps~~el~~  263 (279)
T cd05111         219 EVPDLL-EKGERLA----------------------------QPQICTIDVYMVMVKCWMIDENVRPTFKELAN  263 (279)
T ss_pred             HHHHHH-HCCCcCC----------------------------CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            332222 1110000                            00134567899999999999999999999876

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=9.8e-34  Score=237.11  Aligned_cols=198  Identities=23%  Similarity=0.335  Sum_probs=151.2

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCC-----CCCHHHHHHHHHHHHHHHHHHHHCCceeccC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ-----ALSEEHCQYFLYQILRGLKYIHSANVLHRDL   74 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~-----~l~~~~~~~i~~qll~al~~LH~~gi~H~di   74 (280)
                      ++||||+++++.+...     ...|+||||++ |+|.+++....     ..++..+..++.||+.||+|||++|++||||
T Consensus        52 l~h~nii~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dl  126 (269)
T cd05042          52 LNHPNVLQCLGQCIES-----IPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDL  126 (269)
T ss_pred             CCCCCcceEEEEECCC-----CceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccc
Confidence            5799999999998665     66899999997 69999997543     2467888999999999999999999999999


Q ss_pred             CCCcEEEccCCCEEEeeccceeeccCCCc---cccceeccccccchhccC------CCCCCcchhHHHHHHHHHHHHh-C
Q 023609           75 KPSNLLLNANCDLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLN------SSDYTAAIDVWSVGCIFMELMD-R  144 (280)
Q Consensus        75 ~~~nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~------~~~~~~~~DiwslG~il~~ll~-g  144 (280)
                      ||+||+++.++.++|+|||++........   .....++..|+|||++..      ...++.++|+||+||++|+|++ |
T Consensus       127 kp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~  206 (269)
T cd05042         127 ALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAA  206 (269)
T ss_pred             cHhheEecCCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCC
Confidence            99999999999999999999864322211   122334567999998642      2245789999999999999998 7


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHH
Q 023609          145 KPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVE  224 (280)
Q Consensus       145 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~  224 (280)
                      ..||......+....+.........                     .   ......++..+.+++..|+ .||.+|||++
T Consensus       207 ~~p~~~~~~~~~~~~~~~~~~~~~~---------------------~---~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~  261 (269)
T cd05042         207 DQPYPDLSDEQVLKQVVREQDIKLP---------------------K---PQLDLKYSDRWYEVMQFCW-LDPETRPTAE  261 (269)
T ss_pred             CCCCCcCCHHHHHHHHhhccCccCC---------------------C---CcccccCCHHHHHHHHHHh-cCcccccCHH
Confidence            8888776655544433222111000                     0   0112356788899999998 5999999999


Q ss_pred             HHhc
Q 023609          225 DALA  228 (280)
Q Consensus       225 ell~  228 (280)
                      ++++
T Consensus       262 ~v~~  265 (269)
T cd05042         262 EVHE  265 (269)
T ss_pred             HHHH
Confidence            9876

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1e-33  Score=241.24  Aligned_cols=193  Identities=26%  Similarity=0.438  Sum_probs=154.5

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC----------------CCCCHHHHHHHHHHHHHHHHHH
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN----------------QALSEEHCQYFLYQILRGLKYI   64 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~----------------~~l~~~~~~~i~~qll~al~~L   64 (280)
                      +||||+++++++...     ...|+||||+. |+|.+++.+.                ..++...+..++.||+.||.||
T Consensus        79 ~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~L  153 (304)
T cd05101          79 KHKNIINLLGACTQD-----GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL  153 (304)
T ss_pred             cCCCchheeEEEecC-----CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHH
Confidence            699999999998665     67899999997 6999999753                2477888999999999999999


Q ss_pred             HHCCceeccCCCCcEEEccCCCEEEeeccceeeccCCCc---cccceeccccccchhccCCCCCCcchhHHHHHHHHHHH
Q 023609           65 HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL  141 (280)
Q Consensus        65 H~~gi~H~di~~~nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l  141 (280)
                      |+.|++||||||+||+++.++.++|+|||.+........   .....++..|+|||++.+. .++.++||||+|+++|+|
T Consensus       154 H~~givH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el  232 (304)
T cd05101         154 ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEI  232 (304)
T ss_pred             HHCCeeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccC-CCCchhhHHHHHHHHHHH
Confidence            999999999999999999999999999999876543221   1223445679999988544 478899999999999999


Q ss_pred             Hh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCC
Q 023609          142 MD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQR  220 (280)
Q Consensus       142 l~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R  220 (280)
                      ++ |..||.+.+..+....+......                             ......+.++++++.+||..+|.+|
T Consensus       233 ~~~g~~p~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~li~~cl~~~p~~R  283 (304)
T cd05101         233 FTLGGSPYPGIPVEELFKLLKEGHRM-----------------------------DKPANCTNELYMMMRDCWHAIPSHR  283 (304)
T ss_pred             HcCCCCCcccCCHHHHHHHHHcCCcC-----------------------------CCCCCCCHHHHHHHHHHcccChhhC
Confidence            98 78888776655544433211000                             0112567899999999999999999


Q ss_pred             CCHHHHhcC
Q 023609          221 ITVEDALAH  229 (280)
Q Consensus       221 ~t~~ell~h  229 (280)
                      ||+.++++.
T Consensus       284 ps~~e~l~~  292 (304)
T cd05101         284 PTFKQLVED  292 (304)
T ss_pred             CCHHHHHHH
Confidence            999999874

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=5.2e-34  Score=241.13  Aligned_cols=204  Identities=20%  Similarity=0.364  Sum_probs=159.5

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nil   80 (280)
                      +||||+++++.+...     ...|+||||+. |+|.+++..++.+++..++.++.|++.||.|||+.|++|+||+|.||+
T Consensus        63 ~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil  137 (288)
T cd05583          63 RCPFLVTLHYAFQTD-----TKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENIL  137 (288)
T ss_pred             CCcchhhhheeeecC-----CEEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeE
Confidence            599999999998655     67899999997 599999987788999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccceeeccCCCc--cccceeccccccchhccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 023609           81 LNANCDLKICDFGLARVTSETDF--MTEYVVTRWYRAPELLLNSS-DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL  157 (280)
Q Consensus        81 i~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  157 (280)
                      ++.++.++|+|||++........  .....++..|++||.+.+.. ..+.++|+||+|+++++|++|..||.........
T Consensus       138 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~  217 (288)
T cd05583         138 LDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQ  217 (288)
T ss_pred             ECCCCCEEEEECccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchH
Confidence            99999999999999875433221  12235788899999875432 2578999999999999999999999643321111


Q ss_pred             HHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCC---HHHHhcCCCCCC
Q 023609          158 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT---VEDALAHPYLGS  234 (280)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t---~~ell~h~~~~~  234 (280)
                      ..+.+..                  ....        ....+.++..+.++|.+||+.||++|||   +.++++||||++
T Consensus       218 ~~~~~~~------------------~~~~--------~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~  271 (288)
T cd05583         218 SEISRRI------------------LKSK--------PPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQG  271 (288)
T ss_pred             HHHHHHH------------------HccC--------CCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCccccc
Confidence            1111100                  0000        0111246788999999999999999998   567899999988


Q ss_pred             Cc
Q 023609          235 LH  236 (280)
Q Consensus       235 ~~  236 (280)
                      +.
T Consensus       272 ~~  273 (288)
T cd05583         272 ID  273 (288)
T ss_pred             CC
Confidence            63

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.6e-33  Score=237.14  Aligned_cols=192  Identities=24%  Similarity=0.313  Sum_probs=152.6

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      ++||||+++++++...      ..+++++|++ |+|.+++..+ +.+++.++..++.|++.||+|||+.|++||||||+|
T Consensus        66 ~~~~~i~~~~~~~~~~------~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~N  139 (279)
T cd05109          66 VGSPYVCRLLGICLTS------TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARN  139 (279)
T ss_pred             cCCCCCceEEEEEcCC------CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccce
Confidence            4799999999998543      4689999997 7999999764 569999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCCCc---cccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 023609           79 LLLNANCDLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHV  154 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~  154 (280)
                      |+++.++.++|+|||+++.......   .....++..|+|||...+. .++.++||||+||++|+|++ |..||.+....
T Consensus       140 il~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~  218 (279)
T cd05109         140 VLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHR-RFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR  218 (279)
T ss_pred             EEEcCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence            9999999999999999886543321   1122345679999988544 47889999999999999998 88998765543


Q ss_pred             HHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          155 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                      .....+.. ...+                            ...+..+.++.+++.+||+.||++|||+.+++.
T Consensus       219 ~~~~~~~~-~~~~----------------------------~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         219 EIPDLLEK-GERL----------------------------PQPPICTIDVYMIMVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             HHHHHHHC-CCcC----------------------------CCCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            33222211 1110                            011356788999999999999999999999985

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=2e-33  Score=232.58  Aligned_cols=193  Identities=23%  Similarity=0.390  Sum_probs=154.0

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      ++||||+++++++...     ...++||||++ ++|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+|
T Consensus        49 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~n  123 (250)
T cd05085          49 YDHPNIVKLIGVCTQR-----QPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARN  123 (250)
T ss_pred             CCCCCcCeEEEEEecC-----CccEEEEECCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChhe
Confidence            5799999999998655     56899999997 6999998753 468999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCCCcc--ccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 023609           79 LLLNANCDLKICDFGLARVTSETDFM--TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVH  155 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~  155 (280)
                      |+++.++.++|+|||.+.........  .....+..|+|||.+.+ ..++.++|+||+|+++|++++ |..||.+.....
T Consensus       124 ili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~  202 (250)
T cd05085         124 CLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNY-GRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ  202 (250)
T ss_pred             EEEcCCCeEEECCCccceeccccccccCCCCCCcccccCHHHhcc-CCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHH
Confidence            99999999999999998754332211  11233567999998844 457889999999999999998 899997765544


Q ss_pred             HHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          156 QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                      ....+......                             ...+.++.++.+++.+||+.+|.+|||+.++++
T Consensus       203 ~~~~~~~~~~~-----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  246 (250)
T cd05085         203 AREQVEKGYRM-----------------------------SCPQKCPDDVYKVMQRCWDYKPENRPKFSELQK  246 (250)
T ss_pred             HHHHHHcCCCC-----------------------------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            33322211000                             111256789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=9.9e-34  Score=241.67  Aligned_cols=193  Identities=27%  Similarity=0.440  Sum_probs=153.1

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCC----------------CCCHHHHHHHHHHHHHHHHHH
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ----------------ALSEEHCQYFLYQILRGLKYI   64 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~----------------~l~~~~~~~i~~qll~al~~L   64 (280)
                      +||||+++++++...     ...|+||||++ |+|.+++...+                .++..++..++.|++.||+||
T Consensus        82 ~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~l  156 (307)
T cd05098          82 KHKNIINLLGACTQD-----GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL  156 (307)
T ss_pred             CCCCEeeEEEEEecC-----CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHH
Confidence            699999999999655     67899999997 69999997542                488899999999999999999


Q ss_pred             HHCCceeccCCCCcEEEccCCCEEEeeccceeeccCCCc---cccceeccccccchhccCCCCCCcchhHHHHHHHHHHH
Q 023609           65 HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL  141 (280)
Q Consensus        65 H~~gi~H~di~~~nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l  141 (280)
                      |++|++||||||+||+++.++.++|+|||.+........   .....++..|+|||.+.+. .++.++|+||+||++|+|
T Consensus       157 H~~gi~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~~l~el  235 (307)
T cd05098         157 ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEI  235 (307)
T ss_pred             HHCCcccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccC-CCCcHHHHHHHHHHHHHH
Confidence            999999999999999999999999999999875433211   1112334679999988544 478899999999999999


Q ss_pred             Hh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCC
Q 023609          142 MD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQR  220 (280)
Q Consensus       142 l~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R  220 (280)
                      ++ |..||.+....+....+.... .                            .......+.++.+++.+||..+|.+|
T Consensus       236 ~~~g~~p~~~~~~~~~~~~~~~~~-~----------------------------~~~~~~~~~~~~~li~~~l~~~p~~R  286 (307)
T cd05098         236 FTLGGSPYPGVPVEELFKLLKEGH-R----------------------------MDKPSNCTNELYMMMRDCWHAVPSQR  286 (307)
T ss_pred             HcCCCCCCCcCCHHHHHHHHHcCC-C----------------------------CCCCCcCCHHHHHHHHHHcccChhhC
Confidence            98 888987665444333222110 0                            01112567899999999999999999


Q ss_pred             CCHHHHhcC
Q 023609          221 ITVEDALAH  229 (280)
Q Consensus       221 ~t~~ell~h  229 (280)
                      ||+.+++++
T Consensus       287 ps~~evl~~  295 (307)
T cd05098         287 PTFKQLVED  295 (307)
T ss_pred             cCHHHHHHH
Confidence            999999863

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1.7e-33  Score=233.98  Aligned_cols=193  Identities=23%  Similarity=0.365  Sum_probs=155.8

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ--ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS   77 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~--~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~   77 (280)
                      ++||||+++++++..      ...++||||++ ++|.+++.++.  .+++..++.++.|++.||+|||+.|++|+||+|+
T Consensus        53 l~h~~iv~~~~~~~~------~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~  126 (257)
T cd05040          53 LDHENLIRLYGVVLT------HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAAR  126 (257)
T ss_pred             cCCCCccceeEEEcC------CeEEEEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcc
Confidence            579999999999854      46899999996 79999998754  6899999999999999999999999999999999


Q ss_pred             cEEEccCCCEEEeeccceeeccCCC----ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 023609           78 NLLLNANCDLKICDFGLARVTSETD----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRD  152 (280)
Q Consensus        78 nili~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~  152 (280)
                      ||+++.++.++|+|||.+.......    ......++..|+|||.+.+ ..++.++|+||+||++++|++ |..||.+.+
T Consensus       127 nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~  205 (257)
T cd05040         127 NILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRT-RTFSHASDVWMFGVTLWEMFTYGEEPWAGLS  205 (257)
T ss_pred             cEEEecCCEEEeccccccccccccccceecccCCCCCceecCHHHhcc-cCcCchhhhHHHHHHHHHHHhCCCCCCCCCC
Confidence            9999999999999999987654321    1112345678999998754 347889999999999999998 999997776


Q ss_pred             hHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          153 HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                      ..+....+.......                            .....++..+.+++.+||+.+|++|||+.++++
T Consensus       206 ~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         206 GSQILKKIDKEGERL----------------------------ERPEACPQDIYNVMLQCWAHNPADRPTFAALRE  253 (257)
T ss_pred             HHHHHHHHHhcCCcC----------------------------CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence            655544443211000                            001245788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-33  Score=234.46  Aligned_cols=193  Identities=27%  Similarity=0.429  Sum_probs=156.3

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ--ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS   77 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~--~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~   77 (280)
                      ++||||+++++++...     ...++||||++ ++|.+++.+..  .+++..+..++.|++.|+.|||++|++|+||+|+
T Consensus        58 l~h~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~  132 (261)
T cd05034          58 LRHDKLVQLYAVCSEE-----EPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAAR  132 (261)
T ss_pred             CCCCCEeeeeeeeecC-----CceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchh
Confidence            5799999999998654     56899999997 59999997643  6999999999999999999999999999999999


Q ss_pred             cEEEccCCCEEEeeccceeeccCCCc--cccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 023609           78 NLLLNANCDLKICDFGLARVTSETDF--MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHV  154 (280)
Q Consensus        78 nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~  154 (280)
                      ||+++.++.++|+|||.+........  ......+..|+|||.+.+ ...+.++|+||+|++++++++ |..||.+....
T Consensus       133 nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~  211 (261)
T cd05034         133 NILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANY-GRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR  211 (261)
T ss_pred             eEEEcCCCCEEECccccceeccchhhhhhhccCCCccccCHHHhcc-CCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999999876543211  112233567999998854 447889999999999999998 99999877665


Q ss_pred             HHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          155 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                      .....+......+.                             ....+.++.+++.+||+.+|.+||++.++++
T Consensus       212 ~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         212 EVLEQVERGYRMPR-----------------------------PPNCPEELYDLMLQCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             HHHHHHHcCCCCCC-----------------------------CCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            55554432211111                             1245778999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=2.1e-33  Score=234.39  Aligned_cols=192  Identities=27%  Similarity=0.417  Sum_probs=153.4

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS   77 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~   77 (280)
                      ++||||+++++.+..      ...|+||||++ |+|.+++.+.  ..+++..+..++.|++.||++||+.|++|+||+|+
T Consensus        58 l~~~~i~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~  131 (262)
T cd05071          58 LRHEKLVQLYAVVSE------EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAA  131 (262)
T ss_pred             CCCCCcceEEEEECC------CCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcc
Confidence            579999999998743      34799999998 6999999753  35899999999999999999999999999999999


Q ss_pred             cEEEccCCCEEEeeccceeeccCCCcc--ccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 023609           78 NLLLNANCDLKICDFGLARVTSETDFM--TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHV  154 (280)
Q Consensus        78 nili~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~  154 (280)
                      ||+++.++.++|+|||.+.........  ....++..|+|||...+ ..++.++|+||+||++|+|++ |..||.+....
T Consensus       132 Nill~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~  210 (262)
T cd05071         132 NILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR  210 (262)
T ss_pred             cEEEcCCCcEEeccCCceeeccccccccccCCcccceecCHhHhcc-CCCCchhhHHHHHHHHHHHHcCCCCCCCCCChH
Confidence            999999999999999999765433221  12334567999998744 447899999999999999999 88899876655


Q ss_pred             HHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          155 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                      +....+......                             ...+.++..+.+++.+||+.||.+|||+.++++
T Consensus       211 ~~~~~~~~~~~~-----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         211 EVLDQVERGYRM-----------------------------PCPPECPESLHDLMCQCWRKEPEERPTFEYLQA  255 (262)
T ss_pred             HHHHHHhcCCCC-----------------------------CCccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            444333211100                             011256788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=2.2e-33  Score=234.82  Aligned_cols=193  Identities=24%  Similarity=0.386  Sum_probs=155.0

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      ++||||+++++++...     ...|+||||++ ++|.+++.. .+.+++..+..++.|++.||+|||+.|++|+||||+|
T Consensus        63 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~N  137 (268)
T cd05063          63 FSHHNIIRLEGVVTKF-----KPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARN  137 (268)
T ss_pred             CCCCCeeEEEEEEccC-----CCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhh
Confidence            5799999999999655     66899999998 599999875 3579999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCCCcc----ccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCh
Q 023609           79 LLLNANCDLKICDFGLARVTSETDFM----TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDH  153 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~  153 (280)
                      |+++.++.++++|||++.........    .....+..|+|||.+.+. .++.++|+||+||++|++++ |..||...+.
T Consensus       138 ili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Dv~slG~il~ell~~g~~p~~~~~~  216 (268)
T cd05063         138 ILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYR-KFTSASDVWSFGIVMWEVMSFGERPYWDMSN  216 (268)
T ss_pred             EEEcCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhcC-CcChHhHHHHHHHHHHHHHhCCCCCCCcCCH
Confidence            99999999999999998765432111    111224569999988544 47899999999999999987 9999977665


Q ss_pred             HHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          154 VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                      .+....+......+.                             ....+.++.+++.+||+.+|.+||++.++++
T Consensus       217 ~~~~~~i~~~~~~~~-----------------------------~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         217 HEVMKAINDGFRLPA-----------------------------PMDCPSAVYQLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             HHHHHHHhcCCCCCC-----------------------------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            554444432111111                             1146788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-33  Score=232.64  Aligned_cols=193  Identities=24%  Similarity=0.379  Sum_probs=153.0

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      ++||||+++++++...     ...++||||++ ++|.+++.. ...+++..+..++.|++.||++||++|++||||+|+|
T Consensus        49 l~~~~i~~~~~~~~~~-----~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~n  123 (251)
T cd05041          49 YDHPNIVKLIGVCVQK-----QPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARN  123 (251)
T ss_pred             CCCCCeEEEEEEEecC-----CCeEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcce
Confidence            5799999999998665     67899999996 699999865 3468999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCCCcc---ccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 023609           79 LLLNANCDLKICDFGLARVTSETDFM---TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHV  154 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~  154 (280)
                      |+++.++.++|+|||.+.........   .....+..|+|||.+.+ ..++.++|+||+|+++++|++ |..||.+....
T Consensus       124 ili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~  202 (251)
T cd05041         124 CLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNY-GRYTSESDVWSYGILLWETFSLGDTPYPGMSNQ  202 (251)
T ss_pred             EEEcCCCcEEEeeccccccccCCcceeccccCcceeccCChHhhcc-CCCCcchhHHHHHHHHHHHHhccCCCCccCCHH
Confidence            99999999999999998755422111   11223556999998754 457899999999999999998 88888766543


Q ss_pred             HHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          155 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                      .....+......                             ......+..+.+++.+||+.+|.+|||+.++++
T Consensus       203 ~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~  247 (251)
T cd05041         203 QTRERIESGYRM-----------------------------PAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYN  247 (251)
T ss_pred             HHHHHHhcCCCC-----------------------------CCCccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence            333322111000                             001246788999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=2.5e-33  Score=233.57  Aligned_cols=192  Identities=27%  Similarity=0.411  Sum_probs=153.1

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS   77 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~   77 (280)
                      ++||||+++++++..      ...|+||||++ ++|.+++.+.  ..+++..+..++.|++.||+|||+.|++|+||+|+
T Consensus        58 l~h~~i~~~~~~~~~------~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~  131 (260)
T cd05069          58 LRHDKLVPLYAVVSE------EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAA  131 (260)
T ss_pred             CCCCCeeeEEEEEcC------CCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcc
Confidence            579999999998732      34799999998 5999999754  34899999999999999999999999999999999


Q ss_pred             cEEEccCCCEEEeeccceeeccCCCc--cccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 023609           78 NLLLNANCDLKICDFGLARVTSETDF--MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHV  154 (280)
Q Consensus        78 nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~  154 (280)
                      ||+++.++.++|+|||.+........  .....++..|+|||...+ ...+.++|+||+|+++|+|++ |..||.+....
T Consensus       132 Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~-~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~  210 (260)
T cd05069         132 NILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPGMVNR  210 (260)
T ss_pred             eEEEcCCCeEEECCCccceEccCCcccccCCCccchhhCCHHHhcc-CCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999999976543321  112234567999998744 447889999999999999998 89999876655


Q ss_pred             HHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          155 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                      .....+......                             ......+..+++++++||..||.+||++.++++
T Consensus       211 ~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         211 EVLEQVERGYRM-----------------------------PCPQGCPESLHELMKLCWKKDPDERPTFEYIQS  255 (260)
T ss_pred             HHHHHHHcCCCC-----------------------------CCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            444333221100                             011256788999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1.5e-33  Score=235.80  Aligned_cols=193  Identities=24%  Similarity=0.380  Sum_probs=154.6

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      ++||||+++++++...     ...|+||||++ ++|.+++... +.+++.++..++.|++.||++||+.|++|+||||+|
T Consensus        62 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~n  136 (267)
T cd05066          62 FDHPNIIHLEGVVTKS-----KPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARN  136 (267)
T ss_pred             CCCCCcceEEEEEecC-----CccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhc
Confidence            5799999999998654     56899999997 6999999764 468999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCCCc----cccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCh
Q 023609           79 LLLNANCDLKICDFGLARVTSETDF----MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDH  153 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~  153 (280)
                      |+++.++.++|+|||.+........    .....++..|++||.+.+. .++.++|+||+||+++++++ |..||.+.+.
T Consensus       137 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~-~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~  215 (267)
T cd05066         137 ILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVMSYGERPYWEMSN  215 (267)
T ss_pred             EEECCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccC-ccCchhhhHHHHHHHHHHhcCCCCCcccCCH
Confidence            9999999999999999876543221    1112234579999988544 47899999999999999886 9999977665


Q ss_pred             HHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          154 VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                      .+....+.+....+                             ....+++.+.+++.+||+.+|.+||++.++++
T Consensus       216 ~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         216 QDVIKAIEEGYRLP-----------------------------APMDCPAALHQLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             HHHHHHHhCCCcCC-----------------------------CCCCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence            44433332211110                             11256788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=1.9e-33  Score=233.40  Aligned_cols=193  Identities=31%  Similarity=0.480  Sum_probs=157.5

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQA--LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS   77 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~--l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~   77 (280)
                      ++||||+++++.+.+.     ...|++||++. ++|.+++.....  +++..+..++.|++.||++||+.|++|+||+|+
T Consensus        58 l~~~~i~~~~~~~~~~-----~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~  132 (258)
T smart00219       58 LDHPNIVKLLGVCTEE-----EPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAAR  132 (258)
T ss_pred             cCCCchheEEEEEcCC-----CeeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccc
Confidence            4799999999999765     67999999997 599999976554  999999999999999999999999999999999


Q ss_pred             cEEEccCCCEEEeeccceeeccCCCccc--cceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 023609           78 NLLLNANCDLKICDFGLARVTSETDFMT--EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHV  154 (280)
Q Consensus        78 nili~~~~~~~l~dfg~~~~~~~~~~~~--~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~  154 (280)
                      ||+++.++.++|+|||.+..........  ...++..|+|||.+. ...++.++|+||+|+++++|++ |.+||.+.+..
T Consensus       133 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~-~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~  211 (258)
T smart00219      133 NCLVGENLVVKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLK-DGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNE  211 (258)
T ss_pred             eEEEccCCeEEEcccCCceecccccccccccCCCcccccChHHhc-cCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            9999999999999999997665442211  123567899999884 4457899999999999999998 78999776655


Q ss_pred             HHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          155 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                      .....+......                             ......+.++.+++.+||..||.+|||+.++++
T Consensus       212 ~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      212 EVLEYLKKGYRL-----------------------------PKPENCPPEIYKLMLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             HHHHHHhcCCCC-----------------------------CCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence            544443221110                             111246788999999999999999999999985

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.3e-33  Score=235.96  Aligned_cols=196  Identities=28%  Similarity=0.445  Sum_probs=154.0

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS----NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK   75 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~----~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~   75 (280)
                      ++||||+++++++...     +..++|+||++ |+|.+++..    +..+++..+..++.|++.||+|||++|++|+||+
T Consensus        59 l~h~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~  133 (267)
T cd08228          59 LNHPNVIKYLDSFIED-----NELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIK  133 (267)
T ss_pred             CCCcceeeeeeeEEEC-----CeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCC
Confidence            5799999999998665     67899999998 599888752    3458999999999999999999999999999999


Q ss_pred             CCcEEEccCCCEEEeeccceeeccCCCc-cccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh-
Q 023609           76 PSNLLLNANCDLKICDFGLARVTSETDF-MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDH-  153 (280)
Q Consensus        76 ~~nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-  153 (280)
                      |+||+++.++.++|+|||.+........ .....++..|+|||.+.+. ..+.++|+||+|+++++|++|..||.+... 
T Consensus       134 ~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~p~~~~~~~  212 (267)
T cd08228         134 PANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMN  212 (267)
T ss_pred             HHHEEEcCCCCEEECccccceeccchhHHHhcCCCCccccChhhhccC-CCCchhhHHHHHHHHHHHhcCCCCCcccccc
Confidence            9999999999999999999876543321 2234577889999988554 478899999999999999999999865432 


Q ss_pred             HHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 023609          154 VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  229 (280)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h  229 (280)
                      ...........+.++.                           ....++..+.++|.+||..+|++||++.++++.
T Consensus       213 ~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~  261 (267)
T cd08228         213 LFSLCQKIEQCDYPPL---------------------------PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI  261 (267)
T ss_pred             HHHHHHHHhcCCCCCC---------------------------ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence            1111111111111110                           011456789999999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=2.1e-33  Score=234.08  Aligned_cols=194  Identities=25%  Similarity=0.382  Sum_probs=149.8

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      ++||||+++++++....    +..++||||+. |+|.+++... ..+++..+..++.|++.||+|||+.|++||||+|+|
T Consensus        53 l~h~~iv~~~~~~~~~~----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~n  128 (262)
T cd05058          53 FSHPNVLSLLGICLPSE----GSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARN  128 (262)
T ss_pred             CCCCCcceEEEEeecCC----CCcEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcce
Confidence            58999999999775432    45789999997 6999999764 357788889999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCCC-----ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 023609           79 LLLNANCDLKICDFGLARVTSETD-----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRD  152 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~  152 (280)
                      |+++.++.++|+|||++.......     ......++..|+|||.+.+. .++.++||||+||++|+|++ |.+||...+
T Consensus       129 ili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~~~~~~~~~~  207 (262)
T cd05058         129 CMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVD  207 (262)
T ss_pred             EEEcCCCcEEECCccccccccCCcceeecccccCcCCccccChhHhccC-ccchHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence            999999999999999987543221     11123346679999988544 57889999999999999999 567776655


Q ss_pred             hHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          153 HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                      ..+....+.... .+.                            .-...+..+.+++.+||..+|++||++.+++.
T Consensus       208 ~~~~~~~~~~~~-~~~----------------------------~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~  254 (262)
T cd05058         208 SFDITVYLLQGR-RLL----------------------------QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVS  254 (262)
T ss_pred             HHHHHHHHhcCC-CCC----------------------------CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            443322221100 000                            00135678999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=2.7e-33  Score=233.33  Aligned_cols=192  Identities=26%  Similarity=0.416  Sum_probs=153.0

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS   77 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~   77 (280)
                      ++||||+++++++..      ...|++|||++ ++|.+++...  ..+++..++.++.|++.||+|||+.|++|+||+|+
T Consensus        58 l~~~~i~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~  131 (260)
T cd05070          58 LRHDKLVQLYAVVSE------EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSA  131 (260)
T ss_pred             cCCCceEEEEeEECC------CCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccc
Confidence            579999999998732      34799999997 6999998753  35899999999999999999999999999999999


Q ss_pred             cEEEccCCCEEEeeccceeeccCCCc--cccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 023609           78 NLLLNANCDLKICDFGLARVTSETDF--MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHV  154 (280)
Q Consensus        78 nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~  154 (280)
                      ||+++.++.++|+|||.+........  .....++..|+|||...+ ..++.++|+||+|+++++|++ |..||.+.+..
T Consensus       132 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~  210 (260)
T cd05070         132 NILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALY-GRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR  210 (260)
T ss_pred             eEEEeCCceEEeCCceeeeeccCcccccccCCCCCccccChHHHhc-CCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH
Confidence            99999999999999999976543321  112234567999998744 447889999999999999998 88999876655


Q ss_pred             HHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          155 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                      +....+......                             ......+..+++++.+||..||.+|||+.++.+
T Consensus       211 ~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  255 (260)
T cd05070         211 EVLEQVERGYRM-----------------------------PCPQDCPISLHELMLQCWKKDPEERPTFEYLQS  255 (260)
T ss_pred             HHHHHHHcCCCC-----------------------------CCCCcCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence            444433211100                             111256788999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-35  Score=251.68  Aligned_cols=202  Identities=32%  Similarity=0.602  Sum_probs=172.4

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIR--SNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~--~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      +.||.||.+--.|..+     ..+|+|||-+.|+....+.  .++++++...+.++.||+.||+|||-.||+|+|+||+|
T Consensus       620 l~HPGiV~le~M~ET~-----ervFVVMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPEN  694 (888)
T KOG4236|consen  620 LHHPGIVNLECMFETP-----ERVFVVMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPEN  694 (888)
T ss_pred             cCCCCeeEEEEeecCC-----ceEEEEehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchh
Confidence            5799999999999777     6799999999999888875  45789999999999999999999999999999999999


Q ss_pred             EEEccC---CCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCC-CChH
Q 023609           79 LLLNAN---CDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPG-RDHV  154 (280)
Q Consensus        79 ili~~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~-~~~~  154 (280)
                      |++...   ..+||||||.++..++.......+|||.|+|||++.+.+ |..+-|+||+|+|+|.-+.|..||.. .+..
T Consensus       695 VLLas~~~FPQvKlCDFGfARiIgEksFRrsVVGTPAYLaPEVLrnkG-yNrSLDMWSVGVIiYVsLSGTFPFNEdEdIn  773 (888)
T KOG4236|consen  695 VLLASASPFPQVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLRNKG-YNRSLDMWSVGVIIYVSLSGTFPFNEDEDIN  773 (888)
T ss_pred             eeeccCCCCCceeeccccceeecchhhhhhhhcCCccccCHHHHhhcc-ccccccceeeeEEEEEEecccccCCCccchh
Confidence            999654   569999999999999988888899999999999996655 89999999999999999999999953 3344


Q ss_pred             HHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCC
Q 023609          155 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS  234 (280)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~  234 (280)
                      ++++...  +-.|+                           .-|..+++++.|||.++|+..-.+|.|++..+.|||+++
T Consensus       774 dQIQNAa--FMyPp---------------------------~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~  824 (888)
T KOG4236|consen  774 DQIQNAA--FMYPP---------------------------NPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQD  824 (888)
T ss_pred             HHhhccc--cccCC---------------------------CchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhc
Confidence            4433221  11111                           123468899999999999999999999999999999998


Q ss_pred             CcC
Q 023609          235 LHD  237 (280)
Q Consensus       235 ~~~  237 (280)
                      +..
T Consensus       825 yq~  827 (888)
T KOG4236|consen  825 YQT  827 (888)
T ss_pred             chH
Confidence            643

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=2.8e-33  Score=234.31  Aligned_cols=195  Identities=26%  Similarity=0.463  Sum_probs=157.9

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIR----SNQALSEEHCQYFLYQILRGLKYIHS-ANVLHRDL   74 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~----~~~~l~~~~~~~i~~qll~al~~LH~-~gi~H~di   74 (280)
                      ++||||+++++++...     ...+++|||++ ++|.+++.    ....+++..++.++.|++.||.|||+ .|++|+||
T Consensus        66 ~~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl  140 (269)
T cd08528          66 LRHPNIVRYYKTFLEN-----DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDL  140 (269)
T ss_pred             CCCCCeeeEEeeEccC-----CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCC
Confidence            4799999999999665     67999999997 58888774    23469999999999999999999996 78999999


Q ss_pred             CCCcEEEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH
Q 023609           75 KPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHV  154 (280)
Q Consensus        75 ~~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  154 (280)
                      +|.||+++.++.++|+|||.+.............++..|++||.+.+ ..++.++|+||+|+++|+|++|..||......
T Consensus       141 ~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~-~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~  219 (269)
T cd08528         141 TPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKN-EPYGEKADVWAFGCILYQMCTLQPPFYSTNML  219 (269)
T ss_pred             CHHHEEECCCCcEEEecccceeecccccccccccCcccCcChhhhcC-CCCchHHHHHHHHHHHHHHHhCCCcccccCHH
Confidence            99999999999999999999987655543445567888999998864 44789999999999999999999999766544


Q ss_pred             HHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 023609          155 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  229 (280)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h  229 (280)
                      .....+......+..                            ...+++.+.++|++||+.||.+||++.|+.++
T Consensus       220 ~~~~~~~~~~~~~~~----------------------------~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         220 SLATKIVEAVYEPLP----------------------------EGMYSEDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             HHHHHHhhccCCcCC----------------------------cccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence            433333221111110                            11467889999999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.2e-33  Score=236.68  Aligned_cols=208  Identities=23%  Similarity=0.280  Sum_probs=151.9

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++....   ....|+||||+. ++|.+++... .+++.++..++.|++.||+|||+.|++|+||||+||
T Consensus        63 l~h~~i~~~~~~~~~~~---~~~~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Ni  138 (283)
T cd05080          63 LYHENIVKYKGCCSEQG---GKGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNV  138 (283)
T ss_pred             CCCCCEeeEEEEEecCC---CceEEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheE
Confidence            58999999999875532   146899999998 6999998764 599999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCCc----cccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 023609           80 LLNANCDLKICDFGLARVTSETDF----MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVH  155 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~  155 (280)
                      +++.++.++|+|||.+........    .....++..|+|||.+.+ ...+.++||||+|+++++|++|..||.......
T Consensus       139 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~  217 (283)
T cd05080         139 LLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKE-NKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF  217 (283)
T ss_pred             EEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcc-cCCCcccccHHHHHHHHHHHhCCCCCCCCcchh
Confidence            999999999999999876543211    112234566999998754 447889999999999999999999885433210


Q ss_pred             HHHHHHHH-hCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          156 QLRLLIEL-IGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       156 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                        ...... .+.....   .    ..........      ...-..++..+.+++.+||+.||++|||+.++++
T Consensus       218 --~~~~~~~~~~~~~~---~----~~~~~~~~~~------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         218 --EEMIGPKQGQMTVV---R----LIELLERGMR------LPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             --hhhhcccccccchh---h----hhhhhhcCCC------CCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence              001000 0000000   0    0000000000      0111356789999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.5e-33  Score=235.60  Aligned_cols=194  Identities=26%  Similarity=0.434  Sum_probs=153.2

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS----NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK   75 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~----~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~   75 (280)
                      ++||||+++++++...     +..+++|||++ ++|.+++..    ...+++..++.++.||+.||+|||++|++|+||+
T Consensus        59 ~~h~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~  133 (267)
T cd08229          59 LNHPNVIKYYASFIED-----NELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIK  133 (267)
T ss_pred             ccCCchhhhhheeEeC-----CeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCC
Confidence            5799999999999765     67899999998 599988863    3568999999999999999999999999999999


Q ss_pred             CCcEEEccCCCEEEeeccceeeccCCCc-cccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH
Q 023609           76 PSNLLLNANCDLKICDFGLARVTSETDF-MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHV  154 (280)
Q Consensus        76 ~~nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  154 (280)
                      |+||+++.++.++|+|||.+........ .....++..|+|||.+.+ ...+.++|+||+|+++++|++|..||.+....
T Consensus       134 p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ape~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~  212 (267)
T cd08229         134 PANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN  212 (267)
T ss_pred             HHHEEEcCCCCEEECcchhhhccccCCcccccccCCcCccCHHHhcC-CCccchhhHHHHHHHHHHHHhCCCCcccccch
Confidence            9999999999999999998876543321 223467888999998854 44788999999999999999999999654321


Q ss_pred             --HHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          155 --HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       155 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                        .....+. ....++                           .....++..+++++.+||..||.+|||+.+++.
T Consensus       213 ~~~~~~~~~-~~~~~~---------------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         213 LYSLCKKIE-QCDYPP---------------------------LPSDHYSEELRQLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             HHHHhhhhh-cCCCCC---------------------------CCcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence              1111111 000000                           001246788999999999999999999997764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=2.4e-33  Score=242.04  Aligned_cols=193  Identities=27%  Similarity=0.440  Sum_probs=154.2

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCC----------------CCCHHHHHHHHHHHHHHHHHH
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ----------------ALSEEHCQYFLYQILRGLKYI   64 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~----------------~l~~~~~~~i~~qll~al~~L   64 (280)
                      +||||+++++++...     ...|+++||++ |+|.+++.+..                .++...+..++.|++.||+||
T Consensus        76 ~h~~iv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~L  150 (334)
T cd05100          76 KHKNIINLLGACTQD-----GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYL  150 (334)
T ss_pred             CCCCeeeeeEEEccC-----CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHH
Confidence            699999999999654     56899999997 69999987532                377888999999999999999


Q ss_pred             HHCCceeccCCCCcEEEccCCCEEEeeccceeeccCCCc---cccceeccccccchhccCCCCCCcchhHHHHHHHHHHH
Q 023609           65 HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL  141 (280)
Q Consensus        65 H~~gi~H~di~~~nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l  141 (280)
                      |++|++||||||+||+++.++.++|+|||.++.......   .....++..|+|||.+.+. .++.++||||+||++|+|
T Consensus       151 H~~givH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el  229 (334)
T cd05100         151 ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLLWEI  229 (334)
T ss_pred             HHCCeeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccC-CcCchhhhHHHHHHHHHH
Confidence            999999999999999999999999999999876543221   1122334679999988544 478899999999999999


Q ss_pred             Hh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCC
Q 023609          142 MD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQR  220 (280)
Q Consensus       142 l~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R  220 (280)
                      ++ |..||.+.+..+....+......                             ......+.++.+++.+||+.+|.+|
T Consensus       230 ~~~g~~p~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~l~~li~~cl~~~p~~R  280 (334)
T cd05100         230 FTLGGSPYPGIPVEELFKLLKEGHRM-----------------------------DKPANCTHELYMIMRECWHAVPSQR  280 (334)
T ss_pred             HhcCCCCCCCCCHHHHHHHHHcCCCC-----------------------------CCCCCCCHHHHHHHHHHcccChhhC
Confidence            98 88999876655544333211100                             1112567789999999999999999


Q ss_pred             CCHHHHhcC
Q 023609          221 ITVEDALAH  229 (280)
Q Consensus       221 ~t~~ell~h  229 (280)
                      ||+.+++++
T Consensus       281 ps~~ell~~  289 (334)
T cd05100         281 PTFKQLVED  289 (334)
T ss_pred             cCHHHHHHH
Confidence            999999985

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=2.7e-33  Score=234.46  Aligned_cols=193  Identities=24%  Similarity=0.383  Sum_probs=153.0

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      ++||||+++++++...     ...++||||++ ++|.+++... +.+++..+..++.|++.||+|||+.|++|+||+|+|
T Consensus        62 l~h~ni~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~n  136 (269)
T cd05065          62 FDHPNIIHLEGVVTKS-----RPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARN  136 (269)
T ss_pred             CCCcCcceEEEEECCC-----CceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChhe
Confidence            5799999999998655     66899999997 5999998754 568999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCCCcc---ccce---eccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 023609           79 LLLNANCDLKICDFGLARVTSETDFM---TEYV---VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGR  151 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~~~~---~~~~---~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~  151 (280)
                      |+++.++.++|+|||.+.........   ....   .+..|+|||.+.+ ..++.++|+||+||+++++++ |..||.+.
T Consensus       137 ili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DvwslG~~l~e~l~~g~~p~~~~  215 (269)
T cd05065         137 ILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAY-RKFTSASDVWSYGIVMWEVMSYGERPYWDM  215 (269)
T ss_pred             EEEcCCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhcc-CcccchhhhhhhHHHHHHHhcCCCCCCCCC
Confidence            99999999999999988654332111   1111   1346999998854 447889999999999999886 99999776


Q ss_pred             ChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          152 DHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                      +.......+......+                             ..+.++..+.+++.+||+.+|.+||++.+++.
T Consensus       216 ~~~~~~~~i~~~~~~~-----------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  263 (269)
T cd05065         216 SNQDVINAIEQDYRLP-----------------------------PPMDCPTALHQLMLDCWQKDRNARPKFGQIVS  263 (269)
T ss_pred             CHHHHHHHHHcCCcCC-----------------------------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            6554433332111111                             01256788999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=2.1e-33  Score=247.26  Aligned_cols=156  Identities=28%  Similarity=0.389  Sum_probs=120.0

Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCCEEEeeccceeeccCCC---ccccceeccccccchhcc
Q 023609           44 ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLL  120 (280)
Q Consensus        44 ~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nili~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~  120 (280)
                      .+++..+..++.||+.||+|||+.|++|+||||+||+++.++.++|+|||++.......   ......++..|+|||.+.
T Consensus       233 ~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~  312 (400)
T cd05105         233 GLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIF  312 (400)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhc
Confidence            37788889999999999999999999999999999999999999999999987643321   112234567799999885


Q ss_pred             CCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCC
Q 023609          121 NSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP  199 (280)
Q Consensus       121 ~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  199 (280)
                      + ..++.++||||+||++|+|++ |..||.+................+                            ...+
T Consensus       313 ~-~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~~~----------------------------~~~~  363 (400)
T cd05105         313 D-NLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRM----------------------------AKPD  363 (400)
T ss_pred             C-CCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhcCCCC----------------------------CCCc
Confidence            4 447899999999999999996 889987654332222111110000                            0112


Q ss_pred             CCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          200 NVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       200 ~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                      .++.++.+++.+||+.||++|||+.++.+
T Consensus       364 ~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         364 HATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             cCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence            56788999999999999999999988765

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=3.4e-33  Score=233.66  Aligned_cols=193  Identities=26%  Similarity=0.414  Sum_probs=152.9

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC-------CCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-------QALSEEHCQYFLYQILRGLKYIHSANVLHR   72 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-------~~l~~~~~~~i~~qll~al~~LH~~gi~H~   72 (280)
                      ++||||+++++++...     ...++||||++ ++|.+++...       ..+++..+..++.|++.||+|||+.|++|+
T Consensus        56 l~h~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~  130 (269)
T cd05044          56 FNHPNIVKLLGVCLLN-----EPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHR  130 (269)
T ss_pred             cCCCCeeeEeeeecCC-----CCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence            5799999999998665     56899999997 6999998642       348889999999999999999999999999


Q ss_pred             cCCCCcEEEccCC-----CEEEeeccceeeccCCCc---cccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-
Q 023609           73 DLKPSNLLLNANC-----DLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-  143 (280)
Q Consensus        73 di~~~nili~~~~-----~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-  143 (280)
                      ||+|+||+++.++     .++++|||++........   .....++..|+|||.+.+ ...+.++|+||+||++|+|++ 
T Consensus       131 dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~ellt~  209 (269)
T cd05044         131 DLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLD-GKFTTQSDVWSFGVLMWEILTL  209 (269)
T ss_pred             CCChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHcc-CCcccchhHHHHHHHHHHHHHc
Confidence            9999999999877     899999999875432211   112344677999998854 457899999999999999998 


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCH
Q 023609          144 RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV  223 (280)
Q Consensus       144 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~  223 (280)
                      |..||...+..+....+.... .+                            ...+.++..+.++|.+||+.+|.+||++
T Consensus       210 g~~p~~~~~~~~~~~~~~~~~-~~----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~  260 (269)
T cd05044         210 GQQPYPALNNQEVLQHVTAGG-RL----------------------------QKPENCPDKIYQLMTNCWAQDPSERPTF  260 (269)
T ss_pred             CCCCCcccCHHHHHHHHhcCC-cc----------------------------CCcccchHHHHHHHHHHcCCCcccCCCH
Confidence            999997666544433321100 00                            1112567889999999999999999999


Q ss_pred             HHHhc
Q 023609          224 EDALA  228 (280)
Q Consensus       224 ~ell~  228 (280)
                      .++++
T Consensus       261 ~~i~~  265 (269)
T cd05044         261 DRIQE  265 (269)
T ss_pred             HHHHH
Confidence            99875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=3.3e-33  Score=233.99  Aligned_cols=193  Identities=25%  Similarity=0.419  Sum_probs=154.0

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ-ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~-~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      ++||||+++++++.+      ...|+||||+. |+|.+++.+.+ .+++..+..++.|++.||+|||+.|++|+||+|+|
T Consensus        64 ~~h~~i~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~n  137 (270)
T cd05056          64 FDHPHIVKLIGVITE------NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARN  137 (270)
T ss_pred             CCCCchhceeEEEcC------CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChhe
Confidence            579999999999854      34689999997 69999997644 58999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCCCcc--ccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 023609           79 LLLNANCDLKICDFGLARVTSETDFM--TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVH  155 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~  155 (280)
                      |+++.++.++|+|||++.........  ....++..|+|||.+.. ..++.++|+||+|++++++++ |..||.+.+..+
T Consensus       138 ili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~  216 (270)
T cd05056         138 VLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINF-RRFTSASDVWMFGVCMWEILMLGVKPFQGVKNND  216 (270)
T ss_pred             EEEecCCCeEEccCceeeecccccceecCCCCccccccChhhhcc-CCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHH
Confidence            99999999999999998765433211  12223457999998744 447899999999999999986 999998776554


Q ss_pred             HHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 023609          156 QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  229 (280)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h  229 (280)
                      ....+......                             ...+.++..+.++|.+||..+|.+|||+.+++..
T Consensus       217 ~~~~~~~~~~~-----------------------------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~  261 (270)
T cd05056         217 VIGRIENGERL-----------------------------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQ  261 (270)
T ss_pred             HHHHHHcCCcC-----------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            43332211100                             1123567899999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=4.4e-33  Score=231.33  Aligned_cols=194  Identities=23%  Similarity=0.392  Sum_probs=154.7

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      ++||||+++++++...     ...++||||+. ++|.+++... +.+++..++.++.|++.||++||+.|++|+||+|+|
T Consensus        56 l~~~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~n  130 (256)
T cd05112          56 LSHPKLVQLYGVCTER-----SPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARN  130 (256)
T ss_pred             CCCCCeeeEEEEEccC-----CceEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccce
Confidence            5799999999998655     56899999997 5999998754 568999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCCCc--cccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 023609           79 LLLNANCDLKICDFGLARVTSETDF--MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVH  155 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~  155 (280)
                      |+++.++.++|+|||.+........  ......+..|+|||.+.+ ..++.++|+||+|+++|+|++ |..||.......
T Consensus       131 i~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~  209 (256)
T cd05112         131 CLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSF-SKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE  209 (256)
T ss_pred             EEEcCCCeEEECCCcceeecccCcccccCCCccchhhcCHhHhcc-CCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHH
Confidence            9999999999999999876543321  112234567999998854 447889999999999999998 899997766544


Q ss_pred             HHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 023609          156 QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  229 (280)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h  229 (280)
                      ....+.+.....                             .-...+..+.+++.+||+.+|.+|||+.++++.
T Consensus       210 ~~~~~~~~~~~~-----------------------------~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         210 VVETINAGFRLY-----------------------------KPRLASQSVYELMQHCWKERPEDRPSFSLLLHQ  254 (256)
T ss_pred             HHHHHhCCCCCC-----------------------------CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence            443332110000                             001356789999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=4.2e-33  Score=232.12  Aligned_cols=192  Identities=24%  Similarity=0.412  Sum_probs=153.8

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS   77 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~   77 (280)
                      ++||||+++++++..      ...+++|||+. ++|.+++...  ..+++.++..++.|++.||+|||+.|++|+||+|+
T Consensus        58 l~h~~i~~~~~~~~~------~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~  131 (260)
T cd05067          58 LQHPRLVRLYAVVTQ------EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAA  131 (260)
T ss_pred             cCCcCeeeEEEEEcc------CCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHH
Confidence            579999999998732      35899999997 6999998653  46899999999999999999999999999999999


Q ss_pred             cEEEccCCCEEEeeccceeeccCCCc--cccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 023609           78 NLLLNANCDLKICDFGLARVTSETDF--MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHV  154 (280)
Q Consensus        78 nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~  154 (280)
                      ||+++.++.++|+|||.+........  .....++..|+|||.+.. ..++.++|+||+|++++++++ |..||.+.+..
T Consensus       132 ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~  210 (260)
T cd05067         132 NILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP  210 (260)
T ss_pred             hEEEcCCCCEEEccCcceeecCCCCcccccCCcccccccCHHHhcc-CCcCcccchHHHHHHHHHHHhCCCCCCCCCChH
Confidence            99999999999999999876542211  112234567999998743 447889999999999999998 99999877655


Q ss_pred             HHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          155 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                      +....+......+                             .....+.++.+++.+||+.+|++|||++++++
T Consensus       211 ~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         211 EVIQNLERGYRMP-----------------------------RPDNCPEELYELMRLCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             HHHHHHHcCCCCC-----------------------------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            5444332211111                             11246788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=3.5e-33  Score=236.06  Aligned_cols=193  Identities=23%  Similarity=0.358  Sum_probs=152.3

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCC----------------------CCCHHHHHHHHHHH
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ----------------------ALSEEHCQYFLYQI   57 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~----------------------~l~~~~~~~i~~ql   57 (280)
                      ++||||+++++++...     ...++||||++ |+|.+++....                      .+++..+..++.|+
T Consensus        65 l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i  139 (288)
T cd05050          65 FDHPNIVKLLGVCAVG-----KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQV  139 (288)
T ss_pred             cCCCchheEEEEEcCC-----CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHH
Confidence            5799999999998665     56899999998 69999996432                      37888999999999


Q ss_pred             HHHHHHHHHCCceeccCCCCcEEEccCCCEEEeeccceeeccCCCc---cccceeccccccchhccCCCCCCcchhHHHH
Q 023609           58 LRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSV  134 (280)
Q Consensus        58 l~al~~LH~~gi~H~di~~~nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Diwsl  134 (280)
                      +.||+|||+.|++||||+|+||+++.++.++|+|||.+........   ......+..|+|||.+.+. .++.++|+||+
T Consensus       140 ~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~sl  218 (288)
T cd05050         140 AAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYN-RYTTESDVWAY  218 (288)
T ss_pred             HHHHHHHHhCCeecccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcC-CCCchhHHHHH
Confidence            9999999999999999999999999999999999999875433211   1122345679999987544 47899999999


Q ss_pred             HHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhh
Q 023609          135 GCIFMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKML  213 (280)
Q Consensus       135 G~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  213 (280)
                      ||++|+|++ |..||.+....+....+.....                             ....+.++.++.++|.+||
T Consensus       219 G~il~el~~~~~~p~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~l~~li~~~l  269 (288)
T cd05050         219 GVVLWEIFSYGMQPYYGMAHEEVIYYVRDGNV-----------------------------LSCPDNCPLELYNLMRLCW  269 (288)
T ss_pred             HHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC-----------------------------CCCCCCCCHHHHHHHHHHc
Confidence            999999997 8788876655443332221100                             0111256788999999999


Q ss_pred             cCCCCCCCCHHHHhc
Q 023609          214 TFDPRQRITVEDALA  228 (280)
Q Consensus       214 ~~dp~~R~t~~ell~  228 (280)
                      +.||.+|||+.|+++
T Consensus       270 ~~~p~~Rpt~~el~~  284 (288)
T cd05050         270 SKLPSDRPSFASINR  284 (288)
T ss_pred             ccCcccCCCHHHHHH
Confidence            999999999999874

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=4.3e-33  Score=233.90  Aligned_cols=195  Identities=22%  Similarity=0.357  Sum_probs=154.7

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCC---------CCCHHHHHHHHHHHHHHHHHHHHCCce
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ---------ALSEEHCQYFLYQILRGLKYIHSANVL   70 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~---------~l~~~~~~~i~~qll~al~~LH~~gi~   70 (280)
                      ++||||+++++++.+.     ...|+||||++ |+|.+++....         .+++..+..++.||+.||+|||+.|++
T Consensus        65 l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~  139 (275)
T cd05046          65 LSHKNVVRLLGLCREA-----EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFV  139 (275)
T ss_pred             cCCcceeeeEEEECCC-----CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcc
Confidence            5799999999998654     56899999998 69999998655         699999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCEEEeeccceeeccCCC--ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCC
Q 023609           71 HRDLKPSNLLLNANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPL  147 (280)
Q Consensus        71 H~di~~~nili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p  147 (280)
                      |+||||+||+++.++.++++|||.+.......  ......++..|+|||.+.+. ..+.++|+||+|++++++++ |..|
T Consensus       140 H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~Di~slG~~l~~l~~~~~~p  218 (275)
T cd05046         140 HRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQED-DFSTKSDVWSFGVLMWEVFTQGELP  218 (275)
T ss_pred             cCcCccceEEEeCCCcEEEcccccccccCcccccccCCceeEEeecChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCC
Confidence            99999999999999999999999876432221  12234556779999987544 47889999999999999998 7888


Q ss_pred             CCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHh
Q 023609          148 FPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDAL  227 (280)
Q Consensus       148 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell  227 (280)
                      |.+.........+......                           + .....++..+.+++.+||+.||.+|||+.+++
T Consensus       219 ~~~~~~~~~~~~~~~~~~~---------------------------~-~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l  270 (275)
T cd05046         219 FYGLSDEEVLNRLQAGKLE---------------------------L-PVPEGCPSRLYKLMTRCWAVNPKDRPSFSELV  270 (275)
T ss_pred             ccccchHHHHHHHHcCCcC---------------------------C-CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHH
Confidence            8765544333322110000                           0 01125678899999999999999999999998


Q ss_pred             cC
Q 023609          228 AH  229 (280)
Q Consensus       228 ~h  229 (280)
                      ..
T Consensus       271 ~~  272 (275)
T cd05046         271 SA  272 (275)
T ss_pred             HH
Confidence            64

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=6.1e-33  Score=232.36  Aligned_cols=198  Identities=22%  Similarity=0.305  Sum_probs=149.2

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC-----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-----QALSEEHCQYFLYQILRGLKYIHSANVLHRDL   74 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-----~~l~~~~~~~i~~qll~al~~LH~~gi~H~di   74 (280)
                      ++||||+++++++...     ...++||||++ |+|.+++...     ...++..+..++.|++.|++|||+.|++|+||
T Consensus        52 l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl  126 (269)
T cd05087          52 LQHSNLLQCLGQCTEV-----TPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDL  126 (269)
T ss_pred             CCCCCEeeEEEEEcCC-----CCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEecccc
Confidence            5799999999998665     56899999998 6999998643     24667788899999999999999999999999


Q ss_pred             CCCcEEEccCCCEEEeeccceeeccCCCc---cccceeccccccchhccCCC------CCCcchhHHHHHHHHHHHHh-C
Q 023609           75 KPSNLLLNANCDLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNSS------DYTAAIDVWSVGCIFMELMD-R  144 (280)
Q Consensus        75 ~~~nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~------~~~~~~DiwslG~il~~ll~-g  144 (280)
                      ||+||+++.++.++|+|||.+........   .....++..|+|||.+.+..      .++.++|+||+|+++++|++ |
T Consensus       127 kp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g  206 (269)
T cd05087         127 ALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELG  206 (269)
T ss_pred             CcceEEEcCCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCC
Confidence            99999999999999999999865432211   12234567899999875321      24779999999999999996 9


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHH
Q 023609          145 KPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVE  224 (280)
Q Consensus       145 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~  224 (280)
                      ..||......+...........                     ....   .......+..+.++++.|+ .+|++|||+.
T Consensus       207 ~~p~~~~~~~~~~~~~~~~~~~---------------------~~~~---~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~  261 (269)
T cd05087         207 SQPYRHLSDEQVLTYTVREQQL---------------------KLPK---PRLKLPLSDRWYEVMQFCW-LQPEQRPSAE  261 (269)
T ss_pred             CCCCCCCChHHHHHHHhhcccC---------------------CCCC---CccCCCCChHHHHHHHHHh-cCcccCCCHH
Confidence            9999766544432221111000                     0000   0111245678999999999 6899999999


Q ss_pred             HHhc
Q 023609          225 DALA  228 (280)
Q Consensus       225 ell~  228 (280)
                      +++.
T Consensus       262 ~l~~  265 (269)
T cd05087         262 EVHL  265 (269)
T ss_pred             HHHH
Confidence            9974

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=5.6e-33  Score=230.60  Aligned_cols=190  Identities=24%  Similarity=0.394  Sum_probs=152.3

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ--ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS   77 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~--~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~   77 (280)
                      ++||||+++++++...      ..++||||+. ++|.+++....  .+++..+..++.|++.||.|||+.|++||||+|+
T Consensus        56 ~~~~~i~~~~~~~~~~------~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~  129 (254)
T cd05083          56 LHHKNLVRLLGVILHN------GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAAR  129 (254)
T ss_pred             CCCCCcCeEEEEEcCC------CcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcc
Confidence            5799999999998542      3699999997 69999997543  4899999999999999999999999999999999


Q ss_pred             cEEEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 023609           78 NLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQ  156 (280)
Q Consensus        78 nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~  156 (280)
                      ||+++.++.++|+|||.+.......  .....+..|+|||.+.+ ..++.++|+||+||++++|++ |..||.+.+..+.
T Consensus       130 nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~y~~pe~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~  206 (254)
T cd05083         130 NILVSEDGVAKVSDFGLARVGSMGV--DNSKLPVKWTAPEALKH-KKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEV  206 (254)
T ss_pred             eEEEcCCCcEEECCCccceeccccC--CCCCCCceecCHHHhcc-CCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHH
Confidence            9999999999999999987643321  22334567999998754 457889999999999999997 9999977665443


Q ss_pred             HHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          157 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                      ...+.+....                             ...+.++..+.+++.+||+.+|.+||++.+++.
T Consensus       207 ~~~~~~~~~~-----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  249 (254)
T cd05083         207 KECVEKGYRM-----------------------------EPPEGCPADVYVLMTSCWETEPKKRPSFHKLRE  249 (254)
T ss_pred             HHHHhCCCCC-----------------------------CCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            3322211000                             011356788999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=8e-33  Score=231.60  Aligned_cols=198  Identities=18%  Similarity=0.267  Sum_probs=150.8

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN----QALSEEHCQYFLYQILRGLKYIHSANVLHRDLK   75 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~----~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~   75 (280)
                      ++||||+++++.+...     ...|+||||++ |+|.+++.+.    ..+++..++.++.||+.||+|||+.|++|||||
T Consensus        52 l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dik  126 (268)
T cd05086          52 LQHPNILQCLGQCVEA-----IPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLA  126 (268)
T ss_pred             cCCcchhheEEEecCC-----CccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCc
Confidence            5899999999998765     66899999998 6999999754    346778889999999999999999999999999


Q ss_pred             CCcEEEccCCCEEEeeccceeeccCC---CccccceeccccccchhccCC------CCCCcchhHHHHHHHHHHHHh-CC
Q 023609           76 PSNLLLNANCDLKICDFGLARVTSET---DFMTEYVVTRWYRAPELLLNS------SDYTAAIDVWSVGCIFMELMD-RK  145 (280)
Q Consensus        76 ~~nili~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~------~~~~~~~DiwslG~il~~ll~-g~  145 (280)
                      |+||+++.++.++|+|||++......   .......++..|+|||.+...      ..++.++|+||+||++|+|++ |.
T Consensus       127 p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~  206 (268)
T cd05086         127 LRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAA  206 (268)
T ss_pred             cceEEEcCCccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCC
Confidence            99999999999999999987542211   112234567889999987421      134678999999999999996 57


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHH
Q 023609          146 PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVED  225 (280)
Q Consensus       146 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e  225 (280)
                      .||...+..+.+..+........                     ..   ......+++.+.+++..|| .+|.+|||+.+
T Consensus       207 ~p~~~~~~~~~~~~~~~~~~~~~---------------------~~---~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~  261 (268)
T cd05086         207 QPYSHLSDREVLNHVIKDQQVKL---------------------FK---PQLELPYSERWYEVLQFCW-LSPEKRATAEE  261 (268)
T ss_pred             CCCCCCCHHHHHHHHHhhccccc---------------------CC---CccCCCCcHHHHHHHHHHh-hCcccCCCHHH
Confidence            78876665544443322111000                     00   0111246788999999999 68999999999


Q ss_pred             Hhc
Q 023609          226 ALA  228 (280)
Q Consensus       226 ll~  228 (280)
                      +++
T Consensus       262 i~~  264 (268)
T cd05086         262 VHR  264 (268)
T ss_pred             HHH
Confidence            875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=4.7e-33  Score=231.40  Aligned_cols=188  Identities=19%  Similarity=0.274  Sum_probs=148.1

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ-ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~-~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      ++||||+++++++..      ...++||||++ |+|.+++...+ .+++..+..++.||+.||+|||++|++|+||||+|
T Consensus        58 l~h~~i~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~N  131 (259)
T cd05037          58 LSHKHLVKLYGVCVR------DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKN  131 (259)
T ss_pred             CCCcchhheeeEEec------CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccce
Confidence            579999999998854      23689999997 69999998765 79999999999999999999999999999999999


Q ss_pred             EEEccCC-------CEEEeeccceeeccCCCccccceeccccccchhccCC-CCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 023609           79 LLLNANC-------DLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNS-SDYTAAIDVWSVGCIFMELMD-RKPLFP  149 (280)
Q Consensus        79 ili~~~~-------~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~-g~~pf~  149 (280)
                      |+++.++       .++|+|||.+......   ....++..|+|||.+.+. ..++.++|+||+|+++++|++ |..||.
T Consensus       132 ill~~~~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~  208 (259)
T cd05037         132 ILVARYGLNEGYVPFIKLSDPGIPITVLSR---EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLS  208 (259)
T ss_pred             EEEecCccccCCceeEEeCCCCcccccccc---cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcc
Confidence            9999887       7999999998765432   233456779999998654 357889999999999999998 577776


Q ss_pred             CCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          150 GRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                      ..+..........    .                   ..        ........+.++|.+||..+|.+|||+.++++
T Consensus       209 ~~~~~~~~~~~~~----~-------------------~~--------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         209 TLSSSEKERFYQD----Q-------------------HR--------LPMPDCAELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             cCCchhHHHHHhc----C-------------------CC--------CCCCCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence            5542221111100    0                   00        00011267899999999999999999999985

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1e-32  Score=234.06  Aligned_cols=200  Identities=24%  Similarity=0.387  Sum_probs=153.6

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCC------------CCCHHHHHHHHHHHHHHHHHHHHC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ------------ALSEEHCQYFLYQILRGLKYIHSA   67 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~------------~l~~~~~~~i~~qll~al~~LH~~   67 (280)
                      ++||||+++++++...     ...++||||+. ++|.+++....            .+++..+..++.|++.||+|||+.
T Consensus        74 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~  148 (295)
T cd05097          74 LKNPNIIRLLGVCVSD-----DPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL  148 (295)
T ss_pred             CCCCCcCeEEEEEcCC-----CccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc
Confidence            5899999999999665     67899999997 59999886431            368889999999999999999999


Q ss_pred             CceeccCCCCcEEEccCCCEEEeeccceeeccCCCc---cccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-
Q 023609           68 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-  143 (280)
Q Consensus        68 gi~H~di~~~nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-  143 (280)
                      |++|+||||+||+++.++.++|+|||++........   .....++..|+|||.+.+. .++.++|+||+||++++|++ 
T Consensus       149 ~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwSlG~~l~el~~~  227 (295)
T cd05097         149 NFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLG-KFTTASDVWAFGVTLWEMFTL  227 (295)
T ss_pred             CeeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccC-CcCchhhHHHHHHHHHHHHHc
Confidence            999999999999999999999999999875432211   1122346689999987544 47899999999999999987 


Q ss_pred             -CCCCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCC
Q 023609          144 -RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT  222 (280)
Q Consensus       144 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t  222 (280)
                       +..||...+..+....+........                      ...+....+..++.+.+++.+||+.||++|||
T Consensus       228 ~~~~p~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs  285 (295)
T cd05097         228 CKEQPYSLLSDEQVIENTGEFFRNQG----------------------RQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPT  285 (295)
T ss_pred             CCCCCCcccChHHHHHHHHHhhhhcc----------------------ccccCCCCCCCCHHHHHHHHHHcCCCchhCcC
Confidence             5678876665554443322111000                      00001122346789999999999999999999


Q ss_pred             HHHHhc
Q 023609          223 VEDALA  228 (280)
Q Consensus       223 ~~ell~  228 (280)
                      ++++++
T Consensus       286 ~~~i~~  291 (295)
T cd05097         286 FNKIHH  291 (295)
T ss_pred             HHHHHH
Confidence            999864

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=8.7e-33  Score=232.70  Aligned_cols=194  Identities=23%  Similarity=0.366  Sum_probs=152.9

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC--------CCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--------QALSEEHCQYFLYQILRGLKYIHSANVLH   71 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~--------~~l~~~~~~~i~~qll~al~~LH~~gi~H   71 (280)
                      |+||||+++++++....    ...+++++|++ ++|.+++...        ..+++..+..++.|++.||+|||+.|++|
T Consensus        65 l~h~ni~~~~~~~~~~~----~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H  140 (280)
T cd05043          65 LSHQNILPILHVCIEDG----EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIH  140 (280)
T ss_pred             CCCCCCCeEEEEEecCC----CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEee
Confidence            58999999999876532    45799999997 7999998643        45899999999999999999999999999


Q ss_pred             ccCCCCcEEEccCCCEEEeeccceeeccCCCc---cccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCC
Q 023609           72 RDLKPSNLLLNANCDLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPL  147 (280)
Q Consensus        72 ~di~~~nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p  147 (280)
                      +||+|+||+++.++.++++|||+++.......   .....++..|+|||.+.+. .++.++||||+||+++++++ |..|
T Consensus       141 ~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p  219 (280)
T cd05043         141 KDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNK-EYSSASDVWSFGVLLWELMTLGQTP  219 (280)
T ss_pred             cccCHhhEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcC-CCCchhhHHHhHHHHHHHhcCCCCC
Confidence            99999999999999999999999875432211   1122345679999988544 47899999999999999998 9999


Q ss_pred             CCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHh
Q 023609          148 FPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDAL  227 (280)
Q Consensus       148 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell  227 (280)
                      |.+.+..+....+.... .+                            .....+++++.+++.+||..||++|||+.+++
T Consensus       220 ~~~~~~~~~~~~~~~~~-~~----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~  270 (280)
T cd05043         220 YVEIDPFEMAAYLKDGY-RL----------------------------AQPINCPDELFAVMACCWALDPEERPSFSQLV  270 (280)
T ss_pred             cCcCCHHHHHHHHHcCC-CC----------------------------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHH
Confidence            97765444322221100 00                            01124578899999999999999999999987


Q ss_pred             c
Q 023609          228 A  228 (280)
Q Consensus       228 ~  228 (280)
                      +
T Consensus       271 ~  271 (280)
T cd05043         271 Q  271 (280)
T ss_pred             H
Confidence            5

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.6e-32  Score=229.13  Aligned_cols=194  Identities=27%  Similarity=0.448  Sum_probs=152.8

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS----NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK   75 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~----~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~   75 (280)
                      ++|+||+++++.+...     +..++||||++ ++|.+++..    +..+++..+..++.|++.||+|||+.|++|+||+
T Consensus        59 ~~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~  133 (267)
T cd08224          59 LDHPNVIKYLASFIEN-----NELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIK  133 (267)
T ss_pred             CCCCCeeeeeeeeecC-----CeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcC
Confidence            5799999999999765     67899999998 599998863    3458999999999999999999999999999999


Q ss_pred             CCcEEEccCCCEEEeeccceeeccCCC-ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH
Q 023609           76 PSNLLLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHV  154 (280)
Q Consensus        76 ~~nili~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  154 (280)
                      |+||+++.++.++|+|||.+....... ......++..|+|||.+.+. .++.++|+||+||++++|++|..||.+....
T Consensus       134 p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~  212 (267)
T cd08224         134 PANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPFYGDKMN  212 (267)
T ss_pred             hhhEEECCCCcEEEeccceeeeccCCCcccceecCCccccCHHHhccC-CCCchhcHHHHHHHHHHHHHCCCCcccCCcc
Confidence            999999999999999999987654332 12334677889999988544 4788999999999999999999999654311


Q ss_pred             --HHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          155 --HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       155 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                        .....+......+                            ...+.++..++++|.+||..+|++|||+.++++
T Consensus       213 ~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         213 LYSLCKKIEKCDYPP----------------------------LPADHYSEELRDLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             HHHHHhhhhcCCCCC----------------------------CChhhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence              1111111000000                            001146778999999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=2.1e-32  Score=232.26  Aligned_cols=200  Identities=24%  Similarity=0.377  Sum_probs=152.3

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCC-----------CCCHHHHHHHHHHHHHHHHHHHHCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ-----------ALSEEHCQYFLYQILRGLKYIHSAN   68 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~-----------~l~~~~~~~i~~qll~al~~LH~~g   68 (280)
                      ++||||+++++++...     ...++||||+. ++|.+++....           .+++..+..++.|++.||+|||+.|
T Consensus        76 l~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~  150 (296)
T cd05095          76 LKDPNIIRLLAVCITS-----DPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN  150 (296)
T ss_pred             CCCCCcceEEEEEecC-----CccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC
Confidence            5899999999998665     56899999997 69999987532           3677899999999999999999999


Q ss_pred             ceeccCCCCcEEEccCCCEEEeeccceeeccCCCc---cccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh--
Q 023609           69 VLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD--  143 (280)
Q Consensus        69 i~H~di~~~nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~--  143 (280)
                      ++|+||||+||+++.++.++|+|||.+........   ......+..|++||...+. .++.++|+||+||++|+|++  
T Consensus       151 i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~-~~~~~~DiwSlG~~l~el~~~~  229 (296)
T cd05095         151 FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLG-KFTTASDVWAFGVTLWEILTLC  229 (296)
T ss_pred             eecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcC-CccchhhhhHHHHHHHHHHHhC
Confidence            99999999999999999999999999875433211   1122335679999987544 48899999999999999998  


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCH
Q 023609          144 RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV  223 (280)
Q Consensus       144 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~  223 (280)
                      |..||...+..+...........                  .    .........+.+++.+.+|+..||+.||.+|||+
T Consensus       230 ~~~p~~~~~~~~~~~~~~~~~~~------------------~----~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~  287 (296)
T cd05095         230 KEQPYSQLSDEQVIENTGEFFRD------------------Q----GRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSF  287 (296)
T ss_pred             CCCCccccChHHHHHHHHHHHhh------------------c----cccccCCCCCCCCHHHHHHHHHHcCCCcccCCCH
Confidence            67888766554443322111100                  0    0000001113467889999999999999999999


Q ss_pred             HHHhc
Q 023609          224 EDALA  228 (280)
Q Consensus       224 ~ell~  228 (280)
                      .++++
T Consensus       288 ~~i~~  292 (296)
T cd05095         288 QEIHA  292 (296)
T ss_pred             HHHHH
Confidence            99864

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=1e-32  Score=232.72  Aligned_cols=211  Identities=21%  Similarity=0.370  Sum_probs=151.3

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      ++||||+++++++.....   ..+++||||++ ++|.+++... ..+++..+..++.|++.||+|||++|++||||||+|
T Consensus        62 l~h~~iv~~~~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~n  138 (284)
T cd05081          62 LQHDNIVKYKGVCYSAGR---RNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRN  138 (284)
T ss_pred             CCCCCeeEEEEEEccCCC---CceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhh
Confidence            589999999998754422   46899999997 6999999754 469999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCCCcc----ccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH
Q 023609           79 LLLNANCDLKICDFGLARVTSETDFM----TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHV  154 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  154 (280)
                      |+++.++.++|+|||++.........    .....+..|+|||.+.+ ..++.++|+||+||++++|++|..++.+....
T Consensus       139 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~  217 (284)
T cd05081         139 ILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTE-SKFSVASDVWSFGVVLYELFTYSDKSCSPPAE  217 (284)
T ss_pred             EEECCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhcc-CCcChHHHHHHHHHHHHHHhhcCCcCCCcchh
Confidence            99999999999999998865432211    11223445999998854 44788999999999999999987766433211


Q ss_pred             HHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          155 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                      .     ....+.......  .............      .....+.++.++.+++.+||..+|++|||+.++++
T Consensus       218 ~-----~~~~~~~~~~~~--~~~~~~~~~~~~~------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05081         218 F-----MRMMGNDKQGQM--IVYHLIELLKNNG------RLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELAL  278 (284)
T ss_pred             h-----hhhccccccccc--chHHHHHHHhcCC------cCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            1     111111000000  0000000000000      00112467889999999999999999999999976

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=1.3e-32  Score=232.14  Aligned_cols=211  Identities=24%  Similarity=0.389  Sum_probs=152.9

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      ++||||+++++++.....   ...++||||++ ++|.+++.+. ..+++.++..++.|++.||+|||+.|++||||||+|
T Consensus        63 l~h~~i~~~~~~~~~~~~---~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~N  139 (284)
T cd05079          63 LYHENIVKYKGICTEDGG---NGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARN  139 (284)
T ss_pred             CCCCCeeeeeeEEecCCC---CceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchhe
Confidence            579999999999865422   55899999996 6999998754 358999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCCCc----cccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH
Q 023609           79 LLLNANCDLKICDFGLARVTSETDF----MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHV  154 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  154 (280)
                      |+++.++.++|+|||.+........    .....++..|+|||.+.+. .++.++||||+||++|+|++++.|+..... 
T Consensus       140 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~-~~~~~~Di~slG~il~ellt~~~~~~~~~~-  217 (284)
T cd05079         140 VLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQS-KFYIASDVWSFGVTLYELLTYCDSESSPMT-  217 (284)
T ss_pred             EEEcCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhccC-CCCccccchhhhhhhhhhhcCCCCCccccc-
Confidence            9999999999999999876543221    1123456679999988544 478899999999999999998765533211 


Q ss_pred             HHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 023609          155 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  229 (280)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h  229 (280)
                          ...+..+.......   ...........      ........++..+.+|+.+||+.||.+|||+.++++.
T Consensus       218 ----~~~~~~~~~~~~~~---~~~~~~~~~~~------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  279 (284)
T cd05079         218 ----LFLKMIGPTHGQMT---VTRLVRVLEEG------KRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG  279 (284)
T ss_pred             ----hhhhhccccccccc---HHHHHHHHHcC------ccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence                01111111110000   00000000000      0111224678899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-33  Score=234.09  Aligned_cols=197  Identities=23%  Similarity=0.447  Sum_probs=172.6

Q ss_pred             CCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE
Q 023609            3 HENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   81 (280)
Q Consensus         3 HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nili   81 (280)
                      -|.+++++..|+.-     ..+|.||||+. |+|--.+.+-+.+-|..+..++.+|+.||-|||++||++||||.+||++
T Consensus       409 ppFL~qlHScFQTm-----DRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmL  483 (683)
T KOG0696|consen  409 PPFLVQLHSCFQTM-----DRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML  483 (683)
T ss_pred             CchHHHHHHHhhhh-----hheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEe
Confidence            46788888888765     67999999997 6999999998999999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccceee-ccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 023609           82 NANCDLKICDFGLARV-TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL  160 (280)
Q Consensus        82 ~~~~~~~l~dfg~~~~-~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~  160 (280)
                      +.+|++||.|||.++. .-+..+..+.+|||.|+|||++. ..+|+.++|.||+|+++|||+.|++||.|.+..+..+.|
T Consensus       484 d~eGHiKi~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~-YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI  562 (683)
T KOG0696|consen  484 DSEGHIKIADFGMCKENIFDGVTTKTFCGTPDYIAPEIIA-YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAI  562 (683)
T ss_pred             ccCCceEeeecccccccccCCcceeeecCCCcccccceEE-ecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence            9999999999999874 33444567889999999999885 456999999999999999999999999999999998888


Q ss_pred             HHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCH-----HHHhcCCCCCCC
Q 023609          161 IELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV-----EDALAHPYLGSL  235 (280)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~-----~ell~h~~~~~~  235 (280)
                      ++..-.-+                              ..+|.++.+++...|.+.|.+|+.+     .++-.||||..+
T Consensus       563 ~ehnvsyP------------------------------KslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~i  612 (683)
T KOG0696|consen  563 MEHNVSYP------------------------------KSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRRI  612 (683)
T ss_pred             HHccCcCc------------------------------ccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhhc
Confidence            76432111                              1578899999999999999999855     588999999865

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.2e-32  Score=230.18  Aligned_cols=192  Identities=26%  Similarity=0.343  Sum_probs=152.9

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      ++||||+++++++..      ...++||||+. |+|.+++..+ ..+++..+..++.|++.||+|||+.|++|+||+|+|
T Consensus        66 l~h~~i~~~~~~~~~------~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~n  139 (279)
T cd05057          66 VDHPHVVRLLGICLS------SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARN  139 (279)
T ss_pred             CCCCCcceEEEEEec------CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcce
Confidence            579999999999854      45899999997 6999999764 469999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCCCcc---ccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 023609           79 LLLNANCDLKICDFGLARVTSETDFM---TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHV  154 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~  154 (280)
                      |+++.++.++|+|||.+.........   .....+..|+|||.+.. ..++.++|+||+|++++++++ |..||.+....
T Consensus       140 il~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~  218 (279)
T cd05057         140 VLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILH-RIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV  218 (279)
T ss_pred             EEEcCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhc-CCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH
Confidence            99999999999999998765432211   11223467999998743 457889999999999999998 99999876654


Q ss_pred             HHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          155 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                      +....+.... ..                            ...+..+.++.+++.+||..||++|||+.++++
T Consensus       219 ~~~~~~~~~~-~~----------------------------~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         219 EIPDLLEKGE-RL----------------------------PQPPICTIDVYMVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             HHHHHHhCCC-CC----------------------------CCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            4433332110 00                            011245678999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=5.4e-33  Score=250.26  Aligned_cols=193  Identities=25%  Similarity=0.420  Sum_probs=163.6

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC--------------CCCCHHHHHHHHHHHHHHHHHHH
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--------------QALSEEHCQYFLYQILRGLKYIH   65 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~--------------~~l~~~~~~~i~~qll~al~~LH   65 (280)
                      |+|||||+++|++...     ..+|+|+|||. |||.++++..              .+++..+...|+.||+.|.+||-
T Consensus       546 l~H~nIVrLlGVC~~~-----~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs  620 (774)
T KOG1026|consen  546 LQHPNIVRLLGVCREG-----DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS  620 (774)
T ss_pred             ccCCCeEEEEEEEccC-----CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence            6899999999999776     67999999998 9999999743              23888999999999999999999


Q ss_pred             HCCceeccCCCCcEEEccCCCEEEeeccceeeccCCCc---cccceeccccccchhccCCCCCCcchhHHHHHHHHHHHH
Q 023609           66 SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM  142 (280)
Q Consensus        66 ~~gi~H~di~~~nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll  142 (280)
                      ++.+|||||-..|++|+++-.+||+|||+++..-..+.   .........|||||.+..+ +|+.++||||+||++||+.
T Consensus       621 ~~~FVHRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~-kFTteSDVWs~GVvLWEIF  699 (774)
T KOG1026|consen  621 SHHFVHRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYG-KFTTESDVWSFGVVLWEIF  699 (774)
T ss_pred             hCcccccchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcC-cccchhhhhhhhhhhhhhh
Confidence            99999999999999999999999999999985433321   1234456789999999755 4999999999999999999


Q ss_pred             h-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCC
Q 023609          143 D-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI  221 (280)
Q Consensus       143 ~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~  221 (280)
                      + |..||.+.+..+.+..+.+.--                             -++-.+.+.++.+||..||+.+|.+||
T Consensus       700 syG~QPy~glSn~EVIe~i~~g~l-----------------------------L~~Pe~CP~~vY~LM~~CW~~~P~~RP  750 (774)
T KOG1026|consen  700 SYGKQPYYGLSNQEVIECIRAGQL-----------------------------LSCPENCPTEVYSLMLECWNENPKRRP  750 (774)
T ss_pred             ccccCcccccchHHHHHHHHcCCc-----------------------------ccCCCCCCHHHHHHHHHHhhcCcccCC
Confidence            6 8899999998888877654221                             122237889999999999999999999


Q ss_pred             CHHHHhc
Q 023609          222 TVEDALA  228 (280)
Q Consensus       222 t~~ell~  228 (280)
                      ++.||-.
T Consensus       751 sF~eI~~  757 (774)
T KOG1026|consen  751 SFKEIHS  757 (774)
T ss_pred             CHHHHHH
Confidence            9998754

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=2.8e-32  Score=227.27  Aligned_cols=192  Identities=26%  Similarity=0.439  Sum_probs=153.2

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS   77 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~   77 (280)
                      ++|+||+++++.+..      ...|++|||++ ++|.+++.+.  ..+++..+..++.|++.||++||+.|++|+||+|+
T Consensus        58 l~~~~i~~~~~~~~~------~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~  131 (260)
T cd05073          58 LQHDKLVKLHAVVTK------EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAA  131 (260)
T ss_pred             cCCCCcceEEEEEcC------CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcc
Confidence            579999999999854      35799999997 6999999753  35788999999999999999999999999999999


Q ss_pred             cEEEccCCCEEEeeccceeeccCCCc--cccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 023609           78 NLLLNANCDLKICDFGLARVTSETDF--MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHV  154 (280)
Q Consensus        78 nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~  154 (280)
                      ||+++.++.++|+|||.+........  .....++..|+|||.+.. ..++.++|+||+||+++++++ |..||.+.+..
T Consensus       132 ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~  210 (260)
T cd05073         132 NILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP  210 (260)
T ss_pred             eEEEcCCCcEEECCCcceeeccCCCcccccCCcccccccCHhHhcc-CCcCccccchHHHHHHHHHHhcCCCCCCCCCHH
Confidence            99999999999999999876543221  112234567999998854 447889999999999999998 89999876655


Q ss_pred             HHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          155 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                      .....+......                             ...+..+.++.+++.+||+.+|.+||++.++++
T Consensus       211 ~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         211 EVIRALERGYRM-----------------------------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             HHHHHHhCCCCC-----------------------------CCcccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence            444333211100                             111356788999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=1.8e-32  Score=233.57  Aligned_cols=193  Identities=24%  Similarity=0.331  Sum_probs=151.7

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ-ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~-~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      ++||||+++++++..+      ..+++++|+. |+|.+++.... .+++..+..++.|++.||+|||++|++|+||||+|
T Consensus        66 l~h~niv~~~~~~~~~------~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~N  139 (303)
T cd05110          66 MDHPHLVRLLGVCLSP------TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARN  139 (303)
T ss_pred             CCCCCcccEEEEEcCC------CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccce
Confidence            5799999999998543      3578999997 79999987644 68999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCCCc---cccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 023609           79 LLLNANCDLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHV  154 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~  154 (280)
                      |+++.++.++|+|||++........   .....++..|++||.+.+ ..++.++||||+||++|+|++ |..||.+....
T Consensus       140 ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~-~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~  218 (303)
T cd05110         140 VLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHY-RKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR  218 (303)
T ss_pred             eeecCCCceEEccccccccccCcccccccCCCccccccCCHHHhcc-CCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            9999999999999999976432211   112334668999998854 447889999999999999987 88999765543


Q ss_pred             HHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 023609          155 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  229 (280)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h  229 (280)
                      .....+ .....+                            ...+..+.++.+++.+||..+|++||++.++++.
T Consensus       219 ~~~~~~-~~~~~~----------------------------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         219 EIPDLL-EKGERL----------------------------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             HHHHHH-HCCCCC----------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            322211 110000                            0112456789999999999999999999998874

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1.6e-32  Score=256.28  Aligned_cols=195  Identities=25%  Similarity=0.377  Sum_probs=150.5

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC-----------CCCCHHHHHHHHHHHHHHHHHHHHCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-----------QALSEEHCQYFLYQILRGLKYIHSAN   68 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-----------~~l~~~~~~~i~~qll~al~~LH~~g   68 (280)
                      ++||||+++++++.+.     +..|+||||++ |+|.+++...           ..++...+..++.||+.||+|||+.|
T Consensus        59 L~HPNIVkl~~v~~d~-----~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G  133 (932)
T PRK13184         59 LIHPGIVPVYSICSDG-----DPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG  133 (932)
T ss_pred             CCCcCcCeEEEEEeeC-----CEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC
Confidence            5799999999998665     67899999997 5999988631           23566788999999999999999999


Q ss_pred             ceeccCCCCcEEEccCCCEEEeeccceeeccCC-------------------CccccceeccccccchhccCCCCCCcch
Q 023609           69 VLHRDLKPSNLLLNANCDLKICDFGLARVTSET-------------------DFMTEYVVTRWYRAPELLLNSSDYTAAI  129 (280)
Q Consensus        69 i~H~di~~~nili~~~~~~~l~dfg~~~~~~~~-------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~  129 (280)
                      ++||||||+||+++.+|.++|+|||++......                   .......||+.|+|||.+.+. .++.++
T Consensus       134 IIHRDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~-~~S~kS  212 (932)
T PRK13184        134 VLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGV-PASEST  212 (932)
T ss_pred             ccccCCchheEEEcCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCC-CCCcHh
Confidence            999999999999999999999999998754110                   001124689999999988544 478999


Q ss_pred             hHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHH
Q 023609          130 DVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLV  209 (280)
Q Consensus       130 DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  209 (280)
                      ||||+||++++|++|..||.+.........  .....|..                         ......+++.+.+++
T Consensus       213 DIWSLGVILyELLTG~~PF~~~~~~ki~~~--~~i~~P~~-------------------------~~p~~~iP~~L~~LI  265 (932)
T PRK13184        213 DIYALGVILYQMLTLSFPYRRKKGRKISYR--DVILSPIE-------------------------VAPYREIPPFLSQIA  265 (932)
T ss_pred             HHHHHHHHHHHHHHCCCCCCCcchhhhhhh--hhccChhh-------------------------ccccccCCHHHHHHH
Confidence            999999999999999999976443222111  00101000                         011236788899999


Q ss_pred             HHhhcCCCCCCCCHHHHhc
Q 023609          210 EKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       210 ~~~L~~dp~~R~t~~ell~  228 (280)
                      .+||+.||++|++..+.+.
T Consensus       266 ~rcL~~DP~kR~ss~eeLl  284 (932)
T PRK13184        266 MKALAVDPAERYSSVQELK  284 (932)
T ss_pred             HHHccCChhhCcCHHHHHH
Confidence            9999999999988766554

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=2.4e-32  Score=224.13  Aligned_cols=199  Identities=38%  Similarity=0.693  Sum_probs=162.6

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++|+||+++++.+...     ...++++|++++ +|.+++.....++...+..++.+++.++.+||+.|++|+||+|.||
T Consensus        44 l~~~~i~~~~~~~~~~-----~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni  118 (244)
T smart00220       44 LKHPNIVRLYDVFEDE-----DKLYLVMEYCDGGDLFDLLKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENI  118 (244)
T ss_pred             CCCCcHHHHHhheeeC-----CEEEEEEeCCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHe
Confidence            4799999999998665     678999999986 9999998766699999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH-HHH
Q 023609           80 LLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVH-QLR  158 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-~~~  158 (280)
                      +++.++.++++|||.+.............++..|++||...+ ...+.++|+||+|++++++++|..||....... ...
T Consensus       119 ~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~~-~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~  197 (244)
T smart00220      119 LLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVLLG-KGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFK  197 (244)
T ss_pred             EECCCCcEEEccccceeeeccccccccccCCcCCCCHHHHcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHH
Confidence            999999999999999987665433445667888999998854 346789999999999999999999997733322 222


Q ss_pred             HHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 023609          159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  232 (280)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~  232 (280)
                      .+........                           .....++.++.+++.+||..+|++||++.++++||||
T Consensus       198 ~~~~~~~~~~---------------------------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~  244 (244)
T smart00220      198 KIGKPKPPFP---------------------------PPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF  244 (244)
T ss_pred             HHhccCCCCc---------------------------cccccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence            2211110000                           0011267889999999999999999999999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=3.7e-32  Score=230.62  Aligned_cols=204  Identities=18%  Similarity=0.198  Sum_probs=153.0

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   80 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nil   80 (280)
                      ++|+||+++++.+..... .....+++++++..++.+.+......++..+..++.|++.||+|||+.|++||||||+||+
T Consensus        80 ~~h~~i~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nil  158 (294)
T PHA02882         80 IDHLGIPKYYGCGSFKRC-RMYYRFILLEKLVENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIM  158 (294)
T ss_pred             CCCCCCCcEEEeeeEecC-CceEEEEEEehhccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence            469999999987644321 1134688999988888888776666789999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccceeeccCCC--------ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 023609           81 LNANCDLKICDFGLARVTSETD--------FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD  152 (280)
Q Consensus        81 i~~~~~~~l~dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  152 (280)
                      ++.++.++|+|||+++......        ......+|+.|+|||+..+ ..++.++||||+||++++|++|..||.+..
T Consensus       159 l~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~-~~~~~~~DiwSlG~~l~el~~g~~P~~~~~  237 (294)
T PHA02882        159 VDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNG-ACVTRRGDLESLGYCMLKWAGIKLPWKGFG  237 (294)
T ss_pred             EcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCccc
Confidence            9999999999999987543211        1123468999999998854 448999999999999999999999998763


Q ss_pred             hHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          153 HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                      .........+.                 .+.......     ....+..+..+.++++.|+..+|.+||+..++++
T Consensus       238 ~~~~~~~~~~~-----------------~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        238 HNGNLIHAAKC-----------------DFIKRLHEG-----KIKIKNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             cchHHHHHhHH-----------------HHHHHhhhh-----hhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            32221111110                 000000000     0012356788999999999999999999999875

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=5.8e-34  Score=243.49  Aligned_cols=223  Identities=33%  Similarity=0.610  Sum_probs=176.2

Q ss_pred             CeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE
Q 023609            5 NVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ---ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   81 (280)
Q Consensus         5 nIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~---~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nili   81 (280)
                      |+++++..|...     +++|+|+|-+.-+|.+++++-+   .|....++.++.||+.||..|-..||+|.||||+|||+
T Consensus       495 Hclrl~r~F~hk-----nHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLV  569 (752)
T KOG0670|consen  495 HCLRLFRHFKHK-----NHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILV  569 (752)
T ss_pred             HHHHHHHHhhhc-----ceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEe
Confidence            566777777555     8999999999999999998654   48999999999999999999999999999999999999


Q ss_pred             ccC-CCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 023609           82 NAN-CDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL  160 (280)
Q Consensus        82 ~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~  160 (280)
                      +.. ..+||||||.|...+++.. .....+..|.|||++.+.. |....|+||+||++|+|.||+..|+|.+..++++..
T Consensus       570 NE~k~iLKLCDfGSA~~~~enei-tPYLVSRFYRaPEIiLG~~-yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~  647 (752)
T KOG0670|consen  570 NESKNILKLCDFGSASFASENEI-TPYLVSRFYRAPEIILGLP-YDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLF  647 (752)
T ss_pred             ccCcceeeeccCccccccccccc-cHHHHHHhccCcceeecCc-ccCCccceeeceeeEEeeccceecCCCCcHHHHHHH
Confidence            875 5589999999998887753 3556688899999998765 889999999999999999999999999999999999


Q ss_pred             HHHhCCCCHHHHhHhhHhHHHHh--hhc-----------------Ccccc-ccc----------cccCCCCChHHHHHHH
Q 023609          161 IELIGTPSEAELGFLNENAKKYI--CQL-----------------PRYQR-QSF----------TEKFPNVHPSAIDLVE  210 (280)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~--~~~-----------------~~~~~-~~~----------~~~~~~~~~~~~~li~  210 (280)
                      ++.-|..+...+..-....-.|.  +.+                 ....+ ..+          +...+..-..+++||.
T Consensus       648 me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLd  727 (752)
T KOG0670|consen  648 MELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLD  727 (752)
T ss_pred             HHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHH
Confidence            99999888764421110000010  000                 00001 111          1111122356899999


Q ss_pred             HhhcCCCCCCCCHHHHhcCCCCCC
Q 023609          211 KMLTFDPRQRITVEDALAHPYLGS  234 (280)
Q Consensus       211 ~~L~~dp~~R~t~~ell~h~~~~~  234 (280)
                      +||..||++|.|+.++|.||||..
T Consensus       728 kml~LdP~KRit~nqAL~HpFi~~  751 (752)
T KOG0670|consen  728 KMLILDPEKRITVNQALKHPFITE  751 (752)
T ss_pred             HHhccChhhcCCHHHHhcCCcccC
Confidence            999999999999999999999964

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=4e-32  Score=239.06  Aligned_cols=156  Identities=26%  Similarity=0.341  Sum_probs=120.7

Q ss_pred             CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCCEEEeeccceeeccCCC---ccccceeccccccchhccC
Q 023609           45 LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLN  121 (280)
Q Consensus        45 l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nili~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~  121 (280)
                      +++..+..++.||+.||+|||+.|++||||||+||+++.++.++|+|||+++......   ......++..|+|||.+.+
T Consensus       236 l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  315 (401)
T cd05107         236 LSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFN  315 (401)
T ss_pred             CCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcC
Confidence            6777888999999999999999999999999999999999999999999987543221   1122345778999998854


Q ss_pred             CCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCC
Q 023609          122 SSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPN  200 (280)
Q Consensus       122 ~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  200 (280)
                       ..++.++|+||+|+++++|++ |..||......+...........+                            ...+.
T Consensus       316 -~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~~~----------------------------~~p~~  366 (401)
T cd05107         316 -NLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRM----------------------------AKPAH  366 (401)
T ss_pred             -CCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCCCC----------------------------CCCCC
Confidence             447889999999999999998 888997654433322221110000                            01125


Q ss_pred             CChHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 023609          201 VHPSAIDLVEKMLTFDPRQRITVEDALAH  229 (280)
Q Consensus       201 ~~~~~~~li~~~L~~dp~~R~t~~ell~h  229 (280)
                      ++.++.+++.+||..+|.+||++.++++.
T Consensus       367 ~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         367 ASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            67899999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=3.4e-32  Score=235.73  Aligned_cols=195  Identities=26%  Similarity=0.411  Sum_probs=148.7

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC--------------------------------------
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--------------------------------------   42 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~--------------------------------------   42 (280)
                      +||||+++++++....    ...++||||++ |+|.+++..+                                      
T Consensus        69 ~h~niv~~~~~~~~~~----~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  144 (343)
T cd05103          69 HHLNVVNLLGACTKPG----GPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSS  144 (343)
T ss_pred             CCccHhhhcceeecCC----CceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccc
Confidence            5899999999885432    46899999998 6999998642                                      


Q ss_pred             -----------------------------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCCEEEeecc
Q 023609           43 -----------------------------QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG   93 (280)
Q Consensus        43 -----------------------------~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nili~~~~~~~l~dfg   93 (280)
                                                   ..+++..+..++.|++.||+|||++|++||||||+||+++.++.++|+|||
T Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg  224 (343)
T cd05103         145 QSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFG  224 (343)
T ss_pred             cccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecc
Confidence                                         236788889999999999999999999999999999999999999999999


Q ss_pred             ceeeccCCCc---cccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCH
Q 023609           94 LARVTSETDF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQLRLLIELIGTPSE  169 (280)
Q Consensus        94 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~  169 (280)
                      ++........   .....++..|+|||.+.+. .++.++|+||+|+++++|++ |..||.+................+  
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~--  301 (343)
T cd05103         225 LARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM--  301 (343)
T ss_pred             cccccccCcchhhcCCCCCCcceECcHHhcCC-CCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCC--
Confidence            9875432211   1122345679999988544 47889999999999999996 889997654322211111000000  


Q ss_pred             HHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 023609          170 AELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  229 (280)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h  229 (280)
                                                ..-...++++.+++..||+.||.+|||+.++++|
T Consensus       302 --------------------------~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~  335 (343)
T cd05103         302 --------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  335 (343)
T ss_pred             --------------------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                                      0001356789999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=3.5e-32  Score=253.51  Aligned_cols=91  Identities=26%  Similarity=0.540  Sum_probs=84.4

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++.+...     ..+||||||+. ++|.+++...+.+++..++.++.||+.||+|||+.||+||||||+||
T Consensus        61 l~hp~Iv~~~~~~~~~-----~~~~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NI  135 (669)
T cd05610          61 SKSPFIVHLYYSLQSA-----NNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNM  135 (669)
T ss_pred             cCCCCcCeEEEEEEEC-----CEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHE
Confidence            5799999999988654     67999999996 69999998878899999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeecccee
Q 023609           80 LLNANCDLKICDFGLAR   96 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~   96 (280)
                      +++.++.++|+|||+++
T Consensus       136 Ll~~~g~vkL~DFGls~  152 (669)
T cd05610         136 LISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EEcCCCCEEEEeCCCCc
Confidence            99999999999999874

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.8e-33  Score=242.49  Aligned_cols=193  Identities=25%  Similarity=0.410  Sum_probs=162.4

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ-ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~-~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      |+|||||++||+....     ..+|||||+|. |+|.+++++++ .++..+...++++.+.|++|||+++++||||-..|
T Consensus       218 l~H~NVVr~yGVa~~~-----~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARN  292 (474)
T KOG0194|consen  218 LNHPNVVRFYGVAVLE-----EPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARN  292 (474)
T ss_pred             CCCCCEEEEEEEEcCC-----CccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHH
Confidence            6899999999998776     56999999997 69999999887 49999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCCCccc-cceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 023609           79 LLLNANCDLKICDFGLARVTSETDFMT-EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQ  156 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~  156 (280)
                      +|++.++.+|++|||+++......... .......|+|||.+... .++.++||||+||++||+.+ |..||.+....+.
T Consensus       293 cL~~~~~~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~-~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v  371 (474)
T KOG0194|consen  293 CLYSKKGVVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTG-IFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEV  371 (474)
T ss_pred             heecCCCeEEeCccccccCCcceeeccccccCcceecChhhhccC-ccccccchhheeeeEEeeeccCCCCCCCCCHHHH
Confidence            999999999999999988765332222 22245679999999544 69999999999999999987 7889999999888


Q ss_pred             HHHHHHH-hCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          157 LRLLIEL-IGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       157 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                      .+++... ...+.+                             +.-+.++..++.+|+..||++|||+.++.+
T Consensus       372 ~~kI~~~~~r~~~~-----------------------------~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~  415 (474)
T KOG0194|consen  372 KAKIVKNGYRMPIP-----------------------------SKTPKELAKVMKQCWKKDPEDRPTMSTIKK  415 (474)
T ss_pred             HHHHHhcCccCCCC-----------------------------CCCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence            8877432 222221                             134567889999999999999999998876

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.8e-33  Score=240.85  Aligned_cols=201  Identities=24%  Similarity=0.470  Sum_probs=159.9

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nil   80 (280)
                      +++-||++|-.|++.     ..+|+||+|+. |++-.++-+.+.|.|+.++.++.++..|+++.|++|++||||||+|||
T Consensus       687 Dn~WVVrLyySFQDk-----dnLYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNIL  761 (1034)
T KOG0608|consen  687 DNEWVVRLYYSFQDK-----DNLYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNIL  761 (1034)
T ss_pred             CCcceEEEEEEeccC-----CceEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceE
Confidence            466799999999877     78999999997 699999888899999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccceeecc-----------CC---C-----------------------------ccccceeccccccch
Q 023609           81 LNANCDLKICDFGLARVTS-----------ET---D-----------------------------FMTEYVVTRWYRAPE  117 (280)
Q Consensus        81 i~~~~~~~l~dfg~~~~~~-----------~~---~-----------------------------~~~~~~~~~~y~aPE  117 (280)
                      ||.+|+|||.|||+++...           +.   .                             ....-+||+.|+|||
T Consensus       762 IDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiape  841 (1034)
T KOG0608|consen  762 IDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPE  841 (1034)
T ss_pred             EccCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChH
Confidence            9999999999999985310           00   0                             001236799999999


Q ss_pred             hccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCcccccccccc
Q 023609          118 LLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEK  197 (280)
Q Consensus       118 ~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (280)
                      ++...+ ++..+|.||.|||+|+|+.|++||-+.+..+.-.++..                ...+    ...      ..
T Consensus       842 vl~r~g-~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~n----------------w~~~----l~~------~~  894 (1034)
T KOG0608|consen  842 VLARTG-YTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVIN----------------WRNF----LHI------PY  894 (1034)
T ss_pred             HhcccC-ccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeee----------------hhhc----ccc------cc
Confidence            997665 88999999999999999999999977665443222210                0000    000      11


Q ss_pred             CCCCChHHHHHHHHhhcCCCCCCC---CHHHHhcCCCCCCC
Q 023609          198 FPNVHPSAIDLVEKMLTFDPRQRI---TVEDALAHPYLGSL  235 (280)
Q Consensus       198 ~~~~~~~~~~li~~~L~~dp~~R~---t~~ell~h~~~~~~  235 (280)
                      ..++|.++.++|.++.+ +++.|+   .++++-.||||+.+
T Consensus       895 ~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaHpfFkgI  934 (1034)
T KOG0608|consen  895 QGNLSKEALDLIQKLCC-SADSRLGKNGADQVKAHPFFKGI  934 (1034)
T ss_pred             ccccCHHHHHHHHHHhc-ChhhhhcccchhhhhcCcccccc
Confidence            13789999999998764 888988   45689999999975

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=8.4e-32  Score=225.72  Aligned_cols=198  Identities=23%  Similarity=0.357  Sum_probs=151.6

Q ss_pred             CCCCCeeeeeceecCCCCCCC-CcEEEEeecCC-ccHHHHHHcC------CCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q 023609            1 MDHENVVAIRDIIPPPQRESF-NDVYIAYELMD-TDLHQIIRSN------QALSEEHCQYFLYQILRGLKYIHSANVLHR   72 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~-~~~~iv~e~~~-g~L~~~l~~~------~~l~~~~~~~i~~qll~al~~LH~~gi~H~   72 (280)
                      ++||||+++++++......+. ...+++++|+. |+|.+++...      ..+++..++.++.|++.||+|||+.|++||
T Consensus        58 l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~  137 (273)
T cd05074          58 FDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHR  137 (273)
T ss_pred             CCCCCcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeec
Confidence            589999999998866532221 23578999997 7998887422      247899999999999999999999999999


Q ss_pred             cCCCCcEEEccCCCEEEeeccceeeccCCC---ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCC
Q 023609           73 DLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLF  148 (280)
Q Consensus        73 di~~~nili~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf  148 (280)
                      ||||+||+++.++.++++|||.++......   ......+++.|++||.+.. ..++.++|+||+||++|+|++ |.+||
T Consensus       138 dikp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~-~~~~~~sDi~slG~il~el~~~g~~p~  216 (273)
T cd05074         138 DLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLAD-NVYTTHSDVWAFGVTMWEIMTRGQTPY  216 (273)
T ss_pred             ccchhhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhc-CccchhhhhHHHHHHHHHHhhCCCCCC
Confidence            999999999999999999999987653321   1112234567999998744 347889999999999999998 88999


Q ss_pred             CCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          149 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                      .+.+.......+.+...                             ...-+..+..+.+++.+||+.+|++|||+.+++.
T Consensus       217 ~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~  267 (273)
T cd05074         217 AGVENSEIYNYLIKGNR-----------------------------LKQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRD  267 (273)
T ss_pred             CCCCHHHHHHHHHcCCc-----------------------------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            76655443332221100                             0011356788999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=1.5e-31  Score=243.93  Aligned_cols=206  Identities=23%  Similarity=0.333  Sum_probs=140.0

Q ss_pred             CcEEEEeecCC-ccHHHHHHcCCC--------------------CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 023609           22 NDVYIAYELMD-TDLHQIIRSNQA--------------------LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   80 (280)
Q Consensus        22 ~~~~iv~e~~~-g~L~~~l~~~~~--------------------l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nil   80 (280)
                      ...++|+||++ ++|.+++.....                    ..+..+..++.||+.||+|||+.||+||||||+||+
T Consensus       208 ~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NIL  287 (566)
T PLN03225        208 DEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNII  287 (566)
T ss_pred             CceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHEE
Confidence            67999999998 689999865321                    123457789999999999999999999999999999


Q ss_pred             Ecc-CCCEEEeeccceeeccCC--CccccceeccccccchhccCCC---------------------CCCcchhHHHHHH
Q 023609           81 LNA-NCDLKICDFGLARVTSET--DFMTEYVVTRWYRAPELLLNSS---------------------DYTAAIDVWSVGC  136 (280)
Q Consensus        81 i~~-~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~---------------------~~~~~~DiwslG~  136 (280)
                      ++. ++.++|+|||+++.....  .......+++.|+|||.+....                     .+..++||||+||
T Consensus       288 l~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGv  367 (566)
T PLN03225        288 FSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGL  367 (566)
T ss_pred             EeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHH
Confidence            986 589999999999754322  2234567889999999763221                     1234569999999


Q ss_pred             HHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCC
Q 023609          137 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFD  216 (280)
Q Consensus       137 il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d  216 (280)
                      ++|+|+++..++  ......+.......+...........        ...........+.....+..+.+||.+||++|
T Consensus       368 iL~el~~~~~~~--~~~~~~~~~~l~~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~d  437 (566)
T PLN03225        368 IFLQMAFPNLRS--DSNLIQFNRQLKRNDYDLVAWRKLVE--------PRASPDLRRGFEVLDLDGGAGWELLKSMMRFK  437 (566)
T ss_pred             HHHHHHhCcCCC--chHHHHHHHHHHhcCCcHHHHHHhhc--------cccchhhhhhhhhccccchHHHHHHHHHccCC
Confidence            999999865443  33333333333333222111100000        00000000001112223456779999999999


Q ss_pred             CCCCCCHHHHhcCCCCCCCcC
Q 023609          217 PRQRITVEDALAHPYLGSLHD  237 (280)
Q Consensus       217 p~~R~t~~ell~h~~~~~~~~  237 (280)
                      |.+|||+.++|+||||.+...
T Consensus       438 P~kR~ta~e~L~Hpff~~~~~  458 (566)
T PLN03225        438 GRQRISAKAALAHPYFDREGL  458 (566)
T ss_pred             cccCCCHHHHhCCcCcCCCCc
Confidence            999999999999999987543

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=6.2e-33  Score=241.69  Aligned_cols=192  Identities=24%  Similarity=0.455  Sum_probs=163.6

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ-ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~-~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      ++||||++++|++.+      ...+||||++. |.|..+++.++ .++......+++||..||+|||+..+|||||-..|
T Consensus       448 fdHphIikLIGv~~e------~P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRN  521 (974)
T KOG4257|consen  448 FDHPHIIKLIGVCVE------QPMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARN  521 (974)
T ss_pred             CCCcchhheeeeeec------cceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhh
Confidence            589999999999965      45899999998 99999998765 69999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCCCccccce--eccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 023609           79 LLLNANCDLKICDFGLARVTSETDFMTEYV--VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVH  155 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~--~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~  155 (280)
                      |++.....+||+|||+++...+........  ...-|||||.+ +-..++.++|||.+|+.+||++. |..||.|....+
T Consensus       522 iLVsSp~CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESI-NfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD  600 (974)
T KOG4257|consen  522 ILVSSPQCVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESI-NFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD  600 (974)
T ss_pred             eeecCcceeeecccchhhhccccchhhccccccceeecCcccc-chhcccchhhHHHHHHHHHHHHHhcCCccccccccc
Confidence            999999999999999999887765433333  34569999988 45569999999999999999885 899999888777


Q ss_pred             HHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          156 QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                      .+..+......|-+                             |++++.+-.|+.+||.+||.+||++.++..
T Consensus       601 VI~~iEnGeRlP~P-----------------------------~nCPp~LYslmskcWayeP~kRPrftei~~  644 (974)
T KOG4257|consen  601 VIGHIENGERLPCP-----------------------------PNCPPALYSLMSKCWAYEPSKRPRFTEIKA  644 (974)
T ss_pred             eEEEecCCCCCCCC-----------------------------CCCChHHHHHHHHHhccCcccCCcHHHHHH
Confidence            76666544333322                             478899999999999999999999876654

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=1.4e-32  Score=231.54  Aligned_cols=203  Identities=27%  Similarity=0.515  Sum_probs=163.4

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN--VLHRDLKPS   77 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~g--i~H~di~~~   77 (280)
                      |+||-||++|++|..+.    ..+|.|+|||+| +|.-++++.+.+++.+++.|+.||+.||.||....  |+|-||||.
T Consensus       524 LDHpRIVKlYDyfslDt----dsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPg  599 (775)
T KOG1151|consen  524 LDHPRIVKLYDYFSLDT----DSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPG  599 (775)
T ss_pred             cCcceeeeeeeeeeecc----ccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCc
Confidence            68999999999997653    678999999997 88888999999999999999999999999999875  999999999


Q ss_pred             cEEEc---cCCCEEEeeccceeeccCCC--------ccccceeccccccchhccCC---CCCCcchhHHHHHHHHHHHHh
Q 023609           78 NLLLN---ANCDLKICDFGLARVTSETD--------FMTEYVVTRWYRAPELLLNS---SDYTAAIDVWSVGCIFMELMD  143 (280)
Q Consensus        78 nili~---~~~~~~l~dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~---~~~~~~~DiwslG~il~~ll~  143 (280)
                      ||++-   .-|.+||.|||+++.+.+..        ......||.+|++||++.-.   ...+.++||||+|||+|.++.
T Consensus       600 NILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClY  679 (775)
T KOG1151|consen  600 NILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLY  679 (775)
T ss_pred             cEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhc
Confidence            99983   34889999999998765432        23446789999999998543   345779999999999999999


Q ss_pred             CCCCCCCCChHH-HHHH--HHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCC
Q 023609          144 RKPLFPGRDHVH-QLRL--LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQR  220 (280)
Q Consensus       144 g~~pf~~~~~~~-~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R  220 (280)
                      |+.||...-..+ +++.  |.+...                  .++         ..-|-+++++++||++||++.-++|
T Consensus       680 GrKPFGhnqsQQdILqeNTIlkAtE------------------VqF---------P~KPvVsseAkaFIRRCLaYRKeDR  732 (775)
T KOG1151|consen  680 GRKPFGHNQSQQDILQENTILKATE------------------VQF---------PPKPVVSSEAKAFIRRCLAYRKEDR  732 (775)
T ss_pred             cCCCCCCchhHHHHHhhhchhccee------------------ccC---------CCCCccCHHHHHHHHHHHHhhhhhh
Confidence            999996543222 1111  100000                  001         1114789999999999999999999


Q ss_pred             CCHHHHhcCCCCCC
Q 023609          221 ITVEDALAHPYLGS  234 (280)
Q Consensus       221 ~t~~ell~h~~~~~  234 (280)
                      ..+.++-.||||-.
T Consensus       733 ~DV~qLA~dpyllP  746 (775)
T KOG1151|consen  733 IDVQQLACDPYLLP  746 (775)
T ss_pred             hhHHHHccCccccc
Confidence            99999999999965

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.98  E-value=1.7e-32  Score=260.87  Aligned_cols=203  Identities=17%  Similarity=0.259  Sum_probs=146.5

Q ss_pred             CC-CCeeeeeceecCCCCCCC--CcEEEEeecCCccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 023609            2 DH-ENVVAIRDIIPPPQRESF--NDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS   77 (280)
Q Consensus         2 ~H-pnIv~~~~~~~~~~~~~~--~~~~iv~e~~~g~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~   77 (280)
                      +| +||++++++|.....++.  ..++.++|+++++|.+++.. ...+++.+++.+++||+.||+|||++||+||||||+
T Consensus        30 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~  109 (793)
T PLN00181         30 SHIDYVRSLLGSHKEGNLDGLDDDSIVRALECEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPS  109 (793)
T ss_pred             hHHHHHHHhhcccCCccccccccchhhhhhccCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCch
Confidence            46 689999998844432221  35788899999999999975 346999999999999999999999999999999999


Q ss_pred             cEEEccCC-------------------CEEEeeccceeeccCCC-----------------ccccceeccccccchhccC
Q 023609           78 NLLLNANC-------------------DLKICDFGLARVTSETD-----------------FMTEYVVTRWYRAPELLLN  121 (280)
Q Consensus        78 nili~~~~-------------------~~~l~dfg~~~~~~~~~-----------------~~~~~~~~~~y~aPE~~~~  121 (280)
                      ||+++..|                   .++++|||+++......                 ......+|+.|+|||++.+
T Consensus       110 NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~  189 (793)
T PLN00181        110 CFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNG  189 (793)
T ss_pred             hEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhcc
Confidence            99996544                   45555666554321100                 0011356888999998865


Q ss_pred             CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCC
Q 023609          122 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNV  201 (280)
Q Consensus       122 ~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  201 (280)
                      . .++.++||||+||++|||++|.+|+.....  ....+.... .++.                            ....
T Consensus       190 ~-~~~~~sDVwSlGviL~ELl~~~~~~~~~~~--~~~~~~~~~-~~~~----------------------------~~~~  237 (793)
T PLN00181        190 S-SSNCASDVYRLGVLLFELFCPVSSREEKSR--TMSSLRHRV-LPPQ----------------------------ILLN  237 (793)
T ss_pred             C-CCCchhhhhhHHHHHHHHhhCCCchhhHHH--HHHHHHHhh-cChh----------------------------hhhc
Confidence            4 479999999999999999998887643211  111111000 0000                            0011


Q ss_pred             ChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCc
Q 023609          202 HPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  236 (280)
Q Consensus       202 ~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~  236 (280)
                      .+...+++.+||++||.+|||+.++++||||....
T Consensus       238 ~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~~~  272 (793)
T PLN00181        238 WPKEASFCLWLLHPEPSCRPSMSELLQSEFINEPR  272 (793)
T ss_pred             CHHHHHHHHHhCCCChhhCcChHHHhhchhhhhhh
Confidence            34567899999999999999999999999998753

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=4.8e-32  Score=233.90  Aligned_cols=205  Identities=24%  Similarity=0.397  Sum_probs=151.7

Q ss_pred             CCCCCeeeeeceecCCCCCCCC-cEEEEeecCC-ccHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHCC---ceecc
Q 023609            1 MDHENVVAIRDIIPPPQRESFN-DVYIAYELMD-TDLHQIIRSNQ--ALSEEHCQYFLYQILRGLKYIHSAN---VLHRD   73 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~-~~~iv~e~~~-g~L~~~l~~~~--~l~~~~~~~i~~qll~al~~LH~~g---i~H~d   73 (280)
                      ++|||||+++|||.+.     . +.++|+||+. |+|.+++....  +++|....+|+.+++.||+|||...   |+|||
T Consensus       128 l~H~Nlv~LlGyC~e~-----~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrD  202 (361)
T KOG1187|consen  128 LRHPNLVKLLGYCLEG-----GEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRD  202 (361)
T ss_pred             CCCcCcccEEEEEecC-----CceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCC
Confidence            5899999999999766     4 5899999998 89999998654  8999999999999999999999864   99999


Q ss_pred             CCCCcEEEccCCCEEEeeccceeeccC-CCccccc-eeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 023609           74 LKPSNLLLNANCDLKICDFGLARVTSE-TDFMTEY-VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGR  151 (280)
Q Consensus        74 i~~~nili~~~~~~~l~dfg~~~~~~~-~~~~~~~-~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~  151 (280)
                      ||++||++|.+...||+|||+++.... ....... .||..|++||.... +..+.++||||+|++++|+++|+.+.+..
T Consensus       203 iKssNILLD~~~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~-g~lt~KsDVySFGVvllElitgr~~~d~~  281 (361)
T KOG1187|consen  203 IKSSNILLDEDFNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYAST-GKLTEKSDVYSFGVVLLELITGRKAVDQS  281 (361)
T ss_pred             CCHHHeeECCCCCEEccCccCcccCCccccceeeecCCCCccCChhhhcc-CCcCcccccccchHHHHHHHhCCcccCCC
Confidence            999999999999999999999966554 3333333 78999999998854 55889999999999999999999877643


Q ss_pred             C---hHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCcccccccc-ccCC--CCChHHHHHHHHhhcCCCCCCCCHHH
Q 023609          152 D---HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFT-EKFP--NVHPSAIDLVEKMLTFDPRQRITVED  225 (280)
Q Consensus       152 ~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~li~~~L~~dp~~R~t~~e  225 (280)
                      .   ...............          .....+       ...+. ..++  ..-..+..+...|++.+|.+||++.+
T Consensus       282 ~~~~~~~l~~w~~~~~~~~----------~~~eii-------D~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~  344 (361)
T KOG1187|consen  282 RPRGELSLVEWAKPLLEEG----------KLREIV-------DPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQ  344 (361)
T ss_pred             CCcccccHHHHHHHHHHCc----------chhhee-------CCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHH
Confidence            2   111111111111111          000000       00000 1111  01123667888999999999999999


Q ss_pred             Hhc
Q 023609          226 ALA  228 (280)
Q Consensus       226 ll~  228 (280)
                      ++.
T Consensus       345 Vv~  347 (361)
T KOG1187|consen  345 VVK  347 (361)
T ss_pred             HHH
Confidence            754

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=99.98  E-value=1.5e-32  Score=238.75  Aligned_cols=196  Identities=21%  Similarity=0.345  Sum_probs=156.5

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCCc-cHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      +|.||+-+.+++-.+      .+.||+.+|+| +|+.++.-. ..|.......|+.|+++|+.|||.++|+|||||..||
T Consensus       446 RH~NIlLFMG~~~~p------~~AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNI  519 (678)
T KOG0193|consen  446 RHENILLFMGACMNP------PLAIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNI  519 (678)
T ss_pred             chhhheeeehhhcCC------ceeeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccce
Confidence            699999999999655      34999999997 999999743 3599999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeecc---CCCccccceeccccccchhccC--CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH
Q 023609           80 LLNANCDLKICDFGLARVTS---ETDFMTEYVVTRWYRAPELLLN--SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHV  154 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~---~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  154 (280)
                      ++..++.++|+|||++..-.   .........+...|||||++..  ..+|++.+||||+|+++|||++|..||......
T Consensus       520 Fl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~d  599 (678)
T KOG0193|consen  520 FLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRD  599 (678)
T ss_pred             EEccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChh
Confidence            99999999999999986421   1222345567888999999853  346899999999999999999999999854443


Q ss_pred             HHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          155 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                      +++-.+-.....|                         .......+.+.++++|+..||.+++++||+..+||.
T Consensus       600 qIifmVGrG~l~p-------------------------d~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  600 QIIFMVGRGYLMP-------------------------DLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             heEEEecccccCc-------------------------cchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence            3322211111111                         112233466779999999999999999999999887

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.98  E-value=1.7e-31  Score=224.96  Aligned_cols=210  Identities=24%  Similarity=0.394  Sum_probs=152.3

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ-ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~-~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      ++||||+++++++.....   ...++||||++ ++|.+++...+ .+++..+..++.||+.||+|||+.|++|+||+|+|
T Consensus        63 l~~~~i~~~~~~~~~~~~---~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~n  139 (284)
T cd05038          63 LDHENIVKYKGVCEKPGG---RSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARN  139 (284)
T ss_pred             CCCCChheEEeeeecCCC---CceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHh
Confidence            579999999998865422   56899999997 69999997654 59999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCCCc----cccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH
Q 023609           79 LLLNANCDLKICDFGLARVTSETDF----MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHV  154 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  154 (280)
                      |+++.++.++|+|||.+........    .....++..|++||.+... .++.++|+||+|+++++|++|..|+......
T Consensus       140 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~-~~~~~~Di~slG~~l~el~tg~~p~~~~~~~  218 (284)
T cd05038         140 ILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTS-KFSSASDVWSFGVTLYELFTYGDPSQSPPAE  218 (284)
T ss_pred             EEEcCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccC-CCCcccchHHHhhhhheeeccCCCcccccch
Confidence            9999999999999999986653211    1112334569999988544 5788999999999999999999888543221


Q ss_pred             HHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          155 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                      ..     ...+.....   ................      ......+.++.+++.+||+.+|.+|||+.++++
T Consensus       219 ~~-----~~~~~~~~~---~~~~~~~~~~~~~~~~------~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         219 FL-----RMIGIAQGQ---MIVTRLLELLKEGERL------PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             hc-----ccccccccc---ccHHHHHHHHHcCCcC------CCCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            10     000000000   0000000000000000      011245678999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.2e-31  Score=249.49  Aligned_cols=193  Identities=26%  Similarity=0.422  Sum_probs=162.6

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC-------CCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-------QALSEEHCQYFLYQILRGLKYIHSANVLHR   72 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-------~~l~~~~~~~i~~qll~al~~LH~~gi~H~   72 (280)
                      ++|||||++++++.+.     ...+|++|||+ |+|..++++.       ..++......++.||+.|..||+++++|||
T Consensus       752 f~HpNiv~liGv~l~~-----~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHR  826 (1025)
T KOG1095|consen  752 FDHPNIVSLIGVCLDS-----GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHR  826 (1025)
T ss_pred             CCCcceeeEEEeecCC-----CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCc
Confidence            5899999999999875     67899999997 7999999865       349999999999999999999999999999


Q ss_pred             cCCCCcEEEccCCCEEEeeccceeeccCCCcc--cc-ceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCC
Q 023609           73 DLKPSNLLLNANCDLKICDFGLARVTSETDFM--TE-YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLF  148 (280)
Q Consensus        73 di~~~nili~~~~~~~l~dfg~~~~~~~~~~~--~~-~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf  148 (280)
                      ||...|+|++....+|++|||+|+..-.....  .. ......|||||.+.. +.++.++||||+||++||+++ |..||
T Consensus       827 DLAaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d-~iFtskSDvWsFGVllWEifslG~~PY  905 (1025)
T KOG1095|consen  827 DLAARNCLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKD-GIFTSKSDVWSFGVLLWEIFSLGATPY  905 (1025)
T ss_pred             chhhhheeecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhh-cccccccchhhhHHHHHHHHhCCCCCC
Confidence            99999999999999999999999844332211  11 234567999999965 569999999999999999997 88999


Q ss_pred             CCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          149 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                      ++.+..+.+....+....+++                             +.++..+.++|..||+.+|++||++..+++
T Consensus       906 ~~~~n~~v~~~~~~ggRL~~P-----------------------------~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  906 PSRSNFEVLLDVLEGGRLDPP-----------------------------SYCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             CCcchHHHHHHHHhCCccCCC-----------------------------CCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence            999888877655443322221                             256778899999999999999999999988

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.2e-31  Score=218.89  Aligned_cols=204  Identities=24%  Similarity=0.466  Sum_probs=163.8

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nil   80 (280)
                      +||.+|.++..|+..     ..+|.|.||++ |+|--.+.+++.+++..++.+..+|+.||.|||++||++||+|.+|++
T Consensus       309 n~pflvglhscfqte-----srlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvl  383 (593)
T KOG0695|consen  309 NNPFLVGLHSCFQTE-----SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVL  383 (593)
T ss_pred             CCCeEEehhhhhccc-----ceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceE
Confidence            699999999999776     66999999997 688888888888999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccceee-ccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC--ChHHHH
Q 023609           81 LNANCDLKICDFGLARV-TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGR--DHVHQL  157 (280)
Q Consensus        81 i~~~~~~~l~dfg~~~~-~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~--~~~~~~  157 (280)
                      ++..|.+||.|+|.++. ..+.....+.+|||.|.|||++.+. .|+.++|.|+||+++++|+.|+.||+-.  ...   
T Consensus       384 ldaeghikltdygmcke~l~~gd~tstfcgtpnyiapeilrge-eygfsvdwwalgvlmfemmagrspfdivgm~n~---  459 (593)
T KOG0695|consen  384 LDAEGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGE-EYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNP---  459 (593)
T ss_pred             EccCCceeecccchhhcCCCCCcccccccCCCcccchhhhccc-ccCceehHHHHHHHHHHHHcCCCCcceecCCCc---
Confidence            99999999999999874 4566677889999999999988554 5999999999999999999999999521  100   


Q ss_pred             HHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCC------HHHHhcCCC
Q 023609          158 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT------VEDALAHPY  231 (280)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t------~~ell~h~~  231 (280)
                                        +++...|..+..-....   +.-..+|-.+..+++..|++||.+|+.      ..++-.|+|
T Consensus       460 ------------------d~ntedylfqvilekqi---riprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~f  518 (593)
T KOG0695|consen  460 ------------------DMNTEDYLFQVILEKQI---RIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAF  518 (593)
T ss_pred             ------------------ccchhHHHHHHHhhhcc---cccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchh
Confidence                              01111111111100000   011145667888999999999999984      578999999


Q ss_pred             CCCC
Q 023609          232 LGSL  235 (280)
Q Consensus       232 ~~~~  235 (280)
                      |..+
T Consensus       519 fr~i  522 (593)
T KOG0695|consen  519 FRSI  522 (593)
T ss_pred             hhhC
Confidence            9864

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.97  E-value=5.1e-33  Score=220.05  Aligned_cols=208  Identities=25%  Similarity=0.406  Sum_probs=164.4

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHH-----cCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCC
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIR-----SNQALSEEHCQYFLYQILRGLKYIHSA-NVLHRDLK   75 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~-----~~~~l~~~~~~~i~~qll~al~~LH~~-gi~H~di~   75 (280)
                      +.||||++|++....     +..+|-||+|+-+|..+.+     ++..++|..+-.|..-.+.||+||-.. .|+|||+|
T Consensus       121 ~cp~IVkfyGa~F~E-----GdcWiCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvK  195 (361)
T KOG1006|consen  121 NCPNIVKFYGALFSE-----GDCWICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVK  195 (361)
T ss_pred             CCcHHHHHhhhhhcC-----CceeeeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCC
Confidence            468999999998765     6789999999977665543     456799999999999999999999964 79999999


Q ss_pred             CCcEEEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCC-CCcchhHHHHHHHHHHHHhCCCCCCCCChH
Q 023609           76 PSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD-YTAAIDVWSVGCIFMELMDRKPLFPGRDHV  154 (280)
Q Consensus        76 ~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~-~~~~~DiwslG~il~~ll~g~~pf~~~~~~  154 (280)
                      |+||+++..|.+||||||++....+..-.+...|-..|||||.+..... +..++|+||||++++|+.||..|+.+-+  
T Consensus       196 PSNILldr~G~vKLCDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~--  273 (361)
T KOG1006|consen  196 PSNILLDRHGDVKLCDFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWD--  273 (361)
T ss_pred             hhheEEecCCCEeeecccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHH--
Confidence            9999999999999999999987655433344566778999999865554 8899999999999999999999986432  


Q ss_pred             HHHHHHHHH-hCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCC
Q 023609          155 HQLRLLIEL-IGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLG  233 (280)
Q Consensus       155 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~  233 (280)
                      ..+..+... .|.|+.-.                      ....--+++..+..+|..||.+|-+.||...+++.+||+.
T Consensus       274 svfeql~~Vv~gdpp~l~----------------------~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr  331 (361)
T KOG1006|consen  274 SVFEQLCQVVIGDPPILL----------------------FDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYR  331 (361)
T ss_pred             HHHHHHHHHHcCCCCeec----------------------CcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhh
Confidence            233333222 23333210                      0011125788999999999999999999999999999998


Q ss_pred             CCcCC
Q 023609          234 SLHDI  238 (280)
Q Consensus       234 ~~~~~  238 (280)
                      .+...
T Consensus       332 ~y~~~  336 (361)
T KOG1006|consen  332 MYAVE  336 (361)
T ss_pred             hhhhc
Confidence            87543

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.97  E-value=4e-32  Score=243.33  Aligned_cols=198  Identities=30%  Similarity=0.413  Sum_probs=152.3

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHcCCC----CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQA----LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS   77 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~----l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~   77 (280)
                      +|||||++|+.-.+.     ...||..|+|..+|.++++..+.    ...-..+.++.|++.||++||+.+|+||||||.
T Consensus       561 ~H~NviRyyc~E~d~-----qF~YIalELC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQ  635 (903)
T KOG1027|consen  561 EHPNVIRYYCSEQDR-----QFLYIALELCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQ  635 (903)
T ss_pred             CCCceEEEEeeccCC-----ceEEEEehHhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCc
Confidence            699999999987655     78999999999999999987411    111345789999999999999999999999999


Q ss_pred             cEEEcc---C--CCEEEeeccceeeccCCC----ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhC-CCC
Q 023609           78 NLLLNA---N--CDLKICDFGLARVTSETD----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR-KPL  147 (280)
Q Consensus        78 nili~~---~--~~~~l~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g-~~p  147 (280)
                      ||+|+.   +  .+++|+|||+++......    ......||..|.|||++.... -..++||||+||++|+.++| ..|
T Consensus       636 NILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~-~~~avDiFslGCvfyYvltgG~Hp  714 (903)
T KOG1027|consen  636 NILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDR-KTQAVDIFSLGCVFYYVLTGGSHP  714 (903)
T ss_pred             eEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccc-cCcccchhhcCceEEEEecCCccC
Confidence            999976   3  468999999998765443    234567899999999996554 46799999999999999875 799


Q ss_pred             CCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHh
Q 023609          148 FPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDAL  227 (280)
Q Consensus       148 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell  227 (280)
                      |.+....+.  .|...                   .        .......+....++.+||.+||.++|..||+|.++|
T Consensus       715 FGd~~~R~~--NIl~~-------------------~--------~~L~~L~~~~d~eA~dLI~~ml~~dP~~RPsa~~VL  765 (903)
T KOG1027|consen  715 FGDSLERQA--NILTG-------------------N--------YTLVHLEPLPDCEAKDLISRMLNPDPQLRPSATDVL  765 (903)
T ss_pred             CCchHHhhh--hhhcC-------------------c--------cceeeeccCchHHHHHHHHHhcCCCcccCCCHHHHh
Confidence            965433221  11100                   0        000011111222799999999999999999999999


Q ss_pred             cCCCCCC
Q 023609          228 AHPYLGS  234 (280)
Q Consensus       228 ~h~~~~~  234 (280)
                      .||+|=.
T Consensus       766 ~HPlFW~  772 (903)
T KOG1027|consen  766 NHPLFWD  772 (903)
T ss_pred             CCCccCC
Confidence            9999954

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=2.7e-31  Score=239.07  Aligned_cols=206  Identities=25%  Similarity=0.453  Sum_probs=166.5

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS--NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~--~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      +|||++.++++|.-......+.+++|||||+ |+.-|+++.  ..++.|..+..|++.++.|+.+||...++|||||-.|
T Consensus        74 ~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~N  153 (953)
T KOG0587|consen   74 HHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQN  153 (953)
T ss_pred             CCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCce
Confidence            6999999999986655455578999999998 699999874  4579999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCC-CccccceeccccccchhccCCC----CCCcchhHHHHHHHHHHHHhCCCCCCCCCh
Q 023609           79 LLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSS----DYTAAIDVWSVGCIFMELMDRKPLFPGRDH  153 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~----~~~~~~DiwslG~il~~ll~g~~pf~~~~~  153 (280)
                      |+++.+|.+||+|||.+...... ....+..||+.|||||++.+..    .|..++|+||||++..+|..|.+|+-+.-+
T Consensus       154 iLLT~e~~VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP  233 (953)
T KOG0587|consen  154 VLLTENAEVKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP  233 (953)
T ss_pred             EEEeccCcEEEeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch
Confidence            99999999999999998765543 3345678999999999986543    356789999999999999999999965433


Q ss_pred             HHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCC
Q 023609          154 VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLG  233 (280)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~  233 (280)
                      .-   .++....-|+..                       + ......+..+.+||..||.+|-.+||+..++|.|||..
T Consensus       234 mr---aLF~IpRNPPPk-----------------------L-krp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~  286 (953)
T KOG0587|consen  234 MR---ALFLIPRNPPPK-----------------------L-KRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFIT  286 (953)
T ss_pred             hh---hhccCCCCCCcc-----------------------c-cchhhHHHHHHHHHHHHHhhccccCcchhhhccCCccc
Confidence            21   112112222211                       0 11124567899999999999999999999999999998


Q ss_pred             C
Q 023609          234 S  234 (280)
Q Consensus       234 ~  234 (280)
                      .
T Consensus       287 e  287 (953)
T KOG0587|consen  287 E  287 (953)
T ss_pred             c
Confidence            3

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.7e-30  Score=220.73  Aligned_cols=230  Identities=28%  Similarity=0.493  Sum_probs=163.7

Q ss_pred             CCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEE
Q 023609            4 ENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHS-ANVLHRDLKPSNLL   80 (280)
Q Consensus         4 pnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~-~gi~H~di~~~nil   80 (280)
                      .+||++++.|...++++ .++++|+|+++.+|..+|...  +.++...++.|++|||.||.|||+ .||+|.||||+|||
T Consensus       142 ~~VV~LlD~FkhsGpNG-~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvL  220 (590)
T KOG1290|consen  142 KCVVQLLDHFKHSGPNG-QHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVL  220 (590)
T ss_pred             ceeeeeeccceecCCCC-cEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceee
Confidence            47999999998887666 789999999999999999854  359999999999999999999996 59999999999999


Q ss_pred             EccC-----------C----------------------------------------------------------------
Q 023609           81 LNAN-----------C----------------------------------------------------------------   85 (280)
Q Consensus        81 i~~~-----------~----------------------------------------------------------------   85 (280)
                      +..+           +                                                                
T Consensus       221 l~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~~kk~~r~~~~~~~~l~~~~~~~~~~~~  300 (590)
T KOG1290|consen  221 LCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKMKKKLKRQAKKLEASLAGLEGIEEEPNQ  300 (590)
T ss_pred             eeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHHHHHHhhhhhhhhhhhcccccccccccc
Confidence            8400           0                                                                


Q ss_pred             --------------------------------------------------------------------------------
Q 023609           86 --------------------------------------------------------------------------------   85 (280)
Q Consensus        86 --------------------------------------------------------------------------------   85 (280)
                                                                                                      
T Consensus       301 ~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~~~~~~t~~~~~~~s~~s~~~~~~n~~v  380 (590)
T KOG1290|consen  301 ESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQLRDSATPSDGSLSSPSSPGTIASNPLV  380 (590)
T ss_pred             cccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchhcccccccccccccCcCCcccccccccc
Confidence                                                                                            


Q ss_pred             -----------CEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCC----
Q 023609           86 -----------DLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPG----  150 (280)
Q Consensus        86 -----------~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~----  150 (280)
                                 .+||.|||-+......  .+.-+.|..|.|||++.+.+ |+..+||||++|+++||+||...|.-    
T Consensus       381 ~p~~~~~~~di~vKIaDlGNACW~~kh--FT~DIQTRQYRapEVllGsg-Y~~~ADiWS~AC~~FELaTGDyLFePhsG~  457 (590)
T KOG1290|consen  381 NPDIPLPECDIRVKIADLGNACWVHKH--FTEDIQTRQYRAPEVLLGSG-YSTSADIWSTACMAFELATGDYLFEPHSGE  457 (590)
T ss_pred             CCCCCCCccceeEEEeeccchhhhhhh--hchhhhhhhccCcceeecCC-CCCchhHHHHHHHHHHhhcCceeecCCCCC
Confidence                       0111111111100000  01113378899999998876 89999999999999999999988852    


Q ss_pred             --CChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCC---------CC----ChHHHHHHHHhhcC
Q 023609          151 --RDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP---------NV----HPSAIDLVEKMLTF  215 (280)
Q Consensus       151 --~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~~----~~~~~~li~~~L~~  215 (280)
                        ..+.+.++.|++.+|..+..... --.....|......-....--+.+|         .+    ..++.+||.-||+.
T Consensus       458 ~Y~rDEDHiA~i~ELLG~iPr~ia~-~Gk~SRdFFnr~G~LrhI~~LK~WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef  536 (590)
T KOG1290|consen  458 NYSRDEDHIALIMELLGKIPRKIAL-GGKYSRDFFNRRGELRHIRRLKPWPLYEVLIEKYEWSEEDAQQFSDFLSPMLEF  536 (590)
T ss_pred             CCCccHHHHHHHHHHHhhccHHHHh-cCcchHhhhccccceecccccCCCcHHHHHHHHhCCCHHHHHHHHHHHHHHHhc
Confidence              24678899999999987764221 0111122222111100000000111         12    35688999999999


Q ss_pred             CCCCCCCHHHHhcCCCCCCCcCC
Q 023609          216 DPRQRITVEDALAHPYLGSLHDI  238 (280)
Q Consensus       216 dp~~R~t~~ell~h~~~~~~~~~  238 (280)
                      +|.+||||.+.|+|||+.....+
T Consensus       537 ~PeKR~tA~~cl~hPwLn~~~~~  559 (590)
T KOG1290|consen  537 DPEKRPTAAQCLKHPWLNPVAGP  559 (590)
T ss_pred             CccccccHHHHhcCccccCCCCC
Confidence            99999999999999999987654

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.97  E-value=3.2e-30  Score=238.90  Aligned_cols=184  Identities=34%  Similarity=0.509  Sum_probs=137.6

Q ss_pred             CcEEEEeecCCc-cHHHHHHcCCCC-CHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCCEEEeeccceeecc
Q 023609           22 NDVYIAYELMDT-DLHQIIRSNQAL-SEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS   99 (280)
Q Consensus        22 ~~~~iv~e~~~g-~L~~~l~~~~~l-~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nili~~~~~~~l~dfg~~~~~~   99 (280)
                      ..+||-||||+. .+.++++.+... ..+..+++++||++||.|+|++|++||||||.|||++.++.+||+|||+++...
T Consensus       669 ~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~  748 (1351)
T KOG1035|consen  669 LILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLK  748 (1351)
T ss_pred             eEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCceeeccCCcceeEEcCCCCeeecccccchhhh
Confidence            358999999996 566666655544 478899999999999999999999999999999999999999999999997511


Q ss_pred             -------------------CCCccccceeccccccchhccCCC--CCCcchhHHHHHHHHHHHHhCCCCCCCCC-hHHHH
Q 023609          100 -------------------ETDFMTEYVVTRWYRAPELLLNSS--DYTAAIDVWSVGCIFMELMDRKPLFPGRD-HVHQL  157 (280)
Q Consensus       100 -------------------~~~~~~~~~~~~~y~aPE~~~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~  157 (280)
                                         .....+..+||.-|+|||.+.+..  .|..++|+||||+|++||+.   ||...- ....+
T Consensus       749 ~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL  825 (1351)
T KOG1035|consen  749 ENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASIL  825 (1351)
T ss_pred             hhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCchHHHHHHH
Confidence                               111345678999999999997666  68999999999999999974   454321 11122


Q ss_pred             HHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCC
Q 023609          158 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS  234 (280)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~  234 (280)
                      ..+.    .+..+.                     + ...+..--+.-..+|+.||+.||++||||.|+|++.||-.
T Consensus       826 ~~LR----~g~iP~---------------------~-~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llpp  876 (1351)
T KOG1035|consen  826 TNLR----KGSIPE---------------------P-ADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSELLPP  876 (1351)
T ss_pred             Hhcc----cCCCCC---------------------C-cccccccchHHHHHHHHHhcCCCccCCCHHHHhhccCCCc
Confidence            2111    111000                     0 0011122234678999999999999999999999999974

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.97  E-value=5.1e-31  Score=232.95  Aligned_cols=150  Identities=28%  Similarity=0.439  Sum_probs=130.5

Q ss_pred             CCCCCeeeeeceecCCCC-CCCCcEEEEeecCC-ccHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCC
Q 023609            1 MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMD-TDLHQIIRSN---QALSEEHCQYFLYQILRGLKYIHSANVLHRDLK   75 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~-~~~~~~~iv~e~~~-g~L~~~l~~~---~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~   75 (280)
                      |+|||||+++++=.+... .-.....+|||||. |+|+..+++-   ..+++.++..++..+..|+.|||.+||+|||||
T Consensus        68 Lnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlK  147 (732)
T KOG4250|consen   68 LNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLK  147 (732)
T ss_pred             cCchhhhhhcccCCccccCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCC
Confidence            689999999998654421 11356799999997 7999999743   359999999999999999999999999999999


Q ss_pred             CCcEEE--ccCCC--EEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 023609           76 PSNLLL--NANCD--LKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPG  150 (280)
Q Consensus        76 ~~nili--~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~  150 (280)
                      |.||++  +.+|+  .||+|||.|+...++.......||..|.+||.+...+.|+..+|.||+||++|+++||..||.-
T Consensus       148 P~NIvl~~Gedgq~IyKLtDfG~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p  226 (732)
T KOG4250|consen  148 PGNIVLQIGEDGQSIYKLTDFGAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIP  226 (732)
T ss_pred             CCcEEEeecCCCceEEeeecccccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCc
Confidence            999987  34454  6999999999999998888999999999999987667799999999999999999999999853

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=99.97  E-value=5.7e-31  Score=234.41  Aligned_cols=193  Identities=24%  Similarity=0.390  Sum_probs=169.2

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      ++||||+++-++..-.     ..++||+|||+ |+|..+++++ +.|+.-++..+++.|+.|..||-++|+|||||...|
T Consensus       687 FdHPNIIrLEGVVTks-----~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARN  761 (996)
T KOG0196|consen  687 FDHPNIIRLEGVVTKS-----KPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARN  761 (996)
T ss_pred             CCCCcEEEEEEEEecC-----ceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhh
Confidence            4799999999999655     77999999998 8999999865 579999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCCC-cccc---ceeccccccchhccCCCCCCcchhHHHHHHHHHHHH-hCCCCCCCCCh
Q 023609           79 LLLNANCDLKICDFGLARVTSETD-FMTE---YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM-DRKPLFPGRDH  153 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~~-~~~~---~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll-~g~~pf~~~~~  153 (280)
                      ||++.+-.+|++|||+++...+.. ...+   ..-...|+|||.+... +++.++||||+|++|||.+ .|..||-+-+.
T Consensus       762 ILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~R-KFTsASDVWSyGIVmWEVmSyGERPYWdmSN  840 (996)
T KOG0196|consen  762 ILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYR-KFTSASDVWSYGIVMWEVMSYGERPYWDMSN  840 (996)
T ss_pred             eeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhc-ccCchhhccccceEEEEecccCCCcccccch
Confidence            999999999999999999775443 1111   1224679999999544 5999999999999999977 58999999999


Q ss_pred             HHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          154 VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                      .+.+..+.+..+.|++-                             +++..+.+||..||++|-++||++.++++
T Consensus       841 QdVIkaIe~gyRLPpPm-----------------------------DCP~aL~qLMldCWqkdR~~RP~F~qiV~  886 (996)
T KOG0196|consen  841 QDVIKAIEQGYRLPPPM-----------------------------DCPAALYQLMLDCWQKDRNRRPKFAQIVS  886 (996)
T ss_pred             HHHHHHHHhccCCCCCC-----------------------------CCcHHHHHHHHHHHHHHhhcCCCHHHHHH
Confidence            99999999988877753                             78889999999999999999999999887

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.97  E-value=8.7e-30  Score=199.94  Aligned_cols=166  Identities=23%  Similarity=0.322  Sum_probs=126.8

Q ss_pred             ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCCEEEeeccceeeccCCCccccceecc
Q 023609           33 TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR  111 (280)
Q Consensus        33 g~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  111 (280)
                      |+|.+++.. ++++++.+++.++.|++.||+|||+.|      ||+||+++.++.+++  ||.+......    ...+++
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~----~~~g~~   68 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE----QSRVDP   68 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc----cCCCcc
Confidence            689999986 456999999999999999999999998      999999999999999  9998876543    236789


Q ss_pred             ccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccc
Q 023609          112 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHV-HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQ  190 (280)
Q Consensus       112 ~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  190 (280)
                      .|+|||++.+. .++.++||||+||++|+|++|..||...... .....+...........                   
T Consensus        69 ~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~-------------------  128 (176)
T smart00750       69 YFMAPEVIQGQ-SYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRD-------------------  128 (176)
T ss_pred             cccChHHhcCC-CCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccc-------------------
Confidence            99999998554 5789999999999999999999999654332 22222221111100000                   


Q ss_pred             cccccccCCCCCh--HHHHHHHHhhcCCCCCCCCHHHHhcCCCCCC
Q 023609          191 RQSFTEKFPNVHP--SAIDLVEKMLTFDPRQRITVEDALAHPYLGS  234 (280)
Q Consensus       191 ~~~~~~~~~~~~~--~~~~li~~~L~~dp~~R~t~~ell~h~~~~~  234 (280)
                       .   .....++.  +++++|.+||..||.+|||+.+++.|+|+..
T Consensus       129 -~---~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~  170 (176)
T smart00750      129 -R---SNLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF  170 (176)
T ss_pred             -c---ccHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence             0   00001222  6899999999999999999999999998753

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.96  E-value=9.6e-30  Score=222.00  Aligned_cols=192  Identities=24%  Similarity=0.411  Sum_probs=160.0

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS   77 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~   77 (280)
                      ++|||+|+++++|...     ..+|||+|||. |+|.+|++..  ..++.-....++.||..|++||.+++++||||-..
T Consensus       320 ikHpNLVqLLGVCT~E-----pPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAAR  394 (1157)
T KOG4278|consen  320 IKHPNLVQLLGVCTHE-----PPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAAR  394 (1157)
T ss_pred             hcCccHHHHhhhhccC-----CCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhh
Confidence            5899999999999665     66999999987 8999999853  34788888999999999999999999999999999


Q ss_pred             cEEEccCCCEEEeeccceeeccCCCccccce---eccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCh
Q 023609           78 NLLLNANCDLKICDFGLARVTSETDFMTEYV---VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDH  153 (280)
Q Consensus        78 nili~~~~~~~l~dfg~~~~~~~~~~~~~~~---~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~  153 (280)
                      |++++.+-.+|+.|||+++.+..... ....   ...-|+|||.+. ...++.++|||++|+++|++.| |-.||+|-+.
T Consensus       395 NCLVgEnhiVKvADFGLsRlMtgDTY-TAHAGAKFPIKWTAPEsLA-yNtFSiKSDVWAFGVLLWEIATYGMsPYPGidl  472 (1157)
T KOG4278|consen  395 NCLVGENHIVKVADFGLSRLMTGDTY-TAHAGAKFPIKWTAPESLA-YNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDL  472 (1157)
T ss_pred             hccccccceEEeeccchhhhhcCCce-ecccCccCcccccCccccc-ccccccchhhHHHHHHHHHHHhcCCCCCCCccH
Confidence            99999999999999999998765432 1222   245599999884 4458999999999999999987 7899999888


Q ss_pred             HHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          154 VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                      .+.+..+.+.......                             .++++...+||+.||+++|++||++.|+-+
T Consensus       473 SqVY~LLEkgyRM~~P-----------------------------eGCPpkVYeLMraCW~WsPsDRPsFaeiHq  518 (1157)
T KOG4278|consen  473 SQVYGLLEKGYRMDGP-----------------------------EGCPPKVYELMRACWNWSPSDRPSFAEIHQ  518 (1157)
T ss_pred             HHHHHHHhccccccCC-----------------------------CCCCHHHHHHHHHHhcCCcccCccHHHHHH
Confidence            7777766543322111                             278889999999999999999999988744

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.96  E-value=4.7e-29  Score=222.79  Aligned_cols=213  Identities=19%  Similarity=0.280  Sum_probs=144.3

Q ss_pred             CeeeeeceecCCCCCC---CCcEEEEeecCC-ccHHHHHHcC------------------------CCCCHHHHHHHHHH
Q 023609            5 NVVAIRDIIPPPQRES---FNDVYIAYELMD-TDLHQIIRSN------------------------QALSEEHCQYFLYQ   56 (280)
Q Consensus         5 nIv~~~~~~~~~~~~~---~~~~~iv~e~~~-g~L~~~l~~~------------------------~~l~~~~~~~i~~q   56 (280)
                      +++++++++.....++   ....++|+||++ ++|.+++...                        ..+++..++.++.|
T Consensus       238 ~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~i~~q  317 (507)
T PLN03224        238 SCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQ  317 (507)
T ss_pred             hhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHHHHHHH
Confidence            4467777765432111   246899999998 6998888532                        12456788999999


Q ss_pred             HHHHHHHHHHCCceeccCCCCcEEEccCCCEEEeeccceeeccCCCcc--ccceeccccccchhccCCCC----------
Q 023609           57 ILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM--TEYVVTRWYRAPELLLNSSD----------  124 (280)
Q Consensus        57 ll~al~~LH~~gi~H~di~~~nili~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~----------  124 (280)
                      ++.||.|||+.|++||||||+||+++.++.++|+|||++.........  .....++.|+|||.+.....          
T Consensus       318 l~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~  397 (507)
T PLN03224        318 VLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMA  397 (507)
T ss_pred             HHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCCCCCCccchhhhh
Confidence            999999999999999999999999999999999999998654332211  12334789999998743211          


Q ss_pred             -----------CCcchhHHHHHHHHHHHHhCCC-CCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccc
Q 023609          125 -----------YTAAIDVWSVGCIFMELMDRKP-LFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQ  192 (280)
Q Consensus       125 -----------~~~~~DiwslG~il~~ll~g~~-pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  192 (280)
                                 .....|+||+||++++|+++.. ||.+......   ..+..        .............     ..
T Consensus       398 ~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~---~~~~~--------~~~~~~~r~~~~~-----~~  461 (507)
T PLN03224        398 ALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNT---ELRQY--------DNDLNRWRMYKGQ-----KY  461 (507)
T ss_pred             hhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhh---HHhhc--------cchHHHHHhhccc-----CC
Confidence                       1124799999999999999874 6643211110   00000        0000000000000     00


Q ss_pred             cccccCCCCChHHHHHHHHhhcCCC---CCCCCHHHHhcCCCCCC
Q 023609          193 SFTEKFPNVHPSAIDLVEKMLTFDP---RQRITVEDALAHPYLGS  234 (280)
Q Consensus       193 ~~~~~~~~~~~~~~~li~~~L~~dp---~~R~t~~ell~h~~~~~  234 (280)
                      .+ ..++..++.+++|+.+||..+|   .+|+|+.|+|+||||..
T Consensus       462 ~~-~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~  505 (507)
T PLN03224        462 DF-SLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP  505 (507)
T ss_pred             Cc-ccccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence            11 2345678999999999999876   68999999999999954

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=99.96  E-value=1.5e-29  Score=219.24  Aligned_cols=200  Identities=23%  Similarity=0.350  Sum_probs=161.3

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ--ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS   77 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~--~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~   77 (280)
                      |+||||+.++++|..+     ..+++|+||++ |+|.+++....  .+......+|+.||+.|++||.+.++||||+.+.
T Consensus       592 LkhPNIveLvGVC~~D-----ePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~r  666 (807)
T KOG1094|consen  592 LKHPNIVELLGVCVQD-----DPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATR  666 (807)
T ss_pred             cCCCCeeEEEeeeecC-----CchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhcccccc
Confidence            6899999999999776     56899999998 89999998763  2344566779999999999999999999999999


Q ss_pred             cEEEccCCCEEEeeccceeeccCCCc---cccceeccccccchhccCCCCCCcchhHHHHHHHHHHHH--hCCCCCCCCC
Q 023609           78 NLLLNANCDLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM--DRKPLFPGRD  152 (280)
Q Consensus        78 nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll--~g~~pf~~~~  152 (280)
                      |++++.++++|++|||.++..-....   .-..+....|||+|.+..+ +++.++|+|++|+++||++  |...||....
T Consensus       667 NcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillg-kFttaSDvWafgvTlwE~~~~C~e~Py~~lt  745 (807)
T KOG1094|consen  667 NCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLG-KFTTASDVWAFGVTLWEVFMLCREQPYSQLT  745 (807)
T ss_pred             ceeecCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhc-cccchhhhhhhHHHHHHHHHHHhhCchhhhh
Confidence            99999999999999999985433221   1233456789999998755 4999999999999999986  6778998887


Q ss_pred             hHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          153 HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                      +.+.....-..+..+...                      .+...-+-++..+.++|..|+..|-.+||+.+++..
T Consensus       746 ~e~vven~~~~~~~~~~~----------------------~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~  799 (807)
T KOG1094|consen  746 DEQVVENAGEFFRDQGRQ----------------------VVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHL  799 (807)
T ss_pred             HHHHHHhhhhhcCCCCcc----------------------eeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence            777766665554443321                      222222356778999999999999999999998854

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.96  E-value=2.5e-29  Score=210.46  Aligned_cols=226  Identities=27%  Similarity=0.457  Sum_probs=165.1

Q ss_pred             CCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE
Q 023609            3 HENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   81 (280)
Q Consensus         3 HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nili   81 (280)
                      +.||+++.+.+...     ++..+|+||++ .+..++...   ++..+++.+++.++.||.++|+.||+||||||.|++.
T Consensus        94 ~~ni~~~~~~~rnn-----d~v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~  165 (418)
T KOG1167|consen   94 SDNIIKLNGCFRNN-----DQVAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLY  165 (418)
T ss_pred             chhhhcchhhhccC-----CeeEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccCccccCCCcccccc
Confidence            56889999988665     78999999999 477777653   7799999999999999999999999999999999999


Q ss_pred             cc-CCCEEEeeccceeec-----------------cC-C----------------C-----------ccccceecccccc
Q 023609           82 NA-NCDLKICDFGLARVT-----------------SE-T----------------D-----------FMTEYVVTRWYRA  115 (280)
Q Consensus        82 ~~-~~~~~l~dfg~~~~~-----------------~~-~----------------~-----------~~~~~~~~~~y~a  115 (280)
                      +. .+.-.|+|||++...                 .. .                .           ......||+.|.|
T Consensus       166 n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRa  245 (418)
T KOG1167|consen  166 NRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRA  245 (418)
T ss_pred             ccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCc
Confidence            75 467799999998610                 00 0                0           0011357999999


Q ss_pred             chhccCCCCCCcchhHHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCCHHHHhHhhHh---------------H
Q 023609          116 PELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF-PGRDHVHQLRLLIELIGTPSEAELGFLNEN---------------A  179 (280)
Q Consensus       116 PE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~  179 (280)
                      ||++.....-+.++||||.|+|++.+++++.|| ...++.+.+.++...+|...-...+.+...               .
T Consensus       246 PEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~  325 (418)
T KOG1167|consen  246 PEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELR  325 (418)
T ss_pred             hHHHhhccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHH
Confidence            999988887889999999999999999988776 455666677777666655433322221111               1


Q ss_pred             HHHhhh-----cCcccc-ccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCc
Q 023609          180 KKYICQ-----LPRYQR-QSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  236 (280)
Q Consensus       180 ~~~~~~-----~~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~  236 (280)
                      ..+...     .+.... ...+.-....+..+.+|+.+||+.||.+|.|++++|.||||....
T Consensus       326 ~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~~  388 (418)
T KOG1167|consen  326 VNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEAD  388 (418)
T ss_pred             hchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcchh
Confidence            111110     000000 111222234566899999999999999999999999999998543

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.96  E-value=4.6e-29  Score=220.03  Aligned_cols=197  Identities=23%  Similarity=0.370  Sum_probs=164.8

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS--NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS   77 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~--~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~   77 (280)
                      |+|||++++|++..+      ....+|||++. |+|.+.+++  +..|-......++.||+.|+.||.++++||||+-..
T Consensus       168 L~H~hliRLyGvVl~------qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAAR  241 (1039)
T KOG0199|consen  168 LQHPHLIRLYGVVLD------QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAAR  241 (1039)
T ss_pred             ccCcceeEEeeeecc------chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhh
Confidence            689999999999865      34789999998 899999986  346888999999999999999999999999999999


Q ss_pred             cEEEccCCCEEEeeccceeeccCCCcccc----ceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 023609           78 NLLLNANCDLKICDFGLARVTSETDFMTE----YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRD  152 (280)
Q Consensus        78 nili~~~~~~~l~dfg~~~~~~~~~~~~~----~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~  152 (280)
                      |+++-....+||+|||+.+..+.++....    ......|+|||.+. ...++.++|+|++||++|||.+ |..||.|..
T Consensus       242 NlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLr-h~kFShaSDvWmyGVTiWEMFtyGEePW~G~~  320 (1039)
T KOG0199|consen  242 NLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLR-HRKFSHASDVWMYGVTIWEMFTYGEEPWVGCR  320 (1039)
T ss_pred             hheecccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhc-cccccccchhhhhhhhHHhhhccCCCCCCCCC
Confidence            99998889999999999998776643221    12245699999985 4559999999999999999996 789999999


Q ss_pred             hHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 023609          153 HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  232 (280)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~  232 (280)
                      ..++++++-+....+-.                             +.+++++.+++..||..+|.+|||+..|.+.-+.
T Consensus       321 g~qIL~~iD~~erLpRP-----------------------------k~csedIY~imk~cWah~paDRptFsair~~~~l  371 (1039)
T KOG0199|consen  321 GIQILKNIDAGERLPRP-----------------------------KYCSEDIYQIMKNCWAHNPADRPTFSAIREDLVL  371 (1039)
T ss_pred             HHHHHHhccccccCCCC-----------------------------CCChHHHHHHHHHhccCCccccccHHHHHHhHHH
Confidence            99888877533222211                             2578899999999999999999999988755544


Q ss_pred             C
Q 023609          233 G  233 (280)
Q Consensus       233 ~  233 (280)
                      .
T Consensus       372 ~  372 (1039)
T KOG0199|consen  372 A  372 (1039)
T ss_pred             H
Confidence            4

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.96  E-value=7.3e-29  Score=189.89  Aligned_cols=156  Identities=29%  Similarity=0.481  Sum_probs=130.1

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHH----HcCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCC
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQII----RSNQALSEEHCQYFLYQILRGLKYIHSA-NVLHRDLKP   76 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l----~~~~~l~~~~~~~i~~qll~al~~LH~~-gi~H~di~~   76 (280)
                      ..|.+|++|+.+...     +.++|-||.|+.+|..+.    .+++.++|..+-+|+..++.||.|||++ .++|||+||
T Consensus       103 ~CPf~V~FyGa~~re-----gdvwIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKP  177 (282)
T KOG0984|consen  103 DCPFTVHFYGALFRE-----GDVWICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKP  177 (282)
T ss_pred             CCCeEEEeehhhhcc-----ccEEEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCc
Confidence            468999999987654     779999999998887664    4567899999999999999999999976 899999999


Q ss_pred             CcEEEccCCCEEEeeccceeeccCCCccccceeccccccchhccC---CCCCCcchhHHHHHHHHHHHHhCCCCCC-CCC
Q 023609           77 SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLN---SSDYTAAIDVWSVGCIFMELMDRKPLFP-GRD  152 (280)
Q Consensus        77 ~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~---~~~~~~~~DiwslG~il~~ll~g~~pf~-~~~  152 (280)
                      +||+++.+|++|+||||.+....+..-.+-..|-..|+|||.+..   ...|+.++||||||+.+.||.+++.||+ +.+
T Consensus       178 sNiLIn~~GqVKiCDFGIsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~t  257 (282)
T KOG0984|consen  178 SNILINYDGQVKICDFGISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGT  257 (282)
T ss_pred             ceEEEccCCcEEEcccccceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCC
Confidence            999999999999999999988766543333455667999998743   2357899999999999999999999996 456


Q ss_pred             hHHHHHHHHH
Q 023609          153 HVHQLRLLIE  162 (280)
Q Consensus       153 ~~~~~~~~~~  162 (280)
                      +.+++..+++
T Consensus       258 pF~qLkqvVe  267 (282)
T KOG0984|consen  258 PFQQLKQVVE  267 (282)
T ss_pred             HHHHHHHHhc
Confidence            6666665544

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.95  E-value=3e-28  Score=237.14  Aligned_cols=203  Identities=20%  Similarity=0.313  Sum_probs=142.3

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIH---SANVLHRDLKP   76 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH---~~gi~H~di~~   76 (280)
                      ++|||||++++++...     ...|+||||++ |+|.+++.   .+++..+..++.|++.|++|||   +.+++||||||
T Consensus       740 l~HpnIv~~~~~~~~~-----~~~~lv~Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp  811 (968)
T PLN00113        740 LQHPNIVKLIGLCRSE-----KGAYLIHEYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSP  811 (968)
T ss_pred             CCCCCcceEEEEEEcC-----CCCEEEEeCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCH
Confidence            5899999999999665     56899999997 79999995   3899999999999999999999   66999999999


Q ss_pred             CcEEEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh-HH
Q 023609           77 SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDH-VH  155 (280)
Q Consensus        77 ~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-~~  155 (280)
                      +||+++.++..++. ++........   ....+++.|+|||++.+ ..++.++||||+||++|||++|+.||..... ..
T Consensus       812 ~Nil~~~~~~~~~~-~~~~~~~~~~---~~~~~t~~y~aPE~~~~-~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~  886 (968)
T PLN00113        812 EKIIIDGKDEPHLR-LSLPGLLCTD---TKCFISSAYVAPETRET-KDITEKSDIYGFGLILIELLTGKSPADAEFGVHG  886 (968)
T ss_pred             HhEEECCCCceEEE-eccccccccC---CCccccccccCcccccC-CCCCcccchhhHHHHHHHHHhCCCCCCcccCCCC
Confidence            99999988887765 5544322111   23367889999998854 4588999999999999999999999853211 00


Q ss_pred             HHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 023609          156 QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  229 (280)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h  229 (280)
                      ..............         ......  +.....  ....+....++.+++.+||+.||++|||+.++++.
T Consensus       887 ~~~~~~~~~~~~~~---------~~~~~~--~~~~~~--~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~  947 (968)
T PLN00113        887 SIVEWARYCYSDCH---------LDMWID--PSIRGD--VSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT  947 (968)
T ss_pred             cHHHHHHHhcCccc---------hhheeC--ccccCC--CCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence            01111110000000         000000  000000  00000112357789999999999999999999875

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.95  E-value=1.4e-27  Score=219.83  Aligned_cols=192  Identities=29%  Similarity=0.473  Sum_probs=154.3

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCC----------------CCCHHHHHHHHHHHHHHHHHH
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ----------------ALSEEHCQYFLYQILRGLKYI   64 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~----------------~l~~~~~~~i~~qll~al~~L   64 (280)
                      +||||+.+++++...     +.+++|+||+. |+|.++++.++                .++......+.+||+.|.+||
T Consensus       360 ~H~niv~llG~~t~~-----~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L  434 (609)
T KOG0200|consen  360 KHPNIVNLLGACTQD-----GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYL  434 (609)
T ss_pred             CCcchhhheeeeccC-----CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHH
Confidence            699999999999764     67999999998 89999998765                489999999999999999999


Q ss_pred             HHCCceeccCCCCcEEEccCCCEEEeeccceeeccCCCccc--cce--eccccccchhccCCCCCCcchhHHHHHHHHHH
Q 023609           65 HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMT--EYV--VTRWYRAPELLLNSSDYTAAIDVWSVGCIFME  140 (280)
Q Consensus        65 H~~gi~H~di~~~nili~~~~~~~l~dfg~~~~~~~~~~~~--~~~--~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~  140 (280)
                      ++..++|||+-..||+++.+..+|++|||+++.........  ...  ....|||||.+.. ..++.++||||+|+++||
T Consensus       435 ~~~~~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~-~~ft~kSDVWSfGI~L~E  513 (609)
T KOG0200|consen  435 ASVPCVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD-RVFTSKSDVWSFGILLWE  513 (609)
T ss_pred             hhCCccchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhcc-CcccccchhhHHHHHHHH
Confidence            99999999999999999999999999999998644432221  112  2345999999965 669999999999999999


Q ss_pred             HHh-CCCCCCCCC-hHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCC
Q 023609          141 LMD-RKPLFPGRD-HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPR  218 (280)
Q Consensus       141 ll~-g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~  218 (280)
                      +.+ |..||++-. ..+.+..+.+.. ....                            -...+.++.++|+.||+.+|+
T Consensus       514 ifsLG~~PYp~~~~~~~l~~~l~~G~-r~~~----------------------------P~~c~~eiY~iM~~CW~~~p~  564 (609)
T KOG0200|consen  514 IFTLGGTPYPGIPPTEELLEFLKEGN-RMEQ----------------------------PEHCSDEIYDLMKSCWNADPE  564 (609)
T ss_pred             HhhCCCCCCCCCCcHHHHHHHHhcCC-CCCC----------------------------CCCCCHHHHHHHHHHhCCCcc
Confidence            987 889998744 233332222111 1000                            015678899999999999999


Q ss_pred             CCCCHHHHhc
Q 023609          219 QRITVEDALA  228 (280)
Q Consensus       219 ~R~t~~ell~  228 (280)
                      +||+..++..
T Consensus       565 ~RP~F~~~~~  574 (609)
T KOG0200|consen  565 DRPTFSECVE  574 (609)
T ss_pred             cCCCHHHHHH
Confidence            9999988765

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=8.8e-29  Score=225.46  Aligned_cols=209  Identities=29%  Similarity=0.405  Sum_probs=164.1

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   80 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nil   80 (280)
                      |+|||++...+.+...     ...+-+||||+++|+.++...+.++..++..++.||+.||+|||++|+.|||+|++|++
T Consensus       378 l~h~~~~e~l~~~~~~-----~~~~~~mE~~~~Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll  452 (601)
T KOG0590|consen  378 LSHPNIIETLDIVQEI-----DGILQSMEYCPYDLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLL  452 (601)
T ss_pred             ccCCchhhhHHHHhhc-----ccchhhhhcccHHHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEE
Confidence            6899998888887654     23344499999999999998888999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccceeecc---CC--CccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 023609           81 LNANCDLKICDFGLARVTS---ET--DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVH  155 (280)
Q Consensus        81 i~~~~~~~l~dfg~~~~~~---~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~  155 (280)
                      +..+|.++++|||.+....   +.  ......+|+..|+|||++.+........||||.|+++..|.+|+.||.-....+
T Consensus       453 ~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~  532 (601)
T KOG0590|consen  453 VTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSD  532 (601)
T ss_pred             EecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccc
Confidence            9999999999999986432   11  234466889999999999777666678999999999999999999996443222


Q ss_pred             HHH-HHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCC
Q 023609          156 QLR-LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS  234 (280)
Q Consensus       156 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~  234 (280)
                      ... ...    .                  .....-..........++.+.+.+|.+||++||.+|.|+++|++.+||+.
T Consensus       533 ~~~~~~~----~------------------~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~  590 (601)
T KOG0590|consen  533 NSFKTNN----Y------------------SDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRS  590 (601)
T ss_pred             cchhhhc----c------------------ccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhh
Confidence            110 000    0                  00000001112233356788999999999999999999999999999998


Q ss_pred             Cc
Q 023609          235 LH  236 (280)
Q Consensus       235 ~~  236 (280)
                      +.
T Consensus       591 i~  592 (601)
T KOG0590|consen  591 IE  592 (601)
T ss_pred             cc
Confidence            75

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.95  E-value=1.3e-28  Score=213.06  Aligned_cols=141  Identities=26%  Similarity=0.466  Sum_probs=129.1

Q ss_pred             CCCeeeeeceecCCCCCCCCcEEEEeecCC-c-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 023609            3 HENVVAIRDIIPPPQRESFNDVYIAYELMD-T-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   80 (280)
Q Consensus         3 HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g-~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nil   80 (280)
                      |+||+|++++|+++     ..+||+||.-+ | +|+++++-+..++|.+++.|++|+..|+++||+.||+|||||-+|+.
T Consensus       628 H~NIlKlLdfFEdd-----d~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvi  702 (772)
T KOG1152|consen  628 HENILKLLDFFEDD-----DYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVI  702 (772)
T ss_pred             ccchhhhhheeecC-----CeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEE
Confidence            99999999999776     77999999987 5 99999999999999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 023609           81 LNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFP  149 (280)
Q Consensus        81 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  149 (280)
                      ++.+|.+||+|||.+.....+ +.....||..|+|||++.+....+..-|||++|+++|.++....||.
T Consensus       703 vd~~g~~klidfgsaa~~ksg-pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  703 VDSNGFVKLIDFGSAAYTKSG-PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             EecCCeEEEeeccchhhhcCC-CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            999999999999998765544 34567899999999999777777888999999999999998888885

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.95  E-value=3.8e-27  Score=199.85  Aligned_cols=213  Identities=24%  Similarity=0.318  Sum_probs=153.7

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC---------Cce
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA---------NVL   70 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~---------gi~   70 (280)
                      |+|+||++++++-.-.... ...++||++|.+ |+|.+++..+ .+++.+..+|+..|+.||+|||+.         .|+
T Consensus       261 m~h~nIl~Fi~~ekr~t~~-~~eywLVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~Ia  338 (534)
T KOG3653|consen  261 MKHENILQFIGAEKRGTAD-RMEYWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIA  338 (534)
T ss_pred             ccchhHHHhhchhccCCcc-ccceeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccc
Confidence            6899999999886443212 357999999997 9999999864 699999999999999999999963         499


Q ss_pred             eccCCCCcEEEccCCCEEEeeccceeeccCCC---ccccceeccccccchhccCCCCCC-----cchhHHHHHHHHHHHH
Q 023609           71 HRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYT-----AAIDVWSVGCIFMELM  142 (280)
Q Consensus        71 H~di~~~nili~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~-----~~~DiwslG~il~~ll  142 (280)
                      |||||..||++..|+++.|+|||++.......   .....+||..|||||++.+.-++.     .+.||||+|.++||++
T Consensus       339 HRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~  418 (534)
T KOG3653|consen  339 HRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIA  418 (534)
T ss_pred             cccccccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHH
Confidence            99999999999999999999999998765432   223468999999999997655544     4699999999999999


Q ss_pred             hCCCCCC-CCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCC--CCChHHHHHHHHhhcCCCCC
Q 023609          143 DRKPLFP-GRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP--NVHPSAIDLVEKMLTFDPRQ  219 (280)
Q Consensus       143 ~g~~pf~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~L~~dp~~  219 (280)
                      +++..+. +..+.-++.--.+....|....+..+       +.  ....+..+...+.  ..-..+++.+..||.-|++-
T Consensus       419 SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~-------VV--~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeA  489 (534)
T KOG3653|consen  419 SRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQEL-------VV--RKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEA  489 (534)
T ss_pred             hhcccccCCCCCcccCchhHHhcCCCCHHHHHHH-------HH--hhccCCCChhhhhcCccHHHHHHHHHHHcCCchhh
Confidence            8876553 33222222222223334443322211       00  0011111111111  12245789999999999999


Q ss_pred             CCCHH
Q 023609          220 RITVE  224 (280)
Q Consensus       220 R~t~~  224 (280)
                      |+|+.
T Consensus       490 RLTA~  494 (534)
T KOG3653|consen  490 RLTAG  494 (534)
T ss_pred             hhhhH
Confidence            99985

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.95  E-value=3.4e-28  Score=213.56  Aligned_cols=203  Identities=28%  Similarity=0.442  Sum_probs=166.3

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nil   80 (280)
                      +||||+.+++.|.-.     ..++|.||||+ |+|.+...-.+++++.++..+.+..+.||+|||++|-+|||||-.||+
T Consensus        70 ~h~nivay~gsylr~-----dklwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanil  144 (829)
T KOG0576|consen   70 RHPNIVAYFGSYLRR-----DKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANIL  144 (829)
T ss_pred             CCcChHHHHhhhhhh-----cCcEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCccccccccccee
Confidence            799999999998655     56899999998 699988887889999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccceeeccCC-Cccccceeccccccchhcc--CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 023609           81 LNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLL--NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL  157 (280)
Q Consensus        81 i~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~--~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  157 (280)
                      ++..|.+++.|||.+...+.. .....+.||+.|||||+..  ..+.|...+|+|++|+...++-.-.+|.-+.-....+
T Consensus       145 ltd~gDvklaDfgvsaqitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l  224 (829)
T KOG0576|consen  145 LTDEGDVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRAL  224 (829)
T ss_pred             ecccCceeecccCchhhhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHH
Confidence            999999999999998765443 2235678999999999852  3445789999999999999998777776555444444


Q ss_pred             HHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCC
Q 023609          158 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS  234 (280)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~  234 (280)
                      ..+.+....|+...                         .=...++.+.+|++.+|.++|++|||++.+|.|||...
T Consensus       225 ~LmTkS~~qpp~lk-------------------------Dk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~  276 (829)
T KOG0576|consen  225 FLMTKSGFQPPTLK-------------------------DKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQ  276 (829)
T ss_pred             HHhhccCCCCCccc-------------------------CCccchHHHHHHHHHHhcCCCccCCChhhheeceeecc
Confidence            44444433333211                         00145678999999999999999999999999999975

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=4.7e-27  Score=197.98  Aligned_cols=204  Identities=19%  Similarity=0.278  Sum_probs=147.6

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC--------Ccee
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA--------NVLH   71 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~--------gi~H   71 (280)
                      |+|+||+.+++.-..++ +....+++|++|.+ |+|+|++.. ..++.....+++..++.||++||..        +|+|
T Consensus       262 LRHENILgFIaaD~~~~-gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAH  339 (513)
T KOG2052|consen  262 LRHENILGFIAADNKDN-GSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAH  339 (513)
T ss_pred             hccchhhhhhhccccCC-CceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhc
Confidence            68999999999865543 44578999999998 999999987 6799999999999999999999953        3999


Q ss_pred             ccCCCCcEEEccCCCEEEeeccceeeccCC-----CccccceeccccccchhccCCCCC-----CcchhHHHHHHHHHHH
Q 023609           72 RDLKPSNLLLNANCDLKICDFGLARVTSET-----DFMTEYVVTRWYRAPELLLNSSDY-----TAAIDVWSVGCIFMEL  141 (280)
Q Consensus        72 ~di~~~nili~~~~~~~l~dfg~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~-----~~~~DiwslG~il~~l  141 (280)
                      ||||..||+|..+|.+.|+|+|+|......     ...+..+||..|||||++...-+.     -..+||||+|.|+||+
T Consensus       340 RDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEi  419 (513)
T KOG2052|consen  340 RDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEI  419 (513)
T ss_pred             cccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHH
Confidence            999999999999999999999999764433     234567899999999998654322     1468999999999999


Q ss_pred             HhC----------CCCCCCCChHH-HHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCC--hHHHHH
Q 023609          142 MDR----------KPLFPGRDHVH-QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVH--PSAIDL  208 (280)
Q Consensus       142 l~g----------~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~l  208 (280)
                      +.+          .+||.+-.+.+ ....+.++..                   ..  ..++.++..+...+  ..+..+
T Consensus       420 arRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVC-------------------v~--~~RP~ipnrW~s~~~l~~m~kl  478 (513)
T KOG2052|consen  420 ARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVC-------------------VQ--KLRPNIPNRWKSDPALRVMAKL  478 (513)
T ss_pred             HHHhhcCCEehhhcCCcccCCCCCCCHHHHhccee-------------------ec--ccCCCCCcccccCHHHHHHHHH
Confidence            854          35664432111 1111111110                   00  00111111121111  235678


Q ss_pred             HHHhhcCCCCCCCCHHHHh
Q 023609          209 VEKMLTFDPRQRITVEDAL  227 (280)
Q Consensus       209 i~~~L~~dp~~R~t~~ell  227 (280)
                      |+.||..||.-|.|+--+-
T Consensus       479 MkeCW~~Np~aRltALriK  497 (513)
T KOG2052|consen  479 MKECWYANPAARLTALRIK  497 (513)
T ss_pred             HHHhhcCCchhhhHHHHHH
Confidence            9999999999999986553

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.94  E-value=1.6e-25  Score=179.26  Aligned_cols=164  Identities=38%  Similarity=0.705  Sum_probs=141.7

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      ++|++|+++++++...     ...++++|+++ ++|.+++... ..++...+..++.+++.++.+||+.|++|+||+|.|
T Consensus        48 l~~~~i~~~~~~~~~~-----~~~~~~~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~n  122 (215)
T cd00180          48 LNHPNIVKLYGVFEDE-----NHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPEN  122 (215)
T ss_pred             cCCCCeeeEeeeeecC-----CeEEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhh
Confidence            4789999999999765     67899999999 6999999765 479999999999999999999999999999999999


Q ss_pred             EEEcc-CCCEEEeeccceeeccCCC-ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023609           79 LLLNA-NCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ  156 (280)
Q Consensus        79 ili~~-~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  156 (280)
                      |+++. ++.++|+|||.+....... ......+...|++||........+.+.|+|++|++++++               
T Consensus       123 i~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---------------  187 (215)
T cd00180         123 ILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---------------  187 (215)
T ss_pred             EEEeCCCCcEEEecCCceEEccCCcchhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------
Confidence            99999 8999999999987654432 123355678899999885542578899999999999998               


Q ss_pred             HHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCC
Q 023609          157 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHP  230 (280)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~  230 (280)
                                                                    ..+.+++.+||+.||++||++.++++++
T Consensus       188 ----------------------------------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~  215 (215)
T cd00180         188 ----------------------------------------------PELKDLIRKMLQKDPEKRPSAKEILEHL  215 (215)
T ss_pred             ----------------------------------------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence                                                          1367899999999999999999999875

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.93  E-value=7e-25  Score=182.44  Aligned_cols=194  Identities=19%  Similarity=0.269  Sum_probs=156.6

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHc--------CCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS--------NQALSEEHCQYFLYQILRGLKYIHSANVLH   71 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~--------~~~l~~~~~~~i~~qll~al~~LH~~gi~H   71 (280)
                      +.|||+..+.++.....    ...++.+.+++ |+|..++..        ...++..+...++.|+..|++|||+.|++|
T Consensus       344 ~sH~nll~V~~V~ie~~----~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViH  419 (563)
T KOG1024|consen  344 ASHPNLLSVLGVSIEDY----ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIH  419 (563)
T ss_pred             CcCCCccceeEEEeecc----CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCccc
Confidence            36999999999876542    56789999998 899999972        124778888999999999999999999999


Q ss_pred             ccCCCCcEEEccCCCEEEeeccceeeccCCC--c-cccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCC
Q 023609           72 RDLKPSNLLLNANCDLKICDFGLARVTSETD--F-MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPL  147 (280)
Q Consensus        72 ~di~~~nili~~~~~~~l~dfg~~~~~~~~~--~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~p  147 (280)
                      .||-..|.+|+..-++||+|=.+++..-+.+  + ....-....||+||.+.+. .|+.++|+||+|+++|||++ |+.|
T Consensus       420 kDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~-~yssasDvWsfGVllWELmtlg~~P  498 (563)
T KOG1024|consen  420 KDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNS-HYSSASDVWSFGVLLWELMTLGKLP  498 (563)
T ss_pred             chhhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhh-hhcchhhhHHHHHHHHHHHhcCCCC
Confidence            9999999999999999999988887543322  1 1122335569999999655 59999999999999999997 8899


Q ss_pred             CCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHh
Q 023609          148 FPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDAL  227 (280)
Q Consensus       148 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell  227 (280)
                      +..-++.++...+.+....-.+.                             +++.++-.+|--||..+|++||+.+++.
T Consensus       499 yaeIDPfEm~~ylkdGyRlaQP~-----------------------------NCPDeLf~vMacCWallpeeRPsf~Qlv  549 (563)
T KOG1024|consen  499 YAEIDPFEMEHYLKDGYRLAQPF-----------------------------NCPDELFTVMACCWALLPEERPSFSQLV  549 (563)
T ss_pred             ccccCHHHHHHHHhccceecCCC-----------------------------CCcHHHHHHHHHHHhcCcccCCCHHHHH
Confidence            98888777766665433221111                             6788999999999999999999999886


Q ss_pred             c
Q 023609          228 A  228 (280)
Q Consensus       228 ~  228 (280)
                      .
T Consensus       550 ~  550 (563)
T KOG1024|consen  550 I  550 (563)
T ss_pred             H
Confidence            4

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.93  E-value=7.7e-26  Score=202.86  Aligned_cols=192  Identities=24%  Similarity=0.349  Sum_probs=156.6

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      |+||||+++++++..+      .+.||++|++ |.|.|+++. +.++-.+....|.+||+.|+.|||.++++||||-..|
T Consensus       755 ldHpnl~RLLgvc~~s------~~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRN  828 (1177)
T KOG1025|consen  755 LDHPNLLRLLGVCMLS------TLQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARN  828 (1177)
T ss_pred             CCCchHHHHhhhcccc------hHHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhh
Confidence            6899999999999664      3789999998 899999985 4579999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCCCc-ccc--ceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 023609           79 LLLNANCDLKICDFGLARVTSETDF-MTE--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHV  154 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~~~-~~~--~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~  154 (280)
                      ||+..-..+|+.|||+++....... ...  ....+.|+|-|.+. ...++.++||||+||++||++| |..|+.+....
T Consensus       829 VLVksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~-~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~  907 (1177)
T KOG1025|consen  829 VLVKSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIR-IRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE  907 (1177)
T ss_pred             eeecCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhh-ccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH
Confidence            9999999999999999987655432 112  22345688888874 4458999999999999999997 88999887765


Q ss_pred             HHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          155 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                      ++...+.+....+                             .-|..+-++.-+|.+||-.|+..||+++++..
T Consensus       908 eI~dlle~geRLs-----------------------------qPpiCtiDVy~~mvkCwmid~~~rp~fkel~~  952 (1177)
T KOG1025|consen  908 EIPDLLEKGERLS-----------------------------QPPICTIDVYMVMVKCWMIDADSRPTFKELAE  952 (1177)
T ss_pred             HhhHHHhccccCC-----------------------------CCCCccHHHHHHHHHHhccCcccCccHHHHHH
Confidence            5544333222211                             11356778899999999999999999998765

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.92  E-value=5.6e-26  Score=180.75  Aligned_cols=204  Identities=23%  Similarity=0.356  Sum_probs=148.8

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nil   80 (280)
                      .|.||+.-|+.-....    +.++.++||++ |+|..-+... .+-|...+.++.|++.|+.|+|+.++||||||.+||+
T Consensus        79 ~H~hIi~tY~vaFqt~----d~YvF~qE~aP~gdL~snv~~~-GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiL  153 (378)
T KOG1345|consen   79 PHQHIIDTYEVAFQTS----DAYVFVQEFAPRGDLRSNVEAA-GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENIL  153 (378)
T ss_pred             cchhhhHHHHHHhhcC----ceEEEeeccCccchhhhhcCcc-cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEE
Confidence            4889998888654432    56889999998 8999888764 4888899999999999999999999999999999999


Q ss_pred             Ecc--CCCEEEeeccceeeccCCCccccceeccccccchhccCC----CCCCcchhHHHHHHHHHHHHhCCCCCCCCChH
Q 023609           81 LNA--NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNS----SDYTAAIDVWSVGCIFMELMDRKPLFPGRDHV  154 (280)
Q Consensus        81 i~~--~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  154 (280)
                      |-.  .-++||||||.++..+...  ...-.+..|.+||.....    -...+..|+|++|++++.+++|++||......
T Consensus       154 if~~df~rvKlcDFG~t~k~g~tV--~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~  231 (378)
T KOG1345|consen  154 IFDADFYRVKLCDFGLTRKVGTTV--KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIM  231 (378)
T ss_pred             EecCCccEEEeeecccccccCcee--hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhcc
Confidence            932  3479999999987765432  222345568899876422    23467899999999999999999999633211


Q ss_pred             HHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCC---CCHHHHhcCCC
Q 023609          155 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQR---ITVEDALAHPY  231 (280)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R---~t~~ell~h~~  231 (280)
                      +           ++          ..++..+..+ .....+..|..+++.+..+.++-|..++++|   -++......-|
T Consensus       232 d-----------~~----------Y~~~~~w~~r-k~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w  289 (378)
T KOG1345|consen  232 D-----------KP----------YWEWEQWLKR-KNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLW  289 (378)
T ss_pred             C-----------ch----------HHHHHHHhcc-cCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHH
Confidence            1           11          0111111111 1113345566789999999999999999999   55655555666


Q ss_pred             CCC
Q 023609          232 LGS  234 (280)
Q Consensus       232 ~~~  234 (280)
                      ...
T Consensus       290 ~E~  292 (378)
T KOG1345|consen  290 KEK  292 (378)
T ss_pred             HHh
Confidence            553

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.92  E-value=5.2e-24  Score=172.88  Aligned_cols=145  Identities=38%  Similarity=0.702  Sum_probs=126.4

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCc-cHHHHHHcCCC-CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQA-LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~-l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      ++|+|++++++++...     ...++++|++++ +|.+++..... +++..+..++.+++.++.+||+.|++|+|++|.|
T Consensus        54 ~~~~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~n  128 (225)
T smart00221       54 LKHPNIVKLYGVFEDP-----EPLYLVMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPEN  128 (225)
T ss_pred             CCCCChhhheeeeecC-----CceEEEEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence            4799999999998655     668999999986 99999987666 8999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCCC--ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 023609           79 LLLNANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPG  150 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~  150 (280)
                      |+++.++.++|+|||.+.......  ......++..|++||.+.....++.++|+|++|+++++|++|+.||.+
T Consensus       129 i~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      129 ILLGMDGLVKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             EEEcCCCCEEEeeCceeeEecCcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            999999999999999988765442  234456778899999874344567799999999999999999999977

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.90  E-value=4.7e-23  Score=172.19  Aligned_cols=194  Identities=23%  Similarity=0.334  Sum_probs=141.3

Q ss_pred             CCCCeeeeeceecCCC----------------------CCCCCcEEEEeecCCccHHHHHHcCCCCCHHHHHHHHHHHHH
Q 023609            2 DHENVVAIRDIIPPPQ----------------------RESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR   59 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~----------------------~~~~~~~~iv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qll~   59 (280)
                      +|||||++..+|.++-                      -.....+|+||..+..+|.+++-.+ ..+.....-++.|+++
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~~-~~s~r~~~~~laQlLE  352 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWTR-HRSYRTGRVILAQLLE  352 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhcC-CCchHHHHHHHHHHHH
Confidence            6999999998886521                      1112458999999999999999764 5777788889999999


Q ss_pred             HHHHHHHCCceeccCCCCcEEEc--cC--CCEEEeeccceeeccCC-------CccccceeccccccchhccCCC-C---
Q 023609           60 GLKYIHSANVLHRDLKPSNLLLN--AN--CDLKICDFGLARVTSET-------DFMTEYVVTRWYRAPELLLNSS-D---  124 (280)
Q Consensus        60 al~~LH~~gi~H~di~~~nili~--~~--~~~~l~dfg~~~~~~~~-------~~~~~~~~~~~y~aPE~~~~~~-~---  124 (280)
                      |+.|||++||.|||+|.+||++.  .|  ..+.+.|||++-.-...       ......-|+...||||+.-... +   
T Consensus       353 av~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~av  432 (598)
T KOG4158|consen  353 AVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNAV  432 (598)
T ss_pred             HHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCcee
Confidence            99999999999999999999993  33  45789999987432211       1122345677789999863211 0   


Q ss_pred             -CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCCh
Q 023609          125 -YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHP  203 (280)
Q Consensus       125 -~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  203 (280)
                       .-.++|.|+.|.+.||+++...||.+......                            ....++..+++..-..+++
T Consensus       433 vny~kAD~WA~GalaYEIfg~~NPFY~rGem~L----------------------------~~r~Yqe~qLPalp~~vpp  484 (598)
T KOG4158|consen  433 VNYEKADTWAAGALAYEIFGRSNPFYKRGEMLL----------------------------DTRTYQESQLPALPSRVPP  484 (598)
T ss_pred             eccchhhhhhhhhhHHHHhccCCcccccchhee----------------------------chhhhhhhhCCCCcccCCh
Confidence             12478999999999999999999976432110                            0001122222333346789


Q ss_pred             HHHHHHHHhhcCCCCCCCCHH
Q 023609          204 SAIDLVEKMLTFDPRQRITVE  224 (280)
Q Consensus       204 ~~~~li~~~L~~dp~~R~t~~  224 (280)
                      .+++++..+|+.||++|+++.
T Consensus       485 ~~rqlV~~lL~r~pskRvsp~  505 (598)
T KOG4158|consen  485 VARQLVFDLLKRDPSKRVSPN  505 (598)
T ss_pred             HHHHHHHHHhcCCccccCCcc
Confidence            999999999999999999875

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.88  E-value=2.4e-23  Score=182.97  Aligned_cols=188  Identities=22%  Similarity=0.425  Sum_probs=160.8

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nil   80 (280)
                      .||.+++++-.++.+     +..++++++.. |+|...+.+...+.+...+.+...++.+++++|+.|++|||+|++||+
T Consensus        55 ~~~f~v~lhyafqt~-----~kl~l~ld~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enil  129 (612)
T KOG0603|consen   55 NTPFLVKLHYAFQTD-----GKLYLILDFLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVL  129 (612)
T ss_pred             CCCceeeeeeeeccc-----cchhHhhhhcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhccccccee
Confidence            489999999999877     77899999997 599999988888999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 023609           81 LNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL  160 (280)
Q Consensus        81 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~  160 (280)
                      ++.+|.+++.|||.++..-..+.   .+||..|||||++.   ....++|.||+|+++++|++|..||.+    +....|
T Consensus       130 ld~~Ghi~~tdfglske~v~~~~---~cgt~eymApEI~~---gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~I  199 (612)
T KOG0603|consen  130 LLLEGHIKLTDFGLSKEAVKEKI---ACGTYEYRAPEIIN---GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRI  199 (612)
T ss_pred             ecccCccccCCchhhhHhHhhhh---cccchhhhhhHhhh---ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHH
Confidence            99999999999999986544432   28999999999884   256789999999999999999999977    444444


Q ss_pred             HHH-hCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCH-----HHHhcCCCCCC
Q 023609          161 IEL-IGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV-----EDALAHPYLGS  234 (280)
Q Consensus       161 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~-----~ell~h~~~~~  234 (280)
                      .+. .+.|.                               .++..+++++..|+..+|..|.-.     .|+++|+||+.
T Consensus       200 l~~~~~~p~-------------------------------~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~  248 (612)
T KOG0603|consen  200 LKAELEMPR-------------------------------ELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQS  248 (612)
T ss_pred             hhhccCCch-------------------------------hhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchhee
Confidence            432 22221                               456789999999999999999855     79999999987


Q ss_pred             C
Q 023609          235 L  235 (280)
Q Consensus       235 ~  235 (280)
                      .
T Consensus       249 i  249 (612)
T KOG0603|consen  249 I  249 (612)
T ss_pred             e
Confidence            5

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.87  E-value=5e-23  Score=190.02  Aligned_cols=195  Identities=25%  Similarity=0.394  Sum_probs=143.9

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   80 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nil   80 (280)
                      ++|||.+.+..+....     ...|+|-+|+..+|+|.+..+.-+..-+.+.|+.||+.||..+|+.||+|||||.+||+
T Consensus        78 ~~~pn~lPfqk~~~t~-----kAAylvRqyvkhnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENIL  152 (1431)
T KOG1240|consen   78 MKAPNCLPFQKVLVTD-----KAAYLVRQYVKHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENIL  152 (1431)
T ss_pred             hcCCcccchHHHHHhh-----HHHHHHHHHHhhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEE
Confidence            4789999988876544     56799999999999999998888999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccceeec--cC--CCccccc----eeccccccchhccCCC----------CCCcchhHHHHHHHHHHHH
Q 023609           81 LNANCDLKICDFGLARVT--SE--TDFMTEY----VVTRWYRAPELLLNSS----------DYTAAIDVWSVGCIFMELM  142 (280)
Q Consensus        81 i~~~~~~~l~dfg~~~~~--~~--~~~~~~~----~~~~~y~aPE~~~~~~----------~~~~~~DiwslG~il~~ll  142 (280)
                      |+.=..+.|+||...+..  .+  +......    .....|.|||.+....          ..+++.||||+||+++||+
T Consensus       153 iTSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf  232 (1431)
T KOG1240|consen  153 ITSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELF  232 (1431)
T ss_pred             EeeechhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHH
Confidence            998888999999877532  11  1111111    2233599999885422          1467899999999999998


Q ss_pred             h-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCC
Q 023609          143 D-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI  221 (280)
Q Consensus       143 ~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~  221 (280)
                      + |+++|.-.   +.++.. .  +.                     .......-+..  -+...+.+|..|++.||++|.
T Consensus       233 ~Eg~PlF~LS---QL~aYr-~--~~---------------------~~~~e~~Le~I--ed~~~Rnlil~Mi~rdPs~Rl  283 (1431)
T KOG1240|consen  233 LEGRPLFTLS---QLLAYR-S--GN---------------------ADDPEQLLEKI--EDVSLRNLILSMIQRDPSKRL  283 (1431)
T ss_pred             hcCCCcccHH---HHHhHh-c--cC---------------------ccCHHHHHHhC--cCccHHHHHHHHHccCchhcc
Confidence            6 89999310   000000 0  00                     00000000111  134689999999999999999


Q ss_pred             CHHHHhcC
Q 023609          222 TVEDALAH  229 (280)
Q Consensus       222 t~~ell~h  229 (280)
                      ++++.|+.
T Consensus       284 SAedyL~~  291 (1431)
T KOG1240|consen  284 SAEDYLQK  291 (1431)
T ss_pred             CHHHHHHh
Confidence            99999985

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.86  E-value=6.1e-22  Score=163.69  Aligned_cols=162  Identities=20%  Similarity=0.282  Sum_probs=110.8

Q ss_pred             cEEEEeecCCccHHHHHHc---CCC----CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCCEEEeeccce
Q 023609           23 DVYIAYELMDTDLHQIIRS---NQA----LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA   95 (280)
Q Consensus        23 ~~~iv~e~~~g~L~~~l~~---~~~----l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nili~~~~~~~l~dfg~~   95 (280)
                      +.+++|+-+.++|.+++..   ...    +.......+..|++..+++||+.|++|+||+|+|++++.+|.+.|+||+..
T Consensus       113 n~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~~nfll~~~G~v~Lg~F~~~  192 (288)
T PF14531_consen  113 NRFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKPENFLLDQDGGVFLGDFSSL  192 (288)
T ss_dssp             SEEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE-TTS-EEE--GGGE
T ss_pred             hhhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccceeeEEEcCCCCEEEcChHHH
Confidence            4688999999999888652   111    233344567799999999999999999999999999999999999999988


Q ss_pred             eeccCCCccccceeccccccchhccCC-------CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Q 023609           96 RVTSETDFMTEYVVTRWYRAPELLLNS-------SDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPS  168 (280)
Q Consensus        96 ~~~~~~~~~~~~~~~~~y~aPE~~~~~-------~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~  168 (280)
                      ...+.....  ...+..|.+||.....       ..++.+.|.|+||+++|.+||+..||........            
T Consensus       193 ~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~------------  258 (288)
T PF14531_consen  193 VRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEAD------------  258 (288)
T ss_dssp             EETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGST------------
T ss_pred             eecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCcccc------------
Confidence            776654332  3445779999976432       2367889999999999999999999964321100            


Q ss_pred             HHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCC
Q 023609          169 EAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQR  220 (280)
Q Consensus       169 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R  220 (280)
                                           ....+..+. ++++.+++||++||++||.+|
T Consensus       259 ---------------------~~~~f~~C~-~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  259 ---------------------PEWDFSRCR-DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             ---------------------SGGGGTTSS----HHHHHHHHHHT-SSGGGS
T ss_pred             ---------------------ccccchhcC-CcCHHHHHHHHHHccCCcccC
Confidence                                 001344455 889999999999999999988

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.86  E-value=6.3e-20  Score=156.37  Aligned_cols=211  Identities=32%  Similarity=0.546  Sum_probs=160.0

Q ss_pred             CCCC-CeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCC
Q 023609            1 MDHE-NVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ---ALSEEHCQYFLYQILRGLKYIHSANVLHRDLK   75 (280)
Q Consensus         1 l~Hp-nIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~---~l~~~~~~~i~~qll~al~~LH~~gi~H~di~   75 (280)
                      +.|+ +|+++++.+...     ...+++++++. +++.+++....   .++...+..++.|++.++.++|+.|++|||+|
T Consensus        54 ~~~~~~i~~~~~~~~~~-----~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~k  128 (384)
T COG0515          54 LNHPPNIVKLYDFFQDE-----GSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIK  128 (384)
T ss_pred             ccCCcceeeEEEEEecC-----CEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCC
Confidence            3566 799999999443     44899999998 58887777664   79999999999999999999999999999999


Q ss_pred             CCcEEEccCC-CEEEeeccceeeccCCC-------ccccceeccccccchhccCC--CCCCcchhHHHHHHHHHHHHhCC
Q 023609           76 PSNLLLNANC-DLKICDFGLARVTSETD-------FMTEYVVTRWYRAPELLLNS--SDYTAAIDVWSVGCIFMELMDRK  145 (280)
Q Consensus        76 ~~nili~~~~-~~~l~dfg~~~~~~~~~-------~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~il~~ll~g~  145 (280)
                      |+||+++..+ .++++|||.+.......       ......++..|++||.+.+.  .......|+|++|++++++++|.
T Consensus       129 p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~  208 (384)
T COG0515         129 PENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGL  208 (384)
T ss_pred             HHHeeecCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCC
Confidence            9999999988 69999999987544332       23567889999999998653  46788999999999999999999


Q ss_pred             CCCCCCCh---HHHHHHHHHHhCCC-CHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCC
Q 023609          146 PLFPGRDH---VHQLRLLIELIGTP-SEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI  221 (280)
Q Consensus       146 ~pf~~~~~---~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~  221 (280)
                      .||.....   .............+ ....                  ......   ......+.+++.+++..+|..|.
T Consensus       209 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~---~~~~~~~~~~~~~~~~~~~~~r~  267 (384)
T COG0515         209 PPFEGEKNSSATSQTLKIILELPTPSLASP------------------LSPSNP---ELISKAASDLLKKLLAKDPKNRL  267 (384)
T ss_pred             CCCCCCCccccHHHHHHHHHhcCCcccccc------------------cCcccc---chhhHHHHHHHHHHHhcCchhcC
Confidence            99876653   22222222222211 0000                  000000   11235688999999999999999


Q ss_pred             CHHHHhcCCCCCCCcC
Q 023609          222 TVEDALAHPYLGSLHD  237 (280)
Q Consensus       222 t~~ell~h~~~~~~~~  237 (280)
                      +..+...+++......
T Consensus       268 ~~~~~~~~~~~~~~~~  283 (384)
T COG0515         268 SSSSDLSHDLLAHLKL  283 (384)
T ss_pred             CHHHHhhchHhhCccc
Confidence            9999999877765543

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.84  E-value=2.4e-20  Score=149.07  Aligned_cols=188  Identities=16%  Similarity=0.257  Sum_probs=145.5

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCC--CCHHHHHHHHHHHHHHHHHHHHCC--ceeccCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQA--LSEEHCQYFLYQILRGLKYIHSAN--VLHRDLK   75 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~--l~~~~~~~i~~qll~al~~LH~~g--i~H~di~   75 (280)
                      +.||||+.+++.+..+     .++.++..|++ |+|++.+.....  .+..++.+++..++.|.+|||+..  |.--.++
T Consensus       244 fshpnilpvlgacnsp-----pnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~ln  318 (448)
T KOG0195|consen  244 FSHPNILPVLGACNSP-----PNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLN  318 (448)
T ss_pred             ecCCchhhhhhhccCC-----CCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcc
Confidence            3699999999999776     78999999998 899999986544  677889999999999999999985  4444688


Q ss_pred             CCcEEEccCCCEEEe--eccceeeccCCCccccceeccccccchhccCCCC--CCcchhHHHHHHHHHHHHhCCCCCCCC
Q 023609           76 PSNLLLNANCDLKIC--DFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD--YTAAIDVWSVGCIFMELMDRKPLFPGR  151 (280)
Q Consensus        76 ~~nili~~~~~~~l~--dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~DiwslG~il~~ll~g~~pf~~~  151 (280)
                      ...++|+.+-+.+++  |.-++-.      ......+|.|++||.+.....  .-.++|+||+++++|+|.|+..||.+-
T Consensus       319 s~hvmidedltarismad~kfsfq------e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadl  392 (448)
T KOG0195|consen  319 SKHVMIDEDLTARISMADTKFSFQ------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADL  392 (448)
T ss_pred             cceEEecchhhhheecccceeeee------ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccC
Confidence            889999988766554  3222211      123466889999999865432  235799999999999999999999888


Q ss_pred             ChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHh
Q 023609          152 DHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDAL  227 (280)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell  227 (280)
                      ++.+.-.++.-..-.+                            ..-|+.+.....||.-|++.||.+||..+.++
T Consensus       393 spmecgmkialeglrv----------------------------~ippgis~hm~klm~icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  393 SPMECGMKIALEGLRV----------------------------HIPPGISRHMNKLMNICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             Cchhhhhhhhhccccc----------------------------cCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence            7776655543221111                            22358889999999999999999999987654

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.81  E-value=9e-19  Score=150.33  Aligned_cols=195  Identities=17%  Similarity=0.167  Sum_probs=142.0

Q ss_pred             CCeeeeeceec-CCCCCCCCcEEEEeecCCccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 023609            4 ENVVAIRDIIP-PPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   80 (280)
Q Consensus         4 pnIv~~~~~~~-~~~~~~~~~~~iv~e~~~g~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nil   80 (280)
                      +++.++++... ..     ..-||||++++.+|.++....  +.++...+..++.|++.+|++||+.|++||||||+|+.
T Consensus        80 ~~~~~~~~~G~~~~-----~~~~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~  154 (322)
T KOG1164|consen   80 SHFPKLLDHGRSTE-----DFNFIVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFV  154 (322)
T ss_pred             CCCCEEEEeccCCC-----ceeEEEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHee
Confidence            47778888774 22     567999999999999988544  57999999999999999999999999999999999999


Q ss_pred             EccC-----CCEEEeecccee--ecc-CC----C---c-cccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhC
Q 023609           81 LNAN-----CDLKICDFGLAR--VTS-ET----D---F-MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR  144 (280)
Q Consensus        81 i~~~-----~~~~l~dfg~~~--~~~-~~----~---~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g  144 (280)
                      ++..     ..+.+.|||+++  ... ..    .   . .....||..|+++.+..+. ..+++.|+||++.++.++..|
T Consensus       155 ~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~-e~~r~DDles~~Y~l~el~~g  233 (322)
T KOG1164|consen  155 VGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGI-EQGRRDDLESLFYMLLELLKG  233 (322)
T ss_pred             ecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCC-ccCCchhhhhHHHHHHHHhcC
Confidence            9865     358999999998  311 11    0   1 1234589999999977544 479999999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHH
Q 023609          145 KPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVE  224 (280)
Q Consensus       145 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~  224 (280)
                      ..||.+...........+.......               .          ......+..+.++...+-..+...+|...
T Consensus       234 ~LPW~~~~~~~~~~~~~~~~~~~~~---------------~----------~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~  288 (322)
T KOG1164|consen  234 SLPWEALEMTDLKSKFEKDPRKLLT---------------D----------RFGDLKPEEFAKILEYIDSLDYEDKPDYE  288 (322)
T ss_pred             CCCCccccccchHHHHHHHhhhhcc---------------c----------cccCCChHHHHHHHHHhhccCCcCCCCHH
Confidence            9999765533222222111100000               0          01123345677777777778888888777


Q ss_pred             HHhcC
Q 023609          225 DALAH  229 (280)
Q Consensus       225 ell~h  229 (280)
                      .+...
T Consensus       289 ~~~~~  293 (322)
T KOG1164|consen  289 KLAEL  293 (322)
T ss_pred             HHHHH
Confidence            66554

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.81  E-value=1.3e-20  Score=162.85  Aligned_cols=176  Identities=26%  Similarity=0.462  Sum_probs=131.2

Q ss_pred             CcEEEEeecCC-ccHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCCEEEeeccceee
Q 023609           22 NDVYIAYELMD-TDLHQIIRSNQ---ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV   97 (280)
Q Consensus        22 ~~~~iv~e~~~-g~L~~~l~~~~---~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nili~~~~~~~l~dfg~~~~   97 (280)
                      ..+||.|++|. ++|.++++.+.   ..+......++.|+..|++|   +|.+|+|+||.||++..+..++|+|||+...
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts  405 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS  405 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence            35899999998 79999997554   36777889999999999999   9999999999999999999999999999876


Q ss_pred             ccCCC-------ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHHHHHhCCCCH
Q 023609           98 TSETD-------FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR-KPLFPGRDHVHQLRLLIELIGTPSE  169 (280)
Q Consensus        98 ~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~~~~~~~~~~~~~~~~  169 (280)
                      .....       ......+|..||+||.+.+. .++.++||||||+|+++++.. ...+      +..+.....      
T Consensus       406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~-~y~~kvdIyaLGlil~EL~~~f~T~~------er~~t~~d~------  472 (516)
T KOG1033|consen  406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRGQ-QYSEKVDIYALGLILAELLIQFSTQF------ERIATLTDI------  472 (516)
T ss_pred             cccCCcccchhhhhhhcccccccCCHHHHhhh-hhhhhcchhhHHHHHHHHHHHhccHH------HHHHhhhhh------
Confidence            54433       34556889999999999654 589999999999999999862 2212      111111000      


Q ss_pred             HHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCC
Q 023609          170 AELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLG  233 (280)
Q Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~  233 (280)
                                          ....++..+-.-.+.-..|+..||...|.+||++.+.-.|+|.+
T Consensus       473 --------------------r~g~ip~~~~~d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~~  516 (516)
T KOG1033|consen  473 --------------------RDGIIPPEFLQDYPEEYTLLQQLLSPSPEERPSAIEVALHEFLQ  516 (516)
T ss_pred             --------------------hcCCCChHHhhcCcHHHHHHHHhcCCCcccCchHHHHhhhhhcC
Confidence                                00000000001123456899999999999999888887777753

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.80  E-value=6.7e-20  Score=169.21  Aligned_cols=150  Identities=29%  Similarity=0.430  Sum_probs=123.5

Q ss_pred             HHHHHHHHHCCceeccCCCCcEEEccCCCEEEeeccceeeccCCC----------------ccccceeccccccchhccC
Q 023609           58 LRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD----------------FMTEYVVTRWYRAPELLLN  121 (280)
Q Consensus        58 l~al~~LH~~gi~H~di~~~nili~~~~~~~l~dfg~~~~~~~~~----------------~~~~~~~~~~y~aPE~~~~  121 (280)
                      +.+++|||+.||+|||+||+|.+|+.-|.+|+.|||+++......                .....++|+.|.|||++..
T Consensus       153 vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilr  232 (1205)
T KOG0606|consen  153 VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILR  232 (1205)
T ss_pred             hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhh
Confidence            789999999999999999999999999999999999987532110                1123588999999999976


Q ss_pred             CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCC
Q 023609          122 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNV  201 (280)
Q Consensus       122 ~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  201 (280)
                      .+ |+..+|.|++|+|+|+.+-|+.||.+.+..+.+.....-...-+                           +.-..+
T Consensus       233 qg-ygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wp---------------------------E~dea~  284 (1205)
T KOG0606|consen  233 QG-YGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWP---------------------------EEDEAL  284 (1205)
T ss_pred             hc-cCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhcccc---------------------------ccCcCC
Confidence            55 89999999999999999999999999988877665554322221                           223367


Q ss_pred             ChHHHHHHHHhhcCCCCCCC---CHHHHhcCCCCCCC
Q 023609          202 HPSAIDLVEKMLTFDPRQRI---TVEDALAHPYLGSL  235 (280)
Q Consensus       202 ~~~~~~li~~~L~~dp~~R~---t~~ell~h~~~~~~  235 (280)
                      +++++++|..+|+.+|..|.   .+-++.+|+||+.+
T Consensus       285 p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~L  321 (1205)
T KOG0606|consen  285 PPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLL  321 (1205)
T ss_pred             CHHHHHHHHHHHHhChHhhcccchhhhhhhccceeec
Confidence            88999999999999999998   55688899999975

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.79  E-value=3.9e-19  Score=156.07  Aligned_cols=200  Identities=26%  Similarity=0.351  Sum_probs=149.8

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCc-eeccCCCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANV-LHRDLKPS   77 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~~gi-~H~di~~~   77 (280)
                      +.|.|+.++++.+.+.     ...++|.+||. |+|.|.+.. .-.++......+++.|+.|++|||+.-| +|+.++..
T Consensus         4 l~h~n~~~f~g~~~~~-----~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~   78 (484)
T KOG1023|consen    4 LDHDNLNKFIGASVDG-----PEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSS   78 (484)
T ss_pred             cchhhhhhheeeEecC-----CceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccc
Confidence            5799999999999876     77899999998 899999986 3458888899999999999999998765 99999999


Q ss_pred             cEEEccCCCEEEeeccceeeccCC---CccccceeccccccchhccCCC--C----CCcchhHHHHHHHHHHHHhCCCCC
Q 023609           78 NLLLNANCDLKICDFGLARVTSET---DFMTEYVVTRWYRAPELLLNSS--D----YTAAIDVWSVGCIFMELMDRKPLF  148 (280)
Q Consensus        78 nili~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~--~----~~~~~DiwslG~il~~ll~g~~pf  148 (280)
                      |.+++....+|+.|||+.......   ...........|.|||.+....  .    .+.+.|+||+|++++++++...||
T Consensus        79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~  158 (484)
T KOG1023|consen   79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF  158 (484)
T ss_pred             cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence            999999999999999998766421   1111223456699999885431  1    356799999999999999999999


Q ss_pred             CCCChH----HHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHH
Q 023609          149 PGRDHV----HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVE  224 (280)
Q Consensus       149 ~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~  224 (280)
                      +.....    +....+.+ .+.++.                     .+..... ....+++..++..|+..+|.+||+++
T Consensus       159 ~~~~~~~~~~eii~~~~~-~~~~~~---------------------rP~i~~~-~e~~~~l~~l~~~cw~e~P~~rPs~~  215 (484)
T KOG1023|consen  159 DLRNLVEDPDEIILRVKK-GGSNPF---------------------RPSIELL-NELPPELLLLVARCWEEIPEKRPSIE  215 (484)
T ss_pred             ccccccCChHHHHHHHHh-cCCCCc---------------------Ccchhhh-hhcchHHHHHHHHhcccChhhCccHH
Confidence            753222    22222222 111100                     0000000 03345789999999999999999999


Q ss_pred             HHhc
Q 023609          225 DALA  228 (280)
Q Consensus       225 ell~  228 (280)
                      .+-.
T Consensus       216 ~i~~  219 (484)
T KOG1023|consen  216 QIRS  219 (484)
T ss_pred             HHHh
Confidence            7755

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.75  E-value=3.3e-17  Score=134.42  Aligned_cols=160  Identities=17%  Similarity=0.272  Sum_probs=125.2

Q ss_pred             CCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEc
Q 023609            4 ENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIR-SNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   82 (280)
Q Consensus         4 pnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~-~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nili~   82 (280)
                      ++|..+|-+....     .+=.+|+|+++.+|.|+.. +.+.|+.+.+..++.||+.-++++|++.+++|||||+|+||+
T Consensus        84 ~GIP~vYYFGqeG-----~~NiLVidLLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIG  158 (449)
T KOG1165|consen   84 EGIPQVYYFGQEG-----KYNILVIDLLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIG  158 (449)
T ss_pred             CCCCceeeecccc-----chhhhhhhhhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeec
Confidence            5666666555433     5567999999988877776 556799999999999999999999999999999999999997


Q ss_pred             cCC-----CEEEeeccceeeccCCCcc--------ccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 023609           83 ANC-----DLKICDFGLARVTSETDFM--------TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFP  149 (280)
Q Consensus        83 ~~~-----~~~l~dfg~~~~~~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  149 (280)
                      ..+     .|.++|||+++..-++++.        ..-.||..||+--...+.. -+.+.|+-|||-++++.|.|..||.
T Consensus       159 rp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrE-QSRRDDLEaLGHvFmYFLRGsLPWQ  237 (449)
T KOG1165|consen  159 RPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGRE-QSRRDDLEALGHVFMYFLRGSLPWQ  237 (449)
T ss_pred             CCCCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccch-hhhhhhHHHhhhhhhhhccCCCccc
Confidence            644     3899999999865544322        2345799999987776654 6889999999999999999999998


Q ss_pred             CC---ChHHHHHHHHHHhCCCCH
Q 023609          150 GR---DHVHQLRLLIELIGTPSE  169 (280)
Q Consensus       150 ~~---~~~~~~~~~~~~~~~~~~  169 (280)
                      |.   +..+-+++|-+.-..-+.
T Consensus       238 GLKA~tnK~kYeKIGe~Kr~T~i  260 (449)
T KOG1165|consen  238 GLKADTNKEKYEKIGETKRSTPI  260 (449)
T ss_pred             cccCcchHHHHHHhccccccCCH
Confidence            65   445555666554443333

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.73  E-value=2.4e-17  Score=129.76  Aligned_cols=133  Identities=22%  Similarity=0.345  Sum_probs=108.4

Q ss_pred             CcEEEEeecCCccHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccC---CCEEEeeccceee
Q 023609           22 NDVYIAYELMDTDLHQIIR-SNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN---CDLKICDFGLARV   97 (280)
Q Consensus        22 ~~~~iv~e~~~g~L~~~l~-~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nili~~~---~~~~l~dfg~~~~   97 (280)
                      ..-.+||++++.+|.+... ..+.++...+.-++-|++.-++|+|.++++||||||+|++++-+   ..+.|+|||+++.
T Consensus        84 ~ynvlVMdLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKk  163 (341)
T KOG1163|consen   84 DYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKK  163 (341)
T ss_pred             ccceeeeeccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhh
Confidence            4568999999988888776 45679999999999999999999999999999999999999654   4589999999975


Q ss_pred             ccCCC--------ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 023609           98 TSETD--------FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVH  155 (280)
Q Consensus        98 ~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~  155 (280)
                      .-+..        ....-.||..|++--...+. .-+.+.|+-|+|.++.++..|..||.|-....
T Consensus       164 y~d~~t~~HIpyre~r~ltGTaRYASinAh~g~-eqSRRDDmeSvgYvLmYfnrG~LPWQglka~t  228 (341)
T KOG1163|consen  164 YRDIRTRQHIPYREDRNLTGTARYASINAHLGI-EQSRRDDMESVGYVLMYFNRGSLPWQGLKAAT  228 (341)
T ss_pred             hccccccccCccccCCccceeeeehhhhhhhhh-hhhhhhhhhhhcceeeeeecCCCcccccchhh
Confidence            43321        22334678889887765443 35789999999999999999999998765443

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.71  E-value=4.8e-17  Score=128.33  Aligned_cols=133  Identities=14%  Similarity=0.065  Sum_probs=98.6

Q ss_pred             CCCeeeeeceecCCCCCCCCcEEEEeecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccC-CCCcEE
Q 023609            3 HENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDL-KPSNLL   80 (280)
Q Consensus         3 HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di-~~~nil   80 (280)
                      |++|++++++         +..|++|+|+.| +|.+....      . ...++.|++.+|.++|++||+|||| ||+||+
T Consensus        61 ~~~vP~ll~~---------~~~~lvmeyI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NIL  124 (218)
T PRK12274         61 LPRTPRLLHW---------DGRHLDRSYLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWL  124 (218)
T ss_pred             CCCCCEEEEE---------cCEEEEEeeecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEE
Confidence            5788888885         236999999986 67644321      1 2357889999999999999999999 799999


Q ss_pred             EccCCCEEEeeccceeeccCCCcc--------------ccceeccccccchhccCCCCCC-cchhHHHHHHHHHHHHhCC
Q 023609           81 LNANCDLKICDFGLARVTSETDFM--------------TEYVVTRWYRAPELLLNSSDYT-AAIDVWSVGCIFMELMDRK  145 (280)
Q Consensus        81 i~~~~~~~l~dfg~~~~~~~~~~~--------------~~~~~~~~y~aPE~~~~~~~~~-~~~DiwslG~il~~ll~g~  145 (280)
                      ++.+|.++|+|||++.........              ....+++.+++|+...-....+ .+.+.++.|+.+|.++|++
T Consensus       125 v~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~  204 (218)
T PRK12274        125 VQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRR  204 (218)
T ss_pred             EcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhcc
Confidence            999999999999999865443210              1123467778887543222233 5667778899999999999


Q ss_pred             CCCCCC
Q 023609          146 PLFPGR  151 (280)
Q Consensus       146 ~pf~~~  151 (280)
                      .++-+.
T Consensus       205 ~~~~~~  210 (218)
T PRK12274        205 VLHWED  210 (218)
T ss_pred             CCcccc
Confidence            877543

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.69  E-value=2e-17  Score=135.67  Aligned_cols=201  Identities=21%  Similarity=0.244  Sum_probs=142.9

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccC
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS----NQALSEEHCQYFLYQILRGLKYIHSAN--VLHRDL   74 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~----~~~l~~~~~~~i~~qll~al~~LH~~g--i~H~di   74 (280)
                      .|.|||+++.|+.+...++.....+++||+. |++.+++++    .+.+.....++|+.||+.||.|||+..  ++|+++
T Consensus       125 vHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Ppiihgnl  204 (458)
T KOG1266|consen  125 VHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNL  204 (458)
T ss_pred             HHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCc
Confidence            5899999999998765545566888999998 899999974    346899999999999999999999986  999999


Q ss_pred             CCCcEEEccCCCEEEeeccceeec-----cCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCC-
Q 023609           75 KPSNLLLNANCDLKICDFGLARVT-----SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF-  148 (280)
Q Consensus        75 ~~~nili~~~~~~~l~dfg~~~~~-----~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf-  148 (280)
                      ..+.|++..+|-+|++........     ..........+.+.|.+||.- ...+...++|||++|....+|.-+..-- 
T Consensus       205 Tc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg-~~tn~~~a~dIy~fgmcAlemailEiq~t  283 (458)
T KOG1266|consen  205 TCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESG-TTTNTTGASDIYKFGMCALEMAILEIQST  283 (458)
T ss_pred             chhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcC-cccccccchhhhhhhHHHHHHHHheeccC
Confidence            999999999998888753322111     111111223456778899854 2334567899999999999997665321 


Q ss_pred             CCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          149 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                      .+.+....-..+...+                                 +.--...-++++.+||+..|..||++.+++.
T Consensus       284 nseS~~~~ee~ia~~i---------------------------------~~len~lqr~~i~kcl~~eP~~rp~ar~llf  330 (458)
T KOG1266|consen  284 NSESKVEVEENIANVI---------------------------------IGLENGLQRGSITKCLEGEPNGRPDARLLLF  330 (458)
T ss_pred             CCcceeehhhhhhhhe---------------------------------eeccCccccCcCcccccCCCCCCcchhhhhc
Confidence            1111111101111000                                 0011122457899999999999999999999


Q ss_pred             CCCCCCCc
Q 023609          229 HPYLGSLH  236 (280)
Q Consensus       229 h~~~~~~~  236 (280)
                      ||.+-.+.
T Consensus       331 HpllfeVh  338 (458)
T KOG1266|consen  331 HPLLFEVH  338 (458)
T ss_pred             Cceeeecc
Confidence            99987654

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.68  E-value=2.2e-17  Score=132.82  Aligned_cols=121  Identities=16%  Similarity=0.284  Sum_probs=89.0

Q ss_pred             CCCCCeeeeeceecCCCCCC---CCcEEEEeecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCC
Q 023609            1 MDHENVVAIRDIIPPPQRES---FNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKP   76 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~---~~~~~iv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~   76 (280)
                      |+||+|..+.+++.+.....   .+..+|||||++| +|.++.    .+++.    .+.+++.++..+|+.|++|||++|
T Consensus        92 L~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~~----~~~~i~~~l~~lH~~gi~H~Dikp  163 (232)
T PRK10359         92 VRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMP----EISED----VKAKIKASIESLHQHGMVSGDPHK  163 (232)
T ss_pred             HHHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhh----hccHH----HHHHHHHHHHHHHHcCCccCCCCh
Confidence            46999999999876542111   2458999999997 887773    23432    466999999999999999999999


Q ss_pred             CcEEEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHH
Q 023609           77 SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM  142 (280)
Q Consensus        77 ~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll  142 (280)
                      +||+++.+| ++++|||......+....            ..+.-...+..++|+|+||+++..+.
T Consensus       164 ~Nili~~~g-i~liDfg~~~~~~e~~a~------------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        164 GNFIVSKNG-LRIIDLSGKRCTAQRKAK------------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             HHEEEeCCC-EEEEECCCcccccchhhH------------HHHHHHhHhcccccccceeEeehHHH
Confidence            999999988 999999987654322110            11111223557899999999988653

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.66  E-value=3.1e-16  Score=135.17  Aligned_cols=104  Identities=23%  Similarity=0.315  Sum_probs=78.9

Q ss_pred             CCCCCeee-eeceecCCCCCCCCcEEEEeecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccC-CCC
Q 023609            1 MDHENVVA-IRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDL-KPS   77 (280)
Q Consensus         1 l~HpnIv~-~~~~~~~~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di-~~~   77 (280)
                      |+|+||+. +++.         +..|+||||++| +|.. +..   ..   ...++.|++.||.|||++||+|||| ||+
T Consensus        78 L~h~~iv~~l~~~---------~~~~LVmE~~~G~~L~~-~~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~  141 (365)
T PRK09188         78 VRGIGVVPQLLAT---------GKDGLVRGWTEGVPLHL-ARP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQ  141 (365)
T ss_pred             ccCCCCCcEEEEc---------CCcEEEEEccCCCCHHH-hCc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcc
Confidence            57999985 4432         347999999985 7762 221   11   1467899999999999999999999 999


Q ss_pred             cEEEccCCCEEEeeccceeeccCCCc---------cccceeccccccchhcc
Q 023609           78 NLLLNANCDLKICDFGLARVTSETDF---------MTEYVVTRWYRAPELLL  120 (280)
Q Consensus        78 nili~~~~~~~l~dfg~~~~~~~~~~---------~~~~~~~~~y~aPE~~~  120 (280)
                      ||+++.++.++|+|||+++.......         .....+++.|.+||.+.
T Consensus       142 NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~  193 (365)
T PRK09188        142 NWLMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT  193 (365)
T ss_pred             eEEEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence            99999999999999999986543321         12345677789999874

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.65  E-value=1e-17  Score=153.26  Aligned_cols=202  Identities=26%  Similarity=0.406  Sum_probs=159.6

Q ss_pred             CCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHH-HcCC-CCCHHHHHHHHHHHHHHHHHHH-HCCceeccCCCCc
Q 023609            3 HENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQII-RSNQ-ALSEEHCQYFLYQILRGLKYIH-SANVLHRDLKPSN   78 (280)
Q Consensus         3 HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l-~~~~-~l~~~~~~~i~~qll~al~~LH-~~gi~H~di~~~n   78 (280)
                      |+|++++++....+     ...++++++.. +++++-+ .... ..+...+..++.|+..++.|+| ..|+.|+|++|+|
T Consensus        80 h~n~~~~~~~~~~~-----~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n  154 (601)
T KOG0590|consen   80 HSNTVHMIEPSSSP-----RSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSN  154 (601)
T ss_pred             cccccccCCccCCC-----cccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCcc
Confidence            99999999998666     66899999976 5888888 5554 6788888999999999999999 9999999999999


Q ss_pred             EEEccCC-CEEEeeccceeeccC----CCcccccee-ccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 023609           79 LLLNANC-DLKICDFGLARVTSE----TDFMTEYVV-TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD  152 (280)
Q Consensus        79 ili~~~~-~~~l~dfg~~~~~~~----~~~~~~~~~-~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  152 (280)
                      .+++..+ .+++.|||++.....    .......++ ++.|+|||...+........|+||+|+++..+++|..|+....
T Consensus       155 ~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~  234 (601)
T KOG0590|consen  155 SLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPS  234 (601)
T ss_pred             chhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccc
Confidence            9999999 999999999975443    223345567 9999999988765567889999999999999999999885433


Q ss_pred             hHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 023609          153 HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  232 (280)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~  232 (280)
                      .....                        +..+. ......-...+..++....+++.++|..+|..|.+.+++-.++|+
T Consensus       235 ~~~~~------------------------~~~~~-~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~  289 (601)
T KOG0590|consen  235 RKDGR------------------------YSSWK-SNKGRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWL  289 (601)
T ss_pred             ccccc------------------------ceeec-ccccccccCccccCChhhhhcccccccCCchhccccccccccccc
Confidence            22100                        00000 000000112334677889999999999999999999999999999


Q ss_pred             CC
Q 023609          233 GS  234 (280)
Q Consensus       233 ~~  234 (280)
                      ..
T Consensus       290 ~~  291 (601)
T KOG0590|consen  290 SS  291 (601)
T ss_pred             cc
Confidence            98

>PRK10345 hypothetical protein; Provisional

Probab=99.64  E-value=9.3e-16  Score=122.77  Aligned_cols=87  Identities=20%  Similarity=0.300  Sum_probs=70.0

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEE-EEeecCC---ccHHHHHHcCCCCCHHHHHHHHHHHHHHH-HHHHHCCceeccCCC
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVY-IAYELMD---TDLHQIIRSNQALSEEHCQYFLYQILRGL-KYIHSANVLHRDLKP   76 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~-iv~e~~~---g~L~~~l~~~~~l~~~~~~~i~~qll~al-~~LH~~gi~H~di~~   76 (280)
                      +||||+++++++.++.  +.+.++ +|+||++   |+|.+++.+. .+++.  ..++.|++.++ +|||++||+||||||
T Consensus        59 ~h~nIvr~yg~~et~~--g~g~v~~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp  133 (210)
T PRK10345         59 DWSGIPRYYGTVETDC--GTGYVYDVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKP  133 (210)
T ss_pred             CCcccceeeEEEEeCC--CCeEEEEEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCH
Confidence            6899999999998763  223434 7899955   6999999764 57766  36688888888 999999999999999


Q ss_pred             CcEEEcc----CCCEEEeecc
Q 023609           77 SNLLLNA----NCDLKICDFG   93 (280)
Q Consensus        77 ~nili~~----~~~~~l~dfg   93 (280)
                      +||+++.    ++.++|+|++
T Consensus       134 ~NILl~~~~~~~~~~~LiDg~  154 (210)
T PRK10345        134 QNILCQRISESEVIPVVCDNI  154 (210)
T ss_pred             HHEEEeccCCCCCcEEEEECC
Confidence            9999974    3479999944

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.63  E-value=5.4e-16  Score=122.84  Aligned_cols=75  Identities=19%  Similarity=0.286  Sum_probs=64.8

Q ss_pred             EEEEeecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH-HHCCceeccCCCCcEEEccCCCEEEeeccceeecc
Q 023609           24 VYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYI-HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS   99 (280)
Q Consensus        24 ~~iv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qll~al~~L-H~~gi~H~di~~~nili~~~~~~~l~dfg~~~~~~   99 (280)
                      .+|||||++| ++.......+++++..+..++.|++.+|.++ |+.||+||||||+||+++ ++.++|+|||++....
T Consensus        92 ~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v~LiDFG~a~~~~  168 (190)
T cd05147          92 HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKLYIIDVSQSVEHD  168 (190)
T ss_pred             CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcEEEEEccccccCC
Confidence            3899999986 5555444557899999999999999999999 799999999999999998 5789999999987543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.61  E-value=1.8e-15  Score=142.06  Aligned_cols=134  Identities=22%  Similarity=0.310  Sum_probs=111.9

Q ss_pred             eeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcc-
Q 023609            6 VVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA-   83 (280)
Q Consensus         6 Iv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nili~~-   83 (280)
                      |+.+..++.-.     +.-++|++|.+ |+|.|++...+.+++..++.+..||+.-|++||.+||+|+||||+|+++.. 
T Consensus       756 ~~~~~~a~~~~-----~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~  830 (974)
T KOG1166|consen  756 IMHISSAHVFQ-----NASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRRE  830 (974)
T ss_pred             hHHHHHHHccC-----CcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecc
Confidence            44444444333     44699999998 899999998889999999999999999999999999999999999999942 


Q ss_pred             ------CCCEEEeeccceeec---cCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCC
Q 023609           84 ------NCDLKICDFGLARVT---SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK  145 (280)
Q Consensus        84 ------~~~~~l~dfg~~~~~---~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~  145 (280)
                            ...++|+|||.+-.+   .++......+.|-.+-++|... +++++..+|.|.++.+++.|+.|+
T Consensus       831 ~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~-grpWtYq~DyfGlAa~~h~mLFG~  900 (974)
T KOG1166|consen  831 ICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMRE-GRPWTYQIDYFGLAATVHVMLFGK  900 (974)
T ss_pred             cCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhc-CCCCchhhhhHHHHHHHHHHHHHH
Confidence                  345899999998643   3333455677888999999885 456999999999999999999987

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.60  E-value=2.8e-15  Score=119.02  Aligned_cols=75  Identities=20%  Similarity=0.246  Sum_probs=64.5

Q ss_pred             EEEEeecCCcc-HHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEEccCCCEEEeeccceeecc
Q 023609           24 VYIAYELMDTD-LHQIIRSNQALSEEHCQYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNANCDLKICDFGLARVTS   99 (280)
Q Consensus        24 ~~iv~e~~~g~-L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~-~gi~H~di~~~nili~~~~~~~l~dfg~~~~~~   99 (280)
                      .|+||||++|. +.........++...+..++.|++.++.++|+ .|++||||||+||+++ ++.++|+|||++....
T Consensus        92 ~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~~liDFG~a~~~~  168 (190)
T cd05145          92 NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKPYIIDVSQAVELD  168 (190)
T ss_pred             CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCEEEEEcccceecC
Confidence            38999999863 44333344678899999999999999999999 9999999999999998 8999999999987654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.51  E-value=3.3e-14  Score=125.45  Aligned_cols=195  Identities=28%  Similarity=0.272  Sum_probs=151.9

Q ss_pred             CCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHcCCC-CCHHHHHHHHHHHHH----HHHHHHHCCceeccCCCC
Q 023609            3 HENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQA-LSEEHCQYFLYQILR----GLKYIHSANVLHRDLKPS   77 (280)
Q Consensus         3 HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~-l~~~~~~~i~~qll~----al~~LH~~gi~H~di~~~   77 (280)
                      |+|.++.+..+...     +..|+-+|+|+.+|..+...... +++..++..+.+...    ||.++|+.+++|.|++|+
T Consensus       177 ~~~~v~~~~~~e~~-----~~lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~  251 (524)
T KOG0601|consen  177 HENPVRDSPAWEGS-----GILFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPA  251 (524)
T ss_pred             cccccccCcccccC-----CcceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchh
Confidence            77888866666443     78999999999999999887655 889999999999999    999999999999999999


Q ss_pred             cEEEccC-CCEEEeeccceeeccCCCcc------ccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 023609           78 NLLLNAN-CDLKICDFGLARVTSETDFM------TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPG  150 (280)
Q Consensus        78 nili~~~-~~~~l~dfg~~~~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~  150 (280)
                      ||+...+ ..++++|||.....+.....      ....+...|++||...  +.++...|++++|.++.+..++...+..
T Consensus       252 ~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~--~l~~~~~di~sl~ev~l~~~l~~~~~~~  329 (524)
T KOG0601|consen  252 NIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN--GLATFASDIFSLGEVILEAILGSHLPSV  329 (524)
T ss_pred             heecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc--cccchHhhhcchhhhhHhhHhhcccccC
Confidence            9999999 88999999999877665421      1225677799999874  3378999999999999998887655532


Q ss_pred             C--ChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          151 R--DHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       151 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                      +  ......+..                               ....+...+.+.++...+..|++.+|..|+++..+++
T Consensus       330 g~~~~W~~~r~~-------------------------------~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  330 GKNSSWSQLRQG-------------------------------YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             CCCCCccccccc-------------------------------cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence            2  111110000                               0111222355667777999999999999999999999


Q ss_pred             CCCCCCC
Q 023609          229 HPYLGSL  235 (280)
Q Consensus       229 h~~~~~~  235 (280)
                      ++++.+.
T Consensus       379 l~~i~s~  385 (524)
T KOG0601|consen  379 LNVIHSK  385 (524)
T ss_pred             cccccch
Confidence            9999864

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.51  E-value=2.1e-13  Score=121.86  Aligned_cols=132  Identities=22%  Similarity=0.437  Sum_probs=102.0

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH-HCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIH-SANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH-~~gi~H~di~~~ni   79 (280)
                      |+||||+++++.+...     +.+|||+|-+. .|..++++   ++...+..-++||+.||.||| +.+++|++|..++|
T Consensus        66 lRHP~Il~yL~t~e~~-----~~~ylvTErV~-Pl~~~lk~---l~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SV  136 (690)
T KOG1243|consen   66 LRHPNILSYLDTTEEE-----GTLYLVTERVR-PLETVLKE---LGKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSV  136 (690)
T ss_pred             ccCchhhhhhhhhccc-----CceEEEeeccc-cHHHHHHH---hHHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeE
Confidence            6899999999999665     68999999987 44455544   347788899999999999998 67899999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCCc-cccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhC
Q 023609           80 LLNANCDLKICDFGLARVTSETDF-MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR  144 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g  144 (280)
                      +|+..|..+|++|..+........ .......-.|..|+.....   .-..|.|.|||++++++.|
T Consensus       137 fVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s---~~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  137 FVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPS---EWSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             EEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCcc---ccchhhhhHHHHHHHHhCc
Confidence            999999999999987754332221 1112222336677654222   2568999999999999988

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.45  E-value=8.3e-14  Score=129.52  Aligned_cols=186  Identities=25%  Similarity=0.352  Sum_probs=149.5

Q ss_pred             CcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCCEEEeeccceeecc-
Q 023609           22 NDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-   99 (280)
Q Consensus        22 ~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nili~~~~~~~l~dfg~~~~~~-   99 (280)
                      ...++|++|++ ++|...+.+-+..++..++..+..+..++++||+..+.|+|++|.|.++..+|..++.+||.....+ 
T Consensus       877 sP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~  956 (1205)
T KOG0606|consen  877 SPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGL  956 (1205)
T ss_pred             CCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCcccccccccc
Confidence            56899999997 5999999888888999999999999999999999999999999999999999999999997332110 


Q ss_pred             ---------CC----------------------CccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 023609          100 ---------ET----------------------DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF  148 (280)
Q Consensus       100 ---------~~----------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf  148 (280)
                               ..                      .......+|+.|.+||...+.. .+..+|.|+.|+++++.++|.+||
T Consensus       957 ~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~-hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen  957 IPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRR-HGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred             ccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccccc-CCCcchhhhhhhhhhhhhcCCCCC
Confidence                     00                      0112345789999999987665 577889999999999999999999


Q ss_pred             CCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHH---H
Q 023609          149 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVE---D  225 (280)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~---e  225 (280)
                      .+....+..+.+...-...                           ..--...+.++++++...|..+|.+|..+.   +
T Consensus      1036 na~tpq~~f~ni~~~~~~~---------------------------p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e 1088 (1205)
T KOG0606|consen 1036 NAETPQQIFENILNRDIPW---------------------------PEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAE 1088 (1205)
T ss_pred             CCcchhhhhhccccCCCCC---------------------------CCCccccChhhhhhhhhhhccCchhccCcccccc
Confidence            8887776665443322221                           111224578899999999999999999988   8


Q ss_pred             HhcCCCCCCC
Q 023609          226 ALAHPYLGSL  235 (280)
Q Consensus       226 ll~h~~~~~~  235 (280)
                      +-.|+||+..
T Consensus      1089 ~k~~~~~~~~ 1098 (1205)
T KOG0606|consen 1089 VKGHPFFQDV 1098 (1205)
T ss_pred             cccCCccCCC
Confidence            9999999975

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.41  E-value=5e-13  Score=107.76  Aligned_cols=86  Identities=28%  Similarity=0.387  Sum_probs=71.0

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nil   80 (280)
                      .|+||.....++...     ...++||||++| +|.+.+.....    ....++.+++.+|.++|+.|++|+|++|.||+
T Consensus        57 ~~~~i~~p~~~~~~~-----~~~~lv~e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil  127 (211)
T PRK14879         57 RKAGVNVPAVYFVDP-----ENFIIVMEYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMI  127 (211)
T ss_pred             HHCCCCCCeEEEEeC-----CCCEEEEEEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEE
Confidence            466666555555433     457899999975 99998865432    78899999999999999999999999999999


Q ss_pred             EccCCCEEEeeccceee
Q 023609           81 LNANCDLKICDFGLARV   97 (280)
Q Consensus        81 i~~~~~~~l~dfg~~~~   97 (280)
                      ++ ++.++++|||.+..
T Consensus       128 ~~-~~~~~liDf~~a~~  143 (211)
T PRK14879        128 LS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             EE-CCCEEEEECCcccC
Confidence            99 78899999998765

>smart00090 RIO RIO-like kinase

Probab=99.41  E-value=3.8e-13  Score=110.19  Aligned_cols=75  Identities=17%  Similarity=0.200  Sum_probs=64.6

Q ss_pred             EEEEeecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC-ceeccCCCCcEEEccCCCEEEeeccceeecc
Q 023609           24 VYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN-VLHRDLKPSNLLLNANCDLKICDFGLARVTS   99 (280)
Q Consensus        24 ~~iv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~g-i~H~di~~~nili~~~~~~~l~dfg~~~~~~   99 (280)
                      .++||||++| +|......+..+...++..++.|++.++.+||+.| ++|+||||+||+++ ++.++|+|||.+...+
T Consensus       123 ~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      123 NVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             ceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE-CCCEEEEEChhhhccC
Confidence            4899999997 66665545556777778899999999999999999 99999999999999 8899999999876544

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.37  E-value=1.6e-12  Score=106.65  Aligned_cols=90  Identities=23%  Similarity=0.280  Sum_probs=68.2

Q ss_pred             CCCCe--eeeeceecCCCCCCCCcEEEEeecCCc--cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 023609            2 DHENV--VAIRDIIPPPQRESFNDVYIAYELMDT--DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS   77 (280)
Q Consensus         2 ~HpnI--v~~~~~~~~~~~~~~~~~~iv~e~~~g--~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~   77 (280)
                      +|++|  ++.+++..... ......++|||+++|  +|.+++.. .++++..    +.||+.+|.+||+.||+|+||||.
T Consensus        98 ~~~gi~vP~pl~~~~~~~-~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDlkp~  171 (239)
T PRK01723         98 YEAGLPVPRPIAARVVRH-GLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADLNAH  171 (239)
T ss_pred             HhCCCCCceeEeeeeeec-CcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCCCch
Confidence            45554  56666543321 111234699999985  88888765 4566654    578999999999999999999999


Q ss_pred             cEEEccCCCEEEeeccceee
Q 023609           78 NLLLNANCDLKICDFGLARV   97 (280)
Q Consensus        78 nili~~~~~~~l~dfg~~~~   97 (280)
                      ||+++.++.++|+|||.+..
T Consensus       172 NILv~~~~~v~LIDfg~~~~  191 (239)
T PRK01723        172 NILLDPDGKFWLIDFDRGEL  191 (239)
T ss_pred             hEEEcCCCCEEEEECCCccc
Confidence            99999999999999998754

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.36  E-value=1.9e-12  Score=118.54  Aligned_cols=84  Identities=21%  Similarity=0.331  Sum_probs=70.6

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++|++|+..+.++...     ...++||||++ ++|.+++.        ....++.|++.+|.+||+.|++|||+||+||
T Consensus       393 l~~~~i~~p~~~~~~~-----~~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NI  459 (535)
T PRK09605        393 ARRAGVPTPVIYDVDP-----EEKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNF  459 (535)
T ss_pred             hcccCCCeeEEEEEeC-----CCCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHE
Confidence            4688888776665443     34689999997 49998875        4567899999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeec
Q 023609           80 LLNANCDLKICDFGLARVT   98 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~   98 (280)
                      ++ .++.++|+|||+++..
T Consensus       460 Ll-~~~~~~liDFGla~~~  477 (535)
T PRK09605        460 IV-RDDRLYLIDFGLGKYS  477 (535)
T ss_pred             EE-ECCcEEEEeCcccccC
Confidence            99 6788999999998764

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.35  E-value=1.5e-12  Score=104.04  Aligned_cols=68  Identities=28%  Similarity=0.487  Sum_probs=59.1

Q ss_pred             CcEEEEeecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCCEEEeeccceee
Q 023609           22 NDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV   97 (280)
Q Consensus        22 ~~~~iv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nili~~~~~~~l~dfg~~~~   97 (280)
                      ...++||||++| +|.+.+.....       .++.|++.+|.+||+.|++|+|++|.||+++ ++.++++|||.+..
T Consensus        70 ~~~~lv~e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        70 DNKTIVMEYIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             CCCEEEEEEECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            346899999975 88888754321       7899999999999999999999999999999 88999999998765

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.21  E-value=2.8e-11  Score=96.66  Aligned_cols=71  Identities=21%  Similarity=0.262  Sum_probs=59.7

Q ss_pred             cEEEEeecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCCEEEeeccceeecc
Q 023609           23 DVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS   99 (280)
Q Consensus        23 ~~~iv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nili~~~~~~~l~dfg~~~~~~   99 (280)
                      ..++||||++| +|.+....      .....++.+++.++.++|+.|++|+||+|+||+++.++.++|+|||.+....
T Consensus       105 ~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         105 RHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             CceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcEEEEECCccccCC
Confidence            45899999986 66654321      3456788999999999999999999999999999999999999999886543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.18  E-value=8.3e-12  Score=112.16  Aligned_cols=155  Identities=22%  Similarity=0.352  Sum_probs=110.0

Q ss_pred             HHHHHHHHHHHHHC-CceeccCCCCcEEEccCCCEEEeeccceeeccCCCc----------cccceeccccccchhccCC
Q 023609           54 LYQILRGLKYIHSA-NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF----------MTEYVVTRWYRAPELLLNS  122 (280)
Q Consensus        54 ~~qll~al~~LH~~-gi~H~di~~~nili~~~~~~~l~dfg~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~~  122 (280)
                      +.++..|+.|+|.. ++||++|.|++|.++.+|..|++.|+.+.....+..          ..-......|.+||.+.+ 
T Consensus       105 l~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~-  183 (700)
T KOG2137|consen  105 LGNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG-  183 (700)
T ss_pred             hhcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc-
Confidence            34555899999965 899999999999999999999999988764433111          011123566999999865 


Q ss_pred             CCCCcchhHHHHHHHHHHHH-hCCCCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCC
Q 023609          123 SDYTAAIDVWSVGCIFMELM-DRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNV  201 (280)
Q Consensus       123 ~~~~~~~DiwslG~il~~ll-~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  201 (280)
                      .....++|++|+||.+|.+. .|...+.+.........-....+.+                    ..      ..-..+
T Consensus       184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~--------------------~~------~~s~~~  237 (700)
T KOG2137|consen  184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAG--------------------AF------GYSNNL  237 (700)
T ss_pred             ccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccc--------------------cc------cccccC
Confidence            44688999999999999887 4555554433222111110000000                    00      000367


Q ss_pred             ChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCC
Q 023609          202 HPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  235 (280)
Q Consensus       202 ~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~  235 (280)
                      ++++++=|.++|..++..||++.+++..+||++.
T Consensus       238 p~el~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~  271 (700)
T KOG2137|consen  238 PSELRESLKKLLNGDSAVRPTLDLLLSIPFFSDP  271 (700)
T ss_pred             cHHHHHHHHHHhcCCcccCcchhhhhcccccCCc
Confidence            8999999999999999999999999999999875

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.14  E-value=1.1e-09  Score=95.77  Aligned_cols=175  Identities=19%  Similarity=0.270  Sum_probs=124.9

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC--ccHHHHHHc---------------CCCCCHHHHHHHHHHHHHHHHH
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD--TDLHQIIRS---------------NQALSEEHCQYFLYQILRGLKY   63 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~--g~L~~~l~~---------------~~~l~~~~~~~i~~qll~al~~   63 (280)
                      +.|+|+|++.++|....-.+ ..+++|++|.+  ++|.+.--.               +...+|..+|.++.||..||.+
T Consensus       330 l~h~NvV~frevf~t~tF~D-~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~s  408 (655)
T KOG3741|consen  330 LCHTNVVPFREVFLTYTFGD-LSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYS  408 (655)
T ss_pred             hccCceeehhhhhhhhccCc-ceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHH
Confidence            46999999999997433222 56999999997  488877632               2347889999999999999999


Q ss_pred             HHHCCceeccCCCCcEEEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh
Q 023609           64 IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD  143 (280)
Q Consensus        64 LH~~gi~H~di~~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~  143 (280)
                      +|+.|+..+-+.+.+|+++++.+++++..|.........           .+|  +.    -..+-|.-.||.+++.|.|
T Consensus       409 IHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~-----------~~~--le----~~Qq~D~~~lG~ll~aLAt  471 (655)
T KOG3741|consen  409 IHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP-----------TEP--LE----SQQQNDLRDLGLLLLALAT  471 (655)
T ss_pred             HHhcCceeecccHhHeEeeCcceEEEecccceeeecCCC-----------Ccc--hh----HHhhhhHHHHHHHHHHHhh
Confidence            999999999999999999999999999877765544332           111  21    1246799999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCH
Q 023609          144 RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV  223 (280)
Q Consensus       144 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~  223 (280)
                      |..--...+..+..+                                   .+...+.+|.+++++|.-+-..++.+ -++
T Consensus       472 ~~~ns~~~d~~~~s~-----------------------------------~~~I~~~yS~D~rn~v~yl~s~~~~~-ksI  515 (655)
T KOG3741|consen  472 GTENSNRTDSTQSSH-----------------------------------LTRITTTYSTDLRNVVEYLESLNFRE-KSI  515 (655)
T ss_pred             cccccccccchHHHH-----------------------------------HHHhhhhhhHHHHHHHHHHHhcCccc-ccH
Confidence            964211111111100                                   01222366778888888887777765 666


Q ss_pred             HHHhcC
Q 023609          224 EDALAH  229 (280)
Q Consensus       224 ~ell~h  229 (280)
                      .+++.+
T Consensus       516 ~~llp~  521 (655)
T KOG3741|consen  516 QDLLPM  521 (655)
T ss_pred             HHHHHH
Confidence            666653

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.13  E-value=1.2e-10  Score=91.99  Aligned_cols=74  Identities=20%  Similarity=0.254  Sum_probs=58.4

Q ss_pred             cEEEEeecCCc-cHH-HHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEEccCCCEEEeeccceeecc
Q 023609           23 DVYIAYELMDT-DLH-QIIRSNQALSEEHCQYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNANCDLKICDFGLARVTS   99 (280)
Q Consensus        23 ~~~iv~e~~~g-~L~-~~l~~~~~l~~~~~~~i~~qll~al~~LH~-~gi~H~di~~~nili~~~~~~~l~dfg~~~~~~   99 (280)
                      ..++||||++| .+. ..+... ... .++..++.+++.++.++|. .|++|+||+|+||+++ ++.++++|||.+....
T Consensus        89 ~~~lv~e~~~g~~~~~~~l~~~-~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~~liDfg~a~~~~  165 (187)
T cd05119          89 RHVLVMEFIGGDGIPAPRLKDV-RLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKVYIIDVPQAVEID  165 (187)
T ss_pred             CCEEEEEEeCCCCccChhhhhh-hhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcEEEEECccccccc
Confidence            45899999986 221 111111 111 6788999999999999999 9999999999999999 8999999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.11  E-value=3.1e-11  Score=106.85  Aligned_cols=193  Identities=23%  Similarity=0.254  Sum_probs=137.2

Q ss_pred             CCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE
Q 023609            3 HENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   81 (280)
Q Consensus         3 HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nili   81 (280)
                      |.+++.++..|...     .+.||-.|||+ +++...+.-...+.++..+.+..|++.++.++|+..++|+|++|+||++
T Consensus       325 ~~~~~g~~~~W~~~-----r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i  399 (524)
T KOG0601|consen  325 HLPSVGKNSSWSQL-----RQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILI  399 (524)
T ss_pred             ccccCCCCCCcccc-----ccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceee
Confidence            66777777766544     55679999997 4555444444568899999999999999999999999999999999999


Q ss_pred             ccC-CCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 023609           82 NAN-CDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL  160 (280)
Q Consensus        82 ~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~  160 (280)
                      ..+ +..+++|||+.....-.. ......+..|...|++.....+..+.|++|+|..+.+.+++.+.-........++  
T Consensus       400 ~~~~~~~~~~~~~~~t~~~~~~-~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~~~i~--  476 (524)
T KOG0601|consen  400 SNDGFFSKLGDFGCWTRLAFSS-GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQSLTIR--  476 (524)
T ss_pred             ccchhhhhccccccccccceec-ccccccccccccchhhccccccccccccccccccccccccCcccCcccccceeee--
Confidence            876 778999999886532211 1112223333235666666678899999999999999998875433221111000  


Q ss_pred             HHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCC
Q 023609          161 IELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS  234 (280)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~  234 (280)
                                                     ...+...++....+..+.+.|+.+++..|+.+.++..|.-|..
T Consensus       477 -------------------------------~~~~p~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~  519 (524)
T KOG0601|consen  477 -------------------------------SGDTPNLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYR  519 (524)
T ss_pred             -------------------------------cccccCCCchHHhhhhhhhhhcCCccccchhhhhhcccchhhh
Confidence                                           0001122344466888999999999999999999998886654

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.08  E-value=3.6e-10  Score=89.20  Aligned_cols=76  Identities=18%  Similarity=0.297  Sum_probs=60.2

Q ss_pred             cEEEEeecCCcc-HHHHHHcCCCCCHHHHHHHHHHHHHHHHHH-HHCCceeccCCCCcEEEccCCCEEEeeccceeecc
Q 023609           23 DVYIAYELMDTD-LHQIIRSNQALSEEHCQYFLYQILRGLKYI-HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS   99 (280)
Q Consensus        23 ~~~iv~e~~~g~-L~~~l~~~~~l~~~~~~~i~~qll~al~~L-H~~gi~H~di~~~nili~~~~~~~l~dfg~~~~~~   99 (280)
                      .-+|||||++++ +.....+...+++..+..+..|++.++..| |+.|++|+|+++.||+++ ++.+.++|||.+....
T Consensus        98 ~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146          98 KHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             CCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEE-CCcEEEEECCCceeCC
Confidence            358999999863 322222334566677788899999999998 899999999999999996 5779999999876554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.02  E-value=9e-10  Score=83.30  Aligned_cols=82  Identities=24%  Similarity=0.267  Sum_probs=67.2

Q ss_pred             CCeeeeeceecCCCCCCCCcEEEEeecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCCCcE
Q 023609            4 ENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA---NVLHRDLKPSNL   79 (280)
Q Consensus         4 pnIv~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~---gi~H~di~~~ni   79 (280)
                      .++++++.+....     +..+++|||++| .+..+       +......++.+++.+++.||..   |++|+|++|+||
T Consensus        53 ~~~p~~~~~~~~~-----~~~~~v~e~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Ni  120 (155)
T cd05120          53 LPVPKVLASGESD-----GWSYLLMEWIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNI  120 (155)
T ss_pred             CCCCeEEEEcCCC-----CccEEEEEecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceE
Confidence            4777777776443     568999999986 44432       5567778899999999999985   799999999999


Q ss_pred             EEccCCCEEEeeccceee
Q 023609           80 LLNANCDLKICDFGLARV   97 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~   97 (280)
                      +++..+.++++|||.+..
T Consensus       121 l~~~~~~~~l~Df~~~~~  138 (155)
T cd05120         121 LVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             EEECCcEEEEEecccccC
Confidence            999989999999998754

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.01  E-value=2.1e-09  Score=89.33  Aligned_cols=75  Identities=17%  Similarity=0.266  Sum_probs=64.6

Q ss_pred             CcEEEEeecCCc--cHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcc-------CCCEEEe
Q 023609           22 NDVYIAYELMDT--DLHQIIRS--NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA-------NCDLKIC   90 (280)
Q Consensus        22 ~~~~iv~e~~~g--~L~~~l~~--~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nili~~-------~~~~~l~   90 (280)
                      ..-++|||+++|  +|.+++..  ..+.+......++.++...+.-||..||+|+|+++.||+++.       ++.+.++
T Consensus       108 ~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LI  187 (268)
T PRK15123        108 RTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVI  187 (268)
T ss_pred             ceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEE
Confidence            457899999987  79988864  345677788899999999999999999999999999999975       4679999


Q ss_pred             ecccee
Q 023609           91 DFGLAR   96 (280)
Q Consensus        91 dfg~~~   96 (280)
                      ||+.+.
T Consensus       188 Dl~r~~  193 (268)
T PRK15123        188 DLHRAQ  193 (268)
T ss_pred             ECCccc
Confidence            999774

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.00  E-value=1.8e-09  Score=82.93  Aligned_cols=69  Identities=25%  Similarity=0.416  Sum_probs=57.2

Q ss_pred             CcEEEEeecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCCEEEeeccceeec
Q 023609           22 NDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVT   98 (280)
Q Consensus        22 ~~~~iv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nili~~~~~~~l~dfg~~~~~   98 (280)
                      ....|+|||++| .|.+.+...       .-.++..+-..+.-||..||+|+|+.++|++++..+ +.++|||++...
T Consensus        72 ~~~~I~me~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~s  141 (204)
T COG3642          72 DNGLIVMEYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEFS  141 (204)
T ss_pred             CCCEEEEEEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCccccc
Confidence            345799999998 677788764       245677778888899999999999999999997765 999999998643

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.00  E-value=2.4e-09  Score=85.98  Aligned_cols=76  Identities=24%  Similarity=0.420  Sum_probs=67.6

Q ss_pred             CcEEEEeecCCc--cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCC---CEEEeecccee
Q 023609           22 NDVYIAYELMDT--DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANC---DLKICDFGLAR   96 (280)
Q Consensus        22 ~~~~iv~e~~~g--~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nili~~~~---~~~l~dfg~~~   96 (280)
                      ...++|||+++|  +|.+++......+......++.++...++-||.+||+|+|+++.||+++.++   .+.++||+.++
T Consensus        90 ~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~  169 (206)
T PF06293_consen   90 YRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMR  169 (206)
T ss_pred             eeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhce
Confidence            456999999986  7999998755577888899999999999999999999999999999999887   89999998765


Q ss_pred             e
Q 023609           97 V   97 (280)
Q Consensus        97 ~   97 (280)
                      .
T Consensus       170 ~  170 (206)
T PF06293_consen  170 F  170 (206)
T ss_pred             e
Confidence            4

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.97  E-value=2e-08  Score=86.18  Aligned_cols=127  Identities=12%  Similarity=0.173  Sum_probs=99.8

Q ss_pred             EEEEeecCCc--cHHHHHHc---C---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCCEEEeeccce
Q 023609           24 VYIAYELMDT--DLHQIIRS---N---QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA   95 (280)
Q Consensus        24 ~~iv~e~~~g--~L~~~l~~---~---~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nili~~~~~~~l~dfg~~   95 (280)
                      .-+.|+.+.|  .+.++.+.   +   ....++...+..+.|+.+.+-||..|.+-+|+.++|++++.++.+.|.|-..-
T Consensus        85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsf  164 (637)
T COG4248          85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSF  164 (637)
T ss_pred             eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccce
Confidence            6788888875  56665532   2   34778899999999999999999999999999999999999999999985544


Q ss_pred             eeccCCCccccceeccccccchhcc-C---CCCCCcchhHHHHHHHHHHHHhC-CCCCCC
Q 023609           96 RVTSETDFMTEYVVTRWYRAPELLL-N---SSDYTAAIDVWSVGCIFMELMDR-KPLFPG  150 (280)
Q Consensus        96 ~~~~~~~~~~~~~~~~~y~aPE~~~-~---~~~~~~~~DiwslG~il~~ll~g-~~pf~~  150 (280)
                      ............++...|++||... +   ...-....|.|.||+++++++.| +.||.|
T Consensus       165 qi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysG  224 (637)
T COG4248         165 QINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSG  224 (637)
T ss_pred             eeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCc
Confidence            4434344445668899999999642 0   11235679999999999999875 899975

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=98.91  E-value=3.7e-09  Score=94.19  Aligned_cols=76  Identities=22%  Similarity=0.348  Sum_probs=58.3

Q ss_pred             CcEEEEeecCCc-cHHHHHHcC-CCCCHHHHHHHHHHHHH-HHHHHHHCCceeccCCCCcEEEccCCCEEEeeccceeec
Q 023609           22 NDVYIAYELMDT-DLHQIIRSN-QALSEEHCQYFLYQILR-GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVT   98 (280)
Q Consensus        22 ~~~~iv~e~~~g-~L~~~l~~~-~~l~~~~~~~i~~qll~-al~~LH~~gi~H~di~~~nili~~~~~~~l~dfg~~~~~   98 (280)
                      ...++||||++| +|.+..... ...+   ...++.+++. .+..+|..|++|+|++|.||+++.+|.++++|||.+...
T Consensus       231 ~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l  307 (437)
T TIGR01982       231 SERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDGFFHADLHPGNIFVLKDGKIIALDFGIVGRL  307 (437)
T ss_pred             CCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCCceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence            346999999986 777765432 1222   2345555555 478899999999999999999999999999999998766


Q ss_pred             cC
Q 023609           99 SE  100 (280)
Q Consensus        99 ~~  100 (280)
                      ++
T Consensus       308 ~~  309 (437)
T TIGR01982       308 SE  309 (437)
T ss_pred             CH
Confidence            53

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=98.75  E-value=1.8e-08  Score=91.32  Aligned_cols=73  Identities=19%  Similarity=0.402  Sum_probs=56.3

Q ss_pred             CcEEEEeecCCc-cHHHH--HHcCC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCC----CEEEe
Q 023609           22 NDVYIAYELMDT-DLHQI--IRSNQ----ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANC----DLKIC   90 (280)
Q Consensus        22 ~~~~iv~e~~~g-~L~~~--l~~~~----~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nili~~~~----~~~l~   90 (280)
                      ...+|||||++| .+.+.  +...+    .+.+..+..++.|++       ..|++|+|+||.||+++.+|    .++++
T Consensus       234 t~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif-------~~GffHaDpHPGNIlv~~~g~~~~~i~ll  306 (537)
T PRK04750        234 SETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF-------RDGFFHADMHPGNIFVSYDPPENPRYIAL  306 (537)
T ss_pred             CCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-------hCCeeeCCCChHHeEEecCCCCCCeEEEE
Confidence            456899999986 78764  33333    255556666666665       48999999999999999888    99999


Q ss_pred             eccceeeccCC
Q 023609           91 DFGLARVTSET  101 (280)
Q Consensus        91 dfg~~~~~~~~  101 (280)
                      |||.+...+..
T Consensus       307 DFGivg~l~~~  317 (537)
T PRK04750        307 DFGIVGSLNKE  317 (537)
T ss_pred             ecceEEECCHH
Confidence            99999876543

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.74  E-value=3.2e-08  Score=75.91  Aligned_cols=76  Identities=28%  Similarity=0.388  Sum_probs=60.7

Q ss_pred             cEEEEeecCCc--cHHHHHHcCC-CCCHHH-HHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCC---CEEEeeccce
Q 023609           23 DVYIAYELMDT--DLHQIIRSNQ-ALSEEH-CQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANC---DLKICDFGLA   95 (280)
Q Consensus        23 ~~~iv~e~~~g--~L~~~l~~~~-~l~~~~-~~~i~~qll~al~~LH~~gi~H~di~~~nili~~~~---~~~l~dfg~~   95 (280)
                      .-.|+|||++|  ++.+++.+.- .-.+++ ...++.+|-+.+.-||..+++|+||..+||++..+|   .+.++|||++
T Consensus        84 ~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls  163 (229)
T KOG3087|consen   84 GGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLS  163 (229)
T ss_pred             CCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecch
Confidence            34799999998  8999987532 223333 378899999999999999999999999999996554   3589999998


Q ss_pred             eec
Q 023609           96 RVT   98 (280)
Q Consensus        96 ~~~   98 (280)
                      ...
T Consensus       164 ~~s  166 (229)
T KOG3087|consen  164 SVS  166 (229)
T ss_pred             hcc
Confidence            654

>cd05151 ChoK Choline Kinase (ChoK)

Probab=98.70  E-value=2.2e-08  Score=77.69  Aligned_cols=65  Identities=28%  Similarity=0.344  Sum_probs=51.5

Q ss_pred             EEEEeecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCc-----eeccCCCCcEEEccCCCEEEeeccceee
Q 023609           24 VYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANV-----LHRDLKPSNLLLNANCDLKICDFGLARV   97 (280)
Q Consensus        24 ~~iv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi-----~H~di~~~nili~~~~~~~l~dfg~~~~   97 (280)
                      .++|||+++| ++.+.        ......++.+++.+|+.||+.++     +|+|++|.||+++ ++.++++||+.+..
T Consensus        66 ~~lv~e~i~G~~l~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          66 GVLITEFIEGSELLTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             CeEEEEecCCCccccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            4799999997 54432        11123467899999999999985     9999999999998 67899999997653

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.65  E-value=2.8e-08  Score=78.12  Aligned_cols=73  Identities=30%  Similarity=0.427  Sum_probs=49.9

Q ss_pred             EEEEeecCC--c-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHH-HHHCCceeccCCCCcEEEccCCCEEEeeccceeecc
Q 023609           24 VYIAYELMD--T-DLHQIIRSNQALSEEHCQYFLYQILRGLKY-IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS   99 (280)
Q Consensus        24 ~~iv~e~~~--g-~L~~~l~~~~~l~~~~~~~i~~qll~al~~-LH~~gi~H~di~~~nili~~~~~~~l~dfg~~~~~~   99 (280)
                      -+|||||++  | .+.. +... .++......++.+++..+.. +|+.|++|+|+++.||+++.+ .+.++|||.+....
T Consensus        81 ~~ivME~I~~~G~~~~~-l~~~-~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~qav~~~  157 (188)
T PF01163_consen   81 NVIVMEYIGEDGVPLPR-LKDV-DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQAVDSS  157 (188)
T ss_dssp             TEEEEE--EETTEEGGC-HHHC-GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTTEEETT
T ss_pred             CEEEEEecCCCccchhh-HHhc-cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCcceecC
Confidence            379999998  6 3333 3221 12245667788888885554 689999999999999999887 89999999886654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK09902 hypothetical protein; Provisional

Probab=98.60  E-value=2.7e-07  Score=73.24  Aligned_cols=76  Identities=17%  Similarity=0.142  Sum_probs=65.7

Q ss_pred             CcEEEEeecCCc--cHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCC--EEEeeccce
Q 023609           22 NDVYIAYELMDT--DLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD--LKICDFGLA   95 (280)
Q Consensus        22 ~~~~iv~e~~~g--~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nili~~~~~--~~l~dfg~~   95 (280)
                      ..-+||+|-++|  +|.+++.+.  .+.+......++.++..+++-||+.|+.|+|+.+.||+++.+|.  +.++||..+
T Consensus        98 ~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~  177 (216)
T PRK09902         98 WRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKS  177 (216)
T ss_pred             eEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhcc
Confidence            557999998885  999998653  34678888899999999999999999999999999999987677  999999866


Q ss_pred             ee
Q 023609           96 RV   97 (280)
Q Consensus        96 ~~   97 (280)
                      +.
T Consensus       178 r~  179 (216)
T PRK09902        178 RR  179 (216)
T ss_pred             ch
Confidence            53

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.53  E-value=2.3e-07  Score=88.54  Aligned_cols=192  Identities=18%  Similarity=0.256  Sum_probs=134.6

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC---
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS---   77 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~---   77 (280)
                      .|+|++.++.|.......+ -...+..++|.+ ++.+.+..-+.++....+.+..++++||+++|+....|.-+...   
T Consensus       240 ~~~n~~~~~~~~le~~~~g-~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~l~~v~L~~s~~~  318 (1351)
T KOG1035|consen  240 AHDNLGGYFVYGLERLFRG-IVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLSLEHVVLSASSSK  318 (1351)
T ss_pred             ccccccceeEEeehhhcch-HHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhccceeEEeccccc
Confidence            6999999999876653222 134455667764 88888888888999999999999999999999997666666555   


Q ss_pred             cEEEccCCCEEEe--eccceeeccCCCccccceeccccccchhccCC-CCCCcchhHHHHHHHHHHHHhCCCCCC-CCCh
Q 023609           78 NLLLNANCDLKIC--DFGLARVTSETDFMTEYVVTRWYRAPELLLNS-SDYTAAIDVWSVGCIFMELMDRKPLFP-GRDH  153 (280)
Q Consensus        78 nili~~~~~~~l~--dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~-~~~~  153 (280)
                      +..++..+....+  ||+..+................+.++|..... ...+...|+|++|.....+..|..+-. +...
T Consensus       319 ~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i~~~~~~~  398 (1351)
T KOG1035|consen  319 ESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDISEKSAVP  398 (1351)
T ss_pred             ccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhhhhcCcccccccch
Confidence            4444556666666  88887776665544444555667777765322 223345799999999999987764321 1000


Q ss_pred             HHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCCh-HHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 023609          154 VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHP-SAIDLVEKMLTFDPRQRITVEDALAHPYL  232 (280)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~li~~~L~~dp~~R~t~~ell~h~~~  232 (280)
                                                               ....+..+. ...+++.+|+..++++|+.+.+++.|+|.
T Consensus       399 -----------------------------------------~~~l~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~  437 (1351)
T KOG1035|consen  399 -----------------------------------------VSLLDVLSTSELLDALPKCLDEDSEERLSALELLTHPFL  437 (1351)
T ss_pred             -----------------------------------------hhhhccccchhhhhhhhhhcchhhhhccchhhhhhchhc
Confidence                                                     001111121 57789999999999999999999999999


Q ss_pred             CCC
Q 023609          233 GSL  235 (280)
Q Consensus       233 ~~~  235 (280)
                      +..
T Consensus       438 ~~~  440 (1351)
T KOG1035|consen  438 RFP  440 (1351)
T ss_pred             ccc
Confidence            754

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.44  E-value=5.5e-07  Score=71.78  Aligned_cols=66  Identities=24%  Similarity=0.439  Sum_probs=50.7

Q ss_pred             CcEEEEeecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCCEEEeecccee
Q 023609           22 NDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR   96 (280)
Q Consensus        22 ~~~~iv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nili~~~~~~~l~dfg~~~   96 (280)
                      ...+++|||++| .|.+...    +++.    +.-.+.+++..||+.|++|+|++|.|++++.++ ++++|++..+
T Consensus       116 ~~~~ll~EYIeG~~l~d~~~----i~e~----~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~~-i~iID~~~k~  182 (229)
T PF06176_consen  116 SSYVLLMEYIEGVELNDIED----IDED----LAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNNG-IRIIDTQGKR  182 (229)
T ss_pred             eEEEEEEEEecCeecccchh----cCHH----HHHHHHHHHHHHHHcCCccCCCCcCcEEEECCc-EEEEECcccc
Confidence            346789999998 6665532    3332    345667789999999999999999999998555 9999997554

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.28  E-value=1.4e-06  Score=71.10  Aligned_cols=81  Identities=22%  Similarity=0.332  Sum_probs=61.3

Q ss_pred             cCCCCCCCCcEEEEeecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCCEEEeec
Q 023609           14 PPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDF   92 (280)
Q Consensus        14 ~~~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nili~~~~~~~l~df   92 (280)
                      ..|.+-+.+.-.+|||+++| .|...     +++......++..|++-+.-.-..|++|+|+++-||+++.+|.+.++||
T Consensus       172 ~VP~P~~~nRHaVvMe~ieG~eL~~~-----r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~vIDw  246 (304)
T COG0478         172 KVPKPIAWNRHAVVMEYIEGVELYRL-----RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVVIDW  246 (304)
T ss_pred             CCCCccccccceeeeehcccceeecc-----cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEEEEeC
Confidence            34444455667999999998 55433     2244556667777777777777999999999999999999999999999


Q ss_pred             cceeecc
Q 023609           93 GLARVTS   99 (280)
Q Consensus        93 g~~~~~~   99 (280)
                      .-+...+
T Consensus       247 PQ~v~~~  253 (304)
T COG0478         247 PQAVPIS  253 (304)
T ss_pred             cccccCC
Confidence            7655433

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=98.22  E-value=3.9e-06  Score=67.83  Aligned_cols=90  Identities=20%  Similarity=0.293  Sum_probs=61.8

Q ss_pred             CeeeeeceecCCCCCCCCcEEEEeecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-----------------
Q 023609            5 NVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHS-----------------   66 (280)
Q Consensus         5 nIv~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~-----------------   66 (280)
                      ++.+++.+.....  ..+..++|||+++| ++.+.+.. ..+++.....++.+++.+|..||+                 
T Consensus        58 ~vp~~~~~~~~~~--~~~~~~~v~e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~  134 (223)
T cd05154          58 PVPKVLALCEDPS--VLGTPFYVMERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGY  134 (223)
T ss_pred             CCCCEEEECCCCC--ccCCceEEEEEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCch
Confidence            3455666654321  11356899999986 55544321 346666666777777777777763                 


Q ss_pred             ---------------------------------------CCceeccCCCCcEEEcc--CCCEEEeeccceee
Q 023609           67 ---------------------------------------ANVLHRDLKPSNLLLNA--NCDLKICDFGLARV   97 (280)
Q Consensus        67 ---------------------------------------~gi~H~di~~~nili~~--~~~~~l~dfg~~~~   97 (280)
                                                             ..++|+|+++.||+++.  ++.+.++||+.+..
T Consensus       135 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         135 LERQVARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                                                   23689999999999988  56689999987754

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=97.99  E-value=4.7e-05  Score=67.65  Aligned_cols=162  Identities=22%  Similarity=0.300  Sum_probs=105.7

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   80 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nil   80 (280)
                      +.|+|+..++++-....    ....+|||+++-+|.+.+..+. +-.....              .+|+.|-     |+ 
T Consensus        39 l~~~~l~~yl~~~r~~~----~r~IVV~e~~~~Sled~~~~~~-l~~~s~~--------------~~~~~~~-----~~-   93 (725)
T KOG1093|consen   39 LQHDNLCQYLDFSRGKH----ERVIVVMEHYTMSLEDILKTGN-LKDESLL--------------AHGVLHL-----NI-   93 (725)
T ss_pred             hcCccceeeEeeecCcc----ceEEEEehhhccchHHHHHhcc-cchhhhc--------------cccccee-----hh-
Confidence            36888888888764432    3378999999999999987653 2221111              2222211     11 


Q ss_pred             EccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 023609           81 LNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL  160 (280)
Q Consensus        81 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~  160 (280)
                            +..+| .              ..|. |  |-      ..++++|||++|.++.++.-|...+...........+
T Consensus        94 ------~~~td-~--------------~~t~-~--~~------~~~pKsdVwsl~~i~~el~L~~~l~~~~~~s~~l~~i  143 (725)
T KOG1093|consen   94 ------IYITD-H--------------FLTK-Y--PS------PIGPKSDVWSLGFIILELYLGISLEAELTESEYLEIL  143 (725)
T ss_pred             ------hhccc-c--------------cccc-C--CC------CCCcchhhhhHHHHHHHHHHhhHHHHHHHHHHHHHHH
Confidence                  12222 0              0010 1  11      1125999999999999999998888877777777777


Q ss_pred             HHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCC
Q 023609          161 IELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  235 (280)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~  235 (280)
                      .+....+..........   .+..               ..+.-.+.+..+|+-..|..||...++..++-|...
T Consensus       144 ~k~~~~d~~~~~~a~e~---~~~~---------------~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev  200 (725)
T KOG1093|consen  144 LKYYTDDQELLSTAMEH---LIQL---------------LADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEV  200 (725)
T ss_pred             HHhccCchhHHHHHHHH---HHHH---------------hhhHhHHHHhccCCccccccccchhHHhcCccHHHH
Confidence            77766665544332222   1111               345668899999999999999999999999998765

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=97.85  E-value=2.2e-05  Score=63.57  Aligned_cols=79  Identities=18%  Similarity=0.265  Sum_probs=58.8

Q ss_pred             CCCCcEEEEeecCCccH--HHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEEccCCCEEEeeccce
Q 023609           19 ESFNDVYIAYELMDTDL--HQIIRSNQALSEEHCQYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNANCDLKICDFGLA   95 (280)
Q Consensus        19 ~~~~~~~iv~e~~~g~L--~~~l~~~~~l~~~~~~~i~~qll~al~~LH~-~gi~H~di~~~nili~~~~~~~l~dfg~~   95 (280)
                      -...+-.+|||+++..-  .-.+ +.-++...++..+..++++.+.-|-. .|+||+||+.-||++. ++.+.++|||-+
T Consensus       136 i~~~~nVLvMEfIg~~g~pAP~L-kDv~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~iID~~Qa  213 (268)
T COG1718         136 IAFRNNVLVMEFIGDDGLPAPRL-KDVPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPYIIDVSQA  213 (268)
T ss_pred             eeecCCeEEEEeccCCCCCCCCc-ccCCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEEEEECccc
Confidence            33445689999998431  1111 11234444788888999999988887 8999999999999998 888999999987


Q ss_pred             eecc
Q 023609           96 RVTS   99 (280)
Q Consensus        96 ~~~~   99 (280)
                      ....
T Consensus       214 V~~~  217 (268)
T COG1718         214 VTID  217 (268)
T ss_pred             cccC
Confidence            6544

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=97.70  E-value=0.00014  Score=65.91  Aligned_cols=77  Identities=18%  Similarity=0.380  Sum_probs=55.2

Q ss_pred             CcEEEEeecCCc-cHHHHH--HcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCCEEEeeccceeec
Q 023609           22 NDVYIAYELMDT-DLHQII--RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVT   98 (280)
Q Consensus        22 ~~~~iv~e~~~g-~L~~~l--~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nili~~~~~~~l~dfg~~~~~   98 (280)
                      +.-.++|||++| .+.+..  ++ ..++.+.+...+.++.  +..+-..|++|.|.+|.||+++.+|.+.+.|||.....
T Consensus       239 ~~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~ia~~~~~~f--~~q~~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l  315 (517)
T COG0661         239 TRRVLTMEWIDGIKISDIAALKS-AGIDRKELAELLVRAF--LRQLLRDGFFHADPHPGNILVRSDGRIVLLDFGIVGRL  315 (517)
T ss_pred             CCcEEEEEeeCCEecccHHHHHh-cCCCHHHHHHHHHHHH--HHHHHhcCccccCCCccceEEecCCcEEEEcCcceecC
Confidence            456899999998 666663  33 3355444333332222  23444589999999999999999999999999998776


Q ss_pred             cCC
Q 023609           99 SET  101 (280)
Q Consensus        99 ~~~  101 (280)
                      ++.
T Consensus       316 ~~~  318 (517)
T COG0661         316 DPK  318 (517)
T ss_pred             CHH
Confidence            544

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.63  E-value=0.00023  Score=56.20  Aligned_cols=85  Identities=18%  Similarity=0.137  Sum_probs=67.1

Q ss_pred             CCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHH---HHHcCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCC
Q 023609            4 ENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQ---IIRSNQALSEEHCQYFLYQILRGLKYIHS---ANVLHRDLKP   76 (280)
Q Consensus         4 pnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~---~l~~~~~l~~~~~~~i~~qll~al~~LH~---~gi~H~di~~   76 (280)
                      +++++++|++        ++ ++|+||.+ +++.+   .+.+....++..+.+|+.++++.+++|+.   ..+.-.|+++
T Consensus        20 ~~~pk~lG~C--------G~-~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~lcDv~~   90 (188)
T PF12260_consen   20 EPFPKLLGSC--------GR-FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFFYLCDVSP   90 (188)
T ss_pred             CCCCCeeeEC--------CC-EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcEEEeecch
Confidence            4888999988        33 56888887 45532   11222346899999999999999999997   3588899999


Q ss_pred             CcEEEccCCCEEEeeccceee
Q 023609           77 SNLLLNANCDLKICDFGLARV   97 (280)
Q Consensus        77 ~nili~~~~~~~l~dfg~~~~   97 (280)
                      +|+.++.+|.++++|+.....
T Consensus        91 ~nfgv~~~~~lk~iDld~v~~  111 (188)
T PF12260_consen   91 DNFGVNDDGRLKLIDLDDVFV  111 (188)
T ss_pred             HHeEEeCCCcEEEEechhcch
Confidence            999999999999999976643

Proteins in this uncharacterised family are described as transmembrane proteins.

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=97.59  E-value=0.00037  Score=63.20  Aligned_cols=76  Identities=25%  Similarity=0.377  Sum_probs=53.2

Q ss_pred             CcEEEEeecCCc----cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcc----CCCEEEeecc
Q 023609           22 NDVYIAYELMDT----DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA----NCDLKICDFG   93 (280)
Q Consensus        22 ~~~~iv~e~~~g----~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nili~~----~~~~~l~dfg   93 (280)
                      ....++||||+|    ++ +.+.+.+ ++...+..-+.+..  ++.+=..|++|.|-+|.||+++.    ++.+.+.|+|
T Consensus       275 t~RVLtME~~~G~~i~Dl-~~i~~~g-i~~~~i~~~l~~~~--~~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhG  350 (538)
T KOG1235|consen  275 TKRVLTMEYVDGIKINDL-DAIDKRG-ISPHDILNKLVEAY--LEQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHG  350 (538)
T ss_pred             cceEEEEEecCCccCCCH-HHHHHcC-CCHHHHHHHHHHHH--HHHHHhcCCccCCCCCCcEEEecCCCCCccEEEEccc
Confidence            457999999987    55 4555443 55554433333322  23444678999999999999984    6789999999


Q ss_pred             ceeeccCC
Q 023609           94 LARVTSET  101 (280)
Q Consensus        94 ~~~~~~~~  101 (280)
                      +.....+.
T Consensus       351 l~~~is~~  358 (538)
T KOG1235|consen  351 LYAVISHK  358 (538)
T ss_pred             ccccccHH
Confidence            98776544

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=97.39  E-value=1.3e-05  Score=72.62  Aligned_cols=198  Identities=19%  Similarity=0.179  Sum_probs=124.0

Q ss_pred             CCCCC-eeeeeceecCCCCCCCCcEEEEeecCCcc--HHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCC
Q 023609            1 MDHEN-VVAIRDIIPPPQRESFNDVYIAYELMDTD--LHQIIR-SNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKP   76 (280)
Q Consensus         1 l~Hpn-Iv~~~~~~~~~~~~~~~~~~iv~e~~~g~--L~~~l~-~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~   76 (280)
                      ++||| .+..++-+     +......++++++++.  ...-+. ..-.+-+-+...+.+.-..++++||+.-=+|+|   
T Consensus       290 ~n~P~~~v~~~~d~-----~~E~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d---  361 (829)
T KOG0576|consen  290 VNNPNPVVRYLEDY-----DGEDYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD---  361 (829)
T ss_pred             ccCCCCcccccccC-----CcccccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc---
Confidence            47888 33333322     2236689999999843  221111 111244445566777777899999998768888   


Q ss_pred             CcEEEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023609           77 SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ  156 (280)
Q Consensus        77 ~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  156 (280)
                       ||+.+ ++..++++|+...............+++.++|||+.... .+....|.|++|.-..++.-|.+|-.+.-    
T Consensus       362 -~~l~s-~~~~~~~~~~v~~~L~~~~~~~t~~~~~~~~~pev~~~~-~~~~~p~~~~~~~~~~~~ap~~pPr~~P~----  434 (829)
T KOG0576|consen  362 -NILGS-EEEVKLLDFAVPPQLTRTMKPRTAIGTPEPLAPEVIQEN-TIDGCPDSGSLAVSAIQMAPGLPPRSSPP----  434 (829)
T ss_pred             -ccccc-ccccccccccCCcccCcccccccCCCCCCCCCchhhccc-ccccCCCccCCCcchhhcCCCCCCCCCCc----
Confidence             66544 367899999988776665555677889999999987544 37788999999987778877777654310    


Q ss_pred             HHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCc
Q 023609          157 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  236 (280)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~  236 (280)
                        .....++.++.  ...+..+             ..+...      .-+++...|+...|..|++...++.|.+|.+..
T Consensus       435 --~~~~~~g~~p~--s~~L~~~-------------~aw~~~------~~~~~~~~~~~g~P~~pkv~mgacfsKvfngCp  491 (829)
T KOG0576|consen  435 --AVLPMIGNGPN--SPMLTDK-------------SAWSPV------FHRDFPAPCLNGLPPTPKVHMGACFSKVFNGCP  491 (829)
T ss_pred             --cccCCCCCCCC--ccccchh-------------hhcCcc------cccCCcccccCCCCCCCcchhhHHHHHHhccCc
Confidence              00001111110  0000000             000000      112477889999999999999999999998753

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.29  E-value=6.4e-05  Score=74.45  Aligned_cols=143  Identities=17%  Similarity=0.157  Sum_probs=104.2

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHHC---C--cee
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN----QALSEEHCQYFLYQILRGLKYIHSA---N--VLH   71 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~----~~l~~~~~~~i~~qll~al~~LH~~---g--i~H   71 (280)
                      +|+++...+.-..+..   ....|++++++. |.+++.+.++    ..+....+.....+.+.+..-.|+.   |  .+|
T Consensus      1287 ~h~~~~~~p~rI~ps~---s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~ 1363 (2724)
T KOG1826|consen 1287 KHYLTEVDPLRIPPSE---STEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVS 1363 (2724)
T ss_pred             hceeeecccccCCCCC---ChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchh
Confidence            5777776666554443   266899999997 7999998754    2344444544445547777777754   2  789


Q ss_pred             ccCCCCcEEEccCCCEEEeeccceeeccC-CCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 023609           72 RDLKPSNLLLNANCDLKICDFGLARVTSE-TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF  148 (280)
Q Consensus        72 ~di~~~nili~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf  148 (280)
                      +++++-|.+|..+-.++++++|+.+...+ ........+++.|+.|++.. .-.++.++|+|..|+.+|.+..|..+|
T Consensus      1364 ~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N-~ik~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1364 KSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKN-EIKFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred             hhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHH-HHhhhhHHHHHHHHHHHHHHhcccHHH
Confidence            99999999999999999999999983322 22233456788889998763 334677799999999999988777666

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.25  E-value=0.0027  Score=50.47  Aligned_cols=83  Identities=20%  Similarity=0.348  Sum_probs=59.9

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecC---Cc----cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccC
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELM---DT----DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDL   74 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~---~g----~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di   74 (280)
                      .+.+|.+++|+..++     ...-+|+|.+   +|    +|.+++.. +.+++ +....+   -+-.++|-+.+|+.+|+
T Consensus        75 ~~~~i~r~~G~veT~-----~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~-~~~~~L---~~f~~~l~~~~Iv~~dl  144 (199)
T PF10707_consen   75 DWSHIPRFYGFVETN-----LGLGLVVELIRDADGNISPTLEDYLKE-GGLTE-ELRQAL---DEFKRYLLDHHIVIRDL  144 (199)
T ss_pred             cccccccEeEEEecC-----CceEEEEEEEECCCCCcCccHHHHHHc-CCccH-HHHHHH---HHHHHHHHHcCCeecCC
Confidence            367899999999777     4567888876   23    78888854 44666 433333   34456888999999999


Q ss_pred             CCCcEEEccC--C--CEEEee-ccc
Q 023609           75 KPSNLLLNAN--C--DLKICD-FGL   94 (280)
Q Consensus        75 ~~~nili~~~--~--~~~l~d-fg~   94 (280)
                      +|.||++...  +  .+.++| ||.
T Consensus       145 ~~~NIv~~~~~~~~~~lvlIDG~G~  169 (199)
T PF10707_consen  145 NPHNIVVQRRDSGEFRLVLIDGLGE  169 (199)
T ss_pred             CcccEEEEecCCCceEEEEEeCCCC
Confidence            9999999643  2  477777 453

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=97.05  E-value=0.0024  Score=52.56  Aligned_cols=29  Identities=21%  Similarity=0.187  Sum_probs=25.5

Q ss_pred             CceeccCCCCcEEEccCCCEEEeecccee
Q 023609           68 NVLHRDLKPSNLLLNANCDLKICDFGLAR   96 (280)
Q Consensus        68 gi~H~di~~~nili~~~~~~~l~dfg~~~   96 (280)
                      .++|+|+.|.||+++.++...|+||+.+.
T Consensus       164 ~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         164 VVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             EEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            48999999999999987777899998654

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=97.01  E-value=0.0034  Score=51.10  Aligned_cols=28  Identities=25%  Similarity=0.296  Sum_probs=25.0

Q ss_pred             CceeccCCCCcEEEccCCCEEEeecccee
Q 023609           68 NVLHRDLKPSNLLLNANCDLKICDFGLAR   96 (280)
Q Consensus        68 gi~H~di~~~nili~~~~~~~l~dfg~~~   96 (280)
                      .++|+|++|.|++++.++ +.++||+.+.
T Consensus       154 ~~~HgD~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       154 TCLHGDFQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             ceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence            478999999999999888 9999998764

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.84  E-value=0.0083  Score=51.66  Aligned_cols=107  Identities=17%  Similarity=0.308  Sum_probs=74.5

Q ss_pred             CcEEEEeecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcEEEccCCCEEEeeccceeeccC
Q 023609           22 NDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA-NVLHRDLKPSNLLLNANCDLKICDFGLARVTSE  100 (280)
Q Consensus        22 ~~~~iv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~-gi~H~di~~~nili~~~~~~~l~dfg~~~~~~~  100 (280)
                      -..|++|++-+++|.-.    +.-...++..++++.+..++-+.+. .+-||++...||+|+ +|.+.|+||-+++....
T Consensus       299 ~y~yl~~kdhgt~is~i----k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~GnvtLIDfklsRl~~~  373 (488)
T COG5072         299 LYLYLHFKDHGTPISII----KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-EGNVTLIDFKLSRLSYS  373 (488)
T ss_pred             eEEEEEEecCCceeeee----ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-cCceEEEEeeeeecccC
Confidence            45788999888776532    3356788889999988887777765 689999999999999 99999999999986544


Q ss_pred             CCccccceeccccccchhccCCCCCCcchhHHHHHHHHH
Q 023609          101 TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFM  139 (280)
Q Consensus       101 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~  139 (280)
                      +.....    ...--|-.+.+.  ....-+||-+.-.+.
T Consensus       374 q~~isy----~rldhp~lF~G~--dd~QFeIYrlMr~l~  406 (488)
T COG5072         374 QGIISY----NRLDHPDLFNGV--DDYQFEIYRLMRRLL  406 (488)
T ss_pred             Cceeec----cccCchhhhcCc--cceeeeHHHHHHHHh
Confidence            432221    112334444322  356677777644433

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=96.47  E-value=0.0036  Score=53.06  Aligned_cols=78  Identities=18%  Similarity=0.297  Sum_probs=56.5

Q ss_pred             cCCCCCCCCcEEEEeecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCCEEEeec
Q 023609           14 PPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDF   92 (280)
Q Consensus        14 ~~~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nili~~~~~~~l~df   92 (280)
                      ..|.+-+.+.-++|||++.| .|.+.-.-      ..+..+...++.-+--|-.+|++|+|..--||++..++.++++||
T Consensus       173 pVPkpiD~~RH~Vvmelv~g~Pl~~v~~v------~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i~vIDF  246 (465)
T KOG2268|consen  173 PVPKPIDHNRHCVVMELVDGYPLRQVRHV------EDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKIVVIDF  246 (465)
T ss_pred             CCCCcccccceeeHHHhhcccceeeeeec------CChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCEEEeec
Confidence            34444445667999999987 66654321      122344555556666788999999999999999999999999999


Q ss_pred             cceee
Q 023609           93 GLARV   97 (280)
Q Consensus        93 g~~~~   97 (280)
                      .-...
T Consensus       247 PQmvS  251 (465)
T KOG2268|consen  247 PQMVS  251 (465)
T ss_pred             hHhhc
Confidence            75543

>PLN02876 acyl-CoA dehydrogenase

Probab=96.31  E-value=0.018  Score=56.00  Aligned_cols=31  Identities=23%  Similarity=0.485  Sum_probs=25.1

Q ss_pred             CceeccCCCCcEEEccC-CC-EEEeeccceeec
Q 023609           68 NVLHRDLKPSNLLLNAN-CD-LKICDFGLARVT   98 (280)
Q Consensus        68 gi~H~di~~~nili~~~-~~-~~l~dfg~~~~~   98 (280)
                      .++|+|+++.|++++.+ +. .-++||+.+...
T Consensus       226 ~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~G  258 (822)
T PLN02876        226 GIVHGDFRIDNLVFHPTEDRVIGILDWELSTLG  258 (822)
T ss_pred             ceEecCcccccEEEcCCCCeEEEEEeeeccccC
Confidence            49999999999999853 33 579999987654

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=95.39  E-value=0.017  Score=47.29  Aligned_cols=31  Identities=35%  Similarity=0.479  Sum_probs=25.4

Q ss_pred             CCceeccCCCCcEEEccCCCEEEeeccceee
Q 023609           67 ANVLHRDLKPSNLLLNANCDLKICDFGLARV   97 (280)
Q Consensus        67 ~gi~H~di~~~nili~~~~~~~l~dfg~~~~   97 (280)
                      .+++|+|+++.|++++.++...++||+.+..
T Consensus       164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~  194 (235)
T cd05155         164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV  194 (235)
T ss_pred             ceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence            3589999999999998765567999987643

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=95.24  E-value=0.027  Score=45.91  Aligned_cols=29  Identities=28%  Similarity=0.439  Sum_probs=25.6

Q ss_pred             CceeccCCCCcEEEcc-CCCEEEeecccee
Q 023609           68 NVLHRDLKPSNLLLNA-NCDLKICDFGLAR   96 (280)
Q Consensus        68 gi~H~di~~~nili~~-~~~~~l~dfg~~~   96 (280)
                      +++|+|+++.||+++. ++.+.++||..+.
T Consensus       171 ~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~  200 (235)
T cd05157         171 VFCHNDLLSGNIIYNEEKNSVKFIDYEYAG  200 (235)
T ss_pred             EEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence            5999999999999998 5789999998664

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=95.00  E-value=0.059  Score=45.91  Aligned_cols=29  Identities=24%  Similarity=0.423  Sum_probs=24.9

Q ss_pred             CCceeccCCCCcEEEccCCCEEEeecccee
Q 023609           67 ANVLHRDLKPSNLLLNANCDLKICDFGLAR   96 (280)
Q Consensus        67 ~gi~H~di~~~nili~~~~~~~l~dfg~~~   96 (280)
                      .|++|+|+.+.|++++. +.+.++||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            47899999999999987 678999998553

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=94.98  E-value=0.044  Score=46.76  Aligned_cols=30  Identities=33%  Similarity=0.526  Sum_probs=26.6

Q ss_pred             CCceeccCCCCcEEEccCCCEEEeecccee
Q 023609           67 ANVLHRDLKPSNLLLNANCDLKICDFGLAR   96 (280)
Q Consensus        67 ~gi~H~di~~~nili~~~~~~~l~dfg~~~   96 (280)
                      .+++|+|+++.|++++.++...++||+.+.
T Consensus       187 ~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       187 RGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             CccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            589999999999999988867899998764

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=94.88  E-value=0.052  Score=46.11  Aligned_cols=29  Identities=34%  Similarity=0.438  Sum_probs=25.6

Q ss_pred             CceeccCCCCcEEEccC----CCEEEeecccee
Q 023609           68 NVLHRDLKPSNLLLNAN----CDLKICDFGLAR   96 (280)
Q Consensus        68 gi~H~di~~~nili~~~----~~~~l~dfg~~~   96 (280)
                      +++|+|+.+.||+++.+    +.+.++||..+.
T Consensus       180 ~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~  212 (302)
T cd05156         180 VFCHNDLQEGNILLLNPSSETKKLVLIDFEYAS  212 (302)
T ss_pred             eEEecCCCcCeEEecCCCCCCCcEEEEeeCCCC
Confidence            58999999999999875    889999998664

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK05231 homoserine kinase; Provisional

Probab=94.67  E-value=0.067  Score=45.83  Aligned_cols=31  Identities=29%  Similarity=0.322  Sum_probs=26.0

Q ss_pred             CCceeccCCCCcEEEccCCCEEEeeccceee
Q 023609           67 ANVLHRDLKPSNLLLNANCDLKICDFGLARV   97 (280)
Q Consensus        67 ~gi~H~di~~~nili~~~~~~~l~dfg~~~~   97 (280)
                      .|++|+|+++.||+++.+....++||+.+..
T Consensus       187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             cccCCCCCCCCcEEEECCceEEEEecccccC
Confidence            3899999999999998665568999987643

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=94.58  E-value=0.06  Score=45.58  Aligned_cols=31  Identities=29%  Similarity=0.373  Sum_probs=26.7

Q ss_pred             CCceeccCCCCcEEEccCCCEEEeeccceee
Q 023609           67 ANVLHRDLKPSNLLLNANCDLKICDFGLARV   97 (280)
Q Consensus        67 ~gi~H~di~~~nili~~~~~~~l~dfg~~~~   97 (280)
                      .+++|+|++|.|++++.++.+.++||+.+..
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            4799999999999999887778999986643

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK10271 thiK thiamine kinase; Provisional

Probab=94.55  E-value=0.03  Score=43.90  Aligned_cols=30  Identities=30%  Similarity=0.423  Sum_probs=25.9

Q ss_pred             ceeccCCCCcEEEccCCCEEEeeccceeecc
Q 023609           69 VLHRDLKPSNLLLNANCDLKICDFGLARVTS   99 (280)
Q Consensus        69 i~H~di~~~nili~~~~~~~l~dfg~~~~~~   99 (280)
                      .+|+|+.|.|++++.+| ++++||+.+....
T Consensus        79 p~H~D~~~~N~~~~~~~-~~lIDwe~a~~gD  108 (188)
T PRK10271         79 PLHMDVHAGNLVHSASG-LRLIDWEYAGDGD  108 (188)
T ss_pred             eecCCCCCccEEEECCC-EEEEeCCcccCCC
Confidence            69999999999998777 9999999876543

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=94.51  E-value=0.023  Score=45.83  Aligned_cols=30  Identities=33%  Similarity=0.595  Sum_probs=20.6

Q ss_pred             CCceeccCCCCcEEEc-cCCCEEEeecccee
Q 023609           67 ANVLHRDLKPSNLLLN-ANCDLKICDFGLAR   96 (280)
Q Consensus        67 ~gi~H~di~~~nili~-~~~~~~l~dfg~~~   96 (280)
                      .+++|+|+.+.||+++ .++.+.++||+.+.
T Consensus       166 ~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~  196 (239)
T PF01636_consen  166 PVLIHGDLHPGNILVDPSDGRIGIIDFEDAG  196 (239)
T ss_dssp             EEEE-SS-SGGGEEEESSTTEEEE--GTT-E
T ss_pred             cEEEEeccccccceeeeccceeEEEecccce
Confidence            3599999999999999 66667899998654

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism]

Probab=94.43  E-value=0.067  Score=44.75  Aligned_cols=49  Identities=29%  Similarity=0.360  Sum_probs=37.5

Q ss_pred             HHHHHHHHHHHHHHHHHHC--CceeccCCCCcEEEccCCCEEEeeccceee
Q 023609           49 HCQYFLYQILRGLKYIHSA--NVLHRDLKPSNLLLNANCDLKICDFGLARV   97 (280)
Q Consensus        49 ~~~~i~~qll~al~~LH~~--gi~H~di~~~nili~~~~~~~l~dfg~~~~   97 (280)
                      .+...+..+-.++.-.+..  -++|+|+.|+|++.+..|.++|+||..|..
T Consensus       133 ~~~~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~  183 (269)
T COG0510         133 LLRKKLKELRRALEEVPKDDLVPCHNDLNPGNLLLTDKGGLFLIDWEYAGL  183 (269)
T ss_pred             HHHHHHHHHHHHhhhcCCCceeeecCCCCccceEEcCCCcEEEEecccCCC
Confidence            3444555555566655555  489999999999999999999999987654

>TIGR02721 ycfN_thiK thiamine kinase

Probab=93.77  E-value=0.047  Score=45.21  Aligned_cols=30  Identities=30%  Similarity=0.414  Sum_probs=26.0

Q ss_pred             CceeccCCCCcEEEccCCCEEEeeccceeec
Q 023609           68 NVLHRDLKPSNLLLNANCDLKICDFGLARVT   98 (280)
Q Consensus        68 gi~H~di~~~nili~~~~~~~l~dfg~~~~~   98 (280)
                      .++|+|+.|.||+++.++ +.++||..+...
T Consensus       147 ~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~g  176 (256)
T TIGR02721       147 APLHMDVHAYNLVVTPQG-LKLIDWEYASDG  176 (256)
T ss_pred             eeecCCCCcCcEEEeCCC-CEEEeccccCcC
Confidence            489999999999999877 789999877643

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain

Probab=93.47  E-value=0.18  Score=39.95  Aligned_cols=30  Identities=27%  Similarity=0.455  Sum_probs=24.5

Q ss_pred             CCceeccCCCCcEEEccCC-----CEEEeecccee
Q 023609           67 ANVLHRDLKPSNLLLNANC-----DLKICDFGLAR   96 (280)
Q Consensus        67 ~gi~H~di~~~nili~~~~-----~~~l~dfg~~~   96 (280)
                      ..++|||+.+.|+++..++     .+.++||..+.
T Consensus       120 ~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~  154 (196)
T smart00587      120 NVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSH  154 (196)
T ss_pred             eEEeeCCCCccceeeccCCCCCccceEEEecccCC
Confidence            4589999999999997543     58999998654

subfamily of choline kinases

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=93.40  E-value=0.13  Score=44.28  Aligned_cols=28  Identities=36%  Similarity=0.644  Sum_probs=25.1

Q ss_pred             ceeccCCCCcEEEccCCC-EEEeecccee
Q 023609           69 VLHRDLKPSNLLLNANCD-LKICDFGLAR   96 (280)
Q Consensus        69 i~H~di~~~nili~~~~~-~~l~dfg~~~   96 (280)
                      ++|+|+.|.||+++.+.. +.++||+.+.
T Consensus       199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~  227 (331)
T COG2334         199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAG  227 (331)
T ss_pred             eeecCCCccceeEcCCCCeeeEEEccccc
Confidence            999999999999999875 8999998654

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=93.28  E-value=0.066  Score=45.00  Aligned_cols=31  Identities=26%  Similarity=0.541  Sum_probs=25.5

Q ss_pred             CceeccCCCCcEEEccCCC-EEEeeccceeec
Q 023609           68 NVLHRDLKPSNLLLNANCD-LKICDFGLARVT   98 (280)
Q Consensus        68 gi~H~di~~~nili~~~~~-~~l~dfg~~~~~   98 (280)
                      .++|+|+++.||+++.++. ..++||+.+...
T Consensus       186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG  217 (276)
T cd05152         186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKVG  217 (276)
T ss_pred             eeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence            4899999999999987565 469999977543

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=93.16  E-value=0.063  Score=43.06  Aligned_cols=30  Identities=37%  Similarity=0.643  Sum_probs=21.3

Q ss_pred             CceeccCCCCcEEE-ccCCCEEEeeccceee
Q 023609           68 NVLHRDLKPSNLLL-NANCDLKICDFGLARV   97 (280)
Q Consensus        68 gi~H~di~~~nili-~~~~~~~l~dfg~~~~   97 (280)
                      .++|+|+.+.||++ +.++.++++||..+..
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            48999999999999 8889999999987754

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=92.80  E-value=0.2  Score=42.82  Aligned_cols=29  Identities=21%  Similarity=0.238  Sum_probs=26.5

Q ss_pred             CceeccCCCCcEEEccCCCEEEeecccee
Q 023609           68 NVLHRDLKPSNLLLNANCDLKICDFGLAR   96 (280)
Q Consensus        68 gi~H~di~~~nili~~~~~~~l~dfg~~~   96 (280)
                      |++|+|+.+.|++++.++.+.++||..+.
T Consensus       197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~  225 (309)
T TIGR02904       197 VLVHGKLSLSHFLYDETRGGYFINFEKAS  225 (309)
T ss_pred             eeeCCCCcHHhEEEcCCCCEEEEEhhhcc
Confidence            79999999999999999999999997664

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PLN02236 choline kinase

Probab=92.73  E-value=0.17  Score=44.00  Aligned_cols=30  Identities=23%  Similarity=0.458  Sum_probs=25.8

Q ss_pred             CceeccCCCCcEEEcc-CCCEEEeeccceee
Q 023609           68 NVLHRDLKPSNLLLNA-NCDLKICDFGLARV   97 (280)
Q Consensus        68 gi~H~di~~~nili~~-~~~~~l~dfg~~~~   97 (280)
                      .++|+|+++.||+++. ++.+.++||..+..
T Consensus       201 ~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        201 GFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             eEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            5899999999999976 47899999987654

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=92.37  E-value=0.13  Score=41.57  Aligned_cols=60  Identities=22%  Similarity=0.194  Sum_probs=41.9

Q ss_pred             CcEEEEeecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC--CceeccCCCCcEEEccCCCEEEeecc
Q 023609           22 NDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA--NVLHRDLKPSNLLLNANCDLKICDFG   93 (280)
Q Consensus        22 ~~~~iv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~--gi~H~di~~~nili~~~~~~~l~dfg   93 (280)
                      ..+-++.|.|..--           ... ..++.-=+.+|.-.|+.  +..|+|..|+||+-+..|.+||.|=+
T Consensus       127 ~~yGvIlE~Cy~~~-----------i~~-~N~i~agi~~L~~fH~~~~~~lHGD~np~NiM~D~~G~lKlVDP~  188 (308)
T PF07387_consen  127 YKYGVILERCYKIK-----------INF-SNFITAGIKDLMDFHSENQHCLHGDCNPDNIMCDKFGYLKLVDPV  188 (308)
T ss_pred             ceeEEEEeeccCcc-----------cch-hHHHHHhHHHHHHhhccCCCeecCCCChhheeecCCCCEEecChh
Confidence            56778888886310           000 11122225678888943  69999999999999999999999854

The function of this family is unknown.

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=92.21  E-value=0.33  Score=42.33  Aligned_cols=76  Identities=18%  Similarity=0.242  Sum_probs=56.5

Q ss_pred             CcEEEEeecCCc--cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH-HCCceeccCCCCcEEEccCCCEEEeeccceeec
Q 023609           22 NDVYIAYELMDT--DLHQIIRSNQALSEEHCQYFLYQILRGLKYIH-SANVLHRDLKPSNLLLNANCDLKICDFGLARVT   98 (280)
Q Consensus        22 ~~~~iv~e~~~g--~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH-~~gi~H~di~~~nili~~~~~~~l~dfg~~~~~   98 (280)
                      ..-.|||+++++  .-.-.+ +...++...+..+-.|++.-+.-|. ..++||.||+--|+++ .+|.+.++|.+-+.-.
T Consensus       237 k~hVLVM~FlGrdgw~aPkL-Kd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly-hdG~lyiIDVSQSVE~  314 (520)
T KOG2270|consen  237 KNHVLVMEFLGRDGWAAPKL-KDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY-HDGKLYIIDVSQSVEH  314 (520)
T ss_pred             ecceEeeeeccCCCCcCccc-ccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE-ECCEEEEEEccccccC
Confidence            345899999984  222222 3456888888888888887777775 5689999999999987 5678999999876544


Q ss_pred             c
Q 023609           99 S   99 (280)
Q Consensus        99 ~   99 (280)
                      .
T Consensus       315 D  315 (520)
T KOG2270|consen  315 D  315 (520)
T ss_pred             C
Confidence            3

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=91.39  E-value=0.16  Score=43.43  Aligned_cols=34  Identities=24%  Similarity=0.467  Sum_probs=29.7

Q ss_pred             CceeccCCCCcEEEccCCCEEEeeccceeeccCC
Q 023609           68 NVLHRDLKPSNLLLNANCDLKICDFGLARVTSET  101 (280)
Q Consensus        68 gi~H~di~~~nili~~~~~~~l~dfg~~~~~~~~  101 (280)
                      .++|+|+++.|++++.++.+-++||+.+....+.
T Consensus       199 ~lvHGD~~~gNlii~~~~~~gVlDwe~~~lGDP~  232 (321)
T COG3173         199 VLVHGDYRPGNLIIDPGRPTGVLDWELATLGDPL  232 (321)
T ss_pred             eeeeCCcccCCEEEeCCCeeEEEeccccccCCcH
Confidence            4899999999999999988999999998765543

>PRK14559 putative protein serine/threonine phosphatase; Provisional

Probab=90.77  E-value=0.7  Score=43.50  Aligned_cols=82  Identities=17%  Similarity=0.153  Sum_probs=65.0

Q ss_pred             CCeeeeeceecCCCCCCCCcEEEEeecCC--ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE
Q 023609            4 ENVVAIRDIIPPPQRESFNDVYIAYELMD--TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   81 (280)
Q Consensus         4 pnIv~~~~~~~~~~~~~~~~~~iv~e~~~--g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nili   81 (280)
                      .||.++|++|..+     ..-.+++|+..  ..|.+.+... ..+......|+.||+.--.-|...|++-.=+.++|+.+
T Consensus       180 ~~iP~v~~~~~~~-----~~~i~Lle~~~~~~~l~~~w~~~-~~~~l~~l~Wl~q~~~LW~~l~~~~~~~sll~~~nlrv  253 (645)
T PRK14559        180 TEIPKIHDAWQDG-----DLQVILLEDRSHWQPLLDLWQDQ-TLPTLQILYWLNQMTQLWKALEPWGCCQSLLELENLRV  253 (645)
T ss_pred             ccCcchheeecCC-----CCcEEEeCCCCCCchHHHHhhhc-CCcHHHHHHHHHHHHHHHHHHHhcCeehhccchhheee
Confidence            4599999999774     34578888876  3787777643 46678889999999999999999999999999999999


Q ss_pred             ccCCCEEEee
Q 023609           82 NANCDLKICD   91 (280)
Q Consensus        82 ~~~~~~~l~d   91 (280)
                      +++..+.|..
T Consensus       254 ~~~~~~~l~~  263 (645)
T PRK14559        254 DEDQTLGLQQ  263 (645)
T ss_pred             CCCceehHhh
Confidence            8655444443

>PRK11768 serine/threonine protein kinase; Provisional

Probab=90.55  E-value=0.39  Score=41.37  Aligned_cols=28  Identities=32%  Similarity=0.433  Sum_probs=23.2

Q ss_pred             CCceeccCCCCcEEEccCCCEEEeecccee
Q 023609           67 ANVLHRDLKPSNLLLNANCDLKICDFGLAR   96 (280)
Q Consensus        67 ~gi~H~di~~~nili~~~~~~~l~dfg~~~   96 (280)
                      .|++|+|+.+.||+++ + .+.++||+.+.
T Consensus       196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~  223 (325)
T PRK11768        196 LLRLHGDCHPGNILWR-D-GPHFVDLDDAR  223 (325)
T ss_pred             ccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence            4689999999999995 4 57899998653

>PRK06148 hypothetical protein; Provisional

Probab=89.85  E-value=0.48  Score=47.33  Aligned_cols=31  Identities=35%  Similarity=0.529  Sum_probs=26.0

Q ss_pred             CCceeccCCCCcEEEccCC--CE-EEeeccceee
Q 023609           67 ANVLHRDLKPSNLLLNANC--DL-KICDFGLARV   97 (280)
Q Consensus        67 ~gi~H~di~~~nili~~~~--~~-~l~dfg~~~~   97 (280)
                      .+++|+|+++.||+++.++  .+ -|+|||.+..
T Consensus       203 ~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        203 AQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             cceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            4799999999999998875  45 4999998754

>PHA03111 Ser/Thr kinase; Provisional

Probab=89.80  E-value=0.89  Score=39.09  Aligned_cols=60  Identities=27%  Similarity=0.249  Sum_probs=38.2

Q ss_pred             EEEEeecCCc-----cHHHHHHcCCCCCH-HHHHHHHHHHHHHHHHHH----HCCceeccCCCCcEEEccC
Q 023609           24 VYIAYELMDT-----DLHQIIRSNQALSE-EHCQYFLYQILRGLKYIH----SANVLHRDLKPSNLLLNAN   84 (280)
Q Consensus        24 ~~iv~e~~~g-----~L~~~l~~~~~l~~-~~~~~i~~qll~al~~LH----~~gi~H~di~~~nili~~~   84 (280)
                      -.||+++.-+     ++....+ .+-.|. .-++.++.||+...-..-    ..+++|.||||+||++-..
T Consensus       250 nIIIfPLArcSadkv~~~~~~e-~GF~s~~~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds  319 (444)
T PHA03111        250 NIIIFPLARCSADKVTEENAAE-LGFKSLVEYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDS  319 (444)
T ss_pred             cEEEEehhhcccccCCHHHHHH-cCCccHHHHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecC
Confidence            4789998643     2322222 233333 457788889877553442    3469999999999998443

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=89.78  E-value=0.71  Score=39.87  Aligned_cols=29  Identities=34%  Similarity=0.487  Sum_probs=25.3

Q ss_pred             ceeccCCCCcEEEcc-CCCEEEeeccceee
Q 023609           69 VLHRDLKPSNLLLNA-NCDLKICDFGLARV   97 (280)
Q Consensus        69 i~H~di~~~nili~~-~~~~~l~dfg~~~~   97 (280)
                      ++|+|+.+.||+++. ++.++++||..+..
T Consensus       184 ~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        184 FAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             EEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            799999999999975 57899999987754

>PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function

Probab=89.51  E-value=0.6  Score=39.42  Aligned_cols=28  Identities=36%  Similarity=0.586  Sum_probs=23.2

Q ss_pred             ceeccCCCCcEEEccC--C---CEEEeecccee
Q 023609           69 VLHRDLKPSNLLLNAN--C---DLKICDFGLAR   96 (280)
Q Consensus        69 i~H~di~~~nili~~~--~---~~~l~dfg~~~   96 (280)
                      ++|||++.+||++..+  |   .++++||..++
T Consensus       217 l~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~  249 (294)
T PF02958_consen  217 LCHGDFWTNNILFKYDDDGKPIDVVLIDFQLAR  249 (294)
T ss_pred             EEcCccCHHhEeEccccccccccceeecccccc
Confidence            8999999999999654  3   58999997654

All known members of this group are proteins from drosophila and Caenorhabditis elegans.

>PRK06149 hypothetical protein; Provisional

Probab=88.89  E-value=0.53  Score=46.87  Aligned_cols=32  Identities=19%  Similarity=0.233  Sum_probs=25.6

Q ss_pred             HCCceeccCCCCcEEEccC--CC---EEEeeccceee
Q 023609           66 SANVLHRDLKPSNLLLNAN--CD---LKICDFGLARV   97 (280)
Q Consensus        66 ~~gi~H~di~~~nili~~~--~~---~~l~dfg~~~~   97 (280)
                      ..|++|+|+++.||+++.+  +.   ..++|||.+..
T Consensus       207 ~~g~IH~Dl~~~Nilv~~~~~~~~~v~giIDFgD~~~  243 (972)
T PRK06149        207 PLQAVHLDITDDNVVGSRDADGRWQPDGVIDFGDLVR  243 (972)
T ss_pred             cccccCCCCCcccEEEcCCCCCCcceeEEEEcccchh
Confidence            3589999999999999865  23   37999997653

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=88.80  E-value=0.66  Score=36.96  Aligned_cols=56  Identities=30%  Similarity=0.435  Sum_probs=41.5

Q ss_pred             cEEEEeecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCCEEEeeccce
Q 023609           23 DVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA   95 (280)
Q Consensus        23 ~~~iv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nili~~~~~~~l~dfg~~   95 (280)
                      ..-||.||....-        .++...    +.+|+.-+..+|+.||+-+|+++.|..     .-+|+|||.+
T Consensus       151 ~~aIVKD~v~~~~--------~~~~~~----~~~~~~dl~~~~k~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  151 IRAIVKDFVPDDP--------PLQIRD----IPQMLRDLKILHKLGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             cEEEEEeecCCcc--------ccchhH----HHHHHHHHHHHHHCCeeeccCcccccc-----CCEEEecccC
Confidence            3567888776432        233344    467778888999999999999999997     3488899854

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=86.80  E-value=1.3  Score=34.53  Aligned_cols=66  Identities=21%  Similarity=0.254  Sum_probs=46.5

Q ss_pred             EEEEeecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCC-CcEEEccCCCEEEeecccee
Q 023609           24 VYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKP-SNLLLNANCDLKICDFGLAR   96 (280)
Q Consensus        24 ~~iv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~-~nili~~~~~~~l~dfg~~~   96 (280)
                      -++.|||+.| .|.+.....       -++-+..++++.--|-..||-|+.|+- ...++..++.+.|+||..++
T Consensus        87 ~~i~me~i~G~~L~~~~~~~-------~rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At  154 (201)
T COG2112          87 DFIRMEYIDGRPLGKLEIGG-------DRKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSAT  154 (201)
T ss_pred             hhhhhhhhcCcchhhhhhcc-------cHHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchh
Confidence            4577999988 776654321       133455667777778889999999975 44444455589999998776

>PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly

Probab=85.49  E-value=1.2  Score=38.45  Aligned_cols=59  Identities=25%  Similarity=0.265  Sum_probs=35.9

Q ss_pred             EEEEeecCCcc-----HHHHHHcCCCCC-HHHHHHHHHHHHHHHH---HHH-HCCceeccCCCCcEEEcc
Q 023609           24 VYIAYELMDTD-----LHQIIRSNQALS-EEHCQYFLYQILRGLK---YIH-SANVLHRDLKPSNLLLNA   83 (280)
Q Consensus        24 ~~iv~e~~~g~-----L~~~l~~~~~l~-~~~~~~i~~qll~al~---~LH-~~gi~H~di~~~nili~~   83 (280)
                      -.||++++-++     +....+- |-.+ ..-++.++.||+...-   .|- ..+++|.||||+||++-.
T Consensus       246 nIIIfPLA~~Sadkv~~~~~~e~-GF~s~~~YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFd  314 (434)
T PF05445_consen  246 NIIIFPLARCSADKVTESNAAEL-GFKSNVEYVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFD  314 (434)
T ss_pred             cEEEEehhhcchhhcCHHHHHhc-CchhHHHHHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEec
Confidence            36899987542     2222221 2222 2446778888876432   222 346999999999999843

; GO: 0004672 protein kinase activity, 0005524 ATP binding

>PRK12396 5-methylribose kinase; Reviewed

Probab=85.19  E-value=1.1  Score=39.53  Aligned_cols=29  Identities=21%  Similarity=0.385  Sum_probs=23.7

Q ss_pred             CCceeccCCCCcEEEccCCCEEEeecccee
Q 023609           67 ANVLHRDLKPSNLLLNANCDLKICDFGLAR   96 (280)
Q Consensus        67 ~gi~H~di~~~nili~~~~~~~l~dfg~~~   96 (280)
                      ..++|||++|.||+++.++ .+++|..++.
T Consensus       227 ~aLlHGDlHtGSI~v~~~~-~kvIDpEFAf  255 (409)
T PRK12396        227 QALIHGDLHTGSVFVKNDS-TKVIDPEFAF  255 (409)
T ss_pred             hhhccCcCCCCCEEecCCc-eEEEcccccc
Confidence            4599999999999998864 8889865543

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	280
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-87
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		2e-87
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		2e-87
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		3e-87
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		3e-87
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		3e-87
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		3e-87
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		3e-87
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		3e-87
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		3e-87
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		3e-87
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-87
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		7e-87
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		1e-86
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-86
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		4e-86
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		4e-86
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		5e-86
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		5e-86
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		1e-85
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		1e-85
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		6e-85
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		8e-85
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-84
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		9e-79
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		3e-78
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		3e-78
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		7e-78
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		8e-78
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		3e-73
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		3e-73
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		4e-73
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		5e-73
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		6e-73
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		6e-73
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		6e-73
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		6e-73
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		6e-73
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		7e-73
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		7e-73
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		7e-73
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		7e-73
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		7e-73
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		7e-73
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		7e-73
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		8e-73
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		8e-73
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		8e-73
2oza_B	366	Structure Of P38alpha Complex Length = 366		8e-73
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		8e-73
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		8e-73
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		9e-73
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		9e-73
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		9e-73
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		9e-73
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		9e-73
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		9e-73
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		1e-72
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		1e-72
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		1e-72
3hec_A	348	P38 In Complex With Imatinib Length = 348		1e-72
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		1e-72
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-72
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-72
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		2e-72
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		3e-72
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		3e-72
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		3e-72
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		3e-72
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		3e-72
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		4e-72
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		6e-72
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		6e-72
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		6e-72
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		6e-72
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		7e-72
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-72
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		7e-72
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		7e-72
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		7e-72
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		1e-71
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		1e-71
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		1e-71
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		1e-71
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		1e-71
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		1e-71
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		3e-71
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		3e-71
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		4e-70
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		6e-69
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		4e-68
4exu_A	371	Mapk13, Inactive Form Length = 371		7e-65
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		9e-65
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-64
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-57
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		6e-57
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		9e-57
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		1e-56
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		1e-56
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		1e-56
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		1e-56
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		1e-56
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		1e-56
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		1e-56
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		1e-56
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-56
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		2e-56
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-56
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		2e-56
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		2e-56
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		2e-56
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		3e-56
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		3e-56
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		4e-56
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		4e-56
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		6e-56
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		8e-56
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		8e-56
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		8e-56
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		1e-55
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-55
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		2e-55
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		3e-55
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		4e-55
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		5e-55
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		1e-54
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		5e-54
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		6e-53
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		4e-52
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		8e-52
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		8e-52
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		1e-50
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		1e-50
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-46
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-43
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-43
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		5e-43
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		7e-43
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		8e-43
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		9e-43
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		9e-43
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		1e-42
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-42
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		1e-42
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		1e-42
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		1e-42
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		1e-42
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		1e-42
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-42
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-42
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-42
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		4e-42
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-42
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		4e-42
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		4e-42
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-42
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		4e-42
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		4e-42
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		4e-42
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-42
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		4e-42
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-42
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		4e-42
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		4e-42
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		4e-42
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-42
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		5e-42
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		5e-42
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		5e-42
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-42
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		6e-42
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		6e-42
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		7e-42
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		8e-42
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		3e-41
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		8e-41
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		1e-39
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		1e-39
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		1e-39
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		2e-39
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		2e-39
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		2e-39
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		2e-39
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		2e-39
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-39
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		2e-39
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-39
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		2e-39
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		4e-39
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		6e-39
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		9e-39
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		1e-38
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-38
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-38
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-38
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-38
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-38
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-38
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-38
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-38
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-38
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-38
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		3e-38
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		4e-37
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		1e-36
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		1e-36
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-36
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-36
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		8e-36
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		9e-34
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		1e-32
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		4e-32
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		6e-32
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		6e-32
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		7e-32
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-31
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		1e-29
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		5e-27
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		5e-27
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		5e-27
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		5e-27
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		5e-27
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		5e-27
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		5e-27
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		6e-27
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		6e-27
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		7e-27
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		7e-27
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		7e-27
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		7e-27
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		7e-27
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		7e-27
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		7e-27
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		7e-27
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		7e-27
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		7e-27
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		8e-27
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		8e-27
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		8e-27
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		8e-27
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		8e-27
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		8e-27
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		9e-27
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		9e-27
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		9e-27
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		9e-27
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		9e-27
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		9e-27
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		1e-26
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		1e-26
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		1e-26
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		3e-25
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		5e-25
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		5e-25
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		1e-24
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-24
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		5e-24
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-23
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		1e-22
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		1e-22
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-22
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-22
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		2e-21
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		6e-21
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-20
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-20
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-20
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		3e-20
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		4e-20
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		4e-20
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		4e-20
3kk8_A	284	Camkii Substrate Complex A Length = 284		4e-20
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		5e-20
3kk9_A	282	Camkii Substrate Complex B Length = 282		5e-20
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		5e-20
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		9e-20
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		1e-19
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		1e-19
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		1e-19
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-19
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		3e-19
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-19
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		3e-19
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		3e-19
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-19
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		3e-19
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		3e-19
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		4e-19
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		5e-19
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		7e-19
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		7e-19
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		8e-19
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		9e-19
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		9e-19
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		9e-19
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		9e-19
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		1e-18
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-18
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-18
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-18
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-18
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-18
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		3e-18
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		3e-18
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		3e-18
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		3e-18
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-18
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-18
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		3e-18
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-18
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		3e-18
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		3e-18
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		3e-18
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		3e-18
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		3e-18
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		3e-18
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		3e-18
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		3e-18
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		3e-18
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		3e-18
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		4e-18
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		4e-18
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		4e-18
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		4e-18
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		4e-18
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		5e-18
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		5e-18
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		5e-18
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		5e-18
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		5e-18
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		5e-18
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		5e-18
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		6e-18
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		6e-18
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		6e-18
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		6e-18
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		6e-18
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		6e-18
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		7e-18
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		7e-18
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		7e-18
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		8e-18
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		9e-18
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		1e-17
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		1e-17
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-17
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-17
3soa_A	444	Full-Length Human Camkii Length = 444		1e-17
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		2e-17
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		2e-17
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		2e-17
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		3e-17
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		3e-17
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		3e-17
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		5e-17
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		6e-17
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		6e-17
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		7e-17
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		7e-17
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		9e-17
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		1e-16
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-16
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-16
4fie_A	423	Full-Length Human Pak4 Length = 423		3e-16
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		3e-16
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		3e-16
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		3e-16
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		3e-16
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		3e-16
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		4e-16
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		4e-16
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		4e-16
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		4e-16
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		4e-16
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		4e-16
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		4e-16
2oza_A	356	Structure Of P38alpha Complex Length = 356		4e-16
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		4e-16
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		5e-16
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		5e-16
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		5e-16
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		6e-16
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		6e-16
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		6e-16
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		7e-16
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		7e-16
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-16
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		9e-16
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		1e-15
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		1e-15
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		2e-15
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		2e-15
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		3e-15
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		3e-15
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-15
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		3e-15
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		3e-15
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		3e-15
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		3e-15
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		3e-15
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		3e-15
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		4e-15
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		4e-15
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		4e-15
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		4e-15
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		4e-15
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		4e-15
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		4e-15
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		4e-15
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		5e-15
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		5e-15
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		5e-15
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		5e-15
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		5e-15
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		5e-15
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		5e-15
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		6e-15
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		6e-15
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		6e-15
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		6e-15
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		6e-15
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		6e-15
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		6e-15
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		6e-15
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		7e-15
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		7e-15
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		7e-15
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		7e-15
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		7e-15
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		7e-15
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		7e-15
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		7e-15
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		8e-15
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		8e-15
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		9e-15
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		9e-15
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		9e-15
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		9e-15
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		9e-15
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		9e-15
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		9e-15
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		9e-15
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		1e-14
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-14
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		1e-14
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		1e-14
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-14
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		1e-14
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		1e-14
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		1e-14
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		1e-14
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		1e-14
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-14
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		1e-14
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		2e-14
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		2e-14
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-14
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-14
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-14
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-14
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-14
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-14
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		2e-14
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-14
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-14
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-14
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		3e-14
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		3e-14
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		3e-14
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-14
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		4e-14
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		4e-14
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-14
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		6e-14
3a7f_A	303	Human Mst3 Kinase Length = 303		6e-14
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		7e-14
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		8e-14
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		8e-14
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		8e-14
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		8e-14
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		8e-14
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		8e-14
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		9e-14
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-14
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		1e-13
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		1e-13
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		1e-13
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-13
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-13
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		1e-13
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-13
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		1e-13
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-13
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		1e-13
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		1e-13
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		1e-13
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		1e-13
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		1e-13
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		1e-13
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		1e-13
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		1e-13
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-13
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-13
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-13
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-13
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		2e-13
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-13
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-13
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-13
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-13
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-13
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		2e-13
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-13
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-13
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-13
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-13
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		2e-13
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		2e-13
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		2e-13
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		2e-13
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-13
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		3e-13
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		3e-13
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		3e-13
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		3e-13
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		3e-13
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		3e-13
3g51_A	325	Structural Diversity Of The Active Conformation Of		3e-13
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		3e-13
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		4e-13
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		4e-13
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		4e-13
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		4e-13
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		4e-13
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		4e-13
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		5e-13
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		5e-13
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		5e-13
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		5e-13
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		5e-13
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		5e-13
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		5e-13
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		5e-13
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		5e-13
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		5e-13
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		5e-13
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		5e-13
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		5e-13
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		5e-13
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		6e-13
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		6e-13
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		6e-13
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		6e-13
4ae6_A	343	Structure And Function Of The Human Sperm-specific		6e-13
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		7e-13
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		7e-13
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		7e-13
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		7e-13
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		7e-13
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		7e-13
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-13
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		8e-13
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		8e-13
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		8e-13
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		8e-13
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		9e-13
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-12
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		1e-12
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		1e-12
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		1e-12
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		1e-12
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		1e-12
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-12
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		1e-12
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		1e-12
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		2e-12
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		2e-12
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		2e-12
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		2e-12
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-12
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-12
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		2e-12
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-12
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-12
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-12
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-12
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		2e-12
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-12
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-12
4ae9_A	343	Structure And Function Of The Human Sperm-specific		2e-12
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		2e-12
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		2e-12
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-12
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		2e-12
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		2e-12
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		2e-12
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		3e-12
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		3e-12
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		3e-12
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		3e-12
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		3e-12
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		3e-12
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		3e-12
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		3e-12
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		4e-12
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		4e-12
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		4e-12
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		4e-12
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		4e-12
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		5e-12
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		5e-12
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		5e-12
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		6e-12
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		6e-12
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		6e-12
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		7e-12
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		7e-12
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		7e-12
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		7e-12
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		7e-12
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		7e-12
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		7e-12
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		7e-12
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		7e-12
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		7e-12
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		7e-12
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		7e-12
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		7e-12
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		7e-12
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		7e-12
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		7e-12
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		8e-12
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		8e-12
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		8e-12
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		8e-12
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		8e-12
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		8e-12
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		8e-12
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		8e-12
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		8e-12
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		8e-12
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		8e-12
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		8e-12
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		8e-12
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		8e-12
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		8e-12
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		9e-12
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		9e-12
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		9e-12
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		1e-11
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-11
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-11
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-11
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		2e-11
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-11
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-11
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		2e-11
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		2e-11
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		2e-11
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		2e-11
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		2e-11
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		2e-11
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		3e-11
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		3e-11
3a4o_X	286	Lyn Kinase Domain Length = 286		3e-11
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		4e-11
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-11
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-11
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-11
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-11
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		5e-11
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		5e-11
3b2t_A	311	Structure Of Phosphotransferase Length = 311		5e-11
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		5e-11
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		6e-11
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		6e-11
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-11
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		7e-11
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		7e-11
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		7e-11
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		8e-11
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		8e-11
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		8e-11
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		9e-11
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		9e-11
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-11
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-10
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-10
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		1e-10
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		1e-10
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-10
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		1e-10
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-10
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		1e-10
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-10
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-10
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-10
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-10
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		2e-10
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-10
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		2e-10
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-10
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-10
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-10
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-10
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		2e-10
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-10
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		2e-10
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-10
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-10
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-10
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		2e-10
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		2e-10
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-10
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-10
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-10
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		2e-10
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-10
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-10
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-10
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-10
1wbp_A	397	Srpk1 Bound To 9mer Docking Motif Peptide Length =		2e-10
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		2e-10
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		2e-10
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		2e-10
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		2e-10
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-10
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		2e-10
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		3e-10
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-10
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		3e-10
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		3e-10
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		3e-10
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		3e-10
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		3e-10
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		3e-10
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		3e-10
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-10
3beg_A	381	Crystal Structure Of Sr Protein Kinase 1 Complexed		3e-10
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		3e-10
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		3e-10
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		3e-10
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		3e-10
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		3e-10
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		3e-10
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		3e-10
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		3e-10
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		3e-10
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		3e-10
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		4e-10
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		4e-10
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		4e-10
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		4e-10
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		4e-10
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		4e-10
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		4e-10
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		4e-10
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		4e-10
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		4e-10
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		5e-10
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		5e-10
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		5e-10
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		5e-10
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		5e-10
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		5e-10
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		5e-10
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		5e-10
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		5e-10
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		6e-10
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		6e-10
2pl0_A	289	Lck Bound To Imatinib Length = 289		6e-10
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		6e-10
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		6e-10
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		6e-10
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		7e-10
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		7e-10
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		7e-10
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		7e-10
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		7e-10
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		8e-10
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		8e-10
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		9e-10
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		9e-10
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		9e-10
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		9e-10
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		9e-10
2x7g_A	389	Structure Of Human Serine-Arginine-Rich Protein-Spe		1e-09
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		1e-09
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		1e-09
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		1e-09
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		1e-09
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		1e-09
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		1e-09
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		1e-09
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		2e-09
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-09
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-09
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-09
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-09
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-09
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-09
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-09
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-09
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-09
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-09
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		2e-09
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		2e-09
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-09
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-09
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-09
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		2e-09
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-09
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		3e-09
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		3e-09
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		3e-09
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		3e-09
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-09
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		3e-09
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-09
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-09
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		3e-09
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-09
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		3e-09
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		4e-09
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		4e-09
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		4e-09
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		5e-09
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		5e-09
4fl3_A	635	Structural And Biophysical Characterization Of The		5e-09
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		5e-09
4fl2_A	636	Structural And Biophysical Characterization Of The		5e-09
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		7e-09
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		7e-09
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		7e-09
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		7e-09
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		8e-09
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		8e-09
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		9e-09
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		9e-09
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		1e-08
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		1e-08
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		1e-08
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		1e-08
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-08
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-08
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		1e-08
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		1e-08
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-08
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		2e-08
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-08
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-08
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		2e-08
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		2e-08
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-08
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-08
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-08
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-08
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		2e-08
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-08
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-08
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-08
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-08
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		2e-08
4h58_A	275	Braf In Complex With Compound 3 Length = 275		3e-08
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		3e-08
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		3e-08
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		3e-08
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		3e-08
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-08
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		3e-08
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		3e-08
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		4e-08
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		4e-08
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		4e-08
1fvr_A	327	Tie2 Kinase Domain Length = 327		4e-08
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		4e-08
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		4e-08
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		4e-08
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		5e-08
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		5e-08
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		5e-08
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		5e-08
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		5e-08
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		5e-08
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		5e-08
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		5e-08
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		5e-08
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		5e-08
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		5e-08
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		5e-08
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		5e-08
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		6e-08
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		6e-08
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		6e-08
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		6e-08
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		8e-08
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		1e-07
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-07
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		1e-07
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		1e-07
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		1e-07
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		1e-07
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-07
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		1e-07
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		1e-07
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		1e-07
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		1e-07
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		1e-07
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-07
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-07
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		1e-07
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		1e-07
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		1e-07
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		1e-07
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		2e-07
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-07
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		2e-07
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		2e-07
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-07
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		2e-07
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		2e-07
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		2e-07
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		2e-07
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		2e-07
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		2e-07
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-07
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		2e-07
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-07
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		2e-07
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		2e-07
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		2e-07
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-07
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		2e-07
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-07
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		2e-07
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		3e-07
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-07
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		3e-07
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		3e-07
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		3e-07
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		3e-07
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		3e-07
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-07
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		3e-07
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-07
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		3e-07
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		3e-07
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		3e-07
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		3e-07
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		3e-07
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		3e-07
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		3e-07
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		3e-07
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		3e-07
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-07
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		3e-07
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		3e-07
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		3e-07
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		3e-07
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-07
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		3e-07
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		3e-07
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		3e-07
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-07
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		3e-07
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		3e-07
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		3e-07
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		3e-07
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		3e-07
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		3e-07
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-07
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		4e-07
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		4e-07
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		4e-07
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		4e-07
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		4e-07
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-07
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		4e-07
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		4e-07
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		4e-07
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		4e-07
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-07
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		4e-07
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		4e-07
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		4e-07
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		4e-07
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		5e-07
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		5e-07
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		5e-07
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		5e-07
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		5e-07
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		5e-07
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		5e-07
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		5e-07
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		5e-07
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		5e-07
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		5e-07
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		5e-07
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		6e-07
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		6e-07

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  318 bits (816), Expect = 1e-87,   Method: Compositional matrix adjust.
 Identities = 152/281 (54%), Positives = 200/281 (71%), Gaps = 6/281 (2%)
Query: 3   HENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLK 62
           HEN++ I DII  P  E   DVYI  +LM+TDL++++++ Q LS +H  YFLYQILRGLK
Sbjct: 82  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLK 140
Query: 63  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS----ETDFMTEYVVTRWYRAPEL 118
           YIHSANVLHRDLKPSNLLLN  CDLKICDFGLARV       T F+TEYV TRWYRAPE+
Sbjct: 141 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 200
Query: 119 LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELG-FLNE 177
           +LNS  YT +ID+WSVGCI  E++  +P+FPG+ ++ QL  ++ ++G+PS+ +L   +N 
Sbjct: 201 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 260
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 237
            A+ Y+  LP   +  +   FPN    A+DL++KMLTF+P +RI VE ALAHPYL   +D
Sbjct: 261 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLAQYYD 320
Query: 238 ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYR 278
            SDEP+  +PF FD E   L + ++KELI++E   F P YR
Sbjct: 321 PSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 361

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score =  318 bits (814), Expect = 2e-87,   Method: Compositional matrix adjust.
 Identities = 152/281 (54%), Positives = 200/281 (71%), Gaps = 6/281 (2%)
Query: 3   HENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLK 62
           HEN++ I DII  P  E   DVYI  +LM+TDL++++++ Q LS +H  YFLYQILRGLK
Sbjct: 88  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLK 146
Query: 63  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS----ETDFMTEYVVTRWYRAPEL 118
           YIHSANVLHRDLKPSNLLLN  CDLKICDFGLARV       T F+TEYV TRWYRAPE+
Sbjct: 147 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 206
Query: 119 LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELG-FLNE 177
           +LNS  YT +ID+WSVGCI  E++  +P+FPG+ ++ QL  ++ ++G+PS+ +L   +N 
Sbjct: 207 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 266
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 237
            A+ Y+  LP   +  +   FPN    A+DL++KMLTF+P +RI VE ALAHPYL   +D
Sbjct: 267 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 326
Query: 238 ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYR 278
            SDEP+  +PF FD E   L + ++KELI++E   F P YR
Sbjct: 327 PSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 367

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score =  318 bits (814), Expect = 2e-87,   Method: Compositional matrix adjust.
 Identities = 152/281 (54%), Positives = 200/281 (71%), Gaps = 6/281 (2%)
Query: 3   HENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLK 62
           HEN++ I DII  P  E   DVYI  +LM+TDL++++++ Q LS +H  YFLYQILRGLK
Sbjct: 80  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLK 138
Query: 63  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS----ETDFMTEYVVTRWYRAPEL 118
           YIHSANVLHRDLKPSNLLLN  CDLKICDFGLARV       T F+TEYV TRWYRAPE+
Sbjct: 139 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 198
Query: 119 LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELG-FLNE 177
           +LNS  YT +ID+WSVGCI  E++  +P+FPG+ ++ QL  ++ ++G+PS+ +L   +N 
Sbjct: 199 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 258
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 237
            A+ Y+  LP   +  +   FPN    A+DL++KMLTF+P +RI VE ALAHPYL   +D
Sbjct: 259 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 318
Query: 238 ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYR 278
            SDEP+  +PF FD E   L + ++KELI++E   F P YR
Sbjct: 319 PSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 359

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score =  318 bits (814), Expect = 3e-87,   Method: Compositional matrix adjust.
 Identities = 152/281 (54%), Positives = 200/281 (71%), Gaps = 6/281 (2%)
Query: 3   HENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLK 62
           HEN++ I DII  P  E   DVYI  +LM+TDL++++++ Q LS +H  YFLYQILRGLK
Sbjct: 78  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLK 136
Query: 63  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS----ETDFMTEYVVTRWYRAPEL 118
           YIHSANVLHRDLKPSNLLLN  CDLKICDFGLARV       T F+TEYV TRWYRAPE+
Sbjct: 137 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 196
Query: 119 LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELG-FLNE 177
           +LNS  YT +ID+WSVGCI  E++  +P+FPG+ ++ QL  ++ ++G+PS+ +L   +N 
Sbjct: 197 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 256
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 237
            A+ Y+  LP   +  +   FPN    A+DL++KMLTF+P +RI VE ALAHPYL   +D
Sbjct: 257 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 316
Query: 238 ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYR 278
            SDEP+  +PF FD E   L + ++KELI++E   F P YR
Sbjct: 317 PSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 357

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  318 bits (814), Expect = 3e-87,   Method: Compositional matrix adjust.
 Identities = 152/281 (54%), Positives = 200/281 (71%), Gaps = 6/281 (2%)
Query: 3   HENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLK 62
           HEN++ I DII  P  E   DVYI  +LM+TDL++++++ Q LS +H  YFLYQILRGLK
Sbjct: 85  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLK 143
Query: 63  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS----ETDFMTEYVVTRWYRAPEL 118
           YIHSANVLHRDLKPSNLLLN  CDLKICDFGLARV       T F+TEYV TRWYRAPE+
Sbjct: 144 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 203
Query: 119 LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELG-FLNE 177
           +LNS  YT +ID+WSVGCI  E++  +P+FPG+ ++ QL  ++ ++G+PS+ +L   +N 
Sbjct: 204 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 263
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 237
            A+ Y+  LP   +  +   FPN    A+DL++KMLTF+P +RI VE ALAHPYL   +D
Sbjct: 264 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 323
Query: 238 ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYR 278
            SDEP+  +PF FD E   L + ++KELI++E   F P YR
Sbjct: 324 PSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 364

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score =  318 bits (814), Expect = 3e-87,   Method: Compositional matrix adjust.
 Identities = 152/281 (54%), Positives = 200/281 (71%), Gaps = 6/281 (2%)
Query: 3   HENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLK 62
           HEN++ I DII  P  E   DVYI  +LM+TDL++++++ Q LS +H  YFLYQILRGLK
Sbjct: 86  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLK 144
Query: 63  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS----ETDFMTEYVVTRWYRAPEL 118
           YIHSANVLHRDLKPSNLLLN  CDLKICDFGLARV       T F+TEYV TRWYRAPE+
Sbjct: 145 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 204
Query: 119 LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELG-FLNE 177
           +LNS  YT +ID+WSVGCI  E++  +P+FPG+ ++ QL  ++ ++G+PS+ +L   +N 
Sbjct: 205 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 264
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 237
            A+ Y+  LP   +  +   FPN    A+DL++KMLTF+P +RI VE ALAHPYL   +D
Sbjct: 265 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 324
Query: 238 ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYR 278
            SDEP+  +PF FD E   L + ++KELI++E   F P YR
Sbjct: 325 PSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 365

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score =  318 bits (814), Expect = 3e-87,   Method: Compositional matrix adjust.
 Identities = 152/281 (54%), Positives = 200/281 (71%), Gaps = 6/281 (2%)
Query: 3   HENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLK 62
           HEN++ I DII  P  E   DVYI  +LM+TDL++++++ Q LS +H  YFLYQILRGLK
Sbjct: 77  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLK 135
Query: 63  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS----ETDFMTEYVVTRWYRAPEL 118
           YIHSANVLHRDLKPSNLLLN  CDLKICDFGLARV       T F+TEYV TRWYRAPE+
Sbjct: 136 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 195
Query: 119 LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELG-FLNE 177
           +LNS  YT +ID+WSVGCI  E++  +P+FPG+ ++ QL  ++ ++G+PS+ +L   +N 
Sbjct: 196 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 255
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 237
            A+ Y+  LP   +  +   FPN    A+DL++KMLTF+P +RI VE ALAHPYL   +D
Sbjct: 256 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 315
Query: 238 ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYR 278
            SDEP+  +PF FD E   L + ++KELI++E   F P YR
Sbjct: 316 PSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 356

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score =  318 bits (814), Expect = 3e-87,   Method: Compositional matrix adjust.
 Identities = 152/281 (54%), Positives = 200/281 (71%), Gaps = 6/281 (2%)
Query: 3   HENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLK 62
           HEN++ I DII  P  E   DVYI  +LM+TDL++++++ Q LS +H  YFLYQILRGLK
Sbjct: 84  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLK 142
Query: 63  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS----ETDFMTEYVVTRWYRAPEL 118
           YIHSANVLHRDLKPSNLLLN  CDLKICDFGLARV       T F+TEYV TRWYRAPE+
Sbjct: 143 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 202
Query: 119 LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELG-FLNE 177
           +LNS  YT +ID+WSVGCI  E++  +P+FPG+ ++ QL  ++ ++G+PS+ +L   +N 
Sbjct: 203 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 262
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 237
            A+ Y+  LP   +  +   FPN    A+DL++KMLTF+P +RI VE ALAHPYL   +D
Sbjct: 263 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 322
Query: 238 ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYR 278
            SDEP+  +PF FD E   L + ++KELI++E   F P YR
Sbjct: 323 PSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 363

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score =  317 bits (813), Expect = 3e-87,   Method: Compositional matrix adjust.
 Identities = 152/281 (54%), Positives = 200/281 (71%), Gaps = 6/281 (2%)
Query: 3   HENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLK 62
           HEN++ I DII  P  E   DVYI  +LM+TDL++++++ Q LS +H  YFLYQILRGLK
Sbjct: 80  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLK 138
Query: 63  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS----ETDFMTEYVVTRWYRAPEL 118
           YIHSANVLHRDLKPSNLLLN  CDLKICDFGLARV       T F+TEYV TRWYRAPE+
Sbjct: 139 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 198
Query: 119 LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELG-FLNE 177
           +LNS  YT +ID+WSVGCI  E++  +P+FPG+ ++ QL  ++ ++G+PS+ +L   +N 
Sbjct: 199 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 258
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 237
            A+ Y+  LP   +  +   FPN    A+DL++KMLTF+P +RI VE ALAHPYL   +D
Sbjct: 259 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 318
Query: 238 ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYR 278
            SDEP+  +PF FD E   L + ++KELI++E   F P YR
Sbjct: 319 PSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 359

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score =  317 bits (813), Expect = 3e-87,   Method: Compositional matrix adjust.
 Identities = 152/281 (54%), Positives = 200/281 (71%), Gaps = 6/281 (2%)
Query: 3   HENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLK 62
           HEN++ I DII  P  E   DVYI  +LM+TDL++++++ Q LS +H  YFLYQILRGLK
Sbjct: 100 HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLK 158
Query: 63  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS----ETDFMTEYVVTRWYRAPEL 118
           YIHSANVLHRDLKPSNLLLN  CDLKICDFGLARV       T F+TEYV TRWYRAPE+
Sbjct: 159 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 218
Query: 119 LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELG-FLNE 177
           +LNS  YT +ID+WSVGCI  E++  +P+FPG+ ++ QL  ++ ++G+PS+ +L   +N 
Sbjct: 219 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 278
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 237
            A+ Y+  LP   +  +   FPN    A+DL++KMLTF+P +RI VE ALAHPYL   +D
Sbjct: 279 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 338
Query: 238 ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYR 278
            SDEP+  +PF FD E   L + ++KELI++E   F P YR
Sbjct: 339 PSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 379

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score =  317 bits (813), Expect = 3e-87,   Method: Compositional matrix adjust.
 Identities = 152/281 (54%), Positives = 200/281 (71%), Gaps = 6/281 (2%)
Query: 3   HENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLK 62
           HEN++ I DII  P  E   DVYI  +LM+TDL++++++ Q LS +H  YFLYQILRGLK
Sbjct: 84  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLK 142
Query: 63  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS----ETDFMTEYVVTRWYRAPEL 118
           YIHSANVLHRDLKPSNLLLN  CDLKICDFGLARV       T F+TEYV TRWYRAPE+
Sbjct: 143 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 202
Query: 119 LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELG-FLNE 177
           +LNS  YT +ID+WSVGCI  E++  +P+FPG+ ++ QL  ++ ++G+PS+ +L   +N 
Sbjct: 203 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 262
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 237
            A+ Y+  LP   +  +   FPN    A+DL++KMLTF+P +RI VE ALAHPYL   +D
Sbjct: 263 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 322
Query: 238 ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYR 278
            SDEP+  +PF FD E   L + ++KELI++E   F P YR
Sbjct: 323 PSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 363

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  317 bits (813), Expect = 4e-87,   Method: Compositional matrix adjust.
 Identities = 152/281 (54%), Positives = 200/281 (71%), Gaps = 6/281 (2%)
Query: 3   HENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLK 62
           HEN++ I DII  P  E   DVYI  +LM+TDL++++++ Q LS +H  YFLYQILRGLK
Sbjct: 82  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLK 140
Query: 63  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS----ETDFMTEYVVTRWYRAPEL 118
           YIHSANVLHRDLKPSNLLLN  CDLKICDFGLARV       T F+TEYV TRWYRAPE+
Sbjct: 141 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 200
Query: 119 LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELG-FLNE 177
           +LNS  YT +ID+WSVGCI  E++  +P+FPG+ ++ QL  ++ ++G+PS+ +L   +N 
Sbjct: 201 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 260
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 237
            A+ Y+  LP   +  +   FPN    A+DL++KMLTF+P +RI VE ALAHPYL   +D
Sbjct: 261 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 320
Query: 238 ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYR 278
            SDEP+  +PF FD E   L + ++KELI++E   F P YR
Sbjct: 321 PSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 361

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  317 bits (811), Expect = 7e-87,   Method: Compositional matrix adjust.
 Identities = 152/281 (54%), Positives = 199/281 (70%), Gaps = 6/281 (2%)
Query: 3   HENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLK 62
           HEN++ I DII  P  E   DVYI  +LM+TDL+++++  Q LS +H  YFLYQILRGLK
Sbjct: 84  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKC-QHLSNDHICYFLYQILRGLK 142
Query: 63  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS----ETDFMTEYVVTRWYRAPEL 118
           YIHSANVLHRDLKPSNLLLN  CDLKICDFGLARV       T F+TEYV TRWYRAPE+
Sbjct: 143 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 202
Query: 119 LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELG-FLNE 177
           +LNS  YT +ID+WSVGCI  E++  +P+FPG+ ++ QL  ++ ++G+PS+ +L   +N 
Sbjct: 203 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 262
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 237
            A+ Y+  LP   +  +   FPN    A+DL++KMLTF+P +RI VE ALAHPYL   +D
Sbjct: 263 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 322
Query: 238 ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYR 278
            SDEP+  +PF FD E   L + ++KELI++E   F P YR
Sbjct: 323 PSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 363

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score =  316 bits (809), Expect = 1e-86,   Method: Compositional matrix adjust.
 Identities = 151/281 (53%), Positives = 199/281 (70%), Gaps = 6/281 (2%)
Query: 3   HENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLK 62
           HEN++ I DII  P  E   DVYI  +LM+TDL++++++ Q LS +H  YFLYQILRGLK
Sbjct: 78  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLK 136
Query: 63  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS----ETDFMTEYVVTRWYRAPEL 118
           YIHSANVLHRDLKPSNLLLN  CDLKICDFGLARV       T F+TEYV TRWYRAPE+
Sbjct: 137 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 196
Query: 119 LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELG-FLNE 177
           +LNS  YT +ID+WSVGCI  E++  +P+FPG+ ++ QL  ++ ++G+P + +L   +N 
Sbjct: 197 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPEQEDLNCIINL 256
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 237
            A+ Y+  LP   +  +   FPN    A+DL++KMLTF+P +RI VE ALAHPYL   +D
Sbjct: 257 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 316
Query: 238 ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYR 278
            SDEP+  +PF FD E   L + ++KELI++E   F P YR
Sbjct: 317 PSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 357

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  315 bits (806), Expect = 2e-86,   Method: Compositional matrix adjust.
 Identities = 151/281 (53%), Positives = 199/281 (70%), Gaps = 6/281 (2%)
Query: 3   HENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLK 62
           HEN++ I DII  P  E   DVYI  +LM+TDL++++++ Q LS +H  YFLYQILRGLK
Sbjct: 82  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLK 140
Query: 63  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS----ETDFMTEYVVTRWYRAPEL 118
           YIHSANVLHRDLKPSNLLLN   DLKICDFGLARV       T F+TEYV TRWYRAPE+
Sbjct: 141 YIHSANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 200
Query: 119 LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELG-FLNE 177
           +LNS  YT +ID+WSVGCI  E++  +P+FPG+ ++ QL  ++ ++G+PS+ +L   +N 
Sbjct: 201 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCGINL 260
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 237
            A+ Y+  LP   +  +   FPN    A+DL++KMLTF+P +RI VE ALAHPYL   +D
Sbjct: 261 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLAQYYD 320
Query: 238 ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYR 278
            SDEP+  +PF FD E   L + ++KELI++E   F P YR
Sbjct: 321 PSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 361

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score =  314 bits (804), Expect = 4e-86,   Method: Compositional matrix adjust.
 Identities = 151/281 (53%), Positives = 199/281 (70%), Gaps = 6/281 (2%)
Query: 3   HENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLK 62
           HEN++ I DII  P  E   DVYI  +LM+TDL++++++ Q LS +H  YFLYQILRGLK
Sbjct: 84  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLK 142
Query: 63  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS----ETDFMTEYVVTRWYRAPEL 118
           YIHSANVLHRDLKPSNLLLN   DLKICDFGLARV       T F+TEYV TRWYRAPE+
Sbjct: 143 YIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 202
Query: 119 LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELG-FLNE 177
           +LNS  YT +ID+WSVGCI  E++  +P+FPG+ ++ QL  ++ ++G+PS+ +L   +N 
Sbjct: 203 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 262
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 237
            A+ Y+  LP   +  +   FPN    A+DL++KMLTF+P +RI VE ALAHPYL   +D
Sbjct: 263 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 322
Query: 238 ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYR 278
            SDEP+  +PF FD E   L + ++KELI++E   F P YR
Sbjct: 323 PSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 363

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score =  313 bits (803), Expect = 4e-86,   Method: Compositional matrix adjust.
 Identities = 151/281 (53%), Positives = 199/281 (70%), Gaps = 6/281 (2%)
Query: 3   HENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLK 62
           HEN++ I DII  P  E   DVYI  +LM+TDL++++++ Q LS +H  YFLYQILRGLK
Sbjct: 84  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLK 142
Query: 63  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS----ETDFMTEYVVTRWYRAPEL 118
           YIHSANVLHRDLKPSNLLLN   DLKICDFGLARV       T F+TEYV TRWYRAPE+
Sbjct: 143 YIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 202
Query: 119 LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELG-FLNE 177
           +LNS  YT +ID+WSVGCI  E++  +P+FPG+ ++ QL  ++ ++G+PS+ +L   +N 
Sbjct: 203 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 262
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 237
            A+ Y+  LP   +  +   FPN    A+DL++KMLTF+P +RI VE ALAHPYL   +D
Sbjct: 263 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 322
Query: 238 ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYR 278
            SDEP+  +PF FD E   L + ++KELI++E   F P YR
Sbjct: 323 PSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 363

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score =  313 bits (803), Expect = 5e-86,   Method: Compositional matrix adjust.
 Identities = 151/281 (53%), Positives = 199/281 (70%), Gaps = 6/281 (2%)
Query: 3   HENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLK 62
           HEN++ I DII  P  E   DVYI  +LM+TDL++++++ Q LS +H  YFLYQILRGLK
Sbjct: 80  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLK 138
Query: 63  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS----ETDFMTEYVVTRWYRAPEL 118
           YIHSANVLHRDLKPSNLLLN   DLKICDFGLARV       T F+TEYV TRWYRAPE+
Sbjct: 139 YIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 198
Query: 119 LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELG-FLNE 177
           +LNS  YT +ID+WSVGCI  E++  +P+FPG+ ++ QL  ++ ++G+PS+ +L   +N 
Sbjct: 199 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXIINL 258
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 237
            A+ Y+  LP   +  +   FPN    A+DL++KMLTF+P +RI VE ALAHPYL   +D
Sbjct: 259 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 318
Query: 238 ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYR 278
            SDEP+  +PF FD E   L + ++KELI++E   F P YR
Sbjct: 319 PSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 359

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score =  313 bits (803), Expect = 5e-86,   Method: Compositional matrix adjust.
 Identities = 151/281 (53%), Positives = 199/281 (70%), Gaps = 6/281 (2%)
Query: 3   HENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLK 62
           HEN++ I DII  P  E   DVYI  +LM+TDL++++++ Q LS +H  YFLYQILRGLK
Sbjct: 80  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLK 138
Query: 63  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS----ETDFMTEYVVTRWYRAPEL 118
           YIHSANVLHRDLKPSNLLLN   DLKICDFGLARV       T F+TEYV TRWYRAPE+
Sbjct: 139 YIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 198
Query: 119 LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELG-FLNE 177
           +LNS  YT +ID+WSVGCI  E++  +P+FPG+ ++ QL  ++ ++G+PS+ +L   +N 
Sbjct: 199 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 258
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 237
            A+ Y+  LP   +  +   FPN    A+DL++KMLTF+P +RI VE ALAHPYL   +D
Sbjct: 259 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 318
Query: 238 ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYR 278
            SDEP+  +PF FD E   L + ++KELI++E   F P YR
Sbjct: 319 PSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 359

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  313 bits (801), Expect = 1e-85,   Method: Compositional matrix adjust.
 Identities = 150/281 (53%), Positives = 198/281 (70%), Gaps = 6/281 (2%)
Query: 3   HENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLK 62
           HEN++ I DII  P  E   DVYI  +LM+TDL++++++ Q LS +H  YFLYQILRGLK
Sbjct: 84  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLK 142
Query: 63  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS----ETDFMTEYVVTRWYRAPEL 118
           YIHSANVLHRDLKPSNLLLN  CDLKICDFGLARV       T F+ E V TRWYRAPE+
Sbjct: 143 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEI 202
Query: 119 LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELG-FLNE 177
           +LNS  YT +ID+WSVGCI  E++  +P+FPG+ ++ QL  ++ ++G+PS+ +L   +N 
Sbjct: 203 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 262
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 237
            A+ Y+  LP   +  +   FPN    A+DL++KMLTF+P +RI VE ALAHPYL   +D
Sbjct: 263 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 322
Query: 238 ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYR 278
            SDEP+  +PF FD E   L + ++KELI++E   F P YR
Sbjct: 323 PSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 363

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  313 bits (801), Expect = 1e-85,   Method: Compositional matrix adjust.
 Identities = 150/281 (53%), Positives = 198/281 (70%), Gaps = 6/281 (2%)
Query: 3   HENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLK 62
           HEN++ I DII  P  E   DVYI  +LM+TDL++++++ Q LS +H  YFLYQILRGLK
Sbjct: 85  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLK 143
Query: 63  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS----ETDFMTEYVVTRWYRAPEL 118
           YIHSANVLHRDLKPSNLLLN  CDLKICDFGLARV       T F+ E V TRWYRAPE+
Sbjct: 144 YIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEI 203
Query: 119 LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELG-FLNE 177
           +LNS  YT +ID+WSVGCI  E++  +P+FPG+ ++ QL  ++ ++G+PS+ +L   +N 
Sbjct: 204 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 263
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 237
            A+ Y+  LP   +  +   FPN    A+DL++KMLTF+P +RI VE ALAHPYL   +D
Sbjct: 264 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 323
Query: 238 ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYR 278
            SDEP+  +PF FD E   L + ++KELI++E   F P YR
Sbjct: 324 PSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 364

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score =  310 bits (794), Expect = 6e-85,   Method: Compositional matrix adjust.
 Identities = 150/281 (53%), Positives = 198/281 (70%), Gaps = 6/281 (2%)
Query: 3   HENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLK 62
           HEN++ I DII  P  E   DVYI  +LM+TDL++++++ Q LS +H  YFLYQILRGLK
Sbjct: 80  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLK 138
Query: 63  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS----ETDFMTEYVVTRWYRAPEL 118
           YIHSANVLHRDLKPSNLLLN   DLKI DFGLARV       T F+TEYV TRWYRAPE+
Sbjct: 139 YIHSANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 198
Query: 119 LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELG-FLNE 177
           +LNS  YT +ID+WSVGCI  E++  +P+FPG+ ++ QL  ++ ++G+PS+ +L   +N 
Sbjct: 199 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXIINL 258
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 237
            A+ Y+  LP   +  +   FPN    A+DL++KMLTF+P +RI VE ALAHPYL   +D
Sbjct: 259 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 318
Query: 238 ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYR 278
            SDEP+  +PF FD E   L + ++KELI++E   F P YR
Sbjct: 319 PSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 359

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score =  310 bits (793), Expect = 8e-85,   Method: Compositional matrix adjust.
 Identities = 149/282 (52%), Positives = 196/282 (69%), Gaps = 6/282 (2%)
Query: 3   HENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLK 62
           HEN++ I DII  P  E   DVY+   LM  DL++++++ Q LS +H  YFLYQILRGLK
Sbjct: 100 HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLK 158
Query: 63  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS----ETDFMTEYVVTRWYRAPEL 118
           YIHSANVLHRDLKPSNLLLN   DLKICDFGLARV       T F+TEYV TRWYRAPE+
Sbjct: 159 YIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEI 218
Query: 119 LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELG-FLNE 177
           +LNS  YT +ID+WSVGCI  E++  +P+FPG+ ++ QL  ++ ++G+PS+ +L   +N 
Sbjct: 219 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINL 278
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 237
            A+ Y+  LP   +  +   FPN    A+DL++KMLTF+P +RI VE ALAHPYL   +D
Sbjct: 279 KARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 338
Query: 238 ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYRQ 279
            SDEP+  +PF FD E   L + ++KELI++E   F P YR 
Sbjct: 339 PSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYRS 380

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score =  309 bits (791), Expect = 1e-84,   Method: Compositional matrix adjust.
 Identities = 147/278 (52%), Positives = 200/278 (71%), Gaps = 6/278 (2%)
Query: 3   HENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLK 62
           HENV+ IRDI+     E+  DVYI  +LM+TDL+++++S Q LS +H  YFLYQILRGLK
Sbjct: 100 HENVIGIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQ-LSNDHICYFLYQILRGLK 158
Query: 63  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVT----SETDFMTEYVVTRWYRAPEL 118
           YIHSANVLHRDLKPSNLL+N  CDLKICDFGLAR+       T F+TE V TRWYRAPE+
Sbjct: 159 YIHSANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEI 218
Query: 119 LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELG-FLNE 177
           +LNS  YT +ID+WSVGCI  E++  +P+FPG+ ++ QL  ++ ++G+PS+ +L   +N 
Sbjct: 219 MLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINM 278
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 237
            A+ Y+  LP   + ++ + FP     A+DL+++MLTF+P +RITVE+ALAHPYL   +D
Sbjct: 279 KARNYLQSLPSKTKVAWAKLFPKSDSKALDLLDRMLTFNPNKRITVEEALAHPYLEQYYD 338
Query: 238 ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 275
            +DEPV   PF+F  E   L + ++KELI+QE   F P
Sbjct: 339 PTDEPVAEEPFTFAMELDDLPKERLKELIFQETARFQP 376

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score =  289 bits (740), Expect = 9e-79,   Method: Compositional matrix adjust.
 Identities = 146/287 (50%), Positives = 197/287 (68%), Gaps = 18/287 (6%)
Query: 3   HENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLK 62
           HEN++ I +I  P   E+FN+VYI  ELM TDLH++I S Q LS++H QYF+YQ LR +K
Sbjct: 68  HENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVI-STQMLSDDHIQYFIYQTLRAVK 126
Query: 63  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV-----------TSETDFMTEYVVTR 111
            +H +NV+HRDLKPSNLL+N+NCDLK+CDFGLAR+           T +   MTEYV TR
Sbjct: 127 VLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVATR 186
Query: 112 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTP-SEA 170
           WYRAPE++L S+ Y+ A+DVWS GCI  EL  R+P+FPGRD+ HQL L+  +IGTP S+ 
Sbjct: 187 WYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDN 246
Query: 171 ELGFL-NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 229
           +L  + +  A++YI  LP Y      + FP V+P  IDL+++ML FDP +RIT ++AL H
Sbjct: 247 DLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306
Query: 230 PYLGSLHDISD----EPVCMSPFSFDFEQHALTEGQMKELIYQEALA 272
           PYL + HD +D    EP+  S F FD  + ALT   +K+LI+ E  +
Sbjct: 307 PYLQTYHDPNDEPEGEPIPPSFFEFDHYKEALTTKDLKKLIWNEIFS 353

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score =  288 bits (736), Expect = 3e-78,   Method: Compositional matrix adjust.
 Identities = 144/275 (52%), Positives = 193/275 (70%), Gaps = 9/275 (3%)
Query: 3   HENVVAIRDIIPP--PQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRG 60
           H+N++AI+DI+ P  P  E F  VY+  +LM++DLHQII S+Q L+ EH +YFLYQ+LRG
Sbjct: 112 HDNIIAIKDILRPTVPYGE-FKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRG 170
Query: 61  LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR--VTSETD---FMTEYVVTRWYRA 115
           LKY+HSA V+HRDLKPSNLL+N NC+LKI DFG+AR   TS  +   FMTEYV TRWYRA
Sbjct: 171 LKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRA 230
Query: 116 PELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL 175
           PEL+L+  +YT AID+WSVGCIF E++ R+ LFPG+++VHQL+L++ ++GTPS A +  +
Sbjct: 231 PELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAV 290
Query: 176 N-ENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS 234
             E  + YI  LP  Q   +   +P     A+ L+ +ML F+P  RI+   AL HP+L  
Sbjct: 291 GAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAK 350
Query: 235 LHDISDEPVCMSPFSFDFEQHALTEGQMKELIYQE 269
            HD  DEP C  PF F F++ ALT  ++KE I  E
Sbjct: 351 YHDPDDEPDCAPPFDFAFDREALTRERIKEAIVAE 385

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score =  288 bits (736), Expect = 3e-78,   Method: Compositional matrix adjust.
 Identities = 144/275 (52%), Positives = 193/275 (70%), Gaps = 9/275 (3%)
Query: 3   HENVVAIRDIIPP--PQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRG 60
           H+N++AI+DI+ P  P  E F  VY+  +LM++DLHQII S+Q L+ EH +YFLYQ+LRG
Sbjct: 113 HDNIIAIKDILRPTVPYGE-FKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRG 171
Query: 61  LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR--VTSETD---FMTEYVVTRWYRA 115
           LKY+HSA V+HRDLKPSNLL+N NC+LKI DFG+AR   TS  +   FMTEYV TRWYRA
Sbjct: 172 LKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRA 231
Query: 116 PELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL 175
           PEL+L+  +YT AID+WSVGCIF E++ R+ LFPG+++VHQL+L++ ++GTPS A +  +
Sbjct: 232 PELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAV 291
Query: 176 N-ENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS 234
             E  + YI  LP  Q   +   +P     A+ L+ +ML F+P  RI+   AL HP+L  
Sbjct: 292 GAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAK 351
Query: 235 LHDISDEPVCMSPFSFDFEQHALTEGQMKELIYQE 269
            HD  DEP C  PF F F++ ALT  ++KE I  E
Sbjct: 352 YHDPDDEPDCAPPFDFAFDREALTRERIKEAIVAE 386

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score =  286 bits (733), Expect = 7e-78,   Method: Compositional matrix adjust.
 Identities = 145/287 (50%), Positives = 196/287 (68%), Gaps = 18/287 (6%)
Query: 3   HENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLK 62
           HEN++ I +I  P   E+FN+VYI  ELM TDLH++I S Q LS++H QYF+YQ LR +K
Sbjct: 68  HENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVI-STQMLSDDHIQYFIYQTLRAVK 126
Query: 63  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV-----------TSETDFMTEYVVTR 111
            +H +NV+HRDLKPSNLL+N+NCDLK+CDFGLAR+           T +   MTE V TR
Sbjct: 127 VLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXVATR 186
Query: 112 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTP-SEA 170
           WYRAPE++L S+ Y+ A+DVWS GCI  EL  R+P+FPGRD+ HQL L+  +IGTP S+ 
Sbjct: 187 WYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDN 246
Query: 171 ELGFL-NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 229
           +L  + +  A++YI  LP Y      + FP V+P  IDL+++ML FDP +RIT ++AL H
Sbjct: 247 DLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306
Query: 230 PYLGSLHDISD----EPVCMSPFSFDFEQHALTEGQMKELIYQEALA 272
           PYL + HD +D    EP+  S F FD  + ALT   +K+LI+ E  +
Sbjct: 307 PYLQTYHDPNDEPEGEPIPPSFFEFDHYKEALTTKDLKKLIWNEIFS 353

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score =  286 bits (732), Expect = 8e-78,   Method: Compositional matrix adjust.
 Identities = 144/287 (50%), Positives = 196/287 (68%), Gaps = 18/287 (6%)
Query: 3   HENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLK 62
           HEN++ I +I  P   E+FN+VYI  ELM TDLH++I S Q LS++H QYF+YQ LR +K
Sbjct: 68  HENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVI-STQMLSDDHIQYFIYQTLRAVK 126
Query: 63  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV-----------TSETDFMTEYVVTR 111
            +H +NV+HRDLKPSNLL+N+NCDLK+CDFGLAR+           T +   M E+V TR
Sbjct: 127 VLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATR 186
Query: 112 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTP-SEA 170
           WYRAPE++L S+ Y+ A+DVWS GCI  EL  R+P+FPGRD+ HQL L+  +IGTP S+ 
Sbjct: 187 WYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDN 246
Query: 171 ELGFL-NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 229
           +L  + +  A++YI  LP Y      + FP V+P  IDL+++ML FDP +RIT ++AL H
Sbjct: 247 DLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH 306
Query: 230 PYLGSLHDISD----EPVCMSPFSFDFEQHALTEGQMKELIYQEALA 272
           PYL + HD +D    EP+  S F FD  + ALT   +K+LI+ E  +
Sbjct: 307 PYLQTYHDPNDEPEGEPIPPSFFEFDHYKEALTTKDLKKLIWNEIFS 353

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score =  271 bits (693), Expect = 3e-73,   Method: Compositional matrix adjust.
 Identities = 137/278 (49%), Positives = 182/278 (65%), Gaps = 8/278 (2%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           M HENV+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILR
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 136
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           GLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIM 194
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNE 177
           LN+  Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E
Sbjct: 195 LNAMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSE 253
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 237
           +A+ YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD
Sbjct: 254 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 238 ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 275
             DEPV   P+   FE   L   + K L Y E ++F P
Sbjct: 314 PDDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 350

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score =  271 bits (693), Expect = 3e-73,   Method: Compositional matrix adjust.
 Identities = 138/278 (49%), Positives = 181/278 (65%), Gaps = 8/278 (2%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           M HENV+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILR
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 136
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           GLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIM 194
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNE 177
           LN   Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSE 253
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 237
           +A+ YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD
Sbjct: 254 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 238 ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 275
             DEPV   PF   FE   L   + K L Y E ++F P
Sbjct: 314 PDDEPVA-DPFDQSFESRDLLIDEWKSLTYDEVISFVP 350

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score =  271 bits (692), Expect = 4e-73,   Method: Compositional matrix adjust.
 Identities = 137/278 (49%), Positives = 182/278 (65%), Gaps = 8/278 (2%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           M HENV+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILR
Sbjct: 85  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 143
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           GLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T+  D MT YV TRWYRAPE++
Sbjct: 144 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA--DEMTGYVATRWYRAPEIM 201
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNE 177
           LN   Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E
Sbjct: 202 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSE 260
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 237
           +A+ YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD
Sbjct: 261 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 320
Query: 238 ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 275
             DEPV   P+   FE   L   + K L Y E ++F P
Sbjct: 321 PDDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 357

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  270 bits (691), Expect = 5e-73,   Method: Compositional matrix adjust.
 Identities = 137/278 (49%), Positives = 181/278 (65%), Gaps = 8/278 (2%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           M HENV+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILR
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKX-QKLTDDHVQFLIYQILR 136
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           GLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIM 194
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNE 177
           LN   Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSE 253
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 237
           +A+ YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD
Sbjct: 254 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 238 ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 275
             DEPV   P+   FE   L   + K L Y E ++F P
Sbjct: 314 PDDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 350

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score =  270 bits (690), Expect = 6e-73,   Method: Compositional matrix adjust.
 Identities = 137/278 (49%), Positives = 181/278 (65%), Gaps = 8/278 (2%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           M HENV+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILR
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 136
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           GLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIM 194
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNE 177
           LN   Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSE 253
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 237
           +A+ YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD
Sbjct: 254 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 238 ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 275
             DEPV   P+   FE   L   + K L Y E ++F P
Sbjct: 314 PDDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 350

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score =  270 bits (690), Expect = 6e-73,   Method: Compositional matrix adjust.
 Identities = 137/278 (49%), Positives = 181/278 (65%), Gaps = 8/278 (2%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           M HENV+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILR
Sbjct: 83  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 141
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           GLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++
Sbjct: 142 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIM 199
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNE 177
           LN   Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E
Sbjct: 200 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSE 258
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 237
           +A+ YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD
Sbjct: 259 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 318
Query: 238 ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 275
             DEPV   P+   FE   L   + K L Y E ++F P
Sbjct: 319 PDDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 355

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score =  270 bits (690), Expect = 6e-73,   Method: Compositional matrix adjust.
 Identities = 137/278 (49%), Positives = 181/278 (65%), Gaps = 8/278 (2%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           M HENV+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILR
Sbjct: 77  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 135
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           GLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++
Sbjct: 136 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIM 193
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNE 177
           LN   Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E
Sbjct: 194 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSE 252
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 237
           +A+ YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD
Sbjct: 253 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 312
Query: 238 ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 275
             DEPV   P+   FE   L   + K L Y E ++F P
Sbjct: 313 PDDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 349

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score =  270 bits (690), Expect = 6e-73,   Method: Compositional matrix adjust.
 Identities = 137/278 (49%), Positives = 181/278 (65%), Gaps = 8/278 (2%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           M HENV+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILR
Sbjct: 80  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 138
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           GLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++
Sbjct: 139 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIM 196
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNE 177
           LN   Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E
Sbjct: 197 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSE 255
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 237
           +A+ YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD
Sbjct: 256 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 315
Query: 238 ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 275
             DEPV   P+   FE   L   + K L Y E ++F P
Sbjct: 316 PDDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 352

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score =  270 bits (690), Expect = 6e-73,   Method: Compositional matrix adjust.
 Identities = 137/278 (49%), Positives = 181/278 (65%), Gaps = 8/278 (2%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           M HENV+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILR
Sbjct: 85  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 143
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           GLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++
Sbjct: 144 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIM 201
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNE 177
           LN   Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E
Sbjct: 202 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSE 260
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 237
           +A+ YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD
Sbjct: 261 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 320
Query: 238 ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 275
             DEPV   P+   FE   L   + K L Y E ++F P
Sbjct: 321 PDDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 357

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score =  270 bits (690), Expect = 7e-73,   Method: Compositional matrix adjust.
 Identities = 137/278 (49%), Positives = 181/278 (65%), Gaps = 8/278 (2%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           M HENV+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILR
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 136
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           GLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIM 194
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNE 177
           LN   Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSE 253
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 237
           +A+ YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD
Sbjct: 254 SARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 238 ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 275
             DEPV   P+   FE   L   + K L Y E ++F P
Sbjct: 314 PDDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 350

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score =  270 bits (690), Expect = 7e-73,   Method: Compositional matrix adjust.
 Identities = 137/278 (49%), Positives = 181/278 (65%), Gaps = 8/278 (2%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           M HENV+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILR
Sbjct: 88  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 146
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           GLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++
Sbjct: 147 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIM 204
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNE 177
           LN   Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E
Sbjct: 205 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSE 263
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 237
           +A+ YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD
Sbjct: 264 SARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 323
Query: 238 ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 275
             DEPV   P+   FE   L   + K L Y E ++F P
Sbjct: 324 PDDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 360

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score =  270 bits (690), Expect = 7e-73,   Method: Compositional matrix adjust.
 Identities = 137/278 (49%), Positives = 181/278 (65%), Gaps = 8/278 (2%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           M HENV+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILR
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 136
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           GLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIM 194
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNE 177
           LN   Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSE 253
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 237
           +A+ YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD
Sbjct: 254 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 238 ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 275
             DEPV   P+   FE   L   + K L Y E ++F P
Sbjct: 314 PDDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 350

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score =  270 bits (690), Expect = 7e-73,   Method: Compositional matrix adjust.
 Identities = 137/278 (49%), Positives = 181/278 (65%), Gaps = 8/278 (2%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           M HENV+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILR
Sbjct: 90  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 148
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           GLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++
Sbjct: 149 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIM 206
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNE 177
           LN   Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E
Sbjct: 207 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSE 265
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 237
           +A+ YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD
Sbjct: 266 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 325
Query: 238 ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 275
             DEPV   P+   FE   L   + K L Y E ++F P
Sbjct: 326 PDDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 362

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score =  270 bits (690), Expect = 7e-73,   Method: Compositional matrix adjust.
 Identities = 137/278 (49%), Positives = 181/278 (65%), Gaps = 8/278 (2%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           M HENV+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILR
Sbjct: 101 MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 159
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           GLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++
Sbjct: 160 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIM 217
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNE 177
           LN   Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E
Sbjct: 218 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSE 276
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 237
           +A+ YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD
Sbjct: 277 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 336
Query: 238 ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 275
             DEPV   P+   FE   L   + K L Y E ++F P
Sbjct: 337 PDDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 373

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score =  270 bits (690), Expect = 7e-73,   Method: Compositional matrix adjust.
 Identities = 137/278 (49%), Positives = 181/278 (65%), Gaps = 8/278 (2%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           M HENV+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILR
Sbjct: 90  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 148
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           GLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++
Sbjct: 149 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIM 206
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNE 177
           LN   Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E
Sbjct: 207 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSE 265
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 237
           +A+ YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD
Sbjct: 266 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 325
Query: 238 ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 275
             DEPV   P+   FE   L   + K L Y E ++F P
Sbjct: 326 PDDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 362

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score =  270 bits (690), Expect = 7e-73,   Method: Compositional matrix adjust.
 Identities = 137/278 (49%), Positives = 181/278 (65%), Gaps = 8/278 (2%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           M HENV+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILR
Sbjct: 80  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 138
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           GLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++
Sbjct: 139 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIM 196
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNE 177
           LN   Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E
Sbjct: 197 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSE 255
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 237
           +A+ YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD
Sbjct: 256 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 315
Query: 238 ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 275
             DEPV   P+   FE   L   + K L Y E ++F P
Sbjct: 316 PDDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 352

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score =  270 bits (689), Expect = 8e-73,   Method: Compositional matrix adjust.
 Identities = 137/278 (49%), Positives = 181/278 (65%), Gaps = 8/278 (2%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           M HENV+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILR
Sbjct: 80  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 138
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           GLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++
Sbjct: 139 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIM 196
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNE 177
           LN   Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E
Sbjct: 197 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSE 255
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 237
           +A+ YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD
Sbjct: 256 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 315
Query: 238 ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 275
             DEPV   P+   FE   L   + K L Y E ++F P
Sbjct: 316 PDDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 352

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score =  270 bits (689), Expect = 8e-73,   Method: Compositional matrix adjust.
 Identities = 137/278 (49%), Positives = 181/278 (65%), Gaps = 8/278 (2%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           M HENV+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILR
Sbjct: 89  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 147
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           GLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++
Sbjct: 148 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIM 205
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNE 177
           LN   Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E
Sbjct: 206 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSE 264
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 237
           +A+ YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD
Sbjct: 265 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 324
Query: 238 ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 275
             DEPV   P+   FE   L   + K L Y E ++F P
Sbjct: 325 PDDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 361

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score =  270 bits (689), Expect = 8e-73,   Method: Compositional matrix adjust.
 Identities = 137/278 (49%), Positives = 181/278 (65%), Gaps = 8/278 (2%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           M HENV+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILR
Sbjct: 90  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 148
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           GLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++
Sbjct: 149 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIM 206
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNE 177
           LN   Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E
Sbjct: 207 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSE 265
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 237
           +A+ YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD
Sbjct: 266 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 325
Query: 238 ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 275
             DEPV   P+   FE   L   + K L Y E ++F P
Sbjct: 326 PDDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 362

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score =  270 bits (689), Expect = 8e-73,   Method: Compositional matrix adjust.
 Identities = 137/278 (49%), Positives = 181/278 (65%), Gaps = 8/278 (2%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           M HENV+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILR
Sbjct: 84  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 142
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           GLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++
Sbjct: 143 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIM 200
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNE 177
           LN   Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E
Sbjct: 201 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSE 259
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 237
           +A+ YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD
Sbjct: 260 SARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 319
Query: 238 ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 275
             DEPV   P+   FE   L   + K L Y E ++F P
Sbjct: 320 PDDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 356

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score =  270 bits (689), Expect = 8e-73,   Method: Compositional matrix adjust.
 Identities = 137/278 (49%), Positives = 181/278 (65%), Gaps = 8/278 (2%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           M HENV+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILR
Sbjct: 83  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 141
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           GLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++
Sbjct: 142 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIM 199
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNE 177
           LN   Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E
Sbjct: 200 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSE 258
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 237
           +A+ YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD
Sbjct: 259 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 318
Query: 238 ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 275
             DEPV   P+   FE   L   + K L Y E ++F P
Sbjct: 319 PDDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 355

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score =  270 bits (689), Expect = 8e-73,   Method: Compositional matrix adjust.
 Identities = 137/278 (49%), Positives = 181/278 (65%), Gaps = 8/278 (2%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           M HENV+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILR
Sbjct: 84  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 142
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           GLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++
Sbjct: 143 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIM 200
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNE 177
           LN   Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E
Sbjct: 201 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSE 259
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 237
           +A+ YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD
Sbjct: 260 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 319
Query: 238 ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 275
             DEPV   P+   FE   L   + K L Y E ++F P
Sbjct: 320 PDDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 356

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score =  270 bits (689), Expect = 9e-73,   Method: Compositional matrix adjust.
 Identities = 137/278 (49%), Positives = 181/278 (65%), Gaps = 8/278 (2%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           M HENV+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILR
Sbjct: 97  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 155
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           GLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++
Sbjct: 156 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIM 213
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNE 177
           LN   Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E
Sbjct: 214 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSE 272
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 237
           +A+ YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD
Sbjct: 273 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 332
Query: 238 ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 275
             DEPV   P+   FE   L   + K L Y E ++F P
Sbjct: 333 PDDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 369

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score =  270 bits (689), Expect = 9e-73,   Method: Compositional matrix adjust.
 Identities = 135/277 (48%), Positives = 180/277 (64%), Gaps = 6/277 (2%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           M HENV+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILR
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 136
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           GLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIM 194
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL-NEN 178
           LN   Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP    L  + +E+
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 254
Query: 179 AKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDI 238
           A+ YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD 
Sbjct: 255 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 314
Query: 239 SDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 275
            DEPV   P+   FE   L   + K L Y E ++F P
Sbjct: 315 DDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 350

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score =  270 bits (689), Expect = 9e-73,   Method: Compositional matrix adjust.
 Identities = 137/278 (49%), Positives = 181/278 (65%), Gaps = 8/278 (2%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           M HENV+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILR
Sbjct: 98  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 156
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           GLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++
Sbjct: 157 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIM 214
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNE 177
           LN   Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E
Sbjct: 215 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSE 273
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 237
           +A+ YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD
Sbjct: 274 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 333
Query: 238 ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 275
             DEPV   P+   FE   L   + K L Y E ++F P
Sbjct: 334 PDDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 370

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score =  270 bits (689), Expect = 9e-73,   Method: Compositional matrix adjust.
 Identities = 135/277 (48%), Positives = 180/277 (64%), Gaps = 6/277 (2%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           M HENV+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILR
Sbjct: 75  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 133
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           GLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++
Sbjct: 134 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIM 191
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL-NEN 178
           LN   Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP    L  + +E+
Sbjct: 192 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 251
Query: 179 AKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDI 238
           A+ YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD 
Sbjct: 252 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 311
Query: 239 SDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 275
            DEPV   P+   FE   L   + K L Y E ++F P
Sbjct: 312 DDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 347

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score =  270 bits (689), Expect = 9e-73,   Method: Compositional matrix adjust.
 Identities = 135/277 (48%), Positives = 180/277 (64%), Gaps = 6/277 (2%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           M HENV+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILR
Sbjct: 75  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 133
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           GLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++
Sbjct: 134 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIM 191
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL-NEN 178
           LN   Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP    L  + +E+
Sbjct: 192 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 251
Query: 179 AKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDI 238
           A+ YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD 
Sbjct: 252 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 311
Query: 239 SDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 275
            DEPV   P+   FE   L   + K L Y E ++F P
Sbjct: 312 DDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 347

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score =  270 bits (689), Expect = 9e-73,   Method: Compositional matrix adjust.
 Identities = 135/277 (48%), Positives = 180/277 (64%), Gaps = 6/277 (2%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           M HENV+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILR
Sbjct: 76  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 134
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           GLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++
Sbjct: 135 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIM 192
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL-NEN 178
           LN   Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP    L  + +E+
Sbjct: 193 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 252
Query: 179 AKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDI 238
           A+ YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD 
Sbjct: 253 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 312
Query: 239 SDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 275
            DEPV   P+   FE   L   + K L Y E ++F P
Sbjct: 313 DDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 348

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score =  270 bits (689), Expect = 1e-72,   Method: Compositional matrix adjust.
 Identities = 137/278 (49%), Positives = 181/278 (65%), Gaps = 8/278 (2%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           M HENV+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILR
Sbjct: 98  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 156
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           GLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++
Sbjct: 157 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIM 214
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNE 177
           LN   Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E
Sbjct: 215 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSE 273
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 237
           +A+ YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD
Sbjct: 274 SARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 333
Query: 238 ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 275
             DEPV   P+   FE   L   + K L Y E ++F P
Sbjct: 334 PDDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 370

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score =  269 bits (688), Expect = 1e-72,   Method: Compositional matrix adjust.
 Identities = 137/278 (49%), Positives = 181/278 (65%), Gaps = 8/278 (2%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           M HENV+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILR
Sbjct: 97  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 155
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           GLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++
Sbjct: 156 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIM 213
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNE 177
           LN   Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E
Sbjct: 214 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSE 272
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 237
           +A+ YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD
Sbjct: 273 SARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 332
Query: 238 ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 275
             DEPV   P+   FE   L   + K L Y E ++F P
Sbjct: 333 PDDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 369

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score =  269 bits (688), Expect = 1e-72,   Method: Compositional matrix adjust.
 Identities = 137/278 (49%), Positives = 181/278 (65%), Gaps = 8/278 (2%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           M HENV+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILR
Sbjct: 84  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 142
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           GLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++
Sbjct: 143 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIM 200
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNE 177
           LN   Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E
Sbjct: 201 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSE 259
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 237
           +A+ YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD
Sbjct: 260 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 319
Query: 238 ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 275
             DEPV   P+   FE   L   + K L Y E ++F P
Sbjct: 320 PDDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 356

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score =  269 bits (688), Expect = 1e-72,   Method: Compositional matrix adjust.
 Identities = 135/277 (48%), Positives = 180/277 (64%), Gaps = 6/277 (2%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           M HENV+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILR
Sbjct: 74  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 132
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           GLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++
Sbjct: 133 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIM 190
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL-NEN 178
           LN   Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP    L  + +E+
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 250
Query: 179 AKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDI 238
           A+ YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD 
Sbjct: 251 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 310
Query: 239 SDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 275
            DEPV   P+   FE   L   + K L Y E ++F P
Sbjct: 311 DDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 346

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score =  269 bits (688), Expect = 1e-72,   Method: Compositional matrix adjust.
 Identities = 135/277 (48%), Positives = 180/277 (64%), Gaps = 6/277 (2%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           M HENV+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILR
Sbjct: 74  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 132
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           GLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++
Sbjct: 133 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIM 190
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL-NEN 178
           LN   Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP    L  + +E+
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 250
Query: 179 AKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDI 238
           A+ YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD 
Sbjct: 251 ARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 310
Query: 239 SDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 275
            DEPV   P+   FE   L   + K L Y E ++F P
Sbjct: 311 DDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 346

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  269 bits (687), Expect = 1e-72,   Method: Compositional matrix adjust.
 Identities = 136/278 (48%), Positives = 181/278 (65%), Gaps = 8/278 (2%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           M HENV+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILR
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 136
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           GLKYIHSA+++HRDLKPSNL +N +C+LKI D+GLAR T   D MT YV TRWYRAPE++
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDYGLARHTD--DEMTGYVATRWYRAPEIM 194
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNE 177
           LN   Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSE 253
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 237
           +A+ YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD
Sbjct: 254 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 238 ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 275
             DEPV   P+   FE   L   + K L Y E ++F P
Sbjct: 314 PDDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 350

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score =  268 bits (686), Expect = 2e-72,   Method: Compositional matrix adjust.
 Identities = 136/278 (48%), Positives = 181/278 (65%), Gaps = 8/278 (2%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           M HENV+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILR
Sbjct: 85  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 143
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           GLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T+  D MT YV TRWYRAPE++
Sbjct: 144 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA--DEMTGYVATRWYRAPEIM 201
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNE 177
           LN   Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E
Sbjct: 202 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSE 260
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 237
           +A+ YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD
Sbjct: 261 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 320
Query: 238 ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 275
             DEPV   P+    E   L   + K L Y E ++F P
Sbjct: 321 PDDEPVA-DPYDQSLESRDLLIDEWKSLTYDEVISFVP 357

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score =  268 bits (685), Expect = 2e-72,   Method: Compositional matrix adjust.
 Identities = 137/278 (49%), Positives = 180/278 (64%), Gaps = 8/278 (2%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           M HENV+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILR
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 136
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           GLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIM 194
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNE 177
           LN   Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSE 253
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 237
           +A+ YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD
Sbjct: 254 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 238 ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 275
             DEPV   P    FE   L   + K L Y E ++F P
Sbjct: 314 PDDEPVA-DPTDQSFESRDLLIDEWKSLTYDEVISFVP 350

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score =  268 bits (685), Expect = 3e-72,   Method: Compositional matrix adjust.
 Identities = 136/278 (48%), Positives = 180/278 (64%), Gaps = 8/278 (2%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           M HENV+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILR
Sbjct: 101 MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 159
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           GLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D M  YV TRWYRAPE++
Sbjct: 160 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMXGYVATRWYRAPEIM 217
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNE 177
           LN   Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E
Sbjct: 218 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSE 276
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 237
           +A+ YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD
Sbjct: 277 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 336
Query: 238 ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 275
             DEPV   P+   FE   L   + K L Y E ++F P
Sbjct: 337 PDDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 373

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score =  268 bits (685), Expect = 3e-72,   Method: Compositional matrix adjust.
 Identities = 137/278 (49%), Positives = 180/278 (64%), Gaps = 8/278 (2%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           M HENV+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILR
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 136
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           GLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIM 194
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNE 177
           LN   Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSE 253
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 237
           +A+ YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD
Sbjct: 254 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 238 ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 275
             DEPV   P    FE   L   + K L Y E ++F P
Sbjct: 314 PDDEPVA-DPRDQSFESRDLLIDEWKSLTYDEVISFVP 350

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score =  268 bits (685), Expect = 3e-72,   Method: Compositional matrix adjust.
 Identities = 134/277 (48%), Positives = 180/277 (64%), Gaps = 6/277 (2%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           M HENV+ + D+  P +  E FNDVY+   LM  DL+ I++  + L+++H Q+ +YQILR
Sbjct: 74  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCAK-LTDDHVQFLIYQILR 132
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           GLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++
Sbjct: 133 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIM 190
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL-NEN 178
           LN   Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP    L  + +E+
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 250
Query: 179 AKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDI 238
           A+ YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD 
Sbjct: 251 ARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 310
Query: 239 SDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 275
            DEPV   P+   FE   L   + K L Y E ++F P
Sbjct: 311 DDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 346

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score =  268 bits (684), Expect = 3e-72,   Method: Compositional matrix adjust.
 Identities = 137/278 (49%), Positives = 180/278 (64%), Gaps = 8/278 (2%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           M HENV+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILR
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 136
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           GLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIM 194
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNE 177
           LN   Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSE 253
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 237
           +A+ YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD
Sbjct: 254 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 238 ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 275
             DEPV   P    FE   L   + K L Y E ++F P
Sbjct: 314 PDDEPVA-DPQDQSFESRDLLIDEWKSLTYDEVISFVP 350

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score =  268 bits (684), Expect = 3e-72,   Method: Compositional matrix adjust.
 Identities = 136/278 (48%), Positives = 180/278 (64%), Gaps = 8/278 (2%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           M HENV+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILR
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 136
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           GLKYIHSA+++HRDLKPSNL +N +C+LKI  FGLAR T   D MT YV TRWYRAPE++
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILGFGLARHTD--DEMTGYVATRWYRAPEIM 194
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNE 177
           LN   Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSE 253
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 237
           +A+ YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD
Sbjct: 254 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 238 ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 275
             DEPV   P+   FE   L   + K L Y E ++F P
Sbjct: 314 PDDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 350

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score =  268 bits (684), Expect = 4e-72,   Method: Compositional matrix adjust.
 Identities = 136/278 (48%), Positives = 181/278 (65%), Gaps = 8/278 (2%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           M HENV+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILR
Sbjct: 85  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 143
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           GLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T+  D MT YV TRWYRAPE++
Sbjct: 144 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA--DEMTGYVATRWYRAPEIM 201
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNE 177
           LN   Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E
Sbjct: 202 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSE 260
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 237
           +A+ YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD
Sbjct: 261 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 320
Query: 238 ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 275
             DEPV   P+    E   L   + K L Y E ++F P
Sbjct: 321 PDDEPVA-DPYDQSSESRDLLIDEWKSLTYDEVISFVP 357

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score =  267 bits (682), Expect = 6e-72,   Method: Compositional matrix adjust.
 Identities = 136/278 (48%), Positives = 180/278 (64%), Gaps = 8/278 (2%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           M HENV+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILR
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 136
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           GLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT  V TRWYRAPE++
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGXVATRWYRAPEIM 194
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNE 177
           LN   Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSE 253
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 237
           +A+ YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD
Sbjct: 254 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 238 ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 275
             DEPV   P+   FE   L   + K L Y E ++F P
Sbjct: 314 PDDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 350

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  267 bits (682), Expect = 6e-72,   Method: Compositional matrix adjust.
 Identities = 136/278 (48%), Positives = 180/278 (64%), Gaps = 8/278 (2%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           M HENV+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILR
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 136
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           GLKYIHSA+++HRDLKPSNL +N +C+LKI D GLAR T   D MT YV TRWYRAPE++
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDAGLARHTD--DEMTGYVATRWYRAPEIM 194
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNE 177
           LN   Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSE 253
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 237
           +A+ YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD
Sbjct: 254 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 238 ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 275
             DEPV   P+   FE   L   + K L Y E ++F P
Sbjct: 314 PDDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 350

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  267 bits (682), Expect = 6e-72,   Method: Compositional matrix adjust.
 Identities = 136/278 (48%), Positives = 180/278 (64%), Gaps = 8/278 (2%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           M HENV+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILR
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 136
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           GLKYIHSA+++HRDLKPSNL +N +C+LKI D GLAR T   D MT YV TRWYRAPE++
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDGGLARHTD--DEMTGYVATRWYRAPEIM 194
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNE 177
           LN   Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSE 253
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 237
           +A+ YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD
Sbjct: 254 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 238 ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 275
             DEPV   P+   FE   L   + K L Y E ++F P
Sbjct: 314 PDDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 350

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score =  266 bits (681), Expect = 6e-72,   Method: Compositional matrix adjust.
 Identities = 135/278 (48%), Positives = 180/278 (64%), Gaps = 8/278 (2%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           M HENV+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILR
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 136
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           GLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D M  +V TRWYRAPE++
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMAGFVATRWYRAPEIM 194
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNE 177
           LN   Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSE 253
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 237
           +A+ YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD
Sbjct: 254 SARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 238 ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 275
             DEPV   P+   FE   L   + K L Y E ++F P
Sbjct: 314 PDDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 350

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score =  266 bits (681), Expect = 7e-72,   Method: Compositional matrix adjust.
 Identities = 136/278 (48%), Positives = 180/278 (64%), Gaps = 8/278 (2%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           M HENV+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILR
Sbjct: 84  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 142
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           GLKYIHSA+++HRDLKPSNL +N + +LKI DFGLAR T   D MT YV TRWYRAPE++
Sbjct: 143 GLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLARHTD--DEMTGYVATRWYRAPEIM 200
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNE 177
           LN   Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E
Sbjct: 201 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSE 259
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 237
           +A+ YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD
Sbjct: 260 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 319
Query: 238 ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 275
             DEPV   P+   FE   L   + K L Y E ++F P
Sbjct: 320 PDDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 356

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  266 bits (681), Expect = 7e-72,   Method: Compositional matrix adjust.
 Identities = 136/278 (48%), Positives = 180/278 (64%), Gaps = 8/278 (2%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           M HENV+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILR
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 136
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           GLKYIHSA+++HRDLKPSNL +N +C+LKI D GLAR T   D MT YV TRWYRAPE++
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDRGLARHTD--DEMTGYVATRWYRAPEIM 194
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNE 177
           LN   Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSE 253
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 237
           +A+ YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD
Sbjct: 254 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 238 ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 275
             DEPV   P+   FE   L   + K L Y E ++F P
Sbjct: 314 PDDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 350

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score =  266 bits (681), Expect = 7e-72,   Method: Compositional matrix adjust.
 Identities = 135/278 (48%), Positives = 180/278 (64%), Gaps = 8/278 (2%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           M HENV+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILR
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 136
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           GLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D M  +V TRWYRAPE++
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMAGFVATRWYRAPEIM 194
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNE 177
           LN   Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSE 253
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 237
           +A+ YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD
Sbjct: 254 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 238 ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 275
             DEPV   P+   FE   L   + K L Y E ++F P
Sbjct: 314 PDDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 350

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  266 bits (681), Expect = 7e-72,   Method: Compositional matrix adjust.
 Identities = 136/278 (48%), Positives = 180/278 (64%), Gaps = 8/278 (2%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           M HENV+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILR
Sbjct: 80  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 138
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           GLKYIHSA+++HRDLKPSNL +N + +LKI DFGLAR T   D MT YV TRWYRAPE++
Sbjct: 139 GLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLARHTD--DEMTGYVATRWYRAPEIM 196
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNE 177
           LN   Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E
Sbjct: 197 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSE 255
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 237
           +A+ YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD
Sbjct: 256 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 315
Query: 238 ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 275
             DEPV   P+   FE   L   + K L Y E ++F P
Sbjct: 316 PDDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 352

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  266 bits (681), Expect = 7e-72,   Method: Compositional matrix adjust.
 Identities = 136/278 (48%), Positives = 180/278 (64%), Gaps = 8/278 (2%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           M HENV+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILR
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKX-QKLTDDHVQFLIYQILR 136
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           GLKYIHSA+++HRDLKPSNL +N + +LKI DFGLAR T   D MT YV TRWYRAPE++
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTD--DEMTGYVATRWYRAPEIM 194
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNE 177
           LN   Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSE 253
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 237
           +A+ YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD
Sbjct: 254 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 238 ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 275
             DEPV   P+   FE   L   + K L Y E ++F P
Sbjct: 314 PDDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 350

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score =  266 bits (680), Expect = 1e-71,   Method: Compositional matrix adjust.
 Identities = 133/277 (48%), Positives = 179/277 (64%), Gaps = 6/277 (2%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           M HENV+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILR
Sbjct: 74  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 132
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           GLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D M  +V TRWYRAPE++
Sbjct: 133 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMAGFVATRWYRAPEIM 190
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL-NEN 178
           LN   Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP    L  + +E+
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 250
Query: 179 AKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDI 238
           A+ YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD 
Sbjct: 251 ARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 310
Query: 239 SDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 275
            DEPV   P+   FE   L   + K L Y E ++F P
Sbjct: 311 DDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 346

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score =  266 bits (680), Expect = 1e-71,   Method: Compositional matrix adjust.
 Identities = 136/278 (48%), Positives = 180/278 (64%), Gaps = 8/278 (2%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           M HENV+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILR
Sbjct: 83  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 141
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           GLKYIHSA+++HRDLKPSNL +N + +LKI DFGLAR T   D MT YV TRWYRAPE++
Sbjct: 142 GLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTD--DEMTGYVATRWYRAPEIM 199
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNE 177
           LN   Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E
Sbjct: 200 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSE 258
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 237
           +A+ YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD
Sbjct: 259 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 318
Query: 238 ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 275
             DEPV   P+   FE   L   + K L Y E ++F P
Sbjct: 319 PDDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 355

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score =  266 bits (679), Expect = 1e-71,   Method: Compositional matrix adjust.
 Identities = 136/278 (48%), Positives = 180/278 (64%), Gaps = 8/278 (2%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           M HENV+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILR
Sbjct: 89  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 147
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           GLKYIHSA+++HRDLKPSNL +N + +LKI DFGLAR T   D MT YV TRWYRAPE++
Sbjct: 148 GLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTD--DEMTGYVATRWYRAPEIM 205
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNE 177
           LN   Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E
Sbjct: 206 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSE 264
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 237
           +A+ YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD
Sbjct: 265 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 324
Query: 238 ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 275
             DEPV   P+   FE   L   + K L Y E ++F P
Sbjct: 325 PDDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 361

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score =  266 bits (679), Expect = 1e-71,   Method: Compositional matrix adjust.
 Identities = 136/278 (48%), Positives = 180/278 (64%), Gaps = 8/278 (2%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           M HENV+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILR
Sbjct: 83  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 141
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           GLKYIHSA+++HRDLKPSNL +N + +LKI DFGLAR T   D MT YV TRWYRAPE++
Sbjct: 142 GLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTD--DEMTGYVATRWYRAPEIM 199
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNE 177
           LN   Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E
Sbjct: 200 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSE 258
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 237
           +A+ YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD
Sbjct: 259 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 318
Query: 238 ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 275
             DEPV   P+   FE   L   + K L Y E ++F P
Sbjct: 319 PDDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 355

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score =  266 bits (679), Expect = 1e-71,   Method: Compositional matrix adjust.
 Identities = 132/275 (48%), Positives = 180/275 (65%), Gaps = 6/275 (2%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           M HENV+ + D+  P    E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILR
Sbjct: 107 MKHENVIGLLDVFTPATSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 165
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           GLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D MT YV TRWYRAPE++
Sbjct: 166 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMTGYVATRWYRAPEIM 223
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL-NEN 178
           LN   Y   +D+WSVGCI  EL+  + LFPG DH++QL+ ++ L GTP  + +  + +  
Sbjct: 224 LNWMHYNMTVDIWSVGCIMAELLTGRTLFPGTDHINQLQQIMRLTGTPPASVISRMPSHE 283
Query: 179 AKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDI 238
           A+ YI  LP+  +++F + F   +P A+DL+EKML  D  +RIT  +ALAHPY    HD 
Sbjct: 284 ARNYINSLPQMPKRNFADVFIGANPLAVDLLEKMLVLDTDKRITASEALAHPYFSQYHDP 343
Query: 239 SDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAF 273
            DEP    P+   FE   L   + K L Y+E  +F
Sbjct: 344 DDEPES-EPYDQSFESRQLEIEEWKRLTYEEVCSF 377

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score =  266 bits (679), Expect = 1e-71,   Method: Compositional matrix adjust.
 Identities = 136/278 (48%), Positives = 180/278 (64%), Gaps = 8/278 (2%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           M HENV+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILR
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 136
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           GLKYIHSA+++HRDLKPSNL +N +C+LKI DF LAR T   D MT YV TRWYRAPE++
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFYLARHTD--DEMTGYVATRWYRAPEIM 194
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNE 177
           LN   Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSE 253
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 237
           +A+ YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD
Sbjct: 254 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 238 ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 275
             DEPV   P+   FE   L   + K L Y E ++F P
Sbjct: 314 PDDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 350

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score =  264 bits (675), Expect = 3e-71,   Method: Compositional matrix adjust.
 Identities = 135/278 (48%), Positives = 179/278 (64%), Gaps = 8/278 (2%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           M HENV+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILR
Sbjct: 98  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 156
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           GLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T   D M   V TRWYRAPE++
Sbjct: 157 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD--DEMXGXVATRWYRAPEIM 214
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNE 177
           LN   Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E
Sbjct: 215 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSE 273
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 237
           +A+ YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD
Sbjct: 274 SARNYIQSLAQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 333
Query: 238 ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 275
             DEPV   P+   FE   L   + K L Y E ++F P
Sbjct: 334 PDDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 370

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score =  264 bits (675), Expect = 3e-71,   Method: Compositional matrix adjust.
 Identities = 135/278 (48%), Positives = 179/278 (64%), Gaps = 8/278 (2%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           M HENV+ + D+  P +  E FNDVY+   LM  DL+ I++S Q L+++H Q+ +YQILR
Sbjct: 78  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKS-QKLTDDHVQFLIYQILR 136
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           GLKYIHSA+++HRDLKPSNL +N + +LKI DFGL R T   D MT YV TRWYRAPE++
Sbjct: 137 GLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLCRHTD--DEMTGYVATRWYRAPEIM 194
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL--GFLNE 177
           LN   Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP  AEL     +E
Sbjct: 195 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPG-AELLKKISSE 253
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 237
           +A+ YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD
Sbjct: 254 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHD 313
Query: 238 ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 275
             DEPV   P+    E   L   + K L Y E ++F P
Sbjct: 314 PDDEPVA-DPYDQSLESRDLLIDEWKSLTYDEVISFVP 350

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score =  261 bits (666), Expect = 4e-70,   Method: Compositional matrix adjust.
 Identities = 130/277 (46%), Positives = 179/277 (64%), Gaps = 6/277 (2%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           + HENV+ + D+  P    E F++VY+   LM  DL+ I++  QALS+EH Q+ +YQ+LR
Sbjct: 76  LKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKC-QALSDEHVQFLVYQLLR 134
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           GLKYIHSA ++HRDLKPSN+ +N +C+L+I DFGLAR   E   MT YV TRWYRAPE++
Sbjct: 135 GLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADEE--MTGYVATRWYRAPEIM 192
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL-NEN 178
           LN   Y   +D+WSVGCI  EL+  K LFPG D++ QL+ ++E++GTPS   L  + +E+
Sbjct: 193 LNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEH 252
Query: 179 AKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDI 238
           A+ YI  LP   ++  +  F   +P AIDL+ +ML  D  QR++  +ALAH Y    HD 
Sbjct: 253 ARTYIQSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDP 312
Query: 239 SDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 275
            DEP    P+    E    T  + KEL YQE L+F P
Sbjct: 313 EDEPEA-EPYDESVEAKERTLEEWKELTYQEVLSFKP 348

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score =  257 bits (656), Expect = 6e-69,   Method: Compositional matrix adjust.
 Identities = 129/275 (46%), Positives = 178/275 (64%), Gaps = 6/275 (2%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           + HENV+ + D+  P    E F++VY+   LM  DL+ I++S QALS+EH Q+ +YQ+LR
Sbjct: 84  LKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKS-QALSDEHVQFLVYQLLR 142
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           GLKYIHSA ++HRDLKPSN+ +N + +L+I DFGLAR   E   MT YV TRWYRAPE++
Sbjct: 143 GLKYIHSAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEE--MTGYVATRWYRAPEIM 200
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL-NEN 178
           LN   Y   +D+WSVGCI  EL+  K LFPG D++ QL+ ++E++GTPS   L  + +E+
Sbjct: 201 LNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEH 260
Query: 179 AKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDI 238
           A+ YI  LP   ++  +  F   +P AIDL+ +ML  D  QR++  +ALAH Y    HD 
Sbjct: 261 ARTYIQSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDP 320
Query: 239 SDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAF 273
            DEP    P+    E    T  + KEL YQE L+F
Sbjct: 321 EDEPEA-EPYDESVEAKERTLEEWKELTYQEVLSF 354

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score =  254 bits (649), Expect = 4e-68,   Method: Compositional matrix adjust.
 Identities = 128/275 (46%), Positives = 177/275 (64%), Gaps = 6/275 (2%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           + HENV+ + D+  P    E F++VY+   LM  DL+ I++  QALS+EH Q+ +YQ+LR
Sbjct: 84  LKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKC-QALSDEHVQFLVYQLLR 142
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           GLKYIHSA ++HRDLKPSN+ +N + +L+I DFGLAR   E   MT YV TRWYRAPE++
Sbjct: 143 GLKYIHSAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEE--MTGYVATRWYRAPEIM 200
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL-NEN 178
           LN   Y   +D+WSVGCI  EL+  K LFPG D++ QL+ ++E++GTPS   L  + +E+
Sbjct: 201 LNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEH 260
Query: 179 AKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDI 238
           A+ YI  LP   ++  +  F   +P AIDL+ +ML  D  QR++  +ALAH Y    HD 
Sbjct: 261 ARTYIQSLPPMPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQYHDP 320
Query: 239 SDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAF 273
            DEP    P+    E    T  + KEL YQE L+F
Sbjct: 321 EDEPEA-EPYDESVEAKERTLEEWKELTYQEVLSF 354

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score =  243 bits (621), Expect = 7e-65,   Method: Compositional matrix adjust.
 Identities = 124/277 (44%), Positives = 167/277 (60%), Gaps = 6/277 (2%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           M HENV+ + D+  P     +F D Y+    M TDL +I+      SEE  QY +YQ+L+
Sbjct: 98  MQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIM--GMEFSEEKIQYLVYQMLK 155
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           GLKYIHSA V+HRDLKP NL +N +C+LKI DFGLAR       MT YVVTRWYRAPE++
Sbjct: 156 GLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE--MTGYVVTRWYRAPEVI 213
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNEN- 178
           L+   Y   +D+WSVGCI  E++  K LF G+D++ QL  ++++ G P    +  LN+  
Sbjct: 214 LSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKA 273
Query: 179 AKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDI 238
           AK YI  LP+  R+ FT+ FP   P A DL+EKML  D  +R+T   AL HP+     D 
Sbjct: 274 AKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDP 333
Query: 239 SDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 275
            +E     PF    E   LT  + K+ IY+E + F+P
Sbjct: 334 EEETEAQQPFDDSLEHEKLTVDEWKQHIYKEIVNFSP 370

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score =  243 bits (620), Expect = 9e-65,   Method: Compositional matrix adjust.
 Identities = 124/277 (44%), Positives = 167/277 (60%), Gaps = 6/277 (2%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           M HENV+ + D+  P     +F D Y+    M TDL +I+      SEE  QY +YQ+L+
Sbjct: 80  MQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIM--GLKFSEEKIQYLVYQMLK 137
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           GLKYIHSA V+HRDLKP NL +N +C+LKI DFGLAR       MT YVVTRWYRAPE++
Sbjct: 138 GLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE--MTGYVVTRWYRAPEVI 195
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNEN- 178
           L+   Y   +D+WSVGCI  E++  K LF G+D++ QL  ++++ G P    +  LN+  
Sbjct: 196 LSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKA 255
Query: 179 AKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDI 238
           AK YI  LP+  R+ FT+ FP   P A DL+EKML  D  +R+T   AL HP+     D 
Sbjct: 256 AKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDP 315
Query: 239 SDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 275
            +E     PF    E   LT  + K+ IY+E + F+P
Sbjct: 316 EEETEAQQPFDDSLEHEKLTVDEWKQHIYKEIVNFSP 352

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score =  241 bits (616), Expect = 2e-64,   Method: Compositional matrix adjust.
 Identities = 123/278 (44%), Positives = 174/278 (62%), Gaps = 8/278 (2%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           M HENV+ + D+  P +  + F D Y+    M TDL ++++ ++ L E+  Q+ +YQ+L+
Sbjct: 81  MRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK-HEKLGEDRIQFLVYQMLK 139
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           GL+YIH+A ++HRDLKP NL +N +C+LKI DFGLAR       M   VVTRWYRAPE++
Sbjct: 140 GLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE--MXGXVVTRWYRAPEVI 197
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGT-PSEAELGFLNEN 178
           LN   YT  +D+WSVGCI  E++  K LF G DH+ QL+ ++++ GT P+E      ++ 
Sbjct: 198 LNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 257
Query: 179 AKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDI 238
           AK Y+  LP  +++ F     N  P A++L+EKML  D  QR+T  +ALAHPY  SLHD 
Sbjct: 258 AKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT 317
Query: 239 SDEP-VCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 275
            DEP V     SFD     L E   K + Y+E L+F P
Sbjct: 318 EDEPQVQKYDDSFDDVDRTLDE--WKRVTYKEVLSFKP 353

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  218 bits (555), Expect = 3e-57,   Method: Compositional matrix adjust.
 Identities = 117/287 (40%), Positives = 170/287 (59%), Gaps = 21/287 (7%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           ++H+N++ + ++  P +  E F DVYI  ELMD +L Q+I+    L  E   Y LYQ+L 
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ--MELDHERMSYLLYQMLC 137
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           G+K++HSA ++HRDLKPSN+++ ++C LKI DFGLAR    +  MT YVVTR+YRAPE++
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENA 179
           L    Y   +D+WSVGCI  E++    LFPG DH+ Q   +IE +GTPS   +  L    
Sbjct: 198 LGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTV 256
Query: 180 KKYICQLPRYQRQSFTEKFPNV------------HPSAIDLVEKMLTFDPRQRITVEDAL 227
           + Y+   P+Y   SF + FP+V               A DL+ KML  D  +RI+V++AL
Sbjct: 257 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 316
Query: 228 AHPYLGSLHDISDE---PVCMSPFSFDFEQHALTEGQMKELIYQEAL 271
            HPY+   +D S+    P  +     D  +H + E   KELIY+E +
Sbjct: 317 QHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEE--WKELIYKEVM 361

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  217 bits (552), Expect = 6e-57,   Method: Compositional matrix adjust.
 Identities = 117/287 (40%), Positives = 170/287 (59%), Gaps = 21/287 (7%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           ++H+N++ + ++  P +  E F DVYI  ELMD +L Q+I+    L  E   Y LYQ+L 
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLC 137
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           G+K++HSA ++HRDLKPSN+++ ++C LKI DFGLAR    +  MT YVVTR+YRAPE++
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENA 179
           L    Y   +D+WSVGCI  E++    LFPG DH+ Q   +IE +GTPS   +  L    
Sbjct: 198 LGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTV 256
Query: 180 KKYICQLPRYQRQSFTEKFPNV------------HPSAIDLVEKMLTFDPRQRITVEDAL 227
           + Y+   P+Y   SF + FP+V               A DL+ KML  D  +RI+V++AL
Sbjct: 257 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 316
Query: 228 AHPYLGSLHDISDE---PVCMSPFSFDFEQHALTEGQMKELIYQEAL 271
            HPY+   +D S+    P  +     D  +H + E   KELIY+E +
Sbjct: 317 QHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEE--WKELIYKEVM 361

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  216 bits (551), Expect = 9e-57,   Method: Compositional matrix adjust.
 Identities = 116/287 (40%), Positives = 169/287 (58%), Gaps = 21/287 (7%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           ++H+N++ + ++  P +  E F DVYI  ELMD +L Q+I+    L  E   Y LYQ+L 
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ--MELDHERMSYLLYQMLV 137
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           G+K++HSA ++HRDLKPSN+++ ++  LKI DFGLAR    +  MT YVVTR+YRAPE++
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENA 179
           L    Y   +D+WSVGCI  E++    LFPG DH+ Q   +IE +GTPS   +  L    
Sbjct: 198 LGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTV 256
Query: 180 KKYICQLPRYQRQSFTEKFPNV------------HPSAIDLVEKMLTFDPRQRITVEDAL 227
           + Y+   P+Y   SF + FP+V               A DL+ KML  D  +RI+V++AL
Sbjct: 257 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 316
Query: 228 AHPYLGSLHDISDE---PVCMSPFSFDFEQHALTEGQMKELIYQEAL 271
            HPY+   +D S+    P  +     D  +H + E   KELIY+E +
Sbjct: 317 QHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEE--WKELIYKEVM 361

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score =  216 bits (550), Expect = 1e-56,   Method: Compositional matrix adjust.
 Identities = 116/287 (40%), Positives = 174/287 (60%), Gaps = 21/287 (7%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           ++H+N++++ ++  P +  E F DVY+  ELMD +L Q+I+    L  E   Y LYQ+L 
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLC 137
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           G+K++HSA ++HRDLKPSN+++ ++C LKI DFGLAR    +  MT YVVTR+YRAPE++
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENA 179
           L    Y   +D+WSVGCI  E++  K LFPGRD++ Q   +IE +GTP    +  L    
Sbjct: 198 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 256
Query: 180 KKYICQLPRYQRQSFTEKFPN-VHPS-----------AIDLVEKMLTFDPRQRITVEDAL 227
           + Y+   P+Y   +F + FP+ + P+           A DL+ KML  DP +RI+V+DAL
Sbjct: 257 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 316
Query: 228 AHPYLGSLHD---ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEAL 271
            HPY+   +D   +   P  +     D  +H + E   KELIY+E +
Sbjct: 317 QHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEE--WKELIYKEVM 361

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score =  216 bits (550), Expect = 1e-56,   Method: Compositional matrix adjust.
 Identities = 116/287 (40%), Positives = 174/287 (60%), Gaps = 21/287 (7%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           ++H+N++++ ++  P +  E F DVY+  ELMD +L Q+I+    L  E   Y LYQ+L 
Sbjct: 81  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLC 138
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           G+K++HSA ++HRDLKPSN+++ ++C LKI DFGLAR    +  MT YVVTR+YRAPE++
Sbjct: 139 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 198
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENA 179
           L    Y   +D+WSVGCI  E++  K LFPGRD++ Q   +IE +GTP    +  L    
Sbjct: 199 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 257
Query: 180 KKYICQLPRYQRQSFTEKFPN-VHPS-----------AIDLVEKMLTFDPRQRITVEDAL 227
           + Y+   P+Y   +F + FP+ + P+           A DL+ KML  DP +RI+V+DAL
Sbjct: 258 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 317
Query: 228 AHPYLGSLHD---ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEAL 271
            HPY+   +D   +   P  +     D  +H + E   KELIY+E +
Sbjct: 318 QHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEE--WKELIYKEVM 362

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score =  216 bits (549), Expect = 1e-56,   Method: Compositional matrix adjust.
 Identities = 116/287 (40%), Positives = 174/287 (60%), Gaps = 21/287 (7%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           ++H+N++++ ++  P +  E F DVY+  ELMD +L Q+I+    L  E   Y LYQ+L 
Sbjct: 118 VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLC 175
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           G+K++HSA ++HRDLKPSN+++ ++C LKI DFGLAR    +  MT YVVTR+YRAPE++
Sbjct: 176 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 235
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENA 179
           L    Y   +D+WSVGCI  E++  K LFPGRD++ Q   +IE +GTP    +  L    
Sbjct: 236 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 294
Query: 180 KKYICQLPRYQRQSFTEKFPN-VHPS-----------AIDLVEKMLTFDPRQRITVEDAL 227
           + Y+   P+Y   +F + FP+ + P+           A DL+ KML  DP +RI+V+DAL
Sbjct: 295 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 354
Query: 228 AHPYLGSLHD---ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEAL 271
            HPY+   +D   +   P  +     D  +H + E   KELIY+E +
Sbjct: 355 QHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEE--WKELIYKEVM 399

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score =  216 bits (549), Expect = 1e-56,   Method: Compositional matrix adjust.
 Identities = 116/287 (40%), Positives = 174/287 (60%), Gaps = 21/287 (7%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           ++H+N++++ ++  P +  E F DVY+  ELMD +L Q+I+    L  E   Y LYQ+L 
Sbjct: 79  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLC 136
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           G+K++HSA ++HRDLKPSN+++ ++C LKI DFGLAR    +  MT YVVTR+YRAPE++
Sbjct: 137 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 196
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENA 179
           L    Y   +D+WSVGCI  E++  K LFPGRD++ Q   +IE +GTP    +  L    
Sbjct: 197 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 255
Query: 180 KKYICQLPRYQRQSFTEKFPN-VHPS-----------AIDLVEKMLTFDPRQRITVEDAL 227
           + Y+   P+Y   +F + FP+ + P+           A DL+ KML  DP +RI+V+DAL
Sbjct: 256 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 315
Query: 228 AHPYLGSLHD---ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEAL 271
            HPY+   +D   +   P  +     D  +H + E   KELIY+E +
Sbjct: 316 QHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEE--WKELIYKEVM 360

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score =  216 bits (549), Expect = 1e-56,   Method: Compositional matrix adjust.
 Identities = 116/287 (40%), Positives = 174/287 (60%), Gaps = 21/287 (7%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           ++H+N++++ ++  P +  E F DVY+  ELMD +L Q+I+    L  E   Y LYQ+L 
Sbjct: 118 VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLC 175
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           G+K++HSA ++HRDLKPSN+++ ++C LKI DFGLAR    +  MT YVVTR+YRAPE++
Sbjct: 176 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 235
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENA 179
           L    Y   +D+WSVGCI  E++  K LFPGRD++ Q   +IE +GTP    +  L    
Sbjct: 236 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 294
Query: 180 KKYICQLPRYQRQSFTEKFPN-VHPS-----------AIDLVEKMLTFDPRQRITVEDAL 227
           + Y+   P+Y   +F + FP+ + P+           A DL+ KML  DP +RI+V+DAL
Sbjct: 295 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 354
Query: 228 AHPYLGSLHD---ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEAL 271
            HPY+   +D   +   P  +     D  +H + E   KELIY+E +
Sbjct: 355 QHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEE--WKELIYKEVM 399

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score =  216 bits (549), Expect = 1e-56,   Method: Compositional matrix adjust.
 Identities = 116/287 (40%), Positives = 174/287 (60%), Gaps = 21/287 (7%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           ++H+N++++ ++  P +  E F DVY+  ELMD +L Q+I+    L  E   Y LYQ+L 
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLC 137
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           G+K++HSA ++HRDLKPSN+++ ++C LKI DFGLAR    +  MT YVVTR+YRAPE++
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENA 179
           L    Y   +D+WSVGCI  E++  K LFPGRD++ Q   +IE +GTP    +  L    
Sbjct: 198 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 256
Query: 180 KKYICQLPRYQRQSFTEKFPN-VHPS-----------AIDLVEKMLTFDPRQRITVEDAL 227
           + Y+   P+Y   +F + FP+ + P+           A DL+ KML  DP +RI+V+DAL
Sbjct: 257 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 316
Query: 228 AHPYLGSLHD---ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEAL 271
            HPY+   +D   +   P  +     D  +H + E   KELIY+E +
Sbjct: 317 QHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEE--WKELIYKEVM 361

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score =  216 bits (549), Expect = 1e-56,   Method: Compositional matrix adjust.
 Identities = 116/287 (40%), Positives = 174/287 (60%), Gaps = 21/287 (7%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           ++H+N++++ ++  P +  E F DVY+  ELMD +L Q+I+    L  E   Y LYQ+L 
Sbjct: 81  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLC 138
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           G+K++HSA ++HRDLKPSN+++ ++C LKI DFGLAR    +  MT YVVTR+YRAPE++
Sbjct: 139 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 198
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENA 179
           L    Y   +D+WSVGCI  E++  K LFPGRD++ Q   +IE +GTP    +  L    
Sbjct: 199 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 257
Query: 180 KKYICQLPRYQRQSFTEKFPN-VHPS-----------AIDLVEKMLTFDPRQRITVEDAL 227
           + Y+   P+Y   +F + FP+ + P+           A DL+ KML  DP +RI+V+DAL
Sbjct: 258 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 317
Query: 228 AHPYLGSLHD---ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEAL 271
            HPY+   +D   +   P  +     D  +H + E   KELIY+E +
Sbjct: 318 QHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEE--WKELIYKEVM 362

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score =  216 bits (549), Expect = 1e-56,   Method: Compositional matrix adjust.
 Identities = 116/287 (40%), Positives = 174/287 (60%), Gaps = 21/287 (7%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           ++H+N++++ ++  P +  E F DVY+  ELMD +L Q+I+    L  E   Y LYQ+L 
Sbjct: 74  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLC 131
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           G+K++HSA ++HRDLKPSN+++ ++C LKI DFGLAR    +  MT YVVTR+YRAPE++
Sbjct: 132 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 191
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENA 179
           L    Y   +D+WSVGCI  E++  K LFPGRD++ Q   +IE +GTP    +  L    
Sbjct: 192 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 250
Query: 180 KKYICQLPRYQRQSFTEKFPN-VHPS-----------AIDLVEKMLTFDPRQRITVEDAL 227
           + Y+   P+Y   +F + FP+ + P+           A DL+ KML  DP +RI+V+DAL
Sbjct: 251 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 310
Query: 228 AHPYLGSLHD---ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEAL 271
            HPY+   +D   +   P  +     D  +H + E   KELIY+E +
Sbjct: 311 QHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEE--WKELIYKEVM 355

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score =  216 bits (549), Expect = 1e-56,   Method: Compositional matrix adjust.
 Identities = 116/287 (40%), Positives = 174/287 (60%), Gaps = 21/287 (7%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           ++H+N++++ ++  P +  E F DVY+  ELMD +L Q+I+    L  E   Y LYQ+L 
Sbjct: 73  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLC 130
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           G+K++HSA ++HRDLKPSN+++ ++C LKI DFGLAR    +  MT YVVTR+YRAPE++
Sbjct: 131 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 190
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENA 179
           L    Y   +D+WSVGCI  E++  K LFPGRD++ Q   +IE +GTP    +  L    
Sbjct: 191 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249
Query: 180 KKYICQLPRYQRQSFTEKFPN-VHPS-----------AIDLVEKMLTFDPRQRITVEDAL 227
           + Y+   P+Y   +F + FP+ + P+           A DL+ KML  DP +RI+V+DAL
Sbjct: 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 309
Query: 228 AHPYLGSLHD---ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEAL 271
            HPY+   +D   +   P  +     D  +H + E   KELIY+E +
Sbjct: 310 QHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEE--WKELIYKEVM 354

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score =  216 bits (549), Expect = 2e-56,   Method: Compositional matrix adjust.
 Identities = 116/287 (40%), Positives = 174/287 (60%), Gaps = 21/287 (7%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           ++H+N++++ ++  P +  E F DVY+  ELMD +L Q+I+    L  E   Y LYQ+L 
Sbjct: 74  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLC 131
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           G+K++HSA ++HRDLKPSN+++ ++C LKI DFGLAR    +  MT YVVTR+YRAPE++
Sbjct: 132 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 191
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENA 179
           L    Y   +D+WSVGCI  E++  K LFPGRD++ Q   +IE +GTP    +  L    
Sbjct: 192 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 250
Query: 180 KKYICQLPRYQRQSFTEKFPN-VHPS-----------AIDLVEKMLTFDPRQRITVEDAL 227
           + Y+   P+Y   +F + FP+ + P+           A DL+ KML  DP +RI+V+DAL
Sbjct: 251 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 310
Query: 228 AHPYLGSLHD---ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEAL 271
            HPY+   +D   +   P  +     D  +H + E   KELIY+E +
Sbjct: 311 QHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEE--WKELIYKEVM 355

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  215 bits (547), Expect = 2e-56,   Method: Compositional matrix adjust.
 Identities = 116/287 (40%), Positives = 169/287 (58%), Gaps = 21/287 (7%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           ++H+N++ + ++  P +  E F DVYI  ELMD +L Q+I+    L  E   Y LYQ+L 
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ--MELDHERMSYLLYQMLC 137
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           G+K++HSA ++HRDLKPSN+++ ++  LKI DFGLAR    +  MT YVVTR+YRAPE++
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENA 179
           L    Y   +D+WSVGCI  E++    LFPG DH+ Q   +IE +GTPS   +  L    
Sbjct: 198 LGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTV 256
Query: 180 KKYICQLPRYQRQSFTEKFPNV------------HPSAIDLVEKMLTFDPRQRITVEDAL 227
           + Y+   P+Y   SF + FP+V               A DL+ KML  D  +RI+V++AL
Sbjct: 257 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 316
Query: 228 AHPYLGSLHDISDE---PVCMSPFSFDFEQHALTEGQMKELIYQEAL 271
            HPY+   +D S+    P  +     D  +H + E   KELIY+E +
Sbjct: 317 QHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEE--WKELIYKEVM 361

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score =  215 bits (547), Expect = 2e-56,   Method: Compositional matrix adjust.
 Identities = 117/287 (40%), Positives = 171/287 (59%), Gaps = 21/287 (7%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           ++H+N++ + ++  P +  E F DVYI  ELMD +L Q+I+    L  E   Y LYQ+L 
Sbjct: 85  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLC 142
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           G+K++HSA ++HRDLKPSN+++ ++C LKI DFGLAR    +  MT YVVTR+YRAPE++
Sbjct: 143 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 202
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENA 179
           L    Y   +D+WSVGCI  E++  K LFPGRD++ Q   +IE +GTP    +  L    
Sbjct: 203 LGMG-YKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 261
Query: 180 KKYICQLPRYQRQSFTEKFPNV------------HPSAIDLVEKMLTFDPRQRITVEDAL 227
           + Y+   P+Y   SF + FP+V               A DL+ KML  D  +RI+V++AL
Sbjct: 262 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 321
Query: 228 AHPYLGSLHDISDE---PVCMSPFSFDFEQHALTEGQMKELIYQEAL 271
            HPY+   +D S+    P  +     D  +H + E   KELIY+E +
Sbjct: 322 QHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEE--WKELIYKEVM 366

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score =  215 bits (547), Expect = 2e-56,   Method: Compositional matrix adjust.
 Identities = 117/287 (40%), Positives = 171/287 (59%), Gaps = 21/287 (7%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           ++H+N++ + ++  P +  E F DVYI  ELMD +L Q+I+    L  E   Y LYQ+L 
Sbjct: 74  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLC 131
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           G+K++HSA ++HRDLKPSN+++ ++C LKI DFGLAR    +  MT YVVTR+YRAPE++
Sbjct: 132 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 191
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENA 179
           L    Y   +D+WSVGCI  E++  K LFPGRD++ Q   +IE +GTP    +  L    
Sbjct: 192 LGMG-YKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 250
Query: 180 KKYICQLPRYQRQSFTEKFPNV------------HPSAIDLVEKMLTFDPRQRITVEDAL 227
           + Y+   P+Y   SF + FP+V               A DL+ KML  D  +RI+V++AL
Sbjct: 251 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 310
Query: 228 AHPYLGSLHDISDE---PVCMSPFSFDFEQHALTEGQMKELIYQEAL 271
            HPY+   +D S+    P  +     D  +H + E   KELIY+E +
Sbjct: 311 QHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEE--WKELIYKEVM 355

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  215 bits (547), Expect = 2e-56,   Method: Compositional matrix adjust.
 Identities = 116/287 (40%), Positives = 169/287 (58%), Gaps = 21/287 (7%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           ++H+N++ + ++  P +  E F DVYI  ELMD +L Q+I+    L  E   Y LYQ+L 
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ--MELDHERMSYLLYQMLC 137
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           G+K++HSA ++HRDLKPSN+++ ++  LKI DFGLAR    +  MT YVVTR+YRAPE++
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENA 179
           L    Y   +D+WSVGCI  E++    LFPG DH+ Q   +IE +GTPS   +  L    
Sbjct: 198 LGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTV 256
Query: 180 KKYICQLPRYQRQSFTEKFPNV------------HPSAIDLVEKMLTFDPRQRITVEDAL 227
           + Y+   P+Y   SF + FP+V               A DL+ KML  D  +RI+V++AL
Sbjct: 257 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 316
Query: 228 AHPYLGSLHDISDE---PVCMSPFSFDFEQHALTEGQMKELIYQEAL 271
            HPY+   +D S+    P  +     D  +H + E   KELIY+E +
Sbjct: 317 QHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEE--WKELIYKEVM 361

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score =  215 bits (547), Expect = 3e-56,   Method: Compositional matrix adjust.
 Identities = 116/287 (40%), Positives = 169/287 (58%), Gaps = 21/287 (7%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           ++H+N++ + ++  P +  E F DVYI  ELMD +L Q+I+    L  E   Y LYQ+L 
Sbjct: 81  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLC 138
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           G+K++HSA ++HRDLKPSN+++ ++C LKI DFGLAR    +  MT YVVTR+YRAPE++
Sbjct: 139 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 198
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENA 179
           L    Y   +D+WSVGCI  E++    LFPG DH+ Q   +IE +GTP    +  L    
Sbjct: 199 LGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 257
Query: 180 KKYICQLPRYQRQSFTEKFPNV------------HPSAIDLVEKMLTFDPRQRITVEDAL 227
           + Y+   P+Y   SF + FP+V               A DL+ KML  D  +RI+V++AL
Sbjct: 258 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 317
Query: 228 AHPYLGSLHDISDE---PVCMSPFSFDFEQHALTEGQMKELIYQEAL 271
            HPY+   +D S+    P  +     D  +H + E   KELIY+E +
Sbjct: 318 QHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEE--WKELIYKEVM 362

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score =  215 bits (547), Expect = 3e-56,   Method: Compositional matrix adjust.
 Identities = 116/287 (40%), Positives = 169/287 (58%), Gaps = 21/287 (7%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           ++H+N++ + ++  P +  E F DVYI  ELMD +L Q+I+    L  E   Y LYQ+L 
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLC 137
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           G+K++HSA ++HRDLKPSN+++ ++C LKI DFGLAR    +  MT YVVTR+YRAPE++
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENA 179
           L    Y   +D+WSVGCI  E++    LFPG DH+ Q   +IE +GTP    +  L    
Sbjct: 198 LGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 256
Query: 180 KKYICQLPRYQRQSFTEKFPNV------------HPSAIDLVEKMLTFDPRQRITVEDAL 227
           + Y+   P+Y   SF + FP+V               A DL+ KML  D  +RI+V++AL
Sbjct: 257 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 316
Query: 228 AHPYLGSLHDISDE---PVCMSPFSFDFEQHALTEGQMKELIYQEAL 271
            HPY+   +D S+    P  +     D  +H + E   KELIY+E +
Sbjct: 317 QHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEE--WKELIYKEVM 361

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score =  214 bits (546), Expect = 4e-56,   Method: Compositional matrix adjust.
 Identities = 115/287 (40%), Positives = 173/287 (60%), Gaps = 21/287 (7%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           ++H+N++++ ++  P +  E F DVY+  ELMD +L Q+I+    L  E   Y LYQ+L 
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQ--MELDHERMSYLLYQMLX 137
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           G+K++HSA ++HRDLKPSN+++ ++  LKI DFGLAR    +  MT YVVTR+YRAPE++
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENA 179
           L    Y   +D+WSVGCI  E++  K LFPGRD++ Q   +IE +GTP    +  L    
Sbjct: 198 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 256
Query: 180 KKYICQLPRYQRQSFTEKFPN-VHPS-----------AIDLVEKMLTFDPRQRITVEDAL 227
           + Y+   P+Y   +F + FP+ + P+           A DL+ KML  DP +RI+V+DAL
Sbjct: 257 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 316
Query: 228 AHPYLGSLHD---ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEAL 271
            HPY+   +D   +   P  +     D  +H + E   KELIY+E +
Sbjct: 317 QHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEE--WKELIYKEVM 361

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score =  214 bits (545), Expect = 4e-56,   Method: Compositional matrix adjust.
 Identities = 115/287 (40%), Positives = 173/287 (60%), Gaps = 21/287 (7%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           ++H+N++++ ++  P +  E F DVY+  ELMD +L Q+I+    L  E   Y LYQ+L 
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQ--MELDHERMSYLLYQMLX 137
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           G+K++HSA ++HRDLKPSN+++ ++  LKI DFGLAR    +  MT YVVTR+YRAPE++
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENA 179
           L    Y   +D+WSVGCI  E++  K LFPGRD++ Q   +IE +GTP    +  L    
Sbjct: 198 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 256
Query: 180 KKYICQLPRYQRQSFTEKFPN-VHPS-----------AIDLVEKMLTFDPRQRITVEDAL 227
           + Y+   P+Y   +F + FP+ + P+           A DL+ KML  DP +RI+V+DAL
Sbjct: 257 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 316
Query: 228 AHPYLGSLHD---ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEAL 271
            HPY+   +D   +   P  +     D  +H + E   KELIY+E +
Sbjct: 317 QHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEE--WKELIYKEVM 361

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score =  214 bits (544), Expect = 6e-56,   Method: Compositional matrix adjust.
 Identities = 115/287 (40%), Positives = 173/287 (60%), Gaps = 21/287 (7%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           ++H+N++++ ++  P +  E F DVY+  ELMD +L Q+I+    L  E   Y LYQ+L 
Sbjct: 73  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQ--MELDHERMSYLLYQMLX 130
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           G+K++HSA ++HRDLKPSN+++ ++  LKI DFGLAR    +  MT YVVTR+YRAPE++
Sbjct: 131 GIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 190
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENA 179
           L    Y   +D+WSVGCI  E++  K LFPGRD++ Q   +IE +GTP    +  L    
Sbjct: 191 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249
Query: 180 KKYICQLPRYQRQSFTEKFPN-VHPS-----------AIDLVEKMLTFDPRQRITVEDAL 227
           + Y+   P+Y   +F + FP+ + P+           A DL+ KML  DP +RI+V+DAL
Sbjct: 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 309
Query: 228 AHPYLGSLHD---ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEAL 271
            HPY+   +D   +   P  +     D  +H + E   KELIY+E +
Sbjct: 310 QHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEE--WKELIYKEVM 354

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  213 bits (543), Expect = 8e-56,   Method: Compositional matrix adjust.
 Identities = 115/287 (40%), Positives = 168/287 (58%), Gaps = 21/287 (7%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           ++H+N++ + ++  P +  E F DVYI  ELMD +L Q+I+    L  E   Y LYQ+L 
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ--MELDHERMSYLLYQMLV 137
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           G+K++HSA ++HRDLKPSN+++ ++  LKI DFGLAR    +  MT YVVTR+YRAPE++
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENA 179
           L    Y   +D+WSVG I  E++    LFPG DH+ Q   +IE +GTPS   +  L    
Sbjct: 198 LGMG-YKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTV 256
Query: 180 KKYICQLPRYQRQSFTEKFPNV------------HPSAIDLVEKMLTFDPRQRITVEDAL 227
           + Y+   P+Y   SF + FP+V               A DL+ KML  D  +RI+V++AL
Sbjct: 257 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 316
Query: 228 AHPYLGSLHDISDE---PVCMSPFSFDFEQHALTEGQMKELIYQEAL 271
            HPY+   +D S+    P  +     D  +H + E   KELIY+E +
Sbjct: 317 QHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEE--WKELIYKEVM 361

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score =  213 bits (543), Expect = 8e-56,   Method: Compositional matrix adjust.
 Identities = 117/289 (40%), Positives = 174/289 (60%), Gaps = 21/289 (7%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           ++H+N++++ ++  P +  E F DVY+  ELMD +L Q+I  +  L  E   Y LYQ+L 
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI--HMELDHERMSYLLYQMLC 137
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           G+K++HSA ++HRDLKPSN+++ ++C LKI DFGLAR       MT YVVTR+YRAPE++
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVI 197
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENA 179
           L    Y A +D+WSVGCI  EL+    +F G DH+ Q   +IE +GTPS   +  L    
Sbjct: 198 LGMG-YAANVDIWSVGCIMGELVKGCVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTV 256
Query: 180 KKYICQLPRYQRQSFTEKFPN-VHPS-----------AIDLVEKMLTFDPRQRITVEDAL 227
           + Y+   P+Y    F E FP+ + PS           A DL+ KML  DP +RI+V++AL
Sbjct: 257 RNYVENRPKYPGIKFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEAL 316
Query: 228 AHPYLGSLHDISDE---PVCMSPFSFDFEQHALTEGQMKELIYQEALAF 273
            HPY+   +D ++    P  +     +  +HA+ E   KELIY+E + +
Sbjct: 317 RHPYITVWYDPAEAEAPPPQIYDAQLEEREHAIEE--WKELIYKEVMDW 363

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score =  213 bits (543), Expect = 8e-56,   Method: Compositional matrix adjust.
 Identities = 117/287 (40%), Positives = 173/287 (60%), Gaps = 21/287 (7%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           ++H+N++++ ++  P +  E F DVY+  ELMD +L Q+I  +  L  E   Y LYQ+L 
Sbjct: 78  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI--HMELDHERMSYLLYQMLC 135
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           G+K++HSA ++HRDLKPSN+++ ++C LKI DFGLAR  S    MT YVVTR+YRAPE++
Sbjct: 136 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTASTNFMMTPYVVTRYYRAPEVI 195
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENA 179
           L    Y   +D+WSVGCI  EL+    +F G DH+ Q   +IE +GTPS   +  L    
Sbjct: 196 LGMG-YKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTV 254
Query: 180 KKYICQLPRYQRQSFTEKFPN-VHPS-----------AIDLVEKMLTFDPRQRITVEDAL 227
           + Y+   P Y   +F E FP+ + PS           A DL+ KML  DP +RI+V++AL
Sbjct: 255 RNYVENRPAYPGIAFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEAL 314
Query: 228 AHPYLGSLHDISDE---PVCMSPFSFDFEQHALTEGQMKELIYQEAL 271
            HPY+   +D ++    P  +     +  +HA+ E   KELIY+E +
Sbjct: 315 RHPYITVWYDPAEAEAPPPQIYDAQLEEREHAIEE--WKELIYKEVM 359

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score =  213 bits (541), Expect = 1e-55,   Method: Compositional matrix adjust.
 Identities = 120/288 (41%), Positives = 174/288 (60%), Gaps = 23/288 (7%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           ++H+N++ + ++  P +  E F DVYI  ELMD +L Q+I+    L  E   Y LYQ+L 
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLC 137
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE-YVVTRWYRAPEL 118
           G+K++HSA ++HRDLKPSN+++ ++C LKI DFGLAR T+ T FM E  VVTR+YRAPE+
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMEPEVVTRYYRAPEV 196
Query: 119 LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNEN 178
           +L    Y   +D+WSVGCI  E++  K LFPGRD++ Q   +IE +GTP  A +  L   
Sbjct: 197 ILGMG-YKENVDIWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPAFMKKLQPT 255
Query: 179 AKKYICQLPRYQRQSFTEKFPNV------------HPSAIDLVEKMLTFDPRQRITVEDA 226
            + Y+   P+Y   SF + FP+V               A DL+ KML  D  +RI+V++A
Sbjct: 256 VRNYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315
Query: 227 LAHPYLGSLHDISDE---PVCMSPFSFDFEQHALTEGQMKELIYQEAL 271
           L HPY+   +D S+    P  +     D  +H + E   KELIY+E +
Sbjct: 316 LQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEE--WKELIYKEVM 361

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score =  213 bits (541), Expect = 1e-55,   Method: Compositional matrix adjust.
 Identities = 115/287 (40%), Positives = 168/287 (58%), Gaps = 21/287 (7%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           ++H+N++ + ++  P +  E F DVYI  ELMD +L Q+I+    L  E   Y LYQ+L 
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQ--MELDHERMSYLLYQMLV 137
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           G+K++HSA ++HRDLKPSN+++ ++  LKI DFGLAR    +  MT YVVTR+YRAPE++
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENA 179
           L    Y   +D+WSVG I  E++    LFPG DH+ Q   +IE +GTPS   +  L    
Sbjct: 198 LGMG-YKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSPEFMKKLQPTV 256
Query: 180 KKYICQLPRYQRQSFTEKFPNV------------HPSAIDLVEKMLTFDPRQRITVEDAL 227
           + Y+   P+Y   SF + FP+V               A DL+ KML  D  +RI+V++AL
Sbjct: 257 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 316
Query: 228 AHPYLGSLHDISDE---PVCMSPFSFDFEQHALTEGQMKELIYQEAL 271
            HPY+   +D S+    P  +     D  +H + E   KELIY+E +
Sbjct: 317 QHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEE--WKELIYKEVM 361

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score =  212 bits (539), Expect = 2e-55,   Method: Compositional matrix adjust.
 Identities = 114/287 (39%), Positives = 168/287 (58%), Gaps = 21/287 (7%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           ++H+N++ + ++  P +  E F DVYI  ELMD +L Q+I+    L  E   Y LYQ+L 
Sbjct: 82  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLC 139
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           G+K++HSA ++HRDLKPSN+++ ++C LKI DFGLAR    +  M  +VVTR+YRAPE++
Sbjct: 140 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMVPFVVTRYYRAPEVI 199
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENA 179
           L    Y   +D+WSVGCI  E++    LFPG DH+ Q   +IE +GTP    +  L    
Sbjct: 200 LGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 258
Query: 180 KKYICQLPRYQRQSFTEKFPNV------------HPSAIDLVEKMLTFDPRQRITVEDAL 227
           + Y+   P+Y   SF + FP+V               A DL+ KML  D  +RI+V++AL
Sbjct: 259 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 318
Query: 228 AHPYLGSLHDISDE---PVCMSPFSFDFEQHALTEGQMKELIYQEAL 271
            HPY+   +D S+    P  +     D  +H + E   KELIY+E +
Sbjct: 319 QHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEE--WKELIYKEVM 363

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score =  211 bits (538), Expect = 3e-55,   Method: Compositional matrix adjust.
 Identities = 119/337 (35%), Positives = 179/337 (53%), Gaps = 61/337 (18%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRG 60
           ++H++VV + DI+ P   E F+++Y+  E+ D+D  ++ R+   L+E H +  LY +L G
Sbjct: 109 LNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVG 168
Query: 61  LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS--------------ETDF--- 103
           +KY+HSA +LHRDLKP+N L+N +C +K+CDFGLAR                 E D    
Sbjct: 169 VKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLV 228
Query: 104 -----------MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM---------- 142
                      +T +VVTRWYRAPEL+L   +YT AIDVWS+GCIF EL+          
Sbjct: 229 TFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYH 288
Query: 143 -DRKPLFPG--------------------RDHVHQLRLLIELIGTPSEAELGFL-NENAK 180
            DR PLFPG                    R +  QL ++  ++GTPSE ++  L  E+AK
Sbjct: 289 ADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAK 348
Query: 181 KYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISD 240
           +YI   P+ +     E+FP     AI L+++ML F+P +RIT+ + LAHP+   +     
Sbjct: 349 RYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEV 408
Query: 241 EPVCMSPFSFDF-EQHALTEGQMKELIYQEALAFNPE 276
           E          F +   + E Q++    +E   ++PE
Sbjct: 409 ETNATEKVRLPFNDWMNMDEPQLRYAFVKEIQRYHPE 445

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score =  211 bits (537), Expect = 4e-55,   Method: Compositional matrix adjust.
 Identities = 115/287 (40%), Positives = 168/287 (58%), Gaps = 21/287 (7%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           ++H+N++ + ++  P +  E F DVYI  ELMD +L Q+I+    L  E   Y LYQ+L 
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLC 137
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           G+K++HSA ++HRDLKPSN+++ ++C LKI DFGLAR    +  MT  VVTR+YRAPE++
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPEVVTRYYRAPEVI 197
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENA 179
           L    Y   +D+WSVGCI  E++    LFPG DH+ Q   +IE +GTP    +  L    
Sbjct: 198 LGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 256
Query: 180 KKYICQLPRYQRQSFTEKFPNV------------HPSAIDLVEKMLTFDPRQRITVEDAL 227
           + Y+   P+Y   SF + FP+V               A DL+ KML  D  +RI+V++AL
Sbjct: 257 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNALKASQARDLLSKMLVIDASKRISVDEAL 316
Query: 228 AHPYLGSLHDISDE---PVCMSPFSFDFEQHALTEGQMKELIYQEAL 271
            HPY+   +D S+    P  +     D  +H + E   KELIY+E +
Sbjct: 317 QHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEE--WKELIYKEVM 361

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score =  211 bits (536), Expect = 5e-55,   Method: Compositional matrix adjust.
 Identities = 114/284 (40%), Positives = 171/284 (60%), Gaps = 24/284 (8%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           ++H+N++++ ++  P +  E F DVY+  ELMD +L Q+I+    L  E   Y LYQ+L 
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQ--MELDHERMSYLLYQMLC 137
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           G+K++HSA ++HRDLKPSN+++ ++  LKI DFGLAR    +  MT YVVTR+YRAPE++
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENA 179
           L    Y   +D+WSVGCI  E++  K LFPGRD++ Q   +IE +GTP    +  L    
Sbjct: 198 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 256
Query: 180 KKYICQLPRYQRQSFTEKFPN-VHPS-----------AIDLVEKMLTFDPRQRITVEDAL 227
           + Y+   P+Y   +F + FP+ + P+           A DL+ KML  DP +RI+V+DAL
Sbjct: 257 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 316
Query: 228 AHPYLGSLHDISDEPVCMSPFSFDFEQHALTEGQMKELIYQEAL 271
            HPY+   +D +           D  +H + E   KELIY+E +
Sbjct: 317 QHPYINVWYDPA------XXXXXDEREHTIEE--WKELIYKEVM 352

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score =  209 bits (533), Expect = 1e-54,   Method: Compositional matrix adjust.
 Identities = 119/288 (41%), Positives = 173/288 (60%), Gaps = 23/288 (7%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           ++H+N++ + ++  P +  E F DVYI  ELMD +L Q+I+    L  E   Y LYQ+L 
Sbjct: 80  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLC 137
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE-YVVTRWYRAPEL 118
           G+K++HSA ++HRDLKPSN+++ ++C LKI DFGLAR T+ T FM E  VVTR+YRAPE+
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-TAGTSFMMEPEVVTRYYRAPEV 196
Query: 119 LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNEN 178
           +L    Y   +D+WSVGCI  E++  K LFPGRD++ Q   +IE +GTP    +  L   
Sbjct: 197 ILGMG-YKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 255
Query: 179 AKKYICQLPRYQRQSFTEKFPNV------------HPSAIDLVEKMLTFDPRQRITVEDA 226
            + Y+   P+Y   SF + FP+V               A DL+ KML  D  +RI+V++A
Sbjct: 256 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 315
Query: 227 LAHPYLGSLHDISDE---PVCMSPFSFDFEQHALTEGQMKELIYQEAL 271
           L HPY+   +D S+    P  +     D  +H + E   KELIY+E +
Sbjct: 316 LQHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEE--WKELIYKEVM 361

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score =  207 bits (527), Expect = 5e-54,   Method: Compositional matrix adjust.
 Identities = 113/284 (39%), Positives = 169/284 (59%), Gaps = 26/284 (9%)
Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           ++H+N++++ ++  P +  E F DVY+  ELMD +L Q+I+    L  E   Y LYQ+L 
Sbjct: 80  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLC 137
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           G+K++HSA ++HRDLKPSN+++ ++  LKI DFGLAR    +  MT YVVTR+YRAPE++
Sbjct: 138 GIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 197
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENA 179
           L    Y   +D+WSVGCI  E++  K LFPGRD++ Q   +IE +GTP    +  L    
Sbjct: 198 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 256
Query: 180 KKYICQLPRYQRQSFTEKFPN-VHPS-----------AIDLVEKMLTFDPRQRITVEDAL 227
           + Y+   P+Y   +F + FP+ + P+           A DL+ KML  DP +RI+V+DAL
Sbjct: 257 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 316
Query: 228 AHPYLGSLHDISDEPVCMSPFSFDFEQHALTEGQMKELIYQEAL 271
            HPY+   +              D  +H + E   KELIY+E +
Sbjct: 317 QHPYINVWY--------XXXXXXDEREHTIEE--WKELIYKEVM 350

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score =  204 bits (518), Expect = 6e-53,   Method: Compositional matrix adjust.
 Identities = 115/324 (35%), Positives = 176/324 (54%), Gaps = 53/324 (16%)
Query: 6   VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIH 65
           ++ + D+I P     F+++YI  E+ D+DL ++ ++   L+EEH +  LY +L G  +IH
Sbjct: 87  IIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIH 146
Query: 66  SANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSETDF--------------------- 103
            + ++HRDLKP+N LLN +C +K+CDFGLAR + SE D                      
Sbjct: 147 ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKK 206
Query: 104 -MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM-----------DRKPLFPGR 151
            +T +VVTRWYRAPEL+L   +YT +ID+WS GCIF EL+           +R PLFPG 
Sbjct: 207 QLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGS 266
Query: 152 D-----------HVH------QLRLLIELIGTPSEAELGFLNE-NAKKYICQLPRYQRQS 193
                        VH      QL ++  +IGTP+E +L  +N+    KYI   P  +  +
Sbjct: 267 SCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPIN 326
Query: 194 FTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMSPFSFDFE 253
             +K+P++    I+L+E ML F+P +RIT++ AL HPYL  +     E          F+
Sbjct: 327 LKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKKLENFSTKKIILPFD 386
Query: 254 Q-HALTEGQMKELIYQEALAFNPE 276
               L+E Q++ +  +E  +F+PE
Sbjct: 387 DWMVLSETQLRYIFLKEVQSFHPE 410

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score =  201 bits (511), Expect = 4e-52,   Method: Compositional matrix adjust.
 Identities = 109/264 (41%), Positives = 158/264 (59%), Gaps = 29/264 (10%)
Query: 1   MDHENVVAIRDIIPPPQRE---------SFNDVYIAYELMDTDLHQIIRSNQALSEEHCQ 51
           +DH+N+V + +I+ P   +           N VYI  E M+TDL  ++     L EEH +
Sbjct: 65  LDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLL-EEHAR 123
Query: 52  YFLYQILRGLKYIHSANVLHRDLKPSNLLLNA-NCDLKICDFGLARVT----SETDFMTE 106
            F+YQ+LRGLKYIHSANVLHRDLKP+NL +N  +  LKI DFGLAR+     S    ++E
Sbjct: 124 LFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSE 183
Query: 107 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGT 166
            +VT+WYR+P LLL+ ++YT AID+W+ GCIF E++  K LF G   + Q++L++E I  
Sbjct: 184 GLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPV 243
Query: 167 PSEAELGFLNENAKKYICQLPRYQRQSFTEK-------FPNVHPSAIDLVEKMLTFDPRQ 219
             E       E+ ++ +  +P Y R   TE         P +   A+D +E++LTF P  
Sbjct: 244 VHE-------EDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMD 296
Query: 220 RITVEDALAHPYLGSLHDISDEPV 243
           R+T E+AL+HPY+       DEP+
Sbjct: 297 RLTAEEALSHPYMSIYSFPMDEPI 320

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score =  200 bits (508), Expect = 8e-52,   Method: Compositional matrix adjust.
 Identities = 108/275 (39%), Positives = 158/275 (57%), Gaps = 4/275 (1%)
Query: 3   HENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ-ALSEEHCQYFLYQILRGL 61
           H N++ +RDI    +  + + +Y+  ELM TDL Q+I   +  +S +H QYF+Y IL GL
Sbjct: 88  HPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGL 147
Query: 62  KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLN 121
             +H A V+HRDL P N+LL  N D+ ICDF LAR  +     T YV  RWYRAPEL++ 
Sbjct: 148 HVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQ 207
Query: 122 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPS-EAELGFLNENAK 180
              +T  +D+WS GC+  E+ +RK LF G    +QL  ++E++GTP  E  + F + +A+
Sbjct: 208 FKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSAR 267
Query: 181 KYI-CQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDIS 239
            Y+   L     +++T   P   P A+DL+ KML F+P++RI+ E AL HPY  SL D  
Sbjct: 268 DYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPL 327
Query: 240 DEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFN 274
           D    +S   F F++       M ++   E   FN
Sbjct: 328 DLTEGLSE-RFHFDESVTDVYDMHKIFTAEVERFN 361

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score =  200 bits (508), Expect = 8e-52,   Method: Compositional matrix adjust.
 Identities = 108/275 (39%), Positives = 158/275 (57%), Gaps = 4/275 (1%)
Query: 3   HENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ-ALSEEHCQYFLYQILRGL 61
           H N++ +RDI    +  + + +Y+  ELM TDL Q+I   +  +S +H QYF+Y IL GL
Sbjct: 88  HPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGL 147
Query: 62  KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLN 121
             +H A V+HRDL P N+LL  N D+ ICDF LAR  +     T YV  RWYRAPEL++ 
Sbjct: 148 HVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQ 207
Query: 122 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPS-EAELGFLNENAK 180
              +T  +D+WS GC+  E+ +RK LF G    +QL  ++E++GTP  E  + F + +A+
Sbjct: 208 FKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSAR 267
Query: 181 KYI-CQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDIS 239
            Y+   L     +++T   P   P A+DL+ KML F+P++RI+ E AL HPY  SL D  
Sbjct: 268 DYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDPL 327
Query: 240 DEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFN 274
           D    +S   F F++       M ++   E   FN
Sbjct: 328 DLTEGLSE-RFHFDESVTDVYDMHKIFTAEVERFN 361

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score =  196 bits (497), Expect = 1e-50,   Method: Compositional matrix adjust.
 Identities = 116/331 (35%), Positives = 181/331 (54%), Gaps = 64/331 (19%)
Query: 6   VVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIH 65
           ++ + D+I P     F+++YI  E+ D+DL ++ ++   L+E+H +  LY +L G K+IH
Sbjct: 89  IIRLHDLIIPEDLLKFDELYIVLEIADSDLKKLFKTPIFLTEQHVKTILYNLLLGEKFIH 148
Query: 66  SANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSETDF--------------------- 103
            + ++HRDLKP+N LLN +C +KICDFGLAR + S+ D                      
Sbjct: 149 ESGIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEEKEENEEPGPHNKN 208
Query: 104 ----MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM-----------DRKPLF 148
               +T +VVTRWYRAPEL+L   +YT +ID+WS GCIF EL+           +R PLF
Sbjct: 209 LKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLNMMKSHINNPTNRFPLF 268
Query: 149 PGR-------DH----VH------QLRLLIELIGTPSEAELGFLN-ENAKKYICQLPRYQ 190
           PG        DH    VH      QL ++  +IGTP E +L  +  +   KYI   P   
Sbjct: 269 PGSSCFPLSPDHNSKKVHEKSNRDQLNIIFNVIGTPPEEDLKCITKQEVIKYIKLFPTRD 328
Query: 191 RQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLG-----SLHDISDEPVCM 245
               ++K+ ++    IDL+E ML F+ ++RIT++ AL+HPYL      +L + S E + +
Sbjct: 329 GIDLSKKYSSISKEGIDLLESMLRFNAQKRITIDKALSHPYLKDVRKENLENFSTEKIIL 388
Query: 246 SPFSFDFEQHALTEGQMKELIYQEALAFNPE 276
            PF    +   L+E Q++ +  +E  +F+ +
Sbjct: 389 -PFD---DWMVLSETQLRYIFLKEIQSFHAD 415

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score =  196 bits (497), Expect = 1e-50,   Method: Compositional matrix adjust.
 Identities = 111/310 (35%), Positives = 181/310 (58%), Gaps = 50/310 (16%)
Query: 3   HENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLK 62
           HEN+V + +++   + ++  DVY+ ++ M+TDLH +IR+N  L   H QY +YQ+++ +K
Sbjct: 68  HENIVNLLNVL---RADNDRDVYLVFDYMETDLHAVIRAN-ILEPVHKQYVVYQLIKVIK 123
Query: 63  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR---------------VTSETD----- 102
           Y+HS  +LHRD+KPSN+LLNA C +K+ DFGL+R               +   T+     
Sbjct: 124 YLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDD 183
Query: 103 --FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL 160
              +T+YV TRWYRAPE+LL S+ YT  ID+WS+GCI  E++  KP+FPG   ++QL  +
Sbjct: 184 QPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERI 243
Query: 161 IELIGTPSEAELGFLN--------ENAKKYICQLPRYQRQSFTEKFPN----VHPS---- 204
           I +I  PS  ++  +         E+ K+ +      +R  FT K+ N    ++P     
Sbjct: 244 IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFT-KWKNLLLKINPKADCN 302
Query: 205 --AIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMSPFSF---DFEQHALTE 259
             A+DL++K+L F+P +RI+  DAL HP++   H+ ++EP C    +    D  +H++ +
Sbjct: 303 EEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEPNCDHIITIPINDNVKHSIDD 362
Query: 260 GQMKELIYQE 269
              + L+Y E
Sbjct: 363 --YRNLVYSE 370

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score =  182 bits (462), Expect = 2e-46,   Method: Compositional matrix adjust.
 Identities = 102/255 (40%), Positives = 144/255 (56%), Gaps = 12/255 (4%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILR 59
           + H N+V + DII      +   + + +E +D DL Q +      ++  + + FL+Q+LR
Sbjct: 57  LKHANIVTLHDII-----HTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLR 111
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPEL 118
           GL Y H   VLHRDLKP NLL+N   +LK+ DFGLAR  S  T      VVT WYR P++
Sbjct: 112 GLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDI 171
Query: 119 LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL-GFL-N 176
           LL S+DY+  ID+W VGCIF E+   +PLFPG     QL  +  ++GTP+E    G L N
Sbjct: 172 LLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN 231
Query: 177 ENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH 236
           E  K Y    P+Y+ ++     P +     DL+ K+L F+ R RI+ EDA+ HP+  SL 
Sbjct: 232 EEFKTY--NYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLG 289
Query: 237 D-ISDEPVCMSPFSF 250
           + I   P   S F+ 
Sbjct: 290 ERIHKLPDTTSIFAL 304

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score =  173 bits (438), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 88/237 (37%), Positives = 137/237 (57%), Gaps = 7/237 (2%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ-ALSEEHCQYFLYQILR 59
           + H N+V++ D+I      S   + + +E M+ DL +++  N+  L +   + +LYQ+LR
Sbjct: 76  LHHPNIVSLIDVI-----HSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLR 130
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPEL 118
           G+ + H   +LHRDLKP NLL+N++  LK+ DFGLAR         T  VVT WYRAP++
Sbjct: 131 GVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDV 190
Query: 119 LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNEN 178
           L+ S  Y+ ++D+WS+GCIF E++  KPLFPG     QL  +  ++GTP+  E   + E 
Sbjct: 191 LMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQEL 250
Query: 179 AKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL 235
                     ++++ ++   P      IDL+  ML FDP +RI+  DA+ HPY   L
Sbjct: 251 PLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score =  173 bits (438), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 88/237 (37%), Positives = 137/237 (57%), Gaps = 7/237 (2%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ-ALSEEHCQYFLYQILR 59
           + H N+V++ D+I      S   + + +E M+ DL +++  N+  L +   + +LYQ+LR
Sbjct: 76  LHHPNIVSLIDVI-----HSERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLR 130
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPEL 118
           G+ + H   +LHRDLKP NLL+N++  LK+ DFGLAR         T  VVT WYRAP++
Sbjct: 131 GVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDV 190
Query: 119 LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNEN 178
           L+ S  Y+ ++D+WS+GCIF E++  KPLFPG     QL  +  ++GTP+  E   + E 
Sbjct: 191 LMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQEL 250
Query: 179 AKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL 235
                     ++++ ++   P      IDL+  ML FDP +RI+  DA+ HPY   L
Sbjct: 251 PLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score =  171 bits (432), Expect = 5e-43,   Method: Compositional matrix adjust.
 Identities = 87/235 (37%), Positives = 136/235 (57%), Gaps = 9/235 (3%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQIL 58
           ++H N+V + D+I      + N +Y+ +E +  DL + + ++    +     + +L+Q+L
Sbjct: 66  LNHPNIVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL 120
Query: 59  RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPE 117
           +GL + HS  VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT WYRAPE
Sbjct: 121 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 180
Query: 118 LLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNE 177
           +LL    Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  
Sbjct: 181 ILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT- 239
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
           +   Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 240 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 294

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score =  170 bits (431), Expect = 7e-43,   Method: Compositional matrix adjust.
 Identities = 87/235 (37%), Positives = 136/235 (57%), Gaps = 9/235 (3%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQIL 58
           ++H N+V + D+I      + N +Y+ +E +  DL + + ++    +     + +L+Q+L
Sbjct: 59  LNHPNIVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 59  RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPE 117
           +GL + HS  VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT WYRAPE
Sbjct: 114 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 173
Query: 118 LLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNE 177
           +LL    Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  
Sbjct: 174 ILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT- 232
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
           +   Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 233 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score =  170 bits (430), Expect = 8e-43,   Method: Compositional matrix adjust.
 Identities = 87/235 (37%), Positives = 136/235 (57%), Gaps = 9/235 (3%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQIL 58
           ++H N+V + D+I      + N +Y+ +E +  DL + + ++    +     + +L+Q+L
Sbjct: 66  LNHPNIVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL 120
Query: 59  RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPE 117
           +GL + HS  VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT WYRAPE
Sbjct: 121 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 180
Query: 118 LLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNE 177
           +LL    Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  
Sbjct: 181 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT- 239
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
           +   Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 240 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 294

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score =  170 bits (430), Expect = 9e-43,   Method: Compositional matrix adjust.
 Identities = 87/235 (37%), Positives = 136/235 (57%), Gaps = 9/235 (3%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQIL 58
           ++H N+V + D+I      + N +Y+ +E +  DL + + ++    +     + +L+Q+L
Sbjct: 58  LNHPNIVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL 112
Query: 59  RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPE 117
           +GL + HS  VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT WYRAPE
Sbjct: 113 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 172
Query: 118 LLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNE 177
           +LL    Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT- 231
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
           +   Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score =  170 bits (430), Expect = 9e-43,   Method: Compositional matrix adjust.
 Identities = 87/235 (37%), Positives = 136/235 (57%), Gaps = 9/235 (3%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQIL 58
           ++H N+V + D+I      + N +Y+ +E +  DL + + ++    +     + +L+Q+L
Sbjct: 59  LNHPNIVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 59  RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPE 117
           +GL + HS  VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT WYRAPE
Sbjct: 114 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 173
Query: 118 LLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNE 177
           +LL    Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT- 232
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
           +   Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 233 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score =  170 bits (430), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 87/235 (37%), Positives = 136/235 (57%), Gaps = 9/235 (3%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQIL 58
           ++H N+V + D+I      + N +Y+ +E +  DL + + ++    +     + +L+Q+L
Sbjct: 60  LNHPNIVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL 114
Query: 59  RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPE 117
           +GL + HS  VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT WYRAPE
Sbjct: 115 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 174
Query: 118 LLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNE 177
           +LL    Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT- 233
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
           +   Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 234 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 288

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score =  170 bits (430), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 87/235 (37%), Positives = 136/235 (57%), Gaps = 9/235 (3%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQIL 58
           ++H N+V + D+I      + N +Y+ +E +  DL + + ++    +     + +L+Q+L
Sbjct: 59  LNHPNIVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 59  RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPE 117
           +GL + HS  VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT WYRAPE
Sbjct: 114 QGLSFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 173
Query: 118 LLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNE 177
           +LL    Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT- 232
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
           +   Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 233 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score =  170 bits (430), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 87/235 (37%), Positives = 136/235 (57%), Gaps = 9/235 (3%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQIL 58
           ++H N+V + D+I      + N +Y+ +E +  DL + + ++    +     + +L+Q+L
Sbjct: 63  LNHPNIVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL 117
Query: 59  RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPE 117
           +GL + HS  VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT WYRAPE
Sbjct: 118 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 177
Query: 118 LLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNE 177
           +LL    Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  
Sbjct: 178 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT- 236
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
           +   Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 237 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 291

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score =  169 bits (429), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 87/235 (37%), Positives = 136/235 (57%), Gaps = 9/235 (3%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQIL 58
           ++H N+V + D+I      + N +Y+ +E +  DL + + ++    +     + +L+Q+L
Sbjct: 59  LNHPNIVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 59  RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPE 117
           +GL + HS  VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT WYRAPE
Sbjct: 114 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 173
Query: 118 LLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNE 177
           +LL    Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT- 232
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
           +   Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 233 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score =  169 bits (429), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 87/235 (37%), Positives = 136/235 (57%), Gaps = 9/235 (3%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQIL 58
           ++H N+V + D+I      + N +Y+ +E +  DL + + ++    +     + +L+Q+L
Sbjct: 58  LNHPNIVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL 112
Query: 59  RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPE 117
           +GL + HS  VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT WYRAPE
Sbjct: 113 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 172
Query: 118 LLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNE 177
           +LL    Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT- 231
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
           +   Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score =  169 bits (429), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 87/235 (37%), Positives = 136/235 (57%), Gaps = 9/235 (3%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQIL 58
           ++H N+V + D+I      + N +Y+ +E +  DL + + ++    +     + +L+Q+L
Sbjct: 59  LNHPNIVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 59  RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPE 117
           +GL + HS  VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT WYRAPE
Sbjct: 114 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 173
Query: 118 LLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNE 177
           +LL    Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT- 232
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
           +   Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 233 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  169 bits (429), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 87/235 (37%), Positives = 136/235 (57%), Gaps = 9/235 (3%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQIL 58
           ++H N+V + D+I      + N +Y+ +E +  DL + + ++    +     + +L+Q+L
Sbjct: 58  LNHPNIVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL 112
Query: 59  RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPE 117
           +GL + HS  VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT WYRAPE
Sbjct: 113 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 172
Query: 118 LLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNE 177
           +LL    Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT- 231
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
           +   Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score =  169 bits (427), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 87/235 (37%), Positives = 136/235 (57%), Gaps = 9/235 (3%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQIL 58
           ++H N+V + D+I      + N +Y+ +E +D DL + + ++    +     + +L+Q+L
Sbjct: 62  LNHPNIVKLLDVI-----HTENKLYLVFEHVDQDLKKFMDASALTGIPLPLIKSYLFQLL 116
Query: 59  RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPE 117
           +GL + HS  VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE
Sbjct: 117 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 176
Query: 118 LLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNE 177
           +LL    Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT- 235
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
           +   Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 236 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  168 bits (426), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 86/235 (36%), Positives = 135/235 (57%), Gaps = 9/235 (3%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQIL 58
           ++H N+V + D+I      + N +Y+ +E +  DL + + ++    +     + +L+Q+L
Sbjct: 62  LNHPNIVKLLDVI-----HTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLL 116
Query: 59  RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPE 117
           +GL + HS  VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE
Sbjct: 117 QGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 176
Query: 118 LLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNE 177
           +LL    Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT- 235
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
           +   Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 236 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  168 bits (426), Expect = 3e-42,   Method: Compositional matrix adjust.
 Identities = 86/235 (36%), Positives = 135/235 (57%), Gaps = 9/235 (3%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQIL 58
           ++H N+V + D+I      + N +Y+ +E +  DL + + ++    +     + +L+Q+L
Sbjct: 60  LNHPNIVKLLDVI-----HTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQLL 114
Query: 59  RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPE 117
           +GL + HS  VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE
Sbjct: 115 QGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 174
Query: 118 LLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNE 177
           +LL    Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT- 233
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
           +   Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 234 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 288

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  168 bits (425), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 86/235 (36%), Positives = 135/235 (57%), Gaps = 9/235 (3%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQIL 58
           ++H N+V + D+I      + N +Y+ +E +  DL + + ++    +     + +L+Q+L
Sbjct: 62  LNHPNIVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL 116
Query: 59  RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPE 117
           +GL + HS  VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE
Sbjct: 117 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 176
Query: 118 LLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNE 177
           +LL    Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT- 235
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
           +   Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 236 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  168 bits (425), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 86/235 (36%), Positives = 135/235 (57%), Gaps = 9/235 (3%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQIL 58
           ++H N+V + D+I      + N +Y+ +E +  DL + + ++    +     + +L+Q+L
Sbjct: 62  LNHPNIVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL 116
Query: 59  RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPE 117
           +GL + HS  VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE
Sbjct: 117 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 176
Query: 118 LLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNE 177
           +LL    Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT- 235
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
           +   Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 236 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score =  168 bits (425), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 86/235 (36%), Positives = 135/235 (57%), Gaps = 9/235 (3%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQIL 58
           ++H N+V + D+I      + N +Y+ +E +  DL + + ++    +     + +L+Q+L
Sbjct: 61  LNHPNIVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL 115
Query: 59  RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPE 117
           +GL + HS  VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE
Sbjct: 116 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 175
Query: 118 LLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNE 177
           +LL    Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT- 234
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
           +   Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 235 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 289

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score =  168 bits (425), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 86/235 (36%), Positives = 135/235 (57%), Gaps = 9/235 (3%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQIL 58
           ++H N+V + D+I      + N +Y+ +E +  DL + + ++    +     + +L+Q+L
Sbjct: 58  LNHPNIVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL 112
Query: 59  RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPE 117
           +GL + HS  VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE
Sbjct: 113 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 172
Query: 118 LLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNE 177
           +LL    Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT- 231
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
           +   Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  168 bits (425), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 86/235 (36%), Positives = 135/235 (57%), Gaps = 9/235 (3%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQIL 58
           ++H N+V + D+I      + N +Y+ +E +  DL + + ++    +     + +L+Q+L
Sbjct: 61  LNHPNIVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL 115
Query: 59  RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPE 117
           +GL + HS  VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE
Sbjct: 116 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 175
Query: 118 LLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNE 177
           +LL    Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT- 234
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
           +   Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 235 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 289

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score =  168 bits (425), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 86/235 (36%), Positives = 135/235 (57%), Gaps = 9/235 (3%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQIL 58
           ++H N+V + D+I      + N +Y+ +E +  DL + + ++    +     + +L+Q+L
Sbjct: 59  LNHPNIVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 59  RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPE 117
           +GL + HS  VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE
Sbjct: 114 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 173
Query: 118 LLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNE 177
           +LL    Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT- 232
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
           +   Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 233 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score =  167 bits (424), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 86/235 (36%), Positives = 135/235 (57%), Gaps = 9/235 (3%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQIL 58
           ++H N+V + D+I      + N +Y+ +E +  DL + + ++    +     + +L+Q+L
Sbjct: 60  LNHPNIVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL 114
Query: 59  RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPE 117
           +GL + HS  VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE
Sbjct: 115 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 174
Query: 118 LLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNE 177
           +LL    Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT- 233
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
           +   Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 234 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 288

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score =  167 bits (424), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 97/244 (39%), Positives = 134/244 (54%), Gaps = 28/244 (11%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIR-SNQALSEEHCQYFLYQILR 59
           + H N+V + D+I   +R     + + +E +D DL +++      L     + FL Q+L 
Sbjct: 57  LKHSNIVKLYDVIHTKKR-----LVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLN 111
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPEL 118
           G+ Y H   VLHRDLKP NLL+N   +LKI DFGLAR         T  VVT WYRAP++
Sbjct: 112 GIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDV 171
Query: 119 LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNEN 178
           L+ S  Y+  ID+WSVGCIF E+++  PLFPG     QL  +  ++GTP          N
Sbjct: 172 LMGSKKYSTTIDIWSVGCIFAEMVNGAPLFPGVSEADQLMRIFRILGTP----------N 221
Query: 179 AKKY--ICQLPRYQRQSFT--EKFP------NVHPSAIDLVEKMLTFDPRQRITVEDALA 228
           +K +  + +LP+Y   +FT  E  P       +  S IDL+ KML  DP QRIT + AL 
Sbjct: 222 SKNWPNVTELPKYD-PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
Query: 229 HPYL 232
           H Y 
Sbjct: 281 HAYF 284

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  167 bits (424), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 86/235 (36%), Positives = 135/235 (57%), Gaps = 9/235 (3%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQIL 58
           ++H N+V + D+I      + N +Y+ +E +  DL + + ++    +     + +L+Q+L
Sbjct: 61  LNHPNIVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL 115
Query: 59  RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPE 117
           +GL + HS  VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE
Sbjct: 116 QGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 175
Query: 118 LLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNE 177
           +LL    Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT- 234
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
           +   Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 235 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 289

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score =  167 bits (424), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 86/235 (36%), Positives = 135/235 (57%), Gaps = 9/235 (3%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQIL 58
           ++H N+V + D+I      + N +Y+ +E +  DL + + ++    +     + +L+Q+L
Sbjct: 59  LNHPNIVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 59  RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPE 117
           +GL + HS  VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE
Sbjct: 114 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 173
Query: 118 LLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNE 177
           +LL    Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT- 232
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
           +   Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 233 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score =  167 bits (424), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 86/235 (36%), Positives = 134/235 (57%), Gaps = 9/235 (3%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQIL 58
           ++H N+V + D+I      + N +Y+ +E +  DL   + ++    +     + +L+Q+L
Sbjct: 62  LNHPNIVKLLDVI-----HTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLL 116
Query: 59  RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPE 117
           +GL + HS  VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE
Sbjct: 117 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 176
Query: 118 LLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNE 177
           +LL    Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT- 235
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
           +   Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 236 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score =  167 bits (424), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 97/244 (39%), Positives = 134/244 (54%), Gaps = 28/244 (11%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIR-SNQALSEEHCQYFLYQILR 59
           + H N+V + D+I   +R     + + +E +D DL +++      L     + FL Q+L 
Sbjct: 57  LKHSNIVKLYDVIHTKKR-----LVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLN 111
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPEL 118
           G+ Y H   VLHRDLKP NLL+N   +LKI DFGLAR         T  VVT WYRAP++
Sbjct: 112 GIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDV 171
Query: 119 LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNEN 178
           L+ S  Y+  ID+WSVGCIF E+++  PLFPG     QL  +  ++GTP          N
Sbjct: 172 LMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTP----------N 221
Query: 179 AKKY--ICQLPRYQRQSFT--EKFP------NVHPSAIDLVEKMLTFDPRQRITVEDALA 228
           +K +  + +LP+Y   +FT  E  P       +  S IDL+ KML  DP QRIT + AL 
Sbjct: 222 SKNWPNVTELPKYD-PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
Query: 229 HPYL 232
           H Y 
Sbjct: 281 HAYF 284

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score =  167 bits (424), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 86/235 (36%), Positives = 135/235 (57%), Gaps = 9/235 (3%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQIL 58
           ++H N+V + D+I      + N +Y+ +E +  DL + + ++    +     + +L+Q+L
Sbjct: 60  LNHPNIVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL 114
Query: 59  RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPE 117
           +GL + HS  VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE
Sbjct: 115 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 174
Query: 118 LLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNE 177
           +LL    Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT- 233
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
           +   Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 234 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 288

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score =  167 bits (424), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 86/235 (36%), Positives = 135/235 (57%), Gaps = 9/235 (3%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQIL 58
           ++H N+V + D+I      + N +Y+ +E +  DL + + ++    +     + +L+Q+L
Sbjct: 63  LNHPNIVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL 117
Query: 59  RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPE 117
           +GL + HS  VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE
Sbjct: 118 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 177
Query: 118 LLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNE 177
           +LL    Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  
Sbjct: 178 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT- 236
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
           +   Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 237 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 291

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score =  167 bits (424), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 86/235 (36%), Positives = 135/235 (57%), Gaps = 9/235 (3%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQIL 58
           ++H N+V + D+I      + N +Y+ +E +  DL + + ++    +     + +L+Q+L
Sbjct: 60  LNHPNIVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL 114
Query: 59  RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPE 117
           +GL + HS  VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE
Sbjct: 115 QGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 174
Query: 118 LLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNE 177
           +LL    Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  
Sbjct: 175 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT- 233
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
           +   Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 234 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 288

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score =  167 bits (424), Expect = 5e-42,   Method: Compositional matrix adjust.
 Identities = 86/235 (36%), Positives = 135/235 (57%), Gaps = 9/235 (3%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQIL 58
           ++H N+V + D+I      + N +Y+ +E +  DL + + ++    +     + +L+Q+L
Sbjct: 58  LNHPNIVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL 112
Query: 59  RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPE 117
           +GL + HS  VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE
Sbjct: 113 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 172
Query: 118 LLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNE 177
           +LL    Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT- 231
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
           +   Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score =  167 bits (424), Expect = 5e-42,   Method: Compositional matrix adjust.
 Identities = 86/235 (36%), Positives = 135/235 (57%), Gaps = 9/235 (3%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQIL 58
           ++H N+V + D+I      + N +Y+ +E +  DL + + ++    +     + +L+Q+L
Sbjct: 59  LNHPNIVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 59  RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPE 117
           +GL + HS  VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE
Sbjct: 114 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 173
Query: 118 LLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNE 177
           +LL    Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT- 232
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
           +   Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 233 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score =  167 bits (424), Expect = 5e-42,   Method: Compositional matrix adjust.
 Identities = 86/235 (36%), Positives = 135/235 (57%), Gaps = 9/235 (3%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQIL 58
           ++H N+V + D+I      + N +Y+ +E +  DL + + ++    +     + +L+Q+L
Sbjct: 59  LNHPNIVKLLDVI-----HTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL 113
Query: 59  RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPE 117
           +GL + HS  VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE
Sbjct: 114 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 173
Query: 118 LLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNE 177
           +LL    Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT- 232
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
           +   Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 233 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score =  167 bits (423), Expect = 5e-42,   Method: Compositional matrix adjust.
 Identities = 86/235 (36%), Positives = 134/235 (57%), Gaps = 9/235 (3%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQIL 58
           ++H N+V + D+I      + N +Y+ +E +  DL   + ++    +     + +L+Q+L
Sbjct: 61  LNHPNIVKLLDVI-----HTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQLL 115
Query: 59  RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPE 117
           +GL + HS  VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE
Sbjct: 116 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 175
Query: 118 LLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNE 177
           +LL    Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  
Sbjct: 176 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT- 234
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
           +   Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 235 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 289

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score =  167 bits (423), Expect = 6e-42,   Method: Compositional matrix adjust.
 Identities = 96/244 (39%), Positives = 134/244 (54%), Gaps = 28/244 (11%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIR-SNQALSEEHCQYFLYQILR 59
           + H N+V + D+I   +R     + + +E +D DL +++      L     + FL Q+L 
Sbjct: 57  LKHSNIVKLYDVIHTKKR-----LVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLN 111
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPEL 118
           G+ Y H   VLHRDLKP NLL+N   +LKI DFGLAR         T  +VT WYRAP++
Sbjct: 112 GIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDV 171
Query: 119 LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNEN 178
           L+ S  Y+  ID+WSVGCIF E+++  PLFPG     QL  +  ++GTP          N
Sbjct: 172 LMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTP----------N 221
Query: 179 AKKY--ICQLPRYQRQSFT--EKFP------NVHPSAIDLVEKMLTFDPRQRITVEDALA 228
           +K +  + +LP+Y   +FT  E  P       +  S IDL+ KML  DP QRIT + AL 
Sbjct: 222 SKNWPNVTELPKYD-PNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280
Query: 229 HPYL 232
           H Y 
Sbjct: 281 HAYF 284

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  167 bits (423), Expect = 6e-42,   Method: Compositional matrix adjust.
 Identities = 86/235 (36%), Positives = 134/235 (57%), Gaps = 9/235 (3%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQIL 58
           ++H N+V + D+I      + N +Y+ +E +  DL   + ++    +     + +L+Q+L
Sbjct: 62  LNHPNIVKLLDVI-----HTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQLL 116
Query: 59  RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPE 117
           +GL + HS  VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE
Sbjct: 117 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 176
Query: 118 LLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNE 177
           +LL    Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  
Sbjct: 177 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT- 235
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
           +   Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 236 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  167 bits (422), Expect = 7e-42,   Method: Compositional matrix adjust.
 Identities = 87/235 (37%), Positives = 135/235 (57%), Gaps = 9/235 (3%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQIL 58
           ++H N+V + D+I      + N +Y+ +E +  DL   + ++    +     + +L+Q+L
Sbjct: 58  LNHPNIVKLLDVI-----HTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYLFQLL 112
Query: 59  RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPE 117
           +GL + HS  VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT WYRAPE
Sbjct: 113 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 172
Query: 118 LLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNE 177
           +LL    Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT- 231
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
           +   Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score =  167 bits (422), Expect = 8e-42,   Method: Compositional matrix adjust.
 Identities = 86/235 (36%), Positives = 134/235 (57%), Gaps = 9/235 (3%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQIL 58
           ++H N+V + D+I      + N +Y+ +E +  DL   + ++    +     + +L+Q+L
Sbjct: 59  LNHPNIVKLLDVI-----HTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIKSYLFQLL 113
Query: 59  RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPE 117
           +GL + HS  VLHRDLKP NLL+N    +K+ DFGLAR            VVT WYRAPE
Sbjct: 114 QGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPE 173
Query: 118 LLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNE 177
           +LL    Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E     +  
Sbjct: 174 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVT- 232
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
           +   Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+ 
Sbjct: 233 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score =  165 bits (417), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 93/242 (38%), Positives = 137/242 (56%), Gaps = 23/242 (9%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILR 59
           + H+N+V + D++      S   + + +E  D DL +   S N  L  E  + FL+Q+L+
Sbjct: 58  LKHKNIVRLHDVL-----HSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLK 112
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPEL 118
           GL + HS NVLHRDLKP NLL+N N +LK+ DFGLAR         +  VVT WYR P++
Sbjct: 113 GLGFCHSRNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDV 172
Query: 119 LLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNE 177
           L  +  Y+ +ID+WS GCIF EL +  +PLFPG D   QL+ +  L+GTP+E +      
Sbjct: 173 LFGAKLYSTSIDMWSAGCIFAELANAARPLFPGNDVDDQLKRIFRLLGTPTEEQW----- 227
Query: 178 NAKKYICQLPRYQ-------RQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHP 230
                + +LP Y+         S     P ++ +  DL++ +L  +P QRI+ E+AL HP
Sbjct: 228 ---PSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHP 284
Query: 231 YL 232
           Y 
Sbjct: 285 YF 286

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score =  163 bits (413), Expect = 8e-41,   Method: Compositional matrix adjust.
 Identities = 92/242 (38%), Positives = 137/242 (56%), Gaps = 23/242 (9%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILR 59
           + H+N+V + D++      S   + + +E  D DL +   S N  L  E  + FL+Q+L+
Sbjct: 58  LKHKNIVRLHDVL-----HSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLK 112
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPEL 118
           GL + HS NVLHRDLKP NLL+N N +LK+ +FGLAR         +  VVT WYR P++
Sbjct: 113 GLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDV 172
Query: 119 LLNSSDYTAAIDVWSVGCIFMELMDR-KPLFPGRDHVHQLRLLIELIGTPSEAELGFLNE 177
           L  +  Y+ +ID+WS GCIF EL +  +PLFPG D   QL+ +  L+GTP+E +      
Sbjct: 173 LFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQW----- 227
Query: 178 NAKKYICQLPRYQ-------RQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHP 230
                + +LP Y+         S     P ++ +  DL++ +L  +P QRI+ E+AL HP
Sbjct: 228 ---PSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHP 284
Query: 231 YL 232
           Y 
Sbjct: 285 YF 286

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score =  159 bits (403), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 94/241 (39%), Positives = 139/241 (57%), Gaps = 16/241 (6%)
Query: 2   DHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS--NQALSEEHCQYFLYQILR 59
           +H NVV + D+    + +    + + +E +D DL   +       +  E  +  ++Q+LR
Sbjct: 72  EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLR 131
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           GL ++HS  V+HRDLKP N+L+ ++  +K+ DFGLAR+ S    +T  VVT WYRAPE+L
Sbjct: 132 GLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVL 191
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENA 179
           L SS Y   +D+WSVGCIF E+  RKPLF G   V QL  ++++IG P E       E+ 
Sbjct: 192 LQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE-------EDW 243
Query: 180 KKYICQLPRYQRQSFT----EKF-PNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS 234
            + +  LPR    S +    EKF  ++     DL+ K LTF+P +RI+   AL+HPY   
Sbjct: 244 PRDVA-LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 302
Query: 235 L 235
           L
Sbjct: 303 L 303

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score =  159 bits (403), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 94/241 (39%), Positives = 139/241 (57%), Gaps = 16/241 (6%)
Query: 2   DHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS--NQALSEEHCQYFLYQILR 59
           +H NVV + D+    + +    + + +E +D DL   +       +  E  +  ++Q+LR
Sbjct: 72  EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLR 131
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           GL ++HS  V+HRDLKP N+L+ ++  +K+ DFGLAR+ S    +T  VVT WYRAPE+L
Sbjct: 132 GLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVL 191
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENA 179
           L SS Y   +D+WSVGCIF E+  RKPLF G   V QL  ++++IG P E       E+ 
Sbjct: 192 LQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE-------EDW 243
Query: 180 KKYICQLPRYQRQSFT----EKF-PNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS 234
            + +  LPR    S +    EKF  ++     DL+ K LTF+P +RI+   AL+HPY   
Sbjct: 244 PRDVA-LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQD 302
Query: 235 L 235
           L
Sbjct: 303 L 303

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score =  159 bits (402), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 93/238 (39%), Positives = 138/238 (57%), Gaps = 16/238 (6%)
Query: 2   DHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS--NQALSEEHCQYFLYQILR 59
           +H NVV + D+    + +    + + +E +D DL   +       +  E  +  ++Q+LR
Sbjct: 72  EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLR 131
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           GL ++HS  V+HRDLKP N+L+ ++  +K+ DFGLAR+ S    +T  VVT WYRAPE+L
Sbjct: 132 GLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVL 191
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENA 179
           L SS Y   +D+WSVGCIF E+  RKPLF G   V QL  ++++IG P E       E+ 
Sbjct: 192 LQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE-------EDW 243
Query: 180 KKYICQLPRYQRQSFT----EKF-PNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
            + +  LPR    S +    EKF  ++     DL+ K LTF+P +RI+   AL+HPY 
Sbjct: 244 PRDVA-LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 300

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score =  159 bits (402), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 77/200 (38%), Positives = 123/200 (61%), Gaps = 4/200 (2%)
Query: 40  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARVT 98
           R+ Q L   + + ++YQ+ R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 142 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 201
Query: 99  SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR 158
              +    Y+ +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG   V QL 
Sbjct: 202 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 261
Query: 159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF-PNVHPSAIDLVEKMLTFDP 217
            +I+++GTP+  ++  +N N  ++  + P+ +   +T+ F P   P AI L  ++L + P
Sbjct: 262 EIIKVLGTPTREQIREMNPNYTEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 319
Query: 218 RQRITVEDALAHPYLGSLHD 237
             R+T  +A AH +   L D
Sbjct: 320 TARLTPLEACAHSFFDELRD 339

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score =  159 bits (401), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 77/200 (38%), Positives = 123/200 (61%), Gaps = 4/200 (2%)
Query: 40  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARVT 98
           R+ Q L   + + ++YQ+ R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 148 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207
Query: 99  SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR 158
              +    Y+ +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG   V QL 
Sbjct: 208 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 267
Query: 159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF-PNVHPSAIDLVEKMLTFDP 217
            +I+++GTP+  ++  +N N  ++  + P+ +   +T+ F P   P AI L  ++L + P
Sbjct: 268 EIIKVLGTPTREQIREMNPNYTEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 325
Query: 218 RQRITVEDALAHPYLGSLHD 237
             R+T  +A AH +   L D
Sbjct: 326 TARLTPLEACAHSFFDELRD 345

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score =  159 bits (401), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 77/200 (38%), Positives = 123/200 (61%), Gaps = 4/200 (2%)
Query: 40  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARVT 98
           R+ Q L   + + ++YQ+ R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 152 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 211
Query: 99  SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR 158
              +    Y+ +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG   V QL 
Sbjct: 212 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 271
Query: 159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF-PNVHPSAIDLVEKMLTFDP 217
            +I+++GTP+  ++  +N N  ++  + P+ +   +T+ F P   P AI L  ++L + P
Sbjct: 272 EIIKVLGTPTREQIREMNPNYTEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 329
Query: 218 RQRITVEDALAHPYLGSLHD 237
             R+T  +A AH +   L D
Sbjct: 330 TARLTPLEACAHSFFDELRD 349

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score =  159 bits (401), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 77/200 (38%), Positives = 123/200 (61%), Gaps = 4/200 (2%)
Query: 40  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARVT 98
           R+ Q L   + + ++YQ+ R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 127 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 186
Query: 99  SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR 158
              +    Y+ +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG   V QL 
Sbjct: 187 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 246
Query: 159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF-PNVHPSAIDLVEKMLTFDP 217
            +I+++GTP+  ++  +N N  ++  + P+ +   +T+ F P   P AI L  ++L + P
Sbjct: 247 EIIKVLGTPTREQIREMNPNYTEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 304
Query: 218 RQRITVEDALAHPYLGSLHD 237
             R+T  +A AH +   L D
Sbjct: 305 TARLTPLEACAHSFFDELRD 324

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score =  159 bits (401), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 77/200 (38%), Positives = 123/200 (61%), Gaps = 4/200 (2%)
Query: 40  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARVT 98
           R+ Q L   + + ++YQ+ R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 114 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173
Query: 99  SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR 158
              +    Y+ +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG   V QL 
Sbjct: 174 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 233
Query: 159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF-PNVHPSAIDLVEKMLTFDP 217
            +I+++GTP+  ++  +N N  ++  + P+ +   +T+ F P   P AI L  ++L + P
Sbjct: 234 EIIKVLGTPTREQIREMNPNYTEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 291
Query: 218 RQRITVEDALAHPYLGSLHD 237
             R+T  +A AH +   L D
Sbjct: 292 TARLTPLEACAHSFFDELRD 311

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score =  159 bits (401), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 77/200 (38%), Positives = 123/200 (61%), Gaps = 4/200 (2%)
Query: 40  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARVT 98
           R+ Q L   + + ++YQ+ R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 150 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 209
Query: 99  SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR 158
              +    Y+ +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG   V QL 
Sbjct: 210 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 269
Query: 159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF-PNVHPSAIDLVEKMLTFDP 217
            +I+++GTP+  ++  +N N  ++  + P+ +   +T+ F P   P AI L  ++L + P
Sbjct: 270 EIIKVLGTPTREQIREMNPNYTEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 327
Query: 218 RQRITVEDALAHPYLGSLHD 237
             R+T  +A AH +   L D
Sbjct: 328 TARLTPLEACAHSFFDELRD 347

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score =  159 bits (401), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 77/200 (38%), Positives = 123/200 (61%), Gaps = 4/200 (2%)
Query: 40  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARVT 98
           R+ Q L   + + ++YQ+ R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 193 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 252
Query: 99  SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR 158
              +    Y+ +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG   V QL 
Sbjct: 253 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 312
Query: 159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF-PNVHPSAIDLVEKMLTFDP 217
            +I+++GTP+  ++  +N N  ++  + P+ +   +T+ F P   P AI L  ++L + P
Sbjct: 313 EIIKVLGTPTREQIREMNPNYTEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 370
Query: 218 RQRITVEDALAHPYLGSLHD 237
             R+T  +A AH +   L D
Sbjct: 371 TARLTPLEACAHSFFDELRD 390

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score =  159 bits (401), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 77/200 (38%), Positives = 123/200 (61%), Gaps = 4/200 (2%)
Query: 40  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARVT 98
           R+ Q L   + + ++YQ+ R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 114 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173
Query: 99  SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR 158
              +    Y+ +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG   V QL 
Sbjct: 174 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 233
Query: 159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF-PNVHPSAIDLVEKMLTFDP 217
            +I+++GTP+  ++  +N N  ++  + P+ +   +T+ F P   P AI L  ++L + P
Sbjct: 234 EIIKVLGTPTREQIREMNPNYTEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 291
Query: 218 RQRITVEDALAHPYLGSLHD 237
             R+T  +A AH +   L D
Sbjct: 292 TARLTPLEACAHSFFDELRD 311

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score =  158 bits (400), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 77/200 (38%), Positives = 123/200 (61%), Gaps = 4/200 (2%)
Query: 40  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARVT 98
           R+ Q L   + + ++YQ+ R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 119 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 178
Query: 99  SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR 158
              +    Y+ +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG   V QL 
Sbjct: 179 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 238
Query: 159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF-PNVHPSAIDLVEKMLTFDP 217
            +I+++GTP+  ++  +N N  ++  + P+ +   +T+ F P   P AI L  ++L + P
Sbjct: 239 EIIKVLGTPTREQIREMNPNYTEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 296
Query: 218 RQRITVEDALAHPYLGSLHD 237
             R+T  +A AH +   L D
Sbjct: 297 TARLTPLEACAHSFFDELRD 316

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score =  158 bits (399), Expect = 4e-39,   Method: Compositional matrix adjust.
 Identities = 77/200 (38%), Positives = 122/200 (61%), Gaps = 4/200 (2%)
Query: 40  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARVT 98
           R+ Q L   + + ++YQ+ R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 114 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173
Query: 99  SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR 158
              +    Y+ +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG   V QL 
Sbjct: 174 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 233
Query: 159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF-PNVHPSAIDLVEKMLTFDP 217
            +I+++GTP+  ++  +N N  ++    P+ +   +T+ F P   P AI L  ++L + P
Sbjct: 234 EIIKVLGTPTREQIREMNPNYTEF--AFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 291
Query: 218 RQRITVEDALAHPYLGSLHD 237
             R+T  +A AH +   L D
Sbjct: 292 TARLTPLEACAHSFFDELRD 311

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score =  157 bits (397), Expect = 6e-39,   Method: Compositional matrix adjust.
 Identities = 89/247 (36%), Positives = 140/247 (56%), Gaps = 24/247 (9%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN------QALSEEHCQYFL 54
           + HEN+V + D+I      + N + + +E MD DL + + S       + L     +YF 
Sbjct: 60  LKHENIVRLYDVI-----HTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQ 114
Query: 55  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWY 113
           +Q+L+GL + H   +LHRDLKP NLL+N    LK+ DFGLAR      +  +  VVT WY
Sbjct: 115 WQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWY 174
Query: 114 RAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEA--- 170
           RAP++L+ S  Y+ +ID+WS GCI  E++  KPLFPG +   QL+L+ +++GTP+E+   
Sbjct: 175 RAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWP 234
Query: 171 ---ELGFLNENAKKYICQLPRYQRQSFT--EKFPNVHPSAIDLVEKMLTFDPRQRITVED 225
              +L   N N ++   + PR  RQ      K P +  + +D +  +L  +P  R++ + 
Sbjct: 235 SVTKLPKYNPNIQQ---RPPRDLRQVLQPHTKEP-LDGNLMDFLHGLLQLNPDMRLSAKQ 290
Query: 226 ALAHPYL 232
           AL HP+ 
Sbjct: 291 ALHHPWF 297

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score =  157 bits (396), Expect = 9e-39,   Method: Compositional matrix adjust.
 Identities = 74/188 (39%), Positives = 117/188 (62%), Gaps = 4/188 (2%)
Query: 51  QYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARVTSETDFMTEYVV 109
           + ++YQ+LR L YIHS  + HRD+KP NLLL+     LK+ DFG A++    +     + 
Sbjct: 144 KLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXIC 203
Query: 110 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSE 169
           +R+YRAPEL+  +++YT  ID+WS GC+  ELM  +PLFPG   + QL  +I+++GTPS 
Sbjct: 204 SRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSR 263
Query: 170 AELGFLNENAKKYICQLPRYQRQSFTEKF-PNVHPSAIDLVEKMLTFDPRQRITVEDALA 228
            ++  +N N  ++  + P+ +   F++ F P   P AIDL+ ++L + P  R+T  +AL 
Sbjct: 264 EQIKTMNPNYMEH--KFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC 321
Query: 229 HPYLGSLH 236
           HP+   L 
Sbjct: 322 HPFFDELR 329

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score =  156 bits (394), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 79/232 (34%), Positives = 142/232 (61%), Gaps = 6/232 (2%)
Query: 10  RDIIPPPQRESFNDVYIAY--ELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA 67
           + +I  P +  + +V + Y  + +   L   IRS +++       ++YQ+ R + +IHS 
Sbjct: 101 KSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL 160
Query: 68  NVLHRDLKPSNLLLNANCD-LKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYT 126
            + HRD+KP NLL+N+  + LK+CDFG A+    ++     + +R+YRAPEL+L +++YT
Sbjct: 161 GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAXICSRFYRAPELMLGATEYT 220
Query: 127 AAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQL 186
            +ID+WS+GC+F EL+  KPLF G   + QL  +I+++GTP++ ++  +N +  +   + 
Sbjct: 221 PSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTE--VRF 278
Query: 187 PRYQRQSFTEKFPNVHPS-AIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 237
           P  + + + +  P   PS AIDL+E++L ++P  RI   +A+AHP+   L +
Sbjct: 279 PTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRN 330

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score =  155 bits (393), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 76/200 (38%), Positives = 122/200 (61%), Gaps = 4/200 (2%)
Query: 40  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARVT 98
           R+ Q L   + + ++YQ+ R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 114 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173
Query: 99  SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR 158
              +     + +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG   V QL 
Sbjct: 174 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 233
Query: 159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF-PNVHPSAIDLVEKMLTFDP 217
            +I+++GTP+  ++  +N N  ++  + P+ +   +T+ F P   P AI L  ++L + P
Sbjct: 234 EIIKVLGTPTREQIREMNPNYTEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 291
Query: 218 RQRITVEDALAHPYLGSLHD 237
             R+T  +A AH +   L D
Sbjct: 292 TARLTPLEACAHSFFDELRD 311

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score =  155 bits (393), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 76/200 (38%), Positives = 122/200 (61%), Gaps = 4/200 (2%)
Query: 40  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARVT 98
           R+ Q L   + + ++YQ+ R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 148 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 207
Query: 99  SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR 158
              +     + +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG   V QL 
Sbjct: 208 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 267
Query: 159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF-PNVHPSAIDLVEKMLTFDP 217
            +I+++GTP+  ++  +N N  ++  + P+ +   +T+ F P   P AI L  ++L + P
Sbjct: 268 EIIKVLGTPTREQIREMNPNYTEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 325
Query: 218 RQRITVEDALAHPYLGSLHD 237
             R+T  +A AH +   L D
Sbjct: 326 TARLTPLEACAHSFFDELRD 345

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score =  155 bits (393), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 76/200 (38%), Positives = 122/200 (61%), Gaps = 4/200 (2%)
Query: 40  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARVT 98
           R+ Q L   + + ++YQ+ R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 118 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 177
Query: 99  SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR 158
              +     + +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG   V QL 
Sbjct: 178 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 237
Query: 159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF-PNVHPSAIDLVEKMLTFDP 217
            +I+++GTP+  ++  +N N  ++  + P+ +   +T+ F P   P AI L  ++L + P
Sbjct: 238 EIIKVLGTPTREQIREMNPNYTEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 295
Query: 218 RQRITVEDALAHPYLGSLHD 237
             R+T  +A AH +   L D
Sbjct: 296 TARLTPLEACAHSFFDELRD 315

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score =  155 bits (393), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 76/200 (38%), Positives = 122/200 (61%), Gaps = 4/200 (2%)
Query: 40  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARVT 98
           R+ Q L   + + ++YQ+ R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 126 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 185
Query: 99  SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR 158
              +     + +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG   V QL 
Sbjct: 186 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 245
Query: 159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF-PNVHPSAIDLVEKMLTFDP 217
            +I+++GTP+  ++  +N N  ++  + P+ +   +T+ F P   P AI L  ++L + P
Sbjct: 246 EIIKVLGTPTREQIREMNPNYTEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 303
Query: 218 RQRITVEDALAHPYLGSLHD 237
             R+T  +A AH +   L D
Sbjct: 304 TARLTPLEACAHSFFDELRD 323

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score =  155 bits (393), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 76/200 (38%), Positives = 122/200 (61%), Gaps = 4/200 (2%)
Query: 40  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARVT 98
           R+ Q L   + + ++YQ+ R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 133 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 192
Query: 99  SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR 158
              +     + +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG   V QL 
Sbjct: 193 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 252
Query: 159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF-PNVHPSAIDLVEKMLTFDP 217
            +I+++GTP+  ++  +N N  ++  + P+ +   +T+ F P   P AI L  ++L + P
Sbjct: 253 EIIKVLGTPTREQIREMNPNYTEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 310
Query: 218 RQRITVEDALAHPYLGSLHD 237
             R+T  +A AH +   L D
Sbjct: 311 TARLTPLEACAHSFFDELRD 330

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score =  155 bits (393), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 76/200 (38%), Positives = 122/200 (61%), Gaps = 4/200 (2%)
Query: 40  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARVT 98
           R+ Q L   + + ++YQ+ R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 126 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 185
Query: 99  SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR 158
              +     + +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG   V QL 
Sbjct: 186 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 245
Query: 159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF-PNVHPSAIDLVEKMLTFDP 217
            +I+++GTP+  ++  +N N  ++  + P+ +   +T+ F P   P AI L  ++L + P
Sbjct: 246 EIIKVLGTPTREQIREMNPNYTEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 303
Query: 218 RQRITVEDALAHPYLGSLHD 237
             R+T  +A AH +   L D
Sbjct: 304 TARLTPLEACAHSFFDELRD 323

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score =  155 bits (393), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 76/200 (38%), Positives = 122/200 (61%), Gaps = 4/200 (2%)
Query: 40  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARVT 98
           R+ Q L   + + ++YQ+ R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 114 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173
Query: 99  SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR 158
              +     + +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG   V QL 
Sbjct: 174 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 233
Query: 159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF-PNVHPSAIDLVEKMLTFDP 217
            +I+++GTP+  ++  +N N  ++  + P+ +   +T+ F P   P AI L  ++L + P
Sbjct: 234 EIIKVLGTPTREQIREMNPNYTEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 291
Query: 218 RQRITVEDALAHPYLGSLHD 237
             R+T  +A AH +   L D
Sbjct: 292 TARLTPLEACAHSFFDELRD 311

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score =  155 bits (393), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 76/200 (38%), Positives = 122/200 (61%), Gaps = 4/200 (2%)
Query: 40  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARVT 98
           R+ Q L   + + ++YQ+ R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 114 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173
Query: 99  SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR 158
              +     + +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG   V QL 
Sbjct: 174 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 233
Query: 159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF-PNVHPSAIDLVEKMLTFDP 217
            +I+++GTP+  ++  +N N  ++  + P+ +   +T+ F P   P AI L  ++L + P
Sbjct: 234 EIIKVLGTPTREQIREMNPNYTEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 291
Query: 218 RQRITVEDALAHPYLGSLHD 237
             R+T  +A AH +   L D
Sbjct: 292 TARLTPLEACAHSFFDELRD 311

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score =  155 bits (392), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 76/200 (38%), Positives = 122/200 (61%), Gaps = 4/200 (2%)
Query: 40  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARVT 98
           R+ Q L   + + ++YQ+ R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 122 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 181
Query: 99  SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR 158
              +     + +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG   V QL 
Sbjct: 182 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 241
Query: 159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF-PNVHPSAIDLVEKMLTFDP 217
            +I+++GTP+  ++  +N N  ++  + P+ +   +T+ F P   P AI L  ++L + P
Sbjct: 242 EIIKVLGTPTREQIREMNPNYTEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 299
Query: 218 RQRITVEDALAHPYLGSLHD 237
             R+T  +A AH +   L D
Sbjct: 300 TARLTPLEACAHSFFDELRD 319

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score =  155 bits (392), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 76/200 (38%), Positives = 122/200 (61%), Gaps = 4/200 (2%)
Query: 40  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARVT 98
           R+ Q L   + + ++YQ+ R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+  
Sbjct: 115 RAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 174
Query: 99  SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR 158
              +     + +R+YRAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG   V QL 
Sbjct: 175 VRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 234
Query: 159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF-PNVHPSAIDLVEKMLTFDP 217
            +I+++GTP+  ++  +N N  ++  + P+ +   +T+ F P   P AI L  ++L + P
Sbjct: 235 EIIKVLGTPTREQIREMNPNYTEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTP 292
Query: 218 RQRITVEDALAHPYLGSLHD 237
             R+T  +A AH +   L D
Sbjct: 293 TARLTPLEACAHSFFDELRD 312

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score =  155 bits (392), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 85/245 (34%), Positives = 141/245 (57%), Gaps = 11/245 (4%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYEL--MDTDLHQIIR----SNQALSEEHCQYFL 54
           +DH N+V +R        E  ++VY+   L  +   ++++ R    + Q L   + + ++
Sbjct: 70  LDHCNIVRLRYFFYS-SGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYM 128
Query: 55  YQILRGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARVTSETDFMTEYVVTRWY 113
           YQ+ R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+     +     + +R+Y
Sbjct: 129 YQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYY 188
Query: 114 RAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELG 173
           RAPEL+  ++DYT++IDVWS GC+  EL+  +P+FPG   V QL  +I+++GTP+  ++ 
Sbjct: 189 RAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIR 248
Query: 174 FLNENAKKYICQLPRYQRQSFTEKF-PNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
            +N N  ++    P+ +   +T+ F P   P AI L  ++L + P  R+T  +A AH + 
Sbjct: 249 EMNPNYTEF--AFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 306
Query: 233 GSLHD 237
             L D
Sbjct: 307 DELRD 311

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score =  151 bits (382), Expect = 4e-37,   Method: Compositional matrix adjust.
 Identities = 80/243 (32%), Positives = 136/243 (55%), Gaps = 8/243 (3%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILR 59
           + H N+V + ++    +R     +++ +E  D T LH++ R  + + E   +   +Q L+
Sbjct: 59  LKHPNLVNLLEVFRRKRR-----LHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQ 113
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV-TSETDFMTEYVVTRWYRAPEL 118
            + + H  N +HRD+KP N+L+  +  +K+CDFG AR+ T  +D+  + V TRWYR+PEL
Sbjct: 114 AVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPEL 173
Query: 119 LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNEN 178
           L+  + Y   +DVW++GC+F EL+   PL+PG+  V QL L+ + +G          + N
Sbjct: 174 LVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTN 233
Query: 179 AKKYICQLPRYQRQSFTE-KFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 237
                 ++P  +     E KFPN+   A+ L++  L  DP +R+T E  L HPY  ++ +
Sbjct: 234 QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIRE 293
Query: 238 ISD 240
           I D
Sbjct: 294 IED 296

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score =  150 bits (378), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 86/242 (35%), Positives = 128/242 (52%), Gaps = 21/242 (8%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ-ALSEEHCQYFLYQILR 59
           + H N++ + D          +++ + ++ M+TDL  II+ N   L+  H + ++   L+
Sbjct: 69  LSHPNIIGLLDAF-----GHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQ 123
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSETDFMTEYVVTRWYRAPEL 118
           GL+Y+H   +LHRDLKP+NLLL+ N  LK+ DFGLA+   S        VVTRWYRAPEL
Sbjct: 124 GLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVVTRWYRAPEL 183
Query: 119 LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNEN 178
           L  +  Y   +D+W+VGCI  EL+ R P  PG   + QL  + E +GTP+E +       
Sbjct: 184 LFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQW------ 237
Query: 179 AKKYICQLPRYQR-QSFT-----EKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
               +C LP Y   +SF        F       +DL++ +  F+P  RIT   AL   Y 
Sbjct: 238 --PDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF 295
Query: 233 GS 234
            +
Sbjct: 296 SN 297

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score =  150 bits (378), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 86/233 (36%), Positives = 125/233 (53%), Gaps = 6/233 (2%)
Query: 2   DHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ--ALSEEHCQYFLYQILR 59
           +H NVV + D+    + +    V + +E +D DL   +       L  E  +  + Q LR
Sbjct: 72  EHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLR 131
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           GL ++H+  ++HRDLKP N+L+ +   +K+ DFGLAR+ S    +T  VVT WYRAPE+L
Sbjct: 132 GLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVL 191
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENA 179
           L S+ Y   +D+WSVGCIF E+  RKPLF G     QL  + +LIG P E +      + 
Sbjct: 192 LQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD---WPRDV 247
Query: 180 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
                  P    +      P +  S   L+ +MLTF+P +RI+   AL H YL
Sbjct: 248 SLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYL 300

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  148 bits (373), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 85/233 (36%), Positives = 124/233 (53%), Gaps = 6/233 (2%)
Query: 2   DHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ--ALSEEHCQYFLYQILR 59
           +H NVV + D+    + +    V + +E +D DL   +       L  E  +  + Q LR
Sbjct: 64  EHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLR 123
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           GL ++H+  ++HRDLKP N+L+ +   +K+ DFGLAR+ S    +   VVT WYRAPE+L
Sbjct: 124 GLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPVVVTLWYRAPEVL 183
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENA 179
           L S+ Y   +D+WSVGCIF E+  RKPLF G     QL  + +LIG P E +      + 
Sbjct: 184 LQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD---WPRDV 239
Query: 180 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
                  P    +      P +  S   L+ +MLTF+P +RI+   AL H YL
Sbjct: 240 SLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYL 292

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  147 bits (371), Expect = 6e-36,   Method: Compositional matrix adjust.
 Identities = 85/233 (36%), Positives = 124/233 (53%), Gaps = 6/233 (2%)
Query: 2   DHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ--ALSEEHCQYFLYQILR 59
           +H NVV + D+    + +    V + +E +D DL   +       L  E  +  + Q LR
Sbjct: 64  EHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLR 123
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           GL ++H+  ++HRDLKP N+L+ +   +K+ DFGLAR+ S    +   VVT WYRAPE+L
Sbjct: 124 GLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDPVVVTLWYRAPEVL 183
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENA 179
           L S+ Y   +D+WSVGCIF E+  RKPLF G     QL  + +LIG P E +      + 
Sbjct: 184 LQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD---WPRDV 239
Query: 180 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
                  P    +      P +  S   L+ +MLTF+P +RI+   AL H YL
Sbjct: 240 SLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYL 292

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  147 bits (370), Expect = 8e-36,   Method: Compositional matrix adjust.
 Identities = 85/233 (36%), Positives = 124/233 (53%), Gaps = 6/233 (2%)
Query: 2   DHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ--ALSEEHCQYFLYQILR 59
           +H NVV + D+    + +    V + +E +D DL   +       L  E  +  + Q LR
Sbjct: 64  EHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLR 123
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           GL ++H+  ++HRDLKP N+L+ +   +K+ DFGLAR+ S    +   VVT WYRAPE+L
Sbjct: 124 GLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPVVVTLWYRAPEVL 183
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENA 179
           L S+ Y   +D+WSVGCIF E+  RKPLF G     QL  + +LIG P E +      + 
Sbjct: 184 LQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD---WPRDV 239
Query: 180 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
                  P    +      P +  S   L+ +MLTF+P +RI+   AL H YL
Sbjct: 240 SLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYL 292

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score =  140 bits (353), Expect = 9e-34,   Method: Compositional matrix adjust.
 Identities = 79/235 (33%), Positives = 129/235 (54%), Gaps = 12/235 (5%)
Query: 3   HENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGL 61
           HEN+V + ++    +R      Y+ +E +D T L  +      L  +  Q +L+QI+ G+
Sbjct: 83  HENLVNLLEVCKKKKR-----WYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGI 137
Query: 62  KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSETDFMTEYVVTRWYRAPELLL 120
            + HS N++HRD+KP N+L++ +  +K+CDFG AR + +  +   + V TRWYRAPELL+
Sbjct: 138 GFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLV 197
Query: 121 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGT--PSEAELGFLNEN 178
               Y  A+DVW++GC+  E+   +PLFPG   + QL  ++  +G   P   EL   N+N
Sbjct: 198 GDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQEL--FNKN 255
Query: 179 AKKYICQLPRY-QRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
                 +LP   +R+    ++P +    IDL +K L  DP +R    + L H + 
Sbjct: 256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFF 310

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score =  136 bits (343), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 79/251 (31%), Positives = 127/251 (50%), Gaps = 37/251 (14%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRG 60
           + H N++ ++ +I    R     +++ +E  + DL + +  N  +S    + FLYQ++ G
Sbjct: 90  LQHRNIIELKSVIHHNHR-----LHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLING 144
Query: 61  LKYIHSANVLHRDLKPSNLLLNANCD-----LKICDFGLARVTS-ETDFMTEYVVTRWYR 114
           + + HS   LHRDLKP NLLL+ +       LKI DFGLAR         T  ++T WYR
Sbjct: 145 VNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYR 204
Query: 115 APELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGF 174
            PE+LL S  Y+ ++D+WS+ CI+ E++ + PLFPG   + QL  + E++G P       
Sbjct: 205 PPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLP------- 257
Query: 175 LNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLV-------------EKMLTFDPRQRI 221
            ++     +  LP ++     + FP      +  V               ML  DP +RI
Sbjct: 258 -DDTTWPGVTALPDWK-----QSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRI 311
Query: 222 TVEDALAHPYL 232
           + ++AL HPY 
Sbjct: 312 SAKNALEHPYF 322

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score =  135 bits (339), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 73/196 (37%), Positives = 113/196 (57%), Gaps = 13/196 (6%)
Query: 51  QYFLYQILRGLKYIH--SANVLHRDLKPSNLLLN-ANCDLKICDFGLARVTSETDFMTEY 107
           + FL+Q++R +  +H  S NV HRD+KP N+L+N A+  LK+CDFG A+  S ++    Y
Sbjct: 132 KVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAY 191
Query: 108 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTP 167
           + +R+YRAPEL+  +  YT A+D+WSVGCIF E+M  +P+F G +   QL  ++ ++G P
Sbjct: 192 ICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCP 251
Query: 168 SEAELGFLNENAKKYICQLPRYQRQS------FTEKFPNVHPSAIDLVEKMLTFDPRQRI 221
           S   L  LN +       +  Y  +       F++        A DL+  +L + P +R+
Sbjct: 252 SREVLRKLNPSHT----DVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERM 307
Query: 222 TVEDALAHPYLGSLHD 237
              +AL HPY   LHD
Sbjct: 308 KPYEALCHPYFDELHD 323

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score =  134 bits (337), Expect = 6e-32,   Method: Compositional matrix adjust.
 Identities = 82/247 (33%), Positives = 126/247 (51%), Gaps = 15/247 (6%)
Query: 1   MDHENVVAIRDII---PPPQRESFNDVYIAYELMDTDLHQIIRS---NQALSEEHCQYFL 54
           + HENVV + +I      P       +Y+ ++  + DL  ++ +      LSE   +  +
Sbjct: 74  LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSE--IKRVM 131
Query: 55  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV-----TSETDFMTEYVV 109
             +L GL YIH   +LHRD+K +N+L+  +  LK+ DFGLAR       S+ +     VV
Sbjct: 132 QMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV 191
Query: 110 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSE 169
           T WYR PELLL   DY   ID+W  GCI  E+  R P+  G    HQL L+ +L G+ + 
Sbjct: 192 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 251
Query: 170 AELGFLNENAKKYICQLPRYQRQSFTEKFPNV--HPSAIDLVEKMLTFDPRQRITVEDAL 227
                ++        +L + Q++   ++       P A+DL++K+L  DP QRI  +DAL
Sbjct: 252 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 311
Query: 228 AHPYLGS 234
            H +  S
Sbjct: 312 NHDFFWS 318

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score =  134 bits (336), Expect = 6e-32,   Method: Compositional matrix adjust.
 Identities = 82/247 (33%), Positives = 126/247 (51%), Gaps = 15/247 (6%)
Query: 1   MDHENVVAIRDII---PPPQRESFNDVYIAYELMDTDLHQIIRS---NQALSEEHCQYFL 54
           + HENVV + +I      P       +Y+ ++  + DL  ++ +      LSE   +  +
Sbjct: 73  LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSE--IKRVM 130
Query: 55  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV-----TSETDFMTEYVV 109
             +L GL YIH   +LHRD+K +N+L+  +  LK+ DFGLAR       S+ +     VV
Sbjct: 131 QMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV 190
Query: 110 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSE 169
           T WYR PELLL   DY   ID+W  GCI  E+  R P+  G    HQL L+ +L G+ + 
Sbjct: 191 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 250
Query: 170 AELGFLNENAKKYICQLPRYQRQSFTEKFPNV--HPSAIDLVEKMLTFDPRQRITVEDAL 227
                ++        +L + Q++   ++       P A+DL++K+L  DP QRI  +DAL
Sbjct: 251 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 310
Query: 228 AHPYLGS 234
            H +  S
Sbjct: 311 NHDFFWS 317

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score =  134 bits (336), Expect = 7e-32,   Method: Compositional matrix adjust.
 Identities = 82/247 (33%), Positives = 126/247 (51%), Gaps = 15/247 (6%)
Query: 1   MDHENVVAIRDII---PPPQRESFNDVYIAYELMDTDLHQIIRS---NQALSEEHCQYFL 54
           + HENVV + +I      P       +Y+ ++  + DL  ++ +      LSE   +  +
Sbjct: 74  LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSE--IKRVM 131
Query: 55  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV-----TSETDFMTEYVV 109
             +L GL YIH   +LHRD+K +N+L+  +  LK+ DFGLAR       S+ +     VV
Sbjct: 132 QMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV 191
Query: 110 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSE 169
           T WYR PELLL   DY   ID+W  GCI  E+  R P+  G    HQL L+ +L G+ + 
Sbjct: 192 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 251
Query: 170 AELGFLNENAKKYICQLPRYQRQSFTEKFPNV--HPSAIDLVEKMLTFDPRQRITVEDAL 227
                ++        +L + Q++   ++       P A+DL++K+L  DP QRI  +DAL
Sbjct: 252 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 311
Query: 228 AHPYLGS 234
            H +  S
Sbjct: 312 NHDFFWS 318

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score =  133 bits (334), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 82/247 (33%), Positives = 126/247 (51%), Gaps = 15/247 (6%)
Query: 1   MDHENVVAIRDII---PPPQRESFNDVYIAYELMDTDLHQIIRS---NQALSEEHCQYFL 54
           + HENVV + +I      P       +Y+ ++  + DL  ++ +      LSE   +  +
Sbjct: 74  LKHENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSE--IKRVM 131
Query: 55  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV-----TSETDFMTEYVV 109
             +L GL YIH   +LHRD+K +N+L+  +  LK+ DFGLAR       S+ +     VV
Sbjct: 132 QMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV 191
Query: 110 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSE 169
           T WYR PELLL   DY   ID+W  GCI  E+  R P+  G    HQL L+ +L G+ + 
Sbjct: 192 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 251
Query: 170 AELGFLNENAKKYICQLPRYQRQSFTEKFPNV--HPSAIDLVEKMLTFDPRQRITVEDAL 227
                ++        +L + Q++   ++       P A+DL++K+L  DP QRI  +DAL
Sbjct: 252 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 311
Query: 228 AHPYLGS 234
            H +  S
Sbjct: 312 NHDFFWS 318

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score =  126 bits (317), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 87/270 (32%), Positives = 139/270 (51%), Gaps = 45/270 (16%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQA---------LSEEHCQ 51
           + H NV++++ +       +   V++ ++  + DL  II+ ++A         L     +
Sbjct: 75  LKHPNVISLQKVF---LSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVK 131
Query: 52  YFLYQILRGLKYIHSANVLHRDLKPSNLLLNA----NCDLKICDFGLARVTSET----DF 103
             LYQIL G+ Y+H+  VLHRDLKP+N+L+         +KI D G AR+ +        
Sbjct: 132 SLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLAD 191
Query: 104 MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD---------HV 154
           +   VVT WYRAPELLL +  YT AID+W++GCIF EL+  +P+F  R          H 
Sbjct: 192 LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHH 251
Query: 155 HQLRLLIELIGTPSEAELGFLNENAKK---YICQLPRYQRQSFTE----KFPNVH----- 202
            QL  +  ++G P++ +     E+ KK   +   +  ++R ++T     K+   H     
Sbjct: 252 DQLDRIFNVMGFPADKDW----EDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPD 307
Query: 203 PSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
             A  L++K+LT DP +RIT E A+  PY 
Sbjct: 308 SKAFHLLQKLLTMDPIKRITSEQAMQDPYF 337

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score =  117 bits (294), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 72/216 (33%), Positives = 112/216 (51%), Gaps = 31/216 (14%)
Query: 23  DVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 81
           D YI  ELM+  +L   +  N+ L E  C+ + YQ+L  ++Y+H   ++HRDLKP N+LL
Sbjct: 88  DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLL 147
Query: 82  NA---NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLN--SSDYTAAIDVWSVGC 136
           ++   +C +KI DFG +++  ET  M     T  Y APE+L++  ++ Y  A+D WS+G 
Sbjct: 148 SSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGV 207
Query: 137 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 196
           I    +   P  P  +H  Q+ L  ++               + KY             E
Sbjct: 208 ILFICLSGYP--PFSEHRTQVSLKDQI--------------TSGKY---------NFIPE 242
Query: 197 KFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
            +  V   A+DLV+K+L  DP+ R T E+AL HP+L
Sbjct: 243 VWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 278

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score =  117 bits (294), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 72/216 (33%), Positives = 112/216 (51%), Gaps = 31/216 (14%)
Query: 23  DVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 81
           D YI  ELM+  +L   +  N+ L E  C+ + YQ+L  ++Y+H   ++HRDLKP N+LL
Sbjct: 88  DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLL 147
Query: 82  NA---NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLN--SSDYTAAIDVWSVGC 136
           ++   +C +KI DFG +++  ET  M     T  Y APE+L++  ++ Y  A+D WS+G 
Sbjct: 148 SSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGV 207
Query: 137 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 196
           I    +   P  P  +H  Q+ L  ++               + KY             E
Sbjct: 208 ILFICLSGYP--PFSEHRTQVSLKDQI--------------TSGKY---------NFIPE 242
Query: 197 KFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
            +  V   A+DLV+K+L  DP+ R T E+AL HP+L
Sbjct: 243 VWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 278

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score =  117 bits (294), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 71/243 (29%), Positives = 129/243 (53%), Gaps = 26/243 (10%)
Query: 5   NVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 64
           N++ + DI+  P   S     +   + +TD  Q+    Q L++   ++++Y+IL+ L Y 
Sbjct: 93  NIITLADIVKDPV--SRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYC 147
Query: 65  HSANVLHRDLKPSNLLLN-ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 123
           HS  ++HRD+KP N+L++  +  L++ D+GLA            V +R+++ PELL++  
Sbjct: 148 HSMGIMHRDVKPHNVLIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 124 DYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKY 182
            Y  ++D+WS+GC+   ++ RK P F G D+  QL  + +++GT        L +   KY
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED------LYDYIDKY 261
Query: 183 ICQL-------------PRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 229
             +L              R++R   +E    V P A+D ++K+L +D + R+T  +A+ H
Sbjct: 262 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 321
Query: 230 PYL 232
           PY 
Sbjct: 322 PYF 324

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score =  117 bits (294), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 72/216 (33%), Positives = 112/216 (51%), Gaps = 31/216 (14%)
Query: 23  DVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 81
           D YI  ELM+  +L   +  N+ L E  C+ + YQ+L  ++Y+H   ++HRDLKP N+LL
Sbjct: 88  DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLL 147
Query: 82  NA---NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLN--SSDYTAAIDVWSVGC 136
           ++   +C +KI DFG +++  ET  M     T  Y APE+L++  ++ Y  A+D WS+G 
Sbjct: 148 SSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGV 207
Query: 137 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 196
           I    +   P  P  +H  Q+ L  ++               + KY             E
Sbjct: 208 ILFICLSGYP--PFSEHRTQVSLKDQI--------------TSGKY---------NFIPE 242
Query: 197 KFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
            +  V   A+DLV+K+L  DP+ R T E+AL HP+L
Sbjct: 243 VWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 278

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score =  117 bits (294), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 116/205 (56%), Gaps = 23/205 (11%)
Query: 44  ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANC-DLKICDFGLARVTSETD 102
            L++   +Y++Y++L+ L Y HS  ++HRD+KP N++++     L++ D+GLA       
Sbjct: 142 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 201
Query: 103 FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLLI 161
                V +R+++ PELL++  DY  ++D+WS+GC+F  ++ RK P F G D+  QL  + 
Sbjct: 202 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 261
Query: 162 ELIGTPSEAELGFLNENAKKYICQL--------PRYQRQSFTEKFPN------VHPSAID 207
           +++GT        LN    KY  +L         R+ R+ +  KF N      V P AID
Sbjct: 262 KVLGTDG------LNAYLNKYRIELDPQLEALVGRHSRKPWL-KFMNADNQHLVSPEAID 314
Query: 208 LVEKMLTFDPRQRITVEDALAHPYL 232
            ++K+L +D ++R+T  +A+ HPY 
Sbjct: 315 FLDKLLRYDHQERLTALEAMTHPYF 339

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score =  117 bits (294), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 74/238 (31%), Positives = 120/238 (50%), Gaps = 37/238 (15%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILR 59
           ++H  ++ I++           D YI  ELM+  +L   +  N+ L E  C+ + YQ+L 
Sbjct: 78  LNHPCIIKIKNFF------DAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL 131
Query: 60  GLKYIHSANVLHRDLKPSNLLLNA---NCDLKICDFGLARVTSETDFMTEYVVTRWYRAP 116
            ++Y+H   ++HRDLKP N+LL++   +C +KI DFG +++  ET  M     T  Y AP
Sbjct: 132 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 191
Query: 117 ELLLN--SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGF 174
           E+L++  ++ Y  A+D WS+G I    +   P  P  +H  Q+ L  ++           
Sbjct: 192 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYP--PFSEHRTQVSLKDQI----------- 238
Query: 175 LNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
               + KY             E +  V   A+DLV+K+L  DP+ R T E+AL HP+L
Sbjct: 239 ---TSGKY---------NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 284

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score =  117 bits (294), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 72/216 (33%), Positives = 112/216 (51%), Gaps = 31/216 (14%)
Query: 23  DVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 81
           D YI  ELM+  +L   +  N+ L E  C+ + YQ+L  ++Y+H   ++HRDLKP N+LL
Sbjct: 87  DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLL 146
Query: 82  NA---NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLN--SSDYTAAIDVWSVGC 136
           ++   +C +KI DFG +++  ET  M     T  Y APE+L++  ++ Y  A+D WS+G 
Sbjct: 147 SSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGV 206
Query: 137 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 196
           I    +   P  P  +H  Q+ L  ++               + KY             E
Sbjct: 207 ILFICLSGYP--PFSEHRTQVSLKDQI--------------TSGKY---------NFIPE 241
Query: 197 KFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
            +  V   A+DLV+K+L  DP+ R T E+AL HP+L
Sbjct: 242 VWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 277

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score =  117 bits (293), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 72/243 (29%), Positives = 137/243 (56%), Gaps = 26/243 (10%)
Query: 5   NVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 64
           N++ + D +  P  ++   V+    + +TD  Q+    Q L++   ++++Y++L+ L Y 
Sbjct: 94  NIIKLIDTVKDPVSKTPALVFEY--INNTDFKQLY---QILTDFDIRFYMYELLKALDYC 148
Query: 65  HSANVLHRDLKPSNLLLN-ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 123
           HS  ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++  
Sbjct: 149 HSKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQ 208
Query: 124 DYTAAIDVWSVGCIFMELM-DRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKY 182
            Y  ++D+WS+GC+   ++  R+P F G+D+  QL  + +++GT  E   G+L    KKY
Sbjct: 209 MYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGT--EELYGYL----KKY 262
Query: 183 -----------ICQLPRYQRQSF--TEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 229
                      + Q  R + ++F  +E    V P A+DL++K+L +D +QR+T ++A+ H
Sbjct: 263 HIDLDPHFNDILGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEH 322
Query: 230 PYL 232
           PY 
Sbjct: 323 PYF 325

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score =  117 bits (293), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 70/243 (28%), Positives = 129/243 (53%), Gaps = 26/243 (10%)
Query: 5   NVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 64
           N++ + DI+  P   S     +   + +TD  Q+    Q L++   ++++Y+IL+ L Y 
Sbjct: 93  NIITLADIVKDPV--SRTPALVFEHVNNTDFKQL---RQTLTDYDIRFYMYEILKALDYC 147
Query: 65  HSANVLHRDLKPSNLLLN-ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 123
           HS  ++HRD+KP N++++  +  L++ D+GLA            V +R+++ PELL++  
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 124 DYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKY 182
            Y  ++D+WS+GC+   ++ RK P F G D+  QL  + +++GT        L +   KY
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED------LYDYIDKY 261
Query: 183 ICQL-------------PRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 229
             +L              R++R   +E    V P A+D ++K+L +D + R+T  +A+ H
Sbjct: 262 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 321
Query: 230 PYL 232
           PY 
Sbjct: 322 PYF 324

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score =  117 bits (293), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 72/243 (29%), Positives = 137/243 (56%), Gaps = 26/243 (10%)
Query: 5   NVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 64
           N++ + D +  P  ++   V+    + +TD  Q+    Q L++   ++++Y++L+ L Y 
Sbjct: 99  NIIKLIDTVKDPVSKTPALVFEY--INNTDFKQLY---QILTDFDIRFYMYELLKALDYC 153
Query: 65  HSANVLHRDLKPSNLLLN-ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 123
           HS  ++HRD+KP N++++     L++ D+GLA            V +R+++ PELL++  
Sbjct: 154 HSKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEYNVRVASRYFKGPELLVDYQ 213
Query: 124 DYTAAIDVWSVGCIFMELM-DRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKY 182
            Y  ++D+WS+GC+   ++  R+P F G+D+  QL  + +++GT  E   G+L    KKY
Sbjct: 214 MYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGT--EELYGYL----KKY 267
Query: 183 -----------ICQLPRYQRQSF--TEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 229
                      + Q  R + ++F  +E    V P A+DL++K+L +D +QR+T ++A+ H
Sbjct: 268 HIDLDPHFNDILGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEAMEH 327
Query: 230 PYL 232
           PY 
Sbjct: 328 PYF 330

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score =  117 bits (293), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 70/243 (28%), Positives = 129/243 (53%), Gaps = 26/243 (10%)
Query: 5   NVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 64
           N++ + DI+  P   S     +   + +TD  Q+    Q L++   ++++Y+IL+ L Y 
Sbjct: 93  NIITLADIVKDPV--SRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYC 147
Query: 65  HSANVLHRDLKPSNLLLN-ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 123
           HS  ++HRD+KP N++++  +  L++ D+GLA            V +R+++ PELL++  
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 124 DYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKY 182
            Y  ++D+WS+GC+   ++ RK P F G D+  QL  + +++GT        L +   KY
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED------LYDYIDKY 261
Query: 183 ICQL-------------PRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 229
             +L              R++R   +E    V P A+D ++K+L +D + R+T  +A+ H
Sbjct: 262 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 321
Query: 230 PYL 232
           PY 
Sbjct: 322 PYF 324

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score =  117 bits (293), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 70/243 (28%), Positives = 129/243 (53%), Gaps = 26/243 (10%)
Query: 5   NVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 64
           N++ + DI+  P   S     +   + +TD  Q+    Q L++   ++++Y+IL+ L Y 
Sbjct: 93  NIITLADIVKDPV--SRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYC 147
Query: 65  HSANVLHRDLKPSNLLLN-ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 123
           HS  ++HRD+KP N++++  +  L++ D+GLA            V +R+++ PELL++  
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 124 DYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKY 182
            Y  ++D+WS+GC+   ++ RK P F G D+  QL  + +++GT        L +   KY
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED------LYDYIDKY 261
Query: 183 ICQL-------------PRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 229
             +L              R++R   +E    V P A+D ++K+L +D + R+T  +A+ H
Sbjct: 262 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 321
Query: 230 PYL 232
           PY 
Sbjct: 322 PYF 324

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score =  117 bits (293), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 70/243 (28%), Positives = 129/243 (53%), Gaps = 26/243 (10%)
Query: 5   NVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 64
           N++ + DI+  P   S     +   + +TD  Q+    Q L++   ++++Y+IL+ L Y 
Sbjct: 93  NIITLADIVKDPV--SRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYC 147
Query: 65  HSANVLHRDLKPSNLLLN-ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 123
           HS  ++HRD+KP N++++  +  L++ D+GLA            V +R+++ PELL++  
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 124 DYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKY 182
            Y  ++D+WS+GC+   ++ RK P F G D+  QL  + +++GT        L +   KY
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED------LYDYIDKY 261
Query: 183 ICQL-------------PRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 229
             +L              R++R   +E    V P A+D ++K+L +D + R+T  +A+ H
Sbjct: 262 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 321
Query: 230 PYL 232
           PY 
Sbjct: 322 PYF 324

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score =  117 bits (293), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 70/243 (28%), Positives = 129/243 (53%), Gaps = 26/243 (10%)
Query: 5   NVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 64
           N++ + DI+  P   S     +   + +TD  Q+    Q L++   ++++Y+IL+ L Y 
Sbjct: 93  NIITLADIVKDPV--SRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYC 147
Query: 65  HSANVLHRDLKPSNLLLN-ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 123
           HS  ++HRD+KP N++++  +  L++ D+GLA            V +R+++ PELL++  
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 124 DYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKY 182
            Y  ++D+WS+GC+   ++ RK P F G D+  QL  + +++GT        L +   KY
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED------LYDYIDKY 261
Query: 183 ICQL-------------PRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 229
             +L              R++R   +E    V P A+D ++K+L +D + R+T  +A+ H
Sbjct: 262 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 321
Query: 230 PYL 232
           PY 
Sbjct: 322 PYF 324

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score =  117 bits (293), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 70/243 (28%), Positives = 129/243 (53%), Gaps = 26/243 (10%)
Query: 5   NVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 64
           N++ + DI+  P   S     +   + +TD  Q+    Q L++   ++++Y+IL+ L Y 
Sbjct: 92  NIITLADIVKDPV--SRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYC 146
Query: 65  HSANVLHRDLKPSNLLLN-ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 123
           HS  ++HRD+KP N++++  +  L++ D+GLA            V +R+++ PELL++  
Sbjct: 147 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 206
Query: 124 DYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKY 182
            Y  ++D+WS+GC+   ++ RK P F G D+  QL  + +++GT        L +   KY
Sbjct: 207 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED------LYDYIDKY 260
Query: 183 ICQL-------------PRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 229
             +L              R++R   +E    V P A+D ++K+L +D + R+T  +A+ H
Sbjct: 261 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320
Query: 230 PYL 232
           PY 
Sbjct: 321 PYF 323

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score =  117 bits (293), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 70/243 (28%), Positives = 129/243 (53%), Gaps = 26/243 (10%)
Query: 5   NVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 64
           N++ + DI+  P   S     +   + +TD  Q+    Q L++   ++++Y+IL+ L Y 
Sbjct: 93  NIITLADIVKDPV--SRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYC 147
Query: 65  HSANVLHRDLKPSNLLLN-ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 123
           HS  ++HRD+KP N++++  +  L++ D+GLA            V +R+++ PELL++  
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 124 DYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKY 182
            Y  ++D+WS+GC+   ++ RK P F G D+  QL  + +++GT        L +   KY
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED------LYDYIDKY 261
Query: 183 ICQL-------------PRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 229
             +L              R++R   +E    V P A+D ++K+L +D + R+T  +A+ H
Sbjct: 262 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 321
Query: 230 PYL 232
           PY 
Sbjct: 322 PYF 324

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score =  117 bits (293), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 70/246 (28%), Positives = 131/246 (53%), Gaps = 26/246 (10%)
Query: 5   NVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 64
           N++ + DI+  P   S     +   + +TD  Q+    Q L++   ++++Y+IL+ L Y 
Sbjct: 93  NIITLADIVKDPV--SRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYC 147
Query: 65  HSANVLHRDLKPSNLLLN-ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 123
           HS  ++HRD+KP N++++  +  L++ D+GLA            V +R+++ PELL++  
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 124 DYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKY 182
            Y  ++D+WS+GC+   ++ RK P F G D+  QL  + +++GT        L +   KY
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED------LYDYIDKY 261
Query: 183 ICQL-------------PRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 229
             +L              R++R   +E    V P A+D ++K+L +D + R+T  +A+ H
Sbjct: 262 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 321
Query: 230 PYLGSL 235
           PY  ++
Sbjct: 322 PYFYTV 327

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score =  117 bits (293), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 70/246 (28%), Positives = 131/246 (53%), Gaps = 26/246 (10%)
Query: 5   NVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 64
           N++ + DI+  P   S     +   + +TD  Q+    Q L++   ++++Y+IL+ L Y 
Sbjct: 93  NIITLADIVKDPV--SRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYC 147
Query: 65  HSANVLHRDLKPSNLLLN-ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 123
           HS  ++HRD+KP N++++  +  L++ D+GLA            V +R+++ PELL++  
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 124 DYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKY 182
            Y  ++D+WS+GC+   ++ RK P F G D+  QL  + +++GT        L +   KY
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED------LYDYIDKY 261
Query: 183 ICQL-------------PRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 229
             +L              R++R   +E    V P A+D ++K+L +D + R+T  +A+ H
Sbjct: 262 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 321
Query: 230 PYLGSL 235
           PY  ++
Sbjct: 322 PYFYTV 327

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score =  117 bits (293), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 70/243 (28%), Positives = 129/243 (53%), Gaps = 26/243 (10%)
Query: 5   NVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 64
           N++ + DI+  P   S     +   + +TD  Q+    Q L++   ++++Y+IL+ L Y 
Sbjct: 92  NIITLADIVKDPV--SRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYC 146
Query: 65  HSANVLHRDLKPSNLLLN-ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 123
           HS  ++HRD+KP N++++  +  L++ D+GLA            V +R+++ PELL++  
Sbjct: 147 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 206
Query: 124 DYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKY 182
            Y  ++D+WS+GC+   ++ RK P F G D+  QL  + +++GT        L +   KY
Sbjct: 207 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED------LYDYIDKY 260
Query: 183 ICQL-------------PRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 229
             +L              R++R   +E    V P A+D ++K+L +D + R+T  +A+ H
Sbjct: 261 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 320
Query: 230 PYL 232
           PY 
Sbjct: 321 PYF 323

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score =  117 bits (293), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 116/205 (56%), Gaps = 23/205 (11%)
Query: 44  ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANC-DLKICDFGLARVTSETD 102
            L++   +Y++Y++L+ L Y HS  ++HRD+KP N++++     L++ D+GLA       
Sbjct: 122 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 181
Query: 103 FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLLI 161
                V +R+++ PELL++  DY  ++D+WS+GC+F  ++ RK P F G D+  QL  + 
Sbjct: 182 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 241
Query: 162 ELIGTPSEAELGFLNENAKKYICQL--------PRYQRQSFTEKFPN------VHPSAID 207
           +++GT        LN    KY  +L         R+ R+ +  KF N      V P AID
Sbjct: 242 KVLGTDG------LNVYLNKYRIELDPQLEALVGRHSRKPWL-KFMNADNQHLVSPEAID 294
Query: 208 LVEKMLTFDPRQRITVEDALAHPYL 232
            ++K+L +D ++R+T  +A+ HPY 
Sbjct: 295 FLDKLLRYDHQERLTALEAMTHPYF 319

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score =  117 bits (293), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 73/238 (30%), Positives = 121/238 (50%), Gaps = 37/238 (15%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILR 59
           ++H  ++ I++           D YI  ELM+  +L   +  N+ L E  C+ + YQ+L 
Sbjct: 211 LNHPCIIKIKNFFDA------EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL 264
Query: 60  GLKYIHSANVLHRDLKPSNLLLNA---NCDLKICDFGLARVTSETDFMTEYVVTRWYRAP 116
            ++Y+H   ++HRDLKP N+LL++   +C +KI DFG +++  ET  M     T  Y AP
Sbjct: 265 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 324
Query: 117 ELLLN--SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGF 174
           E+L++  ++ Y  A+D WS+G I    +   P  P  +H  Q+ L  ++    +  +  F
Sbjct: 325 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYP--PFSEHRTQVSLKDQI----TSGKYNF 378
Query: 175 LNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
           +                    E +  V   A+DLV+K+L  DP+ R T E+AL HP+L
Sbjct: 379 I-------------------PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 417

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score =  117 bits (293), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 70/243 (28%), Positives = 129/243 (53%), Gaps = 26/243 (10%)
Query: 5   NVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 64
           N++ + DI+  P   S     +   + +TD  Q+    Q L++   ++++Y+IL+ L Y 
Sbjct: 98  NIITLADIVKDPV--SRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYC 152
Query: 65  HSANVLHRDLKPSNLLLN-ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 123
           HS  ++HRD+KP N++++  +  L++ D+GLA            V +R+++ PELL++  
Sbjct: 153 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 212
Query: 124 DYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKY 182
            Y  ++D+WS+GC+   ++ RK P F G D+  QL  + +++GT        L +   KY
Sbjct: 213 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED------LYDYIDKY 266
Query: 183 ICQL-------------PRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 229
             +L              R++R   +E    V P A+D ++K+L +D + R+T  +A+ H
Sbjct: 267 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 326
Query: 230 PYL 232
           PY 
Sbjct: 327 PYF 329

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score =  117 bits (292), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 116/205 (56%), Gaps = 23/205 (11%)
Query: 44  ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANC-DLKICDFGLARVTSETD 102
            L++   +Y++Y++L+ L Y HS  ++HRD+KP N++++     L++ D+GLA       
Sbjct: 121 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 180
Query: 103 FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLLI 161
                V +R+++ PELL++  DY  ++D+WS+GC+F  ++ RK P F G D+  QL  + 
Sbjct: 181 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 240
Query: 162 ELIGTPSEAELGFLNENAKKYICQL--------PRYQRQSFTEKFPN------VHPSAID 207
           +++GT        LN    KY  +L         R+ R+ +  KF N      V P AID
Sbjct: 241 KVLGTDG------LNVYLNKYRIELDPQLEALVGRHSRKPWL-KFMNADNQHLVSPEAID 293
Query: 208 LVEKMLTFDPRQRITVEDALAHPYL 232
            ++K+L +D ++R+T  +A+ HPY 
Sbjct: 294 FLDKLLRYDHQERLTALEAMTHPYF 318

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score =  117 bits (292), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 73/238 (30%), Positives = 121/238 (50%), Gaps = 37/238 (15%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILR 59
           ++H  ++ I++           D YI  ELM+  +L   +  N+ L E  C+ + YQ+L 
Sbjct: 197 LNHPCIIKIKNFFDA------EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL 250
Query: 60  GLKYIHSANVLHRDLKPSNLLLNA---NCDLKICDFGLARVTSETDFMTEYVVTRWYRAP 116
            ++Y+H   ++HRDLKP N+LL++   +C +KI DFG +++  ET  M     T  Y AP
Sbjct: 251 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 310
Query: 117 ELLLN--SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGF 174
           E+L++  ++ Y  A+D WS+G I    +   P  P  +H  Q+ L  ++    +  +  F
Sbjct: 311 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYP--PFSEHRTQVSLKDQI----TSGKYNF 364
Query: 175 LNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
           +                    E +  V   A+DLV+K+L  DP+ R T E+AL HP+L
Sbjct: 365 I-------------------PEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 403

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score =  117 bits (292), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 116/205 (56%), Gaps = 23/205 (11%)
Query: 44  ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANC-DLKICDFGLARVTSETD 102
            L++   +Y++Y++L+ L Y HS  ++HRD+KP N++++     L++ D+GLA       
Sbjct: 121 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 180
Query: 103 FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLLI 161
                V +R+++ PELL++  DY  ++D+WS+GC+F  ++ RK P F G D+  QL  + 
Sbjct: 181 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 240
Query: 162 ELIGTPSEAELGFLNENAKKYICQL--------PRYQRQSFTEKFPN------VHPSAID 207
           +++GT        LN    KY  +L         R+ R+ +  KF N      V P AID
Sbjct: 241 KVLGTDG------LNVYLNKYRIELDPQLEALVGRHSRKPWL-KFMNADNQHLVSPEAID 293
Query: 208 LVEKMLTFDPRQRITVEDALAHPYL 232
            ++K+L +D ++R+T  +A+ HPY 
Sbjct: 294 FLDKLLRYDHQERLTALEAMTHPYF 318

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score =  117 bits (292), Expect = 9e-27,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 116/205 (56%), Gaps = 23/205 (11%)
Query: 44  ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANC-DLKICDFGLARVTSETD 102
            L++   +Y++Y++L+ L Y HS  ++HRD+KP N++++     L++ D+GLA       
Sbjct: 121 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 180
Query: 103 FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLLI 161
                V +R+++ PELL++  DY  ++D+WS+GC+F  ++ RK P F G D+  QL  + 
Sbjct: 181 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 240
Query: 162 ELIGTPSEAELGFLNENAKKYICQL--------PRYQRQSFTEKFPN------VHPSAID 207
           +++GT        LN    KY  +L         R+ R+ +  KF N      V P AID
Sbjct: 241 KVLGTDG------LNVYLNKYRIELDPQLEALVGRHSRKPWL-KFMNADNQHLVSPEAID 293
Query: 208 LVEKMLTFDPRQRITVEDALAHPYL 232
            ++K+L +D ++R+T  +A+ HPY 
Sbjct: 294 FLDKLLRYDHQERLTALEAMTHPYF 318

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score =  117 bits (292), Expect = 9e-27,   Method: Compositional matrix adjust.
 Identities = 70/246 (28%), Positives = 131/246 (53%), Gaps = 26/246 (10%)
Query: 5   NVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 64
           N++ + DI+  P   S     +   + +TD  Q+    Q L++   ++++Y+IL+ L Y 
Sbjct: 91  NIITLADIVKDPV--SRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYC 145
Query: 65  HSANVLHRDLKPSNLLLN-ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 123
           HS  ++HRD+KP N++++  +  L++ D+GLA            V +R+++ PELL++  
Sbjct: 146 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 205
Query: 124 DYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKY 182
            Y  ++D+WS+GC+   ++ RK P F G D+  QL  + +++GT        L +   KY
Sbjct: 206 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED------LYDYIDKY 259
Query: 183 ICQL-------------PRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 229
             +L              R++R   +E    V P A+D ++K+L +D + R+T  +A+ H
Sbjct: 260 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 319
Query: 230 PYLGSL 235
           PY  ++
Sbjct: 320 PYFYTV 325

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score =  117 bits (292), Expect = 9e-27,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 116/205 (56%), Gaps = 23/205 (11%)
Query: 44  ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANC-DLKICDFGLARVTSETD 102
            L++   +Y++Y++L+ L Y HS  ++HRD+KP N++++     L++ D+GLA       
Sbjct: 121 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 180
Query: 103 FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLLI 161
                V +R+++ PELL++  DY  ++D+WS+GC+F  ++ RK P F G D+  QL  + 
Sbjct: 181 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 240
Query: 162 ELIGTPSEAELGFLNENAKKYICQL--------PRYQRQSFTEKFPN------VHPSAID 207
           +++GT        LN    KY  +L         R+ R+ +  KF N      V P AID
Sbjct: 241 KVLGTDG------LNVYLNKYRIELDPQLEALVGRHSRKPWL-KFMNADNQHLVSPEAID 293
Query: 208 LVEKMLTFDPRQRITVEDALAHPYL 232
            ++K+L +D ++R+T  +A+ HPY 
Sbjct: 294 FLDKLLRYDHQERLTALEAMTHPYF 318

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score =  117 bits (292), Expect = 9e-27,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 116/205 (56%), Gaps = 23/205 (11%)
Query: 44  ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANC-DLKICDFGLARVTSETD 102
            L++   +Y++Y++L+ L Y HS  ++HRD+KP N++++     L++ D+GLA       
Sbjct: 123 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 182
Query: 103 FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLLI 161
                V +R+++ PELL++  DY  ++D+WS+GC+F  ++ RK P F G D+  QL  + 
Sbjct: 183 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 242
Query: 162 ELIGTPSEAELGFLNENAKKYICQL--------PRYQRQSFTEKFPN------VHPSAID 207
           +++GT        LN    KY  +L         R+ R+ +  KF N      V P AID
Sbjct: 243 KVLGTDG------LNVYLNKYRIELDPQLEALVGRHSRKPWL-KFMNADNQHLVSPEAID 295
Query: 208 LVEKMLTFDPRQRITVEDALAHPYL 232
            ++K+L +D ++R+T  +A+ HPY 
Sbjct: 296 FLDKLLRYDHQERLTALEAMTHPYF 320

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score =  117 bits (292), Expect = 9e-27,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 116/205 (56%), Gaps = 23/205 (11%)
Query: 44  ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANC-DLKICDFGLARVTSETD 102
            L++   +Y++Y++L+ L Y HS  ++HRD+KP N++++     L++ D+GLA       
Sbjct: 122 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 181
Query: 103 FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLLI 161
                V +R+++ PELL++  DY  ++D+WS+GC+F  ++ RK P F G D+  QL  + 
Sbjct: 182 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 241
Query: 162 ELIGTPSEAELGFLNENAKKYICQL--------PRYQRQSFTEKFPN------VHPSAID 207
           +++GT        LN    KY  +L         R+ R+ +  KF N      V P AID
Sbjct: 242 KVLGTDG------LNVYLNKYRIELDPQLEALVGRHSRKPWL-KFMNADNQHLVSPEAID 294
Query: 208 LVEKMLTFDPRQRITVEDALAHPYL 232
            ++K+L +D ++R+T  +A+ HPY 
Sbjct: 295 FLDKLLRYDHQERLTALEAMTHPYF 319

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score =  117 bits (292), Expect = 9e-27,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 116/205 (56%), Gaps = 23/205 (11%)
Query: 44  ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANC-DLKICDFGLARVTSETD 102
            L++   +Y++Y++L+ L Y HS  ++HRD+KP N++++     L++ D+GLA       
Sbjct: 121 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 180
Query: 103 FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLLI 161
                V +R+++ PELL++  DY  ++D+WS+GC+F  ++ RK P F G D+  QL  + 
Sbjct: 181 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 240
Query: 162 ELIGTPSEAELGFLNENAKKYICQL--------PRYQRQSFTEKFPN------VHPSAID 207
           +++GT        LN    KY  +L         R+ R+ +  KF N      V P AID
Sbjct: 241 KVLGTDG------LNVYLNKYRIELDPQLEALVGRHSRKPWL-KFMNADNQHLVSPEAID 293
Query: 208 LVEKMLTFDPRQRITVEDALAHPYL 232
            ++K+L +D ++R+T  +A+ HPY 
Sbjct: 294 FLDKLLRYDHQERLTALEAMTHPYF 318

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score =  117 bits (292), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 67/205 (32%), Positives = 116/205 (56%), Gaps = 23/205 (11%)
Query: 44  ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANC-DLKICDFGLARVTSETD 102
            L++   +Y++Y++L+ L Y HS  ++HRD+KP N++++     L++ D+GLA       
Sbjct: 121 TLTDYDIRYYIYELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK 180
Query: 103 FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLLI 161
                V +R+++ PELL++  DY  ++D+WS+GC+F  ++ RK P F G D+  QL  + 
Sbjct: 181 EYNVRVASRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIA 240
Query: 162 ELIGTPSEAELGFLNENAKKYICQL--------PRYQRQSFTEKFPN------VHPSAID 207
           +++GT        LN    KY  +L         R+ R+ +  KF N      V P AID
Sbjct: 241 KVLGTDG------LNVYLNKYRIELDPQLEALVGRHSRKPWL-KFMNADNQHLVSPEAID 293
Query: 208 LVEKMLTFDPRQRITVEDALAHPYL 232
            ++K+L +D ++R+T  +A+ HPY 
Sbjct: 294 FLDKLLRYDHQERLTALEAMTHPYF 318

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score =  117 bits (292), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 70/243 (28%), Positives = 129/243 (53%), Gaps = 26/243 (10%)
Query: 5   NVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 64
           N++ + DI+  P   S     +   + +TD  Q+    Q L++   ++++Y+IL+ L Y 
Sbjct: 93  NIITLADIVKDPV--SRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYC 147
Query: 65  HSANVLHRDLKPSNLLLN-ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 123
           HS  ++HRD+KP N++++  +  L++ D+GLA            V +R+++ PELL++  
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 124 DYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKY 182
            Y  ++D+WS+GC+   ++ RK P F G D+  QL  + +++GT        L +   KY
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED------LYDYIDKY 261
Query: 183 ICQL-------------PRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 229
             +L              R++R   +E    V P A+D ++K+L +D + R+T  +A+ H
Sbjct: 262 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 321
Query: 230 PYL 232
           PY 
Sbjct: 322 PYF 324

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score =  117 bits (292), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 70/246 (28%), Positives = 131/246 (53%), Gaps = 26/246 (10%)
Query: 5   NVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYI 64
           N++ + DI+  P   S     +   + +TD  Q+    Q L++   ++++Y+IL+ L Y 
Sbjct: 93  NIITLADIVKDPV--SRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYC 147
Query: 65  HSANVLHRDLKPSNLLLN-ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSS 123
           HS  ++HRD+KP N++++  +  L++ D+GLA            V +R+++ PELL++  
Sbjct: 148 HSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 207
Query: 124 DYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKY 182
            Y  ++D+WS+GC+   ++ RK P F G D+  QL  + +++GT        L +   KY
Sbjct: 208 MYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTED------LYDYIDKY 261
Query: 183 ICQL-------------PRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 229
             +L              R++R   +E    V P A+D ++K+L +D + R+T  +A+ H
Sbjct: 262 NIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH 321
Query: 230 PYLGSL 235
           PY  ++
Sbjct: 322 PYFYTV 327

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  112 bits (280), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 76/238 (31%), Positives = 115/238 (48%), Gaps = 41/238 (17%)
Query: 1   MDHENVVAIRDIIPPPQRESF---NDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQI 57
           +DH N++ + +I+      SF    ++Y   EL D    +II+  +  SE      + Q+
Sbjct: 78  LDHPNIMKLFEILEDSS--SFYIVGELYTGGELFD----EIIKRKR-FSEHDAARIIKQV 130
Query: 58  LRGLKYIHSANVLHRDLKPSNLLLNA---NCDLKICDFGLARVTSETDFMTEYVVTRWYR 114
             G+ Y+H  N++HRDLKP N+LL +   +CD+KI DFGL+    +   M + + T +Y 
Sbjct: 131 FSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYI 190
Query: 115 APELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGF 174
           APE+L  +  Y    DVWS G I   L+   P F G++    L+            E G 
Sbjct: 191 APEVLRGT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILK----------RVETG- 237
Query: 175 LNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
                 KY   LP+++          +   A DL+ KMLTF P  RIT    L HP++
Sbjct: 238 ------KYAFDLPQWR---------TISDDAKDLIRKMLTFHPSLRITATQCLEHPWI 280

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  111 bits (277), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 76/238 (31%), Positives = 115/238 (48%), Gaps = 41/238 (17%)
Query: 1   MDHENVVAIRDIIPPPQRESF---NDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQI 57
           +DH N++ + +I+      SF    ++Y   EL D    +II+  +  SE      + Q+
Sbjct: 78  LDHPNIMKLFEILEDSS--SFYIVGELYTGGELFD----EIIKRKR-FSEHDAARIIKQV 130
Query: 58  LRGLKYIHSANVLHRDLKPSNLLLNA---NCDLKICDFGLARVTSETDFMTEYVVTRWYR 114
             G+ Y+H  N++HRDLKP N+LL +   +CD+KI DFGL+    +   M + + T +Y 
Sbjct: 131 FSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYI 190
Query: 115 APELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGF 174
           APE+L  +  Y    DVWS G I   L+   P F G++    L+            E G 
Sbjct: 191 APEVLRGT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILK----------RVETG- 237
Query: 175 LNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
                 KY   LP+++          +   A DL+ KMLTF P  RIT    L HP++
Sbjct: 238 ------KYAFDLPQWR---------TISDDAKDLIRKMLTFHPSLRITATQCLEHPWI 280

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  111 bits (277), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 75/236 (31%), Positives = 112/236 (47%), Gaps = 37/236 (15%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYEL-MDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           +DH N++ + +I+     E  +  YI  EL    +L   I   +  SE      + Q+  
Sbjct: 78  LDHPNIMKLFEIL-----EDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFS 132
Query: 60  GLKYIHSANVLHRDLKPSNLLLNA---NCDLKICDFGLARVTSETDFMTEYVVTRWYRAP 116
           G+ Y+H  N++HRDLKP N+LL +   +CD+KI DFGL+    +   M + + T +Y AP
Sbjct: 133 GITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAP 192
Query: 117 ELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLN 176
           E+L  +  Y    DVWS G I   L+   P F G++    L+            E G   
Sbjct: 193 EVLRGT--YDEKCDVWSAGVILYILLSGTPPFYGKNEYDILK----------RVETG--- 237
Query: 177 ENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
               KY   LP+++          +   A DL+ KMLTF P  RIT    L HP++
Sbjct: 238 ----KYAFDLPQWR---------TISDDAKDLIRKMLTFHPSLRITATQCLEHPWI 280

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score =  109 bits (273), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 76/245 (31%), Positives = 120/245 (48%), Gaps = 38/245 (15%)
Query: 22  NDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL 79
           N + + +EL+  +L+++I+ N  Q  S    + F + IL+ L  +H   ++H DLKP N+
Sbjct: 172 NHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENI 231
Query: 80  LLN--ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 137
           LL       +K+ DFG +    E   +   + +R+YRAPE++L +  Y   ID+WS+GCI
Sbjct: 232 LLKQQGRSGIKVIDFGSS--CYEHQRVYTXIQSRFYRAPEVILGAR-YGMPIDMWSLGCI 288
Query: 138 FMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQ--LPRY------ 189
             EL+   PL PG D   QL  +IEL+G PS+  L   ++ AK ++     PRY      
Sbjct: 289 LAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLD-ASKRAKNFVSXKGYPRYCTVTTL 347
Query: 190 -----------QRQSFTEKFPNVH-----------PSAIDLVEKMLTFDPRQRITVEDAL 227
                       R+      P              P  +D +++ L +DP  R+T   AL
Sbjct: 348 SDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQAL 407
Query: 228 AHPYL 232
            HP+L
Sbjct: 408 RHPWL 412

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score =  109 bits (273), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 76/245 (31%), Positives = 120/245 (48%), Gaps = 38/245 (15%)
Query: 22  NDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL 79
           N + + +EL+  +L+++I+ N  Q  S    + F + IL+ L  +H   ++H DLKP N+
Sbjct: 172 NHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENI 231
Query: 80  LLN--ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 137
           LL       +K+ DFG +    E   +   + +R+YRAPE++L +  Y   ID+WS+GCI
Sbjct: 232 LLKQQGRSGIKVIDFGSS--CYEHQRVYTXIQSRFYRAPEVILGAR-YGMPIDMWSLGCI 288
Query: 138 FMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQ--LPRY------ 189
             EL+   PL PG D   QL  +IEL+G PS+  L   ++ AK ++     PRY      
Sbjct: 289 LAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLD-ASKRAKNFVSXKGYPRYCTVTTL 347
Query: 190 -----------QRQSFTEKFPNVH-----------PSAIDLVEKMLTFDPRQRITVEDAL 227
                       R+      P              P  +D +++ L +DP  R+T   AL
Sbjct: 348 SDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQAL 407
Query: 228 AHPYL 232
            HP+L
Sbjct: 408 RHPWL 412

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score =  107 bits (268), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 75/245 (30%), Positives = 119/245 (48%), Gaps = 38/245 (15%)
Query: 22  NDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL 79
           N + + +EL+  +L+++I+ N  Q  S    + F + IL+ L  +H   ++H DLKP N+
Sbjct: 172 NHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENI 231
Query: 80  LLN--ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 137
           LL       +K+ DFG +    E   +   + +R+YRAPE++L +  Y   ID+WS+GCI
Sbjct: 232 LLKQQGRSGIKVIDFGSS--CYEHQRVYXXIQSRFYRAPEVILGAR-YGMPIDMWSLGCI 288
Query: 138 FMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQ--LPRY------ 189
             EL+   PL PG D   QL  +IEL+G P +  L   ++ AK ++     PRY      
Sbjct: 289 LAELLTGYPLLPGEDEGDQLACMIELLGMPXQKLLD-ASKRAKNFVSXKGYPRYCTVTTL 347
Query: 190 -----------QRQSFTEKFPNVH-----------PSAIDLVEKMLTFDPRQRITVEDAL 227
                       R+      P              P  +D +++ L +DP  R+T   AL
Sbjct: 348 SDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQAL 407
Query: 228 AHPYL 232
            HP+L
Sbjct: 408 RHPWL 412

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score =  106 bits (265), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 74/236 (31%), Positives = 112/236 (47%), Gaps = 37/236 (15%)
Query: 1   MDHENVVAIRDIIPPPQRESF-NDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           +DH N++ + D     +      + Y   EL D  +H++       +E      + Q+L 
Sbjct: 93  LDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRM-----KFNEVDAAVIIKQVLS 147
Query: 60  GLKYIHSANVLHRDLKPSNLLLNA---NCDLKICDFGLARVTSETDFMTEYVVTRWYRAP 116
           G+ Y+H  N++HRDLKP NLLL +   +  +KI DFGL+ V      M E + T +Y AP
Sbjct: 148 GVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAP 207
Query: 117 ELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLN 176
           E+L     Y    DVWS+G I   L+   P F G+     LR          + E G   
Sbjct: 208 EVL--RKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILR----------KVEKG--- 252
Query: 177 ENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
               KY    P ++         NV   A DL+++ML FD ++RI+ + AL HP++
Sbjct: 253 ----KYTFDSPEWK---------NVSEGAKDLIKQMLQFDSQRRISAQQALEHPWI 295

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 70/214 (32%), Positives = 104/214 (48%), Gaps = 36/214 (16%)
Query: 22  NDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 81
            +VY   EL D      I S +  SE      + Q+L G+ Y+H   ++HRDLKP NLLL
Sbjct: 128 GEVYTGGELFDE-----IISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLL 182
Query: 82  NA---NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIF 138
            +   + +++I DFGL+     +  M + + T +Y APE+L  +  Y    DVWS G I 
Sbjct: 183 ESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT--YDEKCDVWSTGVIL 240
Query: 139 MELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF 198
             L+   P F G +    L+          + E G       KY  +LP++++       
Sbjct: 241 YILLSGCPPFNGANEYDILK----------KVEKG-------KYTFELPQWKK------- 276
Query: 199 PNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
             V  SA DL+ KMLT+ P  RI+  DAL H ++
Sbjct: 277 --VSESAKDLIRKMLTYVPSMRISARDALDHEWI 308

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 70/214 (32%), Positives = 104/214 (48%), Gaps = 36/214 (16%)
Query: 22  NDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 81
            +VY   EL D      I S +  SE      + Q+L G+ Y+H   ++HRDLKP NLLL
Sbjct: 129 GEVYTGGELFDE-----IISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLL 183
Query: 82  NA---NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIF 138
            +   + +++I DFGL+     +  M + + T +Y APE+L  +  Y    DVWS G I 
Sbjct: 184 ESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT--YDEKCDVWSTGVIL 241
Query: 139 MELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF 198
             L+   P F G +    L+          + E G       KY  +LP++++       
Sbjct: 242 YILLSGCPPFNGANEYDILK----------KVEKG-------KYTFELPQWKK------- 277
Query: 199 PNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
             V  SA DL+ KMLT+ P  RI+  DAL H ++
Sbjct: 278 --VSESAKDLIRKMLTYVPSMRISARDALDHEWI 309

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  103 bits (257), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 70/214 (32%), Positives = 104/214 (48%), Gaps = 36/214 (16%)
Query: 22  NDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 81
            +VY   EL D      I S +  SE      + Q+L G+ Y+H   ++HRDLKP NLLL
Sbjct: 105 GEVYTGGELFDE-----IISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLL 159
Query: 82  NA---NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIF 138
            +   + +++I DFGL+     +  M + + T +Y APE+L  +  Y    DVWS G I 
Sbjct: 160 ESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT--YDEKCDVWSTGVIL 217
Query: 139 MELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF 198
             L+   P F G +    L+          + E G       KY  +LP++++       
Sbjct: 218 YILLSGCPPFNGANEYDILK----------KVEKG-------KYTFELPQWKK------- 253
Query: 199 PNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
             V  SA DL+ KMLT+ P  RI+  DAL H ++
Sbjct: 254 --VSESAKDLIRKMLTYVPSMRISARDALDHEWI 285

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score =  102 bits (255), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 70/214 (32%), Positives = 104/214 (48%), Gaps = 36/214 (16%)
Query: 22  NDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 81
            +VY   EL D      I S +  SE      + Q+L G+ Y+H   ++HRDLKP NLLL
Sbjct: 111 GEVYTGGELFDE-----IISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLL 165
Query: 82  NA---NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIF 138
            +   + +++I DFGL+     +  M + + T +Y APE+L  +  Y    DVWS G I 
Sbjct: 166 ESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGT--YDEKCDVWSTGVIL 223
Query: 139 MELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF 198
             L+   P F G +    L+          + E G       KY  +LP++++       
Sbjct: 224 YILLSGCPPFNGANEYDILK----------KVEKG-------KYTFELPQWKK------- 259
Query: 199 PNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
             V  SA DL+ KMLT+ P  RI+  DAL H ++
Sbjct: 260 --VSESAKDLIRKMLTYVPSMRISARDALDHEWI 291

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 99.4 bits (246), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 63/220 (28%), Positives = 106/220 (48%), Gaps = 32/220 (14%)
Query: 19  ESFNDVYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 77
           ES + +++ ++LM   +L   +    ALSE+  +  +  +L  + ++H+ N++HRDLKP 
Sbjct: 170 ESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPE 229
Query: 78  NLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD-----YTAAIDVW 132
           N+LL+ N  +++ DFG +      + + E   T  Y APE+L  S D     Y   +D+W
Sbjct: 230 NILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLW 289
Query: 133 SVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQ 192
           + G I   L+   P F  R  +  LR+++E                  +Y    P +  +
Sbjct: 290 ACGVILFTLLAGSPPFWHRRQILMLRMIME-----------------GQYQFSSPEWDDR 332
Query: 193 SFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
           S T K         DL+ ++L  DP  R+T E AL HP+ 
Sbjct: 333 SSTVK---------DLISRLLQVDPEARLTAEQALQHPFF 363

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 97.8 bits (242), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 68/214 (31%), Positives = 101/214 (47%), Gaps = 36/214 (16%)
Query: 22  NDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 81
            +VY   EL D      I S +  SE      + Q+L G+ Y H   ++HRDLKP NLLL
Sbjct: 105 GEVYTGGELFDE-----IISRKRFSEVDAARIIRQVLSGITYXHKNKIVHRDLKPENLLL 159
Query: 82  NA---NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIF 138
            +   + +++I DFGL+     +    + + T +Y APE+L  +  Y    DVWS G I 
Sbjct: 160 ESKSKDANIRIIDFGLSTHFEASKKXKDKIGTAYYIAPEVLHGT--YDEKCDVWSTGVIL 217
Query: 139 MELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF 198
             L+   P F G +    L+          + E G       KY  +LP++++       
Sbjct: 218 YILLSGCPPFNGANEYDILK----------KVEKG-------KYTFELPQWKK------- 253
Query: 199 PNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
             V  SA DL+ K LT+ P  RI+  DAL H ++
Sbjct: 254 --VSESAKDLIRKXLTYVPSXRISARDALDHEWI 285

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 71/237 (29%), Positives = 115/237 (48%), Gaps = 37/237 (15%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILR 59
           + H N+V + D I     E F+  Y+ ++L+   +L + I + +  SE    + ++QIL 
Sbjct: 87  LKHPNIVRLHDSI---SEEGFH--YLVFDLVTGGELFEDIVAREYYSEADASHCIHQILE 141
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCD---LKICDFGLA-RVTSETDFMTEYVVTRWYRA 115
            + +IH  +++HRDLKP NLLL + C    +K+ DFGLA  V  E      +  T  Y +
Sbjct: 142 SVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFAGTPGYLS 201
Query: 116 PELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL 175
           PE+L     Y   +D+W+ G I                     L I L+G P      F 
Sbjct: 202 PEVL-RKDPYGKPVDIWACGVI---------------------LYILLVGYPP-----FW 234
Query: 176 NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
           +E+  K   Q+        + ++  V P A +L+ +MLT +P +RIT + AL HP++
Sbjct: 235 DEDQHKLYQQIKAGAYDFPSPEWDTVTPEAKNLINQMLTINPAKRITADQALKHPWV 291

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 96.3 bits (238), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 109/238 (45%), Gaps = 36/238 (15%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILR 59
           + HEN+VA+ DI   P     N +Y+  +L+   +L   I      +E+     + Q+L 
Sbjct: 77  IKHENIVALEDIYESP-----NHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLD 131
Query: 60  GLKYIHSANVLHRDLKPSNLLL---NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAP 116
            + Y+H   ++HRDLKP NLL    +    + I DFGL+++  + D M+    T  Y AP
Sbjct: 132 AVYYLHRMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTACGTPGYVAP 191
Query: 117 ELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLN 176
           E+L     Y+ A+D WS+G I                       I L G P      F +
Sbjct: 192 EVLAQKP-YSKAVDCWSIGVI---------------------AYILLCGYPP-----FYD 224
Query: 177 ENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS 234
           EN  K   Q+ + + +  +  + ++  SA D +  ++  DP +R T E A  HP++  
Sbjct: 225 ENDSKLFEQILKAEYEFDSPYWDDISDSAKDFIRNLMEKDPNKRYTCEQAARHPWIAG 282

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 95.9 bits (237), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 85/281 (30%), Positives = 125/281 (44%), Gaps = 54/281 (19%)
Query: 1   MDHENVVAIRDIIPPPQRESF-NDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           +DH N++ + +     +      +VY   EL D     I+R  Q  SE      + Q+L 
Sbjct: 61  LDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFD---EIILR--QKFSEVDAAVIMKQVLS 115
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCD---LKICDFGLARVTSETDFMTEYVVTRWYRAP 116
           G  Y+H  N++HRDLKP NLLL +      +KI DFGL+        M E + T +Y AP
Sbjct: 116 GTTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAP 175
Query: 117 ELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLN 176
           E+L     Y    DVWS G I   L+   P F G+                ++ E+    
Sbjct: 176 EVL--RKKYDEKCDVWSCGVILYILLCGYPPFGGQ----------------TDQEI---- 213
Query: 177 ENAKKYICQLPRYQRQSFTEKFPN---VHPSAIDLVEKMLTFDPRQRITVEDALAHPYLG 233
                    L R ++  F+   P+   V   A  LV+ MLT++P +RI+ E+AL HP++ 
Sbjct: 214 ---------LKRVEKGKFSFDPPDWTQVSDEAKQLVKLMLTYEPSKRISAEEALNHPWIV 264
Query: 234 SLHDISDEPVCMSPFSFDFEQHALTE--GQMKELIYQEALA 272
                     C    + D  +HALT   G MK+    + LA
Sbjct: 265 KF--------CSQKHT-DVGKHALTGALGNMKKFQSSQKLA 296

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 95.1 bits (235), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 110/238 (46%), Gaps = 36/238 (15%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILR 59
           + H N+VA+ DI      ES   +Y+  +L+   +L   I      +E      ++Q+L 
Sbjct: 73  IKHPNIVALDDIY-----ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLD 127
Query: 60  GLKYIHSANVLHRDLKPSNLL---LNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAP 116
            +KY+H   ++HRDLKP NLL   L+ +  + I DFGL+++      ++    T  Y AP
Sbjct: 128 AVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAP 187
Query: 117 ELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLN 176
           E+L     Y+ A+D WS+G I                       I L G P      F +
Sbjct: 188 EVLAQKP-YSKAVDCWSIGVI---------------------AYILLCGYPP-----FYD 220
Query: 177 ENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS 234
           EN  K   Q+ + + +  +  + ++  SA D +  ++  DP +R T E AL HP++  
Sbjct: 221 ENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG 278

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 95.1 bits (235), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 110/238 (46%), Gaps = 36/238 (15%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILR 59
           + H N+VA+ DI      ES   +Y+  +L+   +L   I      +E      ++Q+L 
Sbjct: 73  IKHPNIVALDDIY-----ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLD 127
Query: 60  GLKYIHSANVLHRDLKPSNLL---LNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAP 116
            +KY+H   ++HRDLKP NLL   L+ +  + I DFGL+++      ++    T  Y AP
Sbjct: 128 AVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAP 187
Query: 117 ELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLN 176
           E+L     Y+ A+D WS+G I                       I L G P      F +
Sbjct: 188 EVLAQKP-YSKAVDCWSIGVI---------------------AYILLCGYPP-----FYD 220
Query: 177 ENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS 234
           EN  K   Q+ + + +  +  + ++  SA D +  ++  DP +R T E AL HP++  
Sbjct: 221 ENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG 278

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 95.1 bits (235), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 68/236 (28%), Positives = 116/236 (49%), Gaps = 36/236 (15%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILR 59
           + H N+V + D I   Q ESF+  Y+ ++L+   +L + I + +  SE    + + QIL 
Sbjct: 62  LQHPNIVRLHDSI---QEESFH--YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILE 116
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCD---LKICDFGLARVTSETDFMTEYVVTRWYRAP 116
            + Y HS  ++HR+LKP NLLL +      +K+ DFGLA   ++++    +  T  Y +P
Sbjct: 117 SIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSP 176
Query: 117 ELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLN 176
           E +L    Y+  +D+W+ G I                     L I L+G P      F +
Sbjct: 177 E-VLKKDPYSKPVDIWACGVI---------------------LYILLVGYPP-----FWD 209
Query: 177 ENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
           E+  +   Q+        + ++  V P A  L++ MLT +P++RIT + AL  P++
Sbjct: 210 EDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWI 265

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 94.7 bits (234), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 68/236 (28%), Positives = 116/236 (49%), Gaps = 36/236 (15%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILR 59
           + H N+V + D I   Q ESF+  Y+ ++L+   +L + I + +  SE    + + QIL 
Sbjct: 85  LQHPNIVRLHDSI---QEESFH--YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILE 139
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCD---LKICDFGLARVTSETDFMTEYVVTRWYRAP 116
            + Y HS  ++HR+LKP NLLL +      +K+ DFGLA   ++++    +  T  Y +P
Sbjct: 140 SIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSP 199
Query: 117 ELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLN 176
           E +L    Y+  +D+W+ G I                     L I L+G P      F +
Sbjct: 200 E-VLKKDPYSKPVDIWACGVI---------------------LYILLVGYPP-----FWD 232
Query: 177 ENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
           E+  +   Q+        + ++  V P A  L++ MLT +P++RIT + AL  P++
Sbjct: 233 EDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWI 288

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 94.7 bits (234), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 68/236 (28%), Positives = 116/236 (49%), Gaps = 36/236 (15%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILR 59
           + H N+V + D I   Q ESF+  Y+ ++L+   +L + I + +  SE    + + QIL 
Sbjct: 62  LQHPNIVRLHDSI---QEESFH--YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILE 116
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCD---LKICDFGLARVTSETDFMTEYVVTRWYRAP 116
            + Y HS  ++HR+LKP NLLL +      +K+ DFGLA   ++++    +  T  Y +P
Sbjct: 117 SIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSP 176
Query: 117 ELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLN 176
           E +L    Y+  +D+W+ G I                     L I L+G P      F +
Sbjct: 177 E-VLKKDPYSKPVDIWACGVI---------------------LYILLVGYPP-----FWD 209
Query: 177 ENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
           E+  +   Q+        + ++  V P A  L++ MLT +P++RIT + AL  P++
Sbjct: 210 EDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWI 265

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 94.7 bits (234), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 110/238 (46%), Gaps = 36/238 (15%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILR 59
           + H N+VA+ DI      ES   +Y+  +L+   +L   I      +E      ++Q+L 
Sbjct: 73  IKHPNIVALDDIY-----ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLD 127
Query: 60  GLKYIHSANVLHRDLKPSNLL---LNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAP 116
            +KY+H   ++HRDLKP NLL   L+ +  + I DFGL+++      ++    T  Y AP
Sbjct: 128 AVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAP 187
Query: 117 ELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLN 176
           E+L     Y+ A+D WS+G I                       I L G P      F +
Sbjct: 188 EVLAQKP-YSKAVDCWSIGVI---------------------AYILLCGYPP-----FYD 220
Query: 177 ENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS 234
           EN  K   Q+ + + +  +  + ++  SA D +  ++  DP +R T E AL HP++  
Sbjct: 221 ENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG 278

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 94.7 bits (234), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 68/236 (28%), Positives = 116/236 (49%), Gaps = 36/236 (15%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILR 59
           + H N+V + D I   Q ESF+  Y+ ++L+   +L + I + +  SE    + + QIL 
Sbjct: 61  LQHPNIVRLHDSI---QEESFH--YLVFDLVTGGELFEDIVAREFYSEADASHCIQQILE 115
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCD---LKICDFGLARVTSETDFMTEYVVTRWYRAP 116
            + Y HS  ++HR+LKP NLLL +      +K+ DFGLA   ++++    +  T  Y +P
Sbjct: 116 SIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSP 175
Query: 117 ELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLN 176
           E +L    Y+  +D+W+ G I                     L I L+G P      F +
Sbjct: 176 E-VLKKDPYSKPVDIWACGVI---------------------LYILLVGYPP-----FWD 208
Query: 177 ENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
           E+  +   Q+        + ++  V P A  L++ MLT +P++RIT + AL  P++
Sbjct: 209 EDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWI 264

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 94.7 bits (234), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 67/238 (28%), Positives = 110/238 (46%), Gaps = 36/238 (15%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILR 59
           + H N+VA+ DI      ES   +Y+  +L+   +L   I      +E      ++Q+L 
Sbjct: 73  IKHPNIVALDDIY-----ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLD 127
Query: 60  GLKYIHSANVLHRDLKPSNLL---LNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAP 116
            +KY+H   ++HRDLKP NLL   L+ +  + I DFGL+++      ++    T  Y AP
Sbjct: 128 AVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAP 187
Query: 117 ELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLN 176
           E+L     Y+ A+D WS+G I                       I L G P      F +
Sbjct: 188 EVLAQKP-YSKAVDCWSIGVI---------------------AYILLCGYPP-----FYD 220
Query: 177 ENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS 234
           EN  K   Q+ + + +  +  + ++  SA D +  ++  DP +R T E AL HP++  
Sbjct: 221 ENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAG 278

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 94.0 bits (232), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 70/253 (27%), Positives = 117/253 (46%), Gaps = 40/253 (15%)
Query: 19  ESFNDVYIAYELMDTDLHQIIRSNQAL--SEEHCQYFLYQILRGLKYIHSANVLHRDLKP 76
           E    + I +EL+    +  I+ N  L    +H +   YQI + + ++HS  + H DLKP
Sbjct: 87  EHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKP 146
Query: 77  SNLLLNA-------------------NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPE 117
            N+L                      N D+K+ DFG A  T + +  +  V TR YRAPE
Sbjct: 147 ENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA--TYDDEHHSTLVSTRHYRAPE 204
Query: 118 LLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIG-------TPSEA 170
           ++L +  ++   DVWS+GCI +E      +FP  D    L ++  ++G         +  
Sbjct: 205 VIL-ALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRK 263
Query: 171 ELGFLNE--------NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT 222
              F ++        +A +Y+ +  +  ++ F       H    DL++KML +DP +RIT
Sbjct: 264 RKYFHHDRLDWDEHSSAGRYVSRACKPLKE-FMLSQDVEHERLFDLIQKMLEYDPAKRIT 322
Query: 223 VEDALAHPYLGSL 235
           + +AL HP+   L
Sbjct: 323 LREALKHPFFDLL 335

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 75/242 (30%), Positives = 109/242 (45%), Gaps = 47/242 (19%)
Query: 3   HENVVAIRDIIPPPQRESFNDVYIAYELMDTD--LHQIIRSNQALSEEHCQYFLYQILRG 60
           H N++ ++D+      +    VY+  ELM     L +I+R  +  SE    + L+ I + 
Sbjct: 80  HPNIITLKDVY-----DDGKHVYLVTELMRGGELLDKILR-QKFFSEREASFVLHTIGKT 133
Query: 61  LKYIHSANVLHRDLKPSNLLL-----NANCDLKICDFGLAR-VTSETDFMTEYVVTRWYR 114
           ++Y+HS  V+HRDLKPSN+L      N  C L+ICDFG A+ + +E   +     T  + 
Sbjct: 134 VEYLHSQGVVHRDLKPSNILYVDESGNPEC-LRICDFGFAKQLRAENGLLMTPCYTANFV 192
Query: 115 APELLLNSSDYTAAIDVWSVGC-IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELG 173
           APE +L    Y    D+WS+G  ++  L    P   G               TP E    
Sbjct: 193 APE-VLKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSD------------TPEEI--- 236
Query: 174 FLNENAKKYICQLPRYQRQSFTEKFPN---VHPSAIDLVEKMLTFDPRQRITVEDALAHP 230
                       L R     FT    N   V  +A DLV KML  DP QR+T +  L HP
Sbjct: 237 ------------LTRIGSGKFTLSGGNWNTVSETAKDLVSKMLHVDPHQRLTAKQVLQHP 284
Query: 231 YL 232
           ++
Sbjct: 285 WV 286

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 93.6 bits (231), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 75/242 (30%), Positives = 109/242 (45%), Gaps = 47/242 (19%)
Query: 3   HENVVAIRDIIPPPQRESFNDVYIAYELMDTD--LHQIIRSNQALSEEHCQYFLYQILRG 60
           H N++ ++D+      +    VY+  ELM     L +I+R  +  SE    + L+ I + 
Sbjct: 80  HPNIITLKDVY-----DDGKHVYLVTELMRGGELLDKILR-QKFFSEREASFVLHTIGKT 133
Query: 61  LKYIHSANVLHRDLKPSNLLL-----NANCDLKICDFGLAR-VTSETDFMTEYVVTRWYR 114
           ++Y+HS  V+HRDLKPSN+L      N  C L+ICDFG A+ + +E   +     T  + 
Sbjct: 134 VEYLHSQGVVHRDLKPSNILYVDESGNPEC-LRICDFGFAKQLRAENGLLMTPCYTANFV 192
Query: 115 APELLLNSSDYTAAIDVWSVGC-IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELG 173
           APE +L    Y    D+WS+G  ++  L    P   G               TP E    
Sbjct: 193 APE-VLKRQGYDEGCDIWSLGILLYTMLAGYTPFANGPSD------------TPEEI--- 236
Query: 174 FLNENAKKYICQLPRYQRQSFTEKFPN---VHPSAIDLVEKMLTFDPRQRITVEDALAHP 230
                       L R     FT    N   V  +A DLV KML  DP QR+T +  L HP
Sbjct: 237 ------------LTRIGSGKFTLSGGNWNTVSETAKDLVSKMLHVDPHQRLTAKQVLQHP 284
Query: 231 YL 232
           ++
Sbjct: 285 WV 286

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 93.2 bits (230), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 70/237 (29%), Positives = 113/237 (47%), Gaps = 37/237 (15%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILR 59
           + H N+V + D I     E F+  Y+ ++L+   +L + I + +  SE    + + QIL 
Sbjct: 60  LKHSNIVRLHDSI---SEEGFH--YLVFDLVTGGELFEDIVAREYYSEADASHCIQQILE 114
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCD---LKICDFGLA-RVTSETDFMTEYVVTRWYRA 115
            + + H   V+HRDLKP NLLL + C    +K+ DFGLA  V  +      +  T  Y +
Sbjct: 115 AVLHCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLS 174
Query: 116 PELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL 175
           PE+L   + Y   +D+W+ G I                     L I L+G P      F 
Sbjct: 175 PEVLRKEA-YGKPVDIWACGVI---------------------LYILLVGYPP-----FW 207
Query: 176 NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
           +E+  K   Q+        + ++  V P A +L+ +MLT +P +RIT  +AL HP++
Sbjct: 208 DEDQHKLYQQIKAGAYDFPSPEWDTVTPEAKNLINQMLTINPAKRITAHEALKHPWV 264

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 92.8 bits (229), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 74/239 (30%), Positives = 110/239 (46%), Gaps = 43/239 (17%)
Query: 1   MDHENVVAIRDIIPPPQRESF-NDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           +DH N++ + +     +      +VY   EL D     I+R  Q  SE      + Q+L 
Sbjct: 78  LDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFD---EIILR--QKFSEVDAAVIMKQVLS 132
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCD---LKICDFGLARVTSETDFMTEYVVTRWYRAP 116
           G  Y+H  N++HRDLKP NLLL +      +KI DFGL+        M E + T +Y AP
Sbjct: 133 GTTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAP 192
Query: 117 ELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLN 176
           E+L     Y    DVWS G I   L+   P F G+                ++ E+    
Sbjct: 193 EVL--RKKYDEKCDVWSCGVILYILLCGYPPFGGQ----------------TDQEI---- 230
Query: 177 ENAKKYICQLPRYQRQSFTEKFPN---VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
                    L R ++  F+   P+   V   A  LV+ MLT++P +RI+ E+AL HP++
Sbjct: 231 ---------LKRVEKGKFSFDPPDWTQVSDEAKQLVKLMLTYEPSKRISAEEALNHPWI 280

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 92.4 bits (228), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 73/250 (29%), Positives = 116/250 (46%), Gaps = 48/250 (19%)
Query: 26  IAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL-LN 82
           IA+EL+  +  + ++ N  Q     H ++  YQ+   L+++H   + H DLKP N+L +N
Sbjct: 99  IAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVN 158
Query: 83  A------------------NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 124
           +                  N  +++ DFG A  T + +  T  V TR YR PE++L    
Sbjct: 159 SEFETLYNEHKSCEEKSVKNTSIRVADFGSA--TFDHEHHTTIVATRHYRPPEVILELG- 215
Query: 125 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIG-TPSEA-----------EL 172
           +    DVWS+GCI  E      LF   ++   L ++ +++G  PS             + 
Sbjct: 216 WAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKG 275
Query: 173 GFL---NENAKKYI---CQ-LPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVED 225
           G +   N +  +Y+   C+ L  Y  Q   E     H    DL+ +ML FDP QRIT+ +
Sbjct: 276 GLVWDENSSDGRYVKENCKPLKSYMLQDSLE-----HVQLFDLMRRMLEFDPAQRITLAE 330
Query: 226 ALAHPYLGSL 235
           AL HP+   L
Sbjct: 331 ALLHPFFAGL 340

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 92.0 bits (227), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 124/272 (45%), Gaps = 46/272 (16%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILR 59
           + H++VV           E  + V++  EL     L ++ +  +AL+E   +Y+L QI+ 
Sbjct: 74  LAHQHVVGFHGFF-----EDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVL 128
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPEL 118
           G +Y+H   V+HRDLK  NL LN + ++KI DFGLA +V  + +       T  Y APE 
Sbjct: 129 GCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPE- 187
Query: 119 LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNEN 178
           +L+   ++  +DVWS+GCI   L+  KP F                      E   L E 
Sbjct: 188 VLSKKGHSFEVDVWSIGCIMYTLLVGKPPF----------------------ETSCLKET 225
Query: 179 ---AKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL 235
               KK    +P++           ++P A  L++KML  DP  R T+ + L   +  S 
Sbjct: 226 YLRIKKNEYSIPKH-----------INPVAASLIQKMLQTDPTARPTINELLNDEFFTSG 274
Query: 236 HDISDEPV-CMS-PFSFDFEQHALTEGQMKEL 265
           +  +  P+ C++ P  F     +L     K L
Sbjct: 275 YIPARLPITCLTIPPRFSIAPSSLDPSNRKPL 306

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 92.0 bits (227), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 73/250 (29%), Positives = 116/250 (46%), Gaps = 48/250 (19%)
Query: 26  IAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL-LN 82
           IA+EL+  +  + ++ N  Q     H ++  YQ+   L+++H   + H DLKP N+L +N
Sbjct: 131 IAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVN 190
Query: 83  A------------------NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 124
           +                  N  +++ DFG A  T + +  T  V TR YR PE++L    
Sbjct: 191 SEFETLYNEHKSCEEKSVKNTSIRVADFGSA--TFDHEHHTTIVATRHYRPPEVILELG- 247
Query: 125 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIG-TPSEA-----------EL 172
           +    DVWS+GCI  E      LF   ++   L ++ +++G  PS             + 
Sbjct: 248 WAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKG 307
Query: 173 GFL---NENAKKYI---CQ-LPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVED 225
           G +   N +  +Y+   C+ L  Y  Q   E     H    DL+ +ML FDP QRIT+ +
Sbjct: 308 GLVWDENSSDGRYVKENCKPLKSYMLQDSLE-----HVQLFDLMRRMLEFDPAQRITLAE 362
Query: 226 ALAHPYLGSL 235
           AL HP+   L
Sbjct: 363 ALLHPFFAGL 372

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 92.0 bits (227), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 73/250 (29%), Positives = 116/250 (46%), Gaps = 48/250 (19%)
Query: 26  IAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL-LN 82
           IA+EL+  +  + ++ N  Q     H ++  YQ+   L+++H   + H DLKP N+L +N
Sbjct: 108 IAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVN 167
Query: 83  A------------------NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 124
           +                  N  +++ DFG A  T + +  T  V TR YR PE++L    
Sbjct: 168 SEFETLYNEHKSCEEKSVKNTSIRVADFGSA--TFDHEHHTTIVATRHYRPPEVILELG- 224
Query: 125 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIG-TPSEA-----------EL 172
           +    DVWS+GCI  E      LF   ++   L ++ +++G  PS             + 
Sbjct: 225 WAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKG 284
Query: 173 GFL---NENAKKYI---CQ-LPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVED 225
           G +   N +  +Y+   C+ L  Y  Q   E     H    DL+ +ML FDP QRIT+ +
Sbjct: 285 GLVWDENSSDGRYVKENCKPLKSYMLQDSLE-----HVQLFDLMRRMLEFDPAQRITLAE 339
Query: 226 ALAHPYLGSL 235
           AL HP+   L
Sbjct: 340 ALLHPFFAGL 349

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 92.0 bits (227), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 124/272 (45%), Gaps = 46/272 (16%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILR 59
           + H++VV           E  + V++  EL     L ++ +  +AL+E   +Y+L QI+ 
Sbjct: 74  LAHQHVVGFHGFF-----EDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVL 128
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPEL 118
           G +Y+H   V+HRDLK  NL LN + ++KI DFGLA +V  + +       T  Y APE 
Sbjct: 129 GCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPE- 187
Query: 119 LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNEN 178
           +L+   ++  +DVWS+GCI   L+  KP F                      E   L E 
Sbjct: 188 VLSKKGHSFEVDVWSIGCIMYTLLVGKPPF----------------------ETSCLKET 225
Query: 179 ---AKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL 235
               KK    +P++           ++P A  L++KML  DP  R T+ + L   +  S 
Sbjct: 226 YLRIKKNEYSIPKH-----------INPVAASLIQKMLQTDPTARPTINELLNDEFFTSG 274
Query: 236 HDISDEPV-CMS-PFSFDFEQHALTEGQMKEL 265
           +  +  P+ C++ P  F     +L     K L
Sbjct: 275 YIPARLPITCLTIPPXFSIAPSSLDPSNRKPL 306

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 92.0 bits (227), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 124/272 (45%), Gaps = 46/272 (16%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILR 59
           + H++VV           E  + V++  EL     L ++ +  +AL+E   +Y+L QI+ 
Sbjct: 78  LAHQHVVGFHGFF-----EDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVL 132
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPEL 118
           G +Y+H   V+HRDLK  NL LN + ++KI DFGLA +V  + +       T  Y APE 
Sbjct: 133 GCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPE- 191
Query: 119 LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNEN 178
           +L+   ++  +DVWS+GCI   L+  KP F                      E   L E 
Sbjct: 192 VLSKKGHSFEVDVWSIGCIMYTLLVGKPPF----------------------ETSCLKET 229
Query: 179 ---AKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL 235
               KK    +P++           ++P A  L++KML  DP  R T+ + L   +  S 
Sbjct: 230 YLRIKKNEYSIPKH-----------INPVAASLIQKMLQTDPTARPTINELLNDEFFTSG 278
Query: 236 HDISDEPV-CMS-PFSFDFEQHALTEGQMKEL 265
           +  +  P+ C++ P  F     +L     K L
Sbjct: 279 YIPARLPITCLTIPPRFSIAPSSLDPSNRKPL 310

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 92.0 bits (227), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 69/253 (27%), Positives = 116/253 (45%), Gaps = 40/253 (15%)
Query: 19  ESFNDVYIAYELMDTDLHQIIRSNQAL--SEEHCQYFLYQILRGLKYIHSANVLHRDLKP 76
           E    + I +EL+    +  I+ N  L    +H +   YQI + + ++HS  + H DLKP
Sbjct: 87  EHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKP 146
Query: 77  SNLLLNA-------------------NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPE 117
            N+L                      N D+K+ DFG A  T + +  +  V  R YRAPE
Sbjct: 147 ENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA--TYDDEHHSTLVXXRHYRAPE 204
Query: 118 LLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIG-------TPSEA 170
           ++L +  ++   DVWS+GCI +E      +FP  D    L ++  ++G         +  
Sbjct: 205 VIL-ALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRK 263
Query: 171 ELGFLNE--------NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT 222
              F ++        +A +Y+ +  +  ++ F       H    DL++KML +DP +RIT
Sbjct: 264 RKYFHHDRLDWDEHSSAGRYVSRACKPLKE-FMLSQDVEHERLFDLIQKMLEYDPAKRIT 322
Query: 223 VEDALAHPYLGSL 235
           + +AL HP+   L
Sbjct: 323 LREALKHPFFDLL 335

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 91.7 bits (226), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 124/272 (45%), Gaps = 46/272 (16%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILR 59
           + H++VV           E  + V++  EL     L ++ +  +AL+E   +Y+L QI+ 
Sbjct: 98  LAHQHVVGFHGFF-----EDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVL 152
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPEL 118
           G +Y+H   V+HRDLK  NL LN + ++KI DFGLA +V  + +       T  Y APE 
Sbjct: 153 GCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPE- 211
Query: 119 LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNEN 178
           +L+   ++  +DVWS+GCI   L+  KP F                      E   L E 
Sbjct: 212 VLSKKGHSFEVDVWSIGCIMYTLLVGKPPF----------------------ETSCLKET 249
Query: 179 ---AKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL 235
               KK    +P++           ++P A  L++KML  DP  R T+ + L   +  S 
Sbjct: 250 YLRIKKNEYSIPKH-----------INPVAASLIQKMLQTDPTARPTINELLNDEFFTSG 298
Query: 236 HDISDEPV-CMS-PFSFDFEQHALTEGQMKEL 265
           +  +  P+ C++ P  F     +L     K L
Sbjct: 299 YIPARLPITCLTIPPRFSIAPSSLDPSNRKPL 330

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 91.3 bits (225), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 78/272 (28%), Positives = 124/272 (45%), Gaps = 46/272 (16%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILR 59
           + H++VV           E  + V++  EL     L ++ +  +AL+E   +Y+L QI+ 
Sbjct: 96  LAHQHVVGFHGFF-----EDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVL 150
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPEL 118
           G +Y+H   V+HRDLK  NL LN + ++KI DFGLA +V  + +       T  Y APE 
Sbjct: 151 GCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPE- 209
Query: 119 LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNEN 178
           +L+   ++  +DVWS+GCI   L+  KP F                      E   L E 
Sbjct: 210 VLSKKGHSFEVDVWSIGCIMYTLLVGKPPF----------------------ETSCLKET 247
Query: 179 ---AKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL 235
               KK    +P++           ++P A  L++KML  DP  R T+ + L   +  S 
Sbjct: 248 YLRIKKNEYSIPKH-----------INPVAASLIQKMLQTDPTARPTINELLNDEFFTSG 296
Query: 236 HDISDEPV-CMS-PFSFDFEQHALTEGQMKEL 265
           +  +  P+ C++ P  F     +L     K L
Sbjct: 297 YIPARLPITCLTIPPRFSIAPSSLDPSNRKPL 328

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 90.9 bits (224), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 107/227 (47%), Gaps = 35/227 (15%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRG 60
           + H +++ + D+I     +S +++ +  E    +L   I     +SE+  + F  QI+  
Sbjct: 65  LRHPHIIKLYDVI-----KSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISA 119
Query: 61  LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL 120
           ++Y H   ++HRDLKP NLLL+ + ++KI DFGL+ + ++ +F+     +  Y APE++ 
Sbjct: 120 VEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVIS 179
Query: 121 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAK 180
                   +DVWS G I   ++ R+  F                    +  +  L +N  
Sbjct: 180 GKLYAGPEVDVWSCGVILYVMLCRRLPF-------------------DDESIPVLFKNIS 220
Query: 181 KYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDAL 227
             +  LP++           + P A  L+++ML  +P  RI++ + +
Sbjct: 221 NGVYTLPKF-----------LSPGAAGLIKRMLIVNPLNRISIHEIM 256

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 90.9 bits (224), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 107/227 (47%), Gaps = 35/227 (15%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRG 60
           + H +++ + D+I     +S +++ +  E    +L   I     +SE+  + F  QI+  
Sbjct: 61  LRHPHIIKLYDVI-----KSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISA 115
Query: 61  LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL 120
           ++Y H   ++HRDLKP NLLL+ + ++KI DFGL+ + ++ +F+     +  Y APE++ 
Sbjct: 116 VEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVIS 175
Query: 121 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAK 180
                   +DVWS G I   ++ R+  F                    +  +  L +N  
Sbjct: 176 GKLYAGPEVDVWSCGVILYVMLCRRLPF-------------------DDESIPVLFKNIS 216
Query: 181 KYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDAL 227
             +  LP++           + P A  L+++ML  +P  RI++ + +
Sbjct: 217 NGVYTLPKF-----------LSPGAAGLIKRMLIVNPLNRISIHEIM 252

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 90.5 bits (223), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 116/253 (45%), Gaps = 37/253 (14%)
Query: 3   HENVVAIRDIIPPPQRESFND---VYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQIL 58
           H N+V + ++        F+D    ++  EL++  +L + I+  +  SE    Y + +++
Sbjct: 65  HPNIVKLHEV--------FHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLV 116
Query: 59  RGLKYIHSANVLHRDLKPSNLLL---NANCDLKICDFGLARVT-SETDFMTEYVVTRWYR 114
             + ++H   V+HRDLKP NLL    N N ++KI DFG AR+   +   +     T  Y 
Sbjct: 117 SAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYA 176
Query: 115 APELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGF 174
           APE LLN + Y  + D+WS+G I   ++  +  F   D        +E++    + +  F
Sbjct: 177 APE-LLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSF 235
Query: 175 LNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS 234
             E  K                   NV   A DL++ +LT DP +R+ +     + +L  
Sbjct: 236 EGEAWK-------------------NVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQD 276
Query: 235 LHDISDEPVCMSP 247
              +S  P+ M+P
Sbjct: 277 GSQLSSNPL-MTP 288

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 90.5 bits (223), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 110/233 (47%), Gaps = 37/233 (15%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRG 60
           + H +++ + D+I  P      D+ +  E    +L   I   + ++E+  + F  QI+  
Sbjct: 66  LRHPHIIKLYDVITTP-----TDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICA 120
Query: 61  LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL 120
           ++Y H   ++HRDLKP NLLL+ N ++KI DFGL+ + ++ +F+     +  Y APE++ 
Sbjct: 121 IEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVIN 180
Query: 121 NSSDYTAAIDVWSVGCI-FMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENA 179
                   +DVWS G + ++ L+ R P     + +  L                F   N+
Sbjct: 181 GKLYAGPEVDVWSCGIVLYVMLVGRLPF--DDEFIPNL----------------FKKVNS 222
Query: 180 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
             Y+  +P +           + P A  L+ +M+  DP QRIT+++    P+ 
Sbjct: 223 CVYV--MPDF-----------LSPGAQSLIRRMIVADPMQRITIQEIRRDPWF 262

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 90.5 bits (223), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 107/227 (47%), Gaps = 35/227 (15%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRG 60
           + H +++ + D+I     +S +++ +  E    +L   I     +SE+  + F  QI+  
Sbjct: 70  LRHPHIIKLYDVI-----KSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISA 124
Query: 61  LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL 120
           ++Y H   ++HRDLKP NLLL+ + ++KI DFGL+ + ++ +F+     +  Y APE++ 
Sbjct: 125 VEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVIS 184
Query: 121 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAK 180
                   +DVWS G I   ++ R+  F                    +  +  L +N  
Sbjct: 185 GKLYAGPEVDVWSCGVILYVMLCRRLPF-------------------DDESIPVLFKNIS 225
Query: 181 KYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDAL 227
             +  LP++           + P A  L+++ML  +P  RI++ + +
Sbjct: 226 NGVYTLPKF-----------LSPGAAGLIKRMLIVNPLNRISIHEIM 261

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 90.5 bits (223), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 55/227 (24%), Positives = 107/227 (47%), Gaps = 35/227 (15%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRG 60
           + H +++ + D+I     +S +++ +  E    +L   I     +SE+  + F  QI+  
Sbjct: 71  LRHPHIIKLYDVI-----KSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISA 125
Query: 61  LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL 120
           ++Y H   ++HRDLKP NLLL+ + ++KI DFGL+ + ++ +F+     +  Y APE++ 
Sbjct: 126 VEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVIS 185
Query: 121 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAK 180
                   +DVWS G I   ++ R+  F                    +  +  L +N  
Sbjct: 186 GKLYAGPEVDVWSCGVILYVMLCRRLPF-------------------DDESIPVLFKNIS 226
Query: 181 KYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDAL 227
             +  LP++           + P A  L+++ML  +P  RI++ + +
Sbjct: 227 NGVYTLPKF-----------LSPGAAGLIKRMLIVNPLNRISIHEIM 262

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 90.5 bits (223), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 73/252 (28%), Positives = 118/252 (46%), Gaps = 45/252 (17%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILR 59
           + H++VV           E  + V++  EL     L ++ +  +AL+E   +Y+L QI+ 
Sbjct: 72  LAHQHVVGFHGFF-----EDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVL 126
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPEL 118
           G +Y+H   V+HRDLK  NL LN + ++KI DFGLA +V  + +       T  Y APE 
Sbjct: 127 GCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPE- 185
Query: 119 LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNEN 178
           +L+   ++  +DVWS+GCI   L+  KP F                      E   L E 
Sbjct: 186 VLSKKGHSFEVDVWSIGCIMYTLLVGKPPF----------------------ETSCLKET 223
Query: 179 ---AKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL 235
               KK    +P++           ++P A  L++KML  DP  R T+ + L   +  S 
Sbjct: 224 YLRIKKNEYSIPKH-----------INPVAASLIQKMLQTDPTARPTINELLNDEFFTSG 272
Query: 236 HDISDEPV-CMS 246
           +  +  P+ C++
Sbjct: 273 YIPARLPITCLT 284

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 90.1 bits (222), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 75/241 (31%), Positives = 116/241 (48%), Gaps = 45/241 (18%)
Query: 3   HENVVAIRDIIPPPQRESFNDVYIAYELMDTD--LHQIIRSNQALSEEHCQYFLYQILRG 60
           H N++ ++D+      +    VY+  ELM     L +I+R  +  SE      L+ I + 
Sbjct: 75  HPNIITLKDVY-----DDGKYVYVVTELMKGGELLDKILR-QKFFSEREASAVLFTITKT 128
Query: 61  LKYIHSANVLHRDLKPSNLLL---NANCD-LKICDFGLAR-VTSETDFMTEYVVTRWYRA 115
           ++Y+H+  V+HRDLKPSN+L    + N + ++ICDFG A+ + +E   +     T  + A
Sbjct: 129 VEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVA 188
Query: 116 PELLLNSSDYTAAIDVWSVGC-IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSE--AEL 172
           PE +L    Y AA D+WS+G  ++  L    P   G D             TP E  A +
Sbjct: 189 PE-VLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDD------------TPEEILARI 235
Query: 173 GFLNENAKKYICQLPRYQRQSFTEKFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPY 231
           G     + K+          S +  + N V  +A DLV KML  DP QR+T    L HP+
Sbjct: 236 G-----SGKF----------SLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPW 280
Query: 232 L 232
           +
Sbjct: 281 I 281

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 69/237 (29%), Positives = 111/237 (46%), Gaps = 37/237 (15%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILR 59
           + H N+V + D I     E F+  Y+ ++L+   +L + I + +  SE    + + QIL 
Sbjct: 60  LKHPNIVRLHDSI---SEEGFH--YLVFDLVTGGELFEDIVAREYYSEADASHCIQQILE 114
Query: 60  GLKYIHSANVLHRDLKPSNLLL---NANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRA 115
            + + H   ++HRDLKP NLLL   +    +K+ DFGLA  V  +      +  T  Y +
Sbjct: 115 SVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLS 174
Query: 116 PELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL 175
           PE+L     Y   +D+W+ G I                     L I L+G P      F 
Sbjct: 175 PEVL-RKDPYGKPVDMWACGVI---------------------LYILLVGYPP-----FW 207
Query: 176 NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
           +E+  +   Q+        + ++  V P A DL+ KMLT +P +RIT  +AL HP++
Sbjct: 208 DEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPAKRITASEALKHPWI 264

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 69/237 (29%), Positives = 111/237 (46%), Gaps = 37/237 (15%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILR 59
           + H N+V + D I     E F+  Y+ ++L+   +L + I + +  SE    + + QIL 
Sbjct: 60  LKHPNIVRLHDSI---SEEGFH--YLVFDLVTGGELFEDIVAREYYSEADASHCIQQILE 114
Query: 60  GLKYIHSANVLHRDLKPSNLLL---NANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRA 115
            + + H   ++HRDLKP NLLL   +    +K+ DFGLA  V  +      +  T  Y +
Sbjct: 115 SVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLS 174
Query: 116 PELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL 175
           PE+L     Y   +D+W+ G I                     L I L+G P      F 
Sbjct: 175 PEVL-RKDPYGKPVDMWACGVI---------------------LYILLVGYPP-----FW 207
Query: 176 NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
           +E+  +   Q+        + ++  V P A DL+ KMLT +P +RIT  +AL HP++
Sbjct: 208 DEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPAKRITASEALKHPWI 264

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 67/231 (29%), Positives = 105/231 (45%), Gaps = 36/231 (15%)
Query: 3   HENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGL 61
           H +++ +  +I  P     +D+++  E +   +L   I  N  L E+  +    QIL G+
Sbjct: 75  HPHIIKLYQVISTP-----SDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGV 129
Query: 62  KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLN 121
            Y H   V+HRDLKP N+LL+A+ + KI DFGL+ + S+ +F+     +  Y APE++  
Sbjct: 130 DYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSCGSPNYAAPEVISG 189
Query: 122 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 181
                  +D+WS G I   L+     F   DHV  L                       K
Sbjct: 190 RLYAGPEVDIWSSGVILYALLCGTLPFDD-DHVPTLF----------------------K 226
Query: 182 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
            IC    Y  Q        ++PS I L++ ML  DP +R T++D   H + 
Sbjct: 227 KICDGIFYTPQY-------LNPSVISLLKHMLQVDPMKRATIKDIREHEWF 270

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 89.4 bits (220), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 40/213 (18%)
Query: 32  DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD 91
           + +L + IR   +  E   +++  +I+  L+Y+H   ++HRDLKP N+LLN +  ++I D
Sbjct: 117 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 176
Query: 92  FGLARV---TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 148
           FG A+V    S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 177 FGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF 235
Query: 149 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDL 208
              +     + +I+L                              F EKF    P A DL
Sbjct: 236 RAGNEYLIFQKIIKL---------------------------EYDFPEKF---FPKARDL 265
Query: 209 VEKMLTFDPRQRITVEDA------LAHPYLGSL 235
           VEK+L  D  +R+  E+        AHP+  S+
Sbjct: 266 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 298

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 40/213 (18%)
Query: 32  DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD 91
           + +L + IR   +  E   +++  +I+  L+Y+H   ++HRDLKP N+LLN +  ++I D
Sbjct: 114 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 173
Query: 92  FGLARV---TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 148
           FG A+V    S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 174 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF 232
Query: 149 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDL 208
              +     + +I+L                              F EKF    P A DL
Sbjct: 233 RAGNEYLIFQKIIKL---------------------------EYDFPEKF---FPKARDL 262
Query: 209 VEKMLTFDPRQRITVEDA------LAHPYLGSL 235
           VEK+L  D  +R+  E+        AHP+  S+
Sbjct: 263 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 295

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 40/213 (18%)
Query: 32  DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD 91
           + +L + IR   +  E   +++  +I+  L+Y+H   ++HRDLKP N+LLN +  ++I D
Sbjct: 114 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 173
Query: 92  FGLARV---TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 148
           FG A+V    S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 174 FGTAKVLSPESKQARANAFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF 232
Query: 149 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDL 208
              +     + +I+L                              F EKF    P A DL
Sbjct: 233 RAGNEYLIFQKIIKL---------------------------EYDFPEKF---FPKARDL 262
Query: 209 VEKMLTFDPRQRITVEDA------LAHPYLGSL 235
           VEK+L  D  +R+  E+        AHP+  S+
Sbjct: 263 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 295

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 40/213 (18%)
Query: 32  DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD 91
           + +L + IR   +  E   +++  +I+  L+Y+H   ++HRDLKP N+LLN +  ++I D
Sbjct: 113 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 172
Query: 92  FGLARV---TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 148
           FG A+V    S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 173 FGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF 231
Query: 149 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDL 208
              +     + +I+L                              F EKF    P A DL
Sbjct: 232 RAGNEYLIFQKIIKL---------------------------EYDFPEKF---FPKARDL 261
Query: 209 VEKMLTFDPRQRITVEDA------LAHPYLGSL 235
           VEK+L  D  +R+  E+        AHP+  S+
Sbjct: 262 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 294

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 40/213 (18%)
Query: 32  DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD 91
           + +L + IR   +  E   +++  +I+  L+Y+H   ++HRDLKP N+LLN +  ++I D
Sbjct: 121 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 180
Query: 92  FGLARV---TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 148
           FG A+V    S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 181 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF 239
Query: 149 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDL 208
              +     + +I+L                              F EKF    P A DL
Sbjct: 240 RAGNEYLIFQKIIKL---------------------------EYDFPEKF---FPKARDL 269
Query: 209 VEKMLTFDPRQRITVEDA------LAHPYLGSL 235
           VEK+L  D  +R+  E+        AHP+  S+
Sbjct: 270 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 302

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 40/213 (18%)
Query: 32  DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD 91
           + +L + IR   +  E   +++  +I+  L+Y+H   ++HRDLKP N+LLN +  ++I D
Sbjct: 116 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 175
Query: 92  FGLARV---TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 148
           FG A+V    S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 176 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF 234
Query: 149 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDL 208
              +     + +I+L                              F EKF    P A DL
Sbjct: 235 RAGNEYLIFQKIIKL---------------------------EYDFPEKF---FPKARDL 264
Query: 209 VEKMLTFDPRQRITVEDA------LAHPYLGSL 235
           VEK+L  D  +R+  E+        AHP+  S+
Sbjct: 265 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 297

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 40/213 (18%)
Query: 32  DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD 91
           + +L + IR   +  E   +++  +I+  L+Y+H   ++HRDLKP N+LLN +  ++I D
Sbjct: 114 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 173
Query: 92  FGLARV---TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 148
           FG A+V    S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 174 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF 232
Query: 149 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDL 208
              +     + +I+L                              F EKF    P A DL
Sbjct: 233 RAGNEYLIFQKIIKL---------------------------EYDFPEKF---FPKARDL 262
Query: 209 VEKMLTFDPRQRITVEDA------LAHPYLGSL 235
           VEK+L  D  +R+  E+        AHP+  S+
Sbjct: 263 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 295

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 40/213 (18%)
Query: 32  DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD 91
           + +L + IR   +  E   +++  +I+  L+Y+H   ++HRDLKP N+LLN +  ++I D
Sbjct: 93  NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 152
Query: 92  FGLARV---TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 148
           FG A+V    S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 153 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF 211
Query: 149 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDL 208
              +     + +I+L                              F EKF    P A DL
Sbjct: 212 RAGNEYLIFQKIIKL---------------------------EYDFPEKF---FPKARDL 241
Query: 209 VEKMLTFDPRQRITVEDA------LAHPYLGSL 235
           VEK+L  D  +R+  E+        AHP+  S+
Sbjct: 242 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 274

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 40/213 (18%)
Query: 32  DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD 91
           + +L + IR   +  E   +++  +I+  L+Y+H   ++HRDLKP N+LLN +  ++I D
Sbjct: 117 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 176
Query: 92  FGLARV---TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 148
           FG A+V    S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 177 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF 235
Query: 149 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDL 208
              +     + +I+L                              F EKF    P A DL
Sbjct: 236 RAGNEYLIFQKIIKL---------------------------EYDFPEKF---FPKARDL 265
Query: 209 VEKMLTFDPRQRITVEDA------LAHPYLGSL 235
           VEK+L  D  +R+  E+        AHP+  S+
Sbjct: 266 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 298

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 40/213 (18%)
Query: 32  DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD 91
           + +L + IR   +  E   +++  +I+  L+Y+H   ++HRDLKP N+LLN +  ++I D
Sbjct: 114 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 173
Query: 92  FGLARV---TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 148
           FG A+V    S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 174 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF 232
Query: 149 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDL 208
              +     + +I+L                              F EKF    P A DL
Sbjct: 233 RAGNEYLIFQKIIKL---------------------------EYDFPEKF---FPKARDL 262
Query: 209 VEKMLTFDPRQRITVEDA------LAHPYLGSL 235
           VEK+L  D  +R+  E+        AHP+  S+
Sbjct: 263 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 295

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 89.0 bits (219), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 40/213 (18%)
Query: 32  DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD 91
           + +L + IR   +  E   +++  +I+  L+Y+H   ++HRDLKP N+LLN +  ++I D
Sbjct: 116 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 175
Query: 92  FGLARV---TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 148
           FG A+V    S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 176 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF 234
Query: 149 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDL 208
              +     + +I+L                              F EKF    P A DL
Sbjct: 235 RAGNEYLIFQKIIKL---------------------------EYDFPEKF---FPKARDL 264
Query: 209 VEKMLTFDPRQRITVEDA------LAHPYLGSL 235
           VEK+L  D  +R+  E+        AHP+  S+
Sbjct: 265 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 297

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 88.6 bits (218), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 40/213 (18%)
Query: 32  DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD 91
           + +L + IR   +  E   +++  +I+  L+Y+H   ++HRDLKP N+LLN +  ++I D
Sbjct: 92  NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 151
Query: 92  FGLARV---TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 148
           FG A+V    S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 152 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF 210
Query: 149 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDL 208
              +     + +I+L                              F EKF    P A DL
Sbjct: 211 RAGNEYLIFQKIIKL---------------------------EYDFPEKF---FPKARDL 240
Query: 209 VEKMLTFDPRQRITVEDA------LAHPYLGSL 235
           VEK+L  D  +R+  E+        AHP+  S+
Sbjct: 241 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 273

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 88.6 bits (218), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 40/213 (18%)
Query: 32  DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD 91
           + +L + IR   +  E   +++  +I+  L+Y+H   ++HRDLKP N+LLN +  ++I D
Sbjct: 94  NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 153
Query: 92  FGLARV---TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 148
           FG A+V    S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 154 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF 212
Query: 149 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDL 208
              +     + +I+L                              F EKF    P A DL
Sbjct: 213 RAGNEYLIFQKIIKL---------------------------EYDFPEKF---FPKARDL 242
Query: 209 VEKMLTFDPRQRITVEDA------LAHPYLGSL 235
           VEK+L  D  +R+  E+        AHP+  S+
Sbjct: 243 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 275

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 88.6 bits (218), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 64/224 (28%), Positives = 107/224 (47%), Gaps = 36/224 (16%)
Query: 22  NDVYIAYELMDTDL----HQIIRSNQALSEEHCQYFLYQILRGLKYIHSA-NVLHRDLKP 76
            DV+I  ELMDT L     Q+I   Q + E+        I++ L+++HS  +V+HRD+KP
Sbjct: 123 GDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKP 182
Query: 77  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL---LNSSDYTAAIDVWS 133
           SN+L+NA   +K+CDFG++    ++   T     + Y APE +   LN   Y+   D+WS
Sbjct: 183 SNVLINALGQVKMCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYSVKSDIWS 242
Query: 134 VGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQS 193
           +G   +EL               LR   +  GTP +     + E +       P+     
Sbjct: 243 LGITMIELA-------------ILRFPYDSWGTPFQQLKQVVEEPS-------PQLPADK 282
Query: 194 FTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 237
           F+ +F       +D   + L  + ++R T  + + HP+  +LH+
Sbjct: 283 FSAEF-------VDFTSQCLKKNSKERPTYPELMQHPFF-TLHE 318

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 88.6 bits (218), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 40/213 (18%)
Query: 32  DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD 91
           + +L + IR   +  E   +++  +I+  L+Y+H   ++HRDLKP N+LLN +  ++I D
Sbjct: 116 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 175
Query: 92  FGLARV---TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 148
           FG A+V    S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 176 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF 234
Query: 149 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDL 208
              +     + +I+L                              F EKF    P A DL
Sbjct: 235 RAGNEYLIFQKIIKL---------------------------EYDFPEKF---FPKARDL 264
Query: 209 VEKMLTFDPRQRITVEDA------LAHPYLGSL 235
           VEK+L  D  +R+  E+        AHP+  S+
Sbjct: 265 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 297

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 88.6 bits (218), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 40/213 (18%)
Query: 32  DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD 91
           + +L + IR   +  E   +++  +I+  L+Y+H   ++HRDLKP N+LLN +  ++I D
Sbjct: 113 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 172
Query: 92  FGLARV---TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 148
           FG A+V    S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 173 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF 231
Query: 149 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDL 208
              +     + +I+L                              F EKF    P A DL
Sbjct: 232 RAGNEYLIFQKIIKL---------------------------EYDFPEKF---FPKARDL 261
Query: 209 VEKMLTFDPRQRITVEDA------LAHPYLGSL 235
           VEK+L  D  +R+  E+        AHP+  S+
Sbjct: 262 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 294

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 88.6 bits (218), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 40/213 (18%)
Query: 32  DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD 91
           + +L + IR   +  E   +++  +I+  L+Y+H   ++HRDLKP N+LLN +  ++I D
Sbjct: 98  NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 157
Query: 92  FGLARV---TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 148
           FG A+V    S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 158 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF 216
Query: 149 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDL 208
              +     + +I+L                              F EKF    P A DL
Sbjct: 217 RAGNEYLIFQKIIKL---------------------------EYDFPEKF---FPKARDL 246
Query: 209 VEKMLTFDPRQRITVEDA------LAHPYLGSL 235
           VEK+L  D  +R+  E+        AHP+  S+
Sbjct: 247 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 279

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 88.6 bits (218), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 69/237 (29%), Positives = 108/237 (45%), Gaps = 37/237 (15%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILR 59
           + H N+V + D I           Y+ ++L+   +L + I + +  SE    + + QIL 
Sbjct: 78  LKHPNIVRLHDSISEEGHH-----YLIFDLVTGGELFEDIVAREYYSEADASHCIQQILE 132
Query: 60  GLKYIHSANVLHRDLKPSNLLLNA---NCDLKICDFGLA-RVTSETDFMTEYVVTRWYRA 115
            + + H   V+HRDLKP NLLL +      +K+ DFGLA  V  E      +  T  Y +
Sbjct: 133 AVLHCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLS 192
Query: 116 PELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL 175
           PE+L     Y   +D+W+ G I                     L I L+G P      F 
Sbjct: 193 PEVL-RKDPYGKPVDLWACGVI---------------------LYILLVGYPP-----FW 225
Query: 176 NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
           +E+  +   Q+        + ++  V P A DL+ KMLT +P +RIT  +AL HP++
Sbjct: 226 DEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWI 282

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 88.6 bits (218), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 100/213 (46%), Gaps = 40/213 (18%)
Query: 32  DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD 91
           + +L + IR   +  E   +++  +I+  L+Y+H   ++HRDLKP N+LLN +  ++I D
Sbjct: 91  NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 150
Query: 92  FGLARV---TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 148
           FG A+V    S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 151 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF 209
Query: 149 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDL 208
              +     + +I+L                              F EKF    P A DL
Sbjct: 210 RAGNEYLIFQKIIKL---------------------------EYDFPEKF---FPKARDL 239
Query: 209 VEKMLTFDPRQRITVEDA------LAHPYLGSL 235
           VEK+L  D  +R+  E+        AHP+  S+
Sbjct: 240 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 272

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 88.6 bits (218), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 62/210 (29%), Positives = 98/210 (46%), Gaps = 40/210 (19%)
Query: 35  LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL 94
           L + IR   +  E   +++  +I+  L+Y+H   ++HRDLKP N+LLN +  ++I DFG 
Sbjct: 119 LLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGT 178
Query: 95  ARV---TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGR 151
           A+V    S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F   
Sbjct: 179 AKVLSPESKQARANSFVGTAQYVSPELLTEKSASKSS-DLWALGCIIYQLVAGLPPFRAG 237
Query: 152 DHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEK 211
           +     + +I+L                              F EKF    P A DLVEK
Sbjct: 238 NEYLIFQKIIKL---------------------------EYDFPEKF---FPKARDLVEK 267
Query: 212 MLTFDPRQRITVEDA------LAHPYLGSL 235
           +L  D  +R+  E+        AHP+  S+
Sbjct: 268 LLVLDATKRLGCEEMEGYGPLKAHPFFESV 297

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 99/213 (46%), Gaps = 40/213 (18%)
Query: 32  DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD 91
           + +L + IR   +  E   +++  +I+  L+Y+H   ++HRDLKP N+LLN +  ++I D
Sbjct: 116 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 175
Query: 92  FGLARV---TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 148
           FG A+V    S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 176 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSAXKSS-DLWALGCIIYQLVAGLPPF 234
Query: 149 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDL 208
              +       +I+L                              F EKF    P A DL
Sbjct: 235 RAGNEGLIFAKIIKL---------------------------EYDFPEKF---FPKARDL 264
Query: 209 VEKMLTFDPRQRITVEDA------LAHPYLGSL 235
           VEK+L  D  +R+  E+        AHP+  S+
Sbjct: 265 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 297

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 107/236 (45%), Gaps = 37/236 (15%)
Query: 3   HENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGL 61
           H N++ ++D       E+    ++ ++LM   +L   +     LSE+  +  +  +L  +
Sbjct: 70  HPNIIQLKDTY-----ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 124
Query: 62  KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL- 120
             +H  N++HRDLKP N+LL+ + ++K+ DFG +      + + E   T  Y APE++  
Sbjct: 125 CALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIEC 184
Query: 121 ----NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLN 176
               N   Y   +D+WS G I   L+   P F  R  +  LR+++               
Sbjct: 185 SMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM--------------- 229
Query: 177 ENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
             +  Y    P +   S T K         DLV + L   P++R T E+ALAHP+ 
Sbjct: 230 --SGNYQFGSPEWDDYSDTVK---------DLVSRFLVVQPQKRYTAEEALAHPFF 274

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 88.6 bits (218), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 107/236 (45%), Gaps = 37/236 (15%)
Query: 3   HENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGL 61
           H N++ ++D       E+    ++ ++LM   +L   +     LSE+  +  +  +L  +
Sbjct: 83  HPNIIQLKDTY-----ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 137
Query: 62  KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL- 120
             +H  N++HRDLKP N+LL+ + ++K+ DFG +      + + E   T  Y APE++  
Sbjct: 138 CALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIEC 197
Query: 121 ----NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLN 176
               N   Y   +D+WS G I   L+   P F  R  +  LR+++               
Sbjct: 198 SMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM--------------- 242
Query: 177 ENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
             +  Y    P +   S T K         DLV + L   P++R T E+ALAHP+ 
Sbjct: 243 --SGNYQFGSPEWDDYSDTVK---------DLVSRFLVVQPQKRYTAEEALAHPFF 287

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 88.2 bits (217), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 104/216 (48%), Gaps = 39/216 (18%)
Query: 24  VYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 82
           VY+  E+     L ++ +  +A++E   +YF+ Q ++G++Y+H+  V+HRDLK  NL LN
Sbjct: 117 VYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLN 176
Query: 83  ANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 141
            + D+KI DFGLA ++  + +   +   T  Y APE+L     ++  +D+WS+GCI   L
Sbjct: 177 DDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKG-HSFEVDIWSLGCILYTL 235
Query: 142 MDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNEN---AKKYICQLPRYQRQSFTEKF 198
           +  KP F                      E   L E     KK    +PR+         
Sbjct: 236 LVGKPPF----------------------ETSCLKETYIRIKKNEYSVPRH--------- 264
Query: 199 PNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS 234
             ++P A  L+ +ML  DP  R +V + L   +  S
Sbjct: 265 --INPVASALIRRMLHADPTLRPSVAELLTDEFFTS 298

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 88.2 bits (217), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 104/216 (48%), Gaps = 39/216 (18%)
Query: 24  VYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 82
           VY+  E+     L ++ +  +A++E   +YF+ Q ++G++Y+H+  V+HRDLK  NL LN
Sbjct: 101 VYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLN 160
Query: 83  ANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 141
            + D+KI DFGLA ++  + +   +   T  Y APE+L     ++  +D+WS+GCI   L
Sbjct: 161 DDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKG-HSFEVDIWSLGCILYTL 219
Query: 142 MDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNEN---AKKYICQLPRYQRQSFTEKF 198
           +  KP F                      E   L E     KK    +PR+         
Sbjct: 220 LVGKPPF----------------------ETSCLKETYIRIKKNEYSVPRH--------- 248
Query: 199 PNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS 234
             ++P A  L+ +ML  DP  R +V + L   +  S
Sbjct: 249 --INPVASALIRRMLHADPTLRPSVAELLTDEFFTS 282

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 88.2 bits (217), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 68/240 (28%), Positives = 113/240 (47%), Gaps = 43/240 (17%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILR 59
           + H NV+ + ++      E+  DV +  EL+   +L   +   ++L+EE    FL QIL 
Sbjct: 70  IQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN 124
Query: 60  GLKYIHSANVLHRDLKPSN-LLLNANC---DLKICDFGLARVTSETDFMTEY---VVTRW 112
           G+ Y+HS  + H DLKP N +LL+ N     +KI DFGLA    + DF  E+     T  
Sbjct: 125 GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPE 181
Query: 113 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL 172
           + APE ++N        D+WS+G I   L+                       +P     
Sbjct: 182 FVAPE-IVNYEPLGLEADMWSIGVITYILLSG--------------------ASP----- 215
Query: 173 GFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
            FL +  ++ +  +     +   E F N    A D + ++L  DP++R+T++D+L HP++
Sbjct: 216 -FLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 274

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 88.2 bits (217), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 68/240 (28%), Positives = 113/240 (47%), Gaps = 43/240 (17%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILR 59
           + H NV+ + ++      E+  DV +  EL+   +L   +   ++L+EE    FL QIL 
Sbjct: 71  IQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN 125
Query: 60  GLKYIHSANVLHRDLKPSN-LLLNANC---DLKICDFGLARVTSETDFMTEY---VVTRW 112
           G+ Y+HS  + H DLKP N +LL+ N     +KI DFGLA    + DF  E+     T  
Sbjct: 126 GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPE 182
Query: 113 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL 172
           + APE ++N        D+WS+G I   L+                       +P     
Sbjct: 183 FVAPE-IVNYEPLGLEADMWSIGVITYILLSG--------------------ASP----- 216
Query: 173 GFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
            FL +  ++ +  +     +   E F N    A D + ++L  DP++R+T++D+L HP++
Sbjct: 217 -FLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 88.2 bits (217), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 68/240 (28%), Positives = 113/240 (47%), Gaps = 43/240 (17%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILR 59
           + H NV+ + ++      E+  DV +  EL+   +L   +   ++L+EE    FL QIL 
Sbjct: 71  IQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN 125
Query: 60  GLKYIHSANVLHRDLKPSN-LLLNANC---DLKICDFGLARVTSETDFMTEY---VVTRW 112
           G+ Y+HS  + H DLKP N +LL+ N     +KI DFGLA    + DF  E+     T  
Sbjct: 126 GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPE 182
Query: 113 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL 172
           + APE ++N        D+WS+G I   L+                       +P     
Sbjct: 183 FVAPE-IVNYEPLGLEADMWSIGVITYILLSG--------------------ASP----- 216
Query: 173 GFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
            FL +  ++ +  +     +   E F N    A D + ++L  DP++R+T++D+L HP++
Sbjct: 217 -FLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 88.2 bits (217), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 68/240 (28%), Positives = 113/240 (47%), Gaps = 43/240 (17%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILR 59
           + H NV+ + ++      E+  DV +  EL+   +L   +   ++L+EE    FL QIL 
Sbjct: 71  IQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN 125
Query: 60  GLKYIHSANVLHRDLKPSN-LLLNANC---DLKICDFGLARVTSETDFMTEY---VVTRW 112
           G+ Y+HS  + H DLKP N +LL+ N     +KI DFGLA    + DF  E+     T  
Sbjct: 126 GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPE 182
Query: 113 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL 172
           + APE ++N        D+WS+G I   L+                       +P     
Sbjct: 183 FVAPE-IVNYEPLGLEADMWSIGVITYILLSG--------------------ASP----- 216
Query: 173 GFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
            FL +  ++ +  +     +   E F N    A D + ++L  DP++R+T++D+L HP++
Sbjct: 217 -FLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 87.8 bits (216), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 68/240 (28%), Positives = 113/240 (47%), Gaps = 43/240 (17%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILR 59
           + H NV+ + ++      E+  DV +  EL+   +L   +   ++L+EE    FL QIL 
Sbjct: 71  IQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN 125
Query: 60  GLKYIHSANVLHRDLKPSN-LLLNANC---DLKICDFGLARVTSETDFMTEY---VVTRW 112
           G+ Y+HS  + H DLKP N +LL+ N     +KI DFGLA    + DF  E+     T  
Sbjct: 126 GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPE 182
Query: 113 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL 172
           + APE ++N        D+WS+G I   L+                       +P     
Sbjct: 183 FVAPE-IVNYEPLGLEADMWSIGVITYILLSG--------------------ASP----- 216
Query: 173 GFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
            FL +  ++ +  +     +   E F N    A D + ++L  DP++R+T++D+L HP++
Sbjct: 217 -FLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 87.8 bits (216), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 68/241 (28%), Positives = 113/241 (46%), Gaps = 45/241 (18%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILR 59
           + H NV+ + ++      E+  DV +  EL+   +L   +   ++L+EE    FL QIL 
Sbjct: 71  IQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN 125
Query: 60  GLKYIHSANVLHRDLKPSN-LLLNANC---DLKICDFGLARVTSETDFMTEY---VVTRW 112
           G+ Y+HS  + H DLKP N +LL+ N     +KI DFGLA    + DF  E+     T  
Sbjct: 126 GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPE 182
Query: 113 YRAPELLLNSSDYTAAIDVWSVGCI-FMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAE 171
           + APE ++N        D+WS+G I ++ L    P                         
Sbjct: 183 FVAPE-IVNYEPLGLEADMWSIGVITYILLSGASP------------------------- 216
Query: 172 LGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPY 231
             FL +  ++ +  +     +   E F N    A D + ++L  DP++R+T++D+L HP+
Sbjct: 217 --FLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPW 274
Query: 232 L 232
           +
Sbjct: 275 I 275

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 87.8 bits (216), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 68/240 (28%), Positives = 113/240 (47%), Gaps = 43/240 (17%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILR 59
           + H NV+ + ++      E+  DV +  EL+   +L   +   ++L+EE    FL QIL 
Sbjct: 70  IQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN 124
Query: 60  GLKYIHSANVLHRDLKPSN-LLLNANC---DLKICDFGLARVTSETDFMTEY---VVTRW 112
           G+ Y+HS  + H DLKP N +LL+ N     +KI DFGLA    + DF  E+     T  
Sbjct: 125 GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPE 181
Query: 113 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL 172
           + APE ++N        D+WS+G I   L+                       +P     
Sbjct: 182 FVAPE-IVNYEPLGLEADMWSIGVITYILLSG--------------------ASP----- 215
Query: 173 GFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
            FL +  ++ +  +     +   E F N    A D + ++L  DP++R+T++D+L HP++
Sbjct: 216 -FLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 274

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 87.8 bits (216), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 68/240 (28%), Positives = 113/240 (47%), Gaps = 43/240 (17%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILR 59
           + H NV+ + ++      E+  DV +  EL+   +L   +   ++L+EE    FL QIL 
Sbjct: 71  IQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN 125
Query: 60  GLKYIHSANVLHRDLKPSN-LLLNANC---DLKICDFGLARVTSETDFMTEY---VVTRW 112
           G+ Y+HS  + H DLKP N +LL+ N     +KI DFGLA    + DF  E+     T  
Sbjct: 126 GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPE 182
Query: 113 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL 172
           + APE ++N        D+WS+G I   L+                       +P     
Sbjct: 183 FVAPE-IVNYEPLGLEADMWSIGVITYILLSG--------------------ASP----- 216
Query: 173 GFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
            FL +  ++ +  +     +   E F N    A D + ++L  DP++R+T++D+L HP++
Sbjct: 217 -FLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 87.8 bits (216), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 99/213 (46%), Gaps = 40/213 (18%)
Query: 32  DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD 91
           + +L + IR   +  E   +++  +I+  L+Y+H   ++HRDLKP N+LLN +  ++I D
Sbjct: 116 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 175
Query: 92  FGLARV---TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 148
           FG A+V    S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 176 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF 234
Query: 149 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDL 208
              +       +I+L                              F EKF    P A DL
Sbjct: 235 RAGNEGLIFAKIIKL---------------------------EYDFPEKF---FPKARDL 264
Query: 209 VEKMLTFDPRQRITVEDA------LAHPYLGSL 235
           VEK+L  D  +R+  E+        AHP+  S+
Sbjct: 265 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 297

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 87.8 bits (216), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 68/240 (28%), Positives = 113/240 (47%), Gaps = 43/240 (17%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILR 59
           + H NV+ + ++      E+  DV +  EL+   +L   +   ++L+EE    FL QIL 
Sbjct: 71  IQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN 125
Query: 60  GLKYIHSANVLHRDLKPSN-LLLNANC---DLKICDFGLARVTSETDFMTEY---VVTRW 112
           G+ Y+HS  + H DLKP N +LL+ N     +KI DFGLA    + DF  E+     T  
Sbjct: 126 GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPE 182
Query: 113 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL 172
           + APE ++N        D+WS+G I   L+                       +P     
Sbjct: 183 FVAPE-IVNYEPLGLEADMWSIGVITYILLSG--------------------ASP----- 216
Query: 173 GFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
            FL +  ++ +  +     +   E F N    A D + ++L  DP++R+T++D+L HP++
Sbjct: 217 -FLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 87.8 bits (216), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 68/240 (28%), Positives = 113/240 (47%), Gaps = 43/240 (17%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILR 59
           + H NV+ + ++      E+  DV +  EL+   +L   +   ++L+EE    FL QIL 
Sbjct: 71  IQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN 125
Query: 60  GLKYIHSANVLHRDLKPSN-LLLNANC---DLKICDFGLARVTSETDFMTEY---VVTRW 112
           G+ Y+HS  + H DLKP N +LL+ N     +KI DFGLA    + DF  E+     T  
Sbjct: 126 GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPE 182
Query: 113 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL 172
           + APE ++N        D+WS+G I   L+                       +P     
Sbjct: 183 FVAPE-IVNYEPLGLEADMWSIGVITYILLSG--------------------ASP----- 216
Query: 173 GFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
            FL +  ++ +  +     +   E F N    A D + ++L  DP++R+T++D+L HP++
Sbjct: 217 -FLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 87.8 bits (216), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 68/240 (28%), Positives = 113/240 (47%), Gaps = 43/240 (17%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILR 59
           + H NV+ + ++      E+  DV +  EL+   +L   +   ++L+EE    FL QIL 
Sbjct: 71  IQHPNVITLHEVY-----ENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLKQILN 125
Query: 60  GLKYIHSANVLHRDLKPSN-LLLNANC---DLKICDFGLARVTSETDFMTEY---VVTRW 112
           G+ Y+HS  + H DLKP N +LL+ N     +KI DFGLA    + DF  E+     T  
Sbjct: 126 GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPE 182
Query: 113 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL 172
           + APE ++N        D+WS+G I   L+                       +P     
Sbjct: 183 FVAPE-IVNYEPLGLEADMWSIGVITYILLSG--------------------ASP----- 216
Query: 173 GFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
            FL +  ++ +  +     +   E F N    A D + ++L  DP++R+T++D+L HP++
Sbjct: 217 -FLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 87.8 bits (216), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 68/240 (28%), Positives = 113/240 (47%), Gaps = 43/240 (17%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILR 59
           + H NV+ + ++      E+  DV +  EL+   +L   +   ++L+EE    FL QIL 
Sbjct: 71  IQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN 125
Query: 60  GLKYIHSANVLHRDLKPSN-LLLNANC---DLKICDFGLARVTSETDFMTEY---VVTRW 112
           G+ Y+HS  + H DLKP N +LL+ N     +KI DFGLA    + DF  E+     T  
Sbjct: 126 GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPE 182
Query: 113 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL 172
           + APE ++N        D+WS+G I   L+                       +P     
Sbjct: 183 FVAPE-IVNYEPLGLEADMWSIGVITYILLSG--------------------ASP----- 216
Query: 173 GFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
            FL +  ++ +  +     +   E F N    A D + ++L  DP++R+T++D+L HP++
Sbjct: 217 -FLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 87.8 bits (216), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 103/216 (47%), Gaps = 39/216 (18%)
Query: 24  VYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 82
           VY+  E+     L ++ +  +A++E   +YF+ Q ++G++Y+H+  V+HRDLK  NL LN
Sbjct: 117 VYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLN 176
Query: 83  ANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 141
            + D+KI DFGLA ++  + +       T  Y APE+L     ++  +D+WS+GCI   L
Sbjct: 177 DDMDVKIGDFGLATKIEFDGERKKTLCGTPNYIAPEVLCKKG-HSFEVDIWSLGCILYTL 235
Query: 142 MDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNEN---AKKYICQLPRYQRQSFTEKF 198
           +  KP F                      E   L E     KK    +PR+         
Sbjct: 236 LVGKPPF----------------------ETSCLKETYIRIKKNEYSVPRH--------- 264
Query: 199 PNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS 234
             ++P A  L+ +ML  DP  R +V + L   +  S
Sbjct: 265 --INPVASALIRRMLHADPTLRPSVAELLTDEFFTS 298

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 87.4 bits (215), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 68/240 (28%), Positives = 113/240 (47%), Gaps = 43/240 (17%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILR 59
           + H NV+ + ++      E+  DV +  EL+   +L   +   ++L+EE    FL QIL 
Sbjct: 71  IQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN 125
Query: 60  GLKYIHSANVLHRDLKPSN-LLLNANC---DLKICDFGLARVTSETDFMTEY---VVTRW 112
           G+ Y+HS  + H DLKP N +LL+ N     +KI DFGLA    + DF  E+     T  
Sbjct: 126 GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPA 182
Query: 113 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL 172
           + APE ++N        D+WS+G I   L+                       +P     
Sbjct: 183 FVAPE-IVNYEPLGLEADMWSIGVITYILLSG--------------------ASP----- 216
Query: 173 GFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
            FL +  ++ +  +     +   E F N    A D + ++L  DP++R+T++D+L HP++
Sbjct: 217 -FLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 87.4 bits (215), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 103/216 (47%), Gaps = 39/216 (18%)
Query: 24  VYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 82
           VY+  E+     L ++ +  +A++E   +YF+ Q ++G++Y+H+  V+HRDLK  NL LN
Sbjct: 117 VYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLN 176
Query: 83  ANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 141
            + D+KI DFGLA ++  + +       T  Y APE+L     ++  +D+WS+GCI   L
Sbjct: 177 DDMDVKIGDFGLATKIEFDGERKKXLCGTPNYIAPEVLCKKG-HSFEVDIWSLGCILYTL 235
Query: 142 MDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNEN---AKKYICQLPRYQRQSFTEKF 198
           +  KP F                      E   L E     KK    +PR+         
Sbjct: 236 LVGKPPF----------------------ETSCLKETYIRIKKNEYSVPRH--------- 264
Query: 199 PNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS 234
             ++P A  L+ +ML  DP  R +V + L   +  S
Sbjct: 265 --INPVASALIRRMLHADPTLRPSVAELLTDEFFTS 298

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 87.4 bits (215), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 68/240 (28%), Positives = 109/240 (45%), Gaps = 42/240 (17%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTD--LHQIIRS---NQALSEEHCQYFLY 55
           +DH N++ I ++      E ++++YI  E  +    L +I+ +    +ALSE +    + 
Sbjct: 77  LDHPNIIKIFEVF-----EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMK 131
Query: 56  QILRGLKYIHSANVLHRDLKPSNLLL---NANCDLKICDFGLARVTSETDFMTEYVVTRW 112
           Q++  L Y HS +V+H+DLKP N+L    + +  +KI DFGLA +    +  T    T  
Sbjct: 132 QMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTAL 191
Query: 113 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL 172
           Y APE+     D T   D+WS G +   L+     F G                      
Sbjct: 192 YMAPEVF--KRDVTFKCDIWSAGVVMYFLLTGCLPFTGTS-------------------- 229
Query: 173 GFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
             L E  +K   + P Y      E  P + P A+DL+++MLT DP +R +    L H + 
Sbjct: 230 --LEEVQQKATYKEPNYA----VECRP-LTPQAVDLLKQMLTKDPERRPSAAQVLHHEWF 282

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 87.0 bits (214), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 68/240 (28%), Positives = 113/240 (47%), Gaps = 43/240 (17%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILR 59
           + H NV+ + ++      E+  DV +  EL+   +L   +   ++L+EE    FL QIL 
Sbjct: 71  IQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN 125
Query: 60  GLKYIHSANVLHRDLKPSN-LLLNANC---DLKICDFGLARVTSETDFMTEY---VVTRW 112
           G+ Y+HS  + H DLKP N +LL+ N     +KI DFGLA    + DF  E+     T  
Sbjct: 126 GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAH---KIDFGNEFKNIFGTPE 182
Query: 113 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL 172
           + APE ++N        D+WS+G I   L+                       +P     
Sbjct: 183 FVAPE-IVNYEPLGLEADMWSIGVITYILLSG--------------------ASP----- 216
Query: 173 GFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
            FL +  ++ +  +     +   E F N    A D + ++L  DP++R+T++D+L HP++
Sbjct: 217 -FLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 58/238 (24%), Positives = 110/238 (46%), Gaps = 39/238 (16%)
Query: 22  NDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 81
           +++++  E ++      I ++  ++EE        +LR L Y+H+  V+HRD+K  ++LL
Sbjct: 115 DELWVVMEFLEGGALTDIVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILL 174
Query: 82  NANCDLKICDFGL-ARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 140
            ++  +K+ DFG  A+V+ E       V T ++ APE +++   Y   +D+WS+G + +E
Sbjct: 175 TSDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPE-VISRLPYGTEVDIWSLGIMVIE 233
Query: 141 LMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPN 200
           ++D +P                           + NE       Q  R  R S   +  +
Sbjct: 234 MIDGEP--------------------------PYFNEPP----LQAMRRIRDSLPPRVKD 263
Query: 201 VHPSAIDL---VEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMSPFSFDFEQH 255
           +H  +  L   ++ ML  +P QR T ++ L HP+L     ++  P C+ P    +  H
Sbjct: 264 LHKVSSVLRGFLDLMLVREPSQRATAQELLGHPFL----KLAGPPSCIVPLMRQYRHH 317

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 87.0 bits (214), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 66/237 (27%), Positives = 105/237 (44%), Gaps = 37/237 (15%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILR 59
           + H N++ +++I   P      ++ +  EL+   +L   I      SE      + QIL 
Sbjct: 105 LSHPNIIKLKEIFETP-----TEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILE 159
Query: 60  GLKYIHSANVLHRDLKPSNLLLNA---NCDLKICDFGLARVTSETDFMTEYVVTRWYRAP 116
            + Y+H   ++HRDLKP NLL      +  LKI DFGL+++      M     T  Y AP
Sbjct: 160 AVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAP 219
Query: 117 ELLLNSSDYTAAIDVWSVGCI-FMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL 175
           E+L   + Y   +D+WSVG I ++ L   +P +  R      R ++              
Sbjct: 220 EILRGCA-YGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRIL-------------- 264
Query: 176 NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
             N + Y    P +   S   K         DLV K++  DP++R+T   AL HP++
Sbjct: 265 --NCEYYFIS-PWWDEVSLNAK---------DLVRKLIVLDPKKRLTTFQALQHPWV 309

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 86.7 bits (213), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/236 (28%), Positives = 105/236 (44%), Gaps = 37/236 (15%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILR 59
           + HEN+V + DI      ES    Y+  +L+   +L   I      +E+     + Q+L 
Sbjct: 63  IKHENIVTLEDIY-----ESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLS 117
Query: 60  GLKYIHSANVLHRDLKPSNLLL---NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAP 116
            +KY+H   ++HRDLKP NLL      N  + I DFGL+++  +   M+    T  Y AP
Sbjct: 118 AVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKM-EQNGIMSTACGTPGYVAP 176
Query: 117 ELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLN 176
           E+L     Y+ A+D WS+G I                       I L G P      F  
Sbjct: 177 EVLAQKP-YSKAVDCWSIGVI---------------------TYILLCGYPP-----FYE 209
Query: 177 ENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
           E   K   ++     +  +  + ++  SA D +  +L  DP +R T E AL+HP++
Sbjct: 210 ETESKLFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWI 265

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 86.7 bits (213), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 106/236 (44%), Gaps = 37/236 (15%)
Query: 3   HENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGL 61
           H N++ ++D       E+    ++ ++LM   +L   +     LSE+  +  +  +L  +
Sbjct: 83  HPNIIQLKDTY-----ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 137
Query: 62  KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL- 120
             +H  N++HRDLKP N+LL+ + ++K+ DFG +      + +     T  Y APE++  
Sbjct: 138 CALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRSVCGTPSYLAPEIIEC 197
Query: 121 ----NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLN 176
               N   Y   +D+WS G I   L+   P F  R  +  LR+++               
Sbjct: 198 SMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIM--------------- 242
Query: 177 ENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
             +  Y    P +   S T K         DLV + L   P++R T E+ALAHP+ 
Sbjct: 243 --SGNYQFGSPEWDDYSDTVK---------DLVSRFLVVQPQKRYTAEEALAHPFF 287

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 86.7 bits (213), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/237 (28%), Positives = 108/237 (45%), Gaps = 37/237 (15%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILR 59
           + H N+V + D I           Y+ ++L+   +L + I + +  SE    + + QIL 
Sbjct: 67  LKHPNIVRLHDSISEEGHH-----YLIFDLVTGGELFEDIVAREYYSEADASHCIQQILE 121
Query: 60  GLKYIHSANVLHRDLKPSNLLLNA---NCDLKICDFGLA-RVTSETDFMTEYVVTRWYRA 115
            + + H   V+HR+LKP NLLL +      +K+ DFGLA  V  E      +  T  Y +
Sbjct: 122 AVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLS 181
Query: 116 PELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL 175
           PE+L     Y   +D+W+ G I                     L I L+G P      F 
Sbjct: 182 PEVL-RKDPYGKPVDLWACGVI---------------------LYILLVGYPP-----FW 214
Query: 176 NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
           +E+  +   Q+        + ++  V P A DL+ KMLT +P +RIT  +AL HP++
Sbjct: 215 DEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWI 271

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 86.3 bits (212), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/218 (31%), Positives = 103/218 (47%), Gaps = 37/218 (16%)
Query: 24  VYIAYELMD-TDL-HQIIRSNQA---LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN 78
           +Y+ +E MD  DL  +I++   A    SE    +++ QIL  L+Y H  N++HRD+KP N
Sbjct: 101 LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPEN 160
Query: 79  LLLNA---NCDLKICDFGLARVTSETDFMT-EYVVTRWYRAPELLLNSSDYTAAIDVWSV 134
           +LL +   +  +K+ DFG+A    E+  +    V T  + APE ++    Y   +DVW  
Sbjct: 161 VLLASKENSAPVKLGDFGVAIQLGESGLVAGGRVGTPHFMAPE-VVKREPYGKPVDVWGC 219
Query: 135 GCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSF 194
           G I   L               L   +   GT      G +    K      PR      
Sbjct: 220 GVILFIL---------------LSGCLPFYGTKERLFEGIIKGKYK----MNPR------ 254
Query: 195 TEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
             ++ ++  SA DLV +ML  DP +RITV +AL HP+L
Sbjct: 255 --QWSHISESAKDLVRRMLMLDPAERITVYEALNHPWL 290

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 65/236 (27%), Positives = 110/236 (46%), Gaps = 37/236 (15%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILR 59
           +DH N++ + D+    +       Y+  E  +  +L + I +     E      + QIL 
Sbjct: 103 LDHPNIIKLFDVFEDKKY-----FYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILS 157
Query: 60  GLKYIHSANVLHRDLKPSNLLL---NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAP 116
           G+ Y+H  N++HRD+KP N+LL   N+  ++KI DFGL+   S+   + + + T +Y AP
Sbjct: 158 GICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAP 217
Query: 117 ELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLN 176
           E+L     Y    DVWS G I   L+   P F G++    ++ +                
Sbjct: 218 EVL--KKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKV---------------- 259
Query: 177 ENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
           E  K Y           F + + N+   A +L++ MLT+D  +R T E+AL   ++
Sbjct: 260 EKGKYYF---------DFND-WKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWI 305

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 85.9 bits (211), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 73/241 (30%), Positives = 114/241 (47%), Gaps = 45/241 (18%)
Query: 3   HENVVAIRDIIPPPQRESFNDVYIAYELMDTD--LHQIIRSNQALSEEHCQYFLYQILRG 60
           H N++ ++D+      +    VY+  EL      L +I+R  +  SE      L+ I + 
Sbjct: 75  HPNIITLKDVY-----DDGKYVYVVTELXKGGELLDKILR-QKFFSEREASAVLFTITKT 128
Query: 61  LKYIHSANVLHRDLKPSNLLL---NANCD-LKICDFGLAR-VTSETDFMTEYVVTRWYRA 115
           ++Y+H+  V+HRDLKPSN+L    + N + ++ICDFG A+ + +E   +     T  + A
Sbjct: 129 VEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCYTANFVA 188
Query: 116 PELLLNSSDYTAAIDVWSVGC-IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSE--AEL 172
           PE +L    Y AA D+WS+G  ++  L    P   G D             TP E  A +
Sbjct: 189 PE-VLERQGYDAACDIWSLGVLLYTXLTGYTPFANGPDD------------TPEEILARI 235
Query: 173 GFLNENAKKYICQLPRYQRQSFTEKFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPY 231
           G     + K+          S +  + N V  +A DLV K L  DP QR+T    L HP+
Sbjct: 236 G-----SGKF----------SLSGGYWNSVSDTAKDLVSKXLHVDPHQRLTAALVLRHPW 280
Query: 232 L 232
           +
Sbjct: 281 I 281

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 70/257 (27%), Positives = 123/257 (47%), Gaps = 45/257 (17%)
Query: 22  NDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSA--NVLHRDLKPS 77
           N + + +E++  +L+ ++R+   + +S    + F  Q+   L ++ +   +++H DLKP 
Sbjct: 129 NHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPE 188
Query: 78  NLLL--NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVG 135
           N+LL       +KI DFG +    +  +  + + +R+YR+PE+LL    Y  AID+WS+G
Sbjct: 189 NILLCNPKRSAIKIVDFGSSCQLGQRIY--QXIQSRFYRSPEVLLGMP-YDLAIDMWSLG 245
Query: 136 CIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLP-------- 187
           CI +E+   +PLF G + V Q+  ++E++G P  A +      A+K+  +LP        
Sbjct: 246 CILVEMHTGEPLFSGANEVDQMNKIVEVLGIPP-AHILDQAPKARKFFEKLPDGTWNLKK 304
Query: 188 -----RYQRQSFTEKFPNV-----------------HPSA-----IDLVEKMLTFDPRQR 220
                R  +   T K  N+                 H  A      DL+ +ML +DP+ R
Sbjct: 305 TKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTR 364
Query: 221 ITVEDALAHPYLGSLHD 237
           I    AL H +     D
Sbjct: 365 IQPYYALQHSFFKKTAD 381

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 71/260 (27%), Positives = 125/260 (48%), Gaps = 51/260 (19%)
Query: 22  NDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSA--NVLHRDLKPS 77
           N + + +E++  +L+ ++R+   + +S    + F  Q+   L ++ +   +++H DLKP 
Sbjct: 129 NHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPE 188
Query: 78  NLLLNANCD-----LKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVW 132
           N+LL   C+     +KI DFG +    +  +  + + +R+YR+PE+LL    Y  AID+W
Sbjct: 189 NILL---CNPKRXAIKIVDFGSSCQLGQRIY--QXIQSRFYRSPEVLLGMP-YDLAIDMW 242
Query: 133 SVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLP----- 187
           S+GCI +E+   +PLF G + V Q+  ++E++G P  A +      A+K+  +LP     
Sbjct: 243 SLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPP-AHILDQAPKARKFFEKLPDGTWN 301
Query: 188 --------RYQRQSFTEKFPNV-----------------HPSA-----IDLVEKMLTFDP 217
                   R  +   T K  N+                 H  A      DL+ +ML +DP
Sbjct: 302 LKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDP 361
Query: 218 RQRITVEDALAHPYLGSLHD 237
           + RI    AL H +     D
Sbjct: 362 KTRIQPYYALQHSFFKKTAD 381

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 85.5 bits (210), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 70/257 (27%), Positives = 123/257 (47%), Gaps = 45/257 (17%)
Query: 22  NDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSA--NVLHRDLKPS 77
           N + + +E++  +L+ ++R+   + +S    + F  Q+   L ++ +   +++H DLKP 
Sbjct: 110 NHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPE 169
Query: 78  NLLL--NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVG 135
           N+LL       +KI DFG +    +  +  + + +R+YR+PE+LL    Y  AID+WS+G
Sbjct: 170 NILLCNPKRSAIKIVDFGSSCQLGQRIY--QXIQSRFYRSPEVLLGMP-YDLAIDMWSLG 226
Query: 136 CIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLP-------- 187
           CI +E+   +PLF G + V Q+  ++E++G P  A +      A+K+  +LP        
Sbjct: 227 CILVEMHTGEPLFSGANEVDQMNKIVEVLGIPP-AHILDQAPKARKFFEKLPDGTWNLKK 285
Query: 188 -----RYQRQSFTEKFPNV-----------------HPSA-----IDLVEKMLTFDPRQR 220
                R  +   T K  N+                 H  A      DL+ +ML +DP+ R
Sbjct: 286 TKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTR 345
Query: 221 ITVEDALAHPYLGSLHD 237
           I    AL H +     D
Sbjct: 346 IQPYYALQHSFFKKTAD 362

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 84.7 bits (208), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 105/230 (45%), Gaps = 39/230 (16%)
Query: 23  DVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 82
           ++++  E +       I S   L+EE        +L+ L Y+H+  V+HRD+K  ++LL 
Sbjct: 116 ELWVLMEFLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLT 175
Query: 83  ANCDLKICDFGL-ARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 141
            +  +K+ DFG  A+++ +       V T ++ APE +++ S Y   +D+WS+G + +E+
Sbjct: 176 LDGRVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPE-VISRSLYATEVDIWSLGIMVIEM 234
Query: 142 MDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNV 201
           +D +P +     V  ++ L                              R S   K  N 
Sbjct: 235 VDGEPPYFSDSPVQAMKRL------------------------------RDSPPPKLKNS 264
Query: 202 H---PSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMSPF 248
           H   P   D +E+ML  DP++R T ++ L HP+L      +  P C+ P 
Sbjct: 265 HKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQ----TGLPECLVPL 310

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 84.7 bits (208), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 98/213 (46%), Gaps = 40/213 (18%)
Query: 32  DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD 91
           + +L + IR   +  E   +++  +I+  L+Y+H   ++HRDLKP N+LLN +  ++I D
Sbjct: 119 NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITD 178
Query: 92  FGLARV---TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 148
           FG A+V    S+      +V T  Y +PELL   S   ++ D+W++GCI  +L+   P F
Sbjct: 179 FGTAKVLSPESKQARANXFVGTAQYVSPELLTEKSACKSS-DLWALGCIIYQLVAGLPPF 237
Query: 149 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDL 208
              +     + +I+L                              F   F    P A DL
Sbjct: 238 RAGNEYLIFQKIIKL---------------------------EYDFPAAF---FPKARDL 267
Query: 209 VEKMLTFDPRQRITVEDA------LAHPYLGSL 235
           VEK+L  D  +R+  E+        AHP+  S+
Sbjct: 268 VEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 300

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 84.3 bits (207), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 59/237 (24%), Positives = 119/237 (50%), Gaps = 38/237 (16%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRG 60
           +DH NVV + +++  P  +    +Y+ +EL++      + + + LSE+  +++   +++G
Sbjct: 93  LDHPNVVKLVEVLDDPNEDH---LYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKG 149
Query: 61  LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELL 119
           ++Y+H   ++HRD+KPSNLL+  +  +KI DFG++     +D  ++  V T  + APE L
Sbjct: 150 IEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESL 209
Query: 120 LNSSDY--TAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNE 177
             +       A+DVW++G                     + L   + G     +  F++E
Sbjct: 210 SETRKIFSGKALDVWAMG---------------------VTLYCFVFG-----QCPFMDE 243
Query: 178 NAKKYICQLPRYQRQS--FTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
              + +C   + + Q+  F ++ P++     DL+ +ML  +P  RI V +   HP++
Sbjct: 244 ---RIMCLHSKIKSQALEFPDQ-PDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWV 296

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 84.3 bits (207), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 116/246 (47%), Gaps = 40/246 (16%)
Query: 26  IAYELMDTDLHQIIRSNQALSE--EHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL-LN 82
           I++EL+       ++ N  L       ++  +Q+ + +K++H   + H DLKP N+L +N
Sbjct: 113 ISFELLGLSTFDFLKDNNYLPYPIHQVRHMAFQLCQAVKFLHDNKLTHTDLKPENILFVN 172
Query: 83  ANCDL------------------KICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 124
           ++ +L                  ++ DFG A  T + +  +  V TR YRAPE++L    
Sbjct: 173 SDYELTYNLEKKRDERSVKSTAVRVVDFGSA--TFDHEHHSTIVSTRHYRAPEVILELG- 229
Query: 125 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIG-TPSEA----------ELG 173
           ++   DVWS+GCI  E      LF   D+   L ++  ++G  PS              G
Sbjct: 230 WSQPCDVWSIGCIIFEYYVGFTLFQTHDNREHLAMMERILGPIPSRMIRKTRKQKYFYRG 289
Query: 174 FL----NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 229
            L    N +A +Y+ +  +  R+  T +    H    DL+E ML ++P +R+T+ +AL H
Sbjct: 290 RLDWDENTSAGRYVRENCKPLRRYLTSE-AEEHHQLFDLIESMLEYEPAKRLTLGEALQH 348
Query: 230 PYLGSL 235
           P+   L
Sbjct: 349 PFFARL 354

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 84.3 bits (207), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 105/224 (46%), Gaps = 36/224 (16%)
Query: 22  NDVYIAYELMDTDL----HQIIRSNQALSEEHCQYFLYQILRGLKYIHSA-NVLHRDLKP 76
            DV+I  ELMDT L     Q+I   Q + E+        I++ L+++HS  +V+HRD+KP
Sbjct: 79  GDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKP 138
Query: 77  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL---LNSSDYTAAIDVWS 133
           SN+L+NA   +K+CDFG++    +          + Y APE +   LN   Y+   D+WS
Sbjct: 139 SNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWS 198
Query: 134 VGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQS 193
           +G   +EL               LR   +  GTP +     + E +       P+     
Sbjct: 199 LGITMIELA-------------ILRFPYDSWGTPFQQLKQVVEEPS-------PQLPADK 238
Query: 194 FTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 237
           F+ +F       +D   + L  + ++R T  + + HP+  +LH+
Sbjct: 239 FSAEF-------VDFTSQCLKKNSKERPTYPELMQHPFF-TLHE 274

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 84.0 bits (206), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 95/212 (44%), Gaps = 36/212 (16%)
Query: 40  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA---NCDLKICDFGLAR 96
           R +QA +E      +  I   ++Y+HS N+ HRD+KP NLL  +   N  LK+ DFG A+
Sbjct: 107 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 166
Query: 97  VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ 156
            T+  + +TE   T +Y APE +L    Y  + D+WS+G I   L+   P          
Sbjct: 167 ETTSHNSLTEPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYP---------- 215
Query: 157 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAID-----LVEK 211
                     P  +  G       K   ++ +Y+       FPN   S +      L+  
Sbjct: 216 ----------PFYSNHGLAISPGMKTRIRMGQYE-------FPNPEWSEVSEEVKMLIRN 258
Query: 212 MLTFDPRQRITVEDALAHPYLGSLHDISDEPV 243
           +L  +P QR+T+ + + HP++     +   P+
Sbjct: 259 LLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 290

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 82.8 bits (203), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 108/219 (49%), Gaps = 38/219 (17%)
Query: 19  ESFNDVYIAYELM-DTDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKP 76
           E  N VY+  E+  + ++++ +++  +  SE   ++F++QI+ G+ Y+HS  +LHRDL  
Sbjct: 81  EDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTL 140
Query: 77  SNLLLNANCDLKICDFGLA---RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWS 133
           SNLLL  N ++KI DFGLA   ++  E  +      T  Y +PE+   S+ +    DVWS
Sbjct: 141 SNLLLTRNMNIKIADFGLATQLKMPHEKHY--TLCGTPNYISPEIATRSA-HGLESDVWS 197
Query: 134 VGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQS 193
           +GC+F  L+  +P F      + L  ++                        L  Y+  S
Sbjct: 198 LGCMFYTLLIGRPPFDTDTVKNTLNKVV------------------------LADYEMPS 233
Query: 194 FTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
           F      +   A DL+ ++L  +P  R+++   L HP++
Sbjct: 234 F------LSIEAKDLIHQLLRRNPADRLSLSSVLDHPFM 266

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 82.4 bits (202), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 101/217 (46%), Gaps = 35/217 (16%)
Query: 22  NDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 81
           +++++  E ++      I ++  ++EE        +L+ L  +H+  V+HRD+K  ++LL
Sbjct: 144 DELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL 203
Query: 82  NANCDLKICDFGL-ARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 140
             +  +K+ DFG  A+V+ E       V T ++ APE L++   Y   +D+WS+G + +E
Sbjct: 204 THDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE-LISRLPYGPEVDIWSLGIMVIE 262
Query: 141 LMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPN 200
           ++D +P                           + NE   K +  +    R +   +  N
Sbjct: 263 MVDGEP--------------------------PYFNEPPLKAMKMI----RDNLPPRLKN 292
Query: 201 VH---PSAIDLVEKMLTFDPRQRITVEDALAHPYLGS 234
           +H   PS    ++++L  DP QR T  + L HP+L  
Sbjct: 293 LHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK 329

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 82.4 bits (202), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 53/216 (24%), Positives = 101/216 (46%), Gaps = 35/216 (16%)
Query: 22  NDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 81
           +++++  E ++      I ++  ++EE        +L+ L  +H+  V+HRD+K  ++LL
Sbjct: 221 DELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL 280
Query: 82  NANCDLKICDFGL-ARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 140
             +  +K+ DFG  A+V+ E       V T ++ APE L++   Y   +D+WS+G + +E
Sbjct: 281 THDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE-LISRLPYGPEVDIWSLGIMVIE 339
Query: 141 LMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPN 200
           ++D +P                           + NE   K +  +    R +   +  N
Sbjct: 340 MVDGEP--------------------------PYFNEPPLKAMKMI----RDNLPPRLKN 369
Query: 201 VH---PSAIDLVEKMLTFDPRQRITVEDALAHPYLG 233
           +H   PS    ++++L  DP QR T  + L HP+L 
Sbjct: 370 LHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLA 405

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 95/215 (44%), Gaps = 36/215 (16%)
Query: 40  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA---NCDLKICDFGLAR 96
           R +QA +E      +  I   ++Y+HS N+ HRD+KP NLL  +   N  LK+ DFG A+
Sbjct: 113 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 172
Query: 97  VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ 156
            T+  + +T    T +Y APE +L    Y  + D+WS+G I   L+   P          
Sbjct: 173 ETTSHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYP---------- 221
Query: 157 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAID-----LVEK 211
                     P  +  G       K   ++ +Y+       FPN   S +      L+  
Sbjct: 222 ----------PFYSNHGLAISPGMKTRIRMGQYE-------FPNPEWSEVSEEVKMLIRN 264
Query: 212 MLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMS 246
           +L  +P QR+T+ + + HP++     +   P+  S
Sbjct: 265 LLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTS 299

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 94/212 (44%), Gaps = 36/212 (16%)
Query: 40  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA---NCDLKICDFGLAR 96
           R +QA +E      +  I   ++Y+HS N+ HRD+KP NLL  +   N  LK+ DFG A+
Sbjct: 114 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 173
Query: 97  VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ 156
            T+  + +T    T +Y APE +L    Y  + D+WS+G I   L+   P          
Sbjct: 174 ETTSHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYP---------- 222
Query: 157 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAID-----LVEK 211
                     P  +  G       K   ++ +Y+       FPN   S +      L+  
Sbjct: 223 ----------PFYSNHGLAISPGMKTRIRMGQYE-------FPNPEWSEVSEEVKMLIRN 265
Query: 212 MLTFDPRQRITVEDALAHPYLGSLHDISDEPV 243
           +L  +P QR+T+ + + HP++     +   P+
Sbjct: 266 LLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 297

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 106/235 (45%), Gaps = 37/235 (15%)
Query: 3   HENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGL 61
           H NV+ + D+      E+  DV +  EL+   +L   +   ++LSEE    F+ QIL G+
Sbjct: 74  HHNVITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGV 128
Query: 62  KYIHSANVLHRDLKPSN-LLLNANC---DLKICDFGLARVTSETDFMTEYVVTRWYRAPE 117
            Y+H+  + H DLKP N +LL+ N     +K+ DFGLA    +         T  + APE
Sbjct: 129 NYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188
Query: 118 LLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNE 177
            ++N        D+WS+G I   L+                       +P      FL +
Sbjct: 189 -IVNYEPLGLEADMWSIGVITYILLSG--------------------ASP------FLGD 221
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
             ++ +  +         E F +    A D + K+L  + R+R+T+++AL HP++
Sbjct: 222 TKQETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 95/215 (44%), Gaps = 36/215 (16%)
Query: 40  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA---NCDLKICDFGLAR 96
           R +QA +E      +  I   ++Y+HS N+ HRD+KP NLL  +   N  LK+ DFG A+
Sbjct: 115 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 174
Query: 97  VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ 156
            T+  + +T    T +Y APE +L    Y  + D+WS+G I   L+   P          
Sbjct: 175 ETTSHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYP---------- 223
Query: 157 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAID-----LVEK 211
                     P  +  G       K   ++ +Y+       FPN   S +      L+  
Sbjct: 224 ----------PFYSNHGLAISPGMKTRIRMGQYE-------FPNPEWSEVSEEVKMLIRN 266
Query: 212 MLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMS 246
           +L  +P QR+T+ + + HP++     +   P+  S
Sbjct: 267 LLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTS 301

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 82.0 bits (201), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 94/212 (44%), Gaps = 36/212 (16%)
Query: 40  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA---NCDLKICDFGLAR 96
           R +QA +E      +  I   ++Y+HS N+ HRD+KP NLL  +   N  LK+ DFG A+
Sbjct: 123 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 182
Query: 97  VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ 156
            T+  + +T    T +Y APE +L    Y  + D+WS+G I   L+   P          
Sbjct: 183 ETTSHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYP---------- 231
Query: 157 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAID-----LVEK 211
                     P  +  G       K   ++ +Y+       FPN   S +      L+  
Sbjct: 232 ----------PFYSNHGLAISPGMKTRIRMGQYE-------FPNPEWSEVSEEVKMLIRN 274
Query: 212 MLTFDPRQRITVEDALAHPYLGSLHDISDEPV 243
           +L  +P QR+T+ + + HP++     +   P+
Sbjct: 275 LLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 306

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 101/217 (46%), Gaps = 35/217 (16%)
Query: 22  NDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 81
           +++++  E ++      I ++  ++EE        +L+ L  +H+  V+HRD+K  ++LL
Sbjct: 99  DELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL 158
Query: 82  NANCDLKICDFGL-ARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 140
             +  +K+ DFG  A+V+ E       V T ++ APE L++   Y   +D+WS+G + +E
Sbjct: 159 THDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE-LISRLPYGPEVDIWSLGIMVIE 217
Query: 141 LMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPN 200
           ++D +P                           + NE   K +  +    R +   +  N
Sbjct: 218 MVDGEP--------------------------PYFNEPPLKAMKMI----RDNLPPRLKN 247
Query: 201 VH---PSAIDLVEKMLTFDPRQRITVEDALAHPYLGS 234
           +H   PS    ++++L  DP QR T  + L HP+L  
Sbjct: 248 LHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK 284

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 95/215 (44%), Gaps = 36/215 (16%)
Query: 40  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA---NCDLKICDFGLAR 96
           R +QA +E      +  I   ++Y+HS N+ HRD+KP NLL  +   N  LK+ DFG A+
Sbjct: 109 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
Query: 97  VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ 156
            T+  + +T    T +Y APE +L    Y  + D+WS+G I   L+   P          
Sbjct: 169 ETTSHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYP---------- 217
Query: 157 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAID-----LVEK 211
                     P  +  G       K   ++ +Y+       FPN   S +      L+  
Sbjct: 218 ----------PFYSNHGLAISPGMKTRIRMGQYE-------FPNPEWSEVSEEVKMLIRN 260
Query: 212 MLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMS 246
           +L  +P QR+T+ + + HP++     +   P+  S
Sbjct: 261 LLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTS 295

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 82.0 bits (201), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 53/217 (24%), Positives = 101/217 (46%), Gaps = 35/217 (16%)
Query: 22  NDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 81
           +++++  E ++      I ++  ++EE        +L+ L  +H+  V+HRD+K  ++LL
Sbjct: 101 DELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILL 160
Query: 82  NANCDLKICDFGL-ARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 140
             +  +K+ DFG  A+V+ E       V T ++ APE L++   Y   +D+WS+G + +E
Sbjct: 161 THDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE-LISRLPYGPEVDIWSLGIMVIE 219
Query: 141 LMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPN 200
           ++D +P                           + NE   K +  +    R +   +  N
Sbjct: 220 MVDGEP--------------------------PYFNEPPLKAMKMI----RDNLPPRLKN 249
Query: 201 VH---PSAIDLVEKMLTFDPRQRITVEDALAHPYLGS 234
           +H   PS    ++++L  DP QR T  + L HP+L  
Sbjct: 250 LHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK 286

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 81.6 bits (200), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 94/212 (44%), Gaps = 36/212 (16%)
Query: 40  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA---NCDLKICDFGLAR 96
           R +QA +E      +  I   ++Y+HS N+ HRD+KP NLL  +   N  LK+ DFG A+
Sbjct: 108 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 167
Query: 97  VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ 156
            T+  + +T    T +Y APE +L    Y  + D+WS+G I   L+   P          
Sbjct: 168 ETTSHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYP---------- 216
Query: 157 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAID-----LVEK 211
                     P  +  G       K   ++ +Y+       FPN   S +      L+  
Sbjct: 217 ----------PFYSNHGLAISPGMKTRIRMGQYE-------FPNPEWSEVSEEVKMLIRN 259
Query: 212 MLTFDPRQRITVEDALAHPYLGSLHDISDEPV 243
           +L  +P QR+T+ + + HP++     +   P+
Sbjct: 260 LLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 291

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 81.6 bits (200), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 95/215 (44%), Gaps = 36/215 (16%)
Query: 40  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA---NCDLKICDFGLAR 96
           R +QA +E      +  I   ++Y+HS N+ HRD+KP NLL  +   N  LK+ DFG A+
Sbjct: 159 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 218
Query: 97  VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ 156
            T+  + +T    T +Y APE +L    Y  + D+WS+G I   L+   P          
Sbjct: 219 ETTSHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYP---------- 267
Query: 157 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAID-----LVEK 211
                     P  +  G       K   ++ +Y+       FPN   S +      L+  
Sbjct: 268 ----------PFYSNHGLAISPGMKTRIRMGQYE-------FPNPEWSEVSEEVKMLIRN 310
Query: 212 MLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMS 246
           +L  +P QR+T+ + + HP++     +   P+  S
Sbjct: 311 LLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTS 345

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 81.6 bits (200), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 57/193 (29%), Positives = 89/193 (46%), Gaps = 30/193 (15%)
Query: 43  QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN---CDLKICDFGLARVTS 99
           + +SE      + QIL G+ Y+H  N++H DLKP N+LL++     D+KI DFG++R   
Sbjct: 126 EMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIG 185
Query: 100 ETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL 159
               + E + T  Y APE +LN    T A D+W++G I   L+     F G D       
Sbjct: 186 HACELREIMGTPEYLAPE-ILNYDPITTATDMWNIGIIAYMLLTHTSPFVGED------- 237
Query: 160 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQ 219
                             N + Y+  + +       E F +V   A D ++ +L  +P +
Sbjct: 238 ------------------NQETYL-NISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEK 278
Query: 220 RITVEDALAHPYL 232
           R T E  L+H +L
Sbjct: 279 RPTAEICLSHSWL 291

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 81.6 bits (200), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 94/212 (44%), Gaps = 36/212 (16%)
Query: 40  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA---NCDLKICDFGLAR 96
           R +QA +E      +  I   ++Y+HS N+ HRD+KP NLL  +   N  LK+ DFG A+
Sbjct: 107 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 166
Query: 97  VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ 156
            T+  + +T    T +Y APE +L    Y  + D+WS+G I   L+   P          
Sbjct: 167 ETTSHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYP---------- 215
Query: 157 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAID-----LVEK 211
                     P  +  G       K   ++ +Y+       FPN   S +      L+  
Sbjct: 216 ----------PFYSNHGLAISPGMKTRIRMGQYE-------FPNPEWSEVSEEVKMLIRN 258
Query: 212 MLTFDPRQRITVEDALAHPYLGSLHDISDEPV 243
           +L  +P QR+T+ + + HP++     +   P+
Sbjct: 259 LLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 290

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 81.6 bits (200), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 95/215 (44%), Gaps = 36/215 (16%)
Query: 40  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA---NCDLKICDFGLAR 96
           R +QA +E      +  I   ++Y+HS N+ HRD+KP NLL  +   N  LK+ DFG A+
Sbjct: 109 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
Query: 97  VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ 156
            T+  + +T    T +Y APE +L    Y  + D+WS+G I   L+   P          
Sbjct: 169 ETTSHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYP---------- 217
Query: 157 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAID-----LVEK 211
                     P  +  G       K   ++ +Y+       FPN   S +      L+  
Sbjct: 218 ----------PFYSNHGLAISPGMKTRIRMGQYE-------FPNPEWSEVSEEVKMLIRN 260
Query: 212 MLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMS 246
           +L  +P QR+T+ + + HP++     +   P+  S
Sbjct: 261 LLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTS 295

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 81.6 bits (200), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 95/215 (44%), Gaps = 36/215 (16%)
Query: 40  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA---NCDLKICDFGLAR 96
           R +QA +E      +  I   ++Y+HS N+ HRD+KP NLL  +   N  LK+ DFG A+
Sbjct: 153 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212
Query: 97  VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ 156
            T+  + +T    T +Y APE +L    Y  + D+WS+G I   L+   P          
Sbjct: 213 ETTSHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYP---------- 261
Query: 157 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAID-----LVEK 211
                     P  +  G       K   ++ +Y+       FPN   S +      L+  
Sbjct: 262 ----------PFYSNHGLAISPGMKTRIRMGQYE-------FPNPEWSEVSEEVKMLIRN 304
Query: 212 MLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMS 246
           +L  +P QR+T+ + + HP++     +   P+  S
Sbjct: 305 LLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTS 339

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 81.6 bits (200), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 58/236 (24%), Positives = 108/236 (45%), Gaps = 40/236 (16%)
Query: 3   HENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLK 62
           HENVV + +          +++++  E ++      I ++  ++EE        +L+ L 
Sbjct: 76  HENVVEMYN-----SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALS 130
Query: 63  YIHSANVLHRDLKPSNLLLNANCDLKICDFGL-ARVTSETDFMTEYVVTRWYRAPELLLN 121
            +H+  V+HRD+K  ++LL  +  +K+ DFG  A+V+ E       V T ++ APE L++
Sbjct: 131 VLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE-LIS 189
Query: 122 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 181
              Y   +D+WS+G + +E++D +P                           + NE   K
Sbjct: 190 RLPYGPEVDIWSLGIMVIEMVDGEP--------------------------PYFNEPPLK 223
Query: 182 YICQLPRYQRQSFTEKFPNVH---PSAIDLVEKMLTFDPRQRITVEDALAHPYLGS 234
            +  +    R +   +  N+H   PS    ++++L  DP QR T  + L HP+L  
Sbjct: 224 AMKMI----RDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK 275

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 81.3 bits (199), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 58/236 (24%), Positives = 108/236 (45%), Gaps = 40/236 (16%)
Query: 3   HENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLK 62
           HENVV + +          +++++  E ++      I ++  ++EE        +L+ L 
Sbjct: 80  HENVVEMYN-----SYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAAVCLAVLQALS 134
Query: 63  YIHSANVLHRDLKPSNLLLNANCDLKICDFGL-ARVTSETDFMTEYVVTRWYRAPELLLN 121
            +H+  V+HRD+K  ++LL  +  +K+ DFG  A+V+ E       V T ++ APE L++
Sbjct: 135 VLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPE-LIS 193
Query: 122 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 181
              Y   +D+WS+G + +E++D +P                           + NE   K
Sbjct: 194 RLPYGPEVDIWSLGIMVIEMVDGEP--------------------------PYFNEPPLK 227
Query: 182 YICQLPRYQRQSFTEKFPNVH---PSAIDLVEKMLTFDPRQRITVEDALAHPYLGS 234
            +  +    R +   +  N+H   PS    ++++L  DP QR T  + L HP+L  
Sbjct: 228 AMKMI----RDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK 279

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 81.3 bits (199), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 61/239 (25%), Positives = 105/239 (43%), Gaps = 39/239 (16%)
Query: 3   HENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGL 61
           H N++ + DI      E+  DV +  EL+   +L   +   ++L+E+    FL QIL G+
Sbjct: 67  HPNIITLHDIF-----ENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGV 121
Query: 62  KYIHSANVLHRDLKPSNLLL----NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPE 117
            Y+HS  + H DLKP N++L      N  +K+ DFG+A      +       T  + APE
Sbjct: 122 HYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPE 181
Query: 118 LLLNSSDYTAAIDVWSVGCI-FMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLN 176
            ++N        D+WS+G I ++ L    P                           FL 
Sbjct: 182 -IVNYEPLGLEADMWSIGVITYILLSGASP---------------------------FLG 213
Query: 177 ENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL 235
           E  ++ +  +         E F N    A D + ++L  DP++R+T+  +L H ++ ++
Sbjct: 214 ETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI 272

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 106/235 (45%), Gaps = 37/235 (15%)
Query: 3   HENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGL 61
           H NV+ + D+      E+  DV +  EL+   +L   +   ++LSEE    F+ QIL G+
Sbjct: 74  HHNVITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGV 128
Query: 62  KYIHSANVLHRDLKPSN-LLLNANC---DLKICDFGLARVTSETDFMTEYVVTRWYRAPE 117
            Y+H+  + H DLKP N +LL+ N     +K+ DFGLA    +         T  + APE
Sbjct: 129 NYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188
Query: 118 LLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNE 177
            ++N        D+WS+G I   L+                       +P      FL +
Sbjct: 189 -IVNYEPLGLEADMWSIGVITYILLSG--------------------ASP------FLGD 221
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
             ++ +  +         E F +    A D + K+L  + R+R+T+++AL HP++
Sbjct: 222 TKQETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 106/235 (45%), Gaps = 37/235 (15%)
Query: 3   HENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGL 61
           H NV+ + D+      E+  DV +  EL+   +L   +   ++LSEE    F+ QIL G+
Sbjct: 74  HHNVITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGV 128
Query: 62  KYIHSANVLHRDLKPSN-LLLNANC---DLKICDFGLARVTSETDFMTEYVVTRWYRAPE 117
            Y+H+  + H DLKP N +LL+ N     +K+ DFGLA    +         T  + APE
Sbjct: 129 NYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188
Query: 118 LLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNE 177
            ++N        D+WS+G I   L+                       +P      FL +
Sbjct: 189 -IVNYEPLGLEADMWSIGVITYILLSG--------------------ASP------FLGD 221
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
             ++ +  +         E F +    A D + K+L  + R+R+T+++AL HP++
Sbjct: 222 TKQETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 81.3 bits (199), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 97/221 (43%), Gaps = 31/221 (14%)
Query: 22  NDVYIAYELMDT-DLHQIIR-SNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL 79
            D++I  E      +  IIR  N+ L+E+     L   L+GL+Y+H    +HRD+K  N+
Sbjct: 97  TDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNI 156
Query: 80  LLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIF 138
           LLN     K+ DFG+A ++T         + T ++ APE ++    Y    D+WS+G   
Sbjct: 157 LLNTEGHAKLADFGVAGQLTDXMAKRNXVIGTPFWMAPE-VIQEIGYNCVADIWSLGITA 215
Query: 139 MELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF 198
           +E+ + KP +     +H +R +  +   P                 + P     +FT   
Sbjct: 216 IEMAEGKPPYA---DIHPMRAIFMIPTNPPPT-------------FRKPELWSDNFT--- 256
Query: 199 PNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDIS 239
                   D V++ L   P QR T    L HP++ S   +S
Sbjct: 257 --------DFVKQCLVKSPEQRATATQLLQHPFVRSAKGVS 289

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 80.9 bits (198), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 105/235 (44%), Gaps = 37/235 (15%)
Query: 3   HENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGL 61
           H NV+ + D+      E+  DV +  EL+   +L   +   ++LSEE    F+ QIL G+
Sbjct: 74  HHNVITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGV 128
Query: 62  KYIHSANVLHRDLKPSN-LLLNANC---DLKICDFGLARVTSETDFMTEYVVTRWYRAPE 117
            Y+H+  + H DLKP N +LL+ N     +K+ DFGLA    +         T  + APE
Sbjct: 129 NYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188
Query: 118 LLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNE 177
            ++N        D+WS+G I   L+                       +P      FL +
Sbjct: 189 -IVNYEPLGLEADMWSIGVITYILLSG--------------------ASP------FLGD 221
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
             ++ +  +         E F      A D + K+L  + R+R+T+++AL HP++
Sbjct: 222 TKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 80.9 bits (198), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 63/235 (26%), Positives = 105/235 (44%), Gaps = 37/235 (15%)
Query: 3   HENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGL 61
           H NV+ + D+      E+  DV +  EL+   +L   +   ++LSEE    F+ QIL G+
Sbjct: 74  HHNVITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGV 128
Query: 62  KYIHSANVLHRDLKPSN-LLLNANC---DLKICDFGLARVTSETDFMTEYVVTRWYRAPE 117
            Y+H+  + H DLKP N +LL+ N     +K+ DFGLA    +         T  + APE
Sbjct: 129 NYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188
Query: 118 LLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNE 177
            ++N        D+WS+G I   L+                       +P      FL +
Sbjct: 189 -IVNYEPLGLEADMWSIGVITYILLSG--------------------ASP------FLGD 221
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
             ++ +  +         E F      A D + K+L  + R+R+T+++AL HP++
Sbjct: 222 TKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 80.9 bits (198), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 46/133 (34%), Positives = 77/133 (57%), Gaps = 5/133 (3%)
Query: 20  SFNDVYIAYELMDTD-LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN-VLHRDLKPS 77
           S  ++ I  E MD   L Q+++  + + EE        +LRGL Y+   + ++HRD+KPS
Sbjct: 85  SDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPS 144
Query: 78  NLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 137
           N+L+N+  ++K+CDFG++    ++     +V TR Y APE  L  + Y+   D+WS+G  
Sbjct: 145 NILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMAPE-RLQGTHYSVQSDIWSMGLS 202
Query: 138 FMEL-MDRKPLFP 149
            +EL + R P+ P
Sbjct: 203 LVELAVGRYPIPP 215

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 80.5 bits (197), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 97/217 (44%), Gaps = 38/217 (17%)
Query: 21  FNDVYIAYELMD-TDLHQIIRSNQALS---EEHCQYFLYQILRGLKYIHSANVLHRDLKP 76
           F+D    Y +++   L  + R  Q LS   E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 77  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 136
Query: 77  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 136
            NLLL +  +LKI DFG + V + +   TE   T  Y  PE ++    +   +D+WS+G 
Sbjct: 137 ENLLLGSAGELKIADFGWS-VHAPSSRRTELCGTLDYLPPE-MIEGRMHDEKVDLWSLGV 194
Query: 137 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 196
           +  E +  KP F                              A  Y     R  R  FT 
Sbjct: 195 LCYEFLVGKPPF-----------------------------EANTYQETYKRISRVEFT- 224
Query: 197 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
            FP+ V   A DL+ ++L  +P QR  + + L HP++
Sbjct: 225 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 101/218 (46%), Gaps = 37/218 (16%)
Query: 24  VYIAYELMD-TDL-HQIIRSNQA---LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN 78
           +Y+ +E MD  DL  +I++   A    SE    +++ QIL  L+Y H  N++HRD+KP  
Sbjct: 103 LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHC 162
Query: 79  LLLNA---NCDLKICDFGLARVTSETDFMT-EYVVTRWYRAPELLLNSSDYTAAIDVWSV 134
           +LL +   +  +K+  FG+A    E+  +    V T  + APE ++    Y   +DVW  
Sbjct: 163 VLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPE-VVKREPYGKPVDVWGC 221
Query: 135 GCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSF 194
           G I   L               L   +   GT      G +    K      PR      
Sbjct: 222 GVILFIL---------------LSGCLPFYGTKERLFEGIIKGKYK----MNPR------ 256
Query: 195 TEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
             ++ ++  SA DLV +ML  DP +RITV +AL HP+L
Sbjct: 257 --QWSHISESAKDLVRRMLMLDPAERITVYEALNHPWL 292

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 80.1 bits (196), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 101/218 (46%), Gaps = 37/218 (16%)
Query: 24  VYIAYELMD-TDL-HQIIRSNQA---LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN 78
           +Y+ +E MD  DL  +I++   A    SE    +++ QIL  L+Y H  N++HRD+KP  
Sbjct: 101 LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHC 160
Query: 79  LLLNA---NCDLKICDFGLARVTSETDFMT-EYVVTRWYRAPELLLNSSDYTAAIDVWSV 134
           +LL +   +  +K+  FG+A    E+  +    V T  + APE ++    Y   +DVW  
Sbjct: 161 VLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPE-VVKREPYGKPVDVWGC 219
Query: 135 GCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSF 194
           G I   L               L   +   GT      G +    K      PR      
Sbjct: 220 GVILFIL---------------LSGCLPFYGTKERLFEGIIKGKYK----MNPR------ 254
Query: 195 TEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
             ++ ++  SA DLV +ML  DP +RITV +AL HP+L
Sbjct: 255 --QWSHISESAKDLVRRMLMLDPAERITVYEALNHPWL 290

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/224 (27%), Positives = 102/224 (45%), Gaps = 36/224 (16%)
Query: 22  NDVYIAYELMDTDL----HQIIRSNQALSEEHCQYFLYQILRGLKYIHSA-NVLHRDLKP 76
            DV+I  EL DT L     Q+I   Q + E+        I++ L+++HS  +V+HRD+KP
Sbjct: 106 GDVWICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKP 165
Query: 77  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL---LNSSDYTAAIDVWS 133
           SN+L+NA   +K CDFG++    +          + Y APE +   LN   Y+   D+WS
Sbjct: 166 SNVLINALGQVKXCDFGISGYLVDDVAKDIDAGCKPYXAPERINPELNQKGYSVKSDIWS 225
Query: 134 VGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQS 193
           +G   +EL               LR   +  GTP +     + E +       P+     
Sbjct: 226 LGITXIELA-------------ILRFPYDSWGTPFQQLKQVVEEPS-------PQLPADK 265
Query: 194 FTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 237
           F+ +F       +D   + L  + ++R T  +   HP+  +LH+
Sbjct: 266 FSAEF-------VDFTSQCLKKNSKERPTYPELXQHPFF-TLHE 301

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 79.3 bits (194), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/239 (25%), Positives = 105/239 (43%), Gaps = 39/239 (16%)
Query: 3   HENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGL 61
           H N++ + DI      E+  DV +  EL+   +L   +   ++L+E+    FL QIL G+
Sbjct: 88  HPNIITLHDIF-----ENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGV 142
Query: 62  KYIHSANVLHRDLKPSN-LLLNANC---DLKICDFGLARVTSETDFMTEYVVTRWYRAPE 117
            Y+HS  + H DLKP N +LL+ N     +K+ DFG+A      +       T  + APE
Sbjct: 143 HYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPE 202
Query: 118 LLLNSSDYTAAIDVWSVGCI-FMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLN 176
            ++N        D+WS+G I ++ L    P                           FL 
Sbjct: 203 -IVNYEPLGLEADMWSIGVITYILLSGASP---------------------------FLG 234
Query: 177 ENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL 235
           E  ++ +  +         E F N    A D + ++L  DP++R+ +  +L H ++ ++
Sbjct: 235 ETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMXIAQSLEHSWIKAI 293

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/235 (26%), Positives = 105/235 (44%), Gaps = 37/235 (15%)
Query: 3   HENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGL 61
           H N++ + D+      E+  DV +  EL+   +L   +   ++LSEE    F+ QIL G+
Sbjct: 74  HPNIITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGV 128
Query: 62  KYIHSANVLHRDLKPSN-LLLNANC---DLKICDFGLARVTSETDFMTEYVVTRWYRAPE 117
            Y+H+  + H DLKP N +LL+ N     +K+ DFGLA    +         T  + APE
Sbjct: 129 NYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE 188
Query: 118 LLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNE 177
            ++N        D+WS+G I   L+                       +P      FL +
Sbjct: 189 -IVNYEPLGLEADMWSIGVITYILLSG--------------------ASP------FLGD 221
Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
             ++ +  +         E F      A D + K+L  + R+R+T+++AL HP++
Sbjct: 222 TKQETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 60/236 (25%), Positives = 102/236 (43%), Gaps = 39/236 (16%)
Query: 3   HENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGL 61
           H N++ + DI      E+  DV +  EL+   +L   +   ++L+E+    FL QIL G+
Sbjct: 74  HPNIITLHDIF-----ENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGV 128
Query: 62  KYIHSANVLHRDLKPSNLLL----NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPE 117
            Y+HS  + H DLKP N++L      N  +K+ DFG+A      +       T  + APE
Sbjct: 129 HYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPE 188
Query: 118 LLLNSSDYTAAIDVWSVGCI-FMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLN 176
            ++N        D+WS+G I ++ L    P                           FL 
Sbjct: 189 -IVNYEPLGLEADMWSIGVITYILLSGASP---------------------------FLG 220
Query: 177 ENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
           E  ++ +  +         E F N    A D + ++L  DP++R+ +  +L H ++
Sbjct: 221 ETKQETLTNISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMXIAQSLEHSWI 276

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 97/217 (44%), Gaps = 38/217 (17%)
Query: 21  FNDVYIAYELMD-TDLHQIIRSNQALS---EEHCQYFLYQILRGLKYIHSANVLHRDLKP 76
           F+D    Y +++   L  + R  Q LS   E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 82  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 141
Query: 77  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 136
            NLLL +  +LKI DFG + V + +   T+   T  Y  PE ++    +   +D+WS+G 
Sbjct: 142 ENLLLGSAGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPE-MIEGRMHDEKVDLWSLGV 199
Query: 137 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 196
           +  E +  KP F                              A  Y     R  R  FT 
Sbjct: 200 LCYEFLVGKPPF-----------------------------EANTYQETYKRISRVEFT- 229
Query: 197 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
            FP+ V   A DL+ ++L  +P QR  + + L HP++
Sbjct: 230 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 265

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 96/217 (44%), Gaps = 38/217 (17%)
Query: 21  FNDVYIAYELMD-TDLHQIIRSNQALS---EEHCQYFLYQILRGLKYIHSANVLHRDLKP 76
           F+D    Y +++   L  + R  Q LS   E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 103 FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 162
Query: 77  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 136
            NLLL +  +LKI DFG + V + +   T    T  Y  PE ++    +   +D+WS+G 
Sbjct: 163 ENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPE-MIEGRMHDEKVDLWSLGV 220
Query: 137 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 196
           +  E +  KP F                              A  Y     R  R  FT 
Sbjct: 221 LCYEFLVGKPPF-----------------------------EANTYQETYKRISRVEFT- 250
Query: 197 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
            FP+ V   A DL+ ++L  +P QR  + + L HP++
Sbjct: 251 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 286

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 97/217 (44%), Gaps = 38/217 (17%)
Query: 21  FNDVYIAYELMD-TDLHQIIRSNQALS---EEHCQYFLYQILRGLKYIHSANVLHRDLKP 76
           F+D    Y +++   L  + R  Q LS   E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 77  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 136
Query: 77  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 136
            NLLL +  +LKI DFG + V + +   T+   T  Y  PE ++    +   +D+WS+G 
Sbjct: 137 ENLLLGSAGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPE-MIEGRMHDEKVDLWSLGV 194
Query: 137 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 196
           +  E +  KP F                              A  Y     R  R  FT 
Sbjct: 195 LCYEFLVGKPPF-----------------------------EANTYQETYKRISRVEFT- 224
Query: 197 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
            FP+ V   A DL+ ++L  +P QR  + + L HP++
Sbjct: 225 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 97/217 (44%), Gaps = 38/217 (17%)
Query: 21  FNDVYIAYELMD-TDLHQIIRSNQALS---EEHCQYFLYQILRGLKYIHSANVLHRDLKP 76
           F+D    Y +++   L  + R  Q LS   E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 78  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 137
Query: 77  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 136
            NLLL +  +LKI DFG + V + +   T+   T  Y  PE ++    +   +D+WS+G 
Sbjct: 138 ENLLLGSAGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPE-MIEGRMHDEKVDLWSLGV 195
Query: 137 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 196
           +  E +  KP F                              A  Y     R  R  FT 
Sbjct: 196 LCYEFLVGKPPF-----------------------------EANTYQETYKRISRVEFT- 225
Query: 197 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
            FP+ V   A DL+ ++L  +P QR  + + L HP++
Sbjct: 226 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 261

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 79.0 bits (193), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 97/217 (44%), Gaps = 38/217 (17%)
Query: 21  FNDVYIAYELMD-TDLHQIIRSNQALS---EEHCQYFLYQILRGLKYIHSANVLHRDLKP 76
           F+D    Y +++   L  + R  Q LS   E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 77  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 136
Query: 77  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 136
            NLLL +  +LKI DFG + V + +   T+   T  Y  PE ++    +   +D+WS+G 
Sbjct: 137 ENLLLGSAGELKIADFGWS-VHAPSSRRTDLCGTLDYLPPE-MIEGRMHDEKVDLWSLGV 194
Query: 137 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 196
           +  E +  KP F                              A  Y     R  R  FT 
Sbjct: 195 LCYEFLVGKPPF-----------------------------EANTYQETYKRISRVEFT- 224
Query: 197 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
            FP+ V   A DL+ ++L  +P QR  + + L HP++
Sbjct: 225 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 78.6 bits (192), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 51/157 (32%), Positives = 86/157 (54%), Gaps = 9/157 (5%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILR 59
           + H+N+V++ D+      E  +  Y+  E ++   L + I S+  LS +    F  QIL 
Sbjct: 68  LSHQNIVSMIDV-----DEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILD 122
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM-TEYVV-TRWYRAPE 117
           G+K+ H   ++HRD+KP N+L+++N  LKI DFG+A+  SET    T +V+ T  Y +PE
Sbjct: 123 GIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPE 182
Query: 118 LLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHV 154
                +      D++S+G +  E++  +P F G   V
Sbjct: 183 QAKGEA-TDECTDIYSIGIVLYEMLVGEPPFNGETAV 218

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 78.6 bits (192), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 55/159 (34%), Positives = 81/159 (50%), Gaps = 15/159 (9%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQII----RSNQALSEEHCQYFLY 55
           + H N+V   D I      +   +YI  E  +  DL  +I    +  Q L EE     + 
Sbjct: 62  LKHPNIVRYYDRIID---RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT 118
Query: 56  QILRGLKYIHSAN-----VLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVV 109
           Q+   LK  H  +     VLHRDLKP+N+ L+   ++K+ DFGLAR+ + + DF  E+V 
Sbjct: 119 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFVG 178
Query: 110 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 148
           T +Y +PE  +N   Y    D+WS+GC+  EL    P F
Sbjct: 179 TPYYMSPE-QMNRMSYNEKSDIWSLGCLLYELCALMPPF 216

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 96/217 (44%), Gaps = 38/217 (17%)
Query: 21  FNDVYIAYELMD-TDLHQIIRSNQALS---EEHCQYFLYQILRGLKYIHSANVLHRDLKP 76
           F+D    Y +++   L  + R  Q LS   E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 94  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 153
Query: 77  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 136
            NLLL +  +LKI DFG + V + +   T    T  Y  PE ++    +   +D+WS+G 
Sbjct: 154 ENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPE-MIEGRMHDEKVDLWSLGV 211
Query: 137 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 196
           +  E +  KP F                              A  Y     R  R  FT 
Sbjct: 212 LCYEFLVGKPPF-----------------------------EANTYQETYKRISRVEFT- 241
Query: 197 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
            FP+ V   A DL+ ++L  +P QR  + + L HP++
Sbjct: 242 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 277

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 96/217 (44%), Gaps = 38/217 (17%)
Query: 21  FNDVYIAYELMD-TDLHQIIRSNQALS---EEHCQYFLYQILRGLKYIHSANVLHRDLKP 76
           F+D    Y +++   L  + R  Q LS   E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 81  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 140
Query: 77  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 136
            NLLL +  +LKI DFG + V + +   T    T  Y  PE ++    +   +D+WS+G 
Sbjct: 141 ENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPE-MIEGRMHDEKVDLWSLGV 198
Query: 137 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 196
           +  E +  KP F                              A  Y     R  R  FT 
Sbjct: 199 LCYEFLVGKPPF-----------------------------EANTYQETYKRISRVEFT- 228
Query: 197 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
            FP+ V   A DL+ ++L  +P QR  + + L HP++
Sbjct: 229 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 264

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 78.6 bits (192), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 96/217 (44%), Gaps = 38/217 (17%)
Query: 21  FNDVYIAYELMD-TDLHQIIRSNQALS---EEHCQYFLYQILRGLKYIHSANVLHRDLKP 76
           F+D    Y +++   L  + R  Q LS   E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 82  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 141
Query: 77  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 136
            NLLL +  +LKI DFG + V + +   T    T  Y  PE ++    +   +D+WS+G 
Sbjct: 142 ENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPE-MIEGRMHDEKVDLWSLGV 199
Query: 137 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 196
           +  E +  KP F                              A  Y     R  R  FT 
Sbjct: 200 LCYEFLVGKPPF-----------------------------EANTYQETYKRISRVEFT- 229
Query: 197 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
            FP+ V   A DL+ ++L  +P QR  + + L HP++
Sbjct: 230 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 265

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 78.2 bits (191), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 96/217 (44%), Gaps = 38/217 (17%)
Query: 21  FNDVYIAYELMD-TDLHQIIRSNQALS---EEHCQYFLYQILRGLKYIHSANVLHRDLKP 76
           F+D    Y +++   L  + R  Q LS   E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 77  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 136
Query: 77  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 136
            NLLL +  +LKI DFG + V + +   T    T  Y  PE ++    +   +D+WS+G 
Sbjct: 137 ENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPE-MIEGRMHDEKVDLWSLGV 194
Query: 137 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 196
           +  E +  KP F                              A  Y     R  R  FT 
Sbjct: 195 LCYEFLVGKPPF-----------------------------EANTYQETYKRISRVEFT- 224
Query: 197 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
            FP+ V   A DL+ ++L  +P QR  + + L HP++
Sbjct: 225 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 78.2 bits (191), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 54/216 (25%), Positives = 101/216 (46%), Gaps = 30/216 (13%)
Query: 20  SFNDVYIAYELMDTD-LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA-NVLHRDLKPS 77
           S  ++ I  E MD   L Q+++    + E+        +++GL Y+     ++HRD+KPS
Sbjct: 94  SDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPS 153
Query: 78  NLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 137
           N+L+N+  ++K+CDFG++    ++     +V TR Y +PE  L  + Y+   D+WS+G  
Sbjct: 154 NILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLS 211
Query: 138 FMEL-MDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 196
            +E+ + R P+  G   +    LL  ++  P                   P+     F+ 
Sbjct: 212 LVEMAVGRYPIGSGSGSMAIFELLDYIVNEPP------------------PKLPSGVFSL 253
Query: 197 KFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
           +F        D V K L  +P +R  ++  + H ++
Sbjct: 254 EFQ-------DFVNKCLIKNPAERADLKQLMVHAFI 282

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 78.2 bits (191), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 96/217 (44%), Gaps = 38/217 (17%)
Query: 21  FNDVYIAYELMD-TDLHQIIRSNQALS---EEHCQYFLYQILRGLKYIHSANVLHRDLKP 76
           F+D    Y +++   L  + R  Q LS   E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 77  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 136
Query: 77  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 136
            NLLL +  +LKI DFG + V + +   T    T  Y  PE ++    +   +D+WS+G 
Sbjct: 137 ENLLLGSAGELKIADFGWS-VHAPSSRRTXLCGTLDYLPPE-MIEGRMHDEKVDLWSLGV 194
Query: 137 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 196
           +  E +  KP F                              A  Y     R  R  FT 
Sbjct: 195 LCYEFLVGKPPF-----------------------------EANTYQETYKRISRVEFT- 224
Query: 197 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
            FP+ V   A DL+ ++L  +P QR  + + L HP++
Sbjct: 225 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 78.2 bits (191), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 96/217 (44%), Gaps = 38/217 (17%)
Query: 21  FNDVYIAYELMD-TDLHQIIRSNQALS---EEHCQYFLYQILRGLKYIHSANVLHRDLKP 76
           F+D    Y +++   L  + R  Q LS   E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 76  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 135
Query: 77  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 136
            NLLL +  +LKI DFG + V + +   T    T  Y  PE ++    +   +D+WS+G 
Sbjct: 136 ENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPE-MIEGRMHDEKVDLWSLGV 193
Query: 137 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 196
           +  E +  KP F                              A  Y     R  R  FT 
Sbjct: 194 LCYEFLVGKPPF-----------------------------EANTYQETYKRISRVEFT- 223
Query: 197 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
            FP+ V   A DL+ ++L  +P QR  + + L HP++
Sbjct: 224 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 259

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 78.2 bits (191), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 97/185 (52%), Gaps = 21/185 (11%)
Query: 54  LYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM-TEYVVTRW 112
           L +IL+GL Y+HS   +HRD+K +N+LL+   D+K+ DFG+A   ++T      +V T +
Sbjct: 126 LKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPF 185
Query: 113 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL 172
           + APE++  S+ Y +  D+WS+G   +EL   +P  P  D +H +R+L  +        +
Sbjct: 186 WMAPEVIQQSA-YDSKADIWSLGITAIELAKGEP--PNSD-MHPMRVLFLIPKNNPPTLV 241
Query: 173 GFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
           G   ++ K++I         +   K P+  P+A +L+        + +  V+++    YL
Sbjct: 242 GDFTKSFKEFI--------DACLNKDPSFRPTAKELL--------KHKFIVKNSKKTSYL 285
Query: 233 GSLHD 237
             L D
Sbjct: 286 TELID 290

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/241 (26%), Positives = 100/241 (41%), Gaps = 47/241 (19%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYEL-MDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           +DH N++ + +       E   D+Y+  EL    +L + +   +   E      +  +L 
Sbjct: 80  LDHPNIIRLYETF-----EDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLS 134
Query: 60  GLKYIHSANVLHRDLKPSNLLL---NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAP 116
            + Y H  NV HRDLKP N L    + +  LK+ DFGLA        M   V T +Y +P
Sbjct: 135 AVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSP 194
Query: 117 ELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLN 176
           ++L     Y    D WS G +   L+   P F                  P++ E+    
Sbjct: 195 QVL--EGLYGPECDEWSAGVMMYVLLCGYPPF----------------SAPTDXEV---- 232
Query: 177 ENAKKYICQLPRYQRQSFTEKFP-----NVHPSAIDLVEKMLTFDPRQRITVEDALAHPY 231
                    + + +  +FT  FP     NV P A  L+ ++LT  P+QRIT   AL H +
Sbjct: 233 ---------MLKIREGTFT--FPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEW 281
Query: 232 L 232
Sbjct: 282 F 282

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 97/217 (44%), Gaps = 38/217 (17%)
Query: 21  FNDVYIAYELMD-TDLHQIIRSNQALS---EEHCQYFLYQILRGLKYIHSANVLHRDLKP 76
           F+D    Y +++   L  + R  Q LS   E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 81  FHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSKRVIHRDIKP 140
Query: 77  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 136
            NLLL +N +LKI DFG + V + +   T    T  Y  PE ++    +   +D+WS+G 
Sbjct: 141 ENLLLGSNGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPE-MIEGRMHDEKVDLWSLGV 198
Query: 137 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 196
           +  E +   P F                              A  Y     R  R  FT 
Sbjct: 199 LCYEFLVGMPPF-----------------------------EAHTYQETYRRISRVEFT- 228
Query: 197 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
            FP+ V   A DL+ ++L  +  QR+T+ + L HP++
Sbjct: 229 -FPDFVTEGARDLISRLLKHNASQRLTLAEVLEHPWI 264

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 96/217 (44%), Gaps = 38/217 (17%)
Query: 21  FNDVYIAYELMD-TDLHQIIRSNQALS---EEHCQYFLYQILRGLKYIHSANVLHRDLKP 76
           F+D    Y +++   L  + R  Q LS   E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 80  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 139
Query: 77  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 136
            NLLL +  +LKI DFG + V + +   T    T  Y  PE ++    +   +D+WS+G 
Sbjct: 140 ENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPE-MIEGRMHDEKVDLWSLGV 197
Query: 137 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 196
           +  E +  KP F                              A  Y     R  R  FT 
Sbjct: 198 LCYEFLVGKPPF-----------------------------EANTYQETYKRISRVEFT- 227
Query: 197 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
            FP+ V   A DL+ ++L  +P QR  + + L HP++
Sbjct: 228 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 263

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/241 (26%), Positives = 100/241 (41%), Gaps = 47/241 (19%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYEL-MDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           +DH N++ + +       E   D+Y+  EL    +L + +   +   E      +  +L 
Sbjct: 63  LDHPNIIRLYETF-----EDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLS 117
Query: 60  GLKYIHSANVLHRDLKPSNLLL---NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAP 116
            + Y H  NV HRDLKP N L    + +  LK+ DFGLA        M   V T +Y +P
Sbjct: 118 AVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSP 177
Query: 117 ELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLN 176
           ++L     Y    D WS G +   L+   P F                  P++ E+    
Sbjct: 178 QVL--EGLYGPECDEWSAGVMMYVLLCGYPPF----------------SAPTDXEV---- 215
Query: 177 ENAKKYICQLPRYQRQSFTEKFP-----NVHPSAIDLVEKMLTFDPRQRITVEDALAHPY 231
                    + + +  +FT  FP     NV P A  L+ ++LT  P+QRIT   AL H +
Sbjct: 216 ---------MLKIREGTFT--FPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEW 264
Query: 232 L 232
Sbjct: 265 F 265

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 93/189 (49%), Gaps = 31/189 (16%)
Query: 45  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM 104
           L E +    L +IL+GL Y+HS   +HRD+K +N+LL+   D+K+ DFG+A   ++T   
Sbjct: 113 LEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK 172
Query: 105 -TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIEL 163
              +V T ++ APE++  S+ Y    D+WS+G   +EL   +P  P  D +H +R+L  +
Sbjct: 173 RNXFVGTPFWMAPEVIKQSA-YDFKADIWSLGITAIELAKGEP--PNSD-LHPMRVLFLI 228
Query: 164 IGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV 223
              P  +      +++K +                        + VE  L  DPR R T 
Sbjct: 229 ---PKNSPPTLEGQHSKPF-----------------------KEFVEACLNKDPRFRPTA 262
Query: 224 EDALAHPYL 232
           ++ L H ++
Sbjct: 263 KELLKHKFI 271

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 96/217 (44%), Gaps = 38/217 (17%)
Query: 21  FNDVYIAYELMD-TDLHQIIRSNQALS---EEHCQYFLYQILRGLKYIHSANVLHRDLKP 76
           F+D    Y +++   L  + R  Q LS   E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 80  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 139
Query: 77  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 136
            NLLL +  +LKI DFG + V + +   T    T  Y  PE ++    +   +D+WS+G 
Sbjct: 140 ENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPE-MIEGRMHDEKVDLWSLGV 197
Query: 137 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 196
           +  E +  KP F                              A  Y     R  R  FT 
Sbjct: 198 LCYEFLVGKPPF-----------------------------EANTYQETYKRISRVEFT- 227
Query: 197 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
            FP+ V   A DL+ ++L  +P QR  + + L HP++
Sbjct: 228 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 263

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 78.2 bits (191), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 95/217 (43%), Gaps = 38/217 (17%)
Query: 21  FNDVYIAYELMD-TDLHQIIRSNQALS---EEHCQYFLYQILRGLKYIHSANVLHRDLKP 76
           F+D    Y +++   L  + R  Q LS   E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 82  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 141
Query: 77  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 136
            NLLL +  +LKI DFG + V + +   T    T  Y  PE  +    +   +D+WS+G 
Sbjct: 142 ENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPE-XIEGRXHDEKVDLWSLGV 199
Query: 137 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 196
           +  E +  KP F                              A  Y     R  R  FT 
Sbjct: 200 LCYEFLVGKPPF-----------------------------EANTYQETYKRISRVEFT- 229
Query: 197 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
            FP+ V   A DL+ ++L  +P QR  + + L HP++
Sbjct: 230 -FPDFVTEGARDLISRLLKHNPSQRPXLREVLEHPWI 265

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 96/217 (44%), Gaps = 38/217 (17%)
Query: 21  FNDVYIAYELMD-TDLHQIIRSNQALS---EEHCQYFLYQILRGLKYIHSANVLHRDLKP 76
           F+D    Y +++   L  + R  Q LS   E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 74  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 133
Query: 77  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 136
            NLLL +  +LKI DFG + V + +   T    T  Y  PE ++    +   +D+WS+G 
Sbjct: 134 ENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPE-MIEGRMHDEKVDLWSLGV 191
Query: 137 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 196
           +  E +  KP F                              A  Y     R  R  FT 
Sbjct: 192 LCYEFLVGKPPF-----------------------------EANTYQETYKRISRVEFT- 221
Query: 197 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
            FP+ V   A DL+ ++L  +P QR  + + L HP++
Sbjct: 222 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 257

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 48/146 (32%), Positives = 71/146 (48%), Gaps = 9/146 (6%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYE-LMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           ++HENVV          R   N  Y+  E     +L   I  +  + E   Q F +Q++ 
Sbjct: 62  LNHENVVKFYG-----HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA 116
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA---RVTSETDFMTEYVVTRWYRAP 116
           G+ Y+H   + HRD+KP NLLL+   +LKI DFGLA   R  +    + +   T  Y AP
Sbjct: 117 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 117 ELLLNSSDYTAAIDVWSVGCIFMELM 142
           ELL     +   +DVWS G +   ++
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAML 202

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 48/146 (32%), Positives = 71/146 (48%), Gaps = 9/146 (6%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYE-LMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           ++HENVV          R   N  Y+  E     +L   I  +  + E   Q F +Q++ 
Sbjct: 62  LNHENVVKFYG-----HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA 116
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA---RVTSETDFMTEYVVTRWYRAP 116
           G+ Y+H   + HRD+KP NLLL+   +LKI DFGLA   R  +    + +   T  Y AP
Sbjct: 117 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 176
Query: 117 ELLLNSSDYTAAIDVWSVGCIFMELM 142
           ELL     +   +DVWS G +   ++
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAML 202

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 48/146 (32%), Positives = 71/146 (48%), Gaps = 9/146 (6%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYE-LMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           ++HENVV          R   N  Y+  E     +L   I  +  + E   Q F +Q++ 
Sbjct: 61  LNHENVVKFYG-----HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA 115
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA---RVTSETDFMTEYVVTRWYRAP 116
           G+ Y+H   + HRD+KP NLLL+   +LKI DFGLA   R  +    + +   T  Y AP
Sbjct: 116 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 117 ELLLNSSDYTAAIDVWSVGCIFMELM 142
           ELL     +   +DVWS G +   ++
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAML 201

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 48/146 (32%), Positives = 71/146 (48%), Gaps = 9/146 (6%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYE-LMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           ++HENVV          R   N  Y+  E     +L   I  +  + E   Q F +Q++ 
Sbjct: 62  LNHENVVKFYG-----HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA 116
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA---RVTSETDFMTEYVVTRWYRAP 116
           G+ Y+H   + HRD+KP NLLL+   +LKI DFGLA   R  +    + +   T  Y AP
Sbjct: 117 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 117 ELLLNSSDYTAAIDVWSVGCIFMELM 142
           ELL     +   +DVWS G +   ++
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAML 202

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 48/146 (32%), Positives = 71/146 (48%), Gaps = 9/146 (6%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYE-LMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           ++HENVV          R   N  Y+  E     +L   I  +  + E   Q F +Q++ 
Sbjct: 62  LNHENVVKFYG-----HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA 116
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA---RVTSETDFMTEYVVTRWYRAP 116
           G+ Y+H   + HRD+KP NLLL+   +LKI DFGLA   R  +    + +   T  Y AP
Sbjct: 117 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 117 ELLLNSSDYTAAIDVWSVGCIFMELM 142
           ELL     +   +DVWS G +   ++
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAML 202

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 48/146 (32%), Positives = 71/146 (48%), Gaps = 9/146 (6%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYE-LMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           ++HENVV          R   N  Y+  E     +L   I  +  + E   Q F +Q++ 
Sbjct: 62  LNHENVVKFYG-----HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA 116
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA---RVTSETDFMTEYVVTRWYRAP 116
           G+ Y+H   + HRD+KP NLLL+   +LKI DFGLA   R  +    + +   T  Y AP
Sbjct: 117 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 117 ELLLNSSDYTAAIDVWSVGCIFMELM 142
           ELL     +   +DVWS G +   ++
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAML 202

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 77.8 bits (190), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 92/203 (45%), Gaps = 31/203 (15%)
Query: 37  QIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN--CDLKICDFGL 94
           +I   +  +SE     ++ Q   GLK++H  +++H D+KP N++        +KI DFGL
Sbjct: 138 RIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGL 197
Query: 95  ARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHV 154
           A   +  + +     T  + APE++ +        D+W++G +   L+     F G D +
Sbjct: 198 ATKLNPDEIVKVTTATAEFAAPEIV-DREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL 256
Query: 155 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE-KFPNVHPSAIDLVEKML 213
             L                   +N K+  C         F E  F +V P A D ++ +L
Sbjct: 257 ETL-------------------QNVKR--CDW------EFDEDAFSSVSPEAKDFIKNLL 289
Query: 214 TFDPRQRITVEDALAHPYLGSLH 236
             +PR+R+TV DAL HP+L   H
Sbjct: 290 QKEPRKRLTVHDALEHPWLKGDH 312

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 48/146 (32%), Positives = 71/146 (48%), Gaps = 9/146 (6%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYE-LMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           ++HENVV          R   N  Y+  E     +L   I  +  + E   Q F +Q++ 
Sbjct: 61  LNHENVVKFYG-----HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA 115
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA---RVTSETDFMTEYVVTRWYRAP 116
           G+ Y+H   + HRD+KP NLLL+   +LKI DFGLA   R  +    + +   T  Y AP
Sbjct: 116 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175
Query: 117 ELLLNSSDYTAAIDVWSVGCIFMELM 142
           ELL     +   +DVWS G +   ++
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAML 201

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 48/146 (32%), Positives = 71/146 (48%), Gaps = 9/146 (6%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYE-LMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           ++HENVV          R   N  Y+  E     +L   I  +  + E   Q F +Q++ 
Sbjct: 61  LNHENVVKFYG-----HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA 115
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA---RVTSETDFMTEYVVTRWYRAP 116
           G+ Y+H   + HRD+KP NLLL+   +LKI DFGLA   R  +    + +   T  Y AP
Sbjct: 116 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175
Query: 117 ELLLNSSDYTAAIDVWSVGCIFMELM 142
           ELL     +   +DVWS G +   ++
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAML 201

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 77.8 bits (190), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 48/146 (32%), Positives = 71/146 (48%), Gaps = 9/146 (6%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYE-LMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           ++HENVV          R   N  Y+  E     +L   I  +  + E   Q F +Q++ 
Sbjct: 61  LNHENVVKFYG-----HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA 115
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA---RVTSETDFMTEYVVTRWYRAP 116
           G+ Y+H   + HRD+KP NLLL+   +LKI DFGLA   R  +    + +   T  Y AP
Sbjct: 116 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 117 ELLLNSSDYTAAIDVWSVGCIFMELM 142
           ELL     +   +DVWS G +   ++
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAML 201

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 77.4 bits (189), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 48/146 (32%), Positives = 71/146 (48%), Gaps = 9/146 (6%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYE-LMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           ++HENVV          R   N  Y+  E     +L   I  +  + E   Q F +Q++ 
Sbjct: 62  LNHENVVKFYG-----HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA 116
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA---RVTSETDFMTEYVVTRWYRAP 116
           G+ Y+H   + HRD+KP NLLL+   +LKI DFGLA   R  +    + +   T  Y AP
Sbjct: 117 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 117 ELLLNSSDYTAAIDVWSVGCIFMELM 142
           ELL     +   +DVWS G +   ++
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAML 202

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 77.4 bits (189), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 48/146 (32%), Positives = 71/146 (48%), Gaps = 9/146 (6%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYE-LMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           ++HENVV          R   N  Y+  E     +L   I  +  + E   Q F +Q++ 
Sbjct: 60  LNHENVVKFYG-----HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA 114
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA---RVTSETDFMTEYVVTRWYRAP 116
           G+ Y+H   + HRD+KP NLLL+   +LKI DFGLA   R  +    + +   T  Y AP
Sbjct: 115 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 174
Query: 117 ELLLNSSDYTAAIDVWSVGCIFMELM 142
           ELL     +   +DVWS G +   ++
Sbjct: 175 ELLKRREFHAEPVDVWSCGIVLTAML 200

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 77.4 bits (189), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 48/146 (32%), Positives = 71/146 (48%), Gaps = 9/146 (6%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYE-LMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           ++HENVV          R   N  Y+  E     +L   I  +  + E   Q F +Q++ 
Sbjct: 61  LNHENVVKFYG-----HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA 115
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA---RVTSETDFMTEYVVTRWYRAP 116
           G+ Y+H   + HRD+KP NLLL+   +LKI DFGLA   R  +    + +   T  Y AP
Sbjct: 116 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175
Query: 117 ELLLNSSDYTAAIDVWSVGCIFMELM 142
           ELL     +   +DVWS G +   ++
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAML 201

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 77.4 bits (189), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 48/146 (32%), Positives = 71/146 (48%), Gaps = 9/146 (6%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYE-LMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           ++HENVV          R   N  Y+  E     +L   I  +  + E   Q F +Q++ 
Sbjct: 61  LNHENVVKFYG-----HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA 115
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA---RVTSETDFMTEYVVTRWYRAP 116
           G+ Y+H   + HRD+KP NLLL+   +LKI DFGLA   R  +    + +   T  Y AP
Sbjct: 116 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 117 ELLLNSSDYTAAIDVWSVGCIFMELM 142
           ELL     +   +DVWS G +   ++
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAML 201

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 77.4 bits (189), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 40/106 (37%), Positives = 61/106 (57%), Gaps = 3/106 (2%)
Query: 46  SEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARVTSETDFM 104
           +E+   ++  QIL GLKY+H   ++HRD+K  N+L+N     LKI DFG ++  +  +  
Sbjct: 120 NEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC 179
Query: 105 TE-YVVTRWYRAPELL-LNSSDYTAAIDVWSVGCIFMELMDRKPLF 148
           TE +  T  Y APE++      Y  A D+WS+GC  +E+   KP F
Sbjct: 180 TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPF 225

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 77.4 bits (189), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 48/146 (32%), Positives = 71/146 (48%), Gaps = 9/146 (6%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYE-LMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           ++HENVV          R   N  Y+  E     +L   I  +  + E   Q F +Q++ 
Sbjct: 61  LNHENVVKFYG-----HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA 115
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA---RVTSETDFMTEYVVTRWYRAP 116
           G+ Y+H   + HRD+KP NLLL+   +LKI DFGLA   R  +    + +   T  Y AP
Sbjct: 116 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 117 ELLLNSSDYTAAIDVWSVGCIFMELM 142
           ELL     +   +DVWS G +   ++
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAML 201

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 77.4 bits (189), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 48/146 (32%), Positives = 71/146 (48%), Gaps = 9/146 (6%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYE-LMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           ++HENVV          R   N  Y+  E     +L   I  +  + E   Q F +Q++ 
Sbjct: 61  LNHENVVKFYG-----HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA 115
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA---RVTSETDFMTEYVVTRWYRAP 116
           G+ Y+H   + HRD+KP NLLL+   +LKI DFGLA   R  +    + +   T  Y AP
Sbjct: 116 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 117 ELLLNSSDYTAAIDVWSVGCIFMELM 142
           ELL     +   +DVWS G +   ++
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAML 201

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 77.4 bits (189), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 40/106 (37%), Positives = 61/106 (57%), Gaps = 3/106 (2%)
Query: 46  SEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARVTSETDFM 104
           +E+   ++  QIL GLKY+H   ++HRD+K  N+L+N     LKI DFG ++  +  +  
Sbjct: 106 NEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPC 165
Query: 105 TE-YVVTRWYRAPELL-LNSSDYTAAIDVWSVGCIFMELMDRKPLF 148
           TE +  T  Y APE++      Y  A D+WS+GC  +E+   KP F
Sbjct: 166 TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPF 211

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 77.4 bits (189), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 55/184 (29%), Positives = 90/184 (48%), Gaps = 32/184 (17%)
Query: 39  IRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-V 97
           +   +  +EE  +++  +I+  L+Y+HS +V++RD+K  NL+L+ +  +KI DFGL +  
Sbjct: 96  LSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG 155
Query: 98  TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL 157
            S+   M  +  T  Y APE +L  +DY  A+D W +G +  E+M  +  F  +DH    
Sbjct: 156 ISDGATMKXFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-- 212
Query: 158 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDP 217
             L ELI          L E  +      PR            + P A  L+  +L  DP
Sbjct: 213 --LFELI----------LMEEIR-----FPR-----------TLSPEAKSLLAGLLKKDP 244
Query: 218 RQRI 221
           +QR+
Sbjct: 245 KQRL 248

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 77.4 bits (189), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 48/146 (32%), Positives = 71/146 (48%), Gaps = 9/146 (6%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYE-LMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           ++HENVV          R   N  Y+  E     +L   I  +  + E   Q F +Q++ 
Sbjct: 61  LNHENVVKFYG-----HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA 115
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA---RVTSETDFMTEYVVTRWYRAP 116
           G+ Y+H   + HRD+KP NLLL+   +LKI DFGLA   R  +    + +   T  Y AP
Sbjct: 116 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 117 ELLLNSSDYTAAIDVWSVGCIFMELM 142
           ELL     +   +DVWS G +   ++
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAML 201

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 77.0 bits (188), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 48/146 (32%), Positives = 71/146 (48%), Gaps = 9/146 (6%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYE-LMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           ++HENVV          R   N  Y+  E     +L   I  +  + E   Q F +Q++ 
Sbjct: 62  LNHENVVKFYG-----HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA 116
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA---RVTSETDFMTEYVVTRWYRAP 116
           G+ Y+H   + HRD+KP NLLL+   +LKI DFGLA   R  +    + +   T  Y AP
Sbjct: 117 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 117 ELLLNSSDYTAAIDVWSVGCIFMELM 142
           ELL     +   +DVWS G +   ++
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAML 202

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 77.0 bits (188), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 96/217 (44%), Gaps = 38/217 (17%)
Query: 21  FNDVYIAYELMD-TDLHQIIRSNQALS---EEHCQYFLYQILRGLKYIHSANVLHRDLKP 76
           F+D    Y +++   L  + R  Q LS   E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 103 FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 162
Query: 77  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 136
            NLLL +  +LKI DFG + V + +    +   T  Y  PE ++    +   +D+WS+G 
Sbjct: 163 ENLLLGSAGELKIADFGWS-VHAPSSRRDDLCGTLDYLPPE-MIEGRMHDEKVDLWSLGV 220
Query: 137 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 196
           +  E +  KP F                              A  Y     R  R  FT 
Sbjct: 221 LCYEFLVGKPPF-----------------------------EANTYQETYKRISRVEFT- 250
Query: 197 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
            FP+ V   A DL+ ++L  +P QR  + + L HP++
Sbjct: 251 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 286

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 77.0 bits (188), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 48/146 (32%), Positives = 71/146 (48%), Gaps = 9/146 (6%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYE-LMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           ++HENVV          R   N  Y+  E     +L   I  +  + E   Q F +Q++ 
Sbjct: 61  LNHENVVKFYG-----HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA 115
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA---RVTSETDFMTEYVVTRWYRAP 116
           G+ Y+H   + HRD+KP NLLL+   +LKI DFGLA   R  +    + +   T  Y AP
Sbjct: 116 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAP 175
Query: 117 ELLLNSSDYTAAIDVWSVGCIFMELM 142
           ELL     +   +DVWS G +   ++
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAML 201

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 77.0 bits (188), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 56/205 (27%), Positives = 97/205 (47%), Gaps = 34/205 (16%)
Query: 33  TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDF 92
           TDL +  + N  L EE   Y   +ILRGL ++H   V+HRD+K  N+LL  N ++K+ DF
Sbjct: 115 TDLIKNTKGN-TLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDF 173
Query: 93  GL-ARVTSETDFMTEYVVTRWYRAPELLLNSSD----YTAAIDVWSVGCIFMELMDRKPL 147
           G+ A++         ++ T ++ APE++    +    Y    D+WS+G   +E+ +  P 
Sbjct: 174 GVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP- 232
Query: 148 FPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAID 207
            P  D +H +R L  +   P+                  PR + + +++KF +       
Sbjct: 233 -PLCD-MHPMRALFLIPRNPA------------------PRLKSKKWSKKFQS------- 265
Query: 208 LVEKMLTFDPRQRITVEDALAHPYL 232
            +E  L  +  QR   E  + HP++
Sbjct: 266 FIESCLVKNHSQRPATEQLMKHPFI 290

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 77.0 bits (188), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 48/146 (32%), Positives = 71/146 (48%), Gaps = 9/146 (6%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYE-LMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           ++HENVV          R   N  Y+  E     +L   I  +  + E   Q F +Q++ 
Sbjct: 61  LNHENVVKFYG-----HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA 115
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA---RVTSETDFMTEYVVTRWYRAP 116
           G+ Y+H   + HRD+KP NLLL+   +LKI DFGLA   R  +    + +   T  Y AP
Sbjct: 116 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 117 ELLLNSSDYTAAIDVWSVGCIFMELM 142
           ELL     +   +DVWS G +   ++
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAML 201

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 48/146 (32%), Positives = 71/146 (48%), Gaps = 9/146 (6%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYE-LMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           ++HENVV          R   N  Y+  E     +L   I  +  + E   Q F +Q++ 
Sbjct: 61  LNHENVVKFYG-----HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA 115
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA---RVTSETDFMTEYVVTRWYRAP 116
           G+ Y+H   + HRD+KP NLLL+   +LKI DFGLA   R  +    + +   T  Y AP
Sbjct: 116 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 175
Query: 117 ELLLNSSDYTAAIDVWSVGCIFMELM 142
           ELL     +   +DVWS G +   ++
Sbjct: 176 ELLKRREFHAEPVDVWSCGIVLTAML 201

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/184 (29%), Positives = 90/184 (48%), Gaps = 32/184 (17%)
Query: 39  IRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-V 97
           +   +  +EE  +++  +I+  L+Y+HS +V++RD+K  NL+L+ +  +KI DFGL +  
Sbjct: 101 LSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEG 160
Query: 98  TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL 157
            S+   M  +  T  Y APE +L  +DY  A+D W +G +  E+M  +  F  +DH    
Sbjct: 161 ISDGATMKXFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER-- 217
Query: 158 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDP 217
             L ELI          L E  +      PR            + P A  L+  +L  DP
Sbjct: 218 --LFELI----------LMEEIR-----FPR-----------TLSPEAKSLLAGLLKKDP 249
Query: 218 RQRI 221
           +QR+
Sbjct: 250 KQRL 253

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/180 (30%), Positives = 89/180 (49%), Gaps = 32/180 (17%)
Query: 43  QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSET 101
           +  +EE  +++  +I+  L+Y+HS +V++RD+K  NL+L+ +  +KI DFGL +   S+ 
Sbjct: 100 RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159
Query: 102 DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI 161
             M  +  T  Y APE +L  +DY  A+D W +G +  E+M  +  F  +DH      L 
Sbjct: 160 ATMKXFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER----LF 214
Query: 162 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI 221
           ELI          L E  +      PR            + P A  L+  +L  DP+QR+
Sbjct: 215 ELI----------LMEEIR-----FPR-----------TLSPEAKSLLAGLLKKDPKQRL 248

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 89/180 (49%), Gaps = 32/180 (17%)
Query: 43  QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSET 101
           +  +EE  +++  +I+  L+Y+HS +V++RD+K  NL+L+ +  +KI DFGL +   S+ 
Sbjct: 103 RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 162
Query: 102 DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI 161
             M  +  T  Y APE +L  +DY  A+D W +G +  E+M  +  F  +DH      L 
Sbjct: 163 ATMKTFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER----LF 217
Query: 162 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI 221
           ELI          + E       + PR            + P A  L+  +L  DP+QR+
Sbjct: 218 ELI---------LMEE------IRFPR-----------TLSPEAKSLLAGLLKKDPKQRL 251

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 48/146 (32%), Positives = 71/146 (48%), Gaps = 9/146 (6%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYE-LMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           ++HENVV          R   N  Y+  E     +L   I  +  + E   Q F +Q++ 
Sbjct: 62  LNHENVVKFYG-----HRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA 116
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA---RVTSETDFMTEYVVTRWYRAP 116
           G+ Y+H   + HRD+KP NLLL+   +LKI DFGLA   R  +    + +   T  Y AP
Sbjct: 117 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 176
Query: 117 ELLLNSSDYTAAIDVWSVGCIFMELM 142
           ELL     +   +DVWS G +   ++
Sbjct: 177 ELLKRREFHAEPVDVWSCGIVLTAML 202

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/180 (30%), Positives = 89/180 (49%), Gaps = 32/180 (17%)
Query: 43  QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSET 101
           +  +EE  +++  +I+  L+Y+HS +V++RD+K  NL+L+ +  +KI DFGL +   S+ 
Sbjct: 100 RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159
Query: 102 DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI 161
             M  +  T  Y APE +L  +DY  A+D W +G +  E+M  +  F  +DH      L 
Sbjct: 160 ATMKTFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER----LF 214
Query: 162 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI 221
           ELI          L E  +      PR            + P A  L+  +L  DP+QR+
Sbjct: 215 ELI----------LMEEIR-----FPR-----------TLSPEAKSLLAGLLKKDPKQRL 248

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 89/180 (49%), Gaps = 32/180 (17%)
Query: 43  QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSET 101
           +  +EE  +++  +I+  L+Y+HS +V++RD+K  NL+L+ +  +KI DFGL +   S+ 
Sbjct: 100 RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159
Query: 102 DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI 161
             M  +  T  Y APE +L  +DY  A+D W +G +  E+M  +  F  +DH      L 
Sbjct: 160 ATMKTFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER----LF 214
Query: 162 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI 221
           ELI          + E       + PR            + P A  L+  +L  DP+QR+
Sbjct: 215 ELI---------LMEE------IRFPR-----------TLSPEAKSLLAGLLKKDPKQRL 248

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 77.0 bits (188), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/180 (30%), Positives = 89/180 (49%), Gaps = 32/180 (17%)
Query: 43  QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSET 101
           +  +EE  +++  +I+  L+Y+HS +V++RD+K  NL+L+ +  +KI DFGL +   S+ 
Sbjct: 100 RVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159
Query: 102 DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI 161
             M  +  T  Y APE +L  +DY  A+D W +G +  E+M  +  F  +DH      L 
Sbjct: 160 ATMKXFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER----LF 214
Query: 162 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI 221
           ELI          L E  +      PR            + P A  L+  +L  DP+QR+
Sbjct: 215 ELI----------LMEEIR-----FPR-----------TLSPEAKSLLAGLLKKDPKQRL 248

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 96/217 (44%), Gaps = 38/217 (17%)
Query: 21  FNDVYIAYELMD-TDLHQIIRSNQALS---EEHCQYFLYQILRGLKYIHSANVLHRDLKP 76
           F+D    Y +++   L  + R  Q LS   E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 80  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 139
Query: 77  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 136
            NLLL +  +LKI DFG + V + +    +   T  Y  PE ++    +   +D+WS+G 
Sbjct: 140 ENLLLGSAGELKIADFGWS-VHAPSSRRDDLCGTLDYLPPE-MIEGRMHDEKVDLWSLGV 197
Query: 137 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 196
           +  E +  KP F                              A  Y     R  R  FT 
Sbjct: 198 LCYEFLVGKPPF-----------------------------EANTYQETYKRISRVEFT- 227
Query: 197 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
            FP+ V   A DL+ ++L  +P QR  + + L HP++
Sbjct: 228 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 263

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 90/215 (41%), Gaps = 36/215 (16%)
Query: 40  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA---NCDLKICDFGLAR 96
           R +QA +E         I   ++Y+HS N+ HRD+KP NLL  +   N  LK+ DFG A+
Sbjct: 153 RGDQAFTEREASEIXKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212
Query: 97  VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ 156
            T+  + +T    T +Y APE +L    Y  + D WS+G I   L+   P          
Sbjct: 213 ETTSHNSLTTPCYTPYYVAPE-VLGPEKYDKSCDXWSLGVIXYILLCGYP---------- 261
Query: 157 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAID-----LVEK 211
                     P  +  G       K   +  +Y+       FPN   S +      L+  
Sbjct: 262 ----------PFYSNHGLAISPGXKTRIRXGQYE-------FPNPEWSEVSEEVKXLIRN 304
Query: 212 MLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMS 246
           +L  +P QR T+ +   HP++     +   P+  S
Sbjct: 305 LLKTEPTQRXTITEFXNHPWIXQSTKVPQTPLHTS 339

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 96/217 (44%), Gaps = 38/217 (17%)
Query: 21  FNDVYIAYELMD-TDLHQIIRSNQALS---EEHCQYFLYQILRGLKYIHSANVLHRDLKP 76
           F+D    Y +++   L  + R  Q LS   E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 80  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 139
Query: 77  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 136
            NLLL +  +LKI +FG + V + +   T    T  Y  PE ++    +   +D+WS+G 
Sbjct: 140 ENLLLGSAGELKIANFGWS-VHAPSSRRTTLCGTLDYLPPE-MIEGRMHDEKVDLWSLGV 197
Query: 137 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 196
           +  E +  KP F                              A  Y     R  R  FT 
Sbjct: 198 LCYEFLVGKPPF-----------------------------EANTYQETYKRISRVEFT- 227
Query: 197 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
            FP+ V   A DL+ ++L  +P QR  + + L HP++
Sbjct: 228 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 263

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 76.6 bits (187), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 96/217 (44%), Gaps = 38/217 (17%)
Query: 21  FNDVYIAYELMD-TDLHQIIRSNQALS---EEHCQYFLYQILRGLKYIHSANVLHRDLKP 76
           F+D    Y +++   L  + R  Q LS   E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 79  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 138
Query: 77  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 136
            NLLL +  +LKI +FG + V + +   T    T  Y  PE ++    +   +D+WS+G 
Sbjct: 139 ENLLLGSAGELKIANFGWS-VHAPSSRRTTLCGTLDYLPPE-MIEGRMHDEKVDLWSLGV 196
Query: 137 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 196
           +  E +  KP F                              A  Y     R  R  FT 
Sbjct: 197 LCYEFLVGKPPF-----------------------------EANTYQETYKRISRVEFT- 226
Query: 197 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
            FP+ V   A DL+ ++L  +P QR  + + L HP++
Sbjct: 227 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 262

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 95/217 (43%), Gaps = 38/217 (17%)
Query: 21  FNDVYIAYELMD-TDLHQIIRSNQALS---EEHCQYFLYQILRGLKYIHSANVLHRDLKP 76
           F+D    Y +++   L  + R  Q LS   E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 80  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 139
Query: 77  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 136
            NLLL +  +LKI DFG + V + +        T  Y  PE ++    +   +D+WS+G 
Sbjct: 140 ENLLLGSAGELKIADFGWS-VHAPSSRRAALCGTLDYLPPE-MIEGRMHDEKVDLWSLGV 197
Query: 137 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 196
           +  E +  KP F                              A  Y     R  R  FT 
Sbjct: 198 LCYEFLVGKPPF-----------------------------EANTYQETYKRISRVEFT- 227
Query: 197 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
            FP+ V   A DL+ ++L  +P QR  + + L HP++
Sbjct: 228 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 263

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 95/217 (43%), Gaps = 38/217 (17%)
Query: 21  FNDVYIAYELMD-TDLHQIIRSNQALS---EEHCQYFLYQILRGLKYIHSANVLHRDLKP 76
           F+D    Y +++   L  + R  Q LS   E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 77  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 136
Query: 77  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 136
            NLLL +  +LKI DFG + V + +        T  Y  PE ++    +   +D+WS+G 
Sbjct: 137 ENLLLGSAGELKIADFGWS-VHAPSSRRAALCGTLDYLPPE-MIEGRMHDEKVDLWSLGV 194
Query: 137 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 196
           +  E +  KP F                              A  Y     R  R  FT 
Sbjct: 195 LCYEFLVGKPPF-----------------------------EANTYQETYKRISRVEFT- 224
Query: 197 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
            FP+ V   A DL+ ++L  +P QR  + + L HP++
Sbjct: 225 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/159 (33%), Positives = 80/159 (50%), Gaps = 15/159 (9%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQII----RSNQALSEEHCQYFLY 55
           + H N+V   D I      +   +YI  E  +  DL  +I    +  Q L EE     + 
Sbjct: 62  LKHPNIVRYYDRIID---RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT 118
Query: 56  QILRGLKYIHSAN-----VLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVV 109
           Q+   LK  H  +     VLHRDLKP+N+ L+   ++K+ DFGLAR+ + +T F   +V 
Sbjct: 119 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVG 178
Query: 110 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 148
           T +Y +PE  +N   Y    D+WS+GC+  EL    P F
Sbjct: 179 TPYYMSPE-QMNRMSYNEKSDIWSLGCLLYELCALMPPF 216

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 54/159 (33%), Positives = 80/159 (50%), Gaps = 15/159 (9%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQII----RSNQALSEEHCQYFLY 55
           + H N+V   D I      +   +YI  E  +  DL  +I    +  Q L EE     + 
Sbjct: 62  LKHPNIVRYYDRIID---RTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT 118
Query: 56  QILRGLKYIHSAN-----VLHRDLKPSNLLLNANCDLKICDFGLARVTS-ETDFMTEYVV 109
           Q+   LK  H  +     VLHRDLKP+N+ L+   ++K+ DFGLAR+ + +T F   +V 
Sbjct: 119 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVG 178
Query: 110 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 148
           T +Y +PE  +N   Y    D+WS+GC+  EL    P F
Sbjct: 179 TPYYMSPE-QMNRMSYNEKSDIWSLGCLLYELCALMPPF 216

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 95/217 (43%), Gaps = 38/217 (17%)
Query: 21  FNDVYIAYELMD-TDLHQIIRSNQALS---EEHCQYFLYQILRGLKYIHSANVLHRDLKP 76
           F+D    Y +++   L  + R  Q LS   E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 78  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 137
Query: 77  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 136
            NLLL +  +LKI DFG +   + +   T    T  Y  PE ++    +   +D+WS+G 
Sbjct: 138 ENLLLGSAGELKIADFGWS-CHAPSSRRTTLSGTLDYLPPE-MIEGRMHDEKVDLWSLGV 195
Query: 137 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 196
           +  E +  KP F                              A  Y     R  R  FT 
Sbjct: 196 LCYEFLVGKPPF-----------------------------EANTYQETYKRISRVEFT- 225
Query: 197 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
            FP+ V   A DL+ ++L  +P QR  + + L HP++
Sbjct: 226 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 261

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 95/217 (43%), Gaps = 38/217 (17%)
Query: 21  FNDVYIAYELMD-TDLHQIIRSNQALS---EEHCQYFLYQILRGLKYIHSANVLHRDLKP 76
           F+D    Y +++   L  + R  Q LS   E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 77  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 136
Query: 77  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 136
            NLLL +  +LKI DFG + V + +        T  Y  PE ++    +   +D+WS+G 
Sbjct: 137 ENLLLGSAGELKIADFGWS-VHAPSSRRXXLCGTLDYLPPE-MIEGRMHDEKVDLWSLGV 194
Query: 137 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 196
           +  E +  KP F                              A  Y     R  R  FT 
Sbjct: 195 LCYEFLVGKPPF-----------------------------EANTYQETYKRISRVEFT- 224
Query: 197 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
            FP+ V   A DL+ ++L  +P QR  + + L HP++
Sbjct: 225 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 76.3 bits (186), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 95/217 (43%), Gaps = 38/217 (17%)
Query: 21  FNDVYIAYELMD-TDLHQIIRSNQALS---EEHCQYFLYQILRGLKYIHSANVLHRDLKP 76
           F+D    Y +++   L  + R  Q LS   E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 80  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 139
Query: 77  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 136
            NLLL +  +LKI DFG + V + +        T  Y  PE ++    +   +D+WS+G 
Sbjct: 140 ENLLLGSAGELKIADFGWS-VHAPSSRRXXLCGTLDYLPPE-MIEGRMHDEKVDLWSLGV 197
Query: 137 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 196
           +  E +  KP F                              A  Y     R  R  FT 
Sbjct: 198 LCYEFLVGKPPF-----------------------------EANTYQETYKRISRVEFT- 227
Query: 197 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
            FP+ V   A DL+ ++L  +P QR  + + L HP++
Sbjct: 228 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 263

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 95/217 (43%), Gaps = 38/217 (17%)
Query: 21  FNDVYIAYELMD-TDLHQIIRSNQALS---EEHCQYFLYQILRGLKYIHSANVLHRDLKP 76
           F+D    Y +++   L  + R  Q LS   E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 79  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 138
Query: 77  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 136
            NLLL +  +LKI DFG + V + +        T  Y  PE ++    +   +D+WS+G 
Sbjct: 139 ENLLLGSAGELKIADFGWS-VHAPSSRRXXLCGTLDYLPPE-MIEGRMHDEKVDLWSLGV 196
Query: 137 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 196
           +  E +  KP F                              A  Y     R  R  FT 
Sbjct: 197 LCYEFLVGKPPF-----------------------------EANTYQETYKRISRVEFT- 226
Query: 197 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
            FP+ V   A DL+ ++L  +P QR  + + L HP++
Sbjct: 227 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 262

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/217 (26%), Positives = 96/217 (44%), Gaps = 38/217 (17%)
Query: 21  FNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKP 76
           F+D    Y +++     ++++ ++      E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 82  FHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 141
Query: 77  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 136
            NLLL +  +LKI DFG + V + +   T    T  Y  PE ++    +   +D+WS+G 
Sbjct: 142 ENLLLGSAGELKIADFGWS-VHAPSSRRTTLCGTLDYLPPE-MIEGRMHDEKVDLWSLGV 199
Query: 137 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 196
           +  E +  KP F                              A  Y     R  R  FT 
Sbjct: 200 LCYEFLVGKPPF-----------------------------EANTYQETYKRISRVEFT- 229
Query: 197 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
            FP+ V   A DL+ ++L  +P QR  + + L HP++
Sbjct: 230 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 265

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 47/134 (35%), Positives = 73/134 (54%), Gaps = 9/134 (6%)
Query: 20  SFND---VYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 75
           SF D   +Y+  E M   D+   +R     SE H +++  QI+   +Y+HS ++++RDLK
Sbjct: 109 SFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 76  PSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 134
           P NLL++    +K+ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++
Sbjct: 169 PENLLIDQQGYIKVADFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWAL 224
Query: 135 GCIFMELMDRKPLF 148
           G +  E+    P F
Sbjct: 225 GVLIYEMAAGYPPF 238

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 47/134 (35%), Positives = 73/134 (54%), Gaps = 9/134 (6%)
Query: 20  SFND---VYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 75
           SF D   +Y+  E M   D+   +R     SE H +++  QI+   +Y+HS ++++RDLK
Sbjct: 109 SFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 76  PSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 134
           P NLL++    +K+ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++
Sbjct: 169 PENLLIDQQGYIKVADFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWAL 224
Query: 135 GCIFMELMDRKPLF 148
           G +  E+    P F
Sbjct: 225 GVLIYEMAAGYPPF 238

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 75.9 bits (185), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 95/217 (43%), Gaps = 38/217 (17%)
Query: 21  FNDVYIAYELMD-TDLHQIIRSNQALS---EEHCQYFLYQILRGLKYIHSANVLHRDLKP 76
           F+D    Y +++   L  + R  Q LS   E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 77  FHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKKVIHRDIKP 136
Query: 77  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 136
            NLLL +  +LKI DFG + V + +        T  Y  PE ++    +   +D+WS+G 
Sbjct: 137 ENLLLGSAGELKIADFGWS-VHAPSSRRAALCGTLDYLPPE-MIEGRMHDEKVDLWSLGV 194
Query: 137 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 196
           +  E +  KP F                              A  Y     R  R  FT 
Sbjct: 195 LCYEFLVGKPPF-----------------------------EANTYQDTYKRISRVEFT- 224
Query: 197 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
            FP+ V   A DL+ ++L  +P QR  + + L HP++
Sbjct: 225 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 95/217 (43%), Gaps = 38/217 (17%)
Query: 21  FNDVYIAYELMD-TDLHQIIRSNQALS---EEHCQYFLYQILRGLKYIHSANVLHRDLKP 76
           F+D    Y +++   L  + R  Q LS   E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 78  FHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 137
Query: 77  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 136
            NLLL +  +LKI DFG + V + +        T  Y  PE ++    +   +D+WS+G 
Sbjct: 138 ENLLLGSAGELKIADFGWS-VHAPSSRRDTLCGTLDYLPPE-MIEGRMHDEKVDLWSLGV 195
Query: 137 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 196
           +  E +  KP F                              A  Y     R  R  FT 
Sbjct: 196 LCYEFLVGKPPF-----------------------------EANTYQETYKRISRVEFT- 225
Query: 197 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
            FP+ V   A DL+ ++L  +P QR  + + L HP++
Sbjct: 226 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 261

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 96/217 (44%), Gaps = 38/217 (17%)
Query: 21  FNDVYIAYELMD-TDLHQIIRSNQALS---EEHCQYFLYQILRGLKYIHSANVLHRDLKP 76
           F+D    Y +++   L  + R  Q LS   E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 81  FHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSKRVIHRDIKP 140
Query: 77  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 136
            NLLL +N +LKI DFG + V + +        T  Y  PE ++    +   +D+WS+G 
Sbjct: 141 ENLLLGSNGELKIADFGWS-VHAPSSRRDTLCGTLDYLPPE-MIEGRMHDEKVDLWSLGV 198
Query: 137 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 196
           +  E +   P F                              A  Y     R  R  FT 
Sbjct: 199 LCYEFLVGMPPF-----------------------------EAHTYQETYRRISRVEFT- 228
Query: 197 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
            FP+ V   A DL+ ++L  +  QR+T+ + L HP++
Sbjct: 229 -FPDFVTEGARDLISRLLKHNASQRLTLAEVLEHPWI 264

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 65/237 (27%), Positives = 108/237 (45%), Gaps = 38/237 (16%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTD--LHQIIRSNQALSEEHCQYFLYQIL 58
           +DH N++ + D       ES ND+ +  E +D      +II  +  L+E     F+ QI 
Sbjct: 143 LDHANLIQLYDAF-----ESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQIC 197
Query: 59  RGLKYIHSANVLHRDLKPSNLL-LNANCD-LKICDFGLARVTSETDFMTEYVVTRWYRAP 116
            G++++H   +LH DLKP N+L +N +   +KI DFGLAR     + +     T  + AP
Sbjct: 198 EGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAP 257
Query: 117 ELLLNSSDYTAAIDVWSVGCI-FMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL 175
           E++ N    +   D+WSVG I +M L    P                           FL
Sbjct: 258 EVV-NYDFVSFPTDMWSVGVIAYMLLSGLSP---------------------------FL 289
Query: 176 NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
            +N  + +  +   +     E+F ++   A + + K+L  +   RI+  +AL HP+L
Sbjct: 290 GDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWL 346

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 75.5 bits (184), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 47/143 (32%), Positives = 78/143 (54%), Gaps = 20/143 (13%)
Query: 35  LHQIIRSNQALSEEHCQYF--LYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDF 92
           L+ +I S + L+++  +Y+    QIL  L YIHS  ++HRDLKP N+ ++ + ++KI DF
Sbjct: 102 LYDLIHS-ENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDF 160
Query: 93  GLAR---------------VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 137
           GLA+               +   +D +T  + T  Y A E+L  +  Y   ID++S+G I
Sbjct: 161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGII 220
Query: 138 FMELMDRKPLFPGRDHVHQLRLL 160
           F E++   P   G + V+ L+ L
Sbjct: 221 FFEMI--YPFSTGMERVNILKKL 241

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 47/143 (32%), Positives = 78/143 (54%), Gaps = 20/143 (13%)
Query: 35  LHQIIRSNQALSEEHCQYF--LYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDF 92
           L+ +I S + L+++  +Y+    QIL  L YIHS  ++HRDLKP N+ ++ + ++KI DF
Sbjct: 102 LYDLIHS-ENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDF 160
Query: 93  GLAR---------------VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 137
           GLA+               +   +D +T  + T  Y A E+L  +  Y   ID++S+G I
Sbjct: 161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGII 220
Query: 138 FMELMDRKPLFPGRDHVHQLRLL 160
           F E++   P   G + V+ L+ L
Sbjct: 221 FFEMI--YPFSTGMERVNILKKL 241

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 75.1 bits (183), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 75/133 (56%), Gaps = 5/133 (3%)
Query: 20  SFNDVYIAYELMDTD-LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA-NVLHRDLKPS 77
           S  ++ I  E MD   L Q+++    + E+        +++GL Y+     ++HRD+KPS
Sbjct: 137 SDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPS 196
Query: 78  NLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 137
           N+L+N+  ++K+CDFG++    ++     +V TR Y +PE  L  + Y+   D+WS+G  
Sbjct: 197 NILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLS 254
Query: 138 FMEL-MDRKPLFP 149
            +E+ + R P+ P
Sbjct: 255 LVEMAVGRYPIPP 267

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 74.3 bits (181), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 75/133 (56%), Gaps = 5/133 (3%)
Query: 20  SFNDVYIAYELMDTD-LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA-NVLHRDLKPS 77
           S  ++ I  E MD   L Q+++    + E+        +++GL Y+     ++HRD+KPS
Sbjct: 102 SDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPS 161
Query: 78  NLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 137
           N+L+N+  ++K+CDFG++    ++     +V TR Y +PE  L  + Y+   D+WS+G  
Sbjct: 162 NILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLS 219
Query: 138 FMEL-MDRKPLFP 149
            +E+ + R P+ P
Sbjct: 220 LVEMAVGRYPIPP 232

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 74.3 bits (181), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 101/233 (43%), Gaps = 40/233 (17%)
Query: 3   HENVVAIRDIIPPPQRESFNDVYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGL 61
           H +++ +  +I  P      D ++  E +   +L   I  +  + E   +    QIL  +
Sbjct: 70  HPHIIKLYQVISTP-----TDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAV 124
Query: 62  KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLN 121
            Y H   V+HRDLKP N+LL+A+ + KI DFGL+ + S+ +F+ +   +  Y APE++  
Sbjct: 125 DYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSCGSPNYAAPEVISG 184
Query: 122 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGT-PSEAE-LGFLNENA 179
                  +D+WS G I   L                     L GT P + E +  L +  
Sbjct: 185 RLYAGPEVDIWSCGVILYAL---------------------LCGTLPFDDEHVPTLFKKI 223
Query: 180 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
           +  +  +P Y  +S              L+  ML  DP +R T++D   H + 
Sbjct: 224 RGGVFYIPEYLNRSVAT-----------LLMHMLQVDPLKRATIKDIREHEWF 265

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 74.3 bits (181), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 37/103 (35%), Positives = 63/103 (61%), Gaps = 2/103 (1%)
Query: 45  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM 104
           L E      L +IL+GL Y+HS   +HRD+K +N+LL+ + ++K+ DFG+A   ++T   
Sbjct: 116 LDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 175
Query: 105 -TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP 146
              +V T ++ APE++  S+ Y +  D+WS+G   +EL   +P
Sbjct: 176 RNXFVGTPFWMAPEVIKQSA-YDSKADIWSLGITAIELARGEP 217

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 74.3 bits (181), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 38/107 (35%), Positives = 62/107 (57%), Gaps = 5/107 (4%)
Query: 42  NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET 101
            + L E       +  L+GL Y+HS N++HRD+K  N+LL+    +K+ DFG A + +  
Sbjct: 148 KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 207
Query: 102 DFMTEYVVTRWYRAPELLL--NSSDYTAAIDVWSVGCIFMELMDRKP 146
           +    +V T ++ APE++L  +   Y   +DVWS+G   +EL +RKP
Sbjct: 208 N---XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 251

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 73.9 bits (180), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 76/133 (57%), Gaps = 5/133 (3%)
Query: 20  SFNDVYIAYELMDTD-LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN-VLHRDLKPS 77
           S  ++ I  E MD   L Q+++    + E+        +++GL Y+   + ++HRD+KPS
Sbjct: 75  SDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPS 134
Query: 78  NLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 137
           N+L+N+  ++K+CDFG++    ++     +V TR Y +PE  L  + Y+   D+WS+G  
Sbjct: 135 NILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLS 192
Query: 138 FMEL-MDRKPLFP 149
            +E+ + R P+ P
Sbjct: 193 LVEMAVGRYPIPP 205

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 73.9 bits (180), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 37/103 (35%), Positives = 63/103 (61%), Gaps = 2/103 (1%)
Query: 45  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM 104
           L E      L +IL+GL Y+HS   +HRD+K +N+LL+ + ++K+ DFG+A   ++T   
Sbjct: 121 LDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 180
Query: 105 -TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP 146
              +V T ++ APE++  S+ Y +  D+WS+G   +EL   +P
Sbjct: 181 RNTFVGTPFWMAPEVIKQSA-YDSKADIWSLGITAIELARGEP 222

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 73.9 bits (180), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 37/103 (35%), Positives = 63/103 (61%), Gaps = 2/103 (1%)
Query: 45  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM 104
           L E      L +IL+GL Y+HS   +HRD+K +N+LL+ + ++K+ DFG+A   ++T   
Sbjct: 101 LDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 160
Query: 105 -TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP 146
              +V T ++ APE++  S+ Y +  D+WS+G   +EL   +P
Sbjct: 161 RNXFVGTPFWMAPEVIKQSA-YDSKADIWSLGITAIELARGEP 202

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 73.9 bits (180), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 37/103 (35%), Positives = 63/103 (61%), Gaps = 2/103 (1%)
Query: 45  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM 104
           L E      L +IL+GL Y+HS   +HRD+K +N+LL+ + ++K+ DFG+A   ++T   
Sbjct: 101 LDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 160
Query: 105 -TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP 146
              +V T ++ APE++  S+ Y +  D+WS+G   +EL   +P
Sbjct: 161 RNTFVGTPFWMAPEVIKQSA-YDSKADIWSLGITAIELARGEP 202

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 73.9 bits (180), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 42/133 (31%), Positives = 76/133 (57%), Gaps = 5/133 (3%)
Query: 20  SFNDVYIAYELMDTD-LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN-VLHRDLKPS 77
           S  ++ I  E MD   L Q+++    + E+        +++GL Y+   + ++HRD+KPS
Sbjct: 78  SDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPS 137
Query: 78  NLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 137
           N+L+N+  ++K+CDFG++    + +   E+V TR Y +PE  L  + Y+   D+WS+G  
Sbjct: 138 NILVNSRGEIKLCDFGVSGQLID-EMANEFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLS 195
Query: 138 FMEL-MDRKPLFP 149
            +E+ + R P  P
Sbjct: 196 LVEMAVGRYPRPP 208

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 73.9 bits (180), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 75/133 (56%), Gaps = 5/133 (3%)
Query: 20  SFNDVYIAYELMDTD-LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA-NVLHRDLKPS 77
           S  ++ I  E MD   L Q+++    + E+        +++GL Y+     ++HRD+KPS
Sbjct: 75  SDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPS 134
Query: 78  NLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 137
           N+L+N+  ++K+CDFG++    ++     +V TR Y +PE  L  + Y+   D+WS+G  
Sbjct: 135 NILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLS 192
Query: 138 FMEL-MDRKPLFP 149
            +E+ + R P+ P
Sbjct: 193 LVEMAVGRYPIPP 205

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 73.9 bits (180), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 56/217 (25%), Positives = 95/217 (43%), Gaps = 38/217 (17%)
Query: 21  FNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKP 76
           F+D    Y +++     ++++ ++      E+    ++ ++   L Y HS  V+HRD+KP
Sbjct: 82  FHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKP 141
Query: 77  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 136
            NLLL +  +LKI DFG + V + +        T  Y  PE ++    +   +D+WS+G 
Sbjct: 142 ENLLLGSAGELKIADFGWS-VHAPSSRRXXLXGTLDYLPPE-MIEGRMHDEKVDLWSLGV 199
Query: 137 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTE 196
           +  E +  KP F                              A  Y     R  R  FT 
Sbjct: 200 LCYEFLVGKPPF-----------------------------EANTYQETYKRISRVEFT- 229
Query: 197 KFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
            FP+ V   A DL+ ++L  +P QR  + + L HP++
Sbjct: 230 -FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 265

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 73.9 bits (180), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 76/133 (57%), Gaps = 5/133 (3%)
Query: 20  SFNDVYIAYELMDTD-LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN-VLHRDLKPS 77
           S  ++ I  E MD   L Q+++    + E+        +++GL Y+   + ++HRD+KPS
Sbjct: 75  SDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPS 134
Query: 78  NLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 137
           N+L+N+  ++K+CDFG++    ++     +V TR Y +PE  L  + Y+   D+WS+G  
Sbjct: 135 NILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLS 192
Query: 138 FMEL-MDRKPLFP 149
            +E+ + R P+ P
Sbjct: 193 LVEMAVGRYPIPP 205

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 48/155 (30%), Positives = 77/155 (49%), Gaps = 16/155 (10%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMD----TDLHQIIRSNQAL--SEEHCQYFL 54
           M H N+V  R        ESF +    Y +MD     DL + I + + +   E+    + 
Sbjct: 80  MKHPNIVQYR--------ESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWF 131
Query: 55  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWY 113
            QI   LK++H   +LHRD+K  N+ L  +  +++ DFG+ARV + T +     + T +Y
Sbjct: 132 VQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYY 191
Query: 114 RAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 148
            +PE+  N   Y    D+W++GC+  EL   K  F
Sbjct: 192 LSPEICENKP-YNNKSDIWALGCVLYELCTLKHAF 225

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 44/125 (35%), Positives = 70/125 (56%), Gaps = 9/125 (7%)
Query: 25  YIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN 84
           Y+A   M + L +I R     SE H +++  QI+   +Y+HS ++++RDLKP NLL++  
Sbjct: 122 YVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ 177
Query: 85  CDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD 143
             +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++G +  E+  
Sbjct: 178 GYIQVTDFGFAKRVKGRTWXLAG---TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAA 233
Query: 144 RKPLF 148
             P F
Sbjct: 234 GYPPF 238

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 93/210 (44%), Gaps = 33/210 (15%)
Query: 40  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA---NCDLKICDFGLAR 96
           R +QA +E      +  I   ++++HS N+ HRD+KP NLL  +   +  LK+ DFG A+
Sbjct: 120 RGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 179
Query: 97  VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF---PGRDH 153
            T++    T    T +Y APE +L    Y  + D+WS+G I   L+   P F    G+  
Sbjct: 180 ETTQNALQTP-CYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAI 237
Query: 154 VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKML 213
              ++  I L       + GF N                    ++  V   A  L+  +L
Sbjct: 238 SPGMKRRIRL------GQYGFPN-------------------PEWSEVSEDAKQLIRLLL 272
Query: 214 TFDPRQRITVEDALAHPYLGSLHDISDEPV 243
             DP +R+T+   + HP++     +   P+
Sbjct: 273 KTDPTERLTITQFMNHPWINQSMVVPQTPL 302

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 75/133 (56%), Gaps = 5/133 (3%)
Query: 20  SFNDVYIAYELMDTD-LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA-NVLHRDLKPS 77
           S  ++ I  E MD   L Q+++    + E+        +++GL Y+     ++HRD+KPS
Sbjct: 75  SDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPS 134
Query: 78  NLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 137
           N+L+N+  ++K+CDFG++    ++     +V TR Y +PE  L  + Y+   D+WS+G  
Sbjct: 135 NILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLS 192
Query: 138 FMEL-MDRKPLFP 149
            +E+ + R P+ P
Sbjct: 193 LVEMAVGRYPIPP 205

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 75/133 (56%), Gaps = 5/133 (3%)
Query: 20  SFNDVYIAYELMDTD-LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA-NVLHRDLKPS 77
           S  ++ I  E MD   L Q+++    + E+        +++GL Y+     ++HRD+KPS
Sbjct: 75  SDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPS 134
Query: 78  NLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 137
           N+L+N+  ++K+CDFG++    ++     +V TR Y +PE  L  + Y+   D+WS+G  
Sbjct: 135 NILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPE-RLQGTHYSVQSDIWSMGLS 192
Query: 138 FMEL-MDRKPLFP 149
            +E+ + R P+ P
Sbjct: 193 LVEMAVGRYPIPP 205

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/210 (26%), Positives = 93/210 (44%), Gaps = 33/210 (15%)
Query: 40  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA---NCDLKICDFGLAR 96
           R +QA +E      +  I   ++++HS N+ HRD+KP NLL  +   +  LK+ DFG A+
Sbjct: 101 RGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAK 160
Query: 97  VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF---PGRDH 153
            T++    T    T +Y APE +L    Y  + D+WS+G I   L+   P F    G+  
Sbjct: 161 ETTQNALQTP-CYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAI 218
Query: 154 VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKML 213
              ++  I L       + GF N                    ++  V   A  L+  +L
Sbjct: 219 SPGMKRRIRL------GQYGFPN-------------------PEWSEVSEDAKQLIRLLL 253
Query: 214 TFDPRQRITVEDALAHPYLGSLHDISDEPV 243
             DP +R+T+   + HP++     +   P+
Sbjct: 254 KTDPTERLTITQFMNHPWINQSMVVPQTPL 283

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 38/107 (35%), Positives = 62/107 (57%), Gaps = 5/107 (4%)
Query: 42  NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET 101
            + L E       +  L+GL Y+HS N++HRD+K  N+LL+    +K+ DFG A + +  
Sbjct: 109 KKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168
Query: 102 DFMTEYVVTRWYRAPELLL--NSSDYTAAIDVWSVGCIFMELMDRKP 146
           +    +V T ++ APE++L  +   Y   +DVWS+G   +EL +RKP
Sbjct: 169 N---XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 212

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 87/181 (48%), Gaps = 33/181 (18%)
Query: 43  QALSEEHCQYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSE 100
           +  SE+  +++  +I+  L Y+HS  NV++RDLK  NL+L+ +  +KI DFGL +    +
Sbjct: 105 RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD 164
Query: 101 TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL 160
              M  +  T  Y APE +L  +DY  A+D W +G +  E+M  +  F  +DH      L
Sbjct: 165 GATMKXFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----EKL 219
Query: 161 IELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQR 220
            ELI          + E       + PR            + P A  L+  +L  DP+QR
Sbjct: 220 FELI---------LMEE------IRFPR-----------TLGPEAKSLLSGLLKKDPKQR 253
Query: 221 I 221
           +
Sbjct: 254 L 254

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 45/134 (33%), Positives = 73/134 (54%), Gaps = 9/134 (6%)
Query: 20  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 75
           SF D    Y +M+     ++   +R     SE H +++  QI+   +Y+HS ++++RDLK
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 76  PSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 134
           P NL+++    +K+ DFGLA RV   T  +     T  Y APE++L S  Y  A+D W++
Sbjct: 169 PENLMIDQQGYIKVTDFGLAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWAL 224
Query: 135 GCIFMELMDRKPLF 148
           G +  E+    P F
Sbjct: 225 GVLIYEMAAGYPPF 238

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 100/233 (42%), Gaps = 40/233 (17%)
Query: 3   HENVVAIRDIIPPPQRESFNDVYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGL 61
           H +++ +  +I  P      D ++  E +   +L   I  +  + E   +    QIL  +
Sbjct: 70  HPHIIKLYQVISTP-----TDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAV 124
Query: 62  KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLN 121
            Y H   V+HRDLKP N+LL+A+ + KI DFGL+ + S+ +F+     +  Y APE++  
Sbjct: 125 DYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISG 184
Query: 122 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGT-PSEAE-LGFLNENA 179
                  +D+WS G I   L                     L GT P + E +  L +  
Sbjct: 185 RLYAGPEVDIWSCGVILYAL---------------------LCGTLPFDDEHVPTLFKKI 223
Query: 180 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
           +  +  +P Y  +S              L+  ML  DP +R T++D   H + 
Sbjct: 224 RGGVFYIPEYLNRSVAT-----------LLMHMLQVDPLKRATIKDIREHEWF 265

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 87/181 (48%), Gaps = 33/181 (18%)
Query: 43  QALSEEHCQYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSE 100
           +  SE+  +++  +I+  L Y+HS  NV++RDLK  NL+L+ +  +KI DFGL +    +
Sbjct: 104 RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD 163
Query: 101 TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL 160
              M  +  T  Y APE +L  +DY  A+D W +G +  E+M  +  F  +DH      L
Sbjct: 164 GATMKXFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----EKL 218
Query: 161 IELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQR 220
            ELI          + E       + PR            + P A  L+  +L  DP+QR
Sbjct: 219 FELI---------LMEE------IRFPR-----------TLGPEAKSLLSGLLKKDPKQR 252
Query: 221 I 221
           +
Sbjct: 253 L 253

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 40/147 (27%), Positives = 80/147 (54%), Gaps = 3/147 (2%)
Query: 22  NDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 81
           +++++  E +       + +   + E        + L+ L+++HS  V+HRD+K  N+LL
Sbjct: 90  DELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL 149
Query: 82  NANCDLKICDFGL-ARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 140
             +  +K+ DFG  A++T E    +E V T ++ APE++   + Y   +D+WS+G + +E
Sbjct: 150 GMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIE 208
Query: 141 LMDRKPLFPGRDHVHQLRLLIELIGTP 167
           +++ +P +   + +  L  LI   GTP
Sbjct: 209 MIEGEPPYLNENPLRAL-YLIATNGTP 234

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 44/125 (35%), Positives = 70/125 (56%), Gaps = 9/125 (7%)
Query: 25  YIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN 84
           Y+A   M + L +I R     SE H +++  QI+   +Y+HS ++++RDLKP NLL++  
Sbjct: 122 YVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ 177
Query: 85  CDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD 143
             +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++G +  E+  
Sbjct: 178 GYIQVTDFGFAKRVKGRTWXLXG---TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAA 233
Query: 144 RKPLF 148
             P F
Sbjct: 234 GYPPF 238

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 73.6 bits (179), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 87/181 (48%), Gaps = 33/181 (18%)
Query: 43  QALSEEHCQYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSE 100
           +  SE+  +++  +I+  L Y+HS  NV++RDLK  NL+L+ +  +KI DFGL +    +
Sbjct: 103 RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD 162
Query: 101 TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL 160
              M  +  T  Y APE +L  +DY  A+D W +G +  E+M  +  F  +DH      L
Sbjct: 163 GATMKXFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----EKL 217
Query: 161 IELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQR 220
            ELI          + E       + PR            + P A  L+  +L  DP+QR
Sbjct: 218 FELI---------LMEE------IRFPR-----------TLGPEAKSLLSGLLKKDPKQR 251
Query: 221 I 221
           +
Sbjct: 252 L 252

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 87/181 (48%), Gaps = 33/181 (18%)
Query: 43  QALSEEHCQYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSE 100
           +  SE+  +++  +I+  L Y+HS  NV++RDLK  NL+L+ +  +KI DFGL +    +
Sbjct: 243 RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD 302
Query: 101 TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL 160
              M  +  T  Y APE +L  +DY  A+D W +G +  E+M  +  F  +DH      L
Sbjct: 303 GATMKTFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----EKL 357
Query: 161 IELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQR 220
            ELI          + E       + PR            + P A  L+  +L  DP+QR
Sbjct: 358 FELI---------LMEE------IRFPR-----------TLGPEAKSLLSGLLKKDPKQR 391
Query: 221 I 221
           +
Sbjct: 392 L 392

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 45/134 (33%), Positives = 72/134 (53%), Gaps = 9/134 (6%)
Query: 20  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 75
           SF D    Y +M+     ++   +R     SE H +++  QI+   +Y+HS ++++RDLK
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 76  PSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 134
           P NLL++    +K+ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++
Sbjct: 169 PENLLIDQQGYIKVADFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWAL 224
Query: 135 GCIFMELMDRKPLF 148
           G +  E+    P F
Sbjct: 225 GVLIYEMAAGYPPF 238

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 73.2 bits (178), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/181 (30%), Positives = 87/181 (48%), Gaps = 33/181 (18%)
Query: 43  QALSEEHCQYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSE 100
           +  SE+  +++  +I+  L Y+HS  NV++RDLK  NL+L+ +  +KI DFGL +    +
Sbjct: 246 RVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD 305
Query: 101 TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL 160
              M  +  T  Y APE +L  +DY  A+D W +G +  E+M  +  F  +DH      L
Sbjct: 306 GATMKTFCGTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH----EKL 360
Query: 161 IELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQR 220
            ELI          + E       + PR            + P A  L+  +L  DP+QR
Sbjct: 361 FELI---------LMEE------IRFPR-----------TLGPEAKSLLSGLLKKDPKQR 394
Query: 221 I 221
           +
Sbjct: 395 L 395

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 44/125 (35%), Positives = 70/125 (56%), Gaps = 9/125 (7%)
Query: 25  YIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN 84
           Y+A   M + L +I R     SE H +++  QI+   +Y+HS ++++RDLKP NLL++  
Sbjct: 122 YVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ 177
Query: 85  CDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD 143
             +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++G +  E+  
Sbjct: 178 GYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAA 233
Query: 144 RKPLF 148
             P F
Sbjct: 234 GYPPF 238

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/244 (24%), Positives = 111/244 (45%), Gaps = 29/244 (11%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILR 59
           ++H N+V + ++I     E+   +Y+  E     ++   + ++  + E+  +    QI+ 
Sbjct: 70  LNHPNIVKLFEVI-----ETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS 124
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
            ++Y H   ++HRDLK  NLLL+A+ ++KI DFG +   +  + + E+  +  Y APEL 
Sbjct: 125 AVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDEFCGSPPYAAPELF 184
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENA 179
                    +DVWS+G I   L+     F G++                   L  L E  
Sbjct: 185 QGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN-------------------LKELRERV 225
Query: 180 KKYICQLPRYQR---QSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH 236
            +   ++P Y     ++  +KF  ++PS    +E+++  D    +  ED    PY+  L 
Sbjct: 226 LRGKYRIPFYMSTDCENLLKKFLILNPSKRGTLEQIMK-DRWMNVGHEDDELKPYVEPLP 284
Query: 237 DISD 240
           D  D
Sbjct: 285 DYKD 288

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 115/235 (48%), Gaps = 42/235 (17%)
Query: 20  SFNDVYIAYELMDTDLHQIIRSNQ---ALSEEHCQYFLYQILR--------GLKYIHS-A 67
           ++++VYI YE M+ D   I++ ++    L + +  +   Q+++           YIH+  
Sbjct: 114 NYDEVYIIYEYMEND--SILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK 171
Query: 68  NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVV-----TRWYRAPELLLNS 122
           N+ HRD+KPSN+L++ N  +K+ DFG      E+++M +  +     T  +  PE   N 
Sbjct: 172 NICHRDVKPSNILMDKNGRVKLSDFG------ESEYMVDKKIKGSRGTYEFMPPEFFSNE 225
Query: 123 SDYTAA-IDVWSVG-CIFMELMDRKPLFPGRDHVHQLRL-LIELIGTPSEAELGF-LNEN 178
           S Y  A +D+WS+G C+++   +  P          L++ L+EL        + + L+ N
Sbjct: 226 SSYNGAKVDIWSLGICLYVMFYNVVPF--------SLKISLVELFNNIRTKNIEYPLDRN 277
Query: 179 AKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLG 233
              Y    P   ++S T     +    ID ++  L  +P +RIT EDAL H +L 
Sbjct: 278 HFLY----PLTNKKS-TCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLA 327

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 44/125 (35%), Positives = 70/125 (56%), Gaps = 9/125 (7%)
Query: 25  YIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN 84
           Y+A   M + L +I R     SE H +++  QI+   +Y+HS ++++RDLKP NLL++  
Sbjct: 122 YVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ 177
Query: 85  CDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD 143
             +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++G +  E+  
Sbjct: 178 GYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAA 233
Query: 144 RKPLF 148
             P F
Sbjct: 234 GYPPF 238

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 73.2 bits (178), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 44/142 (30%), Positives = 74/142 (52%), Gaps = 5/142 (3%)
Query: 22  NDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 81
           N  ++   L   DL   I+S          ++  +I+ GL+++HS  +++RDLK  N+LL
Sbjct: 93  NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL 152
Query: 82  NANCDLKICDFGLARVTSETDFMT-EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 140
           + +  +KI DFG+ +     D  T E+  T  Y APE+LL    Y  ++D WS G +  E
Sbjct: 153 DKDGHIKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILLGQK-YNHSVDWWSFGVLLYE 211
Query: 141 LMDRKPLFPGRDH---VHQLRL 159
           ++  +  F G+D     H +R+
Sbjct: 212 MLIGQSPFHGQDEEELFHSIRM 233

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 44/125 (35%), Positives = 70/125 (56%), Gaps = 9/125 (7%)
Query: 25  YIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN 84
           Y+A   M + L +I R     SE H +++  QI+   +Y+HS ++++RDLKP NLL++  
Sbjct: 122 YVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ 177
Query: 85  CDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD 143
             +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++G +  E+  
Sbjct: 178 GYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAA 233
Query: 144 RKPLF 148
             P F
Sbjct: 234 GYPPF 238

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/158 (32%), Positives = 79/158 (50%), Gaps = 10/158 (6%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDV-YIAYELMDT-DLHQIIRSNQ---ALSEEHCQYFLY 55
           ++H NVV+ R++    Q+ + ND+  +A E  +  DL + +   +    L E   +  L 
Sbjct: 69  LNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS 128
Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDL---KICDFGLARVTSETDFMTEYVVTRW 112
            I   L+Y+H   ++HRDLKP N++L         KI D G A+   + +  TE+V T  
Sbjct: 129 DISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQ 188
Query: 113 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDR-KPLFP 149
           Y APE LL    YT  +D WS G +  E +   +P  P
Sbjct: 189 YLAPE-LLEQKKYTVTVDYWSFGTLAFECITGFRPFLP 225

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 44/125 (35%), Positives = 70/125 (56%), Gaps = 9/125 (7%)
Query: 25  YIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN 84
           Y+A   M + L +I R     SE H +++  QI+   +Y+HS ++++RDLKP NLL++  
Sbjct: 122 YVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ 177
Query: 85  CDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD 143
             +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++G +  E+  
Sbjct: 178 GYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAA 233
Query: 144 RKPLF 148
             P F
Sbjct: 234 GYPPF 238

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 44/125 (35%), Positives = 70/125 (56%), Gaps = 9/125 (7%)
Query: 25  YIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN 84
           Y+A   M + L +I R     SE H +++  QI+   +Y+HS ++++RDLKP NLL++  
Sbjct: 122 YVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ 177
Query: 85  CDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD 143
             +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++G +  E+  
Sbjct: 178 GYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAA 233
Query: 144 RKPLF 148
             P F
Sbjct: 234 GYPPF 238

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 44/125 (35%), Positives = 70/125 (56%), Gaps = 9/125 (7%)
Query: 25  YIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN 84
           Y+A   M + L +I R     SE H +++  QI+   +Y+HS ++++RDLKP NLL++  
Sbjct: 122 YVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ 177
Query: 85  CDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD 143
             +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++G +  E+  
Sbjct: 178 GYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAA 233
Query: 144 RKPLF 148
             P F
Sbjct: 234 GYPPF 238

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 91/193 (47%), Gaps = 28/193 (14%)
Query: 35  LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL 94
           ++ +   N    E    ++  QI+ GL+++H  N+++RDLKP N+LL+ + +++I D GL
Sbjct: 276 IYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGL 335
Query: 95  ARVTSETDFMTE-YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDH 153
           A         T+ Y  T  + APELLL   +Y  ++D +++G    E++  +  F  R  
Sbjct: 336 AVELKAGQTKTKGYAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGE 394
Query: 154 VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKML 213
             +                   N+  K+ + +    Q  ++ +KF    P++ D  E +L
Sbjct: 395 KVE-------------------NKELKQRVLE----QAVTYPDKF---SPASKDFCEALL 428
Query: 214 TFDPRQRITVEDA 226
             DP +R+   D 
Sbjct: 429 QKDPEKRLGFRDG 441

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/158 (32%), Positives = 79/158 (50%), Gaps = 10/158 (6%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDV-YIAYELMDT-DLHQIIRSNQ---ALSEEHCQYFLY 55
           ++H NVV+ R++    Q+ + ND+  +A E  +  DL + +   +    L E   +  L 
Sbjct: 70  LNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS 129
Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDL---KICDFGLARVTSETDFMTEYVVTRW 112
            I   L+Y+H   ++HRDLKP N++L         KI D G A+   + +  TE+V T  
Sbjct: 130 DISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQ 189
Query: 113 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDR-KPLFP 149
           Y APE LL    YT  +D WS G +  E +   +P  P
Sbjct: 190 YLAPE-LLEQKKYTVTVDYWSFGTLAFECITGFRPFLP 226

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 44/125 (35%), Positives = 70/125 (56%), Gaps = 9/125 (7%)
Query: 25  YIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN 84
           Y+A   M + L +I R     SE H +++  QI+   +Y+HS ++++RDLKP NLL++  
Sbjct: 123 YVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ 178
Query: 85  CDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD 143
             +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++G +  E+  
Sbjct: 179 GYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAA 234
Query: 144 RKPLF 148
             P F
Sbjct: 235 GYPPF 239

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 40/140 (28%), Positives = 75/140 (53%), Gaps = 3/140 (2%)
Query: 30  LMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKI 89
           L   DL   +      +EE  +++L ++  GL ++HS  +++RDLKP N+LL+    +K+
Sbjct: 112 LRGGDLFTRLSKEVMFTEEDVKFYLAELALGLDHLHSLGIIYRDLKPENILLDEEGHIKL 171
Query: 90  CDFGLARVTSETDFMT-EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 148
            DFGL++   + +     +  T  Y APE ++N   ++ + D WS G +  E++     F
Sbjct: 172 TDFGLSKEAIDHEKKAYSFCGTVEYMAPE-VVNRQGHSHSADWWSYGVLMFEMLTGSLPF 230
Query: 149 PGRDHVHQLRLLIEL-IGTP 167
            G+D    + L+++  +G P
Sbjct: 231 QGKDRKETMTLILKAKLGMP 250

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 91/193 (47%), Gaps = 28/193 (14%)
Query: 35  LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL 94
           ++ +   N    E    ++  QI+ GL+++H  N+++RDLKP N+LL+ + +++I D GL
Sbjct: 276 IYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGL 335
Query: 95  ARVTSETDFMTE-YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDH 153
           A         T+ Y  T  + APELLL   +Y  ++D +++G    E++  +  F  R  
Sbjct: 336 AVELKAGQTKTKGYAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGE 394
Query: 154 VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKML 213
             +                   N+  K+ + +    Q  ++ +KF    P++ D  E +L
Sbjct: 395 KVE-------------------NKELKQRVLE----QAVTYPDKF---SPASKDFCEALL 428
Query: 214 TFDPRQRITVEDA 226
             DP +R+   D 
Sbjct: 429 QKDPEKRLGFRDG 441

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 72.8 bits (177), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 91/193 (47%), Gaps = 28/193 (14%)
Query: 35  LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL 94
           ++ +   N    E    ++  QI+ GL+++H  N+++RDLKP N+LL+ + +++I D GL
Sbjct: 276 IYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGL 335
Query: 95  ARVTSETDFMTE-YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDH 153
           A         T+ Y  T  + APELLL   +Y  ++D +++G    E++  +  F  R  
Sbjct: 336 AVELKAGQTKTKGYAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGE 394
Query: 154 VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKML 213
             +                   N+  K+ + +    Q  ++ +KF    P++ D  E +L
Sbjct: 395 KVE-------------------NKELKQRVLE----QAVTYPDKF---SPASKDFCEALL 428
Query: 214 TFDPRQRITVEDA 226
             DP +R+   D 
Sbjct: 429 QKDPEKRLGFRDG 441

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 44/125 (35%), Positives = 70/125 (56%), Gaps = 9/125 (7%)
Query: 25  YIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN 84
           Y+A   M + L +I R     SE H +++  QI+   +Y+HS ++++RDLKP NLL++  
Sbjct: 109 YVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDEQ 164
Query: 85  CDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD 143
             +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++G +  E+  
Sbjct: 165 GYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAA 220
Query: 144 RKPLF 148
             P F
Sbjct: 221 GYPPF 225

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 38/127 (29%), Positives = 70/127 (55%), Gaps = 7/127 (5%)
Query: 20  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 75
           +F D    + +MD     +L  ++R +Q       +++  ++   L+Y+HS ++++RDLK
Sbjct: 74  TFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLK 133
Query: 76  PSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVG 135
           P N+LL+ N  +KI DFG A+   +  +      T  Y APE ++++  Y  +ID WS G
Sbjct: 134 PENILLDKNGHIKITDFGFAKYVPDVTYXL--CGTPDYIAPE-VVSTKPYNKSIDWWSFG 190
Query: 136 CIFMELM 142
            +  E++
Sbjct: 191 ILIYEML 197

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 44/125 (35%), Positives = 70/125 (56%), Gaps = 9/125 (7%)
Query: 25  YIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN 84
           Y+A   M + L +I R     SE H +++  QI+   +Y+HS ++++RDLKP NLL++  
Sbjct: 143 YVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ 198
Query: 85  CDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD 143
             +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++G +  E+  
Sbjct: 199 GYIQVTDFGFAKRVKGATWTLCG---TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAA 254
Query: 144 RKPLF 148
             P F
Sbjct: 255 GYPPF 259

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 72.4 bits (176), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 40/111 (36%), Positives = 63/111 (56%), Gaps = 5/111 (4%)
Query: 39  IRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA-RV 97
           +R     SE H +++  QI+   +Y+HS ++++RDLKP NLL++    +K+ DFG A RV
Sbjct: 133 LRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIKVADFGFAKRV 192
Query: 98  TSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 148
              T  +     T  Y APE++L S  Y  A+D W++G +  E+    P F
Sbjct: 193 KGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 49/193 (25%), Positives = 91/193 (47%), Gaps = 28/193 (14%)
Query: 35  LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL 94
           ++ +   N    E    ++  QI+ GL+++H  N+++RDLKP N+LL+ + +++I D GL
Sbjct: 276 IYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGL 335
Query: 95  ARVTSETDFMTE-YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDH 153
           A         T+ Y  T  + APELLL   +Y  ++D +++G    E++  +  F  R  
Sbjct: 336 AVELKAGQTKTKGYAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGE 394
Query: 154 VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKML 213
             +                   N+  K+ + +    Q  ++ +KF    P++ D  E +L
Sbjct: 395 KVE-------------------NKELKQRVLE----QAVTYPDKF---SPASKDFCEALL 428
Query: 214 TFDPRQRITVEDA 226
             DP +R+   D 
Sbjct: 429 QKDPEKRLGFRDG 441

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 72/134 (53%), Gaps = 9/134 (6%)
Query: 20  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 75
           SF D    Y +M+     ++   +R     SE H +++  QI+   +Y+HS ++++RDLK
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 76  PSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 134
           P NL+++    +K+ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++
Sbjct: 169 PENLMIDQQGYIKVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWAL 224
Query: 135 GCIFMELMDRKPLF 148
           G +  E+    P F
Sbjct: 225 GVLIYEMAAGYPPF 238

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 72/134 (53%), Gaps = 9/134 (6%)
Query: 20  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 75
           SF D    Y +M+     ++   +R     SE H +++  QI+   +Y+HS ++++RDLK
Sbjct: 110 SFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 169
Query: 76  PSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 134
           P NL+++    +K+ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++
Sbjct: 170 PENLMIDQQGYIKVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWAL 225
Query: 135 GCIFMELMDRKPLF 148
           G +  E+    P F
Sbjct: 226 GVLIYEMAAGYPPF 239

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 72.4 bits (176), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 72/134 (53%), Gaps = 9/134 (6%)
Query: 20  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 75
           SF D    Y +M+     ++   +R     SE H +++  QI+   +Y+HS ++++RDLK
Sbjct: 110 SFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 169
Query: 76  PSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 134
           P NL+++    +K+ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++
Sbjct: 170 PENLMIDQQGYIKVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWAL 225
Query: 135 GCIFMELMDRKPLF 148
           G +  E+    P F
Sbjct: 226 GVLIYEMAAGYPPF 239

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 72/134 (53%), Gaps = 9/134 (6%)
Query: 20  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 75
           SF D    Y +M+     ++   +R     SE H +++  QI+   +Y+HS ++++RDLK
Sbjct: 110 SFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 169
Query: 76  PSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 134
           P NL+++    +K+ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++
Sbjct: 170 PENLMIDQQGYIKVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWAL 225
Query: 135 GCIFMELMDRKPLF 148
           G +  E+    P F
Sbjct: 226 GVLIYEMAAGYPPF 239

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 46/143 (32%), Positives = 76/143 (53%), Gaps = 20/143 (13%)
Query: 35  LHQIIRSNQALSEEHCQYF--LYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDF 92
           L+ +I S + L+++  +Y+    QIL  L YIHS  ++HR+LKP N+ ++ + ++KI DF
Sbjct: 102 LYDLIHS-ENLNQQRDEYWRLFRQILEALSYIHSQGIIHRNLKPXNIFIDESRNVKIGDF 160
Query: 93  GLAR---------------VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 137
           GLA+               +   +D +T  + T  Y A E+L  +  Y   ID +S+G I
Sbjct: 161 GLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGII 220
Query: 138 FMELMDRKPLFPGRDHVHQLRLL 160
           F E +   P   G + V+ L+ L
Sbjct: 221 FFEXI--YPFSTGXERVNILKKL 241

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 75/140 (53%), Gaps = 3/140 (2%)
Query: 30  LMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKI 89
           L   DL   +      +EE  +++L ++   L ++HS  +++RDLKP N+LL+    +K+
Sbjct: 108 LRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKL 167
Query: 90  CDFGLARVTSETDFMT-EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 148
            DFGL++ + + +     +  T  Y APE ++N   +T + D WS G +  E++     F
Sbjct: 168 TDFGLSKESIDHEKKAYSFCGTVEYMAPE-VVNRRGHTQSADWWSFGVLMFEMLTGTLPF 226
Query: 149 PGRDHVHQLRLLIEL-IGTP 167
            G+D    + ++++  +G P
Sbjct: 227 QGKDRKETMTMILKAKLGMP 246

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 72.0 bits (175), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 73/134 (54%), Gaps = 9/134 (6%)
Query: 20  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 75
           SF D    Y +M+     ++   +R     SE H +++  QI+   +Y+HS ++++RDLK
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 76  PSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 134
           P NL+++    +++ DFGLA RV   T  +     T  Y APE++L S  Y  A+D W++
Sbjct: 169 PENLMIDQQGYIQVTDFGLAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWAL 224
Query: 135 GCIFMELMDRKPLF 148
           G +  E+    P F
Sbjct: 225 GVLIYEMAAGYPPF 238

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 72.0 bits (175), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 110/244 (45%), Gaps = 29/244 (11%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILR 59
           ++H N+V + ++I     E+   +Y+  E     ++   + ++  + E+  +    QI+ 
Sbjct: 70  LNHPNIVKLFEVI-----ETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS 124
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
            ++Y H   ++HRDLK  NLLL+A+ ++KI DFG +   +  + +  +  +  Y APEL 
Sbjct: 125 AVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELF 184
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENA 179
                    +DVWS+G I   L+     F G++                   L  L E  
Sbjct: 185 QGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN-------------------LKELRERV 225
Query: 180 KKYICQLPRYQR---QSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH 236
            +   ++P Y     ++  +KF  ++PS    +E+++  D    +  ED    PY+  L 
Sbjct: 226 LRGKYRIPFYMSTDCENLLKKFLILNPSKRGTLEQIMK-DRWMNVGHEDDELKPYVAPLP 284
Query: 237 DISD 240
           D  D
Sbjct: 285 DYKD 288

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 43/125 (34%), Positives = 70/125 (56%), Gaps = 9/125 (7%)
Query: 25  YIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN 84
           Y+A   M + L +I R     SE H +++  QI+   +Y+HS ++++RDLKP NLL++  
Sbjct: 122 YVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ 177
Query: 85  CDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD 143
             +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++G +  ++  
Sbjct: 178 GYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWALGVLIYQMAA 233
Query: 144 RKPLF 148
             P F
Sbjct: 234 GYPPF 238

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 45/153 (29%), Positives = 81/153 (52%), Gaps = 8/153 (5%)
Query: 22  NDVYIAYELMDT-DLHQIIR----SNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKP 76
           N++ I  EL D  DL ++I+      + + E     +  Q+   L+++HS  V+HRD+KP
Sbjct: 105 NELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKP 164
Query: 77  SNLLLNANCDLKICDFGLAR-VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVG 135
           +N+ + A   +K+ D GL R  +S+T      V T +Y +PE  ++ + Y    D+WS+G
Sbjct: 165 ANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPE-RIHENGYNFKSDIWSLG 223
Query: 136 CIFMELMD-RKPLFPGRDHVHQLRLLIELIGTP 167
           C+  E+   + P +  + +++ L   IE    P
Sbjct: 224 CLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYP 256

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 43/125 (34%), Positives = 70/125 (56%), Gaps = 9/125 (7%)
Query: 25  YIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN 84
           Y+A   M + L +I R     +E H +++  QI+   +Y+HS ++++RDLKP NLL++  
Sbjct: 122 YVAGGEMFSHLRRIGR----FAEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ 177
Query: 85  CDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD 143
             +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++G +  E+  
Sbjct: 178 GYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAA 233
Query: 144 RKPLF 148
             P F
Sbjct: 234 GYPPF 238

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 72/134 (53%), Gaps = 9/134 (6%)
Query: 20  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 75
           SF D    Y +M+     ++   +R     SE H +++  QI+   +Y+HS ++++RDLK
Sbjct: 130 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 189
Query: 76  PSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 134
           P NLL++    +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++
Sbjct: 190 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWAL 245
Query: 135 GCIFMELMDRKPLF 148
           G +  E+    P F
Sbjct: 246 GVLIYEMAAGYPPF 259

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 71.6 bits (174), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/246 (24%), Positives = 96/246 (39%), Gaps = 59/246 (23%)
Query: 44  ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARVTSETD 102
           +LS +  + ++  + + LK IH   ++HRD+KPSN L N       + DFGLA+ T +T 
Sbjct: 113 SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTK 172
Query: 103 F-----------------------------MTEYVVTRWYRAPELLLNSSDYTAAIDVWS 133
                                         +     T  +RAPE+L    + T AID+WS
Sbjct: 173 IELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWS 232
Query: 134 VGCIFMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYIC--QLPRYQ 190
            G IF+ L+  R P +   D +  L  ++ + G  S   +       K  +C  ++P   
Sbjct: 233 AGVIFLSLLSGRYPFYKASDDLTALAQIMTIRG--SRETIQAAKTFGKSILCSKEVPAQD 290
Query: 191 RQSFTEKFPNVHPSAIDLVEKM------------------------LTFDPRQRITVEDA 226
            +   E+   +  S   L   +                        L  +P  RIT E+A
Sbjct: 291 LRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEA 350
Query: 227 LAHPYL 232
           L HP+ 
Sbjct: 351 LLHPFF 356

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 75/140 (53%), Gaps = 3/140 (2%)
Query: 30  LMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKI 89
           L   DL   +      +EE  +++L ++   L ++HS  +++RDLKP N+LL+    +K+
Sbjct: 108 LRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKL 167
Query: 90  CDFGLARVTSETDFMT-EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 148
            DFGL++ + + +     +  T  Y APE ++N   +T + D WS G +  E++     F
Sbjct: 168 TDFGLSKESIDHEKKAYSFCGTVEYMAPE-VVNRRGHTQSADWWSFGVLMFEMLTGTLPF 226
Query: 149 PGRDHVHQLRLLIEL-IGTP 167
            G+D    + ++++  +G P
Sbjct: 227 QGKDRKETMTMILKAKLGMP 246

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 39/140 (27%), Positives = 75/140 (53%), Gaps = 3/140 (2%)
Query: 30  LMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKI 89
           L   DL   +      +EE  +++L ++   L ++HS  +++RDLKP N+LL+    +K+
Sbjct: 109 LRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKL 168
Query: 90  CDFGLARVTSETDFMT-EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 148
            DFGL++ + + +     +  T  Y APE ++N   +T + D WS G +  E++     F
Sbjct: 169 TDFGLSKESIDHEKKAYSFCGTVEYMAPE-VVNRRGHTQSADWWSFGVLMFEMLTGTLPF 227
Query: 149 PGRDHVHQLRLLIEL-IGTP 167
            G+D    + ++++  +G P
Sbjct: 228 QGKDRKETMTMILKAKLGMP 247

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 72/134 (53%), Gaps = 9/134 (6%)
Query: 20  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 75
           SF D    Y +M+     ++   +R     SE H +++  QI+   +Y+HS ++++RDLK
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 169
Query: 76  PSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 134
           P NLL++    +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++
Sbjct: 170 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWAL 225
Query: 135 GCIFMELMDRKPLF 148
           G +  E+    P F
Sbjct: 226 GVLIYEMAAGYPPF 239

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 72/134 (53%), Gaps = 9/134 (6%)
Query: 20  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 75
           SF D    Y +M+     ++   +R     SE H +++  QI+   +Y+HS ++++RDLK
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 169
Query: 76  PSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 134
           P NLL++    +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++
Sbjct: 170 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWAL 225
Query: 135 GCIFMELMDRKPLF 148
           G +  E+    P F
Sbjct: 226 GVLIYEMAAGYPPF 239

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 71.6 bits (174), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 72/134 (53%), Gaps = 9/134 (6%)
Query: 20  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 75
           SF D    Y +M+     ++   +R     SE H +++  QI+   +Y+HS ++++RDLK
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 76  PSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 134
           P NLL++    +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWAL 224
Query: 135 GCIFMELMDRKPLF 148
           G +  E+    P F
Sbjct: 225 GVLIYEMAAGYPPF 238

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 71.2 bits (173), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 72/134 (53%), Gaps = 9/134 (6%)
Query: 20  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 75
           SF D    Y +M+     ++   +R     SE H +++  QI+   +Y+HS ++++RDLK
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 76  PSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 134
           P NLL++    +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWAL 224
Query: 135 GCIFMELMDRKPLF 148
           G +  E+    P F
Sbjct: 225 GVLIYEMAAGYPPF 238

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 71.2 bits (173), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 72/134 (53%), Gaps = 9/134 (6%)
Query: 20  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 75
           SF D    Y +M+     ++   +R     SE H +++  QI+   +Y+HS ++++RDLK
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 76  PSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 134
           P NLL++    +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWAL 224
Query: 135 GCIFMELMDRKPLF 148
           G +  E+    P F
Sbjct: 225 GVLIYEMAAGYPPF 238

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 71.2 bits (173), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 72/134 (53%), Gaps = 9/134 (6%)
Query: 20  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 75
           SF D    Y +M+     ++   +R     SE H +++  QI+   +Y+HS ++++RDLK
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 76  PSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 134
           P NLL++    +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWAL 224
Query: 135 GCIFMELMDRKPLF 148
           G +  E+    P F
Sbjct: 225 GVLIYEMAAGYPPF 238

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 71.2 bits (173), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 72/134 (53%), Gaps = 9/134 (6%)
Query: 20  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 75
           SF D    Y +M+     ++   +R     SE H +++  QI+   +Y+HS ++++RDLK
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 76  PSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 134
           P NLL++    +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWAL 224
Query: 135 GCIFMELMDRKPLF 148
           G +  E+    P F
Sbjct: 225 GVLIYEMAAGYPPF 238

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 71.2 bits (173), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 72/134 (53%), Gaps = 9/134 (6%)
Query: 20  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 75
           SF D    Y +M+     ++   +R     SE H +++  QI+   +Y+HS ++++RDLK
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 76  PSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 134
           P NLL++    +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWAL 224
Query: 135 GCIFMELMDRKPLF 148
           G +  E+    P F
Sbjct: 225 GVLIYEMAAGYPPF 238

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 71.2 bits (173), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 72/134 (53%), Gaps = 9/134 (6%)
Query: 20  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 75
           SF D    Y +M+     ++   +R     SE H +++  QI+   +Y+HS ++++RDLK
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 169
Query: 76  PSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 134
           P NLL++    +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++
Sbjct: 170 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWAL 225
Query: 135 GCIFMELMDRKPLF 148
           G +  E+    P F
Sbjct: 226 GVLIYEMAAGYPPF 239

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 71.2 bits (173), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 39/147 (26%), Positives = 79/147 (53%), Gaps = 3/147 (2%)
Query: 22  NDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 81
           +++++  E +       + +   + E        + L+ L+++HS  V+HRD+K  N+LL
Sbjct: 90  DELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL 149
Query: 82  NANCDLKICDFGL-ARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 140
             +  +K+ DFG  A++T E    +  V T ++ APE++   + Y   +D+WS+G + +E
Sbjct: 150 GMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIE 208
Query: 141 LMDRKPLFPGRDHVHQLRLLIELIGTP 167
           +++ +P +   + +  L  LI   GTP
Sbjct: 209 MIEGEPPYLNENPLRAL-YLIATNGTP 234

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 71.2 bits (173), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 72/134 (53%), Gaps = 9/134 (6%)
Query: 20  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 75
           SF D    Y +M+     ++   +R     SE H +++  QI+   +Y+HS ++++RDLK
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 169
Query: 76  PSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 134
           P NLL++    +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++
Sbjct: 170 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWAL 225
Query: 135 GCIFMELMDRKPLF 148
           G +  E+    P F
Sbjct: 226 GVLIYEMAAGYPPF 239

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 71.2 bits (173), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 42/125 (33%), Positives = 70/125 (56%), Gaps = 9/125 (7%)
Query: 25  YIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN 84
           Y+A   M + L +I R     SE H +++  QI+   +Y+HS ++++RDLKP NL+++  
Sbjct: 122 YVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLIIDQQ 177
Query: 85  CDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD 143
             +++ DFG A RV   T  +     T  Y APE+++ S  Y  A+D W++G +  E+  
Sbjct: 178 GYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIII-SKGYNKAVDWWALGVLIYEMAA 233
Query: 144 RKPLF 148
             P F
Sbjct: 234 GYPPF 238

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 43/125 (34%), Positives = 69/125 (55%), Gaps = 9/125 (7%)
Query: 25  YIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN 84
           Y+A   M + L +I R      E H +++  QI+   +Y+HS ++++RDLKP NLL++  
Sbjct: 143 YVAGGEMFSHLRRIGR----FXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ 198
Query: 85  CDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD 143
             +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++G +  E+  
Sbjct: 199 GYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAA 254
Query: 144 RKPLF 148
             P F
Sbjct: 255 GYPPF 259

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 62/255 (24%), Positives = 106/255 (41%), Gaps = 46/255 (18%)
Query: 21  FNDVYIAYELMDTDLHQIIRSNQ--ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN 78
           ++ + + +E +   L++II  N       E  + +  +IL+ L Y+   ++ H DLKP N
Sbjct: 108 YDHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPEN 167
Query: 79  LLLN-------------------------ANCDLKICDFGLARVTSETDFMTEYVVTRWY 113
           +LL+                          +  +K+ DFG A  T ++D+    + TR Y
Sbjct: 168 ILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA--TFKSDYHGSIINTRQY 225
Query: 114 RAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIG-TPSEAEL 172
           RAPE++LN   +  + D+WS GC+  EL     LF   +H+  L ++  +I   P     
Sbjct: 226 RAPEVILNLG-WDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLY 284
Query: 173 GFLNENAKKYI----CQLPRYQRQSFTEKFPNV-----------HPSAIDLVEKMLTFDP 217
                N  KY+     +L   +  S      +V           H    D +  +L  DP
Sbjct: 285 EATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDP 344
Query: 218 RQRITVEDALAHPYL 232
             R +  + L H +L
Sbjct: 345 TLRPSPAELLKHKFL 359

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 39/147 (26%), Positives = 79/147 (53%), Gaps = 3/147 (2%)
Query: 22  NDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 81
           +++++  E +       + +   + E        + L+ L+++HS  V+HRD+K  N+LL
Sbjct: 91  DELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL 150
Query: 82  NANCDLKICDFGL-ARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 140
             +  +K+ DFG  A++T E    +  V T ++ APE++   + Y   +D+WS+G + +E
Sbjct: 151 GMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIE 209
Query: 141 LMDRKPLFPGRDHVHQLRLLIELIGTP 167
           +++ +P +   + +  L  LI   GTP
Sbjct: 210 MIEGEPPYLNENPLRAL-YLIATNGTP 235

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 39/147 (26%), Positives = 79/147 (53%), Gaps = 3/147 (2%)
Query: 22  NDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 81
           +++++  E +       + +   + E        + L+ L+++HS  V+HRD+K  N+LL
Sbjct: 90  DELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL 149
Query: 82  NANCDLKICDFGL-ARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 140
             +  +K+ DFG  A++T E    +  V T ++ APE++   + Y   +D+WS+G + +E
Sbjct: 150 GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIE 208
Query: 141 LMDRKPLFPGRDHVHQLRLLIELIGTP 167
           +++ +P +   + +  L  LI   GTP
Sbjct: 209 MIEGEPPYLNENPLRAL-YLIATNGTP 234

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 71.2 bits (173), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 72/134 (53%), Gaps = 9/134 (6%)
Query: 20  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 75
           SF D    Y +M+     ++   +R     SE H +++  QI+   +Y+HS ++++RDLK
Sbjct: 102 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 161
Query: 76  PSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 134
           P NLL++    +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++
Sbjct: 162 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWAL 217
Query: 135 GCIFMELMDRKPLF 148
           G +  E+    P F
Sbjct: 218 GVLIYEMAAGYPPF 231

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 43/125 (34%), Positives = 69/125 (55%), Gaps = 9/125 (7%)
Query: 25  YIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN 84
           Y+A   M + L +I R      E H +++  QI+   +Y+HS ++++RDLKP NLL++  
Sbjct: 122 YVAGGEMFSHLRRIGR----FXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ 177
Query: 85  CDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD 143
             +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++G +  E+  
Sbjct: 178 GYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAA 233
Query: 144 RKPLF 148
             P F
Sbjct: 234 GYPPF 238

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 72/134 (53%), Gaps = 9/134 (6%)
Query: 20  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 75
           SF D    Y +M+     ++   +R     SE H +++  QI+   +Y+HS ++++RDLK
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 169
Query: 76  PSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 134
           P NLL++    +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++
Sbjct: 170 PENLLIDQQGYIQVTDFGFAKRVKGRTWTLCG---TPEYLAPEIIL-SKGYNKAVDWWAL 225
Query: 135 GCIFMELMDRKPLF 148
           G +  E+    P F
Sbjct: 226 GVLIYEMAAGYPPF 239

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 43/125 (34%), Positives = 69/125 (55%), Gaps = 9/125 (7%)
Query: 25  YIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN 84
           Y+A   M + L +I R      E H +++  QI+   +Y+HS ++++RDLKP NLL++  
Sbjct: 122 YVAGGEMFSHLRRIGR----FXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ 177
Query: 85  CDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD 143
             +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++G +  E+  
Sbjct: 178 GYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAA 233
Query: 144 RKPLF 148
             P F
Sbjct: 234 GYPPF 238

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 44/134 (32%), Positives = 72/134 (53%), Gaps = 9/134 (6%)
Query: 20  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 75
           SF D    Y +M+     ++   +R     SE H +++  QI+   +Y+HS ++++RDLK
Sbjct: 95  SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 154
Query: 76  PSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 134
           P NLL++    +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++
Sbjct: 155 PENLLIDQQGYIQVTDFGFAKRVKGRTWTLCG---TPEYLAPEIIL-SKGYNKAVDWWAL 210
Query: 135 GCIFMELMDRKPLF 148
           G +  E+    P F
Sbjct: 211 GVLIYEMAAGYPPF 224

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 43/125 (34%), Positives = 69/125 (55%), Gaps = 9/125 (7%)
Query: 25  YIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN 84
           Y+A   M + L +I R      E H +++  QI+   +Y+HS ++++RDLKP NLL++  
Sbjct: 117 YVAGGEMFSHLRRIGR----FXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ 172
Query: 85  CDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD 143
             +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++G +  E+  
Sbjct: 173 GYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAA 228
Query: 144 RKPLF 148
             P F
Sbjct: 229 GYPPF 233

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 70.9 bits (172), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 110/244 (45%), Gaps = 29/244 (11%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILR 59
           ++H N+V + ++I     E+   +Y+  E     ++   + ++  + E+  +    QI+ 
Sbjct: 70  LNHPNIVKLFEVI-----ETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS 124
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
            ++Y H   ++HRDLK  NLLL+A+ ++KI DFG +   +  + +  +  +  Y APEL 
Sbjct: 125 AVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELF 184
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENA 179
                    +DVWS+G I   L+     F G++                   L  L E  
Sbjct: 185 QGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN-------------------LKELRERV 225
Query: 180 KKYICQLPRYQR---QSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH 236
            +   ++P Y     ++  +KF  ++PS    +E+++  D    +  ED    PY+  L 
Sbjct: 226 LRGKYRIPFYMSTDCENLLKKFLILNPSKRGTLEQIMK-DRWMNVGHEDDELKPYVEPLP 284
Query: 237 DISD 240
           D  D
Sbjct: 285 DYKD 288

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 110/244 (45%), Gaps = 29/244 (11%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILR 59
           ++H N+V + ++I     E+   +Y+  E     ++   + ++  + E+  +    QI+ 
Sbjct: 70  LNHPNIVKLFEVI-----ETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS 124
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
            ++Y H   ++HRDLK  NLLL+A+ ++KI DFG +   +  + +  +  +  Y APEL 
Sbjct: 125 AVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELF 184
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENA 179
                    +DVWS+G I   L+     F G++                   L  L E  
Sbjct: 185 QGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN-------------------LKELRERV 225
Query: 180 KKYICQLPRYQR---QSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH 236
            +   ++P Y     ++  +KF  ++PS    +E+++  D    +  ED    PY+  L 
Sbjct: 226 LRGKYRIPFYMSTDCENLLKKFLILNPSKRGTLEQIMK-DRWMNVGHEDDELKPYVEPLP 284
Query: 237 DISD 240
           D  D
Sbjct: 285 DYKD 288

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 43/142 (30%), Positives = 73/142 (51%), Gaps = 5/142 (3%)
Query: 22  NDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 81
           N  ++   L   DL   I+S          ++  +I+ GL+++HS  +++RDLK  N+LL
Sbjct: 92  NLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL 151
Query: 82  NANCDLKICDFGLARVTSETDFMTE-YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 140
           + +  +KI DFG+ +     D  T  +  T  Y APE+LL    Y  ++D WS G +  E
Sbjct: 152 DKDGHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILLGQK-YNHSVDWWSFGVLLYE 210
Query: 141 LMDRKPLFPGRDH---VHQLRL 159
           ++  +  F G+D     H +R+
Sbjct: 211 MLIGQSPFHGQDEEELFHSIRM 232

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 43/125 (34%), Positives = 69/125 (55%), Gaps = 9/125 (7%)
Query: 25  YIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN 84
           Y+A   M + L +I R     SE H +++  QI+   +Y+HS ++++RDLKP NLL++  
Sbjct: 122 YVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ 177
Query: 85  CDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD 143
             +++ DFG A RV   T  +     T  Y AP ++L S  Y  A+D W++G +  E+  
Sbjct: 178 GYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPAIIL-SKGYNKAVDWWALGVLIYEMAA 233
Query: 144 RKPLF 148
             P F
Sbjct: 234 GYPPF 238

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 43/125 (34%), Positives = 69/125 (55%), Gaps = 9/125 (7%)
Query: 25  YIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN 84
           Y+A   M + L +I R      E H +++  QI+   +Y+HS ++++RDLKP NLL++  
Sbjct: 122 YVAGGEMFSHLRRIGR----FXEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ 177
Query: 85  CDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD 143
             +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++G +  E+  
Sbjct: 178 GYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAA 233
Query: 144 RKPLF 148
             P F
Sbjct: 234 GYPPF 238

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 70.9 bits (172), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 43/134 (32%), Positives = 72/134 (53%), Gaps = 9/134 (6%)
Query: 20  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 75
           SF D    Y +M+     ++   +R     SE H +++  QI+   +Y+HS ++++RDLK
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 76  PSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 134
           P NL+++    +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++
Sbjct: 169 PENLMIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWAL 224
Query: 135 GCIFMELMDRKPLF 148
           G +  E+    P F
Sbjct: 225 GVLIYEMAAGYPPF 238

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 70.5 bits (171), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 59/253 (23%), Positives = 106/253 (41%), Gaps = 39/253 (15%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLY--QIL 58
           + H+NV+ + D++     E    +Y+  E     + +++ S        CQ   Y  Q++
Sbjct: 63  LRHKNVIQLVDVL---YNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLI 119
Query: 59  RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVT---SETDFMTEYVVTRWYRA 115
            GL+Y+HS  ++H+D+KP NLLL     LKI   G+A      +  D       +  ++ 
Sbjct: 120 DGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQP 179
Query: 116 PELLLNSSDYTA-AIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGF 174
           PE+      ++   +D+WS G     +      F G D++++   L E IG  S A  G 
Sbjct: 180 PEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG-DNIYK---LFENIGKGSYAIPG- 234
Query: 175 LNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS 234
                                    +  P   DL++ ML ++P +R ++     H +   
Sbjct: 235 -------------------------DCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRK 269
Query: 235 LHDISDEPVCMSP 247
            H  ++ PV + P
Sbjct: 270 KHPPAEAPVPIPP 282

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 109/244 (44%), Gaps = 29/244 (11%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILR 59
           ++H N+V + ++I     E+   +Y+  E     ++   + ++  + E+  +    QI+ 
Sbjct: 70  LNHPNIVKLFEVI-----ETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS 124
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
            ++Y H   ++HRDLK  NLLL+A+ ++KI DFG +   +  + +  +     Y APEL 
Sbjct: 125 AVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELF 184
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENA 179
                    +DVWS+G I   L+     F G++                   L  L E  
Sbjct: 185 QGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN-------------------LKELRERV 225
Query: 180 KKYICQLPRYQR---QSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH 236
            +   ++P Y     ++  +KF  ++PS    +E+++  D    +  ED    PY+  L 
Sbjct: 226 LRGKYRIPFYMSTDCENLLKKFLILNPSKRGTLEQIMK-DRWMNVGHEDDELKPYVEPLP 284
Query: 237 DISD 240
           D  D
Sbjct: 285 DYKD 288

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 43/134 (32%), Positives = 71/134 (52%), Gaps = 9/134 (6%)
Query: 20  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 75
           SF D    Y +M+     ++   +R      E H +++  QI+   +Y+HS ++++RDLK
Sbjct: 109 SFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 76  PSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 134
           P NL+++    +K+ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++
Sbjct: 169 PENLMIDQQGYIKVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWAL 224
Query: 135 GCIFMELMDRKPLF 148
           G +  E+    P F
Sbjct: 225 GVLIYEMAAGYPPF 238

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 43/134 (32%), Positives = 71/134 (52%), Gaps = 9/134 (6%)
Query: 20  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 75
           SF D    Y +M+     ++   +R      E H +++  QI+   +Y+HS ++++RDLK
Sbjct: 110 SFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLK 169
Query: 76  PSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 134
           P NL+++    +K+ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++
Sbjct: 170 PENLMIDQQGYIKVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWAL 225
Query: 135 GCIFMELMDRKPLF 148
           G +  E+    P F
Sbjct: 226 GVLIYEMAAGYPPF 239

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 59/244 (24%), Positives = 110/244 (45%), Gaps = 29/244 (11%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILR 59
           ++H N+V + ++I     E+   +Y+  E     ++   + ++  + E+  +    QI+ 
Sbjct: 63  LNHPNIVKLFEVI-----ETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVS 117
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
            ++Y H   ++HRDLK  NLLL+A+ ++KI DFG +   +  + +  +  +  Y APEL 
Sbjct: 118 AVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELF 177
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENA 179
                    +DVWS+G I   L+     F G++                   L  L E  
Sbjct: 178 QGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN-------------------LKELRERV 218
Query: 180 KKYICQLPRYQR---QSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH 236
            +   ++P Y     ++  +KF  ++PS    +E+++  D    +  ED    PY+  L 
Sbjct: 219 LRGKYRIPFYMSTDCENLLKKFLILNPSKRGTLEQIMK-DRWMNVGHEDDELKPYVEPLP 277
Query: 237 DISD 240
           D  D
Sbjct: 278 DYKD 281

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 70.5 bits (171), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 44/129 (34%), Positives = 73/129 (56%), Gaps = 11/129 (8%)
Query: 24  VYIAYELMDTD-LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 82
           V I  EL++   L Q+++    L E+   Y+L Q L GL+Y+HS  +LH D+K  N+LL+
Sbjct: 160 VNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDVKADNVLLS 219
Query: 83  ANCD-LKICDFGLARVTSETDFMTEYVVTRWY-------RAPELLLNSSDYTAAIDVWSV 134
           ++     +CDFG A V  + D + + ++T  Y        APE++L  S   A +DVWS 
Sbjct: 220 SDGSHAALCDFGHA-VCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRS-CDAKVDVWSS 277
Query: 135 GCIFMELMD 143
            C+ + +++
Sbjct: 278 CCMMLHMLN 286

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 94/212 (44%), Gaps = 34/212 (16%)
Query: 32  DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD 91
           D   H          E    ++  +I  GL+ +H   +++RDLKP N+LL+ +  ++I D
Sbjct: 270 DLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISD 329
Query: 92  FGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGR 151
            GLA    E   +   V T  Y APE++ N   YT + D W++GC+  E++       G+
Sbjct: 330 LGLAVHVPEGQTIKGRVGTVGYMAPEVVKNER-YTFSPDWWALGCLLYEMI------AGQ 382
Query: 152 DHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEK 211
               Q +  I+              E  ++ + ++P    + ++E+F    P A  L  +
Sbjct: 383 SPFQQRKKKIK-------------REEVERLVKEVP----EEYSERF---SPQARSLCSQ 422
Query: 212 MLTFDPRQRITVEDALAHPYLGSLHDISDEPV 243
           +L  DP +R+           GS  ++ + P+
Sbjct: 423 LLCKDPAERLGCRG-------GSAREVKEHPL 447

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 94/212 (44%), Gaps = 34/212 (16%)
Query: 32  DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICD 91
           D   H          E    ++  +I  GL+ +H   +++RDLKP N+LL+ +  ++I D
Sbjct: 270 DLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISD 329
Query: 92  FGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGR 151
            GLA    E   +   V T  Y APE++ N   YT + D W++GC+  E++       G+
Sbjct: 330 LGLAVHVPEGQTIKGRVGTVGYMAPEVVKNER-YTFSPDWWALGCLLYEMI------AGQ 382
Query: 152 DHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEK 211
               Q +  I+              E  ++ + ++P    + ++E+F    P A  L  +
Sbjct: 383 SPFQQRKKKIK-------------REEVERLVKEVP----EEYSERF---SPQARSLCSQ 422
Query: 212 MLTFDPRQRITVEDALAHPYLGSLHDISDEPV 243
           +L  DP +R+           GS  ++ + P+
Sbjct: 423 LLCKDPAERLGCRG-------GSAREVKEHPL 447

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 47/145 (32%), Positives = 75/145 (51%), Gaps = 11/145 (7%)
Query: 24  VYIAYELM-DTDLHQIIRSNQALSEEHCQY--FLYQILRGLKYIHSANVLHRDLKPSNLL 80
           +YI  E M    L   ++S++   +   +   F  QI  G+ +I   N +HRDL+ +N+L
Sbjct: 84  IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANIL 143
Query: 81  LNANCDLKICDFGLARVTSETDFMTEYVVT---RWYRAPELLLNSSDYTAAIDVWSVGCI 137
           ++A+   KI DFGLARV  + ++          +W  APE  +N   +T   DVWS G +
Sbjct: 144 VSASLVCKIADFGLARVIEDNEYTAREGAKFPIKW-TAPE-AINFGSFTIKSDVWSFGIL 201
Query: 138 FMELM--DRKPLFPGRDHVHQLRLL 160
            ME++   R P +PG  +   +R L
Sbjct: 202 LMEIVTYGRIP-YPGMSNPEVIRAL 225

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 70.1 bits (170), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 45/135 (33%), Positives = 67/135 (49%), Gaps = 6/135 (4%)
Query: 3   HENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLK 62
           H N+V  +++I  P   +    Y +      +L++ I +    SE+  ++F  Q+L G+ 
Sbjct: 75  HPNIVRFKEVILTPTHLAIIMEYAS----GGELYERICNAGRFSEDEARFFFQQLLSGVS 130
Query: 63  YIHSANVLHRDLKPSNLLLNANCD--LKICDFGLARVTSETDFMTEYVVTRWYRAPELLL 120
           Y HS  + HRDLK  N LL+ +    LKICDFG ++ +         V T  Y APE+LL
Sbjct: 131 YCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 190
Query: 121 NSSDYTAAIDVWSVG 135
                    DVWS G
Sbjct: 191 RQEYDGKIADVWSCG 205

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 41/153 (26%), Positives = 77/153 (50%), Gaps = 6/153 (3%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILR 59
           ++H N+V + ++I     E+   +Y+  E     ++   + ++  + E+  +    QI+ 
Sbjct: 68  LNHPNIVKLFEVI-----ETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVS 122
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
            ++Y H   ++HRDLK  NLLL+A+ ++KI DFG +   +    +  +  +  Y APEL 
Sbjct: 123 AVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTFCGSPPYAAPELF 182
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD 152
                    +DVWS+G I   L+     F G++
Sbjct: 183 QGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 215

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/145 (32%), Positives = 75/145 (51%), Gaps = 11/145 (7%)
Query: 24  VYIAYELM-DTDLHQIIRSNQALSEEHCQY--FLYQILRGLKYIHSANVLHRDLKPSNLL 80
           +YI  E M    L   ++S++   +   +   F  QI  G+ +I   N +HRDL+ +N+L
Sbjct: 257 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANIL 316
Query: 81  LNANCDLKICDFGLARVTSETDFMTEYVVT---RWYRAPELLLNSSDYTAAIDVWSVGCI 137
           ++A+   KI DFGLARV  + ++          +W  APE  +N   +T   DVWS G +
Sbjct: 317 VSASLVCKIADFGLARVIEDNEYTAREGAKFPIKW-TAPE-AINFGSFTIKSDVWSFGIL 374
Query: 138 FMELM--DRKPLFPGRDHVHQLRLL 160
            ME++   R P +PG  +   +R L
Sbjct: 375 LMEIVTYGRIP-YPGMSNPEVIRAL 398

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 39/131 (29%), Positives = 69/131 (52%), Gaps = 6/131 (4%)
Query: 25  YIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA 83
           YI  E +D   L  I+ +   ++ +     +    + L + H   ++HRD+KP+N+L++A
Sbjct: 92  YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANILISA 151
Query: 84  NCDLKICDFGLARVTSETD---FMTEYVV-TRWYRAPELLLNSSDYTAAIDVWSVGCIFM 139
              +K+ DFG+AR  +++      T  V+ T  Y +PE     S   A  DV+S+GC+  
Sbjct: 152 TNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLY 210
Query: 140 ELMDRKPLFPG 150
           E++  +P F G
Sbjct: 211 EVLTGEPPFTG 221

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 43/125 (34%), Positives = 69/125 (55%), Gaps = 9/125 (7%)
Query: 25  YIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN 84
           Y+A   M + L +I R     SE H +++  QI+   +Y+HS ++++RDLKP NLL++  
Sbjct: 122 YVAGGEMFSHLRRIGR----FSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ 177
Query: 85  CDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD 143
             +++ DFG A RV   T  +     T    APE++L S  Y  A+D W++G +  E+  
Sbjct: 178 GYIQVTDFGFAKRVKGRTWXLCG---TPEALAPEIIL-SKGYNKAVDWWALGVLIYEMAA 233
Query: 144 RKPLF 148
             P F
Sbjct: 234 GYPPF 238

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 43/134 (32%), Positives = 71/134 (52%), Gaps = 9/134 (6%)
Query: 20  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 75
           SF D    Y +M+     ++   +R      E H +++  QI+   +Y+HS ++++RDLK
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 76  PSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 134
           P NLL++    +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWAL 224
Query: 135 GCIFMELMDRKPLF 148
           G +  E+    P F
Sbjct: 225 GVLIYEMAAGYPPF 238

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 37/120 (30%), Positives = 66/120 (55%), Gaps = 3/120 (2%)
Query: 30  LMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKI 89
           L+  DL   ++ N    EE  + F+ +++  L Y+ +  ++HRD+KP N+LL+ +  + I
Sbjct: 97  LLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHI 156
Query: 90  CDFGLARVTSETDFMTEYVVTRWYRAPELLLN--SSDYTAAIDVWSVGCIFMELM-DRKP 146
            DF +A +      +T    T+ Y APE+  +   + Y+ A+D WS+G    EL+  R+P
Sbjct: 157 TDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP 216

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 43/134 (32%), Positives = 71/134 (52%), Gaps = 9/134 (6%)
Query: 20  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 75
           SF D    Y +M+     ++   +R      E H +++  QI+   +Y+HS ++++RDLK
Sbjct: 109 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168
Query: 76  PSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 134
           P NLL++    +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWAL 224
Query: 135 GCIFMELMDRKPLF 148
           G +  E+    P F
Sbjct: 225 GVLIYEMAAGYPPF 238

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 69.7 bits (169), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 43/134 (32%), Positives = 71/134 (52%), Gaps = 9/134 (6%)
Query: 20  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 75
           SF D    Y +M+     ++   +R      E H +++  QI+   +Y+HS ++++RDLK
Sbjct: 110 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLK 169
Query: 76  PSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 134
           P NLL++    +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++
Sbjct: 170 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWAL 225
Query: 135 GCIFMELMDRKPLF 148
           G +  E+    P F
Sbjct: 226 GVLIYEMAAGYPPF 239

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 38/147 (25%), Positives = 79/147 (53%), Gaps = 3/147 (2%)
Query: 22  NDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 81
           +++++  E +       + +   + E        + L+ L+++HS  V+HR++K  N+LL
Sbjct: 91  DELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHSNQVIHRNIKSDNILL 150
Query: 82  NANCDLKICDFGL-ARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 140
             +  +K+ DFG  A++T E    +  V T ++ APE++   + Y   +D+WS+G + +E
Sbjct: 151 GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIE 209
Query: 141 LMDRKPLFPGRDHVHQLRLLIELIGTP 167
           +++ +P +   + +  L  LI   GTP
Sbjct: 210 MIEGEPPYLNENPLRAL-YLIATNGTP 235

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 38/113 (33%), Positives = 66/113 (58%), Gaps = 9/113 (7%)
Query: 34  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 93
           DLH  +  +   SE   +++  +I+ GL+++H+  V++RDLKP+N+LL+ +  ++I D G
Sbjct: 278 DLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLG 337
Query: 94  LARVTSETDFMTEY----VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
           LA      DF  +     V T  Y APE+L     Y ++ D +S+GC+  +L+
Sbjct: 338 LA-----CDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 38/113 (33%), Positives = 66/113 (58%), Gaps = 9/113 (7%)
Query: 34  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 93
           DLH  +  +   SE   +++  +I+ GL+++H+  V++RDLKP+N+LL+ +  ++I D G
Sbjct: 278 DLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLG 337
Query: 94  LARVTSETDFMTEY----VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
           LA      DF  +     V T  Y APE+L     Y ++ D +S+GC+  +L+
Sbjct: 338 LA-----CDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 44/129 (34%), Positives = 73/129 (56%), Gaps = 11/129 (8%)
Query: 24  VYIAYELMDTD-LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 82
           V I  EL++   L Q+++    L E+   Y+L Q L GL+Y+HS  +LH D+K  N+LL+
Sbjct: 141 VNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDVKADNVLLS 200
Query: 83  ANCD-LKICDFGLARVTSETDFMTEYVVTRWY-------RAPELLLNSSDYTAAIDVWSV 134
           ++     +CDFG A V  + D + + ++T  Y        APE++L  S   A +DVWS 
Sbjct: 201 SDGSHAALCDFGHA-VCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRS-CDAKVDVWSS 258
Query: 135 GCIFMELMD 143
            C+ + +++
Sbjct: 259 CCMMLHMLN 267

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 38/113 (33%), Positives = 66/113 (58%), Gaps = 9/113 (7%)
Query: 34  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 93
           DLH  +  +   SE   +++  +I+ GL+++H+  V++RDLKP+N+LL+ +  ++I D G
Sbjct: 278 DLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLG 337
Query: 94  LARVTSETDFMTEY----VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
           LA      DF  +     V T  Y APE+L     Y ++ D +S+GC+  +L+
Sbjct: 338 LA-----CDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 385

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 38/113 (33%), Positives = 66/113 (58%), Gaps = 9/113 (7%)
Query: 34  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 93
           DLH  +  +   SE   +++  +I+ GL+++H+  V++RDLKP+N+LL+ +  ++I D G
Sbjct: 277 DLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLG 336
Query: 94  LARVTSETDFMTEY----VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
           LA      DF  +     V T  Y APE+L     Y ++ D +S+GC+  +L+
Sbjct: 337 LA-----CDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLL 384

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 43/134 (32%), Positives = 71/134 (52%), Gaps = 9/134 (6%)
Query: 20  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 75
           SF D    Y +M+     ++   +R      E H +++  QI+   +Y+HS ++++RDLK
Sbjct: 102 SFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHSLDLIYRDLK 161
Query: 76  PSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 134
           P NLL++    +++ DFG A RV   T  +     T  Y APE++L S  Y  A+D W++
Sbjct: 162 PENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG---TPEYLAPEIIL-SKGYNKAVDWWAL 217
Query: 135 GCIFMELMDRKPLF 148
           G +  E+    P F
Sbjct: 218 GVLIYEMAAGYPPF 231

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/239 (25%), Positives = 101/239 (42%), Gaps = 40/239 (16%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRG 60
           + H N+V  +++I  P   +    Y +      +L + I +    SE+  ++F  Q++ G
Sbjct: 71  LRHPNIVRFKEVILTPTHLAIVMEYAS----GGELFERICNAGRFSEDEARFFFQQLISG 126
Query: 61  LKYIHSANVLHRDLKPSNLLLNANCD--LKICDFGLARVTSETDFMTEYVVTRWYRAPEL 118
           + Y H+  V HRDLK  N LL+ +    LKICDFG ++ +         V T  Y APE+
Sbjct: 127 VSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEV 186
Query: 119 LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGT-----PSEAELG 173
           LL         DVWS G                     + L + L+G      P E    
Sbjct: 187 LLKKEYDGKVADVWSCG---------------------VTLYVMLVGAYPFEDPEEP--- 222
Query: 174 FLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
              +N +K I ++     Q     + ++ P    L+ ++   DP +RI++ +   H + 
Sbjct: 223 ---KNFRKTIHRI--LNVQYAIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 276

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 60/237 (25%), Positives = 100/237 (42%), Gaps = 40/237 (16%)
Query: 3   HENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLK 62
           H N+V  +++I  P   +    Y +      +L + I +    SE+  ++F  Q++ G+ 
Sbjct: 74  HPNIVRFKEVILTPTHLAIVMEYAS----GGELFERICNAGRFSEDEARFFFQQLISGVS 129
Query: 63  YIHSANVLHRDLKPSNLLLNANCD--LKICDFGLARVTSETDFMTEYVVTRWYRAPELLL 120
           Y H+  V HRDLK  N LL+ +    LKICDFG ++ +         V T  Y APE+LL
Sbjct: 130 YCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 189
Query: 121 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGT-----PSEAELGFL 175
                    DVWS G                     + L + L+G      P E      
Sbjct: 190 KKEYDGKVADVWSCG---------------------VTLYVMLVGAYPFEDPEEP----- 223
Query: 176 NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
            +N +K I ++     Q     + ++ P    L+ ++   DP +RI++ +   H + 
Sbjct: 224 -KNFRKTIHRI--LNVQYAIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 277

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 41/153 (26%), Positives = 76/153 (49%), Gaps = 6/153 (3%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILR 59
           ++H N+V + ++I     E+   +Y+  E     ++   + ++  + E+  +    QI+ 
Sbjct: 71  LNHPNIVKLFEVI-----ETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVS 125
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
            ++Y H   ++HRDLK  NLLL+A+ ++KI DFG +   +    +  +     Y APEL 
Sbjct: 126 AVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELF 185
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD 152
                    +DVWS+G I   L+     F G++
Sbjct: 186 QGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 218

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 36/117 (30%), Positives = 65/117 (55%), Gaps = 3/117 (2%)
Query: 37  QIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 96
           Q+ R    + +  C ++L +I   L ++H   +++RDLKP N++LN    +K+ DFGL +
Sbjct: 111 QLEREGIFMEDTAC-FYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK 169
Query: 97  VTSETDFMTE-YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD 152
            +     +T  +  T  Y APE+L+ S  +  A+D WS+G +  +++   P F G +
Sbjct: 170 ESIHDGTVTHTFCGTIEYMAPEILMRSG-HNRAVDWWSLGALMYDMLTGAPPFTGEN 225

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 36/117 (30%), Positives = 65/117 (55%), Gaps = 3/117 (2%)
Query: 37  QIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 96
           Q+ R    + +  C ++L +I   L ++H   +++RDLKP N++LN    +K+ DFGL +
Sbjct: 111 QLEREGIFMEDTAC-FYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK 169
Query: 97  VTSETDFMTE-YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD 152
            +     +T  +  T  Y APE+L+ S  +  A+D WS+G +  +++   P F G +
Sbjct: 170 ESIHDGTVTHXFCGTIEYMAPEILMRSG-HNRAVDWWSLGALMYDMLTGAPPFTGEN 225

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 69.3 bits (168), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/239 (27%), Positives = 109/239 (45%), Gaps = 57/239 (23%)
Query: 24  VYIAYELMDTDLHQIIRSNQALSEEHCQY--------FLYQILRGLKYIHSANVLHRDLK 75
           +YIA EL + +L  ++ S + +S+E+ +          L QI  G+ ++HS  ++HRDLK
Sbjct: 84  LYIALELCNLNLQDLVES-KNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLK 142
Query: 76  PSNLLLNA-------------NCDLKICDFGLARV--TSETDFMTEY---VVTRWYRAPE 117
           P N+L++              N  + I DFGL +   + ++ F T       T  +RAPE
Sbjct: 143 PQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPE 202
Query: 118 LLLNSSD------YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAE 171
           LL  S++       T +ID++S+GC+F  ++  K   P  D   +   +I   G  S  E
Sbjct: 203 LLEESNNLQTKRRLTRSIDIFSMGCVFYYILS-KGKHPFGDKYSRESNIIR--GIFSLDE 259
Query: 172 LGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHP 230
           +  L++ +                     +   A DL+ +M+  DP +R T    L HP
Sbjct: 260 MKCLHDRS---------------------LIAEATDLISQMIDHDPLKRPTAMKVLRHP 297

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/224 (22%), Positives = 108/224 (48%), Gaps = 30/224 (13%)
Query: 34  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 93
           DL   ++  + L EEH +++  +I   L Y+H   +++RDLK  N+LL++   +K+ D+G
Sbjct: 96  DLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYG 155
Query: 94  LARVT-SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD 152
           + +      D  + +  T  Y APE +L   DY  ++D W++G +  E+M  +  F    
Sbjct: 156 MCKEGLRPGDTTSXFCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSPF---- 210
Query: 153 HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKM 212
                    +++G+    +     +N + Y+ Q+   ++Q    +  +V  +++  ++  
Sbjct: 211 ---------DIVGSSDNPD-----QNTEDYLFQVI-LEKQIRIPRSLSVKAASV--LKSF 253
Query: 213 LTFDPRQRITVE------DALAHPYLGSLH-DISDEPVCMSPFS 249
           L  DP++R+         D   HP+  ++  D+ ++   + PF 
Sbjct: 254 LNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFK 297

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 90/218 (41%), Gaps = 31/218 (14%)
Query: 19  ESFNDVYIAYELMDTD--LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKP 76
           E  N++ + YE M       ++   +  +SE+    ++ Q+ +GL ++H  N +H DLKP
Sbjct: 224 EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKP 283
Query: 77  SNLLLNA--NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 134
            N++     + +LK+ DFGL         +     T  + APE +          D+WSV
Sbjct: 284 ENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPE-VAEGKPVGYYTDMWSV 342
Query: 135 GCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSF 194
           G +   L+     F G +    LR +        ++    ++E+ K              
Sbjct: 343 GVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK-------------- 388
Query: 195 TEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
                       D + K+L  DP  R+T+  AL HP+L
Sbjct: 389 ------------DFIRKLLLADPNTRMTIHQALEHPWL 414

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/233 (25%), Positives = 103/233 (44%), Gaps = 35/233 (15%)
Query: 22  NDVYIAYELMDTDLHQIIRS-----NQALSEEHCQYFLYQILRGLKYI-HSANVLHRDLK 75
            D +I  ELM T   +  +      +  + EE         ++ L ++  +  ++HRD+K
Sbjct: 94  GDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIK 153
Query: 76  PSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD---YTAAIDVW 132
           PSN+LL+ + ++K+CDFG++    ++   T     R Y APE +  S+    Y    DVW
Sbjct: 154 PSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVW 213
Query: 133 SVGCIFMELMDRKPLFPGRDHV-HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQR 191
           S+G    EL   +  +P  + V  QL  +++  G P                 QL   + 
Sbjct: 214 SLGITLYELATGRFPYPKWNSVFDQLTQVVK--GDPP----------------QLSNSEE 255
Query: 192 QSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVC 244
           + F+       PS I+ V   LT D  +R   ++ L HP++    + + E  C
Sbjct: 256 REFS-------PSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERAVEVAC 301

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 40/153 (26%), Positives = 77/153 (50%), Gaps = 6/153 (3%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILR 59
           ++H N+V + ++I     E+   +Y+  E     ++   + ++  + E+  +    QI+ 
Sbjct: 71  LNHPNIVKLFEVI-----ETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVS 125
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
            ++Y H   ++HRDLK  NLLL+ + ++KI DFG +   +  + +  +  +  Y APEL 
Sbjct: 126 AVQYCHQKYIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTFCGSPPYAAPELF 185
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD 152
                    +DVWS+G I   L+     F G++
Sbjct: 186 QGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 218

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 90/218 (41%), Gaps = 31/218 (14%)
Query: 19  ESFNDVYIAYELMDTD--LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKP 76
           E  N++ + YE M       ++   +  +SE+    ++ Q+ +GL ++H  N +H DLKP
Sbjct: 118 EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKP 177
Query: 77  SNLLLNA--NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 134
            N++     + +LK+ DFGL         +     T  + APE +          D+WSV
Sbjct: 178 ENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPE-VAEGKPVGYYTDMWSV 236
Query: 135 GCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSF 194
           G +   L+     F G +    LR +        ++    ++E+ K              
Sbjct: 237 GVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGK-------------- 282
Query: 195 TEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
                       D + K+L  DP  R+T+  AL HP+L
Sbjct: 283 ------------DFIRKLLLADPNTRMTIHQALEHPWL 308

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/223 (22%), Positives = 108/223 (48%), Gaps = 30/223 (13%)
Query: 34  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 93
           DL   ++  + L EEH +++  +I   L Y+H   +++RDLK  N+LL++   +K+ D+G
Sbjct: 107 DLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYG 166
Query: 94  LARVT-SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD 152
           + +      D  + +  T  Y APE +L   DY  ++D W++G +  E+M  +  F    
Sbjct: 167 MCKEGLRPGDTTSXFCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSPF---- 221
Query: 153 HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKM 212
                    +++G+         ++N + Y+ Q+   ++Q    +  +V  +++  ++  
Sbjct: 222 ---------DIVGSSDNP-----DQNTEDYLFQVI-LEKQIRIPRSMSVKAASV--LKSF 264
Query: 213 LTFDPRQRITV------EDALAHPYLGSLH-DISDEPVCMSPF 248
           L  DP++R+         D   HP+  ++  D+ ++   + PF
Sbjct: 265 LNKDPKERLGCLPQTGFADIQGHPFFRNVDWDMMEQKQVVPPF 307

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 68.9 bits (167), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/224 (22%), Positives = 108/224 (48%), Gaps = 30/224 (13%)
Query: 34  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 93
           DL   ++  + L EEH +++  +I   L Y+H   +++RDLK  N+LL++   +K+ D+G
Sbjct: 92  DLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYG 151
Query: 94  LARVT-SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD 152
           + +      D  + +  T  Y APE +L   DY  ++D W++G +  E+M  +  F    
Sbjct: 152 MCKEGLRPGDTTSXFCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSPF---- 206
Query: 153 HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKM 212
                    +++G+         ++N + Y+ Q+   ++Q    +  +V  +++  ++  
Sbjct: 207 ---------DIVGSSDNP-----DQNTEDYLFQVI-LEKQIRIPRSLSVKAASV--LKSF 249
Query: 213 LTFDPRQRITVE------DALAHPYLGSLH-DISDEPVCMSPFS 249
           L  DP++R+         D   HP+  ++  D+ ++   + PF 
Sbjct: 250 LNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFK 293

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 68.6 bits (166), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 51/223 (22%), Positives = 108/223 (48%), Gaps = 30/223 (13%)
Query: 34  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 93
           DL   ++  + L EEH +++  +I   L Y+H   +++RDLK  N+LL++   +K+ D+G
Sbjct: 139 DLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYG 198
Query: 94  LARVT-SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD 152
           + +      D  + +  T  Y APE +L   DY  ++D W++G +  E+M  +  F    
Sbjct: 199 MCKEGLRPGDTTSTFCGTPNYIAPE-ILRGEDYGFSVDWWALGVLMFEMMAGRSPF---- 253
Query: 153 HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKM 212
                    +++G+         ++N + Y+ Q+   ++Q    +  +V  +++  ++  
Sbjct: 254 ---------DIVGSSDNP-----DQNTEDYLFQVI-LEKQIRIPRSLSVKAASV--LKSF 296
Query: 213 LTFDPRQRITVE------DALAHPYLGSLH-DISDEPVCMSPF 248
           L  DP++R+         D   HP+  ++  D+ ++   + PF
Sbjct: 297 LNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPF 339

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/206 (29%), Positives = 92/206 (44%), Gaps = 44/206 (21%)
Query: 53  FLYQILRGLKYIHSANVLHRDLKPSNLLL---NANCDLK--ICDFGLAR--VTSETDFMT 105
            L Q   GL ++HS N++HRDLKP N+L+   NA+  +K  I DFGL +        F  
Sbjct: 123 LLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSR 182
Query: 106 EYVV--TRWYRAPELLLN--SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI 161
              V  T  + APE+L      + T  +D++S GC+F  ++       G+    Q  +L+
Sbjct: 183 RSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILL 242
Query: 162 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI 221
                            A    C  P        EK  +V   A +L+EKM+  DP++R 
Sbjct: 243 ----------------GACSLDCLHP--------EKHEDV--IARELIEKMIAMDPQKRP 276
Query: 222 TVEDALAHPYLGSL-------HDISD 240
           + +  L HP+  SL        D+SD
Sbjct: 277 SAKHVLKHPFFWSLEKQLQFFQDVSD 302

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 38/131 (29%), Positives = 69/131 (52%), Gaps = 6/131 (4%)
Query: 25  YIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA 83
           YI  E +D   L  I+ +   ++ +     +    + L + H   ++HRD+KP+N++++A
Sbjct: 92  YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISA 151
Query: 84  NCDLKICDFGLARVTSETD---FMTEYVV-TRWYRAPELLLNSSDYTAAIDVWSVGCIFM 139
              +K+ DFG+AR  +++      T  V+ T  Y +PE     S   A  DV+S+GC+  
Sbjct: 152 TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLY 210
Query: 140 ELMDRKPLFPG 150
           E++  +P F G
Sbjct: 211 EVLTGEPPFTG 221

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 38/131 (29%), Positives = 69/131 (52%), Gaps = 6/131 (4%)
Query: 25  YIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA 83
           YI  E +D   L  I+ +   ++ +     +    + L + H   ++HRD+KP+N++++A
Sbjct: 92  YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISA 151
Query: 84  NCDLKICDFGLARVTSETD---FMTEYVV-TRWYRAPELLLNSSDYTAAIDVWSVGCIFM 139
              +K+ DFG+AR  +++      T  V+ T  Y +PE     S   A  DV+S+GC+  
Sbjct: 152 TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLY 210
Query: 140 ELMDRKPLFPG 150
           E++  +P F G
Sbjct: 211 EVLTGEPPFTG 221

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 38/131 (29%), Positives = 69/131 (52%), Gaps = 6/131 (4%)
Query: 25  YIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA 83
           YI  E +D   L  I+ +   ++ +     +    + L + H   ++HRD+KP+N++++A
Sbjct: 92  YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISA 151
Query: 84  NCDLKICDFGLARVTSETD---FMTEYVV-TRWYRAPELLLNSSDYTAAIDVWSVGCIFM 139
              +K+ DFG+AR  +++      T  V+ T  Y +PE     S   A  DV+S+GC+  
Sbjct: 152 TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLY 210
Query: 140 ELMDRKPLFPG 150
           E++  +P F G
Sbjct: 211 EVLTGEPPFTG 221

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 68.2 bits (165), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 38/131 (29%), Positives = 69/131 (52%), Gaps = 6/131 (4%)
Query: 25  YIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA 83
           YI  E +D   L  I+ +   ++ +     +    + L + H   ++HRD+KP+N++++A
Sbjct: 92  YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISA 151
Query: 84  NCDLKICDFGLARVTSETD---FMTEYVV-TRWYRAPELLLNSSDYTAAIDVWSVGCIFM 139
              +K+ DFG+AR  +++      T  V+ T  Y +PE     S   A  DV+S+GC+  
Sbjct: 152 TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLY 210
Query: 140 ELMDRKPLFPG 150
           E++  +P F G
Sbjct: 211 EVLTGEPPFTG 221

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 107/235 (45%), Gaps = 53/235 (22%)
Query: 24  VYIAYELMDTDLHQIIRSNQALSEEHCQY--------FLYQILRGLKYIHSANVLHRDLK 75
           +YIA EL + +L  ++ S + +S+E+ +          L QI  G+ ++HS  ++HRDLK
Sbjct: 102 LYIALELCNLNLQDLVES-KNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLK 160
Query: 76  PSNLLLNA-------------NCDLKICDFGLARV--TSETDF---MTEYVVTRWYRAPE 117
           P N+L++              N  + I DFGL +   + +  F   +     T  +RAPE
Sbjct: 161 PQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPE 220
Query: 118 LLLNSSD--YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL 175
           LL  S+    T +ID++S+GC+F  ++  K   P  D   +   +I   G  S  E+  L
Sbjct: 221 LLEESTKRRLTRSIDIFSMGCVFYYILS-KGKHPFGDKYSRESNIIR--GIFSLDEMKCL 277
Query: 176 NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHP 230
           ++ +                     +   A DL+ +M+  DP +R T    L HP
Sbjct: 278 HDRS---------------------LIAEATDLISQMIDHDPLKRPTAMKVLRHP 311

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 38/131 (29%), Positives = 69/131 (52%), Gaps = 6/131 (4%)
Query: 25  YIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA 83
           YI  E +D   L  I+ +   ++ +     +    + L + H   ++HRD+KP+N++++A
Sbjct: 109 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISA 168
Query: 84  NCDLKICDFGLARVTSETD---FMTEYVV-TRWYRAPELLLNSSDYTAAIDVWSVGCIFM 139
              +K+ DFG+AR  +++      T  V+ T  Y +PE     S   A  DV+S+GC+  
Sbjct: 169 TNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLY 227
Query: 140 ELMDRKPLFPG 150
           E++  +P F G
Sbjct: 228 EVLTGEPPFTG 238

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 68.2 bits (165), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 107/235 (45%), Gaps = 53/235 (22%)
Query: 24  VYIAYELMDTDLHQIIRSNQALSEEHCQY--------FLYQILRGLKYIHSANVLHRDLK 75
           +YIA EL + +L  ++ S + +S+E+ +          L QI  G+ ++HS  ++HRDLK
Sbjct: 102 LYIALELCNLNLQDLVES-KNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLK 160
Query: 76  PSNLLLNA-------------NCDLKICDFGLARV--TSETDF---MTEYVVTRWYRAPE 117
           P N+L++              N  + I DFGL +   + +  F   +     T  +RAPE
Sbjct: 161 PQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPE 220
Query: 118 LLLNSSD--YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL 175
           LL  S+    T +ID++S+GC+F  ++  K   P  D   +   +I   G  S  E+  L
Sbjct: 221 LLEESTKRRLTRSIDIFSMGCVFYYILS-KGKHPFGDKYSRESNIIR--GIFSLDEMKCL 277
Query: 176 NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHP 230
           ++ +                     +   A DL+ +M+  DP +R T    L HP
Sbjct: 278 HDRS---------------------LIAEATDLISQMIDHDPLKRPTAMKVLRHP 311

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 41/153 (26%), Positives = 76/153 (49%), Gaps = 6/153 (3%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILR 59
           ++H N+V + ++I     E+   +Y+  E     ++   + ++    E+  +    QI+ 
Sbjct: 70  LNHPNIVKLFEVI-----ETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVS 124
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
            ++Y H   ++HRDLK  NLLL+A+ ++KI DFG +   +  + +  +     Y APEL 
Sbjct: 125 AVQYCHQKFIVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELF 184
Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD 152
                    +DVWS+G I   L+     F G++
Sbjct: 185 QGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQN 217

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 62/110 (56%), Gaps = 2/110 (1%)
Query: 34  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDF 92
           DL   I    AL EE  + F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 123 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 182
Query: 93  GLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
           G   +  +T + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 183 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 231

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 67.8 bits (164), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 62/110 (56%), Gaps = 2/110 (1%)
Query: 34  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDF 92
           DL   I    AL EE  + F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 101 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 160
Query: 93  GLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
           G   +  +T + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 161 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 209

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 62/110 (56%), Gaps = 2/110 (1%)
Query: 34  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDF 92
           DL   I    AL EE  + F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 100 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 159
Query: 93  GLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
           G   +  +T + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 160 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 208

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 62/110 (56%), Gaps = 2/110 (1%)
Query: 34  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDF 92
           DL   I    AL EE  + F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 101 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 160
Query: 93  GLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
           G   +  +T + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 161 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 209

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 62/110 (56%), Gaps = 2/110 (1%)
Query: 34  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDF 92
           DL   I    AL EE  + F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 135 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 194
Query: 93  GLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
           G   +  +T + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 195 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 243

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 62/110 (56%), Gaps = 2/110 (1%)
Query: 34  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDF 92
           DL   I    AL EE  + F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 116 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 175
Query: 93  GLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
           G   +  +T + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 176 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 224

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 62/110 (56%), Gaps = 2/110 (1%)
Query: 34  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDF 92
           DL   I    AL EE  + F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 116 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 175
Query: 93  GLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
           G   +  +T + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 176 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 224

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 62/110 (56%), Gaps = 2/110 (1%)
Query: 34  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDF 92
           DL   I    AL EE  + F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 101 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 160
Query: 93  GLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
           G   +  +T + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 161 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 209

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 62/110 (56%), Gaps = 2/110 (1%)
Query: 34  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDF 92
           DL   I    AL EE  + F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 115 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 174
Query: 93  GLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
           G   +  +T + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 175 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 223

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 62/110 (56%), Gaps = 2/110 (1%)
Query: 34  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDF 92
           DL   I    AL EE  + F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 115 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 174
Query: 93  GLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
           G   +  +T + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 175 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 223

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 62/110 (56%), Gaps = 2/110 (1%)
Query: 34  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDF 92
           DL   I    AL EE  + F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 116 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 175
Query: 93  GLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
           G   +  +T + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 176 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 224

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 67.8 bits (164), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 62/110 (56%), Gaps = 2/110 (1%)
Query: 34  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDF 92
           DL   I    AL EE  + F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 148 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 207
Query: 93  GLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
           G   +  +T + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 208 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 256

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 67.4 bits (163), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 62/110 (56%), Gaps = 2/110 (1%)
Query: 34  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDF 92
           DL   I    AL EE  + F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 100 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 159
Query: 93  GLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
           G   +  +T + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 160 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 208

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 67.4 bits (163), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 43/122 (35%), Positives = 62/122 (50%), Gaps = 4/122 (3%)
Query: 24  VYIAYELMDTD-LHQII--RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL 80
           ++I  E  D   L Q I  R  + L +        QI +G+ YIHS  ++HRDLKPSN+ 
Sbjct: 109 LFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIF 168
Query: 81  LNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 140
           L     +KI DFGL          T    T  Y +PE  ++S DY   +D++++G I  E
Sbjct: 169 LVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPE-QISSQDYGKEVDLYALGLILAE 227
Query: 141 LM 142
           L+
Sbjct: 228 LL 229

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 67.4 bits (163), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 62/110 (56%), Gaps = 2/110 (1%)
Query: 34  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDF 92
           DL   I    AL EE  + F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 96  DLFDFITERGALQEELARSFFWQVLEAVRHCHNXGVLHRDIKDENILIDLNRGELKLIDF 155
Query: 93  GLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
           G   +  +T + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 156 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 204

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 67.4 bits (163), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 77/146 (52%), Gaps = 10/146 (6%)
Query: 45  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL-ARVTSETDF 103
           L+E   Q    Q L  L Y+H   ++HRDLK  N+L   + D+K+ DFG+ A+ T     
Sbjct: 132 LTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQR 191
Query: 104 MTEYVVTRWYRAPELLL--NSSD--YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL 159
              ++ T ++ APE+++   S D  Y    DVWS+G   +E+ +   + P    ++ +R+
Sbjct: 192 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAE---IEPPHHELNPMRV 248
Query: 160 LIELIGT--PSEAELGFLNENAKKYI 183
           L+++  +  P+ A+    + N K ++
Sbjct: 249 LLKIAKSEPPTLAQPSRWSSNFKDFL 274

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 67.4 bits (163), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 47/142 (33%), Positives = 74/142 (52%), Gaps = 15/142 (10%)
Query: 24  VYIAYELM-DTDLHQIIRSNQALSEEHCQY--FLYQILRGLKYIHSANVLHRDLKPSNLL 80
           +YI  E M    L   ++S++   +   +   F  QI  G+ +I   N +HRDL+ +N+L
Sbjct: 251 IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANIL 310
Query: 81  LNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 140
           ++A+   KI DFGLARV ++          +W  APE  +N   +T   DVWS G + ME
Sbjct: 311 VSASLVCKIADFGLARVGAK-------FPIKW-TAPE-AINFGSFTIKSDVWSFGILLME 361
Query: 141 LM--DRKPLFPGRDHVHQLRLL 160
           ++   R P +PG  +   +R L
Sbjct: 362 IVTYGRIP-YPGMSNPEVIRAL 382

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 77/146 (52%), Gaps = 10/146 (6%)
Query: 45  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL-ARVTSETDF 103
           L+E   Q    Q L  L Y+H   ++HRDLK  N+L   + D+K+ DFG+ A+ T     
Sbjct: 132 LTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR 191
Query: 104 MTEYVVTRWYRAPELLL--NSSD--YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL 159
              ++ T ++ APE+++   S D  Y    DVWS+G   +E+ +   + P    ++ +R+
Sbjct: 192 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAE---IEPPHHELNPMRV 248
Query: 160 LIELIGT--PSEAELGFLNENAKKYI 183
           L+++  +  P+ A+    + N K ++
Sbjct: 249 LLKIAKSEPPTLAQPSRWSSNFKDFL 274

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 62/110 (56%), Gaps = 2/110 (1%)
Query: 34  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDF 92
           DL   I    AL EE  + F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 99  DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 158
Query: 93  GLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
           G   +  +T + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 159 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 207

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 62/110 (56%), Gaps = 2/110 (1%)
Query: 34  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDF 92
           DL   I    AL EE  + F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 96  DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 155
Query: 93  GLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
           G   +  +T + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 156 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 204

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 62/110 (56%), Gaps = 2/110 (1%)
Query: 34  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDF 92
           DL   I    AL EE  + F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 129 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 188
Query: 93  GLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
           G   +  +T + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 189 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 237

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 62/110 (56%), Gaps = 2/110 (1%)
Query: 34  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDF 92
           DL   I    AL EE  + F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 128 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 187
Query: 93  GLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
           G   +  +T + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 188 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 236

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 62/110 (56%), Gaps = 2/110 (1%)
Query: 34  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDF 92
           DL   I    AL EE  + F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 143 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 202
Query: 93  GLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
           G   +  +T + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 203 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 251

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 62/110 (56%), Gaps = 2/110 (1%)
Query: 34  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDF 92
           DL   I    AL EE  + F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 129 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 188
Query: 93  GLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
           G   +  +T + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 189 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 237

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 62/110 (56%), Gaps = 2/110 (1%)
Query: 34  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDF 92
           DL   I    AL EE  + F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 128 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 187
Query: 93  GLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
           G   +  +T + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 188 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 236

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 62/110 (56%), Gaps = 2/110 (1%)
Query: 34  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDF 92
           DL   I    AL EE  + F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 128 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 187
Query: 93  GLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
           G   +  +T + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 188 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 236

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 62/110 (56%), Gaps = 2/110 (1%)
Query: 34  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDF 92
           DL   I    AL EE  + F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 128 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 187
Query: 93  GLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
           G   +  +T + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 188 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 236

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 62/110 (56%), Gaps = 2/110 (1%)
Query: 34  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDF 92
           DL   I    AL EE  + F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 96  DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 155
Query: 93  GLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
           G   +  +T + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 156 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 204

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 62/110 (56%), Gaps = 2/110 (1%)
Query: 34  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDF 92
           DL   I    AL EE  + F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 129 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 188
Query: 93  GLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
           G   +  +T + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 189 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 237

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 62/110 (56%), Gaps = 2/110 (1%)
Query: 34  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDF 92
           DL   I    AL EE  + F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 143 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 202
Query: 93  GLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
           G   +  +T + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 203 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 251

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 62/110 (56%), Gaps = 2/110 (1%)
Query: 34  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDF 92
           DL   I    AL EE  + F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 143 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 202
Query: 93  GLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
           G   +  +T + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 203 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 251

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 67.4 bits (163), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 36/110 (32%), Positives = 62/110 (56%), Gaps = 2/110 (1%)
Query: 34  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDF 92
           DL   I    AL EE  + F +Q+L  +++ H+  VLHRD+K  N+L++ N  +LK+ DF
Sbjct: 129 DLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDF 188
Query: 93  GLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
           G   +  +T + T++  TR Y  PE +     +  +  VWS+G +  +++
Sbjct: 189 GSGALLKDTVY-TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMV 237

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 66/241 (27%), Positives = 108/241 (44%), Gaps = 40/241 (16%)
Query: 24  VYIAYELMDTDLHQIIRS--NQALSEEHCQYFLYQILRGLKYIHS-ANVLHRDLKPSNLL 80
           V + +E++  +L  +I+   ++ +   + +    Q+L GL Y+H    ++H D+KP N+L
Sbjct: 105 VVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVL 164
Query: 81  LNAN------CDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 134
           +           +KI D G A    E    T  + TR YR+PE+LL +  +    D+WS 
Sbjct: 165 MEIVDSPENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAP-WGCGADIWST 221
Query: 135 GCIFMELMDRKPLF-PGRDHVH-----QLRLLIELIGT-PSEAELGFLNENAK------- 180
            C+  EL+    LF P   H +      +  +IEL+G  PS     +L  N K       
Sbjct: 222 ACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPS-----YLLRNGKYTRTFFN 276
Query: 181 -----KYICQLPRYQRQS-FTEKFPNVHPSA---IDLVEKMLTFDPRQRITVEDALAHPY 231
                + I +L  +  +   TEK+      A    D +  ML  DPR+R      + HP+
Sbjct: 277 SRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPW 336
Query: 232 L 232
           L
Sbjct: 337 L 337

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 77/146 (52%), Gaps = 10/146 (6%)
Query: 45  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL-ARVTSETDF 103
           L+E   Q    Q L  L Y+H   ++HRDLK  N+L   + D+K+ DFG+ A+ T     
Sbjct: 132 LTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRXIQR 191
Query: 104 MTEYVVTRWYRAPELLL--NSSD--YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL 159
              ++ T ++ APE+++   S D  Y    DVWS+G   +E+ +   + P    ++ +R+
Sbjct: 192 RDXFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAE---IEPPHHELNPMRV 248
Query: 160 LIELIGT--PSEAELGFLNENAKKYI 183
           L+++  +  P+ A+    + N K ++
Sbjct: 249 LLKIAKSEPPTLAQPSRWSSNFKDFL 274

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 67.4 bits (163), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 66/241 (27%), Positives = 108/241 (44%), Gaps = 40/241 (16%)
Query: 24  VYIAYELMDTDLHQIIRS--NQALSEEHCQYFLYQILRGLKYIHS-ANVLHRDLKPSNLL 80
           V + +E++  +L  +I+   ++ +   + +    Q+L GL Y+H    ++H D+KP N+L
Sbjct: 105 VVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVL 164
Query: 81  LNAN------CDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 134
           +           +KI D G A    E    T  + TR YR+PE+LL +  +    D+WS 
Sbjct: 165 MEIVDSPENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAP-WGCGADIWST 221
Query: 135 GCIFMELMDRKPLF-PGRDHVH-----QLRLLIELIGT-PSEAELGFLNENAK------- 180
            C+  EL+    LF P   H +      +  +IEL+G  PS     +L  N K       
Sbjct: 222 ACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPS-----YLLRNGKYTRTFFN 276
Query: 181 -----KYICQLPRYQRQS-FTEKFPNVHPSA---IDLVEKMLTFDPRQRITVEDALAHPY 231
                + I +L  +  +   TEK+      A    D +  ML  DPR+R      + HP+
Sbjct: 277 SRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPW 336
Query: 232 L 232
           L
Sbjct: 337 L 337

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 67.0 bits (162), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 59/237 (24%), Positives = 100/237 (42%), Gaps = 40/237 (16%)
Query: 3   HENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLK 62
           H N+V  +++I  P   +    Y +      +L + I +    SE+  ++F  Q++ G+ 
Sbjct: 74  HPNIVRFKEVILTPTHLAIVMEYAS----GGELFERICNAGRFSEDEARFFFQQLISGVS 129
Query: 63  YIHSANVLHRDLKPSNLLLNANCD--LKICDFGLARVTSETDFMTEYVVTRWYRAPELLL 120
           Y H+  V HRDLK  N LL+ +    LKIC FG ++ +       + V T  Y APE+LL
Sbjct: 130 YCHAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTVGTPAYIAPEVLL 189
Query: 121 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGT-----PSEAELGFL 175
                    DVWS G                     + L + L+G      P E      
Sbjct: 190 KKEYDGKVADVWSCG---------------------VTLYVMLVGAYPFEDPEEP----- 223
Query: 176 NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
            +N +K I ++     Q     + ++ P    L+ ++   DP +RI++ +   H + 
Sbjct: 224 -KNFRKTIHRI--LNVQYAIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 277

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/203 (23%), Positives = 89/203 (43%), Gaps = 36/203 (17%)
Query: 34  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 93
           +L++ ++ +    E+    F+ ++   L Y H   V+HRD+KP NLL+    +LKI DFG
Sbjct: 100 ELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFG 159
Query: 94  LARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF--PGR 151
            + V + +        T  Y  PE ++    +   +D+W  G +  E +   P F  P  
Sbjct: 160 WS-VHAPSLRRRXMCGTLDYLPPE-MIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH 217
Query: 152 DHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEK 211
              H+  + ++L   P      FL++ +K                          DL+ K
Sbjct: 218 TETHRRIVNVDLKFPP------FLSDGSK--------------------------DLISK 245
Query: 212 MLTFDPRQRITVEDALAHPYLGS 234
           +L + P QR+ ++  + HP++ +
Sbjct: 246 LLRYHPPQRLPLKGVMEHPWVKA 268

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/203 (23%), Positives = 89/203 (43%), Gaps = 36/203 (17%)
Query: 34  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 93
           +L++ ++ +    E+    F+ ++   L Y H   V+HRD+KP NLL+    +LKI DFG
Sbjct: 101 ELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFG 160
Query: 94  LARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF--PGR 151
            + V + +        T  Y  PE ++    +   +D+W  G +  E +   P F  P  
Sbjct: 161 WS-VHAPSLRRRXMCGTLDYLPPE-MIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH 218
Query: 152 DHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEK 211
              H+  + ++L   P      FL++ +K                          DL+ K
Sbjct: 219 TETHRRIVNVDLKFPP------FLSDGSK--------------------------DLISK 246
Query: 212 MLTFDPRQRITVEDALAHPYLGS 234
           +L + P QR+ ++  + HP++ +
Sbjct: 247 LLRYHPPQRLPLKGVMEHPWVKA 269

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 35/107 (32%), Positives = 59/107 (55%), Gaps = 2/107 (1%)
Query: 47  EEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE 106
           E   +++  +I   L Y+HS N+++RDLKP N+LL++   + + DFGL +   E +  T 
Sbjct: 138 EPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTS 197
Query: 107 -YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD 152
            +  T  Y APE +L+   Y   +D W +G +  E++   P F  R+
Sbjct: 198 TFCGTPEYLAPE-VLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRN 243

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/239 (26%), Positives = 108/239 (45%), Gaps = 57/239 (23%)
Query: 24  VYIAYELMDTDLHQIIRSNQALSEEHCQY--------FLYQILRGLKYIHSANVLHRDLK 75
           +YIA EL + +L  ++ S + +S+E+ +          L QI  G+ ++HS  ++HRDLK
Sbjct: 84  LYIALELCNLNLQDLVES-KNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLK 142
Query: 76  PSNLLLNA-------------NCDLKICDFGLARV--TSETDF---MTEYVVTRWYRAPE 117
           P N+L++              N  + I DFGL +   + +  F   +     T  +RAPE
Sbjct: 143 PQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPE 202
Query: 118 LLLNSSD------YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAE 171
           LL  S++       T +ID++S+GC+F  ++  K   P  D   +   +I   G  S  E
Sbjct: 203 LLEESNNLQTKRRLTRSIDIFSMGCVFYYILS-KGKHPFGDKYSRESNIIR--GIFSLDE 259
Query: 172 LGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHP 230
           +  L++ +                     +   A DL+ +M+  DP +R T    L HP
Sbjct: 260 MKCLHDRS---------------------LIAEATDLISQMIDHDPLKRPTAMKVLRHP 297

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 42/174 (24%), Positives = 86/174 (49%), Gaps = 14/174 (8%)
Query: 42  NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET 101
           ++ L+E   Q    Q+L  L ++HS  ++HRDLK  N+L+    D+++ DFG++    +T
Sbjct: 103 DRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT 162
Query: 102 -DFMTEYVVTRWYRAPELL----LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ 156
                 ++ T ++ APE++    +  + Y    D+WS+G   +E+     + P    ++ 
Sbjct: 163 LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQ---IEPPHHELNP 219
Query: 157 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVE 210
           +R+L+++  +     L        K+  +   + + +  +K P   PSA  L+E
Sbjct: 220 MRVLLKIAKSDPPTLL-----TPSKWSVEFRDFLKIAL-DKNPETRPSAAQLLE 267

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 42/174 (24%), Positives = 86/174 (49%), Gaps = 14/174 (8%)
Query: 42  NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET 101
           ++ L+E   Q    Q+L  L ++HS  ++HRDLK  N+L+    D+++ DFG++    +T
Sbjct: 111 DRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT 170
Query: 102 -DFMTEYVVTRWYRAPELL----LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ 156
                 ++ T ++ APE++    +  + Y    D+WS+G   +E+     + P    ++ 
Sbjct: 171 LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQ---IEPPHHELNP 227
Query: 157 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVE 210
           +R+L+++  +     L        K+  +   + + +  +K P   PSA  L+E
Sbjct: 228 MRVLLKIAKSDPPTLL-----TPSKWSVEFRDFLKIAL-DKNPETRPSAAQLLE 275

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/225 (24%), Positives = 95/225 (42%), Gaps = 29/225 (12%)
Query: 25  YIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL-- 81
           Y+ +E M    +   I   +  +E      +  +   L ++H+  + HRDLKP N+L   
Sbjct: 87  YLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEH 146
Query: 82  -NANCDLKICDFGLARVTS--------ETDFMTEYVVTRWYRAPELL----LNSSDYTAA 128
            N    +KICDFGL              T  +     +  Y APE++      +S Y   
Sbjct: 147 PNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKR 206
Query: 129 IDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPR 188
            D+WS+G I   L+   P F GR             G+    + G      +  + +  +
Sbjct: 207 CDLWSLGVILYILLSGYPPFVGR------------CGSDCGWDRGEACPACQNMLFESIQ 254
Query: 189 YQRQSFTEK-FPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
             +  F +K + ++  +A DL+ K+L  D +QR++    L HP++
Sbjct: 255 EGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWV 299

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/237 (24%), Positives = 99/237 (41%), Gaps = 40/237 (16%)
Query: 3   HENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLK 62
           H N+V  +++I  P   +    Y +      +L + I +    SE+  ++F  Q++ G+ 
Sbjct: 74  HPNIVRFKEVILTPTHLAIVMEYAS----GGELFERICNAGRFSEDEARFFFQQLISGVS 129
Query: 63  YIHSANVLHRDLKPSNLLLNANCD--LKICDFGLARVTSETDFMTEYVVTRWYRAPELLL 120
           Y H+  V HRDLK  N LL+ +    LKIC FG ++ +         V T  Y APE+LL
Sbjct: 130 YCHAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTVGTPAYIAPEVLL 189
Query: 121 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGT-----PSEAELGFL 175
                    DVWS G                     + L + L+G      P E      
Sbjct: 190 KKEYDGKVADVWSCG---------------------VTLYVMLVGAYPFEDPEEP----- 223
Query: 176 NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
            +N +K I ++     Q     + ++ P    L+ ++   DP +RI++ +   H + 
Sbjct: 224 -KNFRKTIHRI--LNVQYAIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 277

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/239 (24%), Positives = 100/239 (41%), Gaps = 40/239 (16%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRG 60
           + H N+V  +++I  P   +    Y +      +L + I +    SE+  ++F  Q++ G
Sbjct: 72  LRHPNIVRFKEVILTPTHLAIVMEYAS----GGELFERICNAGRFSEDEARFFFQQLISG 127
Query: 61  LKYIHSANVLHRDLKPSNLLLNANCD--LKICDFGLARVTSETDFMTEYVVTRWYRAPEL 118
           + Y H+  V HRDLK  N LL+ +    LKI DFG ++ +         V T  Y APE+
Sbjct: 128 VSYAHAMQVAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAVGTPAYIAPEV 187
Query: 119 LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGT-----PSEAELG 173
           LL         DVWS G                     + L + L+G      P E    
Sbjct: 188 LLKKEYDGKVADVWSCG---------------------VTLYVMLVGAYPFEDPEEP--- 223
Query: 174 FLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
              +N +K I ++     Q     + ++ P    L+ ++   DP +RI++ +   H + 
Sbjct: 224 ---KNFRKTIHRI--LNVQYAIPDYVHISPECRHLISRIFVADPAKRISIPEIRNHEWF 277

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/151 (30%), Positives = 75/151 (49%), Gaps = 12/151 (7%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQA-LSEEHCQYFLYQILR 59
           ++H NV+A+  I+ PP  E    V + Y +   DL Q IRS Q   + +    F  Q+ R
Sbjct: 79  LNHPNVLALIGIMLPP--EGLPHVLLPY-MCHGDLLQFIRSPQRNPTVKDLISFGLQVAR 135
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMT------EYVVTRWY 113
           G++Y+     +HRDL   N +L+ +  +K+ DFGLAR   + ++ +        +  +W 
Sbjct: 136 GMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWT 195
Query: 114 RAPELLLNSSDYTAAIDVWSVGCIFMELMDR 144
                 L +  +T   DVWS G +  EL+ R
Sbjct: 196 ALES--LQTYRFTTKSDVWSFGVLLWELLTR 224

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 66.2 bits (160), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 47/148 (31%), Positives = 72/148 (48%), Gaps = 16/148 (10%)
Query: 3   HENVVAIRDIIPPPQRESFNDVYIAYELMDTD-LHQIIRSNQA-LSEEHCQYFLYQILRG 60
           H N++ +  +I       +  + I  E M+   L + +R      S       L  I  G
Sbjct: 105 HHNIIRLEGVI-----SKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAG 159
Query: 61  LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT------RWYR 114
           +KY+ + N +HRDL   N+L+N+N   K+ DFGL+RV  E D    Y  +      RW  
Sbjct: 160 MKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL-EDDPEATYTTSGGKIPIRW-T 217
Query: 115 APELLLNSSDYTAAIDVWSVGCIFMELM 142
           APE  ++   +T+A DVWS G +  E+M
Sbjct: 218 APE-AISYRKFTSASDVWSFGIVMWEVM 244

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 41/126 (32%), Positives = 61/126 (48%), Gaps = 6/126 (4%)
Query: 22  NDVYIAYELMDTDLHQIIRSNQA-LSEEHCQYFLYQILRGLKYIHSA-NVLHRDLKPSNL 79
            DV+IA ELM T   ++ +  Q  + E         I++ L Y+     V+HRD+KPSN+
Sbjct: 97  TDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNI 156
Query: 80  LLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL----LNSSDYTAAIDVWSVG 135
           LL+    +K+CDFG++    +            Y APE +        DY    DVWS+G
Sbjct: 157 LLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLG 216
Query: 136 CIFMEL 141
              +EL
Sbjct: 217 ISLVEL 222

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 51/193 (26%), Positives = 81/193 (41%), Gaps = 34/193 (17%)
Query: 53  FLYQILRGLKYIHSANVLHRDLKPSNLLLNAN--CDLKICDFGLAR-----VTSETDFMT 105
            + QI   L Y+H+  + HRD+KP N L + N   ++K+ DFGL++        E   MT
Sbjct: 173 IMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMT 232
Query: 106 EYVVTRWYRAPELLLNSSD-YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELI 164
               T ++ APE+L  +++ Y    D WS G +   L+     FPG +    +  ++   
Sbjct: 233 TKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLN-- 290
Query: 165 GTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVE 224
                          KK   + P Y   S         P A DL+  +L  +  +R    
Sbjct: 291 ---------------KKLCFENPNYNVLS---------PLARDLLSNLLNRNVDERFDAM 326
Query: 225 DALAHPYLGSLHD 237
            AL HP++    D
Sbjct: 327 RALQHPWISQFSD 339

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 65.5 bits (158), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 38/112 (33%), Positives = 59/112 (52%), Gaps = 6/112 (5%)
Query: 53  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-- 110
           F  QI  G+ YI   N +HRDL+ +N+L++ +   KI DFGLARV  + ++         
Sbjct: 115 FSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFP 174
Query: 111 -RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL-FPGRDHVHQLRLL 160
            +W  APE  +N   +T   DVWS G +  E++    + +PGR +   +  L
Sbjct: 175 IKW-TAPE-AINFGCFTIKSDVWSFGILLYEIVTYGKIPYPGRTNADVMTAL 224

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 65.5 bits (158), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 48/150 (32%), Positives = 71/150 (47%), Gaps = 16/150 (10%)
Query: 2   DHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQA-LSEEHCQYFLYQILR 59
           DH NV+ +  ++          V I  E M+   L   +R N    +       L  I  
Sbjct: 92  DHPNVIHLEGVV-----TKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAA 146
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV----TSE---TDFMTEYVVTRW 112
           G+KY+   N +HRDL   N+L+N+N   K+ DFGL+R     TS+   T  +   +  RW
Sbjct: 147 GMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRW 206
Query: 113 YRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
             APE  +    +T+A DVWS G +  E+M
Sbjct: 207 -TAPE-AIQYRKFTSASDVWSYGIVMWEVM 234

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 35/90 (38%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 55  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRW-- 112
           YQ+ RG++Y+ S   +HRDL   N+L+  N  +KI DFGLAR  +  D+  +    R   
Sbjct: 164 YQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPV 223
Query: 113 -YRAPELLLNSSDYTAAIDVWSVGCIFMEL 141
            + APE L +   YT   DVWS G +  E+
Sbjct: 224 KWMAPEALFDRV-YTHQSDVWSFGVLMWEI 252

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 65.1 bits (157), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 35/90 (38%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 55  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRW-- 112
           YQ+ RG++Y+ S   +HRDL   N+L+  N  +KI DFGLAR  +  D+  +    R   
Sbjct: 164 YQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPV 223
Query: 113 -YRAPELLLNSSDYTAAIDVWSVGCIFMEL 141
            + APE L +   YT   DVWS G +  E+
Sbjct: 224 KWMAPEALFDRV-YTHQSDVWSFGVLMWEI 252

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 35/90 (38%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 55  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRW-- 112
           YQ+ RG++Y+ S   +HRDL   N+L+  N  +KI DFGLAR  +  D+  +    R   
Sbjct: 164 YQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPV 223
Query: 113 -YRAPELLLNSSDYTAAIDVWSVGCIFMEL 141
            + APE L +   YT   DVWS G +  E+
Sbjct: 224 KWMAPEALFDRV-YTHQSDVWSFGVLMWEI 252

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 65.1 bits (157), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 35/90 (38%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 55  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRW-- 112
           YQ+ RG++Y+ S   +HRDL   N+L+  N  +KI DFGLAR  +  D+  +    R   
Sbjct: 164 YQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPV 223
Query: 113 -YRAPELLLNSSDYTAAIDVWSVGCIFMEL 141
            + APE L +   YT   DVWS G +  E+
Sbjct: 224 KWMAPEALFDRV-YTHQSDVWSFGVLMWEI 252

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 43/186 (23%), Positives = 90/186 (48%), Gaps = 29/186 (15%)
Query: 39  IRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-- 96
           +   +  +E   Q ++ +I+  L+++H   +++RD+K  N+LL++N  + + DFGL++  
Sbjct: 150 LSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 209
Query: 97  VTSETDFMTEYVVTRWYRAPELLLNS-SDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVH 155
           V  ET+   ++  T  Y AP+++    S +  A+D WS+G +  EL+     F       
Sbjct: 210 VADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPF------- 262
Query: 156 QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTF 215
                        + E     E +++ +   P Y ++        +   A DL++++L  
Sbjct: 263 -----------TVDGEKNSQAEISRRILKSEPPYPQE--------MSALAKDLIQRLLMK 303
Query: 216 DPRQRI 221
           DP++R+
Sbjct: 304 DPKKRL 309

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 35/90 (38%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 55  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRW-- 112
           YQ+ RG++Y+ S   +HRDL   N+L+  N  +KI DFGLAR  +  D+  +    R   
Sbjct: 164 YQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPV 223
Query: 113 -YRAPELLLNSSDYTAAIDVWSVGCIFMEL 141
            + APE L +   YT   DVWS G +  E+
Sbjct: 224 KWMAPEALFDRV-YTHQSDVWSFGVLMWEI 252

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 35/90 (38%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 55  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRW-- 112
           YQ+ RG++Y+ S   +HRDL   N+L+  N  +KI DFGLAR  +  D+  +    R   
Sbjct: 151 YQLARGMEYLASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPV 210
Query: 113 -YRAPELLLNSSDYTAAIDVWSVGCIFMEL 141
            + APE L +   YT   DVWS G +  E+
Sbjct: 211 KWMAPEALFDRV-YTHQSDVWSFGVLMWEI 239

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 64.7 bits (156), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 35/90 (38%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 55  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRW-- 112
           YQ+ RG++Y+ S   +HRDL   N+L+  N  +KI DFGLAR  +  D+  +    R   
Sbjct: 210 YQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPV 269
Query: 113 -YRAPELLLNSSDYTAAIDVWSVGCIFMEL 141
            + APE L +   YT   DVWS G +  E+
Sbjct: 270 KWMAPEALFDRV-YTHQSDVWSFGVLMWEI 298

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 35/90 (38%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 55  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRW-- 112
           YQ+ RG++Y+ S   +HRDL   N+L+  N  +KI DFGLAR  +  D+  +    R   
Sbjct: 156 YQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPV 215
Query: 113 -YRAPELLLNSSDYTAAIDVWSVGCIFMEL 141
            + APE L +   YT   DVWS G +  E+
Sbjct: 216 KWMAPEALFDRV-YTHQSDVWSFGVLMWEI 244

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 64.7 bits (156), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 35/90 (38%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 55  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRW-- 112
           YQ+ RG++Y+ S   +HRDL   N+L+  N  +KI DFGLAR  +  D+  +    R   
Sbjct: 153 YQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPV 212
Query: 113 -YRAPELLLNSSDYTAAIDVWSVGCIFMEL 141
            + APE L +   YT   DVWS G +  E+
Sbjct: 213 KWMAPEALFDRV-YTHQSDVWSFGVLMWEI 241

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 35/90 (38%), Positives = 49/90 (54%), Gaps = 4/90 (4%)
Query: 55  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRW-- 112
           YQ+ RG++Y+ S   +HRDL   N+L+  N  +KI DFGLAR  +  D+       R   
Sbjct: 164 YQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNGRLPV 223
Query: 113 -YRAPELLLNSSDYTAAIDVWSVGCIFMEL 141
            + APE L +   YT   DVWS G +  E+
Sbjct: 224 KWMAPEALFDRV-YTHQSDVWSFGVLMWEI 252

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 39/104 (37%), Positives = 59/104 (56%), Gaps = 9/104 (8%)
Query: 53  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSETDFMTE---YV 108
           F YQ+ +G+ ++ S N +HRDL   N+LL      KICDFGLAR + ++++++ +    +
Sbjct: 173 FSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVVKGNARL 232
Query: 109 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL--MDRKPLFPG 150
             +W  APE + N   YT   DVWS G    EL  +   P +PG
Sbjct: 233 PVKW-MAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSP-YPG 273

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 39/104 (37%), Positives = 59/104 (56%), Gaps = 9/104 (8%)
Query: 53  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSETDFMTE---YV 108
           F YQ+ +G+ ++ S N +HRDL   N+LL      KICDFGLAR + ++++++ +    +
Sbjct: 173 FSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARL 232
Query: 109 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL--MDRKPLFPG 150
             +W  APE + N   YT   DVWS G    EL  +   P +PG
Sbjct: 233 PVKW-MAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSP-YPG 273

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score = 64.3 bits (155), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 51/215 (23%), Positives = 84/215 (39%), Gaps = 57/215 (26%)
Query: 40  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA---NCDLKICDFGLAR 96
           R +QA +E      +  I   ++Y+HS N+ HRD+KP NLL  +   N  LK+ DFG A+
Sbjct: 109 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
Query: 97  VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ 156
            T+                         Y  + D+WS+G I   L+   P          
Sbjct: 169 ETT----------------------GEKYDKSCDMWSLGVIMYILLCGYP---------- 196
Query: 157 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAID-----LVEK 211
                     P  +  G       K   ++ +Y+       FPN   S +      L+  
Sbjct: 197 ----------PFYSNHGLAISPGMKTRIRMGQYE-------FPNPEWSEVSEEVKMLIRN 239
Query: 212 MLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMS 246
           +L  +P QR+T+ + + HP++     +   P+  S
Sbjct: 240 LLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTS 274

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 39/104 (37%), Positives = 59/104 (56%), Gaps = 9/104 (8%)
Query: 53  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSETDFMTE---YV 108
           F YQ+ +G+ ++ S N +HRDL   N+LL      KICDFGLAR + ++++++ +    +
Sbjct: 168 FSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARL 227
Query: 109 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL--MDRKPLFPG 150
             +W  APE + N   YT   DVWS G    EL  +   P +PG
Sbjct: 228 PVKW-MAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSP-YPG 268

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 64.3 bits (155), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 39/104 (37%), Positives = 59/104 (56%), Gaps = 9/104 (8%)
Query: 53  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSETDFMTE---YV 108
           F YQ+ +G+ ++ S N +HRDL   N+LL      KICDFGLAR + ++++++ +    +
Sbjct: 166 FSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARL 225
Query: 109 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL--MDRKPLFPG 150
             +W  APE + N   YT   DVWS G    EL  +   P +PG
Sbjct: 226 PVKWM-APESIFNCV-YTFESDVWSYGIFLWELFSLGSSP-YPG 266

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 63.9 bits (154), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 39/104 (37%), Positives = 59/104 (56%), Gaps = 9/104 (8%)
Query: 53  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSETDFMTE---YV 108
           F YQ+ +G+ ++ S N +HRDL   N+LL      KICDFGLAR + ++++++ +    +
Sbjct: 150 FSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARL 209
Query: 109 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL--MDRKPLFPG 150
             +W  APE + N   YT   DVWS G    EL  +   P +PG
Sbjct: 210 PVKW-MAPESIFNCV-YTFESDVWSYGIFLWELFSLGSSP-YPG 250

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 68/121 (56%), Gaps = 11/121 (9%)
Query: 25  YIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN 84
           ++ Y++   DL++       L+ EH   + +Q+ +G++++ S   +HRDL   N+LL+  
Sbjct: 167 FVPYKVAPEDLYK-----DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 221
Query: 85  CDLKICDFGLAR-VTSETDFMTE---YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 140
             +KICDFGLAR +  + D++ +    +  +W  APE + +   YT   DVWS G +  E
Sbjct: 222 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWE 279
Query: 141 L 141
           +
Sbjct: 280 I 280

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 37/112 (33%), Positives = 59/112 (52%), Gaps = 6/112 (5%)
Query: 53  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-- 110
           F  QI  G+ YI   N +HRDL+ +N+L++ +   KI DFGLARV  + ++         
Sbjct: 114 FSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFP 173
Query: 111 -RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL-FPGRDHVHQLRLL 160
            +W  APE  +N   +T   +VWS G +  E++    + +PGR +   +  L
Sbjct: 174 IKW-TAPE-AINFGCFTIKSNVWSFGILLYEIVTYGKIPYPGRTNADVMSAL 223

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 63.9 bits (154), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 68/121 (56%), Gaps = 11/121 (9%)
Query: 25  YIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN 84
           ++ Y++   DL++       L+ EH   + +Q+ +G++++ S   +HRDL   N+LL+  
Sbjct: 130 FVPYKVAPEDLYK-----DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 184
Query: 85  CDLKICDFGLAR-VTSETDFMTE---YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 140
             +KICDFGLAR +  + D++ +    +  +W  APE + +   YT   DVWS G +  E
Sbjct: 185 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWE 242
Query: 141 L 141
           +
Sbjct: 243 I 243

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 70/126 (55%), Gaps = 11/126 (8%)
Query: 20  SFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL 79
           S  + ++ Y++   DL++       L+ EH   + +Q+ +G++++ S   +HRDL   N+
Sbjct: 116 SKRNEFVPYKVAPEDLYK-----DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 170
Query: 80  LLNANCDLKICDFGLAR-VTSETDFMTE---YVVTRWYRAPELLLNSSDYTAAIDVWSVG 135
           LL+    +KICDFGLAR +  + D++ +    +  +W  APE + +   YT   DVWS G
Sbjct: 171 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFG 228
Query: 136 CIFMEL 141
            +  E+
Sbjct: 229 VLLWEI 234

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 40/129 (31%), Positives = 72/129 (55%), Gaps = 11/129 (8%)
Query: 24  VYIAYELMDTD-LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 82
           V I  EL++   L Q+I+    L E+   Y+L Q L GL+Y+H+  +LH D+K  N+LL+
Sbjct: 125 VNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLS 184
Query: 83  ANCD-LKICDFGLARVTSETDFMTEYVVTRWY-------RAPELLLNSSDYTAAIDVWSV 134
           ++     +CDFG A +  + D + + ++T  Y        APE+++      A +D+WS 
Sbjct: 185 SDGSRAALCDFGHA-LCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP-CDAKVDIWSS 242
Query: 135 GCIFMELMD 143
            C+ + +++
Sbjct: 243 CCMMLHMLN 251

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 80/174 (45%), Gaps = 27/174 (15%)
Query: 50  CQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD------- 102
           C +   QI   ++++HS  ++HRDLKPSN+    +  +K+ DFGL     + +       
Sbjct: 120 CLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 179
Query: 103 ------FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ 156
                   T  V T+ Y +PE +  +S Y+  +D++S+G I  EL     L+P    + +
Sbjct: 180 PMPAYARHTGQVGTKLYMSPEQIHGNS-YSHKVDIFSLGLILFEL-----LYPFSTQMER 233
Query: 157 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVE 210
           +R L ++        L F     +KY C+      Q      P   P AI+++E
Sbjct: 234 VRTLTDV------RNLKFPPLFTQKYPCEY--VMVQDMLSPSPMERPEAINIIE 279

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 40/129 (31%), Positives = 72/129 (55%), Gaps = 11/129 (8%)
Query: 24  VYIAYELMDTD-LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 82
           V I  EL++   L Q+I+    L E+   Y+L Q L GL+Y+H+  +LH D+K  N+LL+
Sbjct: 141 VNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLS 200
Query: 83  ANCD-LKICDFGLARVTSETDFMTEYVVTRWY-------RAPELLLNSSDYTAAIDVWSV 134
           ++     +CDFG A +  + D + + ++T  Y        APE+++      A +D+WS 
Sbjct: 201 SDGSRAALCDFGHA-LCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP-CDAKVDIWSS 258
Query: 135 GCIFMELMD 143
            C+ + +++
Sbjct: 259 CCMMLHMLN 267

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 34/90 (37%), Positives = 50/90 (55%), Gaps = 4/90 (4%)
Query: 55  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRW-- 112
           YQ+ RG++Y+ S   +HRDL   N+L+  N  ++I DFGLAR  +  D+  +    R   
Sbjct: 164 YQLARGMEYLASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNGRLPV 223
Query: 113 -YRAPELLLNSSDYTAAIDVWSVGCIFMEL 141
            + APE L +   YT   DVWS G +  E+
Sbjct: 224 KWMAPEALFDRV-YTHQSDVWSFGVLMWEI 252

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 35/90 (38%), Positives = 49/90 (54%), Gaps = 4/90 (4%)
Query: 55  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRW-- 112
           YQ+ RG++Y+ S   +HRDL   N+L+  N  +KI DFGLAR  +  D   +    R   
Sbjct: 164 YQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLPV 223
Query: 113 -YRAPELLLNSSDYTAAIDVWSVGCIFMEL 141
            + APE L +   YT   DVWS G +  E+
Sbjct: 224 KWMAPEALFDRV-YTHQSDVWSFGVLMWEI 252

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 70/126 (55%), Gaps = 11/126 (8%)
Query: 20  SFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL 79
           S  + ++ Y++   DL++       L+ EH   + +Q+ +G++++ S   +HRDL   N+
Sbjct: 116 SKRNEFVPYKVAPEDLYK-----DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 170
Query: 80  LLNANCDLKICDFGLAR-VTSETDFMTE---YVVTRWYRAPELLLNSSDYTAAIDVWSVG 135
           LL+    +KICDFGLAR +  + D++ +    +  +W  APE + +   YT   DVWS G
Sbjct: 171 LLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFG 228
Query: 136 CIFMEL 141
            +  E+
Sbjct: 229 VLLWEI 234

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 35/90 (38%), Positives = 49/90 (54%), Gaps = 4/90 (4%)
Query: 55  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRW-- 112
           YQ+ RG++Y+ S   +HRDL   N+L+  N  +KI DFGLAR  +  D   +    R   
Sbjct: 164 YQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLPV 223
Query: 113 -YRAPELLLNSSDYTAAIDVWSVGCIFMEL 141
            + APE L +   YT   DVWS G +  E+
Sbjct: 224 KWMAPEALFDRV-YTHQSDVWSFGVLMWEI 252

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 40/129 (31%), Positives = 72/129 (55%), Gaps = 11/129 (8%)
Query: 24  VYIAYELMDTD-LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 82
           V I  EL++   L Q+I+    L E+   Y+L Q L GL+Y+H+  +LH D+K  N+LL+
Sbjct: 139 VNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLS 198
Query: 83  ANCD-LKICDFGLARVTSETDFMTEYVVTRWY-------RAPELLLNSSDYTAAIDVWSV 134
           ++     +CDFG A +  + D + + ++T  Y        APE+++      A +D+WS 
Sbjct: 199 SDGSRAALCDFGHA-LCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP-CDAKVDIWSS 256
Query: 135 GCIFMELMD 143
            C+ + +++
Sbjct: 257 CCMMLHMLN 265

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 63.5 bits (153), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 46/148 (31%), Positives = 71/148 (47%), Gaps = 14/148 (9%)
Query: 2   DHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQA-LSEEHCQYFLYQILR 59
           DH N++ +  ++   +      V I  E M+   L   +R + A  +       L  I  
Sbjct: 104 DHPNIIRLEGVVTKSK-----PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIAS 158
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS---ETDFMTE--YVVTRWYR 114
           G+KY+     +HRDL   N+L+N+N   K+ DFGLARV     E  + T    +  RW  
Sbjct: 159 GMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRW-T 217
Query: 115 APELLLNSSDYTAAIDVWSVGCIFMELM 142
           +PE +     +T+A DVWS G +  E+M
Sbjct: 218 SPEAIAYRK-FTSASDVWSYGIVLWEVM 244

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 63.2 bits (152), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 43/144 (29%), Positives = 71/144 (49%), Gaps = 5/144 (3%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRG 60
           + H N+V     +  P   S    Y++   +   LH+     Q L E       Y + +G
Sbjct: 91  LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQ-LDERRRLSMAYDVAKG 149
Query: 61  LKYIHSAN--VLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVV-TRWYRAPE 117
           + Y+H+ N  ++HRDLK  NLL++    +K+CDFGL+R+ +     ++    T  + APE
Sbjct: 150 MNYLHNRNPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAAGTPEWMAPE 209
Query: 118 LLLNSSDYTAAIDVWSVGCIFMEL 141
           +L +      + DV+S G I  EL
Sbjct: 210 VLRDEPSNEKS-DVYSFGVILWEL 232

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 71/148 (47%), Gaps = 14/148 (9%)
Query: 2   DHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQA-LSEEHCQYFLYQILR 59
           DH N++ +  ++   +      V I  E M+   L   +R + A  +       L  I  
Sbjct: 104 DHPNIIRLEGVVTKSK-----PVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIAS 158
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS---ETDFMTE--YVVTRWYR 114
           G+KY+     +HRDL   N+L+N+N   K+ DFGL+RV     E  + T    +  RW  
Sbjct: 159 GMKYLSDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-T 217
Query: 115 APELLLNSSDYTAAIDVWSVGCIFMELM 142
           +PE +     +T+A DVWS G +  E+M
Sbjct: 218 SPEAIAYRK-FTSASDVWSYGIVLWEVM 244

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/225 (24%), Positives = 94/225 (41%), Gaps = 29/225 (12%)
Query: 25  YIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL-- 81
           Y+ +E M    +   I   +  +E      +  +   L ++H+  + HRDLKP N+L   
Sbjct: 87  YLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEH 146
Query: 82  -NANCDLKICDFGLARVTS--------ETDFMTEYVVTRWYRAPELL----LNSSDYTAA 128
            N    +KICDF L              T  +     +  Y APE++      +S Y   
Sbjct: 147 PNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKR 206
Query: 129 IDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPR 188
            D+WS+G I   L+   P F GR             G+    + G      +  + +  +
Sbjct: 207 CDLWSLGVILYILLSGYPPFVGR------------CGSDCGWDRGEACPACQNMLFESIQ 254
Query: 189 YQRQSFTEK-FPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
             +  F +K + ++  +A DL+ K+L  D +QR++    L HP++
Sbjct: 255 EGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWV 299

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/144 (29%), Positives = 72/144 (50%), Gaps = 5/144 (3%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRG 60
           + H N+V     +  P   S    Y++   +   LH+     Q L E       Y + +G
Sbjct: 91  LRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQ-LDERRRLSMAYDVAKG 149
Query: 61  LKYIHSAN--VLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVV-TRWYRAPE 117
           + Y+H+ N  ++HR+LK  NLL++    +K+CDFGL+R+ + T   ++    T  + APE
Sbjct: 150 MNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPE 209
Query: 118 LLLNSSDYTAAIDVWSVGCIFMEL 141
           +L +      + DV+S G I  EL
Sbjct: 210 VLRDEPSNEKS-DVYSFGVILWEL 232

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/122 (33%), Positives = 61/122 (50%), Gaps = 4/122 (3%)
Query: 24  VYIAYELMDTD-LHQII--RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL 80
           ++I  E  D   L Q I  R  + L +        QI +G+ YIHS  +++RDLKPSN+ 
Sbjct: 95  LFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIF 154
Query: 81  LNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 140
           L     +KI DFGL               T  Y +PE  ++S DY   +D++++G I  E
Sbjct: 155 LVDTKQVKIGDFGLVTSLKNDGKRXRSKGTLRYMSPE-QISSQDYGKEVDLYALGLILAE 213
Query: 141 LM 142
           L+
Sbjct: 214 LL 215

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 67/121 (55%), Gaps = 11/121 (9%)
Query: 25  YIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN 84
           ++ Y++   DL++       L+ EH   + +Q+ +G++++ S   +HRDL   N+LL+  
Sbjct: 130 FVPYKVAPEDLYK-----DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 184
Query: 85  CDLKICDFGLAR-VTSETDFMTE---YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 140
             +KICDFGLAR +  + D + +    +  +W  APE + +   YT   DVWS G +  E
Sbjct: 185 NVVKICDFGLARDIXKDPDXVRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWE 242
Query: 141 L 141
           +
Sbjct: 243 I 243

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 39/126 (30%), Positives = 69/126 (54%), Gaps = 11/126 (8%)
Query: 20  SFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL 79
           S  + ++ Y++   DL++       L+ EH   + +Q+ +G++++ S   +HRDL   N+
Sbjct: 116 SKRNEFVPYKVAPEDLYK-----DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNI 170
Query: 80  LLNANCDLKICDFGLAR-VTSETDFMTE---YVVTRWYRAPELLLNSSDYTAAIDVWSVG 135
           LL+    +KICDFGLAR +  + D + +    +  +W  APE + +   YT   DVWS G
Sbjct: 171 LLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFG 228
Query: 136 CIFMEL 141
            +  E+
Sbjct: 229 VLLWEI 234

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 63.2 bits (152), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 67/121 (55%), Gaps = 11/121 (9%)
Query: 25  YIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN 84
           ++ Y++   DL++       L+ EH   + +Q+ +G++++ S   +HRDL   N+LL+  
Sbjct: 121 FVPYKVAPEDLYK-----DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 175
Query: 85  CDLKICDFGLAR-VTSETDFMTE---YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 140
             +KICDFGLAR +  + D + +    +  +W  APE + +   YT   DVWS G +  E
Sbjct: 176 NVVKICDFGLARDIXKDPDXVRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWE 233
Query: 141 L 141
           +
Sbjct: 234 I 234

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 59/101 (58%), Gaps = 6/101 (5%)
Query: 45  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSETDF 103
           L+ EH   + +Q+ +G++++ S   +HRDL   N+LL+    +KICDFGLAR +  + D+
Sbjct: 197 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 256
Query: 104 MTE---YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 141
           + +    +  +W  APE + +   YT   DVWS G +  E+
Sbjct: 257 VRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEI 295

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 75/171 (43%), Gaps = 8/171 (4%)
Query: 45  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM 104
           L E      L ++L GL+Y+H    +HRD+K  N+LL  +  ++I DFG++   +    +
Sbjct: 118 LDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDI 177
Query: 105 TE------YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR 158
           T       +V T  + APE++     Y    D+WS G   +EL       P   +     
Sbjct: 178 TRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAA--PYHKYPPMKV 235
Query: 159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLV 209
           L++ L   P   E G  ++   K   +  R       +K P   P+A +L+
Sbjct: 236 LMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 286

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/149 (32%), Positives = 70/149 (46%), Gaps = 16/149 (10%)
Query: 2   DHENVVAIRDIIPPPQRESFNDVYIAYELMDTD-LHQIIRSNQA-LSEEHCQYFLYQILR 59
           DH NVV +  ++   +      V I  E M+   L   +R +    +       L  I  
Sbjct: 102 DHPNVVHLEGVVTRGK-----PVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLRGIAA 156
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT------RWY 113
           G++Y+     +HRDL   N+L+N+N   K+ DFGL+RV  E D    Y  T      RW 
Sbjct: 157 GMRYLADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVI-EDDPEAVYTTTGGKIPVRW- 214
Query: 114 RAPELLLNSSDYTAAIDVWSVGCIFMELM 142
            APE  +    +T+A DVWS G +  E+M
Sbjct: 215 TAPE-AIQYRKFTSASDVWSYGIVMWEVM 242

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 59/101 (58%), Gaps = 6/101 (5%)
Query: 45  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSETDF 103
           L+ EH   + +Q+ +G++++ S   +HRDL   N+LL+    +KICDFGLAR +  + D+
Sbjct: 195 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 254
Query: 104 MTE---YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 141
           + +    +  +W  APE + +   YT   DVWS G +  E+
Sbjct: 255 VRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEI 293

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 38/146 (26%), Positives = 73/146 (50%), Gaps = 3/146 (2%)
Query: 19  ESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 77
           ++ + +Y   E ++  DL   I+      E    ++  +I  GL ++H   +++RDLK  
Sbjct: 90  QTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGLFFLHKRGIIYRDLKLD 149
Query: 78  NLLLNANCDLKICDFGLARVTSETDFMT-EYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 136
           N++L++   +KI DFG+ +        T E+  T  Y APE++     Y  ++D W+ G 
Sbjct: 150 NVMLDSEGHIKIADFGMCKEHMMDGVTTREFCGTPDYIAPEIIAYQP-YGKSVDWWAYGV 208
Query: 137 IFMELMDRKPLFPGRDHVHQLRLLIE 162
           +  E++  +P F G D     + ++E
Sbjct: 209 LLYEMLAGQPPFDGEDEDELFQSIME 234

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 101/223 (45%), Gaps = 43/223 (19%)
Query: 24  VYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA 83
           +Y+  E  + DL+  ++  +++     + +   +L  +  IH   ++H DLKP+N L+  
Sbjct: 103 IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-V 161
Query: 84  NCDLKICDFGLA-RVTSETDFMTE--YVVTRWYRAPELLLNSSD----------YTAAID 130
           +  LK+ DFG+A ++  +T  + +   V T  Y  PE + + S            +   D
Sbjct: 162 DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSD 221
Query: 131 VWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQ 190
           VWS+GCI   +   K   P +  ++Q+  L  +I    E E                   
Sbjct: 222 VWSLGCILYYMTYGKT--PFQQIINQISKLHAIIDPNHEIE------------------- 260
Query: 191 RQSFTEKFPNVHPSAI-DLVEKMLTFDPRQRITVEDALAHPYL 232
                  FP++    + D+++  L  DP+QRI++ + LAHPY+
Sbjct: 261 -------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 296

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 59/101 (58%), Gaps = 6/101 (5%)
Query: 45  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSETDF 103
           L+ EH   + +Q+ +G++++ S   +HRDL   N+LL+    +KICDFGLAR +  + D+
Sbjct: 190 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 249
Query: 104 MTE---YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 141
           + +    +  +W  APE + +   YT   DVWS G +  E+
Sbjct: 250 VRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEI 288

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 101/223 (45%), Gaps = 43/223 (19%)
Query: 24  VYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA 83
           +Y+  E  + DL+  ++  +++     + +   +L  +  IH   ++H DLKP+N L+  
Sbjct: 87  IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-V 145
Query: 84  NCDLKICDFGLA-RVTSETDFMTE--YVVTRWYRAPELLLNSSD----------YTAAID 130
           +  LK+ DFG+A ++  +T  + +   V T  Y  PE + + S            +   D
Sbjct: 146 DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSD 205
Query: 131 VWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQ 190
           VWS+GCI   +   K   P +  ++Q+  L  +I    E E                   
Sbjct: 206 VWSLGCILYYMTYGKT--PFQQIINQISKLHAIIDPNHEIE------------------- 244
Query: 191 RQSFTEKFPNVHPSAI-DLVEKMLTFDPRQRITVEDALAHPYL 232
                  FP++    + D+++  L  DP+QRI++ + LAHPY+
Sbjct: 245 -------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 280

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 101/223 (45%), Gaps = 43/223 (19%)
Query: 24  VYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA 83
           +Y+  E  + DL+  ++  +++     + +   +L  +  IH   ++H DLKP+N L+  
Sbjct: 84  IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-V 142
Query: 84  NCDLKICDFGLA-RVTSETDFMTE--YVVTRWYRAPELLLNSSD----------YTAAID 130
           +  LK+ DFG+A ++  +T  + +   V T  Y  PE + + S            +   D
Sbjct: 143 DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSD 202
Query: 131 VWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQ 190
           VWS+GCI   +   K   P +  ++Q+  L  +I    E E                   
Sbjct: 203 VWSLGCILYYMTYGKT--PFQQIINQISKLHAIIDPNHEIE------------------- 241
Query: 191 RQSFTEKFPNVHPSAI-DLVEKMLTFDPRQRITVEDALAHPYL 232
                  FP++    + D+++  L  DP+QRI++ + LAHPY+
Sbjct: 242 -------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 277

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 101/223 (45%), Gaps = 43/223 (19%)
Query: 24  VYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA 83
           +Y+  E  + DL+  ++  +++     + +   +L  +  IH   ++H DLKP+N L+  
Sbjct: 131 IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-V 189
Query: 84  NCDLKICDFGLA-RVTSETDFMTE--YVVTRWYRAPELLLNSSD----------YTAAID 130
           +  LK+ DFG+A ++  +T  + +   V T  Y  PE + + S            +   D
Sbjct: 190 DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSD 249
Query: 131 VWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQ 190
           VWS+GCI   +   K  F  +  ++Q+  L  +I    E E                   
Sbjct: 250 VWSLGCILYYMTYGKTPF--QQIINQISKLHAIIDPNHEIE------------------- 288
Query: 191 RQSFTEKFPNVHPSAI-DLVEKMLTFDPRQRITVEDALAHPYL 232
                  FP++    + D+++  L  DP+QRI++ + LAHPY+
Sbjct: 289 -------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 324

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 101/223 (45%), Gaps = 43/223 (19%)
Query: 24  VYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA 83
           +Y+  E  + DL+  ++  +++     + +   +L  +  IH   ++H DLKP+N L+  
Sbjct: 83  IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-V 141
Query: 84  NCDLKICDFGLA-RVTSETDFMTE--YVVTRWYRAPELLLNSSD----------YTAAID 130
           +  LK+ DFG+A ++  +T  + +   V T  Y  PE + + S            +   D
Sbjct: 142 DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSD 201
Query: 131 VWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQ 190
           VWS+GCI   +   K   P +  ++Q+  L  +I    E E                   
Sbjct: 202 VWSLGCILYYMTYGKT--PFQQIINQISKLHAIIDPNHEIE------------------- 240
Query: 191 RQSFTEKFPNVHPSAI-DLVEKMLTFDPRQRITVEDALAHPYL 232
                  FP++    + D+++  L  DP+QRI++ + LAHPY+
Sbjct: 241 -------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 276

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 59/101 (58%), Gaps = 6/101 (5%)
Query: 45  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSETDF 103
           L+ EH   + +Q+ +G++++ S   +HRDL   N+LL+    +KICDFGLAR +  + D+
Sbjct: 188 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 247
Query: 104 MTE---YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 141
           + +    +  +W  APE + +   YT   DVWS G +  E+
Sbjct: 248 VRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEI 286

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 36/102 (35%), Positives = 53/102 (51%), Gaps = 4/102 (3%)
Query: 43  QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD 102
           + LS +      YQ+ RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR     D
Sbjct: 145 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 204
Query: 103 FMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFMEL 141
           +  +    R    + APE L +   YT   DVWS G +  E+
Sbjct: 205 YYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEI 245

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 36/102 (35%), Positives = 53/102 (51%), Gaps = 4/102 (3%)
Query: 43  QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD 102
           + LS +      YQ+ RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR     D
Sbjct: 145 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 204
Query: 103 FMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFMEL 141
           +  +    R    + APE L +   YT   DVWS G +  E+
Sbjct: 205 YYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEI 245

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 36/102 (35%), Positives = 53/102 (51%), Gaps = 4/102 (3%)
Query: 43  QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD 102
           + LS +      YQ+ RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR     D
Sbjct: 137 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 196
Query: 103 FMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFMEL 141
           +  +    R    + APE L +   YT   DVWS G +  E+
Sbjct: 197 YYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEI 237

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 36/102 (35%), Positives = 53/102 (51%), Gaps = 4/102 (3%)
Query: 43  QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD 102
           + LS +      YQ+ RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR     D
Sbjct: 134 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 193
Query: 103 FMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFMEL 141
           +  +    R    + APE L +   YT   DVWS G +  E+
Sbjct: 194 YYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEI 234

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 36/102 (35%), Positives = 53/102 (51%), Gaps = 4/102 (3%)
Query: 43  QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD 102
           + LS +      YQ+ RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR     D
Sbjct: 138 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 197
Query: 103 FMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFMEL 141
           +  +    R    + APE L +   YT   DVWS G +  E+
Sbjct: 198 YYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEI 238

>pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 106/270 (39%), Gaps = 74/270 (27%)
Query: 35  LHQIIRSN-QALSEEHCQYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNAN-------- 84
           L  II+SN Q L     +  + Q+L+GL Y+H+   ++H D+KP N+LL+ N        
Sbjct: 132 LKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLA 191
Query: 85  -----------------------------------------CDLKICDFGLARVTSETDF 103
                                                      +KI D G A    +   
Sbjct: 192 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK--H 249
Query: 104 MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFP-------GRDHVHQ 156
            TE + TR YR+ E+L+ S  Y    D+WS  C+  EL     LF         RD  H 
Sbjct: 250 FTEDIQTRQYRSLEVLIGSG-YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDH- 307
Query: 157 LRLLIELIG-TPSEAELG-------FLNENAKKYICQL-PRYQRQSFTEKFPNVHPSA-- 205
           + L+IEL+G  P +  +        F  +   K+I +L P    +   EK+      A  
Sbjct: 308 IALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAG 367
Query: 206 -IDLVEKMLTFDPRQRITVEDALAHPYLGS 234
             D +  ML   P +R T  + L HP+L S
Sbjct: 368 FTDFLLPMLELIPEKRATAAECLRHPWLNS 397

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 75/171 (43%), Gaps = 8/171 (4%)
Query: 45  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM 104
           L E      L ++L GL+Y+H    +HRD+K  N+LL  +  ++I DFG++   +    +
Sbjct: 113 LDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDI 172
Query: 105 TE------YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR 158
           T       +V T  + APE++     Y    D+WS G   +EL       P   +     
Sbjct: 173 TRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAA--PYHKYPPMKV 230
Query: 159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLV 209
           L++ L   P   E G  ++   K   +  R       +K P   P+A +L+
Sbjct: 231 LMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 281

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 55/223 (24%), Positives = 101/223 (45%), Gaps = 43/223 (19%)
Query: 24  VYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA 83
           +Y+  E  + DL+  ++  +++     + +   +L  +  IH   ++H DLKP+N L+  
Sbjct: 131 IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-V 189
Query: 84  NCDLKICDFGLA-RVTSETDFMTE--YVVTRWYRAPELLLNSSD----------YTAAID 130
           +  LK+ DFG+A ++  +T  + +   V T  Y  PE + + S            +   D
Sbjct: 190 DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSD 249
Query: 131 VWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQ 190
           VWS+GCI   +   K  F  +  ++Q+  L  +I    E E                   
Sbjct: 250 VWSLGCILYYMTYGKTPF--QQIINQISKLHAIIDPNHEIE------------------- 288
Query: 191 RQSFTEKFPNVHPSAI-DLVEKMLTFDPRQRITVEDALAHPYL 232
                  FP++    + D+++  L  DP+QRI++ + LAHPY+
Sbjct: 289 -------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 324

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/172 (28%), Positives = 83/172 (48%), Gaps = 13/172 (7%)
Query: 24  VYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 82
           +Y+  E M   DL  ++ SN  + E+  +++  +++  L  IHS  ++HRD+KP N+LL+
Sbjct: 150 LYMVMEYMPGGDLVNLM-SNYDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLD 208
Query: 83  ANCDLKICDFGLARVTSETDFM--TEYVVTRWYRAPELLLNSSD---YTAAIDVWSVGCI 137
            +  LK+ DFG      ET  +     V T  Y +PE+L +      Y    D WSVG  
Sbjct: 209 KHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVF 268
Query: 138 FMELMDRKPLFPGRDHVHQLRLLIELIGT---PSEAELGFLNENAKKYICQL 186
             E++     F     V     +++   +   P +AE   ++++AK  IC  
Sbjct: 269 LFEMLVGDTPFYADSLVGTYSKIMDHKNSLCFPEDAE---ISKHAKNLICAF 317

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 62.8 bits (151), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 36/102 (35%), Positives = 53/102 (51%), Gaps = 4/102 (3%)
Query: 43  QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD 102
           + LS +      YQ+ RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR     D
Sbjct: 130 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 103 FMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFMEL 141
           +  +    R    + APE L +   YT   DVWS G +  E+
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEI 230

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 71/148 (47%), Gaps = 14/148 (9%)
Query: 2   DHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQA-LSEEHCQYFLYQILR 59
           DH N++ +  ++   +      V I  E M+   L   +R + A  +       L  I  
Sbjct: 104 DHPNIIRLEGVVTKSK-----PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIAS 158
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS---ETDFMTE--YVVTRWYR 114
           G+KY+     +HRDL   N+L+N+N   K+ DFGL+RV     E  + T    +  RW  
Sbjct: 159 GMKYLSDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-T 217
Query: 115 APELLLNSSDYTAAIDVWSVGCIFMELM 142
           +PE +     +T+A DVWS G +  E+M
Sbjct: 218 SPEAIAYRK-FTSASDVWSYGIVLWEVM 244

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 62.4 bits (150), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 59/101 (58%), Gaps = 6/101 (5%)
Query: 45  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSETDF 103
           L+ EH   + +Q+ +G++++ S   +HRDL   N+LL+    +KICDFGLAR +  + D+
Sbjct: 147 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 206
Query: 104 MTE---YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 141
           + +    +  +W  APE + +   YT   DVWS G +  E+
Sbjct: 207 VRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEI 245

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 36/102 (35%), Positives = 53/102 (51%), Gaps = 4/102 (3%)
Query: 43  QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD 102
           + LS +      YQ+ RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR     D
Sbjct: 186 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 245
Query: 103 FMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFMEL 141
           +  +    R    + APE L +   YT   DVWS G +  E+
Sbjct: 246 YYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEI 286

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 36/102 (35%), Positives = 53/102 (51%), Gaps = 4/102 (3%)
Query: 43  QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD 102
           + LS +      YQ+ RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR     D
Sbjct: 145 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 204
Query: 103 FMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFMEL 141
           +  +    R    + APE L +   YT   DVWS G +  E+
Sbjct: 205 YYKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEI 245

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 38/121 (31%), Positives = 67/121 (55%), Gaps = 11/121 (9%)
Query: 25  YIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNAN 84
           ++ Y++   DL++       L+ EH   + +Q+ +G++++ S   +HRDL   N+LL+  
Sbjct: 130 FVPYKVAPEDLYK-----DFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK 184
Query: 85  CDLKICDFGLAR-VTSETDFMTE---YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 140
             +KICDFGLAR +  + D + +    +  +W  APE + +   YT   DVWS G +  E
Sbjct: 185 NVVKICDFGLARDIYKDPDXVRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWE 242
Query: 141 L 141
           +
Sbjct: 243 I 243

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/160 (28%), Positives = 73/160 (45%), Gaps = 21/160 (13%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILR 59
           ++H NV+    ++   +R +F   YI        L  II+S +          F   I  
Sbjct: 64  LEHPNVLKFIGVLYKDKRLNFITEYIK----GGTLRGIIKSMDSQYPWSQRVSFAKDIAS 119
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVT-------------SETDFMTE 106
           G+ Y+HS N++HRDL   N L+  N ++ + DFGLAR+               + D    
Sbjct: 120 GMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKR 179
Query: 107 YVVTR--WYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR 144
           Y V    ++ APE ++N   Y   +DV+S G +  E++ R
Sbjct: 180 YTVVGNPYWMAPE-MINGRSYDEKVDVFSFGIVLCEIIGR 218

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 71/148 (47%), Gaps = 14/148 (9%)
Query: 2   DHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQA-LSEEHCQYFLYQILR 59
           DH N++ +  ++   +      V I  E M+   L   +R + A  +       L  I  
Sbjct: 104 DHPNIIRLEGVVTKSK-----PVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIAS 158
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS---ETDFMTE--YVVTRWYR 114
           G+KY+     +HRDL   N+L+N+N   K+ DFGL+RV     E  + T    +  RW  
Sbjct: 159 GMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-T 217
Query: 115 APELLLNSSDYTAAIDVWSVGCIFMELM 142
           +PE +     +T+A DVWS G +  E+M
Sbjct: 218 SPEAIAYRK-FTSASDVWSYGIVLWEVM 244

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 70/148 (47%), Gaps = 14/148 (9%)
Query: 2   DHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQA-LSEEHCQYFLYQILR 59
           DH N++ +  ++   +      V I  E M+   L   +R + A  +       L  I  
Sbjct: 104 DHPNIIRLEGVVTKSK-----PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIAS 158
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS---ETDFMTE--YVVTRWYR 114
           G+KY+     +HRDL   N+L+N+N   K+ DFGL RV     E  + T    +  RW  
Sbjct: 159 GMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRW-T 217
Query: 115 APELLLNSSDYTAAIDVWSVGCIFMELM 142
           +PE +     +T+A DVWS G +  E+M
Sbjct: 218 SPEAIAYRK-FTSASDVWSYGIVLWEVM 244

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 58/101 (57%), Gaps = 6/101 (5%)
Query: 45  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSETDF 103
           L+ EH   + +Q+ +G++++ S   +HRDL   N+LL+    +KICDFGLAR +  + D 
Sbjct: 145 LTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDX 204
Query: 104 MTE---YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 141
           + +    +  +W  APE + +   YT   DVWS G +  E+
Sbjct: 205 VRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEI 243

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 59/101 (58%), Gaps = 6/101 (5%)
Query: 45  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSETDF 103
           L+ EH   + +Q+ +G++++ S   +HRDL   N+LL+    +KICDFGLAR +  + D+
Sbjct: 141 LTLEHLICYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDY 200
Query: 104 MTE---YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 141
           + +    +  +W  APE + +   YT   DVWS G +  E+
Sbjct: 201 VRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEI 239

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 70/148 (47%), Gaps = 14/148 (9%)
Query: 2   DHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQA-LSEEHCQYFLYQILR 59
           DH N++ +  ++          V I  E M+   L   +R N    +       L  I  
Sbjct: 88  DHPNIIHLEGVV-----TKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGS 142
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS---ETDFMTE--YVVTRWYR 114
           G+KY+   + +HRDL   N+L+N+N   K+ DFG++RV     E  + T    +  RW  
Sbjct: 143 GMKYLSDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWT- 201
Query: 115 APELLLNSSDYTAAIDVWSVGCIFMELM 142
           APE +     +T+A DVWS G +  E+M
Sbjct: 202 APEAIAYRK-FTSASDVWSYGIVMWEVM 228

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 62.4 bits (150), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 71/148 (47%), Gaps = 14/148 (9%)
Query: 2   DHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQA-LSEEHCQYFLYQILR 59
           DH N++ +  ++   +      V I  E M+   L   +R + A  +       L  I  
Sbjct: 104 DHPNIIRLEGVVTKSK-----PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIAS 158
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS---ETDFMTE--YVVTRWYR 114
           G+KY+     +HRDL   N+L+N+N   K+ DFGL+RV     E  + T    +  RW  
Sbjct: 159 GMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-T 217
Query: 115 APELLLNSSDYTAAIDVWSVGCIFMELM 142
           +PE +     +T+A DVWS G +  E+M
Sbjct: 218 SPEAIAYRK-FTSASDVWSYGIVLWEVM 244

>pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 106/270 (39%), Gaps = 74/270 (27%)
Query: 35  LHQIIRSN-QALSEEHCQYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNAN-------- 84
           L  II+SN Q L     +  + Q+L+GL Y+H+   ++H D+KP N+LL+ N        
Sbjct: 116 LKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLA 175
Query: 85  -----------------------------------------CDLKICDFGLARVTSETDF 103
                                                      +KI D G A    +   
Sbjct: 176 AEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHK--H 233
Query: 104 MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFP-------GRDHVHQ 156
            TE + TR YR+ E+L+ S  Y    D+WS  C+  EL     LF         RD  H 
Sbjct: 234 FTEDIQTRQYRSLEVLIGSG-YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDH- 291
Query: 157 LRLLIELIG-TPSEAELG-------FLNENAKKYICQL-PRYQRQSFTEKFPNVHPSA-- 205
           + L+IEL+G  P +  +        F  +   K+I +L P    +   EK+      A  
Sbjct: 292 IALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAG 351
Query: 206 -IDLVEKMLTFDPRQRITVEDALAHPYLGS 234
             D +  ML   P +R T  + L HP+L S
Sbjct: 352 FTDFLLPMLELIPEKRATAAECLRHPWLNS 381

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 71/148 (47%), Gaps = 14/148 (9%)
Query: 2   DHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQA-LSEEHCQYFLYQILR 59
           DH N++ +  ++   +      V I  E M+   L   +R + A  +       L  I  
Sbjct: 102 DHPNIIRLEGVVTKSK-----PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIAS 156
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS---ETDFMTE--YVVTRWYR 114
           G+KY+     +HRDL   N+L+N+N   K+ DFGL+RV     E  + T    +  RW  
Sbjct: 157 GMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-T 215
Query: 115 APELLLNSSDYTAAIDVWSVGCIFMELM 142
           +PE +     +T+A DVWS G +  E+M
Sbjct: 216 SPEAIAYRK-FTSASDVWSYGIVLWEVM 242

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 71/148 (47%), Gaps = 14/148 (9%)
Query: 2   DHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQA-LSEEHCQYFLYQILR 59
           DH N++ +  ++   +      V I  E M+   L   +R + A  +       L  I  
Sbjct: 75  DHPNIIRLEGVVTKSK-----PVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIAS 129
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS---ETDFMTE--YVVTRWYR 114
           G+KY+     +HRDL   N+L+N+N   K+ DFGL+RV     E  + T    +  RW  
Sbjct: 130 GMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-T 188
Query: 115 APELLLNSSDYTAAIDVWSVGCIFMELM 142
           +PE +     +T+A DVWS G +  E+M
Sbjct: 189 SPEAIAYRK-FTSASDVWSYGIVLWEVM 215

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 71/148 (47%), Gaps = 14/148 (9%)
Query: 2   DHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQA-LSEEHCQYFLYQILR 59
           DH N++ +  ++   +      V I  E M+   L   +R + A  +       L  I  
Sbjct: 104 DHPNIIRLEGVVTKSK-----PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIAS 158
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS---ETDFMTE--YVVTRWYR 114
           G+KY+     +HRDL   N+L+N+N   K+ DFGL+RV     E  + T    +  RW  
Sbjct: 159 GMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-T 217
Query: 115 APELLLNSSDYTAAIDVWSVGCIFMELM 142
           +PE +     +T+A DVWS G +  E+M
Sbjct: 218 SPEAIAYRK-FTSASDVWSYGIVLWEVM 244

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 71/148 (47%), Gaps = 14/148 (9%)
Query: 2   DHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQA-LSEEHCQYFLYQILR 59
           DH N++ +  ++   +      V I  E M+   L   +R + A  +       L  I  
Sbjct: 104 DHPNIIRLEGVVTKSK-----PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIAS 158
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS---ETDFMTE--YVVTRWYR 114
           G+KY+     +HRDL   N+L+N+N   K+ DFGL+RV     E  + T    +  RW  
Sbjct: 159 GMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-T 217
Query: 115 APELLLNSSDYTAAIDVWSVGCIFMELM 142
           +PE +     +T+A DVWS G +  E+M
Sbjct: 218 SPEAIAYRK-FTSASDVWSYGIVLWEVM 244

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 71/148 (47%), Gaps = 14/148 (9%)
Query: 2   DHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQA-LSEEHCQYFLYQILR 59
           DH N++ +  ++   +      V I  E M+   L   +R + A  +       L  I  
Sbjct: 104 DHPNIIRLEGVVTKSK-----PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIAS 158
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS---ETDFMTE--YVVTRWYR 114
           G+KY+     +HRDL   N+L+N+N   K+ DFGL+RV     E  + T    +  RW  
Sbjct: 159 GMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-T 217
Query: 115 APELLLNSSDYTAAIDVWSVGCIFMELM 142
           +PE +     +T+A DVWS G +  E+M
Sbjct: 218 SPEAIAYRK-FTSASDVWSYGIVLWEVM 244

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 71/148 (47%), Gaps = 14/148 (9%)
Query: 2   DHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQA-LSEEHCQYFLYQILR 59
           DH N++ +  ++   +      V I  E M+   L   +R + A  +       L  I  
Sbjct: 92  DHPNIIRLEGVVTKSK-----PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIAS 146
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS---ETDFMTE--YVVTRWYR 114
           G+KY+     +HRDL   N+L+N+N   K+ DFGL+RV     E  + T    +  RW  
Sbjct: 147 GMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-T 205
Query: 115 APELLLNSSDYTAAIDVWSVGCIFMELM 142
           +PE +     +T+A DVWS G +  E+M
Sbjct: 206 SPEAIAYRK-FTSASDVWSYGIVLWEVM 232

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 112
           QI  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR+  + ++          +W
Sbjct: 371 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 430
Query: 113 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL-FPG 150
             APE  L    +T   DVWS G +  EL  +  + +PG
Sbjct: 431 -TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 467

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 55/93 (59%), Gaps = 6/93 (6%)
Query: 53  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSETDFMTE---YV 108
           + +Q+ RG++++ S   +HRDL   N+LL+ N  +KICDFGLAR +    D++ +    +
Sbjct: 204 YSFQVARGMEFLSSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRL 263
Query: 109 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 141
             +W  APE + +   Y+   DVWS G +  E+
Sbjct: 264 PLKWM-APESIFDKI-YSTKSDVWSYGVLLWEI 294

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 47/150 (31%), Positives = 70/150 (46%), Gaps = 16/150 (10%)
Query: 2   DHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQA-LSEEHCQYFLYQILR 59
           DH NV+ +  ++          V I  E M+   L   +R N    +       L  I  
Sbjct: 66  DHPNVIHLEGVVTKS-----TPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAA 120
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV----TSE---TDFMTEYVVTRW 112
           G+KY+   N +HR L   N+L+N+N   K+ DFGL+R     TS+   T  +   +  RW
Sbjct: 121 GMKYLADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRW 180
Query: 113 YRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
             APE  +    +T+A DVWS G +  E+M
Sbjct: 181 -TAPE-AIQYRKFTSASDVWSYGIVMWEVM 208

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 62.0 bits (149), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/218 (23%), Positives = 98/218 (44%), Gaps = 31/218 (14%)
Query: 19  ESFNDVYIAYELMDT-DLHQIIRSNQ-ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKP 76
           ES  ++ + +E +   D+ + I ++   L+E     +++Q+   L+++HS N+ H D++P
Sbjct: 71  ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRP 130
Query: 77  SNLLLNA--NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV 134
            N++     +  +KI +FG AR     D          Y APE+  +    TA  D+WS+
Sbjct: 131 ENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTAT-DMWSL 189
Query: 135 GCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSF 194
           G +   L+    + P                        FL E  ++ I  +   +    
Sbjct: 190 GTLVYVLLS--GINP------------------------FLAETNQQIIENIMNAEYTFD 223
Query: 195 TEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
            E F  +   A+D V+++L  + + R+T  +AL HP+L
Sbjct: 224 EEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWL 261

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 71/148 (47%), Gaps = 14/148 (9%)
Query: 2   DHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQA-LSEEHCQYFLYQILR 59
           DH N++ +  ++   +      V I  E M+   L   +R + A  +       L  I  
Sbjct: 75  DHPNIIRLEGVVTKSK-----PVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIAS 129
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS---ETDFMTE--YVVTRWYR 114
           G+KY+     +HRDL   N+L+N+N   K+ DFGL+RV     E  + T    +  RW  
Sbjct: 130 GMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-T 188
Query: 115 APELLLNSSDYTAAIDVWSVGCIFMELM 142
           +PE +     +T+A DVWS G +  E+M
Sbjct: 189 SPEAIAYRK-FTSASDVWSYGIVLWEVM 215

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 79/166 (47%), Gaps = 20/166 (12%)
Query: 1   MDHENVVAIRDI-IPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           + H N++A+R + +  P      ++ +  E         + S + +  +    +  QI R
Sbjct: 63  LKHPNIIALRGVCLKEP------NLCLVMEFARGGPLNRVLSGKRIPPDILVNWAVQIAR 116
Query: 60  GLKYIHS---ANVLHRDLKPSNLLLN--------ANCDLKICDFGLARVTSETDFMTEYV 108
           G+ Y+H      ++HRDLK SN+L+         +N  LKI DFGLAR    T  M+   
Sbjct: 117 GMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAG 176
Query: 109 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHV 154
              W  APE++  +S ++   DVWS G +  EL+  +  F G D +
Sbjct: 177 AYAWM-APEVI-RASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGL 220

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 112
           QI  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR+  + ++          +W
Sbjct: 288 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 347
Query: 113 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL-FPG 150
             APE  L    +T   DVWS G +  EL  +  + +PG
Sbjct: 348 -TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 384

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 112
           QI  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR+  + ++          +W
Sbjct: 288 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 347
Query: 113 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL-FPG 150
             APE  L    +T   DVWS G +  EL  +  + +PG
Sbjct: 348 -TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 384

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 62.0 bits (149), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 112
           QI  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR+  + ++          +W
Sbjct: 288 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 347
Query: 113 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL-FPG 150
             APE  L    +T   DVWS G +  EL  +  + +PG
Sbjct: 348 -TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 384

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 112
           QI  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR+  + ++          +W
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 181
Query: 113 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL-FPG 150
             APE  L    +T   DVWS G +  EL  +  + +PG
Sbjct: 182 -TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 218

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 112
           QI  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR+  + ++          +W
Sbjct: 119 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 178
Query: 113 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL-FPG 150
             APE  L    +T   DVWS G +  EL  +  + +PG
Sbjct: 179 -TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 215

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 112
           QI  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR+  + ++          +W
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 181
Query: 113 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL-FPG 150
             APE  L    +T   DVWS G +  EL  +  + +PG
Sbjct: 182 -TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 218

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/230 (24%), Positives = 97/230 (42%), Gaps = 39/230 (16%)
Query: 25  YIAYE-LMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA 83
           Y+ +E L    +   I+  +  +E      +  +   L ++H+  + HRDLKP N+L  +
Sbjct: 87  YLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLKPENILCES 146
Query: 84  N---CDLKICDF----GLARVTSETDFMTEYVVT----RWYRAPELLLNSSD----YTAA 128
                 +KICDF    G+    S T   T  + T      Y APE++   +D    Y   
Sbjct: 147 PEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKR 206
Query: 129 IDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPR 188
            D+WS+G +   ++   P F G                   A+ G+ +      +CQ   
Sbjct: 207 CDLWSLGVVLYIMLSGYPPFVGH----------------CGADCGW-DRGEVCRVCQNKL 249
Query: 189 YQR-QSFTEKFPN-----VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
           ++  Q    +FP+     +   A DL+ K+L  D +QR++    L HP++
Sbjct: 250 FESIQEGKYEFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWV 299

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 61.6 bits (148), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 112
           QI  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR+  + ++          +W
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 181
Query: 113 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL-FPG 150
             APE  L    +T   DVWS G +  EL  +  + +PG
Sbjct: 182 -TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 218

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 112
           QI  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR+  + ++          +W
Sbjct: 115 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 174
Query: 113 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL-FPG 150
             APE  L    +T   DVWS G +  EL  +  + +PG
Sbjct: 175 -TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 211

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 112
           QI  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR+  + ++          +W
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 181
Query: 113 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL-FPG 150
             APE  L    +T   DVWS G +  EL  +  + +PG
Sbjct: 182 -TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 218

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 36/102 (35%), Positives = 52/102 (50%), Gaps = 4/102 (3%)
Query: 43  QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD 102
           + LS +      YQ+ RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR     D
Sbjct: 145 EQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 204
Query: 103 FMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFMEL 141
              +    R    + APE L +   YT   DVWS G +  E+
Sbjct: 205 XXKKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEI 245

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 112
           QI  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR+  + ++          +W
Sbjct: 113 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 172
Query: 113 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL-FPG 150
             APE  L    +T   DVWS G +  EL  +  + +PG
Sbjct: 173 -TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 209

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 112
           QI  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR+  + ++          +W
Sbjct: 111 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 170
Query: 113 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL-FPG 150
             APE  L    +T   DVWS G +  EL  +  + +PG
Sbjct: 171 -TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 207

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 112
           QI  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR+  + ++          +W
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 181
Query: 113 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL-FPG 150
             APE  L    +T   DVWS G +  EL  +  + +PG
Sbjct: 182 -TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 218

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 112
           QI  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR+  + ++          +W
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 181
Query: 113 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL-FPG 150
             APE  L    +T   DVWS G +  EL  +  + +PG
Sbjct: 182 -TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 218

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 61.6 bits (148), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 35/101 (34%), Positives = 58/101 (57%), Gaps = 6/101 (5%)
Query: 45  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSETDF 103
           L+ EH   + +Q+ +G++++ S   +HRDL   N+LL+    +KICDFGLAR +  + D 
Sbjct: 145 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDX 204
Query: 104 MTE---YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 141
           + +    +  +W  APE + +   YT   DVWS G +  E+
Sbjct: 205 VRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEI 243

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 61.2 bits (147), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 74/156 (47%), Gaps = 18/156 (11%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQAL---SEEHCQYFLYQ 56
           ++H N+V +            N V +  E  +   L+ ++   + L   +  H   +  Q
Sbjct: 59  VNHPNIVKLYG-------ACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQ 111
Query: 57  ILRGLKYIHSAN---VLHRDLKPSNLLLNANCD-LKICDFGLARVTSETDFMTEYVVTRW 112
             +G+ Y+HS     ++HRDLKP NLLL A    LKICDFG A        MT    +  
Sbjct: 112 CSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA--CDIQTHMTNNKGSAA 169
Query: 113 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 148
           + APE +   S+Y+   DV+S G I  E++ R+  F
Sbjct: 170 WMAPE-VFEGSNYSEKCDVFSWGIILWEVITRRKPF 204

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 95/223 (42%), Gaps = 43/223 (19%)
Query: 24  VYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA 83
           +Y+  E  + DL+  ++  +++     + +   +L  +  IH   ++H DLKP+N L+  
Sbjct: 103 IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-V 161
Query: 84  NCDLKICDFGLARVTSETDFMT---EYVVTRWYRAPELLLNSSD----------YTAAID 130
           +  LK+ DFG+A               V T  Y  PE + + S            +   D
Sbjct: 162 DGMLKLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSD 221
Query: 131 VWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQ 190
           VWS+GCI   +   K   P +  ++Q+  L  +I    E E                   
Sbjct: 222 VWSLGCILYYMTYGKT--PFQQIINQISKLHAIIDPNHEIE------------------- 260
Query: 191 RQSFTEKFPNVHPSAI-DLVEKMLTFDPRQRITVEDALAHPYL 232
                  FP++    + D+++  L  DP+QRI++ + LAHPY+
Sbjct: 261 -------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 296

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 52/99 (52%), Gaps = 6/99 (6%)
Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 112
           QI  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR+  + ++          +W
Sbjct: 119 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKW 178
Query: 113 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL-FPG 150
             APE  L    +T   DVWS G +  EL  +  + +PG
Sbjct: 179 -TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 215

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 54/100 (54%), Gaps = 8/100 (8%)
Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 112
           QI  G+ +I   N +HRDL+ +N+L++     KI DFGLAR+  + ++          +W
Sbjct: 127 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKW 186
Query: 113 YRAPELLLNSSDYTAAIDVWSVGCIFMELM--DRKPLFPG 150
             APE  +N   +T   DVWS G +  E++   R P +PG
Sbjct: 187 -TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIP-YPG 223

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 48/156 (30%), Positives = 74/156 (47%), Gaps = 18/156 (11%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQAL---SEEHCQYFLYQ 56
           ++H N+V +            N V +  E  +   L+ ++   + L   +  H   +  Q
Sbjct: 58  VNHPNIVKLYG-------ACLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQ 110
Query: 57  ILRGLKYIHSAN---VLHRDLKPSNLLLNANCD-LKICDFGLARVTSETDFMTEYVVTRW 112
             +G+ Y+HS     ++HRDLKP NLLL A    LKICDFG A        MT    +  
Sbjct: 111 CSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA--CDIQTHMTNNKGSAA 168
Query: 113 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF 148
           + APE +   S+Y+   DV+S G I  E++ R+  F
Sbjct: 169 WMAPE-VFEGSNYSEKCDVFSWGIILWEVITRRKPF 203

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 37/146 (25%), Positives = 73/146 (50%), Gaps = 3/146 (2%)
Query: 19  ESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 77
           ++ + +Y   E ++  DL   I+      E H  ++  +I  GL ++ S  +++RDLK  
Sbjct: 91  QTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLD 150
Query: 78  NLLLNANCDLKICDFGLARVTSETDFMTE-YVVTRWYRAPELLLNSSDYTAAIDVWSVGC 136
           N++L++   +KI DFG+ +        T+ +  T  Y APE++     Y  ++D W+ G 
Sbjct: 151 NVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQP-YGKSVDWWAFGV 209
Query: 137 IFMELMDRKPLFPGRDHVHQLRLLIE 162
           +  E++  +  F G D     + ++E
Sbjct: 210 LLYEMLAGQAPFEGEDEDELFQSIME 235

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 61.2 bits (147), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 70/148 (47%), Gaps = 14/148 (9%)
Query: 2   DHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQA-LSEEHCQYFLYQILR 59
           DH N++ +  ++          V I  E M+   L   +R N    +       L  I  
Sbjct: 73  DHPNIIHLEGVV-----TKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGS 127
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS---ETDFMTE--YVVTRWYR 114
           G+KY+   + +HRDL   N+L+N+N   K+ DFG++RV     E  + T    +  RW  
Sbjct: 128 GMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWT- 186
Query: 115 APELLLNSSDYTAAIDVWSVGCIFMELM 142
           APE +     +T+A DVWS G +  E+M
Sbjct: 187 APEAIAYRK-FTSASDVWSYGIVMWEVM 213

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 60.8 bits (146), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 54/100 (54%), Gaps = 8/100 (8%)
Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 112
           QI  G+ +I   N +HRDL+ +N+L++     KI DFGLAR+  + ++          +W
Sbjct: 123 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKW 182
Query: 113 YRAPELLLNSSDYTAAIDVWSVGCIFMELM--DRKPLFPG 150
             APE  +N   +T   DVWS G +  E++   R P +PG
Sbjct: 183 -TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIP-YPG 219

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 60.8 bits (146), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 54/100 (54%), Gaps = 8/100 (8%)
Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 112
           QI  G+ +I   N +HRDL+ +N+L++     KI DFGLAR+  + ++          +W
Sbjct: 112 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKW 171
Query: 113 YRAPELLLNSSDYTAAIDVWSVGCIFMELM--DRKPLFPG 150
             APE  +N   +T   DVWS G +  E++   R P +PG
Sbjct: 172 -TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIP-YPG 208

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 60.8 bits (146), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 54/100 (54%), Gaps = 8/100 (8%)
Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 112
           QI  G+ +I   N +HRDL+ +N+L++     KI DFGLAR+  + ++          +W
Sbjct: 122 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKW 181
Query: 113 YRAPELLLNSSDYTAAIDVWSVGCIFMELM--DRKPLFPG 150
             APE  +N   +T   DVWS G +  E++   R P +PG
Sbjct: 182 -TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIP-YPG 218

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 60.8 bits (146), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 70/148 (47%), Gaps = 14/148 (9%)
Query: 2   DHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQA-LSEEHCQYFLYQILR 59
           DH N++ +  ++          V I  E M+   L   +R N    +       L  I  
Sbjct: 67  DHPNIIHLEGVV-----TKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGS 121
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS---ETDFMTE--YVVTRWYR 114
           G+KY+   + +HRDL   N+L+N+N   K+ DFG++RV     E  + T    +  RW  
Sbjct: 122 GMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRW-T 180
Query: 115 APELLLNSSDYTAAIDVWSVGCIFMELM 142
           APE +     +T+A DVWS G +  E+M
Sbjct: 181 APEAIAYRK-FTSASDVWSYGIVMWEVM 207

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 60.8 bits (146), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 42/146 (28%), Positives = 70/146 (47%), Gaps = 10/146 (6%)
Query: 2   DHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGL 61
           DH N++ +  ++   +       Y+    +DT L    +++   +       L  I  G+
Sbjct: 81  DHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLK---KNDGQFTVIQLVGMLRGISAGM 137
Query: 62  KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS---ETDFMTE--YVVTRWYRAP 116
           KY+     +HRDL   N+L+N+N   K+ DFGL+RV     E  + T    +  RW  AP
Sbjct: 138 KYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRW-TAP 196
Query: 117 ELLLNSSDYTAAIDVWSVGCIFMELM 142
           E +     +T+A DVWS G +  E++
Sbjct: 197 EAIA-FRKFTSASDVWSYGIVMWEVV 221

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 33/93 (35%), Positives = 54/93 (58%), Gaps = 6/93 (6%)
Query: 53  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSETDFMTE---YV 108
           F YQ+ +G++++   + +HRDL   N+L+     +KICDFGLAR + S+++++      +
Sbjct: 177 FAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARL 236
Query: 109 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 141
             +W  APE L     YT   DVWS G +  E+
Sbjct: 237 PVKW-MAPESLFEGI-YTIKSDVWSYGILLWEI 267

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 60.8 bits (146), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 100/223 (44%), Gaps = 43/223 (19%)
Query: 24  VYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA 83
           +Y+  E  + DL+  ++  +++     + +   +L  +  IH   ++H DLKP+N L+  
Sbjct: 131 IYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-V 189
Query: 84  NCDLKICDFGLA-RVTSETDFMTE--YVVTRWYRAPELLLNSSD----------YTAAID 130
           +  LK+ DFG+A ++  +T  + +   V    Y  PE + + S            +   D
Sbjct: 190 DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSD 249
Query: 131 VWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQ 190
           VWS+GCI   +   K  F  +  ++Q+  L  +I    E E                   
Sbjct: 250 VWSLGCILYYMTYGKTPF--QQIINQISKLHAIIDPNHEIE------------------- 288
Query: 191 RQSFTEKFPNVHPSAI-DLVEKMLTFDPRQRITVEDALAHPYL 232
                  FP++    + D+++  L  DP+QRI++ + LAHPY+
Sbjct: 289 -------FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 324

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 54/100 (54%), Gaps = 8/100 (8%)
Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 112
           QI  G+ +I   N +HRDL+ +N+L++     KI DFGLAR+  + ++          +W
Sbjct: 117 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKW 176
Query: 113 YRAPELLLNSSDYTAAIDVWSVGCIFMELM--DRKPLFPG 150
             APE  +N   +T   DVWS G +  E++   R P +PG
Sbjct: 177 -TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIP-YPG 213

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 41/137 (29%), Positives = 75/137 (54%), Gaps = 9/137 (6%)
Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEY---VVTRW 112
           Q  RG+ Y+H+ +++HRDLK +N+ L+ +  +KI DFGLA V S      ++     +  
Sbjct: 116 QTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 175
Query: 113 YRAPEL--LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPS-E 169
           + APE+  + +S+ Y+   DV++ G +  ELM  +  +   ++  Q   +IE++G  S  
Sbjct: 176 WMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIEMVGRGSLS 232
Query: 170 AELGFLNENAKKYICQL 186
            +L  +  N  K + +L
Sbjct: 233 PDLSKVRSNCPKRMKRL 249

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 37/146 (25%), Positives = 73/146 (50%), Gaps = 3/146 (2%)
Query: 19  ESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 77
           ++ + +Y   E ++  DL   I+      E H  ++  +I  GL ++ S  +++RDLK  
Sbjct: 412 QTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLD 471
Query: 78  NLLLNANCDLKICDFGLARVTSETDFMTE-YVVTRWYRAPELLLNSSDYTAAIDVWSVGC 136
           N++L++   +KI DFG+ +        T+ +  T  Y APE++     Y  ++D W+ G 
Sbjct: 472 NVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQP-YGKSVDWWAFGV 530
Query: 137 IFMELMDRKPLFPGRDHVHQLRLLIE 162
           +  E++  +  F G D     + ++E
Sbjct: 531 LLYEMLAGQAPFEGEDEDELFQSIME 556

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 60.8 bits (146), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 51/99 (51%), Gaps = 6/99 (6%)
Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 112
           QI  G+ Y+   N +HRDL  +N+L+  N   K+ DFGLAR+  + ++          +W
Sbjct: 122 QIASGMAYVERMNYVHRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 181
Query: 113 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL-FPG 150
             APE  L    +T   DVWS G +  EL  +  + +PG
Sbjct: 182 -TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 218

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 60.5 bits (145), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 33/99 (33%), Positives = 51/99 (51%), Gaps = 6/99 (6%)
Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 112
           QI  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGL R+  + ++          +W
Sbjct: 289 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKW 348
Query: 113 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL-FPG 150
             APE  L    +T   DVWS G +  EL  +  + +PG
Sbjct: 349 -TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 385

>pdb|2X7G|A Chain A, Structure Of Human Serine-Arginine-Rich Protein-Specific Kinase 2 (Srpk2) Bound To Purvalanol B Length = 389

Iteration: 1
 Score = 60.5 bits (145), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 72/268 (26%), Positives = 107/268 (39%), Gaps = 72/268 (26%)
Query: 35  LHQIIRSN-QALSEEHCQYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNA--------- 83
           L  II+SN Q L     +  + Q+L+GL Y+HS   ++H D+KP N+L+           
Sbjct: 126 LKWIIKSNYQGLPVRCVKSIIRQVLQGLDYLHSKCKIIHTDIKPENILMCVDDAYVRRMA 185
Query: 84  -----------------------------------NCD---LKICDFGLARVTSETDFMT 105
                                              N D   +KI D G A    +    T
Sbjct: 186 AEATEWQKAGAPPPSGSAVSTAPAADLLVNPLDPRNADKIRVKIADLGNACWVHK--HFT 243
Query: 106 EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFP-------GRDHVHQLR 158
           E + TR YR+ E+L+ +  Y+   D+WS  C+  EL     LF         RD  H + 
Sbjct: 244 EDIQTRQYRSIEVLIGAG-YSTPADIWSTACMAFELATGDYLFEPHSGEDYSRDEDH-IA 301
Query: 159 LLIELIGT-PSEAELG------FLNENAK-KYICQL-PRYQRQSFTEKFPNVHPSA---I 206
            +IEL+G+ P    L       F N   + ++I +L P        EK+   H  A    
Sbjct: 302 HIIELLGSIPRHFALSGKYSREFFNRRGELRHITKLKPWSLFDVLVEKYGWPHEDAAQFT 361
Query: 207 DLVEKMLTFDPRQRITVEDALAHPYLGS 234
           D +  ML   P +R +  + L HP+L S
Sbjct: 362 DFLIPMLEMVPEKRASAGECLRHPWLNS 389

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/148 (31%), Positives = 72/148 (48%), Gaps = 14/148 (9%)
Query: 3   HENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQ-ALSEEHCQYFLYQILRG 60
           HEN+V  + I      +  N + +  E + +  L + +  N+  ++ +    +  QI +G
Sbjct: 82  HENIVKYKGIC---TEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKG 138
Query: 61  LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR------WYR 114
           + Y+ S   +HRDL   N+L+ +   +KI DFGL +   ETD     V         WY 
Sbjct: 139 MDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI-ETDKEXXTVKDDRDSPVFWY- 196
Query: 115 APELLLNSSDYTAAIDVWSVGCIFMELM 142
           APE L+ S  Y A+ DVWS G    EL+
Sbjct: 197 APECLMQSKFYIAS-DVWSFGVTLHELL 223

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 53/104 (50%), Gaps = 9/104 (8%)
Query: 53  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-- 110
           F  Q+ +G+KY+ S   +HRDL   N +L+    +K+ DFGLAR   + ++ + +  T  
Sbjct: 136 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGA 195
Query: 111 ----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFP 149
               +W       L +  +T   DVWS G +  ELM R  P +P
Sbjct: 196 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 237

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 51/99 (51%), Gaps = 6/99 (6%)
Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 112
           QI  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR+  + +           +W
Sbjct: 122 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKW 181
Query: 113 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL-FPG 150
             APE  L    +T   DVWS G +  EL  +  + +PG
Sbjct: 182 -TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 218

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 53/104 (50%), Gaps = 9/104 (8%)
Query: 53  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-- 110
           F  Q+ +G+KY+ S   +HRDL   N +L+    +K+ DFGLAR   + ++ + +  T  
Sbjct: 138 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGA 197
Query: 111 ----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFP 149
               +W       L +  +T   DVWS G +  ELM R  P +P
Sbjct: 198 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 239

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 53/104 (50%), Gaps = 9/104 (8%)
Query: 53  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-- 110
           F  Q+ +G+KY+ S   +HRDL   N +L+    +K+ DFGLAR   + ++ + +  T  
Sbjct: 137 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGA 196
Query: 111 ----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFP 149
               +W       L +  +T   DVWS G +  ELM R  P +P
Sbjct: 197 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 238

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/148 (31%), Positives = 72/148 (48%), Gaps = 14/148 (9%)
Query: 3   HENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQ-ALSEEHCQYFLYQILRG 60
           HEN+V  + I      +  N + +  E + +  L + +  N+  ++ +    +  QI +G
Sbjct: 70  HENIVKYKGIC---TEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKG 126
Query: 61  LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR------WYR 114
           + Y+ S   +HRDL   N+L+ +   +KI DFGL +   ETD     V         WY 
Sbjct: 127 MDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAI-ETDKEXXTVKDDRDSPVFWY- 184
Query: 115 APELLLNSSDYTAAIDVWSVGCIFMELM 142
           APE L+ S  Y A+ DVWS G    EL+
Sbjct: 185 APECLMQSKFYIAS-DVWSFGVTLHELL 211

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 60.1 bits (144), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 53/104 (50%), Gaps = 9/104 (8%)
Query: 53  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-- 110
           F  Q+ +G+KY+ S   +HRDL   N +L+    +K+ DFGLAR   + ++ + +  T  
Sbjct: 138 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGA 197
Query: 111 ----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFP 149
               +W       L +  +T   DVWS G +  ELM R  P +P
Sbjct: 198 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 239

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/142 (23%), Positives = 66/142 (46%), Gaps = 3/142 (2%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRG 60
           ++H N++ + DI    + + F  + +       DL   I  +  L E    Y   Q++  
Sbjct: 86  VEHANIIKVLDIF---ENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSA 142
Query: 61  LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL 120
           + Y+   +++HRD+K  N+++  +  +K+ DFG A           +  T  Y APE+L+
Sbjct: 143 VGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLM 202
Query: 121 NSSDYTAAIDVWSVGCIFMELM 142
            +      +++WS+G     L+
Sbjct: 203 GNPYRGPELEMWSLGVTLYTLV 224

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/99 (34%), Positives = 51/99 (51%), Gaps = 6/99 (6%)
Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 112
           QI  G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR+  + +           +W
Sbjct: 112 QIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKW 171
Query: 113 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL-FPG 150
             APE  L    +T   DVWS G +  EL  +  + +PG
Sbjct: 172 -TAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPG 208

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 53/104 (50%), Gaps = 9/104 (8%)
Query: 53  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-- 110
           F  Q+ +G+KY+ S   +HRDL   N +L+    +K+ DFGLAR   + ++ + +  T  
Sbjct: 133 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGA 192
Query: 111 ----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFP 149
               +W       L +  +T   DVWS G +  ELM R  P +P
Sbjct: 193 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 234

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 53/104 (50%), Gaps = 9/104 (8%)
Query: 53  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-- 110
           F  Q+ +G+KY+ S   +HRDL   N +L+    +K+ DFGLAR   + ++ + +  T  
Sbjct: 135 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGA 194
Query: 111 ----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFP 149
               +W       L +  +T   DVWS G +  ELM R  P +P
Sbjct: 195 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 236

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 53/104 (50%), Gaps = 9/104 (8%)
Query: 53  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-- 110
           F  Q+ +G+KY+ S   +HRDL   N +L+    +K+ DFGLAR   + ++ + +  T  
Sbjct: 157 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGA 216
Query: 111 ----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFP 149
               +W       L +  +T   DVWS G +  ELM R  P +P
Sbjct: 217 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 258

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 53/104 (50%), Gaps = 9/104 (8%)
Query: 53  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-- 110
           F  Q+ +G+KY+ S   +HRDL   N +L+    +K+ DFGLAR   + ++ + +  T  
Sbjct: 156 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGA 215
Query: 111 ----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFP 149
               +W       L +  +T   DVWS G +  ELM R  P +P
Sbjct: 216 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 257

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 53/104 (50%), Gaps = 9/104 (8%)
Query: 53  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-- 110
           F  Q+ +G+KY+ S   +HRDL   N +L+    +K+ DFGLAR   + ++ + +  T  
Sbjct: 130 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGA 189
Query: 111 ----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFP 149
               +W       L +  +T   DVWS G +  ELM R  P +P
Sbjct: 190 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 231

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 59.7 bits (143), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 53/100 (53%), Gaps = 8/100 (8%)
Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 112
           QI  G+ +I   N +HRDL+ +N+L++     KI DFGLAR+  + +           +W
Sbjct: 123 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKW 182
Query: 113 YRAPELLLNSSDYTAAIDVWSVGCIFMELM--DRKPLFPG 150
             APE  +N   +T   DVWS G +  E++   R P +PG
Sbjct: 183 -TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIP-YPG 219

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 53/100 (53%), Gaps = 8/100 (8%)
Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 112
           QI  G+ +I   N +HRDL+ +N+L++     KI DFGLAR+  + +           +W
Sbjct: 125 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKW 184
Query: 113 YRAPELLLNSSDYTAAIDVWSVGCIFMELM--DRKPLFPG 150
             APE  +N   +T   DVWS G +  E++   R P +PG
Sbjct: 185 -TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIP-YPG 221

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 51/97 (52%), Gaps = 9/97 (9%)
Query: 53  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV-------TSETDFMT 105
            L  I  G++Y+   + +HRDL   N+L+N+N   K+ DFGL+R         +ET  + 
Sbjct: 123 MLRGIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLG 182
Query: 106 EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
             +  RW  APE +     +T+A D WS G +  E+M
Sbjct: 183 GKIPIRWT-APEAIA-FRKFTSASDAWSYGIVMWEVM 217

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 53/100 (53%), Gaps = 8/100 (8%)
Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 112
           QI  G+ +I   N +HRDL+ +N+L++     KI DFGLAR+  + +           +W
Sbjct: 117 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKW 176
Query: 113 YRAPELLLNSSDYTAAIDVWSVGCIFMELM--DRKPLFPG 150
             APE  +N   +T   DVWS G +  E++   R P +PG
Sbjct: 177 -TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIP-YPG 213

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 53/100 (53%), Gaps = 8/100 (8%)
Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 112
           QI  G+ +I   N +HRDL+ +N+L++     KI DFGLAR+  + +           +W
Sbjct: 126 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKW 185
Query: 113 YRAPELLLNSSDYTAAIDVWSVGCIFMELM--DRKPLFPG 150
             APE  +N   +T   DVWS G +  E++   R P +PG
Sbjct: 186 -TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIP-YPG 222

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 53/100 (53%), Gaps = 8/100 (8%)
Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 112
           QI  G+ +I   N +HRDL+ +N+L++     KI DFGLAR+  + +           +W
Sbjct: 117 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKW 176
Query: 113 YRAPELLLNSSDYTAAIDVWSVGCIFMELM--DRKPLFPG 150
             APE  +N   +T   DVWS G +  E++   R P +PG
Sbjct: 177 -TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIP-YPG 213

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 58/101 (57%), Gaps = 6/101 (5%)
Query: 45  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSETDF 103
           L+ EH   + +Q+ +G++++ S   +HRDL   N+LL+    +KI DFGLAR +  + D+
Sbjct: 141 LTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDY 200
Query: 104 MTE---YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 141
           + +    +  +W  APE + +   YT   DVWS G +  E+
Sbjct: 201 VRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEI 239

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/102 (33%), Positives = 53/102 (51%), Gaps = 6/102 (5%)
Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 112
           Q+  G+ YI   N +HRDL+ +N+L+      KI DFGLAR+  + +           +W
Sbjct: 113 QVAAGMAYIERMNYIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKW 172
Query: 113 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL-FPGRDH 153
             APE  L    +T   DVWS G +  EL+ +  + +PG ++
Sbjct: 173 -TAPEAALYGR-FTIKSDVWSFGILLTELVTKGRVPYPGMNN 212

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/100 (34%), Positives = 54/100 (54%), Gaps = 8/100 (8%)
Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 112
           QI  G+ +I   N +HR+L+ +N+L++     KI DFGLAR+  + ++          +W
Sbjct: 113 QIAEGMAFIEERNYIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKW 172
Query: 113 YRAPELLLNSSDYTAAIDVWSVGCIFMELM--DRKPLFPG 150
             APE  +N   +T   DVWS G +  E++   R P +PG
Sbjct: 173 -TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIP-YPG 209

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 32/106 (30%), Positives = 57/106 (53%), Gaps = 14/106 (13%)
Query: 50  CQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF------ 103
           C +   QI   ++++HS  ++HRDLKPSN+    +  +K+ DFGL     + +       
Sbjct: 166 CLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 225
Query: 104 -MTEY------VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
            M  Y      V T+ Y +PE  ++ ++Y+  +D++S+G I  EL+
Sbjct: 226 PMPAYATHXGQVGTKLYMSPE-QIHGNNYSHKVDIFSLGLILFELL 270

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 59.3 bits (142), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 53/100 (53%), Gaps = 8/100 (8%)
Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 112
           QI  G+ +I   N +HRDL+ +N+L++     KI DFGLAR+  + +           +W
Sbjct: 118 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKW 177
Query: 113 YRAPELLLNSSDYTAAIDVWSVGCIFMELM--DRKPLFPG 150
             APE  +N   +T   DVWS G +  E++   R P +PG
Sbjct: 178 -TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIP-YPG 214

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 59.3 bits (142), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 53/100 (53%), Gaps = 8/100 (8%)
Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 112
           QI  G+ +I   N +HRDL+ +N+L++     KI DFGLAR+  + +           +W
Sbjct: 119 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKW 178
Query: 113 YRAPELLLNSSDYTAAIDVWSVGCIFMELM--DRKPLFPG 150
             APE  +N   +T   DVWS G +  E++   R P +PG
Sbjct: 179 -TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIP-YPG 215

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 35/100 (35%), Positives = 53/100 (53%), Gaps = 8/100 (8%)
Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RW 112
           QI  G+ +I   N +HRDL+ +N+L++     KI DFGLAR+  + +           +W
Sbjct: 117 QIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKW 176
Query: 113 YRAPELLLNSSDYTAAIDVWSVGCIFMELM--DRKPLFPG 150
             APE  +N   +T   DVWS G +  E++   R P +PG
Sbjct: 177 -TAPE-AINYGTFTIKSDVWSFGILLTEIVTHGRIP-YPG 213

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 53/104 (50%), Gaps = 9/104 (8%)
Query: 53  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-- 110
           F  Q+ +G+K++ S   +HRDL   N +L+    +K+ DFGLAR   + +F + +  T  
Sbjct: 138 FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 197
Query: 111 ----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFP 149
               +W       L +  +T   DVWS G +  ELM R  P +P
Sbjct: 198 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 239

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 53/104 (50%), Gaps = 9/104 (8%)
Query: 53  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-- 110
           F  Q+ +G+K++ S   +HRDL   N +L+    +K+ DFGLAR   + +F + +  T  
Sbjct: 139 FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 198
Query: 111 ----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFP 149
               +W       L +  +T   DVWS G +  ELM R  P +P
Sbjct: 199 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 240

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 53/104 (50%), Gaps = 9/104 (8%)
Query: 53  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-- 110
           F  Q+ +G+K++ S   +HRDL   N +L+    +K+ DFGLAR   + +F + +  T  
Sbjct: 197 FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 256
Query: 111 ----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFP 149
               +W       L +  +T   DVWS G +  ELM R  P +P
Sbjct: 257 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 298

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 53/104 (50%), Gaps = 9/104 (8%)
Query: 53  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-- 110
           F  Q+ +G+K++ S   +HRDL   N +L+    +K+ DFGLAR   + +F + +  T  
Sbjct: 143 FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 202
Query: 111 ----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFP 149
               +W       L +  +T   DVWS G +  ELM R  P +P
Sbjct: 203 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 244

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 53/104 (50%), Gaps = 9/104 (8%)
Query: 53  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-- 110
           F  Q+ +G+K++ S   +HRDL   N +L+    +K+ DFGLAR   + +F + +  T  
Sbjct: 138 FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 197
Query: 111 ----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFP 149
               +W       L +  +T   DVWS G +  ELM R  P +P
Sbjct: 198 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 239

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 53/104 (50%), Gaps = 9/104 (8%)
Query: 53  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-- 110
           F  Q+ +G+K++ S   +HRDL   N +L+    +K+ DFGLAR   + +F + +  T  
Sbjct: 136 FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGA 195
Query: 111 ----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFP 149
               +W       L +  +T   DVWS G +  ELM R  P +P
Sbjct: 196 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 237

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 53/104 (50%), Gaps = 9/104 (8%)
Query: 53  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-- 110
           F  Q+ +G+K++ S   +HRDL   N +L+    +K+ DFGLAR   + +F + +  T  
Sbjct: 139 FGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGA 198
Query: 111 ----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFP 149
               +W       L +  +T   DVWS G +  ELM R  P +P
Sbjct: 199 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 240

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 38/119 (31%), Positives = 65/119 (54%), Gaps = 10/119 (8%)
Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA----RVTSETDFMTEYVVTR 111
           Q  RG+ Y+H+ +++HRDLK +N+ L+ +  +KI DFGLA    R +    F        
Sbjct: 128 QTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSIL 187
Query: 112 WYRAPEL--LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPS 168
           W  APE+  + +S+ Y+   DV++ G +  ELM  +  +   ++  Q   +IE++G  S
Sbjct: 188 WM-APEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIEMVGRGS 242

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 58.9 bits (141), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 52/104 (50%), Gaps = 9/104 (8%)
Query: 53  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-- 110
           F  Q+ +G+KY+ S   +HRDL   N +L+    +K+ DFGLAR   + +  + +  T  
Sbjct: 137 FGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGA 196
Query: 111 ----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFP 149
               +W       L +  +T   DVWS G +  ELM R  P +P
Sbjct: 197 KLPVKWMALES--LQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 238

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 39/98 (39%), Positives = 51/98 (52%), Gaps = 13/98 (13%)
Query: 53  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR- 111
           F  QI  G+ Y+HS + +HR+L   N+LL+ +  +KI DFGLA+   E     EY   R 
Sbjct: 122 FAQQICEGMAYLHSQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGH---EYYRVRE 178
Query: 112 -------WYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
                  WY APE L     Y A+ DVWS G    EL+
Sbjct: 179 DGDSPVFWY-APECLKEYKFYYAS-DVWSFGVTLYELL 214

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 38/119 (31%), Positives = 65/119 (54%), Gaps = 10/119 (8%)
Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA----RVTSETDFMTEYVVTR 111
           Q  RG+ Y+H+ +++HRDLK +N+ L+ +  +KI DFGLA    R +    F        
Sbjct: 128 QTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSIL 187
Query: 112 WYRAPEL--LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPS 168
           W  APE+  + +S+ Y+   DV++ G +  ELM  +  +   ++  Q   +IE++G  S
Sbjct: 188 WM-APEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ---IIEMVGRGS 242

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 58.5 bits (140), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 51/90 (56%), Gaps = 5/90 (5%)
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVT---SETDFMTEYVVTRWYRAP 116
           G+ ++H  + +HRD+K +N+LL+     KI DFGLAR +   ++T   +  V T  Y AP
Sbjct: 145 GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAP 204
Query: 117 ELLLNSSDYTAAIDVWSVGCIFMELMDRKP 146
           E L    + T   D++S G + +E++   P
Sbjct: 205 EAL--RGEITPKSDIYSFGVVLLEIITGLP 232

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 34/107 (31%), Positives = 58/107 (54%), Gaps = 6/107 (5%)
Query: 41  SNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTS 99
           +N  LS     +F  Q+ +G+ ++ S N +HRD+   N+LL      KI DFGLAR + +
Sbjct: 157 ANSTLSTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMN 216
Query: 100 ETDFMTE---YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD 143
           +++++ +    +  +W  APE + +   YT   DVWS G +  E+  
Sbjct: 217 DSNYIVKGNARLPVKWM-APESIFDCV-YTVQSDVWSYGILLWEIFS 261

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 50/97 (51%), Gaps = 9/97 (9%)
Query: 53  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSE-------TDFMT 105
            L  I  G++Y+   + +HRDL   N+L+N+N   K+ DFGL+R   E       T  + 
Sbjct: 121 MLRGIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLG 180
Query: 106 EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
             +  RW  APE +     +T+A D WS G +  E+M
Sbjct: 181 GKIPIRWT-APEAIA-FRKFTSASDAWSYGIVMWEVM 215

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 31/110 (28%), Positives = 62/110 (56%), Gaps = 5/110 (4%)
Query: 35  LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL 94
           L++ ++ N+ + +++    ++Q+  G+KY+  +N +HRDL   N+LL      KI DFGL
Sbjct: 456 LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 515
Query: 95  AR-VTSETDFMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFME 140
           ++ + ++ ++       +W   + APE  +N   +++  DVWS G +  E
Sbjct: 516 SKALRADENYYKAQTHGKWPVKWYAPE-CINYYKFSSKSDVWSFGVLMWE 564

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 43/141 (30%), Positives = 61/141 (43%), Gaps = 3/141 (2%)
Query: 19  ESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS 77
           E    +Y+  EL    L Q   +   +L E     +L   L  L ++HS  ++H D+KP+
Sbjct: 127 EEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPA 186
Query: 78  NLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI 137
           N+ L      K+ DFGL                  Y APELL  S  Y  A DV+S+G  
Sbjct: 187 NIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQGS--YGTAADVFSLGLT 244
Query: 138 FMELMDRKPLFPGRDHVHQLR 158
            +E+     L  G +   QLR
Sbjct: 245 ILEVACNMELPHGGEGWQQLR 265

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 58.2 bits (139), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 31/110 (28%), Positives = 62/110 (56%), Gaps = 5/110 (4%)
Query: 35  LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL 94
           L++ ++ N+ + +++    ++Q+  G+KY+  +N +HRDL   N+LL      KI DFGL
Sbjct: 457 LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 516
Query: 95  AR-VTSETDFMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFME 140
           ++ + ++ ++       +W   + APE  +N   +++  DVWS G +  E
Sbjct: 517 SKALRADENYYKAQTHGKWPVKWYAPE-CINYYKFSSKSDVWSFGVLMWE 565

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 31/110 (28%), Positives = 62/110 (56%), Gaps = 5/110 (4%)
Query: 35  LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL 94
           L++ ++ N+ + +++    ++Q+  G+KY+  +N +HRDL   N+LL      KI DFGL
Sbjct: 114 LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 173
Query: 95  AR-VTSETDFMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFME 140
           ++ + ++ ++       +W   + APE  +N   +++  DVWS G +  E
Sbjct: 174 SKALRADENYYKAQTHGKWPVKWYAPE-CINYYKFSSKSDVWSFGVLMWE 222

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 31/110 (28%), Positives = 62/110 (56%), Gaps = 5/110 (4%)
Query: 35  LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL 94
           L++ ++ N+ + +++    ++Q+  G+KY+  +N +HRDL   N+LL      KI DFGL
Sbjct: 114 LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 173
Query: 95  AR-VTSETDFMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFME 140
           ++ + ++ ++       +W   + APE  +N   +++  DVWS G +  E
Sbjct: 174 SKALRADENYYKAQTHGKWPVKWYAPE-CINYYKFSSKSDVWSFGVLMWE 222

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 31/110 (28%), Positives = 62/110 (56%), Gaps = 5/110 (4%)
Query: 35  LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL 94
           L++ ++ N+ + +++    ++Q+  G+KY+  +N +HRDL   N+LL      KI DFGL
Sbjct: 112 LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 171
Query: 95  AR-VTSETDFMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFME 140
           ++ + ++ ++       +W   + APE  +N   +++  DVWS G +  E
Sbjct: 172 SKALRADENYYKAQTHGKWPVKWYAPE-CINYYKFSSKSDVWSFGVLMWE 220

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 57.8 bits (138), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 38/98 (38%), Positives = 51/98 (52%), Gaps = 13/98 (13%)
Query: 53  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR- 111
           F  QI  G+ Y+H+ + +HR+L   N+LL+ +  +KI DFGLA+   E     EY   R 
Sbjct: 122 FAQQICEGMAYLHAQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGH---EYYRVRE 178
Query: 112 -------WYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
                  WY APE L     Y A+ DVWS G    EL+
Sbjct: 179 DGDSPVFWY-APECLKEYKFYYAS-DVWSFGVTLYELL 214

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 57.4 bits (137), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 31/90 (34%), Positives = 50/90 (55%), Gaps = 5/90 (5%)
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVT---SETDFMTEYVVTRWYRAP 116
           G+ ++H  + +HRD+K +N+LL+     KI DFGLAR +   ++T      V T  Y AP
Sbjct: 145 GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAP 204
Query: 117 ELLLNSSDYTAAIDVWSVGCIFMELMDRKP 146
           E L    + T   D++S G + +E++   P
Sbjct: 205 EAL--RGEITPKSDIYSFGVVLLEIITGLP 232

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 57.4 bits (137), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 55/92 (59%), Gaps = 5/92 (5%)
Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSE---TDFMTEYVVTRW 112
           Q  +G+ Y+H+ N++HRD+K +N+ L+    +KI DFGLA V S    +  + +   +  
Sbjct: 140 QTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVL 199
Query: 113 YRAPEL--LLNSSDYTAAIDVWSVGCIFMELM 142
           + APE+  + +++ ++   DV+S G +  ELM
Sbjct: 200 WMAPEVIRMQDNNPFSFQSDVYSYGIVLYELM 231

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 31/110 (28%), Positives = 62/110 (56%), Gaps = 5/110 (4%)
Query: 35  LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL 94
           L++ ++ N+ + +++    ++Q+  G+KY+  +N +HRDL   N+LL      KI DFGL
Sbjct: 104 LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 163
Query: 95  AR-VTSETDFMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFME 140
           ++ + ++ ++       +W   + APE  +N   +++  DVWS G +  E
Sbjct: 164 SKALRADENYYKAQTHGKWPVKWYAPE-CINYYKFSSKSDVWSFGVLMWE 212

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 57.4 bits (137), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 31/110 (28%), Positives = 62/110 (56%), Gaps = 5/110 (4%)
Query: 35  LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL 94
           L++ ++ N+ + +++    ++Q+  G+KY+  +N +HRDL   N+LL      KI DFGL
Sbjct: 98  LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 157
Query: 95  AR-VTSETDFMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFME 140
           ++ + ++ ++       +W   + APE  +N   +++  DVWS G +  E
Sbjct: 158 SKALRADENYYKAQTHGKWPVKWYAPE-CINYYKFSSKSDVWSFGVLMWE 206

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 38/125 (30%), Positives = 64/125 (51%), Gaps = 7/125 (5%)
Query: 24  VYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 82
           +Y+  E M   DL  ++ SN  + E+  +++  +++  L  IHS   +HRD+KP N+LL+
Sbjct: 149 LYMVMEYMPGGDLVNLM-SNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD 207
Query: 83  ANCDLKICDFGLARVTSETDFM--TEYVVTRWYRAPELLLNSSD---YTAAIDVWSVGCI 137
            +  LK+ DFG     ++   +     V T  Y +PE+L +      Y    D WSVG  
Sbjct: 208 KSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVF 267
Query: 138 FMELM 142
             E++
Sbjct: 268 LYEML 272

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 31/110 (28%), Positives = 62/110 (56%), Gaps = 5/110 (4%)
Query: 35  LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL 94
           L++ ++ N+ + +++    ++Q+  G+KY+  +N +HRDL   N+LL      KI DFGL
Sbjct: 94  LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 153
Query: 95  AR-VTSETDFMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFME 140
           ++ + ++ ++       +W   + APE  +N   +++  DVWS G +  E
Sbjct: 154 SKALRADENYYKAQTHGKWPVKWYAPE-CINYYKFSSKSDVWSFGVLMWE 202

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 31/110 (28%), Positives = 62/110 (56%), Gaps = 5/110 (4%)
Query: 35  LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL 94
           L++ ++ N+ + +++    ++Q+  G+KY+  +N +HRDL   N+LL      KI DFGL
Sbjct: 92  LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 151
Query: 95  AR-VTSETDFMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIFME 140
           ++ + ++ ++       +W   + APE  +N   +++  DVWS G +  E
Sbjct: 152 SKALRADENYYKAQTHGKWPVKWYAPE-CINYYKFSSKSDVWSFGVLMWE 200

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 38/97 (39%), Positives = 50/97 (51%), Gaps = 11/97 (11%)
Query: 53  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR- 111
           F  QI  G+ Y+H+ + +HRDL   N+LL+ +  +KI DFGLA+   E      Y V   
Sbjct: 139 FAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH--EXYRVRED 196
Query: 112 ------WYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
                 WY APE L     Y A+ DVWS G    EL+
Sbjct: 197 GDSPVFWY-APECLKEYKFYYAS-DVWSFGVTLYELL 231

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 38/98 (38%), Positives = 50/98 (51%), Gaps = 13/98 (13%)
Query: 53  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR- 111
           F  QI  G+ Y+H+ + +HR L   N+LL+ +  +KI DFGLA+   E     EY   R 
Sbjct: 116 FAQQICEGMAYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGH---EYYRVRE 172
Query: 112 -------WYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
                  WY APE L     Y A+ DVWS G    EL+
Sbjct: 173 DGDSPVFWY-APECLKECKFYYAS-DVWSFGVTLYELL 208

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 38/98 (38%), Positives = 50/98 (51%), Gaps = 13/98 (13%)
Query: 53  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR- 111
           F  QI  G+ Y+H+ + +HR L   N+LL+ +  +KI DFGLA+   E     EY   R 
Sbjct: 117 FAQQICEGMAYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGH---EYYRVRE 173
Query: 112 -------WYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
                  WY APE L     Y A+ DVWS G    EL+
Sbjct: 174 DGDSPVFWY-APECLKECKFYYAS-DVWSFGVTLYELL 209

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 38/125 (30%), Positives = 64/125 (51%), Gaps = 7/125 (5%)
Query: 24  VYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 82
           +Y+  E M   DL  ++ SN  + E+  +++  +++  L  IHS   +HRD+KP N+LL+
Sbjct: 144 LYMVMEYMPGGDLVNLM-SNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD 202
Query: 83  ANCDLKICDFGLARVTSETDFM--TEYVVTRWYRAPELLLNSSD---YTAAIDVWSVGCI 137
            +  LK+ DFG     ++   +     V T  Y +PE+L +      Y    D WSVG  
Sbjct: 203 KSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVF 262
Query: 138 FMELM 142
             E++
Sbjct: 263 LYEML 267

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 38/125 (30%), Positives = 64/125 (51%), Gaps = 7/125 (5%)
Query: 24  VYIAYELM-DTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 82
           +Y+  E M   DL  ++ SN  + E+  +++  +++  L  IHS   +HRD+KP N+LL+
Sbjct: 149 LYMVMEYMPGGDLVNLM-SNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLD 207
Query: 83  ANCDLKICDFGLARVTSETDFM--TEYVVTRWYRAPELLLNSSD---YTAAIDVWSVGCI 137
            +  LK+ DFG     ++   +     V T  Y +PE+L +      Y    D WSVG  
Sbjct: 208 KSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVF 267
Query: 138 FMELM 142
             E++
Sbjct: 268 LYEML 272

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 57.0 bits (136), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 40/147 (27%), Positives = 69/147 (46%), Gaps = 12/147 (8%)
Query: 2   DHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGL 61
           DH N++ +  ++   +       Y+    +DT L      +   +       L  +  G+
Sbjct: 108 DHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGM 164
Query: 62  KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT------RWYRA 115
           +Y+     +HRDL   N+L+++N   K+ DFGL+RV  E D    Y  T      RW  A
Sbjct: 165 RYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL-EDDPDAAYTTTGGKIPIRWT-A 222
Query: 116 PELLLNSSDYTAAIDVWSVGCIFMELM 142
           PE +   + +++A DVWS G +  E++
Sbjct: 223 PEAIAFRT-FSSASDVWSFGVVMWEVL 248

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 51/99 (51%), Gaps = 8/99 (8%)
Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMT----EYVVTR 111
           QI  G+ Y+ S + +HRDL   N L+ AN  +KI DFG++R    TD+        +  R
Sbjct: 141 QIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR 200
Query: 112 WYRAPELLLNSSDYTAAIDVWSVGCIFMELM--DRKPLF 148
           W   PE ++    +T   DVWS G I  E+    ++P F
Sbjct: 201 WM-PPESIMYRK-FTTESDVWSFGVILWEIFTYGKQPWF 237

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/107 (30%), Positives = 57/107 (53%), Gaps = 6/107 (5%)
Query: 41  SNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTS 99
           +N   S     +F  Q+ +G+ ++ S N +HRD+   N+LL      KI DFGLAR + +
Sbjct: 157 ANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMN 216
Query: 100 ETDFMTE---YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD 143
           +++++ +    +  +W  APE + +   YT   DVWS G +  E+  
Sbjct: 217 DSNYIVKGNARLPVKWM-APESIFDCV-YTVQSDVWSYGILLWEIFS 261

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 55/104 (52%), Gaps = 6/104 (5%)
Query: 43  QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD 102
           +AL+      F +QI +G++Y+   +++HRDL   N+L+     +KI DFGL+R   E D
Sbjct: 145 RALTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204
Query: 103 FMTE----YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
              +     +  +W  A E L +   YT   DVWS G +  E++
Sbjct: 205 SXVKRSQGRIPVKWM-AIESLFDHI-YTTQSDVWSFGVLLWEIV 246

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/140 (29%), Positives = 66/140 (47%), Gaps = 20/140 (14%)
Query: 29  ELMDTDLHQIIRSNQALSEEHCQYFL---YQILRGLKYIHSAN--VLHRDLKPSNLLLNA 83
           EL    L + ++  ++     C   L   YQ  R ++++H     ++HRDLK  NLLL+ 
Sbjct: 114 ELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSN 173
Query: 84  NCDLKICDFGLARVTS---------ETDFMTEYVVTR----WYRAPELLLNSSDYTAA-- 128
              +K+CDFG A   S         +   + E  +TR     YR PE++   S++     
Sbjct: 174 QGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEK 233
Query: 129 IDVWSVGCIFMELMDRKPLF 148
            D+W++GCI   L  R+  F
Sbjct: 234 QDIWALGCILYLLCFRQHPF 253

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 56.2 bits (134), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/105 (31%), Positives = 57/105 (54%), Gaps = 6/105 (5%)
Query: 43  QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSET 101
           + LS     +F  Q+ +G+ ++ S N +HRD+   N+LL      KI DFGLAR + +++
Sbjct: 161 EQLSSRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDS 220
Query: 102 DFMTE---YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD 143
           +++ +    +  +W  APE + +   YT   DVWS G +  E+  
Sbjct: 221 NYIVKGNARLPVKW-MAPESIFDCV-YTVQSDVWSYGILLWEIFS 263

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 86/200 (43%), Gaps = 34/200 (17%)
Query: 34  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 93
           +L++ ++ +    E+     + ++   L Y H   V+HRD+KP NLLL    +LKI DFG
Sbjct: 109 ELYKELQKSCTFDEQRTATIMEELADALMYCHGKKVIHRDIKPENLLLGLKGELKIADFG 168
Query: 94  LARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDH 153
            + V + +        T  Y  PE ++    +   +D+W +G +  EL+   P F    H
Sbjct: 169 WS-VHAPSLRRKTMCGTLDYLPPE-MIEGRMHNEKVDLWCIGVLCYELLVGNPPFESASH 226
Query: 154 VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPS-AIDLVEKM 212
               R ++++                                 KFP   P+ A DL+ K+
Sbjct: 227 NETYRRIVKV-------------------------------DLKFPASVPTGAQDLISKL 255
Query: 213 LTFDPRQRITVEDALAHPYL 232
           L  +P +R+ +    AHP++
Sbjct: 256 LRHNPSERLPLAQVSAHPWV 275

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 54/92 (58%), Gaps = 5/92 (5%)
Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEY---VVTRW 112
           Q  +G+ Y+H+ +++HRDLK +N+ L+ +  +KI DFGLA V S      ++     +  
Sbjct: 117 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 176
Query: 113 YRAPEL--LLNSSDYTAAIDVWSVGCIFMELM 142
           + APE+  + + + Y+   DV++ G +  ELM
Sbjct: 177 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELM 208

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 54/92 (58%), Gaps = 5/92 (5%)
Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEY---VVTRW 112
           Q  +G+ Y+H+ +++HRDLK +N+ L+ +  +KI DFGLA V S      ++     +  
Sbjct: 117 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 176
Query: 113 YRAPEL--LLNSSDYTAAIDVWSVGCIFMELM 142
           + APE+  + + + Y+   DV++ G +  ELM
Sbjct: 177 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELM 208

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 54/92 (58%), Gaps = 5/92 (5%)
Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEY---VVTRW 112
           Q  +G+ Y+H+ +++HRDLK +N+ L+ +  +KI DFGLA V S      ++     +  
Sbjct: 140 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 199
Query: 113 YRAPEL--LLNSSDYTAAIDVWSVGCIFMELM 142
           + APE+  + + + Y+   DV++ G +  ELM
Sbjct: 200 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELM 231

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 48/94 (51%), Gaps = 5/94 (5%)
Query: 53  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD-FMTEYVVTR 111
            L+Q+  G+KY+   N +HRDL   N+LL      KI DFGL++     D + T     +
Sbjct: 115 LLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 174
Query: 112 W---YRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
           W   + APE  +N   +++  DVWS G    E +
Sbjct: 175 WPLKWYAPE-CINFRKFSSRSDVWSYGVTMWEAL 207

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 54/92 (58%), Gaps = 5/92 (5%)
Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEY---VVTRW 112
           Q  +G+ Y+H+ +++HRDLK +N+ L+ +  +KI DFGLA V S      ++     +  
Sbjct: 114 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 173
Query: 113 YRAPEL--LLNSSDYTAAIDVWSVGCIFMELM 142
           + APE+  + + + Y+   DV++ G +  ELM
Sbjct: 174 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELM 205

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/104 (32%), Positives = 54/104 (51%), Gaps = 6/104 (5%)
Query: 43  QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD 102
           +AL+      F +QI +G++Y+    ++HRDL   N+L+     +KI DFGL+R   E D
Sbjct: 145 RALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204
Query: 103 FMTE----YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
              +     +  +W  A E L +   YT   DVWS G +  E++
Sbjct: 205 SXVKRSQGRIPVKWM-AIESLFDHI-YTTQSDVWSFGVLLWEIV 246

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 54/92 (58%), Gaps = 5/92 (5%)
Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEY---VVTRW 112
           Q  +G+ Y+H+ +++HRDLK +N+ L+ +  +KI DFGLA V S      ++     +  
Sbjct: 139 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 198
Query: 113 YRAPEL--LLNSSDYTAAIDVWSVGCIFMELM 142
           + APE+  + + + Y+   DV++ G +  ELM
Sbjct: 199 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELM 230

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 50/97 (51%), Gaps = 13/97 (13%)
Query: 53  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR- 111
           +  QI +G++Y+ +   +HRDL   N+L+     +KI DFGL +V  +     E+   + 
Sbjct: 119 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQD---KEFFKVKE 175
Query: 112 -------WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 141
                  WY APE  L  S ++ A DVWS G +  EL
Sbjct: 176 PGESPIFWY-APE-SLTESKFSVASDVWSFGVVLYEL 210

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 55.8 bits (133), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/95 (35%), Positives = 51/95 (53%), Gaps = 13/95 (13%)
Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR---- 111
           QI +G++Y+ S   +HRDL   N+L+ +   +KI DFGLA++        +Y V R    
Sbjct: 122 QICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLP---LDKDYYVVREPGQ 178
Query: 112 ----WYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
               WY APE  L+ + ++   DVWS G +  EL 
Sbjct: 179 SPIFWY-APE-SLSDNIFSRQSDVWSFGVVLYELF 211

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 54/92 (58%), Gaps = 5/92 (5%)
Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEY---VVTRW 112
           Q  +G+ Y+H+ +++HRDLK +N+ L+ +  +KI DFGLA V S      ++     +  
Sbjct: 112 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 171
Query: 113 YRAPEL--LLNSSDYTAAIDVWSVGCIFMELM 142
           + APE+  + + + Y+   DV++ G +  ELM
Sbjct: 172 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELM 203

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 30/92 (32%), Positives = 54/92 (58%), Gaps = 5/92 (5%)
Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEY---VVTRW 112
           Q  +G+ Y+H+ +++HRDLK +N+ L+ +  +KI DFGLA V S      ++     +  
Sbjct: 112 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 171
Query: 113 YRAPEL--LLNSSDYTAAIDVWSVGCIFMELM 142
           + APE+  + + + Y+   DV++ G +  ELM
Sbjct: 172 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELM 203

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 50/90 (55%), Gaps = 5/90 (5%)
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVT---SETDFMTEYVVTRWYRAP 116
           G+ ++H  + +HRD+K +N+LL+     KI DFGLAR +   ++    +  V T  Y AP
Sbjct: 136 GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAP 195
Query: 117 ELLLNSSDYTAAIDVWSVGCIFMELMDRKP 146
           E L    + T   D++S G + +E++   P
Sbjct: 196 EAL--RGEITPKSDIYSFGVVLLEIITGLP 223

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/95 (35%), Positives = 51/95 (53%), Gaps = 13/95 (13%)
Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR---- 111
           QI +G++Y+ S   +HRDL   N+L+ +   +KI DFGLA++        +Y V R    
Sbjct: 123 QICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLP---LDKDYYVVREPGQ 179
Query: 112 ----WYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
               WY APE  L+ + ++   DVWS G +  EL 
Sbjct: 180 SPIFWY-APE-SLSDNIFSRQSDVWSFGVVLYELF 212

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/105 (32%), Positives = 51/105 (48%), Gaps = 8/105 (7%)
Query: 43  QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD 102
           +AL+      F +QI +G++Y+    ++HRDL   N+L+     +KI DFGL+R   E D
Sbjct: 145 RALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEED 204
Query: 103 FMTEYVVTRWYRAPELLLNSSD-----YTAAIDVWSVGCIFMELM 142
               YV     R P   +         YT   DVWS G +  E++
Sbjct: 205 ---SYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 246

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 33/111 (29%), Positives = 60/111 (54%), Gaps = 7/111 (6%)
Query: 35  LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL 94
           L++ ++ N+ + +++    ++Q+  G+KY+  +N +HRDL   N+LL      KI DFGL
Sbjct: 98  LNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGL 157
Query: 95  ARV--TSETDFMTEY---VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME 140
           ++     E  +  +       +WY APE  +N   +++  DVWS G +  E
Sbjct: 158 SKALRADENXYKAQTHGKWPVKWY-APE-CINYYKFSSKSDVWSFGVLMWE 206

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 55.8 bits (133), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 33/115 (28%), Positives = 60/115 (52%), Gaps = 12/115 (10%)
Query: 34  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 93
           DL   I+ ++   E   +++  +I+  L ++H   +++RDLK  N+LL+     K+ DFG
Sbjct: 110 DLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFG 169
Query: 94  LAR------VTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
           + +      VT+ T     +  T  Y APE +L    Y  A+D W++G +  E++
Sbjct: 170 MCKEGICNGVTTAT-----FCGTPDYIAPE-ILQEMLYGPAVDWWAMGVLLYEML 218

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 55.5 bits (132), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 34/94 (36%), Positives = 51/94 (54%), Gaps = 13/94 (13%)
Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR---- 111
           QI +G++Y+ S   +HRDL   N+L+ +   +KI DFGLA++        +Y V R    
Sbjct: 135 QICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLP---LDKDYYVVREPGQ 191
Query: 112 ----WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 141
               WY APE  L+ + ++   DVWS G +  EL
Sbjct: 192 SPIFWY-APE-SLSDNIFSRQSDVWSFGVVLYEL 223

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 33/97 (34%), Positives = 50/97 (51%), Gaps = 13/97 (13%)
Query: 53  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR- 111
           +  QI +G++Y+ +   +HR+L   N+L+     +KI DFGL +V  +     EY   + 
Sbjct: 120 YTSQICKGMEYLGTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQD---KEYYKVKE 176
Query: 112 -------WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 141
                  WY APE  L  S ++ A DVWS G +  EL
Sbjct: 177 PGESPIFWY-APE-SLTESKFSVASDVWSFGVVLYEL 211

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 55.5 bits (132), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 49/90 (54%), Gaps = 5/90 (5%)
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVT---SETDFMTEYVVTRWYRAP 116
           G+ ++H  + +HRD+K +N+LL+     KI DFGLAR +   ++       V T  Y AP
Sbjct: 139 GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAP 198
Query: 117 ELLLNSSDYTAAIDVWSVGCIFMELMDRKP 146
           E L    + T   D++S G + +E++   P
Sbjct: 199 EAL--RGEITPKSDIYSFGVVLLEIITGLP 226

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 44/152 (28%), Positives = 71/152 (46%), Gaps = 20/152 (13%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDV--YIAYELMDTDLHQIIRSNQALSE--EHCQYFLY- 55
           + H+N+V  + +     R +   +  Y+ Y  +   L       QA +E  +H +   Y 
Sbjct: 71  LQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL-------QAHAERIDHIKLLQYT 123
Query: 56  -QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR--- 111
            QI +G++Y+ +   +HRDL   N+L+     +KI DFGL +V  +     +        
Sbjct: 124 SQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESP 183
Query: 112 --WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 141
             WY APE  L  S ++ A DVWS G +  EL
Sbjct: 184 IFWY-APE-SLTESKFSVASDVWSFGVVLYEL 213

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 38/116 (32%), Positives = 56/116 (48%), Gaps = 5/116 (4%)
Query: 30  LMDTDLHQIIRSNQA--LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDL 87
           +++TD    I ++ A  LS +   +F   + RG+ Y+     +HRDL   N+L+  N   
Sbjct: 122 VLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA 181
Query: 88  KICDFGLARVTSETDFMT-EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
           KI DFGL+R        T   +  RW       LN S YT   DVWS G +  E++
Sbjct: 182 KIADFGLSRGQEVYVKKTMGRLPVRWMAIES--LNYSVYTTNSDVWSYGVLLWEIV 235

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 35/109 (32%), Positives = 55/109 (50%), Gaps = 7/109 (6%)
Query: 39  IRSNQA-LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV 97
           +R N+  L  +    +  QI +G+ Y+    ++HRDL   N+L+ +   +KI DFGLAR+
Sbjct: 109 VRENRGRLGSQDLLNWCMQIAKGMSYLEDVRLVHRDLAARNVLVKSPNHVKITDFGLARL 168
Query: 98  --TSETDFMTE--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
               ET++  +   V  +W     +L     +T   DVWS G    ELM
Sbjct: 169 LDIDETEYHADGGKVPIKWMALESILRRR--FTHQSDVWSYGVTVWELM 215

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 37/110 (33%), Positives = 51/110 (46%), Gaps = 12/110 (10%)
Query: 45  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG-----LARVTS 99
           L+E+   + L  I RGL+ IH+    HRDLKP+N+LL       + D G        V  
Sbjct: 131 LTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEG 190
Query: 100 ETDFMT--EYVVTRW---YRAPELLLNSSDYT--AAIDVWSVGCIFMELM 142
               +T  ++   R    YRAPEL    S        DVWS+GC+   +M
Sbjct: 191 SRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMM 240

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 55.1 bits (131), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 38/116 (32%), Positives = 56/116 (48%), Gaps = 5/116 (4%)
Query: 30  LMDTDLHQIIRSNQA--LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDL 87
           +++TD    I ++ A  LS +   +F   + RG+ Y+     +HRDL   N+L+  N   
Sbjct: 112 VLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA 171
Query: 88  KICDFGLARVTSETDFMT-EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
           KI DFGL+R        T   +  RW       LN S YT   DVWS G +  E++
Sbjct: 172 KIADFGLSRGQEVYVKKTMGRLPVRWMAIES--LNYSVYTTNSDVWSYGVLLWEIV 225

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 55.1 bits (131), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 54/94 (57%), Gaps = 6/94 (6%)
Query: 52  YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSETDFMTE---Y 107
           +F  Q+ +G+ ++ S N +HRD+   N+LL      KI DFGLAR + ++++++ +    
Sbjct: 164 HFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNAR 223
Query: 108 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 141
           +  +W  APE + +   YT   DVWS G +  E+
Sbjct: 224 LPVKWM-APESIFDCV-YTVQSDVWSYGILLWEI 255

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 48/94 (51%), Gaps = 7/94 (7%)
Query: 53  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR- 111
           +  QI +G++Y+ +   +HRDL   N+L+     +KI DFGL +V  +     +      
Sbjct: 150 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 209
Query: 112 ----WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 141
               WY APE  L  S ++ A DVWS G +  EL
Sbjct: 210 SPIFWY-APE-SLTESKFSVASDVWSFGVVLYEL 241

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 48/94 (51%), Gaps = 7/94 (7%)
Query: 53  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR- 111
           +  QI +G++Y+ +   +HRDL   N+L+     +KI DFGL +V  +     +      
Sbjct: 117 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 176
Query: 112 ----WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 141
               WY APE  L  S ++ A DVWS G +  EL
Sbjct: 177 SPIFWY-APE-SLTESKFSVASDVWSFGVVLYEL 208

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 48/94 (51%), Gaps = 7/94 (7%)
Query: 53  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR- 111
           +  QI +G++Y+ +   +HRDL   N+L+     +KI DFGL +V  +     +      
Sbjct: 122 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 181
Query: 112 ----WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 141
               WY APE  L  S ++ A DVWS G +  EL
Sbjct: 182 SPIFWY-APE-SLTESKFSVASDVWSFGVVLYEL 213

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 54/94 (57%), Gaps = 6/94 (6%)
Query: 52  YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSETDFMTE---Y 107
           +F  Q+ +G+ ++ S N +HRD+   N+LL      KI DFGLAR + ++++++ +    
Sbjct: 162 HFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNAR 221
Query: 108 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 141
           +  +W  APE + +   YT   DVWS G +  E+
Sbjct: 222 LPVKWM-APESIFDCV-YTVQSDVWSYGILLWEI 253

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 54/94 (57%), Gaps = 6/94 (6%)
Query: 52  YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSETDFMTE---Y 107
           +F  Q+ +G+ ++ S N +HRD+   N+LL      KI DFGLAR + ++++++ +    
Sbjct: 156 HFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNAR 215
Query: 108 VVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 141
           +  +W  APE + +   YT   DVWS G +  E+
Sbjct: 216 LPVKWM-APESIFDCV-YTVQSDVWSYGILLWEI 247

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 48/94 (51%), Gaps = 7/94 (7%)
Query: 53  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR- 111
           +  QI +G++Y+ +   +HRDL   N+L+     +KI DFGL +V  +     +      
Sbjct: 118 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 177
Query: 112 ----WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 141
               WY APE  L  S ++ A DVWS G +  EL
Sbjct: 178 SPIFWY-APE-SLTESKFSVASDVWSFGVVLYEL 209

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 48/94 (51%), Gaps = 7/94 (7%)
Query: 53  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR- 111
           +  QI +G++Y+ +   +HRDL   N+L+     +KI DFGL +V  +     +      
Sbjct: 126 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 185
Query: 112 ----WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 141
               WY APE  L  S ++ A DVWS G +  EL
Sbjct: 186 SPIFWY-APE-SLTESKFSVASDVWSFGVVLYEL 217

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 48/94 (51%), Gaps = 7/94 (7%)
Query: 53  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR- 111
           +  QI +G++Y+ +   +HRDL   N+L+     +KI DFGL +V  +     +      
Sbjct: 123 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 182
Query: 112 ----WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 141
               WY APE  L  S ++ A DVWS G +  EL
Sbjct: 183 SPIFWY-APE-SLTESKFSVASDVWSFGVVLYEL 214

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 48/94 (51%), Gaps = 7/94 (7%)
Query: 53  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR- 111
           +  QI +G++Y+ +   +HRDL   N+L+     +KI DFGL +V  +     +      
Sbjct: 119 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 178
Query: 112 ----WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 141
               WY APE  L  S ++ A DVWS G +  EL
Sbjct: 179 SPIFWY-APE-SLTESKFSVASDVWSFGVVLYEL 210

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 48/94 (51%), Gaps = 7/94 (7%)
Query: 53  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR- 111
           +  QI +G++Y+ +   +HRDL   N+L+     +KI DFGL +V  +     +      
Sbjct: 122 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 181
Query: 112 ----WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 141
               WY APE  L  S ++ A DVWS G +  EL
Sbjct: 182 SPIFWY-APE-SLTESKFSVASDVWSFGVVLYEL 213

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 48/94 (51%), Gaps = 7/94 (7%)
Query: 53  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR- 111
           +  QI +G++Y+ +   +HRDL   N+L+     +KI DFGL +V  +     +      
Sbjct: 119 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 178
Query: 112 ----WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 141
               WY APE  L  S ++ A DVWS G +  EL
Sbjct: 179 SPIFWY-APE-SLTESKFSVASDVWSFGVVLYEL 210

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 54.7 bits (130), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 48/94 (51%), Gaps = 5/94 (5%)
Query: 53  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD-FMTEYVVTR 111
            L+Q+  G+KY+   N +HR+L   N+LL      KI DFGL++     D + T     +
Sbjct: 441 LLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 500
Query: 112 W---YRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
           W   + APE  +N   +++  DVWS G    E +
Sbjct: 501 WPLKWYAPE-CINFRKFSSRSDVWSYGVTMWEAL 533

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 48/94 (51%), Gaps = 7/94 (7%)
Query: 53  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR- 111
           +  QI +G++Y+ +   +HRDL   N+L+     +KI DFGL +V  +     +      
Sbjct: 124 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 183
Query: 112 ----WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 141
               WY APE  L  S ++ A DVWS G +  EL
Sbjct: 184 SPIFWY-APE-SLTESKFSVASDVWSFGVVLYEL 215

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 48/94 (51%), Gaps = 7/94 (7%)
Query: 53  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR- 111
           +  QI +G++Y+ +   +HRDL   N+L+     +KI DFGL +V  +     +      
Sbjct: 125 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 184
Query: 112 ----WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 141
               WY APE  L  S ++ A DVWS G +  EL
Sbjct: 185 SPIFWY-APE-SLTESKFSVASDVWSFGVVLYEL 216

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 48/94 (51%), Gaps = 7/94 (7%)
Query: 53  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR- 111
           +  QI +G++Y+ +   +HRDL   N+L+     +KI DFGL +V  +     +      
Sbjct: 137 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 196
Query: 112 ----WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 141
               WY APE  L  S ++ A DVWS G +  EL
Sbjct: 197 SPIFWY-APE-SLTESKFSVASDVWSFGVVLYEL 228

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 54.7 bits (130), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 32/94 (34%), Positives = 48/94 (51%), Gaps = 7/94 (7%)
Query: 53  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR- 111
           +  QI +G++Y+ +   +HRDL   N+L+     +KI DFGL +V  +     +      
Sbjct: 137 YTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGE 196
Query: 112 ----WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 141
               WY APE  L  S ++ A DVWS G +  EL
Sbjct: 197 SPIFWY-APE-SLTESKFSVASDVWSFGVVLYEL 228

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 54.3 bits (129), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 36/146 (24%), Positives = 67/146 (45%), Gaps = 10/146 (6%)
Query: 2   DHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGL 61
           DH N++ +  ++   +       Y+    +DT L      +   +       L  +  G+
Sbjct: 108 DHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRT---HDGQFTIMQLVGMLRGVGAGM 164
Query: 62  KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV-----TSETDFMTEYVVTRWYRAP 116
           +Y+     +HRDL   N+L+++N   K+ DFGL+RV      +        +  RW  AP
Sbjct: 165 RYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAXTTTGGKIPIRWT-AP 223
Query: 117 ELLLNSSDYTAAIDVWSVGCIFMELM 142
           E +   + +++A DVWS G +  E++
Sbjct: 224 EAIAFRT-FSSASDVWSFGVVMWEVL 248

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 52/93 (55%), Gaps = 7/93 (7%)
Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA----RVTSETDFMTEYVVTR 111
           Q  +G+ Y+H+ +++HRDLK +N+ L+ +  +KI DFGLA    R +    F        
Sbjct: 140 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSIL 199
Query: 112 WYRAPEL--LLNSSDYTAAIDVWSVGCIFMELM 142
           W  APE+  + + + Y+   DV++ G +  ELM
Sbjct: 200 WM-APEVIRMQDKNPYSFQSDVYAFGIVLYELM 231

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 52/93 (55%), Gaps = 7/93 (7%)
Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA----RVTSETDFMTEYVVTR 111
           Q  +G+ Y+H+ +++HRDLK +N+ L+ +  +KI DFGLA    R +    F        
Sbjct: 132 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSIL 191
Query: 112 WYRAPEL--LLNSSDYTAAIDVWSVGCIFMELM 142
           W  APE+  + + + Y+   DV++ G +  ELM
Sbjct: 192 WM-APEVIRMQDKNPYSFQSDVYAFGIVLYELM 223

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/129 (26%), Positives = 64/129 (49%), Gaps = 7/129 (5%)
Query: 24  VYIAYELMDTD-LHQIIRSNQAL-SEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 81
           + + +E M+   L   +R+ + L + E        +  G+ Y+  A+V+HRDL   N L+
Sbjct: 77  ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEASVIHRDLAARNCLV 136
Query: 82  NANCDLKICDFGLARVTSETDFMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIF 138
             N  +K+ DFG+ R   +  + T    T++   + +PE + + S Y++  DVWS G + 
Sbjct: 137 GENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPE-VFSFSRYSSKSDVWSFGVLM 194
Query: 139 MELMDRKPL 147
            E+     +
Sbjct: 195 WEVFSEGKI 203

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 53.9 bits (128), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 31/93 (33%), Positives = 52/93 (55%), Gaps = 7/93 (7%)
Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA----RVTSETDFMTEYVVTR 111
           Q  +G+ Y+H+ +++HRDLK +N+ L+ +  +KI DFGLA    R +    F        
Sbjct: 112 QTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSIL 171
Query: 112 WYRAPEL--LLNSSDYTAAIDVWSVGCIFMELM 142
           W  APE+  + + + Y+   DV++ G +  ELM
Sbjct: 172 WM-APEVIRMQDKNPYSFQSDVYAFGIVLYELM 203

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/153 (26%), Positives = 72/153 (47%), Gaps = 11/153 (7%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRG 60
           +DH ++V +  II         ++Y   EL     H + R+  +L       +  QI + 
Sbjct: 70  LDHPHIVKLIGIIEEEPTWIIMELYPYGELG----HYLERNKNSLKVLTLVLYSLQICKA 125
Query: 61  LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVV---TRWYRAPE 117
           + Y+ S N +HRD+   N+L+ +   +K+ DFGL+R   + D+    V     +W  +PE
Sbjct: 126 MAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKW-MSPE 184
Query: 118 LLLNSSDYTAAIDVWSVGCIFMELMD--RKPLF 148
             +N   +T A DVW       E++   ++P F
Sbjct: 185 -SINFRRFTTASDVWMFAVCMWEILSFGKQPFF 216

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/153 (26%), Positives = 72/153 (47%), Gaps = 11/153 (7%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRG 60
           +DH ++V +  II         ++Y   EL     H + R+  +L       +  QI + 
Sbjct: 82  LDHPHIVKLIGIIEEEPTWIIMELYPYGELG----HYLERNKNSLKVLTLVLYSLQICKA 137
Query: 61  LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVV---TRWYRAPE 117
           + Y+ S N +HRD+   N+L+ +   +K+ DFGL+R   + D+    V     +W  +PE
Sbjct: 138 MAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWM-SPE 196
Query: 118 LLLNSSDYTAAIDVWSVGCIFMELMD--RKPLF 148
             +N   +T A DVW       E++   ++P F
Sbjct: 197 -SINFRRFTTASDVWMFAVCMWEILSFGKQPFF 228

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 73/146 (50%), Gaps = 13/146 (8%)
Query: 2   DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ-ALSEEHCQYFLYQILR 59
           DH ++V +  +I      + N V+I  EL    +L   ++  + +L       + YQ+  
Sbjct: 449 DHPHIVKLIGVI------TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLST 502
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE---YVVTRWYRAP 116
            L Y+ S   +HRD+   N+L+++N  +K+ DFGL+R   ++ +       +  +W  AP
Sbjct: 503 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM-AP 561
Query: 117 ELLLNSSDYTAAIDVWSVGCIFMELM 142
           E  +N   +T+A DVW  G    E++
Sbjct: 562 E-SINFRRFTSASDVWMFGVCMWEIL 586

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 73/146 (50%), Gaps = 13/146 (8%)
Query: 2   DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ-ALSEEHCQYFLYQILR 59
           DH ++V +  +I      + N V+I  EL    +L   ++  + +L       + YQ+  
Sbjct: 97  DHPHIVKLIGVI------TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 150
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEY---VVTRWYRAP 116
            L Y+ S   +HRD+   N+L+++N  +K+ DFGL+R   ++ +       +  +W  AP
Sbjct: 151 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM-AP 209
Query: 117 ELLLNSSDYTAAIDVWSVGCIFMELM 142
           E  +N   +T+A DVW  G    E++
Sbjct: 210 E-SINFRRFTSASDVWMFGVCMWEIL 234

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/153 (26%), Positives = 72/153 (47%), Gaps = 11/153 (7%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRG 60
           +DH ++V +  II         ++Y   EL     H + R+  +L       +  QI + 
Sbjct: 66  LDHPHIVKLIGIIEEEPTWIIMELYPYGELG----HYLERNKNSLKVLTLVLYSLQICKA 121
Query: 61  LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVV---TRWYRAPE 117
           + Y+ S N +HRD+   N+L+ +   +K+ DFGL+R   + D+    V     +W  +PE
Sbjct: 122 MAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKW-MSPE 180
Query: 118 LLLNSSDYTAAIDVWSVGCIFMELMD--RKPLF 148
             +N   +T A DVW       E++   ++P F
Sbjct: 181 -SINFRRFTTASDVWMFAVCMWEILSFGKQPFF 212

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 73/146 (50%), Gaps = 13/146 (8%)
Query: 2   DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ-ALSEEHCQYFLYQILR 59
           DH ++V +  +I      + N V+I  EL    +L   ++  + +L       + YQ+  
Sbjct: 71  DHPHIVKLIGVI------TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 124
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE---YVVTRWYRAP 116
            L Y+ S   +HRD+   N+L+++N  +K+ DFGL+R   ++ +       +  +W  AP
Sbjct: 125 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM-AP 183
Query: 117 ELLLNSSDYTAAIDVWSVGCIFMELM 142
           E  +N   +T+A DVW  G    E++
Sbjct: 184 E-SINFRRFTSASDVWMFGVCMWEIL 208

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 73/146 (50%), Gaps = 13/146 (8%)
Query: 2   DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ-ALSEEHCQYFLYQILR 59
           DH ++V +  +I      + N V+I  EL    +L   ++  + +L       + YQ+  
Sbjct: 66  DHPHIVKLIGVI------TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 119
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE---YVVTRWYRAP 116
            L Y+ S   +HRD+   N+L+++N  +K+ DFGL+R   ++ +       +  +W  AP
Sbjct: 120 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM-AP 178
Query: 117 ELLLNSSDYTAAIDVWSVGCIFMELM 142
           E  +N   +T+A DVW  G    E++
Sbjct: 179 E-SINFRRFTSASDVWMFGVCMWEIL 203

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/235 (22%), Positives = 101/235 (42%), Gaps = 40/235 (17%)
Query: 23  DVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 82
           D Y+  +L    L  + +    L EE  +++L +++  +  +H  + +HRD+KP N+L++
Sbjct: 154 DYYVGGDL----LTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMD 209
Query: 83  ANCDLKICDFG--LARVTSETDFMTEYVVTRWYRAPELLL----NSSDYTAAIDVWSVG- 135
            N  +++ DFG  L  +   T   +  V T  Y +PE+L         Y    D WS+G 
Sbjct: 210 MNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGV 269
Query: 136 CIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFT 195
           C++  L    P +           L+E  G               K +    R+Q   F 
Sbjct: 270 CMYEMLYGETPFYA--------ESLVETYG---------------KIMNHKERFQ---FP 303
Query: 196 EKFPNVHPSAIDLVEKMLTFDPRQ--RITVEDALAHPYLGSLHDISDEPVCMSPF 248
            +  +V  +A DL+ +++     +  +  +ED   HP+   + D  +   C +P+
Sbjct: 304 TQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGI-DWDNIRNCEAPY 357

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 73/146 (50%), Gaps = 13/146 (8%)
Query: 2   DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ-ALSEEHCQYFLYQILR 59
           DH ++V +  +I      + N V+I  EL    +L   ++  + +L       + YQ+  
Sbjct: 69  DHPHIVKLIGVI------TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 122
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE---YVVTRWYRAP 116
            L Y+ S   +HRD+   N+L+++N  +K+ DFGL+R   ++ +       +  +W  AP
Sbjct: 123 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM-AP 181
Query: 117 ELLLNSSDYTAAIDVWSVGCIFMELM 142
           E  +N   +T+A DVW  G    E++
Sbjct: 182 E-SINFRRFTSASDVWMFGVCMWEIL 206

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 73/146 (50%), Gaps = 13/146 (8%)
Query: 2   DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ-ALSEEHCQYFLYQILR 59
           DH ++V +  +I      + N V+I  EL    +L   ++  + +L       + YQ+  
Sbjct: 72  DHPHIVKLIGVI------TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 125
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE---YVVTRWYRAP 116
            L Y+ S   +HRD+   N+L+++N  +K+ DFGL+R   ++ +       +  +W  AP
Sbjct: 126 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM-AP 184
Query: 117 ELLLNSSDYTAAIDVWSVGCIFMELM 142
           E  +N   +T+A DVW  G    E++
Sbjct: 185 E-SINFRRFTSASDVWMFGVCMWEIL 209

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 53.5 bits (127), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 73/146 (50%), Gaps = 13/146 (8%)
Query: 2   DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ-ALSEEHCQYFLYQILR 59
           DH ++V +  +I      + N V+I  EL    +L   ++  + +L       + YQ+  
Sbjct: 69  DHPHIVKLIGVI------TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 122
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE---YVVTRWYRAP 116
            L Y+ S   +HRD+   N+L+++N  +K+ DFGL+R   ++ +       +  +W  AP
Sbjct: 123 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM-AP 181
Query: 117 ELLLNSSDYTAAIDVWSVGCIFMELM 142
           E  +N   +T+A DVW  G    E++
Sbjct: 182 E-SINFRRFTSASDVWMFGVCMWEIL 206

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 32/101 (31%), Positives = 51/101 (50%), Gaps = 6/101 (5%)
Query: 45  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM 104
           L++    +   QI  G+ Y+ S + +HRDL   N L+  N  +KI DFG++R    TD+ 
Sbjct: 125 LTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYY 184
Query: 105 T----EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 141
                  +  RW   PE ++    +T   DVWS+G +  E+
Sbjct: 185 RVGGHTMLPIRWM-PPESIM-YRKFTTESDVWSLGVVLWEI 223

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 37/116 (31%), Positives = 56/116 (48%), Gaps = 5/116 (4%)
Query: 30  LMDTDLHQIIRSNQA--LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDL 87
           +++TD    I ++ A  LS +   +F   + RG+ Y+     +HR+L   N+L+  N   
Sbjct: 119 VLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRNLAARNILVGENYVA 178
Query: 88  KICDFGLARVTSETDFMT-EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
           KI DFGL+R        T   +  RW       LN S YT   DVWS G +  E++
Sbjct: 179 KIADFGLSRGQEVYVKKTMGRLPVRWMAIES--LNYSVYTTNSDVWSYGVLLWEIV 232

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 53.1 bits (126), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 73/146 (50%), Gaps = 13/146 (8%)
Query: 2   DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ-ALSEEHCQYFLYQILR 59
           DH ++V +  +I      + N V+I  EL    +L   ++  + +L       + YQ+  
Sbjct: 74  DHPHIVKLIGVI------TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLST 127
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE---YVVTRWYRAP 116
            L Y+ S   +HRD+   N+L+++N  +K+ DFGL+R   ++ +       +  +W  AP
Sbjct: 128 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM-AP 186
Query: 117 ELLLNSSDYTAAIDVWSVGCIFMELM 142
           E  +N   +T+A DVW  G    E++
Sbjct: 187 E-SINFRRFTSASDVWMFGVCMWEIL 211

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 49/90 (54%), Gaps = 6/90 (6%)
Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE----YVVTR 111
           +I  G+ Y+++   +HRDL   N ++  +  +KI DFG+ R   ETD+  +     +  R
Sbjct: 137 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 196
Query: 112 WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 141
           W  APE L +   +T + D+WS G +  E+
Sbjct: 197 WM-APESLKDGV-FTTSSDMWSFGVVLWEI 224

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 49/90 (54%), Gaps = 6/90 (6%)
Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE----YVVTR 111
           +I  G+ Y+++   +HRDL   N ++  +  +KI DFG+ R   ETD+  +     +  R
Sbjct: 138 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 197
Query: 112 WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 141
           W  APE L +   +T + D+WS G +  E+
Sbjct: 198 WM-APESLKDGV-FTTSSDMWSFGVVLWEI 225

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 59/113 (52%), Gaps = 9/113 (7%)
Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE----YVVTR 111
           +I  G+ Y+++   +HRDL   N ++  +  +KI DFG+ R   ETD+  +     +  R
Sbjct: 146 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 205
Query: 112 WYRAPELLLNSSDYTAAIDVWSVGCIFMEL--MDRKPLFPGRDHVHQLRLLIE 162
           W  +PE L +   +T   DVWS G +  E+  +  +P + G  +   LR ++E
Sbjct: 206 WM-SPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQP-YQGLSNEQVLRFVME 255

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 53.1 bits (126), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 30/96 (31%), Positives = 46/96 (47%), Gaps = 6/96 (6%)
Query: 53  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-- 110
           F+  I  G++Y+ S N +HRDL   N +L  +  + + DFGL+R     D+  +   +  
Sbjct: 142 FMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKL 201
Query: 111 --RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR 144
             +W     L  N   YT   DVW+ G    E+M R
Sbjct: 202 PVKWLALESLADNL--YTVHSDVWAFGVTMWEIMTR 235

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 40/144 (27%), Positives = 66/144 (45%), Gaps = 10/144 (6%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELM-DTDLHQIIRSN--QALSEEHCQYFLYQI 57
           + H N+V +  +I     E    +YI  E M    L   +RS     L  +    F   +
Sbjct: 62  LRHSNLVQLLGVIV----EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 117
Query: 58  LRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPE 117
              ++Y+   N +HRDL   N+L++ +   K+ DFGL +  S T    +  V   + APE
Sbjct: 118 CEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK--WTAPE 175
Query: 118 LLLNSSDYTAAIDVWSVGCIFMEL 141
            L  ++ ++   DVWS G +  E+
Sbjct: 176 ALREAA-FSTKSDVWSFGILLWEI 198

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 59/113 (52%), Gaps = 9/113 (7%)
Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE----YVVTR 111
           +I  G+ Y+++   +HRDL   N ++  +  +KI DFG+ R   ETD+  +     +  R
Sbjct: 146 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 205
Query: 112 WYRAPELLLNSSDYTAAIDVWSVGCIFMEL--MDRKPLFPGRDHVHQLRLLIE 162
           W  +PE L +   +T   DVWS G +  E+  +  +P + G  +   LR ++E
Sbjct: 206 WM-SPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQP-YQGLSNEQVLRFVME 255

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 59/113 (52%), Gaps = 9/113 (7%)
Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE----YVVTR 111
           +I  G+ Y+++   +HRDL   N ++  +  +KI DFG+ R   ETD+  +     +  R
Sbjct: 137 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 196
Query: 112 WYRAPELLLNSSDYTAAIDVWSVGCIFMEL--MDRKPLFPGRDHVHQLRLLIE 162
           W  +PE L +   +T   DVWS G +  E+  +  +P + G  +   LR ++E
Sbjct: 197 WM-SPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQP-YQGLSNEQVLRFVME 246

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 59/113 (52%), Gaps = 9/113 (7%)
Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE----YVVTR 111
           +I  G+ Y+++   +HRDL   N ++  +  +KI DFG+ R   ETD+  +     +  R
Sbjct: 140 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 199
Query: 112 WYRAPELLLNSSDYTAAIDVWSVGCIFMEL--MDRKPLFPGRDHVHQLRLLIE 162
           W  +PE L +   +T   DVWS G +  E+  +  +P + G  +   LR ++E
Sbjct: 200 WM-SPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQP-YQGLSNEQVLRFVME 249

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 59/113 (52%), Gaps = 9/113 (7%)
Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE----YVVTR 111
           +I  G+ Y+++   +HRDL   N ++  +  +KI DFG+ R   ETD+  +     +  R
Sbjct: 168 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 227
Query: 112 WYRAPELLLNSSDYTAAIDVWSVGCIFMEL--MDRKPLFPGRDHVHQLRLLIE 162
           W  +PE L +   +T   DVWS G +  E+  +  +P + G  +   LR ++E
Sbjct: 228 WM-SPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQP-YQGLSNEQVLRFVME 277

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 65/145 (44%), Gaps = 13/145 (8%)
Query: 2   DHENVVAIRDIIPPPQRESFNDVYIAYELM-DTDLHQIIRSNQA-LSEEHCQYFLYQILR 59
            H N+V +  +    Q      +YI  EL+   D    +R+  A L  +     +     
Sbjct: 170 SHPNIVRLIGVCTQKQ-----PIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAA 224
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMT----EYVVTRWYRA 115
           G++Y+ S   +HRDL   N L+     LKI DFG++R  ++  +        V  +W  A
Sbjct: 225 GMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKW-TA 283
Query: 116 PELLLNSSDYTAAIDVWSVGCIFME 140
           PE  LN   Y++  DVWS G +  E
Sbjct: 284 PE-ALNYGRYSSESDVWSFGILLWE 307

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 59/113 (52%), Gaps = 9/113 (7%)
Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE----YVVTR 111
           +I  G+ Y+++   +HRDL   N ++  +  +KI DFG+ R   ETD+  +     +  R
Sbjct: 133 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 192
Query: 112 WYRAPELLLNSSDYTAAIDVWSVGCIFMEL--MDRKPLFPGRDHVHQLRLLIE 162
           W  +PE L +   +T   DVWS G +  E+  +  +P + G  +   LR ++E
Sbjct: 193 WM-SPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQP-YQGLSNEQVLRFVME 242

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 33/94 (35%), Positives = 50/94 (53%), Gaps = 13/94 (13%)
Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR---- 111
           QI +G++Y+ S   +HRDL   N+L+ +   +KI DFGLA++        +  V R    
Sbjct: 119 QICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLP---LDKDXXVVREPGQ 175
Query: 112 ----WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 141
               WY APE  L+ + ++   DVWS G +  EL
Sbjct: 176 SPIFWY-APE-SLSDNIFSRQSDVWSFGVVLYEL 207

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 59/113 (52%), Gaps = 9/113 (7%)
Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE----YVVTR 111
           +I  G+ Y+++   +HRDL   N ++  +  +KI DFG+ R   ETD+  +     +  R
Sbjct: 139 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 198
Query: 112 WYRAPELLLNSSDYTAAIDVWSVGCIFMEL--MDRKPLFPGRDHVHQLRLLIE 162
           W  +PE L +   +T   DVWS G +  E+  +  +P + G  +   LR ++E
Sbjct: 199 WM-SPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQP-YQGLSNEQVLRFVME 248

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 48/90 (53%), Gaps = 6/90 (6%)
Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE----YVVTR 111
           +I  G+ Y+++   +HRDL   N ++  +  +KI DFG+ R   ETD   +     +  R
Sbjct: 138 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 197
Query: 112 WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 141
           W  APE L +   +T + D+WS G +  E+
Sbjct: 198 WM-APESLKDGV-FTTSSDMWSFGVVLWEI 225

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 59/113 (52%), Gaps = 9/113 (7%)
Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE----YVVTR 111
           +I  G+ Y+++   +HRDL   N ++  +  +KI DFG+ R   ETD+  +     +  R
Sbjct: 139 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 198
Query: 112 WYRAPELLLNSSDYTAAIDVWSVGCIFMEL--MDRKPLFPGRDHVHQLRLLIE 162
           W  +PE L +   +T   DVWS G +  E+  +  +P + G  +   LR ++E
Sbjct: 199 WM-SPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQP-YQGLSNEQVLRFVME 248

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 32/111 (28%), Positives = 54/111 (48%), Gaps = 4/111 (3%)
Query: 34  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL--LNANCDLKICD 91
           DL   I     L E   + F  Q++  +++ HS  V+HRD+K  N+L  L   C  K+ D
Sbjct: 125 DLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGC-AKLID 183
Query: 92  FGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
           FG   +  +  + T++  TR Y  PE +     +     VWS+G +  +++
Sbjct: 184 FGSGALLHDEPY-TDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMV 233

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 28/90 (31%), Positives = 42/90 (46%), Gaps = 6/90 (6%)
Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM----TEYVVTR 111
           Q+  G+ Y+     +HRDL   N L+  N  +KI DFGL+R     D+      + +  R
Sbjct: 182 QVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIR 241
Query: 112 WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 141
           W     +  N   YT   DVW+ G +  E+
Sbjct: 242 WMPPESIFYNR--YTTESDVWAYGVVLWEI 269

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 72/146 (49%), Gaps = 13/146 (8%)
Query: 2   DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ-ALSEEHCQYFLYQILR 59
           DH ++V +  +I      + N V+I  EL    +L   ++  + +L       + YQ+  
Sbjct: 69  DHPHIVKLIGVI------TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLST 122
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE---YVVTRWYRAP 116
            L Y+ S   +HRD+   N+L++A   +K+ DFGL+R   ++ +       +  +W  AP
Sbjct: 123 ALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM-AP 181
Query: 117 ELLLNSSDYTAAIDVWSVGCIFMELM 142
           E  +N   +T+A DVW  G    E++
Sbjct: 182 E-SINFRRFTSASDVWMFGVCMWEIL 206

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 59/113 (52%), Gaps = 9/113 (7%)
Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE----YVVTR 111
           +I  G+ Y+++   +HRDL   N ++  +  +KI DFG+ R   ETD+  +     +  R
Sbjct: 136 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 195
Query: 112 WYRAPELLLNSSDYTAAIDVWSVGCIFMEL--MDRKPLFPGRDHVHQLRLLIE 162
           W  +PE L +   +T   DVWS G +  E+  +  +P + G  +   LR ++E
Sbjct: 196 WM-SPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQP-YQGLSNEQVLRFVME 245

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 52.8 bits (125), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 48/90 (53%), Gaps = 6/90 (6%)
Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE----YVVTR 111
           +I  G+ Y+++   +HRDL   N ++  +  +KI DFG+ R   ETD   +     +  R
Sbjct: 135 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 194
Query: 112 WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 141
           W  APE L +   +T + D+WS G +  E+
Sbjct: 195 WM-APESLKDGV-FTTSSDMWSFGVVLWEI 222

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 52.4 bits (124), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 49/99 (49%), Gaps = 9/99 (9%)
Query: 51  QYFL---YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV--TSETDFMT 105
           QY L    QI +G+ Y+    ++HRDL   N+L+     +KI DFGLA++    E ++  
Sbjct: 151 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 210
Query: 106 E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
           E   V  +W     +L     YT   DVWS G    ELM
Sbjct: 211 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELM 247

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 34/129 (26%), Positives = 63/129 (48%), Gaps = 7/129 (5%)
Query: 24  VYIAYELMDTD-LHQIIRSNQAL-SEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 81
           + + +E M+   L   +R+ + L + E        +  G+ Y+  A V+HRDL   N L+
Sbjct: 97  ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV 156
Query: 82  NANCDLKICDFGLARVTSETDFMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIF 138
             N  +K+ DFG+ R   +  + T    T++   + +PE + + S Y++  DVWS G + 
Sbjct: 157 GENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPE-VFSFSRYSSKSDVWSFGVLM 214
Query: 139 MELMDRKPL 147
            E+     +
Sbjct: 215 WEVFSEGKI 223

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 72/146 (49%), Gaps = 13/146 (8%)
Query: 2   DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ-ALSEEHCQYFLYQILR 59
           DH ++V +  +I      + N V+I  EL    +L   ++  + +L       + YQ+  
Sbjct: 449 DHPHIVKLIGVI------TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLST 502
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE---YVVTRWYRAP 116
            L Y+ S   +HRD+   N+L++A   +K+ DFGL+R   ++ +       +  +W  AP
Sbjct: 503 ALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWM-AP 561
Query: 117 ELLLNSSDYTAAIDVWSVGCIFMELM 142
           E  +N   +T+A DVW  G    E++
Sbjct: 562 E-SINFRRFTSASDVWMFGVCMWEIL 586

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 29/90 (32%), Positives = 48/90 (53%), Gaps = 6/90 (6%)
Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE----YVVTR 111
           +I  G+ Y+++   +HRDL   N ++  +  +KI DFG+ R   ETD   +     +  R
Sbjct: 138 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 197
Query: 112 WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 141
           W  APE L +   +T + D+WS G +  E+
Sbjct: 198 WM-APESLKDGV-FTTSSDMWSFGVVLWEI 225

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 34/129 (26%), Positives = 63/129 (48%), Gaps = 7/129 (5%)
Query: 24  VYIAYELMDTD-LHQIIRSNQAL-SEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 81
           + + +E M+   L   +R+ + L + E        +  G+ Y+  A V+HRDL   N L+
Sbjct: 77  ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV 136
Query: 82  NANCDLKICDFGLARVTSETDFMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIF 138
             N  +K+ DFG+ R   +  + T    T++   + +PE + + S Y++  DVWS G + 
Sbjct: 137 GENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPE-VFSFSRYSSKSDVWSFGVLM 194
Query: 139 MELMDRKPL 147
            E+     +
Sbjct: 195 WEVFSEGKI 203

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 65/144 (45%), Gaps = 10/144 (6%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELM-DTDLHQIIRSN--QALSEEHCQYFLYQI 57
           + H N+V +  +I     E    +YI  E M    L   +RS     L  +    F   +
Sbjct: 71  LRHSNLVQLLGVIV----EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 126
Query: 58  LRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPE 117
              ++Y+   N +HRDL   N+L++ +   K+ DFGL +  S T   T  +  +W  APE
Sbjct: 127 CEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-DTGKLPVKW-TAPE 184
Query: 118 LLLNSSDYTAAIDVWSVGCIFMEL 141
             L    ++   DVWS G +  E+
Sbjct: 185 -ALREKKFSTKSDVWSFGILLWEI 207

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 34/129 (26%), Positives = 63/129 (48%), Gaps = 7/129 (5%)
Query: 24  VYIAYELMDTD-LHQIIRSNQAL-SEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 81
           + + +E M+   L   +R+ + L + E        +  G+ Y+  A V+HRDL   N L+
Sbjct: 75  ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV 134
Query: 82  NANCDLKICDFGLARVTSETDFMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIF 138
             N  +K+ DFG+ R   +  + T    T++   + +PE + + S Y++  DVWS G + 
Sbjct: 135 GENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPE-VFSFSRYSSKSDVWSFGVLM 192
Query: 139 MELMDRKPL 147
            E+     +
Sbjct: 193 WEVFSEGKI 201

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 34/129 (26%), Positives = 63/129 (48%), Gaps = 7/129 (5%)
Query: 24  VYIAYELMDTD-LHQIIRSNQAL-SEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 81
           + + +E M+   L   +R+ + L + E        +  G+ Y+  A V+HRDL   N L+
Sbjct: 80  ICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV 139
Query: 82  NANCDLKICDFGLARVTSETDFMTEYVVTRW---YRAPELLLNSSDYTAAIDVWSVGCIF 138
             N  +K+ DFG+ R   +  + T    T++   + +PE + + S Y++  DVWS G + 
Sbjct: 140 GENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASPE-VFSFSRYSSKSDVWSFGVLM 197
Query: 139 MELMDRKPL 147
            E+     +
Sbjct: 198 WEVFSEGKI 206

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 49/99 (49%), Gaps = 9/99 (9%)
Query: 51  QYFL---YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV--TSETDFMT 105
           QY L    QI +G+ Y+    ++HRDL   N+L+     +KI DFGLA++    E ++  
Sbjct: 117 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 176
Query: 106 E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
           E   V  +W     +L     YT   DVWS G    ELM
Sbjct: 177 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELM 213

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 40/144 (27%), Positives = 64/144 (44%), Gaps = 10/144 (6%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELM-DTDLHQIIRSN--QALSEEHCQYFLYQI 57
           + H N+V +  +I     E    +YI  E M    L   +RS     L  +    F   +
Sbjct: 56  LRHSNLVQLLGVIV----EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 111
Query: 58  LRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPE 117
              ++Y+   N +HRDL   N+L++ +   K+ DFGL +  S T    +  V   + APE
Sbjct: 112 CEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK--WTAPE 169
Query: 118 LLLNSSDYTAAIDVWSVGCIFMEL 141
             L    ++   DVWS G +  E+
Sbjct: 170 -ALREKKFSTKSDVWSFGILLWEI 192

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 49/99 (49%), Gaps = 9/99 (9%)
Query: 51  QYFL---YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV--TSETDFMT 105
           QY L    QI +G+ Y+    ++HRDL   N+L+     +KI DFGLA++    E ++  
Sbjct: 118 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 177
Query: 106 E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
           E   V  +W     +L     YT   DVWS G    ELM
Sbjct: 178 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELM 214

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 65/146 (44%), Gaps = 11/146 (7%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQA-LSEEHCQYFLYQILR 59
           +DH N++ +  ++  P  +   ++     L+D      +R +Q          +  Q+  
Sbjct: 78  LDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDR-----LRKHQGHFLLGTLSRYAVQVAE 132
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEY-VVTRWYRA 115
           G+ Y+ S   +HRDL   NLLL     +KI DFGL R   + D    M E+  V   + A
Sbjct: 133 GMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 192
Query: 116 PELLLNSSDYTAAIDVWSVGCIFMEL 141
           PE  L +  ++ A D W  G    E+
Sbjct: 193 PE-SLKTRTFSHASDTWMFGVTLWEM 217

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 49/99 (49%), Gaps = 9/99 (9%)
Query: 51  QYFL---YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV--TSETDFMT 105
           QY L    QI +G+ Y+    ++HRDL   N+L+     +KI DFGLA++    E ++  
Sbjct: 127 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 186
Query: 106 E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
           E   V  +W     +L     YT   DVWS G    ELM
Sbjct: 187 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELM 223

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 41/144 (28%), Positives = 65/144 (45%), Gaps = 10/144 (6%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELM-DTDLHQIIRSN--QALSEEHCQYFLYQI 57
           + H N+V +  +I     E    +YI  E M    L   +RS     L  +    F   +
Sbjct: 243 LRHSNLVQLLGVIV----EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 298
Query: 58  LRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPE 117
              ++Y+   N +HRDL   N+L++ +   K+ DFGL +  S T   T  +  +W  APE
Sbjct: 299 CEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-DTGKLPVKW-TAPE 356
Query: 118 LLLNSSDYTAAIDVWSVGCIFMEL 141
             L    ++   DVWS G +  E+
Sbjct: 357 -ALREKKFSTKSDVWSFGILLWEI 379

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 65/146 (44%), Gaps = 11/146 (7%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQA-LSEEHCQYFLYQILR 59
           +DH N++ +  ++  P  +   ++     L+D      +R +Q          +  Q+  
Sbjct: 78  LDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDR-----LRKHQGHFLLGTLSRYAVQVAE 132
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEY-VVTRWYRA 115
           G+ Y+ S   +HRDL   NLLL     +KI DFGL R   + D    M E+  V   + A
Sbjct: 133 GMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCA 192
Query: 116 PELLLNSSDYTAAIDVWSVGCIFMEL 141
           PE  L +  ++ A D W  G    E+
Sbjct: 193 PE-SLKTRTFSHASDTWMFGVTLWEM 217

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 47/87 (54%), Gaps = 4/87 (4%)
Query: 59  RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR---WYRA 115
           RGL Y+H+  ++HRD+K  N+LL+ N   KI DFG+++  +E D      V +    Y  
Sbjct: 150 RGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGTLGYID 209
Query: 116 PELLLNSSDYTAAIDVWSVGCIFMELM 142
           PE  +     T   DV+S G +  E++
Sbjct: 210 PEYFIKGR-LTEKSDVYSFGVVLFEVL 235

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 49/99 (49%), Gaps = 9/99 (9%)
Query: 51  QYFL---YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV--TSETDFMT 105
           QY L    QI +G+ Y+    ++HRDL   N+L+     +KI DFGLA++    E ++  
Sbjct: 120 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 179
Query: 106 E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
           E   V  +W     +L     YT   DVWS G    ELM
Sbjct: 180 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELM 216

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 49/99 (49%), Gaps = 9/99 (9%)
Query: 51  QYFL---YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV--TSETDFMT 105
           QY L    QI +G+ Y+    ++HRDL   N+L+     +KI DFGLA++    E ++  
Sbjct: 119 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 178
Query: 106 E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
           E   V  +W     +L     YT   DVWS G    ELM
Sbjct: 179 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELM 215

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 49/99 (49%), Gaps = 9/99 (9%)
Query: 51  QYFL---YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV--TSETDFMT 105
           QY L    QI +G+ Y+    ++HRDL   N+L+     +KI DFGLA++    E ++  
Sbjct: 142 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 201
Query: 106 E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
           E   V  +W     +L     YT   DVWS G    ELM
Sbjct: 202 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELM 238

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 49/99 (49%), Gaps = 9/99 (9%)
Query: 51  QYFL---YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV--TSETDFMT 105
           QY L    QI +G+ Y+    ++HRDL   N+L+     +KI DFGLA++    E ++  
Sbjct: 121 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 180
Query: 106 E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
           E   V  +W     +L     YT   DVWS G    ELM
Sbjct: 181 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELM 217

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 49/99 (49%), Gaps = 9/99 (9%)
Query: 51  QYFL---YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV--TSETDFMT 105
           QY L    QI +G+ Y+    ++HRDL   N+L+     +KI DFGLA++    E ++  
Sbjct: 117 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 176
Query: 106 E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
           E   V  +W     +L     YT   DVWS G    ELM
Sbjct: 177 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELM 213

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 49/99 (49%), Gaps = 9/99 (9%)
Query: 51  QYFL---YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV--TSETDFMT 105
           QY L    QI +G+ Y+    ++HRDL   N+L+     +KI DFGLA++    E ++  
Sbjct: 123 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 182
Query: 106 E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
           E   V  +W     +L     YT   DVWS G    ELM
Sbjct: 183 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELM 219

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 72/146 (49%), Gaps = 13/146 (8%)
Query: 2   DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ-ALSEEHCQYFLYQILR 59
           DH ++V +  +I      + N V+I  EL    +L   ++  + +L       + YQ+  
Sbjct: 69  DHPHIVKLIGVI------TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLST 122
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE---YVVTRWYRAP 116
            L Y+ S   +HRD+   N+L+++N  +K+ DFGL+R   ++         +  +W  AP
Sbjct: 123 ALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWM-AP 181
Query: 117 ELLLNSSDYTAAIDVWSVGCIFMELM 142
           E  +N   +T+A DVW  G    E++
Sbjct: 182 E-SINFRRFTSASDVWMFGVCMWEIL 206

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 49/99 (49%), Gaps = 9/99 (9%)
Query: 51  QYFL---YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV--TSETDFMT 105
           QY L    QI +G+ Y+    ++HRDL   N+L+     +KI DFGLA++    E ++  
Sbjct: 119 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 178
Query: 106 E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
           E   V  +W     +L     YT   DVWS G    ELM
Sbjct: 179 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELM 215

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 49/99 (49%), Gaps = 9/99 (9%)
Query: 51  QYFL---YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV--TSETDFMT 105
           QY L    QI +G+ Y+    ++HRDL   N+L+     +KI DFGLA++    E ++  
Sbjct: 124 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 183
Query: 106 E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
           E   V  +W     +L     YT   DVWS G    ELM
Sbjct: 184 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELM 220

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 49/99 (49%), Gaps = 9/99 (9%)
Query: 51  QYFL---YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV--TSETDFMT 105
           QY L    QI +G+ Y+    ++HRDL   N+L+     +KI DFGLA++    E ++  
Sbjct: 118 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 177
Query: 106 E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
           E   V  +W     +L     YT   DVWS G    ELM
Sbjct: 178 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELM 214

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 49/99 (49%), Gaps = 9/99 (9%)
Query: 51  QYFL---YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV--TSETDFMT 105
           QY L    QI +G+ Y+    ++HRDL   N+L+     +KI DFGLA++    E ++  
Sbjct: 117 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 176
Query: 106 E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
           E   V  +W     +L     YT   DVWS G    ELM
Sbjct: 177 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELM 213

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 49/99 (49%), Gaps = 9/99 (9%)
Query: 51  QYFL---YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV--TSETDFMT 105
           QY L    QI +G+ Y+    ++HRDL   N+L+     +KI DFGLA++    E ++  
Sbjct: 124 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 183
Query: 106 E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
           E   V  +W     +L     YT   DVWS G    ELM
Sbjct: 184 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELM 220

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 49/99 (49%), Gaps = 9/99 (9%)
Query: 51  QYFL---YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV--TSETDFMT 105
           QY L    QI +G+ Y+    ++HRDL   N+L+     +KI DFGLA++    E ++  
Sbjct: 124 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 183
Query: 106 E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
           E   V  +W     +L     YT   DVWS G    ELM
Sbjct: 184 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELM 220

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 52.4 bits (124), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 49/99 (49%), Gaps = 9/99 (9%)
Query: 51  QYFL---YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV--TSETDFMT 105
           QY L    QI +G+ Y+    ++HRDL   N+L+     +KI DFGLA++    E ++  
Sbjct: 117 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 176
Query: 106 E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
           E   V  +W     +L     YT   DVWS G    ELM
Sbjct: 177 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELM 213

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 49/99 (49%), Gaps = 9/99 (9%)
Query: 51  QYFL---YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV--TSETDFMT 105
           QY L    QI +G+ Y+    ++HRDL   N+L+     +KI DFGLA++    E ++  
Sbjct: 120 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 179
Query: 106 E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
           E   V  +W     +L     YT   DVWS G    ELM
Sbjct: 180 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELM 216

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 58/113 (51%), Gaps = 9/113 (7%)
Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE----YVVTR 111
           +I  G+ Y+++   +HRDL   N ++  +  +KI DFG+ R   ETD   +     +  R
Sbjct: 140 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 199
Query: 112 WYRAPELLLNSSDYTAAIDVWSVGCIFMEL--MDRKPLFPGRDHVHQLRLLIE 162
           W  +PE L +   +T   DVWS G +  E+  +  +P + G  +   LR ++E
Sbjct: 200 WM-SPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQP-YQGLSNEQVLRFVME 249

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 49/99 (49%), Gaps = 9/99 (9%)
Query: 51  QYFL---YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV--TSETDFMT 105
           QY L    QI +G+ Y+    ++HRDL   N+L+     +KI DFGLA++    E ++  
Sbjct: 120 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 179
Query: 106 E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
           E   V  +W     +L     YT   DVWS G    ELM
Sbjct: 180 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELM 216

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 65/146 (44%), Gaps = 11/146 (7%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQA-LSEEHCQYFLYQILR 59
           +DH N++ +  ++  P  +   ++     L+D      +R +Q          +  Q+  
Sbjct: 68  LDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDR-----LRKHQGHFLLGTLSRYAVQVAE 122
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEY-VVTRWYRA 115
           G+ Y+ S   +HRDL   NLLL     +KI DFGL R   + D    M E+  V   + A
Sbjct: 123 GMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCA 182
Query: 116 PELLLNSSDYTAAIDVWSVGCIFMEL 141
           PE  L +  ++ A D W  G    E+
Sbjct: 183 PE-SLKTRTFSHASDTWMFGVTLWEM 207

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 49/99 (49%), Gaps = 9/99 (9%)
Query: 51  QYFL---YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV--TSETDFMT 105
           QY L    QI +G+ Y+    ++HRDL   N+L+     +KI DFGLA++    E ++  
Sbjct: 120 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 179
Query: 106 E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
           E   V  +W     +L     YT   DVWS G    ELM
Sbjct: 180 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELM 216

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 65/146 (44%), Gaps = 11/146 (7%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQA-LSEEHCQYFLYQILR 59
           +DH N++ +  ++  P  +   ++     L+D      +R +Q          +  Q+  
Sbjct: 68  LDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDR-----LRKHQGHFLLGTLSRYAVQVAE 122
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEY-VVTRWYRA 115
           G+ Y+ S   +HRDL   NLLL     +KI DFGL R   + D    M E+  V   + A
Sbjct: 123 GMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 182
Query: 116 PELLLNSSDYTAAIDVWSVGCIFMEL 141
           PE  L +  ++ A D W  G    E+
Sbjct: 183 PE-SLKTRTFSHASDTWMFGVTLWEM 207

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 52.0 bits (123), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 35/114 (30%), Positives = 56/114 (49%), Gaps = 8/114 (7%)
Query: 52  YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR 111
           Y   QI   ++Y+   N +HRDL   N L+  N  +K+ DFGL+R+ +  D  T +   +
Sbjct: 113 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTFTAHAGAK 171
Query: 112 W---YRAPELLLNSSDYTAAIDVWSVGCIFMELM--DRKPLFPGRDHVHQLRLL 160
           +   + APE L  +  ++   DVW+ G +  E+      P +PG D      LL
Sbjct: 172 FPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSP-YPGIDPSQVYELL 223

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 58/113 (51%), Gaps = 9/113 (7%)
Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE----YVVTR 111
           +I  G+ Y+++   +HRDL   N ++  +  +KI DFG+ R   ETD   +     +  R
Sbjct: 131 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVR 190
Query: 112 WYRAPELLLNSSDYTAAIDVWSVGCIFMEL--MDRKPLFPGRDHVHQLRLLIE 162
           W  +PE L +   +T   DVWS G +  E+  +  +P + G  +   LR ++E
Sbjct: 191 WM-SPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQP-YQGLSNEQVLRFVME 240

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 65/146 (44%), Gaps = 11/146 (7%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQA-LSEEHCQYFLYQILR 59
           +DH N++ +  ++  P  +   ++     L+D      +R +Q          +  Q+  
Sbjct: 72  LDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDR-----LRKHQGHFLLGTLSRYAVQVAE 126
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEY-VVTRWYRA 115
           G+ Y+ S   +HRDL   NLLL     +KI DFGL R   + D    M E+  V   + A
Sbjct: 127 GMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 186
Query: 116 PELLLNSSDYTAAIDVWSVGCIFMEL 141
           PE  L +  ++ A D W  G    E+
Sbjct: 187 PE-SLKTRTFSHASDTWMFGVTLWEM 211

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 67/146 (45%), Gaps = 15/146 (10%)
Query: 2   DHENVVAIRDIIPPPQRESFNDVYIAYELM-DTDLHQIIRSNQA-LSEEHCQYFLYQILR 59
            H N+V +  +    Q      +YI  EL+   D    +R+  A L  +     +     
Sbjct: 170 SHPNIVRLIGVCTQKQ-----PIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAA 224
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-----VTSETDFMTEYVVTRWYR 114
           G++Y+ S   +HRDL   N L+     LKI DFG++R     V + +  + + V  +W  
Sbjct: 225 GMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQ-VPVKWT- 282
Query: 115 APELLLNSSDYTAAIDVWSVGCIFME 140
           APE  LN   Y++  DVWS G +  E
Sbjct: 283 APE-ALNYGRYSSESDVWSFGILLWE 307

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 65/146 (44%), Gaps = 11/146 (7%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQA-LSEEHCQYFLYQILR 59
           +DH N++ +  ++  P  +   ++     L+D      +R +Q          +  Q+  
Sbjct: 68  LDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDR-----LRKHQGHFLLGTLSRYAVQVAE 122
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEY-VVTRWYRA 115
           G+ Y+ S   +HRDL   NLLL     +KI DFGL R   + D    M E+  V   + A
Sbjct: 123 GMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 182
Query: 116 PELLLNSSDYTAAIDVWSVGCIFMEL 141
           PE  L +  ++ A D W  G    E+
Sbjct: 183 PE-SLKTRTFSHASDTWMFGVTLWEM 207

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 28/88 (31%), Positives = 46/88 (52%), Gaps = 5/88 (5%)
Query: 57  ILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVT---SETDFMTEYVVTRWY 113
           +   ++Y+ S   LHRDL   N L+N    +K+ DFGL+R      ET  +      RW 
Sbjct: 129 VCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRW- 187
Query: 114 RAPELLLNSSDYTAAIDVWSVGCIFMEL 141
             PE+L+ S  +++  D+W+ G +  E+
Sbjct: 188 SPPEVLMYSK-FSSKSDIWAFGVLMWEI 214

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 35/114 (30%), Positives = 56/114 (49%), Gaps = 8/114 (7%)
Query: 52  YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR 111
           Y   QI   ++Y+   N +HRDL   N L+  N  +K+ DFGL+R+ +  D  T +   +
Sbjct: 113 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTXTAHAGAK 171
Query: 112 W---YRAPELLLNSSDYTAAIDVWSVGCIFMELM--DRKPLFPGRDHVHQLRLL 160
           +   + APE L  +  ++   DVW+ G +  E+      P +PG D      LL
Sbjct: 172 FPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSP-YPGIDPSQVYELL 223

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 49/99 (49%), Gaps = 9/99 (9%)
Query: 51  QYFL---YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV--TSETDFMT 105
           QY L    QI +G+ Y+    ++HRDL   N+L+     +KI DFGLA++    E ++  
Sbjct: 117 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 176
Query: 106 E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
           E   V  +W     +L     YT   DVWS G    ELM
Sbjct: 177 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELM 213

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 35/99 (35%), Positives = 49/99 (49%), Gaps = 9/99 (9%)
Query: 51  QYFL---YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV--TSETDFMT 105
           QY L    QI +G+ Y+    ++HRDL   N+L+     +KI DFGLA++    E ++  
Sbjct: 111 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHA 170
Query: 106 E--YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
           E   V  +W     +L     YT   DVWS G    ELM
Sbjct: 171 EGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELM 207

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 35/133 (26%), Positives = 65/133 (48%), Gaps = 11/133 (8%)
Query: 23  DVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 82
           D Y+  +L    L  + +    L E+  ++++ +++  +  IH  + +HRD+KP N+LL+
Sbjct: 170 DYYVGGDL----LTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHYVHRDIKPDNVLLD 225
Query: 83  ANCDLKICDFGLARVTSETDFMTEYVV--TRWYRAPELLLNSSD----YTAAIDVWSVG- 135
            N  +++ DFG     ++   +   V   T  Y +PE+L    D    Y    D WS+G 
Sbjct: 226 VNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGV 285
Query: 136 CIFMELMDRKPLF 148
           C++  L    P +
Sbjct: 286 CMYEMLYGETPFY 298

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 52.0 bits (123), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 35/133 (26%), Positives = 65/133 (48%), Gaps = 11/133 (8%)
Query: 23  DVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN 82
           D Y+  +L    L  + +    L E+  ++++ +++  +  IH  + +HRD+KP N+LL+
Sbjct: 154 DYYVGGDL----LTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHYVHRDIKPDNVLLD 209
Query: 83  ANCDLKICDFGLARVTSETDFMTEYVV--TRWYRAPELLLNSSD----YTAAIDVWSVG- 135
            N  +++ DFG     ++   +   V   T  Y +PE+L    D    Y    D WS+G 
Sbjct: 210 VNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGV 269
Query: 136 CIFMELMDRKPLF 148
           C++  L    P +
Sbjct: 270 CMYEMLYGETPFY 282

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 35/114 (30%), Positives = 56/114 (49%), Gaps = 8/114 (7%)
Query: 52  YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR 111
           Y   QI   ++Y+   N +HRDL   N L+  N  +K+ DFGL+R+ +  D  T +   +
Sbjct: 113 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTXTAHAGAK 171
Query: 112 W---YRAPELLLNSSDYTAAIDVWSVGCIFMELM--DRKPLFPGRDHVHQLRLL 160
           +   + APE L  +  ++   DVW+ G +  E+      P +PG D      LL
Sbjct: 172 FPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSP-YPGIDPSQVYELL 223

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 37/132 (28%), Positives = 64/132 (48%), Gaps = 4/132 (3%)
Query: 22  NDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL 80
             +Y+   L++  DL   +R    L+       + QI   L   H+A   HRD+KP N+L
Sbjct: 107 GQLYVDXRLINGVDLAAXLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENIL 166
Query: 81  LNANCDLKICDFGLARVTSETDF--MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIF 138
           ++A+    + DFG+A  T++     +   V T +Y APE   + S  T   D++++ C+ 
Sbjct: 167 VSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYXAPE-RFSESHATYRADIYALTCVL 225
Query: 139 MELMDRKPLFPG 150
            E +   P + G
Sbjct: 226 YECLTGSPPYQG 237

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 28/94 (29%), Positives = 49/94 (52%), Gaps = 5/94 (5%)
Query: 57  ILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRW---Y 113
           +  G+ Y+  A V+HRDL   N L+  N  +K+ DFG+ R   +  + T    T++   +
Sbjct: 113 VCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKW 171
Query: 114 RAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL 147
            +PE + + S Y++  DVWS G +  E+     +
Sbjct: 172 ASPE-VFSFSRYSSKSDVWSFGVLMWEVFSEGKI 204

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 33/106 (31%), Positives = 55/106 (51%), Gaps = 8/106 (7%)
Query: 52  YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR 111
           Y   QI   ++Y+   N +HRDL   N L+  N  +K+ DFGL+R+ +  D  T +   +
Sbjct: 134 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHVVKVADFGLSRLMT-GDTYTAHAGAK 192
Query: 112 W---YRAPELLLNSSDYTAAIDVWSVGCIFMELM--DRKPLFPGRD 152
           +   + APE L  ++ ++   DVW+ G +  E+      P +PG D
Sbjct: 193 FPIKWTAPESLAYNT-FSIKSDVWAFGVLLWEIATYGMSP-YPGID 236

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 51.6 bits (122), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 35/114 (30%), Positives = 56/114 (49%), Gaps = 8/114 (7%)
Query: 52  YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR 111
           Y   QI   ++Y+   N +HRDL   N L+  N  +K+ DFGL+R+ +  D  T +   +
Sbjct: 116 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTXTAHAGAK 174
Query: 112 W---YRAPELLLNSSDYTAAIDVWSVGCIFMELM--DRKPLFPGRDHVHQLRLL 160
           +   + APE L  +  ++   DVW+ G +  E+      P +PG D      LL
Sbjct: 175 FPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSP-YPGIDLSQVYELL 226

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 40/146 (27%), Positives = 65/146 (44%), Gaps = 11/146 (7%)
Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQA-LSEEHCQYFLYQILR 59
           +DH N++ +  ++  P  +   ++     L+D      +R +Q          +  Q+  
Sbjct: 72  LDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDR-----LRKHQGHFLLGTLSRYAVQVAE 126
Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEY-VVTRWYRA 115
           G+ Y+ S   +HRDL   NLLL     +KI DFGL R   + D    M E+  V   + A
Sbjct: 127 GMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCA 186
Query: 116 PELLLNSSDYTAAIDVWSVGCIFMEL 141
           PE  L +  ++ A D W  G    E+
Sbjct: 187 PE-SLKTRTFSHASDTWMFGVTLWEM 211

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 55/113 (48%), Gaps = 6/113 (5%)
Query: 52  YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR 111
           Y   QI   ++Y+   N +HRDL   N L+  N  +K+ DFGL+R+ +  D  T +   +
Sbjct: 120 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAK 178
Query: 112 W---YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLL 160
           +   + APE L  +  ++   DVW+ G +  E+       +PG D      LL
Sbjct: 179 FPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 230

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 55/113 (48%), Gaps = 6/113 (5%)
Query: 52  YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR 111
           Y   QI   ++Y+   N +HRDL   N L+  N  +K+ DFGL+R+ +  D  T +   +
Sbjct: 120 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTXTAHAGAK 178
Query: 112 W---YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLL 160
           +   + APE L  +  ++   DVW+ G +  E+       +PG D      LL
Sbjct: 179 FPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 230

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 35/114 (30%), Positives = 56/114 (49%), Gaps = 8/114 (7%)
Query: 52  YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR 111
           Y   QI   ++Y+   N +HRDL   N L+  N  +K+ DFGL+R+ +  D  T +   +
Sbjct: 117 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAK 175
Query: 112 W---YRAPELLLNSSDYTAAIDVWSVGCIFMELM--DRKPLFPGRDHVHQLRLL 160
           +   + APE L  +  ++   DVW+ G +  E+      P +PG D      LL
Sbjct: 176 FPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSP-YPGIDLSQVYELL 227

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 35/114 (30%), Positives = 56/114 (49%), Gaps = 8/114 (7%)
Query: 52  YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR 111
           Y   QI   ++Y+   N +HRDL   N L+  N  +K+ DFGL+R+ +  D  T +   +
Sbjct: 115 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAK 173
Query: 112 W---YRAPELLLNSSDYTAAIDVWSVGCIFMELM--DRKPLFPGRDHVHQLRLL 160
           +   + APE L  +  ++   DVW+ G +  E+      P +PG D      LL
Sbjct: 174 FPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSP-YPGIDLSQVYELL 225

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 35/114 (30%), Positives = 56/114 (49%), Gaps = 8/114 (7%)
Query: 52  YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR 111
           Y   QI   ++Y+   N +HRDL   N L+  N  +K+ DFGL+R+ +  D  T +   +
Sbjct: 115 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAK 173
Query: 112 W---YRAPELLLNSSDYTAAIDVWSVGCIFMELM--DRKPLFPGRDHVHQLRLL 160
           +   + APE L  +  ++   DVW+ G +  E+      P +PG D      LL
Sbjct: 174 FPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSP-YPGIDLSQVYELL 225

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 35/114 (30%), Positives = 56/114 (49%), Gaps = 8/114 (7%)
Query: 52  YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR 111
           Y   QI   ++Y+   N +HRDL   N L+  N  +K+ DFGL+R+ +  D  T +   +
Sbjct: 117 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAK 175
Query: 112 W---YRAPELLLNSSDYTAAIDVWSVGCIFMELM--DRKPLFPGRDHVHQLRLL 160
           +   + APE L  +  ++   DVW+ G +  E+      P +PG D      LL
Sbjct: 176 FPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSP-YPGIDLSQVYELL 227

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 55/113 (48%), Gaps = 6/113 (5%)
Query: 52  YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR 111
           Y   QI   ++Y+   N +HRDL   N L+  N  +K+ DFGL+R+ +  D  T +   +
Sbjct: 120 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAK 178
Query: 112 W---YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLL 160
           +   + APE L  +  ++   DVW+ G +  E+       +PG D      LL
Sbjct: 179 FPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 230

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 35/114 (30%), Positives = 56/114 (49%), Gaps = 8/114 (7%)
Query: 52  YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR 111
           Y   QI   ++Y+   N +HRDL   N L+  N  +K+ DFGL+R+ +  D  T +   +
Sbjct: 115 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAK 173
Query: 112 W---YRAPELLLNSSDYTAAIDVWSVGCIFMELM--DRKPLFPGRDHVHQLRLL 160
           +   + APE L  +  ++   DVW+ G +  E+      P +PG D      LL
Sbjct: 174 FPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSP-YPGIDLSQVYELL 225

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 51.6 bits (122), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 58/113 (51%), Gaps = 9/113 (7%)
Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE----YVVTR 111
           +I  G+ Y+++   +HRDL   N  +  +  +KI DFG+ R   ETD+  +     +  R
Sbjct: 133 EIADGMAYLNANKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 192
Query: 112 WYRAPELLLNSSDYTAAIDVWSVGCIFMEL--MDRKPLFPGRDHVHQLRLLIE 162
           W  +PE L +   +T   DVWS G +  E+  +  +P + G  +   LR ++E
Sbjct: 193 WM-SPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQP-YQGLSNEQVLRFVME 242

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 34/113 (30%), Positives = 55/113 (48%), Gaps = 6/113 (5%)
Query: 52  YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR 111
           Y   QI   ++Y+   N +HRDL   N L+  N  +K+ DFGL+R+ +  D  T +   +
Sbjct: 128 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAK 186
Query: 112 W---YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLL 160
           +   + APE L  +  ++   DVW+ G +  E+       +PG D      LL
Sbjct: 187 FPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELL 238

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 51.2 bits (121), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 28/90 (31%), Positives = 49/90 (54%), Gaps = 6/90 (6%)
Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE----YVVTR 111
           +I  G+ Y+++   +HR+L   N ++  +  +KI DFG+ R   ETD+  +     +  R
Sbjct: 139 EIADGMAYLNAKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR 198
Query: 112 WYRAPELLLNSSDYTAAIDVWSVGCIFMEL 141
           W  APE L +   +T + D+WS G +  E+
Sbjct: 199 WM-APESLKDGV-FTTSSDMWSFGVVLWEI 226

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 30/87 (34%), Positives = 46/87 (52%), Gaps = 4/87 (4%)
Query: 59  RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSE---TDFMTEYVVTRWYRA 115
           RGL Y+H+  ++HRD+K  N+LL+ N   KI DFG+++  +E   T        T  Y  
Sbjct: 150 RGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKGTLGYID 209
Query: 116 PELLLNSSDYTAAIDVWSVGCIFMELM 142
           PE  +     T   DV+S G +  E++
Sbjct: 210 PEYFIKGR-LTEKSDVYSFGVVLFEVL 235

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 51.2 bits (121), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 35/114 (30%), Positives = 56/114 (49%), Gaps = 8/114 (7%)
Query: 52  YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR 111
           Y   QI   ++Y+   N +HRDL   N L+  N  +K+ DFGL+R+ +  D  T +   +
Sbjct: 115 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT-GDTYTAHAGAK 173
Query: 112 W---YRAPELLLNSSDYTAAIDVWSVGCIFMELM--DRKPLFPGRDHVHQLRLL 160
           +   + APE L  +  ++   DVW+ G +  E+      P +PG D      LL
Sbjct: 174 FPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSP-YPGIDLSQVYELL 225
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	280
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	0.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-178
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-176
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-173
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-172
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	1e-172
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	1e-172
3rp9_A	458	Mitogen-activated protein kinase; structural genom	1e-170
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-165
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	1e-164
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-162
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-160
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-145
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-142
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-141
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-140
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	1e-128
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-110
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-100
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-95
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	5e-95
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-94
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-94
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-94
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-93
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-93
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	4e-92
3o0g_A	292	Cell division protein kinase 5; kinase activator c	7e-91
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	9e-91
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-89
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-79
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	3e-53
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	2e-50
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	2e-50
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	6e-50
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	6e-50
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	2e-49
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	4e-49
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	6e-49
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	6e-49
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	2e-48
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	1e-47
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	5e-47
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-46
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-46
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-46
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	3e-46
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	3e-46
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	2e-45
3bhy_A	283	Death-associated protein kinase 3; death associate	8e-45
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-44
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	3e-44
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	4e-44
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	4e-44
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	5e-44
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	7e-44
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	7e-44
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	7e-44
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	1e-43
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	1e-43
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-43
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	2e-43
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	2e-43
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	3e-43
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	5e-43
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	5e-43
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-42
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-42
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	1e-42
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	1e-42
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-42
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	7e-42
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	7e-42
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	8e-42
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	9e-42
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-41
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	6e-41
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	9e-41
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-40
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-40
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	3e-40
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	6e-40
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	9e-40
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-39
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	3e-39
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	5e-39
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	2e-38
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	2e-37
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-37
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	7e-37
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	7e-37
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	7e-37
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-36
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-36
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	3e-36
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-34
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-34
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-34
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-34
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	8e-34
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	4e-33
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	5e-33
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	8e-33
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	9e-33
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	2e-32
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	5e-32
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-31
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	3e-31
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	4e-31
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	5e-31
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	6e-31
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-30
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-30
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	1e-30
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	1e-30
3aln_A	327	Dual specificity mitogen-activated protein kinase;	3e-30
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	3e-30
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	9e-30
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	2e-29
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	5e-29
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	1e-28
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	4e-27
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	4e-27
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	5e-27
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	6e-27
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-26
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	1e-26
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	2e-26
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	3e-26
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	5e-26
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	6e-26
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	9e-26
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-25
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	3e-25
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	3e-25
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	5e-25
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	5e-25
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	6e-25
3q4u_A	301	Activin receptor type-1; structural genomics conso	7e-25
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-24
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-24
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	3e-24
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	3e-24
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	6e-24
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	9e-24
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	9e-24
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-23
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	2e-23
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	3e-23
3ork_A	311	Serine/threonine protein kinase; structural genomi	8e-23
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	8e-23
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	1e-22
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-22
3soc_A	322	Activin receptor type-2A; structural genomics cons	4e-22
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	6e-22
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	7e-22
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	1e-21
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-21
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	3e-21
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	3e-21
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	4e-21
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	4e-21
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	4e-21
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	7e-21
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	8e-21
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	1e-20
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-20
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	3e-20
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	4e-20
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	4e-20
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	5e-20
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	8e-20
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	9e-20
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-19
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-19
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	4e-19
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	4e-19
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	6e-19
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	7e-19
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-18
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-18
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	3e-18
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	3e-18
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	3e-18
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	4e-18
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	5e-18
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	7e-18
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	7e-18
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	7e-18
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	1e-17
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	1e-17
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-17
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-17
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-17
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	3e-17
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	4e-17
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	5e-17
3pls_A	298	Macrophage-stimulating protein receptor; protein k	5e-17
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	6e-17
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	7e-17
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-16
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	1e-16
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-16
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-16
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-16
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	4e-16
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	7e-16
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	8e-16
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	4e-15
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	5e-15
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	6e-15
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	2e-14
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	3e-14
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	3e-14
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	5e-14
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	5e-14
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	7e-14
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	8e-14
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	9e-14
4aoj_A	329	High affinity nerve growth factor receptor; transf	1e-13
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-13
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-13
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	2e-13
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-13
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	4e-13
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	8e-13
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-12
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-12
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	3e-12
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	8e-10
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	1e-07
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	1e-07
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	1e-07
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	7e-07
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	8e-07
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	4e-06

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  504 bits (1301), Expect = 0.0
 Identities = 152/283 (53%), Positives = 200/283 (70%), Gaps = 6/283 (2%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRG 60
             HEN++ I DII  P  E   DVYI  +LM+TDL++++++ Q LS +H  YFLYQILRG
Sbjct: 82  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRG 140

Query: 61  LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS----ETDFMTEYVVTRWYRAP 116
           LKYIHSANVLHRDLKPSNLLLN  CDLKICDFGLARV       T F+TEYV TRWYRAP
Sbjct: 141 LKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 200

Query: 117 ELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL- 175
           E++LNS  YT +ID+WSVGCI  E++  +P+FPG+ ++ QL  ++ ++G+PS+ +L  + 
Sbjct: 201 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 260

Query: 176 NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL 235
           N  A+ Y+  LP   +  +   FPN    A+DL++KMLTF+P +RI VE ALAHPYL   
Sbjct: 261 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 320

Query: 236 HDISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYR 278
           +D SDEP+  +PF FD E   L + ++KELI++E   F P YR
Sbjct: 321 YDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 363

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  493 bits (1272), Expect = e-178
 Identities = 105/277 (37%), Positives = 155/277 (55%), Gaps = 4/277 (1%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQA-LSEEHCQYFLYQILR 59
             H N++ +RDI    +  + + +Y+  ELM TDL Q+I   +  +S +H QYF+Y IL 
Sbjct: 86  FHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILL 145

Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           GL  +H A V+HRDL P N+LL  N D+ ICDF LAR  +     T YV  RWYRAPEL+
Sbjct: 146 GLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELV 205

Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL-NEN 178
           +    +T  +D+WS GC+  E+ +RK LF G    +QL  ++E++GTP   ++    + +
Sbjct: 206 MQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPS 265

Query: 179 AKKYI-CQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 237
           A+ Y+   L     +++T   P   P A+DL+ KML F+P++RI+ E AL HPY  SL D
Sbjct: 266 ARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFD 325

Query: 238 ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFN 274
             D         F F++       M ++   E   FN
Sbjct: 326 PLDLTEG-LSERFHFDESVTDVYDMHKIFTAEVERFN 361

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  489 bits (1260), Expect = e-176
 Identities = 143/289 (49%), Positives = 195/289 (67%), Gaps = 18/289 (6%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRG 60
             HEN++ I +I  P   E+FN+VYI  ELM TDLH++I + Q LS++H QYF+YQ LR 
Sbjct: 66  FKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIST-QMLSDDHIQYFIYQTLRA 124

Query: 61  LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV-----------TSETDFMTEYVV 109
           +K +H +NV+HRDLKPSNLL+N+NCDLK+CDFGLAR+           T +   M E+V 
Sbjct: 125 VKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVA 184

Query: 110 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTP-S 168
           TRWYRAPE++L S+ Y+ A+DVWS GCI  EL  R+P+FPGRD+ HQL L+  +IGTP S
Sbjct: 185 TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHS 244

Query: 169 EAELGFL-NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDAL 227
           + +L  + +  A++YI  LP Y      + FP V+P  IDL+++ML FDP +RIT ++AL
Sbjct: 245 DNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEAL 304

Query: 228 AHPYLGSLHDISDEPVC----MSPFSFDFEQHALTEGQMKELIYQEALA 272
            HPYL + HD +DEP       S F FD  + ALT   +K+LI+ E  +
Sbjct: 305 EHPYLQTYHDPNDEPEGEPIPPSFFEFDHYKEALTTKDLKKLIWNEIFS 353

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  482 bits (1244), Expect = e-173
 Identities = 121/282 (42%), Positives = 174/282 (61%), Gaps = 6/282 (2%)

Query: 1   MDHENVVAIRDII-PPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           M HENV+ + D+  P    + F D Y+    M TDL ++++  + L E+  Q+ +YQ+L+
Sbjct: 81  MRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH-EKLGEDRIQFLVYQMLK 139

Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           GL+YIH+A ++HRDLKP NL +N +C+LKI DFGLAR       MT YVVTRWYRAPE++
Sbjct: 140 GLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD--SEMTGYVVTRWYRAPEVI 197

Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL-NEN 178
           LN   YT  +D+WSVGCI  E++  K LF G DH+ QL+ ++++ GTP    +  L ++ 
Sbjct: 198 LNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 257

Query: 179 AKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDI 238
           AK Y+  LP  +++ F     N  P A++L+EKML  D  QR+T  +ALAHPY  SLHD 
Sbjct: 258 AKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT 317

Query: 239 SDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYRQQ 280
            DEP     +   F+    T  + K + Y+E L+F P  +  
Sbjct: 318 EDEPQV-QKYDDSFDDVDRTLDEWKRVTYKEVLSFKPPRQLG 358

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  482 bits (1243), Expect = e-172
 Identities = 109/333 (32%), Positives = 173/333 (51%), Gaps = 53/333 (15%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRG 60
           +  + ++ + D+I P     F+++YI  E+ D+DL ++ ++   L+EEH +  LY +L G
Sbjct: 82  LKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLG 141

Query: 61  LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS--------------------- 99
             +IH + ++HRDLKP+N LLN +C +K+CDFGLAR  +                     
Sbjct: 142 ENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHN 201

Query: 100 --ETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM-----------DRKP 146
                 +T +VVTRWYRAPEL+L   +YT +ID+WS GCIF EL+           +R P
Sbjct: 202 KNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFP 261

Query: 147 LFPG-----------------RDHVHQLRLLIELIGTPSEAELGFL-NENAKKYICQLPR 188
           LFPG                 + +  QL ++  +IGTP+E +L  +      KYI   P 
Sbjct: 262 LFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPH 321

Query: 189 YQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMSPF 248
            +  +  +K+P++    I+L+E ML F+P +RIT++ AL HPYL  +     E       
Sbjct: 322 RKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKKLENFSTKKI 381

Query: 249 SFDFEQ-HALTEGQMKELIYQEALAFNPEYRQQ 280
              F+    L+E Q++ +  +E  +F+PE    
Sbjct: 382 ILPFDDWMVLSETQLRYIFLKEVQSFHPELVIP 414

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  480 bits (1237), Expect = e-172
 Identities = 135/282 (47%), Positives = 181/282 (64%), Gaps = 6/282 (2%)

Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           M HENV+ + D+  P +  E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILR
Sbjct: 85  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILR 143

Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           GLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T+  D MT YV TRWYRAPE++
Sbjct: 144 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA--DEMTGYVATRWYRAPEIM 201

Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL-NEN 178
           LN   Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP    L  + +E+
Sbjct: 202 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 261

Query: 179 AKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDI 238
           A+ YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD 
Sbjct: 262 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 321

Query: 239 SDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYRQQ 280
            DEPV   P+    E   L   + K L Y E ++F P    Q
Sbjct: 322 DDEPVA-DPYDQSLESRDLLIDEWKSLTYDEVISFVPPPLDQ 362

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  478 bits (1233), Expect = e-172
 Identities = 123/277 (44%), Positives = 167/277 (60%), Gaps = 6/277 (2%)

Query: 1   MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           M HENV+ + D+  P     +F D Y+    M TDL +I+      SEE  QY +YQ+L+
Sbjct: 80  MQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGLK--FSEEKIQYLVYQMLK 137

Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           GLKYIHSA V+HRDLKP NL +N +C+LKI DFGLAR       MT YVVTRWYRAPE++
Sbjct: 138 GLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHAD--AEMTGYVVTRWYRAPEVI 195

Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL-NEN 178
           L+   Y   +D+WSVGCI  E++  K LF G+D++ QL  ++++ G P    +  L ++ 
Sbjct: 196 LSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKA 255

Query: 179 AKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDI 238
           AK YI  LP+  R+ FT+ FP   P A DL+EKML  D  +R+T   AL HP+     D 
Sbjct: 256 AKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDP 315

Query: 239 SDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 275
            +E     PF    E   LT  + K+ IY+E + F+P
Sbjct: 316 EEETEAQQPFDDSLEHEKLTVDEWKQHIYKEIVNFSP 352

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  476 bits (1227), Expect = e-170
 Identities = 116/341 (34%), Positives = 177/341 (51%), Gaps = 61/341 (17%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRG 60
           ++H++VV + DI+ P   E F+++Y+  E+ D+D  ++ R+   L+E H +  LY +L G
Sbjct: 109 LNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVG 168

Query: 61  LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD------------------ 102
           +KY+HSA +LHRDLKP+N L+N +C +K+CDFGLAR     +                  
Sbjct: 169 VKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLV 228

Query: 103 ----------FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM---------- 142
                      +T +VVTRWYRAPEL+L   +YT AIDVWS+GCIF EL+          
Sbjct: 229 TFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYH 288

Query: 143 -DRKPLFPGRD--------------------HVHQLRLLIELIGTPSEAELGFL-NENAK 180
            DR PLFPG                      +  QL ++  ++GTPSE ++  L  E+AK
Sbjct: 289 ADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAK 348

Query: 181 KYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISD 240
           +YI   P+ +     E+FP     AI L+++ML F+P +RIT+ + LAHP+   +     
Sbjct: 349 RYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEV 408

Query: 241 EPVCMSPFSFDFE-QHALTEGQMKELIYQEALAFNPEYRQQ 280
           E          F     + E Q++    +E   ++PE +  
Sbjct: 409 ETNATEKVRLPFNDWMNMDEPQLRYAFVKEIQRYHPEIQLP 449

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  463 bits (1193), Expect = e-165
 Identities = 105/319 (32%), Positives = 167/319 (52%), Gaps = 44/319 (13%)

Query: 2   DHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGL 61
            HEN+V + +++      +  DVY+ ++ M+TDLH +IR+   L   H QY +YQ+++ +
Sbjct: 67  GHENIVNLLNVLRAD---NDRDVYLVFDYMETDLHAVIRA-NILEPVHKQYVVYQLIKVI 122

Query: 62  KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV----------------------TS 99
           KY+HS  +LHRD+KPSN+LLNA C +K+ DFGL+R                         
Sbjct: 123 KYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDD 182

Query: 100 ETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL 159
           +   +T+YV TRWYRAPE+LL S+ YT  ID+WS+GCI  E++  KP+FPG   ++QL  
Sbjct: 183 DQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLER 242

Query: 160 LIELIGTPSEAELGFL-NENAKKYICQLPRYQRQSFTEKF----------------PNVH 202
           +I +I  PS  ++  + +  AK  I  L        + K                  + +
Sbjct: 243 IIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCN 302

Query: 203 PSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMSPFSFDFEQHA-LTEGQ 261
             A+DL++K+L F+P +RI+  DAL HP++   H+ ++EP C    +     +   +   
Sbjct: 303 EEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEPNCDHIITIPINDNVKHSIDD 362

Query: 262 MKELIYQEALAFNPEYRQQ 280
            + L+Y E      E    
Sbjct: 363 YRNLVYSEISRRKRELISN 381

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  459 bits (1183), Expect = e-164
 Identities = 113/294 (38%), Positives = 166/294 (56%), Gaps = 17/294 (5%)

Query: 1   MDHENVVAIRDII-PPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           ++H+N++ + ++  P    E F DVYI  ELMD +L Q+I+    L  E   Y LYQ+L 
Sbjct: 81  VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLC 138

Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           G+K++HSA ++HRDLKPSN+++ ++C LKI DFGLAR    +  MT YVVTR+YRAPE++
Sbjct: 139 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 198

Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENA 179
           L    Y   +D+WSVGCI  E++    LFPG DH+ Q   +IE +GTP    +  L    
Sbjct: 199 LGMG-YKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV 257

Query: 180 KKYICQLPRYQRQSFTEKFPNVH------------PSAIDLVEKMLTFDPRQRITVEDAL 227
           + Y+   P+Y   SF + FP+V               A DL+ KML  D  +RI+V++AL
Sbjct: 258 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL 317

Query: 228 AHPYLGSLHDISDEPVCM-SPFSFDFEQHALTEGQMKELIYQEALAFNPEYRQQ 280
            HPY+   +D S+             ++   T  + KELIY+E +     +   
Sbjct: 318 QHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKEVMDLEHHHHHH 371

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  457 bits (1176), Expect = e-162
 Identities = 112/294 (38%), Positives = 171/294 (58%), Gaps = 17/294 (5%)

Query: 1   MDHENVVAIRDII-PPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           ++H+N++++ ++  P    E F DVY+  ELMD +L Q+I+    L  E   Y LYQ+L 
Sbjct: 118 VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLC 175

Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           G+K++HSA ++HRDLKPSN+++ ++C LKI DFGLAR    +  MT YVVTR+YRAPE++
Sbjct: 176 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 235

Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENA 179
           L    Y   +D+WSVGCI  E++  K LFPGRD++ Q   +IE +GTP    +  L    
Sbjct: 236 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 294

Query: 180 KKYICQLPRYQRQSFTEKFPNVH------------PSAIDLVEKMLTFDPRQRITVEDAL 227
           + Y+   P+Y   +F + FP+                A DL+ KML  DP +RI+V+DAL
Sbjct: 295 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 354

Query: 228 AHPYLGSLHDISDE-PVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYRQQ 280
            HPY+   +D ++        +    ++   T  + KELIY+E +    + +  
Sbjct: 355 QHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVMNSEEKTKNG 408

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  447 bits (1153), Expect = e-160
 Identities = 106/257 (41%), Positives = 152/257 (59%), Gaps = 15/257 (5%)

Query: 1   MDHENVVAIRDIIPPPQR---------ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQ 51
           +DH+N+V + +I+ P               N VYI  E M+TDL  ++     L EEH +
Sbjct: 65  LDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGP-LLEEHAR 123

Query: 52  YFLYQILRGLKYIHSANVLHRDLKPSNLLLNA-NCDLKICDFGLARVTS----ETDFMTE 106
            F+YQ+LRGLKYIHSANVLHRDLKP+NL +N  +  LKI DFGLAR+          ++E
Sbjct: 124 LFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSE 183

Query: 107 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGT 166
            +VT+WYR+P LLL+ ++YT AID+W+ GCIF E++  K LF G   + Q++L++E I  
Sbjct: 184 GLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPV 243

Query: 167 PSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDA 226
             E +   L      YI        +  T+  P +   A+D +E++LTF P  R+T E+A
Sbjct: 244 VHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEA 303

Query: 227 LAHPYLGSLHDISDEPV 243
           L+HPY+       DEP+
Sbjct: 304 LSHPYMSIYSFPMDEPI 320

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  412 bits (1060), Expect = e-145
 Identities = 85/285 (29%), Positives = 141/285 (49%), Gaps = 16/285 (5%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVY--IAYELMDTDLHQIIRS----NQALSEEHCQYFL 54
           + H N+V ++            D+Y  +  E +   LH+  R+      A      + FL
Sbjct: 76  LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFL 135

Query: 55  YQILRGLKYIH--SANVLHRDLKPSNLLLN-ANCDLKICDFGLARVTSETDFMTEYVVTR 111
           +Q++R +  +H  S NV HRD+KP N+L+N A+  LK+CDFG A+  S ++    Y+ +R
Sbjct: 136 FQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSR 195

Query: 112 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAE 171
           +YRAPEL+  +  YT A+D+WSVGCIF E+M  +P+F G +   QL  ++ ++G PS   
Sbjct: 196 YYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREV 255

Query: 172 LGFLN-ENAKKYICQLPRYQ-RQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 229
           L  LN  +    +           F++        A DL+  +L + P +R+   +AL H
Sbjct: 256 LRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH 315

Query: 230 PYLGSLHDISDE-----PVCMSPFSFDFEQHALTEGQMKELIYQE 269
           PY   LHD + +      +    F F   +  +     K  + ++
Sbjct: 316 PYFDELHDPATKLPNNKDLPEDLFRFLPNEIEVMSEAQKAKLVRK 360

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  406 bits (1045), Expect = e-142
 Identities = 86/290 (29%), Positives = 154/290 (53%), Gaps = 12/290 (4%)

Query: 1   MDHENVVAIRDIIPPP-QRESFNDVYIAYELMDTDLHQIIR----SNQALSEEHCQYFLY 55
           +DH N+V +R       +++    + +  + +   ++++ R    + Q L   + + ++Y
Sbjct: 104 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 163

Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARVTSETDFMTEYVVTRWYR 114
           Q+ R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+     +    Y+ +R+YR
Sbjct: 164 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR 223

Query: 115 APELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGF 174
           APEL+  ++DYT++IDVWS GC+  EL+  +P+FPG   V QL  +I+++GTP+  ++  
Sbjct: 224 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 283

Query: 175 LNENAKKYICQLPRYQRQSFTEKF-PNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLG 233
           +N N  ++  + P+ +   +T+ F P   P AI L  ++L + P  R+T  +A AH +  
Sbjct: 284 MNPNYTEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFD 341

Query: 234 SLHDISDEP--VCMSPFSFDFEQHALTE-GQMKELIYQEALAFNPEYRQQ 280
            L D + +      +P  F+F    L+    +  ++              
Sbjct: 342 ELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILIPPHARIQAAASTP 391

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  402 bits (1035), Expect = e-141
 Identities = 86/329 (26%), Positives = 163/329 (49%), Gaps = 54/329 (16%)

Query: 1   MDHENVVAIRDII---------------------------------PPPQRESFNDVYIA 27
           +DH N++ + D                                             + + 
Sbjct: 57  LDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVI 116

Query: 28  YELMDTDLHQIIR----SNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA 83
            E +   LH++++    S +++       ++YQ+ R + +IHS  + HRD+KP NLL+N+
Sbjct: 117 MEYVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNS 176

Query: 84  NCD-LKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
             + LK+CDFG A+    ++    Y+ +R+YRAPEL+L +++YT +ID+WS+GC+F EL+
Sbjct: 177 KDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELI 236

Query: 143 DRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVH 202
             KPLF G   + QL  +I+++GTP++ ++  +N +  +   + P  + + + +  P   
Sbjct: 237 LGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEV--RFPTLKAKDWRKILPEGT 294

Query: 203 PS-AIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMSP-------------F 248
           PS AIDL+E++L ++P  RI   +A+AHP+   L +  +  V  +              F
Sbjct: 295 PSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRNSYESEVKNNSNFPHGVNQNIPQLF 354

Query: 249 SFDFEQHALTEGQMKELIYQEALAFNPEY 277
           +F   + ++  G +   I  +  + N ++
Sbjct: 355 NFSPYELSIIPGNVLNRILPKNFSPNYKH 383

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  400 bits (1030), Expect = e-140
 Identities = 87/281 (30%), Positives = 151/281 (53%), Gaps = 13/281 (4%)

Query: 1   MDHENVVAIRDIIPPP-QRESFNDVYIAYELMDTDLHQIIRS----NQALSEEHCQYFLY 55
           + H NVV ++        ++    + +  E +   +++  R      Q +     + ++Y
Sbjct: 89  VKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMY 148

Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCD-LKICDFGLARVTSETDFMTEYVVTRWYR 114
           Q+LR L YIHS  + HRD+KP NLLL+     LK+ DFG A++    +    Y+ +R+YR
Sbjct: 149 QLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYR 208

Query: 115 APELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGF 174
           APEL+  +++YT  ID+WS GC+  ELM  +PLFPG   + QL  +I+++GTPS  ++  
Sbjct: 209 APELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKT 268

Query: 175 LNENAKKYICQLPRYQRQSFTEKF-PNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLG 233
           +N N  ++  + P+ +   F++ F P   P AIDL+ ++L + P  R+T  +AL HP+  
Sbjct: 269 MNPNYMEH--KFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFD 326

Query: 234 SLHD----ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEA 270
            L      + +       F++  E+ ++    +  L+ Q A
Sbjct: 327 ELRTGEARMPNGRELPPLFNWTKEELSVRPDLISRLVPQHA 367

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  367 bits (944), Expect = e-128
 Identities = 68/245 (27%), Positives = 132/245 (53%), Gaps = 14/245 (5%)

Query: 2   DHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGL 61
              N++ + DI+  P   S     +   + +TD  Q+    Q L++   ++++Y+IL+ L
Sbjct: 89  GGPNIITLADIVKDPV--SRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKAL 143

Query: 62  KYIHSANVLHRDLKPSNLLLN-ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL 120
            Y HS  ++HRD+KP N++++  +  L++ D+GLA            V +R+++ PELL+
Sbjct: 144 DYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLV 203

Query: 121 NSSDYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLLIELIGTPSEAE-LGFLN-E 177
           +   Y  ++D+WS+GC+   ++ RK P F G D+  QL  + +++GT    + +   N E
Sbjct: 204 DYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIE 263

Query: 178 NAKKYICQLPRYQRQSFTEKFPN-----VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
              ++   L R+ R+ +     +     V P A+D ++K+L +D + R+T  +A+ HPY 
Sbjct: 264 LDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYF 323

Query: 233 GSLHD 237
            ++  
Sbjct: 324 YTVVK 328

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  319 bits (820), Expect = e-110
 Identities = 77/258 (29%), Positives = 132/258 (51%), Gaps = 9/258 (3%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDL-HQIIRSNQALSEEHCQYFLYQILR 59
           + H N+V + ++           +++ +E  D  + H++ R  + + E   +   +Q L+
Sbjct: 59  LKHPNLVNLLEVFR-----RKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQ 113

Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV-TSETDFMTEYVVTRWYRAPEL 118
            + + H  N +HRD+KP N+L+  +  +K+CDFG AR+ T  +D+  + V TRWYR+PEL
Sbjct: 114 AVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPEL 173

Query: 119 LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL-GFLNE 177
           L+  + Y   +DVW++GC+F EL+   PL+PG+  V QL L+ + +G         F   
Sbjct: 174 LVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTN 233

Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 237
                +        +    KFPN+   A+ L++  L  DP +R+T E  L HPY  ++ +
Sbjct: 234 QYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIRE 293

Query: 238 ISDEPVCMS-PFSFDFEQ 254
           I D       P    + Q
Sbjct: 294 IEDLAKEHDKPAENLYFQ 311

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  294 bits (755), Expect = e-100
 Identities = 73/234 (31%), Positives = 123/234 (52%), Gaps = 8/234 (3%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILR 59
           + HEN+V + ++            Y+ +E +D  +   +      L  +  Q +L+QI+ 
Sbjct: 81  LRHENLVNLLEVCK-----KKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIIN 135

Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV-TSETDFMTEYVVTRWYRAPEL 118
           G+ + HS N++HRD+KP N+L++ +  +K+CDFG AR   +  +   + V TRWYRAPEL
Sbjct: 136 GIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPEL 195

Query: 119 LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNEN 178
           L+    Y  A+DVW++GC+  E+   +PLFPG   + QL  ++  +G          N+N
Sbjct: 196 LVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN 255

Query: 179 AKKYICQLPRYQ-RQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPY 231
                 +LP  + R+    ++P +    IDL +K L  DP +R    + L H +
Sbjct: 256 PVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDF 309

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  282 bits (724), Expect = 1e-95
 Identities = 89/234 (38%), Positives = 124/234 (52%), Gaps = 10/234 (4%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILR 59
           + H N+V + D+I      +   + + +E +D DL +++      L     + FL Q+L 
Sbjct: 57  LKHSNIVKLYDVIH-----TKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLN 111

Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV-TSETDFMTEYVVTRWYRAPEL 118
           G+ Y H   VLHRDLKP NLL+N   +LKI DFGLAR         T  +VT WYRAP++
Sbjct: 112 GIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDV 171

Query: 119 LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL-GFLNE 177
           L+ S  Y+  ID+WSVGCIF E+++  PLFPG     QL  +  ++GTP+          
Sbjct: 172 LMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNV--T 229

Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPY 231
              KY      Y+   +      +  S IDL+ KML  DP QRIT + AL H Y
Sbjct: 230 ELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAY 283

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  281 bits (721), Expect = 5e-95
 Identities = 85/233 (36%), Positives = 125/233 (53%), Gaps = 8/233 (3%)

Query: 2   DHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS--NQALSEEHCQYFLYQILR 59
           +H NVV + D+    + +    V + +E +D DL   +       L  E  +  + Q LR
Sbjct: 72  EHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLR 131

Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           GL ++H+  ++HRDLKP N+L+ +   +K+ DFGLAR+ S    +T  VVT WYRAPE+L
Sbjct: 132 GLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVL 191

Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL-GFLNEN 178
           L S+ Y   +D+WSVGCIF E+  RKPLF G     QL  + +LIG P E +       +
Sbjct: 192 LQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRD--VS 248

Query: 179 AKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPY 231
             +     P    +      P +  S   L+ +MLTF+P +RI+   AL H Y
Sbjct: 249 LPRG--AFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSY 299

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  281 bits (720), Expect = 1e-94
 Identities = 88/257 (34%), Positives = 132/257 (51%), Gaps = 14/257 (5%)

Query: 2   DHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS--NQALSEEHCQYFLYQILR 59
           +H NVV + D+    + +    + + +E +D DL   +       +  E  +  ++Q+LR
Sbjct: 72  EHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLR 131

Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           GL ++HS  V+HRDLKP N+L+ ++  +K+ DFGLAR+ S    +T  VVT WYRAPE+L
Sbjct: 132 GLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVL 191

Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL-GFLNEN 178
           L SS Y   +D+WSVGCIF E+  RKPLF G   V QL  ++++IG P E +        
Sbjct: 192 LQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRD--VA 248

Query: 179 AKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDI 238
             +          Q   +   ++     DL+ K LTF+P +RI+   AL+HPY       
Sbjct: 249 LPRQ--AFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF------ 300

Query: 239 SDEPVCMSPFSFDFEQH 255
            D   C           
Sbjct: 301 QDLERCKENLDSHLPPS 317

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  280 bits (719), Expect = 1e-94
 Identities = 87/239 (36%), Positives = 135/239 (56%), Gaps = 11/239 (4%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILR 59
           + H N+V++ D+I      S   + + +E M+ DL +++      L +   + +LYQ+LR
Sbjct: 76  LHHPNIVSLIDVIH-----SERCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLR 130

Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV-TSETDFMTEYVVTRWYRAPEL 118
           G+ + H   +LHRDLKP NLL+N++  LK+ DFGLAR         T  VVT WYRAP++
Sbjct: 131 GVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDV 190

Query: 119 LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL-GFLN- 176
           L+ S  Y+ ++D+WS+GCIF E++  KPLFPG     QL  +  ++GTP+  E       
Sbjct: 191 LMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQEL 250

Query: 177 ENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL 235
              K+       ++++ ++   P      IDL+  ML FDP +RI+  DA+ HPY   L
Sbjct: 251 PLWKQR--TFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL 307

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  279 bits (716), Expect = 1e-93
 Identities = 80/235 (34%), Positives = 124/235 (52%), Gaps = 13/235 (5%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILR 59
           + H N++ + D          +++ + ++ M+TDL  II+  +  L+  H + ++   L+
Sbjct: 69  LSHPNIIGLLDAFG-----HKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQ 123

Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV-TSETDFMTEYVVTRWYRAPEL 118
           GL+Y+H   +LHRDLKP+NLLL+ N  LK+ DFGLA+   S     T  VVTRWYRAPEL
Sbjct: 124 GLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPEL 183

Query: 119 LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL-GFLN- 176
           L  +  Y   +D+W+VGCI  EL+ R P  PG   + QL  + E +GTP+E +     + 
Sbjct: 184 LFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSL 243

Query: 177 ENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPY 231
            +   +      +        F       +DL++ +  F+P  RIT   AL   Y
Sbjct: 244 PDYVTF----KSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKY 294

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  278 bits (713), Expect = 1e-93
 Identities = 99/264 (37%), Positives = 145/264 (54%), Gaps = 15/264 (5%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILR 59
           + H N+V + DII      +   + + +E +D DL Q +      ++  + + FL+Q+LR
Sbjct: 57  LKHANIVTLHDIIH-----TEKSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLR 111

Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV-TSETDFMTEYVVTRWYRAPEL 118
           GL Y H   VLHRDLKP NLL+N   +LK+ DFGLAR  +  T      VVT WYR P++
Sbjct: 112 GLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDI 171

Query: 119 LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL-GFLN- 176
           LL S+DY+  ID+W VGCIF E+   +PLFPG     QL  +  ++GTP+E    G L+ 
Sbjct: 172 LLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSN 231

Query: 177 ENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL- 235
           E  K Y    P+Y+ ++     P +     DL+ K+L F+ R RI+ EDA+ HP+  SL 
Sbjct: 232 EEFKTY--NYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLG 289

Query: 236 ---HDISDEPVCMSPFSFDFEQHA 256
              H + D     +      ++ A
Sbjct: 290 ERIHKLPDTTSIFALKEIQLQKEA 313

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  274 bits (704), Expect = 4e-92
 Identities = 77/243 (31%), Positives = 129/243 (53%), Gaps = 15/243 (6%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRG 60
           + H N++ ++ +I        + +++ +E  + DL + +  N  +S    + FLYQ++ G
Sbjct: 90  LQHRNIIELKSVIH-----HNHRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLING 144

Query: 61  LKYIHSANVLHRDLKPSNLLLNANCD-----LKICDFGLARV-TSETDFMTEYVVTRWYR 114
           + + HS   LHRDLKP NLLL+ +       LKI DFGLAR         T  ++T WYR
Sbjct: 145 VNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYR 204

Query: 115 APELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL-G 173
            PE+LL S  Y+ ++D+WS+ CI+ E++ + PLFPG   + QL  + E++G P +    G
Sbjct: 205 PPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPG 264

Query: 174 FLNENAKKYICQLPRYQRQSFTEKFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
                   +    P+++ ++        +    +DL+  ML  DP +RI+ ++AL HPY 
Sbjct: 265 V--TALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYF 322

Query: 233 GSL 235
              
Sbjct: 323 SHN 325

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  270 bits (692), Expect = 7e-91
 Identities = 92/246 (37%), Positives = 135/246 (54%), Gaps = 25/246 (10%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILR 59
           + H+N+V + D++      S   + + +E  D DL +   S N  L  E  + FL+Q+L+
Sbjct: 58  LKHKNIVRLHDVLH-----SDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLK 112

Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV-TSETDFMTEYVVTRWYRAPEL 118
           GL + HS NVLHRDLKP NLL+N N +LK+ +FGLAR         +  VVT WYR P++
Sbjct: 113 GLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDV 172

Query: 119 LLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAEL-GFLN 176
           L  +  Y+ +ID+WS GCIF EL +  +PLFPG D   QL+ +  L+GTP+E +      
Sbjct: 173 LFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSM-- 230

Query: 177 ENAKKYICQLPRY-------QRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 229
                   +LP Y          S     P ++ +  DL++ +L  +P QRI+ E+AL H
Sbjct: 231 -------TKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283

Query: 230 PYLGSL 235
           PY    
Sbjct: 284 PYFSDF 289

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  272 bits (697), Expect = 9e-91
 Identities = 85/272 (31%), Positives = 132/272 (48%), Gaps = 18/272 (6%)

Query: 1   MDHENVVAIRDII---PPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQ 56
           + HENVV + +I      P       +Y+ ++  + DL  ++ +     +    +  +  
Sbjct: 73  LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQM 132

Query: 57  ILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-----VTSETDFMTEYVVTR 111
           +L GL YIH   +LHRD+K +N+L+  +  LK+ DFGLAR       S+ +  T  VVT 
Sbjct: 133 LLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTL 192

Query: 112 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAE 171
           WYR PELLL   DY   ID+W  GCI  E+  R P+  G    HQL L+ +L G+ +   
Sbjct: 193 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 252

Query: 172 L-GFLN-ENAKKYICQLPRYQRQSFTEKFPNVH--PSAIDLVEKMLTFDPRQRITVEDAL 227
                N E  +K   +L + Q++   ++       P A+DL++K+L  DP QRI  +DAL
Sbjct: 253 WPNVDNYELYEKL--ELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDAL 310

Query: 228 AHPYLGSL---HDISDEPVCMSPFSFDFEQHA 256
            H +  S     D+           F++    
Sbjct: 311 NHDFFWSDPMPSDLKGMLSTHLTSMFEYLAPP 342

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  267 bits (685), Expect = 2e-89
 Identities = 82/255 (32%), Positives = 135/255 (52%), Gaps = 20/255 (7%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN------QALSEEHCQYFL 54
           + HEN+V + D+I      + N + + +E MD DL + + S       + L     +YF 
Sbjct: 60  LKHENIVRLYDVIH-----TENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQ 114

Query: 55  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV-TSETDFMTEYVVTRWY 113
           +Q+L+GL + H   +LHRDLKP NLL+N    LK+ DFGLAR      +  +  VVT WY
Sbjct: 115 WQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWY 174

Query: 114 RAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL- 172
           RAP++L+ S  Y+ +ID+WS GCI  E++  KPLFPG +   QL+L+ +++GTP+E+   
Sbjct: 175 RAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWP 234

Query: 173 GFLNENAKKYICQLPRYQRQSFTEKF-----PNVHPSAIDLVEKMLTFDPRQRITVEDAL 227
                   KY   + +   +   +         +  + +D +  +L  +P  R++ + AL
Sbjct: 235 SV--TKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQAL 292

Query: 228 AHPYLGSLHDISDEP 242
            HP+    +  +   
Sbjct: 293 HHPWFAEYYHHASMG 307

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  245 bits (626), Expect = 2e-79
 Identities = 82/268 (30%), Positives = 130/268 (48%), Gaps = 43/268 (16%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS---------NQALSEEHCQ 51
           + H NV++++ +           V++ ++  + DL  II+             L     +
Sbjct: 75  LKHPNVISLQKVFLSHADRK---VWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVK 131

Query: 52  YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD----LKICDFGLAR-----VTSETD 102
             LYQIL G+ Y+H+  VLHRDLKP+N+L+         +KI D G AR     +    D
Sbjct: 132 SLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLAD 191

Query: 103 FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD---------H 153
                VVT WYRAPELLL +  YT AID+W++GCIF EL+  +P+F  R          H
Sbjct: 192 LDPV-VVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYH 250

Query: 154 VHQLRLLIELIGTPSEAEL-GFLNENAKKYICQLPRYQRQSFT---------EKFPNVHP 203
             QL  +  ++G P++ +      +   ++   +  ++R ++T         +       
Sbjct: 251 HDQLDRIFNVMGFPADKDWEDI--KKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDS 308

Query: 204 SAIDLVEKMLTFDPRQRITVEDALAHPY 231
            A  L++K+LT DP +RIT E A+  PY
Sbjct: 309 KAFHLLQKLLTMDPIKRITSEQAMQDPY 336

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  177 bits (451), Expect = 3e-53
 Identities = 71/240 (29%), Positives = 116/240 (48%), Gaps = 36/240 (15%)

Query: 26  IAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN- 82
           + +EL+  +L+++I+ N  Q  S    + F + IL+ L  +H   ++H DLKP N+LL  
Sbjct: 176 MTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQ 235

Query: 83  -ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 141
                +K+ DFG +    E   +  Y+ +R+YRAPE++L +  Y   ID+WS+GCI  EL
Sbjct: 236 QGRSGIKVIDFGSS--CYEHQRVYTYIQSRFYRAPEVILGAR-YGMPIDMWSLGCILAEL 292

Query: 142 MDRKPLFPGRDHVHQLRLLIELIGTPSE--------AELGFLNENA-------------- 179
           +   PL PG D   QL  +IEL+G PS+        A+    ++                
Sbjct: 293 LTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSV 352

Query: 180 -------KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
                  ++   + P   R+          P  +D +++ L +DP  R+T   AL HP+L
Sbjct: 353 VLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWL 412

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  169 bits (429), Expect = 2e-50
 Identities = 54/234 (23%), Positives = 96/234 (41%), Gaps = 30/234 (12%)

Query: 26  IAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLN 82
           + +E++  +L  +I+    + +   + +    Q+L GL Y+H    ++H D+KP N+L+ 
Sbjct: 107 MVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLME 166

Query: 83  ANCD------LKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC 136
                     +KI D G A      +  T  + TR YR+PE+LL +  +    D+WS  C
Sbjct: 167 IVDSPENLIQIKIADLGNA--CWYDEHYTNSIQTREYRSPEVLLGAP-WGCGADIWSTAC 223

Query: 137 IFMELMDRKPLFPGRD------HVHQLRLLIELIGTPSE--------AELGFLNENAKKY 182
           +  EL+    LF   +          +  +IEL+G                F +    + 
Sbjct: 224 LIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRN 283

Query: 183 ICQLPRYQRQSFTEKFPNV----HPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
           I +L  +  +    +             D +  ML  DPR+R      + HP+L
Sbjct: 284 ISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWL 337

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  169 bits (429), Expect = 2e-50
 Identities = 62/247 (25%), Positives = 111/247 (44%), Gaps = 43/247 (17%)

Query: 26  IAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHS--ANVLHRDLKPSNLLL 81
           + +E++  +L+ ++R+   + +S    + F  Q+   L ++ +   +++H DLKP N+LL
Sbjct: 133 LVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILL 192

Query: 82  --NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFM 139
                  +KI DFG +        + +Y+ +R+YR+PE+LL    Y  AID+WS+GCI +
Sbjct: 193 CNPKRSAIKIVDFGSS--CQLGQRIYQYIQSRFYRSPEVLLGMP-YDLAIDMWSLGCILV 249

Query: 140 ELMDRKPLFPGRDHVHQLRLLIELIGTPSE--------AELGFLNENAKKY--------- 182
           E+   +PLF G + V Q+  ++E++G P          A   F       +         
Sbjct: 250 EMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGK 309

Query: 183 -----------------ICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVED 225
                                P  +R   +      +    DL+ +ML +DP+ RI    
Sbjct: 310 REYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYY 369

Query: 226 ALAHPYL 232
           AL H + 
Sbjct: 370 ALQHSFF 376

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  167 bits (424), Expect = 6e-50
 Identities = 68/254 (26%), Positives = 115/254 (45%), Gaps = 43/254 (16%)

Query: 18  RESF---NDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHR 72
            E F     + I +EL+    +  I+ N       +H +   YQI + + ++HS  + H 
Sbjct: 83  LEWFEHHGHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHT 142

Query: 73  DLKPSNLLLN-------------------ANCDLKICDFGLARVTSETDFMTEYVVTRWY 113
           DLKP N+L                      N D+K+ DFG A  T + +  +  V TR Y
Sbjct: 143 DLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSA--TYDDEHHSTLVSTRHY 200

Query: 114 RAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL- 172
           RAPE++L    ++   DVWS+GCI +E      +FP  D    L ++  ++G   +  + 
Sbjct: 201 RAPEVILALG-WSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQ 259

Query: 173 ----------GFLN----ENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPR 218
                       L+     +A +Y+ +  +  ++    +    H    DL++KML +DP 
Sbjct: 260 KTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVE-HERLFDLIQKMLEYDPA 318

Query: 219 QRITVEDALAHPYL 232
           +RIT+ +AL HP+ 
Sbjct: 319 KRITLREALKHPFF 332

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  167 bits (425), Expect = 6e-50
 Identities = 63/242 (26%), Positives = 106/242 (43%), Gaps = 38/242 (15%)

Query: 26  IAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN- 82
           IA+EL+  +  + ++ N  Q     H ++  YQ+   L+++H   + H DLKP N+L   
Sbjct: 99  IAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVN 158

Query: 83  ------------------ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD 124
                              N  +++ DFG A  T + +  T  V TR YR PE++L    
Sbjct: 159 SEFETLYNEHKSCEEKSVKNTSIRVADFGSA--TFDHEHHTTIVATRHYRPPEVILELG- 215

Query: 125 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPS--------------EA 170
           +    DVWS+GCI  E      LF   ++   L ++ +++G                 + 
Sbjct: 216 WAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKG 275

Query: 171 ELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHP 230
            L +   ++     +      +S+  +    H    DL+ +ML FDP QRIT+ +AL HP
Sbjct: 276 GLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHP 335

Query: 231 YL 232
           + 
Sbjct: 336 FF 337

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  165 bits (421), Expect = 2e-49
 Identities = 57/250 (22%), Positives = 103/250 (41%), Gaps = 46/250 (18%)

Query: 26  IAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN- 82
           + +E +   L++II  N       E  + +  +IL+ L Y+   ++ H DLKP N+LL+ 
Sbjct: 113 LIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDD 172

Query: 83  ------------------------ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPEL 118
                                    +  +K+ DFG A  T ++D+    + TR YRAPE+
Sbjct: 173 PYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA--TFKSDYHGSIINTRQYRAPEV 230

Query: 119 LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSE--------- 169
           +LN   +  + D+WS GC+  EL     LF   +H+  L ++  +I    +         
Sbjct: 231 ILNLG-WDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKT 289

Query: 170 AELGFLNENAKKYICQLP-------RYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT 222
               ++N++  K             ++ ++         H    D +  +L  DP  R +
Sbjct: 290 NGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPS 349

Query: 223 VEDALAHPYL 232
             + L H +L
Sbjct: 350 PAELLKHKFL 359

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  164 bits (416), Expect = 4e-49
 Identities = 52/243 (21%), Positives = 96/243 (39%), Gaps = 46/243 (18%)

Query: 3   HENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLK 62
            + ++ + D        +   +Y+  E  + DL+  ++  +++     + +   +L  + 
Sbjct: 87  SDKIIRLYDYE-----ITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVH 141

Query: 63  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSE---TDFMTEYVVTRWYRAPELL 119
            IH   ++H DLKP+N L+  +  LK+ DFG+A        +      V T  Y  PE +
Sbjct: 142 TIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 200

Query: 120 LNSSD----------YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSE 169
            + S            +   DVWS+GCI   +   K  F      +Q+  L  +I     
Sbjct: 201 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII--NQISKLHAII----- 253

Query: 170 AELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 229
                       +  + P                   D+++  L  DP+QRI++ + LAH
Sbjct: 254 ---------DPNHEIEFP-----------DIPEKDLQDVLKCCLKRDPKQRISIPELLAH 293

Query: 230 PYL 232
           PY+
Sbjct: 294 PYV 296

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  166 bits (423), Expect = 6e-49
 Identities = 60/258 (23%), Positives = 95/258 (36%), Gaps = 50/258 (19%)

Query: 2   DHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ-ALSEEHCQYFLYQILRG 60
           +H NV+           +     YIA EL    L + +     A         L Q   G
Sbjct: 76  EHPNVIRYFCTE-----KDRQFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSG 130

Query: 61  LKYIHSANVLHRDLKPSNLLL-----NANCDLKICDFGLARV----TSETDFMTEYVVTR 111
           L ++HS N++HRDLKP N+L+     +      I DFGL +            +    T 
Sbjct: 131 LAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTE 190

Query: 112 WYRAPELLLNSSD--YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSE 169
            + APE+L        T  +D++S GC+F  ++       G+    Q  +L+        
Sbjct: 191 GWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILL-------- 242

Query: 170 AELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 229
                    A                    +    A +L+EKM+  DP++R + +  L H
Sbjct: 243 --------GACSL----------DCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH 284

Query: 230 PY-------LGSLHDISD 240
           P+       L    D+SD
Sbjct: 285 PFFWSLEKQLQFFQDVSD 302

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  165 bits (418), Expect = 6e-49
 Identities = 32/240 (13%), Positives = 65/240 (27%), Gaps = 31/240 (12%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIR-------SNQALSEEHCQYF 53
           +  ++      + P     +  +  +       DL  +                      
Sbjct: 140 VAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHIL 199

Query: 54  LYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWY 113
             Q++R    + S  ++H    P NL +  +  L + D                 V   Y
Sbjct: 200 TAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR--GPASSVPVTY 257

Query: 114 RAPELL-LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL 172
              E L  +++ +T A++ W +G     +      F       +       +  P    L
Sbjct: 258 APREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSL 317

Query: 173 GFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
            F                          +      L+ + L FD R+R+   +A+  P  
Sbjct: 318 AF---------------------GSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEF 356

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  162 bits (411), Expect = 2e-48
 Identities = 61/258 (23%), Positives = 101/258 (39%), Gaps = 55/258 (21%)

Query: 1   MDHENVVAIRD--------IIPPPQRESFNDVYIAYELMDT-DLHQIIRS-NQALSEEHC 50
           ++H+ VV            + P    +  + ++I  E  +   L+ +I S N     +  
Sbjct: 59  LNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEY 118

Query: 51  QYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET--------- 101
                QIL  L YIHS  ++HRDLKP N+ ++ + ++KI DFGLA+    +         
Sbjct: 119 WRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178

Query: 102 ------DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVH 155
                 D +T  + T  Y A E+L  +  Y   ID++S+G IF E++   P   G + V+
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGMERVN 236

Query: 156 QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP-NVHPSAIDLVEKMLT 214
            L+ L                           R     F   F  N       ++  ++ 
Sbjct: 237 ILKKL---------------------------RSVSIEFPPDFDDNKMKVEKKIIRLLID 269

Query: 215 FDPRQRITVEDALAHPYL 232
            DP +R      L   +L
Sbjct: 270 HDPNKRPGARTLLNSGWL 287

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  161 bits (408), Expect = 1e-47
 Identities = 55/292 (18%), Positives = 106/292 (36%), Gaps = 48/292 (16%)

Query: 3   HENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLK 62
            + ++ + D        +   +Y+  E  + DL+  ++  +++     + +   +L  + 
Sbjct: 68  SDKIIRLYDYE-----ITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVH 122

Query: 63  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSE---TDFMTEYVVTRWYRAPELL 119
            IH   ++H DLKP+N L+  +  LK+ DFG+A        +      V T  Y  PE +
Sbjct: 123 TIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAI 181

Query: 120 LNSSD----------YTAAIDVWSVGCIFMELMDRKPLFPG-RDHVHQLRLLIELIGTPS 168
            + S            +   DVWS+GCI   +   K  F    + + +L  +I+      
Sbjct: 182 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID------ 235

Query: 169 EAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA 228
                        +  + P                   D+++  L  DP+QRI++ + LA
Sbjct: 236 -----------PNHEIEFP-----------DIPEKDLQDVLKCCLKRDPKQRISIPELLA 273

Query: 229 HPYLGSLHDISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYRQQ 280
           HPY+       ++    +     +    L        I + A      Y   
Sbjct: 274 HPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGG 325

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  158 bits (402), Expect = 5e-47
 Identities = 54/235 (22%), Positives = 79/235 (33%), Gaps = 45/235 (19%)

Query: 2   DHENVVAIRDIIPPPQRESF---NDVYIAYELMDTDLHQII-RSNQALSEEHCQYFLYQI 57
            H   V +          ++     +Y+  EL    L Q       +L E     +L   
Sbjct: 115 QHPCCVRLEQ--------AWEEGGILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDT 166

Query: 58  LRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPE 117
           L  L ++HS  ++H D+KP+N+ L      K+ DFGL                  Y APE
Sbjct: 167 LLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPE 226

Query: 118 LLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNE 177
           LL     Y  A DV+S+G   +E+     L  G +   QLR                   
Sbjct: 227 LLQG--SYGTAADVFSLGLTILEVACNMELPHGGEGWQQLR------------------- 265

Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
                  +               +      ++  ML  DP+ R T E  LA P L
Sbjct: 266 -QGYLPPEFT-----------AGLSSELRSVLVMMLEPDPKLRATAEALLALPVL 308

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  160 bits (406), Expect = 1e-46
 Identities = 74/239 (30%), Positives = 118/239 (49%), Gaps = 39/239 (16%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILR 59
           ++H  ++ I++       ++  D YI  ELM+  +L   +  N+ L E  C+ + YQ+L 
Sbjct: 197 LNHPCIIKIKNFF-----DA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL 250

Query: 60  GLKYIHSANVLHRDLKPSNLLLNA---NCDLKICDFGLARVTSETDFMTEYVVTRWYRAP 116
            ++Y+H   ++HRDLKP N+LL++   +C +KI DFG +++  ET  M     T  Y AP
Sbjct: 251 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 310

Query: 117 ELLLNSSD--YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGF 174
           E+L++     Y  A+D WS+G I                     L I L G P      F
Sbjct: 311 EVLVSVGTAGYNRAVDCWSLGVI---------------------LFICLSGYPP-----F 344

Query: 175 LNENAKKYICQLPRYQRQSFT-EKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
                +  +       + +F  E +  V   A+DLV+K+L  DP+ R T E+AL HP+L
Sbjct: 345 SEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 403

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  156 bits (397), Expect = 2e-46
 Identities = 57/237 (24%), Positives = 103/237 (43%), Gaps = 39/237 (16%)

Query: 3   HENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGL 61
           H N++ ++D       E+    ++ ++LM   +L   +     LSE+  +  +  +L  +
Sbjct: 83  HPNIIQLKDTY-----ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVI 137

Query: 62  KYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLN 121
             +H  N++HRDLKP N+LL+ + ++K+ DFG +      + + E   T  Y APE++  
Sbjct: 138 CALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIEC 197

Query: 122 SSD-----YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLN 176
           S +     Y   +D+WS G I                     +   L G+P      F +
Sbjct: 198 SMNDNHPGYGKEVDMWSTGVI---------------------MYTLLAGSPP-----FWH 231

Query: 177 ENAKKYICQLPRYQRQSFTEKF-PNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
                 + ++       F      +   +  DLV + L   P++R T E+ALAHP+ 
Sbjct: 232 RKQML-MLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 287

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  156 bits (396), Expect = 2e-46
 Identities = 52/246 (21%), Positives = 85/246 (34%), Gaps = 49/246 (19%)

Query: 1   MDHENVV-----------AIRDIIPPPQRESFNDVYIAYELMDT-DLHQII--RSNQALS 46
           +DH N+V                     R     ++I  E  D   L Q I  R  + L 
Sbjct: 61  LDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLD 120

Query: 47  EEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE 106
           +        QI +G+ YIHS  +++RDLKPSN+ L     +KI DFGL          T 
Sbjct: 121 KVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTR 180

Query: 107 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGT 166
              T  Y +PE + +   Y   +D++++G I  EL+             +       +  
Sbjct: 181 SKGTLRYMSPEQISSQD-YGKEVDLYALGLILAELL--HVCDTA----FETSKFFTDL-- 231

Query: 167 PSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDA 226
                                  +    ++ F         L++K+L+  P  R    + 
Sbjct: 232 -----------------------RDGIISDIFD---KKEKTLLQKLLSKKPEDRPNTSEI 265

Query: 227 LAHPYL 232
           L    +
Sbjct: 266 LRTLTV 271

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  158 bits (402), Expect = 3e-46
 Identities = 53/291 (18%), Positives = 100/291 (34%), Gaps = 46/291 (15%)

Query: 3   HENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLK 62
            + ++ + D        +   +Y+  E  + DL+  ++  +++     + +   +L  + 
Sbjct: 115 SDKIIRLYDYE-----ITDQYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVH 169

Query: 63  YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSE---TDFMTEYVVTRWYRAPELL 119
            IH   ++H DLKP+N L+  +  LK+ DFG+A        +      V    Y  PE +
Sbjct: 170 TIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAI 228

Query: 120 LNSSD----------YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSE 169
            + S            +   DVWS+GCI   +   K  F    +       I        
Sbjct: 229 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIID------ 282

Query: 170 AELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 229
                       +  + P                   D+++  L  DP+QRI++ + LAH
Sbjct: 283 ----------PNHEIEFP-----------DIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321

Query: 230 PYLGSLHDISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYRQQ 280
           PY+       ++    +     +    L        I + A      Y   
Sbjct: 322 PYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGG 372

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  156 bits (397), Expect = 3e-46
 Identities = 75/256 (29%), Positives = 121/256 (47%), Gaps = 39/256 (15%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILR 59
           ++H  ++ I++       ++  D YI  ELM+  +L   +  N+ L E  C+ + YQ+L 
Sbjct: 72  LNHPCIIKIKNFF-----DA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL 125

Query: 60  GLKYIHSANVLHRDLKPSNLLLNA---NCDLKICDFGLARVTSETDFMTEYVVTRWYRAP 116
            ++Y+H   ++HRDLKP N+LL++   +C +KI DFG +++  ET  M     T  Y AP
Sbjct: 126 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 185

Query: 117 ELLLNSSD--YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGF 174
           E+L++     Y  A+D WS+G I                     L I L G P      F
Sbjct: 186 EVLVSVGTAGYNRAVDCWSLGVI---------------------LFICLSGYPP-----F 219

Query: 175 LNENAKKYICQLPRYQRQSF-TEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLG 233
                +  +       + +F  E +  V   A+DLV+K+L  DP+ R T E+AL HP+L 
Sbjct: 220 SEHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 279

Query: 234 SLHDISDEPVCMSPFS 249
                      +S  +
Sbjct: 280 DEDMKRKFQDLLSEEN 295

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  156 bits (395), Expect = 2e-45
 Identities = 59/241 (24%), Positives = 104/241 (43%), Gaps = 49/241 (20%)

Query: 2   DHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRG 60
            H +++ + D       ES + +++ ++LM   +L   +    ALSE+  +  +  +L  
Sbjct: 158 GHPHIITLIDSY-----ESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEA 212

Query: 61  LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL 120
           + ++H+ N++HRDLKP N+LL+ N  +++ DFG +      + + E   T  Y APE+L 
Sbjct: 213 VSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILK 272

Query: 121 NSSD-----YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTP-----SEA 170
            S D     Y   +D+W+ G I                     L   L G+P      + 
Sbjct: 273 CSMDETHPGYGKEVDLWACGVI---------------------LFTLLAGSPPFWHRRQI 311

Query: 171 ELGFLNENAKKYICQLPRYQRQSFTEKF-PNVHPSAIDLVEKMLTFDPRQRITVEDALAH 229
            +        +Y           F+     +   +  DL+ ++L  DP  R+T E AL H
Sbjct: 312 LM-LRMIMEGQY----------QFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQH 360

Query: 230 P 230
           P
Sbjct: 361 P 361

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  151 bits (385), Expect = 8e-45
 Identities = 64/253 (25%), Positives = 108/253 (42%), Gaps = 49/253 (19%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILR 59
           + H N++ + DI      E+  DV +  EL+   +L   +   ++L+E+    FL QIL 
Sbjct: 65  IRHPNIITLHDIF-----ENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILD 119

Query: 60  GLKYIHSANVLHRDLKPSNLLL----NANCDLKICDFGLARVTSETDFMTEYVVTRWYRA 115
           G+ Y+HS  + H DLKP N++L      N  +K+ DFG+A      +       T  + A
Sbjct: 120 GVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVA 179

Query: 116 PELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTP-----SEA 170
           PE ++N        D+WS+G I                       I L G       ++ 
Sbjct: 180 PE-IVNYEPLGLEADMWSIGVI---------------------TYILLSGASPFLGETKQ 217

Query: 171 ELGFLNENAKKYICQLPRYQRQSFTEK-FPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 229
           E    N +A  Y           F E+ F N    A D + ++L  DP++R+T+  +L H
Sbjct: 218 ET-LTNISAVNY----------DFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEH 266

Query: 230 PYLGSLHDISDEP 242
            ++ ++   +   
Sbjct: 267 SWIKAIRRRNVRG 279

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  150 bits (382), Expect = 2e-44
 Identities = 65/247 (26%), Positives = 98/247 (39%), Gaps = 39/247 (15%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILR 59
           +DH N++ + +       E   D+Y+  EL    +L + +   +   E      +  +L 
Sbjct: 63  LDHPNIIRLYETF-----EDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLS 117

Query: 60  GLKYIHSANVLHRDLKPSNLLL---NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAP 116
            + Y H  NV HRDLKP N L    + +  LK+ DFGLA        M   V T +Y +P
Sbjct: 118 AVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSP 177

Query: 117 ELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLN 176
           ++L     Y    D WS G +                     + + L G P      F  
Sbjct: 178 QVLEGL--YGPECDEWSAGVM---------------------MYVLLCGYPP-----FSA 209

Query: 177 ENAKKYICQLPRYQRQSFTEK-FPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL 235
               + +    R    +F EK + NV P A  L+ ++LT  P+QRIT   AL H +    
Sbjct: 210 PTDSE-VMLKIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQ 268

Query: 236 HDISDEP 242
              S   
Sbjct: 269 LSSSPRN 275

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  150 bits (381), Expect = 3e-44
 Identities = 64/235 (27%), Positives = 110/235 (46%), Gaps = 38/235 (16%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILR 59
           + H N+V + D I     +  +  Y+ ++L+   +L + I + +  SE    + + QIL 
Sbjct: 62  LQHPNIVRLHDSI-----QEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILE 116

Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCD---LKICDFGLARVTSETDFMTEYVVTRWYRAP 116
            + Y HS  ++HR+LKP NLLL +      +K+ DFGLA   ++++    +  T  Y +P
Sbjct: 117 SIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSP 176

Query: 117 ELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLN 176
           E +L    Y+  +D+W+ G I                     L I L+G P      F +
Sbjct: 177 E-VLKKDPYSKPVDIWACGVI---------------------LYILLVGYPP-----FWD 209

Query: 177 ENAKKYICQLPRYQRQSFTEK-FPNVHPSAIDLVEKMLTFDPRQRITVEDALAHP 230
           E+  +   Q+       +    +  V P A  L++ MLT +P++RIT + AL  P
Sbjct: 210 EDQHRLYAQIKAGAY-DYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVP 263

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  151 bits (383), Expect = 4e-44
 Identities = 64/243 (26%), Positives = 104/243 (42%), Gaps = 49/243 (20%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILR 59
           + H NV+ + D+      E+  DV +  EL+   +L   +   ++LSEE    F+ QIL 
Sbjct: 72  VLHHNVITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD 126

Query: 60  GLKYIHSANVLHRDLKPSNLLL----NANCDLKICDFGLARVTSETDFMTEYVVTRWYRA 115
           G+ Y+H+  + H DLKP N++L         +K+ DFGLA    +         T  + A
Sbjct: 127 GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVA 186

Query: 116 PELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTP-----SEA 170
           PE ++N        D+WS+G I                       I L G       ++ 
Sbjct: 187 PE-IVNYEPLGLEADMWSIGVI---------------------TYILLSGASPFLGDTKQ 224

Query: 171 ELGFLNENAKKYICQLPRYQRQSFT-EKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 229
           E    N  +  Y           F  E F +    A D + K+L  + R+R+T+++AL H
Sbjct: 225 ET-LANITSVSY----------DFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRH 273

Query: 230 PYL 232
           P++
Sbjct: 274 PWI 276

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  152 bits (385), Expect = 4e-44
 Identities = 54/236 (22%), Positives = 93/236 (39%), Gaps = 39/236 (16%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQII--RSNQALSEEHCQYFLYQI 57
           M H N+V  R+       E    +YI  +  +  DL + I  +      E+    +  QI
Sbjct: 80  MKHPNIVQYRESF-----EENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQI 134

Query: 58  LRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVV-TRWYRAP 116
              LK++H   +LHRD+K  N+ L  +  +++ DFG+ARV + T  +    + T +Y +P
Sbjct: 135 CLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSP 194

Query: 117 ELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLN 176
           E+  N   Y    D+W++GC+  EL   K  F      +    L+  I            
Sbjct: 195 EICENKP-YNNKSDIWALGCVLYELCTLKHAFEAGSMKN----LVLKI------------ 237

Query: 177 ENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
                    +             +       LV ++   +PR R +V   L   ++
Sbjct: 238 --ISGSFPPVS-----------LHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFI 280

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  150 bits (380), Expect = 5e-44
 Identities = 61/243 (25%), Positives = 102/243 (41%), Gaps = 52/243 (21%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-----TDLHQIIRSNQALSEEHCQYFLY 55
           +DH N++ I ++      E ++++YI  E  +       +       +ALSE +    + 
Sbjct: 77  LDHPNIIKIFEVF-----EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMK 131

Query: 56  QILRGLKYIHSANVLHRDLKPSNLLL---NANCDLKICDFGLARVTSETDFMTEYVVTRW 112
           Q++  L Y HS +V+H+DLKP N+L    + +  +KI DFGLA +    +  T    T  
Sbjct: 132 QMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTAL 191

Query: 113 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTP----- 167
           Y APE+     D T   D+WS G +                     +   L G       
Sbjct: 192 YMAPEVF--KRDVTFKCDIWSAGVV---------------------MYFLLTGCLPFTGT 228

Query: 168 SEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDAL 227
           S  E+       K+           ++  +   + P A+DL+++MLT DP +R +    L
Sbjct: 229 SLEEV-QQKATYKEP----------NYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVL 277

Query: 228 AHP 230
            H 
Sbjct: 278 HHE 280

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  154 bits (391), Expect = 7e-44
 Identities = 70/247 (28%), Positives = 106/247 (42%), Gaps = 39/247 (15%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILR 59
           +DH N++ + +       E     Y+  E+    +L   I S +  SE      + Q+L 
Sbjct: 83  LDHPNIMKLYEFF-----EDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLS 137

Query: 60  GLKYIHSANVLHRDLKPSNLLL---NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAP 116
           G+ Y+H   ++HRDLKP NLLL   + + +++I DFGL+     +  M + + T +Y AP
Sbjct: 138 GITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAP 197

Query: 117 ELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLN 176
           E+L     Y    DVWS G I                     L I L G P      F  
Sbjct: 198 EVL--HGTYDEKCDVWSTGVI---------------------LYILLSGCP-----PFNG 229

Query: 177 ENAKKYICQLPRYQRQSFTEK-FPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL 235
            N    I +     + +F    +  V  SA DL+ KMLT+ P  RI+  DAL H ++ + 
Sbjct: 230 ANEYD-ILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTY 288

Query: 236 HDISDEP 242
                  
Sbjct: 289 TKEQISV 295

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  154 bits (391), Expect = 7e-44
 Identities = 69/237 (29%), Positives = 106/237 (44%), Gaps = 39/237 (16%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILR 59
           +DH N++ + D       E   + Y+  E     +L   I      +E      + Q+L 
Sbjct: 93  LDHPNIMKLYDFF-----EDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLS 147

Query: 60  GLKYIHSANVLHRDLKPSNLLL---NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAP 116
           G+ Y+H  N++HRDLKP NLLL     +  +KI DFGL+ V      M E + T +Y AP
Sbjct: 148 GVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAP 207

Query: 117 ELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLN 176
           E+L     Y    DVWS+G I   L+   P F G+                         
Sbjct: 208 EVL--RKKYDEKCDVWSIGVILFILLAGYPPFGGQTD----------------------- 242

Query: 177 ENAKKYICQLPRYQRQSFTEK-FPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
               + I +     + +F    + NV   A DL+++ML FD ++RI+ + AL HP++
Sbjct: 243 ----QEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWI 295

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  150 bits (382), Expect = 7e-44
 Identities = 66/243 (27%), Positives = 107/243 (44%), Gaps = 49/243 (20%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILR 59
           + H NV+ + ++      E+  DV +  EL+   +L   +   ++L+EE    FL QIL 
Sbjct: 71  IQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN 125

Query: 60  GLKYIHSANVLHRDLKPSNLLL----NANCDLKICDFGLARVTSETDFMTEYVVTRWYRA 115
           G+ Y+HS  + H DLKP N++L         +KI DFGLA      +       T  + A
Sbjct: 126 GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVA 185

Query: 116 PELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTP-----SEA 170
           PE ++N        D+WS+G I                       I L G       ++ 
Sbjct: 186 PE-IVNYEPLGLEADMWSIGVI---------------------TYILLSGASPFLGDTKQ 223

Query: 171 ELGFLNENAKKYICQLPRYQRQSFTEK-FPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 229
           E    N +A  Y           F ++ F N    A D + ++L  DP++R+T++D+L H
Sbjct: 224 ET-LANVSAVNY----------EFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQH 272

Query: 230 PYL 232
           P++
Sbjct: 273 PWI 275

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  150 bits (380), Expect = 1e-43
 Identities = 44/249 (17%), Positives = 88/249 (35%), Gaps = 27/249 (10%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQ---ALSEEHCQYFLYQ 56
           ++H+N+V +  I    +  +     +  E      L+ ++        L E      L  
Sbjct: 64  LNHKNIVKLFAIE---EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRD 120

Query: 57  ILRGLKYIHSANVLHRDLKPSNLLLNANCD----LKICDFGLARVTSETDFMTEYVVTRW 112
           ++ G+ ++    ++HR++KP N++     D     K+ DFG AR   + +       T  
Sbjct: 121 VVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEE 180

Query: 113 YRAPELLLNSSD-------YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELI- 164
           Y  P++   +         Y A +D+WS+G  F         F   +   + + ++  I 
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240

Query: 165 -GTPSEAELGF--LNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI 221
            G PS A  G          +   +P     S       +      ++  +L  D  +  
Sbjct: 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLS-----RGLQVLLTPVLANILEADQEKCW 295

Query: 222 TVEDALAHP 230
             +   A  
Sbjct: 296 GFDQFFAET 304

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  150 bits (382), Expect = 1e-43
 Identities = 64/246 (26%), Positives = 116/246 (47%), Gaps = 36/246 (14%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILR 59
           + H N+V + D I     +  +  Y+ ++L+   +L + I + +  SE    + + QIL 
Sbjct: 85  LQHPNIVRLHDSI-----QEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILE 139

Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCD---LKICDFGLARVTSETDFMTEYVVTRWYRAP 116
            + Y HS  ++HR+LKP NLLL +      +K+ DFGLA   ++++    +  T  Y +P
Sbjct: 140 SIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSP 199

Query: 117 ELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLN 176
           E +L    Y+  +D+W+ G I                     L I L+G P      F +
Sbjct: 200 E-VLKKDPYSKPVDIWACGVI---------------------LYILLVGYPP-----FWD 232

Query: 177 ENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH 236
           E+  +   Q+        + ++  V P A  L++ MLT +P++RIT + AL  P++ +  
Sbjct: 233 EDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRE 292

Query: 237 DISDEP 242
            ++   
Sbjct: 293 RVASAI 298

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  148 bits (377), Expect = 1e-43
 Identities = 74/235 (31%), Positives = 106/235 (45%), Gaps = 39/235 (16%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILR 59
           +DH N++ + +I+     E  +  YI  EL    +L   I   +  SE      + Q+  
Sbjct: 78  LDHPNIMKLFEIL-----EDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFS 132

Query: 60  GLKYIHSANVLHRDLKPSNLLL---NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAP 116
           G+ Y+H  N++HRDLKP N+LL     +CD+KI DFGL+    +   M + + T +Y AP
Sbjct: 133 GITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAP 192

Query: 117 ELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLN 176
           E+L  +  Y    DVWS G I                     L I L GTP      F  
Sbjct: 193 EVLRGT--YDEKCDVWSAGVI---------------------LYILLSGTPP-----FYG 224

Query: 177 ENAKKYICQLPRYQRQSFTEK-FPNVHPSAIDLVEKMLTFDPRQRITVEDALAHP 230
           +N    I +     + +F    +  +   A DL+ KMLTF P  RIT    L HP
Sbjct: 225 KNEYD-ILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHP 278

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  150 bits (382), Expect = 2e-43
 Identities = 64/243 (26%), Positives = 104/243 (42%), Gaps = 49/243 (20%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILR 59
           + H N++ + D+      E+  DV +  EL+   +L   +   ++LSEE    F+ QIL 
Sbjct: 72  VLHPNIITLHDVY-----ENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILD 126

Query: 60  GLKYIHSANVLHRDLKPSNLLL----NANCDLKICDFGLARVTSETDFMTEYVVTRWYRA 115
           G+ Y+H+  + H DLKP N++L         +K+ DFGLA    +         T  + A
Sbjct: 127 GVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVA 186

Query: 116 PELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTP-----SEA 170
           PE ++N        D+WS+G I                       I L G       ++ 
Sbjct: 187 PE-IVNYEPLGLEADMWSIGVI---------------------TYILLSGASPFLGDTKQ 224

Query: 171 ELGFLNENAKKYICQLPRYQRQSFTEK-FPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 229
           E    N  A  Y           F E+ F      A D + K+L  + R+R+T+++AL H
Sbjct: 225 ET-LANITAVSY----------DFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRH 273

Query: 230 PYL 232
           P++
Sbjct: 274 PWI 276

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  149 bits (379), Expect = 2e-43
 Identities = 53/242 (21%), Positives = 103/242 (42%), Gaps = 48/242 (19%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLH-QIIRSNQALSEEHCQYFLYQIL 58
             H N++ + +       ES  ++ + +E +   D+  +I  S   L+E     +++Q+ 
Sbjct: 58  ARHRNILHLHESF-----ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVC 112

Query: 59  RGLKYIHSANVLHRDLKPSNLLLNA--NCDLKICDFGLARVTSETDFMTEYVVTRWYRAP 116
             L+++HS N+ H D++P N++     +  +KI +FG AR     D          Y AP
Sbjct: 113 EALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAP 172

Query: 117 ELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTP-----SEAE 171
           E +      + A D+WS+G +                     + + L G       +  +
Sbjct: 173 E-VHQHDVVSTATDMWSLGTL---------------------VYVLLSGINPFLAETNQQ 210

Query: 172 LGFLNENAKKYICQLPRYQRQSFTEK-FPNVHPSAIDLVEKMLTFDPRQRITVEDALAHP 230
           +   N    +Y          +F E+ F  +   A+D V+++L  + + R+T  +AL HP
Sbjct: 211 I-IENIMNAEY----------TFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHP 259

Query: 231 YL 232
           +L
Sbjct: 260 WL 261

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  149 bits (378), Expect = 3e-43
 Identities = 59/242 (24%), Positives = 102/242 (42%), Gaps = 50/242 (20%)

Query: 3   HENVVAIRDIIPPPQRESFNDVYIAYELMDT-DL-HQII-RSNQALSEEHCQYFLYQILR 59
              V+ + ++      E+ +++ +  E     ++    +    + +SE      + QIL 
Sbjct: 88  CPRVINLHEVY-----ENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILE 142

Query: 60  GLKYIHSANVLHRDLKPSNLLL---NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAP 116
           G+ Y+H  N++H DLKP N+LL       D+KI DFG++R       + E + T  Y AP
Sbjct: 143 GVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAP 202

Query: 117 ELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTP-----SEAE 171
           E +LN    T A D+W++G I                       + L  T         E
Sbjct: 203 E-ILNYDPITTATDMWNIGII---------------------AYMLLTHTSPFVGEDNQE 240

Query: 172 LGFLNENAKKYICQLPRYQRQSFTEK-FPNVHPSAIDLVEKMLTFDPRQRITVEDALAHP 230
             +LN +               ++E+ F +V   A D ++ +L  +P +R T E  L+H 
Sbjct: 241 T-YLNISQVNV----------DYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHS 289

Query: 231 YL 232
           +L
Sbjct: 290 WL 291

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  149 bits (379), Expect = 5e-43
 Identities = 56/253 (22%), Positives = 102/253 (40%), Gaps = 48/253 (18%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLH-QIIRSNQALSEEHCQYFLYQIL 58
           + H  ++ + D       E   ++ +  E +   +L  +I   +  +SE     ++ Q  
Sbjct: 105 LHHPKLINLHDAF-----EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQAC 159

Query: 59  RGLKYIHSANVLHRDLKPSNLLL--NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAP 116
            GLK++H  +++H D+KP N++        +KI DFGLA   +  + +     T  + AP
Sbjct: 160 EGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAP 219

Query: 117 ELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTP-----SEAE 171
           E +++        D+W++G +                       + L G        + E
Sbjct: 220 E-IVDREPVGFYTDMWAIGVL---------------------GYVLLSGLSPFAGEDDLE 257

Query: 172 LGFLNENAKKYICQLPRYQRQSFTEK-FPNVHPSAIDLVEKMLTFDPRQRITVEDALAHP 230
               N     +           F E  F +V P A D ++ +L  +PR+R+TV DAL HP
Sbjct: 258 T-LQNVKRCDW----------EFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHP 306

Query: 231 YLGSLHDISDEPV 243
           +L   H      +
Sbjct: 307 WLKGDHSNLTSRI 319

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  147 bits (372), Expect = 5e-43
 Identities = 64/243 (26%), Positives = 101/243 (41%), Gaps = 44/243 (18%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQII----RSNQALSEEHCQYFLY 55
           + H N+V   D I      +   +YI  E  +  DL  +I    +  Q L EE     + 
Sbjct: 62  LKHPNIVRYYDRI---IDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT 118

Query: 56  QILRGLKYIHSAN-----VLHRDLKPSNLLLNANCDLKICDFGLARV-TSETDFMTEYVV 109
           Q+   LK  H  +     VLHRDLKP+N+ L+   ++K+ DFGLAR+   +T F   +V 
Sbjct: 119 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVG 178

Query: 110 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSE 169
           T +Y +PE +   S Y    D+WS+GC+  EL    P F       +L   I        
Sbjct: 179 TPYYMSPEQMNRMS-YNEKSDIWSLGCLLYELCALMPPFTAFSQ-KELAGKIR------- 229

Query: 170 AELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 229
                     +    ++P                   +++ +ML      R +VE+ L +
Sbjct: 230 ----------EGKFRRIP-----------YRYSDELNEIITRMLNLKDYHRPSVEEILEN 268

Query: 230 PYL 232
           P +
Sbjct: 269 PLI 271

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  151 bits (384), Expect = 1e-42
 Identities = 64/246 (26%), Positives = 113/246 (45%), Gaps = 37/246 (15%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILR 59
           +DH N++ + D+      E     Y+  E  +  +L + I +     E      + QIL 
Sbjct: 103 LDHPNIIKLFDVF-----EDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILS 157

Query: 60  GLKYIHSANVLHRDLKPSNLLL---NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAP 116
           G+ Y+H  N++HRD+KP N+LL   N+  ++KI DFGL+   S+   + + + T +Y AP
Sbjct: 158 GICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAP 217

Query: 117 ELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLN 176
           E+L     Y    DVWS G I   L+   P F G++     + +I+ +    + +  F  
Sbjct: 218 EVL--KKKYNEKCDVWSCGVIMYILLCGYPPFGGQND----QDIIKKV---EKGKYYFD- 267

Query: 177 ENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH 236
                                + N+   A +L++ MLT+D  +R T E+AL   ++    
Sbjct: 268 ------------------FNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA 309

Query: 237 DISDEP 242
           +  ++ 
Sbjct: 310 NNINKS 315

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  148 bits (375), Expect = 1e-42
 Identities = 65/237 (27%), Positives = 104/237 (43%), Gaps = 37/237 (15%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILR 59
           + H N++ +++I      E+  ++ +  EL+   +L   I      SE      + QIL 
Sbjct: 105 LSHPNIIKLKEIF-----ETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILE 159

Query: 60  GLKYIHSANVLHRDLKPSNLLL---NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAP 116
            + Y+H   ++HRDLKP NLL      +  LKI DFGL+++      M     T  Y AP
Sbjct: 160 AVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAP 219

Query: 117 ELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLN 176
           E+L   + Y   +D+WSVG I                       I L G        F +
Sbjct: 220 EILRGCA-YGPEVDMWSVGII---------------------TYILLCGFEP-----FYD 252

Query: 177 ENAKKYICQLPRYQRQSFTEK-FPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
           E   +++ +        F    +  V  +A DLV K++  DP++R+T   AL HP++
Sbjct: 253 ERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWV 309

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  149 bits (379), Expect = 1e-42
 Identities = 67/277 (24%), Positives = 108/277 (38%), Gaps = 67/277 (24%)

Query: 2   DHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ-------ALSEEHCQYFL 54
           DH NV+            +   +YIA EL + +L  ++ S            E +    L
Sbjct: 67  DHPNVIRYYCSE-----TTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLL 121

Query: 55  YQILRGLKYIHSANVLHRDLKPSNLLL-------------NANCDLKICDFGLARV---- 97
            QI  G+ ++HS  ++HRDLKP N+L+               N  + I DFGL +     
Sbjct: 122 RQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSG 181

Query: 98  -TSETDFMTEYVVTRWYRAPELLLNSSD------YTAAIDVWSVGCIFMELMDRKPLFPG 150
            +S    +     T  +RAPELL  S++       T +ID++S+GC+F  ++ +     G
Sbjct: 182 QSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFG 241

Query: 151 RDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVE 210
             +  +                     N  + I  L   +         ++   A DL+ 
Sbjct: 242 DKYSRE--------------------SNIIRGIFSLDEMKC----LHDRSLIAEATDLIS 277

Query: 211 KMLTFDPRQRITVEDALAHPY-------LGSLHDISD 240
           +M+  DP +R T    L HP        L  L  +SD
Sbjct: 278 QMIDHDPLKRPTAMKVLRHPLFWPKSKKLEFLLKVSD 314

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  146 bits (371), Expect = 1e-42
 Identities = 49/256 (19%), Positives = 92/256 (35%), Gaps = 56/256 (21%)

Query: 1   MDHENVVAIRD-------IIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALS---EEH 49
           ++H  +V   +                   +YI  +L    +L   +     +       
Sbjct: 60  LEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSV 119

Query: 50  CQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM----- 104
           C +   QI   ++++HS  ++HRDLKPSN+    +  +K+ DFGL     + +       
Sbjct: 120 CLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 179

Query: 105 --------TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ 156
                   T  V T+ Y +PE +  +S Y+  +D++S+G I  EL+   P     + V  
Sbjct: 180 PMPAYARHTGQVGTKLYMSPEQIHGNS-YSHKVDIFSLGLILFELL--YPFSTQMERVRT 236

Query: 157 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFD 216
           L  +                             +   F   F   +P    +V+ ML+  
Sbjct: 237 LTDV-----------------------------RNLKFPPLFTQKYPCEYVMVQDMLSPS 267

Query: 217 PRQRITVEDALAHPYL 232
           P +R    + + +   
Sbjct: 268 PMERPEAINIIENAVF 283

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  150 bits (382), Expect = 1e-42
 Identities = 74/237 (31%), Positives = 108/237 (45%), Gaps = 39/237 (16%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILR 59
           +DH N++ + +I+     E  +  YI  EL    +L   I   +  SE      + Q+  
Sbjct: 78  LDHPNIMKLFEIL-----EDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFS 132

Query: 60  GLKYIHSANVLHRDLKPSNLLL---NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAP 116
           G+ Y+H  N++HRDLKP N+LL     +CD+KI DFGL+    +   M + + T +Y AP
Sbjct: 133 GITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAP 192

Query: 117 ELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLN 176
           E+L  +  Y    DVWS G I                     L I L GTP      F  
Sbjct: 193 EVLRGT--YDEKCDVWSAGVI---------------------LYILLSGTP-----PFYG 224

Query: 177 ENAKKYICQLPRYQRQSFTEK-FPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
           +N    I +     + +F    +  +   A DL+ KMLTF P  RIT    L HP++
Sbjct: 225 KNEYD-ILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWI 280

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  146 bits (371), Expect = 7e-42
 Identities = 64/242 (26%), Positives = 106/242 (43%), Gaps = 48/242 (19%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLH-QIIRSNQALSEEHCQYFLYQIL 58
           +DH N++ + D       ES ND+ +  E +D  +L  +II  +  L+E     F+ QI 
Sbjct: 143 LDHANLIQLYDAF-----ESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQIC 197

Query: 59  RGLKYIHSANVLHRDLKPSNLLL--NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAP 116
            G++++H   +LH DLKP N+L        +KI DFGLAR     + +     T  + AP
Sbjct: 198 EGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAP 257

Query: 117 ELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTP-----SEAE 171
           E ++N    +   D+WSVG I                       + L G       ++AE
Sbjct: 258 E-VVNYDFVSFPTDMWSVGVI---------------------AYMLLSGLSPFLGDNDAE 295

Query: 172 LGFLNENAKKYICQLPRYQRQSFTEK-FPNVHPSAIDLVEKMLTFDPRQRITVEDALAHP 230
               N  A ++             ++ F ++   A + + K+L  +   RI+  +AL HP
Sbjct: 296 T-LNNILACRW----------DLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHP 344

Query: 231 YL 232
           +L
Sbjct: 345 WL 346

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  145 bits (369), Expect = 7e-42
 Identities = 65/248 (26%), Positives = 105/248 (42%), Gaps = 35/248 (14%)

Query: 2   DHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRG 60
            H N++ ++D+      +    VY+  ELM   +L   I   +  SE      L+ I + 
Sbjct: 74  QHPNIITLKDVY-----DDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKT 128

Query: 61  LKYIHSANVLHRDLKPSNLLLNANCD----LKICDFGLAR-VTSETDFMTEYVVTRWYRA 115
           ++Y+H+  V+HRDLKPSN+L          ++ICDFG A+ + +E   +     T  + A
Sbjct: 129 VEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVA 188

Query: 116 PELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL 175
           PE+L     Y AA D+WS+G +   ++     F          +L   IG     +    
Sbjct: 189 PEVLERQG-YDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEIL-ARIG---SGKFSLS 243

Query: 176 NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL 235
                                 + +V  +A DLV KML  DP QR+T    L HP++   
Sbjct: 244 GGY-------------------WNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHW 284

Query: 236 HDISDEPV 243
             +    +
Sbjct: 285 DQLPQYQL 292

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  145 bits (369), Expect = 8e-42
 Identities = 66/254 (25%), Positives = 109/254 (42%), Gaps = 48/254 (18%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDL-HQIIR---SNQALSEEHCQYFLY 55
           + H ++V + +        S   +Y+ +E MD  DL  +I++   +    SE    +++ 
Sbjct: 83  LKHPHIVELLETY-----SSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMR 137

Query: 56  QILRGLKYIHSANVLHRDLKPSNLLL---NANCDLKICDFGLAR-VTSETDFMTEYVVTR 111
           QIL  L+Y H  N++HRD+KP  +LL     +  +K+  FG+A  +          V T 
Sbjct: 138 QILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTP 197

Query: 112 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAE 171
            + APE ++    Y   +DVW  G I                     L I L G      
Sbjct: 198 HFMAPE-VVKREPYGKPVDVWGCGVI---------------------LFILLSGCLP--- 232

Query: 172 LGFLNENAKKY--ICQLPRYQRQSFTEK-FPNVHPSAIDLVEKMLTFDPRQRITVEDALA 228
             F     + +  I +  +Y       + + ++  SA DLV +ML  DP +RITV +AL 
Sbjct: 233 --FYGTKERLFEGIIKG-KY---KMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN 286

Query: 229 HPYLGSLHDISDEP 242
           HP+L      + + 
Sbjct: 287 HPWLKERDRYAYKI 300

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  145 bits (367), Expect = 9e-42
 Identities = 63/261 (24%), Positives = 110/261 (42%), Gaps = 30/261 (11%)

Query: 3   HENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGL 61
           H N+V + ++            ++  EL++  +L + I+  +  SE    Y + +++  +
Sbjct: 65  HPNIVKLHEVF-----HDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAV 119

Query: 62  KYIHSANVLHRDLKPSNLLL---NANCDLKICDFGLAR-VTSETDFMTEYVVTRWYRAPE 117
            ++H   V+HRDLKP NLL    N N ++KI DFG AR    +   +     T  Y APE
Sbjct: 120 SHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPE 179

Query: 118 LLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNE 177
            LLN + Y  + D+WS+G I   ++  +  F   D        +E++    + +  F  E
Sbjct: 180 -LLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGE 238

Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 237
                               + NV   A DL++ +LT DP +R+ +     + +L     
Sbjct: 239 A-------------------WKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQ 279

Query: 238 ISDEPVCMSPFSFDFEQHALT 258
           +S  P+              T
Sbjct: 280 LSSNPLMTPDILGSSGAAVHT 300

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  144 bits (365), Expect = 2e-41
 Identities = 62/262 (23%), Positives = 104/262 (39%), Gaps = 31/262 (11%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTD--LHQII-RSNQALSEEHCQYFLYQI 57
               ++V I D+           + I  E M+      +I  R +QA +E      +  I
Sbjct: 79  SGGPHIVCILDVYENMHHGK-RCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDI 137

Query: 58  LRGLKYIHSANVLHRDLKPSNLLL---NANCDLKICDFGLARVTSETDFMTEYVVTRWYR 114
              ++++HS N+ HRD+KP NLL      +  LK+ DFG A+ T++    T    T +Y 
Sbjct: 138 GTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTP-CYTPYYV 196

Query: 115 APELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGF 174
           APE+L     Y  + D+WS+G I   L+   P F           +   I      + GF
Sbjct: 197 APEVLGPEK-YDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIR---LGQYGF 252

Query: 175 LNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS 234
            N                     +  V   A  L+  +L  DP +R+T+   + HP++  
Sbjct: 253 PNPE-------------------WSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ 293

Query: 235 LHDISDEPVCMSPFSFDFEQHA 256
              +   P+  +    + + H 
Sbjct: 294 SMVVPQTPLHTARVLQEDKDHW 315

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  143 bits (361), Expect = 6e-41
 Identities = 48/250 (19%), Positives = 92/250 (36%), Gaps = 49/250 (19%)

Query: 3   HENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALS---EEHCQYFLYQIL 58
            +       +           +YI  +L    +L   +    +L       C +   QI 
Sbjct: 115 MDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIA 174

Query: 59  RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF-------------MT 105
             ++++HS  ++HRDLKPSN+    +  +K+ DFGL     + +               T
Sbjct: 175 EAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHT 234

Query: 106 EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIG 165
             V T+ Y +PE  ++ ++Y+  +D++S+G I  EL                     L  
Sbjct: 235 GQVGTKLYMSPE-QIHGNNYSHKVDIFSLGLILFEL---------------------LYS 272

Query: 166 TPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVED 225
             ++ E   +  + +             F   F   +P    +V+ ML+  P +R    D
Sbjct: 273 FSTQMERVRIITDVRNLK----------FPLLFTQKYPQEHMMVQDMLSPSPTERPEATD 322

Query: 226 ALAHPYLGSL 235
            + +    +L
Sbjct: 323 IIENAIFENL 332

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  147 bits (372), Expect = 9e-41
 Identities = 55/242 (22%), Positives = 95/242 (39%), Gaps = 48/242 (19%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDL-HQIIRSNQALSEEHCQYFLYQIL 58
           + H  +V + D       E  N++ + YE M   +L  ++   +  +SE+    ++ Q+ 
Sbjct: 211 LRHPTLVNLHDAF-----EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVC 265

Query: 59  RGLKYIHSANVLHRDLKPSNLLL--NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAP 116
           +GL ++H  N +H DLKP N++     + +LK+ DFGL         +     T  + AP
Sbjct: 266 KGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAP 325

Query: 117 ELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTP-----SEAE 171
           E +          D+WSVG +                       I L G       ++ E
Sbjct: 326 E-VAEGKPVGYYTDMWSVGVL---------------------SYILLSGLSPFGGENDDE 363

Query: 172 LGFLNENAKKYICQLPRYQRQSFT-EKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHP 230
               N  +  +          +     F  +     D + K+L  DP  R+T+  AL HP
Sbjct: 364 T-LRNVKSCDW----------NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHP 412

Query: 231 YL 232
           +L
Sbjct: 413 WL 414

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  143 bits (363), Expect = 2e-40
 Identities = 61/247 (24%), Positives = 100/247 (40%), Gaps = 30/247 (12%)

Query: 2   DHENVVAIRDIIPPPQRESFNDVYIAYELMD--TDLHQII-RSNQALSEEHCQYFLYQIL 58
              ++V I D+           + I  E +D      +I  R +QA +E      +  I 
Sbjct: 113 QCPHIVRIVDVYENLYAGR-KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 171

Query: 59  RGLKYIHSANVLHRDLKPSNLLL---NANCDLKICDFGLARVTSETDFMTEYVVTRWYRA 115
             ++Y+HS N+ HRD+KP NLL      N  LK+ DFG A+ T+  + +T    T +Y A
Sbjct: 172 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVA 231

Query: 116 PELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL 175
           PE+L     Y  + D+WS+G I   L+   P F     +     +   I      +  F 
Sbjct: 232 PEVLGPEK-YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR---MGQYEFP 287

Query: 176 NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL 235
           N                     +  V      L+  +L  +P QR+T+ + + HP++   
Sbjct: 288 NPE-------------------WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 328

Query: 236 HDISDEP 242
             +   P
Sbjct: 329 TKVPQTP 335

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  142 bits (359), Expect = 2e-40
 Identities = 73/269 (27%), Positives = 115/269 (42%), Gaps = 40/269 (14%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILR 59
           + H++VV           E  + V++  EL     L ++ +  +AL+E   +Y+L QI+ 
Sbjct: 98  LAHQHVVGFHGFF-----EDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVL 152

Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPEL 118
           G +Y+H   V+HRDLK  NL LN + ++KI DFGLA +V  + +       T  Y APE 
Sbjct: 153 GCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPE- 211

Query: 119 LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNEN 178
           +L+   ++  +DVWS+GCI   L+  KP F                              
Sbjct: 212 VLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL-------------------R 252

Query: 179 AKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL--GSLH 236
            KK    +P++           ++P A  L++KML  DP  R T+ + L   +   G + 
Sbjct: 253 IKKNEYSIPKH-----------INPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP 301

Query: 237 DISDEPVCMSPFSFDFEQHALTEGQMKEL 265
                     P  F     +L     K L
Sbjct: 302 ARLPITCLTIPPRFSIAPSSLDPSNRKPL 330

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  140 bits (356), Expect = 3e-40
 Identities = 69/240 (28%), Positives = 104/240 (43%), Gaps = 45/240 (18%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILR 59
           + HEN+V + DI      ES    Y+  +L+   +L   I      +E+     + Q+L 
Sbjct: 63  IKHENIVTLEDIY-----ESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLS 117

Query: 60  GLKYIHSANVLHRDLKPSNLLL---NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAP 116
            +KY+H   ++HRDLKP NLL      N  + I DFGL+++  +   M+    T  Y AP
Sbjct: 118 AVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKM-EQNGIMSTACGTPGYVAP 176

Query: 117 ELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTP---SEAELG 173
           E+L     Y+ A+D WS+G I                       I L G P    E E  
Sbjct: 177 EVLAQKP-YSKAVDCWSIGVI---------------------TYILLCGYPPFYEETESK 214

Query: 174 FLNENAKKYICQLPRYQRQSFTEKF-PNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
              +       +   Y    F   F  ++  SA D +  +L  DP +R T E AL+HP++
Sbjct: 215 LFEK------IKEGYY---EFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWI 265

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  140 bits (354), Expect = 6e-40
 Identities = 59/241 (24%), Positives = 98/241 (40%), Gaps = 44/241 (18%)

Query: 1   MDHENVVAIRDIIPPPQRESF---NDVYIAYELMDT-DLHQII----RSNQALSEEHCQY 52
           ++H NV+            SF   N++ I  EL D  DL ++I    +  + + E     
Sbjct: 89  LNHPNVIKYYA--------SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWK 140

Query: 53  FLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV-TSETDFMTEYVVTR 111
           +  Q+   L+++HS  V+HRD+KP+N+ + A   +K+ D GL R  +S+T      V T 
Sbjct: 141 YFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTP 200

Query: 112 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAE 171
           +Y +PE +  +  Y    D+WS+GC+  E+   +  F G      L  L + I       
Sbjct: 201 YYMSPERIHENG-YNFKSDIWSLGCLLYEMAALQSPFYG--DKMNLYSLCKKIEQ----- 252

Query: 172 LGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPY 231
                       C  P      ++E+          LV   +  DP +R  V        
Sbjct: 253 ------------CDYPPLPSDHYSEEL-------RQLVNMCINPDPEKRPDVTYVYDVAK 293

Query: 232 L 232
            
Sbjct: 294 R 294

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  142 bits (360), Expect = 9e-40
 Identities = 68/251 (27%), Positives = 105/251 (41%), Gaps = 45/251 (17%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILR 59
           + H N+V + D I           Y+ ++L+   +L + I + +  SE    + + QIL 
Sbjct: 67  LKHPNIVRLHDSI-----SEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILE 121

Query: 60  GLKYIHSANVLHRDLKPSNLLL---NANCDLKICDFGLAR-VTSETDFMTEYVVTRWYRA 115
            + + H   V+HR+LKP NLLL        +K+ DFGLA  V  E      +  T  Y +
Sbjct: 122 AVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLS 181

Query: 116 PELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTP---SEAEL 172
           PE+L     Y   +D+W+ G I                     L I L+G P    E + 
Sbjct: 182 PEVLRKDP-YGKPVDLWACGVI---------------------LYILLVGYPPFWDEDQH 219

Query: 173 GFLNENAKKYICQLPRYQRQSFTEKF-PNVHPSAIDLVEKMLTFDPRQRITVEDALAHPY 231
               +       +   Y    F       V P A DL+ KMLT +P +RIT  +AL HP+
Sbjct: 220 RLYQQ------IKAGAY---DFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPW 270

Query: 232 LGSLHDISDEP 242
           +     ++   
Sbjct: 271 ISHRSTVASCM 281

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  138 bits (350), Expect = 2e-39
 Identities = 70/258 (27%), Positives = 111/258 (43%), Gaps = 40/258 (15%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILR 59
           + H++VV           E  + V++  EL     L ++ +  +AL+E   +Y+L QI+ 
Sbjct: 72  LAHQHVVGFHGFF-----EDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVL 126

Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWYRAPEL 118
           G +Y+H   V+HRDLK  NL LN + ++KI DFGLA +V  + +       T  Y APE 
Sbjct: 127 GCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPE- 185

Query: 119 LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNEN 178
           +L+   ++  +DVWS+GCI   L+  KP F                              
Sbjct: 186 VLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL-------------------R 226

Query: 179 AKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL--GSLH 236
            KK    +P++           ++P A  L++KML  DP  R T+ + L   +   G + 
Sbjct: 227 IKKNEYSIPKH-----------INPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP 275

Query: 237 DISDEPVCMSPFSFDFEQ 254
                     P  F    
Sbjct: 276 ARLPITCLTIPPRFSIAP 293

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  140 bits (354), Expect = 3e-39
 Identities = 44/248 (17%), Positives = 88/248 (35%), Gaps = 27/248 (10%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQ---ALSEEHCQYFLYQ 56
           ++H+N+V +  I    +  +     +  E      L+ ++        L E      L  
Sbjct: 64  LNHKNIVKLFAIE---EETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRD 120

Query: 57  ILRGLKYIHSANVLHRDLKPSNLLLNANCD----LKICDFGLARVTSETDFMTEYVVTRW 112
           ++ G+ ++    ++HR++KP N++     D     K+ DFG AR   + +       T  
Sbjct: 121 VVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEE 180

Query: 113 YRAPELLLNSSD-------YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELI- 164
           Y  P++   +         Y A +D+WS+G  F         F   +   + + ++  I 
Sbjct: 181 YLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKII 240

Query: 165 -GTPSEAELGF--LNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI 221
            G PS A  G          +   +P     S       +      ++  +L  D  +  
Sbjct: 241 TGKPSGAISGVQKAENGPIDWSGDMPVSCSLS-----RGLQVLLTPVLANILEADQEKCW 295

Query: 222 TVEDALAH 229
             +   A 
Sbjct: 296 GFDQFFAE 303

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  138 bits (349), Expect = 5e-39
 Identities = 49/201 (24%), Positives = 81/201 (40%), Gaps = 34/201 (16%)

Query: 40  RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL--NANCDLKICDFGLARV 97
             +    E+     + QI   L Y+H+  + HRD+KP N L   N + ++K+ DFGL++ 
Sbjct: 160 SLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKE 219

Query: 98  -----TSETDFMTEYVVTRWYRAPELLLNSSD-YTAAIDVWSVGCIFMELMDRKPLFPGR 151
                  E   MT    T ++ APE+L  +++ Y    D WS G +   L+     FPG 
Sbjct: 220 FYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGV 279

Query: 152 DHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEK 211
           +        I  +      +L F                       +  + P A DL+  
Sbjct: 280 ND----ADTISQV---LNKKLCFE-------------------NPNYNVLSPLARDLLSN 313

Query: 212 MLTFDPRQRITVEDALAHPYL 232
           +L  +  +R     AL HP++
Sbjct: 314 LLNRNVDERFDAMRALQHPWI 334

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  142 bits (358), Expect = 2e-38
 Identities = 64/251 (25%), Positives = 99/251 (39%), Gaps = 15/251 (5%)

Query: 1   MDHENVVAIRDIIPPPQRESFND-VYIAYELMDT-DLHQIIRSNQ---ALSEEHCQYFLY 55
           ++H NVV+ R++    Q+ + ND   +A E  +  DL + +   +    L E   +  L 
Sbjct: 69  LNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS 128

Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCD---LKICDFGLARVTSETDFMTEYVVTRW 112
            I   L+Y+H   ++HRDLKP N++L         KI D G A+   + +  TE+V T  
Sbjct: 129 DISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQ 188

Query: 113 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL 172
           Y APELL     YT  +D WS G +  E +     F       Q    +    +     +
Sbjct: 189 YLAPELLEQKK-YTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVRE-KSNEHIVV 246

Query: 173 GFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
                 A K+   LP     S               ++ ML +  RQR T          
Sbjct: 247 YDDLTGAVKFSSVLPTPNHLSGILA-----GKLERWLQCMLMWHQRQRGTDPQNPNVGCF 301

Query: 233 GSLHDISDEPV 243
            +L  I    +
Sbjct: 302 QALDSILSLKL 312

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  132 bits (334), Expect = 2e-37
 Identities = 59/238 (24%), Positives = 102/238 (42%), Gaps = 49/238 (20%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIA--Y----ELMDTDLHQIIRSNQALSEEHCQYFL 54
           + H +++ + +       E  N VY+        E+       +    +  SE   ++F+
Sbjct: 68  LKHPSILELYNYF-----EDSNYVYLVLEMCHNGEMNR----YLKNRVKPFSENEARHFM 118

Query: 55  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVVTRWY 113
           +QI+ G+ Y+HS  +LHRDL  SNLLL  N ++KI DFGLA ++    +       T  Y
Sbjct: 119 HQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNY 178

Query: 114 RAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELG 173
            +PE +   S +    DVWS+GC+F  L+  +P F      + L                
Sbjct: 179 ISPE-IATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLN--------------- 222

Query: 174 FLNENAKKYICQLPRYQRQSFTEKFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHP 230
                         +     +  + P+ +   A DL+ ++L  +P  R+++   L HP
Sbjct: 223 --------------KVVLADY--EMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHP 264

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  134 bits (338), Expect = 2e-37
 Identities = 54/246 (21%), Positives = 96/246 (39%), Gaps = 37/246 (15%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIA--Y----ELMDTDLHQ---IIRSNQALSEEHCQ 51
           + +E  +    II      ++++VYI   Y     ++  D +           +  +  +
Sbjct: 100 IKNEYCLTCEGII-----TNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIK 154

Query: 52  YFLYQILRGLKYIHSA-NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMT----- 105
             +  +L    YIH+  N+ HRD+KPSN+L++ N  +K+ DFG +    +          
Sbjct: 155 CIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSRGTY 214

Query: 106 EYVVTRWYRAPELLLNSSDY-TAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELI 164
           E++       PE   N S Y  A +D+WS+G     +      F  +  + +L   I   
Sbjct: 215 EFM------PPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNI--- 265

Query: 165 GTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVE 224
                  + +           L     +  T     +    ID ++  L  +P +RIT E
Sbjct: 266 ---RTKNIEY----PLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSE 318

Query: 225 DALAHP 230
           DAL H 
Sbjct: 319 DALKHE 324

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  132 bits (334), Expect = 7e-37
 Identities = 57/247 (23%), Positives = 93/247 (37%), Gaps = 34/247 (13%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILR 59
             H NV+ + +       E  +  Y+ +E M    +   I   +  +E      +  +  
Sbjct: 68  QGHRNVLELIEFF-----EEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVAS 122

Query: 60  GLKYIHSANVLHRDLKPSNLLL---NANCDLKICDFGLARVTSETDFMTEYVVTRW---- 112
            L ++H+  + HRDLKP N+L    N    +KICDF L          +           
Sbjct: 123 ALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC 182

Query: 113 ----YRAPELLLNSSD----YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELI 164
               Y APE++   S+    Y    D+WS+G I   L+   P  P               
Sbjct: 183 GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYP--PFVGRCGSDCGWDRGE 240

Query: 165 GTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF-PNVHPSAIDLVEKMLTFDPRQRITV 223
             P+   + F +    KY           F +K   ++  +A DL+ K+L  D +QR++ 
Sbjct: 241 ACPACQNMLFESIQEGKY----------EFPDKDWAHISCAAKDLISKLLVRDAKQRLSA 290

Query: 224 EDALAHP 230
              L HP
Sbjct: 291 AQVLQHP 297

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  131 bits (332), Expect = 7e-37
 Identities = 48/258 (18%), Positives = 90/258 (34%), Gaps = 70/258 (27%)

Query: 2   DHENVVAIRDIIPPPQRESF---NDVYIAYELMDT-DLHQII----RSNQALSEEHCQYF 53
            H +VV            ++   + + I  E  +   L   I    R      E   +  
Sbjct: 69  QHSHVVRYFS--------AWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDL 120

Query: 54  LYQILRGLKYIHSANVLHRDLKPSNLLLNAN-------------------CDLKICDFGL 94
           L Q+ RGL+YIHS +++H D+KPSN+ ++                        KI D G 
Sbjct: 121 LLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGH 180

Query: 95  ARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHV 154
               S             + A E+L  +  +    D++++    +     +PL    D  
Sbjct: 181 VTRISSPQVE---EGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQW 237

Query: 155 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLT 214
           H++R                     +  + ++P    Q  +++F        +L++ M+ 
Sbjct: 238 HEIR---------------------QGRLPRIP----QVLSQEF-------TELLKVMIH 265

Query: 215 FDPRQRITVEDALAHPYL 232
            DP +R +    + H  L
Sbjct: 266 PDPERRPSAMALVKHSVL 283

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  131 bits (331), Expect = 7e-37
 Identities = 53/237 (22%), Positives = 93/237 (39%), Gaps = 50/237 (21%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILR 59
           + H N++ +              VY+  E      +++ ++      E+    ++ ++  
Sbjct: 66  LRHPNILRLYGYF-----HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELAN 120

Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMT-----EYVVTRWYR 114
            L Y HS  V+HRD+KP NLLL +  +LKI DFG +     +         +Y+      
Sbjct: 121 ALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYL------ 174

Query: 115 APELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGF 174
            PE ++    +   +D+WS+G +  E +  KP F    +    +                
Sbjct: 175 PPE-MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYK---------------- 217

Query: 175 LNENAKKYICQLPRYQRQSFTEKFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHP 230
                        R  R  F   FP+ V   A DL+ ++L  +P QR  + + L HP
Sbjct: 218 -------------RISRVEF--TFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHP 259

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  133 bits (335), Expect = 1e-36
 Identities = 29/247 (11%), Positives = 67/247 (27%), Gaps = 54/247 (21%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTD-------LHQIIRSNQALSEEHCQYF 53
           +       +  +    +       +  Y  M ++       L     ++++L        
Sbjct: 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQL 211

Query: 54  LYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWY 113
             Q++R L  +H   ++H  L+P +++L+    + +  F                V+R +
Sbjct: 212 TLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAR---VVSSVSRGF 268

Query: 114 RAPELL----------LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIEL 163
             PEL              +  T + D W++G +   +            +     +   
Sbjct: 269 EPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFRS 328

Query: 164 IGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV 223
                                               N+      L+E  L +    R+  
Sbjct: 329 C----------------------------------KNIPQPVRALLEGFLRYPKEDRLLP 354

Query: 224 EDALAHP 230
             A+  P
Sbjct: 355 LQAMETP 361

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  130 bits (330), Expect = 2e-36
 Identities = 53/247 (21%), Positives = 85/247 (34%), Gaps = 45/247 (18%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQII----RSNQALSEEHCQYFLY 55
            +H N++ +       +R + ++ ++         L   I         L+E+   + L 
Sbjct: 83  FNHPNILRLVAYCLR-ERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLL 141

Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV------TSETDFMTEYVV 109
            I RGL+ IH+    HRDLKP+N+LL       + D G           S      +   
Sbjct: 142 GICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWA 201

Query: 110 TR----WYRAPELLLNSS--DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIEL 163
            +     YRAPEL    S        DVWS+GC+   +M  +  +           L   
Sbjct: 202 AQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALA-- 259

Query: 164 IGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV 223
                           +  I Q PR+              +   L+  M+T DP QR  +
Sbjct: 260 -------------VQNQLSIPQSPRH------------SSALWQLLNSMMTVDPHQRPHI 294

Query: 224 EDALAHP 230
              L+  
Sbjct: 295 PLLLSQL 301

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  130 bits (328), Expect = 3e-36
 Identities = 57/239 (23%), Positives = 109/239 (45%), Gaps = 46/239 (19%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYE------LMDTDLHQIIRSNQALSEEHCQYFL 54
           +DH NVV + +++  P  +    +Y+ +E      +M+      + + + LSE+  +++ 
Sbjct: 93  LDHPNVVKLVEVLDDPNEDH---LYMVFELVNQGPVME------VPTLKPLSEDQARFYF 143

Query: 55  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVV-TRWY 113
             +++G++Y+H   ++HRD+KPSNLL+  +  +KI DFG++     +D +    V T  +
Sbjct: 144 QDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAF 203

Query: 114 RAPELLLNSS-DYT-AAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAE 171
            APE L  +   ++  A+DVW++G      +  +  F   + +  L   I          
Sbjct: 204 MAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMD-ERIMCLHSKI---------- 252

Query: 172 LGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHP 230
                   K    + P           P++     DL+ +ML  +P  RI V +   HP
Sbjct: 253 --------KSQALEFPDQ---------PDIAEDLKDLITRMLDKNPESRIVVPEIKLHP 294

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  125 bits (317), Expect = 1e-34
 Identities = 60/235 (25%), Positives = 103/235 (43%), Gaps = 38/235 (16%)

Query: 22  NDVYIAYELMDT----DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA-NVLHRDLKP 76
            DV+I  ELMDT       Q+I   Q + E+        I++ L+++HS  +V+HRD+KP
Sbjct: 79  GDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKP 138

Query: 77  SNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPE---LLLNSSDYTAAIDVWS 133
           SN+L+NA   +K+CDFG++    +          + Y APE     LN   Y+   D+WS
Sbjct: 139 SNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWS 198

Query: 134 VGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQS 193
           +G   +EL   +  FP        + L +++  PS                  P+     
Sbjct: 199 LGITMIELAILR--FPYDSWGTPFQQLKQVVEEPS------------------PQLPADK 238

Query: 194 FTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMSPF 248
           F+ +F       +D   + L  + ++R T  + + HP+         +   ++ F
Sbjct: 239 FSAEF-------VDFTSQCLKKNSKERPTYPELMQHPF---FTLHESKGTDVASF 283

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  125 bits (317), Expect = 1e-34
 Identities = 55/261 (21%), Positives = 92/261 (35%), Gaps = 51/261 (19%)

Query: 2   DHENVVAIRDIIPPPQRESFNDVYIAYELMDTD--LHQII-RSNQALSEEHCQYFLYQIL 58
              ++V I D+           + I  E +D      +I  R +QA +E      +  I 
Sbjct: 69  QCPHIVRIVDVYENLYAGRKC-LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIG 127

Query: 59  RGLKYIHSANVLHRDLKPSNLLL---NANCDLKICDFGLARVTSETDFMTEYVVTRWYRA 115
             ++Y+HS N+ HRD+KP NLL      N  LK+ DFG                     A
Sbjct: 128 EAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF--------------------A 167

Query: 116 PELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL 175
            E       Y  + D+WS+G I   L+   P F     +     +   I      +  F 
Sbjct: 168 KETTGEK--YDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIR---MGQYEFP 222

Query: 176 NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL 235
           N                     +  V      L+  +L  +P QR+T+ + + HP++   
Sbjct: 223 NPE-------------------WSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS 263

Query: 236 HDISDEPVCMSPFSFDFEQHA 256
             +   P+  S    + ++  
Sbjct: 264 TKVPQTPLHTSRVLKEDKERW 284

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  127 bits (320), Expect = 2e-34
 Identities = 27/243 (11%), Positives = 63/243 (25%), Gaps = 47/243 (19%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-------NQALSEEHCQYF 53
           +       +  +    +       +  Y  M ++L             +++L        
Sbjct: 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQL 216

Query: 54  LYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM--TEYVVTR 111
             Q++R L  +H   ++H  L+P +++L+    + +  F        +            
Sbjct: 217 TLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGRGFAPP 276

Query: 112 WYRAPELLL----NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTP 167
              A  +L     + +  T A D W++G     +            +     +       
Sbjct: 277 ETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFRSC--- 333

Query: 168 SEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDAL 227
                                           N+      L+E  L +    R+    A+
Sbjct: 334 -------------------------------KNIPQPVRALLEGFLRYPKEDRLLPLQAM 362

Query: 228 AHP 230
             P
Sbjct: 363 ETP 365

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  123 bits (311), Expect = 8e-34
 Identities = 50/237 (21%), Positives = 91/237 (38%), Gaps = 50/237 (21%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILR 59
           + H N++ + +            +Y+  E     +L++ ++ +    E+    F+ ++  
Sbjct: 71  LRHPNILRMYNYF-----HDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELAD 125

Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMT-----EYVVTRWYR 114
            L Y H   V+HRD+KP NLL+    +LKI DFG +         T     +Y+      
Sbjct: 126 ALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMCGTLDYL------ 179

Query: 115 APELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGF 174
            PE ++    +   +D+W  G +  E +   P F    H          I      +L  
Sbjct: 180 PPE-MIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTE----THRRI---VNVDL-- 229

Query: 175 LNENAKKYICQLPRYQRQSFTEKFPN-VHPSAIDLVEKMLTFDPRQRITVEDALAHP 230
                                 KFP  +   + DL+ K+L + P QR+ ++  + HP
Sbjct: 230 ----------------------KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHP 264

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  122 bits (308), Expect = 4e-33
 Identities = 56/270 (20%), Positives = 115/270 (42%), Gaps = 38/270 (14%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILR 59
           ++H N+V + ++I     E+   +Y+  E     ++   + ++  + E+  +    QI+ 
Sbjct: 71  LNHPNIVKLFEVI-----ETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVS 125

Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
            ++Y H   ++HRDLK  NLLL+A+ ++KI DFG +   +    +  +     Y APEL 
Sbjct: 126 AVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELF 185

Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENA 179
                    +DVWS+G I   L+     F G  ++ +LR  +                  
Sbjct: 186 QGKKYDGPEVDVWSLGVILYTLVSGSLPFDG-QNLKELRERV------------------ 226

Query: 180 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDIS 239
            +   ++P Y           +     +L+++ L  +P +R T+E  +   ++ + H+  
Sbjct: 227 LRGKYRIPFY-----------MSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEED 275

Query: 240 DEPVCMSPFSFDFEQHALTEGQMKELIYQE 269
           +    + P     +Q  +    M  + Y +
Sbjct: 276 ELKPFVEPELDISDQKRID--IMVGMGYSQ 303

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  122 bits (308), Expect = 5e-33
 Identities = 48/247 (19%), Positives = 95/247 (38%), Gaps = 41/247 (16%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILR 59
           +    +V +   +          V I  EL++   L Q+I+    L E+   Y+L Q L 
Sbjct: 107 LSSPRIVPLYGAV-----REGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALE 161

Query: 60  GLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDFGLARVTSE-----TDFMTEYVV-TRW 112
           GL+Y+H+  +LH D+K  N+LL+++     +CDFG A          +    +Y+  T  
Sbjct: 162 GLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTET 221

Query: 113 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL 172
           + APE+++      A +D+WS  C+ + +++    +       +  L +  I +      
Sbjct: 222 HMAPEVVMGKP-CDAKVDIWSSCCMMLHMLNGCHPWT---QYFRGPLCL-KIASEPPPIR 276

Query: 173 GFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
                       ++P           P+  P     +++ L  +P  R +  +       
Sbjct: 277 ------------EIP-----------PSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGK 313

Query: 233 GSLHDIS 239
                  
Sbjct: 314 ALQEVGG 320

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  121 bits (305), Expect = 8e-33
 Identities = 46/232 (19%), Positives = 80/232 (34%), Gaps = 47/232 (20%)

Query: 3   HENVVAIRDIIPPPQRESFNDVYIAYELMDT--DLHQIIRSNQALSEEHCQYFLYQILRG 60
           H  V+ + D       E+     +  E      DL   I     L E   + F  Q++  
Sbjct: 97  HPGVIRLLDWF-----ETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAA 151

Query: 61  LKYIHSANVLHRDLKPSNLLLNA-NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           +++ HS  V+HRD+K  N+L++      K+ DFG   +  +  +   +  TR Y  PE +
Sbjct: 152 IQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTD-FDGTRVYSPPEWI 210

Query: 120 LNSSDYTAAIDVWSVGCI-FMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNEN 178
                +     VWS+G + +  +    P F     +                        
Sbjct: 211 SRHQYHALPATVWSLGILLYDMVCGDIP-FERDQEI------------------------ 245

Query: 179 AKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHP 230
             +     P +           V P    L+ + L   P  R ++E+ L  P
Sbjct: 246 -LEAELHFPAH-----------VSPDCCALIRRCLAPKPSSRPSLEEILLDP 285

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  121 bits (304), Expect = 2e-32
 Identities = 56/253 (22%), Positives = 95/253 (37%), Gaps = 55/253 (21%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMD----TDLHQII--RSNQALSEEHCQYFL 54
             H N+V         + ES         L +      +  +    S   LS +      
Sbjct: 83  SGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIF 142

Query: 55  YQILRGLKYIHSAN--VLHRDLKPSNLLLNANCDLKICDFGLARV---------TSETDF 103
           YQ  R ++++H     ++HRDLK  NLLL+    +K+CDFG A           +++   
Sbjct: 143 YQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRA 202

Query: 104 MTEYVVTR----WYRAPEL--LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL 157
           + E  +TR     YR PE+  L ++       D+W++GCI   L  R+  F         
Sbjct: 203 LVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED------- 255

Query: 158 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDP 217
                       A+L  +N    KY   +P +  Q               L+  ML  +P
Sbjct: 256 -----------GAKLRIVN---GKY--SIPPHDTQY---------TVFHSLIRAMLQVNP 290

Query: 218 RQRITVEDALAHP 230
            +R+++ + +   
Sbjct: 291 EERLSIAEVVHQL 303

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  119 bits (301), Expect = 5e-32
 Identities = 54/230 (23%), Positives = 104/230 (45%), Gaps = 35/230 (15%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRG 60
           + H +++ + D+I      +  D+ +  E    +L   I   + ++E+  + F  QI+  
Sbjct: 66  LRHPHIIKLYDVI-----TTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICA 120

Query: 61  LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL 120
           ++Y H   ++HRDLKP NLLL+ N ++KI DFGL+ + ++ +F+     +  Y APE++ 
Sbjct: 121 IEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVIN 180

Query: 121 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAK 180
                   +DVWS G +   ++  +  F   + +  L   +                   
Sbjct: 181 GKLYAGPEVDVWSCGIVLYVMLVGRLPFDD-EFIPNLFKKV------------------N 221

Query: 181 KYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHP 230
             +  +P +           + P A  L+ +M+  DP QRIT+++    P
Sbjct: 222 SCVYVMPDF-----------LSPGAQSLIRRMIVADPMQRITIQEIRRDP 260

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  116 bits (294), Expect = 2e-31
 Identities = 58/231 (25%), Positives = 98/231 (42%), Gaps = 36/231 (15%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILR 59
             H +++ +  +I      +  D ++  E +   +L   I  +  + E   +    QIL 
Sbjct: 68  FRHPHIIKLYQVI-----STPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILS 122

Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
            + Y H   V+HRDLKP N+LL+A+ + KI DFGL+ + S+ +F+     +  Y APE++
Sbjct: 123 AVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVI 182

Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENA 179
                    +D+WS G I   L+     F   +HV  L   I                  
Sbjct: 183 SGRLYAGPEVDIWSCGVILYALLCGTLPFDD-EHVPTLFKKI------------------ 223

Query: 180 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHP 230
           +  +  +P Y           ++ S   L+  ML  DP +R T++D   H 
Sbjct: 224 RGGVFYIPEY-----------LNRSVATLLMHMLQVDPLKRATIKDIREHE 263

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  116 bits (293), Expect = 3e-31
 Identities = 44/236 (18%), Positives = 93/236 (39%), Gaps = 35/236 (14%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILR 59
           + H N+V   D      +     + +  ELM +  L   ++  + +  +  + +  QIL+
Sbjct: 82  LQHPNIVRFYDSWESTVKGK-KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILK 140

Query: 60  GLKYIHSAN--VLHRDLKPSNLLLNA-NCDLKICDFGLARVTSETDFMTEYVVTRWYRAP 116
           GL+++H+    ++HRDLK  N+ +      +KI D GLA +   + F    + T  + AP
Sbjct: 141 GLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS-FAKAVIGTPEFMAP 199

Query: 117 ELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLN 176
           E+      Y  ++DV++ G   +E+   +  +    +  Q+       G    +      
Sbjct: 200 EMY--EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI-YRRVTSGVKPASFDKVAI 256

Query: 177 ENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
              K                          +++E  +  +  +R +++D L H + 
Sbjct: 257 PEVK--------------------------EIIEGCIRQNKDERYSIKDLLNHAFF 286

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  115 bits (291), Expect = 4e-31
 Identities = 58/241 (24%), Positives = 96/241 (39%), Gaps = 50/241 (20%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIA--Y----ELMDTDLHQIIRSNQALSEEHCQYFL 54
           ++HENVV              N  Y+   Y    EL D      I  +  + E   Q F 
Sbjct: 62  LNHENVVKFYGHR-----REGNIQYLFLEYCSGGELFDR-----IEPDIGMPEPDAQRFF 111

Query: 55  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRW-- 112
           +Q++ G+ Y+H   + HRD+KP NLLL+   +LKI DFGLA V        E ++ +   
Sbjct: 112 HQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF--RYNNRERLLNKMCG 169

Query: 113 ---YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSE 169
              Y APELL     +   +DVWS G +   ++  +   P        +   +       
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQEYSD------- 220

Query: 170 AELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 229
                               +++++   +  +  + + L+ K+L  +P  RIT+ D    
Sbjct: 221 ------------------WKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262

Query: 230 P 230
            
Sbjct: 263 R 263

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  116 bits (293), Expect = 5e-31
 Identities = 52/254 (20%), Positives = 100/254 (39%), Gaps = 41/254 (16%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELM---DTDLHQIIRSNQALSEEHCQYFLYQI 57
           + H+NV+ + D++     E    +Y+  E       ++   +   +         +  Q+
Sbjct: 63  LRHKNVIQLVDVL---YNEEKQKMYMVMEYCVCGMQEMLDSV-PEKRFPVCQAHGYFCQL 118

Query: 58  LRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVT---SETDFMTEYVVTRWYR 114
           + GL+Y+HS  ++H+D+KP NLLL     LKI   G+A      +  D       +  ++
Sbjct: 119 IDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQ 178

Query: 115 APELLLNSSDYT-AAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELG 173
            PE+      ++   +D+WS G     +      F G D++++L   I            
Sbjct: 179 PPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEG-DNIYKLFENI------------ 225

Query: 174 FLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLG 233
                  K    +P               P   DL++ ML ++P +R ++     H +  
Sbjct: 226 ------GKGSYAIPGD-----------CGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFR 268

Query: 234 SLHDISDEPVCMSP 247
             H  ++ PV + P
Sbjct: 269 KKHPPAEAPVPIPP 282

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  117 bits (295), Expect = 6e-31
 Identities = 61/234 (26%), Positives = 95/234 (40%), Gaps = 34/234 (14%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILR 59
           + H N+V  +++I      +   + I  E     +L++ I +    SE+  ++F  Q+L 
Sbjct: 73  LRHPNIVRFKEVI-----LTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLS 127

Query: 60  GLKYIHSANVLHRDLKPSNLLL--NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPE 117
           G+ Y HS  + HRDLK  N LL  +    LKICDFG ++ +         V T  Y APE
Sbjct: 128 GVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPE 187

Query: 118 LLLNSSDYTAAIDVWSVGCI-FMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLN 176
           +LL         DVWS G   ++ L+   P F   +     R  I+ I            
Sbjct: 188 VLLRQEYDGKIADVWSCGVTLYVMLVGAYP-FEDPEEPRDYRKTIQRI------------ 234

Query: 177 ENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHP 230
                    +P   R S         P    L+ ++   DP  RI++ +   H 
Sbjct: 235 ---LSVKYSIPDDIRIS---------PECCHLISRIFVADPATRISIPEIKTHS 276

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  115 bits (291), Expect = 1e-30
 Identities = 49/229 (21%), Positives = 87/229 (37%), Gaps = 45/229 (19%)

Query: 5   NVVAIRDIIPPPQRESFNDVYIAYELMDT--DLHQIIRSNQALSEEHCQYFLYQILRGLK 62
            V+ + D       E  +   +  E  +   DL   I    AL EE  + F +Q+L  ++
Sbjct: 109 GVIRLLDWF-----ERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVR 163

Query: 63  YIHSANVLHRDLKPSNLLLNAN-CDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLN 121
           + H+  VLHRD+K  N+L++ N  +LK+ DFG   +  +T +   +  TR Y  PE +  
Sbjct: 164 HCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTD-FDGTRVYSPPEWIRY 222

Query: 122 SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKK 181
              +  +  VWS+G +  +++     F   + + + ++                      
Sbjct: 223 HRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQV---------------------- 260

Query: 182 YICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHP 230
                 +            V      L+   L   P  R T E+   HP
Sbjct: 261 ---FFRQR-----------VSSECQHLIRWCLALRPSDRPTFEEIQNHP 295

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  115 bits (291), Expect = 1e-30
 Identities = 54/217 (24%), Positives = 84/217 (38%), Gaps = 32/217 (14%)

Query: 22  NDVYIAYELMDTDLHQII-RSNQALSEEHCQYFLYQILRGLKYIHSA-NVLHRDLKPSNL 79
            DV+IA ELM T   ++  R    + E         I++ L Y+     V+HRD+KPSN+
Sbjct: 97  TDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNI 156

Query: 80  LLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPE----LLLNSSDYTAAIDVWSVG 135
           LL+    +K+CDFG++    +            Y APE          DY    DVWS+G
Sbjct: 157 LLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLG 216

Query: 136 CIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFT 195
              +EL   +  +          +L +++                     LP +    F+
Sbjct: 217 ISLVELATGQFPYKNCKTD--FEVLTKVLQEEPP---------------LLPGHMG--FS 257

Query: 196 EKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
             F          V+  LT D R+R      L H ++
Sbjct: 258 GDF-------QSFVKDCLTKDHRKRPKYNKLLEHSFI 287

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  116 bits (292), Expect = 1e-30
 Identities = 48/227 (21%), Positives = 95/227 (41%), Gaps = 18/227 (7%)

Query: 22  NDVYIAYELMDTD-LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA-NVLHRDLKPSNL 79
            ++ I  E MD   L Q+++    + E+        +++GL Y+     ++HRD+KPSN+
Sbjct: 104 GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNI 163

Query: 80  LLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFM 139
           L+N+  ++K+CDFG++    ++   + +V TR Y +PE  L  + Y+   D+WS+G   +
Sbjct: 164 LVNSRGEIKLCDFGVSGQLIDSMANS-FVGTRSYMSPE-RLQGTHYSVQSDIWSMGLSLV 221

Query: 140 ELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQ----SFT 195
           E+   +   P  D      +    +   +           +         +         
Sbjct: 222 EMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELL 281

Query: 196 EKFPNVHP----------SAIDLVEKMLTFDPRQRITVEDALAHPYL 232
           +   N  P             D V K L  +P +R  ++  + H ++
Sbjct: 282 DYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 328

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  115 bits (291), Expect = 1e-30
 Identities = 47/232 (20%), Positives = 87/232 (37%), Gaps = 43/232 (18%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT--DLHQIIRSNQALSEEHCQYFLYQIL 58
           ++H N++ + DI      E+     +  E   +  DL   I  +  L E    Y   Q++
Sbjct: 86  VEHANIIKVLDIF-----ENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLV 140

Query: 59  RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPEL 118
             + Y+   +++HRD+K  N+++  +  +K+ DFG A           +  T  Y APE+
Sbjct: 141 SAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEV 200

Query: 119 LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNEN 178
           L+ +      +++WS+G     L+  +  F   +                EA +      
Sbjct: 201 LMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET-------------VEAAI------ 241

Query: 179 AKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHP 230
                   P             V    + LV  +L   P +R T+E  +  P
Sbjct: 242 ------HPPYL-----------VSKELMSLVSGLLQPVPERRTTLEKLVTDP 276

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  115 bits (289), Expect = 3e-30
 Identities = 51/220 (23%), Positives = 92/220 (41%), Gaps = 33/220 (15%)

Query: 22  NDVYIAYELMDTDLHQIIRS-----NQALSEEHCQYFLYQILRGLKYIHSA-NVLHRDLK 75
            D +I  ELM T   +  +      +  + EE         ++ L ++     ++HRD+K
Sbjct: 94  GDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIK 153

Query: 76  PSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL---LNSSDYTAAIDVW 132
           PSN+LL+ + ++K+CDFG++    ++   T     R Y APE +    +   Y    DVW
Sbjct: 154 PSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVW 213

Query: 133 SVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQ 192
           S+G    EL   +  +P  + V      +             +  +  +    L   + +
Sbjct: 214 SLGITLYELATGRFPYPKWNSVFDQLTQV-------------VKGDPPQ----LSNSEER 256

Query: 193 SFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
            F+  F       I+ V   LT D  +R   ++ L HP++
Sbjct: 257 EFSPSF-------INFVNLCLTKDESKRPKYKELLKHPFI 289

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  114 bits (288), Expect = 3e-30
 Identities = 58/241 (24%), Positives = 96/241 (39%), Gaps = 50/241 (20%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIA--Y----ELMDTDLHQIIRSNQALSEEHCQYFL 54
           ++HENVV              N  Y+   Y    EL D      I  +  + E   Q F 
Sbjct: 62  LNHENVVKFYGHR-----REGNIQYLFLEYCSGGELFDR-----IEPDIGMPEPDAQRFF 111

Query: 55  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRW-- 112
           +Q++ G+ Y+H   + HRD+KP NLLL+   +LKI DFGLA V        E ++ +   
Sbjct: 112 HQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF--RYNNRERLLNKMCG 169

Query: 113 ---YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSE 169
              Y APELL     +   +DVWS G +   ++  +   P        +   +       
Sbjct: 170 TLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGE--LPWDQPSDSCQEYSD------- 220

Query: 170 AELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 229
                               +++++   +  +  + + L+ K+L  +P  RIT+ D    
Sbjct: 221 ------------------WKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKD 262

Query: 230 P 230
            
Sbjct: 263 R 263

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  112 bits (283), Expect = 9e-30
 Identities = 59/239 (24%), Positives = 96/239 (40%), Gaps = 39/239 (16%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTD-LHQIIRSNQA---LSEEHCQYFLYQ 56
           + H+N+V                + I  E +    L  ++RS       +E+   ++  Q
Sbjct: 76  LKHKNIVQYLGSF-----SENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQ 130

Query: 57  ILRGLKYIHSANVLHRDLKPSNLLLNA-NCDLKICDFGLARVTSETDFMTEYVV-TRWYR 114
           IL GLKY+H   ++HRD+K  N+L+N  +  LKI DFG ++  +  +  TE    T  Y 
Sbjct: 131 ILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYM 190

Query: 115 APELLLNSSD-YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELG 173
           APE++      Y  A D+WS+GC  +E+   KP F            +  +G        
Sbjct: 191 APEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA---AMFKVGM------- 240

Query: 174 FLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
                  K   ++P            ++   A   + K    DP +R    D L   +L
Sbjct: 241 ------FKVHPEIP-----------ESMSAEAKAFILKCFEPDPDKRACANDLLVDEFL 282

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score =  114 bits (286), Expect = 2e-29
 Identities = 62/279 (22%), Positives = 100/279 (35%), Gaps = 73/279 (26%)

Query: 26  IAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLN 82
           + +E++   L + I  +  Q L     +  + Q+L+GL Y+H+   ++H D+KP N+LL+
Sbjct: 122 MVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLS 181

Query: 83  AN-------------------------------------------------CDLKICDFG 93
            N                                                   +KI D G
Sbjct: 182 VNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLG 241

Query: 94  LARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD- 152
            A    +    TE + TR YR+ E+L+ S  Y    D+WS  C+  EL     LF     
Sbjct: 242 NACWVHKHF--TEDIQTRQYRSLEVLIGS-GYNTPADIWSTACMAFELATGDYLFEPHSG 298

Query: 153 -----HVHQLRLLIELIGTP-------SEAELGFLNENAK-KYICQLPRYQRQSFTEKFP 199
                    + L+IEL+G          +    F  +    K+I +L  +       +  
Sbjct: 299 EEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKY 358

Query: 200 NV----HPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS 234
                      D +  ML   P +R T  + L HP+L S
Sbjct: 359 EWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS 397

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  110 bits (278), Expect = 5e-29
 Identities = 40/226 (17%), Positives = 82/226 (36%), Gaps = 37/226 (16%)

Query: 2   DHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQA-LSEEHCQYFLYQILR 59
            H N++        PQ      + I  +  +   L+  + +++     +       Q  R
Sbjct: 78  RHVNILLFMGYSTAPQ------LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTAR 131

Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV---TSETDFMTEYVVTRWYRAP 116
           G+ Y+H+ +++HRDLK +N+ L+ +  +KI DFGLA      S +    +   +  + AP
Sbjct: 132 GMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAP 191

Query: 117 ELLLNSSD--YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGF 174
           E++       Y+   DV++ G +  ELM  +  +                    +  +  
Sbjct: 192 EVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNI--------------NNRDQIIEM 237

Query: 175 LNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQR 220
           +                   ++   N       L+ + L     +R
Sbjct: 238 VGRG----------SLSPDLSKVRSNCPKRMKRLMAECLKKKRDER 273

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  112 bits (282), Expect = 1e-28
 Identities = 65/231 (28%), Positives = 104/231 (45%), Gaps = 36/231 (15%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILR 59
             H +++ +  +I      + +D+++  E +   +L   I  N  L E+  +    QIL 
Sbjct: 73  FRHPHIIKLYQVI-----STPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILS 127

Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           G+ Y H   V+HRDLKP N+LL+A+ + KI DFGL+ + S+ +F+     +  Y APE++
Sbjct: 128 GVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVI 187

Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENA 179
                    +D+WS G I   L+     F   DHV  L   I                  
Sbjct: 188 SGRLYAGPEVDIWSSGVILYALLCGTLPFDD-DHVPTLFKKI------------------ 228

Query: 180 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHP 230
              I   P+Y           ++PS I L++ ML  DP +R T++D   H 
Sbjct: 229 CDGIFYTPQY-----------LNPSVISLLKHMLQVDPMKRATIKDIREHE 268

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  106 bits (266), Expect = 4e-27
 Identities = 59/241 (24%), Positives = 106/241 (43%), Gaps = 52/241 (21%)

Query: 2   DHENVVAIRDIIPPPQRESF---NDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFL 54
            H NVV +          S+    ++++  E +     TD    I S   L+EE      
Sbjct: 100 QHFNVVEMYK--------SYLVGEELWVLMEFLQGGALTD----IVSQVRLNEEQIATVC 147

Query: 55  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL-ARVTSETDFMTEYVVTRWY 113
             +L+ L Y+H+  V+HRD+K  ++LL  +  +K+ DFG  A+++ +       V T ++
Sbjct: 148 EAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYW 207

Query: 114 RAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR--LLIELIGTPSEAE 171
            APE++   S Y   +D+WS+G + +E++D +P  P       ++    +     P    
Sbjct: 208 MAPEVISR-SLYATEVDIWSLGIMVIEMVDGEP--PYFS-DSPVQAMKRLRDSPPPK--- 260

Query: 172 LGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPY 231
              L  + K              +           D +E+ML  DP++R T ++ L HP+
Sbjct: 261 ---LKNSHK-------------VSPVL-------RDFLERMLVRDPQERATAQELLDHPF 297

Query: 232 L 232
           L
Sbjct: 298 L 298

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  105 bits (265), Expect = 4e-27
 Identities = 57/241 (23%), Positives = 106/241 (43%), Gaps = 52/241 (21%)

Query: 2   DHENVVAIRDIIPPPQRESF---NDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFL 54
            + N+V   D        S+   +++++  E +     TD    + +   + E       
Sbjct: 75  KNPNIVNYLD--------SYLVGDELWVVMEYLAGGSLTD----VVTETCMDEGQIAAVC 122

Query: 55  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL-ARVTSETDFMTEYVVTRWY 113
            + L+ L+++HS  V+HRD+K  N+LL  +  +K+ DFG  A++T E    +  V T ++
Sbjct: 123 RECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYW 182

Query: 114 RAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR--LLIELIGTPSEAE 171
            APE++     Y   +D+WS+G + +E+++ +P  P  +  + LR   LI   GTP    
Sbjct: 183 MAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEP--PYLN-ENPLRALYLIATNGTPE--- 235

Query: 172 LGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPY 231
              L    K              +  F        D + + L  D  +R + ++ L H +
Sbjct: 236 ---LQNPEK-------------LSAIF-------RDFLNRCLEMDVEKRGSAKELLQHQF 272

Query: 232 L 232
           L
Sbjct: 273 L 273

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  106 bits (266), Expect = 5e-27
 Identities = 59/241 (24%), Positives = 104/241 (43%), Gaps = 39/241 (16%)

Query: 2   DHENVVAIRDI-IPPPQRESFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQ 56
            H N+       I        + +++  E       TDL +  +    L EE   Y   +
Sbjct: 79  HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK-GNTLKEEWIAYICRE 137

Query: 57  ILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL-ARVTSETDFMTEYVVTRWYRA 115
           ILRGL ++H   V+HRD+K  N+LL  N ++K+ DFG+ A++         ++ T ++ A
Sbjct: 138 ILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMA 197

Query: 116 PELLL----NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAE 171
           PE++       + Y    D+WS+G   +E+ +  P  P  D +H +R L  +   P+   
Sbjct: 198 PEVIACDENPDATYDFKSDLWSLGITAIEMAEGAP--PLCD-MHPMRALFLIPRNPA--- 251

Query: 172 LGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPY 231
                          PR + + +++KF          +E  L  +  QR   E  + HP+
Sbjct: 252 ---------------PRLKSKKWSKKF-------QSFIESCLVKNHSQRPATEQLMKHPF 289

Query: 232 L 232
           +
Sbjct: 290 I 290

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  106 bits (265), Expect = 1e-26
 Identities = 52/266 (19%), Positives = 93/266 (34%), Gaps = 47/266 (17%)

Query: 2   DHENVVAIRDIIPPPQRESF---NDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFL 54
           +H N+V  R         +F   N++++    M      DL         ++E    Y L
Sbjct: 84  NHPNIVPYRA--------TFIADNELWVVTSFMAYGSAKDLICT-HFMDGMNELAIAYIL 134

Query: 55  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA--------RVTSETDFMTE 106
             +L+ L YIH    +HR +K S++L++ +  + +              R     DF   
Sbjct: 135 QGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKY 194

Query: 107 YVVTRWYRAPELLL-NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIE--- 162
            V    + +PE+L  N   Y A  D++SVG    EL +    F     +   ++L+E   
Sbjct: 195 SVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF---KDMPATQMLLEKLN 251

Query: 163 -----LIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAI----------- 206
                L+ T +          ++            + T +  N    +            
Sbjct: 252 GTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFH 311

Query: 207 DLVEKMLTFDPRQRITVEDALAHPYL 232
             VE+ L  +P  R +    L H + 
Sbjct: 312 HFVEQCLQRNPDARPSASTLLNHSFF 337

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  104 bits (262), Expect = 1e-26
 Identities = 59/241 (24%), Positives = 102/241 (42%), Gaps = 50/241 (20%)

Query: 2   DHENVVAIRDIIPPPQRESF---NDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFL 54
           D  +VV            S+    D++I  E       +D+ ++   N+ L+E+     L
Sbjct: 82  DSPHVVKYYG--------SYFKNTDLWIVMEYCGAGSVSDIIRL--RNKTLTEDEIATIL 131

Query: 55  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL-ARVTSETDFMTEYVVTRWY 113
              L+GL+Y+H    +HRD+K  N+LLN     K+ DFG+  ++T         + T ++
Sbjct: 132 QSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFW 191

Query: 114 RAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR--LLIELIGTPSEAE 171
            APE++     Y    D+WS+G   +E+ + KP  P  D +H +R   +I     P+   
Sbjct: 192 MAPEVIQE-IGYNCVADIWSLGITAIEMAEGKP--PYAD-IHPMRAIFMIPTNPPPT--- 244

Query: 172 LGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPY 231
                +                +++ F        D V++ L   P QR T    L HP+
Sbjct: 245 ---FRKPEL-------------WSDNF-------TDFVKQCLVKSPEQRATATQLLQHPF 281

Query: 232 L 232
           +
Sbjct: 282 V 282

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  105 bits (264), Expect = 2e-26
 Identities = 45/205 (21%), Positives = 87/205 (42%), Gaps = 30/205 (14%)

Query: 34  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 93
           DL   ++ N    EE  + F+ +++  L Y+ +  ++HRD+KP N+LL+ +  + I DF 
Sbjct: 101 DLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFN 160

Query: 94  LARVTSETDFMTEYVVTRWYRAPELLLN--SSDYTAAIDVWSVGCIFMELMDRKPLFPGR 151
           +A +      +T    T+ Y APE+  +   + Y+ A+D WS+G    EL+  +  +  R
Sbjct: 161 IAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIR 220

Query: 152 DHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEK 211
                 + ++          + +            P                  + L++K
Sbjct: 221 SS-TSSKEIVHTF---ETTVVTY------------P-----------SAWSQEMVSLLKK 253

Query: 212 MLTFDPRQRI-TVEDALAHPYLGSL 235
           +L  +P QR   + D    PY+  +
Sbjct: 254 LLEPNPDQRFSQLSDVQNFPYMNDI 278

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  103 bits (260), Expect = 3e-26
 Identities = 56/209 (26%), Positives = 87/209 (41%), Gaps = 54/209 (25%)

Query: 39  IRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVT 98
           IR   +  E   +++  +I+  L+Y+H   ++HRDLKP N+LLN +  ++I DFG A+V 
Sbjct: 121 IRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVL 180

Query: 99  SETDFMT---------EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFP 149
           S               +YV      +PELL        + D+W++GCI  +L+   P F 
Sbjct: 181 SPESKQARANSFVGTAQYV------SPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFR 233

Query: 150 GRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP-NVHPSAIDL 208
             +      L+ + I                +Y               FP    P A DL
Sbjct: 234 AGNE----YLIFQKI-------------IKLEY--------------DFPEKFFPKARDL 262

Query: 209 VEKMLTFDPRQRIT------VEDALAHPY 231
           VEK+L  D  +R+            AHP+
Sbjct: 263 VEKLLVLDATKRLGCEEMEGYGPLKAHPF 291

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  103 bits (258), Expect = 5e-26
 Identities = 41/171 (23%), Positives = 67/171 (39%), Gaps = 31/171 (18%)

Query: 1   MDHENVV----AIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSN-QALSEEHCQYFL 54
           ++H NV+     +              +    E +    L  II+S            F 
Sbjct: 64  LEHPNVLKFIGVLYK--DKR-------LNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFA 114

Query: 55  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF----------- 103
             I  G+ Y+HS N++HRDL   N L+  N ++ + DFGLAR+  +              
Sbjct: 115 KDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKP 174

Query: 104 ----MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPG 150
                   V   ++ APE++   S Y   +DV+S G +  E++ R    P 
Sbjct: 175 DRKKRYTVVGNPYWMAPEMINGRS-YDEKVDVFSFGIVLCEIIGRVNADPD 224

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  102 bits (256), Expect = 6e-26
 Identities = 47/164 (28%), Positives = 78/164 (47%), Gaps = 24/164 (14%)

Query: 1   MDHENVVAIRD--IIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQI 57
           + H N++A+R   +  P        + +  E      L++++   + +  +    +  QI
Sbjct: 63  LKHPNIIALRGVCLKEPN-------LCLVMEFARGGPLNRVLSGKR-IPPDILVNWAVQI 114

Query: 58  LRGLKYIHSAN---VLHRDLKPSNLLLN--------ANCDLKICDFGLARVTSETDFMTE 106
            RG+ Y+H      ++HRDLK SN+L+         +N  LKI DFGLAR    T  M+ 
Sbjct: 115 ARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA 174

Query: 107 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPG 150
                W  APE ++ +S ++   DVWS G +  EL+  +  F G
Sbjct: 175 AGAYAW-MAPE-VIRASMFSKGSDVWSYGVLLWELLTGEVPFRG 216

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  103 bits (258), Expect = 9e-26
 Identities = 65/277 (23%), Positives = 112/277 (40%), Gaps = 48/277 (17%)

Query: 2   DHENVVAIRDIIPPPQRESF---NDVYIAYELMDTDLHQIIRSNQ-ALSEEHCQYFLYQI 57
            H N +  R          +   +  ++  E        ++  ++  L E       +  
Sbjct: 112 RHPNTIQYRG--------CYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGA 163

Query: 58  LRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL-ARVTSETDFMTEYVVTRWYRAP 116
           L+GL Y+HS N++HRD+K  N+LL+    +K+ DFG  + +     F    V T ++ AP
Sbjct: 164 LQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSF----VGTPYWMAP 219

Query: 117 ELLLNS--SDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGF 174
           E++L      Y   +DVWS+G   +EL +RKP  P   +++ +  L   I          
Sbjct: 220 EVILAMDEGQYDGKVDVWSLGITCIELAERKP--P-LFNMNAMSALY-HIAQ-------- 267

Query: 175 LNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS 234
              N        P  Q   ++E F        + V+  L   P+ R T E  L H ++  
Sbjct: 268 ---NES------PALQSGHWSEYF-------RNFVDSCLQKIPQDRPTSEVLLKHRFVLR 311

Query: 235 LHDISD-EPVCMSPFSFDFEQHALTEGQMKELIYQEA 270
               +    +         E   L   +MK++++QEA
Sbjct: 312 ERPPTVIMDLIQRTKDAVRELDNLQYRKMKKILFQEA 348

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  102 bits (255), Expect = 1e-25
 Identities = 47/158 (29%), Positives = 73/158 (46%), Gaps = 18/158 (11%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQ---ALSEEHCQYFLYQ 56
           ++H N+V +            N V +  E  +   L+ ++   +     +  H   +  Q
Sbjct: 58  VNHPNIVKLYGA-------CLNPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQ 110

Query: 57  ILRGLKYIHSAN---VLHRDLKPSNLLLNANCD-LKICDFGLARVTSETDFMTEYVVTRW 112
             +G+ Y+HS     ++HRDLKP NLLL A    LKICDFG A        MT    +  
Sbjct: 111 CSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--MTNNKGSAA 168

Query: 113 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPG 150
           + APE +   S+Y+   DV+S G I  E++ R+  F  
Sbjct: 169 WMAPE-VFEGSNYSEKCDVFSWGIILWEVITRRKPFDE 205

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  100 bits (252), Expect = 3e-25
 Identities = 51/245 (20%), Positives = 103/245 (42%), Gaps = 53/245 (21%)

Query: 2   DHENVVAIRDIIPPPQRESF---NDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFL 54
           DH  +V +          ++     ++I  E         +  ++  ++ L+E   Q   
Sbjct: 74  DHPYIVKLLG--------AYYHDGKLWIMIEFCPGGAVDAI--MLELDRGLTEPQIQVVC 123

Query: 55  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL-ARVTSETDFMTEYVVTRWY 113
            Q+L  L ++HS  ++HRDLK  N+L+    D+++ DFG+ A+          ++ T ++
Sbjct: 124 RQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYW 183

Query: 114 RAPELLL----NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR--LLIELIGTP 167
            APE+++      + Y    D+WS+G   +E+   +P  P  + ++ +R  L I     P
Sbjct: 184 MAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEP--PHHE-LNPMRVLLKIAKSDPP 240

Query: 168 SEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDAL 227
           +      L   +K             ++ +F        D ++  L  +P  R +    L
Sbjct: 241 T------LLTPSK-------------WSVEF-------RDFLKIALDKNPETRPSAAQLL 274

Query: 228 AHPYL 232
            HP++
Sbjct: 275 EHPFV 279

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  100 bits (252), Expect = 3e-25
 Identities = 44/161 (27%), Positives = 74/161 (45%), Gaps = 21/161 (13%)

Query: 1   MDHENVV----AIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQA---LSEEHCQY 52
           + H N+V    A+    PP        + I  E +    L++++  + A   L E     
Sbjct: 91  LRHPNIVLFMGAVTQ--PPN-------LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLS 141

Query: 53  FLYQILRGLKYIHSAN--VLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF-MTEYVV 109
             Y + +G+ Y+H+ N  ++HR+LK  NLL++    +K+CDFGL+R+ + T         
Sbjct: 142 MAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAG 201

Query: 110 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPG 150
           T  + APE +L         DV+S G I  EL   +  +  
Sbjct: 202 TPEWMAPE-VLRDEPSNEKSDVYSFGVILWELATLQQPWGN 241

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  103 bits (258), Expect = 5e-25
 Identities = 42/172 (24%), Positives = 71/172 (41%), Gaps = 10/172 (5%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILR 59
           + H ++V I + +    R      YI  E +    L +     Q L       +L +IL 
Sbjct: 136 VVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG--QKLPVAEAIAYLLEILP 193

Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
            L Y+HS  +++ DLKP N++L     LK+ D G     +   ++     T  ++APE++
Sbjct: 194 ALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGYL---YGTPGFQAPEIV 249

Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAE 171
                 T A D+++VG     L    P   G  +V  L     ++ T     
Sbjct: 250 RTGP--TVATDIYTVGRTLAALTLDLPTRNG-RYVDGLPEDDPVLKTYDSYG 298

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score = 99.7 bits (249), Expect = 5e-25
 Identities = 34/164 (20%), Positives = 68/164 (41%), Gaps = 27/164 (16%)

Query: 1   MDHENVV----AIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSN-QALSEEHCQYFL 54
           ++H N+V     + +   PP         +  E +   DL+  +      +        +
Sbjct: 80  LNHPNIVKLYGLMHN---PP--------RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLM 128

Query: 55  YQILRGLKYIHSAN--VLHRDLKPSNLLL-----NANCDLKICDFGLARVTSETDFMTEY 107
             I  G++Y+ + N  ++HRDL+  N+ L     NA    K+ DFGL++ +  +  ++  
Sbjct: 129 LDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS--VSGL 186

Query: 108 VVTRWYRAPELLLNSSD-YTAAIDVWSVGCIFMELMDRKPLFPG 150
           +    + APE +    + YT   D +S   I   ++  +  F  
Sbjct: 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE 230

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  100 bits (250), Expect = 6e-25
 Identities = 47/212 (22%), Positives = 82/212 (38%), Gaps = 30/212 (14%)

Query: 29  ELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLK 88
           +++   + +    +  L E      L ++L GL+Y+H    +HRD+K  N+LL  +  ++
Sbjct: 102 DIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQ 161

Query: 89  ICDFGLARVTSETDFMTE------YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
           I DFG++   +    +T       +V T  + APE++     Y    D+WS G   +EL 
Sbjct: 162 IADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELA 221

Query: 143 DRKPLFPGRDHVHQLR--LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPN 200
                +        ++  +L      PS        E  KKY                  
Sbjct: 222 TGAAPY---HKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKY----------G------- 261

Query: 201 VHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
              S   ++   L  DP +R T  + L H + 
Sbjct: 262 --KSFRKMISLCLQKDPEKRPTAAELLRHKFF 291

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score = 99.7 bits (249), Expect = 7e-25
 Identities = 37/168 (22%), Positives = 67/168 (39%), Gaps = 31/168 (18%)

Query: 1   MDHENVVA-----IRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFL 54
           + HEN++      +       Q      +++     +   L+  ++    L    C   +
Sbjct: 59  LRHENILGFIASDMTSRHSSTQ------LWLITHYHEMGSLYDYLQLTT-LDTVSCLRIV 111

Query: 55  YQILRGLKYIHSA--------NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE 106
             I  GL ++H           + HRDLK  N+L+  N    I D GLA + S++    +
Sbjct: 112 LSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLD 171

Query: 107 YVV-----TRWYRAPELL-----LNSSDYTAAIDVWSVGCIFMELMDR 144
                   T+ Y APE+L     ++  D    +D+W+ G +  E+  R
Sbjct: 172 VGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score = 99.7 bits (249), Expect = 1e-24
 Identities = 42/170 (24%), Positives = 70/170 (41%), Gaps = 30/170 (17%)

Query: 1   MDHENVV----AIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRS-NQALSEEHCQYFL 54
             HENVV    A     PP        + I   L     L+ ++R     L     +   
Sbjct: 86  TRHENVVLFMGACMS--PPH-------LAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIA 136

Query: 55  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEY----VVT 110
            +I++G+ Y+H+  +LH+DLK  N+  + N  + I DFGL  ++             +  
Sbjct: 137 QEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQN 195

Query: 111 RWYR--APELLLNSSD--------YTAAIDVWSVGCIFMELMDRKPLFPG 150
            W    APE++   S         ++   DV+++G I+ EL  R+  F  
Sbjct: 196 GWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKT 245

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  100 bits (249), Expect = 2e-24
 Identities = 33/251 (13%), Positives = 64/251 (25%), Gaps = 62/251 (24%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIR-----SNQALSEEHCQYFL 54
                 +              N   +  EL     L   I        + + +     F 
Sbjct: 124 SMQHMFMKFYSAH-----LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFA 178

Query: 55  YQILRGLKYIHSANVLHRDLKPSNLLLN-----------ANCDLKICDFGLA---RVTSE 100
            ++L  ++ +H   ++H D+KP N +L             +  L + D G +   ++  +
Sbjct: 179 MRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPK 238

Query: 101 TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL 160
               T    T  ++  E+L N   +   ID + V      ++    +             
Sbjct: 239 GTIFTAKCETSGFQCVEMLSNKP-WNYQIDYFGVAATVYCMLFGTYMK------------ 285

Query: 161 IELIGTPSEAELGFLNENAKKYICQ-LPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQ 219
                          NE  +        R        +F             ML      
Sbjct: 286 -------------VKNEGGECKPEGLFRRLPHLDMWNEF----------FHVMLNIPDCH 322

Query: 220 RITVEDALAHP 230
            +   D L   
Sbjct: 323 HLPSLDLLRQK 333

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 98.5 bits (246), Expect = 3e-24
 Identities = 42/153 (27%), Positives = 70/153 (45%), Gaps = 9/153 (5%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILR 59
           +   +VV I D       E    +Y+   L++  DL  ++R    L+       + QI  
Sbjct: 91  LQEPHVVPIHD-----FGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGS 145

Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF-MTEYVV-TRWYRAPE 117
            L   H+A   HRD+KP N+L++A+    + DFG+A  T++         V T +Y APE
Sbjct: 146 ALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPE 205

Query: 118 LLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPG 150
                S  T   D++++ C+  E +   P + G
Sbjct: 206 RFSE-SHATYRADIYALTCVLYECLTGSPPYQG 237

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  100 bits (251), Expect = 3e-24
 Identities = 48/210 (22%), Positives = 92/210 (43%), Gaps = 36/210 (17%)

Query: 29  ELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLK 88
           ++    ++ +   N    E    ++  QI+ GL+++H  N+++RDLKP N+LL+ + +++
Sbjct: 271 DIR-YHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVR 329

Query: 89  ICDFGLARVTSETDFMTE-YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL 147
           I D GLA         T+ Y  T  + APELLL   +Y  ++D +++G    E++  +  
Sbjct: 330 ISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGP 388

Query: 148 FPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP-NVHPSAI 206
           F  R    + + L + +          L +                    +P    P++ 
Sbjct: 389 FRARGEKVENKELKQRV----------LEQA-----------------VTYPDKFSPASK 421

Query: 207 DLVEKMLTFDPRQRI-----TVEDALAHPY 231
           D  E +L  DP +R+     + +    HP 
Sbjct: 422 DFCEALLQKDPEKRLGFRDGSCDGLRTHPL 451

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 97.3 bits (243), Expect = 6e-24
 Identities = 50/153 (32%), Positives = 83/153 (54%), Gaps = 9/153 (5%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILR 59
           + H+N+V++ D       E  +  Y+  E ++   L + I S+  LS +    F  QIL 
Sbjct: 68  LSHQNIVSMID-----VDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILD 122

Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF-MTEYVV-TRWYRAPE 117
           G+K+ H   ++HRD+KP N+L+++N  LKI DFG+A+  SET    T +V+ T  Y +PE
Sbjct: 123 GIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPE 182

Query: 118 LLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPG 150
                       D++S+G +  E++  +P F G
Sbjct: 183 QAK-GEATDECTDIYSIGIVLYEMLVGEPPFNG 214

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score = 96.1 bits (240), Expect = 9e-24
 Identities = 27/160 (16%), Positives = 54/160 (33%), Gaps = 22/160 (13%)

Query: 2   DHENVV----AIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQ--ALSEEHCQYFL 54
            H NV+    A +   PP          +    M    L+ ++       + +     F 
Sbjct: 65  SHPNVLPVLGACQS--PPAPH-----PTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFA 117

Query: 55  YQILRGLKYIHSAN--VLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRW 112
             + RG+ ++H+    +    L   +++++ +   +I    +         M       W
Sbjct: 118 LDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRMYAP---AW 174

Query: 113 YRAPELLLN--SSDYTAAIDVWSVGCIFMELMDRKPLFPG 150
             APE L          + D+WS   +  EL+ R+  F  
Sbjct: 175 V-APEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFAD 213

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score = 97.5 bits (243), Expect = 1e-23
 Identities = 40/168 (23%), Positives = 63/168 (37%), Gaps = 31/168 (18%)

Query: 1   MDHENVVA-----IRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFL 54
           M HEN++      I+      Q      +Y+  +  +   L+  ++S   L  +      
Sbjct: 88  MRHENILGFIAADIKGTGSWTQ------LYLITDYHENGSLYDYLKST-TLDAKSMLKLA 140

Query: 55  YQILRGLKYIHSAN--------VLHRDLKPSNLLLNANCDLKICDFGLARV-----TSET 101
           Y  + GL ++H+          + HRDLK  N+L+  N    I D GLA           
Sbjct: 141 YSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVD 200

Query: 102 DFMTEYVVTRWYRAPELL-----LNSSDYTAAIDVWSVGCIFMELMDR 144
                 V T+ Y  PE+L      N        D++S G I  E+  R
Sbjct: 201 IPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARR 248

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 96.6 bits (241), Expect = 2e-23
 Identities = 54/226 (23%), Positives = 94/226 (41%), Gaps = 52/226 (23%)

Query: 20  SFNDVYIAYELMDT----DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 75
           SF D    Y +M+     ++   +R     SE H +++  QI+   +Y+HS ++++RDLK
Sbjct: 109 SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLK 168

Query: 76  PSNLLLNANCDLKICDFGLA-RVTSETDFM---TEYVVTRWYRAPELLLNSSDYTAAIDV 131
           P NLL++    +++ DFG A RV   T  +    E +      APE++L+   Y  A+D 
Sbjct: 169 PENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEAL------APEIILS-KGYNKAVDW 221

Query: 132 WSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQR 191
           W++G +  E+    P F     +     + E I          ++               
Sbjct: 222 WALGVLIYEMAAGYPPFFADQPIQ----IYEKI----------VSGKV------------ 255

Query: 192 QSFTEKFP-NVHPSAIDLVEKMLTFDPRQRI-----TVEDALAHPY 231
                +FP +      DL+  +L  D  +R       V D   H +
Sbjct: 256 -----RFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKW 296

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 98.0 bits (244), Expect = 3e-23
 Identities = 48/204 (23%), Positives = 89/204 (43%), Gaps = 35/204 (17%)

Query: 34  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 93
           DLH  +  +   SE   +++  +I+ GL+++H+  V++RDLKP+N+LL+ +  ++I D G
Sbjct: 278 DLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLG 337

Query: 94  LARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDH 153
           LA   S+       V T  Y APE+L     Y ++ D +S+GC+  +L+     F     
Sbjct: 338 LACDFSKKKPHA-SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH-- 394

Query: 154 VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP-NVHPSAIDLVEKM 212
                       T  + E+        +    +          + P +  P    L+E +
Sbjct: 395 -----------KTKDKHEI-------DRMTLTMA--------VELPDSFSPELRSLLEGL 428

Query: 213 LTFDPRQRI-----TVEDALAHPY 231
           L  D  +R+       ++    P+
Sbjct: 429 LQRDVNRRLGCLGRGAQEVKESPF 452

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 94.6 bits (236), Expect = 8e-23
 Identities = 41/155 (26%), Positives = 79/155 (50%), Gaps = 7/155 (4%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILR 59
           ++H  +VA+ D     +  +    YI  E +D   L  I+ +   ++ +     +    +
Sbjct: 69  LNHPAIVAVYDT-GEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQ 127

Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSETDFMTE--YVV-TRWYRA 115
            L + H   ++HRD+KP+N++++A   +K+ DFG+AR +    + +T+   V+ T  Y +
Sbjct: 128 ALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 187

Query: 116 PELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPG 150
           PE         A  DV+S+GC+  E++  +P F G
Sbjct: 188 PEQAR-GDSVDARSDVYSLGCVLYEVLTGEPPFTG 221

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 96.8 bits (241), Expect = 8e-23
 Identities = 46/196 (23%), Positives = 80/196 (40%), Gaps = 34/196 (17%)

Query: 42  NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET 101
                E    ++  +I  GL+ +H   +++RDLKP N+LL+ +  ++I D GLA    E 
Sbjct: 280 QAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG 339

Query: 102 DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI 161
             +   V T  Y APE++ N   YT + D W++GC+  E++  +  F  R    +   + 
Sbjct: 340 QTIKGRVGTVGYMAPEVVKN-ERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVE 398

Query: 162 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP-NVHPSAIDLVEKMLTFDPRQR 220
            L+                               E++     P A  L  ++L  DP +R
Sbjct: 399 RLV----------KEVP-----------------EEYSERFSPQARSLCSQLLCKDPAER 431

Query: 221 I-----TVEDALAHPY 231
           +     +  +   HP 
Sbjct: 432 LGCRGGSAREVKEHPL 447

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 93.9 bits (234), Expect = 1e-22
 Identities = 57/239 (23%), Positives = 102/239 (42%), Gaps = 50/239 (20%)

Query: 2   DHENVVAIRDIIPPPQRESF---NDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFL 54
           D   V             S+     ++I  E +      DL +       L E      L
Sbjct: 78  DSPYVTKYYG--------SYLKDTKLWIIMEYLGGGSALDLLE----PGPLDETQIATIL 125

Query: 55  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL-ARVTSETDFMTEYVVTRWY 113
            +IL+GL Y+HS   +HRD+K +N+LL+ + ++K+ DFG+  ++T        +V T ++
Sbjct: 126 REILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFW 185

Query: 114 RAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELG 173
            APE++  S  Y +  D+WS+G   +EL   +P  P  + +H +++L             
Sbjct: 186 MAPEVIKQS-AYDSKADIWSLGITAIELARGEP--PHSE-LHPMKVL------------- 228

Query: 174 FLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
           FL          +P+    +    +        + VE  L  +P  R T ++ L H ++
Sbjct: 229 FL----------IPKNNPPTLEGNYS---KPLKEFVEACLNKEPSFRPTAKELLKHKFI 274

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 94.2 bits (235), Expect = 2e-22
 Identities = 52/205 (25%), Positives = 86/205 (41%), Gaps = 43/205 (20%)

Query: 34  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 93
           DL   I+S          ++  +I+ GL+++HS  +++RDLK  N+LL+ +  +KI DFG
Sbjct: 104 DLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFG 163

Query: 94  LARVTSETDFMTEYVVTRW------YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL 147
           + +     + M     T        Y APE+LL    Y  ++D WS G +  E++  +  
Sbjct: 164 MCK-----ENMLGDAKTNTFCGTPDYIAPEILLG-QKYNHSVDWWSFGVLLYEMLIGQSP 217

Query: 148 FPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAID 207
           F G+D       L   I            +N        PR+           +   A D
Sbjct: 218 FHGQDE----EELFHSI----------RMDNPF-----YPRW-----------LEKEAKD 247

Query: 208 LVEKMLTFDPRQRI-TVEDALAHPY 231
           L+ K+   +P +R+    D   HP 
Sbjct: 248 LLVKLFVREPEKRLGVRGDIRQHPL 272

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score = 92.5 bits (230), Expect = 4e-22
 Identities = 46/192 (23%), Positives = 72/192 (37%), Gaps = 24/192 (12%)

Query: 1   MDHENVVAIR--DIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQI 57
           M HEN++     +             ++     +   L   +++N  +S     +    +
Sbjct: 75  MKHENILQFIGAEKRGTSVDVDL---WLITAFHEKGSLSDFLKANV-VSWNELCHIAETM 130

Query: 58  LRGLKYIHSA----------NVLHRDLKPSNLLLNANCDLKICDFGLARV---TSETDFM 104
            RGL Y+H             + HRD+K  N+LL  N    I DFGLA            
Sbjct: 131 ARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDT 190

Query: 105 TEYVVTRWYRAPELL----LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL 160
              V TR Y APE+L        D    ID++++G +  EL  R     G    + L   
Sbjct: 191 HGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFE 250

Query: 161 IELIGTPSEAEL 172
            E+   PS  ++
Sbjct: 251 EEIGQHPSLEDM 262

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 92.2 bits (230), Expect = 6e-22
 Identities = 57/225 (25%), Positives = 96/225 (42%), Gaps = 50/225 (22%)

Query: 20  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 75
           +F D    + +MD     +L  ++R +Q       +++  ++   L+Y+HS ++++RDLK
Sbjct: 74  TFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLK 133

Query: 76  PSNLLLNANCDLKICDFGLA-RVTSETDFM---TEYVVTRWYRAPELLLNSSDYTAAIDV 131
           P N+LL+ N  +KI DFG A  V   T  +    +Y+      APE++     Y  +ID 
Sbjct: 134 PENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYI------APEVVST-KPYNKSIDW 186

Query: 132 WSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQR 191
           WS G +  E++     F   +         E I     AEL F            P +  
Sbjct: 187 WSFGILIYEMLAGYTPFYDSNT----MKTYEKI---LNAELRF------------PPF-- 225

Query: 192 QSFTEKFPNVHPSAIDLVEKMLTFDPRQRI-----TVEDALAHPY 231
                     +    DL+ +++T D  QR+       ED   HP+
Sbjct: 226 ---------FNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPW 261

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score = 92.5 bits (230), Expect = 7e-22
 Identities = 35/168 (20%), Positives = 63/168 (37%), Gaps = 31/168 (18%)

Query: 1   MDHENVVA-----IRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFL 54
           + HEN++       +D     Q      +++  +  +   L   +     ++ E      
Sbjct: 93  LRHENILGFIAADNKDNGTWTQ------LWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLA 145

Query: 55  YQILRGLKYIHSA--------NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTE 106
                GL ++H           + HRDLK  N+L+  N    I D GLA          +
Sbjct: 146 LSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTID 205

Query: 107 YVV-----TRWYRAPELLLNSS-----DYTAAIDVWSVGCIFMELMDR 144
                   T+ Y APE+L +S      +     D++++G +F E+  R
Sbjct: 206 IAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARR 253

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 92.5 bits (230), Expect = 1e-21
 Identities = 41/205 (20%), Positives = 80/205 (39%), Gaps = 35/205 (17%)

Query: 35  LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL 94
           L  + +    L EE  +++L +++  +  +H  + +HRD+KP N+L++ N  +++ DFG 
Sbjct: 162 LTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGS 221

Query: 95  A-RVTSETDFMTEYVV-TRWYRAPELLLNSSD----YTAAIDVWSVGCIFMELMDRKPLF 148
             ++  +    +   V T  Y +PE+L         Y    D WS+G    E++  +  F
Sbjct: 222 CLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPF 281

Query: 149 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDL 208
                V         I                     +   +R  F  +  +V  +A DL
Sbjct: 282 YAESLVE----TYGKI---------------------MNHKERFQFPTQVTDVSENAKDL 316

Query: 209 VEKMLTFDPRQRITVEDAL---AHP 230
           + +++      R+          HP
Sbjct: 317 IRRLIC-SREHRLGQNGIEDFKKHP 340

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 90.7 bits (226), Expect = 2e-21
 Identities = 53/215 (24%), Positives = 91/215 (42%), Gaps = 54/215 (25%)

Query: 29  ELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLK 88
           EL      Q+ R      E+   ++L +I   L ++H   +++RDLKP N++LN    +K
Sbjct: 107 ELF----MQLEREGI-FMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVK 161

Query: 89  ICDFGLARVTSETDFMT-------EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL 141
           + DFGL + +     +T       EY+      APE+L+  S +  A+D WS+G +  ++
Sbjct: 162 LTDFGLCKESIHDGTVTHTFCGTIEYM------APEILMR-SGHNRAVDWWSLGALMYDM 214

Query: 142 MDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNV 201
           +   P F G +     +  I+ I          L          LP Y           +
Sbjct: 215 LTGAPPFTGENR----KKTIDKI----------LKCKLN-----LPPY-----------L 244

Query: 202 HPSAIDLVEKMLTFDPRQRI-----TVEDALAHPY 231
              A DL++K+L  +   R+        +  AHP+
Sbjct: 245 TQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPF 279

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 90.7 bits (226), Expect = 3e-21
 Identities = 56/214 (26%), Positives = 99/214 (46%), Gaps = 52/214 (24%)

Query: 29  ELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLK 88
           EL     H  +   +  +EE  +++  +I+  L+Y+HS +V++RD+K  NL+L+ +  +K
Sbjct: 91  ELF---FH--LSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIK 145

Query: 89  ICDFGLARVTSETDFMTEYVVTRW------YRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
           I DFGL +     + +++    +       Y APE+L + +DY  A+D W +G +  E+M
Sbjct: 146 ITDFGLCK-----EGISDGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMM 199

Query: 143 DRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVH 202
             +  F  +DH      L ELI          L E  +      PR            + 
Sbjct: 200 CGRLPFYNQDH----ERLFELI----------LMEEIR-----FPRT-----------LS 229

Query: 203 PSAIDLVEKMLTFDPRQRI-----TVEDALAHPY 231
           P A  L+  +L  DP+QR+       ++ + H +
Sbjct: 230 PEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRF 263

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 90.3 bits (225), Expect = 3e-21
 Identities = 44/198 (22%), Positives = 86/198 (43%), Gaps = 49/198 (24%)

Query: 46  SEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMT 105
           +EE  +++L ++   L ++HS  +++RDLKP N+LL+    +K+ DFGL++ + + +   
Sbjct: 124 TEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKA 183

Query: 106 -------EYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR 158
                  EY+      APE++     +T + D WS G +  E++     F G+D     +
Sbjct: 184 YSFCGTVEYM------APEVVNR-RGHTQSADWWSFGVLMFEMLTGTLPFQGKDR----K 232

Query: 159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPR 218
             + +I          L          +P++           + P A  L+  +   +P 
Sbjct: 233 ETMTMI----------LKAKLG-----MPQF-----------LSPEAQSLLRMLFKRNPA 266

Query: 219 QRI-----TVEDALAHPY 231
            R+      VE+   H +
Sbjct: 267 NRLGAGPDGVEEIKRHSF 284

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 90.1 bits (224), Expect = 4e-21
 Identities = 43/151 (28%), Positives = 73/151 (48%), Gaps = 16/151 (10%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQA-LSEEHCQYFLYQIL 58
           +  + +V  R +   P R+S   + +  E + +  L   ++ ++A L       +  QI 
Sbjct: 81  LHSDFIVKYRGVSYGPGRQS---LRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQIC 137

Query: 59  RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-------R 111
           +G++Y+ S   +HRDL   N+L+ +   +KI DFGLA++         YVV         
Sbjct: 138 KGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDK--DYYVVREPGQSPIF 195

Query: 112 WYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
           WY APE L ++  ++   DVWS G +  EL 
Sbjct: 196 WY-APESLSDNI-FSRQSDVWSFGVVLYELF 224

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 90.4 bits (225), Expect = 4e-21
 Identities = 47/215 (21%), Positives = 85/215 (39%), Gaps = 53/215 (24%)

Query: 29  ELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLK 88
           +LM      I +S +   E   +++  +I+  L ++H   +++RDLK  N+LL+     K
Sbjct: 110 DLM----FHIQKSRR-FDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCK 164

Query: 89  ICDFGLARVTSETDFMTEYVVTRW------YRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
           + DFG+ +     + +   V T        Y APE+L     Y  A+D W++G +  E++
Sbjct: 165 LADFGMCK-----EGICNGVTTATFCGTPDYIAPEILQE-MLYGPAVDWWAMGVLLYEML 218

Query: 143 DRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVH 202
                F   +       L E I          LN+         P +           +H
Sbjct: 219 CGHAPFEAENE----DDLFEAI----------LNDEVV-----YPTW-----------LH 248

Query: 203 PSAIDLVEKMLTFDPRQRI------TVEDALAHPY 231
             A  +++  +T +P  R+           L HP+
Sbjct: 249 EDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPF 283

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 90.9 bits (226), Expect = 4e-21
 Identities = 39/208 (18%), Positives = 77/208 (37%), Gaps = 37/208 (17%)

Query: 35  LHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL 94
           L  + +  + +  E  +++L +I+  +  +H    +HRD+KP N+LL+    +++ DFG 
Sbjct: 149 LTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGS 208

Query: 95  A-RVTSETDFMTEYVV-TRWYRAPELLLN------SSDYTAAIDVWSVGCIFMELMDRKP 146
             ++ ++    +   V T  Y +PE+L        +  Y    D W++G    E+   + 
Sbjct: 209 CLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQT 268

Query: 147 LFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAI 206
            F               I                     +   +  S       V   A 
Sbjct: 269 PFYADSTAE----TYGKI---------------------VHYKEHLSLPLVDEGVPEEAR 303

Query: 207 DLVEKMLTFDPRQRITVEDAL---AHPY 231
           D ++++L   P  R+    A     HP+
Sbjct: 304 DFIQRLLC-PPETRLGRGGAGDFRTHPF 330

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 89.7 bits (223), Expect = 7e-21
 Identities = 45/211 (21%), Positives = 95/211 (45%), Gaps = 39/211 (18%)

Query: 29  ELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLK 88
           EL       + +  +  +E   Q ++ +I+  L+++H   +++RD+K  N+LL++N  + 
Sbjct: 145 ELF----THLSQRER-FTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVV 199

Query: 89  ICDFGLAR--VTSETDFMTEYVVTRWYRAPELLL-NSSDYTAAIDVWSVGCIFMELMDRK 145
           + DFGL++  V  ET+   ++  T  Y AP+++    S +  A+D WS+G +  EL+   
Sbjct: 200 LTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259

Query: 146 PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSA 205
             F      +    +   I    ++E  +            P+            +   A
Sbjct: 260 SPFTVDGEKNSQAEISRRI---LKSEPPY------------PQE-----------MSALA 293

Query: 206 IDLVEKMLTFDPRQRI-----TVEDALAHPY 231
            DL++++L  DP++R+       ++   H +
Sbjct: 294 KDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 88.9 bits (221), Expect = 8e-21
 Identities = 39/151 (25%), Positives = 69/151 (45%), Gaps = 16/151 (10%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQA-LSEEHCQYFLYQIL 58
           + H+N+V  + +     R +   + +  E +    L   ++ ++  +       +  QI 
Sbjct: 68  LQHDNIVKYKGVCYSAGRRN---LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC 124

Query: 59  RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-------R 111
           +G++Y+ +   +HRDL   N+L+     +KI DFGL +V  +      + V         
Sbjct: 125 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK--EFFKVKEPGESPIF 182

Query: 112 WYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
           WY APE L  S  ++ A DVWS G +  EL 
Sbjct: 183 WY-APESLTESK-FSVASDVWSFGVVLYELF 211

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 89.2 bits (222), Expect = 1e-20
 Identities = 44/214 (20%), Positives = 88/214 (41%), Gaps = 52/214 (24%)

Query: 29  ELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLK 88
           +LM    + I +  +   E H  ++  +I  GL ++ S  +++RDLK  N++L++   +K
Sbjct: 107 DLM----YHIQQVGR-FKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIK 161

Query: 89  ICDFGLARVTSETDFMTEYVVTRW------YRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
           I DFG+ +     + + + V T+       Y APE++     Y  ++D W+ G +  E++
Sbjct: 162 IADFGMCK-----ENIWDGVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEML 215

Query: 143 DRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVH 202
             +  F G D       L + I          +  N        P+            + 
Sbjct: 216 AGQAPFEGEDE----DELFQSI----------MEHNVA-----YPKS-----------MS 245

Query: 203 PSAIDLVEKMLTFDPRQRI-----TVEDALAHPY 231
             A+ + + ++T  P +R+        D   H +
Sbjct: 246 KEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAF 279

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 88.2 bits (219), Expect = 2e-20
 Identities = 40/151 (26%), Positives = 69/151 (45%), Gaps = 16/151 (10%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQA-LSEEHCQYFLYQIL 58
           + H+N+V  + +     R +   + +  E +    L   ++ ++  +       +  QI 
Sbjct: 99  LQHDNIVKYKGVCYSAGRRN---LKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQIC 155

Query: 59  RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-------R 111
           +G++Y+ +   +HRDL   N+L+     +KI DFGL +V  +      Y V         
Sbjct: 156 KGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK--EYYKVKEPGESPIF 213

Query: 112 WYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
           WY APE L  S  ++ A DVWS G +  EL 
Sbjct: 214 WY-APESLTESK-FSVASDVWSFGVVLYELF 242

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 88.6 bits (220), Expect = 3e-20
 Identities = 60/210 (28%), Positives = 97/210 (46%), Gaps = 43/210 (20%)

Query: 29  ELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA-NVLHRDLKPSNLLLNANCDL 87
           EL     H  +   +  SE+  +++  +I+  L Y+HS  NV++RDLK  NL+L+ +  +
Sbjct: 234 ELF---FH--LSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHI 288

Query: 88  KICDFGLARVT-SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP 146
           KI DFGL +    +   M  +  T  Y APE+L + +DY  A+D W +G +  E+M  + 
Sbjct: 289 KITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRL 347

Query: 147 LFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAI 206
            F  +DH      L ELI          L E  +      PR            + P A 
Sbjct: 348 PFYNQDH----EKLFELI----------LMEEIR-----FPRT-----------LGPEAK 377

Query: 207 DLVEKMLTFDPRQRI-----TVEDALAHPY 231
            L+  +L  DP+QR+       ++ + H +
Sbjct: 378 SLLSGLLKKDPKQRLGGGSEDAKEIMQHRF 407

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 87.0 bits (216), Expect = 4e-20
 Identities = 42/151 (27%), Positives = 68/151 (45%), Gaps = 16/151 (10%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQA-LSEEHCQYFLYQIL 58
           + HEN+V  + I           + +  E + +  L + +  N+  ++ +    +  QI 
Sbjct: 80  LYHENIVKYKGICTEDGGNG---IKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQIC 136

Query: 59  RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-------R 111
           +G+ Y+ S   +HRDL   N+L+ +   +KI DFGL +          Y V         
Sbjct: 137 KGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK--EYYTVKDDRDSPVF 194

Query: 112 WYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
           WY APE L+ S  +  A DVWS G    EL+
Sbjct: 195 WY-APECLMQSK-FYIASDVWSFGVTLHELL 223

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 87.7 bits (218), Expect = 4e-20
 Identities = 48/213 (22%), Positives = 86/213 (40%), Gaps = 51/213 (23%)

Query: 29  ELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLK 88
           EL     H  ++  +   E   +++  +I   L Y+HS N+++RDLKP N+LL++   + 
Sbjct: 125 ELF---YH--LQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIV 179

Query: 89  ICDFGLARVTSETDFMTEYVVTRW------YRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
           + DFGL +     + +     T        Y APE+L     Y   +D W +G +  E++
Sbjct: 180 LTDFGLCK-----ENIEHNSTTSTFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEML 233

Query: 143 DRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVH 202
              P F  R+       + + I          LN+  +     L              + 
Sbjct: 234 YGLPPFYSRNT----AEMYDNI----------LNKPLQ-----LKPN-----------IT 263

Query: 203 PSAIDLVEKMLTFDPRQRI----TVEDALAHPY 231
            SA  L+E +L  D  +R+       +  +H +
Sbjct: 264 NSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVF 296

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 88.5 bits (219), Expect = 5e-20
 Identities = 44/214 (20%), Positives = 88/214 (41%), Gaps = 52/214 (24%)

Query: 29  ELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLK 88
           +LM    + I +  +   E H  ++  +I  GL ++ S  +++RDLK  N++L++   +K
Sbjct: 428 DLM----YHIQQVGR-FKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIK 482

Query: 89  ICDFGLARVTSETDFMTEYVVTRW------YRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
           I DFG+ +     + + + V T+       Y APE++     Y  ++D W+ G +  E++
Sbjct: 483 IADFGMCK-----ENIWDGVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEML 536

Query: 143 DRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVH 202
             +  F G D       L + I          +  N        P+            + 
Sbjct: 537 AGQAPFEGEDE----DELFQSI----------MEHNVA-----YPKS-----------MS 566

Query: 203 PSAIDLVEKMLTFDPRQRI-----TVEDALAHPY 231
             A+ + + ++T  P +R+        D   H +
Sbjct: 567 KEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAF 600

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 87.4 bits (217), Expect = 8e-20
 Identities = 51/223 (22%), Positives = 90/223 (40%), Gaps = 40/223 (17%)

Query: 20  SFNDVYIAYELMD----TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 75
           +F D    Y +M+     DL  ++  N  + E+  +++  +++  L  IHS   +HRD+K
Sbjct: 137 AFQDDRYLYMVMEYMPGGDLVNLMS-NYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVK 195

Query: 76  PSNLLLNANCDLKICDFGLA-RVTSETDFMTEYVV-TRWYRAPELLLN---SSDYTAAID 130
           P N+LL+ +  LK+ DFG   ++  E     +  V T  Y +PE+L +      Y    D
Sbjct: 196 PDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECD 255

Query: 131 VWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQ 190
            WSVG    E+                     L+G        F  ++      ++  ++
Sbjct: 256 WWSVGVFLYEM---------------------LVGDTP-----FYADSLVGTYSKIMNHK 289

Query: 191 RQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT---VEDALAHP 230
                    ++   A +L+   LT D   R+    VE+   H 
Sbjct: 290 NSLTFPDDNDISKEAKNLICAFLT-DREVRLGRNGVEEIKRHL 331

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 86.5 bits (215), Expect = 9e-20
 Identities = 47/215 (21%), Positives = 89/215 (41%), Gaps = 49/215 (22%)

Query: 34  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 93
           DL   ++  + L EEH +++  +I   L Y+H   +++RDLK  N+LL++   +K+ D+G
Sbjct: 96  DLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYG 155

Query: 94  LARVTSETDFMTEYVVTRW------YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL 147
           + +     + +     T        Y APE+L    DY  ++D W++G +  E+M  +  
Sbjct: 156 MCK-----EGLRPGDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSP 209

Query: 148 FPGRDHVHQLR-----LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVH 202
           F                L ++I          L +  +     +PR            + 
Sbjct: 210 FDIVGSSDNPDQNTEDYLFQVI----------LEKQIR-----IPRS-----------LS 243

Query: 203 PSAIDLVEKMLTFDPRQRI------TVEDALAHPY 231
             A  +++  L  DP++R+         D   HP+
Sbjct: 244 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF 278

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 85.7 bits (213), Expect = 2e-19
 Identities = 40/150 (26%), Positives = 66/150 (44%), Gaps = 18/150 (12%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQA-LSEEHCQYFLYQIL 58
           +D+ +V  +  I           V +  +LM    L   +R ++  +  ++   +  QI 
Sbjct: 74  VDNPHVCRLLGICLTST------VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 127

Query: 59  RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT------RW 112
           +G+ Y+    ++HRDL   N+L+     +KI DFGLA++    +   EY         +W
Sbjct: 128 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE--KEYHAEGGKVPIKW 185

Query: 113 YRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
             A E  +    YT   DVWS G    ELM
Sbjct: 186 M-ALE-SILHRIYTHQSDVWSYGVTVWELM 213

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 84.6 bits (210), Expect = 2e-19
 Identities = 41/151 (27%), Positives = 63/151 (41%), Gaps = 19/151 (12%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQA-LSEEHCQYFLYQIL 58
           +DH N++ +  ++  P       + +  EL     L   +R +Q          +  Q+ 
Sbjct: 78  LDHRNLIRLYGVVLTPP------MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 131

Query: 59  RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-------R 111
            G+ Y+ S   +HRDL   NLLL     +KI DFGL R   + D    YV+         
Sbjct: 132 EGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND--DHYVMQEHRKVPFA 189

Query: 112 WYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
           W  APE  L +  ++ A D W  G    E+ 
Sbjct: 190 WC-APE-SLKTRTFSHASDTWMFGVTLWEMF 218

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 83.8 bits (208), Expect = 4e-19
 Identities = 39/150 (26%), Positives = 73/150 (48%), Gaps = 18/150 (12%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILR 59
           +D+  +V +  I    + ES     +  E+ +   L++ ++ N+ + +++    ++Q+  
Sbjct: 75  LDNPYIVRMIGIC---EAES---WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSM 128

Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-------RW 112
           G+KY+  +N +HRDL   N+LL      KI DFGL++     +    Y          +W
Sbjct: 129 GMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE--NYYKAQTHGKWPVKW 186

Query: 113 YRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
           Y APE  +N   +++  DVWS G +  E  
Sbjct: 187 Y-APE-CINYYKFSSKSDVWSFGVLMWEAF 214

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 85.1 bits (211), Expect = 4e-19
 Identities = 47/215 (21%), Positives = 89/215 (41%), Gaps = 49/215 (22%)

Query: 34  DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFG 93
           DL   ++  + L EEH +++  +I   L Y+H   +++RDLK  N+LL++   +K+ D+G
Sbjct: 139 DLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYG 198

Query: 94  LARVTSETDFMTEYVVTRW------YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL 147
           + +     + +     T        Y APE+L    DY  ++D W++G +  E+M  +  
Sbjct: 199 MCK-----EGLRPGDTTSTFCGTPNYIAPEILRG-EDYGFSVDWWALGVLMFEMMAGRSP 252

Query: 148 FPGRDHVHQLR-----LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVH 202
           F                L ++I          L +  +     +PR            + 
Sbjct: 253 FDIVGSSDNPDQNTEDYLFQVI----------LEKQIR-----IPRS-----------LS 286

Query: 203 PSAIDLVEKMLTFDPRQRI------TVEDALAHPY 231
             A  +++  L  DP++R+         D   HP+
Sbjct: 287 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF 321

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 83.9 bits (208), Expect = 6e-19
 Identities = 42/150 (28%), Positives = 65/150 (43%), Gaps = 16/150 (10%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILR 59
           + HE+++  +         S   + +  E +    L   +  +  +       F  QI  
Sbjct: 90  LYHEHIIKYKGCCEDAGAAS---LQLVMEYVPLGSLRDYLPRHS-IGLAQLLLFAQQICE 145

Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-------RW 112
           G+ Y+H+ + +HRDL   N+LL+ +  +KI DFGLA+   E      Y V         W
Sbjct: 146 GMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH--EYYRVREDGDSPVFW 203

Query: 113 YRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
           Y APE L     +  A DVWS G    EL+
Sbjct: 204 Y-APECLKEYK-FYYASDVWSFGVTLYELL 231

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 83.7 bits (207), Expect = 7e-19
 Identities = 51/286 (17%), Positives = 102/286 (35%), Gaps = 44/286 (15%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILR 59
           M+H+N+            +   +  +  E      L + +  +            + + R
Sbjct: 64  MEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTR 122

Query: 60  GLKYIHSA---------NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF------- 103
           GL Y+H+           + HRDL   N+L+  +    I DFGL+   +           
Sbjct: 123 GLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEED 182

Query: 104 --MTEYVVTRWYRAPELLLNS------SDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVH 155
                 V T  Y APE+L  +            +D++++G I+ E+  R       + V 
Sbjct: 183 NAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP 242

Query: 156 QLRLLIELIGTPSEAELGFLN--ENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKML 213
           + ++         + E+G     E+ +  + +    QR  F E +   +  A+  +++ +
Sbjct: 243 EYQM-------AFQTEVGNHPTFEDMQVLVSR--EKQRPKFPEAWKE-NSLAVRSLKETI 292

Query: 214 TF----DPRQRITVEDALAHPYLGSLHDISDEPVCMSPFSFDFEQH 255
                 D   R+T + A     +  L  I +    +SP +     H
Sbjct: 293 EDCWDQDAEARLTAQXAEE--RMAELMMIWERNKSVSPTAHHHHHH 336

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 82.8 bits (205), Expect = 2e-18
 Identities = 35/151 (23%), Positives = 67/151 (44%), Gaps = 20/151 (13%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQA-LSEEHCQYFLYQIL 58
           +DH ++V +  + P         + +  + +    L   +R ++  L  +    +  QI 
Sbjct: 72  LDHAHIVRLLGLCPGSS------LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIA 125

Query: 59  RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-------R 111
           +G+ Y+    ++HR+L   N+LL +   +++ DFG+A +    D   + ++        +
Sbjct: 126 KGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD---KQLLYSEAKTPIK 182

Query: 112 WYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
           W  A E +     YT   DVWS G    ELM
Sbjct: 183 WM-ALESIHFGK-YTHQSDVWSYGVTVWELM 211

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 81.9 bits (203), Expect = 2e-18
 Identities = 41/145 (28%), Positives = 65/145 (44%), Gaps = 10/145 (6%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSN--QALSEEHCQYFLYQI 57
           + H N+V +  +I     E    +YI  E M    L   +RS     L  +    F   +
Sbjct: 71  LRHSNLVQLLGVIV----EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 126

Query: 58  LRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPE 117
              ++Y+   N +HRDL   N+L++ +   K+ DFGL +  S T    +  V +W  APE
Sbjct: 127 CEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV-KWT-APE 184

Query: 118 LLLNSSDYTAAIDVWSVGCIFMELM 142
            L     ++   DVWS G +  E+ 
Sbjct: 185 ALREKK-FSTKSDVWSFGILLWEIY 208

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 81.5 bits (202), Expect = 3e-18
 Identities = 40/151 (26%), Positives = 69/151 (45%), Gaps = 19/151 (12%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQA-LSEEHCQYFLYQIL 58
           +D+  +V +  +    Q E+   + +  E+     LH+ +   +  +   +    L+Q+ 
Sbjct: 67  LDNPYIVRLIGVC---QAEA---LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVS 120

Query: 59  RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-------R 111
            G+KY+   N +HRDL   N+LL      KI DFGL++     D  + Y          +
Sbjct: 121 MGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD--SYYTARSAGKWPLK 178

Query: 112 WYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
           WY APE  +N   +++  DVWS G    E +
Sbjct: 179 WY-APE-CINFRKFSSRSDVWSYGVTMWEAL 207

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 82.0 bits (203), Expect = 3e-18
 Identities = 40/150 (26%), Positives = 66/150 (44%), Gaps = 18/150 (12%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQA-LSEEHCQYFLYQIL 58
           +D+ +V  +  I           V +  +LM    L   +R ++  +  ++   +  QI 
Sbjct: 74  VDNPHVCRLLGICLTST------VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 127

Query: 59  RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT------RW 112
           +G+ Y+    ++HRDL   N+L+     +KI DFGLA++    +   EY         +W
Sbjct: 128 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE--KEYHAEGGKVPIKW 185

Query: 113 YRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
             A E  +    YT   DVWS G    ELM
Sbjct: 186 M-ALE-SILHRIYTHQSDVWSYGVTVWELM 213

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 82.7 bits (205), Expect = 3e-18
 Identities = 39/151 (25%), Positives = 63/151 (41%), Gaps = 19/151 (12%)

Query: 1   MDHENVVAIRDII---PPPQRESFNDVYIAYELMDT-DLHQIIRSN-QALSEEHCQYFLY 55
             H N+V +  +     P        +YI  EL+   D    +R+    L  +     + 
Sbjct: 169 YSHPNIVRLIGVCTQKQP--------IYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVG 220

Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT----R 111
               G++Y+ S   +HRDL   N L+     LKI DFG++R  ++  +     +     +
Sbjct: 221 DAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVK 280

Query: 112 WYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
           W  APE L     Y++  DVWS G +  E  
Sbjct: 281 WT-APEALNYGR-YSSESDVWSFGILLWETF 309

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 80.7 bits (200), Expect = 4e-18
 Identities = 34/138 (24%), Positives = 62/138 (44%), Gaps = 18/138 (13%)

Query: 24  VYIAYELMDT-DLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 81
           +YI  E +    L   +RS+ + L         Y +  G+ ++ S   +HRDL   N L+
Sbjct: 78  IYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLV 137

Query: 82  NANCDLKICDFGLARVTSETDFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSV 134
           + +  +K+ DFG+ R   +     +YV +       +W  APE+      Y++  DVW+ 
Sbjct: 138 DRDLCVKVSDFGMTRYVLD----DQYVSSVGTKFPVKWS-APEVFHYFK-YSSKSDVWAF 191

Query: 135 GCIFMELMD--RKPLFPG 150
           G +  E+    + P +  
Sbjct: 192 GILMWEVFSLGKMP-YDL 208

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 82.4 bits (204), Expect = 5e-18
 Identities = 41/145 (28%), Positives = 65/145 (44%), Gaps = 10/145 (6%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSN--QALSEEHCQYFLYQI 57
           + H N+V +  +I     E    +YI  E M    L   +RS     L  +    F   +
Sbjct: 243 LRHSNLVQLLGVIV----EEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 298

Query: 58  LRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPE 117
              ++Y+   N +HRDL   N+L++ +   K+ DFGL +  S T    +  V +W  APE
Sbjct: 299 CEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV-KWT-APE 356

Query: 118 LLLNSSDYTAAIDVWSVGCIFMELM 142
            L     ++   DVWS G +  E+ 
Sbjct: 357 ALREKK-FSTKSDVWSFGILLWEIY 380

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 80.4 bits (199), Expect = 7e-18
 Identities = 41/151 (27%), Positives = 71/151 (47%), Gaps = 21/151 (13%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQA-LSEEHCQYFLYQIL 58
            DH ++V +  +I      + N V+I  EL    +L   ++  +  L       + YQ+ 
Sbjct: 73  FDHPHIVKLIGVI------TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLS 126

Query: 59  RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-------R 111
             L Y+ S   +HRD+   N+L+++N  +K+ DFGL+R   ++     Y          +
Sbjct: 127 TALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST----YYKASKGKLPIK 182

Query: 112 WYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
           W  APE  +N   +T+A DVW  G    E++
Sbjct: 183 WM-APE-SINFRRFTSASDVWMFGVCMWEIL 211

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 79.9 bits (198), Expect = 7e-18
 Identities = 36/154 (23%), Positives = 65/154 (42%), Gaps = 26/154 (16%)

Query: 1   MDHENVVAIRDII---PPPQRESFNDVYIAYELMDT-DLHQIIRSNQA-LSEEHCQYFLY 55
           + H  +V +  +     P        + +  E M+   L   +R+ +   + E       
Sbjct: 60  LSHPKLVQLYGVCLEQAP--------ICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCL 111

Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT----- 110
            +  G+ Y+  A V+HRDL   N L+  N  +K+ DFG+ R   +     +Y  +     
Sbjct: 112 DVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD----DQYTSSTGTKF 167

Query: 111 --RWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
             +W  +PE+   S  Y++  DVWS G +  E+ 
Sbjct: 168 PVKWA-SPEVFSFSR-YSSKSDVWSFGVLMWEVF 199

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 82.3 bits (203), Expect = 7e-18
 Identities = 37/151 (24%), Positives = 66/151 (43%), Gaps = 19/151 (12%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQA-LSEEHCQYFLYQIL 58
           +D+  +V +  +           + +  E+     LH+ +   +  +   +    L+Q+ 
Sbjct: 393 LDNPYIVRLIGVCQAEA------LMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVS 446

Query: 59  RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-------R 111
            G+KY+   N +HR+L   N+LL      KI DFGL++     D  + Y          +
Sbjct: 447 MGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADD--SYYTARSAGKWPLK 504

Query: 112 WYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
           WY APE  +N   +++  DVWS G    E +
Sbjct: 505 WY-APE-CINFRKFSSRSDVWSYGVTMWEAL 533

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 81.3 bits (201), Expect = 1e-17
 Identities = 41/148 (27%), Positives = 65/148 (43%), Gaps = 14/148 (9%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQI 57
           + HE +V +  ++      S   +YI  E M    L   ++    + L          QI
Sbjct: 236 LRHEKLVQLYAVV------SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQI 289

Query: 58  LRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RWYR 114
             G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR+  + ++          +W  
Sbjct: 290 ASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT- 348

Query: 115 APELLLNSSDYTAAIDVWSVGCIFMELM 142
           APE       +T   DVWS G +  EL 
Sbjct: 349 APE-AALYGRFTIKSDVWSFGILLTELT 375

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 81.8 bits (202), Expect = 1e-17
 Identities = 41/148 (27%), Positives = 65/148 (43%), Gaps = 14/148 (9%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQI 57
           + HE +V +  ++      S   +YI  E M    L   ++    + L          QI
Sbjct: 319 LRHEKLVQLYAVV------SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQI 372

Query: 58  LRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---RWYR 114
             G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR+  + ++          +W  
Sbjct: 373 ASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWT- 431

Query: 115 APELLLNSSDYTAAIDVWSVGCIFMELM 142
           APE       +T   DVWS G +  EL 
Sbjct: 432 APE-AALYGRFTIKSDVWSFGILLTELT 458

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 79.2 bits (196), Expect = 2e-17
 Identities = 37/154 (24%), Positives = 65/154 (42%), Gaps = 26/154 (16%)

Query: 1   MDHENVVAIRDII---PPPQRESFNDVYIAYELMDT-DLHQIIRSNQA-LSEEHCQYFLY 55
           + HE +V +  +     P        ++I  E M    L   +R  +     +       
Sbjct: 76  LSHEKLVQLYGVCTKQRP--------IFIITEYMANGCLLNYLREMRHRFQTQQLLEMCK 127

Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT----- 110
            +   ++Y+ S   LHRDL   N L+N    +K+ DFGL+R   +     EY  +     
Sbjct: 128 DVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD----DEYTSSVGSKF 183

Query: 111 --RWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
             RW   PE+L+ S  +++  D+W+ G +  E+ 
Sbjct: 184 PVRWS-PPEVLMYSK-FSSKSDIWAFGVLMWEIY 215

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 79.2 bits (196), Expect = 2e-17
 Identities = 43/155 (27%), Positives = 66/155 (42%), Gaps = 27/155 (17%)

Query: 1   MDHENVVAIRDII---PPPQRESFNDVYIAYELMDT-DLHQIIRSN--QALSEEHCQYFL 54
           + H N+V +  +    PP         YI  E M   +L   +R    Q +S     Y  
Sbjct: 66  IKHPNLVQLLGVCTREPP--------FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMA 117

Query: 55  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---- 110
            QI   ++Y+   N +HRDL   N L+  N  +K+ DFGL+R+    D    Y       
Sbjct: 118 TQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-TGD---TYTAHAGAK 173

Query: 111 ---RWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
              +W  APE L  +  ++   DVW+ G +  E+ 
Sbjct: 174 FPIKWT-APESLAYNK-FSIKSDVWAFGVLLWEIA 206

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 80.5 bits (199), Expect = 2e-17
 Identities = 45/152 (29%), Positives = 72/152 (47%), Gaps = 22/152 (14%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSN--QALSEEHCQYFLYQI 57
           + H+ +V +  ++      +   +YI  E M    L   ++S+            F  QI
Sbjct: 240 LQHDKLVKLHAVV------TKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQI 293

Query: 58  LRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT------- 110
             G+ +I   N +HRDL+ +N+L++A+   KI DFGLARV  +     EY          
Sbjct: 294 AEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIED----NEYTAREGAKFPI 349

Query: 111 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
           +W  APE +   S +T   DVWS G + ME++
Sbjct: 350 KWT-APEAINFGS-FTIKSDVWSFGILLMEIV 379

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 78.4 bits (194), Expect = 3e-17
 Identities = 40/151 (26%), Positives = 68/151 (45%), Gaps = 21/151 (13%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQA-LSEEHCQYFLYQIL 58
           +DH ++V +  II   + E     +I  EL    +L   +  N+  L       +  QI 
Sbjct: 70  LDHPHIVKLIGII---EEEP---TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQIC 123

Query: 59  RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-------R 111
           + + Y+ S N +HRD+   N+L+ +   +K+ DFGL+R   + D    Y          +
Sbjct: 124 KAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED----YYKASVTRLPIK 179

Query: 112 WYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
           W  +PE  +N   +T A DVW       E++
Sbjct: 180 WM-SPE-SINFRRFTTASDVWMFAVCMWEIL 208

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 79.8 bits (197), Expect = 4e-17
 Identities = 36/129 (27%), Positives = 57/129 (44%), Gaps = 16/129 (12%)

Query: 24  VYIAYELMDT-DLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL 80
            YI  E M   +L   +R    Q +S     Y   QI   ++Y+   N +HR+L   N L
Sbjct: 291 FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCL 350

Query: 81  LNANCDLKICDFGLARVTSETDFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWS 133
           +  N  +K+ DFGL+R+ +       Y          +W  APE  L  + ++   DVW+
Sbjct: 351 VGENHLVKVADFGLSRLMTG----DTYTAHAGAKFPIKWT-APE-SLAYNKFSIKSDVWA 404

Query: 134 VGCIFMELM 142
            G +  E+ 
Sbjct: 405 FGVLLWEIA 413

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 78.5 bits (194), Expect = 5e-17
 Identities = 48/153 (31%), Positives = 71/153 (46%), Gaps = 22/153 (14%)

Query: 1   MDHENVVAIRDII---PPPQRESFNDVYIAYELMDT-DLHQIIRSNQA-LSEEHCQYFLY 55
             H N++ +  +I    P        + I  E M+   L + +R      S       L 
Sbjct: 103 FSHHNIIRLEGVISKYKP--------MMIITEYMENGALDKFLREKDGEFSVLQLVGMLR 154

Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT----- 110
            I  G+KY+ + N +HRDL   N+L+N+N   K+ DFGL+RV  E D    Y  +     
Sbjct: 155 GIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL-EDDPEATYTTSGGKIP 213

Query: 111 -RWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
            RW  APE +     +T+A DVWS G +  E+M
Sbjct: 214 IRWT-APEAISYRK-FTSASDVWSFGIVMWEVM 244

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 78.1 bits (193), Expect = 5e-17
 Identities = 44/176 (25%), Positives = 73/176 (41%), Gaps = 25/176 (14%)

Query: 1   MDHENVV----AIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSN-QALSEEHCQYFL 54
           ++H NV+     +      P        ++    M   DL Q IRS  +  + +    F 
Sbjct: 79  LNHPNVLALIGIMLPPEGLP--------HVLLPYMCHGDLLQFIRSPQRNPTVKDLISFG 130

Query: 55  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---- 110
            Q+ RG++Y+     +HRDL   N +L+ +  +K+ DFGLAR   + ++ +         
Sbjct: 131 LQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARL 190

Query: 111 --RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD--RKPLFPGRDHVHQLRLLIE 162
             +W  A E L     +T   DVWS G +  EL+     P +   D       L +
Sbjct: 191 PVKWT-ALESLQTYR-FTTKSDVWSFGVLLWELLTRGAPP-YRHIDPFDLTHFLAQ 243

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 78.6 bits (194), Expect = 6e-17
 Identities = 47/153 (30%), Positives = 69/153 (45%), Gaps = 22/153 (14%)

Query: 1   MDHENVVAIRDII---PPPQRESFNDVYIAYELMDT-DLHQIIRSNQA-LSEEHCQYFLY 55
            DH N++ +  ++    P        V I  E M+   L   +R + A  +       L 
Sbjct: 103 FDHPNIIRLEGVVTKSKP--------VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR 154

Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT----- 110
            I  G+KY+     +HRDL   N+L+N+N   K+ DFGL RV  E D    Y        
Sbjct: 155 GIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVL-EDDPEAAYTTRGGKIP 213

Query: 111 -RWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
            RW  +PE  +    +T+A DVWS G +  E+M
Sbjct: 214 IRWT-SPE-AIAYRKFTSASDVWSYGIVLWEVM 244

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 77.6 bits (192), Expect = 7e-17
 Identities = 37/125 (29%), Positives = 61/125 (48%), Gaps = 8/125 (6%)

Query: 24  VYIAYELMDT-DLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL 80
           +YI  E M+   L   +++     L+         QI  G+ +I   N +HRDL+ +N+L
Sbjct: 82  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANIL 141

Query: 81  LNANCDLKICDFGLARVTSETDFMTEYVV---TRWYRAPELLLNSSDYTAAIDVWSVGCI 137
           ++     KI DFGLAR+  + ++          +W  APE  +N   +T   DVWS G +
Sbjct: 142 VSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWT-APE-AINYGTFTIKSDVWSFGIL 199

Query: 138 FMELM 142
             E++
Sbjct: 200 LTEIV 204

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 77.3 bits (191), Expect = 1e-16
 Identities = 41/177 (23%), Positives = 70/177 (39%), Gaps = 22/177 (12%)

Query: 2   DHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSN------QALSEEHCQYFL 54
            H NV+ +  +      +      +    M   DLH  +  +      + +  +    F+
Sbjct: 94  SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFM 153

Query: 55  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---- 110
             I  G++Y+ + N LHRDL   N +L  +  + + DFGL++     D    Y       
Sbjct: 154 VDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGD---YYRQGRIAK 210

Query: 111 ---RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR--KPLFPGRDHVHQLRLLIE 162
              +W  A E L +   YT+  DVW+ G    E+  R   P +PG  +      L+ 
Sbjct: 211 MPVKWI-AIESLADRV-YTSKSDVWAFGVTMWEIATRGMTP-YPGVQNHEMYDYLLH 264

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 78.7 bits (194), Expect = 1e-16
 Identities = 41/151 (27%), Positives = 71/151 (47%), Gaps = 21/151 (13%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQA-LSEEHCQYFLYQIL 58
            DH ++V +  +I      + N V+I  EL    +L   ++  +  L       + YQ+ 
Sbjct: 448 FDHPHIVKLIGVI------TENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLS 501

Query: 59  RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-------R 111
             L Y+ S   +HRD+   N+L+++N  +K+ DFGL+R   ++     Y          +
Sbjct: 502 TALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST----YYKASKGKLPIK 557

Query: 112 WYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
           W  APE  +N   +T+A DVW  G    E++
Sbjct: 558 WM-APE-SINFRRFTSASDVWMFGVCMWEIL 586

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 77.0 bits (190), Expect = 2e-16
 Identities = 41/153 (26%), Positives = 69/153 (45%), Gaps = 22/153 (14%)

Query: 1   MDHENVVAIRDII---PPPQRESFNDVYIAYELMDT-DLHQIIRSNQA-LSEEHCQYFLY 55
            DH N++ +  ++               I  E M+   L   +R++    +       L 
Sbjct: 107 FDHPNIIRLEGVVTRGRL--------AMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLR 158

Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT----- 110
            +  G++Y+     +HRDL   N+L+++N   K+ DFGL+RV  E D    Y  T     
Sbjct: 159 GVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL-EDDPDAAYTTTGGKIP 217

Query: 111 -RWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
            RW  APE  +    +++A DVWS G +  E++
Sbjct: 218 IRWT-APE-AIAFRTFSSASDVWSFGVVMWEVL 248

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 76.2 bits (188), Expect = 2e-16
 Identities = 27/142 (19%), Positives = 51/142 (35%), Gaps = 16/142 (11%)

Query: 24  VYIAYELMDT-DLHQIIRSNQ-ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL 81
             +  E +    L   ++ N+  ++         Q+   + ++    ++H ++   N+LL
Sbjct: 87  NILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILL 146

Query: 82  NANCDL--------KICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWS 133
               D         K+ D G++      D + E +   W   PE + N  +   A D WS
Sbjct: 147 IREEDRKTGNPPFIKLSDPGISITVLPKDILQERI--PWV-PPECIENPKNLNLATDKWS 203

Query: 134 VGCIFMELMD--RKPLFPGRDH 153
            G    E+     KP     D 
Sbjct: 204 FGTTLWEICSGGDKP-LSALDS 224

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 76.1 bits (188), Expect = 2e-16
 Identities = 46/176 (26%), Positives = 72/176 (40%), Gaps = 25/176 (14%)

Query: 1   MDHENVV----AIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQ-ALSEEHCQYFL 54
             H NV+            P         +    M   DL   IR+     + +    F 
Sbjct: 83  FSHPNVLSLLGICLRSEGSP--------LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG 134

Query: 55  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---- 110
            Q+ +G+KY+ S   +HRDL   N +L+    +K+ DFGLAR   + ++ + +  T    
Sbjct: 135 LQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKL 194

Query: 111 --RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR--KPLFPGRDHVHQLRLLIE 162
             +W  A E L     +T   DVWS G +  ELM R   P +P  +       L++
Sbjct: 195 PVKWM-ALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPP-YPDVNTFDITVYLLQ 247

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 76.3 bits (188), Expect = 4e-16
 Identities = 46/176 (26%), Positives = 72/176 (40%), Gaps = 25/176 (14%)

Query: 1   MDHENVV----AIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQ-ALSEEHCQYFL 54
             H NV+            P         +    M   DL   IR+     + +    F 
Sbjct: 147 FSHPNVLSLLGICLRSEGSP--------LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG 198

Query: 55  YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT---- 110
            Q+ +G+K++ S   +HRDL   N +L+    +K+ DFGLAR   + +F + +  T    
Sbjct: 199 LQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKL 258

Query: 111 --RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR--KPLFPGRDHVHQLRLLIE 162
             +W  A E L     +T   DVWS G +  ELM R   P +P  +       L++
Sbjct: 259 PVKWM-ALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPP-YPDVNTFDITVYLLQ 311

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 75.7 bits (186), Expect = 7e-16
 Identities = 36/122 (29%), Positives = 59/122 (48%), Gaps = 12/122 (9%)

Query: 28  YELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDL 87
              ++ +          L+ EH   + +Q+ +G++++ S   +HRDL   N+LL+    +
Sbjct: 173 LSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVV 232

Query: 88  KICDFGLARVTSETDFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVGCIFME 140
           KICDFGLAR   +     +YV         +W  APE + +   YT   DVWS G +  E
Sbjct: 233 KICDFGLARDIYKDP---DYVRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWE 287

Query: 141 LM 142
           + 
Sbjct: 288 IF 289

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 75.1 bits (185), Expect = 8e-16
 Identities = 44/178 (24%), Positives = 72/178 (40%), Gaps = 23/178 (12%)

Query: 2   DHENVVAIRDIIPPPQ-RESFNDVYIAYELMDT-DLHQIIRSN------QALSEEHCQYF 53
           DH +V  +  +    + +       +    M   DLH  + ++        L  +    F
Sbjct: 83  DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142

Query: 54  LYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT--- 110
           +  I  G++Y+ S N +HRDL   N +L  +  + + DFGL+R     D    Y      
Sbjct: 143 MVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGD---YYRQGCAS 199

Query: 111 ----RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR--KPLFPGRDHVHQLRLLIE 162
               +W  A E L ++  YT   DVW+ G    E+M R   P + G ++      LI 
Sbjct: 200 KLPVKWL-ALESLADNL-YTVHSDVWAFGVTMWEIMTRGQTP-YAGIENAEIYNYLIG 254

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 73.1 bits (180), Expect = 4e-15
 Identities = 42/109 (38%), Positives = 51/109 (46%), Gaps = 12/109 (11%)

Query: 41  SNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSE 100
              AL  E    F YQ+ +G+ ++ S N +HRDL   N+LL      KICDFGLAR    
Sbjct: 138 DELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKN 197

Query: 101 TDFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
                 YVV        +W  APE + N   YT   DVWS G    EL 
Sbjct: 198 DS---NYVVKGNARLPVKWM-APESIFNCV-YTFESDVWSYGIFLWELF 241

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 72.6 bits (179), Expect = 5e-15
 Identities = 29/100 (29%), Positives = 51/100 (51%), Gaps = 10/100 (10%)

Query: 59  RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRW-----Y 113
            G+ ++H  + +HRD+K +N+LL+     KI DFGLAR + +       + +R      Y
Sbjct: 144 NGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA--QTVMTSRIVGTTAY 201

Query: 114 RAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRD 152
            APE L    + T   D++S G + +E++     +   R+
Sbjct: 202 MAPEAL--RGEITPKSDIYSFGVVLLEIITGLPAVDEHRE 239

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 72.7 bits (179), Expect = 6e-15
 Identities = 35/114 (30%), Positives = 51/114 (44%), Gaps = 12/114 (10%)

Query: 36  HQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLA 95
                +N   S     +F  Q+ +G+ ++ S N +HRD+   N+LL      KI DFGLA
Sbjct: 152 PAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLA 211

Query: 96  RVTSETDFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
           R          Y+V        +W  APE + +   YT   DVWS G +  E+ 
Sbjct: 212 RDIMNDS---NYIVKGNARLPVKWM-APESIFDCV-YTVQSDVWSYGILLWEIF 260

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 70.8 bits (174), Expect = 2e-14
 Identities = 36/109 (33%), Positives = 56/109 (51%), Gaps = 12/109 (11%)

Query: 41  SNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSE 100
               L+ EH   + +Q+ +G++++ S   +HRDL   N+LL+    +KICDFGLAR   +
Sbjct: 141 YKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYK 200

Query: 101 TDFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
                +YV         +W  APE + +   YT   DVWS G +  E+ 
Sbjct: 201 DP---DYVRKGDARLPLKWM-APETIFDRV-YTIQSDVWSFGVLLWEIF 244

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 70.8 bits (174), Expect = 3e-14
 Identities = 37/109 (33%), Positives = 52/109 (47%), Gaps = 12/109 (11%)

Query: 41  SNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSE 100
               L+ E    F YQ+ +G++++   + +HRDL   N+L+     +KICDFGLAR    
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMS 224

Query: 101 TDFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
                 YVV        +W  APE L     YT   DVWS G +  E+ 
Sbjct: 225 DS---NYVVRGNARLPVKWM-APESLFEGI-YTIKSDVWSYGILLWEIF 268

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 70.4 bits (173), Expect = 3e-14
 Identities = 37/137 (27%), Positives = 58/137 (42%), Gaps = 23/137 (16%)

Query: 24  VYIAYELMDT-DLHQIIRSNQALSEEHCQ----------YFLYQILRGLKYIHSANVLHR 72
             +  ELM   DL   +RS +     +                +I  G+ Y+++   +HR
Sbjct: 103 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHR 162

Query: 73  DLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-------RWYRAPELLLNSSDY 125
           DL   N ++  +  +KI DFG+ R   ETD+   Y          RW  +PE L +   +
Sbjct: 163 DLAARNCMVAEDFTVKIGDFGMTRDIYETDY---YRKGGKGLLPVRWM-SPESLKDGV-F 217

Query: 126 TAAIDVWSVGCIFMELM 142
           T   DVWS G +  E+ 
Sbjct: 218 TTYSDVWSFGVVLWEIA 234

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 70.5 bits (173), Expect = 5e-14
 Identities = 41/143 (28%), Positives = 64/143 (44%), Gaps = 29/143 (20%)

Query: 24  VYIAYELMDT-DLHQIIRSN----------------QALSEEHCQYFLYQILRGLKYIHS 66
           +Y+  E     +L + +R+                 + ++ +      YQ+ RG++Y+ S
Sbjct: 162 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS 221

Query: 67  ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-------RWYRAPELL 119
              +HRDL   N+L+  N  +KI DFGLAR  +  D    Y  T       +W  APE L
Sbjct: 222 QKCIHRDLAARNVLVTENNVMKIADFGLARDINNID---YYKKTTNGRLPVKWM-APEAL 277

Query: 120 LNSSDYTAAIDVWSVGCIFMELM 142
            +   YT   DVWS G +  E+ 
Sbjct: 278 FDRV-YTHQSDVWSFGVLMWEIF 299

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 69.5 bits (171), Expect = 5e-14
 Identities = 33/143 (23%), Positives = 59/143 (41%), Gaps = 29/143 (20%)

Query: 24  VYIAYELMDT-DLHQIIRSNQALSEEHCQ----------------YFLYQILRGLKYIHS 66
           + + +      DLH+ +      S+                    + + QI  G++Y+ S
Sbjct: 87  LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS 146

Query: 67  ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-------RWYRAPELL 119
            +V+H+DL   N+L+    ++KI D GL R     D    Y +        RW  APE +
Sbjct: 147 HHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAAD---YYKLLGNSLLPIRWM-APEAI 202

Query: 120 LNSSDYTAAIDVWSVGCIFMELM 142
           +    ++   D+WS G +  E+ 
Sbjct: 203 MYGK-FSIDSDIWSYGVVLWEVF 224

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 69.6 bits (171), Expect = 7e-14
 Identities = 41/143 (28%), Positives = 64/143 (44%), Gaps = 29/143 (20%)

Query: 24  VYIAYELMDT-DLHQIIRSN----------------QALSEEHCQYFLYQILRGLKYIHS 66
           +Y+  E     +L + +R+                 + ++ +      YQ+ RG++Y+ S
Sbjct: 116 LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS 175

Query: 67  ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-------RWYRAPELL 119
              +HRDL   N+L+  N  +KI DFGLAR  +  D    Y  T       +W  APE L
Sbjct: 176 QKCIHRDLAARNVLVTENNVMKIADFGLARDINNID---YYKKTTNGRLPVKWM-APEAL 231

Query: 120 LNSSDYTAAIDVWSVGCIFMELM 142
            +   YT   DVWS G +  E+ 
Sbjct: 232 FDRV-YTHQSDVWSFGVLMWEIF 253

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 69.7 bits (171), Expect = 8e-14
 Identities = 36/98 (36%), Positives = 49/98 (50%), Gaps = 12/98 (12%)

Query: 52  YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT- 110
              YQ+ RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR     D    Y  T 
Sbjct: 195 SCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID---YYKKTT 251

Query: 111 ------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
                 +W  APE L +   YT   DVWS G +  E+ 
Sbjct: 252 NGRLPVKWM-APEALFDRI-YTHQSDVWSFGVLLWEIF 287

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 68.8 bits (169), Expect = 9e-14
 Identities = 40/143 (27%), Positives = 63/143 (44%), Gaps = 29/143 (20%)

Query: 24  VYIAYELMDT-DLHQIIRSNQALSEEHCQ----------------YFLYQILRGLKYIHS 66
           + + +E M   DL++ +R++   +                     +   QI  G+ Y+ S
Sbjct: 92  LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS 151

Query: 67  ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-------RWYRAPELL 119
            + +HRDL   N L+ AN  +KI DFG++R    TD+   Y V        RW   PE +
Sbjct: 152 QHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDY---YRVGGHTMLPIRWM-PPESI 207

Query: 120 LNSSDYTAAIDVWSVGCIFMELM 142
           +    +T   DVWS G I  E+ 
Sbjct: 208 MYRK-FTTESDVWSFGVILWEIF 229

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 68.9 bits (169), Expect = 1e-13
 Identities = 37/142 (26%), Positives = 60/142 (42%), Gaps = 28/142 (19%)

Query: 24  VYIAYELMDT-DLHQIIRSNQALSEEHCQ---------------YFLYQILRGLKYIHSA 67
           + + +E M   DL++ +RS+   ++                       Q+  G+ Y+   
Sbjct: 118 LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL 177

Query: 68  NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-------RWYRAPELLL 120
           + +HRDL   N L+     +KI DFG++R    TD+   Y V        RW   PE +L
Sbjct: 178 HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY---YRVGGRTMLPIRWM-PPESIL 233

Query: 121 NSSDYTAAIDVWSVGCIFMELM 142
               +T   DVWS G +  E+ 
Sbjct: 234 YRK-FTTESDVWSFGVVLWEIF 254

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 68.4 bits (168), Expect = 1e-13
 Identities = 36/109 (33%), Positives = 54/109 (49%), Gaps = 12/109 (11%)

Query: 41  SNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSE 100
             +AL+      F +QI +G++Y+    ++HRDL   N+L+     +KI DFGL+R   E
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYE 202

Query: 101 TDFMTEYVVT-------RWYRAPELLLNSSDYTAAIDVWSVGCIFMELM 142
            D    YV         +W  A E L +   YT   DVWS G +  E++
Sbjct: 203 ED---SYVKRSQGRIPVKWM-AIESLFDHI-YTTQSDVWSFGVLLWEIV 246

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 68.2 bits (167), Expect = 1e-13
 Identities = 24/221 (10%), Positives = 52/221 (23%), Gaps = 60/221 (27%)

Query: 2   DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRG 60
           D   V  + D++      +     +  E +    L ++  +  + S       +  +   
Sbjct: 89  DKPGVARVLDVV-----HTRAGGLVVAEWIRGGSLQEVADT--SPSPVGAIRAMQSLAAA 141

Query: 61  LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL 120
               H A V      PS + ++ + D+ +                               
Sbjct: 142 ADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPATM------------------------- 176

Query: 121 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI-ELIGTPSEAELGFLNENA 179
              D     D+  +G     L+  +   P       L     +  G P E          
Sbjct: 177 --PDANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIE---------- 224

Query: 180 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQR 220
                  P            ++      +  + +  D   R
Sbjct: 225 -------PADID-------RDIPFQISAVAARSVQGDGGIR 251

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 68.0 bits (167), Expect = 2e-13
 Identities = 31/113 (27%), Positives = 55/113 (48%), Gaps = 13/113 (11%)

Query: 59  RGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRW--- 112
           RGL Y+H      ++HRD+K +N+LL+   +  + DFGLA++    D    +V T     
Sbjct: 142 RGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKD---THVTTAVRGT 198

Query: 113 --YRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQLRLLIE 162
             + APE L  +   +   DV+  G + +EL+  ++     R       +L++
Sbjct: 199 IGHIAPEYLS-TGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLD 250

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 68.1 bits (167), Expect = 2e-13
 Identities = 40/143 (27%), Positives = 59/143 (41%), Gaps = 32/143 (22%)

Query: 24  VYIAYELMDT-DLHQIIRSNQALSEEHCQ----------------YFLYQILRGLKYIHS 66
           +Y+A E     +L   +R ++ L  +                   +F   + RG+ Y+  
Sbjct: 101 LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ 160

Query: 67  ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT-------RWYRAPELL 119
              +HRDL   N+L+  N   KI DFGL+R     +    YV         RW  A E L
Sbjct: 161 KQFIHRDLAARNILVGENYVAKIADFGLSR---GQE---VYVKKTMGRLPVRWM-AIESL 213

Query: 120 LNSSDYTAAIDVWSVGCIFMELM 142
             S  YT   DVWS G +  E++
Sbjct: 214 NYSV-YTTNSDVWSYGVLLWEIV 235

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 67.2 bits (165), Expect = 4e-13
 Identities = 32/106 (30%), Positives = 50/106 (47%), Gaps = 19/106 (17%)

Query: 59  RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRW-----Y 113
           RGL Y+H+  ++HRD+K  N+LL+ N   KI DFG+++  +E D    ++ T       Y
Sbjct: 150 RGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELD--QTHLSTVVKGTLGY 207

Query: 114 RAPE-----LLLNSSDYTAAIDVWSVGCIFMELM-DRKPLFPGRDH 153
             PE      L   S      DV+S G +  E++  R  +      
Sbjct: 208 IDPEYFIKGRLTEKS------DVYSFGVVLFEVLCARSAIVQSLPR 247

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 66.6 bits (163), Expect = 8e-13
 Identities = 34/137 (24%), Positives = 52/137 (37%), Gaps = 23/137 (16%)

Query: 24  VYIAYELMDT-DLHQIIRSN-------QALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 75
            +I  ELM   DL   +R          +L+     +    I  G +Y+   + +HRD+ 
Sbjct: 108 RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIA 167

Query: 76  PSNLLLNANCD---LKICDFGLARVTSETDFMTEYVVT-------RWYRAPELLLNSSDY 125
             N LL         KI DFG+AR      +   Y          +W   PE  +    +
Sbjct: 168 ARNCLLTCPGPGRVAKIGDFGMARDIYRASY---YRKGGCAMLPVKWM-PPEAFMEGI-F 222

Query: 126 TAAIDVWSVGCIFMELM 142
           T+  D WS G +  E+ 
Sbjct: 223 TSKTDTWSFGVLLWEIF 239

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 65.9 bits (161), Expect = 2e-12
 Identities = 34/137 (24%), Positives = 52/137 (37%), Gaps = 23/137 (16%)

Query: 24  VYIAYELMDT-DLHQIIRSN-------QALSEEHCQYFLYQILRGLKYIHSANVLHRDLK 75
            +I  ELM   DL   +R          +L+     +    I  G +Y+   + +HRD+ 
Sbjct: 149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIA 208

Query: 76  PSNLLLNANCD---LKICDFGLARVTSETDFMTEYVVT-------RWYRAPELLLNSSDY 125
             N LL         KI DFG+AR      +   Y          +W   PE  +    +
Sbjct: 209 ARNCLLTCPGPGRVAKIGDFGMARDIYRAGY---YRKGGCAMLPVKWM-PPEAFMEGI-F 263

Query: 126 TAAIDVWSVGCIFMELM 142
           T+  D WS G +  E+ 
Sbjct: 264 TSKTDTWSFGVLLWEIF 280

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 65.3 bits (158), Expect = 2e-12
 Identities = 36/227 (15%), Positives = 69/227 (30%), Gaps = 27/227 (11%)

Query: 14  PPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA-NVLHR 72
             P     + ++I  E     +       +  S    +  L+Q+   L    ++    HR
Sbjct: 127 DRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLRFEHR 186

Query: 73  DLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVW 132
           DL   N+LL      K+      + ++                  L ++  DYT +    
Sbjct: 187 DLHWGNVLLKKTSLKKLHYTLNGKSSTIPSC-------------GLQVSIIDYTLSRLER 233

Query: 133 SVGCIFMELMDRKPLFPGRDHVHQL---RLLIELIGTPSEAELGFLNENAKKYICQL--- 186
               +F ++   + LF G D  +Q    RL+ +           + N     Y+      
Sbjct: 234 DGIVVFCDVSMDEDLFTG-DGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLK 292

Query: 187 -PRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
              ++ +  T     +     +    ML F      +  D L    L
Sbjct: 293 QMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSL 334

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 65.0 bits (159), Expect = 3e-12
 Identities = 29/91 (31%), Positives = 39/91 (42%), Gaps = 12/91 (13%)

Query: 52  YFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVT- 110
               Q+  G+ Y+     +HRDL   N L+  N  +KI DFGL+R     D    Y    
Sbjct: 178 CIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD---YYKADG 234

Query: 111 ------RWYRAPELLLNSSDYTAAIDVWSVG 135
                 RW   PE +  +  YT   DVW+ G
Sbjct: 235 NDAIPIRWM-PPESIFYNR-YTTESDVWAYG 263

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 57.8 bits (140), Expect = 8e-10
 Identities = 22/74 (29%), Positives = 37/74 (50%), Gaps = 2/74 (2%)

Query: 25  YIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN-A 83
           ++  E +  DL +I   N    +        ++L  L+YIH    +H D+K +NLLL   
Sbjct: 128 FMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYK 187

Query: 84  NCD-LKICDFGLAR 96
           N D + + D+GL+ 
Sbjct: 188 NPDQVYLADYGLSY 201

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 51.3 bits (123), Expect = 1e-07
 Identities = 21/43 (48%), Positives = 28/43 (65%), Gaps = 2/43 (4%)

Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLN-ANCD-LKICDFGLAR 96
           +IL  L+YIH    +H D+K SNLLLN  N D + + D+GLA 
Sbjct: 160 RILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAY 202

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 50.8 bits (122), Expect = 1e-07
 Identities = 16/46 (34%), Positives = 29/46 (63%), Gaps = 5/46 (10%)

Query: 56  QILRGLKYIHSANVLHRDLKPSNLLL--NANCDLKIC---DFGLAR 96
           Q++  ++Y+HS N+++RD+KP N L+    N   ++    DF LA+
Sbjct: 113 QLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK 158

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 50.9 bits (122), Expect = 1e-07
 Identities = 11/72 (15%), Positives = 28/72 (38%), Gaps = 4/72 (5%)

Query: 29  ELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCD 86
             +   L   +  +    LSE        ++L  L+++H    +H ++   N+ ++    
Sbjct: 138 PSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQ 197

Query: 87  LKI--CDFGLAR 96
            ++    +G A 
Sbjct: 198 SQVTLAGYGFAF 209

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 48.5 bits (116), Expect = 7e-07
 Identities = 23/76 (30%), Positives = 38/76 (50%), Gaps = 4/76 (5%)

Query: 25  YIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA 83
            +  EL+   L  +    ++  S +       Q++  ++YIHS N +HRD+KP N L+  
Sbjct: 81  VMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGL 140

Query: 84  NCD---LKICDFGLAR 96
                 + I DFGLA+
Sbjct: 141 GKKGNLVYIIDFGLAK 156

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 48.5 bits (116), Expect = 8e-07
 Identities = 13/46 (28%), Positives = 25/46 (54%), Gaps = 5/46 (10%)

Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANCDLK-----ICDFGLAR 96
           Q+L  ++ IH  ++++RD+KP N L+            + DFG+ +
Sbjct: 114 QMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 159

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 46.5 bits (110), Expect = 4e-06
 Identities = 21/76 (27%), Positives = 39/76 (51%), Gaps = 4/76 (5%)

Query: 25  YIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA 83
            +  +L+   L  +    ++ LS +       Q++  ++++HS + LHRD+KP N L+  
Sbjct: 79  VLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 138

Query: 84  NCD---LKICDFGLAR 96
                 + I DFGLA+
Sbjct: 139 GRRANQVYIIDFGLAK 154

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	280
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	99.98
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.85
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.62
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.41
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.25
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	98.69
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.5
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	98.39
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.37
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	98.2
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	97.68
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	97.65
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	97.59
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	97.06
3ats_A	357	Putative uncharacterized protein; hypothetical pro	96.98
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	96.45
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	95.51
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	95.32
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	93.74
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	93.36
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	92.9
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	92.86
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	91.95
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	91.05
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	89.85
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	88.94
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	88.11
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	88.08
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	85.98
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	85.54
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	83.58
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	82.24
3mes_A	424	Choline kinase; malaria, structural genomics, stru	80.99

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.8e-59  Score=410.44  Aligned_cols=277  Identities=51%  Similarity=0.927  Sum_probs=243.1

Q ss_pred             CCCCCeeeeeceecCCC-CCCCCcEEEEeecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQ-RESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~-~~~~~~~~iv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      |+|||||++++++.... ......+|||||||+|+|.+++.+++++++..++.+++||+.||+|||++||+||||||+||
T Consensus       110 l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NI  189 (398)
T 4b99_A          110 FKHDNIIAIKDILRPTVPYGEFKSVYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNL  189 (398)
T ss_dssp             CCCTTBCCEEEECCCSSCTTTCCCEEEEEECCSEEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGE
T ss_pred             cCCCCcceEeeeeecccccccCCEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCcccc
Confidence            68999999999986542 12336799999999999999999989999999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCC-----CccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH
Q 023609           80 LLNANCDLKICDFGLARVTSET-----DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHV  154 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  154 (280)
                      +++.+|.+||+|||+++.....     ......+||+.|+|||++.+...++.++||||+||++|+|++|.+||.+.+..
T Consensus       190 l~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~  269 (398)
T 4b99_A          190 LVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYV  269 (398)
T ss_dssp             EECTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH
T ss_pred             ccCCCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHH
Confidence            9999999999999999764322     23446789999999999877767899999999999999999999999999999


Q ss_pred             HHHHHHHHHhCCCCHHHHhHh-hHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCC
Q 023609          155 HQLRLLIELIGTPSEAELGFL-NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLG  233 (280)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~  233 (280)
                      +++..|....+.|+...+... ......+....+......+...++++|+++++||.+||++||.+|||+.|+|+||||+
T Consensus       270 ~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~  349 (398)
T 4b99_A          270 HQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLA  349 (398)
T ss_dssp             HHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGT
T ss_pred             HHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhC
Confidence            999999999999988765443 3334455666777777778888999999999999999999999999999999999999


Q ss_pred             CCcCCCCCCccCCCCCcchhhccccHHHHHHHHHHHHHhhChhh
Q 023609          234 SLHDISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEY  277 (280)
Q Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (280)
                      .+.++.+++.+.+++++.++...++..++++.++.++..|+++.
T Consensus       350 ~~~~p~~~p~~~~~~~~~~~~~~~~~~~~k~~i~~ei~~~~~~r  393 (398)
T 4b99_A          350 KYHDPDDEPDCAPPFDFAFDREALTRERIKEAIVAEIEDFHARR  393 (398)
T ss_dssp             TTCCGGGSCCCSSCCCCHHHHSCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             cCCCCccccCCCCCCCCccchhhcCHHHHHHHHHHHHHHHHHHH
Confidence            99999999988899999999999999999999999999988753

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.5e-55  Score=366.62  Aligned_cols=199  Identities=26%  Similarity=0.505  Sum_probs=165.9

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   80 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nil   80 (280)
                      |+|||||++++++.+.     +.+|||||||+|+|.+++.+++++++.+++.++.||+.||+|||++||+||||||+||+
T Consensus        70 l~HpnIv~~~~~~~~~-----~~~~ivmEy~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NIL  144 (275)
T 3hyh_A           70 LRHPHIIKLYDVIKSK-----DEIIMVIEYAGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLL  144 (275)
T ss_dssp             CCCTTBCCEEEEEECS-----SEEEEEEECCCEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEE
T ss_pred             CCCCCCCeEEEEEEEC-----CEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeE
Confidence            6899999999999766     77999999999999999999999999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 023609           81 LNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL  160 (280)
Q Consensus        81 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~  160 (280)
                      ++.+|.+||+|||+++...........+||+.|+|||++.+...++.++||||+||++|+|++|+.||.+.+.....+.+
T Consensus       145 l~~~~~vkl~DFGla~~~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i  224 (275)
T 3hyh_A          145 LDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNI  224 (275)
T ss_dssp             ECTTCCEEECCSSCC---------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred             ECCCCCEEEeecCCCeecCCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence            99999999999999987766655667899999999999976665678999999999999999999999988777666655


Q ss_pred             HHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCC
Q 023609          161 IELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS  234 (280)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~  234 (280)
                      ......                              ..+.+|+++++||++||+.||++|||+.|+++||||+.
T Consensus       225 ~~~~~~------------------------------~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~  268 (275)
T 3hyh_A          225 SNGVYT------------------------------LPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV  268 (275)
T ss_dssp             HHTCCC------------------------------CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred             HcCCCC------------------------------CCCCCCHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence            432111                              01257899999999999999999999999999999974

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.7e-54  Score=365.21  Aligned_cols=199  Identities=31%  Similarity=0.535  Sum_probs=175.3

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      |+|||||+++++|.+.     ..+|||||||+ |+|.+++.+.+.+++.+++.++.||+.||+|||++||+||||||+||
T Consensus        89 l~HpnIv~l~~~~~~~-----~~~yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNI  163 (311)
T 4aw0_A           89 LDHPFFVKLYFTFQDD-----EKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENI  163 (311)
T ss_dssp             CCCTTBCCEEEEEECS-----SEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred             CCCCCCCeEEEEEEeC-----CEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHe
Confidence            6899999999999776     78999999997 69999999888999999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCC---CccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023609           80 LLNANCDLKICDFGLARVTSET---DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ  156 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  156 (280)
                      +++.+|.+||+|||+++.....   ......+||+.|+|||++.+. .++.++||||+||++|+|++|.+||.+.+..+.
T Consensus       164 Ll~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~-~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~  242 (311)
T 4aw0_A          164 LLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK-SACKSSDLWALGCIIYQLVAGLPPFRAGNEGLI  242 (311)
T ss_dssp             EECTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHS-CBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             EEcCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            9999999999999999876432   234567899999999998654 489999999999999999999999999888877


Q ss_pred             HHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHH------HhcCC
Q 023609          157 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVED------ALAHP  230 (280)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e------ll~h~  230 (280)
                      +..+.+.....                              -+.+|+++++||++||++||++|||++|      +++||
T Consensus       243 ~~~i~~~~~~~------------------------------p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp  292 (311)
T 4aw0_A          243 FAKIIKLEYDF------------------------------PEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHP  292 (311)
T ss_dssp             HHHHHHTCCCC------------------------------CTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSG
T ss_pred             HHHHHcCCCCC------------------------------CcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCC
Confidence            77665421111                              1257899999999999999999999988      58999


Q ss_pred             CCCCC
Q 023609          231 YLGSL  235 (280)
Q Consensus       231 ~~~~~  235 (280)
                      ||+++
T Consensus       293 ~F~~i  297 (311)
T 4aw0_A          293 FFESV  297 (311)
T ss_dssp             GGTTC
T ss_pred             CcCCC
Confidence            99876

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.3e-53  Score=364.91  Aligned_cols=202  Identities=26%  Similarity=0.521  Sum_probs=175.5

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      |+|||||+++++|.+.     +.+|||||||+ |+|.+++.+ +.+++.+++.++.||+.||+|||++||+||||||+||
T Consensus       128 l~HpnIV~l~~~~~~~-----~~~~ivmEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NI  201 (346)
T 4fih_A          128 YQHENVVEMYNSYLVG-----DELWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSI  201 (346)
T ss_dssp             CCCTTBCCEEEEEEET-----TEEEEEECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred             CCCCCCCcEEEEEEEC-----CEEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHE
Confidence            6899999999999776     77999999998 699999876 5699999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCC-CccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  158 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  158 (280)
                      |++.+|.+||+|||+++..... ......+||+.|+|||++.+ ..++.++||||+||++|+|++|.+||.+.+..+.+.
T Consensus       202 Ll~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~  280 (346)
T 4fih_A          202 LLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK  280 (346)
T ss_dssp             EECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH
T ss_pred             EECCCCCEEEecCcCceecCCCCCcccccccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHH
Confidence            9999999999999999876543 33456789999999998854 458999999999999999999999999988877776


Q ss_pred             HHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCc
Q 023609          159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  236 (280)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~  236 (280)
                      .+.......                           ....+.+|+++++||.+||+.||++|||+.|+++||||++..
T Consensus       281 ~i~~~~~~~---------------------------~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~  331 (346)
T 4fih_A          281 MIRDNLPPR---------------------------LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG  331 (346)
T ss_dssp             HHHHSSCCC---------------------------CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             HHHcCCCCC---------------------------CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCC
Confidence            665422111                           012236789999999999999999999999999999998754

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=9.9e-54  Score=360.33  Aligned_cols=199  Identities=23%  Similarity=0.464  Sum_probs=173.9

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      |+|||||++++++.++     +.+|||||||+ |+|.+++.+.+.+++.+++.++.||+.||+|||++||+||||||+||
T Consensus        83 l~HpnIv~l~~~~~~~-----~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NI  157 (304)
T 3ubd_A           83 VNHPFIVKLHYAFQTE-----GKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENI  157 (304)
T ss_dssp             CCCTTEECEEEEEEET-----TEEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGE
T ss_pred             CCCCCCCeEEEEEEEC-----CEEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHe
Confidence            6899999999999776     77999999997 69999999888999999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCC-CccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  158 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.+|.+||+|||+++..... ......+||+.|+|||++.+. .++.++||||+||++|+|++|++||.+.+..+.+.
T Consensus       158 Ll~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~~~~~-~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~  236 (304)
T 3ubd_A          158 LLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRR-GHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMT  236 (304)
T ss_dssp             EECTTSCEEEESSEEEEC-----CCCCSCCCCGGGCCHHHHHTS-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             EEcCCCCEEecccccceeccCCCccccccccCcccCCHHHhccC-CCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHH
Confidence            9999999999999999865433 334567899999999998654 58999999999999999999999999988888777


Q ss_pred             HHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCC-----HHHHhcCCCCC
Q 023609          159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT-----VEDALAHPYLG  233 (280)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~ell~h~~~~  233 (280)
                      .+.+.....                              .+.+|+++++||++||++||++|||     ++|+++||||+
T Consensus       237 ~i~~~~~~~------------------------------p~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~  286 (304)
T 3ubd_A          237 MILKAKLGM------------------------------PQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFS  286 (304)
T ss_dssp             HHHHCCCCC------------------------------CTTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGT
T ss_pred             HHHcCCCCC------------------------------CCcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCcccc
Confidence            665421111                              1257899999999999999999998     47999999998


Q ss_pred             CC
Q 023609          234 SL  235 (280)
Q Consensus       234 ~~  235 (280)
                      ++
T Consensus       287 ~i  288 (304)
T 3ubd_A          287 TI  288 (304)
T ss_dssp             TC
T ss_pred             CC
Confidence            75

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.8e-52  Score=366.16  Aligned_cols=202  Identities=26%  Similarity=0.521  Sum_probs=175.7

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      |+|||||+++++|.+.     +.+|||||||+ |+|.+++.. +.+++.+++.++.||+.||+|||++||+||||||+||
T Consensus       205 l~HpnIV~l~~~~~~~-----~~~~iVmEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NI  278 (423)
T 4fie_A          205 YQHENVVEMYNSYLVG-----DELWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSI  278 (423)
T ss_dssp             CCCTTBCCEEEEEEET-----TEEEEEEECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTE
T ss_pred             CCCCCCCceEEEEEEC-----CEEEEEEeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHE
Confidence            6899999999999776     77999999997 699999875 4699999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCC-CccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  158 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  158 (280)
                      |++.+|.+||+|||+++..... ......+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+.+..+.+.
T Consensus       279 Ll~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~-~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~  357 (423)
T 4fie_A          279 LLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISR-LPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMK  357 (423)
T ss_dssp             EECTTCCEEECCCTTCEECCSSCCCBCCCEECTTTCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH
T ss_pred             EEcCCCCEEEecCccceECCCCCccccccccCcCcCCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHH
Confidence            9999999999999999876543 34556789999999999854 458999999999999999999999999988877776


Q ss_pred             HHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCc
Q 023609          159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  236 (280)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~  236 (280)
                      .+.......                           ....+.+|+++++||.+||+.||++|||+.|+|+||||+...
T Consensus       358 ~i~~~~~~~---------------------------~~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~  408 (423)
T 4fie_A          358 MIRDNLPPR---------------------------LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG  408 (423)
T ss_dssp             HHHHSCCCC---------------------------CSCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             HHHcCCCCC---------------------------CcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCC
Confidence            664422110                           122347899999999999999999999999999999998754

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1.1e-52  Score=357.98  Aligned_cols=206  Identities=23%  Similarity=0.392  Sum_probs=172.8

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      |+|||||++++++.+.     ..+|||||||+ |+|.+++.+.+++++.+++.++.||+.||+|||++||+||||||+||
T Consensus       107 l~HpnIV~l~~~~~~~-----~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NI  181 (336)
T 4g3f_A          107 LSSPRIVPLYGAVREG-----PWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNV  181 (336)
T ss_dssp             CCCTTBCCEEEEEEET-----TEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGE
T ss_pred             CCCCCCCcEEEEEEEC-----CEEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHE
Confidence            6899999999999765     67999999998 69999999888999999999999999999999999999999999999


Q ss_pred             EEccCC-CEEEeeccceeeccCCCc------cccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 023609           80 LLNANC-DLKICDFGLARVTSETDF------MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD  152 (280)
Q Consensus        80 li~~~~-~~~l~dfg~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  152 (280)
                      |++.+| .+||+|||+++.......      ....+||+.|+|||++.+ ..++.++||||+||++|+|++|++||.+.+
T Consensus       182 Ll~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGvilyemltG~~Pf~~~~  260 (336)
T 4g3f_A          182 LLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMG-KPCDAKVDIWSSCCMMLHMLNGCHPWTQYF  260 (336)
T ss_dssp             EECTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSTTTC
T ss_pred             EEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCcCCCCCCC
Confidence            999988 599999999987543321      223579999999999865 458999999999999999999999998776


Q ss_pred             hHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHH------
Q 023609          153 HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDA------  226 (280)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~el------  226 (280)
                      ..+....+...  .                         ..+....+.+|+++++||.+||++||.+|||+.|+      
T Consensus       261 ~~~~~~~i~~~--~-------------------------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~  313 (336)
T 4g3f_A          261 RGPLCLKIASE--P-------------------------PPIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGK  313 (336)
T ss_dssp             CSCCHHHHHHS--C-------------------------CGGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             HHHHHHHHHcC--C-------------------------CCchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHH
Confidence            55544444321  0                         11123345789999999999999999999999997      


Q ss_pred             -------hcCCCCCCCcCCC
Q 023609          227 -------LAHPYLGSLHDIS  239 (280)
Q Consensus       227 -------l~h~~~~~~~~~~  239 (280)
                             ++|||+..+..+.
T Consensus       314 ~l~~~~~l~hPw~~~~~~Pr  333 (336)
T 4g3f_A          314 ALQEVGGLKSPWKGEYKEPR  333 (336)
T ss_dssp             HHHHTTSSCSCSSSSCCCCC
T ss_pred             HHhhhhhccCCCcCCCCCCC
Confidence                   6799999887654

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=2.9e-53  Score=363.24  Aligned_cols=199  Identities=26%  Similarity=0.454  Sum_probs=173.2

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS   77 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~   77 (280)
                      |+|||||++++++.+.     +.+|||||||+ |+|.+++..+  ..+++.+++.|+.||+.||+|||++||+||||||+
T Consensus        80 l~HpnIV~~~~~~~~~-----~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~  154 (350)
T 4b9d_A           80 MKHPNIVQYRESFEEN-----GSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQ  154 (350)
T ss_dssp             CCCTTBCCEEEEEEET-----TEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGG
T ss_pred             CCCCCCCcEEEEEEEC-----CEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHH
Confidence            6899999999999766     77999999997 6999999754  35899999999999999999999999999999999


Q ss_pred             cEEEccCCCEEEeeccceeeccCCC-ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023609           78 NLLLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ  156 (280)
Q Consensus        78 nili~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  156 (280)
                      |||++.+|.+||+|||+++...... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.
T Consensus       155 NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~l~~-~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~  233 (350)
T 4b9d_A          155 NIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICEN-KPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNL  233 (350)
T ss_dssp             GEEECTTCCEEECSTTEESCCCHHHHHHHHHHSCCTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             HEEECCCCCEEEcccccceeecCCcccccccCCCccccCHHHHCC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH
Confidence            9999999999999999998765432 2345679999999999865 4589999999999999999999999999888877


Q ss_pred             HHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCC
Q 023609          157 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS  234 (280)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~  234 (280)
                      +..+......                             ...+.+|+++++||.+||+.||++|||+.|+|+||||++
T Consensus       234 ~~~i~~~~~~-----------------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~  282 (350)
T 4b9d_A          234 VLKIISGSFP-----------------------------PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAK  282 (350)
T ss_dssp             HHHHHHTCCC-----------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHT
T ss_pred             HHHHHcCCCC-----------------------------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhc
Confidence            7766543211                             112368899999999999999999999999999999975

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1e-52  Score=352.34  Aligned_cols=203  Identities=22%  Similarity=0.393  Sum_probs=167.2

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN--VLHRDLKPS   77 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~g--i~H~di~~~   77 (280)
                      |+|||||+++++|.+.. .+...+|||||||+ |+|.+++.+.+.+++..++.|+.||+.||+|||++|  |+||||||+
T Consensus        82 l~HpnIV~~~~~~~~~~-~~~~~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~  160 (290)
T 3fpq_A           82 LQHPNIVRFYDSWESTV-KGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCD  160 (290)
T ss_dssp             CCCTTBCCEEEEEEEEE-TTEEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGG
T ss_pred             CCCCCCCcEEEEEeecc-CCCcEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChh
Confidence            68999999999986532 11256899999997 699999998889999999999999999999999999  999999999


Q ss_pred             cEEEcc-CCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023609           78 NLLLNA-NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ  156 (280)
Q Consensus        78 nili~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  156 (280)
                      |||++. +|.+||+|||+|+..... .....+||+.|+|||++.+  .++.++||||+||++|+|++|..||.+......
T Consensus       161 NILl~~~~g~vKl~DFGla~~~~~~-~~~~~~GTp~YmAPE~~~~--~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~  237 (290)
T 3fpq_A          161 NIFITGPTGSVKIGDLGLATLKRAS-FAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ  237 (290)
T ss_dssp             GEEESSTTSCEEECCTTGGGGCCTT-SBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH
T ss_pred             heeEECCCCCEEEEeCcCCEeCCCC-ccCCcccCccccCHHHcCC--CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHH
Confidence            999974 799999999999754333 3456789999999998853  489999999999999999999999987655444


Q ss_pred             HHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCC
Q 023609          157 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS  234 (280)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~  234 (280)
                      +.........|.                           ...+..++++++||.+||+.||++|||+.|+++||||++
T Consensus       238 ~~~~i~~~~~~~---------------------------~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          238 IYRRVTSGVKPA---------------------------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             HHHHHTTTCCCG---------------------------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             HHHHHHcCCCCC---------------------------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccC
Confidence            332222111111                           111256789999999999999999999999999999975

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=7.8e-51  Score=361.41  Aligned_cols=278  Identities=39%  Similarity=0.785  Sum_probs=234.1

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   80 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nil   80 (280)
                      |+||||+++++++...........|+||||++|+|.+++..+..+++..++.++.||+.||+|||++||+||||||+||+
T Consensus        82 l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NIL  161 (432)
T 3n9x_A           82 LKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCL  161 (432)
T ss_dssp             CCCTTBCCEEEECCCSCTTTCCCEEEEEECCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred             cCCCCcceEEEEEecCCCCcCCeEEEEEecCCcCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeE
Confidence            58999999999997765444467999999999999999998888999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccceeeccCCC-----------------------ccccceeccccccchhccCCCCCCcchhHHHHHHH
Q 023609           81 LNANCDLKICDFGLARVTSETD-----------------------FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI  137 (280)
Q Consensus        81 i~~~~~~~l~dfg~~~~~~~~~-----------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i  137 (280)
                      ++.++.++|+|||+++......                       .....++|+.|+|||++.....++.++||||+||+
T Consensus       162 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~i  241 (432)
T 3n9x_A          162 LNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCI  241 (432)
T ss_dssp             ECTTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHH
T ss_pred             ECCCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHH
Confidence            9999999999999998654321                       12456789999999987666678999999999999


Q ss_pred             HHHHHh-----------CCCCCCCCC-----------------hHHHHHHHHHHhCCCCHHHHhHh-hHhHHHHhhhcCc
Q 023609          138 FMELMD-----------RKPLFPGRD-----------------HVHQLRLLIELIGTPSEAELGFL-NENAKKYICQLPR  188 (280)
Q Consensus       138 l~~ll~-----------g~~pf~~~~-----------------~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  188 (280)
                      +|+|++           |.++|.+.+                 ..+++..+.+.+|.|+...+... ......+....+.
T Consensus       242 l~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~  321 (432)
T 3n9x_A          242 FAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPH  321 (432)
T ss_dssp             HHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCC
T ss_pred             HHHHHhcccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCC
Confidence            999997           566666654                 46788999999999998876654 4455666777777


Q ss_pred             cccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCcCCCCCCccCCCCCcchhh-ccccHHHHHHHHH
Q 023609          189 YQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMSPFSFDFEQ-HALTEGQMKELIY  267 (280)
Q Consensus       189 ~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  267 (280)
                      .....+...++.+++++++||++||+.||.+|||++|+|+||||+++.....++.+..++...+++ ..++..+++++++
T Consensus       322 ~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~  401 (432)
T 3n9x_A          322 RKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKKKLENFSTKKIILPFDDWMVLSETQLRYIFL  401 (432)
T ss_dssp             CCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCTTTC---CCCCCCSSCTTCCCCHHHHHHHHH
T ss_pred             CCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhccCcccCcCCCCCCCCChhhcccCCHHHHHHHHH
Confidence            777778888899999999999999999999999999999999999999888887766666555544 5789999999999


Q ss_pred             HHHHhhChhhh
Q 023609          268 QEALAFNPEYR  278 (280)
Q Consensus       268 ~~~~~~~~~~~  278 (280)
                      .|+.+|+|..+
T Consensus       402 ~e~~~~~~~~~  412 (432)
T 3n9x_A          402 KEVQSFHPELV  412 (432)
T ss_dssp             HHHHHHCTTCC
T ss_pred             HHHHHhCcccc
Confidence            99999998764

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.9e-50  Score=361.48  Aligned_cols=278  Identities=41%  Similarity=0.814  Sum_probs=232.4

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   80 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nil   80 (280)
                      |+||||+++++++.....+....+|+||||++++|.+++...+.+++..++.++.||+.||+|||+.||+||||||+||+
T Consensus       109 l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NIL  188 (458)
T 3rp9_A          109 LNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCL  188 (458)
T ss_dssp             CCCTTBCCEEEECCCSCTTTCCCEEEEECCCSEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEE
T ss_pred             CCCCCCCceEEEEecCCcccCceEEEEEeccccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEE
Confidence            58999999999997665455578999999999999999998889999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccceeeccCCC----------------------------ccccceeccccccchhccCCCCCCcchhHH
Q 023609           81 LNANCDLKICDFGLARVTSETD----------------------------FMTEYVVTRWYRAPELLLNSSDYTAAIDVW  132 (280)
Q Consensus        81 i~~~~~~~l~dfg~~~~~~~~~----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~Diw  132 (280)
                      ++.++.+||+|||+++......                            .....++|+.|+|||++.....++.++|||
T Consensus       189 l~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~Diw  268 (458)
T 3rp9_A          189 VNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVW  268 (458)
T ss_dssp             ECTTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHH
T ss_pred             ECCCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHH
Confidence            9999999999999998654221                            123456799999999876666789999999


Q ss_pred             HHHHHHHHHHh-----------CCCCCCCCC--------------------hHHHHHHHHHHhCCCCHHHHhHh-hHhHH
Q 023609          133 SVGCIFMELMD-----------RKPLFPGRD--------------------HVHQLRLLIELIGTPSEAELGFL-NENAK  180 (280)
Q Consensus       133 slG~il~~ll~-----------g~~pf~~~~--------------------~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  180 (280)
                      |+||++|+|++           |.++|.+.+                    ..+++..+.+.++.|+...+... .....
T Consensus       269 SlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~  348 (458)
T 3rp9_A          269 SIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAK  348 (458)
T ss_dssp             HHHHHHHHHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHH
T ss_pred             HHHHHHHHHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHH
Confidence            99999999998           778887754                    36788889999999998877655 44556


Q ss_pred             HHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCcCCCCCCccCCCCCcchh-hccccH
Q 023609          181 KYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMSPFSFDFE-QHALTE  259 (280)
Q Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~  259 (280)
                      .+....+......+...++..++++++||++||+.||.+|||++|+|+||||+++.....++....+....++ ...++.
T Consensus       349 ~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~~~~e~~~~~~~~~~~~~~~~~~~  428 (458)
T 3rp9_A          349 RYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRIAEVETNATEKVRLPFNDWMNMDE  428 (458)
T ss_dssp             HHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCCGGGCCCCSSCCCCSSCTTSCCCH
T ss_pred             HHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCCCccCCCCCCCCCCCccccccCCH
Confidence            6677777777778888999999999999999999999999999999999999999877766655544444443 356899


Q ss_pred             HHHHHHHHHHHHhhChhhh
Q 023609          260 GQMKELIYQEALAFNPEYR  278 (280)
Q Consensus       260 ~~~~~~~~~~~~~~~~~~~  278 (280)
                      .++++.++.|+..|+|...
T Consensus       429 ~~~~~~~~~e~~~~~~~~~  447 (458)
T 3rp9_A          429 PQLRYAFVKEIQRYHPEIQ  447 (458)
T ss_dssp             HHHHHHHHHHHTTTCTTCC
T ss_pred             HHHHHHHHHHHHHhCcccc
Confidence            9999999999999998653

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.3e-50  Score=350.22  Aligned_cols=273  Identities=44%  Similarity=0.844  Sum_probs=230.4

Q ss_pred             CCCCCeeeeeceecCCC-CCCCCcEEEEeecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQ-RESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~-~~~~~~~~iv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      |+||||+++++++.... ......+|+||||++++|.+++.. +.+++..++.++.||+.||+|||++||+||||||+||
T Consensus        81 l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NI  159 (367)
T 1cm8_A           81 MRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNL  159 (367)
T ss_dssp             CCBTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred             CCCcCCCCceeeEecCCccccCceEEEEEecCCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHE
Confidence            58999999999997653 223356799999999999999976 5799999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  159 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      +++.++.++|+|||+++.....  .....+|+.|+|||++.+...++.++||||+||++++|++|+.||.+.+..+++..
T Consensus       160 ll~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~  237 (367)
T 1cm8_A          160 AVNEDCELKILDFGLARQADSE--MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKE  237 (367)
T ss_dssp             EECTTCCEEECCCTTCEECCSS--CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             EEcCCCCEEEEeeecccccccc--cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            9999999999999999876543  34567899999999987756689999999999999999999999999999999999


Q ss_pred             HHHHhCCCCHHHHhHh-hHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCcCC
Q 023609          160 LIELIGTPSEAELGFL-NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDI  238 (280)
Q Consensus       160 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~~~  238 (280)
                      +.+..+.|+...+..+ +.....+....+......+...++.+++++++||.+||+.||.+|||+.++++||||+++.++
T Consensus       238 i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~  317 (367)
T 1cm8_A          238 IMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT  317 (367)
T ss_dssp             HHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC--
T ss_pred             HHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCC
Confidence            9999999988766544 445566777777777778888889999999999999999999999999999999999999988


Q ss_pred             CCCCccCCCCCcchhhccccHHHHHHHHHHHHHhhChhh
Q 023609          239 SDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEY  277 (280)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (280)
                      .+++... ++...++....+.++++++++.++..|+|..
T Consensus       318 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  355 (367)
T 1cm8_A          318 EDEPQVQ-KYDDSFDDVDRTLDEWKRVTYKEVLSFKPPR  355 (367)
T ss_dssp             ----CCC-CCCCC-----CCHHHHHHHHHHHHHTCCC--
T ss_pred             ccCCCCC-CCCCChhhhcCCHHHHHHHHHHHHHHhcccc
Confidence            8777554 6777778888899999999999999998874

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=2.4e-51  Score=355.26  Aligned_cols=227  Identities=29%  Similarity=0.509  Sum_probs=175.2

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nil   80 (280)
                      +||||++++++|.+.     +++|||||||+ |+|.+++.   .+++.+++.++.||+.||+|||++||+||||||+||+
T Consensus        78 ~h~nIv~l~~~~~~~-----~~~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiL  149 (361)
T 4f9c_A           78 GQDNVMGVKYCFRKN-----DHVVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFL  149 (361)
T ss_dssp             SBTTBCCCSEEEEET-----TEEEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred             CCCCCceEEEEEEEC-----CEEEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeE
Confidence            699999999999765     78999999997 69999984   5999999999999999999999999999999999999


Q ss_pred             EccC-CCEEEeeccceeeccCCC-----------------------------ccccceeccccccchhccCCCCCCcchh
Q 023609           81 LNAN-CDLKICDFGLARVTSETD-----------------------------FMTEYVVTRWYRAPELLLNSSDYTAAID  130 (280)
Q Consensus        81 i~~~-~~~~l~dfg~~~~~~~~~-----------------------------~~~~~~~~~~y~aPE~~~~~~~~~~~~D  130 (280)
                      ++.+ +.+||+|||+|+......                             .....+||+.|+|||++.+...++.++|
T Consensus       150 l~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~D  229 (361)
T 4f9c_A          150 YNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAID  229 (361)
T ss_dssp             EETTTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHH
T ss_pred             EeCCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccc
Confidence            9877 899999999997543321                             1233579999999999977666899999


Q ss_pred             HHHHHHHHHHHHhCCCCC-CCCChHHHHHHHHHHhCCCCHHHHhHhh-------------------HhHHHHhhhcCcc-
Q 023609          131 VWSVGCIFMELMDRKPLF-PGRDHVHQLRLLIELIGTPSEAELGFLN-------------------ENAKKYICQLPRY-  189 (280)
Q Consensus       131 iwslG~il~~ll~g~~pf-~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~~~~~~~~~~~-  189 (280)
                      |||+||++|+|++|+.|| .+.+..+++..+....|.+.........                   +.........+.. 
T Consensus       230 iWSlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~  309 (361)
T 4f9c_A          230 MWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLT  309 (361)
T ss_dssp             HHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------
T ss_pred             hhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccc
Confidence            999999999999999888 5667788889998888764433221100                   0000000000000 


Q ss_pred             ----ccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCc
Q 023609          190 ----QRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  236 (280)
Q Consensus       190 ----~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~  236 (280)
                          ........++.+|++++|||++||++||++|+|++|+|+||||++++
T Consensus       310 ~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i~  360 (361)
T 4f9c_A          310 SDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKDMS  360 (361)
T ss_dssp             ------------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC-
T ss_pred             cccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence                00112234567899999999999999999999999999999999863

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=2.4e-49  Score=344.39  Aligned_cols=277  Identities=55%  Similarity=1.013  Sum_probs=235.7

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   80 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nil   80 (280)
                      |+||||+++++++..+........|+||||++|+|.+++.. +.+++..++.++.||+.||+|||++||+||||||+||+
T Consensus        82 l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl  160 (364)
T 3qyz_A           82 FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLL  160 (364)
T ss_dssp             CCCTTBCCCCEEECCSSTTTCCCEEEEEECCSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred             cCCCCCccceeEEecCCccccceEEEEEcccCcCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEE
Confidence            58999999999997765444467999999999999999976 46999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccceeeccCCC----ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023609           81 LNANCDLKICDFGLARVTSETD----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ  156 (280)
Q Consensus        81 i~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  156 (280)
                      ++.++.++|+|||.+.......    ......+|+.|+|||++.+...++.++||||+||++|+|++|..||.+.+..+.
T Consensus       161 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~  240 (364)
T 3qyz_A          161 LNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ  240 (364)
T ss_dssp             ECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGH
T ss_pred             ECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHH
Confidence            9999999999999998654332    123457899999999876666689999999999999999999999999999999


Q ss_pred             HHHHHHHhCCCCHHHHhHh-hHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCC
Q 023609          157 LRLLIELIGTPSEAELGFL-NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  235 (280)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~  235 (280)
                      +..+....+.|....+... ......+....+......+...++.+++++++||.+||+.||.+|||+.++++||||+++
T Consensus       241 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  320 (364)
T 3qyz_A          241 LNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY  320 (364)
T ss_dssp             HHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred             HHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence            9999999999988766543 333445555666666667777888999999999999999999999999999999999999


Q ss_pred             cCCCCCCccCCCCCcchhhccccHHHHHHHHHHHHHhhChhhh
Q 023609          236 HDISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYR  278 (280)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (280)
                      ..++.++....++.++.+...++.+++++++++++..|+|..|
T Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~  363 (364)
T 3qyz_A          321 YDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR  363 (364)
T ss_dssp             CCGGGSCCCSSCCCCC-----CCHHHHHHHHHHHTGGGCC---
T ss_pred             cCcccccCCCCcCCcccccccCCHHHHHHHHHHHHHHhhhhcC
Confidence            8888888878888888888889999999999999999999876

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.2e-49  Score=349.14  Aligned_cols=274  Identities=38%  Similarity=0.725  Sum_probs=217.9

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   81 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nili   81 (280)
                      .||||+++++++....   ...+|+||||++|+|.+++.. +.+++..+..++.||+.||+|||+.||+||||||+||++
T Consensus        67 ~h~niv~l~~~~~~~~---~~~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll  142 (388)
T 3oz6_A           67 GHENIVNLLNVLRADN---DRDVYLVFDYMETDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILL  142 (388)
T ss_dssp             TCTTBCCEEEEEECTT---SSCEEEEEECCSEEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred             CCCCCCeeeeEEecCC---CCEEEEEecccCcCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEE
Confidence            3999999999996542   257999999999999999976 479999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccceeeccCC----------------------CccccceeccccccchhccCCCCCCcchhHHHHHHHHH
Q 023609           82 NANCDLKICDFGLARVTSET----------------------DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFM  139 (280)
Q Consensus        82 ~~~~~~~l~dfg~~~~~~~~----------------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~  139 (280)
                      +.++.++|+|||+++.....                      ......++|+.|+|||++.+...++.++||||+||+++
T Consensus       143 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~  222 (388)
T 3oz6_A          143 NAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILG  222 (388)
T ss_dssp             CTTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHH
T ss_pred             cCCCCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHH
Confidence            99999999999999764321                      12234578999999999877667899999999999999


Q ss_pred             HHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhHhhH-hHHHHhhh---cCcccccccccc-------------CCCCC
Q 023609          140 ELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNE-NAKKYICQ---LPRYQRQSFTEK-------------FPNVH  202 (280)
Q Consensus       140 ~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~---~~~~~~~~~~~~-------------~~~~~  202 (280)
                      +|++|.+||.+.+...++..+....+.|....+..... ....+...   ............             .+.++
T Consensus       223 ell~g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (388)
T 3oz6_A          223 EILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCN  302 (388)
T ss_dssp             HHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCC
T ss_pred             HHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCC
Confidence            99999999999999999999999999998765533211 11111111   000001111111             12678


Q ss_pred             hHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCcCCCCCCccCCCCCcchhh-ccccHHHHHHHHHHHHHhhChhhhc
Q 023609          203 PSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDISDEPVCMSPFSFDFEQ-HALTEGQMKELIYQEALAFNPEYRQ  279 (280)
Q Consensus       203 ~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  279 (280)
                      +++++||++||+.||.+|||++|+++||||+.+.++..++.+...+...++. ...+.+++++.++.++..+.+..++
T Consensus       303 ~~~~dll~~~L~~dP~~R~t~~e~l~Hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  380 (388)
T 3oz6_A          303 EEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNPNEEPNCDHIITIPINDNVKHSIDDYRNLVYSEISRRKRELIS  380 (388)
T ss_dssp             HHHHHHHHHHCCSSGGGSCCHHHHTTSTTTTTTCCGGGCCCCSSCCCCC------CCHHHHHHHHHHHHHHHHHHHTC
T ss_pred             HHHHHHHHHhhccCcccCCCHHHHhCCHHHHHhcCCccCCCCCCCCCCCccccccCCHHHHHHHHHHHHHHhhhhhhh
Confidence            9999999999999999999999999999999999988888877777766653 5678999999999999988887654

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=8.3e-50  Score=347.52  Aligned_cols=273  Identities=49%  Similarity=0.900  Sum_probs=223.8

Q ss_pred             CCCCCeeeeeceecCCC-CCCCCcEEEEeecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQ-RESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~-~~~~~~~~iv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      |+||||+++++++.... .+.....|+|||+++++|.+++.. +.+++..++.++.||+.||+|||+.||+||||||+||
T Consensus        85 l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NI  163 (367)
T 2fst_X           85 MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL  163 (367)
T ss_dssp             CCCTTBCCCSEEECSCSSGGGCCCCEEEEECCCEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred             CCCCCCCcEEEEEecCCccccCCeEEEEecccCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhE
Confidence            58999999999986642 122356899999999999999875 5799999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  159 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      +++.++.++|+|||+++.....  .....+|+.|+|||++.+...++.++||||+||++++|++|..||.+.+..+.+..
T Consensus       164 ll~~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~  241 (367)
T 2fst_X          164 AVNEDCELKILDFGLARHTADE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL  241 (367)
T ss_dssp             EECTTCCEEECC-----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred             EECCCCCEEEeecccccccccc--CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            9999999999999999875443  33567899999999987656689999999999999999999999999999999999


Q ss_pred             HHHHhCCCCHHHHhHh-hHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCcCC
Q 023609          160 LIELIGTPSEAELGFL-NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDI  238 (280)
Q Consensus       160 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~~~  238 (280)
                      +.+..+.|....+... ......+....+......+...+++.++++++||++||+.||.+|||+.++|+||||+.+..+
T Consensus       242 i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~  321 (367)
T 2fst_X          242 ILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP  321 (367)
T ss_dssp             HHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCG
T ss_pred             HHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCC
Confidence            9999999988766554 344556666666666777788888999999999999999999999999999999999999888


Q ss_pred             CCCCccCCCCCcchhhccccHHHHHHHHHHHHHhhChhh
Q 023609          239 SDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEY  277 (280)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (280)
                      .+++... ++....+...+..++++++++.++.+|.|..
T Consensus       322 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~  359 (367)
T 2fst_X          322 DDEPVAD-PYDQSLESRDLLIDEWKSLTYDEVISFVPPP  359 (367)
T ss_dssp             GGCCCCC-CCCGGGSSCCCCHHHHHHHHHHHHHHCCCCC
T ss_pred             CCCCCCC-CCCcchhhccCCHHHHHHHHHHHHHHhccCc
Confidence            7776544 6777777788899999999999999998764

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=2.2e-49  Score=354.71  Aligned_cols=274  Identities=41%  Similarity=0.758  Sum_probs=215.6

Q ss_pred             CCCCCeeeeeceecCCCC-CCCCcEEEEeecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~-~~~~~~~iv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++..... +....+|+||||++++|.+.+..  .+++..++.++.||+.||+|||++||+||||||+||
T Consensus       118 l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NI  195 (464)
T 3ttj_A          118 VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI  195 (464)
T ss_dssp             CCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEEHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred             CCCCCCCcEEEEEccCCccccCCeEEEEEeCCCCCHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhE
Confidence            589999999999976532 23467899999999999988864  499999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  159 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      +++.++.+||+|||+++..+.........+|+.|+|||++.+. .++.++||||+||++++|++|++||.+.+..+++..
T Consensus       196 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~  274 (464)
T 3ttj_A          196 VVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK  274 (464)
T ss_dssp             EECTTSCEEECCCCCC-----CCCC----CCCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             EEeCCCCEEEEEEEeeeecCCCcccCCCcccccccCHHHHcCC-CCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            9999999999999999877666555667899999999998654 589999999999999999999999999999999999


Q ss_pred             HHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCC------------ChHHHHHHHHhhcCCCCCCCCHHHHh
Q 023609          160 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNV------------HPSAIDLVEKMLTFDPRQRITVEDAL  227 (280)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~li~~~L~~dp~~R~t~~ell  227 (280)
                      +.+..+.|....+.........+....+......+...++..            ++++++||++||+.||.+|||++|+|
T Consensus       275 i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L  354 (464)
T 3ttj_A          275 VIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL  354 (464)
T ss_dssp             HHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred             HHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHh
Confidence            999999999888777766666776666666555555555543            57799999999999999999999999


Q ss_pred             cCCCCCCCcCCCCCCcc-CCCCCcchhhccccHHHHHHHHHHHHHhhChhh
Q 023609          228 AHPYLGSLHDISDEPVC-MSPFSFDFEQHALTEGQMKELIYQEALAFNPEY  277 (280)
Q Consensus       228 ~h~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (280)
                      +||||+.+.++...... ...+....++...+..+++++++.++..++...
T Consensus       355 ~Hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~  405 (464)
T 3ttj_A          355 QHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVMNSEEKT  405 (464)
T ss_dssp             TSTTTGGGCCHHHHSCCC-----------CCCHHHHHHHHHHHHHC-----
T ss_pred             cChhhhhccCcccccCCCCccCCcchhhccCCHHHHHHHHHHHHHHhhhcc
Confidence            99999987765433221 223445566677889999999999998766543

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=4.7e-49  Score=359.62  Aligned_cols=199  Identities=27%  Similarity=0.452  Sum_probs=170.6

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++|||||+++++|.+.     ..+|||||||. |+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||
T Consensus       249 ~~HP~IV~l~~~f~~~-----~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNI  323 (689)
T 3v5w_A          249 GDCPFIVCMSYAFHTP-----DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANI  323 (689)
T ss_dssp             SCCTTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGE
T ss_pred             CCCCCEeEEEEEEEEC-----CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHe
Confidence            4799999999999876     78999999997 69999999889999999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH---HH
Q 023609           80 LLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHV---HQ  156 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---~~  156 (280)
                      +++.+|.+||+|||+|+...... ....+||+.|+|||++.+...++.++|+|||||++|+|++|.+||.+.+..   ..
T Consensus       324 Lld~~G~vKL~DFGlA~~~~~~~-~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i  402 (689)
T 3v5w_A          324 LLDEHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI  402 (689)
T ss_dssp             EECTTSCEEECCCTTCEECSSCC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHH
T ss_pred             EEeCCCCEEecccceeeecCCCC-CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence            99999999999999998765543 346799999999999865556899999999999999999999999764322   22


Q ss_pred             HHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCC-----HHHHhcCCC
Q 023609          157 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT-----VEDALAHPY  231 (280)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~ell~h~~  231 (280)
                      ...+....                              ....+.+|+++++||.+||+.||++|++     ++|+++|||
T Consensus       403 ~~~i~~~~------------------------------~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~Hpf  452 (689)
T 3v5w_A          403 DRMTLTMA------------------------------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPF  452 (689)
T ss_dssp             HHHHHHCC------------------------------CCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGG
T ss_pred             HHhhcCCC------------------------------CCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCcc
Confidence            22211100                              0111368999999999999999999998     799999999


Q ss_pred             CCCC
Q 023609          232 LGSL  235 (280)
Q Consensus       232 ~~~~  235 (280)
                      |+++
T Consensus       453 F~~i  456 (689)
T 3v5w_A          453 FRSL  456 (689)
T ss_dssp             GTTC
T ss_pred             ccCC
Confidence            9975

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=3e-48  Score=354.58  Aligned_cols=207  Identities=26%  Similarity=0.446  Sum_probs=181.0

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      |+|||||+++++|.+.     ..+|||||||+ |+|.+++.. .+.+++.+++.++.||+.||+|||++||+||||||+|
T Consensus       211 l~hpnIv~l~~~~~~~-----~~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~N  285 (573)
T 3uto_A          211 LRHPTLVNLHDAFEDD-----NEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPEN  285 (573)
T ss_dssp             TCCTTBCCEEEEEECS-----SEEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred             CCCCCCCeEEEEEEEC-----CEEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhh
Confidence            6899999999999776     78999999997 699999964 4679999999999999999999999999999999999


Q ss_pred             EEEccC--CCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023609           79 LLLNAN--CDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ  156 (280)
Q Consensus        79 ili~~~--~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  156 (280)
                      |+++.+  +.+||+|||+++...........+||+.|+|||++.+. .++.++||||+||++|+|++|.+||.+.+..+.
T Consensus       286 ill~~~~~~~vKl~DFG~a~~~~~~~~~~~~~GT~~y~APEv~~~~-~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~  364 (573)
T 3uto_A          286 IMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGK-PVGYYTDMWSVGVLSYILLSGLSPFGGENDDET  364 (573)
T ss_dssp             EEESSSSCCCEEECCCSSCEECCTTSEEEEECSSGGGCCHHHHTTC-CBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH
T ss_pred             ccccCCCCCCEEEeeccceeEccCCCceeeeEECccccCHHHhCCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH
Confidence            999854  89999999999988777666677899999999998654 589999999999999999999999999988887


Q ss_pred             HHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCc
Q 023609          157 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  236 (280)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~  236 (280)
                      +..+.......+.                          ..++.+|+++++||++||+.||.+|||+.|+|+||||+...
T Consensus       365 ~~~i~~~~~~~~~--------------------------~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~  418 (573)
T 3uto_A          365 LRNVKSCDWNMDD--------------------------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGN  418 (573)
T ss_dssp             HHHHHTTCCCCCS--------------------------GGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCC
T ss_pred             HHHHHhCCCCCCc--------------------------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCC
Confidence            7776543322221                          23357899999999999999999999999999999999876


Q ss_pred             CCC
Q 023609          237 DIS  239 (280)
Q Consensus       237 ~~~  239 (280)
                      .+.
T Consensus       419 ~~~  421 (573)
T 3uto_A          419 APG  421 (573)
T ss_dssp             CTT
T ss_pred             CCC
Confidence            544

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=3e-47  Score=332.05  Aligned_cols=271  Identities=46%  Similarity=0.836  Sum_probs=227.1

Q ss_pred             CCCCCeeeeeceecCCCC-CCCCcEEEEeecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~-~~~~~~~iv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++..... .....+|+||||++++|.+.+.  ..+++..++.++.||+.||+|||+.||+||||||+||
T Consensus        98 l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NI  175 (371)
T 4exu_A           98 MQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNL  175 (371)
T ss_dssp             CCCTTBCCCSEEECSCSSSTTCCCCEEEEECCCEEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred             cCCCCchhhhhheeccCCcccceeEEEEEccccccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHe
Confidence            589999999999976532 1223459999999999999874  4599999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  159 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      +++.++.++|+|||.+......  .....+|+.|+|||++.+...++.++||||+||++++|++|..||.+.+..+.+..
T Consensus       176 ll~~~~~~kL~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~  253 (371)
T 4exu_A          176 AVNEDCELKILDFGLARHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQ  253 (371)
T ss_dssp             EECTTCCEEECSTTCC----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred             EECCCCCEEEEecCcccccccC--cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence            9999999999999999865543  23457799999999987656689999999999999999999999999999999999


Q ss_pred             HHHHhCCCCHHHHhHhh-HhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCcCC
Q 023609          160 LIELIGTPSEAELGFLN-ENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDI  238 (280)
Q Consensus       160 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~~~  238 (280)
                      +.+..+.+......... .....+....+......+...++.+++++++||++||+.||.+|||+.++++||||+.+..+
T Consensus       254 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  333 (371)
T 4exu_A          254 ILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDP  333 (371)
T ss_dssp             HHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCG
T ss_pred             HHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCCc
Confidence            99999998877655442 33344555566666666777788999999999999999999999999999999999998877


Q ss_pred             CCCCccCCCCCcchhhccccHHHHHHHHHHHHHhhCh
Q 023609          239 SDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP  275 (280)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (280)
                      ..+.....++....+....+.+++++.++.++.+|.|
T Consensus       334 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  370 (371)
T 4exu_A          334 EEETEAQQPFDDSLEHEKLTVDEWKQHIYKEIVNFSP  370 (371)
T ss_dssp             GGCCCCSSCCCCTTSSCCCCHHHHHHHHHHHHHHCCC
T ss_pred             ccccccccCcCcchhhcccchHHHHHHHHHHHHhccc
Confidence            6666666677776677788999999999999999876

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.8e-48  Score=328.97  Aligned_cols=204  Identities=24%  Similarity=0.412  Sum_probs=152.1

Q ss_pred             CCCCCeeeeeceecCCCC-------CCCCcEEEEeecCC-ccHHHHHHcCCC---CCHHHHHHHHHHHHHHHHHHHHCCc
Q 023609            1 MDHENVVAIRDIIPPPQR-------ESFNDVYIAYELMD-TDLHQIIRSNQA---LSEEHCQYFLYQILRGLKYIHSANV   69 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~-------~~~~~~~iv~e~~~-g~L~~~l~~~~~---l~~~~~~~i~~qll~al~~LH~~gi   69 (280)
                      |+|||||+++++|.+...       .....+|||||||+ |+|.+++..++.   .++..++.++.||+.||+|||++||
T Consensus        60 l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~I  139 (299)
T 4g31_A           60 LEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGL  139 (299)
T ss_dssp             CCCTTBCCEEEEEEEEC----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             CCCCCCCeEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcC
Confidence            689999999999865421       11134799999997 699999987765   4456789999999999999999999


Q ss_pred             eeccCCCCcEEEccCCCEEEeeccceeeccCCC-------------ccccceeccccccchhccCCCCCCcchhHHHHHH
Q 023609           70 LHRDLKPSNLLLNANCDLKICDFGLARVTSETD-------------FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGC  136 (280)
Q Consensus        70 ~H~di~~~nili~~~~~~~l~dfg~~~~~~~~~-------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~  136 (280)
                      +||||||+||+++.+|.+||+|||+++......             .....+||+.|+|||++.+ ..++.++||||+||
T Consensus       140 iHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~-~~y~~~~DiwSlGv  218 (299)
T 4g31_A          140 MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGL  218 (299)
T ss_dssp             CCCCCCGGGEEECTTCCEEECCCCCC--------------------------CCCTTSCHHHHTT-CCCCTHHHHHHHHH
T ss_pred             ccccCcHHHeEECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcC-CCCCCHHHHHHHHH
Confidence            999999999999999999999999998654321             1233579999999999865 45899999999999


Q ss_pred             HHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCC
Q 023609          137 IFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFD  216 (280)
Q Consensus       137 il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d  216 (280)
                      ++|+|++   ||.+..  +....+........+                          ..++..++.+.+||++||+.|
T Consensus       219 ilyell~---Pf~~~~--~~~~~~~~~~~~~~p--------------------------~~~~~~~~~~~~li~~~L~~d  267 (299)
T 4g31_A          219 ILFELLY---PFSTQM--ERVRTLTDVRNLKFP--------------------------PLFTQKYPCEYVMVQDMLSPS  267 (299)
T ss_dssp             HHHHHHS---CCSSHH--HHHHHHHHHHTTCCC--------------------------HHHHHHCHHHHHHHHHHTCSS
T ss_pred             HHHHHcc---CCCCcc--HHHHHHHHHhcCCCC--------------------------CCCcccCHHHHHHHHHHcCCC
Confidence            9999996   675432  222222221111110                          111134567889999999999


Q ss_pred             CCCCCCHHHHhcCCCCCCCc
Q 023609          217 PRQRITVEDALAHPYLGSLH  236 (280)
Q Consensus       217 p~~R~t~~ell~h~~~~~~~  236 (280)
                      |.+|||+.|+++||||+++.
T Consensus       268 P~~Rps~~eil~h~~~~~~~  287 (299)
T 4g31_A          268 PMERPEAINIIENAVFEDLD  287 (299)
T ss_dssp             GGGSCCHHHHHTSGGGCCC-
T ss_pred             hhHCcCHHHHhcCHhhCCCC
Confidence            99999999999999999864

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.1e-47  Score=324.17  Aligned_cols=198  Identities=20%  Similarity=0.323  Sum_probs=159.7

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      |+|||||++++++..      +.+|||||||+ |+|.+++... +++++.++..|+.||+.||+|||++||+||||||+|
T Consensus        89 l~HpNIV~l~g~~~~------~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~N  162 (307)
T 3omv_A           89 TRHVNILLFMGYMTK------DNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNN  162 (307)
T ss_dssp             CCCTTBCCEEEEECS------SSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSS
T ss_pred             CCCCCEeeEEEEEEC------CeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHH
Confidence            689999999998743      34799999998 7999999754 579999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCC---CccccceeccccccchhccC--CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh
Q 023609           79 LLLNANCDLKICDFGLARVTSET---DFMTEYVVTRWYRAPELLLN--SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDH  153 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~  153 (280)
                      ||++.++.+||+|||+|+.....   ......+||+.|+|||++.+  ...++.++||||+||++|+|++|+.||.+.+.
T Consensus       163 ILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~  242 (307)
T 3omv_A          163 IFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN  242 (307)
T ss_dssp             EEEETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred             EEECCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh
Confidence            99999999999999999865432   22345689999999999854  33588999999999999999999999988776


Q ss_pred             HHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          154 VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                      ...+..+......++                        ......+++++++.+||.+||+.||++|||+.++++
T Consensus       243 ~~~~~~~~~~~~~~p------------------------~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~  293 (307)
T 3omv_A          243 RDQIIFMVGRGYASP------------------------DLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILS  293 (307)
T ss_dssp             HHHHHHHHHTTCCCC------------------------CSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHH
T ss_pred             HHHHHHHHhcCCCCC------------------------CcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence            655544433221111                        112334578899999999999999999999997754

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=6.3e-47  Score=322.44  Aligned_cols=231  Identities=38%  Similarity=0.740  Sum_probs=195.6

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ-ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~-~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      |+||||+++++++...     ...|+||||++|+|.+++...+ .+++..++.++.||+.||+|||+.||+||||||+||
T Consensus        76 l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NI  150 (311)
T 3niz_A           76 LHHPNIVSLIDVIHSE-----RCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNL  150 (311)
T ss_dssp             CCCTTBCCEEEEECCS-----SCEEEEEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred             cCCCCEeeeeeEEccC-----CEEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhE
Confidence            5899999999999765     6799999999999999987654 599999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCC-CccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  158 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.++.++|+|||++...+.. .......+|+.|+|||++.+...++.++||||+||++|+|++|..||.+....+...
T Consensus       151 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  230 (311)
T 3niz_A          151 LINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLP  230 (311)
T ss_dssp             EECTTCCEEECCCTTCEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHH
T ss_pred             EECCCCCEEEccCcCceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence            9999999999999999876533 223445789999999998766668999999999999999999999999999989999


Q ss_pred             HHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCc
Q 023609          159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  236 (280)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~  236 (280)
                      .+....+.+....+....+................+....+.+++++++||++||+.||++|||+.|+++||||+++.
T Consensus       231 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  308 (311)
T 3niz_A          231 KIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD  308 (311)
T ss_dssp             HHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred             HHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence            999999988876655443332222223333344455667788999999999999999999999999999999999864

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=1.2e-46  Score=326.03  Aligned_cols=271  Identities=46%  Similarity=0.835  Sum_probs=224.8

Q ss_pred             CCCCCeeeeeceecCCCC-CCCCcEEEEeecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~-~~~~~~~iv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++..... .....+|+||||++++|.+++..  .+++..++.++.||+.||+|||++|++||||||+||
T Consensus        80 l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NI  157 (353)
T 3coi_A           80 MQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNL  157 (353)
T ss_dssp             CCCTTBCCCSEEECSCSSGGGCCCCEEEEECCSEEGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGE
T ss_pred             cCCCCcccHhheEecccccccceeEEEEeccccCCHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHE
Confidence            589999999999976531 11234699999999999888753  599999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  159 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      +++.++.++|+|||.+......  .....+++.|+|||++.+...++.++||||+||++++|++|..||.+.+..+.+..
T Consensus       158 l~~~~~~~kl~Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~  235 (353)
T 3coi_A          158 AVNEDCELKILDFGLARHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQ  235 (353)
T ss_dssp             EECTTCCEEECSTTCTTC----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHH
T ss_pred             eECCCCcEEEeecccccCCCCC--ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            9999999999999998765433  23457899999999987656688999999999999999999999999999999999


Q ss_pred             HHHHhCCCCHHHHhHhh-HhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCcCC
Q 023609          160 LIELIGTPSEAELGFLN-ENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDI  238 (280)
Q Consensus       160 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~~~  238 (280)
                      +.+..+.++........ .....+....+......+....+.+++++++||.+||+.||.+|||+.++++||||+.+..+
T Consensus       236 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~~  315 (353)
T 3coi_A          236 ILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRDP  315 (353)
T ss_dssp             HHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCCG
T ss_pred             HHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccCc
Confidence            99999988876554442 22334445555555556667778899999999999999999999999999999999998877


Q ss_pred             CCCCccCCCCCcchhhccccHHHHHHHHHHHHHhhCh
Q 023609          239 SDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP  275 (280)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (280)
                      ..++....++....+...++.+++++.++.+...|.|
T Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (353)
T 3coi_A          316 EEETEAQQPFDDSLEHEKLTVDEWKQHIYKEIVNFSP  352 (353)
T ss_dssp             GGCCCCSSCCCCTTTTCCCCHHHHHHHHHHHHHTCCC
T ss_pred             cccccCCCCCccchhhccCCHHHHHHHHHHHHHhhcc
Confidence            6666666677777777889999999999999988765

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1.5e-47  Score=323.03  Aligned_cols=198  Identities=22%  Similarity=0.365  Sum_probs=167.1

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC-------------CCCCHHHHHHHHHHHHHHHHHHHH
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-------------QALSEEHCQYFLYQILRGLKYIHS   66 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-------------~~l~~~~~~~i~~qll~al~~LH~   66 (280)
                      |+|||||++++++.++     ..+|||||||+ |+|.+++.+.             ..+++.++..++.||+.||+|||+
T Consensus        72 l~HpnIV~l~g~~~~~-----~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~  146 (299)
T 4asz_A           72 LQHEHIVKFYGVCVEG-----DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS  146 (299)
T ss_dssp             CCCTTBCCEEEEECSS-----SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCCCCCccEEEEEeeC-----CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            6899999999999765     67999999997 7999999753             369999999999999999999999


Q ss_pred             CCceeccCCCCcEEEccCCCEEEeeccceeeccCCC---ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh
Q 023609           67 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD  143 (280)
Q Consensus        67 ~gi~H~di~~~nili~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~  143 (280)
                      +||+||||||+||+++.++.+||+|||+++......   ......+|+.|+|||++.+. .++.++||||+||++|||+|
T Consensus       147 ~~iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~-~~~~k~DVwS~Gvvl~Ellt  225 (299)
T 4asz_A          147 QHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYR-KFTTESDVWSLGVVLWEIFT  225 (299)
T ss_dssp             TTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHT
T ss_pred             CCcccCccCHhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCC-CCCchhhHHHHHHHHHHHHc
Confidence            999999999999999999999999999997644332   22345689999999998654 58999999999999999998


Q ss_pred             -CCCCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCC
Q 023609          144 -RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT  222 (280)
Q Consensus       144 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t  222 (280)
                       |+.||.+.+..+.+..+.+....+.                             -+.+|+++.+||.+||+.||++|||
T Consensus       226 ~G~~Pf~~~~~~~~~~~i~~~~~~~~-----------------------------p~~~~~~~~~li~~cl~~dP~~RPs  276 (299)
T 4asz_A          226 YGKQPWYQLSNNEVIECITQGRVLQR-----------------------------PRTCPQEVYELMLGCWQREPHMRKN  276 (299)
T ss_dssp             TTCCTTTTSCHHHHHHHHHHTCCCCC-----------------------------CTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred             CCCCCCCCCCHHHHHHHHHcCCCCCC-----------------------------CccchHHHHHHHHHHcCCChhHCcC
Confidence             8999999887777666544221111                             1267889999999999999999999


Q ss_pred             HHHHhcCCCCCCC
Q 023609          223 VEDALAHPYLGSL  235 (280)
Q Consensus       223 ~~ell~h~~~~~~  235 (280)
                      +.+++  +|++++
T Consensus       277 ~~~i~--~~L~~~  287 (299)
T 4asz_A          277 IKGIH--TLLQNL  287 (299)
T ss_dssp             HHHHH--HHHHHH
T ss_pred             HHHHH--HHHHHH
Confidence            99994  466654

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=3.6e-47  Score=331.53  Aligned_cols=272  Identities=42%  Similarity=0.758  Sum_probs=207.2

Q ss_pred             CCCCCeeeeeceecCCCC-CCCCcEEEEeecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~-~~~~~~~iv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++..... ......|+||||++|+|.+.+.  ..+++..+..++.||+.||+|||++||+||||||+||
T Consensus        81 l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NI  158 (371)
T 2xrw_A           81 VNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI  158 (371)
T ss_dssp             CCCTTBCCEEEEECSCCSTTTCCEEEEEEECCSEEHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred             cCCCCccceEEeeccccccccccceEEEEEcCCCCHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHE
Confidence            589999999999976531 2234789999999999999986  3599999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  159 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      +++.++.++|+|||++.............+|+.|+|||++.+. .++.++||||+||++|+|++|..||.+.+..+.+..
T Consensus       159 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~  237 (371)
T 2xrw_A          159 VVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNK  237 (371)
T ss_dssp             EECTTSCEEECCCCC----------------CTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             EEcCCCCEEEEEeecccccccccccCCceecCCccCHHHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            9999999999999999876655444566889999999998654 588999999999999999999999999999999999


Q ss_pred             HHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCC------------ChHHHHHHHHhhcCCCCCCCCHHHHh
Q 023609          160 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNV------------HPSAIDLVEKMLTFDPRQRITVEDAL  227 (280)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~li~~~L~~dp~~R~t~~ell  227 (280)
                      +.+..+.+....+.........+....+......+...++..            +.++++||++||+.||++|||+.+++
T Consensus       238 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l  317 (371)
T 2xrw_A          238 VIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEAL  317 (371)
T ss_dssp             HHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred             HHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHh
Confidence            999988888776655555444554444444433333333322            56799999999999999999999999


Q ss_pred             cCCCCCCCcCCCCCCccC-CCCCcchhhccccHHHHHHHHHHHHHhhCh
Q 023609          228 AHPYLGSLHDISDEPVCM-SPFSFDFEQHALTEGQMKELIYQEALAFNP  275 (280)
Q Consensus       228 ~h~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (280)
                      +||||+.+.++....... .......++...+.++++++++.++..++.
T Consensus       318 ~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  366 (371)
T 2xrw_A          318 QHPYINVWYDPSEAEAPPPKIPDKQLDEREHTIEEWKELIYKEVMDLEH  366 (371)
T ss_dssp             HSHHHHTTCCHHHHTCCCCCCCTTTTCCCCCCHHHHHHHHHHHHHHHCC
T ss_pred             CCcchhhhcCccccCCCCCCCCChhhccccCcHHHHHHHHHHHHHHHhh
Confidence            999999876543222111 112233455667889999999999988764

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.5e-46  Score=320.47  Aligned_cols=234  Identities=39%  Similarity=0.752  Sum_probs=194.1

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++...     ...|+||||++|+|.+++... ..+++..++.++.||+.||+|||+.||+||||||+||
T Consensus        57 l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NI  131 (324)
T 3mtl_A           57 LKHANIVTLHDIIHTE-----KSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNL  131 (324)
T ss_dssp             CCCTTBCCEEEEEECS-----SCEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGE
T ss_pred             cCCCCCCeeeeEEeeC-----CEEEEEecccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHE
Confidence            5799999999999765     679999999999999999865 4599999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCC-CccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  158 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.++.++|+|||++...... .......+|+.|+|||++.+...++.++||||+||++|+|++|..||.+.+..+...
T Consensus       132 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~  211 (324)
T 3mtl_A          132 LINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLH  211 (324)
T ss_dssp             EECTTCCEEECSSSEEECC------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             EECCCCCEEEccCcccccccCCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            9999999999999999765433 223445779999999998766668999999999999999999999999999999999


Q ss_pred             HHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCcCC
Q 023609          159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDI  238 (280)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~~~  238 (280)
                      .+....+.|....+..............+...........+.+++++++||.+||+.||.+|||+.|+++||||.++...
T Consensus       212 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~  291 (324)
T 3mtl_A          212 FIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGER  291 (324)
T ss_dssp             HHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCST
T ss_pred             HHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcccc
Confidence            99999998887766544333322233344444445556677899999999999999999999999999999999988654


Q ss_pred             C
Q 023609          239 S  239 (280)
Q Consensus       239 ~  239 (280)
                      .
T Consensus       292 ~  292 (324)
T 3mtl_A          292 I  292 (324)
T ss_dssp             T
T ss_pred             c
Confidence            3

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=8.5e-47  Score=322.54  Aligned_cols=194  Identities=22%  Similarity=0.375  Sum_probs=158.4

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC---------------CCCCHHHHHHHHHHHHHHHHHH
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN---------------QALSEEHCQYFLYQILRGLKYI   64 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~---------------~~l~~~~~~~i~~qll~al~~L   64 (280)
                      |+|||||++++++.+.     ..+|||||||+ |+|.+++.+.               +++++.++..|+.||+.||+||
T Consensus       100 l~HpnIV~l~g~~~~~-----~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yL  174 (329)
T 4aoj_A          100 LQHQHIVRFFGVCTEG-----RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL  174 (329)
T ss_dssp             CCCTTBCCEEEEECSS-----SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHH
T ss_pred             CCCCCCCcEEEEEEEC-----CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHH
Confidence            6899999999999765     67999999998 7999999753               3599999999999999999999


Q ss_pred             HHCCceeccCCCCcEEEccCCCEEEeeccceeeccCCC---ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHH
Q 023609           65 HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL  141 (280)
Q Consensus        65 H~~gi~H~di~~~nili~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l  141 (280)
                      |+.||+||||||+||+++.++.+||+|||+++......   ......+|+.|+|||++.+ ..++.++||||+||++|||
T Consensus       175 H~~~iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~-~~~~~~sDvwS~Gvvl~El  253 (329)
T 4aoj_A          175 AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILY-RKFTTESDVWSFGVVLWEI  253 (329)
T ss_dssp             HHTTCCCSCCCGGGEEEETTTEEEECCCC----------------CCCCGGGCCHHHHTT-CCCCHHHHHHHHHHHHHHH
T ss_pred             hcCCeecccccHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcC-CCCCccccccchHHHHHHH
Confidence            99999999999999999999999999999998653332   2234578999999999854 4589999999999999999


Q ss_pred             Hh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCC
Q 023609          142 MD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQR  220 (280)
Q Consensus       142 l~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R  220 (280)
                      +| |+.||.+.+..+.+..+.+....+                             .-+.+++++.+||.+||+.||++|
T Consensus       254 lt~G~~Pf~~~~~~~~~~~i~~g~~~~-----------------------------~p~~~~~~~~~li~~cl~~dP~~R  304 (329)
T 4aoj_A          254 FTYGKQPWYQLSNTEAIDCITQGRELE-----------------------------RPRACPPEVYAIMRGCWQREPQQR  304 (329)
T ss_dssp             HTTSCCTTCSSCHHHHHHHHHHTCCCC-----------------------------CCTTCCHHHHHHHHHHCCSSTTTS
T ss_pred             HcCCCCCCCCCCHHHHHHHHHcCCCCC-----------------------------CcccccHHHHHHHHHHcCcChhHC
Confidence            98 899999888777766654322111                             112678999999999999999999


Q ss_pred             CCHHHHhcC
Q 023609          221 ITVEDALAH  229 (280)
Q Consensus       221 ~t~~ell~h  229 (280)
                      ||+.|++++
T Consensus       305 Ps~~ei~~~  313 (329)
T 4aoj_A          305 HSIKDVHAR  313 (329)
T ss_dssp             CCHHHHHHH
T ss_pred             cCHHHHHHH
Confidence            999999864

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=6.9e-46  Score=321.00  Aligned_cols=270  Identities=52%  Similarity=0.927  Sum_probs=220.0

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   80 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nil   80 (280)
                      |+||||+++++++...........|+||||++|+|.+++.. +.+++..++.++.||+.||+|||++|++||||||+||+
T Consensus        66 l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil  144 (353)
T 2b9h_A           66 FKHENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLL  144 (353)
T ss_dssp             CCCTTBCCEEEECCCSCSTTCCCEEEEECCCSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE
T ss_pred             CcCCCcCCeeeeecccccCccceEEEEEeccCccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeE
Confidence            58999999999987654344467999999999999999976 57999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccceeeccCCC-----------ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 023609           81 LNANCDLKICDFGLARVTSETD-----------FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFP  149 (280)
Q Consensus        81 i~~~~~~~l~dfg~~~~~~~~~-----------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  149 (280)
                      ++.++.++|+|||++.......           ......+|+.|+|||++.+...++.++||||+||++++|++|.+||.
T Consensus       145 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~  224 (353)
T 2b9h_A          145 INSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFP  224 (353)
T ss_dssp             ECTTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             EcCCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCC
Confidence            9999999999999998654321           11234679999999988666678999999999999999999999999


Q ss_pred             CCChHHHHHHHHHHhCCCCHHHHhHh--hHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHh
Q 023609          150 GRDHVHQLRLLIELIGTPSEAELGFL--NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDAL  227 (280)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell  227 (280)
                      +.+.......+....+.+........  ......+....+..........++.+++++++||.+||+.||++|||+.+++
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell  304 (353)
T 2b9h_A          225 GRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEAL  304 (353)
T ss_dssp             CSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred             CCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHh
Confidence            99999999888888887764322111  1223334445555555566677789999999999999999999999999999


Q ss_pred             cCCCCCCCcCCCCCCcc----CCCCCcchhhccccHHHHHHHHHHHHH
Q 023609          228 AHPYLGSLHDISDEPVC----MSPFSFDFEQHALTEGQMKELIYQEAL  271 (280)
Q Consensus       228 ~h~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (280)
                      +||||+....+..++..    ...++++.....++..++++++++|++
T Consensus       305 ~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  352 (353)
T 2b9h_A          305 EHPYLQTYHDPNDEPEGEPIPPSFFEFDHYKEALTTKDLKKLIWNEIF  352 (353)
T ss_dssp             TSGGGTTTCCTTSSCCCCCCCGGGGGGGCCSSCCCHHHHHHHHHHHHT
T ss_pred             cCccccccCCcccccccCCCCcceeeecchhhcCCHHHHHHHHHHHhh
Confidence            99999998766544422    233556667778999999999999975

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1e-46  Score=319.25  Aligned_cols=194  Identities=21%  Similarity=0.367  Sum_probs=164.6

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC----------------CCCCHHHHHHHHHHHHHHHHH
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN----------------QALSEEHCQYFLYQILRGLKY   63 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~----------------~~l~~~~~~~i~~qll~al~~   63 (280)
                      |+|||||++++++..+     ..+|||||||+ |+|.+++..+                ..+++..+..|+.||+.||+|
T Consensus        86 l~HpNIV~l~g~~~~~-----~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~y  160 (308)
T 4gt4_A           86 LQHPNVVCLLGVVTKD-----QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEY  160 (308)
T ss_dssp             CCCTTBCCEEEEECSS-----SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHH
T ss_pred             CCCCCCCCcceEEEEC-----CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHH
Confidence            6899999999999765     66899999997 7999999643                358999999999999999999


Q ss_pred             HHHCCceeccCCCCcEEEccCCCEEEeeccceeeccCC---CccccceeccccccchhccCCCCCCcchhHHHHHHHHHH
Q 023609           64 IHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET---DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME  140 (280)
Q Consensus        64 LH~~gi~H~di~~~nili~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~  140 (280)
                      ||+++|+||||||+||+++.++.+||+|||+++.....   .......+|+.|+|||++.+. .++.++||||+||++||
T Consensus       161 LH~~~iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~-~~s~ksDVwSfGvvl~E  239 (308)
T 4gt4_A          161 LSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYG-KFSIDSDIWSYGVVLWE  239 (308)
T ss_dssp             HHHTTCCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHH
T ss_pred             HHhCCCCCCCccccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCC-CCCccchhhhHHHHHHH
Confidence            99999999999999999999999999999999864332   223456789999999998654 58999999999999999


Q ss_pred             HHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCC
Q 023609          141 LMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQ  219 (280)
Q Consensus       141 ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~  219 (280)
                      |++ |..||.+.+..+....+......|                             .-+++++++.+||.+||+.||++
T Consensus       240 l~t~g~~Pf~~~~~~~~~~~i~~~~~~~-----------------------------~p~~~~~~~~~li~~C~~~dP~~  290 (308)
T 4gt4_A          240 VFSYGLQPYCGYSNQDVVEMIRNRQVLP-----------------------------CPDDCPAWVYALMIECWNEFPSR  290 (308)
T ss_dssp             HHTTTCCTTTTCCHHHHHHHHHTTCCCC-----------------------------CCTTCCHHHHHHHHHHTCSSGGG
T ss_pred             HHhCCCCCCCCCCHHHHHHHHHcCCCCC-----------------------------CcccchHHHHHHHHHHcCCChhH
Confidence            998 899999988777666554322111                             11367889999999999999999


Q ss_pred             CCCHHHHhcC
Q 023609          220 RITVEDALAH  229 (280)
Q Consensus       220 R~t~~ell~h  229 (280)
                      |||+.+++++
T Consensus       291 RPs~~ei~~~  300 (308)
T 4gt4_A          291 RPRFKDIHSR  300 (308)
T ss_dssp             SCCHHHHHHH
T ss_pred             CcCHHHHHHH
Confidence            9999999874

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.5e-45  Score=320.07  Aligned_cols=273  Identities=38%  Similarity=0.724  Sum_probs=211.6

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ-ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~-~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++...........|+||||++|+|.+.+...+ .+++..++.++.||+.||+|||++|++||||||+||
T Consensus        86 l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NI  165 (362)
T 3pg1_A           86 FHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNI  165 (362)
T ss_dssp             CCCTTBCCCSEEEEECCTTTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred             CCCcCccceeeeEEeccCCCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHE
Confidence            5899999999998654433346799999999999999987654 699999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  159 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      +++.++.++|+|||.+.............+++.|+|||++.+...++.++||||+||++|+|++|..||.+.+.......
T Consensus       166 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~  245 (362)
T 3pg1_A          166 LLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNK  245 (362)
T ss_dssp             EECTTCCEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred             EEcCCCCEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            99999999999999998655554455667899999999987656689999999999999999999999999999999999


Q ss_pred             HHHHhCCCCHHHHhHhhH-hHHHHh-hhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCcC
Q 023609          160 LIELIGTPSEAELGFLNE-NAKKYI-CQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD  237 (280)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~-~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~~  237 (280)
                      +....+.+.......... ....+. ..........+....+..++.+.+||.+||+.||.+|||+.++++||||+++..
T Consensus       246 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  325 (362)
T 3pg1_A          246 IVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFD  325 (362)
T ss_dssp             HHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCC
T ss_pred             HHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccC
Confidence            999999988765543322 122222 122233334455666788999999999999999999999999999999999865


Q ss_pred             CCCCCccCCCCCcchhhccccHHHHHHHHHHHHHhhC
Q 023609          238 ISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFN  274 (280)
Q Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  274 (280)
                      +.+.... ..-.+.+........++++++..+..+++
T Consensus       326 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~e~~~~~  361 (362)
T 3pg1_A          326 PLDLTEG-LSERFHFDESVTDVYDMHKIFTAEVERFN  361 (362)
T ss_dssp             GGGGTTT-CCCCCCCCTTCCCHHHHHHHHHHHHHHHC
T ss_pred             ccccccc-cccccChhhhhhhHHHHHHHHHHHHHHhc
Confidence            4433321 12223445566778899999999988765

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=8.9e-46  Score=325.16  Aligned_cols=238  Identities=34%  Similarity=0.661  Sum_probs=195.8

Q ss_pred             CCCCCeeeeeceecCCCC-CCCCcEEEEeecCCccHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCC
Q 023609            1 MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIR----SNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK   75 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~-~~~~~~~iv~e~~~g~L~~~l~----~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~   75 (280)
                      |+||||+++++++..... .+...+|+||||+++++.+.+.    .+..+++..++.++.||+.||+|||++||+|||||
T Consensus        89 l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlk  168 (394)
T 4e7w_A           89 VKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIK  168 (394)
T ss_dssp             CCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred             CCCCCcceEEEEEEecCCCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCC
Confidence            589999999999865432 2224488999999987766654    35679999999999999999999999999999999


Q ss_pred             CCcEEEc-cCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH
Q 023609           76 PSNLLLN-ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHV  154 (280)
Q Consensus        76 ~~nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  154 (280)
                      |+||+++ .++.++|+|||+++............+|+.|+|||++.+...++.++||||+||++|+|++|.+||.+.+..
T Consensus       169 p~Nill~~~~~~~kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~  248 (394)
T 4e7w_A          169 PQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGI  248 (394)
T ss_dssp             GGGEEEETTTTEEEECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             HHHEEEcCCCCcEEEeeCCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            9999999 789999999999987665555556788999999999876666899999999999999999999999999999


Q ss_pred             HHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCC-CCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCC
Q 023609          155 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP-NVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLG  233 (280)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~  233 (280)
                      +.+..+.+..+.|....+...+.....  ...+......+...++ .+++++++||.+||+.||.+|||+.++++||||+
T Consensus       249 ~~l~~i~~~~g~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~  326 (394)
T 4e7w_A          249 DQLVEIIKVLGTPSREQIKTMNPNYME--HKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFD  326 (394)
T ss_dssp             HHHHHHHHHHCCCCHHHHHHHCGGGSS--SCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGS
T ss_pred             HHHHHHHHHhCCCCHHHHHhhChhhhh--hccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhh
Confidence            999999999999988765543322111  1222223333333333 5899999999999999999999999999999999


Q ss_pred             CCcCCCC
Q 023609          234 SLHDISD  240 (280)
Q Consensus       234 ~~~~~~~  240 (280)
                      +++....
T Consensus       327 ~~~~~~~  333 (394)
T 4e7w_A          327 ELRTGEA  333 (394)
T ss_dssp             TTTSSCC
T ss_pred             hhccccc
Confidence            8876443

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=1.9e-45  Score=315.34  Aligned_cols=203  Identities=23%  Similarity=0.426  Sum_probs=176.8

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++...     ...|+||||++ |+|.+++..++.+++.+++.++.||+.||+|||++||+||||||+||
T Consensus        71 l~hpnIv~l~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NI  145 (328)
T 3fe3_A           71 LNHPNIVKLFEVIETE-----KTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENL  145 (328)
T ss_dssp             CCCTTBCCEEEEEECS-----SEEEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred             CCCCCEeeEEEEEEEC-----CEEEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHE
Confidence            5899999999999665     77999999996 69999998888999999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  159 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      +++.++.++|+|||++............++|+.|+|||++.+....+.++||||+||++|+|++|..||.+.+..+....
T Consensus       146 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~  225 (328)
T 3fe3_A          146 LLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRER  225 (328)
T ss_dssp             EECTTSCEEECSTTCCGGGSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             EEcCCCCEEEeeccCceecCCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            99999999999999998766555556778999999999997666556899999999999999999999998877666555


Q ss_pred             HHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCcCC
Q 023609          160 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDI  238 (280)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~~~  238 (280)
                      +.......+                              ..+++++.+||++||+.||.+|||+.++++||||+.....
T Consensus       226 i~~~~~~~p------------------------------~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~~~  274 (328)
T 3fe3_A          226 VLRGKYRIP------------------------------FYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGHEE  274 (328)
T ss_dssp             HHHCCCCCC------------------------------TTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTCTT
T ss_pred             HHhCCCCCC------------------------------CCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCCcc
Confidence            543211111                              1468899999999999999999999999999999876543

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=8.9e-46  Score=314.71  Aligned_cols=231  Identities=37%  Similarity=0.642  Sum_probs=190.9

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHcCCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQA--LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~--l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      +||||+++++++...........++||||++++|.+++.....  +++..++.++.||+.||+|||++|++||||||+||
T Consensus        72 ~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Ni  151 (308)
T 3g33_A           72 EHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENI  151 (308)
T ss_dssp             CCTTBCCEEEEEEECCSSSEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTE
T ss_pred             CCCCeEEeeeeeeccCCCCceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHE
Confidence            5999999999997654333346899999999999999987654  99999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  159 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      +++.++.++|+|||.+.............+|+.|+|||++.+. .++.++||||+||++|+|++|.+||.+.+..+....
T Consensus       152 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~  230 (308)
T 3g33_A          152 LVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQS-TYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGK  230 (308)
T ss_dssp             EECTTSCEEECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTS-CCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHH
T ss_pred             EEcCCCCEEEeeCccccccCCCcccCCccccccccCchHHcCC-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            9999999999999999876655555667889999999998654 489999999999999999999999999999999999


Q ss_pred             HHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCc
Q 023609          160 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  236 (280)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~  236 (280)
                      +.+..+.++...+.......   ....+...........+.+++++.+||.+||+.||.+|||+.|+++||||++..
T Consensus       231 i~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~~  304 (308)
T 3g33_A          231 IFDLIGLPPEDDWPRDVSLP---RGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE  304 (308)
T ss_dssp             HHHHHCCCCTTTSCSSCSSC---GGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC----
T ss_pred             HHHHhCCCChhhccchhhcc---ccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCCC
Confidence            99998887765432111100   011222233444556678999999999999999999999999999999998743

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.4e-45  Score=310.60  Aligned_cols=229  Identities=39%  Similarity=0.713  Sum_probs=186.2

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      |+||||+++++++...     ...|+||||++++|.+++... +.+++..++.++.||+.||+|||++|++||||||+||
T Consensus        57 l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Ni  131 (288)
T 1ob3_A           57 LKHSNIVKLYDVIHTK-----KRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNL  131 (288)
T ss_dssp             CCCTTBCCEEEEEECS-----SCEEEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred             cCCCCEeeeeeEEccC-----CeEEEEEEecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHE
Confidence            5899999999999765     679999999999999999864 6799999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCC-CccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  158 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.++.++|+|||.+...... .......+|+.|+|||++.+...++.++||||+||++|+|++|..||.+.+..+...
T Consensus       132 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~  211 (288)
T 1ob3_A          132 LINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLM  211 (288)
T ss_dssp             EECTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             EEcCCCCEEEeECccccccCccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            9999999999999999765432 223345789999999998766668999999999999999999999999999999999


Q ss_pred             HHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCC
Q 023609          159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  235 (280)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~  235 (280)
                      .+....+.+....+....+. ..+...........+....+.+++++++||++||+.||++|||+.++++||||++.
T Consensus       212 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  287 (288)
T 1ob3_A          212 RIFRILGTPNSKNWPNVTEL-PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKEN  287 (288)
T ss_dssp             HHHHHHCCCCTTTSTTGGGS-TTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC-
T ss_pred             HHHHHHCCCChhhchhhhcc-cccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence            99888887766544322211 01111122222334455567889999999999999999999999999999999863

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=3.8e-45  Score=308.57  Aligned_cols=230  Identities=38%  Similarity=0.695  Sum_probs=186.8

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++...     ...|+||||++|++.+.+.. ++.+++..++.++.||+.||+|||++||+||||||+||
T Consensus        58 l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Ni  132 (292)
T 3o0g_A           58 LKHKNIVRLHDVLHSD-----KKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNL  132 (292)
T ss_dssp             CCCTTBCCEEEEEEET-----TEEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred             CCCCCEeeEEeEEEeC-----CEEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence            5899999999999765     67999999999988887765 56899999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCC-CccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCC-CCCCChHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL-FPGRDHVHQL  157 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p-f~~~~~~~~~  157 (280)
                      +++.++.++|+|||.+...+.. .......+|+.|+|||++.+...++.++||||+||++++|++|..| |.+.+..+..
T Consensus       133 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~  212 (292)
T 3o0g_A          133 LINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL  212 (292)
T ss_dssp             EECTTSCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHH
T ss_pred             EEcCCCCEEEeecccceecCCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHH
Confidence            9999999999999999876533 2344567899999999987666689999999999999999976655 7788888899


Q ss_pred             HHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCc
Q 023609          158 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  236 (280)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~  236 (280)
                      ..+....+.+....+....... .+................+.+++++++||++||+.||++|||++|+++||||+++.
T Consensus       213 ~~i~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  290 (292)
T 3o0g_A          213 KRIFRLLGTPTEEQWPSMTKLP-DYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             HHHHHHHCCCCTTTCTTGGGST-TCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC-
T ss_pred             HHHHHHhCCCChhhhhhhcccc-cccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccCC
Confidence            9999988888776544322110 00000001112223445567899999999999999999999999999999999864

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.2e-44  Score=314.15  Aligned_cols=203  Identities=29%  Similarity=0.498  Sum_probs=176.9

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      |+||||+++++++.+.     ..+|+||||++ |+|.+++..++.+++..++.++.||+.||+|||+.||+||||||+||
T Consensus        72 l~hpnIv~l~~~~~~~-----~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NI  146 (361)
T 2yab_A           72 VLHPNIITLHDVYENR-----TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENI  146 (361)
T ss_dssp             CCCTTBCCEEEEEECS-----SEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred             CCCcCCCcEEEEEEeC-----CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHE
Confidence            5799999999999765     77999999996 79999999888999999999999999999999999999999999999


Q ss_pred             EEccCC----CEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 023609           80 LLNANC----DLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVH  155 (280)
Q Consensus        80 li~~~~----~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~  155 (280)
                      +++.++    .++|+|||++.............||+.|+|||++.+ ..++.++||||+||++|+|++|.+||.+.+..+
T Consensus       147 ll~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~  225 (361)
T 2yab_A          147 MLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQE  225 (361)
T ss_dssp             EESCTTSSSCCEEECCCSSCEECCTTCCCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH
T ss_pred             EEeCCCCCccCEEEEecCCceEcCCCCccccCCCCccEECchHHcC-CCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence            998776    799999999988766655566789999999999854 458999999999999999999999999888777


Q ss_pred             HHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCC
Q 023609          156 QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  235 (280)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~  235 (280)
                      ....+.......+.                          ..++.+++++++||++||+.||.+|||+.++++||||+..
T Consensus       226 ~~~~i~~~~~~~~~--------------------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  279 (361)
T 2yab_A          226 TLANITAVSYDFDE--------------------------EFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV  279 (361)
T ss_dssp             HHHHHHTTCCCCCH--------------------------HHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCS
T ss_pred             HHHHHHhcCCCCCc--------------------------hhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCC
Confidence            76666543222221                          1234788999999999999999999999999999999864

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=3.8e-45  Score=312.18  Aligned_cols=233  Identities=35%  Similarity=0.697  Sum_probs=187.6

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHcC------CCCCHHHHHHHHHHHHHHHHHHHHCCceeccC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN------QALSEEHCQYFLYQILRGLKYIHSANVLHRDL   74 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~------~~l~~~~~~~i~~qll~al~~LH~~gi~H~di   74 (280)
                      |+||||+++++++...     +..|+||||++|+|.+++...      ..+++..++.++.||+.||+|||+.||+||||
T Consensus        60 l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dl  134 (317)
T 2pmi_A           60 LKHENIVRLYDVIHTE-----NKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDL  134 (317)
T ss_dssp             CCBTTBCCEEEEECCT-----TEEEEEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred             cCCCCcceEEEEEEEC-----CeEEEEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCC
Confidence            5899999999999765     679999999999999998743      35999999999999999999999999999999


Q ss_pred             CCCcEEEccCCCEEEeeccceeeccCC-CccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh
Q 023609           75 KPSNLLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDH  153 (280)
Q Consensus        75 ~~~nili~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~  153 (280)
                      ||+||+++.+|.++|+|||++...... .......+|+.|+|||++.+...++.++||||+||++|+|++|..||.+.+.
T Consensus       135 kp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~  214 (317)
T 2pmi_A          135 KPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTND  214 (317)
T ss_dssp             CGGGEEECTTCCEEECCCSSCEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             ChHHeEEcCCCCEEECcCccceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence            999999999999999999999876533 2234567899999999987656689999999999999999999999999999


Q ss_pred             HHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCcccccc-----ccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          154 VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQS-----FTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                      .+....+.+..+.+....+....... .+...........     .......+++++++||.+||+.||.+|||+.++++
T Consensus       215 ~~~~~~i~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          215 EEQLKLIFDIMGTPNESLWPSVTKLP-KYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             HHHHHHHHHHHCSCCTTTCGGGGGCT-TCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             HHHHHHHHHHhCCCChhHhhhhhhhh-hcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence            99999999988887765443222110 0000000000000     01122367899999999999999999999999999


Q ss_pred             CCCCCCCcCCC
Q 023609          229 HPYLGSLHDIS  239 (280)
Q Consensus       229 h~~~~~~~~~~  239 (280)
                      ||||+++....
T Consensus       294 hp~f~~~~~~~  304 (317)
T 2pmi_A          294 HPWFAEYYHHA  304 (317)
T ss_dssp             SGGGGGGCC--
T ss_pred             Chhhhcccchh
Confidence            99999876543

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.3e-45  Score=317.77  Aligned_cols=195  Identities=26%  Similarity=0.410  Sum_probs=160.5

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC----------------CCCCHHHHHHHHHHHHHHHHHH
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN----------------QALSEEHCQYFLYQILRGLKYI   64 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~----------------~~l~~~~~~~i~~qll~al~~L   64 (280)
                      +|||||++++++..+.    ..+|||||||+ |+|.+++++.                ..+++..+..++.||+.||+||
T Consensus       126 hhpnIV~l~g~~~~~~----~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yL  201 (353)
T 4ase_A          126 HHLNVVNLLGACTKPG----GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL  201 (353)
T ss_dssp             CCTTBCCEEEEECCTT----SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHH
T ss_pred             CCCcEEEEEEEEEecC----CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhH
Confidence            4599999999986542    46899999998 7999999753                3489999999999999999999


Q ss_pred             HHCCceeccCCCCcEEEccCCCEEEeeccceeeccCCC---ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHH
Q 023609           65 HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL  141 (280)
Q Consensus        65 H~~gi~H~di~~~nili~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l  141 (280)
                      |+++|+||||||+||+++.++.+||+|||+++......   ......+|+.|+|||++.+. .++.++||||+||++|||
T Consensus       202 H~~~iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~-~y~~ksDVwS~Gv~l~El  280 (353)
T 4ase_A          202 ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEI  280 (353)
T ss_dssp             HHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHH
T ss_pred             hhCCeecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcC-CCCCcccEeehHHHHHHH
Confidence            99999999999999999999999999999998654332   22345789999999998654 589999999999999999


Q ss_pred             Hh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCC
Q 023609          142 MD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQR  220 (280)
Q Consensus       142 l~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R  220 (280)
                      ++ |..||.+.+..+.+..+......+.                            .-+.+++++.++|.+||+.||++|
T Consensus       281 ~t~G~~Pf~~~~~~~~~~~~i~~g~~~~----------------------------~p~~~~~~~~~li~~c~~~dP~~R  332 (353)
T 4ase_A          281 FSLGASPYPGVKIDEEFCRRLKEGTRMR----------------------------APDYTTPEMYQTMLDCWHGEPSQR  332 (353)
T ss_dssp             TTTSCCSSTTCCCSHHHHHHHHHTCCCC----------------------------CCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred             HhCCCCCCCCCCHHHHHHHHHHcCCCCC----------------------------CCccCCHHHHHHHHHHcCcChhHC
Confidence            98 8999988765444333332221111                            112578899999999999999999


Q ss_pred             CCHHHHhcC
Q 023609          221 ITVEDALAH  229 (280)
Q Consensus       221 ~t~~ell~h  229 (280)
                      ||+.++++|
T Consensus       333 Pt~~eil~~  341 (353)
T 4ase_A          333 PTFSELVEH  341 (353)
T ss_dssp             CCHHHHHHH
T ss_pred             cCHHHHHHH
Confidence            999999987

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=5.1e-44  Score=304.08  Aligned_cols=234  Identities=32%  Similarity=0.673  Sum_probs=184.7

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++...     ...++||||+++ +|.+++...+.+++..++.++.|++.||+|||++|++||||||+||
T Consensus        59 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Ni  133 (311)
T 4agu_A           59 LKHPNLVNLLEVFRRK-----RRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENI  133 (311)
T ss_dssp             CCCTTBCCEEEEEEET-----TEEEEEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred             CCCCCccchhheeecC-----CeEEEEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhE
Confidence            5899999999999665     679999999985 7888888778899999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCC-CccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  158 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.++.++|+|||.+...... .......+++.|+|||++.+...++.++||||+||++++|++|..||.+....+...
T Consensus       134 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~  213 (311)
T 4agu_A          134 LITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLY  213 (311)
T ss_dssp             EECTTSCEEECCCTTCEECC------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             EEcCCCCEEEeeCCCchhccCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            9999999999999999875533 233456789999999998766668999999999999999999999999999999988


Q ss_pred             HHHHHhCCCCHHHHhHhhHhHHHHhhhcCc-cccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCcC
Q 023609          159 LLIELIGTPSEAELGFLNENAKKYICQLPR-YQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD  237 (280)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~~  237 (280)
                      .+.+..+.....................+. .........++.+++++.+||.+||+.||.+|||++++++||||+++..
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  293 (311)
T 4agu_A          214 LIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIRE  293 (311)
T ss_dssp             HHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC-
T ss_pred             HHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccC
Confidence            888888877665433322111100001111 1112234455789999999999999999999999999999999999865


Q ss_pred             CC
Q 023609          238 IS  239 (280)
Q Consensus       238 ~~  239 (280)
                      ..
T Consensus       294 ~~  295 (311)
T 4agu_A          294 IE  295 (311)
T ss_dssp             --
T ss_pred             HH
Confidence            44

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=2.1e-44  Score=318.95  Aligned_cols=238  Identities=34%  Similarity=0.685  Sum_probs=192.0

Q ss_pred             CCCCCeeeeeceecCCCC-CCCCcEEEEeecCCccHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCC
Q 023609            1 MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIR----SNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK   75 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~-~~~~~~~iv~e~~~g~L~~~l~----~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~   75 (280)
                      |+||||+++++++..... .+...+++||||++++|.+.+.    .+..+++..++.++.||+.||+|||++||+|||||
T Consensus       104 l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlk  183 (420)
T 1j1b_A          104 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIK  183 (420)
T ss_dssp             CCCTTBCCEEEEEEEEETTTTEEEEEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCS
T ss_pred             cCCCCccceeeEEeccCCCCcceeEEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCC
Confidence            589999999999855321 1224478999999998877764    35679999999999999999999999999999999


Q ss_pred             CCcEEEccC-CCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH
Q 023609           76 PSNLLLNAN-CDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHV  154 (280)
Q Consensus        76 ~~nili~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  154 (280)
                      |+||+++.+ +.+||+|||+++............+|+.|+|||++.+...++.++||||+||++|+|++|++||.+.+..
T Consensus       184 p~NILl~~~~~~~kl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~  263 (420)
T 1j1b_A          184 PQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV  263 (420)
T ss_dssp             GGGEEEETTTTEEEECCCTTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             hhhEEEeCCCCeEEeccchhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH
Confidence            999999965 5689999999987655544556688999999999876656899999999999999999999999999999


Q ss_pred             HHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccC-CCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCC
Q 023609          155 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF-PNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLG  233 (280)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~  233 (280)
                      +.+..+.+.++.|....+.........+  ..+......+...+ +.+++++++||++||+.||.+|||+.|+++||||+
T Consensus       264 ~~l~~i~~~lg~p~~~~~~~~~~~~~~~--~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~  341 (420)
T 1j1b_A          264 DQLVEIIKVLGTPTREQIREMNPNYTEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFD  341 (420)
T ss_dssp             HHHHHHHHHHCSCCHHHHHHHCSCCCCC--CCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGG
T ss_pred             HHHHHHHHHhCCCCHHHHHhhChhhhhh--ccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhc
Confidence            9999999999999876654332111110  12222222333333 46789999999999999999999999999999999


Q ss_pred             CCcCCCC
Q 023609          234 SLHDISD  240 (280)
Q Consensus       234 ~~~~~~~  240 (280)
                      .+..+..
T Consensus       342 ~~~~~~~  348 (420)
T 1j1b_A          342 ELRDPNV  348 (420)
T ss_dssp             GGGCTTC
T ss_pred             ccccccc
Confidence            8876543

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.9e-44  Score=315.69  Aligned_cols=235  Identities=33%  Similarity=0.700  Sum_probs=192.0

Q ss_pred             CCCCCeeeeeceecCCCC---------------------------------CCCCcEEEEeecCCccHHHHHH----cCC
Q 023609            1 MDHENVVAIRDIIPPPQR---------------------------------ESFNDVYIAYELMDTDLHQIIR----SNQ   43 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~---------------------------------~~~~~~~iv~e~~~g~L~~~l~----~~~   43 (280)
                      |+||||+++++++.....                                 .+....++||||++|+|.+.+.    .++
T Consensus        57 l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~  136 (383)
T 3eb0_A           57 LDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGR  136 (383)
T ss_dssp             CCCTTBCCEEEEEEEC-------------------------------------CCEEEEEECCCSEEHHHHHHHHHHTTC
T ss_pred             cCCCCccchhheeeecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCCccHHHHHHHHHhcCC
Confidence            589999999999855421                                 2224589999999998777765    457


Q ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEc-cCCCEEEeeccceeeccCCCccccceeccccccchhccCC
Q 023609           44 ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN-ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNS  122 (280)
Q Consensus        44 ~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  122 (280)
                      .+++..++.++.||+.||+|||+.||+||||||+||+++ .++.++|+|||++.............+++.|+|||.+.+.
T Consensus       137 ~l~~~~~~~i~~qi~~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~  216 (383)
T 3eb0_A          137 SIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGA  216 (383)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTC
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCC
Confidence            899999999999999999999999999999999999997 6889999999999877666555667889999999998766


Q ss_pred             CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCC-CC
Q 023609          123 SDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP-NV  201 (280)
Q Consensus       123 ~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~  201 (280)
                      ..++.++||||+||++|+|++|.+||.+.+..+.+..+.+..+.|....+...+.....  ...+......+...++ .+
T Consensus       217 ~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~  294 (383)
T 3eb0_A          217 TEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTE--VRFPTLKAKDWRKILPEGT  294 (383)
T ss_dssp             SSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC----CCCCCCCCCCHHHHSCTTC
T ss_pred             CCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCccccc--ccCCccCcccHHhhCCCCC
Confidence            66899999999999999999999999999999999999999999988765433221111  1122222333334444 47


Q ss_pred             ChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCcC
Q 023609          202 HPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD  237 (280)
Q Consensus       202 ~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~~  237 (280)
                      ++++++||.+||+.||.+|||+.|+++||||+.++.
T Consensus       295 ~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~  330 (383)
T 3eb0_A          295 PSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHLRN  330 (383)
T ss_dssp             CHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGHHHHH
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHhcCHHHHHHHh
Confidence            899999999999999999999999999999987643

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=8.6e-45  Score=311.56  Aligned_cols=229  Identities=33%  Similarity=0.686  Sum_probs=180.2

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   80 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nil   80 (280)
                      |+||||+++++++...     ...|+||||++|+|.+++..++.+++..++.++.||+.||+|||++||+||||||+||+
T Consensus        90 l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIl  164 (329)
T 3gbz_A           90 LQHRNIIELKSVIHHN-----HRLHLIFEYAENDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLL  164 (329)
T ss_dssp             CCCTTBCCEEEEEEET-----TEEEEEEECCSEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred             cCCCCcceEEEEEecC-----CEEEEEEecCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEE
Confidence            5899999999999765     67999999999999999999889999999999999999999999999999999999999


Q ss_pred             Ec-----cCCCEEEeeccceeeccCC-CccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH
Q 023609           81 LN-----ANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHV  154 (280)
Q Consensus        81 i~-----~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  154 (280)
                      ++     .++.++|+|||++...... .......+|+.|+|||++.+...++.++||||+||++|+|++|..||.+.+..
T Consensus       165 l~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~  244 (329)
T 3gbz_A          165 LSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEI  244 (329)
T ss_dssp             EEC-----CCEEEECCTTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             EecCCCCccceEEECcCCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHH
Confidence            94     4455999999999765433 22344567999999999876666899999999999999999999999999999


Q ss_pred             HHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccC-CCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCC
Q 023609          155 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF-PNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLG  233 (280)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~  233 (280)
                      +.+..+....+.+....+....... .+....+........... ..+++++++||.+||+.||.+|||+.|+++||||+
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~  323 (329)
T 3gbz_A          245 DQLFKIFEVLGLPDDTTWPGVTALP-DWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFS  323 (329)
T ss_dssp             HHHHHHHHHHCCCCTTTSTTGGGST-TCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGS
T ss_pred             HHHHHHHHHhCCCchhhhhhhhhhh-hhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccC
Confidence            9999999988887765433221100 000111111111111111 13688999999999999999999999999999998


Q ss_pred             CC
Q 023609          234 SL  235 (280)
Q Consensus       234 ~~  235 (280)
                      +.
T Consensus       324 ~~  325 (329)
T 3gbz_A          324 HN  325 (329)
T ss_dssp             SS
T ss_pred             CC
Confidence            75

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.1e-43  Score=305.33  Aligned_cols=199  Identities=27%  Similarity=0.476  Sum_probs=171.9

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++...     ..+|+||||++ |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+||
T Consensus        62 l~hp~iv~l~~~~~~~-----~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NI  136 (337)
T 1o6l_A           62 TRHPFLTALKYAFQTH-----DRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENL  136 (337)
T ss_dssp             CCCTTBCCEEEEEECS-----SEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGE
T ss_pred             CCCCcCcceEEEEEeC-----CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHE
Confidence            5799999999999766     67999999997 59999998888899999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeecc-CCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  158 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.+|.++|+|||+++... ........+||+.|+|||++.+. .++.++|+||+||++|+|++|..||.+.+......
T Consensus       137 ll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~  215 (337)
T 1o6l_A          137 MLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE  215 (337)
T ss_dssp             EECTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSS-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             EECCCCCEEEeeccchhhcccCCCcccccccChhhCChhhhcCC-CCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHH
Confidence            99999999999999997633 23344567899999999998544 58999999999999999999999998877666555


Q ss_pred             HHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCC-----CHHHHhcCCCCC
Q 023609          159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI-----TVEDALAHPYLG  233 (280)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~ell~h~~~~  233 (280)
                      .+......                              .-..+++++++||.+||+.||.+||     ++.++++||||.
T Consensus       216 ~i~~~~~~------------------------------~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~  265 (337)
T 1o6l_A          216 LILMEEIR------------------------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL  265 (337)
T ss_dssp             HHHHCCCC------------------------------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGT
T ss_pred             HHHcCCCC------------------------------CCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcC
Confidence            54331100                              0125789999999999999999999     999999999998


Q ss_pred             CC
Q 023609          234 SL  235 (280)
Q Consensus       234 ~~  235 (280)
                      ++
T Consensus       266 ~~  267 (337)
T 1o6l_A          266 SI  267 (337)
T ss_dssp             TC
T ss_pred             CC
Confidence            75

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.6e-43  Score=303.40  Aligned_cols=203  Identities=30%  Similarity=0.506  Sum_probs=175.3

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      |+||||+++++++...     ...|+||||++ |+|.+++...+.+++..++.++.||+.||+|||+.|++||||||+||
T Consensus        71 l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NI  145 (326)
T 2y0a_A           71 IQHPNVITLHEVYENK-----TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENI  145 (326)
T ss_dssp             CCCTTBCCEEEEEECS-----SEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred             CCCCCCCcEEEEEEeC-----CEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHE
Confidence            5899999999999765     67999999996 69999998888899999999999999999999999999999999999


Q ss_pred             EEccCC----CEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 023609           80 LLNANC----DLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVH  155 (280)
Q Consensus        80 li~~~~----~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~  155 (280)
                      +++.++    .++|+|||++.............+|+.|+|||++.+ ..++.++||||+||++|+|++|..||.+....+
T Consensus       146 ll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~  224 (326)
T 2y0a_A          146 MLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQE  224 (326)
T ss_dssp             EESCSSSSSCCEEECCCTTCEECCTTSCCCCCCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH
T ss_pred             EEecCCCCCCCEEEEECCCCeECCCCCccccccCCcCcCCceeecC-CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHH
Confidence            998877    799999999987765544556789999999998854 458899999999999999999999999887776


Q ss_pred             HHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCC
Q 023609          156 QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  235 (280)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~  235 (280)
                      ....+.........                          ..++.+++.+++||++||+.||.+|||+.++++||||+..
T Consensus       225 ~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~  278 (326)
T 2y0a_A          225 TLANVSAVNYEFED--------------------------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK  278 (326)
T ss_dssp             HHHHHHHTCCCCCH--------------------------HHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred             HHHHHHhcCCCcCc--------------------------cccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence            66655443222221                          1224678899999999999999999999999999999864

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8e-44  Score=307.59  Aligned_cols=232  Identities=35%  Similarity=0.666  Sum_probs=189.7

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      |+||||+++++++...     ...++||||++++|.+++..+ ..+++..++.++.|++.||+|||+.|++||||||+||
T Consensus        69 l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Ni  143 (346)
T 1ua2_A           69 LSHPNIIGLLDAFGHK-----SNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNL  143 (346)
T ss_dssp             CCCTTBCCEEEEECCT-----TCCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred             CCCCCCCeEEEEEeeC-----CceEEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHE
Confidence            5799999999999665     678999999999999998765 3699999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCC-CccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  158 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.+|.++|+|||++...... .......+|+.|+|||++.+...++.++||||+||++|+|++|.+||.+.+..+.+.
T Consensus       144 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~  223 (346)
T 1ua2_A          144 LLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLT  223 (346)
T ss_dssp             EECTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             EEcCCCCEEEEecccceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence            9999999999999999865433 233456789999999998665568899999999999999999999999999999999


Q ss_pred             HHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCcCC
Q 023609          159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDI  238 (280)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~~~  238 (280)
                      .+....+.+....+........ + ..............++.++.++++||++||+.||.+|||+.|+++||||.+...+
T Consensus       224 ~i~~~~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~  301 (346)
T 1ua2_A          224 RIFETLGTPTEEQWPDMCSLPD-Y-VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP  301 (346)
T ss_dssp             HHHHHHCCCCTTTSSSTTSSTT-C-CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCC
T ss_pred             HHHHHcCCCChhhhhhhccCcc-c-ccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCC
Confidence            9999888877654322111000 0 0011111222334556788999999999999999999999999999999886543


Q ss_pred             C
Q 023609          239 S  239 (280)
Q Consensus       239 ~  239 (280)
                      .
T Consensus       302 ~  302 (346)
T 1ua2_A          302 T  302 (346)
T ss_dssp             C
T ss_pred             C
Confidence            3

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=2.2e-45  Score=315.74  Aligned_cols=200  Identities=27%  Similarity=0.506  Sum_probs=169.5

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   80 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nil   80 (280)
                      ++||||+++++++..+     ...|+||||++|+|.+++..++.+++.+++.++.||+.||+|||+.|++||||||+||+
T Consensus        66 l~hpnIv~l~~~~~~~-----~~~~lv~E~~~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIl  140 (336)
T 3h4j_B           66 LRHPHIIKLYDVITTP-----TDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLL  140 (336)
T ss_dssp             CCCTTBCCEEEEEECS-----SEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEE
T ss_pred             CCCCCCCeEEEEEEeC-----CEEEEEEECCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEE
Confidence            5899999999999766     67999999999999999988889999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 023609           81 LNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL  160 (280)
Q Consensus        81 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~  160 (280)
                      ++.++.++|+|||++............++|+.|+|||++.+....+.++||||+||++|+|++|..||.+.........+
T Consensus       141 l~~~~~~kl~DFG~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i  220 (336)
T 3h4j_B          141 LDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV  220 (336)
T ss_dssp             ECTTCCEEECCSSCTBTTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC
T ss_pred             EcCCCCEEEEEeccceeccCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH
Confidence            99999999999999987766655567789999999999866554478999999999999999999999764321110000


Q ss_pred             HHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCC
Q 023609          161 IELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  235 (280)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~  235 (280)
                                                    .......-+.+++++++||++||+.||.+|||+.|+++||||+..
T Consensus       221 ------------------------------~~~~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  265 (336)
T 3h4j_B          221 ------------------------------NSCVYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN  265 (336)
T ss_dssp             ------------------------------CSSCCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTT
T ss_pred             ------------------------------HcCCCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccC
Confidence                                          000001113578999999999999999999999999999999863

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.9e-44  Score=306.44  Aligned_cols=204  Identities=24%  Similarity=0.441  Sum_probs=176.8

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ-ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~-~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      ++||||+++++++.+.     ...|+||||++ |+|.+++...+ .+++.+++.++.||+.||+|||++|++||||||+|
T Consensus        58 l~hpnIv~~~~~~~~~-----~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~N  132 (321)
T 1tki_A           58 ARHRNILHLHESFESM-----EELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPEN  132 (321)
T ss_dssp             SCCTTBCCEEEEEEET-----TEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred             CCCCCCCeEeEEEecC-----CEEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHH
Confidence            5899999999999665     67999999997 59999997654 79999999999999999999999999999999999


Q ss_pred             EEEcc--CCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023609           79 LLLNA--NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ  156 (280)
Q Consensus        79 ili~~--~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  156 (280)
                      |+++.  ++.++|+|||++.............+++.|+|||++.+. .++.++||||+||++|+|++|..||.+.+..+.
T Consensus       133 Il~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  211 (321)
T 1tki_A          133 IIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHD-VVSTATDMWSLGTLVYVLLSGINPFLAETNQQI  211 (321)
T ss_dssp             EEESSSSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTC-EECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred             EEEccCCCCCEEEEECCCCeECCCCCccccccCChhhcCcHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHH
Confidence            99987  789999999999887665555567789999999998543 478999999999999999999999998888777


Q ss_pred             HHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCc
Q 023609          157 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  236 (280)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~  236 (280)
                      ...+.......+..                          .++.++.++++||.+||+.||.+|||+.|+++||||++..
T Consensus       212 ~~~i~~~~~~~~~~--------------------------~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  265 (321)
T 1tki_A          212 IENIMNAEYTFDEE--------------------------AFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKI  265 (321)
T ss_dssp             HHHHHHTCCCCCHH--------------------------HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred             HHHHHcCCCCCChh--------------------------hhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccCc
Confidence            77666544333321                          2347889999999999999999999999999999998753

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=3.4e-44  Score=310.44  Aligned_cols=198  Identities=21%  Similarity=0.418  Sum_probs=168.7

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nil   80 (280)
                      +||||+++++++.+.     ..+|+||||++ |+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||+
T Consensus        82 ~hp~Iv~l~~~~~~~-----~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIL  156 (353)
T 3txo_A           82 NHPFLTQLFCCFQTP-----DRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVL  156 (353)
T ss_dssp             TCTTBCCEEEEEECS-----SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEE
T ss_pred             CCCceeeEEEEEEeC-----CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEE
Confidence            699999999999766     67999999997 599999998889999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccceeeccC-CCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023609           81 LNANCDLKICDFGLARVTSE-TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  159 (280)
Q Consensus        81 i~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      ++.+|.++|+|||+++.... .......+||+.|+|||++.+. .++.++|+||+||++|+|++|..||.+.+..+....
T Consensus       157 l~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~  235 (353)
T 3txo_A          157 LDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEM-LYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEA  235 (353)
T ss_dssp             ECTTSCEEECCCTTCBCSCC---------CCGGGCCHHHHHHH-HCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             ECCCCCEEEccccceeecccCCccccccCCCcCeEChhhcCCC-CcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            99999999999999975332 2334456899999999998544 478999999999999999999999999888777776


Q ss_pred             HHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCH------HHHhcCCCCC
Q 023609          160 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV------EDALAHPYLG  233 (280)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~------~ell~h~~~~  233 (280)
                      +.......+                              +.+++++++||++||+.||.+||++      .++++||||+
T Consensus       236 i~~~~~~~p------------------------------~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~  285 (353)
T 3txo_A          236 ILNDEVVYP------------------------------TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFK  285 (353)
T ss_dssp             HHHCCCCCC------------------------------TTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGT
T ss_pred             HHcCCCCCC------------------------------CCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCccc
Confidence            654211111                              2478899999999999999999999      8999999999


Q ss_pred             CC
Q 023609          234 SL  235 (280)
Q Consensus       234 ~~  235 (280)
                      ++
T Consensus       286 ~~  287 (353)
T 3txo_A          286 EI  287 (353)
T ss_dssp             TC
T ss_pred             CC
Confidence            75

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-43  Score=301.43  Aligned_cols=197  Identities=24%  Similarity=0.477  Sum_probs=172.3

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++.+.     ..+|+||||++ |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+||
T Consensus        63 l~hp~Iv~~~~~~~~~-----~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NI  137 (318)
T 1fot_A           63 VTHPFIIRMWGTFQDA-----QQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENI  137 (318)
T ss_dssp             CCBTTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGE
T ss_pred             CCCCCCceEeEEEEeC-----CEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheE
Confidence            5799999999999765     67999999997 59999999888999999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  159 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      +++.+|.++|+|||++......  ....++|+.|+|||++.+ ..++.++|+||+||++|+|++|..||.+.+.......
T Consensus       138 ll~~~g~~kL~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~  214 (318)
T 1fot_A          138 LLDKNGHIKITDFGFAKYVPDV--TYTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEK  214 (318)
T ss_dssp             EECTTSCEEECCCSSCEECSSC--BCCCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH
T ss_pred             EEcCCCCEEEeecCcceecCCc--cccccCCccccCHhHhcC-CCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            9999999999999999876543  345678999999999854 4588999999999999999999999988877766665


Q ss_pred             HHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCC-----CHHHHhcCCCCCC
Q 023609          160 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI-----TVEDALAHPYLGS  234 (280)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~ell~h~~~~~  234 (280)
                      +......                              .-+.++++++++|++||+.||++||     +++++++||||++
T Consensus       215 i~~~~~~------------------------------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~  264 (318)
T 1fot_A          215 ILNAELR------------------------------FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE  264 (318)
T ss_dssp             HHHCCCC------------------------------CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred             HHhCCCC------------------------------CCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccC
Confidence            5432111                              0125788999999999999999999     9999999999987


Q ss_pred             C
Q 023609          235 L  235 (280)
Q Consensus       235 ~  235 (280)
                      +
T Consensus       265 ~  265 (318)
T 1fot_A          265 V  265 (318)
T ss_dssp             C
T ss_pred             C
Confidence            5

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=3e-43  Score=312.90  Aligned_cols=203  Identities=31%  Similarity=0.497  Sum_probs=174.5

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      |+||||+++++++.+.     ...|+||||+. |+|.+.+..++.+++..+..++.||+.||+|||++||+||||||+||
T Consensus        67 l~hpnIv~l~~~~~~~-----~~~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NI  141 (444)
T 3soa_A           67 LKHPNIVRLHDSISEE-----GHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENL  141 (444)
T ss_dssp             CCBTTBCCEEEEEECS-----SEEEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTE
T ss_pred             CCCcCCCeEEEEEEEC-----CEEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHE
Confidence            5899999999999765     78999999997 59999999989999999999999999999999999999999999999


Q ss_pred             EEc---cCCCEEEeeccceeeccCCC-ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 023609           80 LLN---ANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVH  155 (280)
Q Consensus        80 li~---~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~  155 (280)
                      +++   .++.++|+|||++....... ......||+.|+|||++.+ ..++.++||||+||++|+|++|.+||.+.+...
T Consensus       142 ll~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~  220 (444)
T 3soa_A          142 LLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRK-DPYGKPVDLWACGVILYILLVGYPPFWDEDQHR  220 (444)
T ss_dssp             EESBSSTTCCEEECCCSSCBCCCTTCCBCCCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             EEeccCCCCcEEEccCceeEEecCCCceeecccCCcccCCHHHhcC-CCCCCccccHHHHHHHHHHHhCCCCCCCccHHH
Confidence            998   45889999999997655432 2345679999999999854 458999999999999999999999999888777


Q ss_pred             HHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCC
Q 023609          156 QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  235 (280)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~  235 (280)
                      ....+.......+.                          ..++.+++++++||.+||+.||.+|||+.++|+||||+..
T Consensus       221 ~~~~i~~~~~~~~~--------------------------~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~  274 (444)
T 3soa_A          221 LYQQIKAGAYDFPS--------------------------PEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHR  274 (444)
T ss_dssp             HHHHHHHTCCCCCT--------------------------TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHH
T ss_pred             HHHHHHhCCCCCCc--------------------------cccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCC
Confidence            76666543322221                          2235788999999999999999999999999999999753

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1.8e-43  Score=305.81  Aligned_cols=241  Identities=34%  Similarity=0.582  Sum_probs=185.4

Q ss_pred             CCCCCeeeeeceecCCCC---CCCCcEEEEeecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCC
Q 023609            1 MDHENVVAIRDIIPPPQR---ESFNDVYIAYELMDTDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKP   76 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~---~~~~~~~iv~e~~~g~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~   76 (280)
                      ++||||+++++++.....   ...+..|+||||++|+|.+.+... ..+++.+++.++.||+.||+|||++||+||||||
T Consensus        73 l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp  152 (351)
T 3mi9_A           73 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKA  152 (351)
T ss_dssp             CCCTTBCCEEEEEEEC--------CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred             ccCCCcccHhheeeccccccccCCceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCH
Confidence            589999999999866421   112568999999999999888754 5799999999999999999999999999999999


Q ss_pred             CcEEEccCCCEEEeeccceeeccCC-----CccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 023609           77 SNLLLNANCDLKICDFGLARVTSET-----DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGR  151 (280)
Q Consensus        77 ~nili~~~~~~~l~dfg~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~  151 (280)
                      +||+++.++.++|+|||++......     .......+|+.|+|||++.+...++.++||||+||++|+|++|.+||.+.
T Consensus       153 ~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~  232 (351)
T 3mi9_A          153 ANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN  232 (351)
T ss_dssp             GGEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             HHEEEcCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCC
Confidence            9999999999999999999765422     22344577999999999876666899999999999999999999999999


Q ss_pred             ChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCC--CCChHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 023609          152 DHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP--NVHPSAIDLVEKMLTFDPRQRITVEDALAH  229 (280)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~L~~dp~~R~t~~ell~h  229 (280)
                      +.......+....+.++...+...........................  ..++++++||.+||+.||.+|||+.|+++|
T Consensus       233 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  312 (351)
T 3mi9_A          233 TEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  312 (351)
T ss_dssp             SHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence            999999999888887766543322111000000000000000000000  136789999999999999999999999999


Q ss_pred             CCCCCCcCCCCC
Q 023609          230 PYLGSLHDISDE  241 (280)
Q Consensus       230 ~~~~~~~~~~~~  241 (280)
                      |||.+...++..
T Consensus       313 p~f~~~~~~~~~  324 (351)
T 3mi9_A          313 DFFWSDPMPSDL  324 (351)
T ss_dssp             GGGGSSSCCCCS
T ss_pred             CCcCCCCCcccc
Confidence            999987665543

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=2.4e-43  Score=300.60  Aligned_cols=241  Identities=44%  Similarity=0.781  Sum_probs=189.5

Q ss_pred             CCCCCeeeeeceecCCCC---------CCCCcEEEEeecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q 023609            1 MDHENVVAIRDIIPPPQR---------ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLH   71 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~---------~~~~~~~iv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H   71 (280)
                      |+||||+++++++..+..         ......|+||||++|+|.+++.. +++++..++.++.||+.||+|||++|++|
T Consensus        65 l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H  143 (320)
T 2i6l_A           65 LDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSANVLH  143 (320)
T ss_dssp             CCCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCBC
T ss_pred             cCCCCeeEEEEeccccccccccccccccccCceeEEeeccCCCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCCEec
Confidence            589999999999854321         22367899999999999999865 57999999999999999999999999999


Q ss_pred             ccCCCCcEEEc-cCCCEEEeeccceeeccCC----CccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCC
Q 023609           72 RDLKPSNLLLN-ANCDLKICDFGLARVTSET----DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP  146 (280)
Q Consensus        72 ~di~~~nili~-~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~  146 (280)
                      |||||+||+++ .++.++|+|||.+......    .......++..|+|||.+.+...++.++||||+||++|+|++|..
T Consensus       144 ~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~  223 (320)
T 2i6l_A          144 RDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKT  223 (320)
T ss_dssp             CCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred             CCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCC
Confidence            99999999997 5678999999999865422    122345668899999988765668999999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHH
Q 023609          147 LFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDA  226 (280)
Q Consensus       147 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~el  226 (280)
                      ||.+.........+......+..............+................+.++.++++||++||+.||.+|||+.++
T Consensus       224 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~el  303 (320)
T 2i6l_A          224 LFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEA  303 (320)
T ss_dssp             SSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHH
T ss_pred             CCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHH
Confidence            99999988888888887777666544333222222222222223334455667899999999999999999999999999


Q ss_pred             hcCCCCCCCcCCCCCC
Q 023609          227 LAHPYLGSLHDISDEP  242 (280)
Q Consensus       227 l~h~~~~~~~~~~~~~  242 (280)
                      ++||||+....+..+|
T Consensus       304 l~hp~~~~~~~p~~~~  319 (320)
T 2i6l_A          304 LSHPYMSIYSFPMDEP  319 (320)
T ss_dssp             HTSHHHHTTCC-----
T ss_pred             hCCcccccccCccCCC
Confidence            9999999876665544

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=3.5e-43  Score=304.77  Aligned_cols=240  Identities=33%  Similarity=0.602  Sum_probs=191.8

Q ss_pred             CCCCCeeeeeceecCCCCC--CCCcEEEEeecCCccHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHH--HCCceec
Q 023609            1 MDHENVVAIRDIIPPPQRE--SFNDVYIAYELMDTDLHQIIR----SNQALSEEHCQYFLYQILRGLKYIH--SANVLHR   72 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~--~~~~~~iv~e~~~g~L~~~l~----~~~~l~~~~~~~i~~qll~al~~LH--~~gi~H~   72 (280)
                      ++||||+++++++......  .....++||||++++|.+.+.    ....+++..++.++.|++.||.|||  +.||+||
T Consensus        76 l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~  155 (360)
T 3e3p_A           76 LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHR  155 (360)
T ss_dssp             HCCTTBCCEEEEEEEECSSCTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCS
T ss_pred             cCCCCcccHHHhhhccccccccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecC
Confidence            4799999999998654321  123478999999988776554    4567999999999999999999999  9999999


Q ss_pred             cCCCCcEEEcc-CCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 023609           73 DLKPSNLLLNA-NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGR  151 (280)
Q Consensus        73 di~~~nili~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~  151 (280)
                      ||||+||+++. ++.++|+|||++.............+|+.|+|||++.+...++.++||||+||++|+|++|..||.+.
T Consensus       156 Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~  235 (360)
T 3e3p_A          156 DIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGD  235 (360)
T ss_dssp             CCCGGGEEEETTTTEEEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cCCHHHEEEeCCCCcEEEeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCC
Confidence            99999999997 89999999999987766655556678999999999866666899999999999999999999999999


Q ss_pred             ChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCC----CCChHHHHHHHHhhcCCCCCCCCHHHHh
Q 023609          152 DHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP----NVHPSAIDLVEKMLTFDPRQRITVEDAL  227 (280)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~L~~dp~~R~t~~ell  227 (280)
                      +....+..+....+.++...+...........  ........+...++    ..++++++||.+||+.||.+|||+.|++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l  313 (360)
T 3e3p_A          236 NSAGQLHEIVRVLGCPSREVLRKLNPSHTDVD--LYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEAL  313 (360)
T ss_dssp             SHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGG--GGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHT
T ss_pred             ChHHHHHHHHHHcCCCCHHHHHhcccchhhcc--ccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHh
Confidence            99999999999999988765543322111100  01111112222232    3678899999999999999999999999


Q ss_pred             cCCCCCCCcCCCCCC
Q 023609          228 AHPYLGSLHDISDEP  242 (280)
Q Consensus       228 ~h~~~~~~~~~~~~~  242 (280)
                      +||||++...+....
T Consensus       314 ~hp~f~~~~~~~~~~  328 (360)
T 3e3p_A          314 CHPYFDELHDPATKL  328 (360)
T ss_dssp             TSGGGGGGGCTTCCC
T ss_pred             cCccccccCCccccC
Confidence            999999987655443

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=1.4e-43  Score=305.55  Aligned_cols=199  Identities=25%  Similarity=0.432  Sum_probs=171.9

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++.+.     ..+|+||||++ |+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||
T Consensus        75 ~~hp~iv~l~~~~~~~-----~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NI  149 (345)
T 1xjd_A           75 WEHPFLTHMFCTFQTK-----ENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNI  149 (345)
T ss_dssp             TTCTTBCCEEEEEECS-----SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGE
T ss_pred             CCCCCCCcEEEEEEeC-----CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhE
Confidence            3799999999999766     67999999996 69999999888899999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccC-CCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSE-TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  158 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.+|.++|+|||+++.... .......+||+.|+|||++.+. .++.++|+||+||++|+|++|..||.+.+..+...
T Consensus       150 ll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~  228 (345)
T 1xjd_A          150 LLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH  228 (345)
T ss_dssp             EECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             EECCCCCEEEeEChhhhhcccCCCcccCCCCCcccCChhhhcCC-CCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence            999999999999999975432 2234566899999999998654 48999999999999999999999999887766665


Q ss_pred             HHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHH-HHhcCCCCCCC
Q 023609          159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVE-DALAHPYLGSL  235 (280)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~-ell~h~~~~~~  235 (280)
                      .+......                              .-+.+++++++||.+||+.||++||++. ++++||||+++
T Consensus       229 ~i~~~~~~------------------------------~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~  276 (345)
T 1xjd_A          229 SIRMDNPF------------------------------YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI  276 (345)
T ss_dssp             HHHHCCCC------------------------------CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred             HHHhCCCC------------------------------CCcccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCC
Confidence            55331100                              0125788999999999999999999998 99999999976

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=2e-43  Score=306.80  Aligned_cols=203  Identities=30%  Similarity=0.518  Sum_probs=173.8

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      |+||||+++++++.+.     ...|+||||+. |+|.+++..++.+++..+..++.||+.||+|||++||+||||||+||
T Consensus        85 l~hpnIv~~~~~~~~~-----~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NI  159 (362)
T 2bdw_A           85 LQHPNIVRLHDSIQEE-----SFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENL  159 (362)
T ss_dssp             CCCTTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGE
T ss_pred             CCCCCCCeEEEEEEeC-----CEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHE
Confidence            5899999999999765     67999999997 59999999888899999999999999999999999999999999999


Q ss_pred             EEccC---CCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023609           80 LLNAN---CDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ  156 (280)
Q Consensus        80 li~~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  156 (280)
                      +++.+   +.++|+|||++.............+|+.|+|||++.+ ..++.++||||+||++|+|++|.+||.+.+....
T Consensus       160 ll~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~  238 (362)
T 2bdw_A          160 LLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL  238 (362)
T ss_dssp             EESCSSTTCCEEECCCTTCBCCTTCCSCCCSCSCTTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             EEecCCCCCCEEEeecCcceEecCCcccccCCCCccccCHHHHcc-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH
Confidence            99765   4599999999987765554556789999999999854 4588999999999999999999999998877666


Q ss_pred             HHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCC
Q 023609          157 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  235 (280)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~  235 (280)
                      ...+.......+.                          ..++.+++++++||.+||+.||.+|||+.++++||||...
T Consensus       239 ~~~i~~~~~~~~~--------------------------~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  291 (362)
T 2bdw_A          239 YAQIKAGAYDYPS--------------------------PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR  291 (362)
T ss_dssp             HHHHHHTCCCCCT--------------------------TGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred             HHHHHhCCCCCCc--------------------------ccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence            6655443222111                          1223678899999999999999999999999999999764

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=5.9e-43  Score=299.32  Aligned_cols=233  Identities=37%  Similarity=0.664  Sum_probs=190.4

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ--ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~--~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      ++||||+++++++...........++||||++|+|.+++....  .+++..++.++.||+.||+|||+.|++||||||+|
T Consensus        71 ~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~N  150 (326)
T 1blx_A           71 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQN  150 (326)
T ss_dssp             TCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGG
T ss_pred             cCCCCeEeeeeeeeecccCCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHH
Confidence            4799999999998643222336799999999999999998643  49999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023609           79 LLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  158 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  158 (280)
                      |+++.++.++|+|||.+.............+++.|+|||++.+. .++.++||||+||++|+|++|..||.+.+....+.
T Consensus       151 ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~  229 (326)
T 1blx_A          151 ILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQS-SYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLG  229 (326)
T ss_dssp             EEECTTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             eEEcCCCCEEEecCcccccccCCCCccccccccceeCHHHHhcC-CCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            99999999999999999876544444556789999999998544 48899999999999999999999999999999999


Q ss_pred             HHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCcC
Q 023609          159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD  237 (280)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~~  237 (280)
                      .+.+..+.+....+........   ...............+.++..+++||.+||+.||.+|||+.++++||||+++..
T Consensus       230 ~i~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~  305 (326)
T 1blx_A          230 KILDVIGLPGEEDWPRDVALPR---QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER  305 (326)
T ss_dssp             HHHHHHCCCCGGGSCTTCSSCG---GGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred             HHHHHcCCCCcccCccccccch---hhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccch
Confidence            9998888777654321110000   011111223344556788999999999999999999999999999999998754

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=4.1e-43  Score=307.44  Aligned_cols=198  Identities=24%  Similarity=0.489  Sum_probs=165.8

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nil   80 (280)
                      +||||+++++++.+.     ..+|+||||++ |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+||+
T Consensus       111 ~hp~Iv~l~~~~~~~-----~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NIL  185 (396)
T 4dc2_A          111 NHPFLVGLHSCFQTE-----SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVL  185 (396)
T ss_dssp             TCTTBCCEEEEEECS-----SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEE
T ss_pred             CCCCcCeeEEEEEEC-----CEEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEE
Confidence            799999999999766     67999999997 599999998889999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccceeec-cCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH----
Q 023609           81 LNANCDLKICDFGLARVT-SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVH----  155 (280)
Q Consensus        81 i~~~~~~~l~dfg~~~~~-~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~----  155 (280)
                      ++.+|.++|+|||+++.. .........+||+.|+|||++.+. .++.++|+||+||++|+|++|..||.+.....    
T Consensus       186 l~~~g~ikL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~-~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~  264 (396)
T 4dc2_A          186 LDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ  264 (396)
T ss_dssp             ECTTSCEEECCCTTCBCCCCTTCCBCCCCBCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------
T ss_pred             ECCCCCEEEeecceeeecccCCCccccccCCcccCCchhhcCC-CCChHHHHHHHHHHHHHHHhCCCCCcccccccccch
Confidence            999999999999999863 333445567899999999998654 58999999999999999999999996532211    


Q ss_pred             -----HHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCH------H
Q 023609          156 -----QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV------E  224 (280)
Q Consensus       156 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~------~  224 (280)
                           ....+..                      ...        ..-+.+++++++||++||+.||.+||++      .
T Consensus       265 ~~~~~~~~~i~~----------------------~~~--------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~  314 (396)
T 4dc2_A          265 NTEDYLFQVILE----------------------KQI--------RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFA  314 (396)
T ss_dssp             CCHHHHHHHHHH----------------------CCC--------CCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHH
T ss_pred             hhHHHHHHHHhc----------------------ccc--------CCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHH
Confidence                 1111110                      000        1112578999999999999999999995      7


Q ss_pred             HHhcCCCCCCC
Q 023609          225 DALAHPYLGSL  235 (280)
Q Consensus       225 ell~h~~~~~~  235 (280)
                      ++++||||+++
T Consensus       315 ei~~Hpff~~i  325 (396)
T 4dc2_A          315 DIQGHPFFRNV  325 (396)
T ss_dssp             HHHHSTTTTTC
T ss_pred             HHhcCccccCC
Confidence            99999999876

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=4.9e-43  Score=296.53  Aligned_cols=202  Identities=21%  Similarity=0.421  Sum_probs=170.6

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++...     ...|+||||++ |+|.+++... .+++..++.++.|++.||+|||++|++||||||+||
T Consensus        74 l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Ni  147 (297)
T 3fxz_A           74 NKNPNIVNYLDSYLVG-----DELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNI  147 (297)
T ss_dssp             CCCTTBCCEEEEEEET-----TEEEEEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred             CCCCCCCeEeEEEEEC-----CEEEEEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHE
Confidence            5899999999999765     67999999996 6999999764 699999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCC-ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  158 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.++.++|+|||++....... ......+|+.|+|||++.+. .++.++||||+||++|+|++|..||.+.+......
T Consensus       148 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~  226 (297)
T 3fxz_A          148 LLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRK-AYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY  226 (297)
T ss_dssp             EECTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHHCS-CBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH
T ss_pred             EECCCCCEEEeeCCCceecCCcccccCCccCCcCccChhhhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            99999999999999988655432 23456789999999998654 48899999999999999999999998877666555


Q ss_pred             HHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCc
Q 023609          159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  236 (280)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~  236 (280)
                      .+........                           ...+.++..+++||.+||+.||.+|||+.++++||||+...
T Consensus       227 ~~~~~~~~~~---------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  277 (297)
T 3fxz_A          227 LIATNGTPEL---------------------------QNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAK  277 (297)
T ss_dssp             HHHHHCSCCC---------------------------SCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             HHHhCCCCCC---------------------------CCccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhcccC
Confidence            4433221111                           01125788999999999999999999999999999998754

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=6.5e-43  Score=302.16  Aligned_cols=197  Identities=23%  Similarity=0.410  Sum_probs=172.5

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++.+.     ..+|+||||++ |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+||
T Consensus        98 l~hp~iv~~~~~~~~~-----~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NI  172 (350)
T 1rdq_E           98 VNFPFLVKLEFSFKDN-----SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENL  172 (350)
T ss_dssp             CCCTTBCCEEEEEECS-----SEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred             CCCCCCCeEEEEEEcC-----CEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceE
Confidence            5799999999999765     67999999996 69999999888899999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  159 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      +++.+|.++|+|||++......  ....+||+.|+|||++.+. .++.++|+||+||++|+|++|..||.+.+..+....
T Consensus       173 ll~~~g~~kL~DFg~a~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~  249 (350)
T 1rdq_E          173 LIDQQGYIQVTDFGFAKRVKGR--TWTLCGTPEALAPEIILSK-GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK  249 (350)
T ss_dssp             EECTTSCEEECCCTTCEECSSC--BCCCEECGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             EECCCCCEEEcccccceeccCC--cccccCCccccCHHHhcCC-CCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHH
Confidence            9999999999999999876544  3456899999999998654 488999999999999999999999998877766665


Q ss_pred             HHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCC-----HHHHhcCCCCCC
Q 023609          160 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT-----VEDALAHPYLGS  234 (280)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~ell~h~~~~~  234 (280)
                      +......                              .-+.++++++++|++||+.||.+||+     +.++++||||.+
T Consensus       250 i~~~~~~------------------------------~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~  299 (350)
T 1rdq_E          250 IVSGKVR------------------------------FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT  299 (350)
T ss_dssp             HHHCCCC------------------------------CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred             HHcCCCC------------------------------CCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCC
Confidence            5432111                              01257899999999999999999998     999999999987


Q ss_pred             C
Q 023609          235 L  235 (280)
Q Consensus       235 ~  235 (280)
                      .
T Consensus       300 ~  300 (350)
T 1rdq_E          300 T  300 (350)
T ss_dssp             C
T ss_pred             C
Confidence            4

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=4.2e-43  Score=304.70  Aligned_cols=206  Identities=28%  Similarity=0.443  Sum_probs=155.4

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      |+||||+++++++...     ...|+||||++ |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+||
T Consensus        73 l~hpniv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Ni  147 (361)
T 3uc3_A           73 LRHPNIVRFKEVILTP-----THLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENT  147 (361)
T ss_dssp             CCCTTBCCEEEEEECS-----SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGE
T ss_pred             CCCCCCCcEEEEEeeC-----CEEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHE
Confidence            5899999999999765     67999999996 69999998888899999999999999999999999999999999999


Q ss_pred             EEccCCC--EEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 023609           80 LLNANCD--LKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL  157 (280)
Q Consensus        80 li~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  157 (280)
                      +++.++.  ++|+|||+++............+|+.|+|||++.+....+.++||||+||++|+|++|..||.+.......
T Consensus       148 ll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~  227 (361)
T 3uc3_A          148 LLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDY  227 (361)
T ss_dssp             EECSSSSCCEEECCCCCC---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCH
T ss_pred             EEcCCCCceEEEeecCccccccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHH
Confidence            9987665  99999999975544444456679999999999876654455599999999999999999999765432222


Q ss_pred             HHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCC
Q 023609          158 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  235 (280)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~  235 (280)
                      ..+...+....                  ..      ......+++++++||++||+.||.+|||+.++++||||.+.
T Consensus       228 ~~~~~~~~~~~------------------~~------~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~  281 (361)
T 3uc3_A          228 RKTIQRILSVK------------------YS------IPDDIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKN  281 (361)
T ss_dssp             HHHHHHHHTTC------------------CC------CCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred             HHHHHHHhcCC------------------CC------CCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence            22211110000                  00      00112578999999999999999999999999999999664

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.8e-43  Score=310.43  Aligned_cols=236  Identities=33%  Similarity=0.623  Sum_probs=177.8

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHcC---------CCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN---------QALSEEHCQYFLYQILRGLKYIHSANVLH   71 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~---------~~l~~~~~~~i~~qll~al~~LH~~gi~H   71 (280)
                      |+||||+++++++.....   ...|+||||++|+|.+++...         ..+++..++.++.||+.||+|||+.||+|
T Consensus        75 l~hpniv~~~~~~~~~~~---~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH  151 (405)
T 3rgf_A           75 LKHPNVISLQKVFLSHAD---RKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLH  151 (405)
T ss_dssp             CCCTTBCCCCEEEEETTT---TEEEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             cCCCCeeeEeeEEecCCC---CeEEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeC
Confidence            589999999999954321   679999999999999988632         24999999999999999999999999999


Q ss_pred             ccCCCCcEEE----ccCCCEEEeeccceeeccCC----CccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh
Q 023609           72 RDLKPSNLLL----NANCDLKICDFGLARVTSET----DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD  143 (280)
Q Consensus        72 ~di~~~nili----~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~  143 (280)
                      |||||+||++    +.++.++|+|||++......    .......+|+.|+|||++.+...++.++||||+||++|+|++
T Consensus       152 ~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~  231 (405)
T 3rgf_A          152 RDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT  231 (405)
T ss_dssp             CCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHH
T ss_pred             CCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHh
Confidence            9999999999    67789999999999765432    223346789999999998766668999999999999999999


Q ss_pred             CCCCCCCCCh---------HHHHHHHHHHhCCCCHHHHhHhhHhH--HHHhhhcCccc--c----ccccccCCCCChHHH
Q 023609          144 RKPLFPGRDH---------VHQLRLLIELIGTPSEAELGFLNENA--KKYICQLPRYQ--R----QSFTEKFPNVHPSAI  206 (280)
Q Consensus       144 g~~pf~~~~~---------~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~--~----~~~~~~~~~~~~~~~  206 (280)
                      |.+||.+...         .+.+..+...++.|....+.......  ...........  .    ..........++.+.
T Consensus       232 g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  311 (405)
T 3rgf_A          232 SEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAF  311 (405)
T ss_dssp             SSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHH
T ss_pred             CCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHH
Confidence            9999986654         47888999999988876554432111  01111111000  0    001112224478899


Q ss_pred             HHHHHhhcCCCCCCCCHHHHhcCCCCCCCcCCC
Q 023609          207 DLVEKMLTFDPRQRITVEDALAHPYLGSLHDIS  239 (280)
Q Consensus       207 ~li~~~L~~dp~~R~t~~ell~h~~~~~~~~~~  239 (280)
                      +||++||+.||.+|||+.|+|+||||.+...+.
T Consensus       312 ~Ll~~~L~~dP~~R~ta~e~L~hp~f~~~~~~~  344 (405)
T 3rgf_A          312 HLLQKLLTMDPIKRITSEQAMQDPYFLEDPLPT  344 (405)
T ss_dssp             HHHHHHSCSSGGGSCCHHHHHTSGGGTSSSCCC
T ss_pred             HHHHHHccCCcccCCCHHHHhcChhhccCCCCc
Confidence            999999999999999999999999998865443

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=4.4e-43  Score=313.96  Aligned_cols=200  Identities=30%  Similarity=0.518  Sum_probs=174.9

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++...     ...|+||||++ |+|.+++.+++.+++.+++.++.||+.||+|||+.||+||||||+||
T Consensus        73 l~HpnIv~l~~~~~~~-----~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NI  147 (476)
T 2y94_A           73 FRHPHIIKLYQVISTP-----SDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENV  147 (476)
T ss_dssp             CCCTTBCCEEEEEECS-----SEEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGE
T ss_pred             CCCCCCCcEEEEEEEC-----CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHE
Confidence            5899999999999765     67999999996 69999999888999999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  159 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      +++.++.++|+|||++............++|+.|+|||++.+....+.++||||+||++|+|++|..||.+.........
T Consensus       148 ll~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~  227 (476)
T 2y94_A          148 LLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKK  227 (476)
T ss_dssp             EECTTCCEEECCCSSCEECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHH
T ss_pred             EEecCCCeEEEeccchhhccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHH
Confidence            99999999999999998876665556778999999999987655457899999999999999999999988877666555


Q ss_pred             HHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCC
Q 023609          160 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  235 (280)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~  235 (280)
                      +.......                              -..+++++++||++||+.||.+|||+.++++||||+..
T Consensus       228 i~~~~~~~------------------------------p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~  273 (476)
T 2y94_A          228 ICDGIFYT------------------------------PQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD  273 (476)
T ss_dssp             HHTTCCCC------------------------------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred             HhcCCcCC------------------------------CccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence            54321111                              12578899999999999999999999999999999864

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.4e-42  Score=303.07  Aligned_cols=200  Identities=24%  Similarity=0.474  Sum_probs=169.7

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++.+.     ...|+||||+. |+|.+++..++.+++..++.++.||+.||+|||+.||+||||||+||
T Consensus        72 l~hp~Iv~l~~~~~~~-----~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NI  146 (384)
T 4fr4_A           72 LEHPFLVNLWYSFQDE-----EDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNI  146 (384)
T ss_dssp             CCCTTBCCEEEEEECS-----SEEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred             CCCCCCCcEEEEEEeC-----CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHe
Confidence            5899999999999766     67999999996 69999999888999999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCCccccceeccccccchhccC--CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH---
Q 023609           80 LLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLN--SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHV---  154 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~---  154 (280)
                      +++.+|.++|+|||++............+||+.|+|||++..  ...++.++|+||+||++|+|++|..||.+....   
T Consensus       147 ll~~~g~vkL~DFG~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~  226 (384)
T 4fr4_A          147 LLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSK  226 (384)
T ss_dssp             EECTTSCEEECCCTTCEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHH
T ss_pred             EECCCCCEEEeccceeeeccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHH
Confidence            999999999999999988766655667789999999999854  234788999999999999999999999754322   


Q ss_pred             HHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCC-HHHHhcCCCCC
Q 023609          155 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT-VEDALAHPYLG  233 (280)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-~~ell~h~~~~  233 (280)
                      .....+....                              ...-+.+++++.+||.+||+.||.+||+ ++++++||||+
T Consensus       227 ~~~~~~~~~~------------------------------~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~  276 (384)
T 4fr4_A          227 EIVHTFETTV------------------------------VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMN  276 (384)
T ss_dssp             HHHHHHHHCC------------------------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGT
T ss_pred             HHHHHHhhcc------------------------------cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhh
Confidence            1211111100                              0111257889999999999999999998 89999999998


Q ss_pred             CC
Q 023609          234 SL  235 (280)
Q Consensus       234 ~~  235 (280)
                      ++
T Consensus       277 ~~  278 (384)
T 4fr4_A          277 DI  278 (384)
T ss_dssp             TC
T ss_pred             cC
Confidence            75

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.8e-42  Score=307.28  Aligned_cols=226  Identities=33%  Similarity=0.630  Sum_probs=183.3

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ--ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~--~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      +||||+++++++...     ...++||||++++|.+++....  .+++..++.++.||+.||+|||+.||+||||||+||
T Consensus       157 ~~~~iv~~~~~~~~~-----~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NI  231 (429)
T 3kvw_A          157 NTMNVIHMLENFTFR-----NHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENI  231 (429)
T ss_dssp             SCSCBCCEEEEEEET-----TEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGE
T ss_pred             CCcCEEEEEeecccC-----CeEEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHe
Confidence            689999999999765     7799999999999999998654  499999999999999999999999999999999999


Q ss_pred             EEccCCC--EEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 023609           80 LLNANCD--LKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL  157 (280)
Q Consensus        80 li~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  157 (280)
                      +++.++.  ++|+|||++......  .....+|+.|+|||++.+.. ++.++||||+||++|+|++|.+||.+.+..+.+
T Consensus       232 Ll~~~~~~~vkL~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l  308 (429)
T 3kvw_A          232 LLKQQGRSGIKVIDFGSSCYEHQR--VYTYIQSRFYRAPEVILGAR-YGMPIDMWSLGCILAELLTGYPLLPGEDEGDQL  308 (429)
T ss_dssp             EESSTTSCCEEECCCTTCEETTCC--CCSSCSCGGGCCHHHHHTBC-CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred             EEccCCCcceEEeecccceecCCc--ccccCCCCCccChHHHhCCC-CCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            9999887  999999999765543  33567899999999986554 899999999999999999999999999999999


Q ss_pred             HHHHHHhCCCCHHHHhHhhHhHHHHhhhc--Ccc---------------------------ccccccccC-CCCChHHHH
Q 023609          158 RLLIELIGTPSEAELGFLNENAKKYICQL--PRY---------------------------QRQSFTEKF-PNVHPSAID  207 (280)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~---------------------------~~~~~~~~~-~~~~~~~~~  207 (280)
                      ..+.+..+.|+...+..... ...+....  +..                           ....+.... ...++++++
T Consensus       309 ~~i~~~~~~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~d  387 (429)
T 3kvw_A          309 ACMIELLGMPSQKLLDASKR-AKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLD  387 (429)
T ss_dssp             HHHHHHHCCCCHHHHHTBTT-HHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHH
T ss_pred             HHHHHHcCCCCHHHHHhhhh-hhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHH
Confidence            99999999988765443221 12221110  000                           000111111 234788999


Q ss_pred             HHHHhhcCCCCCCCCHHHHhcCCCCCCCc
Q 023609          208 LVEKMLTFDPRQRITVEDALAHPYLGSLH  236 (280)
Q Consensus       208 li~~~L~~dp~~R~t~~ell~h~~~~~~~  236 (280)
                      ||++||++||++|||+.|+|+||||++..
T Consensus       388 li~~~L~~dP~~Rpta~e~L~Hpw~~~~~  416 (429)
T 3kvw_A          388 FLKQCLEWDPAVRMTPGQALRHPWLRRRL  416 (429)
T ss_dssp             HHHHHTCSSTTTSCCHHHHHTSTTTC---
T ss_pred             HHHHHCCCChhhCCCHHHHhCChhhccCC
Confidence            99999999999999999999999998753

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=5.2e-43  Score=300.63  Aligned_cols=230  Identities=32%  Similarity=0.644  Sum_probs=183.6

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++...     ...|+||||+++ +|.+++...+.+++..++.++.||+.||+|||+.|++||||||+||
T Consensus        81 l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Ni  155 (331)
T 4aaa_A           81 LRHENLVNLLEVCKKK-----KRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENI  155 (331)
T ss_dssp             CCCTTBCCEEEEEEET-----TEEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred             CCCCCEeeEEEEeecC-----CEEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheE
Confidence            5899999999999765     679999999995 6777767777899999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCC-CccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  158 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.++.++|+|||.+...... .......+++.|+|||.+.+...++.++||||+||++|+|++|..||.+.+..+...
T Consensus       156 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~  235 (331)
T 4aaa_A          156 LVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLY  235 (331)
T ss_dssp             EECTTSCEEECCCTTC------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             EEcCCCcEEEEeCCCceeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHH
Confidence            9999999999999999765432 223456789999999998766568899999999999999999999999999999999


Q ss_pred             HHHHHhCCCCHHHHhHhhHhHHHHhhhcCc-cccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCC
Q 023609          159 LLIELIGTPSEAELGFLNENAKKYICQLPR-YQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  235 (280)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~  235 (280)
                      .+....+.....................+. ..........+.+++++.+||.+||+.||.+|||+.|+++||||+..
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  313 (331)
T 4aaa_A          236 HIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD  313 (331)
T ss_dssp             HHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred             HHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence            888888877765443332221111111111 11223445567889999999999999999999999999999999863

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=8.2e-43  Score=301.70  Aligned_cols=198  Identities=21%  Similarity=0.409  Sum_probs=171.5

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nil   80 (280)
                      +||||+++++++.+.     ...|+||||++ |+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||+
T Consensus        79 ~hp~iv~l~~~~~~~-----~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIl  153 (353)
T 2i0e_A           79 KPPFLTQLHSCFQTM-----DRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVM  153 (353)
T ss_dssp             CCTTBCCEEEEEECS-----SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEE
T ss_pred             CCCEEeeEEEEEEcC-----CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEE
Confidence            699999999999765     67999999997 699999998788999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccceeecc-CCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023609           81 LNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  159 (280)
Q Consensus        81 i~~~~~~~l~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      ++.+|.++|+|||++.... ........+||+.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+..+....
T Consensus       154 l~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~  232 (353)
T 2i0e_A          154 LDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS  232 (353)
T ss_dssp             ECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTT-CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             EcCCCcEEEEeCCcccccccCCcccccccCCccccChhhhcC-CCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHH
Confidence            9999999999999998633 2233456689999999999854 4589999999999999999999999998887776666


Q ss_pred             HHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCC-----HHHHhcCCCCCC
Q 023609          160 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT-----VEDALAHPYLGS  234 (280)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~ell~h~~~~~  234 (280)
                      +......                              .-+.+++++++||.+||+.||.+||+     +.++++||||++
T Consensus       233 i~~~~~~------------------------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~  282 (353)
T 2i0e_A          233 IMEHNVA------------------------------YPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY  282 (353)
T ss_dssp             HHHCCCC------------------------------CCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTT
T ss_pred             HHhCCCC------------------------------CCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccC
Confidence            5542111                              01257899999999999999999995     699999999987


Q ss_pred             C
Q 023609          235 L  235 (280)
Q Consensus       235 ~  235 (280)
                      +
T Consensus       283 ~  283 (353)
T 2i0e_A          283 I  283 (353)
T ss_dssp             C
T ss_pred             C
Confidence            5

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=8e-43  Score=303.83  Aligned_cols=199  Identities=24%  Similarity=0.458  Sum_probs=172.5

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++.+.     ..+|+||||++ |+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||
T Consensus        96 ~~hp~Iv~l~~~~~~~-----~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NI  170 (373)
T 2r5t_A           96 VKHPFLVGLHFSFQTA-----DKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENI  170 (373)
T ss_dssp             CCCTTBCCEEEEEECS-----SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred             CCCCCCCCEEEEEEeC-----CEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHE
Confidence            4799999999999765     68999999997 59999999888899999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeecc-CCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  158 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.+|.++|+|||+++... ........+||+.|+|||++.+ ..++.++|+|||||++|+|++|..||.+.+..+...
T Consensus       171 ll~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~  249 (373)
T 2r5t_A          171 LLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHK-QPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYD  249 (373)
T ss_dssp             EECTTSCEEECCCCBCGGGBCCCCCCCSBSCCCCCCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHH
T ss_pred             EECCCCCEEEeeCccccccccCCCccccccCCccccCHHHhCC-CCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            99999999999999997533 2333456789999999999854 458999999999999999999999999888777666


Q ss_pred             HHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCH----HHHhcCCCCCC
Q 023609          159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV----EDALAHPYLGS  234 (280)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~----~ell~h~~~~~  234 (280)
                      .+.....                              ...+.++.++++||++||+.||.+||++    .++++||||++
T Consensus       250 ~i~~~~~------------------------------~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~  299 (373)
T 2r5t_A          250 NILNKPL------------------------------QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSL  299 (373)
T ss_dssp             HHHHSCC------------------------------CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTT
T ss_pred             HHHhccc------------------------------CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccC
Confidence            5543210                              1113678999999999999999999987    69999999987


Q ss_pred             C
Q 023609          235 L  235 (280)
Q Consensus       235 ~  235 (280)
                      +
T Consensus       300 ~  300 (373)
T 2r5t_A          300 I  300 (373)
T ss_dssp             C
T ss_pred             C
Confidence            5

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=1.2e-42  Score=300.10  Aligned_cols=198  Identities=24%  Similarity=0.481  Sum_probs=164.8

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nil   80 (280)
                      +||||+++++++.+.     ...|+||||++ |+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||+
T Consensus        68 ~hp~iv~l~~~~~~~-----~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIl  142 (345)
T 3a8x_A           68 NHPFLVGLHSCFQTE-----SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVL  142 (345)
T ss_dssp             TCTTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEE
T ss_pred             CCCccCeEEEEEEeC-----CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEE
Confidence            799999999999765     67999999997 699999988888999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccceeecc-CCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH-----
Q 023609           81 LNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHV-----  154 (280)
Q Consensus        81 i~~~~~~~l~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~-----  154 (280)
                      ++.+|.++|+|||+++... ........++|+.|+|||++.+. .++.++|+||+||++|+|++|..||.+....     
T Consensus       143 l~~~g~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~  221 (345)
T 3a8x_A          143 LDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQ  221 (345)
T ss_dssp             ECTTSCEEECCGGGCBCSCCTTCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCTTTTTTC------
T ss_pred             ECCCCCEEEEeccccccccCCCCcccccCCCccccCccccCCC-CCChHHhHHHHHHHHHHHHhCCCCcCCccccccccc
Confidence            9999999999999998532 23334566899999999998654 5789999999999999999999999653211     


Q ss_pred             ----HHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCH------H
Q 023609          155 ----HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV------E  224 (280)
Q Consensus       155 ----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~------~  224 (280)
                          .....+..                      ...        ..-+.+++++++||.+||+.||.+||++      .
T Consensus       222 ~~~~~~~~~i~~----------------------~~~--------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~  271 (345)
T 3a8x_A          222 NTEDYLFQVILE----------------------KQI--------RIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFA  271 (345)
T ss_dssp             -CHHHHHHHHHH----------------------CCC--------CCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHH
T ss_pred             ccHHHHHHHHHc----------------------CCC--------CCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHH
Confidence                11111110                      000        0112578999999999999999999995      8


Q ss_pred             HHhcCCCCCCC
Q 023609          225 DALAHPYLGSL  235 (280)
Q Consensus       225 ell~h~~~~~~  235 (280)
                      ++++||||+++
T Consensus       272 ~i~~hp~f~~~  282 (345)
T 3a8x_A          272 DIQGHPFFRNV  282 (345)
T ss_dssp             HHHTSGGGTTC
T ss_pred             HHhcCCccCCC
Confidence            99999999875

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=9.5e-43  Score=291.53  Aligned_cols=204  Identities=30%  Similarity=0.487  Sum_probs=177.1

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      |+||||+++++++...     ...|+||||++ ++|.+++..++.+++..++.++.|++.||+|||++|++||||||+||
T Consensus        63 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Ni  137 (277)
T 3f3z_A           63 LDHPNIIRLYETFEDN-----TDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENF  137 (277)
T ss_dssp             CCCTTBCCEEEEEECS-----SEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred             CCCCCEeeEEEEEecC-----CeEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHE
Confidence            5899999999999765     67999999997 59999998888899999999999999999999999999999999999


Q ss_pred             EE---ccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023609           80 LL---NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ  156 (280)
Q Consensus        80 li---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  156 (280)
                      ++   +.++.++|+|||.+.............+++.|+|||.+.+  .++.++||||+|+++++|++|..||.+....+.
T Consensus       138 l~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~  215 (277)
T 3f3z_A          138 LFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEV  215 (277)
T ss_dssp             EESSSSTTCCEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT--CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             EEecCCCCCcEEEEecccceeccCccchhccCCCCCccChHHhcc--cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHH
Confidence            99   7889999999999987766655566789999999998843  378999999999999999999999998887776


Q ss_pred             HHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCc
Q 023609          157 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  236 (280)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~  236 (280)
                      ...+.......+..                          .+..+++++.++|.+||+.||.+|||+.++++||||++..
T Consensus       216 ~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~  269 (277)
T 3f3z_A          216 MLKIREGTFTFPEK--------------------------DWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQL  269 (277)
T ss_dssp             HHHHHHCCCCCCHH--------------------------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHH
T ss_pred             HHHHHhCCCCCCch--------------------------hhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhccc
Confidence            66665543333322                          1236788999999999999999999999999999998754


Q ss_pred             C
Q 023609          237 D  237 (280)
Q Consensus       237 ~  237 (280)
                      .
T Consensus       270 ~  270 (277)
T 3f3z_A          270 S  270 (277)
T ss_dssp             C
T ss_pred             c
Confidence            3

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=2.7e-42  Score=294.95  Aligned_cols=204  Identities=29%  Similarity=0.499  Sum_probs=175.6

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      |+||||+++++++...     ...|+||||++ ++|.+++..++.+++..++.++.||+.||+|||+.|++||||||+||
T Consensus        72 l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NI  146 (321)
T 2a2a_A           72 VLHHNVITLHDVYENR-----TDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENI  146 (321)
T ss_dssp             CCCTTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred             CCCCCcceEEEEEecC-----CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHE
Confidence            5799999999999765     67999999996 69999999888899999999999999999999999999999999999


Q ss_pred             EEccCC----CEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 023609           80 LLNANC----DLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVH  155 (280)
Q Consensus        80 li~~~~----~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~  155 (280)
                      +++.++    .++|+|||.+.............+++.|+|||++.+ ..++.++||||+||++|+|++|..||.+....+
T Consensus       147 l~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~  225 (321)
T 2a2a_A          147 MLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQE  225 (321)
T ss_dssp             EESCTTSSSCCEEECCCTTCEECCTTCCCCCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH
T ss_pred             EEecCCCCcCCEEEccCccceecCccccccccCCCCCccCcccccC-CCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH
Confidence            999887    799999999987766555556678999999998854 457899999999999999999999998887776


Q ss_pred             HHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCC
Q 023609          156 QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  235 (280)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~  235 (280)
                      ....+.......+.                          ...+.+++.+++||.+||+.||.+|||+.++++||||.+.
T Consensus       226 ~~~~i~~~~~~~~~--------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~  279 (321)
T 2a2a_A          226 TLANITSVSYDFDE--------------------------EFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV  279 (321)
T ss_dssp             HHHHHHTTCCCCCH--------------------------HHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCS
T ss_pred             HHHHHHhcccccCh--------------------------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCC
Confidence            66555433222211                          1224678899999999999999999999999999999875


Q ss_pred             c
Q 023609          236 H  236 (280)
Q Consensus       236 ~  236 (280)
                      .
T Consensus       280 ~  280 (321)
T 2a2a_A          280 D  280 (321)
T ss_dssp             S
T ss_pred             C
Confidence            3

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=2.9e-42  Score=299.18  Aligned_cols=224  Identities=27%  Similarity=0.470  Sum_probs=177.7

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ--ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~--~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      +||||+++++++...     ...|+||||++++|.+++....  .+++..++.++.||+.||+|||+.||+||||||+||
T Consensus        94 ~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NI  168 (360)
T 3llt_A           94 NNNNIVKYHGKFMYY-----DHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENI  168 (360)
T ss_dssp             TGGGBCCEEEEEEET-----TEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred             CCCCeecccceeeEC-----CeeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccE
Confidence            599999999999765     6799999999999999998654  599999999999999999999999999999999999


Q ss_pred             EEcc-------------------------CCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHH
Q 023609           80 LLNA-------------------------NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV  134 (280)
Q Consensus        80 li~~-------------------------~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Diwsl  134 (280)
                      +++.                         ++.++|+|||++......  .....+|+.|+|||++.+. .++.++||||+
T Consensus       169 ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~Diwsl  245 (360)
T 3llt_A          169 LLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY--HGSIINTRQYRAPEVILNL-GWDVSSDMWSF  245 (360)
T ss_dssp             EESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC--CCSCCSCGGGCCHHHHTTC-CCCTTHHHHHH
T ss_pred             EEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC--CcCccCcccccCcHHHcCC-CCCCccchHHH
Confidence            9975                         788999999999875543  2356789999999998654 58999999999


Q ss_pred             HHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHH-HHhhh------cCcccc---------ccccccC
Q 023609          135 GCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAK-KYICQ------LPRYQR---------QSFTEKF  198 (280)
Q Consensus       135 G~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~------~~~~~~---------~~~~~~~  198 (280)
                      ||++|+|++|..||.+.+..+....+....+.++............ .+...      .+....         .......
T Consensus       246 G~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~  325 (360)
T 3llt_A          246 GCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYK  325 (360)
T ss_dssp             HHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHH
T ss_pred             HHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccc
Confidence            9999999999999999999999998888888777654332211100 00000      000000         0000000


Q ss_pred             CCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCC
Q 023609          199 PNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLG  233 (280)
Q Consensus       199 ~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~  233 (280)
                      ...++.+.+||.+||+.||.+|||+.|+|+||||+
T Consensus       326 ~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          326 IIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             HCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred             cchHHHHHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence            12357788999999999999999999999999996

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-42  Score=302.58  Aligned_cols=204  Identities=26%  Similarity=0.484  Sum_probs=173.3

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ-ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~-~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      |+||||+++++++...     ...|+||||++ |+|.+++...+ .+++..++.++.||+.||+|||+.||+||||||+|
T Consensus       105 l~hpnIv~~~~~~~~~-----~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~N  179 (387)
T 1kob_A          105 LHHPKLINLHDAFEDK-----YEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPEN  179 (387)
T ss_dssp             CCSTTBCCEEEEEECS-----SEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred             CCCcCCCeEEEEEEeC-----CEEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHH
Confidence            5899999999999765     77999999997 69999997654 79999999999999999999999999999999999


Q ss_pred             EEEcc--CCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023609           79 LLLNA--NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ  156 (280)
Q Consensus        79 ili~~--~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  156 (280)
                      |+++.  ++.++|+|||++.............+|+.|+|||++.+ ..++.++||||+||++|+|++|..||.+.+..+.
T Consensus       180 Ill~~~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~  258 (387)
T 1kob_A          180 IMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET  258 (387)
T ss_dssp             EEESSTTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH
T ss_pred             eEEecCCCCceEEEecccceecCCCcceeeeccCCCccCchhccC-CCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHH
Confidence            99974  57799999999988766555556678999999998854 4588999999999999999999999998877666


Q ss_pred             HHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCc
Q 023609          157 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  236 (280)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~  236 (280)
                      ...+........                          ...++.+++++++||.+||+.||.+|||+.++++||||++..
T Consensus       259 ~~~i~~~~~~~~--------------------------~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  312 (387)
T 1kob_A          259 LQNVKRCDWEFD--------------------------EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH  312 (387)
T ss_dssp             HHHHHHCCCCCC--------------------------SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             HHHHHhCCCCCC--------------------------ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence            555443211111                          123347889999999999999999999999999999998753

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=1.7e-42  Score=297.11  Aligned_cols=199  Identities=24%  Similarity=0.471  Sum_probs=167.8

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      |+||||+++++++...     ...|+||||++ |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+||
T Consensus        78 l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Ni  152 (327)
T 3a62_A           78 VKHPFIVDLIYAFQTG-----GKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENI  152 (327)
T ss_dssp             CCCTTBCCEEEEEECS-----SCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTE
T ss_pred             CCCCCccceeEEEEcC-----CEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHe
Confidence            5899999999999765     67999999997 69999999888899999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCC-CccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  158 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.+|.++|+|||++...... .......+|+.|+|||++.+. .++.++|+||+||++|+|++|..||.+.+......
T Consensus       153 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~  231 (327)
T 3a62_A          153 MLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRS-GHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTID  231 (327)
T ss_dssp             EECTTSCEEECCCSCC----------CTTSSCCTTSCHHHHTTS-CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             EECCCCcEEEEeCCcccccccCCccccccCCCcCccCHhhCcCC-CCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence            9999999999999998754322 223456789999999998554 47899999999999999999999999887766665


Q ss_pred             HHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCC-----CHHHHhcCCCCC
Q 023609          159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI-----TVEDALAHPYLG  233 (280)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~ell~h~~~~  233 (280)
                      .+......                              .-+.+++++++||.+||+.||.+||     ++.++++||||+
T Consensus       232 ~i~~~~~~------------------------------~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~  281 (327)
T 3a62_A          232 KILKCKLN------------------------------LPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFR  281 (327)
T ss_dssp             HHHHTCCC------------------------------CCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGS
T ss_pred             HHHhCCCC------------------------------CCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCccc
Confidence            55432111                              1125788999999999999999999     889999999998


Q ss_pred             CC
Q 023609          234 SL  235 (280)
Q Consensus       234 ~~  235 (280)
                      .+
T Consensus       282 ~~  283 (327)
T 3a62_A          282 HI  283 (327)
T ss_dssp             SC
T ss_pred             CC
Confidence            75

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.3e-42  Score=297.58  Aligned_cols=209  Identities=27%  Similarity=0.507  Sum_probs=151.4

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nil   80 (280)
                      .||||+++++++.+.     ...|+||||++ |+|.+++..++.+++.+++.++.||+.||+|||++||+||||||+||+
T Consensus        64 ~h~niv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl  138 (325)
T 3kn6_A           64 GHPNIVKLHEVFHDQ-----LHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLL  138 (325)
T ss_dssp             TCTTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred             CCCCeeEEEEEEEcC-----CEEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEE
Confidence            399999999999765     67999999997 599999999889999999999999999999999999999999999999


Q ss_pred             EccCC---CEEEeeccceeeccCC-CccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH--
Q 023609           81 LNANC---DLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHV--  154 (280)
Q Consensus        81 i~~~~---~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~--  154 (280)
                      ++.++   .++|+|||++...... .......+|+.|+|||++.+ ..++.++||||+||++|+|++|..||.+....  
T Consensus       139 l~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  217 (325)
T 3kn6_A          139 FTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQ-NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLT  217 (325)
T ss_dssp             EEC----CEEEECCCTTCEECCC-----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------
T ss_pred             EecCCCcccEEEeccccceecCCCCCcccccCCCcCccCHHHhcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCccccc
Confidence            97765   7999999999865433 23345678999999998854 45899999999999999999999999765431  


Q ss_pred             -----HHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 023609          155 -----HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  229 (280)
Q Consensus       155 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h  229 (280)
                           +....+......                          .....++.+++++++||++||+.||.+|||+.++++|
T Consensus       218 ~~~~~~~~~~i~~~~~~--------------------------~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h  271 (325)
T 3kn6_A          218 CTSAVEIMKKIKKGDFS--------------------------FEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYN  271 (325)
T ss_dssp             CCCHHHHHHHHTTTCCC--------------------------CCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred             cccHHHHHHHHHcCCCC--------------------------CCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcC
Confidence                 111111111000                          0111223688999999999999999999999999999


Q ss_pred             CCCCCCcCCCCCC
Q 023609          230 PYLGSLHDISDEP  242 (280)
Q Consensus       230 ~~~~~~~~~~~~~  242 (280)
                      |||++....+..+
T Consensus       272 ~w~~~~~~~~~~~  284 (325)
T 3kn6_A          272 EWLQDGSQLSSNP  284 (325)
T ss_dssp             GGGCTTCCCCCSC
T ss_pred             hhhccCccCCCCC
Confidence            9999865544433

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=8.4e-43  Score=309.20  Aligned_cols=205  Identities=22%  Similarity=0.419  Sum_probs=174.1

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      ++||||+++++++.+.     ..+|+||||+. |+|.+++.+ .+.+++..++.++.||+.||+|||++||+||||||+|
T Consensus       131 ~~hp~Iv~l~~~~~~~-----~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~N  205 (437)
T 4aw2_A          131 GDSKWITTLHYAFQDD-----NNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDN  205 (437)
T ss_dssp             SCTTTBCCEEEEEECS-----SEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred             CCCCCEEEEEEEEeeC-----CEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHH
Confidence            4799999999999766     77999999996 799999987 5689999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCCCc--cccceeccccccchhcc----CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 023609           79 LLLNANCDLKICDFGLARVTSETDF--MTEYVVTRWYRAPELLL----NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD  152 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~----~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  152 (280)
                      |+++.+|.+||+|||++........  ....+||+.|+|||++.    +...++.++|+||+||++|+|++|..||.+.+
T Consensus       206 ILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~  285 (437)
T 4aw2_A          206 ILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES  285 (437)
T ss_dssp             EEECTTSCEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred             eeEcCCCCEEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCC
Confidence            9999999999999999976544332  23457999999999985    24457899999999999999999999999988


Q ss_pred             hHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCC--CCCHHHHhcCC
Q 023609          153 HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQ--RITVEDALAHP  230 (280)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~--R~t~~ell~h~  230 (280)
                      ..+....+......                         ..++...+.+|+++++||++||+.+|.+  |++++|+++||
T Consensus       286 ~~~~~~~i~~~~~~-------------------------~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hp  340 (437)
T 4aw2_A          286 LVETYGKIMNHKER-------------------------FQFPTQVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHP  340 (437)
T ss_dssp             HHHHHHHHHTHHHH-------------------------CCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSG
T ss_pred             hhHHHHhhhhcccc-------------------------ccCCcccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCC
Confidence            87777766532100                         0112223468999999999999998888  99999999999


Q ss_pred             CCCCC
Q 023609          231 YLGSL  235 (280)
Q Consensus       231 ~~~~~  235 (280)
                      ||+++
T Consensus       341 ff~~i  345 (437)
T 4aw2_A          341 FFSGI  345 (437)
T ss_dssp             GGTTC
T ss_pred             ccCCC
Confidence            99875

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1.8e-42  Score=308.79  Aligned_cols=199  Identities=27%  Similarity=0.476  Sum_probs=170.6

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHS-ANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~-~gi~H~di~~~n   78 (280)
                      ++||||+++++++...     ..+|+||||++ |+|.+++...+.+++..++.++.||+.||+|||+ .||+||||||+|
T Consensus       205 l~h~~iv~l~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~N  279 (446)
T 4ejn_A          205 SRHPFLTALKYSFQTH-----DRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLEN  279 (446)
T ss_dssp             CSCTTSCCEEEEEEET-----TEEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGG
T ss_pred             CCCCeEeeEEEEEeeC-----CEEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHH
Confidence            5799999999999765     67999999997 5999999888899999999999999999999998 999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccC-CCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 023609           79 LLLNANCDLKICDFGLARVTSE-TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL  157 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  157 (280)
                      |+++.++.++|+|||++..... .......+||+.|+|||++.+. .++.++||||+||++|+|++|..||.+.+.....
T Consensus       280 Ill~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~  358 (446)
T 4ejn_A          280 LMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLF  358 (446)
T ss_dssp             EEECSSSCEEECCCCCCCTTCC-----CCSSSCGGGCCHHHHHTS-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred             EEECCCCCEEEccCCCceeccCCCcccccccCCccccCHhhcCCC-CCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHH
Confidence            9999999999999999975332 2334556899999999998554 5899999999999999999999999888776665


Q ss_pred             HHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCC-----CHHHHhcCCCC
Q 023609          158 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI-----TVEDALAHPYL  232 (280)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~ell~h~~~  232 (280)
                      ..+......                              .-+.+++++.+||.+||+.||.+||     |+.++++||||
T Consensus       359 ~~i~~~~~~------------------------------~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f  408 (446)
T 4ejn_A          359 ELILMEEIR------------------------------FPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF  408 (446)
T ss_dssp             HHHHHCCCC------------------------------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGG
T ss_pred             HHHHhCCCC------------------------------CCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccc
Confidence            555432111                              1125788999999999999999999     99999999999


Q ss_pred             CCC
Q 023609          233 GSL  235 (280)
Q Consensus       233 ~~~  235 (280)
                      +++
T Consensus       409 ~~~  411 (446)
T 4ejn_A          409 AGI  411 (446)
T ss_dssp             TTC
T ss_pred             cCC
Confidence            986

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=1.7e-42  Score=296.52  Aligned_cols=204  Identities=28%  Similarity=0.427  Sum_probs=167.7

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++...     ...|+||||++ |+|.+++..++.+++..++.++.||+.||+|||+.||+||||||+||
T Consensus        62 l~hpnIv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NI  136 (323)
T 3tki_A           62 LNHENVVKFYGHRREG-----NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENL  136 (323)
T ss_dssp             CCCTTBCCEEEEEECS-----SEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred             CCCCCCCeEEEEEecC-----CeEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHE
Confidence            5899999999999765     67899999997 59999998888899999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCC---CccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023609           80 LLNANCDLKICDFGLARVTSET---DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ  156 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  156 (280)
                      +++.++.++|+|||++......   .......+|+.|+|||++.+....+.++||||+||++|+|++|..||.+......
T Consensus       137 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  216 (323)
T 3tki_A          137 LLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ  216 (323)
T ss_dssp             EECTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH
T ss_pred             EEeCCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH
Confidence            9999999999999999754322   2234567899999999987665457889999999999999999999976543321


Q ss_pred             HHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCc
Q 023609          157 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  236 (280)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~  236 (280)
                      ..........                           ....+..+++++.+||.+||+.||.+|||+.|+++||||++..
T Consensus       217 ~~~~~~~~~~---------------------------~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~  269 (323)
T 3tki_A          217 EYSDWKEKKT---------------------------YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL  269 (323)
T ss_dssp             HHHHHHTTCT---------------------------TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred             HHHHHhcccc---------------------------cCCccccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhcccc
Confidence            1111110000                           0011235788999999999999999999999999999998753

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1e-42  Score=306.43  Aligned_cols=203  Identities=24%  Similarity=0.355  Sum_probs=172.3

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++.+.     ..+|+||||++ |+|.+++.. ..+++..++.++.||+.||+|||++||+||||||+||
T Consensus       126 l~hp~Iv~l~~~~~~~-----~~~~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NI  199 (410)
T 3v8s_A          126 ANSPWVVQLFYAFQDD-----RYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNM  199 (410)
T ss_dssp             CCCTTBCCEEEEEECS-----SEEEEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred             CCCCCCCeEEEEEEEC-----CEEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHe
Confidence            5899999999999765     77999999996 699999876 4699999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCC--ccccceeccccccchhccCCCC---CCcchhHHHHHHHHHHHHhCCCCCCCCChH
Q 023609           80 LLNANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNSSD---YTAAIDVWSVGCIFMELMDRKPLFPGRDHV  154 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~---~~~~~DiwslG~il~~ll~g~~pf~~~~~~  154 (280)
                      +++.+|.++|+|||++.......  .....+||+.|+|||++.+...   ++.++|+||+||++|+|++|..||.+.+..
T Consensus       200 Ll~~~g~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~  279 (410)
T 3v8s_A          200 LLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV  279 (410)
T ss_dssp             EECTTSCEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred             eECCCCCEEEeccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh
Confidence            99999999999999998765443  2335689999999999865432   678999999999999999999999998887


Q ss_pred             HHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCC--CCCHHHHhcCCCC
Q 023609          155 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQ--RITVEDALAHPYL  232 (280)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~--R~t~~ell~h~~~  232 (280)
                      .....+........                 .         ...+.+|+++++||++||+.+|.+  |++++|+++||||
T Consensus       280 ~~~~~i~~~~~~~~-----------------~---------p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f  333 (410)
T 3v8s_A          280 GTYSKIMNHKNSLT-----------------F---------PDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFF  333 (410)
T ss_dssp             HHHHHHHTHHHHCC-----------------C---------CTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGG
T ss_pred             hHHHHHHhcccccc-----------------C---------CCcccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccc
Confidence            77776654210000                 0         111368899999999999999988  9999999999999


Q ss_pred             CCC
Q 023609          233 GSL  235 (280)
Q Consensus       233 ~~~  235 (280)
                      ++.
T Consensus       334 ~~~  336 (410)
T 3v8s_A          334 KND  336 (410)
T ss_dssp             CCS
T ss_pred             cCC
Confidence            875

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=2.2e-42  Score=298.85  Aligned_cols=204  Identities=30%  Similarity=0.508  Sum_probs=160.8

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      |+||||+++++++...     ...|+||||++ |+|.+++..++.+++.+++.++.||+.||+|||+.|++||||||+||
T Consensus       105 l~h~niv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NI  179 (349)
T 2w4o_A          105 LSHPNIIKLKEIFETP-----TEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENL  179 (349)
T ss_dssp             CCCTTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred             CCCCCCcceeeeEecC-----CeEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccE
Confidence            5899999999999765     67999999997 69999999888899999999999999999999999999999999999


Q ss_pred             EEcc---CCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH-
Q 023609           80 LLNA---NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVH-  155 (280)
Q Consensus        80 li~~---~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-  155 (280)
                      +++.   ++.++|+|||++.............+|+.|+|||++.+. .++.++||||+||++|+|++|..||.+..... 
T Consensus       180 ll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~  258 (349)
T 2w4o_A          180 LYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGC-AYGPEVDMWSVGIITYILLCGFEPFYDERGDQF  258 (349)
T ss_dssp             EESSSSTTCCEEECCCC----------------CGGGSCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHH
T ss_pred             EEecCCCCCCEEEccCccccccCcccccccccCCCCccCHHHhcCC-CCCcccchHHHHHHHHHHHhCCCCCCCCcccHH
Confidence            9975   889999999999876555444566789999999998544 58999999999999999999999997765444 


Q ss_pred             HHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCC
Q 023609          156 QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  235 (280)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~  235 (280)
                      ....+......                          .....++.++.++++||++||+.||++|||+.++++||||.+.
T Consensus       259 ~~~~i~~~~~~--------------------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~  312 (349)
T 2w4o_A          259 MFRRILNCEYY--------------------------FISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGK  312 (349)
T ss_dssp             HHHHHHTTCCC--------------------------CCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTST
T ss_pred             HHHHHHhCCCc--------------------------cCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCC
Confidence            33322221111                          0112235788999999999999999999999999999999875


Q ss_pred             c
Q 023609          236 H  236 (280)
Q Consensus       236 ~  236 (280)
                      .
T Consensus       313 ~  313 (349)
T 2w4o_A          313 A  313 (349)
T ss_dssp             T
T ss_pred             c
Confidence            3

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=1.8e-42  Score=303.65  Aligned_cols=234  Identities=20%  Similarity=0.279  Sum_probs=166.5

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS   77 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~   77 (280)
                      ++||||+++++++...     +..|+||||++ |+|.+++...  +.+++..++.++.||+.||+|||++||+||||||+
T Consensus        83 l~h~niv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~  157 (389)
T 3gni_B           83 FNHPNIVPYRATFIAD-----NELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKAS  157 (389)
T ss_dssp             CCCTTBCCEEEEEEET-----TEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred             CCCCCCCcEeEEEEEC-----CEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH
Confidence            5899999999999765     67999999997 6999999865  67999999999999999999999999999999999


Q ss_pred             cEEEccCCCEEEeeccceeeccCC--------CccccceeccccccchhccCC-CCCCcchhHHHHHHHHHHHHhCCCCC
Q 023609           78 NLLLNANCDLKICDFGLARVTSET--------DFMTEYVVTRWYRAPELLLNS-SDYTAAIDVWSVGCIFMELMDRKPLF  148 (280)
Q Consensus        78 nili~~~~~~~l~dfg~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf  148 (280)
                      ||+++.++.++|+|||.+......        .......+|+.|+|||++.+. ..++.++||||+||++|+|++|..||
T Consensus       158 NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf  237 (389)
T 3gni_B          158 HILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF  237 (389)
T ss_dssp             GEEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             HEEEcCCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCC
Confidence            999999999999999987643211        112234678899999998653 45889999999999999999999999


Q ss_pred             CCCChHHHHHHHHHHhCCC--------CHHHHhHhhHh--------HHHHhhhcCccccccccccCCCCChHHHHHHHHh
Q 023609          149 PGRDHVHQLRLLIELIGTP--------SEAELGFLNEN--------AKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKM  212 (280)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  212 (280)
                      .+.+..+....+.......        ...........        ........+...........+.+++++++||++|
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~  317 (389)
T 3gni_B          238 KDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQC  317 (389)
T ss_dssp             TTCCSTTHHHHC--------------------------------------------------------CCHHHHHHHHHH
T ss_pred             CCCCHHHHHHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHH
Confidence            8876555444332211100        00000000000        0000000000011111223346889999999999


Q ss_pred             hcCCCCCCCCHHHHhcCCCCCCCcCCC
Q 023609          213 LTFDPRQRITVEDALAHPYLGSLHDIS  239 (280)
Q Consensus       213 L~~dp~~R~t~~ell~h~~~~~~~~~~  239 (280)
                      |+.||++|||+.++++||||+++....
T Consensus       318 L~~dP~~Rpta~ell~hp~f~~~~~~~  344 (389)
T 3gni_B          318 LQRNPDARPSASTLLNHSFFKQIKRRA  344 (389)
T ss_dssp             TCSCTTTSCCHHHHTTSGGGGGC---C
T ss_pred             hhcCcccCCCHHHHhcCHHHHHHhhcc
Confidence            999999999999999999999876543

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=1.6e-42  Score=312.39  Aligned_cols=204  Identities=33%  Similarity=0.599  Sum_probs=173.4

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      |+||||+++++++...     ..+|+||||+. |+|.+.+...+.+++..++.++.||+.||+|||++||+||||||+||
T Consensus        78 l~hpniv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Ni  152 (486)
T 3mwu_A           78 LDHPNIMKLFEILEDS-----SSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENI  152 (486)
T ss_dssp             CCCTTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred             CCCCCcCeEEEEEEcC-----CEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHE
Confidence            5899999999999765     77999999997 69999998888999999999999999999999999999999999999


Q ss_pred             EEc---cCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023609           80 LLN---ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ  156 (280)
Q Consensus        80 li~---~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  156 (280)
                      +++   .++.++|+|||++.............+|+.|+|||++.+  .++.++||||+||++|+|++|.+||.+.+..+.
T Consensus       153 l~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  230 (486)
T 3mwu_A          153 LLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI  230 (486)
T ss_dssp             EESSSSTTCCEEECSCSCTTTBCCC----CCTTGGGGCCGGGGGS--CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             EEecCCCCCCEEEEECCcCeECCCCCccCCCcCCCCCCCHHHhCC--CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            995   456799999999987665555556689999999999854  488999999999999999999999999888777


Q ss_pred             HHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCc
Q 023609          157 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  236 (280)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~  236 (280)
                      ...+.........                          ..++.+|+++++||++||+.||.+|||+.++++||||++..
T Consensus       231 ~~~i~~~~~~~~~--------------------------~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~  284 (486)
T 3mwu_A          231 LKRVETGKYAFDL--------------------------PQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS  284 (486)
T ss_dssp             HHHHHHTCCCSCS--------------------------GGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTC
T ss_pred             HHHHHhCCCCCCC--------------------------cccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCc
Confidence            6666543222211                          12236789999999999999999999999999999998865


Q ss_pred             C
Q 023609          237 D  237 (280)
Q Consensus       237 ~  237 (280)
                      .
T Consensus       285 ~  285 (486)
T 3mwu_A          285 S  285 (486)
T ss_dssp             C
T ss_pred             c
Confidence            4

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=3.3e-42  Score=311.60  Aligned_cols=204  Identities=29%  Similarity=0.508  Sum_probs=178.0

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      |+||||+++++++.+.     ..+|+|||||+ |+|.+++..++.+++..++.++.||+.||+|||+.||+||||||+||
T Consensus       103 l~hpniv~~~~~~~~~-----~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Ni  177 (504)
T 3q5i_A          103 LDHPNIIKLFDVFEDK-----KYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENI  177 (504)
T ss_dssp             CCCTTBCCEEEEEECS-----SEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred             CCCCCCCeEEEEEEcC-----CEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHE
Confidence            5799999999999765     77999999997 59999998888899999999999999999999999999999999999


Q ss_pred             EEccCC---CEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023609           80 LLNANC---DLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ  156 (280)
Q Consensus        80 li~~~~---~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  156 (280)
                      +++.++   .++|+|||++.............+|+.|+|||++.  ..++.++||||+||++|+|++|.+||.+.+..+.
T Consensus       178 l~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  255 (504)
T 3q5i_A          178 LLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLK--KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDI  255 (504)
T ss_dssp             EESSTTCCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHT--TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             EEecCCCCccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhc--cCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            998776   69999999998876665556778999999999884  3488999999999999999999999999888777


Q ss_pred             HHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCc
Q 023609          157 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  236 (280)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~  236 (280)
                      ...+.......+..                          .++.+|+++++||++||+.||.+|||+.++++||||+...
T Consensus       256 ~~~i~~~~~~~~~~--------------------------~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~  309 (504)
T 3q5i_A          256 IKKVEKGKYYFDFN--------------------------DWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYA  309 (504)
T ss_dssp             HHHHHHCCCCCCHH--------------------------HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTC
T ss_pred             HHHHHcCCCCCCcc--------------------------ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhch
Confidence            77665533222221                          2247889999999999999999999999999999998865


Q ss_pred             C
Q 023609          237 D  237 (280)
Q Consensus       237 ~  237 (280)
                      .
T Consensus       310 ~  310 (504)
T 3q5i_A          310 N  310 (504)
T ss_dssp             C
T ss_pred             h
Confidence            4

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=3.7e-42  Score=288.85  Aligned_cols=205  Identities=29%  Similarity=0.514  Sum_probs=175.1

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++...     ...|+||||++ ++|.+.+..++.+++..+..++.|++.||+|||+.|++||||||+||
T Consensus        62 l~h~~i~~~~~~~~~~-----~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Ni  136 (284)
T 3kk8_A           62 LQHPNIVRLHDSIQEE-----SFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENL  136 (284)
T ss_dssp             CCCTTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred             cCCCCcCeEEEEEEcC-----CEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHE
Confidence            5899999999999665     67899999997 59999998888899999999999999999999999999999999999


Q ss_pred             EEccCCC---EEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023609           80 LLNANCD---LKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ  156 (280)
Q Consensus        80 li~~~~~---~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  156 (280)
                      +++.++.   ++|+|||.+.............+++.|+|||.+.+ ..++.++||||+|+++++|++|..||.+......
T Consensus       137 l~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~  215 (284)
T 3kk8_A          137 LLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL  215 (284)
T ss_dssp             EESSSSTTCCEEECCCTTCEECCSSCBCCCSCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             EEecCCCCCcEEEeeceeeEEcccCccccCCCCCcCCcCchhhcC-CCCCcccchHHHHHHHHHHHHCCCCCCCCchhHH
Confidence            9976655   99999999987766655556788999999999854 4578999999999999999999999988877666


Q ss_pred             HHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCc
Q 023609          157 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  236 (280)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~  236 (280)
                      ...+.......+.                          ..++.+++++.+||.+||+.||.+|||+.++++||||++..
T Consensus       216 ~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  269 (284)
T 3kk8_A          216 YAQIKAGAYDYPS--------------------------PEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRE  269 (284)
T ss_dssp             HHHHHHTCCCCCT--------------------------TTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCC
T ss_pred             HHHHHhccccCCc--------------------------hhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCCh
Confidence            5555433222111                          22346789999999999999999999999999999998865


Q ss_pred             C
Q 023609          237 D  237 (280)
Q Consensus       237 ~  237 (280)
                      .
T Consensus       270 ~  270 (284)
T 3kk8_A          270 R  270 (284)
T ss_dssp             C
T ss_pred             h
Confidence            4

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=2.7e-42  Score=311.41  Aligned_cols=202  Identities=34%  Similarity=0.592  Sum_probs=175.5

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      |+||||+++++++...     ...|+|||||. |+|.+.+..+..+++..++.++.||+.||+|||++||+||||||+||
T Consensus        93 l~hpniv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Ni  167 (494)
T 3lij_A           93 LDHPNIMKLYDFFEDK-----RNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENL  167 (494)
T ss_dssp             CCCTTBCCEEEEEECS-----SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred             CCCCCCCeEEEEEEeC-----CEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhE
Confidence            5899999999999765     67999999997 59999998888899999999999999999999999999999999999


Q ss_pred             EEcc---CCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023609           80 LLNA---NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ  156 (280)
Q Consensus        80 li~~---~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  156 (280)
                      +++.   ++.++|+|||++.............+|+.|+|||++.  ..++.++||||+||++|+|++|.+||.+.+..+.
T Consensus       168 l~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  245 (494)
T 3lij_A          168 LLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLR--KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEI  245 (494)
T ss_dssp             EESCSSTTCCEEECCCTTCEECBTTBCBCCCCSCTTTCCHHHHT--TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             EEeCCCCCCcEEEEECCCCeECCCCccccccCCCcCeeCHHHHc--ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            9976   4559999999998776665556678999999999884  3488999999999999999999999999888777


Q ss_pred             HHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCC
Q 023609          157 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  235 (280)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~  235 (280)
                      ...+.........                          ..++.+|+++++||++||+.||.+|||+.++++||||+..
T Consensus       246 ~~~i~~~~~~~~~--------------------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~  298 (494)
T 3lij_A          246 LRKVEKGKYTFDS--------------------------PEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM  298 (494)
T ss_dssp             HHHHHHTCCCCCS--------------------------GGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred             HHHHHhCCCCCCc--------------------------hhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence            6666543322221                          2234788999999999999999999999999999999864

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=8.6e-42  Score=296.93  Aligned_cols=202  Identities=28%  Similarity=0.562  Sum_probs=173.9

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nil   80 (280)
                      +||||+++++++...     ...|+||||++ ++|.+++..+..+++..+..++.||+.||+|||+.|++|+||||+||+
T Consensus       158 ~hp~iv~~~~~~~~~-----~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl  232 (365)
T 2y7j_A          158 GHPHIITLIDSYESS-----SFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENIL  232 (365)
T ss_dssp             TCTTBCCEEEEEEBS-----SEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred             CCCCEeEEEEEEeeC-----CEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence            699999999999665     67999999998 599999988788999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccceeeccCCCccccceeccccccchhccC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 023609           81 LNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLN-----SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVH  155 (280)
Q Consensus        81 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~  155 (280)
                      ++.+|.++|+|||++.............+|+.|+|||++.+     ...++.++|||||||++|+|++|..||.+.....
T Consensus       233 ~~~~~~ikl~DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~  312 (365)
T 2y7j_A          233 LDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQIL  312 (365)
T ss_dssp             ECTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             ECCCCCEEEEecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHH
Confidence            99999999999999987766555566789999999998753     2247889999999999999999999998877766


Q ss_pred             HHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCC
Q 023609          156 QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS  234 (280)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~  234 (280)
                      ....+..........                          .++.++..+.++|.+||+.||.+|||+.++++||||+.
T Consensus       313 ~~~~i~~~~~~~~~~--------------------------~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r  365 (365)
T 2y7j_A          313 MLRMIMEGQYQFSSP--------------------------EWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER  365 (365)
T ss_dssp             HHHHHHHTCCCCCHH--------------------------HHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             HHHHHHhCCCCCCCc--------------------------ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence            666554433222221                          12367889999999999999999999999999999973

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.8e-42  Score=301.99  Aligned_cols=203  Identities=29%  Similarity=0.458  Sum_probs=174.1

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      |+||||+++++++...     ...|+||||++ ++|.+++... ..+++..++.++.||+.||+|||+.||+||||||+|
T Consensus       143 l~hpnIv~~~~~~~~~-----~~~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N  217 (373)
T 2x4f_A          143 LDHANLIQLYDAFESK-----NDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPEN  217 (373)
T ss_dssp             CCCTTBCCEEEEEECS-----SEEEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred             CCCCCCCeEEEEEEEC-----CEEEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHH
Confidence            5899999999999765     67999999997 6999988754 469999999999999999999999999999999999


Q ss_pred             EEE--ccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023609           79 LLL--NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ  156 (280)
Q Consensus        79 ili--~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  156 (280)
                      |++  +.++.++|+|||++.............+|+.|+|||++. ...++.++||||+||++|+|++|..||.+.+..+.
T Consensus       218 Ill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~  296 (373)
T 2x4f_A          218 ILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVN-YDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAET  296 (373)
T ss_dssp             EEEEETTTTEEEECCCSSCEECCTTCBCCCCCSSCTTCCHHHHT-TCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred             EEEecCCCCcEEEEeCCCceecCCccccccccCCCcEeChhhcc-CCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            999  566889999999998876655555667999999999885 44578999999999999999999999998887777


Q ss_pred             HHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCC
Q 023609          157 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  235 (280)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~  235 (280)
                      +..+.......+                          ...++.+++++++||.+||+.||.+|||+.++++||||++.
T Consensus       297 ~~~i~~~~~~~~--------------------------~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~  349 (373)
T 2x4f_A          297 LNNILACRWDLE--------------------------DEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDH  349 (373)
T ss_dssp             HHHHHHTCCCSC--------------------------SGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred             HHHHHhccCCCC--------------------------hhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence            666654322211                          12335788999999999999999999999999999999875

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.2e-42  Score=313.05  Aligned_cols=204  Identities=32%  Similarity=0.547  Sum_probs=176.8

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      |+||||+++++++...     ...|+||||+. |+|.+++..++.+++..++.++.||+.||+|||++||+||||||+||
T Consensus        83 l~hpniv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Ni  157 (484)
T 3nyv_A           83 LDHPNIMKLYEFFEDK-----GYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENL  157 (484)
T ss_dssp             CCCTTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred             CCCCCCCcEEEEEEeC-----CEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHE
Confidence            5899999999999765     77999999997 69999999888999999999999999999999999999999999999


Q ss_pred             EE---ccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023609           80 LL---NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ  156 (280)
Q Consensus        80 li---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  156 (280)
                      ++   +.++.++|+|||++.............+|+.|+|||++.+  .++.++||||+||++|+|++|.+||.+.+..+.
T Consensus       158 l~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  235 (484)
T 3nyv_A          158 LLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDI  235 (484)
T ss_dssp             EESSSSTTCCEEECCTTHHHHBCCCCSHHHHTTGGGTCCHHHHHT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             EEecCCCCCcEEEEeeeeeEEcccccccccCCCCccccCceeecC--CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHH
Confidence            99   5678999999999987666555556789999999999854  488999999999999999999999999888777


Q ss_pred             HHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCc
Q 023609          157 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  236 (280)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~  236 (280)
                      ...+.........                          ..++.+|+++++||++||+.||.+|||+.++++||||+...
T Consensus       236 ~~~i~~~~~~~~~--------------------------~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~  289 (484)
T 3nyv_A          236 LKKVEKGKYTFEL--------------------------PQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYT  289 (484)
T ss_dssp             HHHHHHCCCCCCS--------------------------GGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHT
T ss_pred             HHHHHcCCCCCCC--------------------------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcccc
Confidence            7666543222211                          12236789999999999999999999999999999998764


Q ss_pred             C
Q 023609          237 D  237 (280)
Q Consensus       237 ~  237 (280)
                      .
T Consensus       290 ~  290 (484)
T 3nyv_A          290 K  290 (484)
T ss_dssp             C
T ss_pred             c
Confidence            3

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=4.4e-42  Score=297.27  Aligned_cols=202  Identities=31%  Similarity=0.514  Sum_probs=165.6

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN----QALSEEHCQYFLYQILRGLKYIHSANVLHRDLK   75 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~----~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~   75 (280)
                      |+||||+++++++...     ...|+||||++ ++|.+.+...    ..+++..++.++.||+.||+|||++||+|||||
T Consensus        83 l~hpnIv~~~~~~~~~-----~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlk  157 (351)
T 3c0i_A           83 LKHPHIVELLETYSSD-----GMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVK  157 (351)
T ss_dssp             CCCTTBCCEEEEEEET-----TEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred             CCCCCCCcEEEEEEeC-----CEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCC
Confidence            5899999999999765     67999999998 6998887542    359999999999999999999999999999999


Q ss_pred             CCcEEEccCCC---EEEeeccceeeccCCCc-cccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 023609           76 PSNLLLNANCD---LKICDFGLARVTSETDF-MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGR  151 (280)
Q Consensus        76 ~~nili~~~~~---~~l~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~  151 (280)
                      |+||+++.++.   ++|+|||++........ .....+|+.|+|||++.+. .++.++||||+||++|+|++|..||.+.
T Consensus       158 p~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~  236 (351)
T 3c0i_A          158 PHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKRE-PYGKPVDVWGCGVILFILLSGCLPFYGT  236 (351)
T ss_dssp             GGGEEECSSSTTCCEEECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred             hHHeEEecCCCCCcEEEecCcceeEecCCCeeecCCcCCcCccCHHHHcCC-CCCchHhhHHHHHHHHHHHHCCCCCCCc
Confidence            99999986654   99999999987655432 3456789999999998544 5789999999999999999999999875


Q ss_pred             ChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCC
Q 023609          152 DHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPY  231 (280)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~  231 (280)
                      . ......+.........                          ..++.+++++++||++||+.||.+|||+.++++|||
T Consensus       237 ~-~~~~~~i~~~~~~~~~--------------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~  289 (351)
T 3c0i_A          237 K-ERLFEGIIKGKYKMNP--------------------------RQWSHISESAKDLVRRMLMLDPAERITVYEALNHPW  289 (351)
T ss_dssp             H-HHHHHHHHHTCCCCCH--------------------------HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred             H-HHHHHHHHcCCCCCCc--------------------------cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChh
Confidence            3 2333333221111111                          122468899999999999999999999999999999


Q ss_pred             CCCC
Q 023609          232 LGSL  235 (280)
Q Consensus       232 ~~~~  235 (280)
                      |+..
T Consensus       290 ~~~~  293 (351)
T 3c0i_A          290 LKER  293 (351)
T ss_dssp             HHTH
T ss_pred             hcCC
Confidence            9864

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=2.6e-42  Score=293.88  Aligned_cols=195  Identities=28%  Similarity=0.344  Sum_probs=160.1

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nil   80 (280)
                      +||||+++++++...     ...|+||||++++|.+++... ..+++..++.++.||+.||+|||+.||+||||||+||+
T Consensus       115 ~h~~iv~l~~~~~~~-----~~~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl  189 (311)
T 3p1a_A          115 QHPCCVRLEQAWEEG-----GILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIF  189 (311)
T ss_dssp             CCTTBCCEEEEEEET-----TEEEEEEECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred             CCCcEEEEEEEEEeC-----CEEEEEEeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEE
Confidence            799999999999665     679999999999999998754 46999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Q 023609           81 LNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLL  160 (280)
Q Consensus        81 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~  160 (280)
                      ++.++.++|+|||++...+.........+|+.|+|||++.+  .++.++||||+||++++|++|..++.+......   +
T Consensus       190 l~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~---~  264 (311)
T 3p1a_A          190 LGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGGEGWQQ---L  264 (311)
T ss_dssp             ECGGGCEEECCCTTCEECC------CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHHHHHHTCCCCSSHHHHHH---H
T ss_pred             ECCCCCEEEccceeeeecccCCCCcccCCCccccCHhHhcC--CCCchhhHHHHHHHHHHHHhCCCCCCCccHHHH---H
Confidence            99999999999999987765555556678999999998854  488999999999999999999766644322111   1


Q ss_pred             HHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCC
Q 023609          161 IELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS  234 (280)
Q Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~  234 (280)
                      ..  +..+                          ....+.+++++.++|.+||+.||.+|||+.++++||||++
T Consensus       265 ~~--~~~~--------------------------~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          265 RQ--GYLP--------------------------PEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             TT--TCCC--------------------------HHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             hc--cCCC--------------------------cccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence            00  0000                          0112367899999999999999999999999999999976

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=4.8e-43  Score=296.87  Aligned_cols=217  Identities=19%  Similarity=0.290  Sum_probs=150.3

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC--------Ccee
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA--------NVLH   71 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~--------gi~H   71 (280)
                      |+|||||++++++..+.. ....+|||||||+ |+|.+++.. .++++..+..++.|++.||+|||++        ||+|
T Consensus        54 l~HpNIv~l~g~~~~~~~-~~~~~~lV~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiH  131 (303)
T 3hmm_A           54 LRHENILGFIAADNKDNG-TWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAH  131 (303)
T ss_dssp             CCCTTBCCEEEEEEEECS-SSEEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEEC
T ss_pred             CCCCCCCcEEEEEEecCC-CceEEEEEecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEee
Confidence            589999999999976421 1246899999998 799999976 4699999999999999999999987        9999


Q ss_pred             ccCCCCcEEEccCCCEEEeeccceeeccCCC-----ccccceeccccccchhccCCC-----CCCcchhHHHHHHHHHHH
Q 023609           72 RDLKPSNLLLNANCDLKICDFGLARVTSETD-----FMTEYVVTRWYRAPELLLNSS-----DYTAAIDVWSVGCIFMEL  141 (280)
Q Consensus        72 ~di~~~nili~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~-----~~~~~~DiwslG~il~~l  141 (280)
                      |||||+|||++.++.+||+|||+++......     .....+||+.|+|||++.+..     .++.++||||+||++|||
T Consensus       132 RDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El  211 (303)
T 3hmm_A          132 RDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI  211 (303)
T ss_dssp             SCCCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHH
T ss_pred             ccCCcccEEECCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHH
Confidence            9999999999999999999999998654432     122457999999999985432     256789999999999999


Q ss_pred             HhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccC--CCCChHHHHHHHHhhcCCCCC
Q 023609          142 MDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF--PNVHPSAIDLVEKMLTFDPRQ  219 (280)
Q Consensus       142 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~L~~dp~~  219 (280)
                      ++|.+||......+....    ...+.....    +..........  ....++...  ...+..+.+||.+||+.||++
T Consensus       212 ~tg~~~~~~~~~~~~p~~----~~~~~~~~~----~~~~~~~~~~~--~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~  281 (303)
T 3hmm_A          212 ARRCSIGGIHEDYQLPYY----DLVPSDPSV----EEMRKVVCEQK--LRPNIPNRWQSCEALRVMAKIMRECWYANGAA  281 (303)
T ss_dssp             HHTBCBTTBCCCCCCTTT----TTSCSSCCH----HHHHHHHTTSC--CCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGG
T ss_pred             HHCCCCCCccccccccch----hcccccchH----HHHHHHHhccc--CCCCCCccccchHHHHHHHHHHHHHcccCHhH
Confidence            999887643221100000    000000000    00000000000  000001111  112346889999999999999


Q ss_pred             CCCHHHHhcC
Q 023609          220 RITVEDALAH  229 (280)
Q Consensus       220 R~t~~ell~h  229 (280)
                      |||+.|+++.
T Consensus       282 RPt~~ei~~~  291 (303)
T 3hmm_A          282 RLTALRIKKT  291 (303)
T ss_dssp             SCCHHHHHHH
T ss_pred             CcCHHHHHHH
Confidence            9999999863

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.7e-42  Score=298.69  Aligned_cols=206  Identities=30%  Similarity=0.503  Sum_probs=168.0

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nil   80 (280)
                      +||||+++++++.+.     ...|+||||++ |+|.+++...+.+++..+..++.||+.||+|||++||+||||||+||+
T Consensus        74 ~hp~iv~~~~~~~~~-----~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl  148 (342)
T 2qr7_A           74 QHPNIITLKDVYDDG-----KYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNIL  148 (342)
T ss_dssp             TSTTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEE
T ss_pred             CCCCcCeEEEEEEcC-----CEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEE
Confidence            699999999999765     77999999997 699999998889999999999999999999999999999999999999


Q ss_pred             EccC----CCEEEeeccceeeccCC-CccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC---C
Q 023609           81 LNAN----CDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGR---D  152 (280)
Q Consensus        81 i~~~----~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~---~  152 (280)
                      +..+    +.++|+|||++...... ......++|+.|+|||++.+. .++.++||||+||++|+|++|..||.+.   .
T Consensus       149 ~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~  227 (342)
T 2qr7_A          149 YVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQ-GYDAACDIWSLGVLLYTMLTGYTPFANGPDDT  227 (342)
T ss_dssp             ESSSSCSGGGEEECCCTTCEECBCTTCCBCCSSCCSSCCCHHHHHHH-HHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSC
T ss_pred             EecCCCCcCeEEEEECCCcccCcCCCCceeccCCCccccCHHHhcCC-CCCCccCeeeHhHHHHHHhcCCCCCCCCCcCC
Confidence            8443    35999999999865433 334456789999999998543 3788999999999999999999999753   2


Q ss_pred             hHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 023609          153 HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  232 (280)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~  232 (280)
                      ..+....+......                          .....++.+++++++||++||+.||.+|||+.++++||||
T Consensus       228 ~~~~~~~i~~~~~~--------------------------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~  281 (342)
T 2qr7_A          228 PEEILARIGSGKFS--------------------------LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWI  281 (342)
T ss_dssp             HHHHHHHHHHCCCC--------------------------CCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHH
T ss_pred             HHHHHHHHccCCcc--------------------------cCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCee
Confidence            23333332221100                          0112235789999999999999999999999999999999


Q ss_pred             CCCcCCC
Q 023609          233 GSLHDIS  239 (280)
Q Consensus       233 ~~~~~~~  239 (280)
                      .++....
T Consensus       282 ~~~~~~~  288 (342)
T 2qr7_A          282 VHWDQLP  288 (342)
T ss_dssp             HTGGGSC
T ss_pred             cCccccc
Confidence            8765443

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=2.5e-42  Score=303.70  Aligned_cols=209  Identities=27%  Similarity=0.420  Sum_probs=160.6

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ--ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS   77 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~--~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~   77 (280)
                      ++||||+++++++.... .+...+||||||++ |+|.+++...+  .+++.+++.++.||+.||+|||+.||+||||||+
T Consensus       112 ~~hp~iv~l~~~~~~~~-~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~  190 (400)
T 1nxk_A          112 SQCPHIVRIVDVYENLY-AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPE  190 (400)
T ss_dssp             TTSTTBCCEEEEEEEEE-TTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred             cCCCCcceEeEEEeecc-cCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcc
Confidence            37999999999985421 11257899999997 69999998754  5999999999999999999999999999999999


Q ss_pred             cEEEcc---CCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH
Q 023609           78 NLLLNA---NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHV  154 (280)
Q Consensus        78 nili~~---~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  154 (280)
                      ||+++.   ++.+||+|||+++...........++|+.|+|||++. ...++.++||||+||++|+|++|..||.+....
T Consensus       191 Nill~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~  269 (400)
T 1nxk_A          191 NLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLG-PEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL  269 (400)
T ss_dssp             GEEESSSSTTCCEEECCCTTCEECC-----------CTTCCGGGSC-CCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTC
T ss_pred             eEEEecCCCCccEEEEecccccccCCCCccccCCCCCCccCHhhcC-CCCCCCcccHHHHHHHHHHHHhCCCCCCCCccc
Confidence            999987   7889999999998766555455678899999999884 445899999999999999999999999765422


Q ss_pred             H----HHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCC
Q 023609          155 H----QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHP  230 (280)
Q Consensus       155 ~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~  230 (280)
                      .    ....+.....                          ......++.++.++++||++||+.||.+|||+.++++||
T Consensus       270 ~~~~~~~~~i~~~~~--------------------------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp  323 (400)
T 1nxk_A          270 AISPGMKTRIRMGQY--------------------------EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP  323 (400)
T ss_dssp             SSCCSHHHHHHHTCC--------------------------CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred             cccHHHHHHHHcCcc--------------------------cCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence            1    1111111000                          000122346889999999999999999999999999999


Q ss_pred             CCCCCcC
Q 023609          231 YLGSLHD  237 (280)
Q Consensus       231 ~~~~~~~  237 (280)
                      ||.+...
T Consensus       324 ~~~~~~~  330 (400)
T 1nxk_A          324 WIMQSTK  330 (400)
T ss_dssp             HHHTTTT
T ss_pred             cccCCCC
Confidence            9987543

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=1.2e-41  Score=292.64  Aligned_cols=194  Identities=22%  Similarity=0.394  Sum_probs=166.9

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-c-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-T-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g-~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      |+||||+++++++...     ...++||||++ | +|.+++...+.+++..++.++.||+.||+|||+.||+||||||+|
T Consensus        86 l~h~~Iv~~~~~~~~~-----~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~N  160 (335)
T 3dls_A           86 VEHANIIKVLDIFENQ-----GFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDEN  160 (335)
T ss_dssp             CCCTTBCCEEEEEECS-----SEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred             CCCCCEeeEEEEEeeC-----CEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHH
Confidence            5899999999999665     67999999986 5 999999988899999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023609           79 LLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  158 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  158 (280)
                      |+++.++.++|+|||++.............+|+.|+|||++.+....+.++||||+||++|+|++|..||.+....    
T Consensus       161 Ill~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----  236 (335)
T 3dls_A          161 IVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET----  236 (335)
T ss_dssp             EEECTTSCEEECCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG----
T ss_pred             EEEcCCCcEEEeecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH----
Confidence            9999999999999999988766655556778999999999866554588999999999999999999999642110    


Q ss_pred             HHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCC
Q 023609          159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  235 (280)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~  235 (280)
                           .                   .        ........+++++.+||.+||+.||.+|||+.++++||||++.
T Consensus       237 -----~-------------------~--------~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~  281 (335)
T 3dls_A          237 -----V-------------------E--------AAIHPPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP  281 (335)
T ss_dssp             -----T-------------------T--------TCCCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred             -----H-------------------h--------hccCCCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence                 0                   0        0001112478899999999999999999999999999999874

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=1e-41  Score=286.75  Aligned_cols=200  Identities=31%  Similarity=0.498  Sum_probs=160.9

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS----NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK   75 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~----~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~   75 (280)
                      ++||||+++++++...     ...|+||||++ |+|.+++..    ...+++..++.++.||+.||+|||+.|++|||||
T Consensus        77 l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dik  151 (285)
T 3is5_A           77 LDHPNIIKIFEVFEDY-----HNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLK  151 (285)
T ss_dssp             CCCTTBCCEEEEEECS-----SEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCS
T ss_pred             CCCchHHhHHHheecC-----CeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCC
Confidence            5899999999999665     67999999997 599998853    3679999999999999999999999999999999


Q ss_pred             CCcEEE---ccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 023609           76 PSNLLL---NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD  152 (280)
Q Consensus        76 ~~nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  152 (280)
                      |+||++   +.++.++|+|||++.............+++.|+|||.+.  ..++.++||||+||++++|++|..||.+..
T Consensus       152 p~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~--~~~~~~~Di~slG~il~~ll~g~~pf~~~~  229 (285)
T 3is5_A          152 PENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFK--RDVTFKCDIWSAGVVMYFLLTGCLPFTGTS  229 (285)
T ss_dssp             GGGEEESSSSTTCCEEECCCCCCCC----------CTTGGGCCHHHHT--TCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             HHHEEEecCCCCCCEEEEeeecceecCCcccCcCcccccCcCChHHhc--cCCCcccCeehHHHHHHHHHhCCCCCCCCC
Confidence            999999   456889999999998765554455667899999999874  347899999999999999999999998877


Q ss_pred             hHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 023609          153 HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  232 (280)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~  232 (280)
                      .......+......                           +......+++++.+||.+||+.||.+|||+.|+++||||
T Consensus       230 ~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f  282 (285)
T 3is5_A          230 LEEVQQKATYKEPN---------------------------YAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWF  282 (285)
T ss_dssp             HHHHHHHHHHCCCC---------------------------CCC--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGG
T ss_pred             HHHHHhhhccCCcc---------------------------cccccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHh
Confidence            65544433221110                           111123478899999999999999999999999999999


Q ss_pred             CC
Q 023609          233 GS  234 (280)
Q Consensus       233 ~~  234 (280)
                      ++
T Consensus       283 ~~  284 (285)
T 3is5_A          283 KQ  284 (285)
T ss_dssp             GC
T ss_pred             hc
Confidence            86

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=4.3e-42  Score=290.63  Aligned_cols=201  Identities=26%  Similarity=0.530  Sum_probs=164.7

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      |+||||+++++++..+..   ...|+||||++ ++|.+++ ..+.+++..++.++.||+.||+|||++|++||||||+||
T Consensus        93 l~h~~iv~~~~~~~~~~~---~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Ni  168 (298)
T 2zv2_A           93 LDHPNVVKLVEVLDDPNE---DHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNL  168 (298)
T ss_dssp             CCCTTBCCEEEEEECSSS---SEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred             CCCCCCCeEEEEEEcCCC---CEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHE
Confidence            589999999999976422   67999999997 5777754 346799999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCC-ccccceeccccccchhccCCCC--CCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023609           80 LLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSD--YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ  156 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~--~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  156 (280)
                      +++.++.++|+|||++....... ......+|+.|+|||++.+...  .+.++||||+||++|+|++|..||.+......
T Consensus       169 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~  248 (298)
T 2zv2_A          169 LVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCL  248 (298)
T ss_dssp             EECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             EECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHH
Confidence            99999999999999998755432 2345678999999999855432  36789999999999999999999987765544


Q ss_pred             HHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCC
Q 023609          157 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLG  233 (280)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~  233 (280)
                      ...+.......                            ...+.+++++.++|.+||+.||.+|||+.++++||||+
T Consensus       249 ~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~  297 (298)
T 2zv2_A          249 HSKIKSQALEF----------------------------PDQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT  297 (298)
T ss_dssp             HHHHHHCCCCC----------------------------CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred             HHHHhcccCCC----------------------------CCccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence            33332211000                            11246889999999999999999999999999999985

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=5.4e-42  Score=292.20  Aligned_cols=205  Identities=25%  Similarity=0.423  Sum_probs=158.8

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nil   80 (280)
                      +||||+++++++...     ...|+||||++ |+|.+++..++.+++..++.++.||+.||+|||++|++||||||+||+
T Consensus        69 ~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil  143 (316)
T 2ac3_A           69 GHRNVLELIEFFEEE-----DRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENIL  143 (316)
T ss_dssp             CCTTBCCEEEEEEET-----TEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEE
T ss_pred             CCCCeeeEEEEEeeC-----CEEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEE
Confidence            699999999999765     67999999997 699999988888999999999999999999999999999999999999


Q ss_pred             EccCCC---EEEeeccceeeccCC--------CccccceeccccccchhccCC----CCCCcchhHHHHHHHHHHHHhCC
Q 023609           81 LNANCD---LKICDFGLARVTSET--------DFMTEYVVTRWYRAPELLLNS----SDYTAAIDVWSVGCIFMELMDRK  145 (280)
Q Consensus        81 i~~~~~---~~l~dfg~~~~~~~~--------~~~~~~~~~~~y~aPE~~~~~----~~~~~~~DiwslG~il~~ll~g~  145 (280)
                      ++.++.   ++|+|||++......        .......+|+.|+|||++.+.    ..++.++||||+||++|+|++|.
T Consensus       144 ~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~  223 (316)
T 2ac3_A          144 CEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGY  223 (316)
T ss_dssp             ESCSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSS
T ss_pred             EccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCC
Confidence            988766   999999998754321        112234689999999988531    23678999999999999999999


Q ss_pred             CCCCCCChHH---------------HHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHH
Q 023609          146 PLFPGRDHVH---------------QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVE  210 (280)
Q Consensus       146 ~pf~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  210 (280)
                      .||.+....+               ....+......                          .....++.+++++++||+
T Consensus       224 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~--------------------------~~~~~~~~~~~~~~~li~  277 (316)
T 2ac3_A          224 PPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYE--------------------------FPDKDWAHISCAAKDLIS  277 (316)
T ss_dssp             CSCCCCCCSCSCC----CCHHHHHHHHHHHHHCCCC--------------------------CCHHHHTTSCHHHHHHHH
T ss_pred             CCCcccccccccccccccchhHHHHHHHHHhccCcc--------------------------cCchhcccCCHHHHHHHH
Confidence            9997654211               11111110000                          011122467899999999


Q ss_pred             HhhcCCCCCCCCHHHHhcCCCCCCCcC
Q 023609          211 KMLTFDPRQRITVEDALAHPYLGSLHD  237 (280)
Q Consensus       211 ~~L~~dp~~R~t~~ell~h~~~~~~~~  237 (280)
                      +||+.||.+|||+.++++||||++...
T Consensus       278 ~~L~~dP~~Rps~~e~l~hp~~~~~~~  304 (316)
T 2ac3_A          278 KLLVRDAKQRLSAAQVLQHPWVQGCAP  304 (316)
T ss_dssp             HHSCSSTTTSCCHHHHHHSTTCC----
T ss_pred             HHhhCChhhCCCHHHHhcChhhcCCCC
Confidence            999999999999999999999998643

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=6e-42  Score=287.06  Aligned_cols=200  Identities=26%  Similarity=0.437  Sum_probs=167.9

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++...     ...++||||++ |+|.+++...+.+++..+..++.||+.||+|||+.|++||||||+||
T Consensus        66 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Ni  140 (279)
T 3fdn_A           66 LRHPNILRLYGYFHDA-----TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENL  140 (279)
T ss_dssp             CCCTTBCCEEEEEECS-----SEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGE
T ss_pred             CCCCCCcchhheEecC-----CEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhE
Confidence            5799999999999665     67999999998 69999998888899999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  159 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      +++.++.++|+|||.+....... .....+++.|+|||.+.+ ..++.++||||+|+++++|++|..||.+.........
T Consensus       141 li~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~  218 (279)
T 3fdn_A          141 LLGSAGELKIADFGWSVHAPSSR-RTDLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR  218 (279)
T ss_dssp             EECTTSCEEECSCCEESCC---------CCCCTTCCHHHHTT-CCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH
T ss_pred             EEcCCCCEEEEeccccccCCccc-ccccCCCCCccCHhHhcc-CCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHH
Confidence            99999999999999886544332 234578999999998854 4578899999999999999999999988876666555


Q ss_pred             HHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCcC
Q 023609          160 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD  237 (280)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~~  237 (280)
                      +.......                              -+.++.++++||.+||+.||.+|||+.++++||||+....
T Consensus       219 ~~~~~~~~------------------------------~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~~  266 (279)
T 3fdn_A          219 ISRVEFTF------------------------------PDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSS  266 (279)
T ss_dssp             HHHTCCCC------------------------------CTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHCS
T ss_pred             HHhCCCCC------------------------------CCcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCcc
Confidence            43321111                              1246788999999999999999999999999999987543

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=8.6e-42  Score=300.68  Aligned_cols=204  Identities=22%  Similarity=0.351  Sum_probs=170.5

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      ++||||+++++++.+.     ..+|+||||+. |+|.+++.+. ..+++..++.++.||+.||+|||++||+||||||+|
T Consensus       118 ~~hp~Iv~l~~~~~~~-----~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~N  192 (412)
T 2vd5_A          118 GDRRWITQLHFAFQDE-----NYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDN  192 (412)
T ss_dssp             SCTTTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred             cCCCCeeeEEEEEeeC-----CEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHH
Confidence            4799999999999766     77999999996 7999999864 479999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCCCc--cccceeccccccchhccC------CCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 023609           79 LLLNANCDLKICDFGLARVTSETDF--MTEYVVTRWYRAPELLLN------SSDYTAAIDVWSVGCIFMELMDRKPLFPG  150 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~------~~~~~~~~DiwslG~il~~ll~g~~pf~~  150 (280)
                      |+++.+|.+||+|||++........  ....+||+.|+|||++..      ...++.++|+||+||++|+|++|..||.+
T Consensus       193 ILld~~g~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~  272 (412)
T 2vd5_A          193 ILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYA  272 (412)
T ss_dssp             EEECTTSCEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             eeecCCCCEEEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCC
Confidence            9999999999999999987654432  234579999999999862      34578999999999999999999999999


Q ss_pred             CChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCC---CCHHHHh
Q 023609          151 RDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQR---ITVEDAL  227 (280)
Q Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R---~t~~ell  227 (280)
                      .+..+....+.......                         .+....+.+|+++++||++||+ +|.+|   +++++++
T Consensus       273 ~~~~~~~~~i~~~~~~~-------------------------~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~  326 (412)
T 2vd5_A          273 DSTAETYGKIVHYKEHL-------------------------SLPLVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFR  326 (412)
T ss_dssp             SSHHHHHHHHHTHHHHC-------------------------CCC----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHH
T ss_pred             CCHHHHHHHHHhcccCc-------------------------CCCccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHh
Confidence            88877766665321000                         0011113688999999999999 99998   5999999


Q ss_pred             cCCCCCCC
Q 023609          228 AHPYLGSL  235 (280)
Q Consensus       228 ~h~~~~~~  235 (280)
                      +||||+++
T Consensus       327 ~Hpff~~i  334 (412)
T 2vd5_A          327 THPFFFGL  334 (412)
T ss_dssp             TSGGGTTC
T ss_pred             cCCCcCCC
Confidence            99999875

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=3.4e-42  Score=289.86  Aligned_cols=203  Identities=27%  Similarity=0.436  Sum_probs=156.3

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHH----cCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIR----SNQALSEEHCQYFLYQILRGLKYIHSA-NVLHRDLK   75 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~----~~~~l~~~~~~~i~~qll~al~~LH~~-gi~H~di~   75 (280)
                      ++||||+++++++...     ...|+||||++|+|.+++.    .++.+++..++.++.||+.||+|||+. |++|||||
T Consensus        63 ~~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlk  137 (290)
T 3fme_A           63 VDCPFTVTFYGALFRE-----GDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVK  137 (290)
T ss_dssp             CCCTTBCCEEEEEECS-----SSEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCS
T ss_pred             CCCCeEEEEeeeeecc-----CCEEEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCC
Confidence            4799999999999765     6799999999999887775    356899999999999999999999998 99999999


Q ss_pred             CCcEEEccCCCEEEeeccceeeccCCCccccceeccccccchhc---cCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 023609           76 PSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL---LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD  152 (280)
Q Consensus        76 ~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~---~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  152 (280)
                      |+||+++.++.++|+|||.+.............+++.|+|||.+   .....++.++||||+||++++|++|..||.+..
T Consensus       138 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  217 (290)
T 3fme_A          138 PSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWG  217 (290)
T ss_dssp             GGGCEECTTCCEEBCCC---------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCS
T ss_pred             HHHEEECCCCCEEEeecCCcccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccC
Confidence            99999999999999999999876655444556789999999996   244557899999999999999999999997633


Q ss_pred             -hHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCC
Q 023609          153 -HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPY  231 (280)
Q Consensus       153 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~  231 (280)
                       ...............                            ...+.+++++.++|.+||+.||.+|||+.++++|||
T Consensus       218 ~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~  269 (290)
T 3fme_A          218 TPFQQLKQVVEEPSPQ----------------------------LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQHPF  269 (290)
T ss_dssp             CHHHHHHHHHHSCCCC----------------------------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHH
T ss_pred             chHHHHHHHhccCCCC----------------------------cccccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcc
Confidence             333322222111000                            111357889999999999999999999999999999


Q ss_pred             CCCCc
Q 023609          232 LGSLH  236 (280)
Q Consensus       232 ~~~~~  236 (280)
                      |+...
T Consensus       270 f~~~~  274 (290)
T 3fme_A          270 FTLHE  274 (290)
T ss_dssp             HHHHH
T ss_pred             cccCc
Confidence            98643

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.2e-41  Score=291.68  Aligned_cols=203  Identities=29%  Similarity=0.474  Sum_probs=168.7

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      +||||+++++++...     ...|+||||+. |+|.+++...  +.+++..++.++.||+.||+|||++|++||||||+|
T Consensus        87 ~~~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~N  161 (327)
T 3lm5_A           87 SCPRVINLHEVYENT-----SEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQN  161 (327)
T ss_dssp             TCTTBCCEEEEEECS-----SEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred             CCCCEEEEEEEEEeC-----CeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHH
Confidence            579999999999765     67999999997 5999998643  679999999999999999999999999999999999


Q ss_pred             EEEcc---CCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 023609           79 LLLNA---NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVH  155 (280)
Q Consensus        79 ili~~---~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~  155 (280)
                      |+++.   ++.++|+|||++.............+++.|+|||++.+ ..++.++||||+||++|+|++|..||.+.+..+
T Consensus       162 Il~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~  240 (327)
T 3lm5_A          162 ILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNY-DPITTATDMWNIGIIAYMLLTHTSPFVGEDNQE  240 (327)
T ss_dssp             EEESCBTTBCCEEECCGGGCEEC---------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             EEEecCCCCCcEEEeeCccccccCCccccccccCCcCccCCeeecC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCchH
Confidence            99987   78999999999987766554556678999999998854 458899999999999999999999999888777


Q ss_pred             HHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCC
Q 023609          156 QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  235 (280)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~  235 (280)
                      ....+.......+.                          ..++.+++.++++|.+||+.||.+|||++++++||||+++
T Consensus       241 ~~~~i~~~~~~~~~--------------------------~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~  294 (327)
T 3lm5_A          241 TYLNISQVNVDYSE--------------------------ETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQW  294 (327)
T ss_dssp             HHHHHHHTCCCCCT--------------------------TTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCC
T ss_pred             HHHHHHhcccccCc--------------------------hhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccc
Confidence            66655443322221                          2234678999999999999999999999999999999986


Q ss_pred             c
Q 023609          236 H  236 (280)
Q Consensus       236 ~  236 (280)
                      .
T Consensus       295 ~  295 (327)
T 3lm5_A          295 D  295 (327)
T ss_dssp             C
T ss_pred             c
Confidence            4

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=2.3e-41  Score=285.98  Aligned_cols=205  Identities=28%  Similarity=0.517  Sum_probs=174.4

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nil   80 (280)
                      +||||+++++++...     ...|+||||++ ++|.+++..+..+++..++.++.||+.||+|||+.|++|+||+|+||+
T Consensus        82 ~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil  156 (298)
T 1phk_A           82 GHPNIIQLKDTYETN-----TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENIL  156 (298)
T ss_dssp             TCTTBCCEEEEEECS-----SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred             CCCCEeeeeeeeccC-----CeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEE
Confidence            499999999999665     77999999997 699999998888999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccceeeccCCCccccceeccccccchhcc-----CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 023609           81 LNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL-----NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVH  155 (280)
Q Consensus        81 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~-----~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~  155 (280)
                      ++.++.++|+|||.+.............+++.|+|||++.     ....++.++||||+|+++++|++|..||.+.+...
T Consensus       157 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~  236 (298)
T 1phk_A          157 LDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML  236 (298)
T ss_dssp             ECTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             EcCCCcEEEecccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHH
Confidence            9999999999999998766555555667899999999874     23457889999999999999999999998877666


Q ss_pred             HHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCC
Q 023609          156 QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  235 (280)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~  235 (280)
                      ....+.........                          ...+.++..+.++|.+||+.||.+|||+.++++||||++.
T Consensus       237 ~~~~~~~~~~~~~~--------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (298)
T 1phk_A          237 MLRMIMSGNYQFGS--------------------------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY  290 (298)
T ss_dssp             HHHHHHHTCCCCCT--------------------------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred             HHHHHhcCCcccCc--------------------------ccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhc
Confidence            55554432221111                          1123578899999999999999999999999999999986


Q ss_pred             cC
Q 023609          236 HD  237 (280)
Q Consensus       236 ~~  237 (280)
                      ..
T Consensus       291 ~~  292 (298)
T 1phk_A          291 VV  292 (298)
T ss_dssp             C-
T ss_pred             cc
Confidence            43

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=2e-41  Score=315.35  Aligned_cols=198  Identities=21%  Similarity=0.410  Sum_probs=173.3

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nil   80 (280)
                      +||||+++++++.+.     ..+|+||||++ |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+||+
T Consensus       400 ~~~~i~~l~~~~~~~-----~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NIL  474 (674)
T 3pfq_A          400 KPPFLTQLHSCFQTM-----DRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVM  474 (674)
T ss_dssp             CCTTBCCEEEECBCS-----SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEE
T ss_pred             CCCeEEEEEEEEEeC-----CEEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEE
Confidence            699999999999765     67999999997 699999998889999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccceeecc-CCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023609           81 LNANCDLKICDFGLARVTS-ETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  159 (280)
Q Consensus        81 i~~~~~~~l~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      ++.+|.++|+|||+++... ........+||+.|+|||++.+ ..++.++|+|||||++|+|++|.+||.+.+..+....
T Consensus       475 l~~~g~ikL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~  553 (674)
T 3pfq_A          475 LDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAY-QPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQS  553 (674)
T ss_dssp             ECSSSCEEECCCTTCEECCCTTCCBCCCCSCSSSCCHHHHTC-CCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             EcCCCcEEEeecceeeccccCCcccccccCCCcccCHhhhcC-CCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHH
Confidence            9999999999999998633 2333456789999999999854 4589999999999999999999999999888777766


Q ss_pred             HHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCH-----HHHhcCCCCCC
Q 023609          160 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV-----EDALAHPYLGS  234 (280)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~-----~ell~h~~~~~  234 (280)
                      +.......                              -+.+++++++||++||+.||.+||++     +++++||||++
T Consensus       554 i~~~~~~~------------------------------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~  603 (674)
T 3pfq_A          554 IMEHNVAY------------------------------PKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY  603 (674)
T ss_dssp             HHSSCCCC------------------------------CTTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSS
T ss_pred             HHhCCCCC------------------------------CccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccC
Confidence            65321111                              12678999999999999999999998     99999999997


Q ss_pred             C
Q 023609          235 L  235 (280)
Q Consensus       235 ~  235 (280)
                      +
T Consensus       604 i  604 (674)
T 3pfq_A          604 I  604 (674)
T ss_dssp             C
T ss_pred             C
Confidence            5

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=8.9e-42  Score=285.39  Aligned_cols=200  Identities=27%  Similarity=0.450  Sum_probs=161.7

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++...     ...|+||||++ ++|.+++...+.+++..++.++.||+.||+|||++|++|+||+|+||
T Consensus        68 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Ni  142 (276)
T 2h6d_A           68 FRHPHIIKLYQVISTP-----TDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENV  142 (276)
T ss_dssp             CCCTTBCCEEEEEECS-----SEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGE
T ss_pred             CCCCCEeEEEEEEecC-----CeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhE
Confidence            5799999999999765     67999999997 69999998888899999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  159 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      +++.++.++|+|||.+.............+++.|+|||.+.+....+.++|+||+|+++++|++|..||.+.........
T Consensus       143 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~  222 (276)
T 2h6d_A          143 LLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKK  222 (276)
T ss_dssp             EECTTSCEEECCCCGGGCCCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             EECCCCCEEEeecccccccCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHH
Confidence            99999999999999998766554445567899999999986554446899999999999999999999987766554444


Q ss_pred             HHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCC
Q 023609          160 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  235 (280)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~  235 (280)
                      +......                              .-..++..+.++|.+||+.||.+|||+.++++||||++.
T Consensus       223 ~~~~~~~------------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~  268 (276)
T 2h6d_A          223 IRGGVFY------------------------------IPEYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD  268 (276)
T ss_dssp             HHHCCCC------------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             hhcCccc------------------------------CchhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence            3321100                              012467889999999999999999999999999999764

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=2.1e-41  Score=307.67  Aligned_cols=199  Identities=29%  Similarity=0.490  Sum_probs=168.1

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ--ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS   77 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~--~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~   77 (280)
                      ++||||+++++++.+.     ..+|+||||++ |+|.+++...+  .+++..++.++.||+.||+|||++||+||||||+
T Consensus       241 l~hp~Iv~l~~~~~~~-----~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPe  315 (576)
T 2acx_A          241 VNSRFVVSLAYAYETK-----DALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPE  315 (576)
T ss_dssp             CCCTTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred             cCCCCEeeEEEEEeeC-----CEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchh
Confidence            5899999999999765     67999999996 69999998654  4999999999999999999999999999999999


Q ss_pred             cEEEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh----
Q 023609           78 NLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDH----  153 (280)
Q Consensus        78 nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~----  153 (280)
                      ||+++.+|.++|+|||++............+||+.|+|||++.+. .++.++|+||+||++|+|++|..||.+...    
T Consensus       316 NILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~-~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~  394 (576)
T 2acx_A          316 NILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNE-RYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR  394 (576)
T ss_dssp             GEEECTTSCEEECCCTTCEECCTTCCEECCCSCGGGCCHHHHTTC-EESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCH
T ss_pred             eEEEeCCCCeEEEecccceecccCccccccCCCccccCHHHHcCC-CCCccchHHHHHHHHHHHHhCCCCCcccccchhH
Confidence            999999999999999999887665555567899999999998554 488999999999999999999999987542    


Q ss_pred             HHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCC-----CHHHHhc
Q 023609          154 VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI-----TVEDALA  228 (280)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~ell~  228 (280)
                      ......+.. .                      +    .   ...+.+|+++++||++||+.||.+||     ++.|+++
T Consensus       395 ~~i~~~i~~-~----------------------~----~---~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          395 EEVERLVKE-V----------------------P----E---EYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             HHHHHHHHH-C----------------------C----C---CCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             HHHHHHhhc-c----------------------c----c---cCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence            111111111 0                      0    0   11136789999999999999999999     8899999


Q ss_pred             CCCCCCC
Q 023609          229 HPYLGSL  235 (280)
Q Consensus       229 h~~~~~~  235 (280)
                      ||||+++
T Consensus       445 HpfF~~i  451 (576)
T 2acx_A          445 HPLFKKL  451 (576)
T ss_dssp             SGGGTTC
T ss_pred             ChhhccC
Confidence            9999975

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=6.2e-41  Score=286.64  Aligned_cols=202  Identities=28%  Similarity=0.489  Sum_probs=169.1

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++...     ...|+||||++ ++|.+++.. ..+++..+..++.||+.||+|||+.|++||||||+||
T Consensus        99 l~h~niv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NI  172 (321)
T 2c30_A           99 YQHFNVVEMYKSYLVG-----EELWVLMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSI  172 (321)
T ss_dssp             CCCTTBCCEEEEEEET-----TEEEEEECCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred             CCCCCcceEEEEEEEC-----CEEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHE
Confidence            5799999999999765     67999999997 699998864 5799999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCC-ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  158 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.++.++|+|||++....... ......+|+.|+|||++.+ ..++.++||||+||++|+|++|..||.+....+...
T Consensus       173 ll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~  251 (321)
T 2c30_A          173 LLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISR-SLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK  251 (321)
T ss_dssp             EECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH
T ss_pred             EECCCCcEEEeeeeeeeecccCccccccccCCccccCHhhhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            99999999999999988655432 2345678999999998854 457899999999999999999999998877666554


Q ss_pred             HHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCc
Q 023609          159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  236 (280)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~  236 (280)
                      .+........                           .....+++.++++|.+||+.||++|||+.++++||||.+..
T Consensus       252 ~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~  302 (321)
T 2c30_A          252 RLRDSPPPKL---------------------------KNSHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTG  302 (321)
T ss_dssp             HHHHSSCCCC---------------------------TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred             HHhcCCCCCc---------------------------CccccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccCC
Confidence            4432211100                           01125688999999999999999999999999999998754

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.9e-41  Score=292.83  Aligned_cols=199  Identities=26%  Similarity=0.404  Sum_probs=168.4

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIR-SNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~-~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      |+||||+++++++...     ...|+||||+.|+|.+++. .++.+++..++.++.|++.||+|||+.||+||||||+||
T Consensus       111 l~hpniv~~~~~~~~~-----~~~~lv~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI  185 (348)
T 1u5q_A          111 LRHPNTIQYRGCYLRE-----HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNI  185 (348)
T ss_dssp             CCCTTBCCEEEEEEET-----TEEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGE
T ss_pred             CCCCCEeeEEEEEEEC-----CeEEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHE
Confidence            5899999999999765     6799999999999999886 456799999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCCccccceeccccccchhccC--CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLN--SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL  157 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  157 (280)
                      +++.++.++|+|||++......   ....+|+.|+|||++.+  ...++.++||||+||++++|++|..||.+.+.....
T Consensus       186 ll~~~~~~kL~DfG~a~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~  262 (348)
T 1u5q_A          186 LLSEPGLVKLGDFGSASIMAPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL  262 (348)
T ss_dssp             EEETTTEEEECCCTTCBSSSSB---CCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred             EECCCCCEEEeeccCceecCCC---CcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence            9999999999999999765433   34578999999998853  445788999999999999999999999887765554


Q ss_pred             HHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCC
Q 023609          158 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  235 (280)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~  235 (280)
                      ..+.......                            .....+++.+++||.+||+.||.+|||+.++++||||...
T Consensus       263 ~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~  312 (348)
T 1u5q_A          263 YHIAQNESPA----------------------------LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  312 (348)
T ss_dssp             HHHHHSCCCC----------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred             HHHHhcCCCC----------------------------CCCCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhcc
Confidence            4433211100                            0113578899999999999999999999999999999764

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.2e-41  Score=293.43  Aligned_cols=206  Identities=25%  Similarity=0.455  Sum_probs=167.2

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHc--------------------------------------
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS--------------------------------------   41 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~--------------------------------------   41 (280)
                      |+||||+++++++.+.     ...|+||||++ |+|.+++..                                      
T Consensus        85 l~hpniv~~~~~~~~~-----~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (345)
T 3hko_A           85 LHHPNIARLYEVYEDE-----QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRE  159 (345)
T ss_dssp             CCCTTBCCEEEEEECS-----SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEE
T ss_pred             CCCCCcceeehhhccC-----CeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccc
Confidence            5899999999999665     67999999996 699999852                                      


Q ss_pred             --CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCC--CEEEeeccceeeccCCC-----ccccceeccc
Q 023609           42 --NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANC--DLKICDFGLARVTSETD-----FMTEYVVTRW  112 (280)
Q Consensus        42 --~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nili~~~~--~~~l~dfg~~~~~~~~~-----~~~~~~~~~~  112 (280)
                        ...+++..++.++.||+.||+|||+.|++||||||+||+++.++  .++|+|||++.......     ......+++.
T Consensus       160 ~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~  239 (345)
T 3hko_A          160 SLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPY  239 (345)
T ss_dssp             ECCHHHHHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGG
T ss_pred             cccccccHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCcc
Confidence              11246788999999999999999999999999999999998776  89999999998643321     2345678999


Q ss_pred             cccchhccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCcccc
Q 023609          113 YRAPELLLNS-SDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQR  191 (280)
Q Consensus       113 y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (280)
                      |+|||.+.+. ..++.++||||+||++|+|++|..||.+.+..+....+.........                      
T Consensus       240 y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~----------------------  297 (345)
T 3hko_A          240 FVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFEN----------------------  297 (345)
T ss_dssp             GCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTS----------------------
T ss_pred             ccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCC----------------------
Confidence            9999998542 45789999999999999999999999988877766665543222111                      


Q ss_pred             ccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCcC
Q 023609          192 QSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD  237 (280)
Q Consensus       192 ~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~~  237 (280)
                          ..++.+++++++||.+||+.||.+|||+.++++||||+++.+
T Consensus       298 ----~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~~  339 (345)
T 3hko_A          298 ----PNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSD  339 (345)
T ss_dssp             ----GGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTSS
T ss_pred             ----cccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccChH
Confidence                112357889999999999999999999999999999998753

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=2.9e-41  Score=283.57  Aligned_cols=200  Identities=24%  Similarity=0.464  Sum_probs=170.1

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++...     ...|+||||++ |+|.+++...+.+++..+..++.||+.||+|||+.|++||||+|+||
T Consensus        71 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Ni  145 (284)
T 2vgo_A           71 LRHPNILRMYNYFHDR-----KRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENL  145 (284)
T ss_dssp             CCCTTBCCEEEEEECS-----SEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGE
T ss_pred             CCCCCEeeEEEEEEcC-----CEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHE
Confidence            5799999999999765     67999999997 59999998888899999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  159 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      +++.++.++|+|||.+....... .....+++.|+|||.+.+ ..++.++|+||+|+++++|++|..||.+.........
T Consensus       146 l~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~  223 (284)
T 2vgo_A          146 LMGYKGELKIADFGWSVHAPSLR-RRTMCGTLDYLPPEMIEG-KTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRR  223 (284)
T ss_dssp             EECTTCCEEECCCTTCEECSSSC-BCCCCSCGGGCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH
T ss_pred             EEcCCCCEEEecccccccCcccc-cccccCCCCcCCHHHhcc-CCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHH
Confidence            99999999999999987654432 234578999999999854 4478999999999999999999999988766555443


Q ss_pred             HHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCcC
Q 023609          160 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD  237 (280)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~~  237 (280)
                      +.....                              ..-+.++.+++++|.+||+.||.+|||+.++++||||+....
T Consensus       224 ~~~~~~------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~  271 (284)
T 2vgo_A          224 IVNVDL------------------------------KFPPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSR  271 (284)
T ss_dssp             HHTTCC------------------------------CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCC
T ss_pred             Hhcccc------------------------------CCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhcc
Confidence            322110                              011357889999999999999999999999999999987543

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=3e-41  Score=283.20  Aligned_cols=205  Identities=28%  Similarity=0.507  Sum_probs=169.9

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      |+||||+++++++...     ...|+||||++ ++|.+++..++.+++..+..++.||+.||+|||+.|++|+||||+||
T Consensus        65 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Ni  139 (283)
T 3bhy_A           65 IRHPNIITLHDIFENK-----TDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENI  139 (283)
T ss_dssp             CCCTTBCCEEEEEECS-----SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred             CCCCCeeehhheecCC-----CeEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHE
Confidence            5799999999999765     67999999996 69999998888899999999999999999999999999999999999


Q ss_pred             EEccCC----CEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 023609           80 LLNANC----DLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVH  155 (280)
Q Consensus        80 li~~~~----~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~  155 (280)
                      +++.++    .++|+|||.+.............+++.|+|||.+.+ ..++.++|+||+|+++++|++|..||.+....+
T Consensus       140 l~~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~  218 (283)
T 3bhy_A          140 MLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGETKQE  218 (283)
T ss_dssp             EESCSSSSSCCEEECCCTTCEECC--------CCCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHH
T ss_pred             EEecCCCCCCceEEEecccceeccCCCcccccCCCcCccCcceecC-CCCCcchhhhhHHHHHHHHHHCCCCCCCcchHH
Confidence            998876    899999999987665544455678999999998854 458899999999999999999999998887666


Q ss_pred             HHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCC
Q 023609          156 QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  235 (280)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~  235 (280)
                      ....+.........                          ...+.+++.+.++|.+||+.||++|||+.++++||||+..
T Consensus       219 ~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  272 (283)
T 3bhy_A          219 TLTNISAVNYDFDE--------------------------EYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI  272 (283)
T ss_dssp             HHHHHHTTCCCCCH--------------------------HHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred             HHHHhHhcccCCcc--------------------------hhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence            55544332211111                          2224678899999999999999999999999999999876


Q ss_pred             cC
Q 023609          236 HD  237 (280)
Q Consensus       236 ~~  237 (280)
                      +.
T Consensus       273 ~~  274 (283)
T 3bhy_A          273 RR  274 (283)
T ss_dssp             HH
T ss_pred             HH
Confidence            43

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=6.1e-42  Score=303.00  Aligned_cols=203  Identities=34%  Similarity=0.636  Sum_probs=158.3

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      |+||||+++++++..      ...|+||||++ |+|.+++..++.+++..++.++.||+.||+|||++||+||||||+||
T Consensus       197 l~hpniv~l~~~~~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NI  270 (419)
T 3i6u_A          197 LNHPCIIKIKNFFDA------EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENV  270 (419)
T ss_dssp             CCCTTBCCCCEEEES------SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred             CCCCCEeeEEEEEec------CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhE
Confidence            589999999999843      45799999997 69999998888999999999999999999999999999999999999


Q ss_pred             EEccCC---CEEEeeccceeeccCCCccccceeccccccchhccC--CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH
Q 023609           80 LLNANC---DLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLN--SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHV  154 (280)
Q Consensus        80 li~~~~---~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  154 (280)
                      +++.++   .++|+|||+++..+.........+|+.|+|||++.+  ...++.++||||+||++|+|++|..||.+....
T Consensus       271 ll~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~  350 (419)
T 3i6u_A          271 LLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ  350 (419)
T ss_dssp             EESSSSSSCCEEECCSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSS
T ss_pred             EEecCCCcceEEEeecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcch
Confidence            997544   599999999987766555556789999999998753  345778999999999999999999999765432


Q ss_pred             HHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCC
Q 023609          155 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS  234 (280)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~  234 (280)
                      .............                         .....++.+++.+++||.+||+.||.+|||+.++++||||++
T Consensus       351 ~~~~~~i~~~~~~-------------------------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~  405 (419)
T 3i6u_A          351 VSLKDQITSGKYN-------------------------FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD  405 (419)
T ss_dssp             CCHHHHHHTTCCC-------------------------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             HHHHHHHhcCCCC-------------------------CCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence            2222111111110                         111233468899999999999999999999999999999976

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=6.4e-41  Score=287.26  Aligned_cols=227  Identities=28%  Similarity=0.607  Sum_probs=174.6

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nil   80 (280)
                      .||||+++++++..+..   ...++||||++ ++|.+++.   .+++..++.++.||+.||+|||++|++||||||+||+
T Consensus        89 ~~~~i~~~~~~~~~~~~---~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil  162 (330)
T 3nsz_A           89 GGPNIITLADIVKDPVS---RTPALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVM  162 (330)
T ss_dssp             TSTTBCCEEEEEECTTT---CCEEEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred             CCCCEEEeeeeeccCCC---CceEEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEE
Confidence            39999999999976422   67899999998 58888875   3999999999999999999999999999999999999


Q ss_pred             EccCC-CEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCC-CCChHHHHH
Q 023609           81 LNANC-DLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFP-GRDHVHQLR  158 (280)
Q Consensus        81 i~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~-~~~~~~~~~  158 (280)
                      ++.++ .++|+|||++.............+++.|+|||.+.+...++.++||||+||++++|++|..||. +....+.+.
T Consensus       163 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~  242 (330)
T 3nsz_A          163 IDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV  242 (330)
T ss_dssp             EETTTTEEEECCCTTCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHH
T ss_pred             EcCCCCEEEEEeCCCceEcCCCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHH
Confidence            99777 8999999999876665555567889999999998765668999999999999999999998884 556666666


Q ss_pred             HHHHHhCCCCHHHHhHhhHhH----HHHhhhcCccccccccccC-----CCCChHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 023609          159 LLIELIGTPSEAELGFLNENA----KKYICQLPRYQRQSFTEKF-----PNVHPSAIDLVEKMLTFDPRQRITVEDALAH  229 (280)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~li~~~L~~dp~~R~t~~ell~h  229 (280)
                      .+....+.+.....  .....    ..+...........+....     +.+++++++||.+||+.||.+|||+.++++|
T Consensus       243 ~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h  320 (330)
T 3nsz_A          243 RIAKVLGTEDLYDY--IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  320 (330)
T ss_dssp             HHHHHHCHHHHHHH--HHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             HHHHhcCCchhhhH--HHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            66665554322111  00000    0000000011111111111     2378999999999999999999999999999


Q ss_pred             CCCCCCc
Q 023609          230 PYLGSLH  236 (280)
Q Consensus       230 ~~~~~~~  236 (280)
                      |||+++.
T Consensus       321 p~f~~~~  327 (330)
T 3nsz_A          321 PYFYTVV  327 (330)
T ss_dssp             GGGTTCC
T ss_pred             ccHhhhc
Confidence            9999864

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=6e-41  Score=288.32  Aligned_cols=206  Identities=31%  Similarity=0.477  Sum_probs=173.3

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++.+.     ...|+||||++ ++|.+++..++.+++.+++.++.||+.||+|||++|++||||||+||
T Consensus        98 l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NI  172 (335)
T 2owb_A           98 LAHQHVVGFHGFFEDN-----DFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNL  172 (335)
T ss_dssp             CCCTTBCCEEEEEECS-----SEEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred             CCCCCCCeEEEEEecC-----CeEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhE
Confidence            5899999999999765     67999999998 69999998888899999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCC-CccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  158 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.++.++|+|||.+...... .......+++.|+|||++.+. .++.++|||||||++|+|++|..||.+....+...
T Consensus       173 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~  251 (335)
T 2owb_A          173 FLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKK-GHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL  251 (335)
T ss_dssp             EECTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHHTS-CBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH
T ss_pred             EEcCCCCEEEeeccCceecccCcccccccCCCccccCHHHhccC-CCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHH
Confidence            9999999999999999875433 223445789999999998654 47889999999999999999999998776655444


Q ss_pred             HHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCcCC
Q 023609          159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDI  238 (280)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~~~  238 (280)
                      .+.....                              ..-..+++.+.+||++||+.||++|||+.++++||||.+...+
T Consensus       252 ~~~~~~~------------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~~  301 (335)
T 2owb_A          252 RIKKNEY------------------------------SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP  301 (335)
T ss_dssp             HHHHTCC------------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCC
T ss_pred             HHhcCCC------------------------------CCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCCcc
Confidence            3322110                              0112568899999999999999999999999999999886654


Q ss_pred             CCCC
Q 023609          239 SDEP  242 (280)
Q Consensus       239 ~~~~  242 (280)
                      ...+
T Consensus       302 ~~~~  305 (335)
T 2owb_A          302 ARLP  305 (335)
T ss_dssp             SCCC
T ss_pred             ccCC
Confidence            4433

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=7.3e-41  Score=292.77  Aligned_cols=225  Identities=29%  Similarity=0.549  Sum_probs=177.6

Q ss_pred             CCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHH--HCCceeccCCCCc
Q 023609            3 HENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIH--SANVLHRDLKPSN   78 (280)
Q Consensus         3 HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH--~~gi~H~di~~~n   78 (280)
                      |++|+++++++...     ...|+||||++|+|.+++...  +.+++..++.++.||+.||.|||  +.||+||||||+|
T Consensus       115 ~~~iv~~~~~~~~~-----~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~N  189 (382)
T 2vx3_A          115 KYYIVHLKRHFMFR-----NHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPEN  189 (382)
T ss_dssp             GGGBCCEEEEEEET-----TEEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGG
T ss_pred             ceeEEEeeeeeccC-----CceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCccc
Confidence            45699999998765     679999999999999999865  46999999999999999999999  5799999999999


Q ss_pred             EEEc--cCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023609           79 LLLN--ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ  156 (280)
Q Consensus        79 ili~--~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  156 (280)
                      |+++  .++.++|+|||++...+..  .....+|+.|+|||++.+. .++.++||||+||++|+|++|.+||.+.+..+.
T Consensus       190 Ill~~~~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~  266 (382)
T 2vx3_A          190 ILLCNPKRSAIKIVDFGSSCQLGQR--IYQYIQSRFYRSPEVLLGM-PYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQ  266 (382)
T ss_dssp             EEESSTTSCCEEECCCTTCEETTCC--CCSSCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             EEEecCCCCcEEEEeccCceecccc--cccccCCccccChHHHcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            9995  4788999999999876543  3456789999999998654 488999999999999999999999999999999


Q ss_pred             HHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCcccc-----------------cccccc-----------CCCC-------
Q 023609          157 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQR-----------------QSFTEK-----------FPNV-------  201 (280)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~-----------~~~~-------  201 (280)
                      +..+.+..+.++...+..... ...+....+....                 ..+...           ..+.       
T Consensus       267 ~~~i~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  345 (382)
T 2vx3_A          267 MNKIVEVLGIPPAHILDQAPK-ARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVAD  345 (382)
T ss_dssp             HHHHHHHHCSCCHHHHTTCTT-HHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHH
T ss_pred             HHHHHHHhCCCCHHHHHhhHH-HHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchh
Confidence            999999999888765432211 1222222111000                 000000           0000       


Q ss_pred             ChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCc
Q 023609          202 HPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  236 (280)
Q Consensus       202 ~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~  236 (280)
                      ++++++||++||+.||++|||+.|+|+||||++..
T Consensus       346 ~~~~~dli~~mL~~dP~~Rpta~e~L~hp~f~~~~  380 (382)
T 2vx3_A          346 YLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKTA  380 (382)
T ss_dssp             HHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGCC--
T ss_pred             hHHHHHHHHHhcCCChhhCCCHHHHhcCcccccCC
Confidence            13789999999999999999999999999998754

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=9.1e-41  Score=281.90  Aligned_cols=206  Identities=31%  Similarity=0.477  Sum_probs=172.5

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++...     ...|+||||++ ++|.+++..++.+++.+++.++.||+.||+|||+.|++||||||+||
T Consensus        72 l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Ni  146 (294)
T 2rku_A           72 LAHQHVVGFHGFFEDN-----DFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNL  146 (294)
T ss_dssp             CCCTTBCCEEEEEECS-----SEEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred             CCCCCEeeeeeeeccC-----CEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhE
Confidence            5799999999999665     67999999998 69999998888899999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCC-CccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  158 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.++.++|+|||.+...... .......+++.|+|||.+.+ ..++.++|+||+|+++++|++|..||.+....+...
T Consensus       147 l~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~  225 (294)
T 2rku_A          147 FLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL  225 (294)
T ss_dssp             EECTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHTT-SCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH
T ss_pred             EEcCCCCEEEEeccCceecccCccccccccCCCCcCCcchhcc-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            9999999999999999875432 22344568999999998854 447889999999999999999999998876555443


Q ss_pred             HHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCcCC
Q 023609          159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDI  238 (280)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~~~  238 (280)
                      .+.....                              ..-..+++.+.++|.+||+.||++|||+.++++||||.+...+
T Consensus       226 ~~~~~~~------------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~  275 (294)
T 2rku_A          226 RIKKNEY------------------------------SIPKHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIP  275 (294)
T ss_dssp             HHHTTCC------------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCC
T ss_pred             HHhhccC------------------------------CCccccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCCcC
Confidence            3321100                              0112567899999999999999999999999999999886654


Q ss_pred             CCCC
Q 023609          239 SDEP  242 (280)
Q Consensus       239 ~~~~  242 (280)
                      ...+
T Consensus       276 ~~~~  279 (294)
T 2rku_A          276 ARLP  279 (294)
T ss_dssp             SCCC
T ss_pred             CCCC
Confidence            4433

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=1.6e-40  Score=285.26  Aligned_cols=226  Identities=30%  Similarity=0.547  Sum_probs=178.4

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ--ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~--~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      .|++|+++++++...     ...|+||||++++|.+++..++  ++++..++.++.||+.||+|||++|++||||||+||
T Consensus        75 ~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Ni  149 (339)
T 1z57_A           75 STFRCVQMLEWFEHH-----GHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENI  149 (339)
T ss_dssp             CTTCBCCEEEEEEET-----TEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred             CceeeEeeecccccC-----CcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHE
Confidence            466799999999665     6799999999999999998765  689999999999999999999999999999999999


Q ss_pred             EEcc-------------------CCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHH
Q 023609           80 LLNA-------------------NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFME  140 (280)
Q Consensus        80 li~~-------------------~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~  140 (280)
                      +++.                   ++.++|+|||.+......  .....+|+.|+|||++.+. .++.++||||+||++|+
T Consensus       150 l~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~e  226 (339)
T 1z57_A          150 LFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH--HSTLVSTRHYRAPEVILAL-GWSQPCDVWSIGCILIE  226 (339)
T ss_dssp             EESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSC--CCSSCSCGGGCCHHHHTTS-CCCTHHHHHHHHHHHHH
T ss_pred             EEeccccccccCCccccccccccCCCceEeeCcccccCccc--cccccCCccccChHHhhCC-CCCcchhhHHHHHHHHH
Confidence            9987                   678999999999875543  2355789999999998644 48999999999999999


Q ss_pred             HHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhH---------------HHHhhhcCccccccccccCCCCChHH
Q 023609          141 LMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENA---------------KKYICQLPRYQRQSFTEKFPNVHPSA  205 (280)
Q Consensus       141 ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~  205 (280)
                      |++|..||.+.+..+....+....+..+...........               ........ ..........+..++++
T Consensus       227 l~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l  305 (339)
T 1z57_A          227 YYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRAC-KPLKEFMLSQDVEHERL  305 (339)
T ss_dssp             HHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHC-CCGGGGCSCCSHHHHHH
T ss_pred             HHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcC-cchhhhcccchhhHHHH
Confidence            999999999999888888888888777654332211000               00000000 00000111112335678


Q ss_pred             HHHHHHhhcCCCCCCCCHHHHhcCCCCCCCc
Q 023609          206 IDLVEKMLTFDPRQRITVEDALAHPYLGSLH  236 (280)
Q Consensus       206 ~~li~~~L~~dp~~R~t~~ell~h~~~~~~~  236 (280)
                      .+||.+||+.||.+|||+.|+++||||+.++
T Consensus       306 ~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  336 (339)
T 1z57_A          306 FDLIQKMLEYDPAKRITLREALKHPFFDLLK  336 (339)
T ss_dssp             HHHHHHHTCSSTTTSCCHHHHTTSGGGGGGG
T ss_pred             HHHHHHHhCcCcccccCHHHHhcCHHHHHHh
Confidence            9999999999999999999999999999865

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=8e-41  Score=281.73  Aligned_cols=203  Identities=21%  Similarity=0.372  Sum_probs=165.0

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN--VLHRDLKPS   77 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~g--i~H~di~~~   77 (280)
                      ++||||+++++++.... .+....|+||||++ |+|.+++...+.+++..++.++.||+.||+|||+.|  ++|+||||+
T Consensus        82 l~h~~iv~~~~~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~  160 (290)
T 1t4h_A           82 LQHPNIVRFYDSWESTV-KGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCD  160 (290)
T ss_dssp             CCCTTBCCEEEEEEEES-SSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGG
T ss_pred             CCCCCeeeeeeeecccc-CCCceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHH
Confidence            58999999999986532 22256899999997 599999998888999999999999999999999999  999999999


Q ss_pred             cEEEc-cCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023609           78 NLLLN-ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ  156 (280)
Q Consensus        78 nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  156 (280)
                      ||+++ .++.++|+|||++....... .....+++.|+|||.+.  ..++.++||||+||++++|++|..||.+......
T Consensus       161 Nil~~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~t~~y~aPE~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~  237 (290)
T 1t4h_A          161 NIFITGPTGSVKIGDLGLATLKRASF-AKAVIGTPEFMAPEMYE--EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ  237 (290)
T ss_dssp             GEEESSTTSCEEECCTTGGGGCCTTS-BEESCSSCCCCCGGGGG--TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH
T ss_pred             HEEEECCCCCEEEeeCCCcccccccc-cccccCCcCcCCHHHHh--ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHH
Confidence            99997 78999999999997544332 33456899999999875  3488999999999999999999999987554443


Q ss_pred             HHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCC
Q 023609          157 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS  234 (280)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~  234 (280)
                      ..........+.                           ......++++.++|.+||+.||.+|||+.++++||||++
T Consensus       238 ~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~  288 (290)
T 1t4h_A          238 IYRRVTSGVKPA---------------------------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             HHHHHTTTCCCG---------------------------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             HHHHHhccCCcc---------------------------ccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCccccc
Confidence            332221111110                           111256788999999999999999999999999999976

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=5.7e-41  Score=284.54  Aligned_cols=203  Identities=31%  Similarity=0.524  Sum_probs=171.8

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      |+||||+++++++...     ...|+||||++ ++|.+++..++.+++..+..++.||+.||+|||+.|++||||||+||
T Consensus        63 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NI  137 (304)
T 2jam_A           63 IKHENIVTLEDIYEST-----THYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENL  137 (304)
T ss_dssp             CCCTTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGC
T ss_pred             CCCCCeeehhhhcccC-----CEEEEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHE
Confidence            5899999999999665     67999999997 69999998888899999999999999999999999999999999999


Q ss_pred             EE---ccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023609           80 LL---NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ  156 (280)
Q Consensus        80 li---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  156 (280)
                      ++   +.++.++|+|||.+...... ......+++.|+|||++.+ ..++.++||||+||++|+|++|..||.+......
T Consensus       138 l~~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~  215 (304)
T 2jam_A          138 LYLTPEENSKIMITDFGLSKMEQNG-IMSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVITYILLCGYPPFYEETESKL  215 (304)
T ss_dssp             EESSSSTTCCEEBCSCSTTCCCCCB-TTHHHHSCCCBCCTTTBSS-CSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHH
T ss_pred             EEecCCCCCCEEEccCCcceecCCC-ccccccCCCCccChHHhcc-CCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHH
Confidence            99   77899999999998765433 2334568999999998854 4588999999999999999999999988777666


Q ss_pred             HHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCc
Q 023609          157 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  236 (280)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~  236 (280)
                      ...+.+......                          ....+.+++++.++|.+||+.||.+|||+.++++||||++..
T Consensus       216 ~~~i~~~~~~~~--------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  269 (304)
T 2jam_A          216 FEKIKEGYYEFE--------------------------SPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNT  269 (304)
T ss_dssp             HHHHHHCCCCCC--------------------------TTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred             HHHHHcCCCCCC--------------------------ccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence            555543221111                          122346789999999999999999999999999999998754

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=7.1e-41  Score=279.80  Aligned_cols=204  Identities=27%  Similarity=0.441  Sum_probs=166.6

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++...     ...|+||||++ ++|.+++..+..+++..++.++.|++.||+|||+.|++|+||+|+||
T Consensus        62 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Ni  136 (276)
T 2yex_A           62 LNHENVVKFYGHRREG-----NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENL  136 (276)
T ss_dssp             CCCTTBCCEEEEEEET-----TEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred             cCCCCceeeeeEEEcC-----CEEEEEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHE
Confidence            5899999999999665     67899999997 59999998878899999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCC---CccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH-
Q 023609           80 LLNANCDLKICDFGLARVTSET---DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVH-  155 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~-  155 (280)
                      +++.++.++|+|||.+......   .......+++.|+|||.+.+....+.++|+||+|+++++|++|..||.+..... 
T Consensus       137 l~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~  216 (276)
T 2yex_A          137 LLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ  216 (276)
T ss_dssp             EECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH
T ss_pred             EEccCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH
Confidence            9999999999999998764322   123455789999999998655444778999999999999999999997654322 


Q ss_pred             HHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCC
Q 023609          156 QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  235 (280)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~  235 (280)
                      ....+....                            ......+.+++.+.++|.+||+.||.+|||+.++++||||++.
T Consensus       217 ~~~~~~~~~----------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~  268 (276)
T 2yex_A          217 EYSDWKEKK----------------------------TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP  268 (276)
T ss_dssp             HHHHHHTTC----------------------------TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred             HHHHhhhcc----------------------------cccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccCh
Confidence            111111000                            0001123578899999999999999999999999999999876


Q ss_pred             cC
Q 023609          236 HD  237 (280)
Q Consensus       236 ~~  237 (280)
                      ..
T Consensus       269 ~~  270 (276)
T 2yex_A          269 LK  270 (276)
T ss_dssp             CC
T ss_pred             hh
Confidence            43

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=1.7e-40  Score=281.54  Aligned_cols=209  Identities=22%  Similarity=0.405  Sum_probs=168.9

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS--NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~--~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      |+||||+++++++....   ....|+||||++++|.+++..  .+.+++..++.++.||+.||+|||++|++||||||+|
T Consensus        63 l~h~~i~~~~~~~~~~~---~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~N  139 (305)
T 2wtk_C           63 LRHKNVIQLVDVLYNEE---KQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGN  139 (305)
T ss_dssp             CCCTTBCCEEEEEECC------CEEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred             cCCCCeeEEEEEEEcCC---CCeEEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCccc
Confidence            58999999999985432   157899999999888888875  4569999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCC---CccccceeccccccchhccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCChH
Q 023609           79 LLLNANCDLKICDFGLARVTSET---DFMTEYVVTRWYRAPELLLNSS-DYTAAIDVWSVGCIFMELMDRKPLFPGRDHV  154 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  154 (280)
                      |+++.++.++|+|||.+......   .......+++.|+|||++.+.. ..+.++||||+|+++|+|++|..||.+....
T Consensus       140 Il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~  219 (305)
T 2wtk_C          140 LLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIY  219 (305)
T ss_dssp             EEECTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             EEEcCCCcEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHH
Confidence            99999999999999999865432   2233456899999999885432 2367999999999999999999999887765


Q ss_pred             HHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCC
Q 023609          155 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS  234 (280)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~  234 (280)
                      .....+.....                              ...+.+++.+.++|.+||+.||.+|||+.++++||||++
T Consensus       220 ~~~~~i~~~~~------------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~  269 (305)
T 2wtk_C          220 KLFENIGKGSY------------------------------AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRK  269 (305)
T ss_dssp             HHHHHHHHCCC------------------------------CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHS
T ss_pred             HHHHHHhcCCC------------------------------CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcCccccc
Confidence            55444332110                              111257889999999999999999999999999999998


Q ss_pred             CcCCCCCC
Q 023609          235 LHDISDEP  242 (280)
Q Consensus       235 ~~~~~~~~  242 (280)
                      .......+
T Consensus       270 ~~~~~~~~  277 (305)
T 2wtk_C          270 KHPPAEAP  277 (305)
T ss_dssp             CCCC-CCC
T ss_pred             CCCCcCCC
Confidence            76544433

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.5e-40  Score=301.17  Aligned_cols=199  Identities=25%  Similarity=0.449  Sum_probs=166.0

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN----QALSEEHCQYFLYQILRGLKYIHSANVLHRDLK   75 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~----~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~   75 (280)
                      ++||||+++++++...     ..+|+||||++ |+|.+++...    ..+++..++.++.||+.||+|||++||+|||||
T Consensus       242 l~hp~Iv~l~~~~~~~-----~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLK  316 (543)
T 3c4z_A          242 VHSRFIVSLAYAFETK-----TDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLK  316 (543)
T ss_dssp             CCCTTBCCEEEEEECS-----SEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred             cCCCCEeeEEEEEeeC-----CEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCC
Confidence            5899999999999765     67999999997 6999998753    369999999999999999999999999999999


Q ss_pred             CCcEEEccCCCEEEeeccceeeccCCCc-cccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh-
Q 023609           76 PSNLLLNANCDLKICDFGLARVTSETDF-MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDH-  153 (280)
Q Consensus        76 ~~nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~-  153 (280)
                      |+||+++.+|.++|+|||++........ ....+||+.|+|||++.+ ..++.++|+||+||++|+|++|.+||.+... 
T Consensus       317 P~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~~~~~DiwSlGvilyelltG~~PF~~~~~~  395 (543)
T 3c4z_A          317 PENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG-EEYDFSVDYFALGVTLYEMIAARGPFRARGEK  395 (543)
T ss_dssp             GGGEEECTTSCEEECCCTTCEECCTTCCCBCCCCSCTTTSCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCC
T ss_pred             hHHEEEeCCCCEEEeecceeeeccCCCcccccccCCccccChhhhcC-CCCChHHhcCcchHHHHHHHhCCCCCCCCccc
Confidence            9999999999999999999987655433 234589999999999865 4589999999999999999999999987532 


Q ss_pred             ---HHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCC-----HHH
Q 023609          154 ---VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT-----VED  225 (280)
Q Consensus       154 ---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~e  225 (280)
                         ......+....                      .        ..-+.+++++++||++||+.||.+||+     +.+
T Consensus       396 ~~~~~~~~~i~~~~----------------------~--------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~e  445 (543)
T 3c4z_A          396 VENKELKQRVLEQA----------------------V--------TYPDKFSPASKDFCEALLQKDPEKRLGFRDGSCDG  445 (543)
T ss_dssp             CCHHHHHHHHHHCC----------------------C--------CCCTTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHH
T ss_pred             hhHHHHHHHHhhcc----------------------c--------CCCcccCHHHHHHHHHhccCCHhHCCCCcccCHHH
Confidence               22222222110                      0        111367899999999999999999996     589


Q ss_pred             HhcCCCCCCC
Q 023609          226 ALAHPYLGSL  235 (280)
Q Consensus       226 ll~h~~~~~~  235 (280)
                      +++||||+++
T Consensus       446 i~~Hpff~~i  455 (543)
T 3c4z_A          446 LRTHPLFRDI  455 (543)
T ss_dssp             HHTSGGGTTC
T ss_pred             HHcCccccCC
Confidence            9999999975

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=5.5e-41  Score=286.92  Aligned_cols=204  Identities=34%  Similarity=0.636  Sum_probs=165.6

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      |+||||+++++++...      ..|+||||++ ++|.+++..++.+++..++.++.||+.||+|||++|++||||||+||
T Consensus        72 l~h~~i~~~~~~~~~~------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NI  145 (322)
T 2ycf_A           72 LNHPCIIKIKNFFDAE------DYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENV  145 (322)
T ss_dssp             CCCTTBCCEEEEEESS------SEEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred             CCCCCCceEeeEEcCC------ceEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHE
Confidence            5899999999998543      3899999997 59999998888999999999999999999999999999999999999


Q ss_pred             EEccCCC---EEEeeccceeeccCCCccccceeccccccchhcc--CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH
Q 023609           80 LLNANCD---LKICDFGLARVTSETDFMTEYVVTRWYRAPELLL--NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHV  154 (280)
Q Consensus        80 li~~~~~---~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~--~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  154 (280)
                      +++.++.   ++|+|||.+.............+++.|+|||++.  +...++.++||||+||++|+|++|..||.+....
T Consensus       146 l~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~  225 (322)
T 2ycf_A          146 LLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ  225 (322)
T ss_dssp             EESSSSSSCCEEECCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCS
T ss_pred             EEecCCCCCeEEEccCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchH
Confidence            9987654   9999999998776554344557899999999873  3445789999999999999999999999765432


Q ss_pred             HHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCC
Q 023609          155 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS  234 (280)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~  234 (280)
                      ..+..........                         ......+.++.++.+||.+||+.||.+|||+.++++||||+.
T Consensus       226 ~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~  280 (322)
T 2ycf_A          226 VSLKDQITSGKYN-------------------------FIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD  280 (322)
T ss_dssp             SCHHHHHHHTCCC-------------------------CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred             HHHHHHHHhCccc-------------------------cCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence            2111111111000                         011223467899999999999999999999999999999986


Q ss_pred             C
Q 023609          235 L  235 (280)
Q Consensus       235 ~  235 (280)
                      .
T Consensus       281 ~  281 (322)
T 2ycf_A          281 E  281 (322)
T ss_dssp             H
T ss_pred             H
Confidence            3

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=5.2e-41  Score=281.10  Aligned_cols=200  Identities=29%  Similarity=0.516  Sum_probs=144.3

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      ++||||+++++++...     ...|+||||++ ++|.+++... +.+++..++.++.||+.||+|||+.|++|+||||+|
T Consensus        68 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~N  142 (278)
T 3cok_A           68 LKHPSILELYNYFEDS-----NYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSN  142 (278)
T ss_dssp             BCCTTBCCEEEEEECS-----SEEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGG
T ss_pred             CCCCCeEeEEEEEccC-----CeEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHH
Confidence            5799999999999765     67999999997 6999999865 579999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCCC-ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 023609           79 LLLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL  157 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  157 (280)
                      |+++.++.++|+|||.+....... ......+++.|+|||.+.+ ..++.++|+||+|+++++|++|..||.+.......
T Consensus       143 ili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~  221 (278)
T 3cok_A          143 LLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATR-SAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL  221 (278)
T ss_dssp             EEECTTCCEEECCCTTCEECC-----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC---
T ss_pred             EEEcCCCCEEEEeecceeeccCCCCcceeccCCCCcCCcchhcC-CCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH
Confidence            999999999999999998654332 2234568999999998854 44788999999999999999999999765433221


Q ss_pred             HHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCc
Q 023609          158 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  236 (280)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~  236 (280)
                      ..+..                        ..      ......++.++.++|.+||+.||.+|||+.++++||||.+..
T Consensus       222 ~~~~~------------------------~~------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  270 (278)
T 3cok_A          222 NKVVL------------------------AD------YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNS  270 (278)
T ss_dssp             --CCS------------------------SC------CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred             HHHhh------------------------cc------cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCCC
Confidence            11100                        00      011125788999999999999999999999999999998753

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=9.7e-43  Score=304.18  Aligned_cols=199  Identities=17%  Similarity=0.264  Sum_probs=156.9

Q ss_pred             CCCCCeeeee-------ceecCCCC---------CCC---CcEEEEeecCCccHHHHHHcCCCCCH-------HHHHHHH
Q 023609            1 MDHENVVAIR-------DIIPPPQR---------ESF---NDVYIAYELMDTDLHQIIRSNQALSE-------EHCQYFL   54 (280)
Q Consensus         1 l~HpnIv~~~-------~~~~~~~~---------~~~---~~~~iv~e~~~g~L~~~l~~~~~l~~-------~~~~~i~   54 (280)
                      ++||||++++       +++..++.         ++.   ...|+||||++|+|.+++...+.+++       ..+..++
T Consensus       133 l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~  212 (377)
T 3byv_A          133 IKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLT  212 (377)
T ss_dssp             CCSHHHHHHHHCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHHHTTTTTHHHHHHHHHHHH
T ss_pred             cCCHHHHHHHhhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhccccccccccccHHHHHHHH
Confidence            4799999999       44433210         000   13899999999999999986555555       8888999


Q ss_pred             HHHHHHHHHHHHCCceeccCCCCcEEEccCCCEEEeeccceeeccCCCccccceeccccccchhccCC----------CC
Q 023609           55 YQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNS----------SD  124 (280)
Q Consensus        55 ~qll~al~~LH~~gi~H~di~~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~----------~~  124 (280)
                      .||+.||+|||++||+||||||+||+++.++.+||+|||++...+..  .....+ +.|+|||++.+.          ..
T Consensus       213 ~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~  289 (377)
T 3byv_A          213 LQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAR--VVSSVS-RGFEPPELEARRATISYHRDRRTL  289 (377)
T ss_dssp             HHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGGCEETTCE--EECCCC-TTCCCHHHHHHHTSTHHHHCCEEE
T ss_pred             HHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEechhheecCCc--ccCCCC-cCccChhhhccccccccccccccc
Confidence            99999999999999999999999999999999999999999875442  334566 899999998654          25


Q ss_pred             CCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChH
Q 023609          125 YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPS  204 (280)
Q Consensus       125 ~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  204 (280)
                      ++.++||||+||++|+|++|..||.+.......                                  .......+.++++
T Consensus       290 ~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~----------------------------------~~~~~~~~~~~~~  335 (377)
T 3byv_A          290 MTFSFDAWALGLVIYWIWCADLPITKDAALGGS----------------------------------EWIFRSCKNIPQP  335 (377)
T ss_dssp             CCHHHHHHHHHHHHHHHHHSSCCC------CCS----------------------------------GGGGSSCCCCCHH
T ss_pred             CChhhhHHHHHHHHHHHHHCCCCCcccccccch----------------------------------hhhhhhccCCCHH
Confidence            889999999999999999999999654321110                                  0111223578899


Q ss_pred             HHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCc
Q 023609          205 AIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  236 (280)
Q Consensus       205 ~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~  236 (280)
                      +.+||.+||+.||.+|||+.++++||||+++.
T Consensus       336 ~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~  367 (377)
T 3byv_A          336 VRALLEGFLRYPKEDRLLPLQAMETPEYEQLR  367 (377)
T ss_dssp             HHHHHHHHTCSSGGGCCCHHHHHTSHHHHHHH
T ss_pred             HHHHHHHHcCCCchhCCCHHHHhhChHHHHHH
Confidence            99999999999999999999999999998754

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=7.5e-41  Score=283.21  Aligned_cols=212  Identities=23%  Similarity=0.397  Sum_probs=162.0

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHc--------CCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS--------NQALSEEHCQYFLYQILRGLKYIHSANVLH   71 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~--------~~~l~~~~~~~i~~qll~al~~LH~~gi~H   71 (280)
                      ++||||+++++++...     ...|+||||++ ++|.+++..        .+.+++..++.++.||+.||+|||+.|++|
T Consensus        70 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H  144 (303)
T 2vwi_A           70 CHHPNIVSYYTSFVVK-----DELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIH  144 (303)
T ss_dssp             CCCTTBCCEEEEEESS-----SCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred             cCCCCEeeEEEEEeec-----CCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Confidence            5799999999999765     67899999996 699999863        456999999999999999999999999999


Q ss_pred             ccCCCCcEEEccCCCEEEeeccceeeccCCC------ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCC
Q 023609           72 RDLKPSNLLLNANCDLKICDFGLARVTSETD------FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK  145 (280)
Q Consensus        72 ~di~~~nili~~~~~~~l~dfg~~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~  145 (280)
                      |||+|+||+++.++.++|+|||.+.......      ......+++.|+|||.+.+...++.++||||+||++|+|++|.
T Consensus       145 ~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~  224 (303)
T 2vwi_A          145 RDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGA  224 (303)
T ss_dssp             CCCSGGGEEECTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSS
T ss_pred             CCCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCC
Confidence            9999999999999999999999986543221      1234568999999998865445789999999999999999999


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHH
Q 023609          146 PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVED  225 (280)
Q Consensus       146 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e  225 (280)
                      .||.+..............  +...                  ..........+.++.++.++|.+||+.||.+|||+.+
T Consensus       225 ~pf~~~~~~~~~~~~~~~~--~~~~------------------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~  284 (303)
T 2vwi_A          225 APYHKYPPMKVLMLTLQND--PPSL------------------ETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAE  284 (303)
T ss_dssp             CTTTTSCGGGHHHHHHTSS--CCCT------------------TC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred             CCCccCchhhHHHHHhccC--CCcc------------------ccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHH
Confidence            9998766544332221111  0000                  0000112334578899999999999999999999999


Q ss_pred             HhcCCCCCCCcC
Q 023609          226 ALAHPYLGSLHD  237 (280)
Q Consensus       226 ll~h~~~~~~~~  237 (280)
                      +++||||++...
T Consensus       285 ll~h~~~~~~~~  296 (303)
T 2vwi_A          285 LLRHKFFQKAKN  296 (303)
T ss_dssp             HHTSTTC-----
T ss_pred             HhhChhhhcCCC
Confidence            999999998654

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=8.9e-41  Score=293.04  Aligned_cols=227  Identities=28%  Similarity=0.462  Sum_probs=173.1

Q ss_pred             CCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCcE
Q 023609            3 HENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSA-NVLHRDLKPSNL   79 (280)
Q Consensus         3 HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~-gi~H~di~~~ni   79 (280)
                      ||||+++++++..... .....|+||||++++|.+.+...  +.+++..++.++.||+.||+|||++ ||+||||||+||
T Consensus       100 ~~~iv~~~~~~~~~~~-~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NI  178 (397)
T 1wak_A          100 REMVVQLLDDFKISGV-NGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENI  178 (397)
T ss_dssp             GGGBCCEEEEEEEEET-TEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGE
T ss_pred             cceeeeeecceeecCC-CCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHe
Confidence            8899999999864321 12679999999999888888754  4699999999999999999999998 999999999999


Q ss_pred             EEccCC-------------------------------------------------CEEEeeccceeeccCCCccccceec
Q 023609           80 LLNANC-------------------------------------------------DLKICDFGLARVTSETDFMTEYVVT  110 (280)
Q Consensus        80 li~~~~-------------------------------------------------~~~l~dfg~~~~~~~~~~~~~~~~~  110 (280)
                      +++.++                                                 .++|+|||.+......  .....+|
T Consensus       179 ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt  256 (397)
T 1wak_A          179 LLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQT  256 (397)
T ss_dssp             EECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSC
T ss_pred             eEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCC
Confidence            998775                                                 7999999999876543  3455789


Q ss_pred             cccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC------hHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhh
Q 023609          111 RWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD------HVHQLRLLIELIGTPSEAELGFLNENAKKYIC  184 (280)
Q Consensus       111 ~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  184 (280)
                      +.|+|||++.+.. ++.++|||||||++|+|++|..||.+.+      .......+.+..+.++...+...... ..+..
T Consensus       257 ~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~-~~~~~  334 (397)
T 1wak_A          257 RQYRSLEVLIGSG-YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYS-KEFFT  334 (397)
T ss_dssp             GGGCCHHHHHTSC-CCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTG-GGTBC
T ss_pred             CcccCChhhcCCC-CCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhccccc-ccccC
Confidence            9999999986554 8899999999999999999999997654      56677788888888776543211100 00000


Q ss_pred             hcCcccc----------ccccc---cCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCC
Q 023609          185 QLPRYQR----------QSFTE---KFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS  234 (280)
Q Consensus       185 ~~~~~~~----------~~~~~---~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~  234 (280)
                      .......          .....   ..+..+..+++||.+||+.||++|||+.++++||||++
T Consensus       335 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  397 (397)
T 1wak_A          335 KKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLNS  397 (397)
T ss_dssp             TTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred             CccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence            0000000          00000   00123467899999999999999999999999999974

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=9.6e-41  Score=280.90  Aligned_cols=203  Identities=33%  Similarity=0.603  Sum_probs=171.0

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++...     ...|+||||+. ++|.+++...+.+++..++.++.||+.||+|||+.|++|+||+|+||
T Consensus        78 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NI  152 (287)
T 2wei_A           78 LDHPNIMKLFEILEDS-----SSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENI  152 (287)
T ss_dssp             CCCTTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred             ccCCCccEEEEEEeCC-----CeEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhE
Confidence            5899999999999765     67999999997 69999998878899999999999999999999999999999999999


Q ss_pred             EEccC---CCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023609           80 LLNAN---CDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ  156 (280)
Q Consensus        80 li~~~---~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  156 (280)
                      +++.+   +.++|+|||.+.............+++.|+|||.+.+  .++.++||||+|+++++|++|..||.+.+..+.
T Consensus       153 lv~~~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~  230 (287)
T 2wei_A          153 LLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI  230 (287)
T ss_dssp             EESCSSTTCCEEECSTTGGGTBCCCSSCSCHHHHHTTCCHHHHTT--CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             EEecCCCcccEEEeccCcceeecCCCccccccCcccccChHHhcC--CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHH
Confidence            99654   4699999999987655544455678999999998854  378999999999999999999999988876665


Q ss_pred             HHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCc
Q 023609          157 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  236 (280)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~  236 (280)
                      ...+........                          ...++.+++++.++|++||+.||.+|||+.++++||||+++.
T Consensus       231 ~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~  284 (287)
T 2wei_A          231 LKRVETGKYAFD--------------------------LPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS  284 (287)
T ss_dssp             HHHHHHCCCCCC--------------------------SGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHC
T ss_pred             HHHHHcCCCCCC--------------------------chhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhccc
Confidence            554433211111                          112246789999999999999999999999999999998764

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=6.8e-40  Score=280.67  Aligned_cols=181  Identities=25%  Similarity=0.446  Sum_probs=141.9

Q ss_pred             cEEEEeecCC-ccHHHHHHcCCC---CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCCEEEeeccceeec
Q 023609           23 DVYIAYELMD-TDLHQIIRSNQA---LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVT   98 (280)
Q Consensus        23 ~~~iv~e~~~-g~L~~~l~~~~~---l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nili~~~~~~~l~dfg~~~~~   98 (280)
                      ..|+|||||+ |+|.+++..+..   .++..++.++.||+.||+|||++|++||||||+||+++.++.++|+|||++...
T Consensus       135 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~  214 (332)
T 3qd2_B          135 YLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAM  214 (332)
T ss_dssp             EEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             eEEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCccccc
Confidence            4899999997 599999987643   566679999999999999999999999999999999999999999999999876


Q ss_pred             cCCC-------------ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q 023609           99 SETD-------------FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIG  165 (280)
Q Consensus        99 ~~~~-------------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~  165 (280)
                      ....             ......+|+.|+|||++.+. .++.++||||+||++|+|++|..|+.     .....+.....
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~~~~~~-----~~~~~~~~~~~  288 (332)
T 3qd2_B          215 DQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGN-NYSHKVDIFSLGLILFELLYSFSTQM-----ERVRIITDVRN  288 (332)
T ss_dssp             SCC--------------CCCSCC-CGGGSCHHHHHCC-CCCTHHHHHHHHHHHHHHHSCCCCHH-----HHHHHHHHHHT
T ss_pred             ccchhhccccccccccccccccCCCcCccChHHhcCC-CCcchhhHHHHHHHHHHHHHcCCChh-----HHHHHHHHhhc
Confidence            5432             22345689999999998654 58999999999999999999876541     11111111111


Q ss_pred             CCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCC
Q 023609          166 TPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  235 (280)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~  235 (280)
                      ...                          ....+..++++++||.+||+.||.+|||+.++++||||+++
T Consensus       289 ~~~--------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~~  332 (332)
T 3qd2_B          289 LKF--------------------------PLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFENL  332 (332)
T ss_dssp             TCC--------------------------CHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCCC
T ss_pred             cCC--------------------------CcccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhcC
Confidence            000                          01112346778999999999999999999999999999874

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=5.3e-41  Score=285.76  Aligned_cols=209  Identities=22%  Similarity=0.389  Sum_probs=166.2

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++...... ....|+||||++ ++|.+++..++.+++.+++.++.||+.||+|||++|++||||||+||
T Consensus        69 l~hp~iv~~~~~~~~~~~~-~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Ni  147 (311)
T 3ork_A           69 LNHPAIVAVYDTGEAETPA-GPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANI  147 (311)
T ss_dssp             CCCTTBCCEEEEEEEEETT-EEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred             CCCCCcceEEEeeeccCCC-CcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHE
Confidence            5799999999998664321 134699999997 69999998888899999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCC----ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 023609           80 LLNANCDLKICDFGLARVTSETD----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVH  155 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~  155 (280)
                      +++.++.++|+|||++.......    ......+++.|+|||++.+. .++.++||||+||++|+|++|..||.+.+...
T Consensus       148 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~  226 (311)
T 3ork_A          148 MISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS  226 (311)
T ss_dssp             EEETTSCEEECCCSCC------------------CCTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             EEcCCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCChHH
Confidence            99999999999999997654331    12234689999999998654 58899999999999999999999998887766


Q ss_pred             HHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCC
Q 023609          156 QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  235 (280)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~  235 (280)
                      ....+......++                          ....+.++.++.++|.+||+.||.+||++.+++.|+|++..
T Consensus       227 ~~~~~~~~~~~~~--------------------------~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  280 (311)
T 3ork_A          227 VAYQHVREDPIPP--------------------------SARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  280 (311)
T ss_dssp             HHHHHHHCCCCCH--------------------------HHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             HHHHHhcCCCCCc--------------------------ccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence            5544433222221                          12234688999999999999999999999999999999865


Q ss_pred             cC
Q 023609          236 HD  237 (280)
Q Consensus       236 ~~  237 (280)
                      ..
T Consensus       281 ~~  282 (311)
T 3ork_A          281 NG  282 (311)
T ss_dssp             TT
T ss_pred             cC
Confidence            43

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=3.9e-40  Score=276.60  Aligned_cols=194  Identities=23%  Similarity=0.309  Sum_probs=157.6

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCC
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN----QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKP   76 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~----~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~   76 (280)
                      +||||+++++++...     ...|+||||++ ++|.+++...    +.+++..++.++.||+.||+|||++|++||||||
T Consensus        69 ~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp  143 (289)
T 1x8b_A           69 QHSHVVRYFSAWAED-----DHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKP  143 (289)
T ss_dssp             SCTTBCCEEEEEEET-----TEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred             CCCCeeeeeeeeecC-----CeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCH
Confidence            799999999999765     67999999997 5999999754    6799999999999999999999999999999999


Q ss_pred             CcEEEccC-------------------CCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHH
Q 023609           77 SNLLLNAN-------------------CDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI  137 (280)
Q Consensus        77 ~nili~~~-------------------~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i  137 (280)
                      +||+++.+                   +.++|+|||.+.......   ...+++.|+|||++.+...++.++||||+||+
T Consensus       144 ~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~i  220 (289)
T 1x8b_A          144 SNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ---VEEGDSRFLANEVLQENYTHLPKADIFALALT  220 (289)
T ss_dssp             GGEEEC--------------------CCCEEECCCTTCEETTCSC---CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHH
T ss_pred             HHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCcc---ccCCCccccChhHhcCCCCCCchhhHHHHHHH
Confidence            99999844                   479999999998765543   34589999999998765556789999999999


Q ss_pred             HHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCC
Q 023609          138 FMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDP  217 (280)
Q Consensus       138 l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp  217 (280)
                      +++|++|.+++.......   .+..                             .......+.+++++.++|.+||+.||
T Consensus       221 l~~l~~~~~~~~~~~~~~---~~~~-----------------------------~~~~~~~~~~~~~~~~li~~~l~~dp  268 (289)
T 1x8b_A          221 VVCAAGAEPLPRNGDQWH---EIRQ-----------------------------GRLPRIPQVLSQEFTELLKVMIHPDP  268 (289)
T ss_dssp             HHHHTTCCCCCSSSHHHH---HHHT-----------------------------TCCCCCSSCCCHHHHHHHHHHTCSSG
T ss_pred             HHHHhcCCCCCcchhHHH---HHHc-----------------------------CCCCCCCcccCHHHHHHHHHHhCCCc
Confidence            999999988775432211   1110                             00011223678999999999999999


Q ss_pred             CCCCCHHHHhcCCCCCCC
Q 023609          218 RQRITVEDALAHPYLGSL  235 (280)
Q Consensus       218 ~~R~t~~ell~h~~~~~~  235 (280)
                      ++|||+.++++||||.+.
T Consensus       269 ~~Rps~~~ll~h~~~~~~  286 (289)
T 1x8b_A          269 ERRPSAMALVKHSVLLSA  286 (289)
T ss_dssp             GGSCCHHHHHTCTTC---
T ss_pred             ccCCCHHHHhhChHhhhh
Confidence            999999999999999874

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.9e-40  Score=290.76  Aligned_cols=200  Identities=25%  Similarity=0.403  Sum_probs=159.4

Q ss_pred             CCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEc
Q 023609            3 HENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   82 (280)
Q Consensus         3 HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nili~   82 (280)
                      ||||+++++++...     ..+|+|||+.+++|.+++...+.+++.+++.++.||+.||+|||+.||+||||||+||+++
T Consensus       115 ~~~iv~~~~~~~~~-----~~~~lv~E~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~  189 (390)
T 2zmd_A          115 SDKIIRLYDYEITD-----QYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV  189 (390)
T ss_dssp             CTTBCCEEEEEECS-----SEEEEEEECCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES
T ss_pred             CCeEEEEEEEEecC-----CEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE
Confidence            69999999998765     6699999977789999999888999999999999999999999999999999999999995


Q ss_pred             cCCCEEEeeccceeeccCCC---ccccceeccccccchhccC----------CCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 023609           83 ANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLN----------SSDYTAAIDVWSVGCIFMELMDRKPLFP  149 (280)
Q Consensus        83 ~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~----------~~~~~~~~DiwslG~il~~ll~g~~pf~  149 (280)
                       ++.++|+|||++.......   ......+|+.|+|||++.+          ...++.++||||+||++|+|++|..||.
T Consensus       190 -~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~  268 (390)
T 2zmd_A          190 -DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ  268 (390)
T ss_dssp             -SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             -CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcch
Confidence             6899999999998654332   2235578999999999854          1357889999999999999999999997


Q ss_pred             CCChH-HHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          150 GRDHV-HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       150 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                      +.... ..+..+......                            ...-...+.++.+||.+||+.||.+|||+.++++
T Consensus       269 ~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  320 (390)
T 2zmd_A          269 QIINQISKLHAIIDPNHE----------------------------IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  320 (390)
T ss_dssp             TCCCHHHHHHHHHCTTSC----------------------------CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hhhHHHHHHHHHhCcccc----------------------------CCCCccchHHHHHHHHHHcccChhhCCCHHHHhh
Confidence            65332 222211110000                            0011134678999999999999999999999999


Q ss_pred             CCCCCCCc
Q 023609          229 HPYLGSLH  236 (280)
Q Consensus       229 h~~~~~~~  236 (280)
                      ||||+...
T Consensus       321 hp~~~~~~  328 (390)
T 2zmd_A          321 HPYVQIQT  328 (390)
T ss_dssp             SHHHHSCC
T ss_pred             CcCccccC
Confidence            99998654

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.6e-40  Score=285.31  Aligned_cols=199  Identities=26%  Similarity=0.404  Sum_probs=157.2

Q ss_pred             CCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEcc
Q 023609            4 ENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNA   83 (280)
Q Consensus         4 pnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nili~~   83 (280)
                      |||+++++++...     ...|+|||+.+++|.+++...+.+++.+++.++.||+.||+|||+.||+||||||+||+++ 
T Consensus        69 ~~iv~~~~~~~~~-----~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-  142 (343)
T 3dbq_A           69 DKIIRLYDYEITD-----QYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-  142 (343)
T ss_dssp             TTBCCEEEEEECS-----SEEEEEECCCSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-
T ss_pred             CceEEEeeeEeeC-----CEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-
Confidence            9999999999765     6799999988899999999988999999999999999999999999999999999999996 


Q ss_pred             CCCEEEeeccceeeccCCC---ccccceeccccccchhccC----------CCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 023609           84 NCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLN----------SSDYTAAIDVWSVGCIFMELMDRKPLFPG  150 (280)
Q Consensus        84 ~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~----------~~~~~~~~DiwslG~il~~ll~g~~pf~~  150 (280)
                      ++.++|+|||++.......   ......+|+.|+|||++.+          ...++.++||||+||++|+|++|..||.+
T Consensus       143 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  222 (343)
T 3dbq_A          143 DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ  222 (343)
T ss_dssp             TTEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchh
Confidence            6889999999997654332   1234578999999999853          24578899999999999999999999976


Q ss_pred             CChHH-HHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 023609          151 RDHVH-QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  229 (280)
Q Consensus       151 ~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h  229 (280)
                      ..... ....+.   ....                         ........+.++.+||.+||+.||.+|||+.++++|
T Consensus       223 ~~~~~~~~~~~~---~~~~-------------------------~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          223 IINQISKLHAII---DPNH-------------------------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             CCSHHHHHHHHH---CTTS-------------------------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hhhHHHHHHHHh---cCCc-------------------------ccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence            43321 111111   0000                         001112446789999999999999999999999999


Q ss_pred             CCCCCCc
Q 023609          230 PYLGSLH  236 (280)
Q Consensus       230 ~~~~~~~  236 (280)
                      |||+...
T Consensus       275 p~~~~~~  281 (343)
T 3dbq_A          275 PYVQIQT  281 (343)
T ss_dssp             HHHHSCC
T ss_pred             ccccccC
Confidence            9998643

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-40  Score=287.98  Aligned_cols=203  Identities=20%  Similarity=0.371  Sum_probs=163.4

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nil   80 (280)
                      +||||+++++++...     ...|+||||++ |+|.+++..++.+++..++.++.||+.||+|||+.||+||||||+||+
T Consensus       117 ~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIl  191 (355)
T 1vzo_A          117 QSPFLVTLHYAFQTE-----TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENIL  191 (355)
T ss_dssp             TCTTBCCEEEEEEET-----TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEE
T ss_pred             CCCceeEEEEEEeeC-----ceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEE
Confidence            599999999999665     67999999997 599999998888999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccceeeccCCC--ccccceeccccccchhccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 023609           81 LNANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNS-SDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL  157 (280)
Q Consensus        81 i~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  157 (280)
                      ++.++.++|+|||+++......  ......+|+.|+|||++.+. ..++.++|||||||++|+|++|..||.........
T Consensus       192 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~  271 (355)
T 1vzo_A          192 LDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ  271 (355)
T ss_dssp             ECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCH
T ss_pred             ECCCCcEEEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchH
Confidence            9999999999999998653321  23345789999999998642 34678999999999999999999999754321111


Q ss_pred             HHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCC-----CHHHHhcCCCC
Q 023609          158 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI-----TVEDALAHPYL  232 (280)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~ell~h~~~  232 (280)
                      ..+....                  ....        ....+.++..+++||.+||+.||.+||     |+.++++||||
T Consensus       272 ~~~~~~~------------------~~~~--------~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f  325 (355)
T 1vzo_A          272 AEISRRI------------------LKSE--------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF  325 (355)
T ss_dssp             HHHHHHH------------------HHCC--------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGG
T ss_pred             HHHHHHH------------------hccC--------CCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcch
Confidence            1111100                  0000        011236788999999999999999999     99999999999


Q ss_pred             CCC
Q 023609          233 GSL  235 (280)
Q Consensus       233 ~~~  235 (280)
                      +.+
T Consensus       326 ~~~  328 (355)
T 1vzo_A          326 QKI  328 (355)
T ss_dssp             TTC
T ss_pred             hcC
Confidence            975

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=5.3e-40  Score=278.05  Aligned_cols=204  Identities=23%  Similarity=0.414  Sum_probs=163.9

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      ++||||+++++++...     ...|+||||++ ++|.+++.. .+.+++..+..++.||+.||.|||+.|++||||||+|
T Consensus        73 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~N  147 (302)
T 2j7t_A           73 CDHPYIVKLLGAYYHD-----GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGN  147 (302)
T ss_dssp             CCCTTBCCEEEEEECC------CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGG
T ss_pred             CCCCCEeeeeeeeeeC-----CeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHH
Confidence            5899999999999765     67999999997 589988865 5679999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCC-Cccccceeccccccchhcc----CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh
Q 023609           79 LLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLL----NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDH  153 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~----~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~  153 (280)
                      |+++.++.++|+|||++...... .......+++.|+|||.+.    ....++.++||||+|+++++|++|..||.+.+.
T Consensus       148 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~  227 (302)
T 2j7t_A          148 VLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP  227 (302)
T ss_dssp             EEECTTSCEEECCCHHHHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred             EEECCCCCEEEEECCCCccccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCH
Confidence            99999999999999987532211 1123456889999999874    344578899999999999999999999988776


Q ss_pred             HHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCC
Q 023609          154 VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLG  233 (280)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~  233 (280)
                      ......+........                           .....++.++.++|.+||+.||.+|||+.++++||||+
T Consensus       228 ~~~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~  280 (302)
T 2j7t_A          228 MRVLLKIAKSDPPTL---------------------------LTPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVS  280 (302)
T ss_dssp             HHHHHHHHHSCCCCC---------------------------SSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTT
T ss_pred             HHHHHHHhccCCccc---------------------------CCccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHh
Confidence            555444332211100                           00125678899999999999999999999999999998


Q ss_pred             CCc
Q 023609          234 SLH  236 (280)
Q Consensus       234 ~~~  236 (280)
                      +..
T Consensus       281 ~~~  283 (302)
T 2j7t_A          281 SIT  283 (302)
T ss_dssp             TCC
T ss_pred             hhc
Confidence            864

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=2.6e-39  Score=279.55  Aligned_cols=225  Identities=29%  Similarity=0.538  Sum_probs=175.8

Q ss_pred             CCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 023609            3 HENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ--ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   80 (280)
Q Consensus         3 HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~--~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nil   80 (280)
                      |++++.+++++...     ...|+||||++++|.+++....  .+++..++.++.||+.||+|||++||+||||||+||+
T Consensus        81 ~~~~~~~~~~~~~~-----~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIl  155 (355)
T 2eu9_A           81 KFLCVLMSDWFNFH-----GHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENIL  155 (355)
T ss_dssp             CSCBCCEEEEEEET-----TEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEE
T ss_pred             ceeEEEeeeeeeeC-----CeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEE
Confidence            44589999988665     6799999999999998887653  6999999999999999999999999999999999999


Q ss_pred             E-------------------ccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHH
Q 023609           81 L-------------------NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL  141 (280)
Q Consensus        81 i-------------------~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l  141 (280)
                      +                   +.++.++|+|||++......  .....+|+.|+|||++.+. .++.++||||+||++|+|
T Consensus       156 l~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el  232 (355)
T 2eu9_A          156 FVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH--HTTIVATRHYRPPEVILEL-GWAQPCDVWSIGCILFEY  232 (355)
T ss_dssp             ESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC--CCSSCSCGGGCCHHHHTTC-CCCTHHHHHHHHHHHHHH
T ss_pred             EecccccccccccccccccccCCCcEEEeecCcccccccc--ccCCcCCCcccCCeeeecC-CCCCccchHHHHHHHHHH
Confidence            9                   56789999999999875543  2355789999999998544 588999999999999999


Q ss_pred             HhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhH---------------HHHhhhcCccccccccccCCCCChHHH
Q 023609          142 MDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENA---------------KKYICQLPRYQRQSFTEKFPNVHPSAI  206 (280)
Q Consensus       142 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~~~~~~~~  206 (280)
                      ++|..||.+....+....+.+..+.++...........               ..+...... ............+.++.
T Consensus       233 ~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~  311 (355)
T 2eu9_A          233 YRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCK-PLKSYMLQDSLEHVQLF  311 (355)
T ss_dssp             HHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCC-CGGGGCSCCSHHHHHHH
T ss_pred             HhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCC-cccccccccchhHHHHH
Confidence            99999999999888888888888877765332211000               000000000 00000001112345789


Q ss_pred             HHHHHhhcCCCCCCCCHHHHhcCCCCCCCc
Q 023609          207 DLVEKMLTFDPRQRITVEDALAHPYLGSLH  236 (280)
Q Consensus       207 ~li~~~L~~dp~~R~t~~ell~h~~~~~~~  236 (280)
                      +||++||+.||++|||+.++++||||+++.
T Consensus       312 ~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~  341 (355)
T 2eu9_A          312 DLMRRMLEFDPAQRITLAEALLHPFFAGLT  341 (355)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHTTSGGGGGCC
T ss_pred             HHHHHHhcCChhhCcCHHHHhcChhhcCCC
Confidence            999999999999999999999999999864

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.4e-39  Score=277.02  Aligned_cols=203  Identities=28%  Similarity=0.455  Sum_probs=167.6

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIR-SNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~-~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      ++||||+++++++...     ...|+||||++ ++|.+++. ....+++..++.++.||+.||.|||+.|++|+||+|+|
T Consensus        81 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~N  155 (314)
T 3com_A           81 CDSPHVVKYYGSYFKN-----TDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGN  155 (314)
T ss_dssp             CCCTTBCCEEEEEEET-----TEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred             CCCCCCccEEEEEEeC-----CEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHH
Confidence            5799999999999765     67899999998 59999997 45679999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCCC-ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 023609           79 LLLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL  157 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  157 (280)
                      |+++.++.++|+|||.+....... ......+++.|+|||.+.+. .++.++||||+|+++|+|++|..||.+.......
T Consensus       156 il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~  234 (314)
T 3com_A          156 ILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEI-GYNCVADIWSLGITAIEMAEGKPPYADIHPMRAI  234 (314)
T ss_dssp             EEECTTCCEEECCCTTCEECBTTBSCBCCCCSCGGGCCHHHHSSS-CBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred             EEECCCCCEEEeecccchhhhhhccccCccCCCCCccChhhcCCC-CCCccccHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence            999999999999999997655432 23345789999999998544 4789999999999999999999999876654433


Q ss_pred             HHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCc
Q 023609          158 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  236 (280)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~  236 (280)
                      ..+..... +.                          ......++.++.++|.+||+.||.+|||+.++++||||++..
T Consensus       235 ~~~~~~~~-~~--------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~  286 (314)
T 3com_A          235 FMIPTNPP-PT--------------------------FRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAK  286 (314)
T ss_dssp             HHHHHSCC-CC--------------------------CSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred             HHHhcCCC-cc--------------------------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCC
Confidence            32211100 00                          001124678999999999999999999999999999998754

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=2.8e-40  Score=285.27  Aligned_cols=218  Identities=25%  Similarity=0.391  Sum_probs=168.5

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCc-cHHHH------HHc--CCCCCHHHHHHHHHHHHHHHHHHHH-CCce
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQI------IRS--NQALSEEHCQYFLYQILRGLKYIHS-ANVL   70 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~~~------l~~--~~~l~~~~~~~i~~qll~al~~LH~-~gi~   70 (280)
                      |+||||+++++++...     ...|+||||++| +|.++      +..  ...+++..++.++.||+.||+|||+ .|++
T Consensus       100 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~  174 (348)
T 2pml_X          100 IKNEYCLTCEGIITNY-----DEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNIC  174 (348)
T ss_dssp             CCCTTBCCCSEEEESS-----SEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEE
T ss_pred             CCCCCcceEEEEEeeC-----CeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEe
Confidence            5899999999999765     679999999985 99998      665  5679999999999999999999999 9999


Q ss_pred             eccCCCCcEEEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCc-chhHHHHHHHHHHHHhCCCCCC
Q 023609           71 HRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTA-AIDVWSVGCIFMELMDRKPLFP  149 (280)
Q Consensus        71 H~di~~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~-~~DiwslG~il~~ll~g~~pf~  149 (280)
                      |+||+|+||+++.++.++|+|||.+...... ......+++.|+|||++.+...++. ++||||+||++++|++|..||.
T Consensus       175 H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~  253 (348)
T 2pml_X          175 HRDVKPSNILMDKNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFS  253 (348)
T ss_dssp             CCCCCGGGEEECTTSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             ecCCChHhEEEcCCCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCC
Confidence            9999999999999999999999999875443 2345678999999999865534555 9999999999999999999998


Q ss_pred             CCCh-HHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          150 GRDH-VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       150 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                      +... .+....+.......+......           .............+.+++++.+||.+||+.||.+|||+.++++
T Consensus       254 ~~~~~~~~~~~i~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          254 LKISLVELFNNIRTKNIEYPLDRNHF-----------LYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             CSSCSHHHHHHHTSCCCCCCCSSSSS-----------TTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             CCCcHHHHHHHHhccCcCCccchhhh-----------hccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            7765 444443322111111000000           0000000111222578899999999999999999999999999


Q ss_pred             CCCCCCC
Q 023609          229 HPYLGSL  235 (280)
Q Consensus       229 h~~~~~~  235 (280)
                      ||||++.
T Consensus       323 hp~f~~~  329 (348)
T 2pml_X          323 HEWLADT  329 (348)
T ss_dssp             SGGGTTC
T ss_pred             CccccCC
Confidence            9999875

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=3.3e-40  Score=286.32  Aligned_cols=224  Identities=22%  Similarity=0.377  Sum_probs=166.5

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA-NVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~-gi~H~di~~~n   78 (280)
                      ++||||+++++++...     ...|+||||++ ++|.+++...+.+++..+..++.|++.||+|||+. |++||||||+|
T Consensus        88 l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~N  162 (360)
T 3eqc_A           88 CNSPYIVGFYGAFYSD-----GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSN  162 (360)
T ss_dssp             CCCTTBCCEEEEEEET-----TEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGG
T ss_pred             CCCCCEEEEeEEEEEC-----CEEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHH
Confidence            5899999999999765     67999999997 59999999888899999999999999999999996 99999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023609           79 LLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  158 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  158 (280)
                      |+++.++.++|+|||++....... .....+++.|+|||++.+ ..++.++||||+||++|+|++|..||.+.+..+...
T Consensus       163 il~~~~~~~kl~Dfg~~~~~~~~~-~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~  240 (360)
T 3eqc_A          163 ILVNSRGEIKLCDFGVSGQLIDSM-ANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL  240 (360)
T ss_dssp             EEECTTCCEEECCCCCCHHHHHHC-----CCCCTTCCHHHHTT-CCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHH
T ss_pred             EEECCCCCEEEEECCCCccccccc-ccCCCCCCCeECHHHHcC-CCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            999999999999999986543221 234578999999999854 458899999999999999999999998876555433


Q ss_pred             HHHHHhCCCCHHHHhH---hh----------------HhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCC
Q 023609          159 LLIELIGTPSEAELGF---LN----------------ENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQ  219 (280)
Q Consensus       159 ~~~~~~~~~~~~~~~~---~~----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~  219 (280)
                      .+..............   ..                ...........     ........++.++++||++||+.||.+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~li~~~L~~dP~~  315 (360)
T 3eqc_A          241 MFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEP-----PPKLPSGVFSLEFQDFVNKCLIKNPAE  315 (360)
T ss_dssp             HHC------------------------------CCCHHHHHHHHHHSC-----CCCCCTTTSCHHHHHHHHHHHCSSTTT
T ss_pred             HhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccC-----CCCCCcccccHHHHHHHHHHhhcChhh
Confidence            2211110000000000   00                00000000000     000111246889999999999999999


Q ss_pred             CCCHHHHhcCCCCCCCc
Q 023609          220 RITVEDALAHPYLGSLH  236 (280)
Q Consensus       220 R~t~~ell~h~~~~~~~  236 (280)
                      |||+.++++||||++..
T Consensus       316 Rpt~~ell~hp~~~~~~  332 (360)
T 3eqc_A          316 RADLKQLMVHAFIKRSD  332 (360)
T ss_dssp             SCCHHHHHTSHHHHHHH
T ss_pred             CCCHHHHhhChHhhcch
Confidence            99999999999998754

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.4e-39  Score=283.41  Aligned_cols=233  Identities=24%  Similarity=0.419  Sum_probs=173.9

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCc
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSA-NVLHRDLKPSN   78 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~-gi~H~di~~~n   78 (280)
                      .||||+++++++..... .....++|||+++++|.+++...  +.+++..++.++.||+.||+|||++ ||+||||||+|
T Consensus        84 ~~~~i~~~~~~~~~~~~-~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~N  162 (373)
T 1q8y_A           84 GANHILKLLDHFNHKGP-NGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPEN  162 (373)
T ss_dssp             HHTTBCCCCEEEEEEET-TEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGG
T ss_pred             ccchHHHHHHHhhccCC-CCceEEEEEecCCCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHH
Confidence            38999999999865421 12478999999999999999863  4599999999999999999999998 99999999999


Q ss_pred             EEEcc------CCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 023609           79 LLLNA------NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD  152 (280)
Q Consensus        79 ili~~------~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  152 (280)
                      |+++.      .+.++|+|||++......  .....+|+.|+|||++.+. .++.++||||+||++|+|++|..||.+..
T Consensus       163 Ill~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~  239 (373)
T 1q8y_A          163 VLMEIVDSPENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDE  239 (373)
T ss_dssp             EEEEEEETTTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTC-CCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred             eEEeccCCCcCcceEEEcccccccccCCC--CCCCCCCccccCcHHHhCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCc
Confidence            99954      347999999999876543  3355789999999998654 47899999999999999999999998654


Q ss_pred             ------hHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccc---------c-cc---ccCCCCChHHHHHHHHhh
Q 023609          153 ------HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQ---------S-FT---EKFPNVHPSAIDLVEKML  213 (280)
Q Consensus       153 ------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------~-~~---~~~~~~~~~~~~li~~~L  213 (280)
                            ....+..+....+.++...+.... ....+..........         . ..   ...+.++.++.+||.+||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  318 (373)
T 1q8y_A          240 GHSYTKDDDHIAQIIELLGELPSYLLRNGK-YTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPML  318 (373)
T ss_dssp             -----CHHHHHHHHHHHHCSCCHHHHHHCT-THHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGG
T ss_pred             ccccCChHHHHHHHHHhcCCCCHHHHhccc-hhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHh
Confidence                  556677788888877765332111 011110000000000         0 00   001134567899999999


Q ss_pred             cCCCCCCCCHHHHhcCCCCCCCcCCC
Q 023609          214 TFDPRQRITVEDALAHPYLGSLHDIS  239 (280)
Q Consensus       214 ~~dp~~R~t~~ell~h~~~~~~~~~~  239 (280)
                      +.||.+|||+.++++||||++.....
T Consensus       319 ~~dP~~Rpt~~ell~hp~f~~~~~~~  344 (373)
T 1q8y_A          319 QLDPRKRADAGGLVNHPWLKDTLGME  344 (373)
T ss_dssp             CSSTTTCBCHHHHHTCGGGTTCTTCT
T ss_pred             ccCccccCCHHHHhhChhhhcccCcc
Confidence            99999999999999999999865433

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=7.8e-40  Score=278.89  Aligned_cols=205  Identities=25%  Similarity=0.378  Sum_probs=156.6

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSA-NVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~~-gi~H~di~~~n   78 (280)
                      ++||||+++++++...     ...|+||||+++.+..+... .+.+++..++.++.||+.||+|||+. |++|+||||+|
T Consensus        81 ~~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~N  155 (318)
T 2dyl_A           81 HDCPYIVQCFGTFITN-----TDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSN  155 (318)
T ss_dssp             TTCTTBCCEEEEEECS-----SEEEEEECCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGG
T ss_pred             cCCCceeeEEEEEecC-----CcEEEEEeccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHH
Confidence            4799999999999765     67999999997776666653 56799999999999999999999995 99999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCCCccccceeccccccchhcc----CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-h
Q 023609           79 LLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL----NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD-H  153 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~----~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~  153 (280)
                      |+++.++.++|+|||.+.............+++.|+|||++.    ....++.++||||+||++++|++|..||.+.. .
T Consensus       156 il~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~  235 (318)
T 2dyl_A          156 ILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD  235 (318)
T ss_dssp             EEECTTSCEEECCCTTC--------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH
T ss_pred             EEECCCCCEEEEECCCchhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc
Confidence            999999999999999997665544445567899999999984    23457889999999999999999999997643 3


Q ss_pred             HHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCC
Q 023609          154 VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLG  233 (280)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~  233 (280)
                      ......+......                           .......+++++.++|.+||+.||.+|||+.++++||||+
T Consensus       236 ~~~~~~~~~~~~~---------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~  288 (318)
T 2dyl_A          236 FEVLTKVLQEEPP---------------------------LLPGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIK  288 (318)
T ss_dssp             HHHHHHHHHSCCC---------------------------CCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHH
T ss_pred             HHHHHHHhccCCC---------------------------CCCccCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHH
Confidence            3333332221100                           0011235789999999999999999999999999999998


Q ss_pred             CCcC
Q 023609          234 SLHD  237 (280)
Q Consensus       234 ~~~~  237 (280)
                      ++..
T Consensus       289 ~~~~  292 (318)
T 2dyl_A          289 RYET  292 (318)
T ss_dssp             HHHH
T ss_pred             hccc
Confidence            7643

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=1.1e-40  Score=290.51  Aligned_cols=192  Identities=16%  Similarity=0.159  Sum_probs=147.5

Q ss_pred             CcEEEEeecCCccHHHHHHcC-CCCCHHHH------HHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCCEEEeeccc
Q 023609           22 NDVYIAYELMDTDLHQIIRSN-QALSEEHC------QYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL   94 (280)
Q Consensus        22 ~~~~iv~e~~~g~L~~~l~~~-~~l~~~~~------~~i~~qll~al~~LH~~gi~H~di~~~nili~~~~~~~l~dfg~   94 (280)
                      ..+|+||||++|+|.+++... ..+++..+      ..++.||+.||+|||++||+||||||+||+++.+|.+||+|||+
T Consensus       161 ~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~  240 (371)
T 3q60_A          161 ANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSA  240 (371)
T ss_dssp             EEEEEEECCCSEEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEECTTSCEEECCGGG
T ss_pred             eeEEEEecCCCCCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCCHHHEEECCCCCEEEEecce
Confidence            448999999999999999863 34555555      67779999999999999999999999999999999999999999


Q ss_pred             eeeccCCCccccceeccccccchhccC-CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHh
Q 023609           95 ARVTSETDFMTEYVVTRWYRAPELLLN-SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELG  173 (280)
Q Consensus        95 ~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  173 (280)
                      +...+...  ....+++.|+|||++.+ ...++.++||||+||++|+|++|..||.+.......     .....      
T Consensus       241 a~~~~~~~--~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~-----~~~~~------  307 (371)
T 3q60_A          241 LWKVGTRG--PASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKG-----SWKRP------  307 (371)
T ss_dssp             EEETTCEE--EGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTT-----CCCBC------
T ss_pred             eeecCCCc--cCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCccccc-----chhhh------
Confidence            98765432  24566799999999854 145789999999999999999999999765321000     00000      


Q ss_pred             HhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCc
Q 023609          174 FLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  236 (280)
Q Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~  236 (280)
                               . ..............+.+++.+.+||.+||+.||++|||+.++++||||+++.
T Consensus       308 ---------~-~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~  360 (371)
T 3q60_A          308 ---------S-LRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQ  360 (371)
T ss_dssp             ---------C-TTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHHH
T ss_pred             ---------h-hhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHHH
Confidence                     0 0000000111122347899999999999999999999999999999998764

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.4e-39  Score=274.86  Aligned_cols=204  Identities=27%  Similarity=0.414  Sum_probs=162.0

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++...     ...|+||||++ ++|.+++...+++++..+..++.||+.||+|||++|++||||||+||
T Consensus        68 l~hp~iv~~~~~~~~~-----~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Ni  142 (294)
T 4eqm_A           68 LSHQNIVSMIDVDEED-----DCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNI  142 (294)
T ss_dssp             CCBTTBCCEEEEEECS-----SEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred             CCCCCCceEEEeeeeC-----CeEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHE
Confidence            5899999999999665     67999999997 59999999888999999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCC--ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL  157 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  157 (280)
                      +++.++.++|+|||++.......  ......+|+.|+|||.+.+. .++.++||||+||++|+|++|..||.+.+.....
T Consensus       143 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~  221 (294)
T 4eqm_A          143 LIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGE-ATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIA  221 (294)
T ss_dssp             EECTTSCEEECCCSSSTTC-------------CCSSCCHHHHHTC-CCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHH
T ss_pred             EECCCCCEEEEeCCCccccccccccccCccccCccccCHhHhcCC-CCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence            99999999999999997654332  12345689999999998654 4789999999999999999999999887765543


Q ss_pred             HHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCC
Q 023609          158 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  235 (280)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~  235 (280)
                      ....... .+.                        ......+.+++.+.++|.+||+.||.+||+..+.+.+.|..-+
T Consensus       222 ~~~~~~~-~~~------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~  274 (294)
T 4eqm_A          222 IKHIQDS-VPN------------------------VTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVL  274 (294)
T ss_dssp             HHHHSSC-CCC------------------------HHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSS
T ss_pred             HHHhhcc-CCC------------------------cchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHH
Confidence            3322111 111                        0112334788999999999999999999977767766665444

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=2.9e-39  Score=274.83  Aligned_cols=201  Identities=25%  Similarity=0.420  Sum_probs=157.4

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCC---CCHHHHHHHHHHHHHHHHHHHHCC--ceeccC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQA---LSEEHCQYFLYQILRGLKYIHSAN--VLHRDL   74 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~---l~~~~~~~i~~qll~al~~LH~~g--i~H~di   74 (280)
                      |+||||+++++++...     ...++||||++ |+|.+++...+.   +++..+..++.||+.||+|||+.|  ++||||
T Consensus        91 l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Di  165 (309)
T 3p86_A           91 LRHPNIVLFMGAVTQP-----PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNL  165 (309)
T ss_dssp             CCCTTBCCEEEEECST-----TCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTC
T ss_pred             CCCCCEeeEEEEEEEC-----CceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCC
Confidence            5899999999999765     56899999997 599999987654   999999999999999999999999  999999


Q ss_pred             CCCcEEEccCCCEEEeeccceeeccCCC-ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh
Q 023609           75 KPSNLLLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDH  153 (280)
Q Consensus        75 ~~~nili~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~  153 (280)
                      ||+||+++.++.++|+|||++....... ......+|+.|+|||++.+. .++.++||||+||++|+|++|..||.+.+.
T Consensus       166 kp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~elltg~~Pf~~~~~  244 (309)
T 3p86_A          166 KSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDE-PSNEKSDVYSFGVILWELATLQQPWGNLNP  244 (309)
T ss_dssp             CGGGEEECTTCCEEECCCC-----------------CCTTSCHHHHTTC-CCCTTHHHHHHHHHHHHHHHCCCTTTTSCH
T ss_pred             ChhhEEEeCCCcEEECCCCCCccccccccccccCCCCccccChhhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence            9999999999999999999997544332 23356789999999998544 478999999999999999999999988776


Q ss_pred             HHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc--CCC
Q 023609          154 VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA--HPY  231 (280)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~--h~~  231 (280)
                      .+....+......+                            ...+.+++++.++|++||+.||.+|||+.++++  .++
T Consensus       245 ~~~~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~  296 (309)
T 3p86_A          245 AQVVAAVGFKCKRL----------------------------EIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPL  296 (309)
T ss_dssp             HHHHHHHHHSCCCC----------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHhcCCCC----------------------------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHH
Confidence            66554442211111                            112367899999999999999999999999998  566


Q ss_pred             CCCC
Q 023609          232 LGSL  235 (280)
Q Consensus       232 ~~~~  235 (280)
                      +++.
T Consensus       297 ~~~~  300 (309)
T 3p86_A          297 IKSA  300 (309)
T ss_dssp             HC--
T ss_pred             HHhC
Confidence            5553

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=2.8e-39  Score=273.89  Aligned_cols=199  Identities=26%  Similarity=0.406  Sum_probs=167.1

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++...     ...|+||||++ ++|.+++.. +++++..+..++.||+.||+|||+.|++|+||+|+||
T Consensus        77 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Ni  150 (303)
T 3a7i_A           77 CDSPYVTKYYGSYLKD-----TKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKKIHRDIKAANV  150 (303)
T ss_dssp             CCCTTBCCEEEEEEET-----TEEEEEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred             CCCCCEeEEEEEEecC-----CeEEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheE
Confidence            5799999999999765     67999999998 599998865 5799999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCC-ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  158 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.++.++|+|||.+....... ......+++.|+|||.+.+ ..++.++||||+|+++++|++|..||.+........
T Consensus       151 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~  229 (303)
T 3a7i_A          151 LLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQ-SAYDSKADIWSLGITAIELARGEPPHSELHPMKVLF  229 (303)
T ss_dssp             EECTTSCEEECCCTTCEECBTTBCCBCCCCSCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH
T ss_pred             EECCCCCEEEeecccceecCccccccCccCCCcCccCHHHHhc-CCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHH
Confidence            99999999999999998765432 2344578999999999854 457889999999999999999999998776554443


Q ss_pred             HHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCC
Q 023609          159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  235 (280)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~  235 (280)
                      .+....                             .......++..+.++|.+||+.||.+|||+.++++||||...
T Consensus       230 ~~~~~~-----------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~  277 (303)
T 3a7i_A          230 LIPKNN-----------------------------PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRN  277 (303)
T ss_dssp             HHHHSC-----------------------------CCCCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHH
T ss_pred             HhhcCC-----------------------------CCCCccccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcC
Confidence            332110                             011223678899999999999999999999999999999763

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=4.8e-39  Score=271.22  Aligned_cols=204  Identities=27%  Similarity=0.447  Sum_probs=161.6

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC---CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN---QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKP   76 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~---~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~   76 (280)
                      ++||||+++++++...     ...++||||++ ++|.+++...   ..+++..++.++.||+.||+|||+.|++|+||+|
T Consensus        76 l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p  150 (295)
T 2clq_A           76 LKHKNIVQYLGSFSEN-----GFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKG  150 (295)
T ss_dssp             CCCTTBCCEEEEEEET-----TEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred             CCCCCEeeEeeEEEeC-----CcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCCh
Confidence            5899999999999665     67999999997 6999999764   2477999999999999999999999999999999


Q ss_pred             CcEEEcc-CCCEEEeeccceeeccCCC-ccccceeccccccchhccCC-CCCCcchhHHHHHHHHHHHHhCCCCCCCCCh
Q 023609           77 SNLLLNA-NCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNS-SDYTAAIDVWSVGCIFMELMDRKPLFPGRDH  153 (280)
Q Consensus        77 ~nili~~-~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~  153 (280)
                      +||+++. ++.++|+|||.+....... ......+++.|+|||++.+. ..++.++||||+|+++|+|++|..||.+...
T Consensus       151 ~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~  230 (295)
T 2clq_A          151 DNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGE  230 (295)
T ss_dssp             GGEEEETTTCCEEECCTTTCEESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSS
T ss_pred             hhEEEECCCCCEEEeecccccccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCc
Confidence            9999987 8999999999998654322 23345789999999998543 2368899999999999999999999965433


Q ss_pred             HHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCC
Q 023609          154 VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLG  233 (280)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~  233 (280)
                      .............                           .....+.+++++.++|.+||+.||.+|||+.++++||||+
T Consensus       231 ~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~  283 (295)
T 2clq_A          231 PQAAMFKVGMFKV---------------------------HPEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLK  283 (295)
T ss_dssp             HHHHHHHHHHHCC---------------------------CCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGC
T ss_pred             hhHHHHhhccccc---------------------------cccccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhh
Confidence            2221111100000                           0011236788999999999999999999999999999998


Q ss_pred             CCc
Q 023609          234 SLH  236 (280)
Q Consensus       234 ~~~  236 (280)
                      ...
T Consensus       284 ~~~  286 (295)
T 2clq_A          284 VSS  286 (295)
T ss_dssp             C--
T ss_pred             hcc
Confidence            754

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=2.2e-40  Score=284.92  Aligned_cols=214  Identities=26%  Similarity=0.413  Sum_probs=145.8

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ--ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS   77 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~--~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~   77 (280)
                      ++||||+++++++.... .+....|+||||++ |+|.+++...+  .+++.+++.++.||+.||+|||++|++||||||+
T Consensus        79 ~~h~~i~~~~~~~~~~~-~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~  157 (336)
T 3fhr_A           79 SGGPHIVCILDVYENMH-HGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPE  157 (336)
T ss_dssp             TTSTTBCCEEEEEEEEE-TTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred             cCCCChHHHHHHHhhcc-CCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH
Confidence            47999999999986532 11255899999997 59999998654  6999999999999999999999999999999999


Q ss_pred             cEEEcc---CCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH
Q 023609           78 NLLLNA---NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHV  154 (280)
Q Consensus        78 nili~~---~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  154 (280)
                      ||+++.   ++.++|+|||++....... .....+++.|+|||++. ...++.++||||+||++|+|++|..||.+....
T Consensus       158 NIll~~~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~t~~y~aPE~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~  235 (336)
T 3fhr_A          158 NLLYTSKEKDAVLKLTDFGFAKETTQNA-LQTPCYTPYYVAPEVLG-PEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQ  235 (336)
T ss_dssp             GEEESCSSTTCCEEECCCTTCEEC------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred             HEEEEecCCCceEEEeccccceeccccc-cccCCCCcCccChhhhC-CCCCCchhhHHHHHHHHHHHHHCCCCCCCccch
Confidence            999976   4559999999998665432 34567899999999884 445788999999999999999999999765433


Q ss_pred             HHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCC
Q 023609          155 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS  234 (280)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~  234 (280)
                      ............                      .........+..+++++++||.+||+.||.+|||+.++++||||++
T Consensus       236 ~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  293 (336)
T 3fhr_A          236 AISPGMKRRIRL----------------------GQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ  293 (336)
T ss_dssp             -------------------------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred             hhhhhHHHhhhc----------------------cccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccc
Confidence            221111100000                      0000011223468899999999999999999999999999999987


Q ss_pred             CcCCC
Q 023609          235 LHDIS  239 (280)
Q Consensus       235 ~~~~~  239 (280)
                      .....
T Consensus       294 ~~~~~  298 (336)
T 3fhr_A          294 SMVVP  298 (336)
T ss_dssp             GGGSC
T ss_pred             cccCC
Confidence            65433

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=4.1e-39  Score=280.53  Aligned_cols=193  Identities=27%  Similarity=0.426  Sum_probs=159.3

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCC----------------CCCHHHHHHHHHHHHHHHHHH
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ----------------ALSEEHCQYFLYQILRGLKYI   64 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~----------------~l~~~~~~~i~~qll~al~~L   64 (280)
                      +||||+++++++...     ..+|+||||++ |+|.+++...+                .+++.++..++.||+.||+||
T Consensus       145 ~hpnIv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L  219 (370)
T 2psq_A          145 KHKNIINLLGACTQD-----GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL  219 (370)
T ss_dssp             CCTTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             CCCCEeeEEEEEccC-----CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHH
Confidence            799999999999765     67899999997 59999998643                489999999999999999999


Q ss_pred             HHCCceeccCCCCcEEEccCCCEEEeeccceeeccCCC---ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHH
Q 023609           65 HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL  141 (280)
Q Consensus        65 H~~gi~H~di~~~nili~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l  141 (280)
                      |++||+||||||+||+++.++.+||+|||++.......   ......+++.|+|||++.+. .++.++||||+||++|+|
T Consensus       220 H~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~el  298 (370)
T 2psq_A          220 ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEI  298 (370)
T ss_dssp             HHTTEECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTC-CCCHHHHHHHHHHHHHHH
T ss_pred             HhCCeeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCC-CCCcHHHHHHHHHHHHHH
Confidence            99999999999999999999999999999998654432   12334567889999998654 589999999999999999


Q ss_pred             Hh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCC
Q 023609          142 MD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQR  220 (280)
Q Consensus       142 l~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R  220 (280)
                      ++ |..||.+....+....+......                             .....++.++.++|.+||+.||.+|
T Consensus       299 lt~g~~p~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~l~~li~~~l~~dP~~R  349 (370)
T 2psq_A          299 FTLGGSPYPGIPVEELFKLLKEGHRM-----------------------------DKPANCTNELYMMMRDCWHAVPSQR  349 (370)
T ss_dssp             HTTSCCSSTTCCGGGHHHHHHTTCCC-----------------------------CCCTTSCHHHHHHHHHHTCSSGGGS
T ss_pred             HcCCCCCCCCCCHHHHHHHHhcCCCC-----------------------------CCCCCCCHHHHHHHHHHcCCChhhC
Confidence            98 99999877655444333211100                             1113678899999999999999999


Q ss_pred             CCHHHHhcC
Q 023609          221 ITVEDALAH  229 (280)
Q Consensus       221 ~t~~ell~h  229 (280)
                      ||+.+++++
T Consensus       350 pt~~ell~~  358 (370)
T 2psq_A          350 PTFKQLVED  358 (370)
T ss_dssp             CCHHHHHHH
T ss_pred             cCHHHHHHH
Confidence            999999863

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.1e-39  Score=277.37  Aligned_cols=206  Identities=24%  Similarity=0.415  Sum_probs=160.7

Q ss_pred             CCCCeeeeeceecCCCCC-CCCcEEEEeecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 023609            2 DHENVVAIRDIIPPPQRE-SFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS   77 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~-~~~~~~iv~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~   77 (280)
                      +||||+++++++...... .....|+||||++ |+|.+++...  ..+++..++.++.||+.||+|||+.|++|+||||+
T Consensus        79 ~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~  158 (326)
T 2x7f_A           79 HHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQ  158 (326)
T ss_dssp             CSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGG
T ss_pred             CCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHH
Confidence            699999999998764311 1267899999997 5999999864  46999999999999999999999999999999999


Q ss_pred             cEEEccCCCEEEeeccceeeccCC-CccccceeccccccchhccC----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 023609           78 NLLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLN----SSDYTAAIDVWSVGCIFMELMDRKPLFPGRD  152 (280)
Q Consensus        78 nili~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  152 (280)
                      ||+++.++.++|+|||++...... .......+++.|+|||++..    ...++.++||||+||++|+|++|..||.+..
T Consensus       159 NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  238 (326)
T 2x7f_A          159 NVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH  238 (326)
T ss_dssp             GEEECTTCCEEECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             HEEEcCCCCEEEeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCc
Confidence            999999999999999998765432 12334578999999999852    3457889999999999999999999998776


Q ss_pred             hHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 023609          153 HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  232 (280)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~  232 (280)
                      .......+......                            ....+.++..+++||.+||..||.+|||+.++++||||
T Consensus       239 ~~~~~~~~~~~~~~----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~  290 (326)
T 2x7f_A          239 PMRALFLIPRNPAP----------------------------RLKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFI  290 (326)
T ss_dssp             HHHHHHHHHHSCCC----------------------------CCSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHH
T ss_pred             HHHHHHHhhcCccc----------------------------cCCccccCHHHHHHHHHHhccChhhCCCHHHHhhChHH
Confidence            55443332211000                            01123678899999999999999999999999999999


Q ss_pred             CCC
Q 023609          233 GSL  235 (280)
Q Consensus       233 ~~~  235 (280)
                      ++.
T Consensus       291 ~~~  293 (326)
T 2x7f_A          291 RDQ  293 (326)
T ss_dssp             HCC
T ss_pred             hhC
Confidence            875

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.4e-40  Score=281.66  Aligned_cols=222  Identities=18%  Similarity=0.281  Sum_probs=162.6

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ---ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKP   76 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~---~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~   76 (280)
                      ++||||+++++++.....   ...|+||||++ ++|.+++....   .+++..++.++.||+.||+|||+.||+||||||
T Consensus        64 l~h~~iv~~~~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp  140 (319)
T 4euu_A           64 LNHKNIVKLFAIEEETTT---RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKP  140 (319)
T ss_dssp             CCCTTBCCEEEEEECTTT---CCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred             cCCCCcceEEEEeecCCC---ceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCH
Confidence            589999999999866522   47899999997 69999998643   399999999999999999999999999999999


Q ss_pred             CcEEE----ccCCCEEEeeccceeeccCCCccccceeccccccchhccC-------CCCCCcchhHHHHHHHHHHHHhCC
Q 023609           77 SNLLL----NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLN-------SSDYTAAIDVWSVGCIFMELMDRK  145 (280)
Q Consensus        77 ~nili----~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-------~~~~~~~~DiwslG~il~~ll~g~  145 (280)
                      +||++    +.++.++|+|||++.............+++.|+|||++..       ...++.++||||+||++|+|++|.
T Consensus       141 ~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~  220 (319)
T 4euu_A          141 GNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS  220 (319)
T ss_dssp             GGEEEEECTTSCEEEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSS
T ss_pred             HHEEEeccCCCCceEEEccCCCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCC
Confidence            99999    7778899999999988766655556678999999998742       345789999999999999999999


Q ss_pred             CCCCCCCh----HHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCC
Q 023609          146 PLFPGRDH----VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI  221 (280)
Q Consensus       146 ~pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~  221 (280)
                      .||.....    .+.+..+....  |.. .+.................  .........++..+.++|++||+.||++||
T Consensus       221 ~pf~~~~~~~~~~~~~~~~~~~~--p~~-~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~  295 (319)
T 4euu_A          221 LPFRPFEGPRRNKEVMYKIITGK--PSG-AISGVQKAENGPIDWSGDM--PVSCSLSRGLQVLLTPVLANILEADQEKCW  295 (319)
T ss_dssp             CSEECTTCGGGCHHHHHHHHHHC--CTT-CCEEEECSTTCCEEEESSC--CTTCSSCHHHHHHHHHHHHHHSCCCTTTSC
T ss_pred             CCCCCCCccchhHHHHHHHhcCC--Ccc-cchhhhcccCCccccCccC--CcccccchhHHHHhHHHHHHhccCChhhhc
Confidence            99964332    23333332211  110 0000000000000000000  000011123456789999999999999999


Q ss_pred             CHHHHhcCC
Q 023609          222 TVEDALAHP  230 (280)
Q Consensus       222 t~~ell~h~  230 (280)
                      |+.|+++||
T Consensus       296 s~~ell~h~  304 (319)
T 4euu_A          296 GFDQFFAET  304 (319)
T ss_dssp             CHHHHHHHH
T ss_pred             cHHHhhhcc
Confidence            999999987

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=1.6e-39  Score=272.06  Aligned_cols=203  Identities=30%  Similarity=0.458  Sum_probs=164.3

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC----CCCCHHHHHHHHHHHHHHHHHHHHCC-----ce
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN----QALSEEHCQYFLYQILRGLKYIHSAN-----VL   70 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~----~~l~~~~~~~i~~qll~al~~LH~~g-----i~   70 (280)
                      ++||||+++++++.....   ...|+||||++ ++|.+++...    ..+++..++.++.||+.||+|||+.|     ++
T Consensus        62 l~h~~i~~~~~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~iv  138 (279)
T 2w5a_A           62 LKHPNIVRYYDRIIDRTN---TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVL  138 (279)
T ss_dssp             CCCTTBCCEEEEEEEGGG---TEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------C
T ss_pred             cCCCCCCeEEEEEecCCC---ceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeE
Confidence            589999999998754321   57899999997 5999999743    35999999999999999999999999     99


Q ss_pred             eccCCCCcEEEccCCCEEEeeccceeeccCCCc-cccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 023609           71 HRDLKPSNLLLNANCDLKICDFGLARVTSETDF-MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFP  149 (280)
Q Consensus        71 H~di~~~nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  149 (280)
                      ||||||+||+++.++.++|+|||.+........ .....+++.|+|||.+.+. .++.++||||+|+++|+|++|..||.
T Consensus       139 H~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~  217 (279)
T 2w5a_A          139 HRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRM-SYNEKSDIWSLGCLLYELCALMPPFT  217 (279)
T ss_dssp             CCCCSGGGEEECSSSCEEECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC--CCHHHHHHHHHHHHHHHHHSSCSSC
T ss_pred             EeccchhhEEEcCCCCEEEecCchheeeccccccccccCCCccccChHHhccC-CCCchhhHHHHHHHHHHHHHCCCCCc
Confidence            999999999999999999999999876543321 2334678999999998654 47899999999999999999999998


Q ss_pred             CCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 023609          150 GRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  229 (280)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h  229 (280)
                      +.+..+....+......                             .....++.++.++|.+||+.||.+|||+.++++|
T Consensus       218 ~~~~~~~~~~i~~~~~~-----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  268 (279)
T 2w5a_A          218 AFSQKELAGKIREGKFR-----------------------------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN  268 (279)
T ss_dssp             CSSHHHHHHHHHHTCCC-----------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             ccCHHHHHHHHhhcccc-----------------------------cCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhC
Confidence            87765554444321110                             1112578899999999999999999999999999


Q ss_pred             CCCCCCc
Q 023609          230 PYLGSLH  236 (280)
Q Consensus       230 ~~~~~~~  236 (280)
                      +|+....
T Consensus       269 ~~~~~~~  275 (279)
T 2w5a_A          269 PLILEHH  275 (279)
T ss_dssp             TTCCGGG
T ss_pred             hhhhhhc
Confidence            9998743

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.1e-39  Score=289.34  Aligned_cols=202  Identities=29%  Similarity=0.392  Sum_probs=153.0

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ-ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~-~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nil   80 (280)
                      +||||+++++++.+.     ...|||||||+|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+||+
T Consensus        76 ~HpnIv~l~~~~~~~-----~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIl  150 (432)
T 3p23_A           76 EHPNVIRYFCTEKDR-----QFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNIL  150 (432)
T ss_dssp             CCTTBCCEEEEEEET-----TEEEEEEECCSEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEE
T ss_pred             CCCCcCeEEEEEecC-----CEEEEEEECCCCCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEE
Confidence            699999999998665     6789999999999999998654 4666677899999999999999999999999999999


Q ss_pred             Ecc-----CCCEEEeeccceeeccCCC----ccccceeccccccchhccC--CCCCCcchhHHHHHHHHHHHHh-CCCCC
Q 023609           81 LNA-----NCDLKICDFGLARVTSETD----FMTEYVVTRWYRAPELLLN--SSDYTAAIDVWSVGCIFMELMD-RKPLF  148 (280)
Q Consensus        81 i~~-----~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~-g~~pf  148 (280)
                      ++.     ...++|+|||++.......    ......+|+.|+|||++.+  ...++.++||||+||++++|++ |..||
T Consensus       151 l~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf  230 (432)
T 3p23_A          151 ISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPF  230 (432)
T ss_dssp             ECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTT
T ss_pred             EecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCc
Confidence            953     2357899999998654331    2334578999999999864  3446779999999999999999 88999


Q ss_pred             CCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          149 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                      .+........ +   .+.....                       ........+..+++||.+||+.||.+|||+.++++
T Consensus       231 ~~~~~~~~~~-~---~~~~~~~-----------------------~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          231 GKSLQRQANI-L---LGACSLD-----------------------CLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             BSTTTHHHHH-H---TTCCCCT-----------------------TSCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             chhhHHHHHH-H---hccCCcc-----------------------ccCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence            6554332211 1   1110000                       00000123456889999999999999999999999


Q ss_pred             CCCCCCC
Q 023609          229 HPYLGSL  235 (280)
Q Consensus       229 h~~~~~~  235 (280)
                      ||||.++
T Consensus       284 hp~f~~~  290 (432)
T 3p23_A          284 HPFFWSL  290 (432)
T ss_dssp             STTTCCH
T ss_pred             CccccCh
Confidence            9999764

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.5e-39  Score=278.52  Aligned_cols=206  Identities=27%  Similarity=0.424  Sum_probs=147.1

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHc-----CCCCCHHHHHHHHHHHHHHHHHHHHC-CceeccC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-----NQALSEEHCQYFLYQILRGLKYIHSA-NVLHRDL   74 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~-----~~~l~~~~~~~i~~qll~al~~LH~~-gi~H~di   74 (280)
                      ++||||+++++++...     ...|+||||++|+|.+++..     ...+++..+..++.|++.||.|||+. |++||||
T Consensus        78 ~~h~niv~~~~~~~~~-----~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dl  152 (327)
T 3aln_A           78 SDCPYIVQFYGALFRE-----GDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDI  152 (327)
T ss_dssp             CCCTTBCCEEEEEECS-----SEEEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCC
T ss_pred             CCCCcEeeeeeEEEeC-----CceEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCC
Confidence            4799999999999765     67999999999999888863     56799999999999999999999999 9999999


Q ss_pred             CCCcEEEccCCCEEEeeccceeeccCCCccccceeccccccchhcc---CCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 023609           75 KPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL---NSSDYTAAIDVWSVGCIFMELMDRKPLFPGR  151 (280)
Q Consensus        75 ~~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~---~~~~~~~~~DiwslG~il~~ll~g~~pf~~~  151 (280)
                      ||+||+++.++.++|+|||++.............+++.|+|||++.   ....++.++||||+||++++|++|..||.+.
T Consensus       153 kp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~  232 (327)
T 3aln_A          153 KPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKW  232 (327)
T ss_dssp             CGGGEEEETTTEEEECCCSSSCC------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC
T ss_pred             CHHHEEEcCCCCEEEccCCCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence            9999999999999999999998765544444557899999999873   2344788999999999999999999999764


Q ss_pred             ChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCcccc-ccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCC
Q 023609          152 DHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQR-QSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHP  230 (280)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~  230 (280)
                      .....  .+.                       ....... .......+.+++++.+||.+||+.||.+|||+.++++||
T Consensus       233 ~~~~~--~~~-----------------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp  287 (327)
T 3aln_A          233 NSVFD--QLT-----------------------QVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHP  287 (327)
T ss_dssp             ---------C-----------------------CCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSH
T ss_pred             chHHH--HHH-----------------------HHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhCh
Confidence            32110  000                       0000000 001122246789999999999999999999999999999


Q ss_pred             CCCCCc
Q 023609          231 YLGSLH  236 (280)
Q Consensus       231 ~~~~~~  236 (280)
                      ||....
T Consensus       288 ~~~~~~  293 (327)
T 3aln_A          288 FILMYE  293 (327)
T ss_dssp             HHHHHH
T ss_pred             HHHHhH
Confidence            998654

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=6e-39  Score=274.78  Aligned_cols=193  Identities=22%  Similarity=0.335  Sum_probs=159.4

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      |+||||+++++++...     ...|+||||++ |+|.+++... +.+++..+..++.||+.||+|||+.||+||||||+|
T Consensus       107 l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~N  181 (325)
T 3kul_A          107 FDHPNIIRLEGVVTRG-----RLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARN  181 (325)
T ss_dssp             CCCTTBCCEEEEECGG-----GCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred             CCCCCCCcEEEEEEeC-----CccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcce
Confidence            5899999999999665     67899999997 5999999754 579999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCCC----ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCh
Q 023609           79 LLLNANCDLKICDFGLARVTSETD----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDH  153 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~  153 (280)
                      |+++.++.++|+|||++.......    ......+++.|+|||++.+. .++.++||||+||++|+|++ |..||.+...
T Consensus       182 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~  260 (325)
T 3kul_A          182 VLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFR-TFSSASDVWSFGVVMWEVLAYGERPYWNMTN  260 (325)
T ss_dssp             EEECTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTSCH
T ss_pred             EEECCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCC-CCCcHHHHHHHHHHHHHHHcCCCCCcccCCH
Confidence            999999999999999998754432    12223456789999998544 47899999999999999998 9999988877


Q ss_pred             HHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          154 VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                      .+....+......+                             ....+++++.++|.+||+.||.+|||+.++++
T Consensus       261 ~~~~~~~~~~~~~~-----------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~  306 (325)
T 3kul_A          261 RDVISSVEEGYRLP-----------------------------APMGCPHALHQLMLDCWHKDRAQRPRFSQIVS  306 (325)
T ss_dssp             HHHHHHHHTTCCCC-----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHcCCCCC-----------------------------CCCCcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            76655544322111                             11267889999999999999999999999986

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=7.3e-39  Score=266.90  Aligned_cols=194  Identities=21%  Similarity=0.344  Sum_probs=161.1

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      ++||||+++++++.+.     ...|+||||++ ++|.+++... +.+++..++.++.|++.||+|||+.|++||||||+|
T Consensus        62 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~N  136 (269)
T 4hcu_A           62 LSHPKLVQLYGVCLEQ-----APICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARN  136 (269)
T ss_dssp             CCCTTBCCEEEEECSS-----SSEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred             CCCCCEeeEEEEEecC-----CceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchhe
Confidence            5899999999999765     66999999997 5999999754 469999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCCC--ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 023609           79 LLLNANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVH  155 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~  155 (280)
                      |+++.++.++|+|||++.......  ......+++.|+|||.+.+. .++.++|+||+|+++++|++ |..||.+....+
T Consensus       137 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~  215 (269)
T 4hcu_A          137 CLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE  215 (269)
T ss_dssp             EEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred             EEEcCCCCEEeccccccccccccccccccCcccccccCCHHHhcCC-CCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH
Confidence            999999999999999997544321  12234557789999998544 48899999999999999999 999998887766


Q ss_pred             HHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 023609          156 QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  229 (280)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h  229 (280)
                      ....+.......                             ....+++++.++|.+||+.||.+|||+.+++++
T Consensus       216 ~~~~~~~~~~~~-----------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          216 VVEDISTGFRLY-----------------------------KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             HHHHHHTTCCCC-----------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHhcCccCC-----------------------------CCCcCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            655543321111                             112468899999999999999999999999875

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=4.8e-39  Score=274.78  Aligned_cols=193  Identities=26%  Similarity=0.455  Sum_probs=163.7

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCC--ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMD--TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~--g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      .||||+++++++...     ...++|||++.  ++|.+++..++.+++..++.++.||+.||+|||+.||+||||||+||
T Consensus       106 ~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NI  180 (320)
T 3a99_A          106 GFSGVIRLLDWFERP-----DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENI  180 (320)
T ss_dssp             SSCSBCCEEEEEECS-----SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred             CCCCceEEEEEEecC-----CcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHE
Confidence            379999999999765     67999999996  69999999888999999999999999999999999999999999999


Q ss_pred             EEc-cCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023609           80 LLN-ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  158 (280)
Q Consensus        80 li~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++ .++.++|+|||++....... .....+++.|+|||++.+....+.++||||+||++|+|++|..||.+...     
T Consensus       181 ll~~~~~~~kL~Dfg~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~-----  254 (320)
T 3a99_A          181 LIDLNRGELKLIDFGSGALLKDTV-YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-----  254 (320)
T ss_dssp             EEETTTTEEEECCCTTCEECCSSC-BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----
T ss_pred             EEeCCCCCEEEeeCcccccccccc-ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChhh-----
Confidence            999 67999999999998765442 33457899999999986655457889999999999999999999964311     


Q ss_pred             HHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCc
Q 023609          159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  236 (280)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~  236 (280)
                       +..  +.                            ....+.+++++.+||.+||+.||.+|||+.++++||||++..
T Consensus       255 -~~~--~~----------------------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~  301 (320)
T 3a99_A          255 -IIR--GQ----------------------------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL  301 (320)
T ss_dssp             -HHH--CC----------------------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             -hhc--cc----------------------------ccccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence             000  00                            011236789999999999999999999999999999999864

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=2.1e-39  Score=287.96  Aligned_cols=203  Identities=30%  Similarity=0.441  Sum_probs=151.2

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHcCCCC-------CHHHHHHHHHHHHHHHHHHHHCCceeccC
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQAL-------SEEHCQYFLYQILRGLKYIHSANVLHRDL   74 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~l-------~~~~~~~i~~qll~al~~LH~~gi~H~di   74 (280)
                      +||||+++++++...     ...|+|||||+|+|.+++...+..       ++..++.++.||+.||+|||++||+||||
T Consensus        67 ~HpnIv~~~~~~~~~-----~~~~lv~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDL  141 (434)
T 2rio_A           67 DHPNVIRYYCSETTD-----RFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDL  141 (434)
T ss_dssp             TSTTBCCEEEEEECS-----SEEEEEECCCSEEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred             CCCCcCeEEEEEecC-----CeEEEEEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCC
Confidence            799999999998665     679999999999999999865433       23345789999999999999999999999


Q ss_pred             CCCcEEEccC-------------CCEEEeeccceeeccCCC-----ccccceeccccccchhccC------CCCCCcchh
Q 023609           75 KPSNLLLNAN-------------CDLKICDFGLARVTSETD-----FMTEYVVTRWYRAPELLLN------SSDYTAAID  130 (280)
Q Consensus        75 ~~~nili~~~-------------~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~------~~~~~~~~D  130 (280)
                      ||+||+++.+             +.++|+|||++.......     ......+|+.|+|||++.+      ...++.++|
T Consensus       142 kp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~D  221 (434)
T 2rio_A          142 KPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSID  221 (434)
T ss_dssp             SGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHH
T ss_pred             ChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhh
Confidence            9999999754             479999999998765432     1234578999999999854      245789999


Q ss_pred             HHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHH
Q 023609          131 VWSVGCIFMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLV  209 (280)
Q Consensus       131 iwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  209 (280)
                      |||+||++|+|++ |..||.+......  .+.........                   ..    ....+.+++++++||
T Consensus       222 iwSlG~il~ellt~g~~Pf~~~~~~~~--~i~~~~~~~~~-------------------~~----~~~~~~~~~~~~~li  276 (434)
T 2rio_A          222 IFSMGCVFYYILSKGKHPFGDKYSRES--NIIRGIFSLDE-------------------MK----CLHDRSLIAEATDLI  276 (434)
T ss_dssp             HHHHHHHHHHHHTTSCCTTCSTTTHHH--HHHHTCCCCCC-------------------CT----TCCCHHHHHHHHHHH
T ss_pred             hHhHHHHHHHHHhCCCCCCCCchhhHH--HHhcCCCCccc-------------------cc----ccccccchHHHHHHH
Confidence            9999999999998 8999976543321  11111100000                   00    000012457899999


Q ss_pred             HHhhcCCCCCCCCHHHHhcCCCCCC
Q 023609          210 EKMLTFDPRQRITVEDALAHPYLGS  234 (280)
Q Consensus       210 ~~~L~~dp~~R~t~~ell~h~~~~~  234 (280)
                      .+||+.||.+|||+.++++||||.+
T Consensus       277 ~~~L~~dP~~Rps~~eil~hp~f~~  301 (434)
T 2rio_A          277 SQMIDHDPLKRPTAMKVLRHPLFWP  301 (434)
T ss_dssp             HHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred             HHHhhCChhhCCCHHHHHhCCccCC
Confidence            9999999999999999999999964

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.2e-38  Score=269.44  Aligned_cols=206  Identities=27%  Similarity=0.395  Sum_probs=153.9

Q ss_pred             CCCCCeeeeeceecCCC--------CCCCCcEEEEeecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCce
Q 023609            1 MDHENVVAIRDIIPPPQ--------RESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVL   70 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~--------~~~~~~~~iv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~gi~   70 (280)
                      ++||||+++++++....        .......|+||||++ |+|.+++... ..+++..++.++.||+.||+|||++|++
T Consensus        59 l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~  138 (303)
T 1zy4_A           59 LNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGII  138 (303)
T ss_dssp             CCCTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred             cCchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCee
Confidence            57999999999875431        112367899999997 5999999854 3688999999999999999999999999


Q ss_pred             eccCCCCcEEEccCCCEEEeeccceeeccCC---------------CccccceeccccccchhccCCCCCCcchhHHHHH
Q 023609           71 HRDLKPSNLLLNANCDLKICDFGLARVTSET---------------DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVG  135 (280)
Q Consensus        71 H~di~~~nili~~~~~~~l~dfg~~~~~~~~---------------~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG  135 (280)
                      ||||||+||+++.++.++|+|||.+......               .......+++.|+|||++.+...++.++||||+|
T Consensus       139 H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG  218 (303)
T 1zy4_A          139 HRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLG  218 (303)
T ss_dssp             CSCCCGGGEEECTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHH
T ss_pred             cccCCHHhEEEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHH
Confidence            9999999999999999999999998754321               1223456889999999987665688999999999


Q ss_pred             HHHHHHHhCCCCCCCCC-hHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhc
Q 023609          136 CIFMELMDRKPLFPGRD-HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLT  214 (280)
Q Consensus       136 ~il~~ll~g~~pf~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~  214 (280)
                      |++|+|++   ||.... .......+......                          ......+..+..++++|++||+
T Consensus       219 ~il~~l~~---p~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~~~li~~~l~  269 (303)
T 1zy4_A          219 IIFFEMIY---PFSTGMERVNILKKLRSVSIE--------------------------FPPDFDDNKMKVEKKIIRLLID  269 (303)
T ss_dssp             HHHHHHHS---CCSSHHHHHHHHHHHHSTTCC--------------------------CCTTCCTTTSHHHHHHHHHHTC
T ss_pred             HHHHHHHh---ccCCchhHHHHHHhccccccc--------------------------cCccccccchHHHHHHHHHHHh
Confidence            99999998   443221 11111111110000                          0011223567789999999999


Q ss_pred             CCCCCCCCHHHHhcCCCCCCC
Q 023609          215 FDPRQRITVEDALAHPYLGSL  235 (280)
Q Consensus       215 ~dp~~R~t~~ell~h~~~~~~  235 (280)
                      .||.+|||+.++++||||...
T Consensus       270 ~dp~~Rps~~~ll~h~~~~~~  290 (303)
T 1zy4_A          270 HDPNKRPGARTLLNSGWLPVK  290 (303)
T ss_dssp             SSGGGSCCHHHHHHSSCSCCC
T ss_pred             cCcccCcCHHHHhCCCCcCCC
Confidence            999999999999999999763

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=9.5e-39  Score=275.70  Aligned_cols=203  Identities=15%  Similarity=0.135  Sum_probs=160.1

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   80 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nil   80 (280)
                      ++||||+++++++.... .+....|+||||++++|.+++...+.+++..++.++.||+.||+|||+.||+||||||+||+
T Consensus       105 l~h~ni~~~~~~~~~~~-~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIl  183 (345)
T 2v62_A          105 LDYLGIPLFYGSGLTEF-KGRSYRFMVMERLGIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLL  183 (345)
T ss_dssp             CSCCCCCCEEEEEEEES-SSCEEEEEEEECEEEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred             ccccCcceeeccccccc-CCCcEEEEEEeccCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEE
Confidence            47999999999987632 12267999999998899999988778999999999999999999999999999999999999


Q ss_pred             EccCC--CEEEeeccceeeccCCC--------ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 023609           81 LNANC--DLKICDFGLARVTSETD--------FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPG  150 (280)
Q Consensus        81 i~~~~--~~~l~dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~  150 (280)
                      ++.++  .++|+|||+++......        ......+++.|+|||++.+. .++.++||||+||++|+|++|..||.+
T Consensus       184 l~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~pf~~  262 (345)
T 2v62_A          184 LGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGV-ALSRRSDVEILGYCMLRWLCGKLPWEQ  262 (345)
T ss_dssp             EESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred             EccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCC-CCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            98877  99999999997653321        11345789999999998654 589999999999999999999999965


Q ss_pred             C--ChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCC--CCChHHHHHHHHhhcCCCCCCCCHHHH
Q 023609          151 R--DHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP--NVHPSAIDLVEKMLTFDPRQRITVEDA  226 (280)
Q Consensus       151 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~L~~dp~~R~t~~el  226 (280)
                      .  ................+..                       .....+  .+++++.++|.+||+.||.+|||+.++
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l  319 (345)
T 2v62_A          263 NLKDPVAVQTAKTNLLDELPQS-----------------------VLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQAL  319 (345)
T ss_dssp             GTTCHHHHHHHHHHHHHTTTHH-----------------------HHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHH
T ss_pred             cccccHHHHHHHHhhcccccHH-----------------------HHhhccccccHHHHHHHHHHHhhcCcccCCCHHHH
Confidence            3  2222222111111111110                       011112  678899999999999999999999998


Q ss_pred             hc
Q 023609          227 LA  228 (280)
Q Consensus       227 l~  228 (280)
                      ++
T Consensus       320 ~~  321 (345)
T 2v62_A          320 KK  321 (345)
T ss_dssp             HH
T ss_pred             HH
Confidence            87

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.1e-38  Score=265.65  Aligned_cols=194  Identities=19%  Similarity=0.309  Sum_probs=160.4

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ-ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~-~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      ++||||+++++++...     ...|+||||++ ++|.+++...+ .+++..++.++.|++.||+|||+.|++||||||+|
T Consensus        60 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~N  134 (268)
T 3sxs_A           60 LSHPKLVKFYGVCSKE-----YPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARN  134 (268)
T ss_dssp             CCCTTBCCEEEEECSS-----SSEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGG
T ss_pred             CCCCCEeeEEEEEccC-----CceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcce
Confidence            5899999999999655     67999999997 68999997654 59999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCCCc--cccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 023609           79 LLLNANCDLKICDFGLARVTSETDF--MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVH  155 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~  155 (280)
                      |+++.++.++|+|||.+........  .....+++.|+|||.+.+. .++.++||||+|+++++|++ |..||.+.....
T Consensus       135 il~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~  213 (268)
T 3sxs_A          135 CLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYF-KYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSE  213 (268)
T ss_dssp             EEECTTCCEEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHHS-EEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHH
T ss_pred             EEECCCCCEEEccCccceecchhhhhcccCCCcCcccCCHHHHhcc-CCchhhhhHHHHHHHHHHHcCCCCCccccChHH
Confidence            9999999999999999986554422  2233456789999998544 47889999999999999998 999998877665


Q ss_pred             HHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 023609          156 QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  229 (280)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h  229 (280)
                      ....+........                             ....++.+.++|.+||+.||.+|||+.+++++
T Consensus       214 ~~~~~~~~~~~~~-----------------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          214 VVLKVSQGHRLYR-----------------------------PHLASDTIYQIMYSCWHELPEKRPTFQQLLSS  258 (268)
T ss_dssp             HHHHHHTTCCCCC-----------------------------CTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHcCCCCCC-----------------------------CCcChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            5544432111110                             12467889999999999999999999999975

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=7.9e-39  Score=278.15  Aligned_cols=205  Identities=16%  Similarity=0.139  Sum_probs=158.9

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++.... .+....||||||++++|.+++... +.+++..+..++.||+.||+|||+.||+||||||+||
T Consensus       105 l~h~~iv~~~~~~~~~~-~~~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Ni  183 (364)
T 3op5_A          105 LKYLGVPKYWGSGLHDK-NGKSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNL  183 (364)
T ss_dssp             CSCCCSCCEEEEEEEEE-TTEEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred             ccCCCCCeEEeeeeecc-CCcceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHE
Confidence            47999999999986642 222558999999988999999875 6799999999999999999999999999999999999


Q ss_pred             EEc--cCCCEEEeeccceeeccCCCc--------cccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 023609           80 LLN--ANCDLKICDFGLARVTSETDF--------MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFP  149 (280)
Q Consensus        80 li~--~~~~~~l~dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  149 (280)
                      +++  .++.++|+|||+++.......        .....+|+.|+|||++.+. .++.++||||+||++|+|++|..||.
T Consensus       184 ll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~g~~Pf~  262 (364)
T 3op5_A          184 LLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGV-APSRRGDLEILGYCMIQWLTGHLPWE  262 (364)
T ss_dssp             EEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred             EEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCC-CCCchhhHHHHHHHHHHHHhCCCCcc
Confidence            999  889999999999976543211        1234589999999988544 48999999999999999999999998


Q ss_pred             CCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccC--CCCChHHHHHHHHhhcCCCCCCCCHHHHh
Q 023609          150 GRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF--PNVHPSAIDLVEKMLTFDPRQRITVEDAL  227 (280)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~L~~dp~~R~t~~ell  227 (280)
                      +................+.          .....           ..++  ++++.++.++|..||+.||.+||++.+++
T Consensus       263 ~~~~~~~~~~~~~~~~~~~----------~~~~~-----------~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~  321 (364)
T 3op5_A          263 DNLKDPKYVRDSKIRYREN----------IASLM-----------DKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLR  321 (364)
T ss_dssp             GGTTCHHHHHHHHHHHHHC----------HHHHH-----------HHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHH
T ss_pred             ccccCHHHHHHHHHHhhhh----------HHHHH-----------HHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHH
Confidence            5432222111111100000          00000           0111  36789999999999999999999999888


Q ss_pred             c
Q 023609          228 A  228 (280)
Q Consensus       228 ~  228 (280)
                      +
T Consensus       322 ~  322 (364)
T 3op5_A          322 D  322 (364)
T ss_dssp             H
T ss_pred             H
Confidence            6

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1.7e-38  Score=270.34  Aligned_cols=201  Identities=25%  Similarity=0.393  Sum_probs=156.7

Q ss_pred             CCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEc
Q 023609            3 HENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLN   82 (280)
Q Consensus         3 HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nili~   82 (280)
                      ||||+++++++...     ...|+|||+.+++|.+++..++.+++..++.++.||+.||+|||+.|++||||||+||+++
T Consensus        87 ~~~iv~~~~~~~~~-----~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~  161 (313)
T 3cek_A           87 SDKIIRLYDYEITD-----QYIYMVMECGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV  161 (313)
T ss_dssp             CTTBCCEEEEEECS-----SEEEEEECCCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE
T ss_pred             CCceEEEEEEeecC-----CEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE
Confidence            69999999999765     6799999987899999999888999999999999999999999999999999999999996


Q ss_pred             cCCCEEEeeccceeeccCCC---ccccceeccccccchhccCC----------CCCCcchhHHHHHHHHHHHHhCCCCCC
Q 023609           83 ANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNS----------SDYTAAIDVWSVGCIFMELMDRKPLFP  149 (280)
Q Consensus        83 ~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~----------~~~~~~~DiwslG~il~~ll~g~~pf~  149 (280)
                       ++.++|+|||.+.......   ......+++.|+|||.+.+.          ..++.++||||+||++++|++|..||.
T Consensus       162 -~~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~  240 (313)
T 3cek_A          162 -DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ  240 (313)
T ss_dssp             -TTEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred             -CCeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchh
Confidence             5899999999997654332   12345689999999998541          357889999999999999999999997


Q ss_pred             CCChHH-HHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          150 GRDHVH-QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       150 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                      +..... ....+.....                            ........+.++.++|.+||+.||.+|||+.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  292 (313)
T 3cek_A          241 QIINQISKLHAIIDPNH----------------------------EIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  292 (313)
T ss_dssp             TCCSHHHHHHHHHCTTS----------------------------CCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hHHHHHHHHHHHHhccc----------------------------ccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence            654322 1111110000                            00111245778999999999999999999999999


Q ss_pred             CCCCCCCcC
Q 023609          229 HPYLGSLHD  237 (280)
Q Consensus       229 h~~~~~~~~  237 (280)
                      ||||+....
T Consensus       293 h~~~~~~~~  301 (313)
T 3cek_A          293 HPYVQIQTH  301 (313)
T ss_dssp             SHHHHCC--
T ss_pred             CccccCCCC
Confidence            999987543

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=7.9e-39  Score=278.44  Aligned_cols=198  Identities=21%  Similarity=0.288  Sum_probs=162.9

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC-------CCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-------QALSEEHCQYFLYQILRGLKYIHSANVLHR   72 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-------~~l~~~~~~~i~~qll~al~~LH~~gi~H~   72 (280)
                      |+||||+++++++...     ...|+||||++ |+|.+++...       ..+++..++.++.||+.||+|||++||+||
T Consensus       131 l~hpnIv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHr  205 (367)
T 3l9p_A          131 FNHQNIVRCIGVSLQS-----LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHR  205 (367)
T ss_dssp             CCCTTBCCEEEEECSS-----SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             CCCCCCCeEEEEEecC-----CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCC
Confidence            5899999999999765     56799999996 6999999754       359999999999999999999999999999


Q ss_pred             cCCCCcEEEccCC---CEEEeeccceeeccC---CCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CC
Q 023609           73 DLKPSNLLLNANC---DLKICDFGLARVTSE---TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RK  145 (280)
Q Consensus        73 di~~~nili~~~~---~~~l~dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~  145 (280)
                      ||||+||+++.+|   .++|+|||+++....   ........+|+.|+|||++.+. .++.++||||+||++|+|++ |.
T Consensus       206 Dlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DvwslG~il~ellt~g~  284 (367)
T 3l9p_A          206 DIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGY  284 (367)
T ss_dssp             CCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSC
T ss_pred             CCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCC-CCCcHHHHHHHHHHHHHHHhCCC
Confidence            9999999998655   499999999974322   1222345678899999988554 48999999999999999998 99


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHH
Q 023609          146 PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVED  225 (280)
Q Consensus       146 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e  225 (280)
                      .||.+....+....+......+                             ....++..+.+||.+||+.||.+|||+.+
T Consensus       285 ~pf~~~~~~~~~~~i~~~~~~~-----------------------------~~~~~~~~l~~li~~~l~~dP~~Rps~~e  335 (367)
T 3l9p_A          285 MPYPSKSNQEVLEFVTSGGRMD-----------------------------PPKNCPGPVYRIMTQCWQHQPEDRPNFAI  335 (367)
T ss_dssp             CSSTTCCHHHHHHHHHTTCCCC-----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCCCCCCHHHHHHHHHcCCCCC-----------------------------CCccCCHHHHHHHHHHcCCCHhHCcCHHH
Confidence            9998887766655443322111                             11257889999999999999999999999


Q ss_pred             HhcCCCCC
Q 023609          226 ALAHPYLG  233 (280)
Q Consensus       226 ll~h~~~~  233 (280)
                      ++++.++-
T Consensus       336 il~~l~~~  343 (367)
T 3l9p_A          336 ILERIEYC  343 (367)
T ss_dssp             HHHHHHHH
T ss_pred             HHHHHHHH
Confidence            99987664

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=6.8e-39  Score=273.93  Aligned_cols=205  Identities=25%  Similarity=0.389  Sum_probs=152.7

Q ss_pred             CCCCCeeeeeceecCCCCCC-CCcEEEEeecCC-ccHHHHHHcCC------CCCHHHHHHHHHHHHHHHHHHHHCCceec
Q 023609            1 MDHENVVAIRDIIPPPQRES-FNDVYIAYELMD-TDLHQIIRSNQ------ALSEEHCQYFLYQILRGLKYIHSANVLHR   72 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~-~~~~~iv~e~~~-g~L~~~l~~~~------~l~~~~~~~i~~qll~al~~LH~~gi~H~   72 (280)
                      |+||||+++++++......+ ....++||||+. |+|.+++....      .+++..++.++.||+.||+|||++|++||
T Consensus        82 l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~  161 (323)
T 3qup_A           82 FDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHR  161 (323)
T ss_dssp             CCCTTBCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             CCCCceehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccC
Confidence            58999999999987653211 123499999998 59999986432      59999999999999999999999999999


Q ss_pred             cCCCCcEEEccCCCEEEeeccceeeccCCCc---cccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCC
Q 023609           73 DLKPSNLLLNANCDLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLF  148 (280)
Q Consensus        73 di~~~nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf  148 (280)
                      ||||+||+++.++.++|+|||++........   .....+++.|+|||.+.+. .++.++||||+||++|+|++ |..||
T Consensus       162 Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~  240 (323)
T 3qup_A          162 DLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADN-LYTVHSDVWAFGVTMWEIMTRGQTPY  240 (323)
T ss_dssp             CCSGGGEEECTTSCEEECCCCC-----------------CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             CCCcceEEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCC-CCCCccchhhHHHHHHHHHhCCCCCc
Confidence            9999999999999999999999976543321   2233457789999998544 48899999999999999999 89999


Q ss_pred             CCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCC------
Q 023609          149 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT------  222 (280)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t------  222 (280)
                      .+....+....+......                             ...+.+++++.++|.+||+.||.+|||      
T Consensus       241 ~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  291 (323)
T 3qup_A          241 AGIENAEIYNYLIGGNRL-----------------------------KQPPECMEEVYDLMYQCWSADPKQRPSFTCLRM  291 (323)
T ss_dssp             TTCCGGGHHHHHHTTCCC-----------------------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             cccChHHHHHHHhcCCCC-----------------------------CCCCccCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            887665554443321111                             112367889999999999999999999      


Q ss_pred             -HHHHhcCCCCCCC
Q 023609          223 -VEDALAHPYLGSL  235 (280)
Q Consensus       223 -~~ell~h~~~~~~  235 (280)
                       .+++++|+|+.+.
T Consensus       292 ~l~~~l~~~~~~~~  305 (323)
T 3qup_A          292 ELENILGHLSVLST  305 (323)
T ss_dssp             HHHHHHHC------
T ss_pred             HHHHHHHHhhhcCC
Confidence             7888899999774

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=1.3e-38  Score=267.16  Aligned_cols=194  Identities=19%  Similarity=0.309  Sum_probs=161.5

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      ++||||+++++++...     ...|+||||++ ++|.+++.. ...+++..++.++.||+.||+|||++|++||||||+|
T Consensus        76 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~N  150 (283)
T 3gen_A           76 LSHEKLVQLYGVCTKQ-----RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARN  150 (283)
T ss_dssp             CCCTTBCCEEEEECSS-----SSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGG
T ss_pred             CCCCCEeeEEEEEecC-----CCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccce
Confidence            5799999999999665     67999999996 699999976 4679999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCCC--ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 023609           79 LLLNANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVH  155 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~  155 (280)
                      |+++.++.++|+|||.+.......  ......+++.|+|||.+.+. .++.++||||+|+++|+|++ |..||.+.....
T Consensus       151 ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~  229 (283)
T 3gen_A          151 CLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYS-KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE  229 (283)
T ss_dssp             EEECTTSCEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHH
T ss_pred             EEEcCCCCEEEccccccccccccccccccCCccCcccCCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCccccChhH
Confidence            999999999999999997553321  12233457789999998644 47899999999999999998 999998877666


Q ss_pred             HHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 023609          156 QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  229 (280)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h  229 (280)
                      ....+........                             ....++.+.++|.+||+.||.+|||+.++++|
T Consensus       230 ~~~~~~~~~~~~~-----------------------------~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          230 TAEHIAQGLRLYR-----------------------------PHLASEKVYTIMYSCWHEKADERPTFKILLSN  274 (283)
T ss_dssp             HHHHHHTTCCCCC-----------------------------CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHhcccCCCC-----------------------------CCcCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence            5555443221111                             12467889999999999999999999999875

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=1.1e-38  Score=276.46  Aligned_cols=195  Identities=26%  Similarity=0.414  Sum_probs=158.9

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCC------------------------------------
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQA------------------------------------   44 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~------------------------------------   44 (280)
                      +||||+++++++....    ...++||||++ |+|.+++.....                                    
T Consensus        84 ~hpniv~~~~~~~~~~----~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (359)
T 3vhe_A           84 HHLNVVNLLGACTKPG----GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSS  159 (359)
T ss_dssp             CCTTBCCEEEEECSTT----SCCEEEEECCTTEEHHHHHHTTTTSBCSCC------------------------------
T ss_pred             CCcceeeeeeeeecCC----CceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCcc
Confidence            6999999999987642    45899999997 699999976533                                    


Q ss_pred             ------------------------------CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCCEEEeeccc
Q 023609           45 ------------------------------LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL   94 (280)
Q Consensus        45 ------------------------------l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nili~~~~~~~l~dfg~   94 (280)
                                                    +++..++.++.||+.||+|||++||+||||||+||+++.++.++|+|||+
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~  239 (359)
T 3vhe_A          160 QSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGL  239 (359)
T ss_dssp             ------------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGG
T ss_pred             ccccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccc
Confidence                                          89999999999999999999999999999999999999999999999999


Q ss_pred             eeeccCCC---ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHH
Q 023609           95 ARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEA  170 (280)
Q Consensus        95 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~  170 (280)
                      +.......   ......+|+.|+|||++.+ ..++.++||||+||++|+|++ |..||.+................+.  
T Consensus       240 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~--  316 (359)
T 3vhe_A          240 ARDIYKDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR--  316 (359)
T ss_dssp             GSCTTSCTTCEEC--CEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCC--
T ss_pred             eeeecccccchhccccCCCceeEChhhhcC-CCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCC--
Confidence            98653322   2234567889999998864 458899999999999999998 9999987765444333332221111  


Q ss_pred             HHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 023609          171 ELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  229 (280)
Q Consensus       171 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h  229 (280)
                                                ....+++++.++|.+||+.||.+|||+.++++|
T Consensus       317 --------------------------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          317 --------------------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  349 (359)
T ss_dssp             --------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             --------------------------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence                                      112578899999999999999999999999875

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1e-38  Score=271.45  Aligned_cols=194  Identities=24%  Similarity=0.381  Sum_probs=159.7

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCC------------------------CCHHHHHHHHH
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQA------------------------LSEEHCQYFLY   55 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~------------------------l~~~~~~~i~~   55 (280)
                      |+||||+++++++...     ...|+||||++ |+|.+++...+.                        +++..++.++.
T Consensus        83 l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  157 (314)
T 2ivs_A           83 VNHPHVIKLYGACSQD-----GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAW  157 (314)
T ss_dssp             CCCTTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHH
T ss_pred             CCCCceeeEEEEEecC-----CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHH
Confidence            5899999999999665     66899999997 699999986543                        89999999999


Q ss_pred             HHHHHHHHHHHCCceeccCCCCcEEEccCCCEEEeeccceeeccCCCc---cccceeccccccchhccCCCCCCcchhHH
Q 023609           56 QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNSSDYTAAIDVW  132 (280)
Q Consensus        56 qll~al~~LH~~gi~H~di~~~nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Diw  132 (280)
                      ||+.||+|||++|++||||||+||+++.++.++|+|||++........   .....+++.|+|||.+.+ ..++.++|||
T Consensus       158 qi~~~l~~lH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~  236 (314)
T 2ivs_A          158 QISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFD-HIYTTQSDVW  236 (314)
T ss_dssp             HHHHHHHHHHHTTEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHH-CEECHHHHHH
T ss_pred             HHHHHHHHHHHCCCcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcC-CCcCchhhHH
Confidence            999999999999999999999999999999999999999986544321   223456788999998854 3478999999


Q ss_pred             HHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHH
Q 023609          133 SVGCIFMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEK  211 (280)
Q Consensus       133 slG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  211 (280)
                      |+||++|+|++ |..||.+.........+.....                             ....+.+++++.++|.+
T Consensus       237 slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~li~~  287 (314)
T 2ivs_A          237 SFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHR-----------------------------MERPDNCSEEMYRLMLQ  287 (314)
T ss_dssp             HHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC-----------------------------CCCCTTCCHHHHHHHHH
T ss_pred             HHHHHHHHHHhCCCCCCCCCCHHHHHHHhhcCCc-----------------------------CCCCccCCHHHHHHHHH
Confidence            99999999999 9999987765444333221110                             01123678999999999


Q ss_pred             hhcCCCCCCCCHHHHhcC
Q 023609          212 MLTFDPRQRITVEDALAH  229 (280)
Q Consensus       212 ~L~~dp~~R~t~~ell~h  229 (280)
                      ||+.||.+|||+.+++++
T Consensus       288 ~l~~dp~~Rps~~~l~~~  305 (314)
T 2ivs_A          288 CWKQEPDKRPVFADISKD  305 (314)
T ss_dssp             HTCSSGGGSCCHHHHHHH
T ss_pred             HccCChhhCcCHHHHHHH
Confidence            999999999999999864

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.4e-38  Score=276.82  Aligned_cols=193  Identities=27%  Similarity=0.425  Sum_probs=161.7

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCC----------------CCCHHHHHHHHHHHHHHHHHH
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ----------------ALSEEHCQYFLYQILRGLKYI   64 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~----------------~l~~~~~~~i~~qll~al~~L   64 (280)
                      +||||+++++++...     ...|+||||++ |+|.+++...+                .+++..++.++.||+.||+||
T Consensus       133 ~hpnIv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~L  207 (382)
T 3tt0_A          133 KHKNIINLLGACTQD-----GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL  207 (382)
T ss_dssp             CCTTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             CCchhhhheeeeccC-----CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHH
Confidence            799999999999765     66899999997 59999998653                499999999999999999999


Q ss_pred             HHCCceeccCCCCcEEEccCCCEEEeeccceeeccCCC---ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHH
Q 023609           65 HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL  141 (280)
Q Consensus        65 H~~gi~H~di~~~nili~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l  141 (280)
                      |+.||+||||||+||+++.++.++|+|||++.......   ......+++.|+|||++.+. .++.++||||+||++++|
T Consensus       208 H~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwslG~il~el  286 (382)
T 3tt0_A          208 ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDR-IYTHQSDVWSFGVLLWEI  286 (382)
T ss_dssp             HHTTCCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHH
T ss_pred             HhCCEecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCC-CCCchhHHHHHHHHHHHH
Confidence            99999999999999999999999999999998654332   23344567889999998654 588999999999999999


Q ss_pred             Hh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCC
Q 023609          142 MD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQR  220 (280)
Q Consensus       142 l~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R  220 (280)
                      ++ |..||.+....+....+......                             .....+++++.++|.+||+.||.+|
T Consensus       287 lt~g~~p~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~l~~li~~~l~~dP~~R  337 (382)
T 3tt0_A          287 FTLGGSPYPGVPVEELFKLLKEGHRM-----------------------------DKPSNCTNELYMMMRDCWHAVPSQR  337 (382)
T ss_dssp             HTTSCCSSTTCCHHHHHHHHHTTCCC-----------------------------CCCSSCCHHHHHHHHHHTCSSGGGS
T ss_pred             HhCCCCCCCCCCHHHHHHHHHcCCCC-----------------------------CCCccCCHHHHHHHHHHcCCChhhC
Confidence            99 99999887766554444321111                             1113678899999999999999999


Q ss_pred             CCHHHHhcC
Q 023609          221 ITVEDALAH  229 (280)
Q Consensus       221 ~t~~ell~h  229 (280)
                      ||+.+++++
T Consensus       338 ps~~ell~~  346 (382)
T 3tt0_A          338 PTFKQLVED  346 (382)
T ss_dssp             CCHHHHHHH
T ss_pred             cCHHHHHHH
Confidence            999999985

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=6.8e-39  Score=274.52  Aligned_cols=193  Identities=26%  Similarity=0.346  Sum_probs=158.2

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCC----------------CCCHHHHHHHHHHHHHHHHHH
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ----------------ALSEEHCQYFLYQILRGLKYI   64 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~----------------~l~~~~~~~i~~qll~al~~L   64 (280)
                      +||||+++++++...     ...|+||||++ |+|.+++...+                .+++..++.++.||+.||+||
T Consensus        84 ~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L  158 (327)
T 1fvr_A           84 HHPNIINLLGACEHR-----GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL  158 (327)
T ss_dssp             CCTTBCCEEEEEEET-----TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHH
T ss_pred             CCCchhhhceeeeeC-----CceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHH
Confidence            799999999999665     67999999997 59999997654                699999999999999999999


Q ss_pred             HHCCceeccCCCCcEEEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-
Q 023609           65 HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-  143 (280)
Q Consensus        65 H~~gi~H~di~~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-  143 (280)
                      |++|++||||||+||+++.++.++|+|||++.............+++.|+|||.+.+ ..++.++||||+||++|+|++ 
T Consensus       159 H~~~ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~ellt~  237 (327)
T 1fvr_A          159 SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNY-SVYTTNSDVWSYGVLLWEIVSL  237 (327)
T ss_dssp             HHTTEECSCCSGGGEEECGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHH-CEECHHHHHHHHHHHHHHHHTT
T ss_pred             HhCCccCCCCccceEEEcCCCeEEEcccCcCccccccccccCCCCCccccChhhhcc-ccCCchhcchHHHHHHHHHHcC
Confidence            999999999999999999999999999999875443333334556788999998854 347899999999999999998 


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCH
Q 023609          144 RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV  223 (280)
Q Consensus       144 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~  223 (280)
                      |..||.+....+....+.....                             ......+++++.++|.+||+.||.+|||+
T Consensus       238 g~~pf~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~  288 (327)
T 1fvr_A          238 GGTPYCGMTCAELYEKLPQGYR-----------------------------LEKPLNCDDEVYDLMRQCWREKPYERPSF  288 (327)
T ss_dssp             SCCTTTTCCHHHHHHHGGGTCC-----------------------------CCCCTTBCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             CCCCCCCCcHHHHHHHhhcCCC-----------------------------CCCCCCCCHHHHHHHHHHccCChhhCcCH
Confidence            9999988776554433321100                             01112578899999999999999999999


Q ss_pred             HHHhcC
Q 023609          224 EDALAH  229 (280)
Q Consensus       224 ~ell~h  229 (280)
                      .+++++
T Consensus       289 ~ell~~  294 (327)
T 1fvr_A          289 AQILVS  294 (327)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            999984

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=5.3e-38  Score=265.16  Aligned_cols=196  Identities=13%  Similarity=0.165  Sum_probs=159.8

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQ-ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~-~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nil   80 (280)
                      +||||+++++++...     ...|+||||++++|.+++...+ ++++..+..++.||+.||+|||++|++||||||+||+
T Consensus        64 ~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl  138 (298)
T 1csn_A           64 GCTGIPNVYYFGQEG-----LHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFL  138 (298)
T ss_dssp             TCTTCCCEEEEEEET-----TEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEE
T ss_pred             cCCCCCeEEeecCCC-----ceeEEEEEecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEE
Confidence            699999999998655     6799999999889999998654 6999999999999999999999999999999999999


Q ss_pred             EccCCC-----EEEeeccceeeccCCCc--------cccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCC
Q 023609           81 LNANCD-----LKICDFGLARVTSETDF--------MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL  147 (280)
Q Consensus        81 i~~~~~-----~~l~dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p  147 (280)
                      ++.++.     ++|+|||++........        .....+|+.|+|||++.+ ..++.++||||+||++|+|++|..|
T Consensus       139 ~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p  217 (298)
T 1csn_A          139 IGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLP  217 (298)
T ss_dssp             ECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred             eccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcC-CCCChHHHHHHHHHHHHHHHcCCCC
Confidence            987776     99999999986554321        234568999999999854 4589999999999999999999999


Q ss_pred             CCCCC---hHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHH
Q 023609          148 FPGRD---HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVE  224 (280)
Q Consensus       148 f~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~  224 (280)
                      |.+.+   .......+......++                         .....+.+++++.++|.+||+.||.+|||+.
T Consensus       218 f~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~  272 (298)
T 1csn_A          218 WQGLKAATNKQKYERIGEKKQSTP-------------------------LRELCAGFPEEFYKYMHYARNLAFDATPDYD  272 (298)
T ss_dssp             TSSCCSCCHHHHHHHHHHHHHHSC-------------------------HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHH
T ss_pred             cchhhccccHHHHHHHHhhccCcc-------------------------HHHHHhhCcHHHHHHHHHHhcCCcccCCCHH
Confidence            98743   3333333322211111                         1223347889999999999999999999999


Q ss_pred             HHhc
Q 023609          225 DALA  228 (280)
Q Consensus       225 ell~  228 (280)
                      ++++
T Consensus       273 ~l~~  276 (298)
T 1csn_A          273 YLQG  276 (298)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            9876

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.4e-38  Score=270.76  Aligned_cols=194  Identities=23%  Similarity=0.409  Sum_probs=158.5

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeec-CC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYEL-MD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~-~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      +||||+++++++...     ...++|||+ +. ++|.+++..++.+++..++.++.||+.||+|||+.|++||||||+||
T Consensus        96 ~h~~i~~~~~~~~~~-----~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Ni  170 (312)
T 2iwi_A           96 GHPGVIRLLDWFETQ-----EGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENI  170 (312)
T ss_dssp             CCSSBCCEEEEC----------CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGE
T ss_pred             CCCCeeeEEEEEecC-----CeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhE
Confidence            799999999999665     668999998 55 69999999888899999999999999999999999999999999999


Q ss_pred             EEc-cCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023609           80 LLN-ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  158 (280)
Q Consensus        80 li~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++ .++.++|+|||.+....... .....++..|+|||++.+....+.++||||+||++|+|++|..||.+...     
T Consensus       171 l~~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~-----  244 (312)
T 2iwi_A          171 LIDLRRGCAKLIDFGSGALLHDEP-YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQE-----  244 (312)
T ss_dssp             EEETTTTEEEECCCSSCEECCSSC-BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----
T ss_pred             EEeCCCCeEEEEEcchhhhcccCc-ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChHH-----
Confidence            999 78999999999998765443 34556899999999886555445689999999999999999999964211     


Q ss_pred             HHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCcC
Q 023609          159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD  237 (280)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~~  237 (280)
                       +...                      .        ....+.++.+++++|.+||+.||++|||+.++++||||+...+
T Consensus       245 -~~~~----------------------~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~  292 (312)
T 2iwi_A          245 -ILEA----------------------E--------LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAE  292 (312)
T ss_dssp             -HHHT----------------------C--------CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC---
T ss_pred             -Hhhh----------------------c--------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchh
Confidence             0000                      0        0111367889999999999999999999999999999997643

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.1e-38  Score=267.52  Aligned_cols=192  Identities=26%  Similarity=0.427  Sum_probs=148.8

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ-ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~-~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      ++||||+++++++..      +..|+||||++ ++|.+++..++ .+++..+..++.|++.||+|||+.|++||||||+|
T Consensus        73 l~h~~iv~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~N  146 (281)
T 1mp8_A           73 FDHPHIVKLIGVITE------NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARN  146 (281)
T ss_dssp             CCCTTBCCEEEEECS------SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             CCCCccceEEEEEcc------CccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHH
Confidence            579999999999843      45799999998 59999998654 69999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCCCc--cccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 023609           79 LLLNANCDLKICDFGLARVTSETDF--MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVH  155 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~  155 (280)
                      |+++.++.++|+|||++........  .....+++.|+|||.+.+. .++.++||||+||++|+|++ |..||.+....+
T Consensus       147 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~  225 (281)
T 1mp8_A          147 VLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNND  225 (281)
T ss_dssp             EEEEETTEEEECC-------------------CCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG
T ss_pred             EEECCCCCEEECccccccccCcccccccccCCCcccccChhhcccC-CCCCccCchHHHHHHHHHHhcCCCCCCcCCHHH
Confidence            9999999999999999976544321  2234457789999988544 47899999999999999996 999998776655


Q ss_pred             HHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          156 QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                      ....+......                             ...+.+++++.++|.+||+.||.+|||+.++++
T Consensus       226 ~~~~i~~~~~~-----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  269 (281)
T 1mp8_A          226 VIGRIENGERL-----------------------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA  269 (281)
T ss_dssp             HHHHHHTTCCC-----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHcCCCC-----------------------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            44443221110                             112367899999999999999999999999876

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-38  Score=273.24  Aligned_cols=193  Identities=22%  Similarity=0.318  Sum_probs=159.1

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC------------------------CCCCHHHHHHHHH
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN------------------------QALSEEHCQYFLY   55 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~------------------------~~l~~~~~~~i~~   55 (280)
                      |+||||+++++++...     ...|+||||++ |+|.+++...                        ..+++.+++.++.
T Consensus       107 l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~  181 (343)
T 1luf_A          107 FDNPNIVKLLGVCAVG-----KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIAR  181 (343)
T ss_dssp             CCCTTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHH
T ss_pred             CCCCCEEEEEEEEccC-----CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHH
Confidence            5899999999999765     67899999997 5999999763                        5699999999999


Q ss_pred             HHHHHHHHHHHCCceeccCCCCcEEEccCCCEEEeeccceeeccCC---CccccceeccccccchhccCCCCCCcchhHH
Q 023609           56 QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET---DFMTEYVVTRWYRAPELLLNSSDYTAAIDVW  132 (280)
Q Consensus        56 qll~al~~LH~~gi~H~di~~~nili~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Diw  132 (280)
                      ||+.||+|||++|++||||||+||+++.++.++|+|||++......   .......+++.|+|||++.+. .++.++|||
T Consensus       182 qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~  260 (343)
T 1luf_A          182 QVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN-RYTTESDVW  260 (343)
T ss_dssp             HHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHC-CCCHHHHHH
T ss_pred             HHHHHHHHHHhCCeecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccC-CcCcccccH
Confidence            9999999999999999999999999999999999999998754322   122345678889999988644 488999999


Q ss_pred             HHHHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHH
Q 023609          133 SVGCIFMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEK  211 (280)
Q Consensus       133 slG~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  211 (280)
                      |+||++|+|++ |..||.+....+....+......                             ..-+.+++++.++|++
T Consensus       261 slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~l~~li~~  311 (343)
T 1luf_A          261 AYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNIL-----------------------------ACPENCPLELYNLMRL  311 (343)
T ss_dssp             HHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC-----------------------------CCCTTCCHHHHHHHHH
T ss_pred             HHHHHHHHHHhcCCCcCCCCChHHHHHHHhCCCcC-----------------------------CCCCCCCHHHHHHHHH
Confidence            99999999998 99999887766554443321100                             1113678899999999


Q ss_pred             hhcCCCCCCCCHHHHhc
Q 023609          212 MLTFDPRQRITVEDALA  228 (280)
Q Consensus       212 ~L~~dp~~R~t~~ell~  228 (280)
                      ||+.||.+|||+.++++
T Consensus       312 ~l~~~p~~Rps~~~~~~  328 (343)
T 1luf_A          312 CWSKLPADRPSFCSIHR  328 (343)
T ss_dssp             HTCSSGGGSCCHHHHHH
T ss_pred             HcccCcccCCCHHHHHH
Confidence            99999999999999986

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.4e-38  Score=272.38  Aligned_cols=193  Identities=22%  Similarity=0.321  Sum_probs=156.6

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      ++||||+++++++..      ...++||||+. |+|.+++... +.+++..+..++.||+.||+|||+.||+||||||+|
T Consensus        72 l~h~~iv~~~~~~~~------~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~N  145 (325)
T 3kex_A           72 LDHAHIVRLLGLCPG------SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARN  145 (325)
T ss_dssp             CCCTTBCCEEEEECB------SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTT
T ss_pred             CCCCCcCeEEEEEcC------CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchhe
Confidence            589999999999843      45899999997 6999999864 579999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCCC---ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 023609           79 LLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHV  154 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~  154 (280)
                      |+++.++.++|+|||+++......   ......++..|+|||++.+. .++.++||||+||++|+|++ |..||.+....
T Consensus       146 il~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~  224 (325)
T 3kex_A          146 VLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFG-KYTHQSDVWSYGVTVWELMTFGAEPYAGLRLA  224 (325)
T ss_dssp             EEESSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTT
T ss_pred             EEECCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccC-CCChhhHhHHhHHHHHHHHhCCCCCccccCHH
Confidence            999999999999999998654332   22344567789999998544 48999999999999999999 99999877655


Q ss_pred             HHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 023609          155 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  229 (280)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h  229 (280)
                      +....+......                             .....++.++.++|.+||+.||.+|||+.+++++
T Consensus       225 ~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          225 EVPDLLEKGERL-----------------------------AQPQICTIDVYMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             HHHHHHHTTCBC-----------------------------CCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             HHHHHHHcCCCC-----------------------------CCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            544333221100                             1112456788999999999999999999999985

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.6e-38  Score=272.62  Aligned_cols=195  Identities=26%  Similarity=0.399  Sum_probs=158.9

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCC-----------------------CCCHHHHHHHHHHH
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ-----------------------ALSEEHCQYFLYQI   57 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~-----------------------~l~~~~~~~i~~ql   57 (280)
                      +||||+++++++...     ...|+||||++ |+|.+++....                       .+++..++.++.||
T Consensus       107 ~hp~iv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi  181 (344)
T 1rjb_A          107 SHENIVNLLGACTLS-----GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQV  181 (344)
T ss_dssp             CCTTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHH
T ss_pred             CCCCeeeEEEEEeeC-----CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHH
Confidence            799999999999765     66899999997 69999997643                       37999999999999


Q ss_pred             HHHHHHHHHCCceeccCCCCcEEEccCCCEEEeeccceeeccCCC---ccccceeccccccchhccCCCCCCcchhHHHH
Q 023609           58 LRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV  134 (280)
Q Consensus        58 l~al~~LH~~gi~H~di~~~nili~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Diwsl  134 (280)
                      +.||+|||+.||+||||||+||+++.++.++|+|||++.......   ......+++.|+|||++.+. .++.++||||+
T Consensus       182 ~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~sl  260 (344)
T 1rjb_A          182 AKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG-IYTIKSDVWSY  260 (344)
T ss_dssp             HHHHHHHHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHH
T ss_pred             HHHHHHHHhCCcccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccC-CCChhHhHHHH
Confidence            999999999999999999999999999999999999997654332   12344567889999988544 48899999999


Q ss_pred             HHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhh
Q 023609          135 GCIFMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKML  213 (280)
Q Consensus       135 G~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  213 (280)
                      ||++|+|++ |..||.+.........+......+                            .....+++++.++|.+||
T Consensus       261 G~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~~l  312 (344)
T 1rjb_A          261 GILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKM----------------------------DQPFYATEEIYIIMQSCW  312 (344)
T ss_dssp             HHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCC----------------------------CCCTTCCHHHHHHHHHHT
T ss_pred             HHHHHHHHcCCCCCcccCCcHHHHHHHHhcCCCC----------------------------CCCCCCCHHHHHHHHHHc
Confidence            999999998 999998765444333332211111                            111256889999999999


Q ss_pred             cCCCCCCCCHHHHhcCC
Q 023609          214 TFDPRQRITVEDALAHP  230 (280)
Q Consensus       214 ~~dp~~R~t~~ell~h~  230 (280)
                      +.||.+|||+.+++++-
T Consensus       313 ~~dp~~Rps~~~l~~~l  329 (344)
T 1rjb_A          313 AFDSRKRPSFPNLTSFL  329 (344)
T ss_dssp             CSSGGGSCCHHHHHHHH
T ss_pred             CCCchhCcCHHHHHHHH
Confidence            99999999999999854

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=9.3e-38  Score=267.82  Aligned_cols=195  Identities=16%  Similarity=0.222  Sum_probs=157.6

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nil   80 (280)
                      +||||+++++++...     ...|+||||++++|.+++.. ++.+++..+..++.||+.||+|||+.||+||||||+||+
T Consensus        63 ~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nil  137 (330)
T 2izr_A           63 SGDGIPQVYYFGPCG-----KYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFL  137 (330)
T ss_dssp             SCTTSCCEEEEEEET-----TEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred             CCCCCCEEEEEEecC-----CccEEEEEeCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHee
Confidence            799999999999765     67899999998899999986 467999999999999999999999999999999999999


Q ss_pred             EccCCC-----EEEeeccceeeccCCCc--------cccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCC
Q 023609           81 LNANCD-----LKICDFGLARVTSETDF--------MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL  147 (280)
Q Consensus        81 i~~~~~-----~~l~dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p  147 (280)
                      ++.++.     ++|+|||++........        .....||+.|+|||++.+ ..++.++|||||||++|+|++|..|
T Consensus       138 l~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~ell~g~~P  216 (330)
T 2izr_A          138 IGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLG-KEQSRRDDLEALGHMFMYFLRGSLP  216 (330)
T ss_dssp             ECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred             eccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcC-CCCCchhHHHHHHHHHHHHhcCCCC
Confidence            998877     99999999986544321        235678999999999865 4589999999999999999999999


Q ss_pred             CCCCCh---HHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHH
Q 023609          148 FPGRDH---VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVE  224 (280)
Q Consensus       148 f~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~  224 (280)
                      |.+.+.   .+....+.......+.                         ....+.++ ++.++|..||+.||.+||++.
T Consensus       217 f~~~~~~~~~~~~~~i~~~~~~~~~-------------------------~~~~~~~p-~~~~li~~~l~~~p~~RP~~~  270 (330)
T 2izr_A          217 WQGLKADTLKERYQKIGDTKRATPI-------------------------EVLCENFP-EMATYLRYVRRLDFFEKPDYD  270 (330)
T ss_dssp             TTTCCCSSHHHHHHHHHHHHHHSCH-------------------------HHHTTTCH-HHHHHHHHHHHCCTTCCCCHH
T ss_pred             ccccccccHHHHHHHHHhhhccCCH-------------------------HHHhccCh-HHHHHHHHHHhCCCCCCCCHH
Confidence            987432   2333333221111110                         01112344 899999999999999999998


Q ss_pred             HHhc
Q 023609          225 DALA  228 (280)
Q Consensus       225 ell~  228 (280)
                      ++++
T Consensus       271 ~l~~  274 (330)
T 2izr_A          271 YLRK  274 (330)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            8876

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=1.3e-38  Score=267.92  Aligned_cols=190  Identities=15%  Similarity=0.255  Sum_probs=154.6

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCC-CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQA-LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~-l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      ++||||+++++++...     ...|+||||++ |+|.+++...+. +++..+..++.||+.||+|||++|++||||||+|
T Consensus        69 l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~N  143 (289)
T 4fvq_A           69 LSHKHLVLNYGVCVCG-----DENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKN  143 (289)
T ss_dssp             SCCTTBCCEEEEECCT-----TCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGG
T ss_pred             CCCCCEeEEEEEEEeC-----CCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcce
Confidence            5899999999999765     56799999997 699999987654 9999999999999999999999999999999999


Q ss_pred             EEEccCCC--------EEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhC-CCCCC
Q 023609           79 LLLNANCD--------LKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR-KPLFP  149 (280)
Q Consensus        79 ili~~~~~--------~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g-~~pf~  149 (280)
                      |+++.++.        ++|+|||.+......   ....+++.|+|||++.+...++.++||||+||++|+|++| .+||.
T Consensus       144 Ill~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~  220 (289)
T 4fvq_A          144 ILLIREEDRKTGNPPFIKLSDPGISITVLPK---DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLS  220 (289)
T ss_dssp             EEEEECCBGGGTBCCEEEECCCCSCTTTSCH---HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred             EEEecCCcccccccceeeeccCcccccccCc---cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCcc
Confidence            99998887        999999998654332   2345788899999987645689999999999999999995 45555


Q ss_pred             CCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 023609          150 GRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  229 (280)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h  229 (280)
                      ...............                               ...+..++++.++|.+||+.||.+|||+.+++++
T Consensus       221 ~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  269 (289)
T 4fvq_A          221 ALDSQRKLQFYEDRH-------------------------------QLPAPKAAELANLINNCMDYEPDHRPSFRAIIRD  269 (289)
T ss_dssp             TSCHHHHHHHHHTTC-------------------------------CCCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             ccchHHHHHHhhccC-------------------------------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            444333222211100                               1112457789999999999999999999999985

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=3.8e-38  Score=267.86  Aligned_cols=194  Identities=27%  Similarity=0.379  Sum_probs=159.4

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCC------------------CCCHHHHHHHHHHHHHHHH
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ------------------ALSEEHCQYFLYQILRGLK   62 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~------------------~l~~~~~~~i~~qll~al~   62 (280)
                      +||||+++++++...     ...++||||++ |+|.+++...+                  .+++..++.++.||+.||+
T Consensus        85 ~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~  159 (313)
T 1t46_A           85 NHMNIVNLLGACTIG-----GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMA  159 (313)
T ss_dssp             CCTTBCCEEEEECSS-----SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHH
T ss_pred             cCCCeeeEEEEEecC-----CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHH
Confidence            799999999999765     66899999997 59999997653                  4999999999999999999


Q ss_pred             HHHHCCceeccCCCCcEEEccCCCEEEeeccceeeccCCCc---cccceeccccccchhccCCCCCCcchhHHHHHHHHH
Q 023609           63 YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFM  139 (280)
Q Consensus        63 ~LH~~gi~H~di~~~nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~  139 (280)
                      |||++|++||||||+||+++.++.++|+|||.+........   .....+++.|+|||.+.+. .++.++||||+||+++
T Consensus       160 ~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~  238 (313)
T 1t46_A          160 FLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLW  238 (313)
T ss_dssp             HHHHTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHH
T ss_pred             HHHHCCeecCCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCC-CCChHHHHHHHHHHHH
Confidence            99999999999999999999999999999999986544321   2234567889999988544 5889999999999999


Q ss_pred             HHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCC
Q 023609          140 ELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPR  218 (280)
Q Consensus       140 ~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~  218 (280)
                      +|++ |..||.+................+.                            ..+.++.++.++|.+||+.||.
T Consensus       239 ellt~g~~p~~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~l~~li~~~l~~dp~  290 (313)
T 1t46_A          239 ELFSLGSSPYPGMPVDSKFYKMIKEGFRML----------------------------SPEHAPAEMYDIMKTCWDADPL  290 (313)
T ss_dssp             HHHTTTCCSSTTCCSSHHHHHHHHHTCCCC----------------------------CCTTSCHHHHHHHHHHTCSSGG
T ss_pred             HHHhCCCCCCCcccchhHHHHHhccCCCCC----------------------------CcccCCHHHHHHHHHHcCCCch
Confidence            9998 9999987664443333322211110                            1135788999999999999999


Q ss_pred             CCCCHHHHhcC
Q 023609          219 QRITVEDALAH  229 (280)
Q Consensus       219 ~R~t~~ell~h  229 (280)
                      +|||+.+++++
T Consensus       291 ~Rps~~ell~~  301 (313)
T 1t46_A          291 KRPTFKQIVQL  301 (313)
T ss_dssp             GSCCHHHHHHH
T ss_pred             hCcCHHHHHHH
Confidence            99999999874

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=3.6e-38  Score=275.24  Aligned_cols=193  Identities=23%  Similarity=0.374  Sum_probs=158.3

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ-ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~-~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      ++||||+++++++...     ...|+||||++ |+|.+++...+ .+++..+..++.||+.||+|||++|++||||||+|
T Consensus       169 l~hpniv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~N  243 (377)
T 3cbl_A          169 YSHPNIVRLIGVCTQK-----QPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARN  243 (377)
T ss_dssp             CCCTTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred             CCCCCEEEEEEEEecC-----CCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHH
Confidence            5899999999999665     56899999997 69999997643 69999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCCCc---cccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 023609           79 LLLNANCDLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHV  154 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~  154 (280)
                      |+++.++.++|+|||+++.......   .....++..|+|||++... .++.++||||+||++|+|++ |..||.+.+..
T Consensus       244 il~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~DvwslG~il~el~t~g~~p~~~~~~~  322 (377)
T 3cbl_A          244 CLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYG-RYSSESDVWSFGILLWETFSLGASPYPNLSNQ  322 (377)
T ss_dssp             EEECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHH
T ss_pred             EEEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            9999999999999999986543321   1123456789999988543 47899999999999999998 99999887765


Q ss_pred             HHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          155 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                      +....+......+                             ....+++++.++|.+||+.||.+|||+.++++
T Consensus       323 ~~~~~~~~~~~~~-----------------------------~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          323 QTREFVEKGGRLP-----------------------------CPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             HHHHHHHTTCCCC-----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHcCCCCC-----------------------------CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            5544332211111                             11256789999999999999999999999875

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=3.9e-38  Score=268.10  Aligned_cols=199  Identities=21%  Similarity=0.305  Sum_probs=153.2

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHH------cCCCCCHHHHHHHHHHHHHHHHHHHHCCceecc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIR------SNQALSEEHCQYFLYQILRGLKYIHSANVLHRD   73 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~------~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~d   73 (280)
                      ++||||+++++++......+....|+||||++ |+|.+++.      ..+.+++..++.++.||+.||.|||+.|++|||
T Consensus        93 l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~d  172 (313)
T 3brb_A           93 FSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRD  172 (313)
T ss_dssp             CCCTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCC
T ss_pred             CCCCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence            58999999999997764433346799999998 59999984      335699999999999999999999999999999


Q ss_pred             CCCCcEEEccCCCEEEeeccceeeccCCC---ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCCC
Q 023609           74 LKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFP  149 (280)
Q Consensus        74 i~~~nili~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~  149 (280)
                      |||+||+++.++.++|+|||++.......   ......+++.|+|||.+.+ ..++.++||||+||++|+|++ |..||.
T Consensus       173 ikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~  251 (313)
T 3brb_A          173 LAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLAD-RVYTSKSDVWAFGVTMWEIATRGMTPYP  251 (313)
T ss_dssp             CSGGGEEECTTSCEEECSCSCC----------------CCGGGSCHHHHHS-SCCCHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             CCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcC-CCccchhhhHHHHHHHHHHHhcCCCCCc
Confidence            99999999999999999999987654332   1223456778999999854 458899999999999999999 889998


Q ss_pred             CCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 023609          150 GRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  229 (280)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h  229 (280)
                      +.........+......                             ...+.+++++.++|.+||+.||.+|||+.+++++
T Consensus       252 ~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          252 GVQNHEMYDYLLHGHRL-----------------------------KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             TCCGGGHHHHHHTTCCC-----------------------------CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             cCCHHHHHHHHHcCCCC-----------------------------CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            77665544433221111                             1123678899999999999999999999999864

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=9.5e-38  Score=265.41  Aligned_cols=200  Identities=25%  Similarity=0.418  Sum_probs=158.0

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      |+||||+++++++...     ...++||||++ |+|.+++.. .+.+++.++..++.||+.||+|||+.|++||||||+|
T Consensus        64 l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~N  138 (310)
T 3s95_A           64 LEHPNVLKFIGVLYKD-----KRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHN  138 (310)
T ss_dssp             CCCTTBCCEEEEEEET-----TEEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTS
T ss_pred             CCCcCcccEEEEEecC-----CeeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCe
Confidence            5899999999999765     67999999997 599999987 5679999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCCCcc---------------ccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh
Q 023609           79 LLLNANCDLKICDFGLARVTSETDFM---------------TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD  143 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~~~~---------------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~  143 (280)
                      |+++.++.++|+|||.+.........               ....+|+.|+|||++.+ ..++.++||||+|+++|+|++
T Consensus       139 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~~l~el~~  217 (310)
T 3s95_A          139 CLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIG  217 (310)
T ss_dssp             EEECTTSCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTT-CCCCTHHHHHHHHHHHHHHHH
T ss_pred             EEECCCCCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcC-CCCCcHHHHHHHHHHHHHHhc
Confidence            99999999999999999765433211               14568999999999854 458899999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCH
Q 023609          144 RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV  223 (280)
Q Consensus       144 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~  223 (280)
                      |..||........            .  .   .........          ....+.+++.+.++|.+||+.||.+|||+
T Consensus       218 g~~~~~~~~~~~~------------~--~---~~~~~~~~~----------~~~~~~~~~~l~~li~~~l~~dP~~Rps~  270 (310)
T 3s95_A          218 RVNADPDYLPRTM------------D--F---GLNVRGFLD----------RYCPPNCPPSFFPITVRCCDLDPEKRPSF  270 (310)
T ss_dssp             TCCSSTTTSCBCT------------T--S---SBCHHHHHH----------HTCCTTCCTTHHHHHHHHTCSSGGGSCCH
T ss_pred             CCCCCcchhhhHH------------H--H---hhhhhcccc----------ccCCCCCCHHHHHHHHHHccCChhhCcCH
Confidence            9998864321100            0  0   000000000          01124678899999999999999999999


Q ss_pred             HHHhcCCCCCCC
Q 023609          224 EDALAHPYLGSL  235 (280)
Q Consensus       224 ~ell~h~~~~~~  235 (280)
                      .++++  +++.+
T Consensus       271 ~~l~~--~L~~l  280 (310)
T 3s95_A          271 VKLEH--WLETL  280 (310)
T ss_dssp             HHHHH--HHHHH
T ss_pred             HHHHH--HHHHH
Confidence            99987  55554

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1e-37  Score=259.78  Aligned_cols=193  Identities=16%  Similarity=0.277  Sum_probs=158.7

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ--ALSEEHCQYFLYQILRGLKYIHSAN--VLHRDLK   75 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~--~l~~~~~~~i~~qll~al~~LH~~g--i~H~di~   75 (280)
                      ++||||+++++++..+..   ...++||||++ |+|.+++...+  .+++..++.++.||+.||+|||+.|  ++|||||
T Consensus        64 l~h~~iv~~~~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dik  140 (271)
T 3kmu_A           64 FSHPNVLPVLGACQSPPA---PHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALN  140 (271)
T ss_dssp             CSCTTEECEEEEECTTTS---SSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCS
T ss_pred             cCCCchhheEEEEccCCC---CCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCc
Confidence            579999999999966532   56899999998 59999998765  4999999999999999999999999  9999999


Q ss_pred             CCcEEEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCC--CCcchhHHHHHHHHHHHHhCCCCCCCCCh
Q 023609           76 PSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSD--YTAAIDVWSVGCIFMELMDRKPLFPGRDH  153 (280)
Q Consensus        76 ~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~--~~~~~DiwslG~il~~ll~g~~pf~~~~~  153 (280)
                      |+||+++.++.++++|||++.....    ....+|+.|+|||.+.+...  ++.++||||+||++|+|++|..||.+.+.
T Consensus       141 p~Nil~~~~~~~~l~~~~~~~~~~~----~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~  216 (271)
T 3kmu_A          141 SRSVMIDEDMTARISMADVKFSFQS----PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN  216 (271)
T ss_dssp             GGGEEECTTSCEEEEGGGSCCTTSC----TTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH
T ss_pred             cceEEEcCCcceeEEeccceeeecc----cCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh
Confidence            9999999999999999887654332    24567899999999865432  23379999999999999999999988776


Q ss_pred             HHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          154 VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                      ......+......+                            ...+.+++++.++|.+||+.||.+|||+.++++
T Consensus       217 ~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (271)
T 3kmu_A          217 MEIGMKVALEGLRP----------------------------TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP  263 (271)
T ss_dssp             HHHHHHHHHSCCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHhcCCCC----------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            66544443222111                            112367899999999999999999999999985

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=3.5e-38  Score=270.23  Aligned_cols=193  Identities=23%  Similarity=0.315  Sum_probs=157.0

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      ++||||+++++++...      ..++|++++. |+|.+++.. ++.+++..+..++.||+.||+|||++||+||||||+|
T Consensus        74 l~h~~iv~~~~~~~~~------~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~N  147 (327)
T 3poz_A           74 VDNPHVCRLLGICLTS------TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARN  147 (327)
T ss_dssp             CCBTTBCCEEEEEESS------SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred             CCCCCEeEEEEEEecC------CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChhe
Confidence            5899999999999653      3788899987 799999986 4579999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCCCc---cccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 023609           79 LLLNANCDLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHV  154 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~  154 (280)
                      |+++.++.++|+|||+++.......   .....+++.|+|||.+.+. .++.++||||+||++|+|++ |..||.+....
T Consensus       148 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~~  226 (327)
T 3poz_A          148 VLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS  226 (327)
T ss_dssp             EEEEETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG
T ss_pred             EEECCCCCEEEccCcceeEccCCcccccccCCCccccccChHHhccC-CCCchhhhhhhHHHHHHHHhcCCCCccCCCHH
Confidence            9999999999999999986544322   2233457789999998654 58999999999999999999 99999877655


Q ss_pred             HHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 023609          155 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  229 (280)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h  229 (280)
                      .....+......                             ...+.++.++.+++.+||+.||.+|||+.+++++
T Consensus       227 ~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          227 EISSILEKGERL-----------------------------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             GHHHHHHTTCCC-----------------------------CCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             HHHHHHHcCCCC-----------------------------CCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence            443333221111                             1123567899999999999999999999999875

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=1.2e-38  Score=272.46  Aligned_cols=217  Identities=24%  Similarity=0.304  Sum_probs=157.4

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC----------Cc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA----------NV   69 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~----------gi   69 (280)
                      |+||||+++++++..... ....+|+||||++ |+|.+++..+ .+++..++.++.||+.||+|||+.          ||
T Consensus        75 l~hpniv~~~~~~~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~i  152 (322)
T 3soc_A           75 MKHENILQFIGAEKRGTS-VDVDLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAI  152 (322)
T ss_dssp             CCCTTBCCEEEEEEEECS-SSEEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEE
T ss_pred             CCCCCchhhcceeccCCC-CCceEEEEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCE
Confidence            579999999999976431 1245899999997 5999999764 599999999999999999999999          99


Q ss_pred             eeccCCCCcEEEccCCCEEEeeccceeeccCCCc---cccceeccccccchhccCCC----CCCcchhHHHHHHHHHHHH
Q 023609           70 LHRDLKPSNLLLNANCDLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNSS----DYTAAIDVWSVGCIFMELM  142 (280)
Q Consensus        70 ~H~di~~~nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~----~~~~~~DiwslG~il~~ll  142 (280)
                      +||||||+||+++.++.+||+|||++........   .....+|+.|+|||++.+..    .++.++||||+||++|+|+
T Consensus       153 vH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~  232 (322)
T 3soc_A          153 SHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELA  232 (322)
T ss_dssp             ECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             EeCCCChHhEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHH
Confidence            9999999999999999999999999976544321   23357899999999986532    3456789999999999999


Q ss_pred             hCCCCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCC--CCChHHHHHHHHhhcCCCCCC
Q 023609          143 DRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP--NVHPSAIDLVEKMLTFDPRQR  220 (280)
Q Consensus       143 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~L~~dp~~R  220 (280)
                      +|+.||.+................+......       ......  .........++  ..++++.+||.+||+.||++|
T Consensus       233 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~--~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~R  303 (322)
T 3soc_A          233 SRCTAADGPVDEYMLPFEEEIGQHPSLEDMQ-------EVVVHK--KKRPVLRDYWQKHAGMAMLCETIEECWDHDAEAR  303 (322)
T ss_dssp             TTBTTSSSCCCCCCCTTHHHHCSSCCHHHHH-------HHHTTS--CCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGS
T ss_pred             hCCCCCCCCcchhccchhhhhccCCchhhhh-------hhhhcc--cCCCCccccccccchHHHHHHHHHHHccCChhhC
Confidence            9999997654322111111112222221111       000000  00001111111  123459999999999999999


Q ss_pred             CCHHHHhc
Q 023609          221 ITVEDALA  228 (280)
Q Consensus       221 ~t~~ell~  228 (280)
                      ||+.++++
T Consensus       304 ps~~ell~  311 (322)
T 3soc_A          304 LSAGCVGE  311 (322)
T ss_dssp             CCHHHHHH
T ss_pred             cCHHHHHH
Confidence            99999985

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1.1e-37  Score=262.72  Aligned_cols=192  Identities=21%  Similarity=0.315  Sum_probs=158.5

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++. .     ...|+||||++ ++|.+++..++.+++..+..++.||+.||+|||+.|++||||||+||
T Consensus        75 l~h~~i~~~~~~~~-~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Ni  148 (291)
T 1xbb_A           75 LDNPYIVRMIGICE-A-----ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNV  148 (291)
T ss_dssp             CCCTTBCCEEEEEE-S-----SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred             CCCCCEEEEEEEEC-C-----CCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceE
Confidence            58999999999983 2     56899999997 69999999888899999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCCc----cccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 023609           80 LLNANCDLKICDFGLARVTSETDF----MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHV  154 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~  154 (280)
                      +++.++.++|+|||++........    .....+++.|+|||.+.+. .++.++||||+|+++|+|++ |..||.+.+..
T Consensus       149 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~  227 (291)
T 1xbb_A          149 LLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS  227 (291)
T ss_dssp             EEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH
T ss_pred             EEeCCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccC-CCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence            999999999999999986544321    1223456789999998543 47889999999999999999 99999887765


Q ss_pred             HHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          155 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                      +....+......                             ...+.+++++.++|.+||+.||.+|||+.++++
T Consensus       228 ~~~~~~~~~~~~-----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          228 EVTAMLEKGERM-----------------------------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             HHHHHHHTTCCC-----------------------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHcCCCC-----------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            544433221100                             112367889999999999999999999999885

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=6.9e-38  Score=273.02  Aligned_cols=193  Identities=24%  Similarity=0.381  Sum_probs=149.2

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ-ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~-~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      |+||||+++++++...     ...|+||||++ |+|.+++...+ .+++.++..++.||+.||+|||+.||+||||||+|
T Consensus       103 l~h~niv~~~~~~~~~-----~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~N  177 (373)
T 2qol_A          103 FDHPNIIRLEGVVTKS-----KPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARN  177 (373)
T ss_dssp             CCCTTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred             CCCCCCCeEEEEEeeC-----CceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcce
Confidence            5899999999999665     67899999996 69999998654 69999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCCCc----cccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCh
Q 023609           79 LLLNANCDLKICDFGLARVTSETDF----MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDH  153 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~  153 (280)
                      |+++.++.++|+|||++........    .....++..|+|||++.+. .++.++||||+||++|+|++ |..||.+.+.
T Consensus       178 Ill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~  256 (373)
T 2qol_A          178 ILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYR-KFTSASDVWSYGIVLWEVMSYGERPYWEMSN  256 (373)
T ss_dssp             EEECTTCCEEECCC----------------------CTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH
T ss_pred             EEEcCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhccC-CcCchhcHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            9999999999999999976543321    1122346789999998544 58899999999999999997 9999987776


Q ss_pred             HHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          154 VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                      .+....+......+                             ....++..+.++|.+||+.||.+|||+.++++
T Consensus       257 ~~~~~~i~~~~~~~-----------------------------~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          257 QDVIKAVDEGYRLP-----------------------------PPMDCPAALYQLMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             HHHHHHHHTTEECC-----------------------------CCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHcCCCCC-----------------------------CCccccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence            65544433211111                             11256788999999999999999999999876

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-37  Score=266.78  Aligned_cols=194  Identities=24%  Similarity=0.377  Sum_probs=155.1

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      |+||||+++++++...     ...++||||++ |+|.+++... +.+++..+..++.||+.||+|||+.|++||||||+|
T Consensus       103 l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~N  177 (333)
T 1mqb_A          103 FSHHNIIRLEGVISKY-----KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARN  177 (333)
T ss_dssp             CCCTTBCCEEEEECSS-----SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred             CCCCCCCcEEEEEecC-----CCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhe
Confidence            5899999999999665     67999999997 5999999764 579999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCCC----ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCh
Q 023609           79 LLLNANCDLKICDFGLARVTSETD----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDH  153 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~  153 (280)
                      |+++.++.++|+|||.+.......    ......+++.|+|||++.+. .++.++||||+||++|+|++ |..||.+...
T Consensus       178 Il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~pf~~~~~  256 (333)
T 1mqb_A          178 ILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR-KFTSASDVWSFGIVMWEVMTYGERPYWELSN  256 (333)
T ss_dssp             EEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred             EEECCCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccC-CCCchhhhHHHHHHHHHHHcCCCCCcccCCH
Confidence            999999999999999997654331    11223456789999998544 48899999999999999998 9999988776


Q ss_pred             HHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 023609          154 VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  229 (280)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h  229 (280)
                      .+....+......+                             ....++..+.++|.+||+.||.+|||+.+++++
T Consensus       257 ~~~~~~~~~~~~~~-----------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  303 (333)
T 1mqb_A          257 HEVMKAINDGFRLP-----------------------------TPMDCPSAIYQLMMQCWQQERARRPKFADIVSI  303 (333)
T ss_dssp             HHHHHHHHTTCCCC-----------------------------CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             HHHHHHHHCCCcCC-----------------------------CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            65554443221111                             112578899999999999999999999999874

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=7.8e-38  Score=260.11  Aligned_cols=194  Identities=21%  Similarity=0.332  Sum_probs=159.9

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      ++||||+++++++...     ...|+||||++ ++|.+++... +.+++..+..++.|++.||+|||+.|++|+||||+|
T Consensus        60 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~N  134 (267)
T 3t9t_A           60 LSHPKLVQLYGVCLEQ-----APICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARN  134 (267)
T ss_dssp             CCCTTBCCEEEEECSS-----SSCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGG
T ss_pred             CCCCCEeeEEEEEccC-----CCeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchhe
Confidence            5899999999999765     66899999997 6999999865 569999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCCC--ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 023609           79 LLLNANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVH  155 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~  155 (280)
                      |+++.++.++|+|||.+.......  ......++..|+|||++.+. .++.++|+||+|+++|+|++ |..||.+.....
T Consensus       135 ili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~  213 (267)
T 3t9t_A          135 CLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE  213 (267)
T ss_dssp             EEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred             EEECCCCCEEEcccccccccccccccccccccccccccChhhhcCC-CccchhchhhhHHHHHHHhccCCCCCCCCCHHH
Confidence            999999999999999987653321  12234567789999998544 47899999999999999999 899998877665


Q ss_pred             HHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 023609          156 QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  229 (280)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h  229 (280)
                      ....+.......                             ....+++.+.++|.+||+.||.+|||+.+++++
T Consensus       214 ~~~~i~~~~~~~-----------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          214 VVEDISTGFRLY-----------------------------KPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             HHHHHHTTCCCC-----------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHhcCCcCC-----------------------------CCccCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            554443211110                             112467889999999999999999999999863

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.8e-37  Score=261.25  Aligned_cols=198  Identities=21%  Similarity=0.330  Sum_probs=151.0

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      ++||||++++++...      ...++||||++ ++|.+++.. ...+++..+..++.||+.||+|||+.|++||||||+|
T Consensus        77 l~h~~iv~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~N  150 (289)
T 3og7_A           77 TRHVNILLFMGYSTA------PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNN  150 (289)
T ss_dssp             CCCTTBCCEEEEECS------SSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred             CCCCcEEEEEeeccC------CccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccce
Confidence            589999999997632      45799999998 699999964 4569999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCC---Cccccceeccccccchhcc--CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh
Q 023609           79 LLLNANCDLKICDFGLARVTSET---DFMTEYVVTRWYRAPELLL--NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDH  153 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~--~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~  153 (280)
                      |+++.++.++|+|||++......   .......+++.|+|||.+.  ....++.++||||+|+++++|++|..||.+...
T Consensus       151 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~  230 (289)
T 3og7_A          151 IFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINN  230 (289)
T ss_dssp             EEEETTTEEEECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred             EEECCCCCEEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccch
Confidence            99999999999999998754321   2233456899999999885  234578899999999999999999999988766


Q ss_pred             HHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          154 VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                      .............++                        ......+.+++++.+||.+||+.||.+|||+.++++
T Consensus       231 ~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  281 (289)
T 3og7_A          231 RDQIIEMVGRGSLSP------------------------DLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA  281 (289)
T ss_dssp             HHHHHHHHHHTSCCC------------------------CTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHhcccccCc------------------------chhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            555444433322111                        112233467899999999999999999999999985

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=9e-38  Score=260.37  Aligned_cols=193  Identities=26%  Similarity=0.390  Sum_probs=150.8

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN---VLHRDLKP   76 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~g---i~H~di~~   76 (280)
                      ++||||+++++++...     ...|+||||++ ++|.+++. ++.+++..++.++.|++.||+|||+.|   ++||||||
T Consensus        63 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp  136 (271)
T 3dtc_A           63 LKHPNIIALRGVCLKE-----PNLCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKS  136 (271)
T ss_dssp             CCCTTBCCEEEEECCC-------CEEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSG
T ss_pred             cCCCCEeeEEEEEecC-----CceEEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCch
Confidence            5899999999999765     66899999997 68988885 467999999999999999999999999   89999999


Q ss_pred             CcEEEcc--------CCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 023609           77 SNLLLNA--------NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF  148 (280)
Q Consensus        77 ~nili~~--------~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf  148 (280)
                      +||+++.        ++.++|+|||.+....... .....+++.|+|||.+.+. .++.++||||+|+++++|++|..||
T Consensus       137 ~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~p~  214 (271)
T 3dtc_A          137 SNILILQKVENGDLSNKILKITDFGLAREWHRTT-KMSAAGAYAWMAPEVIRAS-MFSKGSDVWSYGVLLWELLTGEVPF  214 (271)
T ss_dssp             GGEEESSCCSSSCCSSCCEEECCCCC--------------CCGGGSCHHHHHHC-CCSHHHHHHHHHHHHHHHHHCCCTT
T ss_pred             HHEEEecccccccccCcceEEccCCccccccccc-ccCCCCccceeCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCC
Confidence            9999986        7789999999997654432 2345789999999988544 4789999999999999999999999


Q ss_pred             CCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          149 PGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       149 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                      .+.+.......+......+                            .....+++.+.++|.+||+.||.+|||+.++++
T Consensus       215 ~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  266 (271)
T 3dtc_A          215 RGIDGLAVAYGVAMNKLAL----------------------------PIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILD  266 (271)
T ss_dssp             TTSCHHHHHHHHHTSCCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCCHHHHHHhhhcCCCCC----------------------------CCCcccCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence            8776555433322111000                            111367889999999999999999999999986


Q ss_pred             C
Q 023609          229 H  229 (280)
Q Consensus       229 h  229 (280)
                      +
T Consensus       267 ~  267 (271)
T 3dtc_A          267 Q  267 (271)
T ss_dssp             H
T ss_pred             H
Confidence            4

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=1.1e-37  Score=262.07  Aligned_cols=193  Identities=24%  Similarity=0.398  Sum_probs=159.9

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS   77 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~   77 (280)
                      ++||||+++++++...     ...|+||||++ ++|.+++...  ..+++..++.++.||+.||+|||++|++|+||||+
T Consensus        66 l~h~~i~~~~~~~~~~-----~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~  140 (288)
T 3kfa_A           66 IKHPNLVQLLGVCTRE-----PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAAR  140 (288)
T ss_dssp             CCCTTBCCEEEEECSS-----SSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGG
T ss_pred             CCCCCEeeEEEEEccC-----CCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcc
Confidence            5899999999999665     67999999998 6999999864  45999999999999999999999999999999999


Q ss_pred             cEEEccCCCEEEeeccceeeccCCC--ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 023609           78 NLLLNANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHV  154 (280)
Q Consensus        78 nili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~  154 (280)
                      ||+++.++.++|+|||.+.......  ......+++.|+|||.+.+. .++.++||||+|+++++|++ |..||.+.+..
T Consensus       141 Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~  219 (288)
T 3kfa_A          141 NCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS  219 (288)
T ss_dssp             GEEECGGGCEEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred             eEEEcCCCCEEEccCccceeccCCccccccCCccccCcCChhhhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            9999999999999999997654332  22334567889999988544 47899999999999999999 99999877655


Q ss_pred             HHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          155 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                      .....+......                             ...+.+++.+.++|.+||+.||.+|||+.++++
T Consensus       220 ~~~~~~~~~~~~-----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~  264 (288)
T 3kfa_A          220 QVYELLEKDYRM-----------------------------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  264 (288)
T ss_dssp             GHHHHHHTTCCC-----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHhccCCC-----------------------------CCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence            444333221111                             112367889999999999999999999999975

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.3e-37  Score=277.68  Aligned_cols=192  Identities=23%  Similarity=0.376  Sum_probs=156.6

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQA--LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS   77 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~--l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~   77 (280)
                      |+||||+++++++....    ...|+||||++ |+|.+++...+.  +++..+..++.||+.||+|||++|++||||||+
T Consensus       243 l~h~niv~~~~~~~~~~----~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~  318 (450)
T 1k9a_A          243 LRHSNLVQLLGVIVEEK----GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAAR  318 (450)
T ss_dssp             CCCTTBCCEEEEEECTT----SCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGG
T ss_pred             ccCCCEEEEEEEEEcCC----CceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHh
Confidence            58999999999976542    46899999997 699999986543  799999999999999999999999999999999


Q ss_pred             cEEEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 023609           78 NLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQ  156 (280)
Q Consensus        78 nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~  156 (280)
                      ||+++.++.+||+|||+++......  ....++..|+|||++.+. .++.++||||+||++|+|++ |..||.+....+.
T Consensus       319 Nill~~~~~~kl~DfG~a~~~~~~~--~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~  395 (450)
T 1k9a_A          319 NVLVSEDNVAKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV  395 (450)
T ss_dssp             GEEECTTSCEEECCCTTCEECC--------CCCTTTSCHHHHHSS-CCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTH
T ss_pred             hEEECCCCCEEEeeCCCcccccccc--cCCCCCcceeCHHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            9999999999999999998654332  233567889999998654 58999999999999999998 9999987665554


Q ss_pred             HHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          157 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                      ...+.+....                             ...+.+++++.++|.+||+.||.+|||+.++++
T Consensus       396 ~~~i~~~~~~-----------------------------~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          396 VPRVEKGYKM-----------------------------DAPDGCPPAVYDVMKNCWHLDAATRPTFLQLRE  438 (450)
T ss_dssp             HHHHHTTCCC-----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHcCCCC-----------------------------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            4433221111                             111367899999999999999999999999875

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.3e-37  Score=265.89  Aligned_cols=194  Identities=24%  Similarity=0.377  Sum_probs=160.5

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC----------CCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN----------QALSEEHCQYFLYQILRGLKYIHSANV   69 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~----------~~l~~~~~~~i~~qll~al~~LH~~gi   69 (280)
                      ++||||+++++++...     ...|+||||++ |+|.+++...          ..+++..+..++.||+.||+|||++|+
T Consensus        85 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i  159 (322)
T 1p4o_A           85 FNCHHVVRLLGVVSQG-----QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKF  159 (322)
T ss_dssp             CCCTTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             cCCCCEeeeEEEEccC-----CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCC
Confidence            5899999999999665     66899999997 5999998742          457999999999999999999999999


Q ss_pred             eeccCCCCcEEEccCCCEEEeeccceeeccCCC---ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CC
Q 023609           70 LHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RK  145 (280)
Q Consensus        70 ~H~di~~~nili~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~  145 (280)
                      +||||||+||+++.++.++|+|||++.......   ......+++.|+|||++.+. .++.++||||+||++|+|++ |.
T Consensus       160 ~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~~g~  238 (322)
T 1p4o_A          160 VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAE  238 (322)
T ss_dssp             BCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTSC
T ss_pred             ccCCCccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccC-CCCchhhHHHHHHHHHHHHhcCC
Confidence            999999999999999999999999987554332   12234568889999988544 47899999999999999999 89


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHH
Q 023609          146 PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVED  225 (280)
Q Consensus       146 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e  225 (280)
                      .||.+.+..+....+.....                             ....+.++..+.++|.+||+.||.+|||+.+
T Consensus       239 ~p~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e  289 (322)
T 1p4o_A          239 QPYQGLSNEQVLRFVMEGGL-----------------------------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLE  289 (322)
T ss_dssp             CTTTTSCHHHHHHHHHTTCC-----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CccccCCHHHHHHHHHcCCc-----------------------------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHH
Confidence            99988776655444332110                             0112367889999999999999999999999


Q ss_pred             HhcC
Q 023609          226 ALAH  229 (280)
Q Consensus       226 ll~h  229 (280)
                      ++++
T Consensus       290 ~l~~  293 (322)
T 1p4o_A          290 IISS  293 (322)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            9986

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.8e-37  Score=266.43  Aligned_cols=193  Identities=27%  Similarity=0.440  Sum_probs=160.3

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCC----------------CCCHHHHHHHHHHHHHHHHHH
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ----------------ALSEEHCQYFLYQILRGLKYI   64 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~----------------~l~~~~~~~i~~qll~al~~L   64 (280)
                      +||||+++++++...     ...|+||||++ |+|.+++...+                .+++..++.++.||+.||+||
T Consensus        99 ~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~L  173 (334)
T 2pvf_A           99 KHKNIINLLGACTQD-----GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYL  173 (334)
T ss_dssp             CCTTBCCEEEEECSS-----SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHH
T ss_pred             cCCCEeeEEEEEccC-----CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHH
Confidence            799999999999665     67899999997 59999998654                389999999999999999999


Q ss_pred             HHCCceeccCCCCcEEEccCCCEEEeeccceeeccCCCc---cccceeccccccchhccCCCCCCcchhHHHHHHHHHHH
Q 023609           65 HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL  141 (280)
Q Consensus        65 H~~gi~H~di~~~nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l  141 (280)
                      |+.|++||||||+||+++.++.++|+|||++........   .....+++.|+|||++.+. .++.++||||+||++|+|
T Consensus       174 H~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el  252 (334)
T 2pvf_A          174 ASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDR-VYTHQSDVWSFGVLMWEI  252 (334)
T ss_dssp             HHTTEECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHH
T ss_pred             HhCCeeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCC-CcChHHHHHHHHHHHHHH
Confidence            999999999999999999999999999999986654321   2234567889999988543 478999999999999999


Q ss_pred             Hh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCC
Q 023609          142 MD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQR  220 (280)
Q Consensus       142 l~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R  220 (280)
                      ++ |..||.+....+....+......                             .....++.++.++|.+||+.||.+|
T Consensus       253 lt~g~~p~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~l~~li~~~l~~dp~~R  303 (334)
T 2pvf_A          253 FTLGGSPYPGIPVEELFKLLKEGHRM-----------------------------DKPANCTNELYMMMRDCWHAVPSQR  303 (334)
T ss_dssp             HTTSCCSSTTCCHHHHHHHHHHTCCC-----------------------------CCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred             HhCCCCCcCcCCHHHHHHHHhcCCCC-----------------------------CCCccCCHHHHHHHHHHccCChhhC
Confidence            99 99999887766554443322111                             1113678899999999999999999


Q ss_pred             CCHHHHhcC
Q 023609          221 ITVEDALAH  229 (280)
Q Consensus       221 ~t~~ell~h  229 (280)
                      ||+.+++++
T Consensus       304 ps~~ell~~  312 (334)
T 2pvf_A          304 PTFKQLVED  312 (334)
T ss_dssp             CCHHHHHHH
T ss_pred             cCHHHHHHH
Confidence            999999874

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=8.9e-38  Score=261.93  Aligned_cols=193  Identities=24%  Similarity=0.366  Sum_probs=155.1

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      |+||||+++++++..      ...|+||||++ ++|.+++... ..+++..+..++.||+.||+|||++|++||||||+|
T Consensus        70 l~h~~i~~~~~~~~~------~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~N  143 (281)
T 3cc6_A           70 LDHPHIVKLIGIIEE------EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRN  143 (281)
T ss_dssp             HCCTTBCCEEEEECS------SSCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGG
T ss_pred             CCCCCcceEEEEEcC------CCCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccce
Confidence            479999999999854      34689999998 6999999754 469999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCCC--ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 023609           79 LLLNANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVH  155 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~  155 (280)
                      |+++.++.++|+|||.+.......  ......+++.|+|||.+.+ ..++.++||||+|+++|+|++ |..||.+.....
T Consensus       144 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~  222 (281)
T 3cc6_A          144 ILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINF-RRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD  222 (281)
T ss_dssp             EEEEETTEEEECCCCGGGCC---------CCCCCGGGCCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG
T ss_pred             EEECCCCcEEeCccCCCcccccccccccccCCCCcceeCchhhcc-CCCCchhccHHHHHHHHHHHhCCCCCcccCChHH
Confidence            999999999999999987654332  1223456778999998854 447899999999999999998 999997665554


Q ss_pred             HHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 023609          156 QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  229 (280)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h  229 (280)
                      ....+......+                             ..+.+++.+.++|.+||+.||.+|||+.+++++
T Consensus       223 ~~~~~~~~~~~~-----------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          223 VIGVLEKGDRLP-----------------------------KPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             HHHHHHHTCCCC-----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHhcCCCCC-----------------------------CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence            443332211111                             112578899999999999999999999999864

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=2e-37  Score=261.80  Aligned_cols=194  Identities=24%  Similarity=0.355  Sum_probs=155.4

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      ++||||+++++++....    +..|+||||++ |+|.+++... ..+++..+..++.|++.||+|||++|++||||||+|
T Consensus        83 l~h~~iv~~~~~~~~~~----~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~N  158 (298)
T 3f66_A           83 FSHPNVLSLLGICLRSE----GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARN  158 (298)
T ss_dssp             CCCTTBCCCCEEECCSS----SCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             CCCCCEeeeeeEEEcCC----CceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchhe
Confidence            58999999999965432    56899999998 5999999764 469999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCCC-----ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 023609           79 LLLNANCDLKICDFGLARVTSETD-----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRD  152 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~  152 (280)
                      |+++.++.++|+|||.+.......     ......+++.|+|||.+.+. .++.++|+||+|+++++|++ +.+||.+..
T Consensus       159 il~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~~~~~~~~~~  237 (298)
T 3f66_A          159 CMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVN  237 (298)
T ss_dssp             EEECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSSTTSC
T ss_pred             EEECCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCC-CCChHHHHHHHHHHHHHHHhCCCCCCccCC
Confidence            999999999999999997654322     12234567889999988544 48899999999999999999 667787665


Q ss_pred             hHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          153 HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                      ..+....+.......                             ....++..+.++|.+||+.||.+|||+.++++
T Consensus       238 ~~~~~~~~~~~~~~~-----------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~  284 (298)
T 3f66_A          238 TFDITVYLLQGRRLL-----------------------------QPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS  284 (298)
T ss_dssp             TTTHHHHHHTTCCCC-----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHhcCCCCC-----------------------------CCccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            544433332211111                             11256788999999999999999999999986

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1.7e-37  Score=263.95  Aligned_cols=195  Identities=24%  Similarity=0.360  Sum_probs=150.9

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++...     ...|+||||++ ++|.+++...+.+++..+..++.||+.||+|||+.|++|+||||+||
T Consensus        91 l~hp~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NI  165 (309)
T 2h34_A           91 LQEPHVVPIHDFGEID-----GQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENI  165 (309)
T ss_dssp             CCCTTBCCEEEEEEET-----TEEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred             cCCCCeeEEEEEEeeC-----CeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHE
Confidence            5799999999999765     67999999998 59999999888899999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCC--ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL  157 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  157 (280)
                      +++.++.++|+|||++.......  ......+++.|+|||.+.+ ..++.++||||+|+++|+|++|..||.+.......
T Consensus       166 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~  244 (309)
T 2h34_A          166 LVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSE-SHATYRADIYALTCVLYECLTGSPPYQGDQLSVMG  244 (309)
T ss_dssp             EECTTSCEEECSCCC----------------CCGGGCCGGGTCC-----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHH
T ss_pred             EEcCCCCEEEecCccCccccccccccccccCCCcCccCHHHHcC-CCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHH
Confidence            99999999999999987654332  2234568899999998854 45788999999999999999999999876543222


Q ss_pred             HHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCC-CHHHHhc
Q 023609          158 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI-TVEDALA  228 (280)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-t~~ell~  228 (280)
                      ..+. ...                          .......+.+++++.++|.+||+.||.+|| |++++++
T Consensus       245 ~~~~-~~~--------------------------~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          245 AHIN-QAI--------------------------PRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             HHHH-SCC--------------------------CCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred             HHhc-cCC--------------------------CCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence            2111 100                          011123357889999999999999999999 7777765

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.9e-37  Score=260.73  Aligned_cols=194  Identities=20%  Similarity=0.306  Sum_probs=159.9

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      |+||||+++++++..      ...++||||++ ++|.+++... ..+++..+..++.||+.||.|||+.|++||||||+|
T Consensus        67 l~h~~i~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~N  140 (287)
T 1u59_A           67 LDNPYIVRLIGVCQA------EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARN  140 (287)
T ss_dssp             CCCTTBCCEEEEEES------SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred             CCCCCEeEEEEEecC------CCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchhe
Confidence            589999999999832      45899999998 5999999644 569999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCCCc----cccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCh
Q 023609           79 LLLNANCDLKICDFGLARVTSETDF----MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDH  153 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~  153 (280)
                      |+++.++.++|+|||.+........    .....+++.|+|||++.+. .++.++||||+||++|+|++ |..||.+...
T Consensus       141 ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~~p~~~~~~  219 (287)
T 1u59_A          141 VLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKG  219 (287)
T ss_dssp             EEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCT
T ss_pred             EEEcCCCCEEECcccceeeeccCcceeeccccccccccccCHHHhccC-CCCchhhHHHHHHHHHHHHcCCCCCcccCCH
Confidence            9999999999999999987643321    2233457889999988543 47899999999999999998 9999988776


Q ss_pred             HHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCC
Q 023609          154 VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHP  230 (280)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~  230 (280)
                      .+....+.....                             ....+.+++++.++|.+||+.||.+|||+.+++++.
T Consensus       220 ~~~~~~i~~~~~-----------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l  267 (287)
T 1u59_A          220 PEVMAFIEQGKR-----------------------------MECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRM  267 (287)
T ss_dssp             HHHHHHHHTTCC-----------------------------CCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHHHhcCCc-----------------------------CCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence            655444322110                             011236789999999999999999999999999863

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.6e-37  Score=264.36  Aligned_cols=195  Identities=26%  Similarity=0.415  Sum_probs=158.4

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCC----------------CCHHHHHHHHHHHHHHHHHH
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQA----------------LSEEHCQYFLYQILRGLKYI   64 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~----------------l~~~~~~~i~~qll~al~~L   64 (280)
                      +||||+++++++....    ...|+||||++ |+|.+++.....                +++..++.++.||+.||+||
T Consensus        89 ~hp~iv~~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~l  164 (316)
T 2xir_A           89 HHLNVVNLLGACTKPG----GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL  164 (316)
T ss_dssp             CCTTBCCEEEEECCTT----SCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHH
T ss_pred             cCCCeeeEEEEEecCC----CceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHH
Confidence            6999999999986542    45899999998 599999987543                89999999999999999999


Q ss_pred             HHCCceeccCCCCcEEEccCCCEEEeeccceeeccCCC---ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHH
Q 023609           65 HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL  141 (280)
Q Consensus        65 H~~gi~H~di~~~nili~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l  141 (280)
                      |+.|++||||||+||+++.++.++|+|||.+.......   ......+++.|+|||++.+. .++.++||||+||++|+|
T Consensus       165 H~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~~l  243 (316)
T 2xir_A          165 ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEI  243 (316)
T ss_dssp             HHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHH
T ss_pred             HhCCcccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccc-cccchhHHHHHHHHHHHH
Confidence            99999999999999999999999999999997654332   12345678899999988544 488999999999999999


Q ss_pred             Hh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCC
Q 023609          142 MD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQR  220 (280)
Q Consensus       142 l~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R  220 (280)
                      ++ |..||.+................+                            ...+.+++.+.++|.+||+.||.+|
T Consensus       244 ~t~g~~p~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~dp~~R  295 (316)
T 2xir_A          244 FSLGASPYPGVKIDEEFCRRLKEGTRM----------------------------RAPDYTTPEMYQTMLDCWHGEPSQR  295 (316)
T ss_dssp             HTTSCCSSTTCCCSHHHHHHHHHTCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred             HhCCCCCCcccchhHHHHHHhccCccC----------------------------CCCCCCCHHHHHHHHHHcCCChhhC
Confidence            98 999998765433332222211111                            1112578899999999999999999


Q ss_pred             CCHHHHhcC
Q 023609          221 ITVEDALAH  229 (280)
Q Consensus       221 ~t~~ell~h  229 (280)
                      ||+.++++|
T Consensus       296 ps~~ell~~  304 (316)
T 2xir_A          296 PTFSELVEH  304 (316)
T ss_dssp             CCHHHHHHH
T ss_pred             cCHHHHHHH
Confidence            999999975

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.1e-37  Score=267.52  Aligned_cols=193  Identities=24%  Similarity=0.343  Sum_probs=157.1

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHc--------------CCCCCHHHHHHHHHHHHHHHHHHHH
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS--------------NQALSEEHCQYFLYQILRGLKYIHS   66 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~--------------~~~l~~~~~~~i~~qll~al~~LH~   66 (280)
                      +||||+++++++...     ...|+||||++ |+|.+++..              ...+++..+..++.||+.||+|||+
T Consensus       108 ~h~~iv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~  182 (333)
T 2i1m_A          108 QHENIVNLLGACTHG-----GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS  182 (333)
T ss_dssp             CCTTBCCEEEEECSS-----SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCCCeeeEEEEEecC-----CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc
Confidence            799999999999665     66899999997 599999974              3468999999999999999999999


Q ss_pred             CCceeccCCCCcEEEccCCCEEEeeccceeeccCCC---ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh
Q 023609           67 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD  143 (280)
Q Consensus        67 ~gi~H~di~~~nili~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~  143 (280)
                      .|++||||||+||+++.++.++|+|||++.......   ......+++.|+|||++.+. .++.++||||+||++|+|++
T Consensus       183 ~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~t  261 (333)
T 2i1m_A          183 KNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDC-VYTVQSDVWSYGILLWEIFS  261 (333)
T ss_dssp             TTEECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHTT
T ss_pred             CCcccCCcccceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccC-CCChHHHHHHHHHHHHHHHc
Confidence            999999999999999999999999999997653332   12334567889999988544 48899999999999999998


Q ss_pred             -CCCCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCC
Q 023609          144 -RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT  222 (280)
Q Consensus       144 -g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t  222 (280)
                       |..||.+.........+......+.                            ..+..+..+.++|.+||+.||.+|||
T Consensus       262 ~g~~p~~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~l~~li~~~l~~~p~~Rps  313 (333)
T 2i1m_A          262 LGLNPYPGILVNSKFYKLVKDGYQMA----------------------------QPAFAPKNIYSIMQACWALEPTHRPT  313 (333)
T ss_dssp             TSCCSSTTCCSSHHHHHHHHHTCCCC----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred             CCCCCCcccchhHHHHHHHhcCCCCC----------------------------CCCCCCHHHHHHHHHHhccChhhCcC
Confidence             9999987654443333322211110                            11246788999999999999999999


Q ss_pred             HHHHhc
Q 023609          223 VEDALA  228 (280)
Q Consensus       223 ~~ell~  228 (280)
                      +.++++
T Consensus       314 ~~~l~~  319 (333)
T 2i1m_A          314 FQQICS  319 (333)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            999986

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.6e-37  Score=266.20  Aligned_cols=192  Identities=23%  Similarity=0.320  Sum_probs=151.9

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      ++||||+++++++...      ..++|++++. |+|.+++.. .+.+++..++.++.||+.||+|||++||+||||||+|
T Consensus        74 l~hp~iv~~~~~~~~~------~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~N  147 (327)
T 3lzb_A           74 VDNPHVCRLLGICLTS------TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARN  147 (327)
T ss_dssp             CCBTTBCCCCEEEESS------SEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred             CCCCCeeEEEEEEecC------CceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHH
Confidence            5899999999999653      3788888887 699999976 4579999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCCCc---cccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 023609           79 LLLNANCDLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHV  154 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~  154 (280)
                      |+++.++.++|+|||++........   .....+++.|+|||.+.+. .++.++||||+||++|+|++ |..||.+....
T Consensus       148 Il~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~~g~~p~~~~~~~  226 (327)
T 3lzb_A          148 VLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS  226 (327)
T ss_dssp             EEEEETTEEEECCTTC----------------CCCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG
T ss_pred             EEEcCCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcCC-CCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH
Confidence            9999999999999999986543321   2233457789999998644 48899999999999999999 99999877655


Q ss_pred             HHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          155 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                      +....+......                             ...+.++.++.++|++||+.||.+|||+.++++
T Consensus       227 ~~~~~~~~~~~~-----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  271 (327)
T 3lzb_A          227 EISSILEKGERL-----------------------------PQPPICTIDVYMIMRKCWMIDADSRPKFRELII  271 (327)
T ss_dssp             GHHHHHHTTCCC-----------------------------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHcCCCC-----------------------------CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            544333221111                             112357889999999999999999999999987

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-37  Score=271.28  Aligned_cols=194  Identities=23%  Similarity=0.350  Sum_probs=148.2

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      |+||||+++++++....    +..|+||||++ |+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|
T Consensus       147 l~hpnIv~~~~~~~~~~----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~N  222 (373)
T 3c1x_A          147 FSHPNVLSLLGICLRSE----GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARN  222 (373)
T ss_dssp             CCCTTBCCCCEEECCCS----SCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred             CCCCCcceEEEEEEcCC----CCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchhe
Confidence            57999999999875432    46799999998 5999999865 458999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCCC-----ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCC
Q 023609           79 LLLNANCDLKICDFGLARVTSETD-----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRD  152 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~  152 (280)
                      |+++.++.++|+|||+++......     ......+++.|+|||.+.+ ..++.++||||+||++|+|++ |.+||.+.+
T Consensus       223 Ill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwSlG~il~ellt~~~~p~~~~~  301 (373)
T 3c1x_A          223 CMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVN  301 (373)
T ss_dssp             EEECTTCCEEECCC---------------------CCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC
T ss_pred             EEECCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcC-CCCCcHHHHHHHHHHHHHHHhCcCCCCCCCC
Confidence            999999999999999997543321     1123456778999999854 458899999999999999999 778887665


Q ss_pred             hHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          153 HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                      ..+....+......                             ..-+.++..+.++|.+||+.||.+|||+.++++
T Consensus       302 ~~~~~~~~~~~~~~-----------------------------~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~  348 (373)
T 3c1x_A          302 TFDITVYLLQGRRL-----------------------------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVS  348 (373)
T ss_dssp             SSCHHHHHHTTCCC-----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHcCCCC-----------------------------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            44333322211100                             011257889999999999999999999999987

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.2e-37  Score=266.71  Aligned_cols=198  Identities=21%  Similarity=0.301  Sum_probs=160.9

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC-------CCCCHHHHHHHHHHHHHHHHHHHHCCceec
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-------QALSEEHCQYFLYQILRGLKYIHSANVLHR   72 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-------~~l~~~~~~~i~~qll~al~~LH~~gi~H~   72 (280)
                      |+||||+++++++...     ...|+||||++ ++|.+++...       ..+++..++.++.||+.||.|||+.|++||
T Consensus        90 l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~  164 (327)
T 2yfx_A           90 FNHQNIVRCIGVSLQS-----LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHR  164 (327)
T ss_dssp             CCCTTBCCEEEEECSS-----SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred             CCCCCCCeEEEEEcCC-----CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecC
Confidence            5899999999999765     56899999995 6999999865       349999999999999999999999999999


Q ss_pred             cCCCCcEEEcc---CCCEEEeeccceeeccCCC---ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CC
Q 023609           73 DLKPSNLLLNA---NCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RK  145 (280)
Q Consensus        73 di~~~nili~~---~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~  145 (280)
                      ||||+||+++.   ++.++|+|||.+.......   ......+++.|+|||.+.+. .++.++||||+||++|+|++ |.
T Consensus       165 dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~ellt~g~  243 (327)
T 2yfx_A          165 DIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEG-IFTSKTDTWSFGVLLWEIFSLGY  243 (327)
T ss_dssp             CCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSC
T ss_pred             cCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCC-CCCchhhHHHHHHHHHHHHcCCC
Confidence            99999999984   4469999999987543221   12234568899999988544 47899999999999999998 99


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHH
Q 023609          146 PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVED  225 (280)
Q Consensus       146 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e  225 (280)
                      .||.+....+....+......                             ...+.+++.+.++|.+||+.||.+|||+.+
T Consensus       244 ~p~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~  294 (327)
T 2yfx_A          244 MPYPSKSNQEVLEFVTSGGRM-----------------------------DPPKNCPGPVYRIMTQCWQHQPEDRPNFAI  294 (327)
T ss_dssp             CSSTTCCHHHHHHHHHTTCCC-----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCCCCcCHHHHHHHHhcCCCC-----------------------------CCCCCCCHHHHHHHHHHhcCChhhCcCHHH
Confidence            999887765554443321111                             111367889999999999999999999999


Q ss_pred             HhcCCCCC
Q 023609          226 ALAHPYLG  233 (280)
Q Consensus       226 ll~h~~~~  233 (280)
                      ++++.|+-
T Consensus       295 ll~~l~~~  302 (327)
T 2yfx_A          295 ILERIEYC  302 (327)
T ss_dssp             HHHHHHHH
T ss_pred             HHHHHHHH
Confidence            99998764

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=7.4e-38  Score=264.20  Aligned_cols=211  Identities=20%  Similarity=0.336  Sum_probs=154.2

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ-ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~-~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      |+||||+++++++.....   ..+++||||++ |+|.+++...+ .+++..+..++.|++.||+|||+.|++||||||+|
T Consensus        68 l~h~~iv~~~~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~N  144 (295)
T 3ugc_A           68 LQHDNIVKYKGVCYSAGR---RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRN  144 (295)
T ss_dssp             CCCTTBCCEEEEECHHHH---TSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             CCCCCEeeEEEEEecCCC---CceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhh
Confidence            589999999999855321   45899999996 69999998754 49999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCCC----ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH
Q 023609           79 LLLNANCDLKICDFGLARVTSETD----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHV  154 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  154 (280)
                      |+++.++.++|+|||++.......    ......++..|+|||.+.+. .++.++||||+|+++++|++|..|+......
T Consensus       145 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~  223 (295)
T 3ugc_A          145 ILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYIEKSKSPPAE  223 (295)
T ss_dssp             EEEEETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH
T ss_pred             EEEcCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCC-CCChHHHHHHHHHHHHHHHhcccccCCChHH
Confidence            999999999999999998654332    12233467779999998544 4899999999999999999999988543211


Q ss_pred             HHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          155 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                           .....+........  .............      ....+.+++++.++|.+||+.||.+|||+.++++
T Consensus       224 -----~~~~~~~~~~~~~~--~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~  284 (295)
T 3ugc_A          224 -----FMRMIGNDKQGQMI--VFHLIELLKNNGR------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  284 (295)
T ss_dssp             -----HHHHHCTTCCTHHH--HHHHHHHHHTTCC------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             -----HHhhhcCccccchh--HHHHHHHHhccCc------CCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence                 11112221111110  0001111111111      1112367899999999999999999999999875

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.8e-37  Score=259.32  Aligned_cols=194  Identities=27%  Similarity=0.397  Sum_probs=155.2

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      ++||||+++++++....    ...++||||+. |+|.+++.. ...+++..+..++.|++.||+|||+.|++||||||+|
T Consensus        79 l~h~~iv~~~~~~~~~~----~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~N  154 (298)
T 3pls_A           79 LNHPNVLALIGIMLPPE----GLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARN  154 (298)
T ss_dssp             CCCTTBCCCCEEECCSS----SCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             CCCCCeeeEEEEEecCC----CCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcce
Confidence            58999999999997652    34589999996 799999986 4569999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCC-----CccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhC-CCCCCCCC
Q 023609           79 LLLNANCDLKICDFGLARVTSET-----DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR-KPLFPGRD  152 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~  152 (280)
                      |+++.++.++|+|||.+......     .......+++.|+|||.+.+ ..++.++||||+||++|+|++| .+||.+.+
T Consensus       155 ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~~g~~~~~~~~~  233 (298)
T 3pls_A          155 CMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQT-YRFTTKSDVWSFGVLLWELLTRGAPPYRHID  233 (298)
T ss_dssp             EEECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTT-CCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC
T ss_pred             EEEcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhcc-CCCChhhchhhHHHHHHHHhhCCCCCCccCC
Confidence            99999999999999999754332     12234466889999999854 4588999999999999999994 55665555


Q ss_pred             hHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          153 HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                      .......+......+                             ....++..+.++|.+||+.||.+|||+.++++
T Consensus       234 ~~~~~~~~~~~~~~~-----------------------------~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~  280 (298)
T 3pls_A          234 PFDLTHFLAQGRRLP-----------------------------QPEYCPDSLYQVMQQCWEADPAVRPTFRVLVG  280 (298)
T ss_dssp             GGGHHHHHHTTCCCC-----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHhhcCCCCC-----------------------------CCccchHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            444333332211111                             11257889999999999999999999999886

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.2e-37  Score=260.83  Aligned_cols=192  Identities=22%  Similarity=0.369  Sum_probs=150.4

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCC--CCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQA--LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS   77 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~--l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~   77 (280)
                      ++||||+++++++....    ...|+||||++ ++|.+++...+.  +++..+..++.|++.||+|||+.|++||||||+
T Consensus        71 l~h~~iv~~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~  146 (278)
T 1byg_A           71 LRHSNLVQLLGVIVEEK----GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAAR  146 (278)
T ss_dssp             CCCTTBCCEEEEECCC------CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred             CCCCCEeeEEEEEEcCC----CceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcc
Confidence            58999999999975542    46899999997 599999976543  899999999999999999999999999999999


Q ss_pred             cEEEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 023609           78 NLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQ  156 (280)
Q Consensus        78 nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~  156 (280)
                      ||+++.++.++|+|||.+.......  ....+++.|+|||.+.+ ..++.++||||+|+++++|++ |..||.+....+.
T Consensus       147 Nil~~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~  223 (278)
T 1byg_A          147 NVLVSEDNVAKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV  223 (278)
T ss_dssp             GEEECTTSCEEECCCCC--------------CCTTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH
T ss_pred             eEEEeCCCcEEEeeccccccccccc--cCCCccccccCHHHhCC-CCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            9999999999999999987654432  23456788999998854 457899999999999999998 9999977654443


Q ss_pred             HHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          157 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                      ...+.....                             ....+.+++.+.++|.+||+.||.+|||+.++++
T Consensus       224 ~~~~~~~~~-----------------------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          224 VPRVEKGYK-----------------------------MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             HHHHTTTCC-----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHhcCCC-----------------------------CCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence            332211100                             0112367899999999999999999999999875

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=6.8e-37  Score=258.15  Aligned_cols=198  Identities=17%  Similarity=0.181  Sum_probs=154.6

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIR-SNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~-~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++|++++..+..+....    ...++||||++++|.+++. .++.+++..+..++.||+.||+|||++|++||||||+||
T Consensus        61 l~~~~~i~~~~~~~~~~----~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NI  136 (296)
T 3uzp_A           61 MQGGVGIPTIRWCGAEG----DYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNF  136 (296)
T ss_dssp             HTTSTTCCCEEEEEEET----TEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred             hhcCCCCCccccccCCC----CceEEEEEecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHe
Confidence            35777666666553321    5689999999889999997 356799999999999999999999999999999999999


Q ss_pred             EE---ccCCCEEEeeccceeeccCCCc--------cccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 023609           80 LL---NANCDLKICDFGLARVTSETDF--------MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF  148 (280)
Q Consensus        80 li---~~~~~~~l~dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf  148 (280)
                      ++   +.++.++|+|||.+........        .....+++.|+|||.+.+. .++.++||||+||++|+|++|..||
T Consensus       137 l~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf  215 (296)
T 3uzp_A          137 LMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFNLGSLPW  215 (296)
T ss_dssp             EECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred             EEecCCCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcCC-CCCcchhhHHHHHHHHHHHhCCCCC
Confidence            99   4889999999999986554321        2345789999999998544 4889999999999999999999999


Q ss_pred             CCCCh---HHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHH
Q 023609          149 PGRDH---VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVED  225 (280)
Q Consensus       149 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e  225 (280)
                      .+...   ......+.......+                         .....+.+++++.++|.+||+.||.+|||+.+
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~  270 (296)
T 3uzp_A          216 QGLKAATKRQKYERISEKKMSTP-------------------------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSY  270 (296)
T ss_dssp             SSCCCSSSSSHHHHHHHHHHHSC-------------------------HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHH
T ss_pred             CCcCchhhhhhhhhhcccccCCc-------------------------hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHH
Confidence            76432   122222221110000                         11222467899999999999999999999999


Q ss_pred             Hhc
Q 023609          226 ALA  228 (280)
Q Consensus       226 ll~  228 (280)
                      +++
T Consensus       271 l~~  273 (296)
T 3uzp_A          271 LRQ  273 (296)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            887

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=2.4e-37  Score=276.33  Aligned_cols=192  Identities=27%  Similarity=0.435  Sum_probs=159.5

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS   77 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~   77 (280)
                      |+||||+++++++..      ...|+||||+. |+|.+++...  ..+++..+..++.||+.||+|||++||+||||||+
T Consensus       240 l~h~~iv~l~~~~~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~  313 (454)
T 1qcf_A          240 LQHDKLVKLHAVVTK------EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAA  313 (454)
T ss_dssp             CCCTTBCCEEEEECS------SSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGG
T ss_pred             CCCCCEeeEEEEEeC------CccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHH
Confidence            589999999999852      45899999997 6999999754  36999999999999999999999999999999999


Q ss_pred             cEEEccCCCEEEeeccceeeccCCC--ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 023609           78 NLLLNANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHV  154 (280)
Q Consensus        78 nili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~  154 (280)
                      ||+++.++.+||+|||+++......  ......++..|+|||++.. ..++.++||||+||++|+|++ |..||.+.+..
T Consensus       314 Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~  392 (454)
T 1qcf_A          314 NILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINF-GSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP  392 (454)
T ss_dssp             GEEECTTCCEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred             HEEECCCCcEEEeeCCCceEcCCCceeccCCCcccccccCHHHhcc-CCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHH
Confidence            9999999999999999998654321  1123345678999999854 448999999999999999999 99999988777


Q ss_pred             HHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          155 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                      +....+......+.                             ...+++++.++|.+||+.||.+|||+.++++
T Consensus       393 ~~~~~i~~~~~~~~-----------------------------~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          393 EVIRALERGYRMPR-----------------------------PENCPEELYNIMMRCWKNRPEERPTFEYIQS  437 (454)
T ss_dssp             HHHHHHHHTCCCCC-----------------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHcCCCCCC-----------------------------CCCCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence            66655543222111                             1257889999999999999999999999876

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=4.7e-37  Score=261.89  Aligned_cols=194  Identities=22%  Similarity=0.314  Sum_probs=155.3

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ-ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~-~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      ++||||+++++++...     ...++||||++ ++|.+++...+ .+++..++.++.||+.||+|||+.|++||||||+|
T Consensus        86 l~h~~iv~~~~~~~~~-----~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~N  160 (319)
T 2y4i_B           86 TRHENVVLFMGACMSP-----PHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKN  160 (319)
T ss_dssp             CCCTTBCCCCEEEECS-----SCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTT
T ss_pred             CCCCCEeEEEEEEecC-----CceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhh
Confidence            5799999999999765     66999999997 69999998654 69999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCC------CccccceeccccccchhccC--------CCCCCcchhHHHHHHHHHHHHhC
Q 023609           79 LLLNANCDLKICDFGLARVTSET------DFMTEYVVTRWYRAPELLLN--------SSDYTAAIDVWSVGCIFMELMDR  144 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~------~~~~~~~~~~~y~aPE~~~~--------~~~~~~~~DiwslG~il~~ll~g  144 (280)
                      |+++ ++.++|+|||++......      .......+++.|+|||++.+        ...++.++||||+||++|+|++|
T Consensus       161 Il~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g  239 (319)
T 2y4i_B          161 VFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAR  239 (319)
T ss_dssp             EEEC---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHS
T ss_pred             EEEe-CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhC
Confidence            9998 789999999987654221      12234458899999999854        23468899999999999999999


Q ss_pred             CCCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHH
Q 023609          145 KPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVE  224 (280)
Q Consensus       145 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~  224 (280)
                      ..||.+.........+.......                            .....++.++.++|.+||+.||.+|||+.
T Consensus       240 ~~p~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~  291 (319)
T 2y4i_B          240 EWPFKTQPAEAIIWQMGTGMKPN----------------------------LSQIGMGKEISDILLFCWAFEQEERPTFT  291 (319)
T ss_dssp             SCSSSSCCHHHHHHHHHTTCCCC----------------------------CCCSSCCTTHHHHHHHHHCSSTTTSCCHH
T ss_pred             CCCCCCCCHHHHHHHhccCCCCC----------------------------CCcCCCCHHHHHHHHHHhcCChhhCcCHH
Confidence            99998877655544332211100                            01125778899999999999999999999


Q ss_pred             HHhc
Q 023609          225 DALA  228 (280)
Q Consensus       225 ell~  228 (280)
                      ++++
T Consensus       292 ~l~~  295 (319)
T 2y4i_B          292 KLMD  295 (319)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            9997

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=7.7e-38  Score=264.76  Aligned_cols=194  Identities=26%  Similarity=0.419  Sum_probs=148.3

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ--ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS   77 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~--~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~   77 (280)
                      ++||||+++++++.... .+....|+||||++ |+|.+++...+  .+++..++.++.||+.||+|||+.|++||||||+
T Consensus        68 ~~h~~i~~~~~~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~  146 (299)
T 3m2w_A           68 SQCPHIVRIVDVYENLY-AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPE  146 (299)
T ss_dssp             TTSTTBCCEEEEEEEEE-TTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred             ccCCCchhHHhhhhhhc-CCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHH
Confidence            37999999999986521 11267899999997 59999998754  6999999999999999999999999999999999


Q ss_pred             cEEEcc---CCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH
Q 023609           78 NLLLNA---NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHV  154 (280)
Q Consensus        78 nili~~---~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  154 (280)
                      ||+++.   ++.++|+|||++.....                      ..++.++||||+||++|+|++|..||.+....
T Consensus       147 Nil~~~~~~~~~~kl~Dfg~a~~~~~----------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~  204 (299)
T 3m2w_A          147 NLLYTSKRPNAILKLTDFGFAKETTG----------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL  204 (299)
T ss_dssp             GEEESSSSTTCCEEECCCTTCEECTT----------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC----
T ss_pred             HEEEecCCCCCcEEEecccccccccc----------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcch
Confidence            999998   78899999998864321                      23577999999999999999999999765432


Q ss_pred             HHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCC
Q 023609          155 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS  234 (280)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~  234 (280)
                      .....+....                      ............+.+++++.++|.+||+.||.+|||+.++++||||++
T Consensus       205 ~~~~~~~~~~----------------------~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~  262 (299)
T 3m2w_A          205 AISPGMKTRI----------------------RMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ  262 (299)
T ss_dssp             ---CCSCCSS----------------------CTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred             hhhHHHHHHH----------------------hhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcc
Confidence            2110000000                      000000011122468899999999999999999999999999999988


Q ss_pred             CcCCC
Q 023609          235 LHDIS  239 (280)
Q Consensus       235 ~~~~~  239 (280)
                      .....
T Consensus       263 ~~~~~  267 (299)
T 3m2w_A          263 STKVP  267 (299)
T ss_dssp             GGGSC
T ss_pred             cccCC
Confidence            65433

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=3.5e-37  Score=277.90  Aligned_cols=193  Identities=24%  Similarity=0.407  Sum_probs=159.3

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS   77 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~   77 (280)
                      |+||||+++++++...     ...||||||+. |+|.+++...  ..+++..+..++.||+.||+|||++||+||||||+
T Consensus       273 l~hpniv~l~~~~~~~-----~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~  347 (495)
T 1opk_A          273 IKHPNLVQLLGVCTRE-----PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAAR  347 (495)
T ss_dssp             CCCTTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred             cCCCCEeeEEEEEecC-----CcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChh
Confidence            5899999999999665     66899999998 7999999853  45999999999999999999999999999999999


Q ss_pred             cEEEccCCCEEEeeccceeeccCCCc--cccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 023609           78 NLLLNANCDLKICDFGLARVTSETDF--MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHV  154 (280)
Q Consensus        78 nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~  154 (280)
                      ||+++.++.+||+|||+++.......  .....++..|+|||++... .++.++|||||||++|+|++ |..||.+.+..
T Consensus       348 NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~  426 (495)
T 1opk_A          348 NCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS  426 (495)
T ss_dssp             GEEECGGGCEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred             hEEECCCCcEEEeecccceeccCCceeecCCCcCCcceeCHhHHhcC-CCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999999987543321  2233456789999998543 48899999999999999998 99999887655


Q ss_pred             HHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          155 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                      +....+......                             .....+++.+.+||.+||+.||.+|||+.++++
T Consensus       427 ~~~~~~~~~~~~-----------------------------~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~  471 (495)
T 1opk_A          427 QVYELLEKDYRM-----------------------------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  471 (495)
T ss_dssp             GHHHHHHTTCCC-----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHcCCCC-----------------------------CCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence            544433221110                             111367889999999999999999999999986

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=4.7e-37  Score=257.16  Aligned_cols=192  Identities=23%  Similarity=0.403  Sum_probs=158.4

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ--ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS   77 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~--~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~   77 (280)
                      ++||||+++++++..      ...|+||||++ ++|.+++....  .+++..+..++.|++.||+|||++|++||||||+
T Consensus        65 l~h~~i~~~~~~~~~------~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~  138 (279)
T 1qpc_A           65 LQHQRLVRLYAVVTQ------EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAA  138 (279)
T ss_dssp             CCCTTBCCEEEEECS------SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred             CCCcCcceEEEEEcC------CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHh
Confidence            589999999999853      34799999996 69999997543  6999999999999999999999999999999999


Q ss_pred             cEEEccCCCEEEeeccceeeccCCCc--cccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 023609           78 NLLLNANCDLKICDFGLARVTSETDF--MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHV  154 (280)
Q Consensus        78 nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~  154 (280)
                      ||+++.++.++|+|||.+........  .....++..|+|||.+.+ ..++.++||||+|+++++|++ |..||.+....
T Consensus       139 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~  217 (279)
T 1qpc_A          139 NILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP  217 (279)
T ss_dssp             GEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH
T ss_pred             hEEEcCCCCEEECCCcccccccCcccccccCCCCccCccChhhhcc-CCCCchhhhHHHHHHHHHHHhCCCCCCcccCHH
Confidence            99999999999999999987654321  223445778999998854 347889999999999999999 89999887766


Q ss_pred             HHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          155 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                      +....+......                             .....+++++.++|.+||+.||++|||+.++++
T Consensus       218 ~~~~~~~~~~~~-----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          218 EVIQNLERGYRM-----------------------------VRPDNCPEELYQLMRLCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             HHHHHHHTTCCC-----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHhcccCC-----------------------------CCcccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence            555444321110                             111367889999999999999999999999886

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=4.2e-37  Score=284.55  Aligned_cols=192  Identities=21%  Similarity=0.317  Sum_probs=158.4

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      |+||||+++++++..      ...++||||++ |+|.+++..++.+++..+..++.||+.||+|||++||+||||||+||
T Consensus       427 l~hpnIv~l~~~~~~------~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NI  500 (635)
T 4fl3_A          427 LDNPYIVRMIGICEA------ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNV  500 (635)
T ss_dssp             CCCTTBCCEEEEEES------SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred             CCCCCEeeEEEEEec------CCEEEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhE
Confidence            589999999999843      34899999997 69999999888999999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCC----ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 023609           80 LLNANCDLKICDFGLARVTSETD----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHV  154 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~  154 (280)
                      +++.++.+||+|||+++......    ......+++.|+|||++.+ ..++.++||||+||++|+|++ |..||.+.+..
T Consensus       501 Ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~  579 (635)
T 4fl3_A          501 LLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINY-YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS  579 (635)
T ss_dssp             EEEETTEEEECCTTHHHHTTC-------------CGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH
T ss_pred             EEeCCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999997654332    1223345778999999854 458999999999999999998 99999988776


Q ss_pred             HHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          155 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                      +....+......                             .....++.++.++|.+||+.||.+|||+.++++
T Consensus       580 ~~~~~i~~~~~~-----------------------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  624 (635)
T 4fl3_A          580 EVTAMLEKGERM-----------------------------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVEL  624 (635)
T ss_dssp             HHHHHHHTTCCC-----------------------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHcCCCC-----------------------------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence            655544332111                             111367889999999999999999999999875

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=9.9e-37  Score=256.24  Aligned_cols=191  Identities=20%  Similarity=0.355  Sum_probs=154.0

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSAN--VLHRDLKP   76 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~g--i~H~di~~   76 (280)
                      ++||||+++++++...       .++||||++ |+|.+++... ..+++..+..++.|++.||+|||+.|  ++||||||
T Consensus        80 l~h~~i~~~~~~~~~~-------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp  152 (287)
T 4f0f_A           80 LNHPNIVKLYGLMHNP-------PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRS  152 (287)
T ss_dssp             CCCTTBCCEEEEETTT-------TEEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSG
T ss_pred             CCCCCchhhheeecCC-------CeEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCc
Confidence            5799999999999554       279999998 7999988754 47999999999999999999999999  99999999


Q ss_pred             CcEEEccCCC-----EEEeeccceeeccCCCccccceeccccccchhccC-CCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 023609           77 SNLLLNANCD-----LKICDFGLARVTSETDFMTEYVVTRWYRAPELLLN-SSDYTAAIDVWSVGCIFMELMDRKPLFPG  150 (280)
Q Consensus        77 ~nili~~~~~-----~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~  150 (280)
                      +||+++.++.     ++|+|||.+......  .....+++.|+|||++.. ...++.++||||+||++|+|++|..||.+
T Consensus       153 ~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~  230 (287)
T 4f0f_A          153 PNIFLQSLDENAPVCAKVADFGLSQQSVHS--VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDE  230 (287)
T ss_dssp             GGEEESCCCTTCSCCEEECCCTTCBCCSSC--EECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             ceEEEeccCCCCceeEEeCCCCcccccccc--ccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcc
Confidence            9999988776     999999999754433  345678999999998743 33467899999999999999999999976


Q ss_pred             CChHHH--HHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          151 RDHVHQ--LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       151 ~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                      ......  ...+... +..                           ....+.+++++.++|.+||+.||.+|||+.++++
T Consensus       231 ~~~~~~~~~~~~~~~-~~~---------------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          231 YSYGKIKFINMIREE-GLR---------------------------PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             CCCCHHHHHHHHHHS-CCC---------------------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ccccHHHHHHHHhcc-CCC---------------------------CCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            543322  1111111 000                           0112367889999999999999999999999985

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=2.4e-37  Score=261.58  Aligned_cols=204  Identities=23%  Similarity=0.320  Sum_probs=152.7

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH--------HCCcee
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIH--------SANVLH   71 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH--------~~gi~H   71 (280)
                      ++||||+++++++.... ......|+||||++ |+|.++++. ..+++..+..++.||+.||+|||        +.|++|
T Consensus        59 l~h~niv~~~~~~~~~~-~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH  136 (301)
T 3q4u_A           59 LRHENILGFIASDMTSR-HSSTQLWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAH  136 (301)
T ss_dssp             CCCTTBCCEEEEEEEEE-TTEEEEEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEEC
T ss_pred             ccCcCeeeEEEeecccc-CCCceeEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeec
Confidence            58999999999875432 12256899999997 599999954 57999999999999999999999        999999


Q ss_pred             ccCCCCcEEEccCCCEEEeeccceeeccCCCc-----cccceeccccccchhccCCCC-----CCcchhHHHHHHHHHHH
Q 023609           72 RDLKPSNLLLNANCDLKICDFGLARVTSETDF-----MTEYVVTRWYRAPELLLNSSD-----YTAAIDVWSVGCIFMEL  141 (280)
Q Consensus        72 ~di~~~nili~~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~-----~~~~~DiwslG~il~~l  141 (280)
                      |||||+||+++.++.++|+|||++........     .....+|+.|+|||++.+...     ++.++||||+||++|+|
T Consensus       137 ~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el  216 (301)
T 3q4u_A          137 RDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV  216 (301)
T ss_dssp             SCCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHH
T ss_pred             CCCChHhEEEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHH
Confidence            99999999999999999999999976544321     223478999999999865432     33689999999999999


Q ss_pred             HhC----------CCCCCCCC----hHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHH
Q 023609          142 MDR----------KPLFPGRD----HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAID  207 (280)
Q Consensus       142 l~g----------~~pf~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  207 (280)
                      ++|          ..||.+..    ...............+.                      ..........++++.+
T Consensus       217 ~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~l~~  274 (301)
T 3q4u_A          217 ARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPN----------------------IPNRWFSDPTLTSLAK  274 (301)
T ss_dssp             HTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCC----------------------CCGGGGGSHHHHHHHH
T ss_pred             HhhhcCccccccccccccccCCCCcchhhhhHHHhccCCCCC----------------------CChhhccCccHHHHHH
Confidence            999          77885432    11111111111100000                      0000001124567999


Q ss_pred             HHHHhhcCCCCCCCCHHHHhc
Q 023609          208 LVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       208 li~~~L~~dp~~R~t~~ell~  228 (280)
                      +|.+||+.||.+|||+.++++
T Consensus       275 li~~cl~~dP~~Rps~~~i~~  295 (301)
T 3q4u_A          275 LMKECWYQNPSARLTALRIKK  295 (301)
T ss_dssp             HHHHHCCSSGGGSCCHHHHHH
T ss_pred             HHHHHhhcChhhCCCHHHHHH
Confidence            999999999999999999985

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=9.7e-37  Score=257.08  Aligned_cols=197  Identities=16%  Similarity=0.173  Sum_probs=154.9

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nil   80 (280)
                      +|++++..+..+....    ...++||||++++|.+++.. .+.+++..+..++.||+.||+|||++|++||||||+||+
T Consensus        62 ~~~~~i~~~~~~~~~~----~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl  137 (296)
T 4hgt_A           62 QGGVGIPTIRWCGAEG----DYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFL  137 (296)
T ss_dssp             TTSTTCCCEEEEEEET----TEEEEEEECCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred             cCCCCCCeeeeecCCC----CceEEEEEccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHee
Confidence            5777776666653321    66899999998899999984 457999999999999999999999999999999999999


Q ss_pred             E---ccCCCEEEeeccceeeccCCCc--------cccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 023609           81 L---NANCDLKICDFGLARVTSETDF--------MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFP  149 (280)
Q Consensus        81 i---~~~~~~~l~dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  149 (280)
                      +   +.++.++|+|||++........        .....+++.|+|||.+.+. .++.++||||+||++|+|++|..||.
T Consensus       138 ~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~  216 (296)
T 4hgt_A          138 MGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFNLGSLPWQ  216 (296)
T ss_dssp             ECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCTTS
T ss_pred             eeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCC-CCCchhHHHHHHHHHHHHhcCCCCCc
Confidence            9   7889999999999986544321        2345789999999998544 48899999999999999999999997


Q ss_pred             CCChH---HHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHH
Q 023609          150 GRDHV---HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDA  226 (280)
Q Consensus       150 ~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~el  226 (280)
                      +.+..   .....+.......                         ......+.+++++.++|.+||+.||.+|||+.++
T Consensus       217 ~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l  271 (296)
T 4hgt_A          217 GLKAATKRQKYERISEKKMST-------------------------PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYL  271 (296)
T ss_dssp             SCCCSSSSSHHHHHHHHHHHS-------------------------CHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHH
T ss_pred             ccchhhhhhhhhhhhcccccc-------------------------hhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHH
Confidence            64322   1111111111000                         1112234678999999999999999999999999


Q ss_pred             hc
Q 023609          227 LA  228 (280)
Q Consensus       227 l~  228 (280)
                      ++
T Consensus       272 ~~  273 (296)
T 4hgt_A          272 RQ  273 (296)
T ss_dssp             HH
T ss_pred             HH
Confidence            87

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=2.4e-37  Score=264.21  Aligned_cols=209  Identities=24%  Similarity=0.332  Sum_probs=155.8

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCC----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ----ALSEEHCQYFLYQILRGLKYIHSANVLHRDLK   75 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~----~l~~~~~~~i~~qll~al~~LH~~gi~H~di~   75 (280)
                      ++||||+++++++...     ...|+||||++ |+|.+++....    .+++..+..++.||+.||+|||+.|++|||||
T Consensus        92 l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlk  166 (321)
T 2qkw_B           92 CRHPHLVSLIGFCDER-----NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVK  166 (321)
T ss_dssp             CCCTTBCCEEEECCCT-----TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCC
T ss_pred             CCCCCEeeEEEEEcCC-----CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCC
Confidence            5899999999999655     67899999997 69999986543    59999999999999999999999999999999


Q ss_pred             CCcEEEccCCCEEEeeccceeeccCCC---ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 023609           76 PSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD  152 (280)
Q Consensus        76 ~~nili~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  152 (280)
                      |+||+++.++.++|+|||++.......   ......+++.|+|||++.+. .++.++||||+||++|+|++|+.||.+..
T Consensus       167 p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~ell~g~~p~~~~~  245 (321)
T 2qkw_B          167 SINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKG-RLTEKSDVYSFGVVLFEVLCARSAIVQSL  245 (321)
T ss_dssp             STTEEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHC-BCCTHHHHHHHHHHHHHHHHCCTTCSCSS
T ss_pred             HHHEEECCCCCEEEeecccccccccccccccccccCCCccccCHHHhcCC-CCCcccchHhHHHHHHHHHhCCCcccccC
Confidence            999999999999999999998644321   22345689999999988544 47899999999999999999999997643


Q ss_pred             hHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCcccccc-ccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 023609          153 HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQS-FTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  229 (280)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h  229 (280)
                      ..+......          +.  .....  ........... .....+..+..+.+++.+||+.||++|||+.+++++
T Consensus       246 ~~~~~~~~~----------~~--~~~~~--~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  309 (321)
T 2qkw_B          246 PREMVNLAE----------WA--VESHN--NGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWK  309 (321)
T ss_dssp             SSSCCCHHH----------HT--HHHHT--TTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cHHHHHHHH----------Hh--hhccc--cccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            221100000          00  00000  00000000000 011112345678999999999999999999999875

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=6e-37  Score=256.89  Aligned_cols=199  Identities=26%  Similarity=0.335  Sum_probs=159.6

Q ss_pred             CCCCCeeeeeceecCCC-----------CCCCCcEEEEeecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHH
Q 023609            1 MDHENVVAIRDIIPPPQ-----------RESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHS   66 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~-----------~~~~~~~~iv~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~   66 (280)
                      |+||||+++++++....           .......|+||||++ ++|.+++...  ..+++..++.++.||+.||.|||+
T Consensus        61 l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~  140 (284)
T 2a19_B           61 LDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHS  140 (284)
T ss_dssp             CCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCCCCEEEEeeeEeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence            58999999999874310           011245899999998 5999999754  579999999999999999999999


Q ss_pred             CCceeccCCCCcEEEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCC
Q 023609           67 ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKP  146 (280)
Q Consensus        67 ~gi~H~di~~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~  146 (280)
                      .|++|+||||+||+++.++.++|+|||.+.............+++.|+|||.+.+. .++.++||||+|+++++|++|..
T Consensus       141 ~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~~~  219 (284)
T 2a19_B          141 KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQ-DYGKEVDLYALGLILAELLHVCD  219 (284)
T ss_dssp             TTEECSCCSGGGEEEEETTEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCS-CCCTHHHHHHHHHHHHHHHSCCS
T ss_pred             CCeeeccCCHHHEEEcCCCCEEECcchhheeccccccccccCCcccccChhhhccC-CCcchhhhHHHHHHHHHHHhcCC
Confidence            99999999999999999999999999999877655545566789999999998654 47899999999999999999988


Q ss_pred             CCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHH
Q 023609          147 LFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDA  226 (280)
Q Consensus       147 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~el  226 (280)
                      |+....  .....+                      ..          ....+.++..++++|.+||+.||.+|||+.++
T Consensus       220 ~~~~~~--~~~~~~----------------------~~----------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~  265 (284)
T 2a19_B          220 TAFETS--KFFTDL----------------------RD----------GIISDIFDKKEKTLLQKLLSKKPEDRPNTSEI  265 (284)
T ss_dssp             SHHHHH--HHHHHH----------------------HT----------TCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHH
T ss_pred             cchhHH--HHHHHh----------------------hc----------ccccccCCHHHHHHHHHHccCChhhCcCHHHH
Confidence            763110  000000                      00          00113578899999999999999999999999


Q ss_pred             hcCCCCCC
Q 023609          227 LAHPYLGS  234 (280)
Q Consensus       227 l~h~~~~~  234 (280)
                      +++.+.-.
T Consensus       266 l~~l~~~~  273 (284)
T 2a19_B          266 LRTLTVWK  273 (284)
T ss_dssp             HHHHHHHT
T ss_pred             HHHHHHHh
Confidence            99876543

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.6e-37  Score=267.33  Aligned_cols=185  Identities=9%  Similarity=0.150  Sum_probs=145.6

Q ss_pred             CcEEEEeecCCccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCC--CEEEeeccceee
Q 023609           22 NDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANC--DLKICDFGLARV   97 (280)
Q Consensus        22 ~~~~iv~e~~~g~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nili~~~~--~~~l~dfg~~~~   97 (280)
                      ...|+||||++++|.+++...  +.+++..+..++.||+.||+|||++|++||||||+||+++.++  .++|+|||++..
T Consensus       131 ~~~~lv~e~~~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~  210 (352)
T 2jii_A          131 KYRFLVLPSLGRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFR  210 (352)
T ss_dssp             TEEEEEEECCCEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETTEEEEEEECCGGGCBC
T ss_pred             cEEEEEecCCCcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCCCCceEEEecCcceee
Confidence            678999999988999999876  6899999999999999999999999999999999999999988  899999999976


Q ss_pred             ccCCC--------ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHHHH-HhCCC
Q 023609           98 TSETD--------FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD-HVHQLRLLIE-LIGTP  167 (280)
Q Consensus        98 ~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~~~~~-~~~~~  167 (280)
                      .....        ......+++.|+|||++.+. .++.++||||+||++|+|++|..||.+.. .......... ....+
T Consensus       211 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  289 (352)
T 2jii_A          211 YCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGC-GPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKP  289 (352)
T ss_dssp             SSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSC
T ss_pred             ccCCCccccccccccccccCCccccCHHHHccC-CCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCCh
Confidence            44321        12334789999999988544 58999999999999999999999997653 2222222111 11110


Q ss_pred             CHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          168 SEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       168 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                      .                   ..  .........+++++.++|.+||+.||.+|||+.++++
T Consensus       290 ~-------------------~~--~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  329 (352)
T 2jii_A          290 G-------------------PF--VGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN  329 (352)
T ss_dssp             C-------------------CE--ECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             h-------------------hh--hhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence            0                   00  0001112357899999999999999999999999987

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=6.8e-37  Score=258.95  Aligned_cols=210  Identities=23%  Similarity=0.381  Sum_probs=157.3

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIR-SNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~-~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      |+||||+++++++.....   ..+++||||++ |+|.+++. ....+++..++.++.||+.||+|||+.|++||||||+|
T Consensus        80 l~h~~i~~~~~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~N  156 (302)
T 4e5w_A           80 LYHENIVKYKGICTEDGG---NGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARN  156 (302)
T ss_dssp             CCCTTBCCEEEEEEC------CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred             CCCCCeeeeeeEEecCCC---ceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchhe
Confidence            589999999999976432   56899999997 59999995 44679999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCCC----ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH
Q 023609           79 LLLNANCDLKICDFGLARVTSETD----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHV  154 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  154 (280)
                      |+++.++.++|+|||.+.......    ......++..|+|||.+.+. .++.++||||+||++|+|++|..|+...   
T Consensus       157 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~p~~~~---  232 (302)
T 4e5w_A          157 VLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQS-KFYIASDVWSFGVTLHELLTYCDSDSSP---  232 (302)
T ss_dssp             EEEEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCGGGSH---
T ss_pred             EEEcCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCC-CCCcchhHHHHHHHHHHHHHccCCCcch---
Confidence            999999999999999998765442    12344577789999988544 4788999999999999999999886422   


Q ss_pred             HHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          155 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                        ........+........   ...........      .....+.+++++.++|.+||+.||.+|||+.++++
T Consensus       233 --~~~~~~~~~~~~~~~~~---~~~~~~~~~~~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          233 --MALFLKMIGPTHGQMTV---TRLVNTLKEGK------RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             --HHHHHHHHCSCCGGGHH---HHHHHHHHTTC------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             --hhHHhhccCCcccccCH---HHHHHHHhccC------CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence              11122222222211110   00011111110      11122478899999999999999999999999875

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=3.2e-37  Score=264.15  Aligned_cols=210  Identities=20%  Similarity=0.314  Sum_probs=157.1

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      |+||||+++++++.....   ...|+||||++ ++|.+++.. .+.+++..++.++.||+.||+|||+.|++||||||+|
T Consensus        81 l~h~~i~~~~~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~N  157 (327)
T 3lxl_A           81 LHSDFIVKYRGVSYGPGR---QSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARN  157 (327)
T ss_dssp             CCCTTBCCEEEEEECSSS---CEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred             cCCCceeEEEEEEecCCC---ceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhh
Confidence            589999999999865322   66899999996 699999976 4569999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCCC----ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH
Q 023609           79 LLLNANCDLKICDFGLARVTSETD----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHV  154 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  154 (280)
                      |+++.++.++|+|||.+.......    ......++..|+|||++.+. .++.++||||+||++++|++|+.||.+....
T Consensus       158 Il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~g~~p~~~~~~~  236 (327)
T 3lxl_A          158 ILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDN-IFSRQSDVWSFGVVLYELFTYCDKSCSPSAE  236 (327)
T ss_dssp             EEEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHH
T ss_pred             EEECCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhccC-CCChHHhHHHHHHHHHHHHhCCCCCccccch
Confidence            999999999999999998754432    12334577889999988544 4788999999999999999999998653322


Q ss_pred             HHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          155 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                      ...     .......  ..... ..........      .....+.+++++.++|.+||+.||.+|||+.++++
T Consensus       237 ~~~-----~~~~~~~--~~~~~-~~~~~~~~~~------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  296 (327)
T 3lxl_A          237 FLR-----MMGCERD--VPALS-RLLELLEEGQ------RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGP  296 (327)
T ss_dssp             HHH-----HCC------CCHHH-HHHHHHHTTC------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hhh-----hcccccc--cccHH-HHHHHhhccc------CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            110     0000000  00000 0001111100      01122467899999999999999999999999965

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=3.6e-37  Score=261.31  Aligned_cols=207  Identities=23%  Similarity=0.345  Sum_probs=156.9

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS---NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKP   76 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~---~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~   76 (280)
                      |+||||+++++++...     ...++||||++ ++|.+++..   ..++++..++.++.||+.||+|||+.|++||||||
T Consensus        87 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp  161 (307)
T 2nru_A           87 CQHENLVELLGFSSDG-----DDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKS  161 (307)
T ss_dssp             CCCTTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCG
T ss_pred             cCCCCeEEEEEEEecC-----CceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCH
Confidence            5899999999999765     67899999996 699999873   35699999999999999999999999999999999


Q ss_pred             CcEEEccCCCEEEeeccceeeccCCC---ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh
Q 023609           77 SNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDH  153 (280)
Q Consensus        77 ~nili~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~  153 (280)
                      +||+++.++.++|+|||.+.......   ......+++.|+|||.+.+  .++.++||||+|+++|+|++|..||.+...
T Consensus       162 ~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~Dv~slG~il~~l~~g~~p~~~~~~  239 (307)
T 2nru_A          162 ANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG--EITPKSDIYSFGVVLLEIITGLPAVDEHRE  239 (307)
T ss_dssp             GGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT--EECTHHHHHHHHHHHHHHHHCCCSBCTTBS
T ss_pred             HHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC--CCCccchhHHHHHHHHHHHHCCCCcccCcc
Confidence            99999999999999999987654322   1234568999999998853  378899999999999999999999976543


Q ss_pred             HHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 023609          154 VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  229 (280)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h  229 (280)
                      ......+.+........        ...+..       .......+..+..+.+++.+||+.||.+|||+.+++++
T Consensus       240 ~~~~~~~~~~~~~~~~~--------~~~~~~-------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~  300 (307)
T 2nru_A          240 PQLLLDIKEEIEDEEKT--------IEDYID-------KKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL  300 (307)
T ss_dssp             SSBTTHHHHHHHTTSCC--------HHHHSC-------SSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             hHHHHHHHHHhhhhhhh--------hhhhcc-------ccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            33222222211110000        000000       00001111234678999999999999999999999863

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.1e-36  Score=256.96  Aligned_cols=197  Identities=28%  Similarity=0.430  Sum_probs=150.5

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHH---CCceecc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ---ALSEEHCQYFLYQILRGLKYIHS---ANVLHRD   73 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~---~l~~~~~~~i~~qll~al~~LH~---~gi~H~d   73 (280)
                      ++||||+++++++.+       ..|+||||++ |+|.+++...+   .+++..+..++.|++.||+|||+   +|++|||
T Consensus        58 l~hp~iv~~~~~~~~-------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~d  130 (307)
T 2eva_A           58 VNHPNIVKLYGACLN-------PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRD  130 (307)
T ss_dssp             CCCTTBCCEEEBCTT-------TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCC
T ss_pred             CCCCCcCeEEEEEcC-------CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCC
Confidence            589999999998853       3699999997 69999998665   37899999999999999999999   8999999


Q ss_pred             CCCCcEEEccCCC-EEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 023609           74 LKPSNLLLNANCD-LKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD  152 (280)
Q Consensus        74 i~~~nili~~~~~-~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  152 (280)
                      |||+||+++.++. ++|+|||.+......  .....+++.|+|||++.+ ..++.++||||+||++++|++|..||....
T Consensus       131 lkp~NIll~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~-~~~~~~~Di~slG~il~el~~g~~p~~~~~  207 (307)
T 2eva_A          131 LKPPNLLLVAGGTVLKICDFGTACDIQTH--MTNNKGSAAWMAPEVFEG-SNYSEKCDVFSWGIILWEVITRRKPFDEIG  207 (307)
T ss_dssp             CSGGGEEEETTTTEEEECCCCC--------------CCTTSSCHHHHTC-CCCCTHHHHHHHHHHHHHHHHTCCTTTTTC
T ss_pred             CChhHEEEeCCCCEEEEcccccccccccc--cccCCCCCceEChhhhCC-CCCCcHHHHHHHHHHHHHHHHCCCCchhhC
Confidence            9999999998887 799999998765433  234568999999999854 458899999999999999999999997543


Q ss_pred             hHHH-HHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc---
Q 023609          153 HVHQ-LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA---  228 (280)
Q Consensus       153 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~---  228 (280)
                      .... ...... .+                           ......+.++..+.++|.+||+.||.+|||+.++++   
T Consensus       208 ~~~~~~~~~~~-~~---------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~  259 (307)
T 2eva_A          208 GPAFRIMWAVH-NG---------------------------TRPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMT  259 (307)
T ss_dssp             SSHHHHHHHHH-TT---------------------------CCCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             ccHHHHHHHHh-cC---------------------------CCCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHH
Confidence            2111 110000 00                           001122467899999999999999999999999988   


Q ss_pred             --CCCCCCC
Q 023609          229 --HPYLGSL  235 (280)
Q Consensus       229 --h~~~~~~  235 (280)
                        ..++.+.
T Consensus       260 ~~~~~~~~~  268 (307)
T 2eva_A          260 HLMRYFPGA  268 (307)
T ss_dssp             HHGGGCCCT
T ss_pred             HHHHhccCC
Confidence              4555443

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=4.6e-37  Score=258.56  Aligned_cols=193  Identities=22%  Similarity=0.325  Sum_probs=157.4

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      ++||||+++++++...      ..++||||+. ++|.+++... +.+++..+..++.||+.||+|||++|++|+||||+|
T Consensus        78 l~h~~i~~~~~~~~~~------~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~N  151 (291)
T 1u46_A           78 LDHRNLIRLYGVVLTP------PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARN  151 (291)
T ss_dssp             CCCTTBCCEEEEECSS------SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred             CCCCCcccEEEEEccC------CceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchhe
Confidence            5799999999999653      3789999997 6999999764 569999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCCCc----cccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCh
Q 023609           79 LLLNANCDLKICDFGLARVTSETDF----MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDH  153 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~  153 (280)
                      |+++.++.++|+|||.+........    .....++..|+|||++.+. .++.++||||+|+++++|++ |..||.+.+.
T Consensus       152 ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~~g~~p~~~~~~  230 (291)
T 1u46_A          152 LLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTR-TFSHASDTWMFGVTLWEMFTYGQEPWIGLNG  230 (291)
T ss_dssp             EEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred             EEEcCCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCC-CCCchhhHHHHHHHHHHHHhCCCCCcccCCH
Confidence            9999999999999999987544321    1234567789999988543 47889999999999999999 9999988876


Q ss_pred             HHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          154 VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                      .+....+......+                            ...+.++.++.++|.+||+.||.+|||+.++++
T Consensus       231 ~~~~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~  277 (291)
T 1u46_A          231 SQILHKIDKEGERL----------------------------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD  277 (291)
T ss_dssp             HHHHHHHHTSCCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHccCCCC----------------------------CCCcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            66554443211111                            112367899999999999999999999999987

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=2.9e-37  Score=264.82  Aligned_cols=197  Identities=23%  Similarity=0.387  Sum_probs=140.6

Q ss_pred             CCCCeeeeeceecCCC---CCCCCcEEEEeecCCccHHHHHHc---CCCCCHHHHHHHHHHHHHHHHHHHHCC--ceecc
Q 023609            2 DHENVVAIRDIIPPPQ---RESFNDVYIAYELMDTDLHQIIRS---NQALSEEHCQYFLYQILRGLKYIHSAN--VLHRD   73 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~---~~~~~~~~iv~e~~~g~L~~~l~~---~~~l~~~~~~~i~~qll~al~~LH~~g--i~H~d   73 (280)
                      +||||+++++++....   ......+++||||++|+|.+++..   .+.+++..++.++.||+.||+|||+.|  ++|||
T Consensus        84 ~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~D  163 (337)
T 3ll6_A           84 GHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRD  163 (337)
T ss_dssp             TSTTBCCEEEEEEECTTTSTTSSEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCC
T ss_pred             cCCChhhccccccccccccccCCceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEcc
Confidence            4999999999984321   122356899999999999998864   567999999999999999999999999  99999


Q ss_pred             CCCCcEEEccCCCEEEeeccceeeccCCCcc-------------ccceeccccccchhcc--CCCCCCcchhHHHHHHHH
Q 023609           74 LKPSNLLLNANCDLKICDFGLARVTSETDFM-------------TEYVVTRWYRAPELLL--NSSDYTAAIDVWSVGCIF  138 (280)
Q Consensus        74 i~~~nili~~~~~~~l~dfg~~~~~~~~~~~-------------~~~~~~~~y~aPE~~~--~~~~~~~~~DiwslG~il  138 (280)
                      |||+||+++.++.++|+|||++.........             ....+++.|+|||++.  ....++.++||||+||++
T Consensus       164 ikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il  243 (337)
T 3ll6_A          164 LKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCIL  243 (337)
T ss_dssp             CCGGGCEECTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHH
T ss_pred             CCcccEEECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHH
Confidence            9999999999999999999999865443211             1345889999999873  234578899999999999


Q ss_pred             HHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCC
Q 023609          139 MELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPR  218 (280)
Q Consensus       139 ~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~  218 (280)
                      |+|++|..||.+.........   ...                             .......+..+.+||++||+.||.
T Consensus       244 ~el~~g~~p~~~~~~~~~~~~---~~~-----------------------------~~~~~~~~~~~~~li~~~l~~~p~  291 (337)
T 3ll6_A          244 YLLCFRQHPFEDGAKLRIVNG---KYS-----------------------------IPPHDTQYTVFHSLIRAMLQVNPE  291 (337)
T ss_dssp             HHHHHSSCCC---------------CC-----------------------------CCTTCCSSGGGHHHHHHHSCSSGG
T ss_pred             HHHHhCCCCCcchhHHHhhcC---ccc-----------------------------CCcccccchHHHHHHHHHccCChh
Confidence            999999999965433221110   000                             011135567899999999999999


Q ss_pred             CCCCHHHHhcCC
Q 023609          219 QRITVEDALAHP  230 (280)
Q Consensus       219 ~R~t~~ell~h~  230 (280)
                      +|||+.+++++-
T Consensus       292 ~Rps~~e~l~~l  303 (337)
T 3ll6_A          292 ERLSIAEVVHQL  303 (337)
T ss_dssp             GSCCHHHHHHHH
T ss_pred             hCcCHHHHHHHH
Confidence            999999999874

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=7.9e-37  Score=272.76  Aligned_cols=199  Identities=28%  Similarity=0.417  Sum_probs=158.7

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS--NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS   77 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~--~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~   77 (280)
                      |+||||+++++++..      ...|+||||++ |+|.+++..  ...+++..+..++.||+.||+|||++|++||||||+
T Consensus       236 l~hp~iv~~~~~~~~------~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~  309 (452)
T 1fmk_A          236 LRHEKLVQLYAVVSE------EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAA  309 (452)
T ss_dssp             CCCTTBCCEEEEECS------SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred             CCCCCEeeEEEEEcC------CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChh
Confidence            589999999999853      35799999997 699999974  356999999999999999999999999999999999


Q ss_pred             cEEEccCCCEEEeeccceeeccCCC--ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 023609           78 NLLLNANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHV  154 (280)
Q Consensus        78 nili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~  154 (280)
                      ||+++.++.++|+|||+++......  ......++..|+|||++... .++.++||||+||++|+|++ |..||.+....
T Consensus       310 Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~  388 (452)
T 1fmk_A          310 NILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNR  388 (452)
T ss_dssp             GEEECGGGCEEECCCCTTC--------------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH
T ss_pred             hEEECCCCCEEECCCccceecCCCceecccCCcccccccCHhHHhcC-CCCccccHHhHHHHHHHHHhCCCCCCCCCCHH
Confidence            9999999999999999998654332  12233456789999988544 58999999999999999999 99999888776


Q ss_pred             HHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc--CCCC
Q 023609          155 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA--HPYL  232 (280)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~--h~~~  232 (280)
                      +....+......+                             .-+.+++.+.++|.+||+.||++|||+.++++  ..++
T Consensus       389 ~~~~~i~~~~~~~-----------------------------~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~  439 (452)
T 1fmk_A          389 EVLDQVERGYRMP-----------------------------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  439 (452)
T ss_dssp             HHHHHHHTTCCCC-----------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred             HHHHHHHcCCCCC-----------------------------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence            6555443221111                             11367889999999999999999999999987  4666


Q ss_pred             CCC
Q 023609          233 GSL  235 (280)
Q Consensus       233 ~~~  235 (280)
                      .+.
T Consensus       440 ~~~  442 (452)
T 1fmk_A          440 TST  442 (452)
T ss_dssp             SCS
T ss_pred             ccC
Confidence            553

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=4.5e-37  Score=262.94  Aligned_cols=210  Identities=22%  Similarity=0.300  Sum_probs=156.3

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCC----CCCHHHHHHHHHHHHHHHHHHHHC---Cceec
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ----ALSEEHCQYFLYQILRGLKYIHSA---NVLHR   72 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~----~l~~~~~~~i~~qll~al~~LH~~---gi~H~   72 (280)
                      ++||||+++++++...     ...++||||++ |+|.+++....    .+++..+..++.|++.||+|||+.   |++||
T Consensus        84 l~h~~iv~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~  158 (326)
T 3uim_A           84 AVHRNLLRLRGFCMTP-----TERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHR  158 (326)
T ss_dssp             CCCTTBCCCCEEECCS-----SCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECC
T ss_pred             ccCCCccceEEEEecC-----CceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeC
Confidence            5799999999999765     66899999997 59999998643    499999999999999999999999   99999


Q ss_pred             cCCCCcEEEccCCCEEEeeccceeeccCCC--ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 023609           73 DLKPSNLLLNANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPG  150 (280)
Q Consensus        73 di~~~nili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~  150 (280)
                      ||||+||+++.++.++|+|||++.......  ......+|+.|+|||.+.+. .++.++||||+||++|+|++|..||..
T Consensus       159 Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~Di~slG~il~~l~~g~~pf~~  237 (326)
T 3uim_A          159 DVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG-KSSEKTDVFGYGVMLLELITGQRAFDL  237 (326)
T ss_dssp             CCSGGGEEECTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHS-EECHHHHHHHHHHHHHHHHHCCCSBCH
T ss_pred             CCchhhEEECCCCCEEeccCccccccCcccccccccccCCcCccCHHHhccC-CCCccccchhHHHHHHHHHhCCCcccc
Confidence            999999999999999999999998654332  22334589999999988544 478999999999999999999999952


Q ss_pred             C-----ChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCcccccc-ccccCCCCChHHHHHHHHhhcCCCCCCCCHH
Q 023609          151 R-----DHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQS-FTEKFPNVHPSAIDLVEKMLTFDPRQRITVE  224 (280)
Q Consensus       151 ~-----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~  224 (280)
                      .     .................                 ........ .....+..+..+.+++.+||+.||.+|||+.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~  300 (326)
T 3uim_A          238 ARLANDDDVMLLDWVKGLLKEKK-----------------LEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMS  300 (326)
T ss_dssp             HHHTTTSCSBHHHHHTTTTSSCC-----------------STTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHH
T ss_pred             cccccccchhHHHHHHHHhhchh-----------------hhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHH
Confidence            1     00000000000000000                 00000000 0001112346789999999999999999999


Q ss_pred             HHhcCCCCC
Q 023609          225 DALAHPYLG  233 (280)
Q Consensus       225 ell~h~~~~  233 (280)
                      ++++|-.-.
T Consensus       301 ell~~L~~~  309 (326)
T 3uim_A          301 EVVRMLEGD  309 (326)
T ss_dssp             HHHHHHHTS
T ss_pred             HHHHHhcCc
Confidence            999976543

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=8.6e-37  Score=260.57  Aligned_cols=209  Identities=22%  Similarity=0.312  Sum_probs=156.9

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      |+||||+++++++....   ...+++||||++ |+|.+++... .+++..++.++.||+.||+|||+.|++||||||+||
T Consensus        90 l~h~~iv~~~~~~~~~~---~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Ni  165 (318)
T 3lxp_A           90 LYHEHIIKYKGCCEDAG---AASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNV  165 (318)
T ss_dssp             CCCTTBCCEEEEEEETT---TTEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred             CCCcchhhEEEEEecCC---CceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheE
Confidence            58999999999997642   267899999997 5999999764 499999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCC----ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 023609           80 LLNANCDLKICDFGLARVTSETD----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVH  155 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~  155 (280)
                      +++.++.++|+|||.+.......    ......++..|+|||.+.+. .++.++||||+||++++|++|..||.......
T Consensus       166 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~  244 (318)
T 3lxp_A          166 LLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEY-KFYYASDVWSFGVTLYELLTHCDSSQSPPTKF  244 (318)
T ss_dssp             EECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH
T ss_pred             EEcCCCCEEECCccccccccccccccccccCCCCCceeeChHHhcCC-CCCcHHHHHHHHHHHHHHHhCCCcccccchhh
Confidence            99999999999999998765432    12334567889999998544 47889999999999999999999986432111


Q ss_pred             HHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          156 QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                           .............   ...........      .....+.+++++.+||++||+.||.+|||+.++++
T Consensus       245 -----~~~~~~~~~~~~~---~~~~~~~~~~~------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  303 (318)
T 3lxp_A          245 -----LELIGIAQGQMTV---LRLTELLERGE------RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP  303 (318)
T ss_dssp             -----HHHHCSCCHHHHH---HHHHHHHHTTC------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----hhhhcccccchhH---HHHHHHHhccc------CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence                 1111111111000   00001111100      11122467899999999999999999999999985

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=2e-37  Score=266.20  Aligned_cols=225  Identities=20%  Similarity=0.277  Sum_probs=155.3

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC---------Cce
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA---------NVL   70 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~---------gi~   70 (280)
                      ++||||+++++.+......+...+|+||||++ |+|.+++... ..++..+..++.||+.||+|||+.         ||+
T Consensus        64 ~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~iv  142 (336)
T 3g2f_A           64 MEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAIS  142 (336)
T ss_dssp             CCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEE
T ss_pred             ccCcchhhheecccccccCCCceEEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHHHHHHHHHHHhhhcccccccccee
Confidence            57999999998654333233357899999996 6999999764 469999999999999999999999         999


Q ss_pred             eccCCCCcEEEccCCCEEEeeccceeeccCCC---------ccccceeccccccchhccCC------CCCCcchhHHHHH
Q 023609           71 HRDLKPSNLLLNANCDLKICDFGLARVTSETD---------FMTEYVVTRWYRAPELLLNS------SDYTAAIDVWSVG  135 (280)
Q Consensus        71 H~di~~~nili~~~~~~~l~dfg~~~~~~~~~---------~~~~~~~~~~y~aPE~~~~~------~~~~~~~DiwslG  135 (280)
                      ||||||+||+++.++.++|+|||++.......         ......+|+.|+|||++.+.      ..++.++||||+|
T Consensus       143 H~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG  222 (336)
T 3g2f_A          143 HRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALG  222 (336)
T ss_dssp             CSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHH
T ss_pred             ecccccceEEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHH
Confidence            99999999999999999999999998654321         12234689999999998542      2345689999999


Q ss_pred             HHHHHHHhCCCCC-CCCChHHHHHHHHHHh-CCCCHHHHhHhhHhHHHHhhhcCccccccccccCC---CCChHHHHHHH
Q 023609          136 CIFMELMDRKPLF-PGRDHVHQLRLLIELI-GTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP---NVHPSAIDLVE  210 (280)
Q Consensus       136 ~il~~ll~g~~pf-~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~li~  210 (280)
                      |++|+|++|..|| .+.............. ..+......       .....  ......+...++   .+++++.+||.
T Consensus       223 ~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~--~~~~~~~~~~~~~~~~~~~~l~~li~  293 (336)
T 3g2f_A          223 LIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQ-------VLVSR--EKQRPKFPEAWKENSLAVRSLKETIE  293 (336)
T ss_dssp             HHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHH-------HHHTT--SCCCCCCCTTCCCCSHHHHHHHHHHH
T ss_pred             HHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHH-------hhhcc--cccCCCCCcccccccchHHHHHHHHH
Confidence            9999999996554 3332111111111111 111111110       00000  000111111111   23457999999


Q ss_pred             HhhcCCCCCCCCHHHHhc------CCCCCCC
Q 023609          211 KMLTFDPRQRITVEDALA------HPYLGSL  235 (280)
Q Consensus       211 ~~L~~dp~~R~t~~ell~------h~~~~~~  235 (280)
                      +||+.||++|||+.++++      ++|-++-
T Consensus       294 ~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~~  324 (336)
T 3g2f_A          294 DCWDQDAEARLTAQXAEERMAELMMIWERNK  324 (336)
T ss_dssp             HHSCSSGGGSCCHHHHHHHHHHHHHCCCC--
T ss_pred             HHhcCChhhCcchHHHHHHHHHHHHHHHhcc
Confidence            999999999999999944      7777664

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.7e-38  Score=276.93  Aligned_cols=220  Identities=18%  Similarity=0.301  Sum_probs=158.8

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ---ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKP   76 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~---~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~   76 (280)
                      |+||||+++++++.....   ...|+||||++ |+|.+++....   .+++..++.++.||+.||+|||+.||+||||||
T Consensus        64 l~hpnIv~~~~~~~~~~~---~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp  140 (396)
T 4eut_A           64 LNHKNIVKLFAIEEETTT---RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKP  140 (396)
T ss_dssp             CCCTTBCCEEEEEECTTT---CCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred             cCCCCCCeEEEeeccCCC---CeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCH
Confidence            589999999999866532   46899999997 69999997543   399999999999999999999999999999999


Q ss_pred             CcEEE----ccCCCEEEeeccceeeccCCCccccceeccccccchhccCC-------CCCCcchhHHHHHHHHHHHHhCC
Q 023609           77 SNLLL----NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNS-------SDYTAAIDVWSVGCIFMELMDRK  145 (280)
Q Consensus        77 ~nili----~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-------~~~~~~~DiwslG~il~~ll~g~  145 (280)
                      +||++    +.++.++|+|||.+.............+|+.|+|||++.+.       ..++.++||||+||++|+|++|.
T Consensus       141 ~NIll~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~  220 (396)
T 4eut_A          141 GNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS  220 (396)
T ss_dssp             GGEEEEECTTSCEEEEECCGGGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSS
T ss_pred             HHEEEeecCCCceeEEEecCCCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCC
Confidence            99999    77778999999999877665555566789999999987531       34678999999999999999999


Q ss_pred             CCCCCC----ChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCC
Q 023609          146 PLFPGR----DHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI  221 (280)
Q Consensus       146 ~pf~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~  221 (280)
                      .||.+.    ...+.+..+..  +.|.. .+............+...  ..........++..+.++|++||+.||++||
T Consensus       221 ~Pf~~~~~~~~~~~~~~~~~~--~~p~~-~~~~~~~~~~~~~~~~~~--~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~  295 (396)
T 4eut_A          221 LPFRPFEGPRRNKEVMYKIIT--GKPSG-AISGVQKAENGPIDWSGD--MPVSCSLSRGLQVLLTPVLANILEADQEKCW  295 (396)
T ss_dssp             CSEECTTCTTTCHHHHHHHHH--SCCTT-CCEEEECSTTCCEEEESS--CCTTCSSCHHHHHHHHHHHHHHSCCCTTTSC
T ss_pred             CCCCCCCcccchHHHHHHHhc--CCCcc-cchhheeccCCCcccCcc--CCcccccchHHHhhchHHHHHhhccChhhhc
Confidence            999643    22333333322  12211 100000000000000000  0000111123456789999999999999999


Q ss_pred             CHHHHhc
Q 023609          222 TVEDALA  228 (280)
Q Consensus       222 t~~ell~  228 (280)
                      |+.++++
T Consensus       296 s~~e~l~  302 (396)
T 4eut_A          296 GFDQFFA  302 (396)
T ss_dssp             CHHHHHH
T ss_pred             cHHHHHH
Confidence            9999855

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=4.8e-36  Score=254.83  Aligned_cols=195  Identities=28%  Similarity=0.441  Sum_probs=146.2

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS----NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK   75 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~----~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~   75 (280)
                      |+||||+++++++...     ...++||||++ ++|.+++..    +..+++..++.++.||+.||+|||+.|++|+||+
T Consensus        89 l~h~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~  163 (310)
T 2wqm_A           89 LNHPNVIKYYASFIED-----NELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIK  163 (310)
T ss_dssp             CCCTTBCCEEEEEEET-----TEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred             CCCCCEeeEEEEEEcC-----CcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCc
Confidence            5899999999999765     67999999998 499998863    4679999999999999999999999999999999


Q ss_pred             CCcEEEccCCCEEEeeccceeeccCCC-ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH
Q 023609           76 PSNLLLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHV  154 (280)
Q Consensus        76 ~~nili~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  154 (280)
                      |+||+++.++.++|+|||++....... ......+++.|+|||.+.+ ..++.++||||+|+++++|++|..||.+....
T Consensus       164 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~  242 (310)
T 2wqm_A          164 PANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN  242 (310)
T ss_dssp             GGGEEECTTSCEEECCC------------------CCSSCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTTC---CC
T ss_pred             HHHEEEcCCCCEEEEeccceeeecCCCccccccCCCeeEeChHHhCC-CCCCchhhHHHHHHHHHHHHhCCCCCcccchh
Confidence            999999999999999999987654332 2234568899999998854 45889999999999999999999999754321


Q ss_pred             -HHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          155 -HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       155 -~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                       ............+.                           .....++.++.++|.+||+.||.+|||+.++++
T Consensus       243 ~~~~~~~~~~~~~~~---------------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~  290 (310)
T 2wqm_A          243 LYSLCKKIEQCDYPP---------------------------LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYD  290 (310)
T ss_dssp             HHHHHHHHHTTCSCC---------------------------CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHhhcccCCC---------------------------CcccccCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence             11111111110000                           011367889999999999999999999999986

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=6.1e-37  Score=281.46  Aligned_cols=228  Identities=25%  Similarity=0.339  Sum_probs=164.8

Q ss_pred             CCCCCeeeeeceecCCC-CCCCCcEEEEeecCC-ccHHHHHHcCC---CCCHHHHHHHHHHHHHHHHHHHHCCceeccCC
Q 023609            1 MDHENVVAIRDIIPPPQ-RESFNDVYIAYELMD-TDLHQIIRSNQ---ALSEEHCQYFLYQILRGLKYIHSANVLHRDLK   75 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~-~~~~~~~~iv~e~~~-g~L~~~l~~~~---~l~~~~~~~i~~qll~al~~LH~~gi~H~di~   75 (280)
                      |+||||+++++++.... .......|+||||++ |+|.+++....   .+++..++.++.||+.||+|||+.|++|||||
T Consensus        69 L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLK  148 (676)
T 3qa8_A           69 LNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLK  148 (676)
T ss_dssp             CCBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCC
T ss_pred             CCCCCCCceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCC
Confidence            58999999999986522 111366899999996 69999998644   59999999999999999999999999999999


Q ss_pred             CCcEEEccCCC---EEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Q 023609           76 PSNLLLNANCD---LKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD  152 (280)
Q Consensus        76 ~~nili~~~~~---~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~  152 (280)
                      |+||+++.++.   ++|+|||.+.............+++.|+|||.+.+ ..++.++||||+||++|+|++|..||.+..
T Consensus       149 P~NILl~~~g~~~~vKL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~s~ksDIwSLGviLyeLltG~~Pf~~~~  227 (676)
T 3qa8_A          149 PENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNW  227 (676)
T ss_dssp             STTEEEECCSSSCEEEECSCCCCCBTTSCCCCCCCCSCCTTCSSCSSCC-SCCSTTHHHHHHHHHHHHHHSSCSSCCSSC
T ss_pred             HHHeEeecCCCceeEEEcccccccccccccccccccCCcccCChHHhcc-CCCCchhHHHHHHHHHHHHHHCCCCCCccc
Confidence            99999997765   89999999988766655556788999999998854 458999999999999999999999997654


Q ss_pred             hHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccc--cccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCC
Q 023609          153 HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQ--RQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHP  230 (280)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~  230 (280)
                      ........   ..............     ........  ........+.+++.+.++|.+||+.||.+|||+.++++||
T Consensus       228 ~~~~~~~~---i~~~~~~~~~~~~~-----l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp  299 (676)
T 3qa8_A          228 QPVQWHGK---VREKSNEHIVVYDD-----LTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVG  299 (676)
T ss_dssp             HHHHSSTT---CC------CCSCCC-----CSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCT
T ss_pred             chhhhhhh---hhcccchhhhhhhh-----hccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCH
Confidence            32211000   00000000000000     00000000  0011122234678899999999999999999999999999


Q ss_pred             CCCCCcC
Q 023609          231 YLGSLHD  237 (280)
Q Consensus       231 ~~~~~~~  237 (280)
                      ||+.+..
T Consensus       300 ~F~~l~~  306 (676)
T 3qa8_A          300 CFQALDS  306 (676)
T ss_dssp             THHHHHH
T ss_pred             HHHHHHH
Confidence            9987643

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.7e-36  Score=277.47  Aligned_cols=192  Identities=20%  Similarity=0.308  Sum_probs=155.5

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      |+||||+++++++..      ...|+||||++ |+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|
T Consensus       393 l~hpniv~l~~~~~~------~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~N  466 (613)
T 2ozo_A          393 LDNPYIVRLIGVCQA------EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARN  466 (613)
T ss_dssp             CCCTTBCCEEEEEES------SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             CCCCCEeeEEEEecc------CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHH
Confidence            589999999999854      34899999997 6999999754 469999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCCCc----cccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCh
Q 023609           79 LLLNANCDLKICDFGLARVTSETDF----MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDH  153 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~  153 (280)
                      |+++.++.+||+|||+++.......    .....+++.|+|||++.+ ..++.++||||+||++|+|++ |..||.+.+.
T Consensus       467 ILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~-~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~  545 (613)
T 2ozo_A          467 VLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG  545 (613)
T ss_dssp             EEEEETTEEEECCCSTTTTCC--------------CCTTSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS
T ss_pred             EEEcCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH
Confidence            9999999999999999976543221    112334578999999854 458999999999999999998 9999998877


Q ss_pred             HHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          154 VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                      .+....+......                             ..-+.+++++.++|.+||+.||.+|||+.++++
T Consensus       546 ~~~~~~i~~~~~~-----------------------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~  591 (613)
T 2ozo_A          546 PEVMAFIEQGKRM-----------------------------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQ  591 (613)
T ss_dssp             HHHHHHHHTTCCC-----------------------------CCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHcCCCC-----------------------------CCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            6655544321111                             111367899999999999999999999998854

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3e-36  Score=258.70  Aligned_cols=204  Identities=22%  Similarity=0.296  Sum_probs=150.3

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC--------Ccee
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA--------NVLH   71 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~--------gi~H   71 (280)
                      ++||||+++++++..... .....|+||||++ |+|.+++... .+++..++.++.|++.||+|||+.        |++|
T Consensus        88 ~~h~~i~~~~~~~~~~~~-~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH  165 (337)
T 3mdy_A           88 MRHENILGFIAADIKGTG-SWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAH  165 (337)
T ss_dssp             CCCTTBCCEEEEEEESCG-GGCEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEEC
T ss_pred             hcCCCeeeEEEEEccCCC-CCCceEEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEe
Confidence            489999999999866421 2256899999997 5999999764 699999999999999999999999        9999


Q ss_pred             ccCCCCcEEEccCCCEEEeeccceeeccCCCc-----cccceeccccccchhccCCCCCCc------chhHHHHHHHHHH
Q 023609           72 RDLKPSNLLLNANCDLKICDFGLARVTSETDF-----MTEYVVTRWYRAPELLLNSSDYTA------AIDVWSVGCIFME  140 (280)
Q Consensus        72 ~di~~~nili~~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~------~~DiwslG~il~~  140 (280)
                      |||||+||+++.++.++|+|||++........     .....+|+.|+|||++.+.. ...      ++||||+||++|+
T Consensus       166 ~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~~~~~~DiwslG~il~e  244 (337)
T 3mdy_A          166 RDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESL-NRNHFQSYIMADMYSFGLILWE  244 (337)
T ss_dssp             SCCCGGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCC-CTTCTHHHHHHHHHHHHHHHHH
T ss_pred             cccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhccccc-CCccccCccccchHHHHHHHHH
Confidence            99999999999999999999999976543321     12457899999999986543 333      3899999999999


Q ss_pred             HHhC----------CCCCCCCC----hHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHH
Q 023609          141 LMDR----------KPLFPGRD----HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAI  206 (280)
Q Consensus       141 ll~g----------~~pf~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  206 (280)
                      |++|          ..||....    ...............                   +..   ........+++++.
T Consensus       245 l~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~-------------------~~~---~~~~~~~~~~~~l~  302 (337)
T 3mdy_A          245 VARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLR-------------------PSF---PNRWSSDECLRQMG  302 (337)
T ss_dssp             HHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCC-------------------CCC---CGGGGGSHHHHHHH
T ss_pred             HHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhccC-------------------ccc---cccchhhHHHHHHH
Confidence            9999          55664321    111111111000000                   000   00000113456799


Q ss_pred             HHHHHhhcCCCCCCCCHHHHhcC
Q 023609          207 DLVEKMLTFDPRQRITVEDALAH  229 (280)
Q Consensus       207 ~li~~~L~~dp~~R~t~~ell~h  229 (280)
                      ++|.+||+.||.+|||+.+++++
T Consensus       303 ~li~~~l~~dP~~Rps~~ell~~  325 (337)
T 3mdy_A          303 KLMTECWAHNPASRLTALRVKKT  325 (337)
T ss_dssp             HHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             HHHHHhhhhChhhCCCHHHHHHH
Confidence            99999999999999999999875

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=9.7e-37  Score=259.84  Aligned_cols=201  Identities=25%  Similarity=0.359  Sum_probs=153.4

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS----NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK   75 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~----~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~   75 (280)
                      ++||||+++++++.... ......|+||||+. |+|.+++..    +..+++..++.++.||+.||+|||+.|++|||||
T Consensus        83 l~h~~iv~~~~~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlk  161 (317)
T 2buj_A           83 FNHPNILRLVAYCLRER-GAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLK  161 (317)
T ss_dssp             CCCTTBCCCCEEEEEEE-TTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCC
T ss_pred             cCCCCeeeEEEEEEecc-CCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCC
Confidence            58999999999986431 12257899999998 599999875    4679999999999999999999999999999999


Q ss_pred             CCcEEEccCCCEEEeeccceeeccCCCc----------cccceeccccccchhccCCC--CCCcchhHHHHHHHHHHHHh
Q 023609           76 PSNLLLNANCDLKICDFGLARVTSETDF----------MTEYVVTRWYRAPELLLNSS--DYTAAIDVWSVGCIFMELMD  143 (280)
Q Consensus        76 ~~nili~~~~~~~l~dfg~~~~~~~~~~----------~~~~~~~~~y~aPE~~~~~~--~~~~~~DiwslG~il~~ll~  143 (280)
                      |+||+++.++.++|+|||.+........          .....+++.|+|||.+.+..  .++.++||||+||++|+|++
T Consensus       162 p~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~  241 (317)
T 2buj_A          162 PTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMF  241 (317)
T ss_dssp             GGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHH
T ss_pred             HHHEEEcCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHh
Confidence            9999999999999999998875432110          11234688999999875432  25789999999999999999


Q ss_pred             CCCCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCH
Q 023609          144 RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV  223 (280)
Q Consensus       144 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~  223 (280)
                      |..||......          .. .          .........      .....+.+++++.++|.+||+.||.+|||+
T Consensus       242 g~~p~~~~~~~----------~~-~----------~~~~~~~~~------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~  294 (317)
T 2buj_A          242 GEGPYDMVFQK----------GD-S----------VALAVQNQL------SIPQSPRHSSALWQLLNSMMTVDPHQRPHI  294 (317)
T ss_dssp             SSCTTHHHHHT----------TS-C----------HHHHHHCC--------CCCCTTSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             CCCChhhhhcc----------cc-h----------hhHHhhccC------CCCccccCCHHHHHHHHHHhhcChhhCCCH
Confidence            99999421000          00 0          000000000      001124678899999999999999999999


Q ss_pred             HHHhcC
Q 023609          224 EDALAH  229 (280)
Q Consensus       224 ~ell~h  229 (280)
                      .+++++
T Consensus       295 ~~ll~~  300 (317)
T 2buj_A          295 PLLLSQ  300 (317)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            999985

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=8.3e-36  Score=276.83  Aligned_cols=192  Identities=26%  Similarity=0.441  Sum_probs=157.6

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ-ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~-~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      ++||||+++++++..      +..|+||||++ |+|.+++..++ .+++..+..++.||+.||+|||++||+||||||+|
T Consensus       448 l~HpnIv~l~~~~~~------~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~N  521 (656)
T 2j0j_A          448 FDHPHIVKLIGVITE------NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARN  521 (656)
T ss_dssp             CCCTTBCCEEEEECS------SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             CCCCCCCeEEEEEec------CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHh
Confidence            589999999999843      45799999998 69999998654 69999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCCCc--cccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 023609           79 LLLNANCDLKICDFGLARVTSETDF--MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVH  155 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~  155 (280)
                      |+++.++.++|+|||++........  .....+++.|+|||++.+. .++.++||||+||++|+|++ |..||.+....+
T Consensus       522 ILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~  600 (656)
T 2j0j_A          522 VLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNND  600 (656)
T ss_dssp             EEEEETTEEEECCCCCCCSCCC----------CCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred             EEEeCCCCEEEEecCCCeecCCCcceeccCCCCCcceeCHHHhcCC-CCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH
Confidence            9999999999999999986544321  2234557789999998544 58999999999999999997 999999887776


Q ss_pred             HHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          156 QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                      ....+......+                             ..+.+++.+.++|.+||+.||.+|||+.++++
T Consensus       601 ~~~~i~~~~~~~-----------------------------~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~  644 (656)
T 2j0j_A          601 VIGRIENGERLP-----------------------------MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKA  644 (656)
T ss_dssp             HHHHHHHTCCCC-----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHcCCCCC-----------------------------CCccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            655554322111                             11367889999999999999999999999875

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=3e-36  Score=274.21  Aligned_cols=199  Identities=28%  Similarity=0.417  Sum_probs=162.0

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS--NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS   77 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~--~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~   77 (280)
                      |+||||+++++++..      ...||||||++ |+|.+++..  ...+++.++..++.||+.||+|||++||+||||||+
T Consensus       319 l~hpniv~~~~~~~~------~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~  392 (535)
T 2h8h_A          319 LRHEKLVQLYAVVSE------EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAA  392 (535)
T ss_dssp             CCCTTBCCEEEEECS------SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred             CCCCCEeeEEEEEee------ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHh
Confidence            589999999999843      35799999997 699999974  356999999999999999999999999999999999


Q ss_pred             cEEEccCCCEEEeeccceeeccCCC--ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 023609           78 NLLLNANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHV  154 (280)
Q Consensus        78 nili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~  154 (280)
                      ||+++.++.+||+|||+++......  ......++..|+|||++... .++.++|||||||++|+|++ |..||.+....
T Consensus       393 NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~  471 (535)
T 2h8h_A          393 NILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNR  471 (535)
T ss_dssp             GEEECGGGCEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHH
T ss_pred             hEEEcCCCcEEEcccccceecCCCceecccCCcCcccccCHHHhccC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            9999999999999999997654321  11233456789999988544 58999999999999999999 89999888776


Q ss_pred             HHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc--CCCC
Q 023609          155 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA--HPYL  232 (280)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~--h~~~  232 (280)
                      +....+......+                             .-+.++.++.+||.+||+.||++|||+.++++  ..++
T Consensus       472 ~~~~~i~~~~~~~-----------------------------~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~  522 (535)
T 2h8h_A          472 EVLDQVERGYRMP-----------------------------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  522 (535)
T ss_dssp             HHHHHHHTTCCCC-----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSS
T ss_pred             HHHHHHHcCCCCC-----------------------------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence            6555443221111                             11367889999999999999999999999987  3555


Q ss_pred             CCC
Q 023609          233 GSL  235 (280)
Q Consensus       233 ~~~  235 (280)
                      ...
T Consensus       523 ~~~  525 (535)
T 2h8h_A          523 TST  525 (535)
T ss_dssp             CCC
T ss_pred             hcc
Confidence            543

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=2.6e-35  Score=264.18  Aligned_cols=197  Identities=17%  Similarity=0.212  Sum_probs=153.5

Q ss_pred             CCC-CCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDH-ENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~H-pnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      |+| ++|..+..++...     ...+|||||++++|.+++.. .+.+++..++.|+.||+.||+|||++||+||||||+|
T Consensus        59 L~~~~~i~~i~~~~~~~-----~~~~lvme~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~N  133 (483)
T 3sv0_A           59 LQGGTGIPNVRWFGVEG-----DYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDN  133 (483)
T ss_dssp             TTTSTTCCCEEEEEEET-----TEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred             hcCCCCCCeEEEEEeeC-----CEEEEEEECCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcce
Confidence            345 4555555554333     67899999999999999984 5679999999999999999999999999999999999


Q ss_pred             EEE---ccCCCEEEeeccceeeccCCCc--------cccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCC
Q 023609           79 LLL---NANCDLKICDFGLARVTSETDF--------MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL  147 (280)
Q Consensus        79 ili---~~~~~~~l~dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p  147 (280)
                      |++   +.++.++|+|||+++.......        .....+|+.|+|||++.+. .++.++|||||||++|+|++|..|
T Consensus       134 ILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~-~~s~~sDvwSlGvil~elltG~~P  212 (483)
T 3sv0_A          134 FLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGI-EQSRRDDLESLGYVLMYFLRGSLP  212 (483)
T ss_dssp             EEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTC-CCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred             EEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCC-CCChHHHHHHHHHHHHHHHhCCCC
Confidence            999   6889999999999987554322        1255789999999998554 489999999999999999999999


Q ss_pred             CCCCCh---HHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHH
Q 023609          148 FPGRDH---VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVE  224 (280)
Q Consensus       148 f~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~  224 (280)
                      |.+...   .+.+..+......                         ........+++.++.++|.+||+.||.+||++.
T Consensus       213 f~~~~~~~~~~~~~~i~~~~~~-------------------------~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~  267 (483)
T 3sv0_A          213 WQGLKAGTKKQKYEKISEKKVA-------------------------TSIEALCRGYPTEFASYFHYCRSLRFDDKPDYS  267 (483)
T ss_dssp             TSSCCCSSHHHHHHHHHHHHHH-------------------------SCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHH
T ss_pred             CccccchhHHHHHHHHhhcccc-------------------------ccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHH
Confidence            987543   2222222211100                         011122246789999999999999999999998


Q ss_pred             HHhc
Q 023609          225 DALA  228 (280)
Q Consensus       225 ell~  228 (280)
                      ++++
T Consensus       268 el~~  271 (483)
T 3sv0_A          268 YLKR  271 (483)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            7765

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=6.7e-37  Score=270.24  Aligned_cols=177  Identities=17%  Similarity=0.240  Sum_probs=146.5

Q ss_pred             CcEEEEeecCCccHHHHHH------c-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCCEEEeeccc
Q 023609           22 NDVYIAYELMDTDLHQIIR------S-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGL   94 (280)
Q Consensus        22 ~~~~iv~e~~~g~L~~~l~------~-~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nili~~~~~~~l~dfg~   94 (280)
                      ..++++|++++++|.++++      . ++.+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+
T Consensus       178 ~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiKp~NILl~~~~~~kL~DFG~  257 (413)
T 3dzo_A          178 LSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEH  257 (413)
T ss_dssp             CSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGG
T ss_pred             cceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcccceEEEecCCeEEEEeccc
Confidence            4589999999999999984      1 33588889999999999999999999999999999999999999999999999


Q ss_pred             eeeccCCCccccceeccccccchhcc---------CCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Q 023609           95 ARVTSETDFMTEYVVTRWYRAPELLL---------NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIG  165 (280)
Q Consensus        95 ~~~~~~~~~~~~~~~~~~y~aPE~~~---------~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~  165 (280)
                      ++..+..  .....+ +.|+|||++.         ....++.++||||+||++|+|++|+.||.+.+.....        
T Consensus       258 a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~--------  326 (413)
T 3dzo_A          258 LVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGS--------  326 (413)
T ss_dssp             CEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCS--------
T ss_pred             eeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhH--------
Confidence            8876544  334566 9999999983         3334778999999999999999999999765321110        


Q ss_pred             CCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCC
Q 023609          166 TPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  235 (280)
Q Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~  235 (280)
                                                .......+.+++++++||.+||+.||.+|||+.++++||||+.+
T Consensus       327 --------------------------~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~  370 (413)
T 3dzo_A          327 --------------------------EWIFRSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL  370 (413)
T ss_dssp             --------------------------GGGGSSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             --------------------------HHHHhhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHH
Confidence                                      00112224678999999999999999999999999999999865

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.2e-35  Score=254.36  Aligned_cols=211  Identities=20%  Similarity=0.329  Sum_probs=156.0

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      |+||||+++++++.....   ...++||||++ ++|.+++... ..+++..+..++.||+.||++||+.|++||||||+|
T Consensus        99 l~h~~iv~~~~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~N  175 (326)
T 2w1i_A           99 LQHDNIVKYKGVCYSAGR---RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRN  175 (326)
T ss_dssp             CCCTTBCCEEEEECC-------CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred             CCCCCeeeEEEEEEecCC---CceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcce
Confidence            579999999999865421   46899999997 5999999865 469999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCCCc----cccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH
Q 023609           79 LLLNANCDLKICDFGLARVTSETDF----MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHV  154 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  154 (280)
                      |+++.++.++|+|||++........    .....++..|+|||.+.+. .++.++||||+||++++|++|..||....  
T Consensus       176 Ili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~Di~slG~il~el~tg~~~~~~~~--  252 (326)
T 2w1i_A          176 ILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTES-KFSVASDVWSFGVVLYELFTYIEKSKSPP--  252 (326)
T ss_dssp             EEEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHHTTCGGGSHH--
T ss_pred             EEEcCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCC-CCCchhhHHHHHHHHHHHHhcCCCCCCCH--
Confidence            9999999999999999987654321    2234566779999988544 47889999999999999999998875321  


Q ss_pred             HHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          155 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                         ....+..+........  .............      ....+.+++++.++|++||+.||.+|||+.++++
T Consensus       253 ---~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          253 ---AEFMRMIGNDKQGQMI--VFHLIELLKNNGR------LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             ---HHHHHHHCTTCCTHHH--HHHHHHHHHTTCC------CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ---HHHHHhhccccchhhh--HHHHHHHhhcCCC------CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence               1111222222111100  0001111111100      0112467899999999999999999999999885

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=1.7e-35  Score=254.62  Aligned_cols=203  Identities=19%  Similarity=0.268  Sum_probs=153.3

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH--------HCCcee
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIH--------SANVLH   71 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH--------~~gi~H   71 (280)
                      ++||||+++++++..... .....|+||||++ |+|.+++.+ ..+++..++.++.|++.||+|||        +.|++|
T Consensus        93 l~h~ni~~~~~~~~~~~~-~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH  170 (342)
T 1b6c_B           93 LRHENILGFIAADNKDNG-TWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAH  170 (342)
T ss_dssp             CCCTTBCCEEEEEECCCS-SCCCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEEC
T ss_pred             cCCCcEEEEEeeecccCC-ccceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeee
Confidence            479999999999876531 1237899999998 599999976 46999999999999999999999        899999


Q ss_pred             ccCCCCcEEEccCCCEEEeeccceeeccCCC-----ccccceeccccccchhccCCCCC-----CcchhHHHHHHHHHHH
Q 023609           72 RDLKPSNLLLNANCDLKICDFGLARVTSETD-----FMTEYVVTRWYRAPELLLNSSDY-----TAAIDVWSVGCIFMEL  141 (280)
Q Consensus        72 ~di~~~nili~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~-----~~~~DiwslG~il~~l  141 (280)
                      |||||+||+++.++.++|+|||++.......     ......+++.|+|||++.+....     +.++||||+||++|+|
T Consensus       171 ~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el  250 (342)
T 1b6c_B          171 RDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI  250 (342)
T ss_dssp             SCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHH
T ss_pred             CCCCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHH
Confidence            9999999999999999999999997655432     22345789999999998654322     2689999999999999


Q ss_pred             HhC----------CCCCCCCCh----HHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCcccccccccc--CCCCChHH
Q 023609          142 MDR----------KPLFPGRDH----VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEK--FPNVHPSA  205 (280)
Q Consensus       142 l~g----------~~pf~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~  205 (280)
                      ++|          ..||.+...    ..............                        ..+...  ....+..+
T Consensus       251 ~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~~~~~l  306 (342)
T 1b6c_B          251 ARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLR------------------------PNIPNRWQSCEALRVM  306 (342)
T ss_dssp             HTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCC------------------------CCCCGGGGTSHHHHHH
T ss_pred             HhccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhC------------------------CCCcccccchhHHHHH
Confidence            999          677754321    11111111000000                        000000  01234578


Q ss_pred             HHHHHHhhcCCCCCCCCHHHHhcC
Q 023609          206 IDLVEKMLTFDPRQRITVEDALAH  229 (280)
Q Consensus       206 ~~li~~~L~~dp~~R~t~~ell~h  229 (280)
                      .++|.+||+.||++|||+.+++++
T Consensus       307 ~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          307 AKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             HHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHhccChhhCCCHHHHHHH
Confidence            999999999999999999999875

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=1.2e-35  Score=258.20  Aligned_cols=189  Identities=15%  Similarity=0.202  Sum_probs=150.7

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHc-----CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCC
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-----NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK   75 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~-----~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~   75 (280)
                      .|+||+++++++...     +..|+||||++ |+|.+++..     .+.+++..++.++.||+.||+|||++||+|||||
T Consensus       125 ~~~~iv~~~~~~~~~-----~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiK  199 (365)
T 3e7e_A          125 MQHMFMKFYSAHLFQ-----NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIK  199 (365)
T ss_dssp             GGGGBCCEEEEEECS-----SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCS
T ss_pred             hhhhhhhhheeeecC-----CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCC
Confidence            389999999999766     67899999997 799999973     4679999999999999999999999999999999


Q ss_pred             CCcEEEcc-----------CCCEEEeeccceeecc---CCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHH
Q 023609           76 PSNLLLNA-----------NCDLKICDFGLARVTS---ETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL  141 (280)
Q Consensus        76 ~~nili~~-----------~~~~~l~dfg~~~~~~---~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l  141 (280)
                      |+||+++.           ++.++|+|||++....   .........||+.|+|||++.+. .++.++||||+||++|+|
T Consensus       200 p~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~il~el  278 (365)
T 3e7e_A          200 PDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNK-PWNYQIDYFGVAATVYCM  278 (365)
T ss_dssp             GGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTC-CBSTHHHHHHHHHHHHHH
T ss_pred             HHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCC-CCCccccHHHHHHHHHHH
Confidence            99999988           8999999999997543   22234456789999999998654 489999999999999999


Q ss_pred             HhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCC
Q 023609          142 MDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI  221 (280)
Q Consensus       142 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~  221 (280)
                      ++|+.||.......                                 .......... ..+..+.+++.+||+.+|.+|+
T Consensus       279 ltg~~pf~~~~~~~---------------------------------~~~~~~~~~~-~~~~~~~~~~~~~l~~~p~~r~  324 (365)
T 3e7e_A          279 LFGTYMKVKNEGGE---------------------------------CKPEGLFRRL-PHLDMWNEFFHVMLNIPDCHHL  324 (365)
T ss_dssp             HHSSCCCEEEETTE---------------------------------EEECSCCTTC-SSHHHHHHHHHHHHCCCCTTCC
T ss_pred             HhCCCccccCCCCc---------------------------------eeechhcccc-CcHHHHHHHHHHHcCCCCCCcc
Confidence            99999984321100                                 0000000001 2356788999999999999997


Q ss_pred             CHHHHhcCC
Q 023609          222 TVEDALAHP  230 (280)
Q Consensus       222 t~~ell~h~  230 (280)
                      +..+.+.+.
T Consensus       325 ~~~~~l~~~  333 (365)
T 3e7e_A          325 PSLDLLRQK  333 (365)
T ss_dssp             CCHHHHHHH
T ss_pred             hHHHHHHHH
Confidence            766555543

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=5.4e-36  Score=257.46  Aligned_cols=196  Identities=16%  Similarity=0.171  Sum_probs=143.3

Q ss_pred             CCCeeeeeceecCCCC--------CCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH-HCCceec
Q 023609            3 HENVVAIRDIIPPPQR--------ESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIH-SANVLHR   72 (280)
Q Consensus         3 HpnIv~~~~~~~~~~~--------~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH-~~gi~H~   72 (280)
                      ||||+++++++.....        .+....||||||+. |++.+.+.+ +.+++..++.++.||+.||+||| ++||+||
T Consensus       108 hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~~ivHr  186 (336)
T 2vuw_A          108 PPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAVAEASLRFEHR  186 (336)
T ss_dssp             CHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHHHHHHHHCCBCS
T ss_pred             cHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHhCCEeEC
Confidence            5666666666643100        01267999999996 556666643 67999999999999999999999 9999999


Q ss_pred             cCCCCcEEEccCC--------------------CEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHH
Q 023609           73 DLKPSNLLLNANC--------------------DLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVW  132 (280)
Q Consensus        73 di~~~nili~~~~--------------------~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Diw  132 (280)
                      ||||+||+++.++                    .+||+|||+++.....    ...+|+.|+|||++.+..  +.++|||
T Consensus       187 DlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~~g~~--~~~~Diw  260 (336)
T 2vuw_A          187 DLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLFTGDG--DYQFDIY  260 (336)
T ss_dssp             CCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGGCCCS--SHHHHHH
T ss_pred             CCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhhhcCCC--ccceehh
Confidence            9999999999887                    8999999999876543    457899999999986443  7899999


Q ss_pred             HHHHH-HHHHHhCCCCCCCCChHH-HHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHH
Q 023609          133 SVGCI-FMELMDRKPLFPGRDHVH-QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVE  210 (280)
Q Consensus       133 slG~i-l~~ll~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  210 (280)
                      |+|++ .++++.|..||.+..+.. ....+......                       .........+.+++++++||+
T Consensus       261 sl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~~~~~~~~s~~~~dli~  317 (336)
T 2vuw_A          261 RLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTF-----------------------KTKCNTPAMKQIKRKIQEFHR  317 (336)
T ss_dssp             HHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCC-----------------------SSCCCSHHHHHHHHHHHHHHH
T ss_pred             hhhCCCCcccccccCCCcchhhhhHHHHhhhhhhcc-----------------------CcccchhhhhhcCHHHHHHHH
Confidence            98777 667888988884321111 11111111000                       001111122356788999999


Q ss_pred             HhhcCCCCCCCCHHHHh-cCCCCC
Q 023609          211 KMLTFDPRQRITVEDAL-AHPYLG  233 (280)
Q Consensus       211 ~~L~~dp~~R~t~~ell-~h~~~~  233 (280)
                      +||++|     |+.|+| +||||+
T Consensus       318 ~~L~~d-----sa~e~l~~Hp~f~  336 (336)
T 2vuw_A          318 TMLNFS-----SATDLLCQHSLFK  336 (336)
T ss_dssp             HGGGSS-----SHHHHHHHCGGGC
T ss_pred             HHhccC-----CHHHHHhcCCCcC
Confidence            999977     999999 999995

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.6e-34  Score=268.58  Aligned_cols=190  Identities=26%  Similarity=0.378  Sum_probs=150.0

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      |+||||+++++++......+....||||||++ ++|.+++..  .+++.+++.++.||+.||+|||++||+||||||+||
T Consensus       136 l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NI  213 (681)
T 2pzi_A          136 VVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENI  213 (681)
T ss_dssp             CCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred             cCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHe
Confidence            58999999999997653222223799999997 589887754  799999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  159 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      +++.+ .++|+|||++......   ....+|+.|+|||++.+.  .+.++||||+||++++|++|.+||.+....     
T Consensus       214 ll~~~-~~kl~DFG~a~~~~~~---~~~~gt~~y~aPE~~~~~--~~~~sDi~slG~~l~~l~~g~~~~~~~~~~-----  282 (681)
T 2pzi_A          214 MLTEE-QLKLIDLGAVSRINSF---GYLYGTPGFQAPEIVRTG--PTVATDIYTVGRTLAALTLDLPTRNGRYVD-----  282 (681)
T ss_dssp             EECSS-CEEECCCTTCEETTCC---SCCCCCTTTSCTTHHHHC--SCHHHHHHHHHHHHHHHHSCCCEETTEECS-----
T ss_pred             EEeCC-cEEEEecccchhcccC---CccCCCccccCHHHHcCC--CCCceehhhhHHHHHHHHhCCCCCcccccc-----
Confidence            99875 8999999999876544   345789999999988543  488999999999999999999888642110     


Q ss_pred             HHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCC
Q 023609          160 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS  234 (280)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~  234 (280)
                           ..+....                          ....++.+.++|.+||+.||.+||+..+++.|+|+.-
T Consensus       283 -----~~~~~~~--------------------------~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  326 (681)
T 2pzi_A          283 -----GLPEDDP--------------------------VLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV  326 (681)
T ss_dssp             -----SCCTTCH--------------------------HHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             -----ccccccc--------------------------ccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence                 0000000                          0023567899999999999999999999999888753

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.98  E-value=1.6e-32  Score=230.75  Aligned_cols=170  Identities=12%  Similarity=0.077  Sum_probs=134.1

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++...     +..|+||||++ ++|.++++.+  ....++..++.||+.||+|||++||+||||||+||
T Consensus        88 l~hp~iv~~~~~~~~~-----~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NI  160 (286)
T 3uqc_A           88 IDKPGVARVLDVVHTR-----AGGLVVAEWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRV  160 (286)
T ss_dssp             CCCTTBCCEEEEEEET-----TEEEEEEECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGE
T ss_pred             CCCCCcceeeEEEEEC-----CcEEEEEEecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccE
Confidence            5899999999999765     67999999997 5999999643  46667889999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  159 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      +++.+|.++|++++                   |++|        ++.++|||||||++|+|++|+.||.+.+....+..
T Consensus       161 ll~~~g~~kl~~~~-------------------~~~~--------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~  213 (286)
T 3uqc_A          161 RVSIDGDVVLAYPA-------------------TMPD--------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAP  213 (286)
T ss_dssp             EEETTSCEEECSCC-------------------CCTT--------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEE
T ss_pred             EEcCCCCEEEEecc-------------------ccCC--------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHH
Confidence            99999999988433                   3332        67899999999999999999999976543211000


Q ss_pred             HHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          160 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                      ..                       ..............+.+++++.++|.+||+.||.+| |+.++++
T Consensus       214 ~~-----------------------~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~  258 (286)
T 3uqc_A          214 AE-----------------------RDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLN  258 (286)
T ss_dssp             CC-----------------------BCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHH
T ss_pred             HH-----------------------HHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHH
Confidence            00                       000001111223445789999999999999999999 9999987

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=8.9e-32  Score=245.75  Aligned_cols=134  Identities=17%  Similarity=0.185  Sum_probs=102.5

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nil   80 (280)
                      .|+||+++++++.+.     ...||||||++| +|.+++..++++++.   .|+.||+.||+|+|++||+||||||+||+
T Consensus       300 ~~~~i~~~~~~~ed~-----~~~yLVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNIL  371 (569)
T 4azs_A          300 AGFDAPAVLAHGENA-----QSGWLVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVM  371 (569)
T ss_dssp             TTCCCCCEEEEEECS-----SEEEEEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEE
T ss_pred             CCCCeeEEEEEEEEC-----CEEEEEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEE
Confidence            699999999999776     789999999985 999999999999876   47899999999999999999999999999


Q ss_pred             EccCCCEEEeeccceeeccCC-CccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCC
Q 023609           81 LNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK  145 (280)
Q Consensus        81 i~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~  145 (280)
                      ++.+|.+||+|||+++..... ......+||+.|+|||++.+.  ....+|+||+|++++.+.++.
T Consensus       372 L~~dg~vKL~DFGlAr~~~~~~~~~~t~vGTp~YmAPE~l~g~--~~~~~d~~s~g~~~~~l~~~~  435 (569)
T 4azs_A          372 VDARQHARLIDFGSIVTTPQDCSWPTNLVQSFFVFVNELFAEN--KSWNGFWRSAPVHPFNLPQPW  435 (569)
T ss_dssp             ECTTSCEEECCCTTEESCC---CCSHHHHHHHHHHHHHHC-------------------CCCCTTH
T ss_pred             ECCCCCEEEeecccCeeCCCCCccccCceechhhccHHHhCCC--CCCcccccccccchhhhcccc
Confidence            999999999999999865443 334567899999999998543  567899999999988876554

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.85  E-value=1.5e-22  Score=183.93  Aligned_cols=133  Identities=20%  Similarity=0.296  Sum_probs=107.5

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      |+||||+++..++...     ...||||||++ ++|.+++..        +..++.|++.||+|||++||+||||||+||
T Consensus       396 l~h~nIv~~~~~~~~~-----~~~~lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NI  462 (540)
T 3en9_A          396 VKDFGIPAPYIFDVDL-----DNKRIMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNF  462 (540)
T ss_dssp             GGGGTCCCCCEEEEET-----TTTEEEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSE
T ss_pred             cCCCCcCceEEEEEeC-----CccEEEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHE
Confidence            4799999444444332     44699999997 799999875        668999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCCc--------cccceeccccccchhccC-CCCCCcchhHHHHHHHHHHHHhCCCCC
Q 023609           80 LLNANCDLKICDFGLARVTSETDF--------MTEYVVTRWYRAPELLLN-SSDYTAAIDVWSVGCIFMELMDRKPLF  148 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~~--------~~~~~~~~~y~aPE~~~~-~~~~~~~~DiwslG~il~~ll~g~~pf  148 (280)
                      +++.  .++|+|||+++.......        .....+|+.|+|||++.. ...|+..+|+|+.++-..+-+.++.+|
T Consensus       463 Ll~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          463 IFDK--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             EESS--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             EECC--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            9998  999999999987755321        135578999999999854 123677889999988888877776655

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.62  E-value=9.1e-17  Score=134.25  Aligned_cols=87  Identities=23%  Similarity=0.261  Sum_probs=69.7

Q ss_pred             eeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCC
Q 023609            7 VAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANC   85 (280)
Q Consensus         7 v~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nili~~~~   85 (280)
                      +++++++..      +..|+||||++ ++|.+ +..      .....++.|++.||++||+.||+||||||+||+++ +|
T Consensus       164 ~~v~~~~~~------~~~~lvmE~~~g~~L~~-l~~------~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~  229 (282)
T 1zar_A          164 LAVPKVYAW------EGNAVLMELIDAKELYR-VRV------ENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EE  229 (282)
T ss_dssp             SSSCCEEEE------ETTEEEEECCCCEEGGG-CCC------SCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TT
T ss_pred             CCcCeEEec------cceEEEEEecCCCcHHH-cch------hhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CC
Confidence            555555422      34699999997 59987 421      33557999999999999999999999999999999 99


Q ss_pred             CEEEeeccceeeccCCCccccceeccccccchhc
Q 023609           86 DLKICDFGLARVTSETDFMTEYVVTRWYRAPELL  119 (280)
Q Consensus        86 ~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~  119 (280)
                      .++|+|||++..            +..+.|||.+
T Consensus       230 ~vkl~DFG~a~~------------~~~~~a~e~l  251 (282)
T 1zar_A          230 GIWIIDFPQSVE------------VGEEGWREIL  251 (282)
T ss_dssp             EEEECCCTTCEE------------TTSTTHHHHH
T ss_pred             cEEEEECCCCeE------------CCCCCHHHHH
Confidence            999999998864            3346788876

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.41  E-value=2e-13  Score=112.49  Aligned_cols=71  Identities=20%  Similarity=0.303  Sum_probs=60.8

Q ss_pred             cEEEEeecCCc------cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHH-HCCceeccCCCCcEEEccCCCEEEeeccce
Q 023609           23 DVYIAYELMDT------DLHQIIRSNQALSEEHCQYFLYQILRGLKYIH-SANVLHRDLKPSNLLLNANCDLKICDFGLA   95 (280)
Q Consensus        23 ~~~iv~e~~~g------~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH-~~gi~H~di~~~nili~~~~~~~l~dfg~~   95 (280)
                      ..++||||+++      +|.+....   .++..+..++.|++.||.+|| +.||+||||||+||+++.  .++|+|||++
T Consensus       142 ~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp~NILl~~--~~~liDFG~a  216 (258)
T 1zth_A          142 KNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSEYNIMYID--KVYFIDMGQA  216 (258)
T ss_dssp             TTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCSTTSEEESS--SEEECCCTTC
T ss_pred             CCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEEcC--cEEEEECccc
Confidence            45899999953      77777543   345678899999999999999 999999999999999988  8999999998


Q ss_pred             eec
Q 023609           96 RVT   98 (280)
Q Consensus        96 ~~~   98 (280)
                      ...
T Consensus       217 ~~~  219 (258)
T 1zth_A          217 VTL  219 (258)
T ss_dssp             EET
T ss_pred             ccC
Confidence            754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.25  E-value=1.5e-12  Score=112.31  Aligned_cols=91  Identities=14%  Similarity=0.127  Sum_probs=65.7

Q ss_pred             CCCeeeeeceecCC-CCCCCCcEEEEeecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 023609            3 HENVVAIRDIIPPP-QRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   80 (280)
Q Consensus         3 HpnIv~~~~~~~~~-~~~~~~~~~iv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nil   80 (280)
                      |+||.++++..... .+-.....+|||||++| +|.++.      .......++.||+.+|.+||++||+||||||.||+
T Consensus       164 ~~nL~rL~~~gv~vp~p~~~~~~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NIL  237 (397)
T 4gyi_A          164 FAFMKALYEEGFPVPEPIAQSRHTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNIL  237 (397)
T ss_dssp             HHHHHHHHHTTCSCCCEEEEETTEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEE
T ss_pred             HHHHHHHHhcCCCCCeeeeccCceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEE
Confidence            67777777654321 11111223799999986 665432      12345678899999999999999999999999999


Q ss_pred             EccCC----------CEEEeeccceeecc
Q 023609           81 LNANC----------DLKICDFGLARVTS   99 (280)
Q Consensus        81 i~~~~----------~~~l~dfg~~~~~~   99 (280)
                      ++.+|          .+.++||+-+....
T Consensus       238 l~~dgd~~d~~~~~~~~~iID~~Q~V~~~  266 (397)
T 4gyi_A          238 IREEKDAEDPSSITLTPIIIXFPQMVSMD  266 (397)
T ss_dssp             EEEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred             EeCCCCcccccccccceEEEEeCCcccCC
Confidence            98776          38899998765543

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=98.69  E-value=2.7e-08  Score=81.62  Aligned_cols=84  Identities=14%  Similarity=0.072  Sum_probs=64.2

Q ss_pred             CCCeeeeeceecCCCCCCCCcEEEEeecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH---------------
Q 023609            3 HENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHS---------------   66 (280)
Q Consensus         3 HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~---------------   66 (280)
                      +..+.++++++...     +..|+|||+++| +|.+.+.     +......++.++..+|+.||+               
T Consensus        69 ~~~vP~v~~~~~~~-----~~~~lv~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~  138 (263)
T 3tm0_A           69 KLPVPKVLHFERHD-----GWSNLLMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSR  138 (263)
T ss_dssp             TSCCCCEEEEEEET-----TEEEEEEECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHH
T ss_pred             CCCCCeEEEEEecC-----CceEEEEEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHH
Confidence            45667788777543     568999999997 7776531     223345788899999999998               


Q ss_pred             --------------------------------------------CCceeccCCCCcEEEccCCCEEEeecccee
Q 023609           67 --------------------------------------------ANVLHRDLKPSNLLLNANCDLKICDFGLAR   96 (280)
Q Consensus        67 --------------------------------------------~gi~H~di~~~nili~~~~~~~l~dfg~~~   96 (280)
                                                                  .+++|+|+++.||+++.++.+.++||+.+.
T Consensus       139 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          139 LAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             HHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                                                        458999999999999875556799998664

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.50  E-value=2.8e-07  Score=79.16  Aligned_cols=91  Identities=15%  Similarity=0.249  Sum_probs=69.5

Q ss_pred             CCeeeeeceecCCCCCCCCcEEEEeecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH----------------
Q 023609            4 ENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHS----------------   66 (280)
Q Consensus         4 pnIv~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~----------------   66 (280)
                      ..+++++.++.+..  ..+..|+|||+++| .+.+.  ....++..+...++.++..+|..||+                
T Consensus        98 vpvP~~~~~~~~~~--~~g~~~~vme~v~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~  173 (359)
T 3dxp_A           98 VPVAKMYALCEDES--VIGRAFYIMEFVSGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGN  173 (359)
T ss_dssp             SCCCCEEEEECCTT--TTSSCEEEEECCCCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSC
T ss_pred             CCCCcEEEECCCCC--ccCCeEEEEEecCCeecCCC--ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCC
Confidence            45677777775542  12457999999997 44331  12347888889999999999999997                


Q ss_pred             ------------------------------------------CCceeccCCCCcEEEccCCC--EEEeeccceeec
Q 023609           67 ------------------------------------------ANVLHRDLKPSNLLLNANCD--LKICDFGLARVT   98 (280)
Q Consensus        67 ------------------------------------------~gi~H~di~~~nili~~~~~--~~l~dfg~~~~~   98 (280)
                                                                .+++|+|+++.||+++.++.  +.++||+.+...
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g  249 (359)
T 3dxp_A          174 YFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG  249 (359)
T ss_dssp             HHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred             chHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence                                                      35899999999999987754  689999988753

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=98.39  E-value=5.8e-07  Score=73.20  Aligned_cols=79  Identities=16%  Similarity=0.194  Sum_probs=56.7

Q ss_pred             eeeeeceecCCCCCCCCcEEEEeecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC----------------
Q 023609            6 VVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN----------------   68 (280)
Q Consensus         6 Iv~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~g----------------   68 (280)
                      +.+++++....     +..++|||+++| +| + ..   ..+   ...++.++...|..||+..                
T Consensus        77 vP~~~~~~~~~-----~~~~~v~e~i~G~~l-~-~~---~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~  143 (264)
T 1nd4_A           77 CAAVLDVVTEA-----GRDWLLLGEVPGQDL-L-SS---HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIER  143 (264)
T ss_dssp             BCCEEEEEECS-----SCEEEEEECCSSEET-T-TS---CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHH
T ss_pred             CCeEEEeccCC-----CCCEEEEEecCCccc-C-cC---cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHH
Confidence            45677766443     458999999987 66 3 21   122   2356677777788888643                


Q ss_pred             ------------------------------------------ceeccCCCCcEEEccCCCEEEeeccceee
Q 023609           69 ------------------------------------------VLHRDLKPSNLLLNANCDLKICDFGLARV   97 (280)
Q Consensus        69 ------------------------------------------i~H~di~~~nili~~~~~~~l~dfg~~~~   97 (280)
                                                                ++|+|++|.||+++.++.+.++||+.+..
T Consensus       144 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          144 ARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             HHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                                                      99999999999998766567999997643

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.37  E-value=2.5e-07  Score=77.63  Aligned_cols=124  Identities=16%  Similarity=0.204  Sum_probs=80.3

Q ss_pred             cEEEEeecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-----------------------------------
Q 023609           23 DVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHS-----------------------------------   66 (280)
Q Consensus        23 ~~~iv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~-----------------------------------   66 (280)
                      ..|+||++++| +|.+...  ..++..+...++.|+...+..||+                                   
T Consensus        90 ~~~~vm~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (304)
T 3sg8_A           90 MSFAGFTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKG  167 (304)
T ss_dssp             CSCEEEECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCH
T ss_pred             cceEEEcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCc
Confidence            45899999997 5554332  347788888888888888888886                                   


Q ss_pred             -----------------------CCceeccCCCCcEEEcc--CCCEEEeeccceeeccCCCccccceeccccccchhcc-
Q 023609           67 -----------------------ANVLHRDLKPSNLLLNA--NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL-  120 (280)
Q Consensus        67 -----------------------~gi~H~di~~~nili~~--~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~-  120 (280)
                                             ..++|+|+++.||+++.  .+.+.++||+.+.................-..|+... 
T Consensus       168 ~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~  247 (304)
T 3sg8_A          168 PQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSK  247 (304)
T ss_dssp             HHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHH
T ss_pred             ccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHH
Confidence                                   13799999999999988  4557899999887643321000000000001222110 


Q ss_pred             ---CCCC---------CCcchhHHHHHHHHHHHHhCCCCC
Q 023609          121 ---NSSD---------YTAAIDVWSVGCIFMELMDRKPLF  148 (280)
Q Consensus       121 ---~~~~---------~~~~~DiwslG~il~~ll~g~~pf  148 (280)
                         ..+.         .....+.|++|.+++.+.+|..+|
T Consensus       248 ~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          248 ILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence               0000         112368999999999999998766

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=98.20  E-value=3.6e-05  Score=60.44  Aligned_cols=98  Identities=19%  Similarity=0.160  Sum_probs=65.1

Q ss_pred             cHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCcEEEccCCCEEEeeccceeeccCCCccccceecc
Q 023609           34 DLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHS-ANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTR  111 (280)
Q Consensus        34 ~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~-~gi~H~di~~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~  111 (280)
                      +|.+.++. +.+++|.++|.+++|.+.+|.-+-. +.-..+=+.|..|++..+|.+.+.+ +.+.           ....
T Consensus        34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------~~~~  101 (229)
T 2yle_A           34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-----------AGEP  101 (229)
T ss_dssp             EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred             cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-----------cccc
Confidence            79999974 5689999999999999999877632 1212334556889999999887764 1110           1122


Q ss_pred             ccccchhccCCCCCCcchhHHHHHHHHHHHHhCC
Q 023609          112 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK  145 (280)
Q Consensus       112 ~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~  145 (280)
                      .+.+||...  ...+.+.=|+|||+++|..+...
T Consensus       102 ~~~~pe~~~--~~~te~~~IysLG~tLY~ALDyg  133 (229)
T 2yle_A          102 PPVAGKLGY--SQCMETEVIESLGIIIYKALDYG  133 (229)
T ss_dssp             -----CCSS--SSSCHHHHHHHHHHHHHHHHTTT
T ss_pred             CCCChhhcc--ccchHHHHHHHHHHHHHHHhhcC
Confidence            356787652  23567889999999999988644

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=97.65  E-value=0.00025  Score=59.30  Aligned_cols=76  Identities=21%  Similarity=0.340  Sum_probs=52.4

Q ss_pred             CcEEEEeecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC---------------------------------
Q 023609           22 NDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA---------------------------------   67 (280)
Q Consensus        22 ~~~~iv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~---------------------------------   67 (280)
                      +..|+||++++| .+.+..-  ..++..+...+..++...|..||+.                                 
T Consensus        86 g~~~~v~e~i~G~~l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~  163 (306)
T 3tdw_A           86 GNPFVGYRKVQGQILGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPL  163 (306)
T ss_dssp             SCEEEEEECCCSEECHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGG
T ss_pred             CceEEEEeccCCeECchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccc
Confidence            456899999997 5554321  2245555555666666666655542                                 


Q ss_pred             ---------------------------CceeccCCCCcEEEcc---CCCE-EEeeccceeecc
Q 023609           68 ---------------------------NVLHRDLKPSNLLLNA---NCDL-KICDFGLARVTS   99 (280)
Q Consensus        68 ---------------------------gi~H~di~~~nili~~---~~~~-~l~dfg~~~~~~   99 (280)
                                                 .++|+|+++.||+++.   ++.+ .|+||+.+....
T Consensus       164 l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~gd  226 (306)
T 3tdw_A          164 LDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAISD  226 (306)
T ss_dssp             SCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEEC
T ss_pred             cchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCCC
Confidence                                       3599999999999987   4565 899999876543

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=97.59  E-value=0.00018  Score=58.83  Aligned_cols=83  Identities=18%  Similarity=0.303  Sum_probs=56.1

Q ss_pred             eeeeeceecCCCCCCCCcEEEEeecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHC-----------------
Q 023609            6 VVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSA-----------------   67 (280)
Q Consensus         6 Iv~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~-----------------   67 (280)
                      +.+++.++.+.     +..|+||++++| ++.+.....    ......+..++...|..||+.                 
T Consensus        82 VP~v~~~~~~~-----~~~~lvme~l~G~~~~~~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~  152 (272)
T 4gkh_A           82 LPTIKHFIRTP-----DDAWLLTTAIPGKTAFQVLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQ  152 (272)
T ss_dssp             CCCEEEEEEET-----TEEEEEEECCCSEEHHHHHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHH
T ss_pred             cCeEEEEEEEC-----CeEEEEEEeeCCccccccccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhh
Confidence            44566666444     568999999987 666654321    122334555566666666631                 


Q ss_pred             -----------------------------------------CceeccCCCCcEEEccCCCEEEeeccceee
Q 023609           68 -----------------------------------------NVLHRDLKPSNLLLNANCDLKICDFGLARV   97 (280)
Q Consensus        68 -----------------------------------------gi~H~di~~~nili~~~~~~~l~dfg~~~~   97 (280)
                                                               .++|+|+.+.||+++.++.+-|+||+.+..
T Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          153 AQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             HHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                                                     168999999999998877677999987654

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=96.98  E-value=0.0007  Score=57.64  Aligned_cols=31  Identities=16%  Similarity=0.269  Sum_probs=25.9

Q ss_pred             CCceeccCCCCcEEEccCCCEEEeeccceee
Q 023609           67 ANVLHRDLKPSNLLLNANCDLKICDFGLARV   97 (280)
Q Consensus        67 ~gi~H~di~~~nili~~~~~~~l~dfg~~~~   97 (280)
                      ..++|+|+++.||+++.++.+.|+||+.+..
T Consensus       222 ~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~  252 (357)
T 3ats_A          222 PVLLWGDARVGNVLYRDFQPVAVLDWEMVAL  252 (357)
T ss_dssp             CEEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred             ceEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence            4689999999999998544578999998764

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=96.45  E-value=0.0052  Score=51.63  Aligned_cols=30  Identities=27%  Similarity=0.394  Sum_probs=26.9

Q ss_pred             CCceeccCCCCcEEEccCCCEEEeecccee
Q 023609           67 ANVLHRDLKPSNLLLNANCDLKICDFGLAR   96 (280)
Q Consensus        67 ~gi~H~di~~~nili~~~~~~~l~dfg~~~   96 (280)
                      .+++|+|+++.||+++.++.+.++||+.+.
T Consensus       222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            579999999999999888889999998654

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=95.51  E-value=0.012  Score=51.36  Aligned_cols=34  Identities=12%  Similarity=0.304  Sum_probs=29.2

Q ss_pred             HHCCceeccCCCCcEEEccCCCEEEeeccceeecc
Q 023609           65 HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS   99 (280)
Q Consensus        65 H~~gi~H~di~~~nili~~~~~~~l~dfg~~~~~~   99 (280)
                      +...++|+|+++.||+++.++ +.++||+.+....
T Consensus       230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~  263 (420)
T 2pyw_A          230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGP  263 (420)
T ss_dssp             BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEEC
T ss_pred             CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccCc
Confidence            456799999999999998877 9999999887644

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=95.32  E-value=0.031  Score=46.14  Aligned_cols=30  Identities=20%  Similarity=0.248  Sum_probs=25.4

Q ss_pred             CceeccCCCCcEEEccCCCEEEeeccceeec
Q 023609           68 NVLHRDLKPSNLLLNANCDLKICDFGLARVT   98 (280)
Q Consensus        68 gi~H~di~~~nili~~~~~~~l~dfg~~~~~   98 (280)
                      .++|+|+.+.||+ ..++.+.++||..+...
T Consensus       174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~g  203 (301)
T 3dxq_A          174 AACHCDPLCENFL-DTGERMWIVDWEYSGMN  203 (301)
T ss_dssp             EEECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred             eeeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence            3899999999999 56778999999887654

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=93.74  E-value=0.034  Score=46.60  Aligned_cols=33  Identities=27%  Similarity=0.425  Sum_probs=27.9

Q ss_pred             CCceeccCCCCcEEEccC----CCEEEeeccceeecc
Q 023609           67 ANVLHRDLKPSNLLLNAN----CDLKICDFGLARVTS   99 (280)
Q Consensus        67 ~gi~H~di~~~nili~~~----~~~~l~dfg~~~~~~   99 (280)
                      .+++|+|+++.||+++.+    +.+.++||+.+....
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G~  219 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLGH  219 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEEC
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcCC
Confidence            469999999999999874    678999999886543

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=93.36  E-value=0.073  Score=44.34  Aligned_cols=29  Identities=28%  Similarity=0.302  Sum_probs=24.9

Q ss_pred             CCceeccCCCCcEEEccCCCEEEeeccceee
Q 023609           67 ANVLHRDLKPSNLLLNANCDLKICDFGLARV   97 (280)
Q Consensus        67 ~gi~H~di~~~nili~~~~~~~l~dfg~~~~   97 (280)
                      .+++|+|+++.||+++ + .+.++||+.+..
T Consensus       195 ~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          195 VLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             eeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            4589999999999998 4 899999987654

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=92.90  E-value=0.079  Score=44.64  Aligned_cols=32  Identities=19%  Similarity=0.320  Sum_probs=27.8

Q ss_pred             CCceeccCCCCcEEEccCCCEEEeeccceeec
Q 023609           67 ANVLHRDLKPSNLLLNANCDLKICDFGLARVT   98 (280)
Q Consensus        67 ~gi~H~di~~~nili~~~~~~~l~dfg~~~~~   98 (280)
                      .+++|+|+.+.||+++.++.+.++||+.+...
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~  237 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA  237 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence            36999999999999998888999999877643

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=92.86  E-value=0.032  Score=46.41  Aligned_cols=31  Identities=29%  Similarity=0.309  Sum_probs=26.0

Q ss_pred             CCceeccCCCCcEEEccCCCEEEeeccceee
Q 023609           67 ANVLHRDLKPSNLLLNANCDLKICDFGLARV   97 (280)
Q Consensus        67 ~gi~H~di~~~nili~~~~~~~l~dfg~~~~   97 (280)
                      .+++|+|+++.||+++.++.+.++||+.+..
T Consensus       187 ~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          187 AGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             cccCCCCCCccCEEEeCCceEEEecchhccC
Confidence            3699999999999998776568999987654

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=91.95  E-value=0.16  Score=43.68  Aligned_cols=32  Identities=19%  Similarity=0.289  Sum_probs=26.4

Q ss_pred             HCCceeccCCCCcEEEccCCCEEEeeccceeec
Q 023609           66 SANVLHRDLKPSNLLLNANCDLKICDFGLARVT   98 (280)
Q Consensus        66 ~~gi~H~di~~~nili~~~~~~~l~dfg~~~~~   98 (280)
                      ...++|||+++.||+++.++ +.++||..+...
T Consensus       226 ~~~L~HGDl~~~Nil~~~~~-~~lID~e~a~~G  257 (397)
T 2olc_A          226 AETLIHGDLHTGSIFASEHE-TKVIDPEFAFYG  257 (397)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred             CCceeeCCCCcCcEEEeCCC-eEEEeCcccccC
Confidence            35799999999999998764 899999876543

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=91.05  E-value=0.22  Score=42.27  Aligned_cols=29  Identities=28%  Similarity=0.595  Sum_probs=24.3

Q ss_pred             CceeccCCCCcEEEccCCCEEEeeccceee
Q 023609           68 NVLHRDLKPSNLLLNANCDLKICDFGLARV   97 (280)
Q Consensus        68 gi~H~di~~~nili~~~~~~~l~dfg~~~~   97 (280)
                      +++|+|+++.||+++.++ +.++||..+..
T Consensus       213 ~l~HgDl~~~Nil~~~~~-~~lID~e~a~~  241 (369)
T 3c5i_A          213 VFCHNDLQENNIINTNKC-LRLIDFEYSGF  241 (369)
T ss_dssp             EEECSCCCGGGEEECC-C-EEECCCTTCEE
T ss_pred             EEEeCCCCcccEEecCCc-EEEEEecCCCC
Confidence            589999999999997655 89999987754

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=89.85  E-value=0.27  Score=43.27  Aligned_cols=15  Identities=33%  Similarity=0.401  Sum_probs=14.1

Q ss_pred             CceeccCCCCcEEEc
Q 023609           68 NVLHRDLKPSNLLLN   82 (280)
Q Consensus        68 gi~H~di~~~nili~   82 (280)
                      .++|+|+.+.||+++
T Consensus       291 v~cHnDl~~gNIL~~  305 (458)
T 2qg7_A          291 VLCHCDLLSSNIINT  305 (458)
T ss_dssp             EEECSCCCGGGEEEC
T ss_pred             eEEecCCCCCcEEee
Confidence            489999999999998

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=88.94  E-value=0.16  Score=44.28  Aligned_cols=30  Identities=33%  Similarity=0.458  Sum_probs=23.9

Q ss_pred             CceeccCCCCcEEEccC----------------------------CCEEEeeccceee
Q 023609           68 NVLHRDLKPSNLLLNAN----------------------------CDLKICDFGLARV   97 (280)
Q Consensus        68 gi~H~di~~~nili~~~----------------------------~~~~l~dfg~~~~   97 (280)
                      .++|+|+.+.||+++.+                            +.+.++||..+..
T Consensus       250 v~~H~Dl~~gNiL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lIDfEya~~  307 (429)
T 1nw1_A          250 TFCHNDLQEGNILLPKASSGNIRMPSLSDETQALGNSLSAFNPADPRLVLIDFEYASY  307 (429)
T ss_dssp             EEECSCCCGGGEEEEC------------------------------CCEECCCTTCEE
T ss_pred             EEEeCCCCCCeEEeeCCccccccccccccccccccccccccccCCCeEEEEecccCCc
Confidence            48999999999999875                            6688888877654

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=88.08  E-value=0.26  Score=42.26  Aligned_cols=30  Identities=27%  Similarity=0.430  Sum_probs=26.4

Q ss_pred             CceeccCCCCcEEEccC----CCEEEeeccceee
Q 023609           68 NVLHRDLKPSNLLLNAN----CDLKICDFGLARV   97 (280)
Q Consensus        68 gi~H~di~~~nili~~~----~~~~l~dfg~~~~   97 (280)
                      .++|+|+.+.||+++.+    +.+.++||..+..
T Consensus       221 ~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          221 VFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             EEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             EEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            48999999999999876    7899999987764

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=85.54  E-value=0.42  Score=41.20  Aligned_cols=29  Identities=28%  Similarity=0.448  Sum_probs=24.7

Q ss_pred             ceeccCCCCcEEE------ccCCCEEEeeccceee
Q 023609           69 VLHRDLKPSNLLL------NANCDLKICDFGLARV   97 (280)
Q Consensus        69 i~H~di~~~nili------~~~~~~~l~dfg~~~~   97 (280)
                      ++|+|+.+.||++      +.++.+.++||..+..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            6899999999999      3457799999988764

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=83.58  E-value=1  Score=35.10  Aligned_cols=99  Identities=16%  Similarity=0.174  Sum_probs=66.7

Q ss_pred             CcEEEEeecCC-c-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEEccCCCEEEeeccceeecc
Q 023609           22 NDVYIAYELMD-T-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTS   99 (280)
Q Consensus        22 ~~~~iv~e~~~-g-~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nili~~~~~~~l~dfg~~~~~~   99 (280)
                      ..+.+.++.-+ + ++.. +   +.++..+.++++.+|+....++++  =+|--++|+|++++.++.+++.-.|+...  
T Consensus        57 D~v~~~y~~~~~~~~f~~-i---k~~~~~eKlr~l~ni~~l~~~~~~--r~tf~L~P~NL~f~~~~~p~i~~RGik~~--  128 (215)
T 4ann_A           57 DSFQIHYDINDNHTPFDN-I---KSFTKNEKLRYLLNIKNLEEVNRT--RYTFVLAPDELFFTRDGLPIAKTRGLQNV--  128 (215)
T ss_dssp             SEEEEEECCCTTSEEGGG-G---GGSCHHHHHHHHHHGGGGGGGGGS--SEECCCSGGGEEECTTSCEEESCCEETTT--
T ss_pred             cEEEEEEEcCcccCCHHH-H---HhcCHHHHHHHHHHHHHHHHHhcC--ceEEEEecceEEEcCCCCEEEEEccCccC--
Confidence            44666666554 2 4443 3   247889999999999987754433  46788999999999999999886664321  


Q ss_pred             CCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 023609          100 ETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF  148 (280)
Q Consensus       100 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf  148 (280)
                                    ++|.      ..+...-.-.+=|++..++.++..|
T Consensus       129 --------------l~P~------~~~ee~fL~qyKAliiall~~K~~F  157 (215)
T 4ann_A          129 --------------VDPL------PVSEAEFLTRYKALVICAFNEKQSF  157 (215)
T ss_dssp             --------------BSCC------CCCHHHHHHHHHHHHHHHHCTTCCH
T ss_pred             --------------CCCC------CCCHHHHHHHHHHHHHHHHcCCCCH
Confidence                          2232      1233333445778888888887776

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=82.24  E-value=3.6  Score=32.12  Aligned_cols=99  Identities=14%  Similarity=0.126  Sum_probs=65.2

Q ss_pred             CcEEEEeecCC-c-cHHHHHHcCCCCCHHHHHHHHHHHHHHHH-HHHHCCceeccCCCCcEEEccCCCEEEeeccceeec
Q 023609           22 NDVYIAYELMD-T-DLHQIIRSNQALSEEHCQYFLYQILRGLK-YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVT   98 (280)
Q Consensus        22 ~~~~iv~e~~~-g-~L~~~l~~~~~l~~~~~~~i~~qll~al~-~LH~~gi~H~di~~~nili~~~~~~~l~dfg~~~~~   98 (280)
                      +.+.+.++.-+ + ++...    +.++..+.++++.+|+.... ++  ..-+|--++|+|++++.++.+++.-.|+-.. 
T Consensus        61 D~~~i~y~~~~~~~~f~~i----~~~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f~~~~~p~i~hRGi~~~-  133 (219)
T 4ano_A           61 DEVKVVIKPPSSFLTFAAI----RKTTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMFNRALEPFFLHVGVKES-  133 (219)
T ss_dssp             SEEEEEEECCTTCEEHHHH----HTSCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEECTTCCEEESCCEETTT-
T ss_pred             CEEEEEEEcCcccCcHHHH----HhcCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEEeCCCcEEEEEcCCccc-
Confidence            44666666653 3 55533    24788899899888888655 44  4457788999999999999999987764321 


Q ss_pred             cCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 023609           99 SETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF  148 (280)
Q Consensus        99 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf  148 (280)
                                     ++|..      .+...-.-++=|++..++.++..|
T Consensus       134 ---------------lpP~e------~~ee~fl~qyKali~all~~K~~F  162 (219)
T 4ano_A          134 ---------------LPPDE------WDDERLLREVKATVLALTEGEYRF  162 (219)
T ss_dssp             ---------------BSSCS------CCHHHHHHHHHHHHHHHTTCSSCH
T ss_pred             ---------------CCCCC------CCHHHHHHHHHHHHHHHHcCCCCH
Confidence                           23321      222323334777777887776655

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=80.99  E-value=0.74  Score=40.03  Aligned_cols=29  Identities=24%  Similarity=0.544  Sum_probs=25.7

Q ss_pred             CceeccCCCCcEEEccCCCEEEeeccceee
Q 023609           68 NVLHRDLKPSNLLLNANCDLKICDFGLARV   97 (280)
Q Consensus        68 gi~H~di~~~nili~~~~~~~l~dfg~~~~   97 (280)
                      .++|+|+.+.||+ +.++.+.++||..+..
T Consensus       263 ~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          263 VFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             eEECCCCCcccee-cCCCcEEEEecccCCc
Confidence            4899999999999 7788899999988764

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	280
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	2e-79
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	6e-71
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-68
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	4e-63
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	6e-61
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	6e-59
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	5e-57
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	1e-56
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	4e-56
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	6e-55
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	8e-55
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-53
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	6e-53
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	2e-51
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	3e-51
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	6e-51
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	6e-51
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	8e-51
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	3e-50
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-49
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-49
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	4e-49
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	5e-49
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	5e-49
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	1e-47
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	1e-46
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	1e-45
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-44
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	3e-42
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	6e-42
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	8e-40
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	8e-40
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-37
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	3e-36
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-35
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	2e-34
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	3e-34
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	3e-34
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-33
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	5e-33
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	7e-33
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	2e-32
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	2e-32
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	4e-32
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	5e-32
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	7e-32
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	5e-31
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	6e-31
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	3e-30
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-29
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	8e-29
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-28
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	4e-28
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	6e-28
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	9e-28
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-27
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-27
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	2e-27
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	5e-26
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	5e-26
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	1e-25
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	3e-25
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	2e-16

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  242 bits (617), Expect = 2e-79
 Identities = 149/283 (52%), Positives = 196/283 (69%), Gaps = 6/283 (2%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRG 60
             HEN++ I DII  P  E   DVY+   LM  DL++++++   LS +H  YFLYQILRG
Sbjct: 63  FRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH-LSNDHICYFLYQILRG 121

Query: 61  LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV----TSETDFMTEYVVTRWYRAP 116
           LKYIHSANVLHRDLKPSNLLLN  CDLKICDFGLARV       T F+TEYV TRWYRAP
Sbjct: 122 LKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 181

Query: 117 ELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL-GFL 175
           E++LNS  YT +ID+WSVGCI  E++  +P+FPG+ ++ QL  ++ ++G+PS+ +L   +
Sbjct: 182 EIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII 241

Query: 176 NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL 235
           N  A+ Y+  LP   +  +   FPN    A+DL++KMLTF+P +RI VE ALAHPYL   
Sbjct: 242 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY 301

Query: 236 HDISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYR 278
           +D SDEP+  +PF FD E   L + ++KELI++E   F P YR
Sbjct: 302 YDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR 344

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  220 bits (560), Expect = 6e-71
 Identities = 121/277 (43%), Positives = 174/277 (62%), Gaps = 6/277 (2%)

Query: 1   MDHENVVAIRDII-PPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           M HENV+ + D+  P    + F D Y+    M TDL ++++ ++ L E+  Q+ +YQ+L+
Sbjct: 74  MRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMK-HEKLGEDRIQFLVYQMLK 132

Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           GL+YIH+A ++HRDLKP NL +N +C+LKI DFGLAR       MT YVVTRWYRAPE++
Sbjct: 133 GLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE--MTGYVVTRWYRAPEVI 190

Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGT-PSEAELGFLNEN 178
           LN   YT  +D+WSVGCI  E++  K LF G DH+ QL+ ++++ GT P+E      ++ 
Sbjct: 191 LNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDE 250

Query: 179 AKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDI 238
           AK Y+  LP  +++ F     N  P A++L+EKML  D  QR+T  +ALAHPY  SLHD 
Sbjct: 251 AKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT 310

Query: 239 SDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 275
            DEP     +   F+    T  + K + Y+E L+F P
Sbjct: 311 EDEPQV-QKYDDSFDDVDRTLDEWKRVTYKEVLSFKP 346

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  214 bits (545), Expect = 1e-68
 Identities = 134/277 (48%), Positives = 178/277 (64%), Gaps = 6/277 (2%)

Query: 1   MDHENVVAIRDII-PPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           M HENV+ + D+  P    E FNDVY+   LM  DL+ I++  Q L+++H Q+ +YQILR
Sbjct: 74  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILR 132

Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           GLKYIHSA+++HRDLKPSNL +N +C+LKI DFGLAR T +   MT YV TRWYRAPE++
Sbjct: 133 GLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIM 190

Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAEL-GFLNEN 178
           LN   Y   +D+WSVGCI  EL+  + LFPG DH+ QL+L++ L+GTP    L    +E+
Sbjct: 191 LNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSES 250

Query: 179 AKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDI 238
           A+ YI  L +  + +F   F   +P A+DL+EKML  D  +RIT   ALAH Y    HD 
Sbjct: 251 ARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 310

Query: 239 SDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP 275
            DEPV   P+   FE   L   + K L Y E ++F P
Sbjct: 311 DDEPVA-DPYDQSFESRDLLIDEWKSLTYDEVISFVP 346

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (509), Expect = 4e-63
 Identities = 86/277 (31%), Positives = 153/277 (55%), Gaps = 13/277 (4%)

Query: 1   MDHENVVAIRDII-PPPQRESFNDVYIAYELMDTDLHQII----RSNQALSEEHCQYFLY 55
           +DH N+V +R       +++    + +  + +   ++++     R+ Q L   + + ++Y
Sbjct: 70  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 129

Query: 56  QILRGLKYIHSANVLHRDLKPSNLLLNANC-DLKICDFGLARVTSETDFMTEYVVTRWYR 114
           Q+ R L YIHS  + HRD+KP NLLL+ +   LK+CDFG A+     +    Y+ +R+YR
Sbjct: 130 QLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR 189

Query: 115 APELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGF 174
           APEL+  ++DYT++IDVWS GC+  EL+  +P+FPG   V QL  +I+++GTP+  ++  
Sbjct: 190 APELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIRE 249

Query: 175 LNENAKKYICQLPRYQRQSFTEKF-PNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLG 233
           +N N  ++  + P+ +   +T+ F P   P AI L  ++L + P  R+T  +A AH +  
Sbjct: 250 MNPNYTEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFD 307

Query: 234 SLHD----ISDEPVCMSPFSFDFEQHALTEGQMKELI 266
            L D    + +     + F+F  ++ +        LI
Sbjct: 308 ELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILI 344

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (494), Expect = 6e-61
 Identities = 111/285 (38%), Positives = 168/285 (58%), Gaps = 17/285 (5%)

Query: 1   MDHENVVAIRDII-PPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILR 59
           ++H+N++++ ++  P    E F DVY+  ELMD +L Q+I+       E   Y LYQ+L 
Sbjct: 73  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL--DHERMSYLLYQMLC 130

Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           G+K++HSA ++HRDLKPSN+++ ++C LKI DFGLAR    +  MT YVVTR+YRAPE++
Sbjct: 131 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 190

Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENA 179
           L    Y   +D+WSVGCI  E++  K LFPGRD++ Q   +IE +GTP    +  L    
Sbjct: 191 LGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV 249

Query: 180 KKYICQLPRYQRQSFTEKFPN------------VHPSAIDLVEKMLTFDPRQRITVEDAL 227
           + Y+   P+Y   +F + FP+                A DL+ KML  DP +RI+V+DAL
Sbjct: 250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL 309

Query: 228 AHPYLGSLHDISDEPVC-MSPFSFDFEQHALTEGQMKELIYQEAL 271
            HPY+   +D ++        +    ++   T  + KELIY+E +
Sbjct: 310 QHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVM 354

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (476), Expect = 6e-59
 Identities = 81/249 (32%), Positives = 126/249 (50%), Gaps = 11/249 (4%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTD-LHQIIRSNQALSEEHCQYFLYQILR 59
           + H N++ + D          +++ + ++ M+TD    I  ++  L+  H + ++   L+
Sbjct: 57  LSHPNIIGLLDA-----FGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQ 111

Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSETDFMTEYVVTRWYRAPEL 118
           GL+Y+H   +LHRDLKP+NLLL+ N  LK+ DFGLA+   S     T  VVTRWYRAPEL
Sbjct: 112 GLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPEL 171

Query: 119 LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNEN 178
           L  +  Y   +D+W+VGCI  EL+ R P  PG   + QL  + E +GTP+E +  + +  
Sbjct: 172 LFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQ--WPDMC 229

Query: 179 AKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDI 238
           +         +        F       +DL++ +  F+P  RIT   AL   Y  +    
Sbjct: 230 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPG- 288

Query: 239 SDEPVCMSP 247
              P C  P
Sbjct: 289 -PTPGCQLP 296

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (464), Expect = 5e-57
 Identities = 85/237 (35%), Positives = 129/237 (54%), Gaps = 6/237 (2%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELM--DTDLHQIIRSNQALSEEHCQYFLYQIL 58
            +H NVV + D+    + +    + + +E +  D   +        +  E  +  ++Q+L
Sbjct: 67  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL 126

Query: 59  RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPEL 118
           RGL ++HS  V+HRDLKP N+L+ ++  +K+ DFGLAR+ S    +T  VVT WYRAPE+
Sbjct: 127 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEV 186

Query: 119 LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNEN 178
           LL SS Y   +D+WSVGCIF E+  RKPLF G   V QL  ++++IG P E +      +
Sbjct: 187 LLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED---WPRD 242

Query: 179 AKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL 235
                        Q   +   ++     DL+ K LTF+P +RI+   AL+HPY   L
Sbjct: 243 VALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL 299

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (463), Expect = 1e-56
 Identities = 57/248 (22%), Positives = 108/248 (43%), Gaps = 23/248 (9%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILR 59
            +   +V            S  ++ I  E MD   L Q+++    + E+        +++
Sbjct: 61  CNSPYIVGFYGAF-----YSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIK 115

Query: 60  GLKYIHSAN-VLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPEL 118
           GL Y+   + ++HRD+KPSN+L+N+  ++K+CDFG++    ++     +V TR Y +PE 
Sbjct: 116 GLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPE- 173

Query: 119 LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD-HVHQLRLLIELIGTPSE-------- 169
            L  + Y+   D+WS+G   +E+   +   P  D    +L    ++ G  +E        
Sbjct: 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233

Query: 170 ---AELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPS--AIDLVEKMLTFDPRQRITVE 224
                   ++      I +L  Y       K P+   S    D V K L  +P +R  ++
Sbjct: 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLK 293

Query: 225 DALAHPYL 232
             + H ++
Sbjct: 294 QLMVHAFI 301

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (459), Expect = 4e-56
 Identities = 82/251 (32%), Positives = 125/251 (49%), Gaps = 11/251 (4%)

Query: 1   MDHENVVAIRDII---PPPQRESFNDVYIAYELMDTDLHQI-IRSNQALSEEHCQYFLYQ 56
           + HENVV + +I      P       +Y+ ++  + DL  +        +    +  +  
Sbjct: 66  LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQM 125

Query: 57  ILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV-----TSETDFMTEYVVTR 111
           +L GL YIH   +LHRD+K +N+L+  +  LK+ DFGLAR       S+ +  T  VVT 
Sbjct: 126 LLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTL 185

Query: 112 WYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAE 171
           WYR PELLL   DY   ID+W  GCI  E+  R P+  G    HQL L+ +L G+ +   
Sbjct: 186 WYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 245

Query: 172 LGFLNENAKKYICQLPRYQRQSFTEKFPN--VHPSAIDLVEKMLTFDPRQRITVEDALAH 229
              ++        +L + Q++   ++       P A+DL++K+L  DP QRI  +DAL H
Sbjct: 246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305

Query: 230 PYLGSLHDISD 240
            +  S    SD
Sbjct: 306 DFFWSDPMPSD 316

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (450), Expect = 6e-55
 Identities = 86/240 (35%), Positives = 135/240 (56%), Gaps = 9/240 (3%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN--QALSEEHCQYFLYQIL 58
           ++H N+V + D+       + N +Y+ +E +  DL + + ++    +     + +L+Q+L
Sbjct: 58  LNHPNIVKLLDV-----IHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLL 112

Query: 59  RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV-TSETDFMTEYVVTRWYRAPE 117
           +GL + HS  VLHRDLKP NLL+N    +K+ DFGLAR         T  VVT WYRAPE
Sbjct: 113 QGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 172

Query: 118 LLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNE 177
           +LL    Y+ A+D+WS+GCIF E++ R+ LFPG   + QL  +   +GTP E        
Sbjct: 173 ILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPG-VT 231

Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 237
           +   Y    P++ RQ F++  P +      L+ +ML +DP +RI+ + ALAHP+   +  
Sbjct: 232 SMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK 291

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  176 bits (448), Expect = 8e-55
 Identities = 88/233 (37%), Positives = 118/233 (50%), Gaps = 6/233 (2%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRG 60
           + H N+V + D+I          V +   L       +      L     + FL Q+L G
Sbjct: 57  LKHSNIVKLYDVIH----TKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNG 112

Query: 61  LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSETDFMTEYVVTRWYRAPELL 119
           + Y H   VLHRDLKP NLL+N   +LKI DFGLAR         T  +VT WYRAP++L
Sbjct: 113 IAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVL 172

Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENA 179
           + S  Y+  ID+WSVGCIF E+++  PLFPG     QL  +  ++GTP+      + E  
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTE-L 231

Query: 180 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
            KY      Y+   +      +  S IDL+ KML  DP QRIT + AL H Y 
Sbjct: 232 PKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (438), Expect = 2e-53
 Identities = 55/236 (23%), Positives = 94/236 (39%), Gaps = 36/236 (15%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLH-QIIRSNQALSEEHCQYFLYQILR 59
           ++HENVV              N  Y+  E          I  +  + E   Q F +Q++ 
Sbjct: 60  LNHENVVKFYGHRREG-----NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMA 114

Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV---TSETDFMTEYVVTRWYRAP 116
           G+ Y+H   + HRD+KP NLLL+   +LKI DFGLA V    +    + +   T  Y AP
Sbjct: 115 GVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAP 174

Query: 117 ELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLN 176
           ELL     +   +DVWS G +   ++  +  +       Q     +              
Sbjct: 175 ELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWK-------------- 220

Query: 177 ENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
                        +++++   +  +  + + L+ K+L  +P  RIT+ D     + 
Sbjct: 221 -------------EKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWY 263

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  172 bits (438), Expect = 6e-53
 Identities = 60/274 (21%), Positives = 108/274 (39%), Gaps = 40/274 (14%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILR 59
           + H N +  R           +  ++  E    +    +    + L E       +  L+
Sbjct: 72  LRHPNTIQYRGCY-----LREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQ 126

Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           GL Y+HS N++HRD+K  N+LL+    +K+ DFG A + +       +V T ++ APE++
Sbjct: 127 GLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---NSFVGTPYWMAPEVI 183

Query: 120 LNSSD--YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNE 177
           L   +  Y   +DVWS+G   +EL +RKP     + +  L  +                 
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA---------------- 227

Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 237
                       Q +S   +  +      + V+  L   P+ R T E  L H ++     
Sbjct: 228 ------------QNESPALQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERP 275

Query: 238 ISD-EPVCMSPFSFDFEQHALTEGQMKELIYQEA 270
            +    +         E   L   +MK++++QEA
Sbjct: 276 PTVIMDLIQRTKDAVRELDNLQYRKMKKILFQEA 309

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (425), Expect = 2e-51
 Identities = 51/233 (21%), Positives = 92/233 (39%), Gaps = 38/233 (16%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILR 59
           + H N++ +              VY+  E      +++ ++      E+    ++ ++  
Sbjct: 63  LRHPNILRLYGYF-----HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELAN 117

Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
            L Y HS  V+HRD+KP NLLL +  +LKI DFG +     +   T    T  Y  PE++
Sbjct: 118 ALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT-LCGTLDYLPPEMI 176

Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENA 179
                +   +D+WS+G +  E +  KP F    +    + +  +  T             
Sbjct: 177 EGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----------- 224

Query: 180 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
                                V   A DL+ ++L  +P QR  + + L HP++
Sbjct: 225 -------------------DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWI 258

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (424), Expect = 3e-51
 Identities = 84/239 (35%), Positives = 124/239 (51%), Gaps = 7/239 (2%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRG 60
           + H+N+V + D++            +               N  L  E  + FL+Q+L+G
Sbjct: 58  LKHKNIVRLHDVL----HSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKG 113

Query: 61  LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSE-TDFMTEYVVTRWYRAPELL 119
           L + HS NVLHRDLKP NLL+N N +LK+ +FGLAR         +  VVT WYR P++L
Sbjct: 114 LGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVL 173

Query: 120 LNSSDYTAAIDVWSVGCIFMELM-DRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNEN 178
             +  Y+ +ID+WS GCIF EL    +PLFPG D   QL+ +  L+GTP+E +   + + 
Sbjct: 174 FGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233

Query: 179 AKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD 237
              Y          S     P ++ +  DL++ +L  +P QRI+ E+AL HPY      
Sbjct: 234 -PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP 291

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  166 bits (422), Expect = 6e-51
 Identities = 58/237 (24%), Positives = 105/237 (44%), Gaps = 37/237 (15%)

Query: 2   DHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRG 60
            H N++ ++D       E+    ++ ++LM   +L   +     LSE+  +  +  +L  
Sbjct: 68  GHPNIIQLKDTY-----ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 122

Query: 61  LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL 120
           +  +H  N++HRDLKP N+LL+ + ++K+ DFG +      + + E   T  Y APE++ 
Sbjct: 123 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIE 182

Query: 121 -----NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL 175
                N   Y   +D+WS G I   L+   P F  R  +  LR+++              
Sbjct: 183 CSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFG------- 235

Query: 176 NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
                              + ++ +   +  DLV + L   P++R T E+ALAHP+ 
Sbjct: 236 -------------------SPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 273

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  168 bits (427), Expect = 6e-51
 Identities = 54/246 (21%), Positives = 94/246 (38%), Gaps = 36/246 (14%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTD--LHQIIRSNQALSEEHCQYFLYQIL 58
           + H  +V + D       E  N++ + YE M       ++   +  +SE+    ++ Q+ 
Sbjct: 80  LRHPTLVNLHDAF-----EDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVC 134

Query: 59  RGLKYIHSANVLHRDLKPSNLLLNA--NCDLKICDFGLARVTSETDFMTEYVVTRWYRAP 116
           +GL ++H  N +H DLKP N++     + +LK+ DFGL         +     T  + AP
Sbjct: 135 KGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAP 194

Query: 117 ELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLN 176
           E+           D+WSVG +   L+     F G +    LR +        +       
Sbjct: 195 EVAEGKP-VGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDD------- 246

Query: 177 ENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH 236
                                F  +     D + K+L  DP  R+T+  AL HP+L   +
Sbjct: 247 -------------------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGN 287

Query: 237 DISDEP 242
               + 
Sbjct: 288 APGRDS 293

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (422), Expect = 8e-51
 Identities = 51/239 (21%), Positives = 94/239 (39%), Gaps = 39/239 (16%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDL--HQIIRSNQALSEEHCQYFLYQIL 58
            DH N+V + D          N+++I  E          ++   + L+E   Q    Q L
Sbjct: 66  CDHPNIVKLLDAF-----YYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTL 120

Query: 59  RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSETDFMTEYVVTRWYRAPE 117
             L Y+H   ++HRDLK  N+L   + D+K+ DFG++   T        ++ T ++ APE
Sbjct: 121 DALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPE 180

Query: 118 LLLNSSD----YTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELG 173
           +++  +     Y    DVWS+G   +E+ + +P     + +  L  + +           
Sbjct: 181 VVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAK----------- 229

Query: 174 FLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
                      + P         +      +  D ++K L  +   R T    L HP++
Sbjct: 230 ----------SEPPTL------AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFV 272

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  166 bits (421), Expect = 3e-50
 Identities = 66/245 (26%), Positives = 134/245 (54%), Gaps = 16/245 (6%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILR 59
               N++ + DI+   +        + +E ++ TD  Q+ ++   L++   ++++Y+IL+
Sbjct: 87  RGGPNIITLADIV---KDPVSRTPALVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILK 140

Query: 60  GLKYIHSANVLHRDLKPSNLLLNA-NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPEL 118
            L Y HS  ++HRD+KP N++++  +  L++ D+GLA            V +R+++ PEL
Sbjct: 141 ALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPEL 200

Query: 119 LLNSSDYTAAIDVWSVGCIFMELMDRK-PLFPGRDHVHQLRLLIELIGTPSEAEL--GFL 175
           L++   Y  ++D+WS+GC+   ++ RK P F G D+  QL  + +++GT    +    + 
Sbjct: 201 LVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN 260

Query: 176 NENAKKYICQLPRYQRQSF-----TEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHP 230
            E   ++   L R+ R+ +     +E    V P A+D ++K+L +D + R+T  +A+ HP
Sbjct: 261 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHP 320

Query: 231 YLGSL 235
           Y  ++
Sbjct: 321 YFYTV 325

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (416), Expect = 2e-49
 Identities = 62/261 (23%), Positives = 108/261 (41%), Gaps = 30/261 (11%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQII--RSNQALSEEHCQYFLYQI 57
               ++V I D+           + I  E +D  +L   I  R +QA +E      +  I
Sbjct: 62  SQCPHIVRIVDVYENLYAGR-KCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSI 120

Query: 58  LRGLKYIHSANVLHRDLKPSNLLLNA---NCDLKICDFGLARVTSETDFMTEYVVTRWYR 114
              ++Y+HS N+ HRD+KP NLL  +   N  LK+ DFG A+ T+  + +T    T +Y 
Sbjct: 121 GEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYV 180

Query: 115 APELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGF 174
           APE +L    Y  + D+WS+G I   L+   P F     +     +   I          
Sbjct: 181 APE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRI---------- 229

Query: 175 LNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS 234
                +    + P         ++  V      L+  +L  +P QR+T+ + + HP++  
Sbjct: 230 -----RMGQYEFPN-------PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ 277

Query: 235 LHDISDEPVCMSPFSFDFEQH 255
              +   P+  S    + ++ 
Sbjct: 278 STKVPQTPLHTSRVLKEDKER 298

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (415), Expect = 2e-49
 Identities = 56/284 (19%), Positives = 114/284 (40%), Gaps = 37/284 (13%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ-ALSEEHCQYFLYQIL 58
             H N++ + +       ES  ++ + +E +   D+ + I ++   L+E     +++Q+ 
Sbjct: 58  ARHRNILHLHESF-----ESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVC 112

Query: 59  RGLKYIHSANVLHRDLKPSNLLLNA--NCDLKICDFGLARVTSETDFMTEYVVTRWYRAP 116
             L+++HS N+ H D++P N++     +  +KI +FG AR     D          Y AP
Sbjct: 113 EALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAP 172

Query: 117 ELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLN 176
           E+  +    + A D+WS+G +   L+     F    +   +  ++    T  E       
Sbjct: 173 EVHQHD-VVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDE------- 224

Query: 177 ENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH 236
                              E F  +   A+D V+++L  + + R+T  +AL HP+L    
Sbjct: 225 -------------------EAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKI 265

Query: 237 DISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYRQQ 280
           +     V +         H L +  +  ++    ++     R Q
Sbjct: 266 ERVSTKV-IRTLKHRRYYHTLIKKDLNMVVSAARISCGGAIRSQ 308

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  164 bits (415), Expect = 4e-49
 Identities = 57/253 (22%), Positives = 106/253 (41%), Gaps = 36/253 (14%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ-ALSEEHCQYFLYQIL 58
           + H  ++ + D       E   ++ +  E +   +L   I +    +SE     ++ Q  
Sbjct: 83  LHHPKLINLHDAF-----EDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQAC 137

Query: 59  RGLKYIHSANVLHRDLKPSNLLLNA--NCDLKICDFGLARVTSETDFMTEYVVTRWYRAP 116
            GLK++H  +++H D+KP N++        +KI DFGLA   +  + +     T  + AP
Sbjct: 138 EGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAP 197

Query: 117 ELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLN 176
           E +++        D+W++G +   L+     F G D +  L+ +        E       
Sbjct: 198 E-IVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDE------- 249

Query: 177 ENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH 236
                              + F +V P A D ++ +L  +PR+R+TV DAL HP+L   H
Sbjct: 250 -------------------DAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH 290

Query: 237 DISDEPVCMSPFS 249
                 +  S ++
Sbjct: 291 SNLTSRIPSSRYN 303

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (410), Expect = 5e-49
 Identities = 48/233 (20%), Positives = 98/233 (42%), Gaps = 34/233 (14%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRG 60
             + N+V   D          +++++  E +       + +   + E        + L+ 
Sbjct: 74  NKNPNIVNYLDSY-----LVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQA 128

Query: 61  LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSETDFMTEYVVTRWYRAPELL 119
           L+++HS  V+HRD+K  N+LL  +  +K+ DFG    +T E    +  V T ++ APE++
Sbjct: 129 LEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 188

Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENA 179
              + Y   +D+WS+G + +E+++ +P +   + +  L  LI   GTP            
Sbjct: 189 TRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY-LIATNGTPEL---------- 236

Query: 180 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
                           +    +     D + + L  D  +R + ++ L H +L
Sbjct: 237 ----------------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFL 273

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (408), Expect = 5e-49
 Identities = 63/243 (25%), Positives = 96/243 (39%), Gaps = 44/243 (18%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQII----RSNQALSEEHCQYFLY 55
           + H N+V   D I      +   +YI  E  +  DL  +I    +  Q L EE     + 
Sbjct: 60  LKHPNIVRYYDRI---IDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMT 116

Query: 56  QILRGLKYIH-----SANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSETDFMTEYVV 109
           Q+   LK  H        VLHRDLKP+N+ L+   ++K+ DFGLAR +  +T F   +V 
Sbjct: 117 QLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVG 176

Query: 110 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSE 169
           T +Y +PE +   S Y    D+WS+GC+  EL    P F           + E       
Sbjct: 177 TPYYMSPEQMNRMS-YNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE------- 228

Query: 170 AELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 229
                                   F            +++ +ML      R +VE+ L +
Sbjct: 229 ----------------------GKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN 266

Query: 230 PYL 232
           P +
Sbjct: 267 PLI 269

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  158 bits (401), Expect = 1e-47
 Identities = 60/236 (25%), Positives = 102/236 (43%), Gaps = 36/236 (15%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILR 59
           + H N+VA+ DI      ES   +Y+  +L+   +L   I      +E      ++Q+L 
Sbjct: 64  IKHPNIVALDDIY-----ESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLD 118

Query: 60  GLKYIHSANVLHRDLKPSNLLL---NANCDLKICDFGLARVTSETDFMTEYVVTRWYRAP 116
            +KY+H   ++HRDLKP NLL    + +  + I DFGL+++      ++    T  Y AP
Sbjct: 119 AVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAP 178

Query: 117 ELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLN 176
           E+L     Y+ A+D WS+G I   L+   P F   +       +++              
Sbjct: 179 EVLAQKP-YSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDS------- 230

Query: 177 ENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
                                + ++  SA D +  ++  DP +R T E AL HP++
Sbjct: 231 -------------------PYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWI 267

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  155 bits (393), Expect = 1e-46
 Identities = 44/236 (18%), Positives = 94/236 (39%), Gaps = 35/236 (14%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILR 59
           + H N+V   D      +     + +  ELM +  L   ++  + +  +  + +  QIL+
Sbjct: 65  LQHPNIVRFYDSWESTVKGK-KCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILK 123

Query: 60  GLKYIHSAN--VLHRDLKPSNLLLNA-NCDLKICDFGLARVTSETDFMTEYVVTRWYRAP 116
           GL+++H+    ++HRDLK  N+ +      +KI D GLA +     F    + T  + AP
Sbjct: 124 GLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL-KRASFAKAVIGTPEFMAP 182

Query: 117 ELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLN 176
           E+      Y  ++DV++ G   +E+   +  +    +  Q+   +     P+  +     
Sbjct: 183 EMY--EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFD----- 235

Query: 177 ENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
                                     P   +++E  +  +  +R +++D L H + 
Sbjct: 236 ----------------------KVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 269

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (386), Expect = 1e-45
 Identities = 63/245 (25%), Positives = 103/245 (42%), Gaps = 46/245 (18%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILR 59
           +DH   V +         +    +Y         +L + IR   +  E   +++  +I+ 
Sbjct: 65  LDHPFFVKLYFTF-----QDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVS 119

Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV---TSETDFMTEYVVTRWYRAP 116
            L+Y+H   ++HRDLKP N+LLN +  ++I DFG A+V    S+      +V T  Y +P
Sbjct: 120 ALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSP 179

Query: 117 ELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLN 176
           ELL   S    + D+W++GCI  +L+   P F   +     + +I+L     E       
Sbjct: 180 ELLTEKS-ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE------- 231

Query: 177 ENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDA------LAHP 230
                                     P A DLVEK+L  D  +R+  E+        AHP
Sbjct: 232 -----------------------KFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHP 268

Query: 231 YLGSL 235
           +  S+
Sbjct: 269 FFESV 273

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (378), Expect = 2e-44
 Identities = 42/236 (17%), Positives = 89/236 (37%), Gaps = 37/236 (15%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQA-LSEEHCQYFLYQIL 58
             H N++            +   + I  +  + + L+  +   +             Q  
Sbjct: 61  TRHVNILLFMGY------STAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTA 114

Query: 59  RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSE---TDFMTEYVVTRWYRA 115
           +G+ Y+H+ +++HRDLK +N+ L+ +  +KI DFGLA V S    +    +   +  + A
Sbjct: 115 QGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMA 174

Query: 116 PELLL--NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELG 173
           PE++   + + Y+   DV++ G +  ELM  +  +   ++  Q+  ++            
Sbjct: 175 PEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGR---------- 224

Query: 174 FLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 229
                          Y     ++   N   +   L+ + L     +R      LA 
Sbjct: 225 --------------GYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (364), Expect = 3e-42
 Identities = 63/237 (26%), Positives = 102/237 (43%), Gaps = 37/237 (15%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTD-LHQIIRSNQALSEEHCQYFLYQILR 59
           + H NV+ + ++      E+  DV +  EL+    L   +   ++L+EE    FL QIL 
Sbjct: 70  IQHPNVITLHEVY-----ENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILN 124

Query: 60  GLKYIHSANVLHRDLKPSNLLLN----ANCDLKICDFGLARVTSETDFMTEYVVTRWYRA 115
           G+ Y+HS  + H DLKP N++L         +KI DFGLA      +       T  + A
Sbjct: 125 GVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVA 184

Query: 116 PELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL 175
           PE++ N        D+WS+G I   L+     F G      L  +  +     +      
Sbjct: 185 PEIV-NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFED------ 237

Query: 176 NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
                               E F N    A D + ++L  DP++R+T++D+L HP++
Sbjct: 238 --------------------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 274

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (361), Expect = 6e-42
 Identities = 50/234 (21%), Positives = 89/234 (38%), Gaps = 45/234 (19%)

Query: 2   DHENVVAIRDIIPPPQRESFNDVYIAYELMD--TDLHQIIRSNQALSEEHCQYFLYQILR 59
               V+ + D    P     +   +  E  +   DL   I    AL EE  + F +Q+L 
Sbjct: 67  GFSGVIRLLDWFERP-----DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 121

Query: 60  GLKYIHSANVLHRDLKPSNLLLNAN-CDLKICDFGLARVTSETDFMTEYVVTRWYRAPEL 118
            +++ H+  VLHRD+K  N+L++ N  +LK+ DFG   +  +T   T++  TR Y  PE 
Sbjct: 122 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEW 180

Query: 119 LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNEN 178
           +     +  +  VWS+G +  +++     F   + + + ++                   
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFR---------------- 224

Query: 179 AKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL 232
                                 V      L+   L   P  R T E+   HP++
Sbjct: 225 --------------------QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 258

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (350), Expect = 8e-40
 Identities = 50/235 (21%), Positives = 92/235 (39%), Gaps = 39/235 (16%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILR 59
            +H  +  +         ++  +++   E ++  DL   I+S          ++  +I+ 
Sbjct: 60  WEHPFLTHMFCTF-----QTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIIL 114

Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSETDFMTEYVVTRWYRAPEL 118
           GL+++HS  +++RDLK  N+LL+ +  +KI DFG+ +           +  T  Y APE+
Sbjct: 115 GLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEI 174

Query: 119 LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNEN 178
           LL    Y  ++D WS G +  E++  +  F G+D                          
Sbjct: 175 LLGQK-YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELF--------------------- 212

Query: 179 AKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVE-DALAHPYL 232
                       R         +   A DL+ K+   +P +R+ V  D   HP  
Sbjct: 213 ---------HSIRMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLF 258

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  139 bits (352), Expect = 8e-40
 Identities = 51/238 (21%), Positives = 96/238 (40%), Gaps = 39/238 (16%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILR 59
            D   +V +          + + +    +LM+  DLH  +  +   SE   +++  +I+ 
Sbjct: 64  GDCPFIVCMSYAF-----HTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIIL 118

Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
           GL+++H+  V++RDLKP+N+LL+ +  ++I D GLA   S+       V T  Y APE+L
Sbjct: 119 GLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVL 177

Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENA 179
                Y ++ D +S+GC+  +L+     F       +  +                    
Sbjct: 178 QKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID------------------- 218

Query: 180 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV-----EDALAHPYL 232
                   R       E   +  P    L+E +L  D  +R+       ++    P+ 
Sbjct: 219 --------RMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 268

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (331), Expect = 1e-37
 Identities = 47/232 (20%), Positives = 81/232 (34%), Gaps = 38/232 (16%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQI 57
           + H N+V +  +I     E    +YI  E M    L   +RS     L  +    F   +
Sbjct: 57  LRHSNLVQLLGVI----VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 112

Query: 58  LRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPE 117
              ++Y+   N +HRDL   N+L++ +   K+ DFGL +  S T       +   + APE
Sbjct: 113 CEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--QDTGKLPVKWTAPE 170

Query: 118 LLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNE 177
            L     ++   DVWS G +  E+     +   R  +  +   +E               
Sbjct: 171 ALREKK-FSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE--------------- 214

Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 229
             K Y    P               P+  ++++     D   R +       
Sbjct: 215 --KGYKMDAP-----------DGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  128 bits (322), Expect = 3e-36
 Identities = 47/235 (20%), Positives = 90/235 (38%), Gaps = 33/235 (14%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILR 59
           ++H  +VA+ D     +  +    YI  E +D   L  I+ +   ++ +     +    +
Sbjct: 64  LNHPAIVAVYDTGEA-ETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQ 122

Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD----FMTEYVVTRWYRA 115
            L + H   ++HRD+KP+N++++A   +K+ DFG+AR  +++          + T  Y +
Sbjct: 123 ALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS 182

Query: 116 PELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL 175
           PE     S   A  DV+S+GC+  E++  +P F G   V      +     P        
Sbjct: 183 PEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPS------ 235

Query: 176 NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHP 230
                                +   +      +V K L  +P  R      +   
Sbjct: 236 --------------------ARHEGLSADLDAVVLKALAKNPENRYQTAAEMRAD 270

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (321), Expect = 2e-35
 Identities = 54/239 (22%), Positives = 99/239 (41%), Gaps = 43/239 (17%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTD-LHQIIRSNQALSEEHCQYFLYQILR 59
             H  + A++       R     +    E  +   L   +   +  +EE  +++  +I+ 
Sbjct: 62  TRHPFLTALKYAFQTHDR-----LCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVS 116

Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSETDFMTEYVVTRWYRAPEL 118
            L+Y+HS +V++RD+K  NL+L+ +  +KI DFGL +   S+   M  +  T  Y APE+
Sbjct: 117 ALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEV 176

Query: 119 LLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNEN 178
           L + +DY  A+D W +G +  E+M  +  F  +DH                         
Sbjct: 177 LED-NDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE-------------------L 216

Query: 179 AKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI-----TVEDALAHPYL 232
                 + P             + P A  L+  +L  DP+QR+       ++ + H + 
Sbjct: 217 ILMEEIRFP-----------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFF 264

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (310), Expect = 2e-34
 Identities = 55/244 (22%), Positives = 86/244 (35%), Gaps = 44/244 (18%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMD---TDLHQIIRSNQALSEEHCQYFLYQI 57
           + HE +V +  ++      S   +YI  E M            + + L          QI
Sbjct: 69  LRHEKLVQLYAVV------SEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQI 122

Query: 58  LRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF--MTEYVVTRWYRA 115
             G+ Y+   N +HRDL+ +N+L+  N   K+ DFGLAR+  + ++           + A
Sbjct: 123 ASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTA 182

Query: 116 PELLLNSSDYTAAIDVWSVGCIFMEL-MDRKPLFPGRDHVHQLRLLIELIGTPSEAELGF 174
           PE  L    +T   DVWS G +  EL    +  +PG  +   L  +      P       
Sbjct: 183 PEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCP----- 236

Query: 175 LNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA--HPYL 232
                                   P    S  DL+ +    +P +R T E   A    Y 
Sbjct: 237 ------------------------PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272

Query: 233 GSLH 236
            S  
Sbjct: 273 TSTE 276

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  124 bits (311), Expect = 3e-34
 Identities = 51/238 (21%), Positives = 101/238 (42%), Gaps = 44/238 (18%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILR 59
           + H  ++ +         +    +++  + ++  +L  ++R +Q       +++  ++  
Sbjct: 61  VTHPFIIRMWGTF-----QDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCL 115

Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELL 119
            L+Y+HS ++++RDLKP N+LL+ N  +KI DFG A+   +         T  Y APE +
Sbjct: 116 ALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--TYTLCGTPDYIAPE-V 172

Query: 120 LNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENA 179
           +++  Y  +ID WS G +  E++     F   + +     ++        AEL F     
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKIL-------NAELRFP---- 221

Query: 180 KKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI-----TVEDALAHPYL 232
                              P  +    DL+ +++T D  QR+       ED   HP+ 
Sbjct: 222 -------------------PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWF 260

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (311), Expect = 3e-34
 Identities = 36/240 (15%), Positives = 88/240 (36%), Gaps = 40/240 (16%)

Query: 2   DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRG 60
               +V +         ++   +++  + ++  +L   +   +  +E   Q ++ +I+  
Sbjct: 87  QSPFLVTLHYAF-----QTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLA 141

Query: 61  LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSE---TDFMTEYVVTRWYRAPE 117
           L+++H   +++RD+K  N+LL++N  + + DFGL++                  +     
Sbjct: 142 LEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDI 201

Query: 118 LLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNE 177
           +    S +  A+D WS+G +  EL+     F      +    +   I             
Sbjct: 202 VRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEP-------- 253

Query: 178 NAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI-----TVEDALAHPYL 232
                                  +   A DL++++L  DP++R+       ++   H + 
Sbjct: 254 ------------------PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 295

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (308), Expect = 1e-33
 Identities = 52/257 (20%), Positives = 85/257 (33%), Gaps = 62/257 (24%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ---------------- 43
             HEN+V +              +Y+ +E     DL   +RS +                
Sbjct: 98  GSHENIVNLLGAC-----TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 152

Query: 44  -------ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 96
                   L+ E    F YQ+ +G++++   + +HRDL   N+L+     +KICDFGLAR
Sbjct: 153 EEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLAR 212

Query: 97  VTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR-KPLFPGRD 152
                          +   + APE L     YT   DVWS G +  E+       +PG  
Sbjct: 213 DIMSDSNYVVRGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILLWEIFSLGVNPYPGIP 271

Query: 153 HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKM 212
                  LI+                   +    P                    +++  
Sbjct: 272 VDANFYKLIQ-----------------NGFKMDQP-----------FYATEEIYIIMQSC 303

Query: 213 LTFDPRQRITVEDALAH 229
             FD R+R +  +  + 
Sbjct: 304 WAFDSRKRPSFPNLTSF 320

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (300), Expect = 5e-33
 Identities = 49/250 (19%), Positives = 91/250 (36%), Gaps = 49/250 (19%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILR 59
           +D+  +V +  I             +  E+ +   L++ ++ N+ + +++    ++Q+  
Sbjct: 65  LDNPYIVRMIGIC------EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSM 118

Query: 60  GLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF----MTEYVVTRWYRA 115
           G+KY+  +N +HRDL   N+LL      KI DFGL++     +      T       + A
Sbjct: 119 GMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA 178

Query: 116 PELLLNSSDYTAAIDVWSVGCIFMELM-DRKPLFPGRDHVHQLRLLIELIGTPSEAELGF 174
           PE +     +++  DVWS G +  E     +  + G        +L              
Sbjct: 179 PECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE------------- 224

Query: 175 LNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT---VEDALAHPY 231
                K      P                   DL+    T+D   R     VE  L + Y
Sbjct: 225 -----KGERMGCP-----------AGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268

Query: 232 LGSLHDISDE 241
               +D+ +E
Sbjct: 269 ----YDVVNE 274

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (301), Expect = 7e-33
 Identities = 46/260 (17%), Positives = 89/260 (34%), Gaps = 34/260 (13%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILR 59
           + HEN++            ++  +++  +  +   L   +     ++ E           
Sbjct: 54  LRHENILGFIAADNKDN-GTWTQLWLVSDYHEHGSLFDYLN-RYTVTVEGMIKLALSTAS 111

Query: 60  GLKYIHSA--------NVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD-----FMTE 106
           GL ++H           + HRDLK  N+L+  N    I D GLA                
Sbjct: 112 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH 171

Query: 107 YVVTRWYRAPELLLNSS-----DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLI 161
            V T+ Y APE+L +S      +     D++++G +F E+  R  +  G    +QL    
Sbjct: 172 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIG-GIHEDYQLPYYD 230

Query: 162 ELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI 221
            +   PS  E+       +K +C+           +          ++ +    +   R+
Sbjct: 231 LVPSDPSVEEM-------RKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARL 283

Query: 222 TVEDALAHPYLGSLHDISDE 241
           T            L  +S +
Sbjct: 284 TALRIKKT-----LSQLSQQ 298

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  120 bits (301), Expect = 2e-32
 Identities = 58/258 (22%), Positives = 102/258 (39%), Gaps = 29/258 (11%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIR-SNQALSEEHCQYFLYQILR 59
           M   +++ + D          + V +   L +  L  I +  ++ +   + +    Q+L 
Sbjct: 77  MGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLL 136

Query: 60  GLKYIH-SANVLHRDLKPSNLLLNAN------CDLKICDFGLARVTSETDFMTEYVVTRW 112
           GL Y+H    ++H D+KP N+L+           +KI D G A    E       + TR 
Sbjct: 137 GLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTN--SIQTRE 194

Query: 113 YRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD------HVHQLRLLIELIGT 166
           YR+PE+LL +  +    D+WS  C+  EL+    LF   +          +  +IEL+G 
Sbjct: 195 YRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGE 253

Query: 167 PSEAEL--------GFLNENAKKYICQLPRYQRQSFTEK----FPNVHPSAIDLVEKMLT 214
                L         F +    + I +L  +  +    +      +      D +  ML 
Sbjct: 254 LPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQ 313

Query: 215 FDPRQRITVEDALAHPYL 232
            DPR+R      + HP+L
Sbjct: 314 LDPRKRADAGGLVNHPWL 331

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  119 bits (300), Expect = 2e-32
 Identities = 44/237 (18%), Positives = 86/237 (36%), Gaps = 42/237 (17%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRG 60
           ++   +V +        +++ N   +   +   ++   +R     SE H +++  QI+  
Sbjct: 98  VNFPFLVKLEF----SFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLT 153

Query: 61  LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLL 120
            +Y+HS ++++RDLKP NLL++    +++ DFG A+             T    APE++L
Sbjct: 154 FEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV--KGRTWTLCGTPEALAPEIIL 211

Query: 121 NSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAK 180
           +   Y  A+D W++G +  E+    P F     +                          
Sbjct: 212 SKG-YNKAVDWWALGVLIYEMAAGYPPFFADQPIQIY----------------------- 247

Query: 181 KYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI-----TVEDALAHPYL 232
                              +      DL+  +L  D  +R       V D   H + 
Sbjct: 248 -------EKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (294), Expect = 4e-32
 Identities = 49/244 (20%), Positives = 87/244 (35%), Gaps = 47/244 (19%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDL---HQIIRSNQALSEEHCQYFLYQI 57
           + H+ +V +  ++      +   +YI  E M+           S   L+         QI
Sbjct: 65  LQHQRLVRLYAVV------TQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 118

Query: 58  LRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF--MTEYVVTRWYRA 115
             G+ +I   N +HRDL+ +N+L++     KI DFGLAR+  + ++           + A
Sbjct: 119 AEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTA 178

Query: 116 PELLLNSSDYTAAIDVWSVGCIFMELM-DRKPLFPGRDHVHQLRLLIELIGTPSEAELGF 174
           PE + N   +T   DVWS G +  E++   +  +PG  +   ++ L              
Sbjct: 179 PEAI-NYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNL-------------- 223

Query: 175 LNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS 234
                          +R     +  N       L+       P  R T +   +      
Sbjct: 224 ---------------ERGYRMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSV----- 263

Query: 235 LHDI 238
           L D 
Sbjct: 264 LEDF 267

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (293), Expect = 5e-32
 Identities = 39/233 (16%), Positives = 75/233 (32%), Gaps = 40/233 (17%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMD--TDLHQIIRSNQALSEEHCQYFLYQIL 58
           +DH N++ +  ++          + +  EL    + L ++ +            +  Q+ 
Sbjct: 68  LDHRNLIRLYGVV------LTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVA 121

Query: 59  RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRA 115
            G+ Y+ S   +HRDL   NLLL     +KI DFGL R   + D    M E+    +   
Sbjct: 122 EGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181

Query: 116 PELLLNSSDYTAAIDVWSVGCIFMELM-DRKPLFPGRDHVHQLRLLIELIGTPSEAELGF 174
               L +  ++ A D W  G    E+    +  + G +    L  + +            
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL------- 234

Query: 175 LNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDAL 227
                                 +  +      +++ +     P  R T     
Sbjct: 235 ---------------------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALR 266

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (293), Expect = 7e-32
 Identities = 43/241 (17%), Positives = 80/241 (33%), Gaps = 46/241 (19%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQIL 58
           +D+  +V +  +           + +  E+     LH+ +    + +   +    L+Q+ 
Sbjct: 66  LDNPYIVRLIGVC------QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVS 119

Query: 59  RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD----FMTEYVVTRWYR 114
            G+KY+   N +HRDL   N+LL      KI DFGL++     D      +       + 
Sbjct: 120 MGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 179

Query: 115 APELLLNSSDYTAAIDVWSVGCIFMELM-DRKPLFPGRDHVHQLRLLIELIGTPSEAELG 173
           APE + N   +++  DVWS G    E +   +  +        +  +             
Sbjct: 180 APECI-NFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI------------- 225

Query: 174 FLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT---VEDALAHP 230
                           ++    E  P   P    L+     +    R     VE  +   
Sbjct: 226 ----------------EQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC 269

Query: 231 Y 231
           Y
Sbjct: 270 Y 270

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (286), Expect = 5e-31
 Identities = 39/234 (16%), Positives = 77/234 (32%), Gaps = 40/234 (17%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELM--DTDLHQIIRSNQALSEEHCQYFLYQIL 58
           + HE +V +  +           ++I  E M     L+ +         +        + 
Sbjct: 56  LSHEKLVQLYGVC-----TKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVC 110

Query: 59  RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF--MTEYVVTRWYRAP 116
             ++Y+ S   LHRDL   N L+N    +K+ DFGL+R   + ++           +  P
Sbjct: 111 EAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPP 170

Query: 117 ELLLNSSDYTAAIDVWSVGCIFMELMDR-KPLFPGRDHVHQLRLLIELIGTPSEAELGFL 175
           E+L+ S  +++  D+W+ G +  E+    K  +    +                      
Sbjct: 171 EVLMYSK-FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH---------------- 213

Query: 176 NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 229
                  I Q  R  R                ++         +R T +  L++
Sbjct: 214 -------IAQGLRLYRP------HLASEKVYTIMYSCWHEKADERPTFKILLSN 254

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (288), Expect = 6e-31
 Identities = 52/245 (21%), Positives = 81/245 (33%), Gaps = 51/245 (20%)

Query: 2   DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN----------------QA 44
            H N++ +              +Y+A E     +L   +R +                  
Sbjct: 69  HHPNIINLLGACEHR-----GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 123

Query: 45  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM 104
           LS +   +F   + RG+ Y+     +HRDL   N+L+  N   KI DFGL+R        
Sbjct: 124 LSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK 183

Query: 105 TEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELI 164
           T   +   + A E  LN S YT   DVWS G +  E++             +L       
Sbjct: 184 TMGRLPVRWMAIE-SLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY------ 236

Query: 165 GTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVE 224
                           + + Q  R       EK  N      DL+ +     P +R +  
Sbjct: 237 ----------------EKLPQGYRL------EKPLNCDDEVYDLMRQCWREKPYERPSFA 274

Query: 225 DALAH 229
             L  
Sbjct: 275 QILVS 279

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (280), Expect = 3e-30
 Identities = 41/233 (17%), Positives = 76/233 (32%), Gaps = 38/233 (16%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQAL-SEEHCQYFLYQIL 58
           + H  +V +  +           + + +E M+   L   +R+ + L + E        + 
Sbjct: 57  LSHPKLVQLYGVC-----LEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVC 111

Query: 59  RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAP 116
            G+ Y+  A V+HRDL   N L+  N  +K+ DFG+ R   +      T       + +P
Sbjct: 112 EGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASP 171

Query: 117 ELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLN 176
           E+  + S Y++  DVWS G +  E+     +        ++   I               
Sbjct: 172 EVF-SFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS-------------- 216

Query: 177 ENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 229
                +    PR                   ++       P  R      L  
Sbjct: 217 ---TGFRLYKPR-----------LASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (275), Expect = 2e-29
 Identities = 48/233 (20%), Positives = 88/233 (37%), Gaps = 39/233 (16%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELM--DTDLHQIIRSNQALSEEHCQYFLYQIL 58
            DH ++V +  +I      + N V+I  EL         +     +L       + YQ+ 
Sbjct: 65  FDHPHIVKLIGVI------TENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLS 118

Query: 59  RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM--TEYVVTRWYRAP 116
             L Y+ S   +HRD+   N+L+++N  +K+ DFGL+R   ++ +   ++  +   + AP
Sbjct: 119 TALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAP 178

Query: 117 ELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLN 176
           E + N   +T+A DVW  G    E++            + +   I               
Sbjct: 179 ESI-NFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI--------------- 222

Query: 177 ENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 229
                        +        PN  P+   L+ K   +DP +R    +  A 
Sbjct: 223 -------------ENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  109 bits (272), Expect = 8e-29
 Identities = 44/231 (19%), Positives = 77/231 (33%), Gaps = 37/231 (16%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMD---TDLHQIIRSNQALSEEHCQYFLYQI 57
           + H N+V +  +            YI  E M       +    + Q +S     Y   QI
Sbjct: 70  IKHPNLVQLLGVC-----TREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQI 124

Query: 58  LRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-VTSETDFMTEYVVTRWYRAP 116
              ++Y+   N +HRDL   N L+  N  +K+ DFGL+R +T +T               
Sbjct: 125 SSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTA 184

Query: 117 ELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLN 176
              L  + ++   DVW+ G +  E+            + Q+  L+E              
Sbjct: 185 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLE-------------- 230

Query: 177 ENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDAL 227
              K Y  + P                   +L+     ++P  R +  +  
Sbjct: 231 ---KDYRMERP-----------EGCPEKVYELMRACWQWNPSDRPSFAEIH 267

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (272), Expect = 1e-28
 Identities = 49/278 (17%), Positives = 93/278 (33%), Gaps = 47/278 (16%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMD--TDLHQIIRSNQALSEEHCQYFLYQIL 58
           +D+ +V  +  I         + V +  +LM     L  +      +  ++   +  QI 
Sbjct: 68  VDNPHVCRLLGIC------LTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIA 121

Query: 59  RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRA 115
           +G+ Y+    ++HRDL   N+L+     +KI DFGLA++    +         V   + A
Sbjct: 122 KGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 181

Query: 116 PELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFL 175
            E +L+   YT   DVWS G    ELM             ++  ++E             
Sbjct: 182 LESILHRI-YTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE------------- 227

Query: 176 NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH------ 229
                          +     + P        ++ K    D   R    + +        
Sbjct: 228 ---------------KGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272

Query: 230 -PYLGSLHDISDEPVCMSPFSFDFEQHALTEGQMKELI 266
            P    +    +     SP   +F +  + E  M +++
Sbjct: 273 DPQRYLVIQGDERMHLPSPTDSNFYRALMDEEDMDDVV 310

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  107 bits (268), Expect = 4e-28
 Identities = 43/237 (18%), Positives = 76/237 (32%), Gaps = 42/237 (17%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQII--RSNQALSEEHCQYFLYQIL 58
            DH NV+ +  ++          V I  E M+         +++   +       L  I 
Sbjct: 84  FDHPNVIHLEGVV-----TKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIA 138

Query: 59  RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPEL 118
            G+KY+   N +HRDL   N+L+N+N   K+ DFGL+R   +      Y      + P  
Sbjct: 139 AGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIR 198

Query: 119 LL-----NSSDYTAAIDVWSVGCIFMELM-DRKPLFPGRDHVHQLRLLIELIGTPSEAEL 172
                      +T+A DVWS G +  E+M   +  +    +   +  + +    P     
Sbjct: 199 WTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPP--- 255

Query: 173 GFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 229
                                      +   +   L+      D   R      +  
Sbjct: 256 --------------------------MDCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  106 bits (266), Expect = 6e-28
 Identities = 36/215 (16%), Positives = 64/215 (29%), Gaps = 34/215 (15%)

Query: 17  QRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKP 76
                    +++  + T           LS         Q+  G+ Y+     +HRDL  
Sbjct: 109 SMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLAT 168

Query: 77  SNLLLNANCDLKICDFGLARVTSETDF---MTEYVVTRWYRAPELLLNSSDYTAAIDVWS 133
            N L+  N  +KI DFGL+R     D+        +   +  PE +  +  YT   DVW+
Sbjct: 169 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN-RYTTESDVWA 227

Query: 134 VGCIFMELMDR-KPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQ 192
            G +  E+       + G  H   +  + +                              
Sbjct: 228 YGVVLWEIFSYGLQPYYGMAHEEVIYYVRD-----------------------------G 258

Query: 193 SFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDAL 227
           +      N      +L+    +  P  R +     
Sbjct: 259 NILACPENCPLELYNLMRLCWSKLPADRPSFCSIH 293

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (264), Expect = 9e-28
 Identities = 49/258 (18%), Positives = 87/258 (33%), Gaps = 46/258 (17%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELM--DTDLHQIIRSNQALSEEHCQYFLYQIL 58
             H N++ +  +I          + I  E M        +   +   S       L  I 
Sbjct: 66  FSHHNIIRLEGVISKY-----KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIA 120

Query: 59  RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSE----TDFMTEYVVTRWYR 114
            G+KY+ + N +HRDL   N+L+N+N   K+ DFGL+RV  +    T   +   +   + 
Sbjct: 121 AGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWT 180

Query: 115 APELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELGF 174
           APE +      +A+ DVWS G +  E+M            H++   I             
Sbjct: 181 APEAISYRKFTSAS-DVWSFGIVMWEVMTYGERPYWELSNHEVMKAI------------- 226

Query: 175 LNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS 234
                                    +   +   L+ +    +  +R    D ++      
Sbjct: 227 ---------------NDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSI----- 266

Query: 235 LHDISDEPVCMSPFSFDF 252
           L  +   P  +   + DF
Sbjct: 267 LDKLIRAPDSLKTLA-DF 283

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (263), Expect = 2e-27
 Identities = 50/250 (20%), Positives = 88/250 (35%), Gaps = 54/250 (21%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ---------------- 43
             H NVV +         +    + +  E     +L   +RS +                
Sbjct: 74  GHHLNVVNLLGAC----TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKD 129

Query: 44  ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD- 102
            L+ EH   + +Q+ +G++++ S   +HRDL   N+LL+    +KICDFGLAR   +   
Sbjct: 130 FLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189

Query: 103 --FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR-KPLFPGRDHVHQLRL 159
                +  +   + APE + +   YT   DVWS G +  E+       +PG     +   
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 248

Query: 160 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQ 219
            ++                 +    + P               P     +      +P Q
Sbjct: 249 RLK-----------------EGTRMRAP-----------DYTTPEMYQTMLDCWHGEPSQ 280

Query: 220 RITVEDALAH 229
           R T  + + H
Sbjct: 281 RPTFSELVEH 290

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  105 bits (262), Expect = 2e-27
 Identities = 35/245 (14%), Positives = 67/245 (27%), Gaps = 43/245 (17%)

Query: 2   DHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQI-IRSNQALSEEHCQYFLYQILRG 60
               +  IR               +  EL+   L  +    ++  S +       Q++  
Sbjct: 61  GGVGIPTIRWCGAEGDY-----NVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISR 115

Query: 61  LKYIHSANVLHRDLKPSNLL---LNANCDLKICDFGLARVTSETD--------FMTEYVV 109
           ++YIHS N +HRD+KP N L         + I DFGLA+   +                 
Sbjct: 116 IEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTG 175

Query: 110 TRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSE 169
           T  Y +    L   + +   D+ S+G + M        + G     + +           
Sbjct: 176 TARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ----------- 223

Query: 170 AELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT---VEDA 226
                      KY     +                    +    +     +     +   
Sbjct: 224 -----------KYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQL 272

Query: 227 LAHPY 231
             + +
Sbjct: 273 FRNLF 277

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (263), Expect = 2e-27
 Identities = 56/250 (22%), Positives = 84/250 (33%), Gaps = 59/250 (23%)

Query: 2   DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ----------------- 43
           +H N+V +                +  E     DL   +R  +                 
Sbjct: 85  NHMNIVNLLGAC-----TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139

Query: 44  -ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARV---TS 99
            AL  E    F YQ+ +G+ ++ S N +HRDL   N+LL      KICDFGLAR     S
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199

Query: 100 ETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM-DRKPLFPGRDHVHQLR 158
                    +   + APE + N   YT   DVWS G    EL       +PG     +  
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNC-VYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258

Query: 159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP-NVHPSAIDLVEKMLTFDP 217
            +I                             ++ F    P +      D+++     DP
Sbjct: 259 KMI-----------------------------KEGFRMLSPEHAPAEMYDIMKTCWDADP 289

Query: 218 RQRITVEDAL 227
            +R T +  +
Sbjct: 290 LKRPTFKQIV 299

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (253), Expect = 5e-26
 Identities = 51/249 (20%), Positives = 87/249 (34%), Gaps = 56/249 (22%)

Query: 2   DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIR----------------SNQA 44
            H+N++ +              +Y+  E     +L + ++                  + 
Sbjct: 77  KHKNIINLLGAC-----TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131

Query: 45  LSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFM 104
           LS +      YQ+ RG++Y+ S   +HRDL   N+L+  +  +KI DFGLAR     D+ 
Sbjct: 132 LSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY 191

Query: 105 TE---YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM-DRKPLFPGRDHVHQLRLL 160
            +     +   + APE L +   YT   DVWS G +  E+       +PG          
Sbjct: 192 KKTTNGRLPVKWMAPEALFDRI-YTHQSDVWSFGVLLWEIFTLGGSPYPGVP-------- 242

Query: 161 IELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQR 220
                           E   K + +  R       +K  N       ++       P QR
Sbjct: 243 ---------------VEELFKLLKEGHRM------DKPSNCTNELYMMMRDCWHAVPSQR 281

Query: 221 ITVEDALAH 229
            T +  +  
Sbjct: 282 PTFKQLVED 290

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  101 bits (252), Expect = 5e-26
 Identities = 29/232 (12%), Positives = 65/232 (28%), Gaps = 42/232 (18%)

Query: 3   HENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGL 61
              +  +         +      +  +L+   L  ++    +  S +       Q+L  +
Sbjct: 60  CTGIPNVYYFG-----QEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARV 114

Query: 62  KYIHSANVLHRDLKPSNLLLNANC-----DLKICDFGLARVTSETD--------FMTEYV 108
           + IH  ++++RD+KP N L+          + + DFG+ +   +                
Sbjct: 115 QSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLS 174

Query: 109 VTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPS 168
            T  Y +    L   + +   D+ ++G +FM  +     + G                  
Sbjct: 175 GTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAA-------------- 219

Query: 169 EAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQR 220
                    N +KY     + Q     E            +           
Sbjct: 220 --------TNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDAT 263

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (251), Expect = 1e-25
 Identities = 45/236 (19%), Positives = 79/236 (33%), Gaps = 40/236 (16%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQ--YFLYQIL 58
             H NV+++  I       S     +    M     +    N+  +        F  Q+ 
Sbjct: 85  FSHPNVLSLLGIC----LRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVA 140

Query: 59  RGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF-----MTEYVVTRWY 113
           +G+K++ S   +HRDL   N +L+    +K+ DFGLAR   + +F      T   +   +
Sbjct: 141 KGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKW 200

Query: 114 RAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRLLIELIGTPSEAELG 173
            A E L     +T   DVWS G +  ELM R        +   +                
Sbjct: 201 MALESLQTQ-KFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDIT--------------- 244

Query: 174 FLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH 229
                   Y+ Q  R  +               +++ K        R +  + ++ 
Sbjct: 245 -------VYLLQGRRLLQPE------YCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =   99 bits (248), Expect = 3e-25
 Identities = 46/244 (18%), Positives = 90/244 (36%), Gaps = 50/244 (20%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ----------ALSEEH 49
            +  +VV +  ++            +  ELM   DL   +RS +            S   
Sbjct: 80  FNCHHVVRLLGVVSQG-----QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSK 134

Query: 50  CQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDF---MTE 106
                 +I  G+ Y+++   +HRDL   N ++  +  +KI DFG+ R   ETD+     +
Sbjct: 135 MIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 194

Query: 107 YVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELM-DRKPLFPGRDHVHQLRLLIELIG 165
            ++   + +PE L +   +T   DVWS G +  E+    +  + G  +   LR ++E   
Sbjct: 195 GLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME--- 250

Query: 166 TPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVED 225
                                         +K  N      +L+     ++P+ R +  +
Sbjct: 251 --------------------------GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLE 284

Query: 226 ALAH 229
            ++ 
Sbjct: 285 IISS 288

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 73.7 bits (180), Expect = 2e-16
 Identities = 21/145 (14%), Positives = 48/145 (33%), Gaps = 21/145 (14%)

Query: 1   MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRG 60
            +   +  ++ +   P+  ++    +  EL+D      +R       E+    L  IL  
Sbjct: 63  NEFRALQKLQGL-AVPKVYAWEGNAVLMELIDAKELYRVR------VENPDEVLDMILEE 115

Query: 61  LKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD-----FMTEYVVTRWYRA 115
           +   +   ++H DL   N+L++    + I DF  +    E             +  ++  
Sbjct: 116 VAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREILERDVRNIITYFS- 173

Query: 116 PELLLNSSDYTAAIDVWSVGCIFME 140
                    Y    D+ S     ++
Sbjct: 174 -------RTYRTEKDINSAIDRILQ 191

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	280
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.65
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	97.16
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	95.52
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	94.66
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	92.54
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	91.32

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-52  Score=359.64  Aligned_cols=271  Identities=45%  Similarity=0.857  Sum_probs=225.3

Q ss_pred             CCCCCeeeeeceecCCCC-CCCCcEEEEeecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~-~~~~~~~iv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      |+|||||+++++|..... ....++|+||||++++|...+.. +.+++..++.++.||+.||+|||++||+||||||+||
T Consensus        74 l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NI  152 (346)
T d1cm8a_          74 MRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNL  152 (346)
T ss_dssp             CCBTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred             cCCCCeeEEEEEeccCccccccceEEEEEecccccHHHHHHh-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchh
Confidence            689999999999976532 22356899999998888887765 5799999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  159 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      +++.++.++++|||.+......  .....+|+.|+|||++.+...++.++||||+||++|+|++|++||.+.+....+..
T Consensus       153 L~~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~  230 (346)
T d1cm8a_         153 AVNEDCELKILDFGLARQADSE--MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKE  230 (346)
T ss_dssp             EECTTCCEEECCCTTCEECCSS--CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             hcccccccccccccceeccCCc--cccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHH
Confidence            9999999999999999876554  34668899999999987777789999999999999999999999999999999999


Q ss_pred             HHHHhCCCCHHHHhHh-hHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCcCC
Q 023609          160 LIELIGTPSEAELGFL-NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDI  238 (280)
Q Consensus       160 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~~~  238 (280)
                      +....+.++...+... ......+....+......+....+++++++++||++||+.||++|||+.|+|+||||+++...
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~~~  310 (346)
T d1cm8a_         231 IMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT  310 (346)
T ss_dssp             HHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC--
T ss_pred             HHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCCCc
Confidence            9999999888765544 233344455566666677778888999999999999999999999999999999999999877


Q ss_pred             CCCCccCCCCCcchhhccccHHHHHHHHHHHHHhhCh
Q 023609          239 SDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNP  275 (280)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (280)
                      +++|.. ..+..+++....+.++++++++.|+++|+|
T Consensus       311 ~~~~~~-~~~~~~~~~~~~~~~e~k~~~~~e~~~~~~  346 (346)
T d1cm8a_         311 EDEPQV-QKYDDSFDDVDRTLDEWKRVTYKEVLSFKP  346 (346)
T ss_dssp             ----CC-CCCCCC-----CCHHHHHHHHHHHHHTCCC
T ss_pred             cccccC-CCCCCchhhhhcCHHHHHHHHHHHhhcCCC
Confidence            776643 455666677778899999999999999987

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-51  Score=353.96  Aligned_cols=277  Identities=54%  Similarity=1.002  Sum_probs=230.4

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   80 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nil   80 (280)
                      |+||||+++++++..+.......+|+++++++|+|.+++.. +++++..++.++.||+.||+|||++||+||||||+||+
T Consensus        63 l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NIL  141 (345)
T d1pmea_          63 FRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLL  141 (345)
T ss_dssp             CCCTTBCCCCEEECCSSTTTCCCEEEEEECCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred             cCCCCCCcEEEEEeeccccccceEEEEEeecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEE
Confidence            68999999999997764333456788888888999999976 46999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccceeeccCC----CccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023609           81 LNANCDLKICDFGLARVTSET----DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ  156 (280)
Q Consensus        81 i~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  156 (280)
                      ++.+|.+||+|||++......    ......++++.|+|||++.....++.++||||+||++|+|++|..||.+.+..+.
T Consensus       142 l~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~  221 (345)
T d1pmea_         142 LNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ  221 (345)
T ss_dssp             ECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             ECCCCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHH
Confidence            999999999999999765332    2234567899999999986666788999999999999999999999999999998


Q ss_pred             HHHHHHHhCCCCHHHHhHh-hHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCC
Q 023609          157 LRLLIELIGTPSEAELGFL-NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  235 (280)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~  235 (280)
                      ..........+........ ...........+......+...++++|+++++||.+||+.||.+|||+.|+|+||||+..
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~  301 (345)
T d1pmea_         222 LNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY  301 (345)
T ss_dssp             HHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred             HHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence            8888888888776644322 333344455556666666778888999999999999999999999999999999999999


Q ss_pred             cCCCCCCccCCCCCcchhhccccHHHHHHHHHHHHHhhChhhh
Q 023609          236 HDISDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPEYR  278 (280)
Q Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (280)
                      ..+.+++....++.++.+...++..++++++++|...+.|.+|
T Consensus       302 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l~~~e~~~~~~~~~  344 (345)
T d1pmea_         302 YDPSDEPIAEAPFKFDMELDDLPKEKLKELIFEETARFQPGYR  344 (345)
T ss_dssp             CCGGGSCCCSSCC--------CCHHHHHHHHHHHSGGGSTTTC
T ss_pred             CCCccCccccCccCCChhhhhCCHHHHHHHHHHHHHhcCCCCC
Confidence            8888888777788888788889999999999999999999887

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-52  Score=344.65  Aligned_cols=197  Identities=26%  Similarity=0.445  Sum_probs=172.4

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++|||||++++++.+.     +.+|||||||+ |+|.+++.+.+.+++..++.++.||+.||+|||++||+||||||+||
T Consensus        63 l~hpnIv~~~~~~~~~-----~~~~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Ni  137 (263)
T d2j4za1          63 LRHPNILRLYGYFHDA-----TRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENL  137 (263)
T ss_dssp             CCCTTBCCEEEEEECS-----SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred             cCCCCCCeEEEEEEEC-----CEEEEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccc
Confidence            5899999999999766     77999999998 69999999888999999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  159 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      +++.+|.+||+|||++....... .....||+.|+|||++.+. .++.++||||+||++|+|++|..||.+.+..+....
T Consensus       138 ll~~~~~~kl~DFG~a~~~~~~~-~~~~~Gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~  215 (263)
T d2j4za1         138 LLGSAGELKIADFGWSVHAPSSR-RTTLCGTLDYLPPEMIEGR-MHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR  215 (263)
T ss_dssp             EECTTSCEEECCCCSCSCCCCCC-CEETTEEGGGCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH
T ss_pred             eecCCCCEeecccceeeecCCCc-ccccCCCCcccCHHHHcCC-CCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHH
Confidence            99999999999999997655443 3456799999999999654 589999999999999999999999998887776665


Q ss_pred             HHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCC
Q 023609          160 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS  234 (280)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~  234 (280)
                      +.+....                              .-+.+|+++++||.+||+.||++|||+.|+++||||++
T Consensus       216 i~~~~~~------------------------------~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~  260 (263)
T d2j4za1         216 ISRVEFT------------------------------FPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITA  260 (263)
T ss_dssp             HHTTCCC------------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred             HHcCCCC------------------------------CCccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence            5332111                              01257899999999999999999999999999999964

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-52  Score=346.13  Aligned_cols=202  Identities=28%  Similarity=0.438  Sum_probs=168.8

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      |+|||||++++++.++     +.+|||||||+ |+|.+++.+++.+++.+++.++.||+.||+|||++||+||||||+||
T Consensus        60 l~HpnIv~~~~~~~~~-----~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NI  134 (271)
T d1nvra_          60 LNHENVVKFYGHRREG-----NIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENL  134 (271)
T ss_dssp             CCCTTBCCEEEEEEET-----TEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred             CCCCCEeeEeeeeccC-----ceeEEEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHE
Confidence            6899999999999776     77999999997 69999998888999999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCC---CccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023609           80 LLNANCDLKICDFGLARVTSET---DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ  156 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  156 (280)
                      +++.++.+||+|||+++.....   ......+||+.|+|||++.+...++.++||||+||++|+|++|++||.+......
T Consensus       135 Ll~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~  214 (271)
T d1nvra_         135 LLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ  214 (271)
T ss_dssp             EECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSH
T ss_pred             EECCCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHH
Confidence            9999999999999999865332   2344568999999999987665457889999999999999999999976543322


Q ss_pred             HHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCC
Q 023609          157 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS  234 (280)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~  234 (280)
                      ..........                           ....++.+|+++++||++||+.||++|||++|+++||||++
T Consensus       215 ~~~~~~~~~~---------------------------~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~  265 (271)
T d1nvra_         215 EYSDWKEKKT---------------------------YLNPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNK  265 (271)
T ss_dssp             HHHHHHTTCT---------------------------TSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred             HHHHHhcCCC---------------------------CCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence            2211111100                           01112367899999999999999999999999999999975

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-51  Score=346.82  Aligned_cols=231  Identities=34%  Similarity=0.633  Sum_probs=190.5

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHH-HHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQ-IIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~-~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++|||||++++++...     +++||||||+.|++.. ....++.+++.+++.++.||+.||+|||++||+||||||+||
T Consensus        57 l~hpnIv~~~~~~~~~-----~~~~ivmE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NI  131 (299)
T d1ua2a_          57 LSHPNIIGLLDAFGHK-----SNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNL  131 (299)
T ss_dssp             CCCTTBCCEEEEECCT-----TCCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred             CCCCCEeEEEeeeccC-----CceeehhhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceE
Confidence            5899999999999766     6799999999965444 444566799999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCC-CccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  158 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.++.+||+|||.++..... ......++|+.|+|||++.....++.++||||+||++|+|++|.+||.+.+..+++.
T Consensus       132 li~~~~~~KL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~  211 (299)
T d1ua2a_         132 LLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLT  211 (299)
T ss_dssp             EECTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             EecCCCccccccCccccccCCCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHH
Confidence            9999999999999999765543 234456789999999998766678999999999999999999999999999999999


Q ss_pred             HHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCcCC
Q 023609          159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDI  238 (280)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~~~  238 (280)
                      .+.+..+.|....+.......  ............+...++.+++++++||.+||+.||++|||+.|+|+||||++...+
T Consensus       212 ~i~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p  289 (299)
T d1ua2a_         212 RIFETLGTPTEEQWPDMCSLP--DYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGP  289 (299)
T ss_dssp             HHHHHHCCCCTTTSSSTTSST--TCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCC
T ss_pred             HHHHhcCCCChhhccchhccc--hhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCC
Confidence            999999988765432211100  001111222334455667889999999999999999999999999999999976543

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-50  Score=346.74  Aligned_cols=272  Identities=49%  Similarity=0.918  Sum_probs=227.8

Q ss_pred             CCCCCeeeeeceecCCCC-CCCCcEEEEeecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~-~~~~~~~iv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      |+|||||++++++..... ++....++++++++|+|.+++.. +++++.+++.++.||+.||+|||++||+||||||+||
T Consensus        74 l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NI  152 (348)
T d2gfsa1          74 MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL  152 (348)
T ss_dssp             CCCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred             cCCCCeeeEEEEEeeccccccCceEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccc
Confidence            689999999999866432 22345677777667899999864 5799999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  159 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      +++.+|.++++|||.+......  .....+++.|+|||...+...++.++||||+||++|+|++|.+||.+.+.......
T Consensus       153 Li~~~~~~kl~dfg~a~~~~~~--~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~  230 (348)
T d2gfsa1         153 AVNEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL  230 (348)
T ss_dssp             EECTTCCEEECCC----CCTGG--GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred             cccccccccccccchhcccCcc--cccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            9999999999999998765433  34567899999999987776678999999999999999999999999999999999


Q ss_pred             HHHHhCCCCHHHHhHh-hHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCcCC
Q 023609          160 LIELIGTPSEAELGFL-NENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHDI  238 (280)
Q Consensus       160 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~~~  238 (280)
                      +....+.+........ ......+....+......+...++++++++++||++||+.||++|||+.|+|+||||+++.++
T Consensus       231 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~  310 (348)
T d2gfsa1         231 ILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP  310 (348)
T ss_dssp             HHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCT
T ss_pred             HHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCC
Confidence            9999888877655433 233344444555555666677788999999999999999999999999999999999999988


Q ss_pred             CCCCccCCCCCcchhhccccHHHHHHHHHHHHHhhChh
Q 023609          239 SDEPVCMSPFSFDFEQHALTEGQMKELIYQEALAFNPE  276 (280)
Q Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  276 (280)
                      +.++. ..++..+++....+.+++++++++|+.+|+|-
T Consensus       311 ~~~~~-~~~~~~~~~~~~~~~~~~k~~~~~e~~~~~p~  347 (348)
T d2gfsa1         311 DDEPV-ADPYDQSFESRDLLIDEWKSLTYDEVISFVPP  347 (348)
T ss_dssp             TSCCC-CCCCCCGGGGCCCCHHHHHHHHHHHHHTCCCC
T ss_pred             ccCCC-CCCCCCcccchhcCHHHHHHHHHHHhhccCCC
Confidence            88774 45777888889999999999999999999874

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.2e-51  Score=344.07  Aligned_cols=203  Identities=29%  Similarity=0.535  Sum_probs=163.3

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      |+|||||++++++.+.     +.+|||||||+ |+|.+++..++.+++.+++.++.||+.||+|||++||+||||||+||
T Consensus        64 l~HpnIv~l~~~~~~~-----~~~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Ni  138 (307)
T d1a06a_          64 IKHPNIVALDDIYESG-----GHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENL  138 (307)
T ss_dssp             CCCTTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred             CCCCCCCcEEEEEEEC-----CEEEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccce
Confidence            6899999999999766     77999999997 69999999888999999999999999999999999999999999999


Q ss_pred             EEc---cCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023609           80 LLN---ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ  156 (280)
Q Consensus        80 li~---~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  156 (280)
                      ++.   .++.+||+|||+++...........+||+.|+|||++.+ ..++.++||||+||++|+|++|..||.+....+.
T Consensus       139 l~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~GT~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~  217 (307)
T d1a06a_         139 LYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKL  217 (307)
T ss_dssp             EESSSSTTCCEEECCC------------------CTTSCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             eecccCCCceEEEeccceeEEccCCCeeeeeeeCccccCcHHHcC-CCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHH
Confidence            995   478999999999987766655667789999999999855 4589999999999999999999999998887776


Q ss_pred             HHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCC
Q 023609          157 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  235 (280)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~  235 (280)
                      ...+.+....++                          ....+.+|+++++||.+||+.||++|||+.|+++||||++-
T Consensus       218 ~~~i~~~~~~~~--------------------------~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  270 (307)
T d1a06a_         218 FEQILKAEYEFD--------------------------SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGD  270 (307)
T ss_dssp             HHHHHTTCCCCC--------------------------TTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSS
T ss_pred             HHHHhccCCCCC--------------------------CccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence            666554322211                          12234789999999999999999999999999999999863

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-50  Score=339.58  Aligned_cols=201  Identities=21%  Similarity=0.420  Sum_probs=171.8

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++|||||++++++.+.     ..+|||||||+ |+|.+++.+ +.+++.+++.++.||+.||+|||++||+||||||+||
T Consensus        74 l~HpnIv~~~~~~~~~-----~~~~ivmEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NI  147 (293)
T d1yhwa1          74 NKNPNIVNYLDSYLVG-----DELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNI  147 (293)
T ss_dssp             CCCTTBCCEEEEEEET-----TEEEEEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred             CCCCCEeeEeEEEEEC-----CEEEEEEEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHe
Confidence            6899999999999776     67999999997 699988765 4699999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCC-CccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  158 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.+|.+||+|||+++..... .......||+.|+|||++.+ ..++.++||||+||++|+|++|..||.+.+..+.+.
T Consensus       148 Ll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~  226 (293)
T d1yhwa1         148 LLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTR-KAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALY  226 (293)
T ss_dssp             EECTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHSS-SCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH
T ss_pred             EECCCCcEeeccchhheeeccccccccccccCCCccChhhhcC-CCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHH
Confidence            9999999999999999876443 33456679999999999865 458899999999999999999999999887776655


Q ss_pred             HHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCC
Q 023609          159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  235 (280)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~  235 (280)
                      .+........                           ...+.+|+++++||.+||+.||++|||+.|+++||||+..
T Consensus       227 ~~~~~~~~~~---------------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~~  276 (293)
T d1yhwa1         227 LIATNGTPEL---------------------------QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA  276 (293)
T ss_dssp             HHHHHCSCCC---------------------------SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             HHHhCCCCCC---------------------------CCcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence            5543221111                           1112578999999999999999999999999999999753

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=2e-50  Score=346.03  Aligned_cols=207  Identities=26%  Similarity=0.446  Sum_probs=179.4

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHH-cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIR-SNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~-~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      |+|||||++++++.+.     +.+|||||||+ |+|.+++. ..+.+++.+++.++.||+.||+|||++||+||||||+|
T Consensus        80 l~HpnIv~~~~~~~~~-----~~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~N  154 (350)
T d1koaa2          80 LRHPTLVNLHDAFEDD-----NEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPEN  154 (350)
T ss_dssp             TCCTTBCCEEEEEEET-----TEEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred             CCCCCCCcEEEEEEEC-----CEEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhH
Confidence            6899999999999765     78999999997 69999995 44679999999999999999999999999999999999


Q ss_pred             EEEcc--CCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023609           79 LLLNA--NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ  156 (280)
Q Consensus        79 ili~~--~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  156 (280)
                      |+++.  ++.+||+|||+++............||+.|+|||++.+. .++.++||||+||++|+|++|..||.+.+..+.
T Consensus       155 Ill~~~~~~~vkL~DFG~a~~~~~~~~~~~~~gT~~Y~aPEv~~~~-~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~  233 (350)
T d1koaa2         155 IMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGK-PVGYYTDMWSVGVLSYILLSGLSPFGGENDDET  233 (350)
T ss_dssp             EEESSTTSCCEEECCCTTCEECCTTSCEEEECSCTTTCCHHHHHTC-CBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             eeeccCCCCeEEEeecchheecccccccceecCcccccCHHHHcCC-CCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHH
Confidence            99954  688999999999987766666677899999999998654 478999999999999999999999999888887


Q ss_pred             HHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCc
Q 023609          157 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  236 (280)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~  236 (280)
                      +..+......++.                          ...+.+|+++++||++||+.||++|||+.|+|+||||+...
T Consensus       234 ~~~i~~~~~~~~~--------------------------~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~  287 (350)
T d1koaa2         234 LRNVKSCDWNMDD--------------------------SAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGN  287 (350)
T ss_dssp             HHHHHHTCCCSCC--------------------------GGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTT
T ss_pred             HHHHHhCCCCCCc--------------------------ccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence            7777654333221                          22346889999999999999999999999999999999865


Q ss_pred             CCC
Q 023609          237 DIS  239 (280)
Q Consensus       237 ~~~  239 (280)
                      .+.
T Consensus       288 ~~~  290 (350)
T d1koaa2         288 APG  290 (350)
T ss_dssp             CCS
T ss_pred             CCC
Confidence            443

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-50  Score=339.02  Aligned_cols=199  Identities=31%  Similarity=0.543  Sum_probs=170.3

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      |+||||+++++++.+.     +.+|+|||||+ |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+||
T Consensus        65 l~HpnIv~l~~~~~~~-----~~~~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NI  139 (288)
T d1uu3a_          65 LDHPFFVKLYFTFQDD-----EKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENI  139 (288)
T ss_dssp             CCSTTBCCEEEEEECS-----SEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred             cCCCCeeEEEEEEEEC-----CEEEEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCcccc
Confidence            6899999999999766     77999999998 69999999889999999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCC---CccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023609           80 LLNANCDLKICDFGLARVTSET---DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ  156 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  156 (280)
                      +++.+|.++|+|||+++.....   ......+||+.|+|||++.+. .++.++||||+||++|+|++|..||.+.+..+.
T Consensus       140 ll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~-~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~  218 (288)
T d1uu3a_         140 LLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK-SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI  218 (288)
T ss_dssp             EECTTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHTC-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             ccCCCceEEecccccceecccCCcccccccccCCccccCceeeccC-CCCcccceehhhHHHHHHhhCCCCCCCcCHHHH
Confidence            9999999999999999876432   223346799999999998654 489999999999999999999999998887776


Q ss_pred             HHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHH------HhcCC
Q 023609          157 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVED------ALAHP  230 (280)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e------ll~h~  230 (280)
                      ...+.+....                              .-..+|+++++||++||+.||++|||++|      +++||
T Consensus       219 ~~~i~~~~~~------------------------------~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hp  268 (288)
T d1uu3a_         219 FQKIIKLEYD------------------------------FPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHP  268 (288)
T ss_dssp             HHHHHTTCCC------------------------------CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSG
T ss_pred             HHHHHcCCCC------------------------------CCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCC
Confidence            6655432110                              01257899999999999999999999988      58899


Q ss_pred             CCCCC
Q 023609          231 YLGSL  235 (280)
Q Consensus       231 ~~~~~  235 (280)
                      ||+++
T Consensus       269 ff~~i  273 (288)
T d1uu3a_         269 FFESV  273 (288)
T ss_dssp             GGTTC
T ss_pred             ccCCC
Confidence            99876

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=5.1e-50  Score=343.80  Aligned_cols=204  Identities=26%  Similarity=0.482  Sum_probs=178.4

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ-ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~-~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      |+|||||+++++|.+.     ..+|||||||+ |+|.+++.+.+ ++++.+++.++.||+.||+|||++||+||||||+|
T Consensus        83 l~HpnIv~~~~~~~~~-----~~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~N  157 (352)
T d1koba_          83 LHHPKLINLHDAFEDK-----YEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPEN  157 (352)
T ss_dssp             CCSTTBCCEEEEEECS-----SEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred             CCCCCCCcEEEEEEEC-----CEEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccccccc
Confidence            6899999999999765     78999999998 69999887654 69999999999999999999999999999999999


Q ss_pred             EEEc--cCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023609           79 LLLN--ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ  156 (280)
Q Consensus        79 ili~--~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  156 (280)
                      |+++  .+|.+||+|||++.............+|+.|+|||++.+ ..++.++||||+||++|+|++|..||.+.+..+.
T Consensus       158 ILl~~~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~  236 (352)
T d1koba_         158 IMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLET  236 (352)
T ss_dssp             EEESSTTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTT-CCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH
T ss_pred             ccccccCCCeEEEeecccceecCCCCceeeccCcccccCHHHHcC-CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence            9997  578999999999998877666667789999999999854 4589999999999999999999999999888887


Q ss_pred             HHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCc
Q 023609          157 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  236 (280)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~  236 (280)
                      +..+......++                          ...++.+|+++++||++||+.||.+|||+.|+|+||||++..
T Consensus       237 ~~~i~~~~~~~~--------------------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~  290 (352)
T d1koba_         237 LQNVKRCDWEFD--------------------------EDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH  290 (352)
T ss_dssp             HHHHHHCCCCCC--------------------------SSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             HHHHHhCCCCCC--------------------------cccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCc
Confidence            776655332222                          123457899999999999999999999999999999998753

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-50  Score=332.75  Aligned_cols=202  Identities=22%  Similarity=0.394  Sum_probs=166.3

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC--ceeccCCCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSAN--VLHRDLKPS   77 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~g--i~H~di~~~   77 (280)
                      |+|||||++++++.... .+...+|||||||+ |+|.+++.+.+.+++.+++.++.||+.||+|||++|  |+||||||+
T Consensus        65 l~HpnIv~~~~~~~~~~-~~~~~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~  143 (270)
T d1t4ha_          65 LQHPNIVRFYDSWESTV-KGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCD  143 (270)
T ss_dssp             CCCTTBCCEEEEEEEES-SSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGG
T ss_pred             CCCCCeeeEEEEEeecc-ccCCEEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChh
Confidence            68999999999986532 12256899999997 699999998889999999999999999999999999  999999999


Q ss_pred             cEEEc-cCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023609           78 NLLLN-ANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ  156 (280)
Q Consensus        78 nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  156 (280)
                      ||+++ .++.+||+|||+++..... ......||+.|+|||++.+  .++.++||||+||++|+|++|..||.+......
T Consensus       144 NILl~~~~~~~Kl~DFGla~~~~~~-~~~~~~GT~~Y~aPE~~~~--~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~  220 (270)
T d1t4ha_         144 NIFITGPTGSVKIGDLGLATLKRAS-FAKAVIGTPEFMAPEMYEE--KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ  220 (270)
T ss_dssp             GEEESSTTSCEEECCTTGGGGCCTT-SBEESCSSCCCCCGGGGGT--CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHH
T ss_pred             hceeeCCCCCEEEeecCcceeccCC-ccCCcccCccccCHHHhCC--CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHH
Confidence            99996 5799999999999764433 2345689999999998853  489999999999999999999999987655443


Q ss_pred             HHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCC
Q 023609          157 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLG  233 (280)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~  233 (280)
                      +.........|.                           ......++++++||.+||+.||++|||+.|+++||||+
T Consensus       221 ~~~~i~~~~~~~---------------------------~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         221 IYRRVTSGVKPA---------------------------SFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             HHHHHTTTCCCG---------------------------GGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             HHHHHHcCCCCc---------------------------ccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence            332221111111                           11125788999999999999999999999999999996

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.8e-50  Score=335.06  Aligned_cols=203  Identities=30%  Similarity=0.506  Sum_probs=177.2

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      |+|||||++++++.+.     ..+|||||||+ |+|.+++.+++.+++..++.++.||+.||+|||++||+||||||+||
T Consensus        70 l~HpnIv~~~~~~~~~-----~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Ni  144 (293)
T d1jksa_          70 IQHPNVITLHEVYENK-----TDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENI  144 (293)
T ss_dssp             CCCTTBCCEEEEEECS-----SEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred             CCCCCCCcEEEEEEEC-----CEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceE
Confidence            6899999999999776     78999999997 69999999888999999999999999999999999999999999999


Q ss_pred             EEccCC----CEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 023609           80 LLNANC----DLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVH  155 (280)
Q Consensus        80 li~~~~----~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~  155 (280)
                      +++.++    .+|++|||++.............+|+.|+|||++.+ ..++.++||||+||++|+|++|..||.+.+..+
T Consensus       145 ll~~~~~~~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~  223 (293)
T d1jksa_         145 MLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQE  223 (293)
T ss_dssp             EESCSSSSSCCEEECCCTTCEECTTSCBCSCCCCCGGGCCHHHHTT-CCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             EEecCCCcccceEecchhhhhhcCCCccccccCCCCcccCHHHHcC-CCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH
Confidence            998776    499999999988766655667789999999999854 458999999999999999999999999988877


Q ss_pred             HHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCC
Q 023609          156 QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  235 (280)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~  235 (280)
                      .+..+.......+.                          ...+++|+++++||++||+.||++|||++|+++||||+..
T Consensus       224 ~~~~i~~~~~~~~~--------------------------~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  277 (293)
T d1jksa_         224 TLANVSAVNYEFED--------------------------EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK  277 (293)
T ss_dssp             HHHHHHTTCCCCCH--------------------------HHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC-
T ss_pred             HHHHHHhcCCCCCc--------------------------hhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence            77666543222221                          1224788999999999999999999999999999999864

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-50  Score=336.44  Aligned_cols=232  Identities=38%  Similarity=0.739  Sum_probs=195.8

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRS--NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~--~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      |+|||||++++++.++     +++|+||||++|++.+++..  .+.+++..++.++.||+.||+|||++||+||||||+|
T Consensus        58 l~Hp~Iv~~~~~~~~~-----~~~~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeN  132 (298)
T d1gz8a_          58 LNHPNIVKLLDVIHTE-----NKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQN  132 (298)
T ss_dssp             CCCTTBCCEEEEEEET-----TEEEEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred             CCCCcEEEeccccccc-----cceeEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchh
Confidence            6899999999999776     78999999999887777653  4569999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCC-CccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 023609           79 LLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL  157 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  157 (280)
                      |+++.++.+||+|||.++..... .......+|+.|+|||.+.....++.++||||+||++|+|++|+.||.+.+..+.+
T Consensus       133 Il~~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~  212 (298)
T d1gz8a_         133 LLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL  212 (298)
T ss_dssp             EEECTTSCEEECSTTHHHHHCCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred             eeecccCcceeccCCcceeccCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHH
Confidence            99999999999999999765443 34456689999999999877666789999999999999999999999999999999


Q ss_pred             HHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCcC
Q 023609          158 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD  237 (280)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~~  237 (280)
                      ..+....+.+....+..... ........+......+....+.+|+++++||++||+.||++|||+.|+++||||+++..
T Consensus       213 ~~i~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~  291 (298)
T d1gz8a_         213 FRIFRTLGTPDEVVWPGVTS-MPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK  291 (298)
T ss_dssp             HHHHHHHCCCCTTTSTTGGG-STTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred             HHHHHhcCCCchhhcccccc-ccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCC
Confidence            99999888877655433221 11222333344445556677789999999999999999999999999999999998854


Q ss_pred             C
Q 023609          238 I  238 (280)
Q Consensus       238 ~  238 (280)
                      +
T Consensus       292 p  292 (298)
T d1gz8a_         292 P  292 (298)
T ss_dssp             C
T ss_pred             C
Confidence            3

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-50  Score=337.13  Aligned_cols=202  Identities=25%  Similarity=0.435  Sum_probs=169.8

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      |+|||||++++++.+.     +.+|+|||||+ |+|.+++.+ .+++++.+++.++.||+.||+|||++||+||||||+|
T Consensus        66 l~HpnIv~l~~~~~~~-----~~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~N  140 (288)
T d2jfla1          66 CDHPNIVKLLDAFYYE-----NNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGN  140 (288)
T ss_dssp             CCCTTBCCEEEEEEET-----TEEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred             CCCCCCCeEEEEEeeC-----CeEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhh
Confidence            6899999999999766     67999999997 699998764 5679999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCC-CccccceeccccccchhccC----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCCh
Q 023609           79 LLLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLN----SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDH  153 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~  153 (280)
                      |+++.+|.+||+|||++...... .......||+.|+|||++..    ...++.++||||+||++|+|++|..||.+.+.
T Consensus       141 Ill~~~~~~Kl~DFG~a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~  220 (288)
T d2jfla1         141 ILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP  220 (288)
T ss_dssp             EEECTTSCEEECCCTTCEECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCG
T ss_pred             eeECCCCCEEEEechhhhccCCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCH
Confidence            99999999999999999764332 12335678999999999842    34478899999999999999999999998877


Q ss_pred             HHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCC
Q 023609          154 VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLG  233 (280)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~  233 (280)
                      .+.+..+........                           ...+.+|+++++||++||+.||++|||+.|+++||||+
T Consensus       221 ~~~~~~i~~~~~~~~---------------------------~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~  273 (288)
T d2jfla1         221 MRVLLKIAKSEPPTL---------------------------AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVT  273 (288)
T ss_dssp             GGHHHHHHHSCCCCC---------------------------SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGC
T ss_pred             HHHHHHHHcCCCCCC---------------------------CccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccC
Confidence            666655543211100                           11135789999999999999999999999999999997


Q ss_pred             C
Q 023609          234 S  234 (280)
Q Consensus       234 ~  234 (280)
                      .
T Consensus       274 ~  274 (288)
T d2jfla1         274 V  274 (288)
T ss_dssp             C
T ss_pred             C
Confidence            5

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-49  Score=338.94  Aligned_cols=199  Identities=27%  Similarity=0.472  Sum_probs=174.9

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++.+.     ..+|+|||||+ |+|.+++.+++.+++..++.++.||+.||+|||++||+||||||+||
T Consensus        62 l~hp~Iv~l~~~~~~~-----~~~~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NI  136 (337)
T d1o6la_          62 TRHPFLTALKYAFQTH-----DRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENL  136 (337)
T ss_dssp             CCCTTBCCEEEEEECS-----SEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGE
T ss_pred             CCCCCEEEEEeeeccc-----cccccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHe
Confidence            5899999999999776     78999999998 69999999989999999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccC-CCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSE-TDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  158 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.+|.+||+|||+++.... .......+||+.|+|||++.+. .++.++|+||+||++|+|++|.+||.+.+..+..+
T Consensus       137 Ll~~~g~vkl~DFG~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~-~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~  215 (337)
T d1o6la_         137 MLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN-DYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFE  215 (337)
T ss_dssp             EECTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSS-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             EecCCCCEEEeecccccccccCCcccccceeCHHHhhhhhccCC-CCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHH
Confidence            999999999999999986543 3445567899999999998655 48999999999999999999999999988777666


Q ss_pred             HHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCC-----CHHHHhcCCCCC
Q 023609          159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI-----TVEDALAHPYLG  233 (280)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~ell~h~~~~  233 (280)
                      .+......                              ..+.+|+++++||++||++||++|+     ++.++++||||+
T Consensus       216 ~i~~~~~~------------------------------~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~  265 (337)
T d1o6la_         216 LILMEEIR------------------------------FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL  265 (337)
T ss_dssp             HHHHCCCC------------------------------CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGT
T ss_pred             HHhcCCCC------------------------------CCccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCcccc
Confidence            55432111                              1126789999999999999999999     489999999998


Q ss_pred             CC
Q 023609          234 SL  235 (280)
Q Consensus       234 ~~  235 (280)
                      ++
T Consensus       266 ~i  267 (337)
T d1o6la_         266 SI  267 (337)
T ss_dssp             TC
T ss_pred             cC
Confidence            75

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.2e-49  Score=330.93  Aligned_cols=203  Identities=28%  Similarity=0.521  Sum_probs=177.5

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nil   80 (280)
                      .||||+++++++.++     +.+|||||||+ |+|.+++..++++++..++.++.||+.||+|||++||+||||||+||+
T Consensus        68 ~hpnIv~~~~~~~~~-----~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nil  142 (277)
T d1phka_          68 GHPNIIQLKDTYETN-----TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENIL  142 (277)
T ss_dssp             TCTTBCCEEEEEECS-----SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred             CCCCeEEEEeecccC-----cceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEE
Confidence            399999999999766     78999999997 699999998889999999999999999999999999999999999999


Q ss_pred             EccCCCEEEeeccceeeccCCCccccceeccccccchhccC-----CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 023609           81 LNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLN-----SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVH  155 (280)
Q Consensus        81 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-----~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~  155 (280)
                      ++.++.+||+|||+++..+.........||+.|+|||.+.+     ...++.++||||+||++|+|++|..||.+.+...
T Consensus       143 l~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~  222 (277)
T d1phka_         143 LDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML  222 (277)
T ss_dssp             ECTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             EcCCCCeEEccchheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHH
Confidence            99999999999999998776655566789999999998752     3346789999999999999999999999988777


Q ss_pred             HHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCC
Q 023609          156 QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  235 (280)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~  235 (280)
                      ....+......++.                          ...+++|+++++||.+||++||++|||++|+++||||+.+
T Consensus       223 ~~~~i~~~~~~~~~--------------------------~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~  276 (277)
T d1phka_         223 MLRMIMSGNYQFGS--------------------------PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY  276 (277)
T ss_dssp             HHHHHHHTCCCCCT--------------------------TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred             HHHHHHhCCCCCCC--------------------------cccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence            76666543222111                          1223789999999999999999999999999999999874

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6.5e-50  Score=337.49  Aligned_cols=199  Identities=26%  Similarity=0.390  Sum_probs=170.3

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      |+|||||++++++.++     +..|||||||. |+|..++..++++++.+++.++.||+.||+|||++||+||||||+||
T Consensus        72 l~HpnIv~~~~~~~~~-----~~~~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NI  146 (309)
T d1u5ra_          72 LRHPNTIQYRGCYLRE-----HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNI  146 (309)
T ss_dssp             CCCTTBCCEEEEEEET-----TEEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGE
T ss_pred             CCCCCEeeEEEEEEEC-----CEEEEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceE
Confidence            6899999999999765     67999999998 46766777778899999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCCccccceeccccccchhccC--CCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLN--SSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQL  157 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  157 (280)
                      +++.+|.+||+|||++......   ....||+.|+|||++.+  .+.++.++||||+||++|+|++|..||.+.+..+.+
T Consensus       147 Ll~~~~~~Kl~DFG~a~~~~~~---~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~  223 (309)
T d1u5ra_         147 LLSEPGLVKLGDFGSASIMAPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSAL  223 (309)
T ss_dssp             EEETTTEEEECCCTTCBSSSSB---CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH
T ss_pred             EECCCCCEEEeecccccccCCC---CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHH
Confidence            9999999999999999865443   35679999999999854  245788999999999999999999999888777666


Q ss_pred             HHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCC
Q 023609          158 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSL  235 (280)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~  235 (280)
                      ..+......+.                            ....+|+++++||.+||+.||.+|||++|+++||||.+-
T Consensus       224 ~~i~~~~~~~~----------------------------~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~  273 (309)
T d1u5ra_         224 YHIAQNESPAL----------------------------QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE  273 (309)
T ss_dssp             HHHHHSCCCCC----------------------------SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred             HHHHhCCCCCC----------------------------CCCCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCC
Confidence            55543211111                            113578999999999999999999999999999999763

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.4e-50  Score=330.73  Aligned_cols=199  Identities=30%  Similarity=0.483  Sum_probs=157.3

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHc----CCCCCHHHHHHHHHHHHHHHHHHHHCC-----ce
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS----NQALSEEHCQYFLYQILRGLKYIHSAN-----VL   70 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~----~~~l~~~~~~~i~~qll~al~~LH~~g-----i~   70 (280)
                      |+|||||++++++.+...   +.+|||||||+ |+|.+++.+    ++.+++..++.++.||+.||+|||+.|     |+
T Consensus        60 l~HpnIv~~~~~~~~~~~---~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~Ii  136 (269)
T d2java1          60 LKHPNIVRYYDRIIDRTN---TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVL  136 (269)
T ss_dssp             CCCTTBCCEEEEEEC-------CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC------
T ss_pred             CCCCCEeeEEEEEEeCCC---CEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEE
Confidence            589999999999865321   56899999997 699999853    467999999999999999999999976     99


Q ss_pred             eccCCCCcEEEccCCCEEEeeccceeeccCCC-ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCC
Q 023609           71 HRDLKPSNLLLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFP  149 (280)
Q Consensus        71 H~di~~~nili~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~  149 (280)
                      ||||||+||+++.+|.+||+|||+++...... ......||+.|+|||++.+ ..++.++||||+||++|+|++|..||.
T Consensus       137 HrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~~DIwSlGvilyel~tg~~Pf~  215 (269)
T d2java1         137 HRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFT  215 (269)
T ss_dssp             ---CCGGGEEECTTSCEEECCHHHHHHC-----------CCCSCCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCC
T ss_pred             eCcCchhhcCcCCCCcEEEeeccceeecccCCCccccCCCCcccCCHHHHcC-CCCChHHHHHhhCHHHHHHhhCCCCCC
Confidence            99999999999999999999999998765432 2345688999999999854 458999999999999999999999999


Q ss_pred             CCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 023609          150 GRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  229 (280)
Q Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h  229 (280)
                      +.+..+....+.+....                             .....+|+++++||++||+.||++|||+.|+++|
T Consensus       216 ~~~~~~~~~~i~~~~~~-----------------------------~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~h  266 (269)
T d2java1         216 AFSQKELAGKIREGKFR-----------------------------RIPYRYSDELNEIITRMLNLKDYHRPSVEEILEN  266 (269)
T ss_dssp             CSSHHHHHHHHHHTCCC-----------------------------CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             CCCHHHHHHHHHcCCCC-----------------------------CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence            88877666555432111                             1113678999999999999999999999999999


Q ss_pred             CCC
Q 023609          230 PYL  232 (280)
Q Consensus       230 ~~~  232 (280)
                      ||+
T Consensus       267 p~i  269 (269)
T d2java1         267 PLI  269 (269)
T ss_dssp             TTC
T ss_pred             CcC
Confidence            996

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.7e-49  Score=334.17  Aligned_cols=232  Identities=37%  Similarity=0.672  Sum_probs=190.7

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIR--SNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~--~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      ++||||++++++|.....+....+|++||++++++..+..  ....+++..++.++.||+.||+|||++||+||||||+|
T Consensus        67 ~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~N  146 (305)
T d1blxa_          67 FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQN  146 (305)
T ss_dssp             TCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGG
T ss_pred             cCCCCcceeeeeecccccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccE
Confidence            3799999999998654333346799999999976554443  34569999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023609           79 LLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  158 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  158 (280)
                      |+++.++.++|+|||.+.............||+.|+|||++.+ ..++.++||||+||++|+|++|.+||.+.+..+.+.
T Consensus       147 ILi~~~~~~kl~dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~~-~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~  225 (305)
T d1blxa_         147 ILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLG  225 (305)
T ss_dssp             EEECTTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTT-CCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             EEEcCCCCeeecchhhhhhhcccccCCCcccChhhcCcchhcC-CCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHH
Confidence            9999999999999999987665555667789999999999855 458999999999999999999999999999999999


Q ss_pred             HHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCc
Q 023609          159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  236 (280)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~  236 (280)
                      .+.+..+.+....+........   ...............+.+++++++||++||++||++|||+.|+|+||||+++.
T Consensus       226 ~i~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i~  300 (305)
T d1blxa_         226 KILDVIGLPGEEDWPRDVALPR---QAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE  300 (305)
T ss_dssp             HHHHHHCCCCGGGSCTTCSSCG---GGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             HHHHhhCCCchhcccccccchh---hhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCch
Confidence            9999999887654432111100   11112223334455668899999999999999999999999999999999874

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=3.2e-49  Score=340.44  Aligned_cols=202  Identities=26%  Similarity=0.428  Sum_probs=170.9

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++|||||++++++.+.     +.+|+|||||+ |+|.+++.+++.+++..++.++.||+.||+|||++||+||||||+||
T Consensus        64 ~~hpnIv~l~~~~~~~-----~~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NI  138 (364)
T d1omwa3          64 GDCPFIVCMSYAFHTP-----DKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANI  138 (364)
T ss_dssp             SCCTTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred             CCCCcEEEEEEEEEEC-----CEEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeecccee
Confidence            4799999999999776     77999999997 69999999888999999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  159 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      +++.+|.+||+|||+++...... .....||+.|+|||++.....++.++||||+||++|+|++|..||.+.+.......
T Consensus       139 Ll~~~g~iKl~DFGla~~~~~~~-~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~  217 (364)
T d1omwa3         139 LLDEHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI  217 (364)
T ss_dssp             EECSSSCEEECCCTTCEECSSSC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHH
T ss_pred             EEcCCCcEEEeeeceeeecCCCc-ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            99999999999999998766543 34568999999999987666689999999999999999999999987543322211


Q ss_pred             HHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCC-----HHHHhcCCCCCC
Q 023609          160 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT-----VEDALAHPYLGS  234 (280)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t-----~~ell~h~~~~~  234 (280)
                      .......+                           ....+.+|+++++||.+||+.||++|||     ++++++||||++
T Consensus       218 ~~~~~~~~---------------------------~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~  270 (364)
T d1omwa3         218 DRMTLTMA---------------------------VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS  270 (364)
T ss_dssp             HHHSSSCC---------------------------CCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTT
T ss_pred             HHhcccCC---------------------------CCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccC
Confidence            11111100                           0112368999999999999999999999     799999999987


Q ss_pred             C
Q 023609          235 L  235 (280)
Q Consensus       235 ~  235 (280)
                      +
T Consensus       271 i  271 (364)
T d1omwa3         271 L  271 (364)
T ss_dssp             C
T ss_pred             C
Confidence            5

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=6e-49  Score=332.69  Aligned_cols=197  Identities=24%  Similarity=0.477  Sum_probs=174.3

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++|||||++++++.++     ..+|+|||||+ |+|..++..+..+++..++.++.||+.||+|||++||+||||||+||
T Consensus        61 l~HpnIv~~~~~~~~~-----~~~~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NI  135 (316)
T d1fota_          61 VTHPFIIRMWGTFQDA-----QQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENI  135 (316)
T ss_dssp             CCBTTBCCEEEEEECS-----SEEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGE
T ss_pred             ccCcChhheeeeEeeC-----CeeeeEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchhe
Confidence            5899999999999776     78999999997 59999999999999999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  159 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      +++.+|.+||+|||+++.....  ....+||+.|+|||++.+ ..++.++||||+||++|+|++|..||.+.+..+....
T Consensus       136 Ll~~~g~vkL~DFG~a~~~~~~--~~~~~Gt~~Y~APE~l~~-~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~  212 (316)
T d1fota_         136 LLDKNGHIKITDFGFAKYVPDV--TYTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEK  212 (316)
T ss_dssp             EECTTSCEEECCCSSCEECSSC--BCCCCSCTTTCCHHHHTT-CCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHH
T ss_pred             eEcCCCCEEEecCccceEeccc--cccccCcccccCHHHHcC-CCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHH
Confidence            9999999999999999876544  345689999999999854 4588999999999999999999999999888777666


Q ss_pred             HHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCC-----CHHHHhcCCCCCC
Q 023609          160 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI-----TVEDALAHPYLGS  234 (280)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~ell~h~~~~~  234 (280)
                      +......                              .-+.+|++++++|.+||++||.+|+     |++++++||||++
T Consensus       213 i~~~~~~------------------------------~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~  262 (316)
T d1fota_         213 ILNAELR------------------------------FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE  262 (316)
T ss_dssp             HHHCCCC------------------------------CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred             HHcCCCC------------------------------CCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCccccc
Confidence            6542211                              1136789999999999999999996     9999999999998


Q ss_pred             C
Q 023609          235 L  235 (280)
Q Consensus       235 ~  235 (280)
                      +
T Consensus       263 i  263 (316)
T d1fota_         263 V  263 (316)
T ss_dssp             C
T ss_pred             C
Confidence            6

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-48  Score=336.90  Aligned_cols=268  Identities=42%  Similarity=0.772  Sum_probs=205.6

Q ss_pred             CCCCCeeeeeceecCCCC-CCCCcEEEEeecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQR-ESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~-~~~~~~~iv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||++++++|..... +...++|+|||||.|++.+.+.  ..+++..++.++.||+.||+|||++||+||||||+||
T Consensus        73 l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~~l~~~~~--~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Ni  150 (355)
T d2b1pa1          73 VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI  150 (355)
T ss_dssp             CCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEEHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred             cCCCCeeEEEEEEecccccccCceeEEEEeccchHHHHhhh--cCCCHHHHHHHHHHHHHHHHHhhhcccccccCCcccc
Confidence            589999999999976532 2347899999999988887764  4699999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  159 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      +++.++.++++|||.++............+|+.|+|||++.+. .++.++||||+||++++|++|.+||.+.+.......
T Consensus       151 l~~~~~~~kl~df~~~~~~~~~~~~~~~~~t~~y~aPE~l~~~-~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~  229 (355)
T d2b1pa1         151 VVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGM-GYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNK  229 (355)
T ss_dssp             EECTTCCEEECCCCC---------------CCTTCCHHHHTTC-CCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             ccccccceeeechhhhhccccccccccccccccccChhhhcCC-CCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHH
Confidence            9999999999999998877766666677899999999998654 589999999999999999999999999999999999


Q ss_pred             HHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCC------------CCChHHHHHHHHhhcCCCCCCCCHHHHh
Q 023609          160 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP------------NVHPSAIDLVEKMLTFDPRQRITVEDAL  227 (280)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------~~~~~~~~li~~~L~~dp~~R~t~~ell  227 (280)
                      +....+.+....+.........+....+..........++            ..|+++++||++||+.||++|||++|+|
T Consensus       230 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL  309 (355)
T d2b1pa1         230 VIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDAL  309 (355)
T ss_dssp             HHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHH
T ss_pred             HHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHh
Confidence            9999999888877666655555555444333333222221            2467899999999999999999999999


Q ss_pred             cCCCCCCCcCCCCCCcc-CCCCCcchhhccccHHHHHHHHHHHHH
Q 023609          228 AHPYLGSLHDISDEPVC-MSPFSFDFEQHALTEGQMKELIYQEAL  271 (280)
Q Consensus       228 ~h~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (280)
                      +||||+...+++..... ...++.+.++...+..+|++++++|+.
T Consensus       310 ~Hpw~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  354 (355)
T d2b1pa1         310 QHPYINVWYDPAEVEAPPPQIYDKQLDEREHTIEEWKELIYKEVM  354 (355)
T ss_dssp             TSTTTGGGCCHHHHTCCCC-------CCCCCCHHHHHHHHHHHHH
T ss_pred             cCcccCCCCCcccccCCCCCCCCcchhhhhcCHHHHHHHHHHHhc
Confidence            99999986543332221 234455667778899999999999975

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-50  Score=341.82  Aligned_cols=226  Identities=22%  Similarity=0.381  Sum_probs=165.9

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHS-ANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~-~gi~H~di~~~n   78 (280)
                      |+|||||+++++|.+.     .++|||||||+ |+|.+++.+++.+++..++.++.||+.||.|||+ +||+||||||+|
T Consensus        61 l~HpnIv~l~~~~~~~-----~~~~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~N  135 (322)
T d1s9ja_          61 CNSPYIVGFYGAFYSD-----GEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSN  135 (322)
T ss_dssp             CCCTTBCCEEEEEECS-----SEEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGG
T ss_pred             CCCCCCCcEEEEEEEC-----CEEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHH
Confidence            6899999999999766     77999999998 6999999988899999999999999999999997 599999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH-H
Q 023609           79 LLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ-L  157 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~  157 (280)
                      |+++.+|.+||+|||+|+...... ....+||+.|+|||++.+. .++.++||||+||++|+|++|+.||.+.+.... .
T Consensus       136 ILl~~~~~vkl~DFGla~~~~~~~-~~~~~GT~~Y~APEvl~~~-~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~  213 (322)
T d1s9ja_         136 ILVNSRGEIKLCDFGVSGQLIDSM-ANSFVGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL  213 (322)
T ss_dssp             EEECTTCCEEECCCCCCHHHHHHT-C---CCSSCCCCHHHHHCS-CCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHH
T ss_pred             eeECCCCCEEEeeCCCccccCCCc-cccccCCccccCchHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence            999999999999999998654332 3456899999999999764 589999999999999999999999987654332 2


Q ss_pred             HHHHHHhCCCCHHHHhHh--hHhHH-------------HHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCC
Q 023609          158 RLLIELIGTPSEAELGFL--NENAK-------------KYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRIT  222 (280)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~--~~~~~-------------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t  222 (280)
                      .......+.+........  .....             .............  .....+|.++++||.+||+.||++|||
T Consensus       214 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~s~~~~dli~~~L~~dP~~R~t  291 (322)
T d1s9ja_         214 MFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPK--LPSGVFSLEFQDFVNKCLIKNPAERAD  291 (322)
T ss_dssp             HC------------------------------CCCCHHHHHHHHHTSCCCC--CCBTTBCHHHHHHHHHHTCSSTTTSCC
T ss_pred             HHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhccCCcc--CccccCCHHHHHHHHHHcCCChhHCcC
Confidence            111111111111000000  00000             0000000000000  001246889999999999999999999


Q ss_pred             HHHHhcCCCCCCC
Q 023609          223 VEDALAHPYLGSL  235 (280)
Q Consensus       223 ~~ell~h~~~~~~  235 (280)
                      ++|+|+||||++.
T Consensus       292 a~e~L~Hpf~~~~  304 (322)
T d1s9ja_         292 LKQLMVHAFIKRS  304 (322)
T ss_dssp             HHHHHTSHHHHHH
T ss_pred             HHHHhhCHhhCcC
Confidence            9999999999864

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.6e-48  Score=334.37  Aligned_cols=197  Identities=23%  Similarity=0.409  Sum_probs=174.0

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++|||||++++++...     ...|+||||+. |+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+||
T Consensus        98 l~hpnIv~~~~~~~~~-----~~~~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NI  172 (350)
T d1rdqe_          98 VNFPFLVKLEFSFKDN-----SNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENL  172 (350)
T ss_dssp             CCCTTBCCEEEEEECS-----SEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred             cCCCcEeecccccccc-----cccccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHc
Confidence            5899999999999766     77999999997 69999999888999999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLRL  159 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~  159 (280)
                      +++.+|.+||+|||+++.....  .....||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+....+..
T Consensus       173 Ll~~~g~ikL~DFG~a~~~~~~--~~~~~Gt~~Y~APE~~~~~-~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~  249 (350)
T d1rdqe_         173 LIDQQGYIQVTDFGFAKRVKGR--TWTLCGTPEALAPEIILSK-GYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEK  249 (350)
T ss_dssp             EECTTSCEEECCCTTCEECSSC--BCCCEECGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred             ccCCCCCEEeeeceeeeecccc--cccccCccccCCHHHHcCC-CCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHH
Confidence            9999999999999999876544  3456899999999998654 488999999999999999999999998887777666


Q ss_pred             HHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCC-----CHHHHhcCCCCCC
Q 023609          160 LIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI-----TVEDALAHPYLGS  234 (280)
Q Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~ell~h~~~~~  234 (280)
                      +.......                              .+.+|+++.+||++||+.||.+|+     |++++++||||++
T Consensus       250 i~~~~~~~------------------------------p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~  299 (350)
T d1rdqe_         250 IVSGKVRF------------------------------PSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT  299 (350)
T ss_dssp             HHHCCCCC------------------------------CTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred             HhcCCCCC------------------------------CccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccC
Confidence            65432111                              136789999999999999999995     9999999999987


Q ss_pred             C
Q 023609          235 L  235 (280)
Q Consensus       235 ~  235 (280)
                      .
T Consensus       300 ~  300 (350)
T d1rdqe_         300 T  300 (350)
T ss_dssp             C
T ss_pred             C
Confidence            5

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-48  Score=333.99  Aligned_cols=237  Identities=34%  Similarity=0.669  Sum_probs=192.8

Q ss_pred             CCCCCeeeeeceecCCC-CCCCCcEEEEeecCCccHHHHH----HcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCC
Q 023609            1 MDHENVVAIRDIIPPPQ-RESFNDVYIAYELMDTDLHQII----RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLK   75 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~-~~~~~~~~iv~e~~~g~L~~~l----~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~   75 (280)
                      |+||||++++++|.... ..+..++|||||||++++.+.+    ..+..+++..++.++.||+.||+|||++||+|||||
T Consensus        70 l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiK  149 (350)
T d1q5ka_          70 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIK  149 (350)
T ss_dssp             CCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCC
T ss_pred             cCCCCCCcEEEEEEecCccCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCC
Confidence            68999999999986543 1233568999999997655554    345679999999999999999999999999999999


Q ss_pred             CCcEEEccCC-CEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH
Q 023609           76 PSNLLLNANC-DLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHV  154 (280)
Q Consensus        76 ~~nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  154 (280)
                      |+||+++.++ .+||+|||++.............+++.|+|||.+.+...++.++||||+||++|+|++|.+||.+.+..
T Consensus       150 p~NILl~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~  229 (350)
T d1q5ka_         150 PQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGV  229 (350)
T ss_dssp             GGGEEECTTTCCEEECCCTTCEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH
T ss_pred             cceEEEecCCCceeEecccchhhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHH
Confidence            9999999875 899999999988766666667789999999999877667899999999999999999999999999999


Q ss_pred             HHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccc-cccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCC
Q 023609          155 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSF-TEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLG  233 (280)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~  233 (280)
                      +.+..+.+..+.+....+..........  ..+......+ ....+..++++.+||.+||+.||.+|||+.|+|+||||+
T Consensus       230 ~~l~~i~~~~g~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~  307 (350)
T d1q5ka_         230 DQLVEIIKVLGTPTREQIREMNPNYTEF--KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFD  307 (350)
T ss_dssp             HHHHHHHHHHCCCCHHHHHHHCC---CC--CCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGG
T ss_pred             HHHHHHHHHhCCChHHhhhhhccchhhc--cccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhc
Confidence            9999999999998877654332211111  1111111122 223457899999999999999999999999999999999


Q ss_pred             CCcCCC
Q 023609          234 SLHDIS  239 (280)
Q Consensus       234 ~~~~~~  239 (280)
                      ++.++.
T Consensus       308 ~~~~~~  313 (350)
T d1q5ka_         308 ELRDPN  313 (350)
T ss_dssp             GGGCTT
T ss_pred             cccCCC
Confidence            886543

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=2.2e-48  Score=325.58  Aligned_cols=228  Identities=39%  Similarity=0.721  Sum_probs=187.7

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHH-HcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQII-RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l-~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++...     +..|++|+++.+++...+ ..++.+++..++.++.||+.||+|||++||+||||||+||
T Consensus        57 l~hpnIv~~~~~~~~~-----~~~~i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NI  131 (286)
T d1ob3a_          57 LKHSNIVKLYDVIHTK-----KRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNL  131 (286)
T ss_dssp             CCCTTBCCEEEEEECS-----SCEEEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred             CCCCcEEeeeeecccC-----CceeEEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCcee
Confidence            5899999999999776     679999999997555444 5567899999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCC-ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  158 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.++.+|++|||.+....... ......+++.|+|||.+.+...++.++||||+||++++|++|+.||.+.+..+.+.
T Consensus       132 ll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~  211 (286)
T d1ob3a_         132 LINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLM  211 (286)
T ss_dssp             EECTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             eEcCCCCEEecccccceecccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHH
Confidence            99999999999999997655432 23445688999999999777778999999999999999999999999999999999


Q ss_pred             HHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCC
Q 023609          159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS  234 (280)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~  234 (280)
                      .+....+.+....+....... ..................+.+++++++||++||++||++|||++|+++||||++
T Consensus       212 ~i~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         212 RIFRILGTPNSKNWPNVTELP-KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             HHHHHHCCCCTTTSTTGGGST-TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             HHHHhhCCCChhhccchhhhh-hcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence            999999888766554332211 112223333344456667789999999999999999999999999999999974

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-48  Score=331.35  Aligned_cols=199  Identities=25%  Similarity=0.450  Sum_probs=174.1

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++|||||++++++.++     +.+|||||||+ |+|.+++..++.+++.+++.++.||+.||+|||++|++||||||+||
T Consensus        60 ~~hp~Iv~~~~~~~~~-----~~~yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~Ni  134 (320)
T d1xjda_          60 WEHPFLTHMFCTFQTK-----ENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNI  134 (320)
T ss_dssp             TTCTTBCCEEEEEECS-----SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGE
T ss_pred             CCCCcEEEEEEEEccC-----CceeEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccce
Confidence            5899999999999776     77999999997 69999999888999999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCC-CccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSET-DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  158 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.+|.++|+|||+++..... .......||+.|+|||++.+. .++.++||||+||++|+|++|..||.+.+..+...
T Consensus       135 L~~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~  213 (320)
T d1xjda_         135 LLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQ-KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFH  213 (320)
T ss_dssp             EECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTC-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             eecCCCceeccccchhhhcccccccccccCCCCCcCCHHHHcCC-CCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHH
Confidence            9999999999999999865433 334456899999999999654 58899999999999999999999999988877766


Q ss_pred             HHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHH-HHhcCCCCCCC
Q 023609          159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVE-DALAHPYLGSL  235 (280)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~-ell~h~~~~~~  235 (280)
                      .+...  .+.                            .-+.+|+++++||++||+.||++|||+. ++++||||+++
T Consensus       214 ~i~~~--~~~----------------------------~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~~  261 (320)
T d1xjda_         214 SIRMD--NPF----------------------------YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI  261 (320)
T ss_dssp             HHHHC--CCC----------------------------CCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred             HHHcC--CCC----------------------------CCccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhccC
Confidence            65431  111                            0125789999999999999999999996 89999999876

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-48  Score=331.47  Aligned_cols=202  Identities=24%  Similarity=0.452  Sum_probs=176.7

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ-ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~-~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      ++|||||+++++|.+.     +.+|||||||+ |+|.+++..++ .+++.+++.++.||+.||+|||++||+||||||+|
T Consensus        58 l~HpnIv~~~~~~~~~-----~~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~N  132 (321)
T d1tkia_          58 ARHRNILHLHESFESM-----EELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPEN  132 (321)
T ss_dssp             SCCTTBCCEEEEEEET-----TEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred             CCCCCCCeEEEEEEEC-----CEEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccc
Confidence            5899999999999766     77999999998 59999998665 79999999999999999999999999999999999


Q ss_pred             EEEccC--CCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHH
Q 023609           79 LLLNAN--CDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQ  156 (280)
Q Consensus        79 ili~~~--~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~  156 (280)
                      |+++.+  +.++|+|||++.............+++.|+|||...+ ..++.++||||+||++|+|++|..||.+.+..+.
T Consensus       133 Ill~~~~~~~ikl~DFG~~~~~~~~~~~~~~~~t~~y~ape~~~~-~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~  211 (321)
T d1tkia_         133 IIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQH-DVVSTATDMWSLGTLVYVLLSGINPFLAETNQQI  211 (321)
T ss_dssp             EEESSSSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTT-CEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred             eeecCCCceEEEEcccchhhccccCCcccccccccccccchhccC-CCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHH
Confidence            999854  5799999999988766655566788999999998854 4588999999999999999999999999988888


Q ss_pred             HHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCC
Q 023609          157 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS  234 (280)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~  234 (280)
                      +..+.+....++..                          .++.+|+++++||++||++||++|||+.|+++||||++
T Consensus       212 ~~~i~~~~~~~~~~--------------------------~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~  263 (321)
T d1tkia_         212 IENIMNAEYTFDEE--------------------------AFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQ  263 (321)
T ss_dssp             HHHHHHTCCCCCHH--------------------------HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHS
T ss_pred             HHHHHhCCCCCChh--------------------------hccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhcc
Confidence            77776544333332                          23478899999999999999999999999999999975

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-49  Score=335.19  Aligned_cols=211  Identities=27%  Similarity=0.427  Sum_probs=167.6

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS   77 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~   77 (280)
                      ++|||||+++++|.+.. .....+|||||||+ |+|.+++.++  ..+++.+++.++.||+.||+|||++||+||||||+
T Consensus        62 ~~hpnIv~l~~~~~~~~-~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~  140 (335)
T d2ozaa1          62 SQCPHIVRIVDVYENLY-AGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPE  140 (335)
T ss_dssp             TTSTTBCCEEEEEEEEE-TTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred             cCCCCCCeEEEEEeecc-cCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCcccccccc
Confidence            37999999999986521 11267999999997 6999999864  46999999999999999999999999999999999


Q ss_pred             cEEEcc---CCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChH
Q 023609           78 NLLLNA---NCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHV  154 (280)
Q Consensus        78 nili~~---~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  154 (280)
                      ||+++.   ++.+||+|||+++............||+.|+|||++.+ ..++.++||||+||++|+|++|.+||.+.+..
T Consensus       141 NIll~~~~~~~~~Kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~  219 (335)
T d2ozaa1         141 NLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL  219 (335)
T ss_dssp             GEEESCSSTTCCEEECCCTTCEECCCCCCCCCCSCCCSSCCCCCCCG-GGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC
T ss_pred             ccccccccccccccccccceeeeccCCCccccccCCcccCCcHHHcC-CCCCHHHHHHhhchhHHHHhhCCCCCCCCCHH
Confidence            999975   56799999999988766666667889999999998854 45899999999999999999999999876544


Q ss_pred             HHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCC
Q 023609          155 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGS  234 (280)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~  234 (280)
                      .....+...+.....                      .......+.+|+++++||++||+.||++|||+.|+++||||.+
T Consensus       220 ~~~~~~~~~i~~~~~----------------------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~  277 (335)
T d2ozaa1         220 AISPGMKTRIRMGQY----------------------EFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ  277 (335)
T ss_dssp             --------CCCSCSS----------------------SCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHT
T ss_pred             HHHHHHHHHHhcCCC----------------------CCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhC
Confidence            433333222111000                      0000112257899999999999999999999999999999976


Q ss_pred             C
Q 023609          235 L  235 (280)
Q Consensus       235 ~  235 (280)
                      .
T Consensus       278 ~  278 (335)
T d2ozaa1         278 S  278 (335)
T ss_dssp             T
T ss_pred             C
Confidence            4

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-47  Score=314.90  Aligned_cols=193  Identities=26%  Similarity=0.438  Sum_probs=164.0

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCC--ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMD--TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~--g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      .|||||++++++.++     +..|+||||+.  +++.+++.+++.+++.+++.++.||+.||+|||++||+||||||+||
T Consensus        67 ~h~nIv~~~~~~~~~-----~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NI  141 (273)
T d1xwsa_          67 GFSGVIRLLDWFERP-----DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENI  141 (273)
T ss_dssp             SSCSBCCEEEEEECS-----SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred             CCCCccEEEEEEeeC-----CeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccce
Confidence            399999999999776     77999999996  48899998888999999999999999999999999999999999999


Q ss_pred             EEccC-CCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023609           80 LLNAN-CDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  158 (280)
Q Consensus        80 li~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +++.+ +.++|+|||++....... .....||+.|+|||++.+...++.++||||+||++|+|++|+.||.+...     
T Consensus       142 ll~~~~~~vkl~DFG~a~~~~~~~-~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~-----  215 (273)
T d1xwsa_         142 LIDLNRGELKLIDFGSGALLKDTV-YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE-----  215 (273)
T ss_dssp             EEETTTTEEEECCCTTCEECCSSC-BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH-----
T ss_pred             EEecCCCeEEECccccceeccccc-ccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCchH-----
Confidence            99865 789999999998755443 34568999999999987665567789999999999999999999965311     


Q ss_pred             HHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCc
Q 023609          159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLH  236 (280)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~  236 (280)
                       +...                      .        ....+.+|+++++||++||+.||++|||++|+++||||++..
T Consensus       216 -i~~~----------------------~--------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~  262 (273)
T d1xwsa_         216 -IIRG----------------------Q--------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL  262 (273)
T ss_dssp             -HHHC----------------------C--------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             -Hhhc----------------------c--------cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence             1100                      0        011236899999999999999999999999999999998863

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-46  Score=308.90  Aligned_cols=199  Identities=21%  Similarity=0.304  Sum_probs=161.0

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      ++|||||++++++..      ..+|||||||+ |+|.+++... +.+++..+..++.||+.||+|||++||+||||||+|
T Consensus        61 l~HpnIv~~~~~~~~------~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~N  134 (276)
T d1uwha_          61 TRHVNILLFMGYSTA------PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNN  134 (276)
T ss_dssp             CCCTTBCCEEEEECS------SSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred             CCCCCEeeeeEEEec------cEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHH
Confidence            589999999998743      35799999998 6999999754 569999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCC---CccccceeccccccchhccCC--CCCCcchhHHHHHHHHHHHHhCCCCCCCCCh
Q 023609           79 LLLNANCDLKICDFGLARVTSET---DFMTEYVVTRWYRAPELLLNS--SDYTAAIDVWSVGCIFMELMDRKPLFPGRDH  153 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~~  153 (280)
                      |+++.++.+||+|||+++.....   .......||+.|+|||++...  ..++.++||||+||++|+|++|+.||.+.+.
T Consensus       135 iLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~  214 (276)
T d1uwha_         135 IFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN  214 (276)
T ss_dssp             EEEETTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred             EEEcCCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCCh
Confidence            99999999999999999765432   223455789999999998542  3478899999999999999999999998776


Q ss_pred             HHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 023609          154 VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  229 (280)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h  229 (280)
                      .............++                        ......+++++++.+||.+||+.||++|||+.+++++
T Consensus       215 ~~~~~~~~~~~~~~p------------------------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         215 RDQIIFMVGRGYLSP------------------------DLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             HHHHHHHHHHTSCCC------------------------CGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHhcCCCCC------------------------cchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            665554443322211                        1122334688999999999999999999999999875

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-46  Score=315.27  Aligned_cols=236  Identities=33%  Similarity=0.591  Sum_probs=179.1

Q ss_pred             CCCCCeeeeeceecCCCC---CCCCcEEEEeecCCccHHHHH-HcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCC
Q 023609            1 MDHENVVAIRDIIPPPQR---ESFNDVYIAYELMDTDLHQII-RSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKP   76 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~---~~~~~~~iv~e~~~g~L~~~l-~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~   76 (280)
                      |+||||+++++++.....   ...+++|+||||+++.+.... .....+++..++.++.||+.||+|||++||+||||||
T Consensus        66 l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp  145 (318)
T d3blha1          66 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKA  145 (318)
T ss_dssp             CCCTTBCCEEEEEEC----------CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred             hcCCCccceEeeeecccccccccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCc
Confidence            689999999999865321   112568999999997655554 4456799999999999999999999999999999999


Q ss_pred             CcEEEccCCCEEEeeccceeeccCCC-----ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Q 023609           77 SNLLLNANCDLKICDFGLARVTSETD-----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGR  151 (280)
Q Consensus        77 ~nili~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~  151 (280)
                      +||+++.++.++++|||++...+...     .....++|+.|+|||++.+...++.++||||+||++|+|++|+.||.+.
T Consensus       146 ~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~  225 (318)
T d3blha1         146 ANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN  225 (318)
T ss_dssp             GGEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             hheeecCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCC
Confidence            99999999999999999997654321     2234578999999999877767899999999999999999999999999


Q ss_pred             ChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCC--CCChHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 023609          152 DHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFP--NVHPSAIDLVEKMLTFDPRQRITVEDALAH  229 (280)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~L~~dp~~R~t~~ell~h  229 (280)
                      +.......+....+.+..............................++  ..++++++||.+||++||++|||+.|+|+|
T Consensus       226 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H  305 (318)
T d3blha1         226 TEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  305 (318)
T ss_dssp             SHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence            999999999998887776533222111111111111111111111111  247789999999999999999999999999


Q ss_pred             CCCCCCc
Q 023609          230 PYLGSLH  236 (280)
Q Consensus       230 ~~~~~~~  236 (280)
                      |||+...
T Consensus       306 pff~~~p  312 (318)
T d3blha1         306 DFFWSDP  312 (318)
T ss_dssp             GGGSSSS
T ss_pred             hhhccCC
Confidence            9998643

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-45  Score=307.96  Aligned_cols=231  Identities=36%  Similarity=0.640  Sum_probs=187.2

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCc-cHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDT-DLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g-~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++..+     ...++|++++.| +|..++...+.+++..++.++.|++.||+|||++||+||||||+||
T Consensus        58 l~h~niv~~~~~~~~~-----~~~~iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NI  132 (292)
T d1unla_          58 LKHKNIVRLHDVLHSD-----KKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNL  132 (292)
T ss_dssp             CCCTTBCCEEEEEECS-----SEEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred             cCcCCEEeeccccccc-----cceeEEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCccc
Confidence            5899999999999776     779999999985 7777778888999999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCC-ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCC-CCCCChHHHH
Q 023609           80 LLNANCDLKICDFGLARVTSETD-FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL-FPGRDHVHQL  157 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p-f~~~~~~~~~  157 (280)
                      +++.++.++|+|||.+....... ......+++.|+|||.+.....++.++||||+||++++|++|+.| |.+.+..+.+
T Consensus       133 li~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~  212 (292)
T d1unla_         133 LINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL  212 (292)
T ss_dssp             EECTTCCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHH
T ss_pred             ccccCCceeeeecchhhcccCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHH
Confidence            99999999999999998765443 333456678899999987666678999999999999999998876 5677788888


Q ss_pred             HHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCCCCCcC
Q 023609          158 RLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYLGSLHD  237 (280)
Q Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~~~~~~  237 (280)
                      ..+....+.+....+......... ................+.+++++++||++||++||.+|||++|+|+||||+++..
T Consensus       213 ~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~~  291 (292)
T d1unla_         213 KRIFRLLGTPTEEQWPSMTKLPDY-KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP  291 (292)
T ss_dssp             HHHHHHHCCCCTTTCTTGGGSTTC-CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCSC
T ss_pred             HHHHhhcCCCChhhhhhhhhcccc-cccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCCC
Confidence            888888888776544332211100 0000011122344455678999999999999999999999999999999998653

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-46  Score=315.36  Aligned_cols=194  Identities=26%  Similarity=0.400  Sum_probs=162.0

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC-----------------------CCCCHHHHHHHHHHH
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-----------------------QALSEEHCQYFLYQI   57 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-----------------------~~l~~~~~~~i~~ql   57 (280)
                      +|||||++++++.+.     +..|+|||||+ |+|.+++.++                       ..+++.+++.++.||
T Consensus        99 ~HpnIv~l~~~~~~~-----~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi  173 (325)
T d1rjba_          99 SHENIVNLLGACTLS-----GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQV  173 (325)
T ss_dssp             CCTTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHH
T ss_pred             CCCcEeEEEEEEeeC-----CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHH
Confidence            799999999999766     67899999997 6999999754                       248999999999999


Q ss_pred             HHHHHHHHHCCceeccCCCCcEEEccCCCEEEeeccceeeccCCC---ccccceeccccccchhccCCCCCCcchhHHHH
Q 023609           58 LRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSV  134 (280)
Q Consensus        58 l~al~~LH~~gi~H~di~~~nili~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Diwsl  134 (280)
                      +.||+|||++||+||||||+||+++.++.+||+|||+++......   ......+|+.|+|||++.+. .++.++||||+
T Consensus       174 ~~gl~yLH~~~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwS~  252 (325)
T d1rjba_         174 AKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEG-IYTIKSDVWSY  252 (325)
T ss_dssp             HHHHHHHHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHC-CCCHHHHHHHH
T ss_pred             HHHHHHHHhCCeeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCC-CCCcceeccch
Confidence            999999999999999999999999999999999999998654432   22345679999999988544 58999999999


Q ss_pred             HHHHHHHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhh
Q 023609          135 GCIFMELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKML  213 (280)
Q Consensus       135 G~il~~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L  213 (280)
                      ||++|+|++ |.+||.+.+....+..+......++                            .-+.+|+++++||.+||
T Consensus       253 Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~~----------------------------~p~~~~~~l~~li~~cl  304 (325)
T d1rjba_         253 GILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMD----------------------------QPFYATEEIYIIMQSCW  304 (325)
T ss_dssp             HHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCC----------------------------CCTTCCHHHHHHHHHHT
T ss_pred             hHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCC----------------------------CCCcCCHHHHHHHHHHc
Confidence            999999997 8999988766555554443222111                            11257889999999999


Q ss_pred             cCCCCCCCCHHHHhcC
Q 023609          214 TFDPRQRITVEDALAH  229 (280)
Q Consensus       214 ~~dp~~R~t~~ell~h  229 (280)
                      +.||++|||++|+++|
T Consensus       305 ~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         305 AFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             CSSGGGSCCHHHHHHH
T ss_pred             CCChhHCcCHHHHHHH
Confidence            9999999999999875

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.3e-46  Score=309.71  Aligned_cols=197  Identities=21%  Similarity=0.319  Sum_probs=162.7

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      |+|||||++++++..      ...|||||||+ |+|.+++.+.+.+++..+..++.||+.||+|||++||+||||||+||
T Consensus        65 l~HpnIv~~~g~~~~------~~~~lvmE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Ni  138 (277)
T d1xbba_          65 LDNPYIVRMIGICEA------ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNV  138 (277)
T ss_dssp             CCCTTBCCEEEEEES------SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred             CCCCCCceEEEEecc------CCEEEEEEcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhh
Confidence            689999999999843      34799999997 69999999989999999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCCCc----cccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 023609           80 LLNANCDLKICDFGLARVTSETDF----MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHV  154 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~  154 (280)
                      +++.++.++++|||+++.......    .....+|+.|+|||++.+. .++.++||||+||++|+|++ |..||.+.+..
T Consensus       139 ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~  217 (277)
T d1xbba_         139 LLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY-KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS  217 (277)
T ss_dssp             EEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHC-EEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH
T ss_pred             cccccCcccccchhhhhhccccccccccccccCCCceecCchhhcCC-CCCchhhhccchhhhhHHhhCCCCCCCCCCHH
Confidence            999999999999999986543321    2234678999999998544 48899999999999999997 89999988776


Q ss_pred             HHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHh---cCCC
Q 023609          155 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDAL---AHPY  231 (280)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell---~h~~  231 (280)
                      +....+.+....                             ..-+.+|+++.+||.+||+.||++|||+.+++   +|+|
T Consensus       218 ~~~~~i~~~~~~-----------------------------~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~  268 (277)
T d1xbba_         218 EVTAMLEKGERM-----------------------------GCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY  268 (277)
T ss_dssp             HHHHHHHTTCCC-----------------------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred             HHHHHHHcCCCC-----------------------------CCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHH
Confidence            655544321111                             11136789999999999999999999999984   5655


Q ss_pred             CC
Q 023609          232 LG  233 (280)
Q Consensus       232 ~~  233 (280)
                      ++
T Consensus       269 ~~  270 (277)
T d1xbba_         269 YD  270 (277)
T ss_dssp             HH
T ss_pred             hh
Confidence            43

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.1e-45  Score=308.78  Aligned_cols=194  Identities=24%  Similarity=0.369  Sum_probs=154.3

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      |+|||||++++++..+     ..+|+|||||+ |+|.+++... +.+++.++..++.||+.||+|||++|++||||||+|
T Consensus        84 l~HpnIv~l~g~~~~~-----~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~N  158 (299)
T d1jpaa_          84 FDHPNVIHLEGVVTKS-----TPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARN  158 (299)
T ss_dssp             CCCTTBCCEEEEECSS-----SSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred             CCCCCCccEEEEEeeC-----CEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccce
Confidence            6899999999999765     67899999998 6999988764 569999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCCCc------cccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCC
Q 023609           79 LLLNANCDLKICDFGLARVTSETDF------MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGR  151 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~  151 (280)
                      |+++.++.+||+|||+++.......      .....+|+.|+|||.+.+ +.++.++||||+||++|+|++ |..||.+.
T Consensus       159 ILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~  237 (299)
T d1jpaa_         159 ILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQY-RKFTSASDVWSYGIVMWEVMSYGERPYWDM  237 (299)
T ss_dssp             EEECTTCCEEECCC-----------------------CGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred             EEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhc-CCCCcccccccchHHHHHHHhCCCCCCCCC
Confidence            9999999999999999986543321      112356889999999854 458999999999999999997 89999988


Q ss_pred             ChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 023609          152 DHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  229 (280)
Q Consensus       152 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h  229 (280)
                      +..+....+......+.                             ...+++++.+||.+||+.||++|||+.+++++
T Consensus       238 ~~~~~~~~i~~~~~~~~-----------------------------~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         238 TNQDVINAIEQDYRLPP-----------------------------PMDCPSALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             CHHHHHHHHHTTCCCCC-----------------------------CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             CHHHHHHHHHcCCCCCC-----------------------------CccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            87766655543222111                             12578899999999999999999999998864

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=7e-45  Score=309.96  Aligned_cols=229  Identities=28%  Similarity=0.561  Sum_probs=174.9

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   80 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nil   80 (280)
                      .||||++++++|....   ....|+|||||+ ++|.+..   +.+++.+++.++.||+.||+|||++||+||||||+||+
T Consensus        88 ~hpnIv~~~~~~~~~~---~~~~~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NIL  161 (328)
T d3bqca1          88 GGPNIITLADIVKDPV---SRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVM  161 (328)
T ss_dssp             TSTTBCCEEEEEECTT---TCSEEEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred             CCCCCcEEEEEEEecC---CCceeEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceE
Confidence            4999999999986542   257999999998 5776553   56999999999999999999999999999999999999


Q ss_pred             EccCC-CEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC-ChHHHHH
Q 023609           81 LNANC-DLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGR-DHVHQLR  158 (280)
Q Consensus        81 i~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~  158 (280)
                      ++.++ .++|+|||++.............+|+.|+|||.+.+...++.++||||+||++++|++|..||... +......
T Consensus       162 i~~~~~~vkl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~  241 (328)
T d3bqca1         162 IDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV  241 (328)
T ss_dssp             EETTTTEEEECCGGGCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHH
T ss_pred             EcCCCCeeeecccccceeccCCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHH
Confidence            98765 589999999988776655667788999999999877767899999999999999999999998654 4555666


Q ss_pred             HHHHHhCCCCHHHHhHhhHh--HHHHhhhcCcccccc-----ccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCC
Q 023609          159 LLIELIGTPSEAELGFLNEN--AKKYICQLPRYQRQS-----FTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPY  231 (280)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~  231 (280)
                      .+....+.+...........  ...+...........     .......+++++++||++||++||++|||++|+|+|||
T Consensus       242 ~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~  321 (328)
T d3bqca1         242 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY  321 (328)
T ss_dssp             HHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGG
T ss_pred             HHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcc
Confidence            66666654433222111000  000000111111111     11122357899999999999999999999999999999


Q ss_pred             CCCCc
Q 023609          232 LGSLH  236 (280)
Q Consensus       232 ~~~~~  236 (280)
                      |+++.
T Consensus       322 F~~v~  326 (328)
T d3bqca1         322 FYTVV  326 (328)
T ss_dssp             GTTSC
T ss_pred             cCCCC
Confidence            98863

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-45  Score=300.91  Aligned_cols=194  Identities=20%  Similarity=0.339  Sum_probs=153.2

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      ++|||||++++++..+     ...|+||||++ |+|.+++... ..+++..+..++.||+.||+|||++||+||||||+|
T Consensus        57 l~HpnIv~~~g~~~~~-----~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~N  131 (263)
T d1sm2a_          57 LSHPKLVQLYGVCLEQ-----APICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARN  131 (263)
T ss_dssp             CCCTTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGG
T ss_pred             cCCCCcccccceeccC-----CceEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhh
Confidence            6899999999999765     66899999997 7999998754 568999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCCC--ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 023609           79 LLLNANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVH  155 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~  155 (280)
                      |+++.++.+||+|||+++......  ......+|+.|+|||++.+. .++.++||||+||++|+|++ |.+||.+.+..+
T Consensus       132 ill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~  210 (263)
T d1sm2a_         132 CLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFS-RYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE  210 (263)
T ss_dssp             EEECGGGCEEECSCC------------------CTTSCCHHHHTTC-CCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHH
T ss_pred             eeecCCCCeEecccchheeccCCCceeecceecCcccCChHHhcCC-CCCchhhhcchHHHHHHHHHCCCCCCCCCCHHH
Confidence            999999999999999998654432  22345678999999998544 58999999999999999998 567777777666


Q ss_pred             HHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 023609          156 QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  229 (280)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h  229 (280)
                      ....+......+.                             -...++++.+||.+||+.||++|||++++++|
T Consensus       211 ~~~~i~~~~~~~~-----------------------------p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         211 VVEDISTGFRLYK-----------------------------PRLASTHVYQIMNHCWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             HHHHHHHTCCCCC-----------------------------CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHhcCCCCC-----------------------------ccccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence            6555543221111                             02467899999999999999999999999876

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=7.3e-45  Score=302.71  Aligned_cols=204  Identities=23%  Similarity=0.398  Sum_probs=160.1

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNL   79 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~ni   79 (280)
                      ++||||+++++++..... .....|||||||+ |+|.+++...+++++.+++.++.||+.||+|||++||+||||||+||
T Consensus        64 ~~hpniv~~~~~~~~~~~-~~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NI  142 (277)
T d1o6ya_          64 LNHPAIVAVYDTGEAETP-AGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANI  142 (277)
T ss_dssp             CCCTTBCCEEEEEEEECS-SSEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred             cCCCCCCcccceeeeccC-CCceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCccc
Confidence            589999999999876431 1245899999998 59999999888999999999999999999999999999999999999


Q ss_pred             EEccCCCEEEeeccceeeccCC----CccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCChHH
Q 023609           80 LLNANCDLKICDFGLARVTSET----DFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRDHVH  155 (280)
Q Consensus        80 li~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~  155 (280)
                      +++.++..+++|||.+......    .......||+.|+|||++.+ ..++.++||||+||++|+|++|.+||.+.+..+
T Consensus       143 ll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~-~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~  221 (277)
T d1o6ya_         143 MISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARG-DSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVS  221 (277)
T ss_dssp             EEETTSCEEECCCTTCEECC----------------TTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred             ccCccccceeehhhhhhhhccccccccccccccCcccccCHHHHcC-CCCCcceecccchHHHHHHHhCCCCCCCcCHHH
Confidence            9999999999999988754332    12345578999999999854 458999999999999999999999999888776


Q ss_pred             HHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcCCCC
Q 023609          156 QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAHPYL  232 (280)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h~~~  232 (280)
                      ....+......+                          .....+++|+++.+||++||++||.+||+..+.+.|+|.
T Consensus       222 ~~~~~~~~~~~~--------------------------~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~  272 (277)
T d1o6ya_         222 VAYQHVREDPIP--------------------------PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLV  272 (277)
T ss_dssp             HHHHHHHCCCCC--------------------------GGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred             HHHHHHhcCCCC--------------------------CchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHH
Confidence            655554322211                          123345789999999999999999999954444445543

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-44  Score=300.91  Aligned_cols=197  Identities=20%  Similarity=0.320  Sum_probs=164.0

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      |+|||||++++++..      ..+|||||||+ |+|.+++.. ++.+++..+..++.||+.||+|||++||+||||||+|
T Consensus        66 l~HpnIv~l~g~~~~------~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~N  139 (285)
T d1u59a_          66 LDNPYIVRLIGVCQA------EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARN  139 (285)
T ss_dssp             CCCTTBCCEEEEEES------SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred             CCCCCEeeEeeeecc------CeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhh
Confidence            689999999999853      34899999998 699999764 4679999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCCCc----cccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCh
Q 023609           79 LLLNANCDLKICDFGLARVTSETDF----MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDH  153 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~  153 (280)
                      |+++.++.+||+|||+++.......    .....+|+.|+|||++... .++.++||||+||++|+|++ |..||.+.+.
T Consensus       140 ill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~  218 (285)
T d1u59a_         140 VLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFR-KFSSRSDVWSYGVTMWEALSYGQKPYKKMKG  218 (285)
T ss_dssp             EEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHC-EECHHHHHHHHHHHHHHHHTTSCCTTTTCCT
T ss_pred             eeeccCCceeeccchhhhcccccccccccccccccCccccChHHHhCC-CCCccchhhcchHHHHHHHhCCCCCCCCCCH
Confidence            9999999999999999987654321    2234678899999998544 58999999999999999997 8999998877


Q ss_pred             HHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHH---hcCC
Q 023609          154 VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDA---LAHP  230 (280)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~el---l~h~  230 (280)
                      .+....+.+....                             ...+.+|+++.+||.+||+.||++|||+.++   |+|+
T Consensus       219 ~~~~~~i~~~~~~-----------------------------~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~  269 (285)
T d1u59a_         219 PEVMAFIEQGKRM-----------------------------ECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRAC  269 (285)
T ss_dssp             HHHHHHHHTTCCC-----------------------------CCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHcCCCC-----------------------------CCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            6665554321111                             1123678999999999999999999999887   5677


Q ss_pred             CCC
Q 023609          231 YLG  233 (280)
Q Consensus       231 ~~~  233 (280)
                      |+.
T Consensus       270 ~~~  272 (285)
T d1u59a_         270 YYS  272 (285)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            764

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.3e-44  Score=300.71  Aligned_cols=193  Identities=24%  Similarity=0.404  Sum_probs=157.5

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS   77 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~   77 (280)
                      |+|||||++++++.+.     ..+|||||||+ |+|.+++...  ..+++..+..++.||+.||+|||++||+||||||+
T Consensus        70 l~HpnIv~~~~~~~~~-----~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~  144 (287)
T d1opja_          70 IKHPNLVQLLGVCTRE-----PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAAR  144 (287)
T ss_dssp             CCCTTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred             CCCCCEecCCccEeeC-----CeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccC
Confidence            6899999999999765     67899999998 7999998754  56999999999999999999999999999999999


Q ss_pred             cEEEccCCCEEEeeccceeeccCCCc--cccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCC-CCCCChH
Q 023609           78 NLLLNANCDLKICDFGLARVTSETDF--MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL-FPGRDHV  154 (280)
Q Consensus        78 nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p-f~~~~~~  154 (280)
                      ||+++.++.+||+|||+++.......  .....+++.|+|||++.+. .++.++||||+||++|+|++|..| |.+.+..
T Consensus       145 NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~-~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~  223 (287)
T d1opja_         145 NCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYN-KFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS  223 (287)
T ss_dssp             GEEECGGGCEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred             eEEECCCCcEEEccccceeecCCCCceeeccccccccccChHHHcCC-CCCchhhhhhHHHHHHHHHhCCCCCCCcchHH
Confidence            99999999999999999986544322  2334578899999988654 589999999999999999996655 4444444


Q ss_pred             HHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          155 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                      +....+.... .+                            ...+.+++++.+||.+||+.||++|||+.++++
T Consensus       224 ~~~~~i~~~~-~~----------------------------~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~  268 (287)
T d1opja_         224 QVYELLEKDY-RM----------------------------ERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQ  268 (287)
T ss_dssp             HHHHHHHTTC-CC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHhcCC-CC----------------------------CCCccchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence            4333222111 11                            112367899999999999999999999999976

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-44  Score=295.58  Aligned_cols=194  Identities=19%  Similarity=0.314  Sum_probs=164.3

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      ++||||+++++++.++     +.+++||||++ |+|.+++.. ...+++..+..++.|++.||+|||+.||+||||||+|
T Consensus        56 l~HpnIv~~~g~~~~~-----~~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~N  130 (258)
T d1k2pa_          56 LSHEKLVQLYGVCTKQ-----RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARN  130 (258)
T ss_dssp             CCCTTBCCEEEEECCS-----SSEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGG
T ss_pred             cCCCceeeEEEEEeeC-----CceEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCccccccccee
Confidence            5899999999999765     67999999997 799998764 4569999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCCC--ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 023609           79 LLLNANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVH  155 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~  155 (280)
                      |+++.++.+||+|||+++......  ......+|+.|+|||.+.+. .++.++||||+||++|+|++ |+.||.+.+..+
T Consensus       131 ill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~  209 (258)
T d1k2pa_         131 CLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYS-KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE  209 (258)
T ss_dssp             EEECTTCCEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH
T ss_pred             EEEcCCCcEEECcchhheeccCCCceeecccCCCCCcCCcHHhcCC-CCCcceeecccchhhHhHHhcCCCCCCCCCHHH
Confidence            999999999999999997654432  23345688999999998644 58999999999999999998 899999888777


Q ss_pred             HHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 023609          156 QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  229 (280)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h  229 (280)
                      ....+.+....+.+                             ...++++.+||++||+.||++|||+.++++|
T Consensus       210 ~~~~i~~~~~~~~p-----------------------------~~~~~~l~~li~~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         210 TAEHIAQGLRLYRP-----------------------------HLASEKVYTIMYSCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             HHHHHHTTCCCCCC-----------------------------TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHhCCCCCCc-----------------------------ccccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence            76665442221111                             2567899999999999999999999999986

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-45  Score=301.06  Aligned_cols=198  Identities=23%  Similarity=0.389  Sum_probs=161.8

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC--CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN--QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS   77 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~--~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~   77 (280)
                      ++|||||++++++..      ...|+||||++ |+|.+++...  ..+++..+..++.||+.||+|||++||+||||||+
T Consensus        65 l~HpnIv~~~g~~~~------~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~  138 (272)
T d1qpca_          65 LQHQRLVRLYAVVTQ------EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAA  138 (272)
T ss_dssp             CCCTTBCCEEEEECS------SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred             CCCCCEeEEEeeecc------CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchh
Confidence            689999999998743      34799999997 7999987543  35999999999999999999999999999999999


Q ss_pred             cEEEccCCCEEEeeccceeeccCCC--ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhC-CCCCCCCChH
Q 023609           78 NLLLNANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR-KPLFPGRDHV  154 (280)
Q Consensus        78 nili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~  154 (280)
                      ||+++.++.+||+|||+++......  ......+++.|+|||++.. ..++.++||||+||++|+|++| .+||...+..
T Consensus       139 NIll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~-~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~  217 (272)
T d1qpca_         139 NILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINY-GTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP  217 (272)
T ss_dssp             GEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHH-CEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHH
T ss_pred             heeeecccceeeccccceEEccCCccccccccCCcccccChHHHhC-CCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHH
Confidence            9999999999999999998765443  2334568899999999854 4588999999999999999985 5666666665


Q ss_pred             HHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc--CCCC
Q 023609          155 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA--HPYL  232 (280)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~--h~~~  232 (280)
                      +....+......+                             .-+.+++++.+||.+||+.||++|||++++++  ++||
T Consensus       218 ~~~~~i~~~~~~~-----------------------------~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f  268 (272)
T d1qpca_         218 EVIQNLERGYRMV-----------------------------RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF  268 (272)
T ss_dssp             HHHHHHHTTCCCC-----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HHHHHHHhcCCCC-----------------------------CcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhh
Confidence            5555443211111                             11367889999999999999999999999998  7777


Q ss_pred             CC
Q 023609          233 GS  234 (280)
Q Consensus       233 ~~  234 (280)
                      .+
T Consensus       269 ts  270 (272)
T d1qpca_         269 TA  270 (272)
T ss_dssp             HH
T ss_pred             hc
Confidence            53

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-44  Score=296.08  Aligned_cols=193  Identities=25%  Similarity=0.408  Sum_probs=151.8

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      ++|||||++++++.+      +.+|+||||++ |+|.+++.. .+.+++..+..++.||+.||+|||++|++||||||+|
T Consensus        65 l~HpnIv~l~~~~~~------~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~N  138 (273)
T d1mp8a_          65 FDHPHIVKLIGVITE------NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARN  138 (273)
T ss_dssp             CCCTTBCCEEEEECS------SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             CCCCCEeeEEEEEec------CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhh
Confidence            589999999999843      45899999998 689988764 4579999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCCC--ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHH
Q 023609           79 LLLNANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVH  155 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~  155 (280)
                      |+++.++.+||+|||+++......  ......+|+.|+|||++.+. .++.++||||+||++|+|++ |.+||.+.+..+
T Consensus       139 Ill~~~~~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~-~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~  217 (273)
T d1mp8a_         139 VLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR-RFTSASDVWMFGVCMWEILMHGVKPFQGVKNND  217 (273)
T ss_dssp             EEEEETTEEEECC-------------------CCGGGCCHHHHHHC-CCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG
T ss_pred             eeecCCCcEEEccchhheeccCCcceeccceecCcccchhhHhccC-CCCCccccccchHHHHHHHhcCCCCCCCCCHHH
Confidence            999999999999999998654332  22345678999999998544 58999999999999999997 899998887766


Q ss_pred             HHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 023609          156 QLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  229 (280)
Q Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h  229 (280)
                      ....+......                             ...+++|+++.+||.+||+.||.+|||+.+++++
T Consensus       218 ~~~~i~~~~~~-----------------------------~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         218 VIGRIENGERL-----------------------------PMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             HHHHHHTTCCC-----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHcCCCC-----------------------------CCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            65554332111                             1224788999999999999999999999999865

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.8e-44  Score=301.44  Aligned_cols=203  Identities=19%  Similarity=0.362  Sum_probs=166.7

Q ss_pred             CCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE
Q 023609            3 HENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   81 (280)
Q Consensus         3 HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nili   81 (280)
                      ||||+++++++.++     ..+|+||||+. |+|.+++...+.+++..++.++.||+.||+|||++||+||||||+||++
T Consensus        88 ~pnIv~~~~~~~~~-----~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill  162 (322)
T d1vzoa_          88 SPFLVTLHYAFQTE-----TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL  162 (322)
T ss_dssp             CTTBCCEEEEEEET-----TEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE
T ss_pred             CCeEEEeeeeeccC-----CceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceee
Confidence            48999999999776     77999999998 6999999988899999999999999999999999999999999999999


Q ss_pred             ccCCCEEEeeccceeeccCC--CccccceeccccccchhccCCC-CCCcchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 023609           82 NANCDLKICDFGLARVTSET--DFMTEYVVTRWYRAPELLLNSS-DYTAAIDVWSVGCIFMELMDRKPLFPGRDHVHQLR  158 (280)
Q Consensus        82 ~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  158 (280)
                      +.+|.++|+|||+++.....  .......+++.|++||.+.+.. .++.++||||+||++|+|++|..||.+.+......
T Consensus       163 ~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~  242 (322)
T d1vzoa_         163 DSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQA  242 (322)
T ss_dssp             CTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHH
T ss_pred             cCCCCEEEeeccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            99999999999999865432  2344567899999999986543 46789999999999999999999998765433333


Q ss_pred             HHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCC-----CHHHHhcCCCCC
Q 023609          159 LLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRI-----TVEDALAHPYLG  233 (280)
Q Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~-----t~~ell~h~~~~  233 (280)
                      .+......                  ..        ....+.+|+++++||++||++||.+||     |++|+++||||+
T Consensus       243 ~i~~~~~~------------------~~--------~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~  296 (322)
T d1vzoa_         243 EISRRILK------------------SE--------PPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQ  296 (322)
T ss_dssp             HHHHHHHH------------------CC--------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGT
T ss_pred             HHHHhccc------------------CC--------CCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhc
Confidence            32221100                  00        011236789999999999999999999     589999999998


Q ss_pred             CCc
Q 023609          234 SLH  236 (280)
Q Consensus       234 ~~~  236 (280)
                      ++.
T Consensus       297 ~i~  299 (322)
T d1vzoa_         297 KIN  299 (322)
T ss_dssp             TCC
T ss_pred             CCC
Confidence            764

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.4e-43  Score=290.89  Aligned_cols=193  Identities=24%  Similarity=0.379  Sum_probs=151.3

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      |+|||||++++++...     ...++|||||. |++.+.+... +.+++.++..++.||+.||+|||+.||+||||||+|
T Consensus        66 l~H~nIv~~~g~~~~~-----~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~N  140 (283)
T d1mqba_          66 FSHHNIIRLEGVISKY-----KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARN  140 (283)
T ss_dssp             CCCTTBCCEEEEECSS-----SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred             cCCCCEeeeeEEEecC-----CceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccce
Confidence            6899999999999765     67899999997 5888877654 579999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCCC----ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCC-CCCCCCCh
Q 023609           79 LLLNANCDLKICDFGLARVTSETD----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRK-PLFPGRDH  153 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~-~pf~~~~~  153 (280)
                      |+++.++.+||+|||+++......    ......+|+.|+|||++.+ ..++.++||||+||++|+|+++. +|+.+.+.
T Consensus       141 ILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~-~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~  219 (283)
T d1mqba_         141 ILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY-RKFTSASDVWSFGIVMWEVMTYGERPYWELSN  219 (283)
T ss_dssp             EEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHS-CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred             EEECCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHcc-CCCCCcccccccHHHHHHHHhCCCCccccCCH
Confidence            999999999999999998654322    1223457889999998855 45899999999999999999855 55555555


Q ss_pred             HHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          154 VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                      .+....+.+....+.                             ..+++.++.+||.+||+.||++|||+.++++
T Consensus       220 ~~~~~~i~~~~~~~~-----------------------------~~~~~~~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         220 HEVMKAINDGFRLPT-----------------------------PMDCPSAIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             HHHHHHHHTTCCCCC-----------------------------CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHhccCCCCC-----------------------------chhhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence            555444332211111                             1257788999999999999999999999986

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-43  Score=295.73  Aligned_cols=195  Identities=26%  Similarity=0.408  Sum_probs=153.9

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC----------------CCCCHHHHHHHHHHHHHHHHHH
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN----------------QALSEEHCQYFLYQILRGLKYI   64 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~----------------~~l~~~~~~~i~~qll~al~~L   64 (280)
                      +||||+.+++++....    ..+++|||||+ |+|.+++..+                ..+++.++..++.||+.||+||
T Consensus        75 ~h~~iv~~~~~~~~~~----~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~yl  150 (299)
T d1ywna1          75 HHLNVVNLLGACTKPG----GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL  150 (299)
T ss_dssp             CCTTBCCEEEEECSTT----SCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHH
T ss_pred             CCCeEEEeeeeeccCC----CeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHH
Confidence            6999999999986542    56899999998 7999999753                3489999999999999999999


Q ss_pred             HHCCceeccCCCCcEEEccCCCEEEeeccceeeccCCC---ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHH
Q 023609           65 HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL  141 (280)
Q Consensus        65 H~~gi~H~di~~~nili~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l  141 (280)
                      |++||+||||||+||+++.++.+||+|||+++......   ......||+.|+|||++.+. .++.++||||+||++|+|
T Consensus       151 H~~~ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDiwS~Gvil~el  229 (299)
T d1ywna1         151 ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDR-VYTIQSDVWSFGVLLWEI  229 (299)
T ss_dssp             HHTTCCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHH
T ss_pred             HhCCCcCCcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcC-CCCcccceeehHHHHHHH
Confidence            99999999999999999999999999999997643322   23345789999999998654 589999999999999999


Q ss_pred             HhC-CCCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCC
Q 023609          142 MDR-KPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQR  220 (280)
Q Consensus       142 l~g-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R  220 (280)
                      ++| .+||.+....+.+..+......+.                            ..+.++++++++|.+||+.||++|
T Consensus       230 lt~~~~p~~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~l~~li~~cl~~dP~~R  281 (299)
T d1ywna1         230 FSLGASPYPGVKIDEEFCRRLKEGTRMR----------------------------APDYTTPEMYQTMLDCWHGEPSQR  281 (299)
T ss_dssp             HTTSCCSSTTCCCSHHHHHHHHHTCCCC----------------------------CCTTCCHHHHHHHHHHTCSSGGGS
T ss_pred             HhCCCCCCCCCCHHHHHHHHHhcCCCCC----------------------------CCccCCHHHHHHHHHHcCCChhHC
Confidence            986 578877665444443332221111                            113578899999999999999999


Q ss_pred             CCHHHHhcC
Q 023609          221 ITVEDALAH  229 (280)
Q Consensus       221 ~t~~ell~h  229 (280)
                      ||+.|+++|
T Consensus       282 pt~~eil~~  290 (299)
T d1ywna1         282 PTFSELVEH  290 (299)
T ss_dssp             CCHHHHHHH
T ss_pred             cCHHHHHHH
Confidence            999999986

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-43  Score=292.62  Aligned_cols=199  Identities=28%  Similarity=0.423  Sum_probs=158.3

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS--NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS   77 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~--~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~   77 (280)
                      ++|||||++++++.+      ...|+||||+. |+|..++..  .+.+++.++..++.||+.||+|||++||+||||||+
T Consensus        69 l~h~nIv~~~g~~~~------~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~  142 (285)
T d1fmka3          69 LRHEKLVQLYAVVSE------EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAA  142 (285)
T ss_dssp             CCCTTBCCEEEEECS------SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred             cccCCEeEEEEEEec------CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccce
Confidence            689999999999843      34799999998 688888753  356999999999999999999999999999999999


Q ss_pred             cEEEccCCCEEEeeccceeeccCCC--ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhC-CCCCCCCChH
Q 023609           78 NLLLNANCDLKICDFGLARVTSETD--FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR-KPLFPGRDHV  154 (280)
Q Consensus        78 nili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g-~~pf~~~~~~  154 (280)
                      ||+++.++.+||+|||+++......  ......+|+.|+|||.+... .++.++||||+||++|+|++| .+++.+....
T Consensus       143 NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~  221 (285)
T d1fmka3         143 NILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG-RFTIKSDVWSFGILLTELTTKGRVPYPGMVNR  221 (285)
T ss_dssp             GEEECGGGCEEECCCCTTC--------------CCGGGSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHH
T ss_pred             EEEECCCCcEEEcccchhhhccCCCceeeccccccccccChHHHhCC-CCCcHHhhhcchHHHHHHHhCCCCCCCCCCHH
Confidence            9999999999999999998654332  23345689999999998644 589999999999999999985 5556666665


Q ss_pred             HHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc--CCCC
Q 023609          155 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA--HPYL  232 (280)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~--h~~~  232 (280)
                      +.+..+.+....+                             ..+.+++++++||.+||+.||++|||++++++  ++||
T Consensus       222 ~~~~~i~~~~~~~-----------------------------~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~  272 (285)
T d1fmka3         222 EVLDQVERGYRMP-----------------------------CPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  272 (285)
T ss_dssp             HHHHHHHTTCCCC-----------------------------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred             HHHHHHHhcCCCC-----------------------------CCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhh
Confidence            5555443321111                             12367889999999999999999999999998  8999


Q ss_pred             CCC
Q 023609          233 GSL  235 (280)
Q Consensus       233 ~~~  235 (280)
                      .+.
T Consensus       273 ~~~  275 (285)
T d1fmka3         273 TST  275 (285)
T ss_dssp             SCS
T ss_pred             cCC
Confidence            875

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-42  Score=290.83  Aligned_cols=192  Identities=27%  Similarity=0.422  Sum_probs=161.6

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC----------------CCCCHHHHHHHHHHHHHHHHHH
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN----------------QALSEEHCQYFLYQILRGLKYI   64 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~----------------~~l~~~~~~~i~~qll~al~~L   64 (280)
                      +|||||++++++.++     +..|+|||||+ |+|.+++..+                ..+++.++..++.||+.||+||
T Consensus        77 ~HpnIv~~~~~~~~~-----~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~yl  151 (299)
T d1fgka_          77 KHKNIINLLGACTQD-----GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL  151 (299)
T ss_dssp             CCTTBCCEEEEECSS-----SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             CCCeEEecccccccC-----CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHh
Confidence            799999999999765     67999999997 7999999754                3589999999999999999999


Q ss_pred             HHCCceeccCCCCcEEEccCCCEEEeeccceeeccCCC---ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHH
Q 023609           65 HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMEL  141 (280)
Q Consensus        65 H~~gi~H~di~~~nili~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l  141 (280)
                      |+.||+||||||+||+++.++.+||+|||++.......   ......+++.|+|||.+.+ +.++.++||||+||++|+|
T Consensus       152 H~~~ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~-~~y~~k~DiwS~Gvvl~el  230 (299)
T d1fgka_         152 ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEI  230 (299)
T ss_dssp             HHTTCCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHH
T ss_pred             hhCCEEeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcC-CCCCchhhhHHhHHHHHHh
Confidence            99999999999999999999999999999998654432   2334578899999999855 4589999999999999999


Q ss_pred             Hh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCC
Q 023609          142 MD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQR  220 (280)
Q Consensus       142 l~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R  220 (280)
                      ++ |.+||.+.+..+....+.... .+.                            .-+.+++++.+||.+||+.||++|
T Consensus       231 l~~g~~p~~~~~~~~~~~~i~~~~-~~~----------------------------~p~~~~~~l~~li~~cl~~dP~~R  281 (299)
T d1fgka_         231 FTLGGSPYPGVPVEELFKLLKEGH-RMD----------------------------KPSNCTNELYMMMRDCWHAVPSQR  281 (299)
T ss_dssp             HTTSCCSSTTCCHHHHHHHHHTTC-CCC----------------------------CCSSCCHHHHHHHHHHTCSSGGGS
T ss_pred             ccCCCCCCCCCCHHHHHHHHHcCC-CCC----------------------------CCccchHHHHHHHHHHccCCHhHC
Confidence            97 789998877766554443211 111                            113678999999999999999999


Q ss_pred             CCHHHHhc
Q 023609          221 ITVEDALA  228 (280)
Q Consensus       221 ~t~~ell~  228 (280)
                      ||+.|+++
T Consensus       282 ps~~eil~  289 (299)
T d1fgka_         282 PTFKQLVE  289 (299)
T ss_dssp             CCHHHHHH
T ss_pred             cCHHHHHH
Confidence            99999986

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.7e-43  Score=294.65  Aligned_cols=193  Identities=26%  Similarity=0.341  Sum_probs=161.1

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC----------------CCCCHHHHHHHHHHHHHHHHHH
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN----------------QALSEEHCQYFLYQILRGLKYI   64 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~----------------~~l~~~~~~~i~~qll~al~~L   64 (280)
                      +|||||++++++.+.     +..|+||||++ |+|.+++..+                ..+++..+..++.||+.||.||
T Consensus        69 ~HpnIv~~~~~~~~~-----~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~l  143 (309)
T d1fvra_          69 HHPNIINLLGACEHR-----GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYL  143 (309)
T ss_dssp             CCTTBCCEEEEEEET-----TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHH
T ss_pred             CCCCEeeEEEEEecC-----CeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhh
Confidence            699999999999765     67999999998 7999999653                5699999999999999999999


Q ss_pred             HHCCceeccCCCCcEEEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhC
Q 023609           65 HSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR  144 (280)
Q Consensus        65 H~~gi~H~di~~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g  144 (280)
                      |+.|++||||||+||+++.++.+||+|||+++............+|..|+|||.+.+. .++.++||||+||++|+|++|
T Consensus       144 H~~~iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~sDvwSfGvil~ell~~  222 (309)
T d1fvra_         144 SQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYS-VYTTNSDVWSYGVLLWEIVSL  222 (309)
T ss_dssp             HHTTEECSCCSGGGEEECGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHC-EECHHHHHHHHHHHHHHHHTT
T ss_pred             hcCCccccccccceEEEcCCCceEEccccccccccccccccceecCCcccchHHhccC-CCCccceeehhHHHHHHHHhc
Confidence            9999999999999999999999999999999866555444556789999999998654 589999999999999999996


Q ss_pred             C-CCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCH
Q 023609          145 K-PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITV  223 (280)
Q Consensus       145 ~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~  223 (280)
                      . +||.+.+..+....+.+....                             .....+++++.+||.+||+.||++|||+
T Consensus       223 ~~~p~~~~~~~~~~~~i~~~~~~-----------------------------~~~~~~~~~~~~li~~cl~~dP~~RPs~  273 (309)
T d1fvra_         223 GGTPYCGMTCAELYEKLPQGYRL-----------------------------EKPLNCDDEVYDLMRQCWREKPYERPSF  273 (309)
T ss_dssp             SCCTTTTCCHHHHHHHGGGTCCC-----------------------------CCCTTBCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             CCCCCCCCCHHHHHHHHHhcCCC-----------------------------CCCccCCHHHHHHHHHHcCCChhHCcCH
Confidence            5 678877766655544321110                             1113678899999999999999999999


Q ss_pred             HHHhcC
Q 023609          224 EDALAH  229 (280)
Q Consensus       224 ~ell~h  229 (280)
                      .+++++
T Consensus       274 ~eil~~  279 (309)
T d1fvra_         274 AQILVS  279 (309)
T ss_dssp             HHHHHH
T ss_pred             HHHHHH
Confidence            999987

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-43  Score=287.66  Aligned_cols=193  Identities=22%  Similarity=0.367  Sum_probs=152.9

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCC
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ--ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPS   77 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~--~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~   77 (280)
                      |+||||+++++++.++.    +.+|+||||++ |+|.+++.+++  .+++..+..++.||+.||.|||+.+++||||||+
T Consensus        57 l~HpnIv~~~g~~~~~~----~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~  132 (262)
T d1byga_          57 LRHSNLVQLLGVIVEEK----GGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAAR  132 (262)
T ss_dssp             CCCTTBCCEEEEECCC------CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred             CCCCCEeeEEEEEEecC----CcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchH
Confidence            68999999999986532    45799999997 79999997543  5999999999999999999999999999999999


Q ss_pred             cEEEccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChHHH
Q 023609           78 NLLLNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHVHQ  156 (280)
Q Consensus        78 nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~~~  156 (280)
                      ||+++.+|.++++|||.++.....  .....++..|+|||.+.+. .++.++||||+||++|+|++ |.+||.+.+..+.
T Consensus       133 Nil~~~~~~~kl~dfg~s~~~~~~--~~~~~~~~~y~aPE~l~~~-~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~  209 (262)
T d1byga_         133 NVLVSEDNVAKVSDFGLTKEASST--QDTGKLPVKWTAPEALREK-KFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV  209 (262)
T ss_dssp             GEEECTTSCEEECCCCC--------------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGH
T ss_pred             hheecCCCCEeecccccceecCCC--CccccccccCCChHHHhCC-CCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHH
Confidence            999999999999999999865543  2345678899999998654 58999999999999999998 7888887766555


Q ss_pred             HHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 023609          157 LRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  229 (280)
Q Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h  229 (280)
                      ...+.+...                             ....+.+++++++||++||+.||++|||+.+++++
T Consensus       210 ~~~i~~~~~-----------------------------~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~  253 (262)
T d1byga_         210 VPRVEKGYK-----------------------------MDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ  253 (262)
T ss_dssp             HHHHTTTCC-----------------------------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHcCCC-----------------------------CCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence            444422110                             11223678899999999999999999999999873

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-42  Score=287.13  Aligned_cols=193  Identities=22%  Similarity=0.309  Sum_probs=159.1

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      |+||||+++++++.+      ...++|||||+ |++.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|
T Consensus        68 l~H~nIv~~~g~~~~------~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~N  141 (273)
T d1u46a_          68 LDHRNLIRLYGVVLT------PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARN  141 (273)
T ss_dssp             CCCTTBCCEEEEECS------SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred             CCCCCEEEEEEEEee------cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHH
Confidence            689999999999954      34689999997 688887764 4579999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCCCc----cccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCCh
Q 023609           79 LLLNANCDLKICDFGLARVTSETDF----MTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDH  153 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~  153 (280)
                      |+++.++.+||+|||+++.......    .....++..|+|||++.+ ..++.++||||+||++|+|++ |..||.+.+.
T Consensus       142 Ill~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~  220 (273)
T d1u46a_         142 LLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG  220 (273)
T ss_dssp             EEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHH-CEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred             hccccccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhC-CCCCcchhhhhhHHHHHHHHhCCCCCCCCcCH
Confidence            9999999999999999987644321    223356778999999865 458899999999999999997 8999999888


Q ss_pred             HHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhc
Q 023609          154 VHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALA  228 (280)
Q Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~  228 (280)
                      .+....+.+....+                            ...+++|+++++||.+||+.||++|||+.++++
T Consensus       221 ~~~~~~i~~~~~~~----------------------------~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~  267 (273)
T d1u46a_         221 SQILHKIDKEGERL----------------------------PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD  267 (273)
T ss_dssp             HHHHHHHHTSCCCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHhCCCCC----------------------------CCcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            87766654322111                            112367899999999999999999999999863

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-42  Score=292.95  Aligned_cols=193  Identities=24%  Similarity=0.335  Sum_probs=156.7

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      |+|||||++++++.++      ..+++++++. |+|.+.+... ..+++..+..++.||+.||+|||++||+||||||+|
T Consensus        68 l~HpnIv~l~g~~~~~------~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~N  141 (317)
T d1xkka_          68 VDNPHVCRLLGICLTS------TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARN  141 (317)
T ss_dssp             CCCTTBCCEEEEEESS------SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred             CCCCCEeeEEEEEecC------CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhc
Confidence            6899999999999653      3567777775 7898887754 579999999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCCC---ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 023609           79 LLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMD-RKPLFPGRDHV  154 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~-g~~pf~~~~~~  154 (280)
                      |+++.++.+||+|||+++......   ......+|+.|+|||++.+. .++.++||||+||++|+|++ |.+||.+.+..
T Consensus       142 Ill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~-~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~  220 (317)
T d1xkka_         142 VLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHR-IYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS  220 (317)
T ss_dssp             EEEEETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHC-CCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG
T ss_pred             ceeCCCCCeEeeccccceecccccccccccccccCccccChHHHhcC-CCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH
Confidence            999999999999999998654332   12334678999999998654 58999999999999999998 78999887665


Q ss_pred             HHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 023609          155 HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  229 (280)
Q Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h  229 (280)
                      +....+.+....+                             .-+.+++++.+||.+||+.||.+|||+.++++|
T Consensus       221 ~~~~~i~~~~~~~-----------------------------~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  266 (317)
T d1xkka_         221 EISSILEKGERLP-----------------------------QPPICTIDVYMIMVKCWMIDADSRPKFRELIIE  266 (317)
T ss_dssp             GHHHHHHHTCCCC-----------------------------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHcCCCCC-----------------------------CCcccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence            5544443221111                             113678899999999999999999999999987

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.1e-41  Score=284.86  Aligned_cols=193  Identities=22%  Similarity=0.318  Sum_probs=159.3

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC------------------------CCCCHHHHHHHHH
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN------------------------QALSEEHCQYFLY   55 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~------------------------~~l~~~~~~~i~~   55 (280)
                      |+||||+++++++...     ...++||||++ |+|.+++...                        ..+++..+..++.
T Consensus        73 l~h~niv~~~~~~~~~-----~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~  147 (301)
T d1lufa_          73 FDNPNIVKLLGVCAVG-----KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIAR  147 (301)
T ss_dssp             CCCTTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHH
T ss_pred             cCCCCcccceeeeccC-----CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHH
Confidence            5899999999999765     67899999997 7999998643                        2489999999999


Q ss_pred             HHHHHHHHHHHCCceeccCCCCcEEEccCCCEEEeeccceeeccCC---CccccceeccccccchhccCCCCCCcchhHH
Q 023609           56 QILRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSET---DFMTEYVVTRWYRAPELLLNSSDYTAAIDVW  132 (280)
Q Consensus        56 qll~al~~LH~~gi~H~di~~~nili~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Diw  132 (280)
                      ||+.||+|||+.|++||||||+||+++.++.+||+|||+++.....   .......+++.|+|||.+.+ ..++.++|||
T Consensus       148 qi~~gl~ylH~~~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~t~ksDVw  226 (301)
T d1lufa_         148 QVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY-NRYTTESDVW  226 (301)
T ss_dssp             HHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH-CCCCHHHHHH
T ss_pred             HHHHHhhhcccCCeEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHcc-CCCChhhhhc
Confidence            9999999999999999999999999999999999999999754332   12234567889999999864 4589999999


Q ss_pred             HHHHHHHHHHhCC-CCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHH
Q 023609          133 SVGCIFMELMDRK-PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEK  211 (280)
Q Consensus       133 slG~il~~ll~g~-~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~  211 (280)
                      |+||++|+|++|. +||.+.+..+....+.+....                             ...+.+++++.+||.+
T Consensus       227 S~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~~~~~-----------------------------~~p~~~~~~~~~li~~  277 (301)
T d1lufa_         227 AYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNIL-----------------------------ACPENCPLELYNLMRL  277 (301)
T ss_dssp             HHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCC-----------------------------CCCTTCCHHHHHHHHH
T ss_pred             cchhhHHHHHccCCCCCCCCCHHHHHHHHHcCCCC-----------------------------CCCccchHHHHHHHHH
Confidence            9999999999885 788888777766554332111                             1123678999999999


Q ss_pred             hhcCCCCCCCCHHHHhc
Q 023609          212 MLTFDPRQRITVEDALA  228 (280)
Q Consensus       212 ~L~~dp~~R~t~~ell~  228 (280)
                      ||+.||++|||+.|+++
T Consensus       278 cl~~~P~~RPt~~ev~~  294 (301)
T d1lufa_         278 CWSKLPADRPSFCSIHR  294 (301)
T ss_dssp             HTCSSGGGSCCHHHHHH
T ss_pred             HcCCChhHCcCHHHHHH
Confidence            99999999999999964

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-41  Score=283.94  Aligned_cols=193  Identities=27%  Similarity=0.390  Sum_probs=160.4

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCC------------------CCCHHHHHHHHHHHHHHHH
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ------------------ALSEEHCQYFLYQILRGLK   62 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~------------------~l~~~~~~~i~~qll~al~   62 (280)
                      +|||||++++++...     ...|+|||||+ |+|.+++....                  .+++..+..++.||+.||+
T Consensus        85 ~HpnIv~~~g~~~~~-----~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~  159 (311)
T d1t46a_          85 NHMNIVNLLGACTIG-----GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMA  159 (311)
T ss_dssp             CCTTBCCEEEEECSS-----SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHH
T ss_pred             CCCCEEEEEEEEeeC-----CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHH
Confidence            699999999999765     67899999997 69999987543                  5999999999999999999


Q ss_pred             HHHHCCceeccCCCCcEEEccCCCEEEeeccceeeccCCC---ccccceeccccccchhccCCCCCCcchhHHHHHHHHH
Q 023609           63 YIHSANVLHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFM  139 (280)
Q Consensus        63 ~LH~~gi~H~di~~~nili~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~  139 (280)
                      |||++|++||||||+||+++.++.++++|||.++......   ......+|+.|+|||.+.+ ..++.++||||+||++|
T Consensus       160 ~LH~~~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DIwS~G~~l~  238 (311)
T d1t46a_         160 FLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLW  238 (311)
T ss_dssp             HHHHTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHH-CCCCHHHHHHHHHHHHH
T ss_pred             HHHhCCeeecccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcC-CCCCCcccccchHHHHH
Confidence            9999999999999999999999999999999998655432   2334578999999999864 45899999999999999


Q ss_pred             HHHh-CCCCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCC
Q 023609          140 ELMD-RKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPR  218 (280)
Q Consensus       140 ~ll~-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~  218 (280)
                      +|++ |.+||.+......+..+.+....+..                            -...++++.+||.+||+.||.
T Consensus       239 ellt~g~p~~~~~~~~~~~~~~i~~~~~~~~----------------------------~~~~~~~l~~Li~~cl~~dP~  290 (311)
T d1t46a_         239 ELFSLGSSPYPGMPVDSKFYKMIKEGFRMLS----------------------------PEHAPAEMYDIMKTCWDADPL  290 (311)
T ss_dssp             HHHTTTCCSSTTCCSSHHHHHHHHHTCCCCC----------------------------CTTSCHHHHHHHHHHTCSSGG
T ss_pred             HHHhCCCCCCCCCCHHHHHHHHHhcCCCCCC----------------------------cccccHHHHHHHHHHcCCChh
Confidence            9998 67777776665555544433222111                            125788999999999999999


Q ss_pred             CCCCHHHHhc
Q 023609          219 QRITVEDALA  228 (280)
Q Consensus       219 ~R~t~~ell~  228 (280)
                      +|||+.++++
T Consensus       291 ~RPs~~~il~  300 (311)
T d1t46a_         291 KRPTFKQIVQ  300 (311)
T ss_dssp             GSCCHHHHHH
T ss_pred             HCcCHHHHHH
Confidence            9999999985

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-40  Score=280.42  Aligned_cols=199  Identities=24%  Similarity=0.368  Sum_probs=165.2

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcC----------CCCCHHHHHHHHHHHHHHHHHHHHCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSN----------QALSEEHCQYFLYQILRGLKYIHSANV   69 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~----------~~l~~~~~~~i~~qll~al~~LH~~gi   69 (280)
                      ++||||+++++++...     ...++||||+. |+|.+++...          ..+++..+..++.|++.||.|||+++|
T Consensus        80 l~h~nIv~~~~~~~~~-----~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~i  154 (308)
T d1p4oa_          80 FNCHHVVRLLGVVSQG-----QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKF  154 (308)
T ss_dssp             CCCTTBCCEEEEECSS-----SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             cCCCCEeeeeeEEecC-----CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCe
Confidence            5899999999999665     66899999997 7999998632          347899999999999999999999999


Q ss_pred             eeccCCCCcEEEccCCCEEEeeccceeeccCCC---ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhC-C
Q 023609           70 LHRDLKPSNLLLNANCDLKICDFGLARVTSETD---FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDR-K  145 (280)
Q Consensus        70 ~H~di~~~nili~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g-~  145 (280)
                      +||||||+||+++.++.+||+|||+++......   ......+++.|+|||.+.+. .++.++||||+||++|+|++| .
T Consensus       155 vHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~-~~~~~~Dv~S~G~il~El~t~~~  233 (308)
T d1p4oa_         155 VHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDG-VFTTYSDVWSFGVVLWEIATLAE  233 (308)
T ss_dssp             BCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHC-CCCHHHHHHHHHHHHHHHHHTSC
T ss_pred             eeceEcCCceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccC-CCCcccccccHHHHHHHHHhCCC
Confidence            999999999999999999999999998654332   23345789999999998654 478899999999999999997 5


Q ss_pred             CCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHH
Q 023609          146 PLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVED  225 (280)
Q Consensus       146 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e  225 (280)
                      +||.+.+..+.+..+.+....+                             .-+.+++.+.++|.+||+.||++|||+.+
T Consensus       234 ~p~~~~~~~~~~~~i~~~~~~~-----------------------------~p~~~~~~l~~li~~cl~~~P~~RPs~~~  284 (308)
T d1p4oa_         234 QPYQGLSNEQVLRFVMEGGLLD-----------------------------KPDNCPDMLFELMRMCWQYNPKMRPSFLE  284 (308)
T ss_dssp             CTTTTSCHHHHHHHHHTTCCCC-----------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHH
T ss_pred             CCCCCCCHHHHHHHHHhCCCCC-----------------------------CcccchHHHHHHHHHHcCCChhHCcCHHH
Confidence            8888888777666554321111                             11367889999999999999999999999


Q ss_pred             Hhc------CCCCCC
Q 023609          226 ALA------HPYLGS  234 (280)
Q Consensus       226 ll~------h~~~~~  234 (280)
                      +++      +|+|++
T Consensus       285 il~~L~~~~~~~~~~  299 (308)
T d1p4oa_         285 IISSIKEEMEPGFRE  299 (308)
T ss_dssp             HHHHHGGGSCTTHHH
T ss_pred             HHHHHHHhcCCCCcC
Confidence            998      666654

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-40  Score=280.06  Aligned_cols=195  Identities=23%  Similarity=0.303  Sum_probs=154.2

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQ-ALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~-~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      |+||||+++++++....    +..++|||||+ |+|.+++.... .+++..+..++.|++.||.|||+.||+||||||+|
T Consensus        85 l~HpnIv~~~g~~~~~~----~~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~N  160 (311)
T d1r0pa_          85 FSHPNVLSLLGICLRSE----GSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARN  160 (311)
T ss_dssp             CCCTTBCCCCEEEEETT----TEEEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred             CCCCCEeEEeEEEEecC----CceEEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHh
Confidence            68999999999975432    56899999998 69999887544 58889999999999999999999999999999999


Q ss_pred             EEEccCCCEEEeeccceeeccCCC-----ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC-
Q 023609           79 LLLNANCDLKICDFGLARVTSETD-----FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPGRD-  152 (280)
Q Consensus        79 ili~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-  152 (280)
                      |+++.++.+||+|||+++......     ......+|+.|+|||.+.. ..++.++||||+|+++|+|++|..||.... 
T Consensus       161 ILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~ksDI~SfGivl~El~t~~~p~~~~~~  239 (311)
T d1r0pa_         161 CMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQT-QKFTTKSDVWSFGVLLWELMTRGAPPYPDVN  239 (311)
T ss_dssp             EEECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHH-CCCCHHHHHHHHHHHHHHHHTTSCCSCC---
T ss_pred             EeECCCCCEEEecccchhhccccccccceecccccccccccChHHHhc-CCCCChhHhhhhHHHHHHHHHCCCCCCCCCC
Confidence            999999999999999998654332     1223467899999998854 458999999999999999999776665432 


Q ss_pred             hHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHHHhcC
Q 023609          153 HVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVEDALAH  229 (280)
Q Consensus       153 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~ell~h  229 (280)
                      ..+....+... ..+                            ..-+.+++++.+||.+||+.||++|||+.|+++|
T Consensus       240 ~~~~~~~i~~g-~~~----------------------------~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         240 TFDITVYLLQG-RRL----------------------------LQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             ---CHHHHHTT-CCC----------------------------CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHcC-CCC----------------------------CCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            22222222111 000                            0113567899999999999999999999999997

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.4e-40  Score=275.05  Aligned_cols=216  Identities=19%  Similarity=0.278  Sum_probs=150.4

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCC-ccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHH--------CCcee
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMD-TDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHS--------ANVLH   71 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~-g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~--------~gi~H   71 (280)
                      ++||||+++++++.... .....+|+|||||. |+|.+++++. .+++..+..++.|++.||+|||+        .||+|
T Consensus        54 ~~HpnIv~~~~~~~~~~-~~~~~~~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvH  131 (303)
T d1vjya_          54 LRHENILGFIAADNKDN-GTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAH  131 (303)
T ss_dssp             CCCTTBCCEEEEEEEEC-SSSEEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEEC
T ss_pred             CCCCcCcceEEEEEeCC-CcceEEEEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeec
Confidence            47999999999987653 22246899999997 6999999864 69999999999999999999996        59999


Q ss_pred             ccCCCCcEEEccCCCEEEeeccceeeccCCC-----ccccceeccccccchhccCCC-----CCCcchhHHHHHHHHHHH
Q 023609           72 RDLKPSNLLLNANCDLKICDFGLARVTSETD-----FMTEYVVTRWYRAPELLLNSS-----DYTAAIDVWSVGCIFMEL  141 (280)
Q Consensus        72 ~di~~~nili~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~-----~~~~~~DiwslG~il~~l  141 (280)
                      |||||+||+++.++.+||+|||++.......     ......||+.|+|||++.+..     .++.++||||+||++|+|
T Consensus       132 rDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el  211 (303)
T d1vjya_         132 RDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI  211 (303)
T ss_dssp             SCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHH
T ss_pred             cccCccceEEcCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHH
Confidence            9999999999999999999999998654332     223457899999999985432     145689999999999999


Q ss_pred             HhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccC--CCCChHHHHHHHHhhcCCCCC
Q 023609          142 MDRKPLFPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKF--PNVHPSAIDLVEKMLTFDPRQ  219 (280)
Q Consensus       142 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~L~~dp~~  219 (280)
                      ++|.+||......+..... .....+...       ..........  ....+....  ......+.+|+.+||+.||++
T Consensus       212 ~tg~~~~~~~~~~~~~~~~-~~~~~~~~~-------~~~~~~~~~~--~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~  281 (303)
T d1vjya_         212 ARRCSIGGIHEDYQLPYYD-LVPSDPSVE-------EMRKVVCEQK--LRPNIPNRWQSCEALRVMAKIMRECWYANGAA  281 (303)
T ss_dssp             HHTBCBTTBCCCCCCTTTT-TSCSSCCHH-------HHHHHHTTSC--CCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGG
T ss_pred             hhCCCCCCcccccccchhh-cccccchHH-------HHHHHHhccc--cCCCCCcccCChHHHHHHHHHHHHHcccCHhH
Confidence            9998877432211000000 000000000       0000000000  000011111  112345889999999999999


Q ss_pred             CCCHHHHhc
Q 023609          220 RITVEDALA  228 (280)
Q Consensus       220 R~t~~ell~  228 (280)
                      |||+.|+++
T Consensus       282 Rps~~ei~~  290 (303)
T d1vjya_         282 RLTALRIKK  290 (303)
T ss_dssp             SCCHHHHHH
T ss_pred             CcCHHHHHH
Confidence            999999976

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.4e-38  Score=267.49  Aligned_cols=206  Identities=16%  Similarity=0.174  Sum_probs=153.7

Q ss_pred             CCCCCeeee-eceecCCCCCCCCcEEEEeecCCccHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCc
Q 023609            1 MDHENVVAI-RDIIPPPQRESFNDVYIAYELMDTDLHQIIRS-NQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSN   78 (280)
Q Consensus         1 l~HpnIv~~-~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~-~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~n   78 (280)
                      ++|+|++.. .+++...     ...++||||++++|.+.+.. .+.+++..+..++.|++.||+|||++||+||||||+|
T Consensus        59 l~~~~~i~~~~~~~~~~-----~~~~ivme~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~N  133 (299)
T d1ckia_          59 MQGGVGIPTIRWCGAEG-----DYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDN  133 (299)
T ss_dssp             STTSTTCCCEEEEEEET-----TEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred             ccCCCcccEEEEEEecC-----CEEEEEEEEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhh
Confidence            456665544 4444433     67899999999988887764 4579999999999999999999999999999999999


Q ss_pred             EEEc---cCCCEEEeeccceeeccCCC--------ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCC
Q 023609           79 LLLN---ANCDLKICDFGLARVTSETD--------FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPL  147 (280)
Q Consensus        79 ili~---~~~~~~l~dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p  147 (280)
                      |+++   .+..++++|||+++......        ......||+.|+|||++.+. .++.++||||+||++|+|++|..|
T Consensus       134 Il~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~~l~el~tg~~P  212 (299)
T d1ckia_         134 FLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGI-EQSRRDDLESLGYVLMYFNLGSLP  212 (299)
T ss_dssp             EEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTB-CCCHHHHHHHHHHHHHHHHHSSCT
T ss_pred             ccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCC-CCCChhhEEecCHHHHHHHhCCCc
Confidence            9975   45679999999998754432        12345789999999998654 489999999999999999999999


Q ss_pred             CCCCChHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHH---
Q 023609          148 FPGRDHVHQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVE---  224 (280)
Q Consensus       148 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~---  224 (280)
                      |.+.........+......                      ..........+++|+++.++|.+||+.||++||++.   
T Consensus       213 ~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~  270 (299)
T d1ckia_         213 WQGLKAATKRQKYERISEK----------------------KMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLR  270 (299)
T ss_dssp             TCCCC-------HHHHHHH----------------------HHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHH
T ss_pred             ccccchHHHHHHHHHhhcc----------------------cCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHH
Confidence            9876554433322211100                      000111233457899999999999999999999987   


Q ss_pred             HHhcCCCCCC
Q 023609          225 DALAHPYLGS  234 (280)
Q Consensus       225 ell~h~~~~~  234 (280)
                      ++|+|+|.+.
T Consensus       271 ~~l~~~~~~~  280 (299)
T d1ckia_         271 QLFRNLFHRQ  280 (299)
T ss_dssp             HHHHHHHHHH
T ss_pred             HHHHHHHHHc
Confidence            4567776543

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.4e-37  Score=260.30  Aligned_cols=195  Identities=13%  Similarity=0.162  Sum_probs=156.5

Q ss_pred             CCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHcC-CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEEE
Q 023609            3 HENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSN-QALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLLL   81 (280)
Q Consensus         3 HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~-~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nili   81 (280)
                      |+||+.+++++...     ...|+||||++++|.+++... ..+++..+..++.|++.||+|||++||+||||||+||++
T Consensus        60 ~~~i~~~~~~~~~~-----~~~~~vme~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili  134 (293)
T d1csna_          60 CTGIPNVYYFGQEG-----LHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLI  134 (293)
T ss_dssp             CTTCCCEEEEEEET-----TEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEE
T ss_pred             CCCCCEEEEEeecC-----CccEEEEEecCCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceee
Confidence            58999999998665     778999999999999999765 469999999999999999999999999999999999999


Q ss_pred             cc-----CCCEEEeeccceeeccCCC--------ccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCC
Q 023609           82 NA-----NCDLKICDFGLARVTSETD--------FMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLF  148 (280)
Q Consensus        82 ~~-----~~~~~l~dfg~~~~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf  148 (280)
                      +.     ++.++|+|||+++......        ......||+.|+|||++.+ ..++.++||||+||++|+|++|..||
T Consensus       135 ~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~-~~~~~~~DiwSlG~~l~elltg~~Pf  213 (293)
T d1csna_         135 GRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPW  213 (293)
T ss_dssp             CCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTT-CCCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred             cCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcC-CCCChHHHHHHhhHHHHHHHhCCCcC
Confidence            64     5789999999998654321        1234578999999999865 45899999999999999999999999


Q ss_pred             CCCChH---HHHHHHHHHhCCCCHHHHhHhhHhHHHHhhhcCccccccccccCCCCChHHHHHHHHhhcCCCCCCCCHHH
Q 023609          149 PGRDHV---HQLRLLIELIGTPSEAELGFLNENAKKYICQLPRYQRQSFTEKFPNVHPSAIDLVEKMLTFDPRQRITVED  225 (280)
Q Consensus       149 ~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e  225 (280)
                      .+....   .....+......+                         ...+..+++|+++.+++..|+..+|++||+...
T Consensus       214 ~~~~~~~~~~~~~~i~~~~~~~-------------------------~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~  268 (293)
T d1csna_         214 QGLKAATNKQKYERIGEKKQST-------------------------PLRELCAGFPEEFYKYMHYARNLAFDATPDYDY  268 (293)
T ss_dssp             SSCCSCCHHHHHHHHHHHHHHS-------------------------CHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHH
T ss_pred             CCccchhHHHHHHHHHhccCCC-------------------------ChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHH
Confidence            765432   2222222211111                         112334578899999999999999999999876


Q ss_pred             Hhc
Q 023609          226 ALA  228 (280)
Q Consensus       226 ll~  228 (280)
                      +.+
T Consensus       269 l~~  271 (293)
T d1csna_         269 LQG  271 (293)
T ss_dssp             HHH
T ss_pred             HHH
Confidence            654

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.1e-37  Score=268.53  Aligned_cols=229  Identities=24%  Similarity=0.411  Sum_probs=164.0

Q ss_pred             CCCCeeeeeceecCCCCCCCCcEEEEeecC--CccHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHH-CCceeccCCC
Q 023609            2 DHENVVAIRDIIPPPQRESFNDVYIAYELM--DTDLHQIIR--SNQALSEEHCQYFLYQILRGLKYIHS-ANVLHRDLKP   76 (280)
Q Consensus         2 ~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~--~g~L~~~l~--~~~~l~~~~~~~i~~qll~al~~LH~-~gi~H~di~~   76 (280)
                      .||||+++++++.....   ...++++.++  .++......  ....+++..++.++.||+.||+|||+ .||+||||||
T Consensus        78 ~~~~iv~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp  154 (362)
T d1q8ya_          78 GANHILKLLDHFNHKGP---NGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKP  154 (362)
T ss_dssp             HHTTBCCCCEEEEEEET---TEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSG
T ss_pred             CcCceEEEEEEeeeccc---cceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCCh
Confidence            47999999999855322   3455555555  344443333  34579999999999999999999998 8999999999


Q ss_pred             CcEEEccCCC------EEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Q 023609           77 SNLLLNANCD------LKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCIFMELMDRKPLFPG  150 (280)
Q Consensus        77 ~nili~~~~~------~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~  150 (280)
                      +||+++.++.      ++++|||.+......  .....+|+.|+|||++... .++.++|+||+||++++|++|+.||..
T Consensus       155 ~NIll~~~~~~~~~~~~kl~dfg~s~~~~~~--~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~el~~g~~pF~~  231 (362)
T d1q8ya_         155 ENVLMEIVDSPENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGA-PWGCGADIWSTACLIFELITGDFLFEP  231 (362)
T ss_dssp             GGEEEEEEETTTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTC-CCCTHHHHHHHHHHHHHHHHSSCCC--
T ss_pred             hHeeeeccCcccccceeeEeecccccccccc--cccccccccccChhhcccc-CCCccccccchHHHHHHHHHCCCCCCC
Confidence            9999987654      899999998865443  3466899999999998654 478999999999999999999999974


Q ss_pred             CC------hHHHHHHHHHHhCCCCHHHHhHhhHhHHHHhhh------cCcccccc-------ccccCCCCChHHHHHHHH
Q 023609          151 RD------HVHQLRLLIELIGTPSEAELGFLNENAKKYICQ------LPRYQRQS-------FTEKFPNVHPSAIDLVEK  211 (280)
Q Consensus       151 ~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~-------~~~~~~~~~~~~~~li~~  211 (280)
                      ..      ..+.+......++.++......... ...+...      ........       .....+..++++++||.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~  310 (362)
T d1q8ya_         232 DEGHSYTKDDDHIAQIIELLGELPSYLLRNGKY-TRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSP  310 (362)
T ss_dssp             -------CHHHHHHHHHHHHCSCCHHHHHHCTT-HHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGG
T ss_pred             CccccccchhHHHHHHHHHhCCCCHHHhhcccc-cccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHH
Confidence            42      4456677777778776544322111 1111110      00000000       001112346789999999


Q ss_pred             hhcCCCCCCCCHHHHhcCCCCCCCcC
Q 023609          212 MLTFDPRQRITVEDALAHPYLGSLHD  237 (280)
Q Consensus       212 ~L~~dp~~R~t~~ell~h~~~~~~~~  237 (280)
                      ||++||.+|||+.|+|+||||++...
T Consensus       311 mL~~dP~~Rpta~e~L~Hp~f~~~~~  336 (362)
T d1q8ya_         311 MLQLDPRKRADAGGLVNHPWLKDTLG  336 (362)
T ss_dssp             GGCSSTTTCBCHHHHHTCGGGTTCTT
T ss_pred             HCCCChhHCcCHHHHhcCcccCCCCC
Confidence            99999999999999999999996643

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.65  E-value=1.8e-17  Score=128.67  Aligned_cols=118  Identities=18%  Similarity=0.124  Sum_probs=79.9

Q ss_pred             CCCCCeeeeeceecCCCCCCCCcEEEEeecCCccHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCCCcEE
Q 023609            1 MDHENVVAIRDIIPPPQRESFNDVYIAYELMDTDLHQIIRSNQALSEEHCQYFLYQILRGLKYIHSANVLHRDLKPSNLL   80 (280)
Q Consensus         1 l~HpnIv~~~~~~~~~~~~~~~~~~iv~e~~~g~L~~~l~~~~~l~~~~~~~i~~qll~al~~LH~~gi~H~di~~~nil   80 (280)
                      +.|++++..+++.         ..+++|||+++...      ..++...+..++.|++.++++||++||+||||||+||+
T Consensus        71 l~~~~v~~~~~~~---------~~~lvme~~~~~~~------~~l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NIL  135 (191)
T d1zara2          71 LQGLAVPKVYAWE---------GNAVLMELIDAKEL------YRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVL  135 (191)
T ss_dssp             TTTSSSCCEEEEE---------TTEEEEECCCCEEG------GGCCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEE
T ss_pred             ccCCCcceEEEec---------CCEEEEEeeccccc------cchhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhhee
Confidence            3567777766553         13799999996322      12555667789999999999999999999999999999


Q ss_pred             EccCCCEEEeeccceeeccCCCccccceeccccccchhccCCCCCCcchhHHHHHHH
Q 023609           81 LNANCDLKICDFGLARVTSETDFMTEYVVTRWYRAPELLLNSSDYTAAIDVWSVGCI  137 (280)
Q Consensus        81 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i  137 (280)
                      ++.++ ++|+|||.+...+.+........... .-.+.+  .+.++.++|+||+.--
T Consensus       136 v~~~~-~~liDFG~a~~~~~~~~~~~l~rd~~-~~~~~f--~r~y~~~~d~~s~~~~  188 (191)
T d1zara2         136 VSEEG-IWIIDFPQSVEVGEEGWREILERDVR-NIITYF--SRTYRTEKDINSAIDR  188 (191)
T ss_dssp             EETTE-EEECCCTTCEETTSTTHHHHHHHHHH-HHHHHH--HHHHCCCCCHHHHHHH
T ss_pred             eeCCC-EEEEECCCcccCCCCCcHHHHHHHHH-HHHHHH--cCCCCCcccHHHHHHH
Confidence            98655 89999999977654421100000000 001112  1346788999997543

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=97.16  E-value=0.00034  Score=54.83  Aligned_cols=29  Identities=24%  Similarity=0.273  Sum_probs=24.5

Q ss_pred             ceeccCCCCcEEEccCCCEEEeeccceee
Q 023609           69 VLHRDLKPSNLLLNANCDLKICDFGLARV   97 (280)
Q Consensus        69 i~H~di~~~nili~~~~~~~l~dfg~~~~   97 (280)
                      ++|+|+.|.||+++.++.+.|+||+.+..
T Consensus       185 l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         185 FSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             EECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             EEEeeccCcceeecCCceEEEeechhccc
Confidence            78999999999998776667999986643

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=95.52  E-value=0.0084  Score=49.77  Aligned_cols=30  Identities=20%  Similarity=0.296  Sum_probs=25.6

Q ss_pred             CceeccCCCCcEEEccCCCEEEeeccceeec
Q 023609           68 NVLHRDLKPSNLLLNANCDLKICDFGLARVT   98 (280)
Q Consensus        68 gi~H~di~~~nili~~~~~~~l~dfg~~~~~   98 (280)
                      .++|||+++.||+++.++ ++++||..+...
T Consensus       224 ~LiHGDl~~gNIlv~~~~-~~vID~E~a~~G  253 (392)
T d2pula1         224 TLIHGDLHTGSIFASEHE-TKVIDPEFAFYG  253 (392)
T ss_dssp             EEECSCCCGGGEEECSSC-EEECCCTTCEEE
T ss_pred             ceeccCCcCCceeEcCCc-eEEechhhcccC
Confidence            589999999999998765 899999877654

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=94.66  E-value=0.0045  Score=49.62  Aligned_cols=30  Identities=30%  Similarity=0.344  Sum_probs=26.6

Q ss_pred             CCceeccCCCCcEEEccCCCEEEeecccee
Q 023609           67 ANVLHRDLKPSNLLLNANCDLKICDFGLAR   96 (280)
Q Consensus        67 ~gi~H~di~~~nili~~~~~~~l~dfg~~~   96 (280)
                      .|++|+|+.++|++++.+....++||+.+.
T Consensus       183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccccCCcchhhhhcccccceeEecccccc
Confidence            479999999999999988777899999764

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=92.54  E-value=0.021  Score=43.79  Aligned_cols=29  Identities=24%  Similarity=0.204  Sum_probs=24.8

Q ss_pred             ceeccCCCCcEEEccCCCEEEeeccceee
Q 023609           69 VLHRDLKPSNLLLNANCDLKICDFGLARV   97 (280)
Q Consensus        69 i~H~di~~~nili~~~~~~~l~dfg~~~~   97 (280)
                      ++|+|+.|.||+++.++.+.++||+.+..
T Consensus       177 liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         177 VTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             EECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             EEeCCCCCcceEEeCCceEEEEEchhccc
Confidence            79999999999998876678999986643

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=91.32  E-value=0.094  Score=41.84  Aligned_cols=29  Identities=28%  Similarity=0.249  Sum_probs=23.3

Q ss_pred             CCceeccCCCCcEEEccCCCEEEeeccceee
Q 023609           67 ANVLHRDLKPSNLLLNANCDLKICDFGLARV   97 (280)
Q Consensus        67 ~gi~H~di~~~nili~~~~~~~l~dfg~~~~   97 (280)
                      .+++|+|+++.||+++. + ..++||+.+..
T Consensus       192 ~~liHgDlh~~NvL~~~-~-~~~IDFdd~~~  220 (325)
T d1zyla1         192 VLRLHGDCHAGNILWRD-G-PMFVDLDDARN  220 (325)
T ss_dssp             CEECCSSCSGGGEEESS-S-EEECCCTTCCE
T ss_pred             ceeecCCCCcccEEEeC-C-ceEEechhccc
Confidence            36899999999999964 3 45899987754